PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Takahashi, T; Nakajima, K; Miyazaki, Y; Miyazaki, Y; Kurokawa, Y; Yamasaki, M; Miyata, H; Takiguchi, S; Nishida, T; Mori, M; Doki, Y				Takahashi, Tsuyoshi; Nakajima, Kiyokazu; Miyazaki, Yasuaki; Miyazaki, Yasuhiro; Kurokawa, Yukinori; Yamasaki, Makoto; Miyata, Hiroshi; Takiguchi, Shuji; Nishida, Toshirou; Mori, Masaki; Doki, Yuichiro			Surgical Strategy for the Gastric Gastrointestinal Stromal Tumors (GISTs) Larger Than 5 cm: Laparoscopic Surgery is Feasible, Safe, and Oncologically Acceptable	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						gastrointestinal stromal tumor; laparoscopic surgery; gastric GIST; large GIST; minimal invasive surgery; intraoperative judgment	OPEN RESECTION; OUTCOMES; STOMACH	Background: The efficacy and feasibility of laparoscopic surgery (LAP) for gastric GISTs > 5cm has not been adequately assessed. Here we investigated the clinical outcomes of these patients. Patients and Methods: Twenty-seven consecutive patients who underwent resection for gastric GISTs > 5cm were enrolled in this retrospective study. We assessed the tumor characteristics, surgical outcomes, tumor recurrence, and patient survival in the open surgery (OPEN) group and in the LAP group. Results: The tumor size in the OPEN group was larger than that in the LAP group, but there were no differences in the mitotic count. There were no differences in operative complications. Finally, there were no differences in the disease-free and no patients in the LAP group died. Conclusions: In patients with gastric GISTs > 5cm, LAP can be performed with outcomes equivalent to those of OPEN if patient selection and intraoperative judgment are appropriate.	[Takahashi, Tsuyoshi; Nakajima, Kiyokazu; Miyazaki, Yasuaki; Miyazaki, Yasuhiro; Kurokawa, Yukinori; Yamasaki, Makoto; Miyata, Hiroshi; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Nishida, Toshirou] Osaka Police Hosp, Dept Surg, Osaka, Japan	Nakajima, K (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, 2-2,E-2, Suita, Osaka 5650871, Japan.	knakajima@gesurg.med.osaka-u.ac.jp			Novartis	N.T. has had a research grant from the Novartis and has received honoraria to disclose from the Novartis, Pfizer, and Bayer within past 2 years. The remaining authors declare no conflicts of interest.	De Vogelaere K, 2013, SURG ENDOSC, V27, P1546, DOI 10.1007/s00464-012-2622-8; Otani Y, 2006, SURGERY, V139, P484, DOI 10.1016/j.surg.2005.08.011; Rutkowski P, 2011, EJSO-EUR J SURG ONC, V37, P890, DOI 10.1016/j.ejso.2011.06.005; Karakousis GC, 2011, ANN SURG ONCOL, V18, P1599, DOI 10.1245/s10434-010-1517-y; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Takahashi T, 2007, INT J CLIN ONCOL, V12, P369, DOI 10.1007/s10147-007-0705-7; Novitsky YW, 2006, ANN SURG, V243, P738, DOI 10.1097/01.sla.0000219739.11758.27; Nishimura J, 2007, SURG ENDOSC, V21, P875, DOI 10.1007/s00464-006-9065-z; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Demetri George D, 2005, J Natl Compr Canc Netw, V3, P158; Hohenberger P, 2010, BRIT J SURG, V97, P1854, DOI 10.1002/bjs.7222; Yano Hiroshi, 2005, Gastric Cancer, V8, P186, DOI 10.1007/s10120-005-0333-8	12	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	APR	2015	25	2					114	118				5	Surgery	Surgery	CF0JV	WOS:000352230800015		
J	Ishihara, S; Matsuda, K; Tanaka, T; Tanaka, J; Kiyomatsu, T; Kawai, K; Nozawa, H; Kazama, S; Kanazawa, T; Yamaguchi, H; Sunami, E; Kitayama, J; Hashiguchi, Y; Watanabe, T				Ishihara, Soichiro; Matsuda, Keiji; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Kawai, Kazushige; Nozawa, Hiroaki; Kazama, Shinsuke; Kanazawa, Takamitsu; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Hashiguchi, Yojiro; Watanabe, Toshiaki			Patient Factors Predisposing to Complications Following Laparoscopic Surgery for Colorectal Cancers	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						colorectal cancer; laparoscopic surgery; complication; risk factor	MRC CLASICC TRIAL; COLON-CANCER; SHORT-TERM; IMPACT; COLECTOMY; OUTCOMES	The aim of this study was to clarify patient factors contributing to complications after laparoscopic surgery for colorectal cancers. A total of 333 colorectal cancer patients who underwent laparoscopic colorectal resection between January 2007 and December 2012 were enrolled. The association between patient factors and the incidence of complications were analyzed. Postoperative complications were divided into 2 categories: infectious complications and noninfectious complications. The overall complication rate was 13% and mortality rate 0%. Multivariate analysis showed that body mass index > 25 kg/m(2) [odds ratio (OR) = 3.02, P = 0.0254] and tumor location (right colon cancer/rectal cancer: OR = 0.11, P = 0.0083) were risk factors for infectious complications; in addition, male sex (OR = 3.91, P = 0.0102) and cancer stage (stage 2/stage 4: OR = 0.17, P = 0.0247) were risk factors for noninfectious complications. This study shows that different patient factors are associated with the risk of different types of complications.	[Ishihara, Soichiro; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Kawai, Kazushige; Nozawa, Hiroaki; Kazama, Shinsuke; Kanazawa, Takamitsu; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, Tokyo 113, Japan; [Matsuda, Keiji; Hashiguchi, Yojiro] Teikyo Univ, Dept Surg, Itabashi Ku, Tokyo 173, Japan	Ishihara, S (reprint author), Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	sochan31@hotmail.com					Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Lascano CA, 2006, AM J SURG, V192, P357, DOI 10.1016/j.amjsurg.2006.04.011; Feroci F, 2013, SURG ENDOSC, V27, P1130, DOI 10.1007/s00464-012-2559-y; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Ata A, 2010, AM SURGEON, V76, P697; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Allaix ME, 2013, SURG ENDOSC, V27, P4596, DOI 10.1007/s00464-013-3072-7; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Denost Q, 2013, COLORECTAL DIS, V15, P463, DOI 10.1111/codi.12026; Drosdeck J, 2013, SURG ENDOSC, V27, P4574, DOI 10.1007/s00464-013-3126-x; Hida K, 2009, WORLD J SURG, V33, P1733, DOI 10.1007/s00268-009-0055-x; Bonjer HJ, 2005, SURG ENDOSC, V19, P687, DOI 10.1007/s00464-004-8920-z; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Tashiro J, 2012, HEPATO-GASTROENTEROL, V59, P2173, DOI 10.5754/hge12110; Watanabe J, 2014, INT J COLORECTAL DIS, V29, P343, DOI 10.1007/s00384-013-1803-9	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	APR	2015	25	2					168	172				5	Surgery	Surgery	CF0JV	WOS:000352230800025		
J	Zhu, D; Nakamura, H; Zhu, HS; Xu, CY; Matsuo, M				Zhu, Dan; Nakamura, Hitomi; Zhu, Hongshu; Xu, Chunye; Matsuo, Masaru			Microfibers from interpolymer complexation of kappa-carrageenan and oligomers of polyaniline for glucose detection	SYNTHETIC METALS			English	Article						Conductive polymer; Polysaccharide; Interpolymer complexation; Self-assembly; Biosensor	CARBON NANOTUBES; CONDUCTING POLYANILINE; ACID; POLYSACCHARIDES; NANOFIBERS; DEPENDENCE; BIOSENSOR; FILM	The molecular order and orientation significantly influence the physical properties of conjugated polymers and the corresponding performance in electronic devices. The precise synthesis and characterization are the challenges to obtain high quality polymer crystalline micro/nanostructures, on the basis of which, the charge transport mechanisms can be discussed and the device performance can be improved. A micro-fibrous complex of conductive polymer and natural polysaccharide has been formed during the in situ polymerization of aniline in the aqueous solution of kappa-carrageenan. With the template of the polyanion, aniline is polymerized and polyaniline (PAN!) chain grows in the vicinity of sulfonic acid groups. Through the comprehensive characterizations of UV-vis spectra, wide-angle X-ray diffraction, and thermal gravimetric analysis, the assembly structure of the interpolymer complex has been illuminated, i.e., oligomers of PANI with expanded conformation are formed, the electrostatic interaction between the protonated PANI oligomers and anionic kappa-carrageenan makes the chains of PAN! and kappa-carrageenan bound together, and a micro-fibrous complex is formed with enhanced orientation of both PANI and kappa-carrageenan, leading to an enhanced conductivity of the complex. The glucose biosensor made of the complex shows high detecting sensitivity and broad linear range in the recognition of the glucose due to its high conductivity and good compatibility with the enzyme. (C) 2015 Elsevier B.V. All rights reserved.	[Zhu, Dan; Zhu, Hongshu] Nanjing Normal Univ, Sch Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China; [Nakamura, Hitomi; Matsuo, Masaru] Nara Womens Univ, Grad Sch Humanities & Sci, Nara 6308263, Japan; [Xu, Chunye] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei 230026, Peoples R China	Zhu, D (reprint author), Nanjing Normal Univ, Sch Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China.	zhudan1013@gmail.com			National Natural Science Foundation of China [21074056]; User's Project of Oak Ridge National Laboratory [CNMS2014-378]	The National Natural Science Foundation of China (Grant No. 21074056) and the User's Project of Oak Ridge National Laboratory (CNMS2014-378) are greatly acknowledged.	Aldalbahi A, 2012, BEILSTEIN J NANOTECH, V3, P415, DOI 10.3762/bjnano.3.48; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Homma T, 2014, J ELECTROANAL CHEM, V712, P119, DOI 10.1016/j.jelechem.2013.11.009; Yao YF, 2013, POLYM CHEM-UK, V4, P5197, DOI 10.1039/c3py00131h; Shiraki T, 2010, J AM CHEM SOC, V132, P13928, DOI 10.1021/ja1067349; ANDERSON NS, 1969, J MOL BIOL, V45, P85, DOI 10.1016/0022-2836(69)90211-3; Laslau C, 2010, PROG POLYM SCI, V35, P1403, DOI 10.1016/j.progpolymsci.2010.08.002; Gribkova OL, 2011, POLYMER, V52, P2474, DOI 10.1016/j.polymer.2011.04.003; Chen XJ, 2012, ANAL CHIM ACTA, V723, P94, DOI 10.1016/j.aca.2012.02.032; POUGET JP, 1991, MACROMOLECULES, V24, P779, DOI 10.1021/ma00003a022; Wan D, 2010, ACS APPL MATER INTER, V2, P3083, DOI 10.1021/am100591t; Yuguchi Y, 2002, FOOD HYDROCOLLOID, V16, P515, DOI 10.1016/S0268-005X(01)00131-X; YUE J, 1991, SYNTHETIC MET, V41, P765, DOI 10.1016/0379-6779(91)91180-I; Li WG, 2004, J AM CHEM SOC, V126, P2278, DOI 10.1021/ja039672q; XIA YN, 1995, CHEM MATER, V7, P443, DOI 10.1021/cm00051a002; De Ruiter GA, 1997, TRENDS FOOD SCI TECH, V8, P389, DOI 10.1016/S0924-2244(97)01091-1; Zhang LJ, 2002, NANOTECHNOLOGY, V13, P750, DOI 10.1088/0957-4484/13/6/311; Dhand C, 2011, BIOSENS BIOELECTRON, V26, P2811, DOI 10.1016/j.bios.2010.10.017; Leppanen AS, 2013, MACROMOL RAPID COMM, V34, P1056, DOI 10.1002/marc.201300275; MORRIS ER, 1980, J MOL BIOL, V138, P349, DOI 10.1016/0022-2836(80)90291-0; Ding LL, 1999, SYNTHETIC MET, V104, P73, DOI 10.1016/S0379-6779(99)00035-1; He C, 2003, J APPL POLYM SCI, V87, P1537, DOI 10.1002/app.11599; Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y; Khalid M., 2013, INDIAN J MAT SCI, V2013; MACDIARMID AG, 1995, SYNTHETIC MET, V69, P85, DOI 10.1016/0379-6779(94)02374-8; Nekrasov AA, 2010, J SOLID STATE ELECTR, V14, P1975, DOI 10.1007/s10008-010-1057-1; Numata M, 2004, ORG LETT, V6, P4447, DOI 10.1021/ol0483448; Pailleret A., 2010, NANOSTRUCTURED CONDU, P99; PAOLETTI S, 1985, MACROMOLECULES, V18, P1834, DOI 10.1021/ma00152a008; Steeman P.A.M., 2003, BROADBAND DIELECTRIC, P495; Sugikawa K, 2008, LANGMUIR, V24, P13270, DOI 10.1021/la802211q; Zhu D, 2011, SYNTHETIC MET, V161, P1820, DOI 10.1016/j.synthmet.2011.06.008; Zhu D, 2014, SYNTHETIC MET, V187, P165, DOI 10.1016/j.synthmet.2013.11.003	33	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	APR	2015	202						133	139		10.1016/j.synthmet.2015.01.026		7	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CE7TX	WOS:000352045800017		
J	Matsumura, A; Fan, Y; Goto, H				Matsumura, Atsushi; Fan, Yang; Goto, Hiromasa			Asymmetric electrochemical polymerization in cholesteric liquid crystalline media: Effect of isomeric structures of chiral inducers containing bornyl group	SYNTHETIC METALS			English	Article						Chiral inducer; Structural isomer; Asymmetric electrochemical polymerization	HELICAL TWISTING POWERS; ABSOLUTE-CONFIGURATION; FILMS; INDUCTION; ELECTROLYTE; PERFORMANCE; MOLECULES; RANGE	Five chiral inducers were synthesized with L-borneol and benzenecarboxylic acids. These chiral inducers have the same substituent (bornyl ester) but different geometries. Para-substituted chiral inducer (I-p) shows relatively high macroscopic helical twisting power (beta(M)), while ortho-substituted chiral inducer (I-o) shows lower. This difference is related with the geometric similarity between the chiral inducers and the host liquid crystals. The result also suggested that distortion of pi system induced by polar solvents causes low beta(M) of the I-o. Optically active poly(3,4-ethylenedioxythiophene) (PEDOT) films were chemically prepared in cholesteric liquid crystal (CLC) electrolyte solution induced by the chiral inducers. Circular dichroism (CD) intensities of the resultant polymer films are almost proportional to helical twisting power (HTP) of the chiral inducers. Optical rotatory dispersion (ORD) spectra of the polymer film prepared in the CLC electrolyte induced by l-p (PF-para) shows isosbestic point during the oxidation. This indicates that electro-chiroptically active polymer film was obtained through chiral induction of the bornyl chiral inducer. (C) 2015 Elsevier B.V. All rights reserved.	[Matsumura, Atsushi; Fan, Yang; Goto, Hiromasa] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan	Goto, H (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.	gotoh@ims.tsukuba.ac.jp					Kawabata K, 2013, MACROMOLECULES, V46, P2078, DOI 10.1021/ma400302j; McGovern PE, 2009, P NATL ACAD SCI USA, V106, P7361, DOI 10.1073/pnas.0811578106; Li C, 2005, J AM CHEM SOC, V127, P4548, DOI 10.1021/ja050168q; Satrijo A, 2005, MACROMOLECULES, V38, P4054, DOI 10.1021/ma047418s; Dong HL, 2008, LANGMUIR, V24, P13241, DOI 10.1021/la8026094; Vogelsang J, 2011, NAT MATER, V10, P942, DOI [10.1038/nmat3127, 10.1038/NMAT3127]; Earl DJ, 2003, J CHEM PHYS, V119, P10280, DOI 10.1063/1.1617980; Shen ZH, 2012, J MATER CHEM, V22, P8069, DOI 10.1039/c2jm30546a; Ferrarini A, 1996, PHYS REV E, V53, P681, DOI 10.1103/PhysRevE.53.681; Dattani R, 2014, J MATER CHEM A, V2, P14711, DOI 10.1039/c4ta03146f; Yoneyama H, 2007, MACROMOLECULES, V40, P5279, DOI 10.1021/ma070247h; Tang CY, 2012, NANO LETT, V12, P1152, DOI 10.1021/nl202692y; Kawagoe Y, 2010, NEW J CHEM, V34, P637, DOI 10.1039/b9nj00733d; Osterbacka R, 2000, SCIENCE, V287, P839, DOI 10.1126/science.287.5454.839; Wang Y, 2012, ADV MATER, V24, P1926, DOI 10.1002/adma.201200241; Hayashi H, 2013, MATER CHEM PHYS, V137, P816, DOI 10.1016/j.matchemphys.2012.10.017; DAVIDSSON A, 1980, CHEM PHYS LETT, V70, P313, DOI 10.1016/0009-2614(80)85341-3; Devlin FJ, 2005, J ORG CHEM, V70, P2980, DOI 10.1021/jo0478611; di Matteo A, 2001, J AM CHEM SOC, V123, P7842, DOI 10.1021/ja010406r; Fujitsu Y, 2013, J POLYM SCI POL CHEM, V51, P780, DOI 10.1002/pola.26467; Goto H, 2009, J MATER CHEM, V19, P4914, DOI 10.1039/b818993e; Goto H, 2007, J POLYM SCI POL CHEM, V45, P1377, DOI 10.1002/pola.21900; Goto H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.253901; Hayashi H., 2014, INT LETT CHEM PHYS A, V8, P6; Iseki T, 2014, SYNTHETIC MET, V187, P217, DOI 10.1016/j.synthmet.2013.11.017; Januszko A, 2006, J MATER CHEM, V16, P452, DOI 10.1039/b512319d; Lazar C, 2000, J AM CHEM SOC, V122, P12586, DOI 10.1021/ja0031319; Liu JH, 2004, J APPL POLYM SCI, V91, P3693, DOI 10.1002/app.13614; Liu JH, 2005, J APPL POLYM SCI, V98, P88, DOI 10.1002/app.22032; Pieraccini S, 2003, J ORG CHEM, V68, P519, DOI 10.1021/jo020427j; Raimundo JM, 2000, CHEM COMMUN, P939, DOI 10.1039/b002369h; SIDMAN JW, 1958, CHEM REV, V58, P689, DOI 10.1021/cr50022a004; Sun L, 2013, P NATL ACAD SCI USA, V110, P12498, DOI 10.1073/pnas.1311771110; Superchi S, 1999, J ORG CHEM, V64, P4762, DOI 10.1021/jo990038y; Tahar-Djebbar I, 2011, CHEM MATER, V23, P4653, DOI 10.1021/cm2014187; Vandeleene S, 2011, MACROMOLECULES, V44, P4911, DOI 10.1021/ma201039x; Zhu YY, 2014, RSC ADV, V4, P40241, DOI 10.1039/c4ra06571a	37	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	APR	2015	202						157	164		10.1016/j.synthmet.2015.01.019		8	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CE7TX	WOS:000352045800020		
J	Komatsu, R; Sasabe, H; Inomata, S; Pu, YJ; Kido, J				Komatsu, Ryutaro; Sasabe, Hisahiro; Inomata, Susumu; Pu, Yong-Jin; Kido, Junji			High efficiency solution processed OLEDs using a thermally activated delayed fluorescence emitter	SYNTHETIC METALS			English	Article						Organic light emitting device; Solution process; Thermally activated delayed fluorescence; Fluorescent material; Electron transport material	DIODES; DEVICES; SINGLET	Highly efficient solution processed organic light-emitting devices (OLEDs) incorporating a thermally activated delayed fluorescent (TADF) emitter are developed. As a green emitter, we used 1,2,3,5-tetrakis (carbazol-9-yl)-4,6-dicyanobenzene (4CzIPN). As an electron transporting layer (ETL), we used phenylpyridine-based wide-energy gap materials. These ETLs have high triplet energy over 2.7 eV, relatively high electron mobility of 10(-4) cm(2) V-1 s(-1), and high hole blocking ability to effectively confine all the excitons and carriers in the emissive layer. A solution processed OLED with a structure of [ITO (130 nm)/PEDOT:PSS (30 nm)/4CzIPN 5 wt% doped 4,4'-N,N'-dicarbazolylbiphenyl (CBP) (35 nm)/bis-4,6-(3,5-di-4-pyridylphenyl)-2-methylpyrimidine (B4PyMPM) (65 nm)/8-quinolinolato lithium (Liq) (3 nm)/Al (100 nm)] were fabricated. This device showed a very low turn-on voltage of 2.5 V at 1 cd m(-2) with a maximum power efficiency of over 55 lm W-1. These performances are highest values reported in solution processed TADF OLEDs so far. (C) 2015 Elsevier B.V. All rights reserved.	[Komatsu, Ryutaro; Sasabe, Hisahiro; Inomata, Susumu; Pu, Yong-Jin; Kido, Junji] Yamagata Univ, Grad Sch Sci & Engn, Dept Organ Device Engn, Yonezawa, Yamagata 9928510, Japan; [Sasabe, Hisahiro; Pu, Yong-Jin; Kido, Junji] Yamagata Univ, Res Ctr Organ Elect ROEL, Grad Sch Sci & Engn, Dept Organ Device Engn, Yonezawa, Yamagata 9928510, Japan	Sasabe, H (reprint author), Yamagata Univ, Dept Organ Device Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	h-sasabe@yz.yamagata-u.ac.jp; kid@yz.yamagata-u.ac.jp	Sasabe, Hisahiro/E-4306-2010; Pu, Yong-Jin/B-5269-2008	Pu, Yong-Jin/0000-0003-3841-2417			Sasabe H, 2013, ADV FUNCT MATER, V23, P5550, DOI 10.1002/adfm.201301069; KIDO J, 1995, SCIENCE, V267, P1332, DOI 10.1126/science.267.5202.1332; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Sasabe H, 2011, ADV FUNCT MATER, V21, P336, DOI 10.1002/adfm.201001252; Duan LA, 2010, J MATER CHEM, V20, P6392, DOI 10.1039/b926348a; Han TH, 2012, NAT PHOTONICS, V6, P105, DOI 10.1038/NPHOTON.2011.318; Seino Y, 2014, ADV MATER, V26, P1612, DOI 10.1002/adma.201304253; Sasabe H, 2013, J MATER CHEM C, V1, P1699, DOI 10.1039/c2tc00584k; Sun JW, 2014, ADV MATER, V26, P5684, DOI 10.1002/adma.201401407; Kawano K, 2014, ORG ELECTRON, V15, P1695, DOI 10.1016/j.orgel.2014.04.035; Goushi K, 2012, NAT PHOTONICS, V6, P253, DOI 10.1038/nphoton.2012.31; Sasabe H, 2008, CHEM MATER, V20, P5951, DOI 10.1021/cm801727d; Helander MG, 2011, SCIENCE, V332, P944, DOI 10.1126/science.1202992; Tanaka D, 2007, JPN J APPL PHYS 2, V46, pL10, DOI 10.1143/JJAP.46.L10; Sun YR, 2006, NATURE, V440, P908, DOI 10.1038/nature04645; Goushi K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737006; D'Andrade B.W., 2008, P SOC PHOTO-OPT INS, V7051; Nakanotani H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02127; Pu Y.-J., 2013, J PHOTOPOLYM SCI TEC, V3, P403; Reineke S., 2009, NATURE, V459; Sasabe H., 2013, EUR J ORG CHEM, P7653; Seo S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.042102	22	3	3	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	APR	2015	202						165	168		10.1016/j.synthmet.2015.02.009		4	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CE7TX	WOS:000352045800021		
J	Compagna, D; Kohlbacher, F				Compagna, Diego; Kohlbacher, Florian			The limits of participatory technology development: The case of service robots in care facilities for older people	TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE			English	Article						Older user; Participatory technology development; Scenario-based design; Ambient assisted living; Care robotics	DEMENTIA; HEALTH; USERS	The paper examines how participatory technology development (pTD) in the field of ambient assisted living (AAL) is marked by several weaknesses. We will discuss these from a theoretical point of view as well as based on empirical findings of a three-year project dedicated to the achievement of pTD within a representative AAL domain, adopting the scenario-based design (SBD) method. The case study - dealing with the introduction of care robots in a care facility for the elderly - will be examined by an ethnographical qualitative analysis as well as by three theoretical approaches often used in the field of Science and Technology Studies (STS). We combine these three approaches with an ethnographical analysis to achieve a deeper understanding of several difficulties with pTD that are typical in the realization within the AAL field, especially when a mediating method, such as SBD, is adopted. In this respect the theoretical contribution consists of outlining the importance of a strictly bottom-up view on pTD. Finally, we conclude with two general recommendations on how the inclusion of care workers and older people as target groups of pTD within the AAL field can be accomplished more successfully. (C) 2014 Published by Elsevier Inc.	[Compagna, Diego] Univ Duisburg Essen, Inst Sociol, D-47057 Duisburg, Germany; [Kohlbacher, Florian] German Inst Japanese Studies DIJ, Tokyo, Japan; [Kohlbacher, Florian] XiAn Jiaotong Liveipool Univ, IBSS, Suzhou, Peoples R China	Compagna, D (reprint author), Univ Duisburg Essen, Inst Sociol, Lotharstr 65, D-47057 Duisburg, Germany.	diego.compagna@uni-duisburg-essen.de			German Federal Ministry for Education and Research [01FC08024-27]	The research presented in this paper was funded by the German Federal Ministry for Education and Research (01FC08024-27). We would like to thank Karen A. Shire for her support and essential advice regarding the fieldwork as well as the respective analysis interpretation of the data. Furthermore we would like to thank two anonymous reviewers and Alexander Peine for comments on earlier versions of this paper.	Akrich M., 1992, SHAPING TECHNOLOGY B; Neven L, 2010, SOCIOL HEALTH ILL, V32, P335, DOI 10.1111/j.1467-9566.2009.01218.x; Powell J, 2010, AGEING SOC, V30, P1073, DOI 10.1017/S0144686X1000019X; Schuitmaker TJ, 2012, TECHNOL FORECAST SOC, V79, P1021, DOI 10.1016/j.techfore.2011.11.008; STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001; Bond J, 2001, AGEING SOC, V21, P95; Peine A, 2012, TECHNOL FORECAST SOC, V79, P1495, DOI 10.1016/j.techfore.2012.04.014; Bailey Cathy, 2009, ALTER EUR J DISABIL, V3, P96, DOI 10.1016/j.alter.2009.01.002; Bechtold Ulrike, 2013, Gerontechnology, V11, DOI 10.4017/gt.2013.11.4.015.00; Bertsche B, 2007, VDI-BUCH, P1, DOI 10.1007/978-3-540-69880-7; Bijker Wiebe E., 1997, BICYCLES BAKELITES B; Blackman T, 2013, AGEING SOC, V33, P763, DOI 10.1017/S0144686X1200027X; Bowker Geoffrey C., 1999, SORTING THINGS OUT C; Brittain Katherine, 2010, SOCIOL HLTH ILLN, V32, P272; Burawoy M, 1982, MANUFACTURING CONSEN; Callen B., 2009, ALTER EUROPEAN J DIS, V3, P110, DOI 10.1016/j.alter.2009.02.001; Callon Michel, 1986, POWER ACTION BELIEF, pS 196; Carroll J. M., 1995, SCENARIO BASED DESIG; Clarkson J., 2003, INCLUSIVE DESIGN DES; Compagna Diego, 2012, POIESIS PRAXIS, V9, P125; Compagna Diego, 2009, ENTERP WORK INNOV ST, V5; Compagna Diego, 2009, WORKING PAPERS KULTU; Deutschrnann Christoph, 2002, POSTINDUSTRIELLE IND; Diego Compagna, 2012, POIESIS PRAX, V9, P125; Dienel H.-L., 2004, GEROTECHNOLOGY RES P, P224; Drucker P., 2002, MANAGING NEXT SOC; EBEL RH, 1979, TECHNOL FORECAST SOC, V13, P131, DOI 10.1016/0040-1625(79)90108-2; Erickson T., 1995, SCENARIO BASED DESIG, P37; Fisk Arthur D., 2009, HUMAN FACTORS AGING; FLECK J, 1994, RES POLICY, V23, P637, DOI 10.1016/0048-7333(94)90014-0; Glaser BG, 1998, GROUNDED THEORY STRA; Goffinan Erving, 2000, RAHMEN ANAL VERSUCH; Johnson Peter, 1995, SCENARIO BASED DESIG, pS209; Joyce K, 2010, SOCIOL HEALTH ILL, V32, P171, DOI 10.1111/j.1467-9566.2009.01219.x; Kohlbacher F., 2011, AGEING INT, V36, P82, DOI DOI 10.1007/S12126-010-9076-X; Kohlbacher F, 2011, SILVER MARKET PHENOMENON: MARKETING AND INNOVATION IN THE AGING SOCIETY, SECOND EDITION, P1, DOI 10.1007/978-3-642-14338-0; Kohlbacher Florian, 2014, TECHNOVATION; Konrad Komelia, 2004, PRAGENDE ERWARTUNGEN; Latour B., 1992, SHAPING TECHNOLOGY B; Law J., 1987, SOCIAL CONSTRUCTION, P111; Mack R., 1995, SCENARIO BASED DESIG, P361; McCabe Louise, 2013, Gerontechnology, V12, DOI 10.4017/gt.2013.12.1.006.00; McDonagh D, 2011, SILVER MARKET PHENOMENON: MARKETING AND INNOVATION IN THE AGING SOCIETY, SECOND EDITION, P91, DOI 10.1007/978-3-642-14338-0_7; Melkas H, 2011, SILVER MARKET PHENOMENON: MARKETING AND INNOVATION IN THE AGING SOCIETY, SECOND EDITION, P435, DOI 10.1007/978.3.642.14338.0_32; Ostlund B, 2011, SILVER MARKET PHENOMENON: MARKETING AND INNOVATION IN THE AGING SOCIETY, SECOND EDITION, P15, DOI 10.1007/978-3-642-14338-0_2; Peine A, 2009, TECHNOL FORECAST SOC, V76, P396, DOI 10.1016/j.techfore.2008.04.002; Peine Alexander, 2011, Gerontechnology, V10, DOI 10.4017/gt.2011.10.3.00.00; Peine A, 2014, TECHNOL FORECAST SOC, V82, P199, DOI 10.1016/j.techfore.2013.06.013; Phillips F, 2011, TECHNOL FORECAST SOC, V78, P1072, DOI 10.1016/j.techfore.2011.03.020; Pinch Trevor J., 1999, SOCIAL CONSTRUCTION, pS 17; Pols Jeannette, 2009, ALTER EUROPEAN J DIS, V3, P159, DOI 10.1016/j.alter.2009.01.003; Popper Karl R., 2005, LOGIK FORSCHUNG; Roberts C., 2009, ALTER EUROPEAN J DIS, V3, P138, DOI 10.1016/j.alter.2009.01.004; ROSSON MB, 2003, HUM FAC ER, P1032; Schmidt-Ruhland Karin, 2011, SILVER MARKET PHENOM, P45, DOI 10.1007/978-3-642-14338-0_4; Stahl BC, 2014, TECHNOL FORECAST SOC, V84, P74, DOI 10.1016/j.techfore.2013.08.001; Strauss A., 1996, GROUNDED THEORY GRUN; Strubing J, 1997, Z SOZIOL, V26, P368; Torrington Judith, 2009, ALTER EUR J DISABIL, V3, P123, DOI 10.1016/j.alter.2009.01.005; Wellmer Albrecht, 1967, METHODOLOGIE ERKENNT	60	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0040-1625	1873-5509		TECHNOL FORECAST SOC	Technol. Forecast. Soc. Chang.	APR	2015	93				SI		19	31		10.1016/j.techfore.2014.07.012		13	Business; Planning & Development	Business & Economics; Public Administration	CE6RG	WOS:000351965000003		
J	Nguyen, MP; Sutou, Y; Koike, J				Mai Phuong Nguyen; Sutou, Yuji; Koike, Junichi			Diffusion barrier property of MnSixOy layer formed by chemical vapor deposition for Cu advanced interconnect application	THIN SOLID FILMS			English	Article						Interconnect application; Cu diffusion barrier; Manganese oxide; Chemical vapor deposition		An amorphous manganese oxide layers formed by chemical vapor deposition have been studied as a copper diffusion barrier. The thermal stability of the barrier layer was assessed by annealing Cu/MnSixOy/SiO2/Si samples at 400 degrees C for various times up to 10 h. Transmission electron microscopy, energy-dispersive X-ray spectroscopy (EDX), secondary ion mass spectroscopy (SIMS), capacitance-voltage and current-voltage measurements were performed. Failure of the barrier property is marked by observing the copper peak appearing in EDX and SIMS spectra data fromthe SiO2 region. Amorphous MnSixOy barrier with a thickness of 1.2 nm has failed in preventing Cu diffusion into SiO2 substrate after anneal at 400 degrees C in vacuum for 1h, as proven by the presence of Cu in the dielectric (SiO2) layer. However, the amorphous MnSixOy with the thickness of 2.0 nm barrier was thermally stable and could prevent Cu from inter-diffusion to the SiO2 substrate after annealing at 400 degrees C even up to 10 h. (C) 2015 Elsevier B.V. All rights reserved.	[Mai Phuong Nguyen; Sutou, Yuji; Koike, Junichi] Tohoku Univ, Dept Mat Sci & Engn, Sendai, Miyagi 9808579, Japan	Nguyen, MP (reprint author), Tohoku Univ, Dept Mat Sci & Engn, Sendai, Miyagi 9808579, Japan.	nmphuong46@gmail.com; koikej@material.tohoku.ac.jp			JSPS [22226012]; Japan Science and Technology Agency (CREST); Tokyo Electron Ltd.	We would like to thank S. Hosaka, K. Maekawa and K. Matsumoto at Tokyo Electron Ltd. for their fruitful discussion. We appreciate T. Miyazaki at Tohoku University for his technical assistance with TEM analysis. This work was supported by JSPS Grant-in-Aid for Scientific Research (S) #22226012, Japan Science and Technology Agency (CREST), and Tokyo Electron Ltd.	Majumder P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2800382; Haneda M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2750402; Cao ZH, 2009, J APPL PHYS, V106, DOI 10.1063/1.3266164; Au Y, 2010, J ELECTROCHEM SOC, V157, pD341, DOI 10.1149/1.3364799; Dixit VK, 2011, IEEE T DEVICE MAT RE, V11, P295, DOI 10.1109/TDMR.2011.2141671; Fisher I., 2008, THIN SOLID FILMS, V516, P411; Kim H., 2008, P ADV MET C, P321; Koike J, 2007, J APPL PHYS, V102, DOI 10.1063/1.2773699; Matsumoto K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.036503; Neishi K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963984; Nguyen M.P., 2013, J PHYS CHEM C, V117, P160; Nguyen M.P., 2011, J PHYS CHEM C, V115, P16731; Pierret R.F., 1996, SEMICONDUCTOR DEVICE; Wang Q, 2004, APPL PHYS LETT, V84, P1380, DOI 10.1063/1.1650044; Wang SJ, 2010, J APPL PHYS, V107, DOI 10.1063/1.3406136; Wen-bin S., 1991, J CRYST GROWTH, V113, P1, DOI 10.1016/0022-0248(91)90002-M	16	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	APR 1	2015	580						56	60		10.1016/j.tsf.2015.03.007		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CF0GE	WOS:000352220300009		
J	Ueno, S; Konishi, Y; Azuma, K				Ueno, Satoko; Konishi, Yoshiyuki; Azuma, Kazufumi			The structures of highly transparent, water impermeable SiNx films prepared using surface-wave-plasma chemical vapor deposition for organic light-emitting displays	THIN SOLID FILMS			English	Article						Surface wave plasma; Chemical vapor deposition; Silicon nitride; Low temperature; Hydrogen content; Hydrogen radical; Optical emission spectroscopy; Actinometry	SILICON-NITRIDE FILMS; OPTICAL-EMISSION; HYDROGEN CONTENT; MECHANISM; ENCAPSULATION; DENSITY; DEVICES; SILANE; MODEL	We have previously developed a highly transparent, water impermeable SiNx film for organic light-emitting displays, using a surface-wave-plasma enhanced chemical vapor deposition system. In the present study we investigated the structure of the impermeable SiNx film with regard to its hydrogen content. We also evaluated the relative density of hydrogen radicals in the gas phase during film fabrication to clarify the relationship between the hydrogen radical density in the plasma and the hydrogen content of the resulting film. When increasing the gap between the dielectric window and the substrate, the film density was observed to increase. In contrast, the hydrogen content was seen to decrease when increasing the gap, demonstrating an association between the observed increases in the film density and the reduced hydrogen concentrations. It is believed that this dense structure leads to the observed high water impermeability. Based on actinometry results, the gas phase hydrogen radical density decreases exponentially as the gap increases, resulting in reduced hydrogen content in SiNx films made with longer gap values. (C) 2014 Elsevier B.V. All rights reserved.	[Ueno, Satoko; Konishi, Yoshiyuki] Shimadzu Co Ltd, Ind Machinery Div, Dept Res & Dev, Hadano, Kanagawa 2591304, Japan; [Azuma, Kazufumi] Shimadzu Co Ltd, Technol Res Lab, Business Dev Dept, Chiyoda Ku, Tokyo 1018448, Japan	Ueno, S (reprint author), Shimadzu Co Ltd, Ind Machinery Div, Dept Res & Dev, 380-1 Horiyamashita, Hadano, Kanagawa 2591304, Japan.	skuji@shimadzu.co.jp			New Energy and Industrial Technology Development Organization (NEDO) [P08011]	This study was partly supported by the New Energy and Industrial Technology Development Organization (NEDO, P08011).	Gicquel A, 1998, J APPL PHYS, V83, P7504, DOI 10.1063/1.367514; Lee YG, 2009, ORG ELECTRON, V10, P1352, DOI 10.1016/j.orgel.2009.07.015; LANFORD WA, 1978, J APPL PHYS, V49, P2473, DOI 10.1063/1.325095; PARSONS GN, 1991, J APPL PHYS, V70, P1553, DOI 10.1063/1.349544; LUCOVSKY G, 1979, PHYS REV B, V19, P2064, DOI 10.1103/PhysRevB.19.2064; Hayashi H, 1999, J VAC SCI TECHNOL A, V17, P2557, DOI 10.1116/1.581997; COBURN JW, 1980, J APPL PHYS, V51, P3134, DOI 10.1063/1.328060; GODYAK VA, 1990, PHYS REV A, V42, P2299, DOI 10.1103/PhysRevA.42.2299; TAWARA H, 1990, J PHYS CHEM REF DATA, V19, P617; Lewis JS, 2004, IEEE J SEL TOP QUANT, V10, P45, DOI 10.1109/JSTQE.2004.824072; Azuma K., 2014, THIN SOLID IN PRESS; Barnett C. F., 1977, ORNL5206; GODYAK VA, 1990, IEEE T PLASMA SCI, V18, P159, DOI 10.1109/27.45519; ITABASHI N, 1990, JPN J APPL PHYS 1, V29, P585, DOI 10.1143/JJAP.29.585; Kinoshita K, 1998, JPN J APPL PHYS 1, V37, P2400, DOI 10.1143/JJAP.37.2400; LUCOVSKY G, 1983, PHYS REV B, V28, P3234, DOI 10.1103/PhysRevB.28.3234; NILSSON PO, 1977, PHYS REV B, V16, P3352, DOI 10.1103/PhysRevB.16.3352; SMITH DL, 1990, J ELECTROCHEM SOC, V137, P614, DOI 10.1149/1.2086517; Suzuki N, 2002, JPN J APPL PHYS 1, V41, P3930, DOI 10.1143/JJAP.41.3930; TAFT EA, 1971, J ELECTROCHEM SOC, V118, P1341, DOI 10.1149/1.2408318; TSU DV, 1986, PHYS REV B, V33, P7069, DOI 10.1103/PhysRevB.33.7069; TSUDA M, 1989, J CHEM PHYS, V91, P6822, DOI 10.1063/1.457657; Ueno S., 2014, THIN SOLID FILMS; Ueno S, 2013, ECS TRANSACTIONS, V50, P57, DOI 10.1149/05041.0057ecst	24	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	APR 1	2015	580						106	110		10.1016/j.tsf.2014.09.070		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CF0GE	WOS:000352220300016		
J	Azuma, K; Ueno, S; Konishi, Y; Takahashi, K				Azuma, Kazufumi; Ueno, Satoko; Konishi, Yoshiyuki; Takahashi, Kazuhiro			Transparent silicon nitride films prepared by surface wave plasma chemical vapor deposition under low temperature conditions	THIN SOLID FILMS			English	Article						Surface wave plasma; Chemical vapor deposition; Silicon nitride; Low temperature; XPS; RBS; FTIR	NITROGEN ALLOYS; DEVICES	Highly transparent silicon nitride films with a low absorption coefficient of only 200 cm(-1) or lower were prepared under high NH3/SiH4 source gas ratio conditions at 80 degrees C or lower temperature using surface wave plasma chemical vapor deposition (SWP-CVD). Rutherford backscattering measurements indicated that a silicon nitride structure Si3Nx (x > 5) with excess nitrogen could be prepared with the SWP-CVD method under high NH3/SiH4 source gas ratio conditions. X-ray photon spectroscopy (XPS) analysis provided verification that the excess nitrogen combined with the oxygen contained in the SiNx film during low-temperature film formation and that the atomic ratio of Si and N was almost stoichiometric, i.e., Si3N4. XPS study also revealed that the Si3N<4 structure contained suboxides, which presence may reduce the transparency of the films. In contrast, suboxides were not observed in the Si3N4 structure obtained under high NH3/SiH4 source gas ratio conditions. Fourier-transform infrared spectroscopy study confirmed that the SiNx film becomes more stable when the SiNx structure approaches the stoichiometric ratio. Achieving a near-transparent Si3N4 structure requires a sufficient amount of N atoms in the periphery of the Si atom, i.e., an adequate amount of NH3 is necessary in the presence of the SiH4. (C) 2014 Elsevier B.V. All rights reserved.	[Azuma, Kazufumi; Ueno, Satoko] Shimadzu Co Ltd, Technol Res Lab, Hadano, Kanagawa 2591304, Japan; [Konishi, Yoshiyuki] Shimadzu Co Ltd, Div Semicond Equipment, Hadano, Kanagawa 2591304, Japan; [Takahashi, Kazuhiro] Shimadzu Co Ltd, Analyt & Measuring Instruments Div, Hadano, Kanagawa 2591304, Japan	Azuma, K (reprint author), Shimadzu Co Ltd, Technol Res Lab, Hadano, Kanagawa 2591304, Japan.	az@shimdzu.co.jp			New Energy and Industrial Technology Development Organization (NEDO) [P08011]	This study was partially supported by New Energy and Industrial Technology Development Organization (NEDO) (P08011).	Almeida SA, 1997, THIN SOLID FILMS, V311, P133, DOI 10.1016/S0040-6090(97)00460-4; BURROWS PE, 1994, APPL PHYS LETT, V65, P2922, DOI 10.1063/1.112532; Demichelis F, 1996, J APPL PHYS, V79, P1730, DOI 10.1063/1.360961; PHILIPP HR, 1973, J ELECTROCHEM SOC, V120, P295, DOI 10.1149/1.2403440; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Burrows PE, 2001, DISPLAYS, V22, P65, DOI 10.1016/S0141-9382(00)00064-0; Ay I., 2001, Turkish Journal of Physics, V25; Azuma K, 2010, ECS TRANSACTIONS, V28, P27, DOI 10.1149/1.3490280; Giorgis F, 2000, J NON-CRYST SOLIDS, V266, P588, DOI 10.1016/S0022-3093(99)00748-6; Lien K.K., 2001, J APPL PHYS, V90, P976; Lipinski M., 2010, ARCH MAT SCI ENG, V46, P69; Madan A., 1988, PHYS APPL AMORPHOUS, P152; MANABE Y, 1989, J APPL PHYS, V66, P2475, DOI 10.1063/1.344258; Seah MP, 2005, SURF INTERFACE ANAL, V37, P300, DOI 10.1002/sia.2020; Tauc J., 1974, AMORPHOUS LIQUID SEM, P159; Tsu D.V., 1986, PHYS REV B, V33; Yamashita K, 2001, J PHYS D APPL PHYS, V34, P740, DOI 10.1088/0022-3727/34/5/312	17	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	APR 1	2015	580						111	115		10.1016/j.tsf.2014.09.068		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CF0GE	WOS:000352220300017		
J	Ueno, S; Konishi, Y; Azuma, K				Ueno, Satoko; Konishi, Yoshiyuki; Azuma, Kazufumi			Highly water-impermeable SiNx film prepared using surface-wave-plasma chemical vapor deposition and improvement of the barrier performance for organic light-emitting displays	THIN SOLID FILMS			English	Article						Surface wave plasma; Chemical vapor deposition; Silicon nitride; Low temperature; Water-impermeable; Multilayer structure; Defect decoupling; High barrier	HEXAMETHYLDISILOXANE	Under the previously developed conditions for highly transparent SiNx films, a highly water-impermeable SiNx film was obtained using surface-wave-plasma enhanced chemical vapor deposition (SWP-CVD) with an increased distance between the dielectric window and a substrate (gap), where a water vapor transmission rate (WVTR) of 1.0 x 10(-5) g/m(2)/day was achieved with a gap of 200 mm. Evaluation of the WVTR indicated that deposition of the SiNx film on both sides of a polyimide base film was more effective than simply increasing the SiNx film thickness. A plasma polymerized SiOxCy film was prepared using SWP-CVD in a vacuum, similar to preparation of SiNx barrier film instead of the polyimide base film. A multilayer structure with a SiOxCy intermediate layer between the SiNx barrier layers resulted in high barrier performance with a low WVTR of 2.0 x 10(-5) g/m(2)/day that could be applied for the fabrication of organic light-emitting diode devices. (C) 2014 Elsevier B.V. All rights reserved.	[Ueno, Satoko; Konishi, Yoshiyuki] Shimadzu Co Ltd, Ind Machinery Div, Dept Res & Dev, Hadano, Kanagawa 2591304, Japan; [Azuma, Kazufumi] Shimadzu Co Ltd, Technol Res Lab, Business Dev Dept, Chiyoda Ku, Tokyo 1018448, Japan	Ueno, S (reprint author), Shimadzu Co Ltd, Ind Machinery Div, Dept Res & Dev, 380-1 Horiyamashita, Hadano, Kanagawa 2591304, Japan.	skuji@shimadzu.co.jp			New Energy and Industrial Technology Development Organization (NEDO) [P08011]	This study was partly supported by the New Energy and Industrial Technology Development Organization (NEDO) (P08011).	Schaepkens M, 2004, J VAC SCI TECHNOL A, V22, P1716, DOI 10.1116/1.1705646; Sugai H, 1998, PLASMA SOURCES SCI T, V7, P192, DOI 10.1088/0963-0252/7/2/014; Graff GL, 2004, J APPL PHYS, V96, P1840, DOI 10.1063/1.1768610; Azuma K., 2014, THIN SOLID IN PRESS; BRIXNER B, 1967, J OPT SOC AM, V57, P674, DOI 10.1364/JOSA.57.000674; Magni D, 2001, J PHYS D APPL PHYS, V34, P87, DOI 10.1088/0022-3727/34/1/315; Mandlik P, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890432; NILSSON PO, 1977, PHYS REV B, V16, P3352, DOI 10.1103/PhysRevB.16.3352; Palik E.D., 1985, HDB OPTICAL CONSTANT, P749; Reuter R, 2012, PLASMA PROCESS POLYM, V9, P1116, DOI 10.1002/ppap.201100146; SASAOKA T, 2001, SID S, V32, P384, DOI 10.1889/1.1831876; Ueno S., 2010, 17 INT DISPL WORKSH, P76; Walkiewicz-Pietrzykowska A, 2005, CHEM VAPOR DEPOS, V11, P317, DOI 10.1002/cvde.200506374	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	APR 1	2015	580						116	119		10.1016/j.tsf.2014.09.067		4	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CF0GE	WOS:000352220300018		
J	Parasrampuria, DA; Marbury, T; Matsushima, N; Chen, SQ; Wickremasingha, PK; He, L; Dishy, V; Brown, KS				Parasrampuria, Dolly A.; Marbury, Thomas; Matsushima, Nobuko; Chen, Shuquan; Wickremasingha, Prachi K.; He, Ling; Dishy, Victor; Brown, Karen S.			Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis	THROMBOSIS AND HAEMOSTASIS			English	Article						Edoxaban; haemodialysis; pharmacokinetics; oral factor Xa inhibitor; elimination	FACTOR XA INHIBITOR; ATRIAL-FIBRILLATION; VENOUS THROMBOEMBOLISM; WARFARIN; AGE	Edoxaban is an oral, direct, once-daily, factor Xa inhibitor developed for stroke prevention in patients with atrial fibrillation and for the treatment and secondary prevention of recurrent thromboembolism in patients with acute symptomatic venous thromboembolism. Among elderly patients who require anticoagulation therapies, some may have end-stage renal disease (ESRD). This open-label, phase 1, randomised, two-way crossover study was conducted to evaluate the pharmacokinetics of edoxaban in 10 subjects on haemodialysis. Eligible subjects with ESRD on chronic haemodialysis received a single, oral dose of edoxaban 15 mg 2 hours (h) prior to (on-dialysis) or in between (off-dialysis) haemodialysis sessions. Haemodialysis resulted in a minor decrease in mean total exposure (AUC(0.infinity); 676.2 ng.h/ml) as compared with that observed in subjects off-dialysis (691.7 ng.h/ml). Mean maximum observed plasma concentration (C-max) values were comparable between on-dialysis and off-dialysis treatments (53.3 vs 56.3 ng/ml, respectively). Mean apparent total body clearance (CUF) values were 24.1 and 22.5 l/h during the on-dialysis and off-dialysis treatment periods, respectively. Dialyser clearance was 5.7 l/h and haemodialysis clearance was 6.1 l/h. Haemodialysis clearance was only 6.1 l/h, suggesting that it only accounts for one-fourth of the total clearance in these subjects. A single, oral dose of 15 mg of edoxaban was well tolerated by subjects with ESRD. In conclusion, based on these single-dose PK data, a supplementary dose of edoxaban may not be required following a haemodialysis session. Importantly, haemodialysis is not an effective mechanism for removal of edoxaban from the blood.	[Parasrampuria, Dolly A.; Chen, Shuquan; He, Ling; Dishy, Victor; Brown, Karen S.] Daiichi Sankyo Pharma Dev, Edison, NJ 08837 USA; [Marbury, Thomas] Orlando Clin Res Ctr, Orlando, FL USA; [Matsushima, Nobuko] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Wickremasingha, Prachi K.] Certified Consultant Pharmacists Inc, Chatham, NJ USA	Parasrampuria, DA (reprint author), Daiichi Sankyo Pharma Dev, 399 Thornall St, Edison, NJ 08837 USA.	dparasrampur@dsi.com			Daiichi Sankyo	This study was funded by Daiichi Sankyo. Editorial support was provided by Courtney Mezzacappa Zeni, PhD, and Meryl Gersh, PhD, of AlphaBioCom, LLC (King of Prussia, PA) and funded by Daiichi Sankyo.	LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278; Verbeeck RK, 2009, EUR J CLIN PHARMACOL, V65, P757, DOI 10.1007/s00228-009-0678-8; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Salazar DE, 2012, THROMB HAEMOSTASIS, V107, P925, DOI 10.1160/TH11-08-0566; Ridout G, 2009, J CLIN PHARMACOL, V49, P1124; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Dreisbach AW, 2008, EXPERT OPIN DRUG MET, V4, P1065, DOI [10.1517/17425255.4.8.1065 , 10.1517/17425250802273527]; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Marinigh R, 2010, J AM COLL CARDIOL, V56, P827, DOI 10.1016/j.jacc.2010.05.028; Bathala MS, 2012, DRUG METAB DISPOS, V40, P2250, DOI 10.1124/dmd.112.046888; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; Matsushima N, 2013, CLIN PHARM DRUG DEV, V2, P358, DOI 10.1002/cpdd.53; U. S. Dept of Health and Human Services Food and Drug Administration Centre for Drug Evaluation and Research (CDER), PHARM PAT IMP REN FU	14	7	7	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0340-6245			THROMB HAEMOSTASIS	Thromb. Haemost.	APR	2015	113	4					719	727		10.1160/TH14-06-0547		9	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CF3QQ	WOS:000352464000006		
J	Saito, K; Miyazawa, M; Nukada, Y; Ei, K; Abo, T; Sakaguchi, H				Saito, Kazutoshi; Miyazawa, Masaaki; Nukada, Yuko; Ei, Kyo; Abo, Takayuki; Sakaguchi, Hitoshi			Predictive performance of the Short Time Exposure test for identifying eye irritation potential of chemical mixtures	TOXICOLOGY IN VITRO			English	Article						STE; Eye irritation; Alternative method; Chemical mixture; SIRC cell line	STE TEST	The Short Time Exposure (STE) test is an in vitro eye irritation test based on the cytotoxicity in SIRC cells (rabbit corneal cell line) following a 5 min treatment of chemicals. This study evaluated the predictive performance of the STE test to identify the globally harmonized system (GHS) Not Classified category and other irritant categories (i.e., GHS Category 1 or 2) when used to test 40 chemical mixtures that included irritants. The STE test correctly identified 30 tested mixtures classified as GHS irritant categories and 5 out of 10 tested mixtures classified as GHS Not Classified. The sensitivity, specificity, positive predictivity, negative predictivity, and overall accuracy of the STE test were 100% (30/30), 50% (5/10), 86% (25/30), 100% (5/5), and 88% (35/40), respectively. These predictive performances were comparative to or greater than those in other in vitro eye irritation tests that have been accepted as test guideline by the Organisation for Economic Co-operation and Development. This suggests that the STE test has sufficient predictivity for identifying the eye irritation potential of chemical mixtures. Since no false negatives in this study were found, this indicates that the STE test is applicable as a part of the bottom-up approach. (c) 2015 Elsevier Ltd. All rights reserved.	[Saito, Kazutoshi; Miyazawa, Masaaki; Nukada, Yuko; Ei, Kyo; Abo, Takayuki; Sakaguchi, Hitoshi] Kao Corp, Safety Sci Res Labs, Ichikai, Tochigi 3213497, Japan	Saito, K (reprint author), Kao Corp, Safety Sci Res Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.	saitou.kazutoshi@kao.co.jp					Takahashi Y, 2008, TOXICOL IN VITRO, V22, P760, DOI 10.1016/j.tiv.2007.11.018; [Anonymous], 2003, OFFICIAL J EUROPEA L, V66, P26; Baker FW, 1997, DEV AN VET, V27, P567; Balls M, 1999, ATLA-ALTERN LAB ANIM, V27, P53; Bruner LH, 1998, TOXICOL IN VITRO, V12, P669, DOI 10.1016/S0887-2333(98)00047-2; Draize I.H., 1944, J PHARMACOL EXP THER, V82, P377; Eskes Chantra, 2005, Altern Lab Anim, V33 Suppl 1, P47; Hayashi K, 2012, TOXICOL IN VITRO, V26, P1199, DOI 10.1016/j.tiv.2012.06.008; Hayashi K, 2012, J TOXICOL SCI, V37, P269; OECD, 2013, OECD SER TEST ASS, V189; OECD, 2012, OECD GUID TEST CHEM; OECD, 2013, OECD SER TEST ASS 1; OECD, 2009, OECD GUID TEST CHEM; Ohno Y, 1999, TOXICOL IN VITRO, V13, P73, DOI 10.1016/S0887-2333(98)00064-2; Takahashi Y, 2009, J TOXICOL SCI, V34, P611	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-2333			TOXICOL IN VITRO	Toxicol. Vitro	APR	2015	29	3					617	620		10.1016/j.tiv.2015.01.008		4	Toxicology	Toxicology	CE7VN	WOS:000352050100023		
J	Araki, J; Sakai, H; Takeuchi, D; Kagaya, Y; Tashiro, K; Naito, M; Mihara, M; Narushima, M; Iida, T; Koshima, I				Araki, Jun; Sakai, Hiromi; Takeuchi, Dai; Kagaya, Yu; Tashiro, Kensuke; Naito, Munekazu; Mihara, Makoto; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao			Normothermic Preservation of the Rat Hind Limb With Artificial Oxygen-carrying Hemoglobin Vesicles	TRANSPLANTATION			English	Article							MICROSURGICAL REPLANTATION; FOLLOW-UP; HAND TRANSPLANTATION; PERFUSION; CARRIER; KIDNEY	Background. For managing major limb amputation, it is important to consider ischemic time and reperfusion injury by free radicals after the blood supply is reestablished. State of preservation during transplant surgery is crucial for the survival and function of the tissue, graft, or organ. In this study, we confirmed the effect of intermittent blood flow in rat ischemic hind limb and developed a new oxygenic preservation method using artificial oxygen carrying hemoglobin vesicles (HbVs). Methods. We first compared a continuous ischemic model and an intermittent reflow model on rat hind limb. At postoperative day 7, hind limbs were evaluated. Next, we performed total amputation, normothermic preservation by perfusion with extracellular-trehalose-Kyoto (ETK) solution or HbV, and microsurgical replantation of the left hind limb. Venous efflux was analyzed, the amputated limb evaluated after 6 hr perfusion, and the replantation outcome of each model was compared. Results. In our early study, 24 hr continuous ischemic model necrotized, but intermittent reflow model almost survived except for partial necrosis at postoperative day 7. Scar tissue on the right limb showed myonecrosis and infiltration of inflammatory cells. Skeletal muscle on the right limb was structurally well maintained. Hemoglobin vesicle-treated limbs appeared to have much better oxygenation than ETK-treated limbs. Aerobic respiration remained in the amputated limb, gastrocnemius muscle was well maintained, and the overall replantation was successful in the limb preserved using HbV. Conclusion. These studies demonstrated that oxygenic preservation is effective for rat ischemic limb, suggesting that this method may be useful for other replantation and transplantation surgeries.	[Araki, Jun; Takeuchi, Dai; Kagaya, Yu; Tashiro, Kensuke; Mihara, Makoto; Narushima, Mitsunaga; Iida, Takuya; Koshima, Isao] Univ Tokyo, Dept Plast Surg, Tokyo 1138655, Japan; [Sakai, Hiromi] Waseda Biosci Res Inst Singapore WABIOS, Artificial Red Cells Grp, Biopolis, Singapore; [Sakai, Hiromi] Nara Med Univ, Sch Med, Dept Chem, Nara, Japan; [Takeuchi, Dai] Saitama Med Univ, Saitama Med Ctr, Dept Plast Surg, Saitama, Japan; [Kagaya, Yu] Univ Yamanashi Hosp, Dept Plast Surg, Chuo, Yamanashi, Japan; [Naito, Munekazu] Aichi Med Univ, Dept Anat, Nagakute, Aichi, Japan	Araki, J (reprint author), Univ Tokyo, Grad Sch Med, Dept Plast Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	arakij-pla@h.u-tokyo.ac.jp			Nakatomi Foundation; JSPS KAKENHI [22300161]; Health and Labour Sciences Research Grants (Health Science Research Including Drug Innovation) from the Ministry of Health, Labour and Welfare, Japan	Research funding from the Nakatomi Foundation, JSPS KAKENHI (B) 22300161, and Health and Labour Sciences Research Grants (Health Science Research Including Drug Innovation) from the Ministry of Health, Labour and Welfare, Japan.	Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Petruzzo P, 2008, TRANSPLANTATION, V86, P487, DOI 10.1097/TP.0b013e318181fce8; Jones JW, 2000, NEW ENGL J MED, V343, P468, DOI 10.1056/NEJM200008173430704; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Araki Jun, 2014, Plast Reconstr Surg Glob Open, V2, pe152, DOI 10.1097/GOX.0000000000000029; Atkins SE, 2008, CURR ORTHOPAED, V22, P31, DOI 10.1016/j.cuor.2008.02.001; Constantinescu MA, 2011, J SURG RES, V171, P291, DOI 10.1016/j.jss.2010.01.040; Griffiths M, 2003, LANCET, V361, P263, DOI 10.1016/S0140-6736(03)12302-1; Hammond DC, 2000, PLAST RECONSTR SURG, V105, P2133, DOI 10.1097/00006534-200005000-00033; Hettiaratchy S, 2003, TRANSPLANTATION, V75, P1605, DOI 10.1097/01.TP.0000059447.40513.FB; Iwai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033157; Cheng KX, 1996, PLAST RECONSTR SURG, V97, P1099; Kind GM, 1997, PLAST RECONSTR SURG, V99, P1858, DOI 10.1097/00006534-199706000-00008; Lloyd MS, 2005, EMERG MED J, V22, P478, DOI 10.1136/emj.2003.008797; Lumb AB, 2010, EUR J ANAESTH, V27, P275, DOI 10.1097/EJA.0b013e3283329dc4; MOEN J, 1989, TRANSPLANTATION, V47, P940, DOI 10.1097/00007890-198906000-00004; Muller S, 2013, J SURG RES, V181, P170, DOI 10.1016/j.jss.2012.05.088; MURAMATSU I, 1985, CLIN ORTHOP RELAT R, P292; Sakai H, 2009, METHOD ENZYMOL, V465, P363, DOI 10.1016/S0076-6879(09)65019-9; Sakai H, 2008, J INTERN MED, V263, P4, DOI 10.1111/j.1365-2796.2007.01893.x; SAKAI H, 1993, PROTEIN EXPRES PURIF, V4, P563, DOI 10.1006/prep.1993.1074; Sakai H, 2002, J BIOCHEM, V131, P611; Salgado CJ, 2010, J PLAST RECONSTR AES, V63, P532, DOI 10.1016/j.bjps.2008.12.027; Steinau H-U, 1988, LIMB REPLANTATION PO, V9, P33; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; Thomas D, 2004, VOX SANG, V87, P70, DOI 10.1111/j.1741-6892.2004.00434.x; Walton RL, 1998, PLAST RECONSTR SURG, V102, P358, DOI 10.1097/00006534-199808000-00009; Wong KH, 2011, EVID-BASED COMPL ALT, DOI 10.1093/ecam/neq062; Yamaoka Ippei, 2012, Transplant Res, V1, P2, DOI 10.1186/2047-1440-1-2	32	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0041-1337	1534-6080		TRANSPLANTATION	Transplantation	APR	2015	99	4					687	692		10.1097/TP.0000000000000528		6	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CE9HR	WOS:000352155400017		
J	Miwa, Y; Yazaki, S; Iwamoto, M; Suzuki, S; Iwasaki, K; Haneda, M; Yamamoto, K; Maruyama, S; Onishi, A; Kobayashi, T				Miwa, Yuko; Yazaki, Satoko; Iwamoto, Masaki; Suzuki, Shunichi; Iwasaki, Kenta; Haneda, Masataka; Yamamoto, Koji; Maruyama, Shoichi; Onishi, Akira; Kobayashi, Takaaki			Functional Difference Between Membrane-bound and Soluble Human Thrombomodulin	TRANSPLANTATION			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; AORTIC ENDOTHELIAL-CELLS; ACTIVATED PROTEIN-C; GENE-KNOCKOUT PIGS; LECTIN-LIKE DOMAIN; TISSUE FACTOR; FACTOR-V; EXPRESSION; COFACTOR; THROMBIN	Background. For successful xenotransplantation, in addition to alpha 1,3-galactosyltransferase gene-knockout and human complement regulatory protein (CD46, CD55, CD59) gene insertion, cloned pigs expressing human thrombomodulin (hTM) have been produced to solve the problem of molecular incompatibility in their coagulation system. Recombinant soluble hTM (S-hTM) which has been recently approved for treatment of disseminated intravascular coagulation might be potentially available. The purpose of this study is to examine the functional difference in endothelial cells between membrane-bound hTM (MB-hTM) and S-hTM and to elucidate effective strategy using both types of hTM. Methods. The following factors regarding coagulation and inflammation were compared between hTM-expressing pig aortic endothelial cells (PAEC) derived from cloned pig and nontransgenic PAEC in the presence of S-hTM under tumor necrosis factor-a-activated conditions; (i) clotting time (ii) pig tissue factor (TF), (iii) pig E-selectin, (iv) direct prothrombinase activity, (v) activated protein C (APC), and (vi) prothrombinase activity. Results. The MB-hTM significantly suppressed the expression of pig TF and E-selectin and direct prothrombinase activity in tumor necrosis factor-a-activated PAEC, suggesting strong anti-inflammatory effect, compared to S-hTM. In contrast, S-hTM had more potent capacity to inhibit thrombin generation and to produce APC than MB-hTM, although MB-hTM had the same level of capacity as human endothelial cells. Conclusions. It was speculated that S-hTM treatment would be of assistance during high-risk periods for excessive thrombin formation (e.g., ischemia reperfusion injury or severe infection/rejection). Considering the properties of MB-hTM exhibiting anti-inflammatory function as well as APC production, hTM-expressing cloned pigs might be indispensible to long-term stabilization of graft endothelial cells.	[Miwa, Yuko; Iwasaki, Kenta; Haneda, Masataka; Kobayashi, Takaaki] Nagoya Univ, Grad Sch Med, Dept Transplant Immunol, Nagoya, Aichi 4668550, Japan; [Yazaki, Satoko; Iwamoto, Masaki] Prime Tech Ltd, Tsuchiura, Ibaraki, Japan; [Suzuki, Shunichi; Onishi, Akira] Natl Inst Agrobiol Sci, Dept Dev Biol, Tsukuba, Ibaraki, Japan; [Yamamoto, Koji] Nagoya Univ, Sch Med, Dept Transfus Med, Nagoya, Aichi 4668550, Japan; [Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4668550, Japan; [Onishi, Akira] Nihon Univ, Coll Bioresource Sci, Dept Anim Sci & Resources, Fujisawa, Kanagawa, Japan; [Kobayashi, Takaaki] Nagoya Univ, Grad Sch Med, Dept Surg 2, Nagoya, Aichi 4668550, Japan	Kobayashi, T (reprint author), Nagoya Univ, Sch Med, Dept Transplant Immunol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	takakoba@med.nagoya-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [25461942]; Novartis Pharma K.K.; Chugai Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Co.	This work was partly supported by a Grant-in-Aid for Scientific Research (No. 25461942) from the Japan Society for the Promotion of Science (KAKENHI).; Y.M., K.I., M.H., and T.K., who belong to an endowed chair, the Department of Transplant Immunology, Nagoya University School of Medicine, which is supported by Novartis Pharma K.K., Chugai Pharmaceutical Co., Ltd. and Asahi Kasei Pharma Co. However, no support has been provided relevant to the present study.	Adams DH, 2001, XENOTRANSPLANTATION, V8, P36, DOI 10.1046/j.0908-665X.2000.00085.x; Sharfuddin AA, 2009, J AM SOC NEPHROL, V20, P524, DOI 10.1681/ASN.2008060593; Miwa Y, 2010, XENOTRANSPLANTATION, V17, P26, DOI 10.1111/j.1399-3089.2009.00555.x; Yazaki S, 2012, XENOTRANSPLANTATION, V19, P82, DOI 10.1111/j.1399-3089.2012.00696.x; Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Lee KFE, 2012, AM J TRANSPLANT, V12, P2363, DOI 10.1111/j.1600-6143.2012.04122.x; Lin CC, 2010, AM J TRANSPLANT, V10, P1556, DOI 10.1111/j.1600-6143.2010.03147.x; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373; Lu JP, 2009, J AM COLL SURGEONS, V209, P589, DOI 10.1016/j.jamcollsurg.2009.08.001; Ozaki T, 2008, NEPHROL DIAL TRANSPL, V23, P110, DOI 10.1093/ndt/gfm563; Tsuruta K, 2011, J CLIN PHARMACOL, V51, P1276, DOI 10.1177/0091270010381900; OWEN WG, 1981, J BIOL CHEM, V256, P5532; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Shimizu A, 2008, AM J PATHOL, V172, P1471, DOI 10.2353/ajpath.2008.070672; Roussel JC, 2008, AM J TRANSPLANT, V8, P1101, DOI 10.1111/j.1600-6143.2008.02210.x; Iwase H, 2014, XENOTRANSPLANTATION, V21, P201, DOI 10.1111/xen.12085; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Lee KFE, 2008, XENOTRANSPLANTATION, V15, P191, DOI 10.1111/j.1399-3089.2008.00476.x; Shi CS, 2008, BLOOD, V112, P3661, DOI 10.1182/blood-2008-03-142760; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Mohri M, 1999, THROMB HAEMOSTASIS, V82, P1687; Caldwell JA, 2010, LAB INVEST, V1; Campbell JE, 2010, BLOOD, V116, P6082, DOI 10.1182/blood-2010-01-266395; Ezzelarab M, 2006, XENOTRANSPLANTATION, V13, P522, DOI 10.1111/j.1399-3089.2006.00342.x; FULCHER CA, 1984, BLOOD, V63, P486; GOMI K, 1990, BLOOD, V75, P1396; Hayakawa M, 2012, SHOCK, V37, P569, DOI 10.1097/SHK.0b013e318252bc82; HORIE S, 1994, BIOCHEM J, V301, P683; Kato Takahiro, 2013, Thromb J, V11, P3, DOI 10.1186/1477-9560-11-3; Kopp CW, 1998, TRANSPLANTATION, V66, P244, DOI 10.1097/00007890-199807270-00019; LENTZ SR, 1991, BLOOD, V77, P542; Lin CC, 2010, J THROMB HAEMOST, V8, P2001, DOI 10.1111/j.1538-7836.2010.03950.x; Salvaris E, 2013, XENOTRANSPLANTATION, V20, P345; Salvaris E, 2007, XENOTRANSPLANTATION, V14, P417; Sun HT, 2005, TRANSPLANTATION, V80, P1331, DOI 10.1097/01.tp.0000177649.30721.31; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; Tran JQ, 1999, J CLIN PHARMACOL, V39, P513; van den Berg CW, 2000, TRANSPLANTATION, V70, P667, DOI 10.1097/00007890-200008270-00022	41	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0041-1337	1534-6080		TRANSPLANTATION	Transplantation	APR	2015	99	4					702	709		10.1097/TP.0000000000000571		8	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CE9HR	WOS:000352155400019		
J	Hockings, KJ; McLennan, MR; Carvalho, S; Ancrenaz, M; Bobe, R; Byrne, RW; Dunbar, RIM; Matsuzawa, T; McGrew, WC; Williamson, EA; Wilson, ML; Wood, B; Wrangham, RW; Hill, CM				Hockings, Kimberley J.; McLennan, Matthew R.; Carvalho, Susana; Ancrenaz, Marc; Bobe, Rene; Byrne, Richard W.; Dunbar, Robin I. M.; Matsuzawa, Tetsuro; McGrew, William C.; Williamson, Elizabeth A.; Wilson, Michael L.; Wood, Bernard; Wrangham, Richard W.; Hill, Catherine M.			Apes in the Anthropocene: flexibility and survival	TRENDS IN ECOLOGY & EVOLUTION			English	Article						great apes; anthropogenic disturbance; behavioural flexibility; ape cognition; hominin coexistence; human-wildlife interaction	CHIMPANZEES PAN-TROGLODYTES; WILD CHIMPANZEES; CONSERVATION; STRATEGIES; BEHAVIOR; ECOLOGY; UGANDA; AGGRESSION; ELEPHANTS; INTERFACE	We are in a new epoch, the Anthropocene, and research into our closest living relatives, the great apes, must keep pace with the rate that our species is driving change. While a goal of many studies is to understand how great apes behave in natural contexts, the impact of human activities must increasingly be taken into account. This is both a challenge and an opportunity, which can importantly inform research in three diverse fields: cognition, human evolution, and conservation. No long-term great ape research site is wholly unaffected by human influence, but research at those that are especially affected by human activity is particularly important for ensuring that our great ape kin survive the Anthropocene.	[Hockings, Kimberley J.; McLennan, Matthew R.; Hill, Catherine M.] Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford OX3 0BP, England; [Hockings, Kimberley J.] Univ Nova Lisboa, FCSH, CRIA, Lisbon, Portugal; [Carvalho, Susana; Bobe, Rene; Wood, Bernard] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Carvalho, Susana] Univ Algarve, Interdisciplinary Ctr Archaeol & Evolut Human Beh, Faro, Portugal; [Ancrenaz, Marc] HUTAN, Kinabatangan Orangutan Conservat Programme, Sabah, Malaysia; [Ancrenaz, Marc] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Dunbar, Robin I. M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Matsuzawa, Tetsuro] Japan Monkey Ctr, Inuyama, Aichi, Japan; [McGrew, William C.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Williamson, Elizabeth A.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Wilson, Michael L.] Univ Minnesota, Dept Anthropol, Minneapolis, MN 55455 USA; [Wilson, Michael L.] Univ Minnesota, Dept Ecol Evolut & Behav, Minneapolis, MN 55455 USA; [Wrangham, Richard W.] Harvard Univ, Dept Human Evolutionary Biol, Boston, MA 02138 USA	Hockings, KJ (reprint author), Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford OX3 0BP, England.	khockings@brookes.ac.uk		Hockings, Kimberley/0000-0002-6187-644X	FCT, Portugal [PTDC/CS-ANT/121124/2010]; MEXT, Japan [CCSN/PWS-U04]	We thank Gail Campbell-Smith, Simon Husson, Andrew Marshall, Erik Meijaard, Maria von Noordwijk, Anne Russon, Carel van Schaik, Ian Singleton, and Stephanie Spehar for rating disturbance to orangutan habitat, and Romain Beville, David Greer, Josephine Head, Philipp Henschel, Fiona Maisels, Christopher Orbell, and Angelique Todd for rating disturbance to gorilla habitat. This work was supported by a research grant to K.J.H. from FCT, Portugal (PTDC/CS-ANT/121124/2010) and from MEXT, Japan (CCSN/PWS-U04).	Amati S, 2008, PAN AFR NEWS, V15, P6; Ancrenaz M., 2014, ORYX; Ancrenaz M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04024; Madden F, 2014, BIOL CONSERV, V178, P97, DOI 10.1016/j.biocon.2014.07.015; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; McComb K, 2014, P NATL ACAD SCI USA, V111, P5433, DOI 10.1073/pnas.1321543111; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Greggor AL, 2014, TRENDS ECOL EVOL, V29, P489, DOI 10.1016/j.tree.2014.06.004; McLennan MR, 2010, AM J PRIMATOL, V72, P907, DOI 10.1002/ajp.20839; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Meijaard E, 2012, ANN NY ACAD SCI, V1249, P29, DOI 10.1111/j.1749-6632.2011.06288.x; Ohashi G, 2011, PRIMATES, V52, P1, DOI 10.1007/s10329-010-0212-8; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Dunbar RIM, 2009, BIOL REV, V84, P413, DOI 10.1111/j.1469-185X.2009.00080.x; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Boesch C., 2000, CHIMPANZEES TAI FORE; Byrne RW, 2006, CURR BIOL, V16, pR445, DOI 10.1016/j.cub.2006.05.040; Byrne RW, 2002, INT J PRIMATOL, V23, P539, DOI 10.1023/A:1014917600198; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Campbell-Smith G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020962; Carvalho S, 2012, CURR BIOL, V22, pR180, DOI 10.1016/j.cub.2012.01.052; Cowlishaw G., 2000, PRIMATE CONSERVATION; Crutzen Paul J., 2000, GLOBAL CHANGE NEWSLE, V41, P17; Dunbar R. I. M., 2014, LUCY LANGUAGE BENCHM, P333; Fuentes A, 2010, AM J PRIMATOL, V72, P841, DOI 10.1002/ajp.20844; Fuentes A, 2012, ANNU REV ANTHROPOL, V41, P101, DOI 10.1146/annurev-anthro-092611-145808; Hicks TC, 2013, FOLIA PRIMATOL, V84, P135, DOI 10.1159/000350650; Hill C.M., 2015, HUM DIMENS WILDL, V20; Hockings K. J., 2009, BEST PRACTICE GUIDEL; Hockings KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033391; Hockings KJ, 2006, CURR BIOL, V16, P668; Hockings KJ, 2010, AM J PRIMATOL, V72, P887, DOI 10.1002/ajp.20784; Hockings KJ, 2012, ANIM BEHAV, V83, P801, DOI 10.1016/j.anbehav.2012.01.002; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Hockings KJ, 2010, J HUM EVOL, V58, P227, DOI 10.1016/j.jhevol.2009.11.004; Hockings KJ, 2014, SCIENCE, V344, P981, DOI 10.1126/science.344.6187.981-c; IUCN, 2014, IUCN RED LIST THREAT; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kormos R, 2003, W AFRICAN CHIMPANZEE; Krief S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109925; Mackinnon K.C., 2010, AM J PRIMATOL, V71, P1; Madden F., 2006, POLICY MATTERS, V14, P180; Matsuzawa T, 2011, PRIMATOL MONOGR, P1, DOI 10.1007/978-4-431-53921-6; McGrew WC, 2004, CULTURED CHIMPANZEE; McLennan MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep05956; McLennan M.R., 2012, ORYX, V41, P598; McLennan MR, 2013, INT J PRIMATOL, V34, P585, DOI 10.1007/s10764-013-9683-y; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Morgan David, 2006, P97; Nelleman C., 2002, GREAT APES ROAD AHEA; Ohashi Gaku, 2007, Pan Africa News, V14, P14; Parsons MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110984; Sheil D, 2010, BIOTROPICA, V42, P566, DOI 10.1111/j.1744-7429.2010.00687.x; Stanford CB, 2006, PRIMATES, V47, P91, DOI 10.1007/s10329-005-0148-6; Stokes Emma J., 2001, Animal Cognition, V4, P11, DOI 10.1007/s100710100082; Tokuyama N, 2012, PRIMATES, V53, P215, DOI 10.1007/s10329-012-0298-2; TUTIN CEG, 1995, J HUM EVOL, V28, P597, DOI 10.1006/jhev.1995.1044; van Schaik CP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0339; Hill CM, 2012, BIODIVERS CONSERV, V21, P2569, DOI 10.1007/s10531-012-0318-y; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049142; Williamson E.A., 2005, GORILLA GAZETTE, V18, P8; Williamson EA, 2014, PRIMATES CETACEANS F, P273; Wilson ML, 2007, BEHAVIOUR, V144, P1621, DOI 10.1163/156853907782512137; Woodroffe R, 2005, PEOPLE WILDLIFE CONF; Wrangham Richard, 2000, Microbial Ecology in Health and Disease, V12, P186, DOI 10.1080/089106000750051855	76	3	3	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0169-5347			TRENDS ECOL EVOL	Trends Ecol. Evol.	APR	2015	30	4					215	222		10.1016/j.tree.2015.02.002		8	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CF6PX	WOS:000352679700007		
J	Inagaki, Y; Kashima, TG; Hookway, ES; Tanaka, Y; Hassan, AB; Oppermann, U; Athanasou, NA				Inagaki, Y.; Kashima, T. G.; Hookway, E. S.; Tanaka, Y.; Hassan, A. B.; Oppermann, U.; Athanasou, N. A.			Dentine matrix protein 1 (DMP-1) is a marker of bone formation and mineralisation in soft tissue tumours	VIRCHOWS ARCHIV			English	Article						DMP-1; Soft tissue tumour; Sarcoma; Diagnosis; Bone formation; Mineralisation	TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; OSTEOBLAST; SATB2; BIOMINERALIZATION; OSTEOMALACIA; ACTIVATION; EXPRESSION; OSTEOCYTES; SARCOMAS	Dentine matrix protein 1 (DMP-1) is a non-collagenous matrix protein found in dentine and bone. It is highly expressed by osteocytes and has been identified in primary benign and malignant osteogenic bone tumours. Bone formation and matrix mineralisation are seen in a variety of benign and malignant soft tissue tumours and tumour-like lesions, and in this study, we analysed immunohistochemically the DMP-1 expression in a wide range of soft tissue lesions (n = 254) in order to assess whether DMP-1 expression is useful in the histological diagnosis of soft tissue tumours. Matrix staining of DMP-1 was seen in all cases of myositis ossificans, fibro-osseous tumour of the digits, extraskeletal soft tissue osteosarcoma and in most cases of ossifying fibromyxoid tumour. DMP-1 was also noted in dense collagenous connective tissue of mineralising soft tissue lesions such as tumoural calcinosis, dermatomyositis and calcific tendinitis. DMP-1 was expressed in areas of focal ossification and calcification in synovial sarcoma and other soft tissue tumours. With few exceptions, DMP-1 was not expressed in other benign and malignant soft tissue tumours. Our findings indicate that DMP-1 is a matrix marker of bone formation and mineralisation in soft tissue tumours. DMP-1 expression should be particularly useful in distinguishing extraskeletal osteosarcoma and ossifying fibromyxoid tumour from other sarcomas and in identifying areas of osteoid/bone formation and mineralisation in soft tissue tumours.	[Inagaki, Y.; Kashima, T. G.; Hookway, E. S.; Hassan, A. B.; Oppermann, U.; Athanasou, N. A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7HE, England; [Inagaki, Y.; Tanaka, Y.] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 6348521, Japan	Athanasou, NA (reprint author), Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Windmill Rd, Oxford OX3 7HE, England.	athanasou@ndorms.ox.ac.uk			Oxford NIHR BRU; Sasakawa Foundation; Rosetrees Trust, Sarcoma (UK); Bone Cancer Research Trust	The authors acknowledge the support of the Oxford NIHR BRU, The Sasakawa Foundation, The Rosetrees Trust, Sarcoma (UK) and The Bone Cancer Research Trust. This paper is dedicated to the memory of Takeshi Kashima, who first identified the utility of DMP-1 in bone and soft tissue tumour diagnosis.	Fisher LW, 2004, CLIN CANCER RES, V10, P8501, DOI 10.1158/1078-0432.CCR-04-1072; Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200; Karadag A, 2005, CANCER RES, V65, P11545, DOI 10.1158/0008-5472.CAN-05-2861; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Golub EE, 2011, SEMIN IMMUNOPATHOL, V33, P409, DOI 10.1007/s00281-010-0230-z; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Feng JQ, 2003, J DENT RES, V82, P776; Huang W, 2007, FRONT BIOSCI, V12, P3068, DOI 10.2741/2296; Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607; Conner JR, 2013, HISTOPATHOLOGY, V63, P36, DOI 10.1111/his.12138; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Dragomir A, 2014, AM J CLIN PATHOL, V141, P630, DOI 10.1309/AJCPWW2URZ9JKQJU; Narayanan K, 2002, CONNECT TISSUE RES, V43, P365, DOI 10.1080/03008200290000592; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Kirsch T, 2012, CONNECT TISSUE RES, V53, P438, DOI 10.3109/03008207.2012.730081; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Bonewald LF, 2007, OSTEOPOROSIS, V1, P169; Bonewald LF, 2013, PRIMER METABOLIC BON, P34; Chaplet M, 2003, J BONE MINER RES, V18, P1506, DOI 10.1359/jbmr.2003.18.8.1506; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Fanburg-Smith JC, 1999, HUM PATHOL, V30, P32, DOI 10.1016/S0046-8177(99)90297-6; Fanburg-Smith JC, 2010, MOD SOFT TISSUE PATH, P862; Fen Jian Q, 2002, J Bone Miner Res, V17, P1822; Fletcher Ch, 2013, WHO CLASSIFICATION T; Kashima TG, 2013, VIRCHOWS ARCH, V462, P583, DOI 10.1007/s00428-013-1399-z; Miettinen M, 2010, MOD SOFT TISSUE PATH, P325; Miettinen MM, 2013, WHO CLASSIF TUMOURS, P206; Morozov A, 2010, CLIN CANCER RES, V16, P5630, DOI 10.1158/1078-0432.CCR-09-2886; Rose Andrew, 2013, WHO CLASSIF TUMOURS, P161; Schiavi SC, 2006, NAT GENET, V38, P1230, DOI 10.1038/ng1106-1230; Silvent J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057344; Toyosawa S, 2004, MODERN PATHOL, V17, P573, DOI 10.1038/modpathol.3800084; Vigorita VJ, 2008, ORTHOP PATHOL, P50; Weiss SW, 2008, SOFT TISSUE TUMORS, P1039; YOSHIKAWA H, 1994, CANCER, V74, P842, DOI 10.1002/1097-0142(19940801)74:3<842::AID-CNCR2820740309>3.0.CO;2-B	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	APR	2015	466	4					445	452		10.1007/s00428-014-1706-3		8	Pathology	Pathology	CF7BD	WOS:000352710200010		
J	Iwasaki, H; Ishiguro, M; Nishio, J; Aoki, M; Yokoyama, R; Yokoyama, K; Taguchi, K; Nabeshima, K				Iwasaki, Hiroshi; Ishiguro, Masako; Nishio, Jun; Aoki, Mikiko; Yokoyama, Ryohei; Yokoyama, Koichiro; Taguchi, Kenichi; Nabeshima, Kazuki			Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses	VIRCHOWS ARCHIV			English	Article						Myxoid liposarcoma; Dedifferentiated liposarcoma; Lipoma-like liposarcoma; FUS-DDIT3; Fusion gene	SOFT-TISSUE TUMORS; ACTIVATED RECEPTOR-GAMMA; CELL-LIPOSARCOMA; DEDIFFERENTIATED LIPOSARCOMA; FUSION TRANSCRIPTS; X-RECEPTOR; VARIANTS; DIFFERENTIATION; REARRANGEMENT; BREAKPOINTS	Myxoid liposarcomas (MLSs) with extensive lipoma-like changes (MLSLC) are rare, and it is often difficult to distinguish them from well-differentiated liposarcoma (LS)/dedifferentiated LS (WDLS/DDLS) with myxoid changes. For the characterization of these neoplasms, we studied 8 MLSLCs, 11 ordinary MLSs, 4 WDLSs, and 6 DDLSs. Cytogenetically, MLSLC and ordinary MLS were characterized by t(12;16)(q13;p11) and FUS-DDIT3 fusion gene, whereas WDLS/DDLS lacked the fusion gene but possessed giant marker/ring chromosomes. Both lipoma-like and myxoid components of the same MLSLC exhibited the identical FUS-DDIT3, as confirmed by fluorescence in situ hybridization (FISH) and reverse transcription polymerase chain reaction (RT-PCR). Immunohistochemically, MDM2 and CDK4 were positive in WDLS/DDLS but negative in MLSLC and ordinary MLS. PPAR gamma, C/EBP alpha, adipophilin, and perilipin were found in each type of LS. Adipophilin was expressed chiefly in tiny fat droplets of immature lipoblasts, whereas perilipin showed a strong positive staining in large fat vacuoles of signet ring and multivacuolated lipoblasts. The Ki-67 labeling index was lower in the lipoma-like component of MLSLC when compared with the myxoid component of the same tumors as well as ordinary MLS (p < 0.001). When compared with ordinary MLS, MLSLC may be less aggressive in clinical behavior (rare recurrences or metastases) after a wide surgical excision. In conclusion, the distinction between MLSLC and WDLS/DDLS is important, because of the differences of molecular cytogenetic features as well as clinical behaviors between these distinct sarcomas presenting similar morphologic features. In addition, the combined immunohistochemical detection of adipophilin and perilipin may provide a useful ancillary tool for identification of lipoblastic cells in soft tissue sarcomas.	[Iwasaki, Hiroshi; Ishiguro, Masako; Aoki, Mikiko; Nabeshima, Kazuki] Fukuoka Univ, Dept Pathol, Sch Med, Jonan Ku, Fukuoka 8140180, Japan; [Nishio, Jun] Fukuoka Univ, Dept Orthoped Surg, Sch Med, Jonan Ku, Fukuoka 8140180, Japan; [Yokoyama, Ryohei; Yokoyama, Koichiro] Natl Hosp Org, Dept Orthoped Surg, Kyushu Canc Ctr, Minami Ku, Fukuoka 8111395, Japan; [Taguchi, Kenichi] Natl Hosp Org, Dept Pathol, Kyushu Canc Ctr, Minami Ku, Fukuoka 8111395, Japan	Iwasaki, H (reprint author), Fukuoka Univ, Dept Pathol, Sch Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	iwasaki@fukuoka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23590419]	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant (No. 23590419).	Bildirici I, 2003, J CLIN ENDOCR METAB, V88, P6056, DOI 10.1210/jc.2003-030628; Boland JM, 2012, AM J SURG PATHOL, V36, P1395, DOI 10.1097/PAS.0b013e3182562bc1; Iwasaki H, 2009, PATHOL INT, V59, P501, DOI 10.1111/j.1440-1827.2009.02401.x; Powers MP, 2010, MODERN PATHOL, V23, P1307, DOI 10.1038/modpathol.2010.118; Meis-Kindblom JM, 2001, VIRCHOWS ARCH, V439, P141, DOI 10.1007/s004280100423; Sioletic S, 2013, HISTOPATHOLOGY, V62, P287, DOI 10.1111/j.1365-2559.2012.04348.x; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; Narendra S, 2011, DIAGN MOL PATHOL, V20, P218, DOI 10.1097/PDM.0b013e3182107eb9; Sandberg AA, 2004, CANCER GENET CYTOGEN, V155, P1, DOI 10.1016/j.cancergencyto.2004.08.005; Tallini G, 1996, AM J SURG PATHOL, V20, P1047, DOI 10.1097/00000478-199609000-00002; Hisaoka M, 1999, AM J SURG PATHOL, V23, P1480, DOI 10.1097/00000478-199912000-00005; Iwasaki H, 1998, VIRCHOWS ARCH, V432, P521, DOI 10.1007/s004280050200; Nishio J, 2003, INT J ONCOL, V22, P535; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Evans HL, 2007, AM J SURG PATHOL, V31, P1, DOI 10.1097/01.pas.0000213406.95440.7a; de Vreeze RSA, 2009, MODERN PATHOL, V22, P223, DOI 10.1038/modpathol.2008.164; Antonescu CR, 2000, J MOL DIAGN, V2, P132, DOI 10.1016/S1525-1578(10)60628-9; de Vreeze RSA, 2011, INT J CANCER, V128, P778, DOI 10.1002/ijc.25390; Deyrup AT, 2013, AM J SURG PATHOL, V37, P1373, DOI 10.1097/PAS.0b013e31829562ed; Fletcher Ch, 2013, WHO CLASSIFICATION T; Goldblum JR, 2014, ENZINGER WEISSS SOFT; Hisaoka M, 1998, DIAGN MOL PATHOL, V7, P96, DOI 10.1097/00019606-199804000-00006; Huang HY, 2003, ULTRASTRUCT PATHOL, V27, P217, DOI 10.1080/01913120390225426; Kuroda M, 1997, AM J PATHOL, V151, P735; Mentzel T, 2008, VIRCHOWS ARCH, V453, P197, DOI 10.1007/s00428-008-0624-7; MIETTINEN M., 2010, MODERN SOFT TISSUE P; Nakanishi H, 2004, DIAGN MOL PATHOL, V13, P92, DOI 10.1097/00019606-200406000-00005; Nishio J, 2012, ONCOL REP, V27, P764, DOI 10.3892/or.2011.1584; OHJIMI Y, 1992, CANCER GENET CYTOGEN, V64, P111, DOI 10.1016/0165-4608(92)90339-A; OHJIMI Y, 1992, PATHOL RES PRACT, V188, P736; Panagopoulos I, 1997, ONCOGENE, V15, P1357, DOI 10.1038/sj.onc.1201281; PANAGOPOULOS I, 1994, CANCER RES, V54, P6500; Perez-Mancera PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002569; Shaffer LG, 2013, ISCN 2013 INT SYSTEM; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P291, DOI 10.1016/0165-4608(86)90011-7	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	APR	2015	466	4					453	464		10.1007/s00428-015-1721-z		12	Pathology	Pathology	CF7BD	WOS:000352710200011		
J	Kawasaki, T; Ishida, M; Tada, T; Matsuya, H; Saitoh, M; Sato, A; Suzuki, M; Sugimoto, R; Mue, Y; Uesugi, N; Ishida, K; Ishida, K; Ariga, H; Ichihara, S; Sugai, T; Sapino, A				Kawasaki, Tomonori; Ishida, Motoo; Tada, Takashi; Matsuya, Hideki; Saitoh, Masao; Sato, Ayaka; Suzuki, Masamichi; Sugimoto, Ryo; Mue, Yoshiharu; Uesugi, Noriyuki; Ishida, Kazuyuki; Ishida, Kazushige; Ariga, Hisatetsu; Ichihara, Shu; Sugai, Tamotsu; Sapino, Anna			Well-differentiated neuroendocrine tumor of the breast with recurrence due to needle tract seeding	VIRCHOWS ARCHIV			English	Letter							BIOPSY		[Kawasaki, Tomonori; Sato, Ayaka; Suzuki, Masamichi; Sugimoto, Ryo; Mue, Yoshiharu; Uesugi, Noriyuki; Ishida, Kazuyuki; Sugai, Tamotsu] Iwate Med Univ, Dept Mol Diagnost Pathol, Sch Med, Morioka, Iwate 0208505, Japan; [Ishida, Motoo; Ishida, Kazushige] Ishida Clin, Dept Breast Surg, Morioka, Iwate 0200034, Japan; [Tada, Takashi; Matsuya, Hideki] Yu Ai Hosp, Dept Surg, Morioka, Iwate 0200834, Japan; [Saitoh, Masao] Univ Yamanashi, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan; [Ariga, Hisatetsu] Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 0208505, Japan; [Ichihara, Shu] Natl Hosp Org Nagoya Med Ctr, Dept Pathol, Naka Ku, Nagoya, Aichi 4600001, Japan; [Kawasaki, Tomonori; Sapino, Anna] Univ Turin, Dept Med Sci, I-10126 Turin, Italy	Kawasaki, T (reprint author), Iwate Med Univ, Dept Mol Diagnost Pathol, Sch Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	tomonori@yamanashi.ac.jp					Diaz LK, 1999, AM J ROENTGENOL, V173, P1303; Loughran CF, 2011, BRIT J RADIOL, V84, P869, DOI 10.1259/bjr/77245199; Bussolati G, 2012, WHO CLASSIFICATION T, P62; Chao C, 2001, Breast J, V7, P124, DOI 10.1046/j.1524-4741.2001.007002124.x; Kawasaki T, 2014, HISTOPATHOLOGY, V64, P597, DOI 10.1111/his.12276	5	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	APR	2015	466	4					479	481		10.1007/s00428-014-1704-5		3	Pathology	Pathology	CF7BD	WOS:000352710200014		
J	Singla, A; Dubey, SK; Ali, MA; Inubushi, K				Singla, Ankit; Dubey, Suresh Kumar; Ali, Muhammad Aslam; Inubushi, Kazuyuki			Methane flux from paddy vegetated soil: a comparison between biogas digested liquid and chemical fertilizer	WETLANDS ECOLOGY AND MANAGEMENT			English	Article						Digested liquid; Inorganic fertilizer; Paddy; CH4 flux; DGGE; Microbial biomass	PRODUCTION BY-PRODUCTS; MICROBIAL BIOMASS; COMMUNITY STRUCTURE; RICE; EMISSION; FIELDS; CATTLE; SLURRY	A microcosm-based study was conducted to evaluate the effects of application of biogas digested liquid or chemical fertilizer on CH4 flux, associated methanogenic archaeal community, soil chemical and microbial properties, and aboveground plant biomass in paddy soil. Our results showed that digested liquid application significantly decreased the seasonal and cumulative CH4 flux compared to chemical fertilizer treatment. The application of digested liquid treatment significantly decreased NH4 (+)-N and soluble total nitrogen content without affecting NO3 (-)-N and microbial biomass nitrogen. The soluble organic carbon and microbial biomass carbon contents were nearly similar for digested liquid and chemical fertilizer treatments. Paddy plant biomass (shoot weight, panicle numbers and weight of panicles) were found to be lower in the digested liquid treated containers but it did not affect the cumulative CH4 flux g(-1) yield. Denaturing Gradient Gel Electrophoresis gave similar banding patterns indicating no differences in the methanogenic archaeal diversity among the control, digested liquid and chemical fertilizer treated containers. Thus, the observed decrease in CH4 flux with the application of digested liquid is possibly due to the variation in the soil variables and aboveground plant biomass without affecting the methanogenic archaeal diversity.	[Singla, Ankit; Dubey, Suresh Kumar; Ali, Muhammad Aslam; Inubushi, Kazuyuki] Chiba Univ, Grad Sch Hort, Bioresource Sci, Matsudo, Chiba 2718510, Japan; [Dubey, Suresh Kumar] Banaras Hindu Univ, Dept Bot, Varanasi 221005, Uttar Pradesh, India; [Ali, Muhammad Aslam] Bangladesh Agr Univ, Dept Environm Sci, Mymensingh 2202, Bangladesh	Singla, A (reprint author), Chiba Univ, Grad Sch Hort, Bioresource Sci, Matsudo, Chiba 2718510, Japan.	ankitsingla2607@yahoo.co.in			ICAR (Indian Council of Agricultural Research), India	Ankit Singla is thankful to ICAR (Indian Council of Agricultural Research), India to provide financial support under International Fellowship Scheme to carry out this study. We are also thankful to Mr. Hirokuni Iwasa, Chiba Prefectural Agricultural and Forestry Research Center, Japan and Dr. Masato Nakamura, National Agriculture and Food Research Organization, Japan to provide the biogas digested liquid.	Anderson JM, 1989, HDB METHODS TROPICAL, P42; Watanabe T, 2006, SOIL BIOL BIOCHEM, V38, P1264, DOI 10.1016/j.soilbio.2005.09.020; Nayak DR, 2007, SOIL BIOL BIOCHEM, V39, P1897, DOI 10.1016/j.soilbio.2007.02.003; Arthurson V, 2009, ENERGIES, V2, P226, DOI 10.3390/en20200226; Alotaibi KD, 2011, APPL SOIL ECOL, V48, P227, DOI 10.1016/j.apsoil.2011.03.002; Liu YJ, 2011, IEEE SYS MAN CYBERN, P2011; Singla A, 2014, PADDY WATER ENVIRON, V12, P239, DOI 10.1007/s10333-013-0357-3; Reichardt W, 1997, APPL ENVIRON MICROB, V63, P233; YAGI K, 1990, SOIL SCI PLANT NUTR, V36, P599; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Win KT, 2009, SOIL SCI PLANT NUTR, V55, P190, DOI 10.1111/j.1747-0765.2008.00337.x; Feng YZ, 2012, SOIL BIOL BIOCHEM, V46, P80, DOI 10.1016/j.soilbio.2011.11.016; Walsh JJ, 2012, BIOL FERT SOILS, V48, P889, DOI 10.1007/s00374-012-0681-6; Cheng WG, 2008, GLOBAL CHANGE BIOL, V14, P644, DOI 10.1111/j.1365-2486.2007.01532.x; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Minamikawa K, 2005, AGR ECOSYST ENVIRON, V107, P371, DOI 10.1016/j.agee.2004.10.027; Alotaibi KD, 2013, BIOL FERT SOILS, V49, P129, DOI 10.1007/s00374-012-0704-3; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Mishra Mamata, 2009, Environment Development and Sustainability, V11, P115, DOI 10.1007/s10668-007-9100-9; Bodegom VP, 2001, APPL ENVIRON MICROB, V67, P3586; Carole RS, 1971, MICROCHEM J, V16, P657; Dubey SK, 2014, BIOL FERT SOILS, V50, P369, DOI 10.1007/s00374-013-0858-7; Finocchiaro R, 2014, WETL ECOL MANAG, V22, P305, DOI 10.1007/s11273-013-9331-5; Singla A, 2015, PADDY WATER ENVIRON, V13, P43, DOI 10.1007/s10333-013-0405-z; Inubushi K., 1989, JPN J SOIL SCI PLANT, V60, P318; IPCC, 2007, PHYS SCI BASIS CONTR; MINAMI K, 1994, FERT RES, V37, P167, DOI 10.1007/BF00748935; Möller K., 2009, European Journal of Agronomy, V30, P1, DOI 10.1016/j.eja.2008.06.003; Nakamura M, 2014, PADDY WATER IN PRESS, DOI 10.1007/s10333-013-0375-1; Sakamoto K., 1999, Soil Microorganisms, V53, P57; Sasada Y, 2011, BIOL FERT SOILS, V47, P949, DOI 10.1007/s00374-011-0601-1; Shibahara F., 1997, SOIL SCI PLANT NUTR, V43, P681; Singla A, 2012, J BIOFUELS, V3, P39; Singla A, 2014, J INTEGR AGR, V13, P635, DOI 10.1016/S2095-3119(13)60721-2; Singla A, 2013, BIOL FERT SOILS, V49, P971, DOI 10.1007/s00374-013-0796-4; Singla A, 2013, INT J AGR ENV BIOTEC, V6, P233; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Watanabe A., 1999, J GEOPHYS RES, V104, P623; Watanabe S, 2012, SOIL SCI PLANT NUTR, V58, P224, DOI 10.1080/00380768.2012.661949	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-4861	1572-9834		WETL ECOL MANAG	Wetl. Ecol. Manag.	APR	2015	23	2					139	148		10.1007/s11273-014-9365-3		10	Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CF0FM	WOS:000352218500003		
J	Matsumoto, N; Shimosaka, T				Matsumoto, Nobuhiro; Shimosaka, Takuya			Validation of a quantitative analytical method based on the effective magnetic moment and the Curie-Weiss law	ACCREDITATION AND QUALITY ASSURANCE			English	Article						Potential primary direct method; Paramagnetism; Diamagnetism; Magnetometer; Inorganic analysis		The Curie-Weiss law has been applied to develop a quantitative analytical method referred to as the "effective magnetic moment method" without the use of any reference material for determining the "amount of substance." This nondestructive and non-separation analytical method was validated by using samples of gadolinium oxide (Gd2O3) mixed in silicon oxide. Prior to validation, the magnetic field strength, temperature, and magnetic moment [measured with a superconducting quantum interference device (SQUID) as magnetometer] were calibrated to improve the accuracy of results obtained by this analytical method, using a nuclear magnetic resonance probe magnetometer with a custom-made probe, a platinum resistance thermometer, and a standard reference material of known magnetic moment. For regression analysis of magnetic moment and temperature data, the values of three unknown parameters and their uncertainties were calculated by using a custom-made program based on the nonlinear least-squares method. In the validation results, the relative difference between the mass fractions of Gd2O3 in mixture samples obtained by this method and those obtained by gravimetric blending was approximately 2 %, when the mass fraction of Gd2O3 ranged from 0.04 kg kg(-1) to 1 kg kg(-1) and the mass of the sample ranged from 17 mg to 62 mg. The uncertainty of the mass fraction was approximately 5 %, as evaluated by this analytical method. A prevalent source of uncertainty in this method is the reproducibility of measured magnetic moments in the SQUID.	[Matsumoto, Nobuhiro; Shimosaka, Takuya] Natl Inst Adv Ind Sci & Technol, NMIJ, Tsukuba, Ibaraki, Japan	Matsumoto, N (reprint author), Natl Inst Adv Ind Sci & Technol, NMIJ, AIST Cent 3,1-1-1 Umezono, Tsukuba, Ibaraki, Japan.	nobu-matsumoto@aist.go.jp			NPF; AIST; JSPS KAKENHI [24750077]	We thank members of the Organic Analytical Division of NMIJ/AIST for fruitful discussions on this study. The help extended by Dr. Y Shimizu of NMIJ/AIST in performing measurements using the ultra-microbalance is greatly appreciated. A portion of this work was conducted at the Nano-Processing Facility (NPF), supported by the NPF and AIST. This work was supported by JSPS KAKENHI Grant Number 24750077 (Grant-in-Aid for Young Scientists (B)).	[Anonymous], 2012, 200 JCGM; [Anonymous], 2006, 352006 ISO, V3rd, P31; Takikawa Y, 2010, J PHYS CHEM SOLIDS, V71, P1592, DOI 10.1016/j.jpcs.2010.08.006; Milton MJT, 2001, METROLOGIA, V38, P289, DOI 10.1088/0026-1394/38/4/1; Blundell S, 2001, MAGNETISM CONDENSED; Bud'ko SL, 2006, J MAGN MAGN MATER, V299, P281, DOI 10.1016/j.jmmm.2005.04.014; CHILD HR, 1967, J APPL PHYS, V38, P1381, DOI 10.1063/1.1709632; Deming WE, 1943, STAT ADJUSTMENT DATA; Gans P, 1992, DATA FITTING CHEM SC, P30; International Organization for Standardization, 2001, 61432001 ISO; Kittel C, 1996, INTRO SOLID STATE PH, V14; Matsumoto N, 2012, METROLOGIA, V49, P530, DOI 10.1088/0026-1394/49/4/530; McElfresh M., 1994, FUNDAMENTALS MAGNETI; Mele P, 2009, J PHYS CHEM SOLIDS, V70, P276, DOI 10.1016/j.jpcs.2008.10.010; Shimizu Y, 2008, ACCREDIT QUAL ASSUR, V13, P389, DOI 10.1007/s00769-008-0389-3	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-1775	1432-0517		ACCREDIT QUAL ASSUR	Accredit. Qual. Assur.	APR	2015	20	2					115	124		10.1007/s00769-014-1101-4		10	Chemistry, Analytical; Instruments & Instrumentation	Chemistry; Instruments & Instrumentation	CE4CD	WOS:000351777500005		
J	Tsujimoto, T; Yamamoto-Honda, R; Kajio, H; Kishimoto, M; Noto, H; Hachiya, R; Kimura, A; Kakei, M; Noda, M				Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Kajio, Hiroshi; Kishimoto, Miyako; Noto, Hiroshi; Hachiya, Remi; Kimura, Akio; Kakei, Masafumi; Noda, Mitsuhiko			Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease	ACTA DIABETOLOGICA			English	Article						Severe hypoglycemia; Cancer; Liver cirrhosis; Sepsis; Non-diabetes; 90 Day mortality	INSULIN-INDUCED HYPOGLYCEMIA; QT INTERVAL PROLONGATION; CRITICALLY-ILL PATIENTS; DE-POINTES; ASSOCIATION; RISK; HYPOTHERMIA; SEPSIS; DEATH	The present study examined the clinical conditions and predictors of death in non-diabetic patients with pre-hospital severe hypoglycemia. From January 2006 to March 2012, we retrospectively reviewed the medical records to assess the patients with pre-hospital severe hypoglycemia at a national center in Japan. Severe hypoglycemia was defined as the presence of any hypoglycemic symptoms requiring the medical assistance of another person. The patients were followed up for 90 days after the severe hypoglycemia episode. A total of 59,602 consecutive cases that visited the emergency room were screened, and 530 patients with severe hypoglycemia were included in the subsequent analysis. The mean blood glucose levels in the non-diabetes (non-DM, n = 163) and diabetes (DM, n = 367) groups were 42.9 and 33.7 mg/dL, respectively. The incidence of extremely abnormal QT prolongation (corrected QT interval a parts per thousand yen0.50 s) was high in both groups [22.1 vs. 14.7 % (P = 0.11)]. Mortalities within 90 days after severe hypoglycemia were significantly higher in the non-DM group than in the DM group [20.3 vs. 1.6 % (P < 0.001)]. In addition to patient age, preexisting advanced liver disease and cancer, and the coexistence of sepsis, a blood glucose level of < 40 mg/dL was identified as a strong predictor of death in the non-DM group using multivariate Cox proportional hazards models (hazard ratio 3.75; 95 % confidence interval 1.52-9.27; P = 0.004). Death in non-diabetic patients with severe hypoglycemia was independently associated not only with age, advanced liver disease, cancer, and sepsis, but also with the blood glucose level upon arrival.	[Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Kajio, Hiroshi; Kishimoto, Miyako; Noto, Hiroshi; Hachiya, Remi] Natl Ctr Global Hlth & Med, Dept Diabet Endocrinol & Metab, Tokyo 1628655, Japan; [Tsujimoto, Tetsuro; Kakei, Masafumi] Jichi Med Univ, Grad Sch Med, Div Gen Med, Shimotsuke, Tochigi, Japan; [Yamamoto-Honda, Ritsuko; Kishimoto, Miyako; Noto, Hiroshi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Kimura, Akio] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Emergency Med & Crit Care, Tokyo 1628655, Japan; [Kakei, Masafumi] Jichi Med Univ, Sch Med, Saitama Med Ctr, Dept Comprehens Med 1, Saitama, Japan	Noda, M (reprint author), Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	mnoda@hosp.ncgm.go.jp					Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011; Passman R, 2001, MED CLIN N AM, V85, P321, DOI 10.1016/S0025-7125(05)70318-7; Brown DJA, 2012, NEW ENGL J MED, V367, P1930, DOI 10.1056/NEJMra1114208; TEASDALE G, 1974, LANCET, V2, P81; HILSTED J, 1984, DIABETOLOGIA, V26, P328; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c; LANG CH, 1993, METABOLISM, V42, P1351, DOI 10.1016/0026-0495(93)90137-D; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Drew BJ, 2010, CIRCULATION, V121, P1047, DOI 10.1161/CIRCULATIONAHA.109.192704; Bonds DE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4909; Christensen TF, 2010, DIABETOLOGIA, V53, P2036, DOI 10.1007/s00125-010-1802-0; FISHER BM, 1987, DIABETOLOGIA, V30, P841; FREINKEL N, 1972, NEW ENGL J MED, V287, P841, DOI 10.1056/NEJM197210262871702; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Gruden G, 2012, DIABETES CARE, V35, P125, DOI 10.2337/dc11-1739; LANG CH, 1991, METABOLISM, V40, P585, DOI 10.1016/0026-0495(91)90048-2; MILLER SI, 1980, AM J MED, V68, P649, DOI 10.1016/0002-9343(80)90250-8; Nielsen JB, 2013, J AM COLL CARDIOL, V61, P2557, DOI 10.1016/j.jacc.2013.03.032; Pickham D, 2012, CRIT CARE MED, V40, P394, DOI 10.1097/CCM.0b013e318232db4a; Robinson RTCE, 2003, DIABETES, V52, P1469, DOI 10.2337/diabetes.52.6.1469; Ssekitoleko R, 2011, CRIT CARE MED, V39, P2271, DOI 10.1097/CCM.0b013e3182227bd2	27	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0940-5429	1432-5233		ACTA DIABETOL	Acta Diabetol.	APR	2015	52	2					307	314		10.1007/s00592-014-0640-9		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CE4YD	WOS:000351835500010		
J	Yanagawa, N; Kawata, N; Matsuura, Y; Sugiura, T; Suzuki, T; Kasai, H; Irie, R; Iesato, K; Tada, Y; Tanabe, N; Suzuki, Y; Tatsumi, K				Yanagawa, Noriyuki; Kawata, Naoko; Matsuura, Yukiko; Sugiura, Toshihiko; Suzuki, Toshio; Kasai, Hajime; Irie, Ryosuke; Iesato, Ken; Tada, Yuji; Tanabe, Nobuhiro; Suzuki, Yoichi; Tatsumi, Koichiro			Effect of threshold on the correlation between airflow obstruction and low attenuation volume in smokers assessed by inspiratory and expiratory MDCT	ACTA RADIOLOGICA			English	Article						Chronic obstructive pulmonary disease; multidetector computed tomography; low attenuation volume; threshold	PULMONARY-FUNCTION TESTS; COMPUTED-TOMOGRAPHY; MICROSCOPIC MORPHOMETRY; CT DENSITOMETRY; LUNG-FUNCTION; EMPHYSEMA; DISEASE; QUANTIFICATION; DIMENSIONS; LIMITATION	Background: The estimation of emphysematous changes is very sensitive to computed tomography (CT) threshold level. In clinical practice, the predetermined threshold is usually set at -950 Hounsfield units (HU) for the detection of low attenuation volume (LAV). However, threshold levels that are tightly connected to pulmonary function abnormalities have not been determined. Purpose: To determine the threshold level for calculating an LAV that closely reflects airflow limitation in patients with chronic obstructive pulmonary disease (COPD). Material and Methods: Seventy-six consecutive non-COPD smokers and COPD patients underwent paired inspiratory and expiratory multidetector CT (MDCT). LAV% was segmented every 10HU between -1000 and -750HU to examine the correlation between LAV% and indexes of obstructive impairment. Results: LAV% gradually increased as the threshold level increased on both inspiratory and expiratory images. LAV% on inspiratory images was higher than that on expiratory images at all threshold levels between -1000 and -750HU. The threshold level that correlated with obstructive impairment differed between the two images: -930HU on inspiratory and -870 or -880HU on expiratory images. Conclusion: LAV% dramatically changed according to the threshold level on both inspiratory and expiratory images, indicating that LAV% is dependent on the attenuation threshold level in patients with COPD. The threshold linking LAV% to airflow limitation was higher on expiratory than on inspiratory images.	[Yanagawa, Noriyuki; Kawata, Naoko; Matsuura, Yukiko; Sugiura, Toshihiko; Suzuki, Toshio; Kasai, Hajime; Irie, Ryosuke; Iesato, Ken; Tada, Yuji; Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba 2608670, Japan; [Suzuki, Yoichi] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba 2608670, Japan	Kawata, N (reprint author), Chiba Univ, Grad Sch Med, Dept Respirol, Chuou Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	chumito_03@yahoo.co.jp					American Thoracic Society European Respiratory Society, 2004, STAND DIAGN MAN PAT; GODDARD PR, 1982, CLIN RADIOL, V33, P379, DOI 10.1016/S0009-9260(82)80301-2; Eda S, 1997, AM J RESP CRIT CARE, V155, P1290; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102; Madani A, 2006, RADIOLOGY, V238, P1036, DOI 10.1148/radiol.2382042196; Gevenois PA, 1996, RADIOLOGY, V199, P825; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Park KJ, 1999, RADIOLOGY, V211, P541; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653; Yuan R, 2007, CHEST, V132, P617, DOI 10.1378/chest.06-2325; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; BLAND JM, 1986, LANCET, V1, P307; Boedeker KL, 2004, RADIOLOGY, V232, P295, DOI 10.1148/radiol.2321030383; Camiciottoli G, 2013, SARCOIDOSIS VASC DIF, V30, P17; Camiciottoli G, 2006, CHEST, V129, P558, DOI 10.1378/chest.129.3.558; Global Initiative for Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kauczor HU, 2002, EUR RADIOL, V12, P2757, DOI 10.1007/s00330-002-1514-z; Kemerink GJ, 1996, J COMPUT ASSIST TOMO, V20, P24, DOI 10.1097/00004728-199601000-00006; Madani A, 2007, RADIOLOGY, V243, P250, DOI 10.1148/radiol.2431060194; Makita M, 2007, THORAX, V62, P932; Mascalchi M, 2012, ACTA RADIOL, V53, P53, DOI 10.1258/ar.2011.110419; Matsuoka S, 2006, J COMPUT ASSIST TOMO, V30, P669, DOI 10.1097/00004728-200607000-00019; Mluller NL, 1988, CHEST, V94, P782; Zaporozhan J, 2005, CHEST, V128, P3212, DOI 10.1378/chest.128.5.3212	30	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	APR	2015	56	4					438	446		10.1177/0284185114528489		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE1TG	WOS:000351594300007		
J	Obokata, M; Negishi, K; Marwick, TH; Kurosawa, K; Ishida, H; Ito, K; Ogawa, T; Ando, Y; Kurabayashi, M				Obokata, Masaru; Negishi, Kazuaki; Marwick, Thomas H.; Kurosawa, Koji; Ishida, Hideki; Ito, Kyoko; Ogawa, Tetsuya; Ando, Yoshitaka; Kurabayashi, Masahiko			Comparison of different interdialytic intervals among hemodialysis patients on their echocardiogram-based cardiovascular parameters	AMERICAN HEART JOURNAL			English	Article							PRESERVED EJECTION FRACTION; HEMODYNAMIC DETERMINANTS; VENTRICULAR EFFICIENCY; OXYGEN-CONSUMPTION; BLOOD-PRESSURE; HEART-FAILURE; VOLUME; DYSFUNCTION; SUDDEN; ENERGY	Background Although cardiovascular events in hemodialysis (HD) patients are the most frequent on the day after a long (2 days) interdialytic interval (IDT), it has been uncertain whether accumulation or elimination of large extracellular fluid volume, electrolyte, and/or uremic substances is the culprit for this. We sought to test our hypothesis that the long IDT alters echocardiographic parameters at rest and during exercise in stable maintenance HD patients compared with other IDTs. Methods We performed a cross-sectional comparison using 1-way repeated analysis of variance or Friedman test of echocardiograms at 3 different IDTs, just after HD, after short IDT (1 day), and after long IDT, among 80 stable Japanese outpatients (age 61 +/- 9 years, 60 males) on thrice weekly maintenance. End-systolic elastance (Ees), arterial elastance (Ea), and pressure-volume area (PVA) were estimated using a noninvasive single-beat technique. Ventricular-arterial coupling was assessed by Ea/Ees ratio. Measurements were repeated after 2-minute handgrip stress to evaluate cardiac reserve. Results Resting left ventricular end-diastolic volume index and stroke volume index were significantly larger after a 1-day IDT compared with just after HD and even more after a 2-day IDT. Although Ees, Ea, and Ea/Ees ratio at rest remained similar between short and long intervals, stroke work (SW) and PVA were higher after the long interval. During handgrip stress, a significant increase in Ea without corresponding rise in Ees was observed only after long IDT, resulting in decreased stroke volume index, SW, and SW/PVA efficiency. Conclusions In a selective Japanese outpatient population on maintenance HD, there were no differences in resting cardiovascular function measured by echocardiography at 3 different IDTs. However, exercise-induced afterload mismatch assessed by the changes in Ea, SV, SW, and SW/PVA efficiency was most pronounced in individuals after the long IDT compared with other IDTs. Our findings report potential pathophysiologic echocardiographic parameters that attempt to explain why cardiovascular events are highest on the day after the long IDT compared to other IDTs in dialysis patients.	[Obokata, Masaru; Negishi, Kazuaki; Kurosawa, Koji; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 3718511, Japan; [Negishi, Kazuaki; Marwick, Thomas H.] Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Ishida, Hideki; Ito, Kyoko; Ogawa, Tetsuya; Ando, Yoshitaka] Hidaka Hosp, Takasaki, Gunma, Japan; [Ito, Kyoko] Heisei Hidaka Clin, Dept Nephrol, Takasaki, Gunma, Japan; [Ogawa, Tetsuya] Tokyo Womens Med Univ, Med Ctr East, Dept Med, Tokyo, Japan	Negishi, K (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	kazz.negishi@nifty.com	Negishi, Kazuaki/J-7242-2014	Negishi, Kazuaki/0000-0002-9086-2565	Select Foundation	We thank Tomiko Shimoda, RN, for study management and Hitomi Arima, RMS, for her assistance with the echocardiographic studies. Dr Negishi is supported by an award from the Select Foundation.	Ujino K, 2006, AM J CARDIOL, V98, P1185, DOI 10.1016/j.amjcard.2006.05.040; Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1; Osranek M, 2008, HYPERTENSION, V51, P275, DOI 10.1161/HYPERTENSIONAHA.107.097964; Chen CH, 2001, J AM COLL CARDIOL, V38, P2028, DOI 10.1016/S0735-1097(01)01651-5; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; SUGA H, 1979, AM J PHYSIOL, V236, pH498; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Borlaug BA, 2010, J AM COLL CARDIOL, V56, P845, DOI 10.1016/j.jacc.2010.03.077; SUGA H, 1990, PHYSIOL REV, V70, P247; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; Warner JG, 1999, J AM COLL CARDIOL, V33, P1567, DOI 10.1016/S0735-1097(99)00048-0; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; TAKAOKA H, 1993, CIRCULATION, V87, P59; BURKHOFF D, 1986, AM J PHYSIOL, V250, P1021; Chen CH, 2003, HYPERTENSION, V42, P257, DOI 10.1161/01.HYP.0000085857.95253.79; Hewitson CL, 2007, J INTERN MED, V262, P571, DOI 10.1111/j.1365-2796.2007.01848.x; Borlaug Barry A, 2008, Heart Fail Clin, V4, P23, DOI 10.1016/j.hfc.2007.10.001; National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC), 2012, KIDN DIS STAT US; NOZAWA T, 1988, CIRCULATION, V77, P1116; Sasso L, 2013, INT J CARDIOL, V168, P1553, DOI 10.1016/j.ijcard.2012.12.024; The Japanese Society for Dialysis Therapy, 2012, J AM SOC NEPHROL, V18, P2644	23	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-8703	1097-5330		AM HEART J	Am. Heart J.	APR	2015	169	4					523	+		10.1016/j.ahj.2015.02.003		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6MC	WOS:000351949500015		
J	Iriyama, N; Fujisawa, S; Yoshida, C; Wakita, H; Chiba, S; Okamoto, S; Kawakami, K; Takezako, N; Kumagai, T; Inokuchi, K; Ohyashiki, K; Taguchi, J; Yano, S; Igarashi, T; Kouzai, Y; Morita, S; Sakamoto, J; Sakamaki, H				Iriyama, Noriyoshi; Fujisawa, Shin; Yoshida, Chikashi; Wakita, Hisashi; Chiba, Shigeru; Okamoto, Shinichiro; Kawakami, Kimihiro; Takezako, Naoki; Kumagai, Takashi; Inokuchi, Koiti; Ohyashiki, Kazuma; Taguchi, Jun; Yano, Shingo; Igarashi, Tadahiko; Kouzai, Yasuji; Morita, Satoshi; Sakamoto, Junichi; Sakamaki, Hisashi			Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group	AMERICAN JOURNAL OF HEMATOLOGY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; KINASE INHIBITOR THERAPY; 2-YEAR FOLLOW-UP; TRIAL DASISION; IMATINIB; MULTICENTER; EXPANSION; NILOTINIB; CELLS	To investigate the factors that affect molecular responses on dasatinib treatment in patients with chronic-phase chronic myeloid leukemia (CML-CP), we performed a clinical trial named the D-First study. Fifty-two patients with newly diagnosed CML-CP were enrolled in this study and received 100 mg dasatinib once daily. A deep molecular response (DMR) was defined as <50 copies/g RNA of BCR-ABL1 transcript value corrected by GAPDH, which ensures <0.01% of BCR-ABL1 transcript value according to International Scale (BCR-ABL1(IS)). The halving time for BCR-ABL1 transcripts was calculated using transcript levels before dasatinib treatment, transcript levels after 3 months of treatment, and the treatment time between these two points. In terms of molecular response, 38 of 51 (75%) patients reached major molecular response (MMR) by 12 months, and the rate of DMR by 18 months was 59% (30/51). While both BCR-ABL1 transcript levels before treatment and a shorter halving time of BCR-ABL1 transcripts (14 days) were significant factors affecting achievement of MMR by 12 months, the Sokal score at diagnosis was not associated with MMR. Importantly, the halving time was the only factor that predicted achievement of DMR by 18 months. We showed that patients with CML-CP treated with dasatinib can be stratified according to the early treatment response as determined by the halving time of BCR-ABL1 transcripts. These data emphasize the significance of the early response from dasatinib treatment in achieving a DMR. (; NCT01464411) Am. J. Hematol. 90:282-287, 2015. (c) 2014 Wiley Periodicals, Inc.	[Iriyama, Noriyoshi] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo 1738610, Japan; [Fujisawa, Shin] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa, Japan; [Yoshida, Chikashi] Natl Hosp Org Mito Med Ctr, Dept Hematol, Ibaraki, Japan; [Wakita, Hisashi] Narita Red Cross Hosp, Div Hematol & Oncol, Japanese Red Cross Soc, Narita, Japan; [Chiba, Shigeru] Univ Tsukuba, Dept Hematol, Fac Med, Ibaraki, Japan; [Okamoto, Shinichiro] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo, Japan; [Kawakami, Kimihiro] Kagawa Prefectural Cent Hosp, Dept Hematol & Clin Oncol, Hiroshima, Kagawa, Japan; [Takezako, Naoki] Natl Hosp Org Disaster Med Ctr, Dept Hematol, Tokyo, Japan; [Kumagai, Takashi] Ohme Municipal Gen Hosp, Dept Hematol, Tokyo, Japan; [Inokuchi, Koiti] Nippon Med Sch, Dept Internal Med, Div Hematol, Tokyo 113, Japan; [Ohyashiki, Kazuma] Tokyo Med Univ, Dept Hematol, Tokyo 1608402, Japan; [Taguchi, Jun] Japanese Red Cross Shizuoka Hosp, Dept Hematol, Shizuoka, Japan; [Yano, Shingo] Jikei Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Hematol, Tokyo, Japan; [Igarashi, Tadahiko] Gunma Prefectural Canc Ctr, Div Hematol & Oncol, Gunma, Japan; [Kouzai, Yasuji] Tokyo Metropolitan Tama Synth Med Ctr, Dept Hematol, Tokyo, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Sakamoto, Junichi] Tokai Cent Hosp, Gifu, Japan; [Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan	Iriyama, N (reprint author), Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol,Itabashi Ku, 30-1 Oyaguchi Kami Cho, Tokyo 1738610, Japan.	iriyama.noriyoshi@nihon-u.ac.jp			Epidemiological and Clinical Research Information Network (ECRIN)	Contract grant sponsor: Epidemiological and Clinical Research Information Network (ECRIN).	Furui Y, 2013, TRANSFUSION, V53, P2190, DOI 10.1111/trf.12390; Yoshida C, 2012, INT J CLIN ONCOL, V17, P584, DOI 10.1007/s10147-011-0328-x; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Nagata Y, 2010, INT J HEMATOL, V91, P799, DOI 10.1007/s12185-010-0565-1; Kumagai T, 2014, INT J HEMATOL, V99, P41, DOI 10.1007/s12185-013-1483-9; Kreutzman A, 2011, LEUKEMIA, V25, P1587, DOI 10.1038/leu.2011.135; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Fujisawa S, 2014, INT J HEMATOL, V99, P141, DOI 10.1007/s12185-013-1470-1; Kantarjian H, 2011, J CLIN ONCOL, V29, P3173, DOI 10.1200/JCO.2010.33.4169; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Ohnishi K, 2012, CANCER SCI, V103, P1071, DOI 10.1111/j.1349-7006.2012.02253.x; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Rousselot P, 2014, J CLIN ONCOL, V32, P424, DOI 10.1200/JCO.2012.48.5797; Kim DH, 2009, HAEMATOL-HEMATOL J, V94, P135, DOI 10.3324/haematol.13151; Tauchi T, 2011, LEUKEMIA RES, V35, P585, DOI 10.1016/j.leukres.2010.10.027; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Branford S, 2014, BLOOD, V124, P511, DOI 10.1182/blood-2014-03-566323; Hanfstein B, 2014, LEUKEMIA, V28, P1988, DOI 10.1038/leu.2014.153; Hughes TP, 2014, BLOOD, V123, P1353, DOI 10.1182/blood-2013-06-510396; Inokuchi Koiti, 2014, J Clin Exp Hematop, V54, P197; Lee SJ, 2011, AM J HEMATOL, V86, P346, DOI 10.1002/ajh.21980; LINHARES MIS, 1989, MICROBIOL IMMUNOL, V33, P975	24	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-8609	1096-8652		AM J HEMATOL	Am. J. Hematol.	APR	2015	90	4					282	287		10.1002/ajh.23923		6	Hematology	Hematology	CE2WE	WOS:000351680800011		
J	Shimojima, K; Okamoto, N; Tamasaki, A; Sangu, N; Shimada, S; Yamamoto, T				Shimojima, Keiko; Okamoto, Nobuhiko; Tamasaki, Akiko; Sangu, Noriko; Shimada, Shino; Yamamoto, Toshiyuki			An Association of 19p13.2 Microdeletions With Malan Syndrome and Chiari Malformation	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						19p13.2 microdeletion; developmental delay; Sotos syndrome-like features (Sotos syndrome 2); Malan syndrome; Chiari malformation type I; NFIX	DNA-BINDING/DIMERIZATION DOMAIN; MARSHALL-SMITH-SYNDROME; SOTOS-LIKE; MENTAL-RETARDATION; DELETION; NFIX; OVERGROWTH; MUTATIONS; FEATURES; CACNA1A	Patients with microdeletions in the 19p13.2 chromosomal region show developmental delays, overgrowth, and distinctive features with big head appearances. These manifestations are now recognized as Sotos syndrome-like features (Sotos syndrome 2) or Malan syndrome. We identified three female patients with 19p13.2 deletions involving NFIX, a gene responsible for Malan syndrome. We compared the genotypic and phenotypic data of these patients with those of the patients previously reported. The most of the clinical features were found to overlap; however, Chiari malformation type I was observed in two of the three patients evaluated in this study. Because Chiari malformation type I has never been reported in the patients with NSD1-related Sotos syndrome, this finding indicates the possible role of 19p13.2 deletion in patients with mimicking features of Sotos syndrome but have negative NSD1 testing results. (c) 2015 Wiley Periodicals, Inc.	[Shimojima, Keiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Shimojima, Keiko; Sangu, Noriko; Shimada, Shino; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Tamasaki, Akiko] Tottori Univ, Div Child Neurol, Tottori 680, Japan; [Sangu, Noriko] Tokyo Womens Med Univ, Dept Dent Surg, Tokyo 1628666, Japan; [Shimada, Shino] Tokyo Womens Med Univ, Dept Pediat, Tokyo 1628666, Japan	Yamamoto, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, 8-1 Kawada Cho,Shinjuku Ward, Tokyo 1628666, Japan.	yamamoto.toshiyuki@twmu.ac.jp			Precursory Research for Embryonic Science and Technology (PRESTO); Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS); Japan Epilepsy Research Foundation (JERF); Kanae Foundation; Health Labor Sciences Research Grants;  [24791090]	Grant sponsor: Precursory Research for Embryonic Science and Technology (PRESTO); Grant sponsor: Japan Science and Technology Agency (JST); Grant sponsor: Grant-in-Aid for Young Scientists; Grant number: 24791090; Grant sponsor: Japan Society for the Promotion of Science (JSPS); Grant sponsor: Japan Epilepsy Research Foundation (JERF); Grant sponsor: Kanae Foundation; Grant sponsor: Health Labor Sciences Research Grants.	Adam MP, 2005, AM J MED GENET A, V137A, P117, DOI 10.1002/ajmg.a.30580; Piper M, 2011, J COMP NEUROL, V519, P3532, DOI 10.1002/cne.22721; Auvin S, 2009, EPILEPSIA, V50, P2501, DOI 10.1111/j.1528-1167.2009.02189.x; Priolo M, 2012, GENE, V511, P103, DOI 10.1016/j.gene.2012.08.040; Jensen DR, 2009, AM J MED GENET A, V149A, P396, DOI 10.1002/ajmg.a.32691; Shimojima K, 2011, AM J MED GENET A, V155A, P732, DOI 10.1002/ajmg.a.33891; Yoneda Y, 2012, J HUM GENET, V57, P207, DOI 10.1038/jhg.2012.7; Nimmakayalu M, 2013, AM J MED GENET A, V161A, P1105, DOI 10.1002/ajmg.a.35790; Lysy PA, 2009, AM J MED GENET A, V149A, P2564, DOI 10.1002/ajmg.a.33056; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Malan V, 2010, AM J HUM GENET, V87, P189, DOI 10.1016/j.ajhg.2010.07.001; Engels H, 2007, NEUROLOGY, V68, P743, DOI 10.1212/01.wnl.0000256367.70365.e0; Dolan M, 2010, GENET MED, V12, P503, DOI 10.1097/GIM.0b013e3181e59291; Bonaglia MC, 2010, EUR J HUM GENET, V18, P1302, DOI 10.1038/ejhg.2010.115; Gallant NM, 2011, AM J MED GENET A, V155A, P2871, DOI 10.1002/ajmg.a.34286; Klaassens M, 2014, EUR J HUM GENET, DOI [10.1038/ejhg.2014.162, DOI 10.1038/EJHG.2014.162]; Marangi G, 2012, AM J MED GENET A, V158A, P888, DOI 10.1002/ajmg.a.35254; Natiq A, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-40; Nussbaum R, 2007, THOMPSON THOMPSON GE, P600; Van der Aa N, 2010, EUR J MED GENET, V53, P291, DOI 10.1016/j.ejmg.2010.05.006	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	APR	2015	167	4					724	730		10.1002/ajmg.a.36959		7	Genetics & Heredity	Genetics & Heredity	CE7KQ	WOS:000352019000010		
J	Fujiwara, I; Murakami, Y; Niihori, T; Kanno, J; Hakoda, A; Sakamoto, O; Okamoto, N; Funayama, R; Nagashima, T; Nakayama, K; Kinoshita, T; Kure, S; Matsubara, Y; Aoki, Y				Fujiwara, Ikuma; Murakami, Yoshiko; Niihori, Tetsuya; Kanno, Junko; Hakoda, Akiko; Sakamoto, Osamu; Okamoto, Nobuhiko; Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko; Kinoshita, Taroh; Kure, Shigeo; Matsubara, Yoichi; Aoki, Yoko			Mutations in PIGL in a Patient with Mabry Syndrome	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						glycosylphosphatidylinositol anchor; Mabry syndrome; hyperphosphatasia mental retardation syndrome; genetic testing	MENTAL-RETARDATION SYNDROME; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; ANCHOR-SYNTHESIS PATHWAY; GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; INTELLECTUAL DISABILITY; CAUSE HYPERPHOSPHATASIA; CONGENITAL-ANOMALIES; DEVELOPMENTAL DELAY; SEQUENCING DATA; HYPOTONIA	Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures. Recent studies have revealed mutations in PIGV, PIGW, PIGO, PGAP2, and PGAP3 (genes that encode molecules of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway) in patients with HPMRS. We performed whole-exome sequencing of a patient with severe intellectual disability, distinctive facial appearance, fragile nails, and persistent increased serum levels of ALP. The result revealed a compound heterozygote with a 13-bp deletion in exon 1 (c.36_48del) and a two-base deletion in exon 2 (c.254_255del) in phosphatidylinositol glycan anchor, class L (PIGL) that caused frameshifts resulting in premature terminations. The 13-bp deletion was inherited from the father, and the two-base deletion was inherited from the mother. Expressing c.36_48del or c.254_255del cDNA with an HA-tag at the C- or N-terminus in PIGL-deficient CHO cells only partially restored the surface expression of GPI-anchored proteins (GPI-APs). Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities. Our patient did not have colobomas, congenital heart defects, or early onset migratory ichthyosiform dermatosis and hence was diagnosed with HPMRS, and not CHIME syndrome. These results suggest that frameshift mutations that result in premature termination in PIGL cause a phenotype that is consistent with HPMRS. (c) 2015 Wiley Periodicals, Inc.	[Fujiwara, Ikuma; Kanno, Junko; Hakoda, Akiko; Sakamoto, Osamu; Kure, Shigeo] Tohoku Univ, Dept Pediat, Sch Med, Sendai, Miyagi 9808574, Japan; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Niihori, Tetsuya; Matsubara, Yoichi; Aoki, Yoko] Tohoku Univ, Dept Med Genet, Sch Med, Sendai, Miyagi 9808574, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Sendai, Miyagi 9808574, Japan; [Matsubara, Yoichi] Natl Res Inst Child Hlth & Dev, Tokyo, Japan	Aoki, Y (reprint author), Tohoku Univ, Dept Med Genet, Sch Med, I-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	aokiy@med.tohoku.ac.jp	Kinoshita, Taroh/C-7353-2009		Biomedical Research Core of Tohoku University Graduate School of Medicine; Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science [C: 25461535, C: 23590363]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25129705]	Grant sponsor: Biomedical Research Core of Tohoku University Graduate School of Medicine; Grant sponsor: Ministry of Health, Labor and Welfare of Japan; Grant sponsor: Japan Society for the Promotion of Science; Grant numbers: C: 25461535, C: 23590363; Grant sponsor: Takeda Science Foundation; Grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant number: 25129705.	Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Watanabe R, 1999, BIOCHEM J, V339, P185, DOI 10.1042/0264-6021:3390185; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; WARE RE, 1994, BLOOD, V83, P2418; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; KRUSE K, 1988, J PEDIATR-US, V112, P436, DOI 10.1016/S0022-3476(88)80331-7; MABRY CC, 1970, J PEDIATR-US, V77, P74, DOI 10.1016/S0022-3476(70)80047-6; Chiyonobu T, 2014, J MED GENET, V51, P203, DOI 10.1136/jmedgenet-2013-102156; Nakamura K, 2014, EPILEPSIA, V55, pE13, DOI 10.1111/epi.12508; Ng Bobby G, 2012, AM J HUM GENET, V90, P685; Ohba C, 2014, NEUROGENETICS, V15, P85, DOI 10.1007/s10048-013-0384-7; Schnur RE, 1997, AM J MED GENET, V72, P24, DOI 10.1002/(SICI)1096-8628(19971003)72:1<24::AID-AJMG5>3.0.CO;2-V; SHASHI V, 1995, J MED GENET, V32, P465, DOI 10.1136/jmg.32.6.465; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	25	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	APR	2015	167	4					777	785		10.1002/ajmg.a.36987		9	Genetics & Heredity	Genetics & Heredity	CE7KQ	WOS:000352019000016		
J	Takenouchi, T; Sakamoto, Y; Torii, C; Hata, K; Kosaki, R; Kosaki, K				Takenouchi, Toshiki; Sakamoto, Yoshiaki; Torii, Chiharu; Hata, Kenichiro; Kosaki, Rika; Kosaki, Kenjiro			Mosaic Overgrowth with Fibroadipose Hyperplasia Due to AKT1 Mutation	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Letter							ACTIVATING MUTATIONS; PROTEUS SYNDROME; PIK3CA CAUSE; LIPOMATOSIS; GERMLINE; SPECTRUM		[Takenouchi, Toshiki] Keio Univ, Dept Pediat, Sch Med, Tokyo 1608582, Japan; [Sakamoto, Yoshiaki] Keio Univ, Dept Plast & Reconstruct Surg, Sch Med, Tokyo 1608582, Japan; [Torii, Chiharu; Kosaki, Kenjiro] Keio Univ, Ctr Med Genet, Sch Med, Tokyo 1608582, Japan; [Hata, Kenichiro] Natl Ctr Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Kosaki, Rika] Natl Ctr Child Hlth & Dev, Div Med Genet, Tokyo, Japan	Kosaki, K (reprint author), Keio Univ, Ctr Med Genet, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kkosaki@z3.keio.jp					Rios JJ, 2013, HUM MOL GENET, V22, P444, DOI 10.1093/hmg/dds440; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Keppler-Noreuil KM, 2014, AM J MED GENET A, V164, P1713, DOI 10.1002/ajmg.a.36552; Cohen MM, 2014, CLIN GENET, V85, P111, DOI 10.1111/cge.12266; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Castiglioni C, 2014, AM J MED GENET A, V164, P2365, DOI 10.1002/ajmg.a.36651; Cohen ASA, 2014, AM J MED GENET A, V164, P2360, DOI 10.1002/ajmg.a.36622; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; Kosaki R, 2014, AM J MED GENET A, V164, P993, DOI 10.1002/ajmg.a.36364; Maclellan RA, 2014, PLAST RECONSTR SURG, V133, p12E, DOI 10.1097/01.prs.0000436822.26709.7c; Rasmussen M, 2014, AM J MED GENET A, V164, P1318, DOI 10.1002/ajmg.a.36454; Wee JS, 2014, JAMA DERMATOL, V150, P990, DOI 10.1001/jamadermatol.2013.10368	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4825	1552-4833		AM J MED GENET A	Am. J. Med. Genet. A	APR	2015	167	4					907	909		10.1002/ajmg.a.36947		3	Genetics & Heredity	Genetics & Heredity	CE7KQ	WOS:000352019000040		
J	Watanabe, Y; Shibuya, M; Someya, T				Watanabe, Yuichiro; Shibuya, Masako; Someya, Toshiyuki			DRD2 Ser311Cys Polymorphism and Risk of Schizophrenia	AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS			English	Letter							DOPAMINE D2 RECEPTOR; PATHWAY GENE POLYMORPHISMS; MOLECULAR VARIANT; NO ASSOCIATION; CYS311 VARIANT; SUSCEPTIBILITY; POPULATION; METAANALYSIS; SER311/CYS311; DISORDERS		[Watanabe, Yuichiro; Shibuya, Masako; Someya, Toshiyuki] Niigata Univ Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Watanabe, Yuichiro] Niigata Univ, Sch Med, Comprehens Med Educ Ctr, Div Med Educ,Fac Med, Niigata, Japan; [Shibuya, Masako] Niigata Univ, Hlth Adm Ctr, Headquarters Hlth Adm, Niigata, Japan	Watanabe, Y (reprint author), Niigata Univ Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.	yuichiro@med.niigata-u.ac.jp					Gupta M, 2009, PHARMACOGENOMICS, V10, P277, DOI 10.2217/14622416.10.2.277; Srivastava V, 2010, NEUROPSYCHOBIOLOGY, V61, P64, DOI 10.1159/000265131; Serretti A, 2000, MOL PSYCHIATR, V5, P270, DOI 10.1038/sj.mp.4000726; Dubertret C, 2004, SCHIZOPHR RES, V67, P75, DOI 10.1016/S0920-9964(03)00220-2; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; Arinami T, 1996, AM J MED GENET, V67, P133, DOI 10.1002/(SICI)1096-8628(19960409)67:2<133::AID-AJMG2>3.0.CO;2-T; ARINAMI T, 1994, LANCET, V343, P703, DOI 10.1016/S0140-6736(94)91581-4; ASHERSON P, 1994, LANCET, V343, P1045; Chen CH, 1996, AM J MED GENET, V67, P418, DOI 10.1002/(SICI)1096-8628(19960726)67:4<418::AID-AJMG19>3.0.CO;2-M; Crawford F, 1996, AM J MED GENET, V67, P483, DOI 10.1002/(SICI)1096-8628(19960920)67:5<483::AID-AJMG8>3.0.CO;2-L; Dubertret C, 2010, PROG NEURO-PSYCHOPH, V34, P492, DOI 10.1016/j.pnpbp.2010.02.003; Fan H, 2010, NEUROSCI LETT, V477, P53, DOI 10.1016/j.neulet.2009.11.017; Fujiwara Y, 1997, EUR NEUROL, V38, P6, DOI 10.1159/000113436; Harano Mutsuo, 1997, Kurume Medical Journal, V44, P201; HATTORI M, 1994, BIOCHEM BIOPH RES CO, V202, P757, DOI 10.1006/bbrc.1994.1995; Himei A, 2002, PSYCHIAT CLIN NEUROS, V56, P97, DOI 10.1046/j.1440-1819.2002.00935.x; Hori H, 2001, AM J MED GENET, V105, P176, DOI 10.1002/ajmg.1196; ITOKAWA M, 1993, BIOCHEM BIOPH RES CO, V196, P1369, DOI 10.1006/bbrc.1993.2404; Itokawa M, 2010, J PHARMACOL SCI, V114, P1, DOI 10.1254/jphs.10R07FM; Jonsson EG, 2003, AM J MED GENET B, V119B, P28, DOI 10.1002/ajmg.b.20004; Kaneshima M, 1997, PSYCHIAT CLIN NEUROS, V51, P379, DOI 10.1111/j.1440-1819.1997.tb02603.x; Laurent C., 1994, Psychiatric Genetics, V4, P229, DOI 10.1097/00041444-199400440-00007; Morimoto K, 2002, NEUROPSYCHOPHARMACOL, V26, P794, DOI 10.1016/S0893-133X(01)00421-3; NANKO S, 1994, LANCET, V343, P1044, DOI 10.1016/S0140-6736(94)90167-8; NOTHEN MM, 1994, LANCET, V343, P1301, DOI 10.1016/S0140-6736(94)92194-6; Ohara K, 1996, BIOL PSYCHIAT, V40, P1209, DOI 10.1016/0006-3223(95)00673-7; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Sasaki T, 1996, AM J MED GENET, V67, P415, DOI 10.1002/(SICI)1096-8628(19960726)67:4<415::AID-AJMG18>3.0.CO;2-M; SHAIKH S, 1994, LANCET, V343, P1045; SOBELL J, 1994, LANCET, V344, P621, DOI 10.1016/S0140-6736(94)92011-7; Spurlock G, 1998, AM J MED GENET, V81, P24, DOI 10.1002/(SICI)1096-8628(19980207)81:1<24::AID-AJMG5>3.0.CO;2-N; Tanaka T, 1996, AM J MED GENET, V67, P208, DOI 10.1002/(SICI)1096-8628(19960409)67:2<208::AID-AJMG12>3.0.CO;2-N; Tsutsumi A, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-43; Verga M, 1997, SCHIZOPHR RES, V25, P117, DOI 10.1016/S0920-9964(97)00013-3; Vijayan NN, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-34; Watanabe Y, 2012, GENET MOL RES, V11, P1142, DOI 10.4238/2012.April.27.13; Yao J, 2015, AM J MED GENET B, V168, P1, DOI 10.1002/ajmg.b.32281	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4841	1552-485X		AM J MED GENET B	Am. J. Med. Genet. B	APR	2015	168	3					224	228		10.1002/ajmg.b.32303		5	Genetics & Heredity; Psychiatry	Genetics & Heredity; Psychiatry	CE8RF	WOS:000352111100010		
J	Koizumi, H; Kano, M; Yamamoto, A; Saito, M; Maruko, I; Kawasaki, R; Sekiryu, T; Okada, AA; Iida, T				Koizumi, Hideki; Kano, Mariko; Yamamoto, Akiko; Saito, Masaaki; Maruko, Ichiro; Kawasaki, Ryo; Sekiryu, Tetsuju; Okada, Annabelle A.; Iida, Tomohiro			Short-Term Changes in Choroidal Thickness After Aflibercept Therapy for Neovascular Age-Related Macular Degeneration	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							RETINAL ANGIOMATOUS PROLIFERATION; OPTICAL COHERENCE TOMOGRAPHY; VEGF TRAP-EYE; INTRAVITREAL AFLIBERCEPT; PHOTODYNAMIC THERAPY; RANIBIZUMAB; VASCULOPATHY; VERTEPORFIN; BEVACIZUMAB; HYPERPERMEABILITY	PURPOSE: To investigate changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration (AMD). DESIGN: Retrospective, consecutive, interventional case series. METHODS: This study included 102 eyes of 102 patients with treatment-naive neovascular AMD. All 102 eyes underwent 3 consecutive monthly 2.0 mg intravitreal aflibercept injections at baseline, 1 month, and 2 months. Choroidal thickness during 3 months were evaluated using either swept-source optical coherence tomography (OCT) or enhanced-depth imaging OCT. RESULTS: Of the 102 eyes, 46 eyes (45.1%) were diagnosed as typical neovascular AMD and 56 eyes (54.9%) as polypoidal choroidal vasculopathy. After intravitreal aflibercept injections, the mean subfoveal choroidal thickness decreased from 252.0 +/- 99.7 mu m at baseline to 217.9 +/- 95.6 mu m at 3 months (P < .0001; percentage change from baseline, 86.5%). Mean choroidal thickness measured at 3 mm from the foveal center in the superior, inferior, temporal, and nasal directions also decreased significantly from 258.7 +/- 85.9 mu m to 236.4 +/- 84.6 mu m, 229.9 +/- 93.0 mu m to 208.6 +/- 86.5 mu m, 237.4 +/- 86.5 mu m to 214.6 +/- 79.5 mu m, and 183.7 +/- 97.0 mu m to 162.3 +/- 90.6 mu m, respectively (P < .0001 for all directions). Both subtypes of neovascular AMD demonstrated a similar trend toward decreasing choroidal thickness during the follow-up period. CONCLUSIONS: Choroidal thickness significantly decreased not only at the foveal center but also in the entire macula after 3 monthly intravitreal aflibercept injections for neovascular AMD. (C) 2015 by Elsevier Inc. All rights reserved.	[Koizumi, Hideki; Maruko, Ichiro; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo 1628666, Japan; [Kano, Mariko; Saito, Masaaki; Sekiryu, Tetsuju] Fukushima Med Univ, Dept Ophthalmol, Fukushima, Japan; [Yamamoto, Akiko; Okada, Annabelle A.] Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Kawasaki, Ryo] Yamagata Univ, Fac Med, Dept Publ Hlth, Yamagata 990, Japan	Koizumi, H (reprint author), Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	koizumi.hideki@twmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology-Japan [25670739]	This study was supported in part by Grant No. 25670739 from the Ministry of Education, Culture, Sports, Science and Technology-Japan (H.K.).	Schmidt-Erfurth U, 2002, INVEST OPHTH VIS SCI, V43, P830; Bakall B, 2013, AM J OPHTHALMOL, V156, P15, DOI 10.1016/j.ajo.2013.02.017; Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Gaudreault J, 2007, RETINA-J RET VIT DIS, V27, P1260; Tilton RG, 1999, INVEST OPHTH VIS SCI, V40, P689; Stewart MW, 2012, BRIT J OPHTHALMOL, V96, P1157, DOI 10.1136/bjophthalmol-2011-300654; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Chang AA, 2014, OPHTHALMOLOGY, V121, P188, DOI 10.1016/j.ophtha.2013.08.035; Maruko I, 2013, AM J OPHTHALMOL, V156, P548, DOI 10.1016/j.ajo.2013.03.041; Ho VY, 2013, AM J OPHTHALMOL, V156, P23, DOI 10.1016/j.ajo.2013.02.009; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yonekawa Y, 2013, AM J OPHTHALMOL, V156, P29, DOI 10.1016/j.ajo.2013.03.030; Kumar N, 2013, RETINA-J RET VIT DIS, V33, P1605, DOI 10.1097/IAE.0b013e31828e8551; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030; Julien S, 2014, BRIT J OPHTHALMOL, V98, P813, DOI 10.1136/bjophthalmol-2013-304019; Browning DJ, 2012, AM J OPHTHALMOL, V154, P222, DOI 10.1016/j.ajo.2012.04.020; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Lowe J, 2007, EXP EYE RES, V85, P425, DOI 10.1016/j.exer.2007.05.008; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Ogasawara Masashi, 2012, Nippon Ganka Gakkai Zasshi, V116, P643; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; Yamazaki T, 2012, OPHTHALMOLOGY, V119, P1621, DOI 10.1016/j.ophtha.2012.02.022; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Cho H, 2013, BRIT J OPHTHALMOL, V97, P1032, DOI 10.1136/bjophthalmol-2013-303344; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Kim JH, 2013, AM J OPHTHALMOL, V155, P743, DOI 10.1016/j.ajo.2012.11.001; Yamazaki T, 2014, RETINA-J RET VIT DIS, V34, P1316, DOI 10.1097/IAE.0000000000000086; Ellabban Abdallah A, 2012, Clin Ophthalmol, V6, P837, DOI 10.2147/OPTH.S30907; Gass JD, 1996, STEREOSCOPIC ATLAS M, P1038; Klais CM, 2005, ARCH OPHTHALMOL-CHIC, V123, P1149, DOI 10.1001/archopht.123.8.1149; KU DD, 1993, AM J PHYSIOL, V265, pH586	40	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					627	633		10.1016/j.ajo.2014.12.025		7	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400002		
J	Manabe, S; Shiragami, C; Hirooka, K; Izumibata, S; Tsujikawa, A; Shiraga, F				Manabe, Saki; Shiragami, Chieko; Hirooka, Kazuyuki; Izumibata, Saeko; Tsujikawa, Akitaka; Shiraga, Fumio			Change of Regional Choroid Thickness After Reduced-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY	PURPOSE: To evaluate macular choroidal thickness after reduced-fluence photodynamic therapy (PDT) for chronic central serous chorioretinopathy (CSC). DESIGN: Prospective, consecutive, interventional case series. METHODS: Twenty-two eyes with chronic CSC were treated with reduced-fluence PDT. Macular choroidal thickness was examined using spectral-domain optical coherence tomography with a 3-dimensinonal radial scan protocol in the choroidal mode before and 1, 3, and 6 -months after the treatment. The mean choroidal thickness in the Early Treatment Diabetic Retinopathy Study grid (center, inner circle, and outer circle) was compared between before and after therapy, as well as between treated eyes and 54 volunteer normal eyes. RESULTS: Chronic CSC eyes showed significantly thicker choroids in the macular area compared with normal controls (P < .0001). After the single treatment session, subretinal fluid resolved completely in all eyes, and there were no recurrences during the study period. Choroidal thickness Within the center area and inner circle showed a significant reduction at all time points after treatment (P < .05). The choroidal thickness in the outer circle showed a statistically significant reduction at 1 and 3 months but not at 6 months. After treatment, the choroidal thickness reduced to the normal values at the center and inner circle, but was still significantly thicker in the outer circle (P < .01). CONCLUSION: Chronic CSC eyes showed significantly thicker choroids in the macular area. After reduced-fluence PDT, macular choroidal thickness beCame thinner within 6 months of treatment. (C) 2015 by Elsevier Inc. All rights reserved.	[Manabe, Saki; Shiragami, Chieko; Hirooka, Kazuyuki; Izumibata, Saeko; Tsujikawa, Akitaka] Kagawa Univ, Fac Med, Dept Ophthalmol, Kagawa 7610793, Japan; [Shiraga, Fumio] Okayama Univ, Dept Ophthalmol, Okayama, Japan	Shiragami, C (reprint author), Kagawa Univ, Fac Med, Dept Ophthalmol, 1750-1 Ikenobe Miki Cho, Kagawa 7610793, Japan.	chappi@kms.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (Tokyo, Japan) [26462689]; Pfizer (Tokyo, Japan); Bayer (Whippany, New Jersey, USA); Novartis (Tokyo, Japan); Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science (Tokyo, Japan); Santen (Osaka, Japan); Ministry of Health, Labour and Welfare, Japan (Tokyo, Japan)	Dr Hirooka received funding from a Grant-in-Aid for Scientific Research (No. 26462689) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Tokyo, Japan); Dr Tsujikawa received funding from Pfizer (Tokyo, Japan), Bayer (Whippany, New Jersey, USA), Novartis (Tokyo, Japan), the Ministry of Health, Labour and Welfare, and Japan Society for the Promotion of Science (Tokyo, Japan); Dr Shiraga received funding from Santen (Osaka, Japan) and the Ministry of Health, Labour and Welfare, Japan (Tokyo, Japan).	ABE S, 1995, JPN J PHYSIOL, V45, P347, DOI 10.2170/jjphysiol.45.347; Alkin Zeynep, 2014, Clin Ophthalmol, V8, P685, DOI 10.2147/OPTH.S58617; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; Nicolo M, 2014, AM J OPHTHALMOL, V157, P1033, DOI 10.1016/j.ajo.2014.01.022; Jirarattanasopa P, 2012, OPHTHALMOLOGY, V119, P1666, DOI 10.1016/j.ophtha.2012.02.021; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; Kuroda S, 2013, RETINA-J RET VIT DIS, V33, P302, DOI 10.1097/IAE.0b013e318263d11f; Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005; Chan WM, 2008, RETINA-J RET VIT DIS, V28, P85, DOI 10.1097/IAE.0b013e318156777f; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Bae SH, 2014, OPHTHALMOLOGY, V121, P558, DOI 10.1016/j.ophtha.2013.09.024; Garg SP, 1997, BRIT J OPHTHALMOL, V81, P962, DOI 10.1136/bjo.81.11.962; Gass J, 1967, AM J OPHTHALMOL, V63, P587; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1921, DOI 10.1097/IAE.0b013e31822bf6b1; Razavi S, 2014, AM J OPHTHALMOL, V157, P85; Saito M, 2013, BRIT J OPHTHALMOL, V97, P775, DOI 10.1136/bjophthalmol-2012-302349; Spaide RF, 1996, RETINA-J RET VIT DIS, V16, P203, DOI 10.1097/00006982-199616030-00004; Tewari HK, 2013, INVEST OPHTH VIS SCI, V47, P3474; Tittl M, 2003, ARCH OPHTHALMOL-CHIC, V121, P975, DOI 10.1001/archopht.121.7.975; Yamashita A, 2010, AM J OPHTHALMOL, V149, P465, DOI 10.1016/j.ajo.2009.09.020	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					644	651		10.1016/j.ajo.2015.01.006		8	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400004		
J	Tanaka, Y; Shimada, N; Ohno-Matsui, K				Tanaka, Yuichiro; Shimada, Noriaki; Ohno-Matsui, Kyoko			Extreme Thinning or Loss of Inner Neural Retina Along the Staphyloma Edge in Eyes With Pathologic Myopia	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRACHOROIDAL CAVITATION; SWEPT-SOURCE; NERVE	PURPOSE: To investigate the morphologic changes along the edge of posterior staphyloma in highly myopic eyes with patchy chorioretinal atrophy and to identify the relationship between retinal thinning and the visual field (VF) defects found in these eyes. DESIGN: Retrospective, observational case series. METHODS: Twenty eyes (17 patients) with pathologic myopia (myopic refractive error >= 8 diopters or an axial length >= 26.5 mm) and patchy atrophy along the staphyloma edge were analyzed retrospectively. The VFs were obtained by Goldmann kinetic perimetry. RESULTS: In the area of patchy atrophy, the inner retinal tissue was very thin or completely absent. Any remnants of the retinal tissue appeared to be adherent to the layer of large choroidal vessels or to the sclera. The. mean thickness of the retina at its thinnest point in the area was 51.6 +/- 29.0 mu m in 20 eyes. The retina was thinner than 50 mu m at its thinnest point in 12 (60.0%) of the 20 eyes, and the mean retinal thickness at its thinnest point in these 12 eyes was 32.1 +/- 16.0 mu m (range, 4 to 49 mu m). Nineteen eyes (VF of 1 eye was not determined) had very similar VF findings by Goldmann perimetry, that is, a defect of the sector corresponding to the course of retinal nerve fiber over the patchy atrophy. CONCLUSIONS: The results show that the thickness of not only the outer retina, but also of most of the inner retina, including the nerve fiber layer, is significantly thinner at the staphyloma edge. Such damage to the inner retina along the siaphyloma edge causes the VF defects in highly myopic eyes. (C) 2015 by Elsevier Inc. All rights reserved.	[Tanaka, Yuichiro; Shimada, Noriaki; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo 113, Japan; [Tanaka, Yuichiro] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan	Ohno-Matsui, K (reprint author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 113, Japan.	k.ohno.oph@tmd.ac.jp			Japan Soceity for the Promotion of Science, Tokyo, Japan [25670727]	Supported in part by Research Grant 25670727 from the Japan Soceity for the Promotion of Science, Tokyo, Japan. Involved in Design of study (Y.T., N.S., K.O.M.); Conduct of study (Y.T.); Literature search (Y.T., N.S., K.O.M.); Critical revision of article (N.S., K.O.M.); Obtaining funding (K.O.M.); and Writing article (Y.T., N.S., K.O.M.). The authors thank Professor Emeritus Duco Hamasaki of the Bascom Palmer Eye Institute for his critical discussion and final manuscript revision.	Akagi T, 2013, AM J OPHTHALMOL, V155, P927, DOI 10.1016/j.ajo.2012.12.014; Ohno-Matsui K, 2014, OPHTHALMOLOGY, V121, P1798, DOI 10.1016/j.ophtha.2014.03.035; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Ohno-Matsui K, 2011, AM J OPHTHALMOL, V152, P256, DOI 10.1016/j.ajo.2011.01.052; Ohno-Matsui K, 2012, AM J OPHTHALMOL, V154, P382, DOI 10.1016/j.ajo.2012.02.010; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ohno-Matsui K, 2012, OPHTHALMOLOGY, V119, P1685, DOI 10.1016/j.ophtha.2012.01.047; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Curtin BJ, 1985, THE MYOPIAS, P277; Curtin B J, 1977, Trans Am Ophthalmol Soc, V75, P67; OhnoMatsui K, 1996, RETINA-J RET VIT DIS, V16, P29; Ohno-Matsui K, 2013, PATHOLOGIC MYOPIA, P177; Ohno-Matsui K., 2014, PATHOLOGIC MYOPIA, P187; Pruett R C, 1998, Curr Opin Ophthalmol, V9, P16, DOI 10.1097/00055735-199806000-00004; Spaide RF, 2013, PATHOLOGIC MYOPIA, P167; Tokoro T, 1998, ATLAS POSTERIOR FUND, P5	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					677	682		10.1016/j.ajo.201.5.01.004		6	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400008		
J	Kimura, S; Morizane, Y; Hosokawa, M; Shiode, Y; Kawata, T; Doi, S; Matoba, R; Hosogi, M; Fujiwara, A; Inoue, Y; Shiraga, F				Kimura, Shuhei; Morizane, Yuki; Hosokawa, Mio; Shiode, Yusuke; Kawata, Tetsuhiro; Doi, Shinichiro; Matoba, Ryo; Hosogi, Mika; Fujiwara, Atsushi; Inoue, Yasushi; Shiraga, Fumio			Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy Treated by Vitrectomy and Subretinal Tissue Plasminogen Activator	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							MACULAR DEGENERATION; NATURAL-HISTORY; PNEUMATIC DISPLACEMENT; INTRAVITREAL INJECTION; RANIBIZUMAB; BEVACIZUMAB; GAS; PHARMACOKINETICS; EYES	PURPOSE: To evaluate vitrectomy with subretinal tissue plasminogen activator (t-PA) injection, and air tamponade, followed by intravitreal anti-vascular endothelial growth factor (VEGF) therapy for submacular hemorrhage in polypoidal choroidal vasculopathy (PCV). DESIGN: Prospective, interventional case series. METHODS: SETTING: Two clinics. PATIENTS: Fifteen eyes of 15 consecutive patients (mean age 72 7 years) with submacular hemorrhage attributable to PCV. INCLUSION CRITERIA: PCV diagnosis with unorganized submacular hemorrhage greater than 500 pm thick. EXCLUSION CRITERIA: Submacular hemorrhage attributable to macular diseases (eg, high myopia, typical age-related macular degeneration, retinal angiomatous proliferation, and angioid streaks). INTERVENTION: Vitrectomy with 4000 IU t-PA injected subretinally and fluid/air exchange. Patients remained facedown for 3 days after surgery. Anti-VEGF drugs were administered as exudative changes required. MAIN OUTCOME MEASURES: Submacular hemorrhage displacement from the macula and changes in best-corrected visual acuities (BCVAs). RESULTS: Mean time from onset to surgery was 9.5 4.5 (range, 5-21) days. Mean follow-up period was 9.4 +/- 3.1 (range, 6-17) months. Surgery successfully displaced submacular hemorrhages from the macula in all eyes. Mean BCVA at baseline (0.98 +/- 0.44) had improved significantly both 1 month after surgery (0.41 +/- 0.25, P < .01) and at final visits (0.23 +/- 0.25, P < .001). In all eyes, exudative retinal changes relapsed after surgery but were completely resolved by anti-VEGF injections. No complications occurred in any patients. CONCLUSION: Treating submacular hemorrhage with vitrectomy and subretinal t-PA injection, followed by intravitreal anti-VEGF therapy, is a promising strategy for improving visual acuity in PCV patients warranting further investigation. (C) 2015 by Elsevier Inc. All rights reserved.	[Kimura, Shuhei; Morizane, Yuki; Hosokawa, Mio; Shiode, Yusuke; Kawata, Tetsuhiro; Doi, Shinichiro; Matoba, Ryo; Hosogi, Mika; Fujiwara, Atsushi; Shiraga, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Okayama 7008558, Japan; [Inoue, Yasushi] Inoue Eye Clin, Okayama, Japan	Kimura, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, 2-5-1 Shikata Cho Kita Ku, Okayama, Okayama 7008558, Japan.	shuheik@cc.okayama-u.ac.jp					Ohji M, 1998, ARCH OPHTHALMOL-CHIC, V116, P1326; Ahn SJ, 2014, INVEST OPHTH VIS SCI, V55, P567, DOI 10.1167/iovs.13-13054; Christoforidis JB, 2013, RETINA-J RET VIT DIS, V33, P946, DOI 10.1097/IAE.0b013e3182753b12; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478; Fine HF, 2010, RETINA-J RET VIT DIS, V30, P1588, DOI 10.1097/IAE.0b013e3181e2263c; van Zeeburg EJT, 2013, OPHTHALMOLOGICA, V229, P1, DOI 10.1159/000343066; Shiraga F, 1999, AM J OPHTHALMOL, V128, P147, DOI 10.1016/S0002-9394(99)00078-1; Chen CY, 2007, RETINA-J RET VIT DIS, V27, P321, DOI 10.1097/01.iae.0000237586.48231.75; Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; Olivier S, 2004, OPHTHALMOLOGY, V111, P1201, DOI 10.1016/j.ophtha.2003.10.020; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Kakinoki M, 2012, INVEST OPHTH VIS SCI, V53, P5877, DOI 10.1167/iovs.12-10164; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; Jung JH, 2010, RETINA-J RET VIT DIS, V30, P865, DOI 10.1097/IAE.0b013e3181c969e9; Hillenkamp J, 2010, GRAEF ARCH CLIN EXP, V248, P5, DOI 10.1007/s00417-009-1158-7; Abraham P, 2010, AM J OPHTHALMOL, V150, P315, DOI 10.1016/j.ajo.2010.04.011; Treumer F, 2012, BRIT J OPHTHALMOL, V96, P708, DOI 10.1136/bjophthalmol-2011-300655; Haupert CL, 2001, AM J OPHTHALMOL, V131, P208, DOI 10.1016/S0002-9394(00)00734-0; Hattenbach LO, 2001, OPHTHALMOLOGY, V108, P1485, DOI 10.1016/S0161-6420(01)00648-0; Uyama M, 1999, ARCH OPHTHALMOL-CHIC, V117, P1035; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; [Anonymous], 1909, ARCH OPHTHALMOL, V117, P1329; Guthoff R, 2011, RETINA-J RET VIT DIS, V31, P36, DOI 10.1097/IAE.0b013e3181e37884; Lalwani Geeta A, 2009, Am J Ophthalmol, V148, P43, DOI 10.1016/j.ajo.2009.01.024; BENNETT SR, 1990, AM J OPHTHALMOL, V109, P33; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Kamei M, 1999, AM J OPHTHALMOL, V128, P739, DOI 10.1016/S0002-9394(99)00239-1; Arias Luis, 2010, Clin Ophthalmol, V4, P67; Matsuo T, 2001, ACTA OPHTHALMOL SCAN, V79, P533, DOI 10.1034/j.1600-0420.2001.790522.x; Mayer WJ, 2011, ACTA OPHTHALMOL, V91, P274; Okubo A, 2010, ACTA OPHTHALMOL, V88, pe107, DOI 10.1111/j.1755-3768.2009.01850.x; Spaide RF, 1994, RETINA, V15, P100; Treumer F, 2009, BR J OPHTHALMOL, V94, P48; Tsymanava A, 2011, ACTA OPHTHALMOL, V90, P633	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					683	689		10.1016/j.ajo.2014.12.020		7	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400009		
J	Hashimoto, H; Kishi, S				Hashimoto, Hideaki; Kishi, Shoji			Ultra-Wide-Field Fundus Autofluorescence in Multiple Evanescent White Dot Syndrome	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OCCULT OUTER RETINOPATHY	PURPOSE: To observe the progression of affected lesions using ultra-wide-field fundus autofluorescence (FAF) in multiple evanescent white dot syndrome. DESIGN: Retrospective, observational case series. METHODS: SETTING: Institutional. PATIENT POPULATION: 14 eyes of 13 patients (mean age, 35.8 years) with acute disease unilaterally. OBSERVATION PROCEDURES: Patients underwent ultra-wide-field FAF, spectral-domain optical coherence tomography (SD OCT), multifocal electroretinography (mfERG), and Goldmann or automated perimetry; the best-corrected visual acuity (BCVA) and refractive error were measured. MAIN OUTCOME MEASURE: Ability of ultra-wide-field FAF "to detect lesions with greater sensitivity compared with color fundus photography. RESULTS: Ultra-wide-field FAF imaging enabled improved visualization of the affected lesions and showed that the core lesion was in the posterior fundus involving the peripapillary retina and posterior pole and surrounded by hyper-autofluorescent spots outside the vascular arcade. The posterior lesions expanded rapidly and peripheral spots spread farther peripherally and reached a maximal extent during the acute stage. During follow-up, the peripheral hyper-autofluorescent spots resolved and then hyper-autofluorescence of the posterior fundus gradually faded. SD OCT showed diffuse disruption of the photoreceptor inner segment/outer segment junction (IS/OS) in the posterior fundus during the acute stage. The correlation between the IS/OS abnormality and hyper-autofluorescent areas was unclear. The disrupted IS/OS was "restored with normalization of the FAF. CONCLUSIONS: Ultra-wide-field FAF showed that the lesions arise from the peripapillary retina and the posterior pole and spread peripherally in a centrifugal manner during the acute stage. The hyper-autofluorescent spots faded from the periphery in a centripetal manner. (C) 2015 by Elsevier Inc. All rights reserved.	[Hashimoto, Hideaki; Kishi, Shoji] Gunma Univ, Sch Med, Dept Ophthalmol, Maebashi, Gunma 3718511, Japan	Hashimoto, H (reprint author), Gunma Univ, Sch Med, Dept Ophthalmol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	hidehashi0111@gmail.com					Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Li DJ, 2009, OPHTHALMOLOGY, V116, P762, DOI 10.1016/j.ophtha.2008.12.060; Jampol LM, 2003, AM J OPHTHALMOL, V135, P376, DOI 10.1016/S0002-9394(02)02088-3; Spaide RF, 2010, RETINA-J RET VIT DIS, V30, P1441, DOI 10.1097/IAE.0b013e3181ee5ce8; Baglivo E, 1996, AM J OPHTHALMOL, V122, P431; Obana A, 1996, RETINA-J RET VIT DIS, V16, P97; JAMPOL LM, 1984, ARCH OPHTHALMOL-CHIC, V102, P671; Hangai M, 2009, ARCH OPHTHALMOL-CHIC, V127, P1307, DOI 10.1001/archophthalmol.2009.250; Asano T, 2004, JPN J OPHTHALMOL, V48, P486, DOI 10.1007/s10384-004-0107-6; Fine HF, 2009, ARCH OPHTHALMOL-CHIC, V127, P66, DOI 10.1001/archophthalmol.2008.530; Joseph A, 2013, OPHTHAL SURG LAS IM, V44, P588, DOI 10.3928/23258160-20131105-08; MCCOLLUM CJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P13; Spaide RF, 2007, ATLAS FUNDUS AUTOFLU, P207; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1881	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					698	706		10.1016/j.ajo.2015.01.015		9	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400011		
J	Toyokawa, N; Kimura, H; Matsumura, M; Kuroda, S				Toyokawa, Noriko; Kimura, Hideya; Matsumura, Miy; Kuroda, Shinichiro			Incidence of Late-onset Ocular Hypertension Following Uncomplicated Pars Plana Vitrectomy in Pseudophakic Eyes	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OPEN-ANGLE GLAUCOMA; INTRAVITREAL TRIAMCINOLONE ACETONIDE; MACULAR HOLE SURGERY; INTRAOCULAR-PRESSURE; TRABECULAR MESHWORK; CATARACT; LENS; PHACOEMULSIFICATION; PREVALENCE; CLEARANCE	PURPOSE: To determine the incidence of late-onset ocular hypertension following uncomplicated vitrectomy in pseudophakic eyes with an open angle. DESIGN: A retrospective observational case series. METHODS: Seven hundred and sixty-seven eyes of 767 patients that underwent vitrectomy combined with cataract surgery in 1 eye were studied. There were 383 men and 384 women. The indications for vitrectomy were: 308 eyes with rhegmatogenous retinal detachment, 202 eyes with epiretinal membrane, 169 eyes with macular hole, 44 eyes with vitreous hemorrhage, 16 eyes with subretinal hemorrhage, 15 eyes with vitreomacular traction syndrome, 12 eyes with vitreous opacity, and 1 eye with retinoschisis. Of these, 176 eyes underwent vitrectomy alone because of previous cataract surgery. Late-onset ocular hypertension was defined as an intraocular pressure (IOP) > 21 mm Hg that developed more than 2 months postoperatively in at least 2 postoperative visits. An increase in the IOP > 4 mm Hg over the preoperative TOP was necessary. Eyes with ocular hypertension, glaucoma (suspect), or a possibility of KW elevation were excluded. RESULTS: The mean age was 63 +/- 11 years. The mean follow-up duration after vitrectomy was 47.8 +/- 25.3 months. Thirty-two eyes (4.2%) developed late-onset ocular hypertension. The mean age was 60 +/- 10 years. The mean interval between vitrectomy and development of ocular hypertension was 31.1 +/- 26.0 months. There were no significant differences in the incidence of late-onset ocular hypertension and the vitreoretinal disease for vitrectomy, sex, or gauge of instruments for vitrectomy. CONCLUSION: Long-term TOP monitoring is necessary after vitrectomy. (C) 2015 by Elsevier Inc. All rights reserved.	[Toyokawa, Noriko; Kimura, Hideya; Matsumura, Miy; Kuroda, Shinichiro] Nagata Eye Clin, Nara, Nara 6310844, Japan	Toyokawa, N (reprint author), Nagata Eye Clin, 1147 Kitayamada Hourai, Nara, Nara 6310844, Japan.	noritama0620@topaz.ocn.ne.jp					KAHN MG, 1983, INVEST OPHTH VIS SCI, V24, P1283; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; HAN DP, 1989, OPHTHALMOLOGY, V96, P1357; [Anonymous], 1990, ARCH OPHTHALMOL, V108, P958; MELBERG NS, 1995, OPHTHALMOLOGY, V102, P1466; DEBUSTROS S, 1988, AM J OPHTHALMOL, V105, P160; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; Shingleton BJ, 1999, J CATARACT REFR SURG, V25, P885, DOI 10.1016/S0886-3350(99)00107-8; Cheng LY, 2001, AM J OPHTHALMOL, V132, P881, DOI 10.1016/S0002-9394(01)01263-6; Luk FOJ, 2009, RETINA-J RET VIT DIS, V29, P218, DOI 10.1097/IAE.0b013e31818ba9ca; MARGHERIO RR, 1985, OPHTHALMOLOGY, V92, P1075; Siegfried CJ, 2010, INVEST OPHTH VIS SCI, V51, P5731, DOI 10.1167/iovs.10-5666; SCHINDLER RH, 1982, AM J OPHTHALMOL, V93, P415; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Kumar DM, 2007, J GLAUCOMA, V16, P334; Chin HS, 2005, RETINA-J RET VIT DIS, V25, P556, DOI 10.1097/00006982-200507000-00002; Chang S, 2006, AM J OPHTHALMOL, V141, P1033, DOI 10.1016/j.ajo.2006.02.014; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; Chen CJ, 1998, OPHTHALMOLOGY, V105, P94, DOI 10.1016/S0161-6420(98)91470-1; Fujikawa M, 2014, GRAEFES ARCH CLIN EX, V252, P389; Ki-I Y, 2013, JPN J OPHTHALMOL, V57, P57, DOI 10.1007/s10384-012-0207-7; Koreen L, 2012, RETINA-J RET VIT DIS, V32, P160, DOI 10.1097/IAE.0b013e318217fffb; Lalezary M, 2011, RETINA-J RET VIT DIS, V31, P679, DOI 10.1097/IAE.0b013e3181ff0d5a; RADIUS RL, 1984, AM J OPHTHALMOL, V97, P738; Thompson JT, 1996, AM J OPHTHALMOL, V121, P615; Tons CB, 2009, MED DIAGNOSIS THERAP, VOne, P55; Tranos P, 2004, BRIT J OPHTHALMOL, V88, P341, DOI 10.1136/bjo.2003.028076	30	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					727	732		10.1016/j.ajo.2015.01.010		6	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400015		
J	Yokoi, N; Uchino, M; Uchino, Y; Dogru, M; Kawashima, M; Komuro, A; Sonomura, Y; Kato, H; Tsubota, K; Kinoshita, S				Yokoi, Norihiko; Uchino, Miki; Uchino, Yuichi; Dogru, Murat; Kawashima, Motoko; Komuro, Aoi; Sonomura, Yukiko; Kato, Hiroaki; Tsubota, Kazuo; Kinoshita, Shigeru			Importance of Tear Film Instability in Dry Eye Disease in Office Workers Using Visual Display Terminals: The Osaka Study	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OCULAR SURFACE; BREAK-UP; DYSFUNCTION; SYMPTOMS; BLINKING; ABERRATIONS; PREVALENCE; ACUITY; USERS; SIGNS	PURPOSE: To evaluate the relationship between subjective symptoms and clinical signs in dry eye disease (DED) in office workers using visual display terminals (VDTs). DESIGN: Cross-sectional study. METHODS: This study involved 672 Japanese young and middle-aged office workers who use VDTs. The subjects completed questionnaires designed to detect subjective symptoms and risk factors for DED. Dry eye tests, including tear film break-up time (TBUT), corneal-conjunctival staining with fluorescein and lissamine green, and the Schirmer test, were performed. Based on the Japanese diagnostic criteria for DED, the subjects were classified into 3 groups: definite DED, probable DED, and non-DED. Between each group, subjective symptoms and clinical signs were compared. RESULTS: Of the 672 subjects, 561 (374 male, 187 female) completed the questionnaire (response rate: 83.5%). Definite DED was diagnosed in 65 subjects (11.6%), probable DED in 303 subjects (54.0%), and non-DED in 193 subjects (34.4%). The mean subjective symptom score was significantly less in subjects with probable DED (2.05 +/- 0.42) and non-DED (1.63 +/- 0.38) than in those with definite DED (2.19 +/- 0.40) (P < .05 and P < .01, respectively). In the subjects with probable DED, a subgroup with positive subjective symptoms and abnormal TBUT (55 seconds) was categorized as short TBUT-type DED, and it was found that they had a higher subjective symptom score (2.09 +/- 0.40), equivalent to that of those with definite DED (P = .269). CONCLUSIONS: Despite no or minor epithelial damage, the severity of subjective symptoms was greater in short TBUT-type DED, most likely attributable to tear film instability. Thus, it might prove important to evaluate TBUT to successfully treat those patients. (C) 2015 by Elsevier Inc. All rights reserved.	[Yokoi, Norihiko; Komuro, Aoi; Sonomura, Yukiko; Kato, Hiroaki; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto 6020841, Japan; [Uchino, Miki; Uchino, Yuichi; Dogru, Murat; Kawashima, Motoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Yokoi, N (reprint author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6020841, Japan.	nyokoi@koto.kpu-m.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Santen Pharmaceutical Co, Ltd, Osaka	This study was supported in part by Grants-in-Aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science and Technology. Provision of facilities, transport of equipment, data analysis, and data management were supported by Santen Pharmaceutical Co, Ltd, Osaka. The funding organization had no role in the design or conduct of this research. The authors have no proprietary or commercial interest in any of the materials discussed in this article.	Rolando M, 2001, SURV OPHTHALMOL, V45, pS203, DOI 10.1016/S0039-6257(00)00203-4; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Begley CG, 2003, INVEST OPHTH VIS SCI, V44, P4753, DOI 10.1167/iovs.03-0270; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615; Himebaugh NL, 2009, OPTOMETRY VISION SCI, V86, P106; TODA I, 1993, ACTA OPHTHALMOL, V71, P347; TODA I, 1995, OPHTHALMOLOGY, V102, P302; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Shimazaki-Den S, 2013, CORNEA, V32, P1120, DOI 10.1097/ICO.0b013e3182930b1d; Koh S, 2008, CORNEA, V27, P275, DOI 10.1097/ICO.0b013e31815be9c8; Koh S, 2002, AM J OPHTHALMOL, V134, P115, DOI 10.1016/S0002-9394(02)01430-7; Schlote T, 2004, GRAEF ARCH CLIN EXP, V242, P306, DOI 10.1007/s00417-003-0845-z; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Lemp MA, 2007, OCUL SURF, V5, P75; Goto E, 2006, OCUL SURF, V4, P207; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Kaido M, 2011, INVEST OPHTH VIS SCI, V52, P9516, DOI 10.1167/iovs.11-8412; Kaido M, 2011, JPN J OPHTHALMOL, V55, P451, DOI 10.1007/s10384-011-0049-8; Nakamura S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011119; Shimazaki J., 2007, ATARASHII GANKA, V24, P181; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266; Shimazaki-Den S, 2013, CORNEA, V32, P1211, DOI 10.1097/ICO.0b013e318295a2a5; Uchino Y, 2013, ATARASHII GANKA, V30, P871; Uchino Y, 2012, JPN J OPHTHALMOL, V56, P8, DOI 10.1007/s10384-011-0099-y; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Watanabe Hitoshi, 2002, Cornea, V21, pS17, DOI 10.1097/00003226-200203001-00005; Woodward AM, 2012, EXP EYE RES, V100, P98, DOI 10.1016/j.exer.2012.04.014; YAGINUMA Y, 1990, ERGONOMICS, V33, P799, DOI 10.1080/00140139008927186; Yamamoto Yuji, 2012, Nippon Ganka Gakkai Zasshi, V116, P1137	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					748	754		10.1016/j.ajo.2014.12.019		7	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400018		
J	Khachatryan, N; Medeiros, FA; Sharpsten, L; Bowd, C; Sample, PA; Liebmann, JM; Girkin, CA; Weinreb, RN; Miki, A; Hammel, N; Zangwill, LM				Khachatryan, Naira; Medeiros, Felipe A.; Sharpsten, Lucie; Bowd, Christopher; Sample, Pamela A.; Liebmann, Jeffrey M.; Girkin, Christopher A.; Weinreb, Robert N.; Miki, Atsuya; Hammel, Na'Ama; Zangwill, Linda M.			The African Descent and Glaucoma Evaluation Study (ADAGES): Predictors of Visual Field Damage in Glaucoma Suspects	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR PERFUSION-PRESSURE; VASCULAR RISK-FACTORS; BLOOD-PRESSURE; HYPERTENSION TREATMENT; RACIAL-DIFFERENCES; NATIONAL-SURVEY; BARBADOS EYE; OPTIC DISC; PREVALENCE	PURPOSE: To evaluate racial differences in the development of visual field (VF) damage in glaucoma suspects. DESIGN: Prospective, observational cohort study. METHODS: Six hundred thirty-six eyes from 357 glaucoma suspects with normal VF at baseline were included from the multicenter African Descent and Glaucoma Evaluation Study (ADAGES). Racial differences in the development of VF damage were examined using multi-variable Cox proportional hazard models. RESULTS: Thirty one of 122 African-descent participants (25.4%) and 47 of 235 European-descent participants (20.0%) developed VF damage (P =.078). In multivariable analysis, worse baseline VF mean deviation, higher mean, arterial pressure during follow-up, and a race * mean intraocular pressure (TOP) interaction term were significantly associated with the development of VF damage, suggesting that racial differences in the risk of VF damage varied by TOP. At higher mean TOP levels, race was predictive of the development of VF damage even after adjusting for potentially confounding factors. At mean IOPs during follow-up of 22, 24, and 26 mm Hg, multivariable hazard ratios (95% confidence intervals) for the development of VF damage in African-descent compared to European-descent subjects were 2.03 (1.15-3.57), 2.71 (1.39-5.29), and 3.61 (1.61-8.08), respectively. However, at lower mean TOP levels (below 22 mm Hg) during follow-up, African descent was not predictive of the development of VF damage. CONCLUSION: In this cohort of glaucoma suspects with similar access to treatment, multivariate analysis revealed that at higher mean TOP during follow-up, individuals of African descent were more likely to develop VF damage than individuals of European descent. (C) 2015 by Elsevier Inc. All rights reserved.	[Khachatryan, Naira; Medeiros, Felipe A.; Sharpsten, Lucie; Bowd, Christopher; Sample, Pamela A.; Weinreb, Robert N.; Hammel, Na'Ama; Zangwill, Linda M.] Univ Calif San Diego, Hamilton Glaucoma Ctr, Dept Ophthalmol, La Jolla, CA 92093 USA; [Liebmann, Jeffrey M.] Columbia Univ, Med Ctr, Harkness Eye Inst, New York, NY USA; [Girkin, Christopher A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Miki, Atsuya] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan	Zangwill, LM (reprint author), Univ Calif San Diego, Hamilton Glaucoma Ctr, Dept Ophthalmol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lzangwill@ucsd.edu			National Eye Institute [P30EY022589, EY08208, U10EY14267, EY019869, EY11008, EY021818, EY022039, EY13959]	Supported by National Eye Institute, P30EY022589, EY08208 (L.M.Z.), U10EY14267 (L.M.Z.), EY019869 (L.M.Z.), EY11008 (L.M.Z.), EY021818 (F.A.M.), EY022039 (C.B.), and EY13959. EyeSight Foundation of Alabama (Birmingham, Alabama, USA), the Edith C. Blum Research Fund of the New York Glaucoma Research Institute (New York, New York, USA), Japan Eye Bank Association, Overseas Research Grant (Tokyo, Japan), Research to Prevent Blindness, an unrestricted grant (New York, New York, USA), Alcon Laboratories Inc (Fort Worth, Texas, USA), Allergan Inc (Irvine, California, USA), Pfizer Inc (New York, New York, USA), Merck Inc (Whitehouse Station, New Jersey, USA), Santen Inc (Osaka, Japan) provided the participants' glaucoma medications at no charge.	Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; Zangwill LM, 2004, ARCH OPHTHALMOL-CHIC, V122, P22, DOI 10.1001/archopht.122.1.22; Mitchell P, 2004, J GLAUCOMA, V13, P319, DOI 10.1097/00061198-200408000-00010; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821; Deokule S, 2008, CAN J OPHTHALMOL, V43, P302, DOI 10.3129/i08-061; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P2797, DOI 10.1167/iovs.06-0107; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819; Orzalesi N, 2007, GRAEF ARCH CLIN EXP, V245, P795, DOI 10.1007/s00417-006-0457-5; Memarzadeh F, 2010, INVEST OPHTH VIS SCI, V51, P2872, DOI 10.1167/iovs.08-2956; Chalmers J, 1999, J HYPERTENS, V17, P151; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Budenz DL, 2013, JAMA OPHTHALMOL, V131, P651, DOI 10.1001/jamaophthalmol.2013.1686; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; Costa VP, 2009, BRIT J OPHTHALMOL, V93, P1276, DOI 10.1136/bjo.2008.149047; Boland MV, 2007, J GLAUCOMA, V16, P406, DOI 10.1097/IJG.0b013e31806540a1; Medeiros FA, 2003, AM J OPHTHALMOL, V136, P805, DOI 10.1016/S0002-9394(03)00484-7; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Le A, 2003, INVEST OPHTH VIS SCI, V44, P3783, DOI 10.1167/iovs.03-0077; Costa VP, 2014, ACTA OPHTHALMOL, V92, pe252, DOI 10.1111/aos.12298; Leske MC, 2002, ARCH OPHTHALMOL-CHIC, V120, P954; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P2199, DOI 10.1167/iovs.11-8639; Ellish NJ, 2007, INVEST OPHTH VIS SCI, V48, P1989, DOI 10.1167/iovs.06-0934; Lee JM, 2014, INVEST OPHTH VIS SCI, V55, P2228, DOI 10.1167/iovs.13-12261; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216; Kosoko-Lasaki O, 2006, J NATL MED ASSOC, V98, P1626; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Zelefsky JR, 2006, J GLAUCOMA, V15, P548, DOI 10.1097/01.ijg.0000212289.00917.a8; Higginbotham EJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P813, DOI 10.1001/archopht.122.6.813; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P4619, DOI 10.1167/iovs.13-12487; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; MASON RP, 1989, OPHTHALMOLOGY, V96, P1363; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Cywinski J., 1980, ESSENTIALS PRESSURE, P23; Girkin CA, 2010, ARCH OPHTHALMOL-CHIC, V128, P541, DOI 10.1001/archophthalmol.2010.49; Gordon MO, 2011, ARCH OPHTHALMOL-CHIC, V129, P1630, DOI 10.1001/archophthalmol.2011.337; LEE EW, 1992, NATO ADV SCI I E-APP, V211, P237; Tishkoff SA, 2004, NAT GENET, V36, P521; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068; Wilson MR, 2003, J GLAUCOMA, V12, P293, DOI 10.1097/00061198-200308000-00001	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	APR	2015	159	4					777	787		10.1016/j.ajo.2015.01.011		11	Ophthalmology	Ophthalmology	CE4FV	WOS:000351787400021		
J	Horikoshi, Y; Kitatani, K; Toriumi, K; Fukunishi, N; Itoh, Y; Nakamura, N; Ohno, S; Matsura, T; Takekoshi, S				Horikoshi, Yosuke; Kitatani, Kanae; Toriumi, Kentaro; Fukunishi, Nahoko; Itoh, Yoshiko; Nakamura, Naoya; Ohno, Shigeo; Matsura, Tatsuya; Takekoshi, Susumu			Aberrant Activation of Atypical Protein Kinase C in Carbon Tetrachloride-Induced Oxidative Stress Provokes a Disturbance of Cell Polarity and Sealing of Bile Canalicular Lumen	AMERICAN JOURNAL OF PATHOLOGY			English	Article							EPITHELIAL-CELLS; MOLECULAR REGULATION; TIGHT JUNCTIONS; PI 3-KINASE; RAT-LIVER; APKC; POLARIZATION; CHOLESTASIS; COMPLEX; INJURY	Polarized hepatocytes contain tight junctions (TJs), which are among the most important junctions for sealing the bile canalicular lumen from the sinusoidal space. Alterations in TJs are implicated in chronic cholestatic liver diseases, such as primary biliary cirrhosis and primary sclerosing cholangitis, which have lipid peroxidation marker elevations or antioxidant vitamin decreases. However, the effect of oxidative stress on hepatocyte polarity or liver morphology is unknown. We found that carbon tetrachloride (CCl4)-induced oxidative stress resulted in disassembly of TJs. Ultrastructural analysis revealed disruption in TJs, Golgi morphology, and expansion of the bile canalicular lumen size in CCl4-treated hepatocytes. The Par complex [Par-3-atypical protein kinase C (aPKC) and Par-6 ternary complex] regulates TJs and lumen formation, and the Par-3-aPKC complex formation was inhibited by CCl4 treatment. Moreover, the antioxidant compound vitamin E prohibited a CCl4-induced disturbance in TJs and Par-3-aPKC complex formation. aPKC phosphorylates Par-3 and down-regulates its own affinity with Par-3. Importantly, aPKC kinase activity and Par-3 phosphorylation were significantly increased in CCl4-treated rat livers. These results indicate that the Par-3-aPKC complex plays a crucial role in the maintenance of hepatocyte polarity and sealing of the bile canalicular lumen. Our findings suggest that bile canalicular lumen expansion might explain the presence of cholestasis in patients with primary biliary cirrhosis and primary sclerosing cholangitis.	[Horikoshi, Yosuke; Toriumi, Kentaro; Nakamura, Naoya; Takekoshi, Susumu] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan; [Kitatani, Kanae; Takekoshi, Susumu] Tokai Univ, Sch Med, Dept Cell Biol, Div Host Def Mech, Isehara, Kanagawa 2591193, Japan; [Horikoshi, Yosuke; Matsura, Tatsuya] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Med Biochem, Yonago, Tottori 683, Japan; [Fukunishi, Nahoko; Itoh, Yoshiko] Tokai Univ, Sch Med, Support Ctr Med Res & Educ, Isehara, Kanagawa 2591193, Japan; [Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 232, Japan	Takekoshi, S (reprint author), Tokai Univ, Sch Med, Dept Cell Biol, Div Host Def Mech, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	takekos@is.icc.u-tokai.ac.jp			Japan Society for Promotion of Science [20590385, 23790379]	Supported in part by a Grant-in-Aid for Science Research (grant 20590385), a Grant-in-Aid for Young Scientists (grant 23790379) from the Japan Society for Promotion of Science (S.T. and Y.H.), and Tokai University School of Medicine research aid from 2009 to 2011 (Y.H.).	Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; KOOP DR, 1992, FASEB J, V6, P724; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Hirose T, 2002, J CELL SCI, V115, P2485; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Sakisaka S, 2001, HEPATOLOGY, V33, P1460, DOI 10.1053/jhep.2001.25086; Yoshihama Y, 2011, CURR BIOL, V21, P705, DOI 10.1016/j.cub.2011.03.029; Kondo S, 1999, FREE RADICAL BIO MED, V27, P401, DOI 10.1016/S0891-5849(99)00087-8; Trauner M, 1999, J HEPATOL, V31, P165, DOI 10.1016/S0168-8278(99)80179-2; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; ROBENEK H, 1980, AM J PATHOL, V100, P93; Bernacchi A, 1984, Toxicol Pathol, V12, P315; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Hirose T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004194; HOFFMAN M, 1989, J CANCER RES CLIN, V115, P175, DOI 10.1007/BF00397920; Horikoshi Y, 2011, CELL STRUCT FUNCT, V36, P97; JONES A, 1990, GUT, V31, P938, DOI 10.1136/gut.31.8.938; Keller P, 1997, J CELL SCI, V110, P3001; Kojima Takashi, 2003, Medical Electron Microscopy, V36, P157, DOI 10.1007/s00795-003-0220-5; LUDWIG J, 1981, Hepatology, V1, P632, DOI 10.1002/hep.1840010612; MEHENDALE HM, 1994, FASEB J, V8, P1285; Orlando K, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001321; REYNOLDS ES, 1963, J CELL BIOL, V19, P139, DOI 10.1083/jcb.19.1.139; ROBENEK H, 1979, EUR J CELL BIOL, V20, P62; SELL DA, 1969, J CELL BIOL, V41, P736, DOI 10.1083/jcb.41.3.736; SMUCKLER EA, 1976, ENVIRON HEALTH PERSP, V15, P13, DOI 10.2307/3428385; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Toriumi K, 2013, LAB INVEST, V93, P218, DOI 10.1038/labinvest.2012.145; Trauner M, 1997, HEPATOLOGY, V25, P1184, DOI 10.1002/hep.510250522; Trauner M, 1998, NEW ENGL J MED, V339, P1217; Wang T, 2014, J CELL SCI, V127, P2483, DOI 10.1242/jcs.139923; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; Yang SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074871	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	APR	2015	185	4					958	968		10.1016/j.ajpath.2014.12.015		11	Pathology	Pathology	CE4FX	WOS:000351787600008		
J	Thuy, LTT; Matsumoto, Y; Thuy, TTV; Hai, H; Suoh, M; Urahara, Y; Motoyama, H; Fujii, H; Tamori, A; Kubo, S; Takemura, S; Morita, T; Yoshizato, K; Kawada, N				Le Thi Thanh Thuy; Matsumoto, Yoshinari; Tuong Thi Van Thuy; Hoang Hai; Suoh, Maito; Urahara, Yuka; Motoyama, Hiroyuki; Fujii, Hideki; Tamori, Akihiro; Kubo, Shoji; Takemura, Shigekazu; Morita, Takashi; Yoshizato, Katsutoshi; Kawada, Norifumi			Cytoglobin Deficiency Promotes Liver Cancer Development from Hepatosteatosis through Activation of the Oxidative Stress Pathway	AMERICAN JOURNAL OF PATHOLOGY			English	Article							HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; OVEREXPRESSION PROTECTS; DOWN-REGULATION; GLOBIN; FIBROSIS; DISEASE; STEATOHEPATITIS; FIBROGENESIS; NEUROGLOBIN	This study was conducted to clarify the role of cytoglobin (Cygb), a globin expressed in hepatic stellate cells (HSCs), in the development of Liver fibrosis and cancer in nonalcoholic steatohepatitis (NASH). Cygb expression was assessed in patients with NASH and hepatocellular carcinoma. Mouse NASH model was generated in Cygb-deficient (Cygb(-/-)) or wild-type (WT) mice by giving a choline-deficient amino acid defined diet and, in some of them, macrophage deletion and N-acetyl cysteine treatment were used. Primary-cultured mouse HSCs isolated from WT (HSCsCygb-wild) or Cygb(-/-) (HSCsCygb-null) mice were characterized. As results, the expression of CYGB was reduced in patients with NASH and hepatocellular carcinoma. Choline-deficient amino acid treatment for 8 weeks induced prominent inflammation and fibrosis in Cygb(-/-) mice, which was inhibited by macrophage deletion. Surprisingly, at 32 weeks, despite no tumor formation in the WT mice, all Cygb(-/-) mice developed liver cancer, which was ameliorated by N-acetyl cysteine treatment. Altered expression of 31 genes involved in the metabolism of reactive oxygen species was notable in Cygb(-/-) mice. Both HSCsCygb-null and Cygb siRNA-transfected-HSCsCYgb-wild exhibited the preactivation condition. Our findings provide important insights into the role that Cygb, expressed in HSCs during liver fibrosis, plays in cancer development with NASH.	[Le Thi Thanh Thuy; Matsumoto, Yoshinari; Tuong Thi Van Thuy; Hoang Hai; Urahara, Yuka; Motoyama, Hiroyuki; Fujii, Hideki; Tamori, Akihiro; Yoshizato, Katsutoshi; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan; [Suoh, Maito] Osaka City Univ, Grad Sch Med, Dept Med Educ & Gen Practice, Osaka 5458585, Japan; [Kubo, Shoji; Takemura, Shigekazu] Osaka City Univ, Grad Sch Med, Dept Hepatobiliaty Pancreat Surg, Osaka 5458585, Japan; [Morita, Takashi] Osaka City Univ, Grad Sch Med, Dept Mol Genet, Osaka 5458585, Japan; [Matsumoto, Yoshinari] Osaka City Univ, Grad Sch Human Life Sci, Dept Med Nutr, Osaka 5458585, Japan; [Yoshizato, Katsutoshi] PhoenixBio Co Ltd, Hiroshima, Japan	Kawada, N (reprint author), Osaka City Univ, Grad Sch Med, Dept Hepatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	kawadanori@med.osaka-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [25860554, 21390232, 23112518, 25293177]; Research on Hepatitis and BSE, the Ministry of Health Labor and Welfare	Supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientific Research grant 25860554 (L.T.T.T.); JSPS Grant-in-Aid for Scientific Research grants 21390232 (N.K.), 23112518 (N.K.), and 25293177 (N.K.); and Research on Hepatitis and BSE, the Ministry of Health Labor and Welfare (N.K.).	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; [Anonymous], 2011, GUIDE CARE USE LAB A; Motoyama H, 2014, LAB INVEST, V94, P192, DOI [10.1038/labinvest.2013.135, 10.1038/Iabinvest.2013.135]; Murata M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/623019; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Ramadori G, 2001, EUR J GASTROEN HEPAT, V13, P777, DOI 10.1097/00042737-200107000-00004; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Denda A, 2002, JPN J CANCER RES, V93, P125; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; McRonald FE, 2006, HUM MOL GENET, V15, P1271, DOI 10.1093/hmg/ddl042; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; Burmester T, 2002, MOL BIOL EVOL, V19, P416; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Hodges NJ, 2008, MUTAGENESIS, V23, P293, DOI 10.1093/mutage/gen013; Bach Kristensen D, 2000, HEPATOLOGY, V32, P268, DOI 10.1053/jhep.2000.9322; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Matsuda Y, 2013, THESCIENTIFICWORLDJO, V2013, DOI 10. 1155/2013/597095; Mimura I, 2010, AM J PHYSIOL-RENAL, V299, pF1120, DOI 10.1152/ajprenal.00145.2010; Nang ler WE, 2007, SCIENCE, V317, P121; Presneau N, 2005, MOL CARCINOGEN, V43, P141, DOI 10.1002/mc.20096; Sawai H, 2003, BIOCHEMISTRY-US, V42, P5133, DOI 10.1021/bi027067e; Shaw RJ, 2009, BRIT J CANCER, V101, P139, DOI 10.1038/sj.bjc.6605121; Tamori A, 1999, HEPATOLOGY, V29, P1429, DOI 10.1002/hep.510290520; Thuy le T.T., 2011, AM J PATHOL, V179, P1050, DOI DOI 10.1016/J.AJPATH.2011.05.006; VESSELIN.SD, 1969, CANCER RES, V29, P1024; Xinarianos G, 2006, HUM MOL GENET, V15, P2038, DOI 10.1093/hmg/ddl128	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	APR	2015	185	4					1045	1060		10.1016/j.ajpath.2014.12.017		16	Pathology	Pathology	CE4FX	WOS:000351787600015		
J	Tasaki, H; Zhao, LJ; Isayama, K; Chen, HT; Yamauchi, N; Shigeyoshi, Y; Hashimoto, S; Hattori, MA				Tasaki, Hirotaka; Zhao, Lijia; Isayama, Keishiro; Chen, Huatao; Yamauchi, Nobuhiko; Shigeyoshi, Yasufumi; Hashimoto, Seiichi; Hattori, Masa-aki			Inhibitory role of REV-ERB alpha in the expression of bone morphogenetic protein gene family in rat uterus endometrium stromal cells	AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY			English	Article						uterus oscillators; bmp genes; RNA interference; SR8278; decidualization	MAMMALIAN CIRCADIAN CLOCK; GRANULOSA-CELLS; SUPRACHIASMATIC NUCLEUS; DOWN-REGULATION; NEGATIVE LIMB; FEMALE MICE; BMAL1; DECIDUALIZATION; IMPLANTATION; MOUSE	Uterus circadian rhythms have been implicated in the gestation processes of mammals through entraining of the clock proteins to numerous downstream genes. Bone morphogenetic proteins (BMPs), having clock-controlled regulatory sites in their gene promoters, are expressed in the uterus during decidualization, but the regulation of the Bmp gene expression is poorly understood. The present study was designed to dissect the physiological roles of the uterus oscillators in the Bmp expression using the uterus endometrial stromal cells (UESCs) isolated from Per2-dLuc transgenic rats on day 4.5 of gestation. The in vitro decidualization of UESCs was induced by medroxyprogesterone acetate and 2-O-dibutyryl cAMP. A significant decline of Per2-dLuc bioluminescence activity was induced in decidual cells, and concomitantly, the expression of canonical clock genes was downregulated. Conversely, the expression of the core Bmp genes Bmp2, Bmp4, Bmp6, and Bmp7 was upregulated. In UESCs transfected with Bmall-specific siRNA, in which Rev-erb alpha expression was downregulated, Bmp genes, such as Bmp2, Bmp4, and Bmp6 were upregulated. However, Bmp1, Bmp7, and Bmp8a were not significantly affected by Bmal1 silencing. The expression of all Bmp genes was enhanced after treatment with the REV-ERB alpha antagonist (SR8278), although their rhythmic profiles were differed from each other. The binding of REV-ERB alpha to the proximal regions of the Bmp2 and Bmp4 promoters was revealed by chromatin immunoprecipitation-PCR analysis. Collectively, these results indicate that the Bmp genes are upregulated by the attenuation of the cellular circadian clock; in particular, its core component REV-ERB alpha functions as a transcriptional silencer in the Bmp gene family.	[Tasaki, Hirotaka; Zhao, Lijia; Isayama, Keishiro; Chen, Huatao; Yamauchi, Nobuhiko; Hattori, Masa-aki] Kyushu Univ, Grad Sch Agr, Dept Anim & Marine Bioresource Sci, Fukuoka 8128581, Japan; [Shigeyoshi, Yasufumi] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan; [Hashimoto, Seiichi] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Hattori, MA (reprint author), Kyushu Univ, Grad Sch Agr, Dept Anim & Marine Bioresource Sci, Higashi Ku, Fukuoka 8128581, Japan.	mhattori@agr.kyushu-u.ac.jp	Chen, Huatao/H-3755-2011	Chen, Huatao/0000-0002-3800-5013	Japan Society for the Promotion of Sciences (JSPS) [19658099, 24658246]; China Scholarship Council [201308050010]; Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists [23-1262]	This work was supported in part by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Sciences (JSPS no. 19658099, 24658246) (to M-A. Hattori). Lijia Zhao is sponsored by the China Scholarship Council (Grant 201308050010). Keishiro Isayama was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (Grant 23-1262).	Akiyama S, 2010, TOHOKU J EXP MED, V221, P278; Alvarez JD, 2005, J BIOL RHYTHM, V20, P111, DOI 10.1177/0748730404274078; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Jabbour HN, 2001, REPRODUCTION, V121, P197; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; CLARKE CL, 1990, ENDOCR REV, V11, P266; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Laposky A, 2005, SLEEP, V28, P395; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Lemos DR, 2006, MOL ENDOCRINOL, V20, P1164, DOI 10.1210/me.2005-0361; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Zeng ZL, 2010, J BIOCHEM, V148, P319, DOI 10.1093/jb/mvq069; Hirai T, 2014, J BIOL CHEM, V289, P17174, DOI 10.1074/jbc.M113.546135; Wu T, 2012, MOL BIOL REP, V39, P9783, DOI 10.1007/s11033-012-1844-0; Boden MJ, 2010, REPRODUCTION, V139, P1077, DOI 10.1530/REP-09-0523; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Ying Y, 2000, BIOL REPROD, V63, P1781, DOI 10.1095/biolreprod63.6.1781; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kodama A, 2010, HUM REPROD, V25, P751, DOI 10.1093/humrep/dep455; Vallejo G, 2010, J CELL PHYSIOL, V222, P127, DOI 10.1002/jcp.21929; Ratajczak CK, 2009, ENDOCRINOLOGY, V150, P1879, DOI 10.1210/en.2008-1021; Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; He PJ, 2007, J ENDOCRINOL, V193, P413, DOI 10.1677/JOE-07-0044; Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Bagchi IC, 2005, SEMIN REPROD MED, V23, P38, DOI 10.1055/s-2005-864032; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Chen HT, 2013, AM J PHYSIOL-ENDOC M, V304, pE566, DOI 10.1152/ajpendo.00432.2012; Chen HT, 2013, AM J PHYSIOL-CELL PH, V304, pC1131, DOI 10.1152/ajpcell.00008.2013; Clementi C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003863; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Erickson GF, 2004, J ENDOCRINOL, V182, P203, DOI 10.1677/joe.0.1820203; He PJ, 2007, MOL CELL BIOCHEM, V302, P111, DOI 10.1007/s11010-007-9432-7; Hirata M, 2009, MOL CELL BIOCHEM, V324, P31, DOI 10.1007/s11010-008-9981-4; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu Y, 2014, P NATL ACAD SCI USA, V111, P14295, DOI 10.1073/pnas.1209249111; Matsumoto K, 2009, CELL TISSUE RES, V335, P575, DOI 10.1007/s00441-008-0734-1; Nakamura TJ, 2005, J NEUROSCI RES, V82, P622, DOI 10.1002/jnr.20677; Oozono S, 2008, J EXP ZOOL PART B, V310B, P642, DOI [10.1002/jez.b.21237, 10.1002/Jez.b.21237]; Ozkaynak E, 1997, BIOCHEM BIOPH RES CO, V234, P242, DOI 10.1006/bbrc.1997.6624; Ratajczak CK, 2012, REPROD FERT DEVELOP, V24, P759, DOI 10.1071/RD11164; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Tanwar PS, 2011, REPRODUCTION, V142, P573, DOI 10.1530/REP-10-0299; Tasaki Hirotaka, 2013, Front Endocrinol (Lausanne), V4, P82, DOI 10.3389/fendo.2013.00082; Uchikawa M, 2011, CHRONOBIOL INT, V28, P1, DOI 10.3109/07420528.2010.522289; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; ZHANG ZM, 1994, ENDOCRINOLOGY, V135, P1256, DOI 10.1210/en.135.3.1256	69	2	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6143	1522-1563		AM J PHYSIOL-CELL PH	Am. J. Physiol.-Cell Physiol.	APR 1	2015	308	7					C528	C538		10.1152/ajpcell.00220.2014		11	Cell Biology; Physiology	Cell Biology; Physiology	CE9JY	WOS:000352161400003		
J	Shibue, K; Yamane, S; Harada, N; Hamasaki, A; Suzuki, K; Joo, E; Iwasaki, K; Nasteska, D; Harada, T; Hayashi, Y; Adachi, Y; Owada, Y; Takayanagi, R; Inagaki, N				Shibue, Kimitaka; Yamane, Shunsuke; Harada, Norio; Hamasaki, Akihiro; Suzuki, Kazuyo; Joo, Erina; Iwasaki, Kanako; Nasteska, Daniela; Harada, Takanari; Hayashi, Yoshitaka; Adachi, Yasuhiro; Owada, Yuji; Takayanagi, Ryoichi; Inagaki, Nobuya			Fatty acid-binding protein 5 regulates diet-induced obesity via GIP secretion from enteroendocrine K cells in response to fat ingestion	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; DEPENDENT INSULINOTROPIC POLYPEPTIDE; RAT ADIPOSE-TISSUE; BILE-ACIDS; METABOLIC-REGULATION; LIPOPROTEIN-LIPASE; TRANSPORT PROTEINS; IN-VITRO; GLUCOSE; RESISTANCE	Gastric inhibitory polypeptide (GIP) is an incretin released from enteroendocrine K cells in response to nutrient intake, especially fat. GIP is one of the contributing factors inducing fat accumulation that results in obesity. A recent study shows that fatty acid-binding protein 5 (FABP5) is expressed in murine K cells and is involved in fat-induced GIP secretion. We investigated the mechanism of fat-induced GIP secretion and the impact of FABP5-related GIP response on diet-induced obesity (DIO). Single oral administration of glucose and fat resulted in a 40% reduction of GIP response to fat but not to glucose in whole body FABP5-knockout (FABP5(-/-)) mice, with no change in K cell count or GIP content in K cells. In an ex vivo experiment using isolated upper small intestine, oleic acid induced only a slight increase in GIP release, which was markedly enhanced by coadministration of bile and oleic acid together with attenuated GIP response in the FABP5(-/-) sample. FABP5(-/-) mice exhibited a 24% reduction in body weight gain and body fat mass under a high-fat diet compared with wild-type (FABP5(+/+)) mice; the difference was not observed between GIP-GFP homozygous knock-in (GIP(gfp/gfp))-FABP5(+/+) mice and GIP(gfp/gfp)-FABP5(-/-) mice, in which GIP is genetically deleted. These results demonstrate that bile efficiently amplifies fat-induced GIP secretion and that FABP5 contributes to the development of DIO in a GIP-dependent manner.	[Shibue, Kimitaka; Yamane, Shunsuke; Harada, Norio; Hamasaki, Akihiro; Suzuki, Kazuyo; Joo, Erina; Iwasaki, Kanako; Nasteska, Daniela; Harada, Takanari; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068507, Japan; [Shibue, Kimitaka; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 464, Japan; [Adachi, Yasuhiro] Univ Occupat & Environm Hlth, Sch Med, Dept Anat, Kitakyushu, Fukuoka 807, Japan; [Owada, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Organ Anat, Ube, Yamaguchi 755, Japan	Inagaki, N (reprint author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; Integration Research for Agriculture and Interdisciplinary Fields, Japan; Merck Sharp Dohme (MSD); Eli Lilly Japan; Japan Diabetes Foundation; Japan Association for Diabetes Education and Care; Suzuken Memorial Foundation; Novo Nordisk Pharma; Shiratori Pharmaceutical; Roche Diagnostics; MSD; Japan Tobacco; Nippon Boehringer Ingelheim; Takeda; Dainippon Sumitomo Pharma; Astellas Pharma; Daiichi-Sankyo; Mitsubishi Tanabe Pharma	This study was supported by scientific research grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, the Ministry of Health, Labor, and Welfare, Japan, and the Integration Research for Agriculture and Interdisciplinary Fields, Japan. N. Inagaki also received a clinical commission/joint research grant from Merck Sharp & Dohme (MSD) and Eli Lilly Japan.; This study was also supported by the Japan Diabetes Foundation, the Japan Association for Diabetes Education and Care, the Suzuken Memorial Foundation, Novo Nordisk Pharma, Shiratori Pharmaceutical, and Roche Diagnostics as well as a scholarship grant from MSD, Japan Tobacco, Nippon Boehringer Ingelheim, Takeda, Dainippon Sumitomo Pharma, Astellas Pharma, Daiichi-Sankyo, and Mitsubishi Tanabe Pharma.	Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; MADSEN P, 1992, J INVEST DERMATOL, V99, P299, DOI 10.1111/1523-1747.ep12616641; Baier LJ, 1996, J BIOL CHEM, V271, P10892; Maeda K, 2003, DIABETES, V52, P300; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Coe NR, 1999, J LIPID RES, V40, P967; Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI [10.1387/ijdb.092976rl, 10.1387/ijdb.092976r1]; Dallaglio K, 2013, EXP DERMATOL, V22, P255, DOI 10.1111/exd.12111; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; IMAMURA M, 1988, AM J GASTROENTEROL, V83, P386; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.0139; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Formanack ML, 2004, DIABETOLOGIA, V47, P349, DOI 10.1007/s00125-003-1289-z; Gally F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051784; Kannan-Thulasiraman P, 2010, J BIOL CHEM, V285, P19106, DOI 10.1074/jbc.M109.099770; KNAPPER JME, 1995, J NUTR, V125, P183; KRARUP T, 1985, AM J PHYSIOL, V249, pE195; Liu JW, 2015, J NEUROCHEM, V132, P85, DOI 10.1111/jnc.12934; Ogawa E, 2011, J INVEST DERMATOL, V131, P604, DOI 10.1038/jid.2010.342; Owada Y, 2001, HISTOCHEM J, V33, P453, DOI 10.1023/A:1014420330284; Owada Y, 2002, J INVEST DERMATOL, V118, P430, DOI 10.1046/j.0022-202x.2001.01616.x; PARKIN SM, 1980, BIOCHEM J, V188, P193; Shikata F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094550; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363; Sommer CA, 2014, MOL ENDOCRINOL, V28, P1855, DOI 10.1210/me.2014-1194; Suzuki K, 2013, J BIOL CHEM, V288, P1929, DOI 10.1074/jbc.M112.423137; Yamane S, 2012, J DIABETES INVEST, V3, P80, DOI 10.1111/j.2040-1124.2011.00143.x; YOSHIDOME K, 1995, SCAND J GASTROENTERO, V30, P586, DOI 10.3109/00365529509089794	45	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1849	1522-1555		AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	APR 1	2015	308	7					E583	E591		10.1152/ajpendo.00543.2014		9	Endocrinology & Metabolism; Physiology	Endocrinology & Metabolism; Physiology	CE9WO	WOS:000352194300005		
J	Kizu, T; Yoshida, Y; Furuta, K; Ogura, S; Egawa, M; Chatani, N; Hamano, M; Takemura, T; Ezaki, H; Kamada, Y; Nishida, K; Nakaoka, Y; Kiso, S; Takehara, T				Kizu, Takashi; Yoshida, Yuichi; Furuta, Kunimaro; Ogura, Satoshi; Egawa, Mayumi; Chatani, Norihiro; Hamano, Mina; Takemura, Takayo; Ezaki, Hisao; Kamada, Yoshihiro; Nishida, Keigo; Nakaoka, Yoshikazu; Kiso, Shinichi; Takehara, Tetsuo			Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						bile duct ligation; chemokine (C-C motif) ligand 5; cholestasis; Grb2-associated binder 1	BILE-DUCT LIGATION; CHRONIC HEPATITIS-C; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; MESSENGER-RNA; EGF RECEPTOR; GENE; CHEMOKINE; INFLAMMATION; ACTIVATION	Grb2-associated binder 1 (Gab1) adaptor protein amplifies signals downstream of a broad range of growth factors/receptor tyrosine kinases. Although these signals are implicated in liver fibrogenesis, the role of Gab1 remains unclear. To elucidate the role of Gab1, liver fibrosis was examined in hepatocyte-specific Gab1-conditional knockout (Gab1CKO) mice upon bile duct ligation (BDL). Gab1CKO mice developed exacerbated liver fibrosis with activation of hepatic myofibroblasts after BDL compared with control mice. The antifibrotic role of hepatocyte Gab1 was further confirmed by another well-established mouse model of liver fibrosis using chronic injections of carbon tetrachloride. After BDL, Gab1CKO mice also displayed exacerbated liver injury, decreased hepatocyte proliferation, and enhanced liver inflammation. Furthermore, cDNA microarray analysis was used to investigate the potential molecular mechanisms of the Gab1-mediated signal in liver fibrosis, and the fibrosis-promoting factor chemokine (C-C motif) ligand 5 (Ccl5) was identified as upregulated in the livers of Gab1CKO mice following BDL. Interestingly, in vitro studies using primary hepatocytes isolated from control and Gab1CKO mice revealed that the loss of Gab1 resulted in increased hepatocyte CCL5 synthesis upon lipopolysaccharide stimulation. Finally, pharmacological antagonism of CCL5 reduced BDL-induced liver fibrosis in Gab1CKO mice. In conclusion, our results demonstrate that hepatocyte Gab1 is required for liver fibrosis and that hepatocyte CCL5 could be an important contributor to this process. Thus, we present a novel antifibrotic function of hepatocyte Gab1 in liver fibrogenesis.	[Kizu, Takashi; Yoshida, Yuichi; Furuta, Kunimaro; Ogura, Satoshi; Egawa, Mayumi; Chatani, Norihiro; Hamano, Mina; Takemura, Takayo; Ezaki, Hisao; Kamada, Yoshihiro; Kiso, Shinichi; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Nishida, Keigo] RIKEN Ctr Integrat Med Sci, RCAI, Lab Homeostat Network, Yokohama, Kanagawa, Japan; [Nakaoka, Yoshikazu] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan	Takehara, T (reprint author), Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp			Japan Society for the Promotion of Science	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; Takemura T, 2013, BIOCHEM BIOPH RES CO, V437, P185, DOI 10.1016/j.bbrc.2013.05.097; Godoy P, 2014, BREAST CANCER-TOKYO, V21, P491, DOI 10.1007/s12282-012-0404-8; Yamasaki S, 2003, ONCOGENE, V22, P1546, DOI 10.1038/sj.onc.1206284; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Huang GC, 2012, LAB INVEST, V92, P703, DOI 10.1038/labinvest.2012.3; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; NELSON PJ, 1993, J IMMUNOL, V151, P2601; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Marquardt JU, 2012, BBA-MOL BASIS DIS, V1822, P942, DOI 10.1016/j.bbadis.2012.02.012; Ueki T, 1999, NAT MED, V5, P226; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Scott MJ, 2010, J HEPATOL, V53, P693, DOI 10.1016/j.jhep.2010.04.026; Clayton E, 2009, BIOCHEM BIOPH RES CO, V381, P549, DOI 10.1016/j.bbrc.2009.02.079; Jia L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4878; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; Katsounas A, 2012, J VIRAL HEPATITIS, V19, P128, DOI 10.1111/j.1365-2893.2011.01503.x; Kobayashi S, 2010, TRANSPL INT, V23, P390, DOI 10.1111/j.1432-2277.2009.00991.x; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Nakaoka Y., 2013, INT J INFLAM, V2013; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Shlomai A, 2013, J VIRAL HEPATITIS, V20, P95, DOI 10.1111/j.1365-2893.2012.01628.x; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711	45	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	APR 1	2015	308	7					G613	G624		10.1152/ajpgi.00289.2014		12	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CE9MA	WOS:000352166900005		
J	Kubota, K; Ohtake, N; Ohbuchi, K; Mase, A; Imamura, S; Sudo, Y; Miyano, K; Yamamoto, M; Kono, T; Uezono, Y				Kubota, Kunitsugu; Ohtake, Nobuhiro; Ohbuchi, Katsuya; Mase, Akihito; Imamura, Sachiko; Sudo, Yuka; Miyano, Kanako; Yamamoto, Masahiro; Kono, Toru; Uezono, Yasuhito			Hydroxy-alpha sanshool induces colonic motor activity in rat proximal colon: a possible involvement of KCNK9	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						hydroxy-alpha sanshool; two-pore domain potassium channels; KCNK9; KCNK3; colonic motility; long distance contraction; rhythmic propulsive motor complex; rhythmic propagating ripple; postoperative ileus	2-PORE-DOMAIN POTASSIUM CHANNELS; JAPANESE MEDICINE KAMPO; GASTROINTESTINAL-TRACT; SENSORY NEURONS; K+ CHANNELS; DAIKENCHUTO; ANESTHETICS; VOLUNTEERS; RELEASE; TRANSIT	Various colonic motor activities are thought to mediate propulsion and mixing/absorption of colonic content. The Japanese traditional medicine daikenchuto (TU-100), which is widely used for postoperative ileus in Japan, accelerates colonic emptying in healthy humans. Hydroxy-alpha sanshool (HAS), a readily absorbable active ingredient of TU-100 and a KCNK3/KCNK9/KCNK18 blocker as well as TRPV1/TRPA1 agonist, has been investigated for its effects on colonic motility. Motility was evaluated by intraluminal pressure and video imaging of rat proximal colons in an organ bath. Distribution of KCNKs was investigated by RT-PCR, in situ hybridization, and immunohistochemistry. Current and membrane potential were evaluated with use of recombinant KCNK3-or KCNK9-expressing Xenopus oocytes and Chinese hamster ovary cells. Defecation frequency in rats was measured. HAS dose dependently induced strong propulsive "squeezing" motility, presumably as long-distance contraction (LDC). TRPV1/TRPA1 agonists induced different motility patterns. The effect of HAS was unaltered by TRPV1/TRPA1 antagonists and desensitization. Lidocaine (a nonselective KCNK blocker) and hydroxy-alpha sanshool (a geometrical isomer of HAS and KCNK3 blocker) also induced colonic motility as a rhythmic propagating ripple (RPR) and a LDC-like motion, respectively. HAS-induced "LDC," but not lidocaine-induced "RPR," was abrogated by a neuroleptic agent tetrodotoxin. KCNK3 and KCNK9 were located mainly in longitudinal smooth muscle cells and in neural cells in the myenteric plexus, respectively. Administration of HAS or TU-100 increased defecation frequency in normal and laparotomy rats. HAS may evoke strong LDC possibly via blockage of the neural KCNK9 channel in the colonic myenteric plexus.	[Kubota, Kunitsugu; Ohtake, Nobuhiro; Ohbuchi, Katsuya; Mase, Akihito; Imamura, Sachiko; Yamamoto, Masahiro] Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan; [Ohbuchi, Katsuya; Sudo, Yuka; Miyano, Kanako; Uezono, Yasuhito] Natl Canc Ctr, Div Canc Pathophysiol, Res Inst, Tokyo 1040045, Japan; [Kono, Toru] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Kono, Toru] Sapporo Higashi Tokushukai Hosp, Ctr Clin & Biomed Res, Sapporo, Hokkaido, Japan	Uezono, Y (reprint author), Natl Canc Ctr, Div Canc Pathophysiol, Res Inst, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	yuezono@ncc.go.jp			Tsumura Co.	This project has been executed by using the institutions' (National Cancer Center Research Institute and Tsumura & Co.) budgets including a grant from Tsumura & Co. providing to T. Kono, Y. Sudo, K. Miyano, and Y. Uezono for this collaborative research.	Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Patel AJ, 1999, NAT NEUROSCI, V2, P422; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Kono T, 2009, SURGERY, V146, P837, DOI 10.1016/j.surg.2009.06.012; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kono T, 2010, J CROHNS COLITIS, V4, P161, DOI 10.1016/j.crohns.2009.09.006; Heredia DJ, 2009, GASTROENTEROLOGY, V136, P1328, DOI 10.1053/j.gastro.2008.12.010; Munekage M, 2013, DRUG METAB DISPOS, V41, P1256, DOI 10.1124/dmd.112.050112; Kovacs I, 2005, VIRCHOWS ARCH, V446, P402, DOI 10.1007/s00428-005-1205-7; Chen JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060474; Cho SY, 2005, J PHYSIOL-LONDON, V565, P243, DOI 10.1113/jphysiol.2005.084574; Doherty TJ, 2010, VET CLIN N AM-EQUINE, V26, P533, DOI 10.1016/j.cveq.2010.07.004; Du GZ, 2011, ANESTHESIOLOGY, V115, P1003, DOI 10.1097/ALN.0b013e3182343660; Hayakawa Terumasa, 1999, Journal of Smooth Muscle Research, V35, P47; Huizinga JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00093; Iwabu J, 2010, DRUG METAB DISPOS, V38, P2040, DOI 10.1124/dmd.110.033589; Kono T, 2013, AM J PHYSIOL-GASTR L, V304, pG428, DOI 10.1152/ajpgi.00356.2012; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Lauretti Gabriela Rocha, 2008, Rev Bras Anestesiol, V58, P280, DOI 10.1590/S0034-70942008000300011; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Sanders KM, 2006, J PHYSIOL-LONDON, V570, P37, DOI 10.1113/jphysiol.2005.098897; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Satoh K, 2001, DIGEST DIS SCI, V46, P250, DOI 10.1023/A:1005636412287; Tokita Y, 2007, J PHARMACOL SCI, V104, P303, DOI 10.1254/jphs.FP0070831; Tokita Y, 2011, J PHARMACOL SCI, V115, P75, DOI 10.1254/jphs.10226FP	32	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	APR 1	2015	308	7					G579	G590		10.1152/ajpgi.00114.2014		12	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CE9MA	WOS:000352166900002		
J	Badescu, I; Sicotte, P; Ting, N; Wikberg, EC				Badescu, Iulia; Sicotte, Pascale; Ting, Nelson; Wikberg, Eva C.			Female Parity, Maternal Kinship, Infant Age and Sex Influence Natal Attraction and Infant Handling in a Wild Colobine (Colobus vellerosus)	AMERICAN JOURNAL OF PRIMATOLOGY			English	Article						colobine; natal attraction; infant handling; parity; kinship; dominance	LANGURS PRESBYTIS-ENTELLUS; FIEMA MONKEY SANCTUARY; VERVET MONKEYS; CERCOPITHECUS-AETHIOPS; REPRODUCTIVE SUCCESS; SOCIAL RELATIONSHIPS; NATURAL-POPULATIONS; RELATEDNESS; BEHAVIOR; PRIMATE	Primate females often inspect, touch and groom others' infants (natal attraction) and they may hold and carry these infants in a manner resembling maternal care (infant handling). While natal attraction and infant handling occur in most wild colobines, little is known about the factors influencing the expression of these behaviors. We examined the effects of female parity, kinship, and dominance rank, as well as infant age and sex in wild Colobus vellerosus at Boabeng-Fiema Monkey Sanctuary, Ghana. We collected data via focal sampling of females in 2008 and 2009 (N=61) and of infants in 2010 (N=12). Accounting for the individuals who interacted with our focal subjects, this study includes 74 females and 66 infants in 8 groups. We recorded female agonistic interactions ad libitum to determine dominance ranks. We used partial pedigree information and genotypes at 17 short tandem repeat loci to determine kinship. We knew female parity, infant age and sex from demographic records. Nulliparous females showed more natal attraction and infant handling than parous females, which may suggest that interactions with infants are more adaptive for nulliparous females because they learn mothering skills through these behaviors. Compared to non-kin, maternal kin were more likely to handle infants. Maternal kin may be permitted greater access to infants because mothers are most familiar with them. Handlers may incur inclusive fitness benefits from infant handling. Dominance rank did not affect female interactions with infants. The youngest infants received the most natal attraction and infant handling, and male infants were handled more than female infants. The potential benefits of learning to mother and inclusive fitness, in combination with the relatively low costs of natal attraction and infant handling, may explain the high rates of these behaviors in many colobines. Am. J. Primatol. 77:376-387, 2015. (c) 2014 Wiley Periodicals, Inc.	[Badescu, Iulia] Univ Toronto, Dept Anthropol, Toronto, ON M5S 2S2, Canada; [Badescu, Iulia; Sicotte, Pascale; Wikberg, Eva C.] Univ Calgary, Dept Anthropol, Calgary, AB, Canada; [Ting, Nelson] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Ting, Nelson] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Wikberg, Eva C.] Univ Tokyo, Dept Integrated Biosci, Kashiwa, Chiba, Japan	Badescu, I (reprint author), Univ Toronto, Dept Anthropol, 19 Russell St, Toronto, ON M5S 2S2, Canada.	i.badescu@mail.utoronto.ca					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altmann J, 1980, BABOON MOTHERS INFAN; Koenig A, 2004, AM J PRIMATOL, V64, P351, DOI 10.1002/ajp.20084; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Saj TL, 2005, PRIMATES, V46, P211, DOI 10.1007/s10329-004-0118-4; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Strier KB, 2011, P NATL ACAD SCI USA, V108, P18915, DOI 10.1073/pnas.1116737108; Robinson SP, 2013, MOL ECOL, V22, P5779, DOI 10.1111/mec.12529; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; CHENEY DL, 1978, ANIM BEHAV, V26, P389, DOI 10.1016/0003-3472(78)90057-X; Koenig A, 2000, BEHAV ECOL SOCIOBIOL, V48, P93, DOI 10.1007/s002650000198; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Wikberg EC, 2013, BEHAVIOUR, V150, P295, DOI 10.1163/1568539X-00003050; MCKENNA JJ, 1979, AM ANTHROPOL, V81, P818, DOI 10.1525/aa.1979.81.4.02a00040; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; Wikberg EC, 2014, BEHAV PROCESS, V106, P27, DOI 10.1016/j.beproc.2014.04.002; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90038-4; Berman CM, 2004, INT J PRIMATOL, V25, P1283, DOI 10.1023/B:IJOP.0000043963.77801.c3; MUROYAMA Y, 1994, BEHAVIOUR, V128, P103, DOI 10.1163/156853994X00064; Korstjens AH, 2002, BEHAVIOUR, V139, P203, DOI 10.1163/156853902760102654; Chapais B, 2001, INT J PRIMATOL, V22, P203, DOI 10.1023/A:1005619430744; Gomes CM, 2011, BEHAV ECOL SOCIOBIOL, V65, P2183, DOI 10.1007/s00265-011-1227-x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Brent LJN, 2008, AM J PRIMATOL, V70, P101, DOI 10.1002/ajp.20478; Milligan BG, 2003, GENETICS, V163, P1153; OBRIEN TG, 1991, BEHAVIOUR, V119, P30, DOI 10.1163/156853991X00355; Barton K., 2013, MUMLN MULTIMODEL INF; Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.1016/J.JSPS.2012.11.002; Bdescu I, 2011, THESIS U CALGARY CAL, P140; Bentley-Condit VK, 2001, AM J PRIMATOL, V55, P117, DOI 10.1002/ajp.1044; Bercovitch FB, 2002, INT J PRIMATOL, V23, P905, DOI 10.1023/A:1015585117114; Borries C, 1988, HUM EVOL, V3, P239, DOI DOI 10.1007/BF02435856; BORRIES C, 1991, INT J PRIMATOL, V12, P231, DOI 10.1007/BF02547586; Burnham K. P., 2002, MODEL SELECTION MULT; Chism J, 2000, FOLIA PRIMATOL, V71, P55, DOI 10.1159/000021730; FAIRBANKS LA, 1988, INT J PRIMATOL, V9, P425, DOI 10.1007/BF02736218; Forster S, 2005, BEHAVIOUR, V142, P869, DOI 10.1163/1568539055010138; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; GOULD L, 1992, FOLIA PRIMATOL, V58, P72, DOI 10.1159/000156611; HORWICH R H, 1975, Primates, V16, P49, DOI 10.1007/BF02381799; Hrdy S, 2009, MOTHERS OTHERS EVOLU; Hrdy Sarah B., 1976, ADV STUD BEHAV, V6, P101, DOI 10.1016/S0065-3454(08)60083-2; HRDY SB, 1976, SCIENCE, V193, P913, DOI 10.1126/science.193.4256.913; JAY PC, 1962, ANN NY ACAD SCI, V102, P468, DOI 10.1111/j.1749-6632.1962.tb13653.x; Kapsalis E., 2004, MATRILINEAL KINSHIP, P153; Kurland JA, 1977, CONTRIBUTIONS PRIMAT; LANCASTE.JB, 1971, FOLIA PRIMATOL, V15, P161, DOI 10.1159/000155377; MacDonald LJ, 2011, THESIS U CALGARY CAL, P129; MacKinnon KC, 2011, PRIMATES PERSPECTIVE, P440; MAESTRIPIERI D, 1994, INT J PRIMATOL, V15, P531, DOI 10.1007/BF02735970; MEANEY MJ, 1990, J COMP PSYCHOL, V104, P377; Paul A, 1996, BEHAV ECOL SOCIOBIOL, V39, P133, DOI 10.1007/s002650050275; POIRIER F E, 1968, Primates, V9, P45, DOI 10.1007/BF01795885; Poirier FE, 1970, PRIMATE BEHAV DEV FI, P252; R Core Team, 2014, R LANG ENV STAT COMP; Rendall D, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P295; Robbins MM, 2005, BEHAVIOUR, V142, P778; Ross C, 2000, FOLIA PRIMATOL, V71, P93, DOI 10.1159/000021733; Saj TL, 2007, INT J PRIMATOL, V28, P315, DOI 10.1007/s10764-007-9124-x; Schino G, 2003, INT J PRIMATOL, V24, P627, DOI 10.1023/A:1023796531972; SCOLLAY PA, 1980, ETHOL SOCIOBIOL, V1, P291, DOI 10.1016/0162-3095(80)90014-X; Sicotte P, 2007, INT J PRIMATOL, V28, P627, DOI 10.1007/s10764-007-9141-9; Silk JB, 2003, ETHOLOGY, V109, P627, DOI 10.1046/j.1439-0310.2003.00907.x; Silk JB, 1999, ANIM BEHAV, V57, P1021, DOI 10.1006/anbe.1998.1065; Sommer V., 1989, P110; STANFORD CB, 1992, BEHAV ECOL SOCIOBIOL, V30, P29; TARDIF SD, 1984, AM J PRIMATOL, V6, P377, DOI 10.1002/ajp.1350060408; Teichroeb JA, 2012, BEHAV ECOL, V23, P1348, DOI 10.1093/beheco/ars128; Teichroeb JA, 2009, BEHAVIOUR, V146, P551, DOI 10.1163/156853909X426363; Teichroeb JA, 2008, AM J PRIMATOL, V71, P49; Teichroeb JA, 2008, BEHAVIOUR, V145, P417; Treves A, 1997, AM J PHYS ANTHROPOL, V104, P47, DOI 10.1002/(SICI)1096-8644(199709)104:1<47::AID-AJPA4>3.0.CO;2-A; van Noordwijk Maria A., 2012, P321; Van Horn RC, 2008, ANIM BEHAV, V75, P1173, DOI 10.1016/j.anbehav.2007.08.027; Wang J, 2010, MOL ECOLOGY RESOURCE, V11, P141, DOI DOI 10.1111/J.1755-0998.2010.02885.X; Wikberg EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048740; Wikberg EC, 2014, AM J PHYS ANTHROPOL, V153, P365, DOI 10.1002/ajpa.22435; Wong SNP, 2006, AM J PRIMATOL, V68, P465, DOI 10.1002/ajp.20242; Yao M, 2012, INT J PRIMATOL, V33, P888, DOI 10.1007/s10764-012-9625-0	84	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-2565	1098-2345		AM J PRIMATOL	Am. J. Primatol.	APR	2015	77	4					376	387		10.1002/ajp.22353		12	Zoology	Zoology	CE2YJ	WOS:000351688000003		
J	Honda, Y; Goto, K; Sentani, K; Yasui, W; Ikeda, K; Matsubara, A; Awai, K				Honda, Yukiko; Goto, Keisuke; Sentani, Kazuhiro; Yasui, Wataru; Ikeda, Kenichiro; Matsubara, Akio; Awai, Kazuo			T Categorization of Urothelial Carcinomas of the Ureter With CT: Preliminary Study of New Diagnostic Criteria Proposed for Differentiating T2 or Lower From T3 or Higher	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						CT; T category; TNM staging system; ureter; urothelial carcinoma	UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; DIFFUSION-WEIGHTED MRI; NEPHROURETERECTOMY; CHEMOTHERAPY; HYDRONEPHROSIS; UROGRAPHY; GRADE; MDCT	OBJECTIVE. The purposes of this study were to propose and evaluate new diagnostic criteria for the differentiation of category T2 or lower from T3 or higher ureteral urothelial carcinomas on contrast-enhanced CT (CECT) images and to investigate the diagnostic applicability of the criteria. MATERIALS AND METHODS. The study included 30 patients with ureteral urothelial carcinoma who underwent CECT before surgery. For all patients, unenhanced and contrast- enhanced images (nephrographic and excretory phases) were acquired with a 16-or 64-MDCT scanner. The slice thickness of axial images was 5 mm. A grading system was devised that focused on spiculation and mass formation along the ureter on CECT images to differentiate T2 or lower from T3 or higher tumors. Three radiologists not specialized in abdominal radiology participated in an observer performance study to investigate the diagnostic utility of the criteria. Jackknife ROC analysis was used to compare the radiologists' diagnostic performance without and with the proposed diagnostic criteria. In addition, two board-certified radiologists used consensus to determine the CT grade, and the correlation between CT and pathologic findings was assessed. RESULTS. The mean AUCs for the three radiologists without and with the proposed criteria were 0.54 (SD, 0.09) and 0.73 (SD, 0.08), indicating a statistically significant difference (p < 0.01). For the CT-pathologic correlation, the diagnostic sensitivity and specificity of the proposed criteria with respect to pT3 and higher tumors were 87.5% (14/16) and 92.9% (13/14). CONCLUSION. The proposed CT grading system was accurate for differentiating T2 or lower from T3 or higher ureteral urothelial carcinoma.	[Honda, Yukiko; Awai, Kazuo] Hiroshima Univ, Inst Biomed Hlth & Sci, Dept Diagnost Radiol, Minami Ku, Hiroshima 7348551, Japan; [Goto, Keisuke; Sentani, Kazuhiro; Yasui, Wataru] Hiroshima Univ, Inst Biomed Hlth & Sci, Dept Mol Pathol, Hiroshima 7348551, Japan; [Ikeda, Kenichiro; Matsubara, Akio] Hiroshima Univ, Inst Biomed Hlth & Sci, Dept Urol, Hiroshima 7348551, Japan	Honda, Y (reprint author), Hiroshima Univ, Inst Biomed Hlth & Sci, Dept Diagnost Radiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	honday@hiroshima-u.ac.jp					Youssef RF, 2011, BJU INT, V108, P1286, DOI 10.1111/j.1464-410X.2011.10075.x; Chakraborty DP, 2011, SEMIN NUCL MED, V41, P401, DOI 10.1053/j.semnuclmed.2011.07.001; Jinzaki M, 2011, AM J ROENTGENOL, V196, P1102, DOI 10.2214/AJR.10.5249; Kondo T, 2011, INT J CLIN ONCOL, V16, P170, DOI 10.1007/s10147-011-0234-2; Akita H, 2011, AM J ROENTGENOL, V197, P1130, DOI 10.2214/AJR.10.6299; Sakano S, 2013, ANN SURG ONCOL, V20, P4389, DOI 10.1245/s10434-013-3259-0; Kitamura H, 2012, JPN J CLIN ONCOL, V42, P1192, DOI 10.1093/jjco/hys166; Fritz GA, 2006, EUR RADIOL, V16, P1244, DOI 10.1007/s00330-005-0078-0; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Scolieri MJ, 2000, UROLOGY, V56, P930, DOI 10.1016/S0090-4295(00)00800-1; Ito Y, 2011, J UROLOGY, V185, P1621, DOI 10.1016/j.juro.2010.12.035; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Bamias A, 2004, J CLIN ONCOL, V22, P2150, DOI 10.1200/JCO.2004.09.043; Besheli LD, 2014, CLIN RADIOL, V69, P661, DOI 10.1016/j.crad.2014.01.003; Caoili EM, 2005, AM J ROENTGENOL, V184, P1873; Cho KS, 2007, UROLOGY, V70, P662, DOI 10.1016/j.urology.2007.06.1106; Obuchi M, 2007, AM J ROENTGENOL, V188, pW256, DOI 10.2214/AJR.05.0172; Gandrup KL, 2013, ACTA RADIOL, V55, P761; Matin SF, 2010, CANCER-AM CANCER SOC, V116, P3127, DOI 10.1002/cncr.25050; Yoshida S, 2011, AM J ROENTGENOL, V196, P110, DOI 10.2214/AJR.10.4632	20	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	APR	2015	204	4					792	797		10.2214/AJR.14.13167		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE2AN	WOS:000351614700034		
J	Kato, S; Asano, N; Miyata-Takata, T; Takata, K; Elsayed, AA; Satou, A; Takahashi, E; Kinoshita, T; Nakamura, S				Kato, Seiichi; Asano, Naoko; Miyata-Takata, Tomoko; Takata, Katsuyoshi; Elsayed, Ahmed Ali; Satou, Akira; Takahashi, Emiko; Kinoshita, Tomohiro; Nakamura, Shigeo			T-cell Receptor (TCR) Phenotype of Nodal Epstein-Barr Virus (EBV)-positive Cytotoxic T-cell Lymphoma (CTL) A Clinicopathologic Study of 39 Cases	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						cytotoxic molecule; Epstein-Barr virus; extranasal NK/T-cell lymphoma of nasal type; nodal cytotoxic T-cell lymphoma; T-cell receptor phenotype	NATURAL-KILLER-CELL; GAMMA-DELTA CELLS; NASAL-TYPE; EXPRESSION; SCLEROSIS; FEATURES; FORMS; NK	Among Epstein-Barr virus (EBV)-positive cytotoxic T/NK-cell lymphoma, there are only a few reports on the clinicopathologic features of patients with primary nodal presentation (nodal EBV+ cytotoxic T-cell lymphoma [CTL]). Here, we compared the clinicopathologic profiles of 39 patients with nodal EBV+ CTL with those of 27 cases of "extranasal" NK/T-cell lymphoma of nasal type (ENKTL), especially addressing their T-cell receptor (TCR) phenotype. Histologically, 22 of 39 nodal EBV+ CTL cases (56%) were unique in having centroblastoid appearance, which was contrasted with the lower incidence of this feature in ENKTL (15%, P - 0.001). In contrast, pleomorphic appearance was more frequently seen in ENKTL than in nodal EBV+ CTL (67% vs. 23%, P = 0.001). Thirty-three of 39 nodal EBV+ CTL cases (85%) were of T-cell lineage on the basis of TCR expression and/or TCR gamma gene rearrangement; in detail, 18 cases (46%) were TCR gamma positive (alpha beta T), 5 (13%) were TCR gamma and/or delta positive (gamma delta T), and 10 (26%) were TCR-silent type with clonal TCRg gene rearrangement but no expression of TCR beta, gamma, or delta. These results were clearly contrasted by a lower incidence of T-cell lineage in ENKTL (7 cases, 26%, P < 0.001). Notably, the survival time of the 5 nodal lymphoma patients with gamma delta T-cell phenotype was within 3 months, which was inferior to those of alpha beta T and TCR-silent types (P = 0.003), and 3 of those with available clinical information were all found to be associated with autoimmune diseases. These data suggest that nodal EBV+ CTL is distinct from ENKTL.	[Kato, Seiichi; Elsayed, Ahmed Ali; Satou, Akira; Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi 4668560, Japan; [Kinoshita, Tomohiro] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Asano, Naoko] Nagano Prefectural Suzaka Hosp, Dept Mol Diag, Suzaka, Japan; [Miyata-Takata, Tomoko; Takata, Katsuyoshi] Okayama Univ, Dept Pathol, Okayama 7008530, Japan; [Takahashi, Emiko] Aichi Med Univ Hosp, Dept Pathol, Nagakute, Aichi, Japan	Kato, S (reprint author), Nagoya Univ Hosp, Dept Pathol & Lab Med, Shouwa Ku, 65 Tsurumaichou, Nagoya, Aichi 4668560, Japan.	katopath@med.nagoya-u.ac.jp	Nakamura, Shigeo/I-1571-2012				Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; STINISSEN P, 1995, J IMMUNOL, V154, P4883; Ko YH, 2000, CANCER, V89, P2106, DOI 10.1002/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G; Asano N, 2005, AM J SURG PATHOL, V29, P1284, DOI 10.1097/01.pas.0000173238.17331.6b; Chauhan SK, 2006, CLIN IMMUNOL, V118, P243, DOI 10.1016/j.clim.2005.10.010; Ko YH, 2004, HISTOPATHOLOGY, V44, P480, DOI 10.1111/j.1365-2559.2004.01867.x; Chan JKC, 2011, AM J SURG PATHOL, V35, P1557, DOI 10.1097/PAS.0b013e318222dfcd; Ohsawa M, 1999, INT J CANCER, V81, P865, DOI 10.1002/(SICI)1097-0215(19990611)81:6<865::AID-IJC5>3.0.CO;2-S; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri.797; Giacomelli R, 1998, ARTHRITIS RHEUM, V41, P327, DOI 10.1002/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Tripodo C, 2009, NAT REV CLIN ONCOL, V6, P707, DOI 10.1038/nrclinonc.2009.169; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Pongpruttipan T, 2012, AM J SURG PATHOL, V36, P481, DOI 10.1097/PAS.0b013e31824433d8; Attygalle AD, 2014, HISTOPATHOLOGY, V64, P171, DOI 10.1111/his.12251; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Chan JKC, 1997, BLOOD, V89, P4501; Li SY, 2013, AM J SURG PATHOL, V37, P14, DOI 10.1097/PAS.0b013e31826731b5; Garcia-Herrera A, 2011, AM J SURG PATHOL, V35, P1214, DOI 10.1097/PAS.0b013e31822067d1; Kato S, 2012, HISTOPATHOLOGY, V61, P186, DOI 10.1111/j.1365-2559.2012.04199.x; Ha SY, 2013, PATHOL RES PRACT, V209, P448, DOI 10.1016/j.prp.2013.04.013; Bank I, 2003, J LAB CLIN MED, V141, P33, DOI 10.1067/mlc.2003.1; Roullet M, 2009, AM J CLIN PATHOL, V131, P820, DOI 10.1309/AJCPMG37MXKYPUBE; Gualco G, 2011, AM J SURG PATHOL, V35, P1195, DOI 10.1097/PAS.0b013e31821ec4b5; Ng SB, 2004, MODERN PATHOL, V17, P1097, DOI 10.1038/modpathol.3800157; BORST J, 1988, J EXP MED, V167, P1625, DOI 10.1084/jem.167.5.1625; Chim CS, 2005, J CLIN PATHOL, V58, P443, DOI 10.1136/jcp.2004.022608; FALINI B, 1989, J IMMUNOL, V143, P2480; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Hassan J, 1996, CLIN EXP IMMUNOL, V103, P353; Lee SY, 2010, SEMIN IMMUNOL, V22, P237, DOI 10.1016/j.smim.2010.04.008; Ohshima K, 1999, VIRCHOWS ARCH, V435, P92, DOI 10.1007/s004280050404; Rodriguez-Pinilla SM, 2013, AM J SURG PATHOL, V37, P375, DOI 10.1097/PAS.0b013e318275d1a2; Swerdlow SH, 2008, WHO CLASSIFICATION O; Takahashi E, 2008, HISTOPATHOLOGY, V52, P585, DOI 10.1111/j.1365-2559.2008.02997.x	36	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	APR	2015	39	4					462	471				10	Pathology; Surgery	Pathology; Surgery	CE2XE	WOS:000351684200004		
J	Miyabe, K; Hori, Y; Nakazawa, T; Hayashi, K; Naitoh, I; Shimizu, S; Kondo, H; Nishi, Y; Yoshida, M; Umemura, S; Kato, A; Ohara, H; Joh, T; Inagaki, H				Miyabe, Katsuyuki; Hori, Yasuki; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Kato, Akihisa; Ohara, Hirotaka; Joh, Takashi; Inagaki, Hiroshi			Locus/Chromosome Aberrations in Intraductal Papillary Mucinous Neoplasms Analyzed by Fluorescence In Situ Hybridization	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						pancreatic tumor; intraductal papillary mucinous neoplasm; fluorescence in situ hybridization	INTERNATIONAL CONSENSUS GUIDELINES; PANCREATIC INTRAEPITHELIAL NEOPLASIA; FINE-NEEDLE-ASPIRATION; ENDOSCOPIC ULTRASOUND; EXPRESSION; MANAGEMENT; CARCINOMA; TUMORS; GENE; ADENOCARCINOMA	Locus and chromosome abnormalities have not been well clarified in intraductal papillary mucinous neoplasms (IPMNs). The aim of this study was to retrospectively examine these abnormalities using fluorescence in situ hybridization. IPMNs (n = 28) were histopathologically classified into noninvasive IPMN (n = 17) and IPMN with an associated invasive carcinoma (invasive IPMN, n = 11) groups. Noninvasive IPMNs possessed non-neoplastic and noninvasive spots in their tissues, and invasive IPMN cases possessed non-neoplastic, noninvasive, and invasive spots. Non-neoplastic (n = 28), noninvasive (n = 28), and invasive (n = 11) spots were then analyzed for aneuploidy of chromosomes 3, 6, 7, 8, 17, and 18 and deletions of p16 and p53 loci. Polysomy 6 and p16 deletion were significantly more frequent in noninvasive than in non-neoplastic spots. Polysomy 7, polysomy 18, p16 deletion, and p53 deletion were significantly more frequent in invasive than in noninvasive spots. Detection of polysomy 7 and p53 deletion gave a high diagnostic accuracy for invasive IPMN (sensitivity, 90.9%; specificity, 94.1%; and accuracy, 92.5%). Our study suggests that: (1) polysomy 6 and p16 deletion may contribute to adenomatous change of IPMN; (2) polysomy 7, polysomy 18, p16 deletion, and p53 deletion play roles in malignant transformation of noninvasive IPMN; and (3) polysomy 7 and p53 deletion may be excellent diagnostic markers for invasive IPMN.	[Miyabe, Katsuyuki; Hori, Yasuki; Nakazawa, Takahiro; Hayashi, Kazuki; Naitoh, Itaru; Shimizu, Shuya; Kondo, Hiromu; Nishi, Yuji; Yoshida, Michihiro; Umemura, Shuichiro; Kato, Akihisa; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan; [Miyabe, Katsuyuki; Hori, Yasuki; Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Anat Pathol & Mol Diagnost, Nagoya, Aichi 4678601, Japan; [Ohara, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan	Inagaki, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Anat Pathol & Mol Diagnost, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	hinagaki@med.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [26461046]; Pancreas Research Foundation of Japan; Aichi Cancer Research Foundation	Supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (26461046 to Itaru Naitoh) and a research grant from Pancreas Research Foundation of Japan and Aichi Cancer Research Foundation. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Adsay NV, 2010, WHO CLASSIFICATION T, P304; Abe K, 2007, PANCREAS, V34, P85, DOI 10.1097/01.mpa.0000240608.56806.0a; Jang JY, 2014, BRIT J SURG, V101, P686, DOI 10.1002/bjs.9491; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Pais SA, 2007, CLIN GASTROENTEROL H, V5, P489, DOI 10.1016/j.cgh.2006.12.007; Hibi Y, 2007, PANCREAS, V34, P197, DOI 10.1097/MPA.0b013e31802dea0; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; Wada Keita, 2002, J Hepatobiliary Pancreat Surg, V9, P76, DOI 10.1007/s005340200007; Fritcher EGB, 2009, GASTROENTEROLOGY, V136, P2180, DOI 10.1053/j.gastro.2009.02.040; Bova RJ, 1999, CLIN CANCER RES, V5, P2810; Cizginer S, 2011, PANCREAS, V40, P1024, DOI 10.1097/MPA.0b013e31821bd62f; Wilentz RE, 1998, CANCER RES, V58, P4740; Amato E, 2014, J PATHOL, V233, P217, DOI 10.1002/path.4344; Goh BKP, 2014, AM J SURG, V208, P202, DOI 10.1016/j.amjsurg.2013.09.031; Fujii H, 1997, AM J PATHOL, V151, P1447; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Biankin AV, 2002, GUT, V50, P861, DOI 10.1136/gut.50.6.861; Biankin AV, 2004, AM J SURG PATHOL, V28, P1184, DOI 10.1097/01.pas.0000131556.22382.3c; Hruban RH, 2007, AFIP ATLAS TUMOR PAT, V4, P75; Kubiliun N, 2011, GASTROINTEST ENDOSC, V74, P541, DOI 10.1016/j.gie.2011.04.043; Levy MJ, 2012, GASTROENTEROLOGY, V142, P1112, DOI 10.1053/j.gastro.2012.02.002; Moore PS, 2001, BRIT J CANCER, V84, P253, DOI 10.1054/bjoc.2000.1567; Nomoto J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-457; Ono J, 2011, CYTOJOURNAL, V8, DOI 10.4103/1742-6413.90084; Pitman MB, 2012, CANCER CYTOPATHOL, V120, P361, DOI 10.1002/cncy.21235; Ribeiro A, 2014, J GASTROEN HEPATOL, V29, P1654, DOI 10.1111/jgh.12575; Schleicher C, 2007, ANN SURG ONCOL, V14, P1327, DOI 10.1245/s10434-006-9113-x; Soldini D, 2003, J PATHOL, V199, P453, DOI 10.1002/path.1301	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	APR	2015	39	4					512	520				9	Pathology; Surgery	Pathology; Surgery	CE2XE	WOS:000351684200010		
J	Matsushita, T; Maruyama, R; Ishikawa, N; Harada, Y; Araki, A; Chen, D; Tauchi-Nishi, P; Yuki, T; Kinoshita, Y				Matsushita, Takashi; Maruyama, Riruke; Ishikawa, Nahoko; Harada, Yuji; Araki, Asuka; Chen, Diane; Tauchi-Nishi, Pamela; Yuki, Takafumi; Kinoshita, Yoshikazu			The Number and Distribution of Eosinophils in the Adult Human Gastrointestinal Tract A Study and Comparison of Racial and Environmental Factors	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						normal; eosinophil; gastrointestinal tract; race	CONSENSUS RECOMMENDATIONS; MUCOSAL EOSINOPHILS; SEASONAL-VARIATION; JAPANESE PATIENTS; GASTROENTERITIS; ESOPHAGITIS; CHILDREN	There are surprisingly limited data regarding normal counts or distribution of eosinophils in the gastrointestinal tract, despite the increasing incidence of eosinophilic gastrointestinal tract diseases. Moreover, there are no published reports on the eosinophil number throughout the gastrointestinal tract of adults or Asian populations, or those investigating the effect of race on eosinophil count. First, in our study, the number of eosinophils from each portion of the gastrointestinal mucosa was quantified on biopsy slides from a Japanese adult population (132 samples). Next, the surgical resections from Japanese (110 samples), Japanese Americans (64), and Caucasians (57) were used to investigate the racial and environmental effects. Our results with the Japanese biopsy samples showed a significant increase in the number of eosinophils from the esophagus to the right colon (mean +/- SD/mm(2) : 0.07 +/- 0.43 for the esophagus, 12.18 +/- 11.39 for the stomach, and 36.59 +/- 15.50 for the right colon), compared with a decrease in the left colon (8.53 +/- 7.83). Investigation using surgical samples showed that the distribution patterns in the gastrointestinal tract were very similar among the 3 ethnic groups, and there were no significant differences in the number of eosinophils among these groups, except in the esophageal epithelium. This study is the first report on the normal numbers and distribution of eosinophils throughout the gastrointestinal tract not only of an Asian population but also of adults. Our data suggest that a cutoff value for eosinophil counts, when rendering a diagnosis of eosinophilic gastrointestinal tract disease, should be individualized to the different biopsy sites. Interestingly, race and environmental factors did not seem to have a significant effect on eosinophil densities and distributions.	[Matsushita, Takashi; Maruyama, Riruke; Ishikawa, Nahoko; Harada, Yuji; Araki, Asuka] Shimane Univ, Sch Med, Dept Pathol, Izumo, Shimane 6938501, Japan; [Yuki, Takafumi; Kinoshita, Yoshikazu] Shimane Univ, Sch Med, Dept Gastroenterol & Hepatol, Izumo, Shimane 6938501, Japan; [Chen, Diane; Tauchi-Nishi, Pamela] Univ Hawaii, Queens Med Ctr, Dept Pathol, Honolulu, HI 96822 USA	Maruyama, R (reprint author), Shimane Univ, Sch Med, Dept Pathol, Organ Pathol Unit, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	hm5995@med.shimane-u.ac.jp					Al-Hussaini A, 2013, J GASTROENTEROL, V48, P1205, DOI 10.1007/s00535-012-0741-6; Powell N, 2010, NAT REV GASTRO HEPAT, V7, P146, DOI 10.1038/nrgastro.2010.5; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Pascal RR, 1997, MODERN PATHOL, V10, P363; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; Prasad GA, 2009, CLIN GASTROENTEROL H, V7, P1055, DOI 10.1016/j.cgh.2009.06.023; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; ODZE RD, 1993, HUM PATHOL, V24, P668, DOI 10.1016/0046-8177(93)90248-F; Baig MA, 2006, J NATL MED ASSOC, V98, P1616; Polydorides AD, 2008, HUM PATHOL, V39, P832, DOI 10.1016/j.humpath.2007.10.012; Sorser SA, 2013, J GASTROENTEROL, V48, P81, DOI 10.1007/s00535-012-0608-x; Kinoshita Y, 2013, J GASTROENTEROL, V48, P333, DOI 10.1007/s00535-012-0640-x; Ingle SB, 2013, WORLD J GASTROENTERO, V19, P5061, DOI 10.3748/wjg.v19.i31.5061; TALLEY NJ, 1990, GUT, V31, P54, DOI 10.1136/gut.31.1.54; Abe Y, 2011, J GASTROENTEROL, V46, P25, DOI 10.1007/s00535-010-0295-4; Fujishiro H, 2011, J GASTROENTEROL, V46, P1142, DOI 10.1007/s00535-011-0435-5; DeBrosse CW, 2006, PEDIATR DEVEL PATHOL, V9, P210, DOI 10.2350/11-05-0130.1; Fenoglio-Preiser CM., 2008, GASTROINTESTINAL PAT; LEE CM, 1993, AM J GASTROENTEROL, V88, P70; Lowichik A, 1996, MODERN PATHOL, V9, P110; Lwin T, 2011, MODERN PATHOL, V24, P556, DOI 10.1038/modpathol.2010.221; Noffsinger A, 2007, GASTROINTESTINAL DIS, P643; Oh HE, 2008, J GASTROENTEROL, V43, P741, DOI 10.1007/s00535-008-2230-5; Saad AG, 2011, PEDIATR DEVEL PATHOL, V14, P294, DOI 10.2350/10-07-0878-OA.1	24	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	APR	2015	39	4					521	527				7	Pathology; Surgery	Pathology; Surgery	CE2XE	WOS:000351684200011		
J	Goto, N; Tsurumi, H; Takami, T; Futamura, M; Morimitsu, K; Takata, K; Sato, Y; Yoshino, T; Adachi, S; Saito, K; Yamakawa, M				Goto, Naoe; Tsurumi, Hisashi; Takami, Tsuyoshi; Futamura, Manabu; Morimitsu, Kasumi; Takata, Katsuyoshi; Sato, Yasuharu; Yoshino, Tadashi; Adachi, Seiji; Saito, Koshiro; Yamakawa, Mitsunori			Cytokeratin-positive Fibroblastic Reticular Cell Tumor With Follicular Dendritic Cell Features A Case Report and Review of the Literature	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						fibroblastic reticular cell tumor; FRC neoplasm; cytokeratin-positive FRC tumors	HUMAN LYMPH-NODES; CLASSIFICATION; NEOPLASM; SARCOMA; SPLEEN	Fibroblastic reticular cell (FRC) neoplasms, which are one of the histiocyte tumor types, are very rare. Here we report a cytokeratin (CK)-positive FRC neoplasm having features of follicular dendritic cells in a 54-year-old woman with right axillary lymph node swelling. The resected lymph node showed multiple nodular aggregations simulating and replacing normal follicles. The tumor cells had a uniform, large and oval to polygonal shape, abundant cytoplasm, and various sizes of nuclei with central eosinophilic nucleoli and coarse nuclear chromatin. They were positive for CK AE1/AE3 + CAM5.2, CK7, tenascin C, l-caldesomone, and CD21, weakly positive for S100, and negative for CD1a. Ultrastructurally, the tumor cells had long interdigitating microvillus-like cell processes and oval to elongated [GRAPHICS] vesicular nuclei. In addition, the intercellular spaces contained accumulations of collagen, and some tumor cells had desmosomal-like junctions. These findings suggest that the present case is a CK-positive FRC tumor with follicular dendritic cell features.	[Goto, Naoe; Tsurumi, Hisashi] Gifu Univ, Grad Sch Med, Dept Hematol, Gifu 5011194, Japan; [Futamura, Manabu; Morimitsu, Kasumi] Gifu Univ, Grad Sch Med, Dept Breast & Mol Oncol, Gifu 5011194, Japan; [Goto, Naoe; Adachi, Seiji; Saito, Koshiro] Gihoku Kosei Hosp, Dept Internal Med, Gifu, Japan; [Takami, Tsuyoshi] Tokai Clin, Gifu, Japan; [Takata, Katsuyoshi; Sato, Yasuharu; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008530, Japan; [Sato, Yasuharu] Okayama Univ, Grad Sch Hlth Sci, Div Pathophysiol, Okayama 7008530, Japan; [Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Diagnost Pathol, Yamagata 990, Japan	Tsurumi, H (reprint author), Gifu Univ, Grad Sch Med, Dept Internal Med 1, 1-1 Yanagido, Gifu 5011194, Japan.	htsuru@gifu-u.ac.jp					TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; [Anonymous], 2013, NATL COMPREHENSIVE C; Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C; WOOD GS, 1985, AM J PATHOL, V119, P73; Chan ACL, 2000, AM J SURG PATHOL, V24, P107, DOI 10.1097/00000478-200001000-00013; DOGLIONI C, 1990, VIRCHOWS ARCH A, V416, P479, DOI 10.1007/BF01600298; FRANKE WW, 1987, DIFFERENTIATION, V36, P145, DOI 10.1111/j.1432-0436.1987.tb00189.x; Futamura Manabu, 2013, Int J Surg Case Rep, V4, P719, DOI 10.1016/j.ijscr.2013.05.010; GLOGHINI A, 1993, HUM PATHOL, V24, P67, DOI 10.1016/0046-8177(93)90065-O; GOULD VE, 1990, EUR J CANCER, V26, P1121, DOI 10.1016/0277-5379(90)90267-W; Jaffe ES, 2001, WHO CLASSIFICATION T; Jones D, 2001, MODERN PATHOL, V14, P1059, DOI 10.1038/modpathol.3880436; Lucioni M, 2003, HISTOPATHOLOGY, V43, P583, DOI 10.1111/j.1365-2559.2003.01725.x; Schuerfeld K, 2003, HISTOPATHOLOGY, V43, P491, DOI 10.1046/j.1365-2559.2003.01738.x; Suarez D, 2011, APMIS, V119, P216, DOI 10.1111/j.1600-0463.2010.02712.x; Swerdlow S, 2008, WHO CLASSIFICATION T; THOMAS R, 1993, J IMMUNOL, V150, P821; VILLENA A, 1983, CELL TISSUE RES, V229, P219	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	APR	2015	39	4					573	580				8	Pathology; Surgery	Pathology; Surgery	CE2XE	WOS:000351684200017		
J	Hiraishi, K; Wada, T; Kubo, K; Otsu, Y; Ikebe, M; Sano, E				Hiraishi, Kazuki; Wada, Toshiki; Kubo, Keishi; Otsu, Yutaro; Ikebe, Masayuki; Sano, Eiichi			Low-power, small-size transmitter module with metamaterial antenna	ANALOG INTEGRATED CIRCUITS AND SIGNAL PROCESSING			English	Article						OOK; VCO; Low-power; Metamaterial; 2.4 GHz; Sensor network	LINES	Development of a low-power, small-size transmitter is needed for wireless sensor networks. An effective way to reduce power consumption is to reduce the operating time in a voltage-controlled oscillator. In this study, a 2.4 GHz on-off keying transmitter circuit is designed and implemented with an electrically small antenna using a left-handed transmission line. The transmitter circuit was fabricated with a standard 0.18 mu m CMOS technology, while the antenna was fabricated with a 3.0 x 4.5 cm printed circuit board, chip capacitors, and chip inductors. Measured output power was -6.8 dBm with a power consumption of 3.59 mW when the baseband signal was always "high". The power consumption was reduced to 1.96 mW for the baseband signal with a mark ratio of 0.5.	[Hiraishi, Kazuki; Wada, Toshiki; Kubo, Keishi; Otsu, Yutaro; Sano, Eiichi] Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0608628, Japan; [Ikebe, Masayuki] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan	Sano, E (reprint author), Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0608628, Japan.	esano@rciqe.hokudai.ac.jp			SCOPE; VDEC; Cadence Design Systems, Inc.; Agilent Technologies Japan, Ltd.	This work was partially supported by SCOPE, and by VDEC in collaboration with Cadence Design Systems, Inc., and Agilent Technologies Japan, Ltd.	Antoniades MA, 2008, IEEE ANTENN WIREL PR, V7, P425, DOI 10.1109/LAWP.2008.2008773; Caloz C, 2004, IEEE T MICROW THEORY, V52, P980, DOI 10.1109/TMTT.2004.823579; Chi PL, 2011, IEEE T ANTENN PROPAG, V59, P48, DOI 10.1109/TAP.2010.2090452; Caekenberghe K. V., 2008, IEEE ANTENN WIREL PR, V7, P346; Chee Y. H., 2006, IEEE VLSI S, P43; Daly C. D., 2007, IEEE J SOLID-ST CIRC, V42, P1003; Huang XC, 2010, IEEE RAD FREQ INTEGR, P263, DOI 10.1109/RFIC.2010.5477317; Kamali S., 2010, INT WORKSH ANT TECHN, P1; Liu Q, 2009, IEEE T ANTENN PROPAG, V57, P3009, DOI 10.1109/TAP.2009.2028642; Mercier PP, 2014, IEEE J SOLID-ST CIRC, V49, P1463, DOI 10.1109/JSSC.2014.2316237; Scardelletti MC, 2008, IEEE RADIO WIRELESS, P731, DOI 10.1109/RWS.2008.4463596; Takahagi K, 2011, IEEE T ANTENN PROPAG, V59, P3624, DOI 10.1109/TAP.2011.2163758; Takahagi K, 2012, ELECTRON LETT, V48, P971, DOI 10.1049/el.2012.0770; Takahagi K, 2013, ANALOG INTEGR CIRC S, V75, P199, DOI 10.1007/s10470-012-9929-1	14	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1030	1573-1979		ANALOG INTEGR CIRC S	Analog Integr. Circuits Process.	APR	2015	83	1					1	9		10.1007/s10470-015-0499-x		9	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CE3PW	WOS:000351741400001		
J	Miyano, K; Minami, K; Yokoyama, T; Ohbuchi, K; Yamaguchi, T; Murakami, S; Shiraishi, S; Yamamoto, M; Matoba, M; Uezono, Y				Miyano, Kanako; Minami, Kouichiro; Yokoyama, Toru; Ohbuchi, Katsuya; Yamaguchi, Takuhiro; Murakami, Satoshi; Shiraishi, Seiji; Yamamoto, Masahiro; Matoba, Motohiro; Uezono, Yasuhito			Tramadol and Its Metabolite M1 Selectively Suppress Transient Receptor Potential Ankyrin 1 Activity, but Not Transient Receptor Potential Vanilloid 1 Activity	ANESTHESIA AND ANALGESIA			English	Article							SUBSTANCE-P RELEASE; ROOT GANGLION NEURONS; O-DESMETHYL TRAMADOL; POSTOPERATIVE PAIN; CAPSAICIN RECEPTOR; XENOPUS OOCYTES; CANCER PAIN; RAT MODEL; INDUCED RESPONSES; NEUROPATHIC PAIN	BACKGROUND: The transient receptor potential vanilloid 1 (TRPV1) and the transient receptor potential ankyrin 1 (TRPA1), which are expressed in sensory neurons, are polymodal nonselective cation channels that sense noxious stimuli. Recent reports showed that these channels play important roles in inflammatory, neuropathic, or cancer pain, suggesting that they may serve as attractive analgesic pharmacological targets. Tramadol is an effective analgesic that is widely used in clinical practice. Reportedly, tramadol and its metabolite (M1) bind to mu-opioid receptors and/or inhibit reuptake of monoamines in the central nervous system, resulting in the activation of the descending inhibitory system. However, the fundamental mechanisms of tramadol in pain control remain unclear. TRPV1 and TRPA1 may be targets of tramadol; however, they have not been studied extensively. METHODS: We examined whether and how tramadol and M1 act on human embryonic kidney 293 (HEK293) cells' expressing human TRPV1 (hTRPV1) or hTRPA1 by using a Ca2+ imaging assay and whole-cell patch-clamp recording. RESULTS: Tramadol and M1 (0.01-10 mu M) alone did not increase in intracellular Ca2+ concentration ([Ca2+](i)) in HEK293 cells expressing hTRPV1 or hTRPA1 compared with capsaicin (a TRPV1 agonist) or the allyl isothiocyanate (AITC, a TRPA1 agonist), respectively. Furthermore, in HEK293 cells expressing hTRPV1, pretreatment with tramadol or M1 for 5 minutes did not change the increase in [Ca2+](i) induced by capsaicin. Conversely, pretreatment with tramadol (0.1-10 mu M) and M1 (1-10 mu M) significantly suppressed the AITC-induced [Ca2+](i) increases in HEK293 cells expressing hTRPA1. In addition, the patch-clamp study showed that pretreatment with tramadol and M1 (10 mu M) decreased the inward currents induced by AITC. CONCLUSIONS: These data indicate that tramadol and M1 selectively inhibit the function of hTRPA1, but not that of hTRPV1, and that hTRPA1 may play a role in the analgesic effects of these compounds.	[Miyano, Kanako; Shiraishi, Seiji; Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, Tokyo 1040045, Japan; [Minami, Kouichiro; Yokoyama, Toru] Jichi Med Univ, Dept Anesthesiol & Crit Care Med, Shimotsuke, Tochigi, Japan; [Ohbuchi, Katsuya] Tumura & Co, Tsumura Res Labs, Hitachi, Ibaraki, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Clin Res Data Ctr, Div Biostat,Tohoku Univ Hosp, Sendai, Miyagi 980, Japan; [Murakami, Satoshi] Seirei Sakura Citizen Hosp, Dept Palliat Med, Sakura, Chiba, Japan; [Matoba, Motohiro] Aomori Prefectural Cent Hosp, Dept Palliat Med, Aomori, Aomori, Japan	Uezono, Y (reprint author), Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yuezono@ncc.go.jp			Ministry of Health, Labor and Welfare, Japan; National Cancer Center Research and Development Fund [23-A-29, 23-A-30]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23592318, 24590740, 23790315, 25860199]	This work was supported by a Grant-in-Aid for the Third-term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare, Japan; the National Cancer Center Research and Development Fund (23-A-29 and 23-A-30); Grants-in-Aid for Scientific Research (C) No. 23592318 and No. 24590740 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Grant-in-Aid for Young Scientists (B) No. 23790315 and No. 25860199 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Altis K, 2009, PAIN, V147, P116, DOI 10.1016/j.pain.2009.08.018; Alvarez P, 2011, J OROFAC PAIN, V25, P354; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Horishita T, 2006, PHARMACOLOGY, V77, P93, DOI 10.1159/000093179; Tang HB, 2008, NEUROPHARMACOLOGY, V55, P1405, DOI 10.1016/j.neuropharm.2008.08.037; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Shinoda M, 2008, J PAIN, V9, P687, DOI 10.1016/j.jpain.2008.02.007; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Grond S, 1999, BRIT J CLIN PHARMACO, V48, P254, DOI 10.1046/j.1365-2125.1999.00986.x; Gillen C, 2000, N-S ARCH PHARMACOL, V362, P116, DOI 10.1007/s002100000266; VICKERS MD, 1992, ANAESTHESIA, V47, P291, DOI 10.1111/j.1365-2044.1992.tb02166.x; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Tang HB, 2008, N-S ARCH PHARMACOL, V377, P325, DOI 10.1007/s00210-007-0211-5; Miyano K, 2009, NEUROPHARMACOLOGY, V57, P25, DOI 10.1016/j.neuropharm.2009.04.001; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ogata J, 2004, ANESTH ANALG, V98, P1401, DOI 10.1213/01.ANE.0000108963.77623.A4; Caterina MJ, 1997, NATURE, V389, P816; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Leppert W, 2005, SUPPORT CARE CANCER, V13, P5, DOI 10.1007/s00520-004-0720-4; Wei H, 2012, ANESTHESIOLOGY, V117, P137, DOI 10.1097/ALN.0b013e31825adb0e; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Marincsak R, 2008, ANESTH ANALG, V106, P1890, DOI 10.1213/ane.0b013e318172fefc; Pospisilova E, 2006, PAIN, V125, P233, DOI 10.1016/j.pain.2006.05.021; DRIESSEN B, 1993, BRIT J PHARMACOL, V108, P806; Garcia-Anoveros J., 2007, V179, P347; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI [10.1021/pr300870t, 10.1021/pr300370t]; Hara K, 2005, ANESTH ANALG, V100, P1400, DOI 10.1213/01.ANE.0000150961.24747.98; HARRIS RA, 1995, FASEB J, V9, P1454; HENNIES HH, 1988, ARZNEIMITTEL-FORSCH, V38-2, P877; HOUMES RJM, 1992, ANESTH ANALG, V74, P510; Hsu JC, 1992, J COMPUTATIONAL STAT, V1, P151, DOI DOI 10.2307/1390839; HUSSLEIN P, 1987, Z GEBURTSH PERINATOL, V191, P234; Kabashima N, 1997, J PHYSIOL-LONDON, V504, P113, DOI 10.1111/j.1469-7793.1997.113bf.x; Kissin I, 2005, ANESTH ANALG, V100, P774, DOI 10.1213/01.ANE.0000143570.75908.7F; Kupers R, 1995, Acta Anaesthesiol Belg, V46, P31; LINTZ W, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1932; Nakamura M, 2005, ANESTH ANALG, V101, P180, DOI 10.1213/01.ANE.0000154303.93909.A3; Nakamura Y, 2012, J NEUROCHEM, V120, P1036, DOI 10.1111/j.1471-4159.2011.07628.x; Oshita K, 2005, J PHARMACOL SCI, V97, P377, DOI 10.1254/jphs.FP0040872; PRESTON KL, 1991, DRUG ALCOHOL DEPEN, V27, P7, DOI 10.1016/0376-8716(91)90081-9; Shiga Y, 2002, ANESTH ANALG, V95, P1269, DOI 10.1213/01.ANE.0000029102.24999.B0; Spicarova D, 2008, PHYSIOL RES, V57, pS69; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Tang HB, 2006, EUR J PHARMACOL, V552, P78, DOI 10.1016/j.ejphar.2006.09.016; Wu CR, 2008, ANESTHESIOLOGY, V108, P1100, DOI 10.1097/ALN.0b013e31817302b3	53	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	APR	2015	120	4					790	798		10.1213/ANE.0000000000000625		9	Anesthesiology	Anesthesiology	CE1GF	WOS:000351559400016		
J	Matsumoto, A; Ohta, N; Goto, Y; Kashiwa, Y; Yamamoto, S; Fujino, Y				Matsumoto, Atsuhiro; Ohta, Noriyuki; Goto, Yukiko; Kashiwa, Yozo; Yamamoto, Shunsuke; Fujino, Yuji			Haloperidol Suppresses Murine Dendritic Cell Maturation and Priming of the T Helper 1-Type Immune Response	ANESTHESIA AND ANALGESIA			English	Article							CRITICALLY-ILL PATIENTS; MOUSE BONE-MARROW; CULTURE METHOD; INTERLEUKIN-2; SCHIZOPHRENIA; CLOZAPINE; DELIRIUM; DYSFUNCTION; PNEUMONIA; RECEPTORS	BACKGROUND: Haloperidol has immunomodulatory effects when used to treat patients with. schizophrenia and also is used to sedate critically ill patients in the intensive care unit. Although the mechanism by which haloperidol affects immune function is unclear, one possibility is that it alters dendritic cell (DC) function. DCs are potent antigen-presenting cells that influence the activation and maturation of T lymphocytes. In this study, we investigated the in vitro and in vivo immunomodulatory effects of haloperidol on DC-mediated immune responses. METHODS: Using bone marrow derived DCs in cell culture, we evaluated the effect of haloperidol on expression of costimulatory molecules (CD80 and CD86), major histocompatibility complex class II molecules, and the DC maturation marker CD83. DC culture supernatants also were evaluated for interleukin-12 p40 levels. In addition, we analyzed the effect of haloperidol on a mixed cell culture containing DCs and lymphocytes and measured the secretion of interferon-gamma in the culture supernatants. We also assessed the in vivo effects of haloperidol on hapten-induced contact hypersensitivity responses. RESULTS: Haloperidol inhibited the expression of CD80, CD86, major histocompatibility complex class II, and CD83 molecules on DCs and the secretion of interleukin-12p40 in DC culture supernatants. In mixed cell cultures containing both T cells (CD4(+) and CD8 alpha(+)) and DCs, haloperidol-treated DCs suppressed the proliferation of allogeneic T cells and effectively inhibited the production of interferon-gamma. In vivo, haloperidol reduced hapten-induced contact hypersensitivity responses. Furthermore, an antagonist to D2-like receptor suppressed the maturation of DCs in a manner similar to haloperidol. CONCLUSIONS: The results of our study suggest that haloperidol suppresses the functional maturation of DCs and plays an important role in the inhibition of DC-induced T helper 1 immune responses in the whole animal. Furthermore, the effect of haloperidol on DCs may be mediated by dopamine D2-like receptors. Together, these results demonstrate that administration of haloperidol suppresses DC-mediated immune responses.	[Matsumoto, Atsuhiro; Ohta, Noriyuki; Goto, Yukiko; Kashiwa, Yozo; Yamamoto, Shunsuke; Fujino, Yuji] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Osaka, Japan	Ohta, N (reprint author), Osaka Univ Hosp, Intens Care Unit, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	mucosalpatch@gmail.com			Japanese Society for the Promotion of the Science of Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of the Science of Japan.	Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; van den Boogaard M, 2011, CRIT CARE, V15, DOI 10.1186/cc10598; Kim YK, 2004, PROG NEURO-PSYCHOPH, V28, P1129, DOI 10.1016/j.pnpbp.2004.05.047; SIBLEY DR, 1993, INT REV NEUROBIOL, V35, P391; Kim YK, 2002, MOL PSYCHIATR, V7, P1107, DOI 10.1038/sj.mp.4001084; Song C, 2000, SCHIZOPHR RES, V42, P157, DOI 10.1016/S0920-9964(99)00116-4; Ulrich S, 1998, CLIN PHARMACOKINET, V34, P227, DOI 10.2165/00003088-199834030-00005; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Missale C, 1998, PHYSIOL REV, V78, P189; Sanders RD, 2013, CRIT CARE MED, V41, P1627, DOI 10.1097/CCM.0b013e31827c0c8d; Van Steijn JHM, 2001, ANTICANCER RES, V21, P3699; Kim HJ, 2007, J ALLERGY CLIN IMMUN, V119, P1225, DOI 10.1016/j.jaci.2007.01.016; ROSENBERG SA, 1989, ANN SURG, V210, P474, DOI 10.1097/00000658-198910000-00008; de Rooij SE, 2007, J PSYCHOSOM RES, V62, P521, DOI 10.1016/j.jpsychores.2006.11.013; Huang Y, 2010, NEUROENDOCRINOL LETT, V31, P782; AYALA A, 1994, J SURG RES, V56, P579, DOI 10.1006/jsre.1994.1092; Basta-Kaim A, 2006, J PHYSIOL PHARMACOL, V57, P247; Chen ML, 2012, INT IMMUNOPHARMACOL, V12, P197, DOI 10.1016/j.intimp.2011.11.011; Ferguson NR, 1999, INTENS CARE MED, V25, P106, DOI 10.1007/s001340050795; Karp BI, 1996, NEUROLOGY, V47, P417; Kazmierski J, 2013, INT PSYCHOGERIATR, V26, P845; Krasteva M, 1998, J IMMUNOL, V160, P1181; LANE HY, 1995, J FORMOS MED ASSOC, V94, P671; Leykin I, 1997, IMMUNOPHARMACOLOGY, V37, P75, DOI 10.1016/S0162-3109(97)00037-4; McGrane S, 2011, CRIT CARE, V15, DOI 10.1186/cc10070; Moots RJ, 1999, ANN RHEUM DIS, V58, P585, DOI 10.1136/ard.58.9.585; Ohta N, 2011, ANESTHESIOLOGY, V114, P355, DOI 10.1097/ALN.0b013e3182070c1f; Ohta N, 2001, CRIT CARE MED, V29, P1012, DOI 10.1097/00003246-200105000-00027; PISCITELLI SC, 1994, J CLIN PSYCHIAT, V55, P94; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Son YI, 2002, J IMMUNOL METHODS, V262, P145, DOI 10.1016/S0022-1759(02)00013-3; Tomiyama H, 2002, J IMMUNOL, V168, P5538	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	APR	2015	120	4					895	902		10.1213/ANE.0000000000000606		8	Anesthesiology	Anesthesiology	CE1GF	WOS:000351559400029		
J	Hirabayashi, K; Kurokawa, S; Maruno, A; Yamada, M; Kawaguchi, Y; Nakagohri, T; Mine, T; Sugiyama, T; Tajiri, T; Nakamura, N				Hirabayashi, Kenichi; Kurokawa, Sachiko; Maruno, Atsuko; Yamada, Misuzu; Kawaguchi, Yoshiaki; Nakagohri, Toshio; Mine, Tetsuya; Sugiyama, Tomoko; Tajiri, Takuma; Nakamura, Naoya			Sex differences in immunohistochemical expression and capillary density in pancreatic solid pseudopapillary neoplasm	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						Pancreas; Solid pseudopapillary neoplasm; Sex; Glypican-3; Capillary density; Immunohistochemistry	BETA-CATENIN; GLYPICAN-3; RECEPTORS; DISTINCT; TUMORS	Solid pseudopapillary neoplasm (SPN) is a rare and low-grade malignant pancreatic neoplasm. Solid pseudopapillaty neoplasm is rare in men, and most SPN cases are in young women. This study aimed to investigate sex differences in SPN clinical histopathology including capillary density and expression of immunochemical markers, including glypican 3. A total of 22 resected tumors from pancreatic SPN patients, including 16 women (73%) and 6 men (27%), were analyzed histopathologically and immunohistochemically for synaptophysin, beta-catenin, estrogen receptor, progesterone receptor, Ki-67, CD10, CD31, and glypican 3. The median age was 52.5 years in men and 24 years in women (P=.046). The median tumor size was 22.5 mm in men and 40 mm in women (P=.337). In 11 of the 16 women (69%), but in none of the men, tumors showed complete or incomplete fibrous capsules (P=.006). Cholesterol clefts were observed in tumors from 10 women (63%) but in none from the men (P=.012). No significant sex differences were noted in tumor characteristics, including size, macroscopic cystic degeneration, necrosis, lymphovascular involvement, and perineural invasion. The SPNs were weakly positive for glypican 3, although there was no significant difference between sexes. Capillary density tended to be lower in tumors from men than in those from women, but not significantly. Thus, except for the fibrous capsule and cholesterol clefts often found in tumors and the younger age of the women, there were no significant sex differences in histopathologic or immunohistochemical features of SPN, despite its markedly higher occurrence in women. (C) 2015 Elsevier Inc. All rights reserved.	[Hirabayashi, Kenichi; Yamada, Misuzu; Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan; [Kurokawa, Sachiko] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Maruno, Atsuko; Kawaguchi, Yoshiaki; Mine, Tetsuya] Tokai Univ, Sch Med, Dept Gastroenterol, Isehara, Kanagawa 25911, Japan; [Yamada, Misuzu; Nakagohri, Toshio] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 25911, Japan; [Sugiyama, Tomoko; Tajiri, Takuma] Tokai Univ, Hachioji Hosp, Dept Pathol, Isehara, Kanagawa 25911, Japan	Hirabayashi, K (reprint author), Tokai Univ, Sch Med, Dept Pathol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	khira@is.icc.u-tokai.ac.jp					Fagotto F, 2013, EMBO REP, V14, P422, DOI 10.1038/embor.2013.45; Notohara K, 2000, AM J SURG PATHOL, V24, P1361, DOI 10.1097/00000478-200010000-00005; Takahashi Y, 2006, VIRCHOWS ARCH, V448, P561, DOI 10.1007/s00428-006-0174-9; Machado MCC, 2008, SURGERY, V143, P29, DOI 10.1016/j.surg.2007.07.030; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; Baumhoer D, 2008, AM J CLIN PATHOL, V129, P899, DOI [10.1309/HCQWPWD50XHD2DW6, 10.1309/HCQWWD50XHD2DW6]; Papavramidis T, 2005, J AM COLL SURGEONS, V200, P965, DOI 10.1016/j.jmacollsurg.2005.02.011; Bosman FT, 2010, WHO CLASSIFICATION T; Hav M, 2011, HISTOPATHOLOGY, V59, P1278, DOI 10.1111/j.1365-2559.2011.03998.x; Hirabayashi K, 2013, WORLD J GASTROENTERO, V19, P3358, DOI 10.3748/wjg.v19.i21.3358; Komiya Yuko, 2008, Organogenesis, V4, P68; Kurokawa S., PANCREAS IN PRESS; Lin MYC, 2010, AM SURGEON, V76, P1075; Tajima Kana, 2011, Clin J Gastroenterol, V4, P112, DOI 10.1007/s12328-011-0202-4; Tien YW, 2005, SURGERY, V137, P591, DOI 10.1016/j.surg.2005.01.015; ZAMBONI G, 1993, VIRCHOWS ARCH A, V423, P425, DOI 10.1007/BF01606531	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	APR	2015	19	2					45	49		10.1016/j.anndiagpath.2015.02.002		5	Pathology	Pathology	CE4NY	WOS:000351808500002		
J	Nuri, T; Ueda, K; Yamada, A; Okada, M; Hara, M				Nuri, Takashi; Ueda, Koichi; Yamada, Akira; Okada, Masashi; Hara, Mai			Reconstruction of the Dynamic Velopharyngeal Function by Combined Radial Forearm-Palmaris Longus Tenocutaneous Free Flap, and Superiorly Based Pharyngeal Flap in Postoncologic Total Palatal Defect	ANNALS OF PLASTIC SURGERY			English	Article						palatal defect; head and neck reconstruction; radial forearm free flap; palmaris longus tendon; reconstruct the function; velopharyngeal incompetence; pharyngeal flap	SOFT PALATE; ISLAND FLAP	We attempted to reconstruct dynamic palatal function using a radial forearm-palmaris longus tenocutaneous free flap in conjunction with a pharyngeal flap for a postoncologic total-palate defect in a 67-year-old male patient. This reconstruction involved 3 important tasks, namely, separating the oral and nasal cavities, preserving the velopharyngeal space to avoid sleep apnea, and maintaining velopharyngeal closure to avoid nasal regurgitation during swallowing. In our technique, the radial forearm flap separates the oral and nasal cavities with an open rhinopharyngeal space, and a superiorly based pharyngeal flap, which is sutured to the posterior end of the forearm flap, limits the rhinopharyngeal space, and forms the bilateral velopharyngeal port. Furthermore, the palmaris longus tendon, which is attached to the forearm flap, is secured to the superior constrictor muscle to create a horizontal muscle sling. Contraction of the superior constrictor muscle leads to shrinkage of the sling, resulting in velopharyngeal closure. Swallowing therapy was started 4 weeks after the surgery. The patient could resume oral intake without any difficulties 6 months after the surgery. Speech intelligibility changed from severe to minimal hypernasality.	[Nuri, Takashi; Ueda, Koichi; Yamada, Akira; Okada, Masashi; Hara, Mai] Osaka Med Coll, Dept Plast & Reconstruct Surg, Takatsuki, Osaka 5698686, Japan	Nuri, T (reprint author), Osaka Med Coll, Dept Plast & Reconstruct Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	pla042@poh.osaka-med.ac.jp					Brown JS, 1997, HEAD NECK-J SCI SPEC, V19, P524, DOI 10.1002/(SICI)1097-0347(199709)19:6<524::AID-HED10>3.0.CO;2-5; CHANTRAIN G, 1994, LARYNGOSCOPE, V104, P1035; Genden EM, 2001, ARCH OTOLARYNGOL, V127, P837; Hanasono MM, 2001, LARYNGOSCOPE, V111, P1719, DOI 10.1097/00005537-200110000-00009; Hogan VM, 1977, RECONSTRUCTIVE PLAST, V4, P2268; Lacombe V, 1999, Arch Facial Plast Surg, V1, P130, DOI 10.1001/archfaci.1.2.130; McCombe D, 2005, BRIT J PLAST SURG, V58, P306, DOI 10.1016/j.bjps.2004.09.007; Moore BA, 2003, LARYNGOSCOPE, V113, P946, DOI 10.1097/00005537-200306000-00007; Roh TS, 2009, HEAD NECK-J SCI SPEC, V31, P1220, DOI 10.1002/hed.21093; SADOVE RC, 1991, PLAST RECONSTR SURG, V88, P209, DOI 10.1097/00006534-199108000-00005; SHAPIRO BM, 1986, OTOLARYNG HEAD NECK, V95, P581; Sullivan SR, 2010, PLAST RECONSTR SURG, V125, P290, DOI 10.1097/PRS.0b013e3181c2a6c1; Thomson CJ, 1977, AUST NZ J SURG, V67, P878; ZOLLER J, 1992, INT J ORAL MAX SURG, V21, P156	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	APR	2015	74	4					437	441		10.1097/SAP.0b013e3182a63618		5	Surgery	Surgery	CE1SK	WOS:000351592000011		
J	Kang, H; Takahashi, Y; Nakano, T; Asamoto, K; Ikeda, H; Kakizaki, H				Kang, Hyera; Takahashi, Yasuhiro; Nakano, Takashi; Asamoto, Ken; Ikeda, Hiroshi; Kakizaki, Hirohiko			Medial Canthal Support Structures The Medial Retinaculum: A Review	ANNALS OF PLASTIC SURGERY			English	Review						medial canthus; support structure; medial retinaculum	LOWER EYELID RETRACTORS; POSITIONED TRANSVERSE LIGAMENT; HORNERS MUSCLE; CAPSULOPALPEBRAL FASCIA; TRANSCARUNCULAR APPROACH; MICROSCOPIC ANATOMY; EXTRAOCULAR-MUSCLES; LACRIMAL APPARATUS; TENDON; SURGERY	The medial canthus is supported by several structures with a complicated 3-dimensional arrangement in a narrow space. Although the medial canthal tendon occupies a major portion of the area, the medial canthal support structures include the following entities: Horner's muscle, the medial rectus capsulopalpebral fascia including the medial check ligament, the medial horn of the levator aponeurosis, the medial horn supporting ligament, the medial horn of the lower eyelid retractors, the preseptal part of the orbicularis oculi muscle, and 3 variations of the Lockwood's ligament. We named the composite of these structures the "medial retinaculum," which is similar to the "lateral retinaculum" of the lateral canthus. Profound comprehension and consideration of the medial retinaculum warrants safe and effective surgery in the medial canthal region.	[Kang, Hyera; Takahashi, Yasuhiro; Kakizaki, Hirohiko] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan; [Kang, Hyera] Presbyterian Med Ctr, Dept Ophthalmol, Jeonju, South Korea; [Nakano, Takashi; Asamoto, Ken] Aichi Med Univ, Dept Anat, Nagakute, Aichi 4801195, Japan; [Ikeda, Hiroshi] Aichi Med Univ, Dept Pathol, Nagakute, Aichi 4801195, Japan	Kakizaki, H (reprint author), Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan.	cosme@d1.dion.ne.jp					Adenis JP, 1991, ORBIT, V10, P187, DOI 10.3109/01676839109087663; AHL NC, 1982, ARCH OPHTHALMOL-CHIC, V100, P488; ANDERSON RL, 1977, ARCH OPHTHALMOL-CHIC, V95, P2051; GIOIA VM, 1987, ARCH OPHTHALMOL-CHIC, V105, P529; Kakizaki H, 2004, OPHTHALMOLOGICA, V218, P419, DOI 10.1159/000080947; Kakizaki H, 2008, OPHTHAL PLAST RECONS, V24, P126, DOI 10.1097/IOP.0b013e3181647cb2; Lagreze WA, 2005, AM J OPHTHALMOL, V140, P1145, DOI 10.1016/j.ajo.2005.06.060; Ettl A, 1997, EYE, V11, P793; Kakizaki H, 2010, OPHTHALMOLOGY, V117, P388, DOI 10.1016/j.ophtha.2009.06.064; SHORE JW, 1984, AM J OPHTHALMOL, V98, P21, DOI 10.1016/0002-9394(84)90183-1; Shorr N, 2000, OPHTHALMOLOGY, V107, P1459, DOI 10.1016/S0161-6420(00)00241-4; Vick VL, 2004, OPHTHAL PLAST RECONS, V20, P37, DOI 10.1097/01.IOP.0000103005.81708.FD; ANDERSON RL, 1977, ARCH OPHTHALMOL-CHIC, V95, P1437; Park JI, 1996, PLAST RECONSTR SURG, V98, P602, DOI 10.1097/00006534-199609001-00002; Burkat CN, 2006, LACRIMAL SYSTEM DIAG, P3, DOI 10.1007/978-0-387-35267-1_1; Chen W., 2006, ATTENTION DEFICIT HY, P3, DOI 10.1016/B978-0-7506-7574-1.50008-6; Ciftci F, 2010, OPHTHAL PLAST RECONS, V26, P254, DOI 10.1097/IOP.0b013e3181bb5942; Clark RA, 2006, INVEST OPHTH VIS SCI, V47, P188, DOI 10.1167/iovs.05-0498; Cook T, 2003, OPHTHALMIC PLAST REC, V19, P297, DOI 10.1097/01.IOP.0000077087.94276.51; COULY G, 1976, Journal of Maxillofacial Surgery, V4, P195, DOI 10.1016/S0301-0503(76)80034-3; DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125; Demer JL, 1997, INVEST OPHTH VIS SCI, V38, P1774; Demirci H, 2007, OPHTHAL PLAST RECONS, V23, P384, DOI 10.1097/IOP.0b013e3181469e3c; Duke-Elder S, 1961, SYSTEM OPHTHALMOLOGY, VII, P504; Dutton JJ, 2011, ATLAS CLIN SURG ORBI, P113; Fante RG, 2001, OPHTHALMIC PLAST REC, V17, P16, DOI 10.1097/00002341-200101000-00004; FERNANDEZVALENCIA R, 1990, ACTA ANAT, V139, P54; FRALICK F B, 1962, Trans Am Acad Ophthalmol Otolaryngol, V66, P575; GOLDBERG RA, 1994, OPHTHALMIC PLAST REC, V10, P87, DOI 10.1097/00002341-199406000-00003; HAWES MJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P1313; JOHNSON CC, 1956, AM J OPHTHALMOL, V41, P71; JONES LT, 1961, ARCH OPHTHALMOL-CHIC, V66, P111; Jones L T, 1977, Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol, V83, P603; JONES LT, 1957, AM J OPHTHALMOL, V43, P203; Jordan DR, 1996, SURG ANATOMY OCULAR, p[16, 17, 26]; JORDAN DR, 1989, ARCH OPHTHALMOL-CHIC, V107, P1532; Kakizaki H, 2009, OPHTHALMOLOGY, V116, P1402, DOI 10.1016/j.ophtha.2009.01.031; Kakizaki H, 2012, OPHTHAL PLAST RECONS, V28, P145, DOI 10.1097/IOP.0b013e318246be9b; Kakizaki Hirohiko, 2008, Orbit, V27, P91, DOI 10.1080/01676830701205909; Kakizaki H, 2004, JPN J OPHTHALMOL, V48, P493, DOI 10.1007/s10384-004-0100-0; Kakizaki H, 2009, OPHTHAL PLAST RECONS, V25, P10, DOI 10.1097/IOP.0b013e318190f064; Kakizaki H, 2006, OPHTHAL PLAST RECONS, V22, P430, DOI 10.1097/01.iop.0000242182.96161.78; Kakizaki H, 2012, PLAST RECONSTR SURG, V130, P494; Kakizaki H, 2005, BRIT J PLAST SURG, V58, P1035, DOI 10.1016/j.bjps.2005.05.020; Kakizaki Hirohiko, 2006, Okajimas Folia Anatomica Japonica, V83, P85, DOI 10.2535/ofaj.83.85; Kakizaki H, 2012, OPHTHAL PLAST RECONS, V28, P66, DOI 10.1097/IOP.0b013e318239321d; Kakizaki H, 2009, ANN PLAS SURG, V63, P344, DOI 10.1097/SAP.0b013e31818c4b22; Kakizaki H, 2005, OPHTHALMOLOGY, V112, P710, DOI 10.1016/j.ophtha.2004.11.043; Kakizaki Hirohiko, 2007, Clin Ophthalmol, V1, P141; Kakizaki H, 2006, OPHTHALMOLOGY, V113, P2346, DOI 10.1016/j.ophtha.2006.06.017; Kakizaki H, 2005, OPHTHAL PLAST RECONS, V21, P379, DOI 10.1097/01.iop.0000173192.84698.d6; Kakizaki Hirohiko, 2004, Okajimas Folia Anatomica Japonica, V81, P97, DOI 10.2535/ofaj.81.97; Kakizaki H, 2010, AM J OPHTHALMOL, V150, P741, DOI 10.1016/j.ajo.2010.05.038; Kakizaki H, 2004, BRIT J PLAST SURG, V57, P370, DOI 10.1016/j.bjps.2003.12.001; Kakizaki H, 2012, AM J OPHTHALMOL, V153, P229, DOI 10.1016/j.ajo.2011.07.010; Kakizaki H, 2005, JPN J OPHTHALMOL, V49, P477, DOI 10.1007/s10384-005-0237-5; Kakizaki H, 2004, OPHTHAL PLAST RECONS, V20, P198, DOI 10.1097/01.IOP.0000124674.75130.DA; Kang Hyera, 2012, Orbit, V31, P279, DOI 10.3109/01676830.2012.694957; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P2923; KOORNNEEF L, 1977, ARCH OPHTHALMOL-CHIC, V95, P1269; Malbouisson JM, 2004, OPHTHAL PLAST RECONS, V20, P207; Mazow ML, 2006, AM J OPHTHALMOL, V141, P773, DOI 10.1016/j.ajo.2005.11.045; McCord CD, 1981, OCULOPLASTIC SURG, P175; Most Sam P, 2005, Facial Plast Surg Clin North Am, V13, P487, DOI 10.1016/j.fsc.2005.06.003; Neard JA, 2001, OCULOPLASTIC SURG RE, P25; Pavlidis M, 2005, GRAEF ARCH CLIN EXP, V243, P228, DOI 10.1007/s00417-004-1033-5; Poh E, 2012, CLIN EXP OPHTHALMOL, V40, P170, DOI 10.1111/j.1442-9071.2011.02657.x; RITLENG P, 1983, ANAT CLIN, V5, P29, DOI 10.1007/BF01798870; Ruskell GL, 2005, J ANAT, V206, P295, DOI 10.1111/j.1469-7580.2005.00383.x; Shinohara Harumichi, 2001, Okajimas Folia Anatomica Japonica, V77, P225; Shinohara H, 2001, CLIN ANAT, V14, P401, DOI 10.1002/ca.1074; Wolff E, 1976, WOLFFS ANATOMY EYE O, P190; Yamamoto H, 2001, AESTHET PLAST SURG, V25, P189, DOI 10.1007/s002660010121; Yuzuriha S, 2000, BRIT J PLAST SURG, V53, P466, DOI 10.1054/bjps.2000.3387; ZIDE BM, 1981, CLIN PLAST SURG, V8, P623	75	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	APR	2015	74	4					508	514		10.1097/SAP.0b013e3182a6365c		7	Surgery	Surgery	CE1SK	WOS:000351592000023		
J	Wakabayashi, G; Cherqui, D; Geller, DA; Buell, JE; Kaneko, H; Han, HS; Asbun, H; O'Rourke, N; Tanabe, M; Koffron, AJ; Tsung, A; Soubrane, O; Machado, MA; Gayet, B; Troisi, RI; Pessaux, P; Van Dam, RM; Scatton, O; Abu Hilal, M; Belli, G; Kwon, CHD; Edwin, B; Choi, GH; Aldrighetti, LA; Cai, XJ; Clemy, S; Chen, KH; Schon, MR; Sugioka, A; Tang, CN; Herman, P; Pekolj, J; Chen, XP; Dagher, I; Jarnagin, W; Yamamoto, M; Strong, R; Jagannath, P; Lo, CM; Clavien, PA; Kokudo, N; Barkun, J; Strasberg, SM				Wakabayashi, Go; Cherqui, Daniel; Geller, David A.; Buell, Joseph E.; Kaneko, Hironori; Han, Ho Seong; Asbun, Horacio; O'Rourke, Nicholas; Tanabe, Minoru; Koffron, Alan J.; Tsung, Allan; Soubrane, Olivier; Machado, Marcel Autran; Gayet, Brice; Troisi, Roberto I.; Pessaux, Patrick; Van Dam, Ronald M.; Scatton, Olivier; Abu Hilal, Mohammad; Belli, Giulio; Kwon, Choon Hyuck David; Edwin, Bjorn; Choi, Gi Hong; Aldrighetti, Luca Antonio; Cai, Xiujun; Clemy, Sean; Chen, Kuo-Hsin; Schoen, Michael R.; Sugioka, Atsushi; Tang, Chung-Ngai; Herman, Paulo; Pekolj, Juan; Chen, Xiao-Ping; Dagher, Ibrahim; Jarnagin, William; Yamamoto, Masakazu; Strong, Russell; Jagannath, Palepu; Lo, Chung-Mau; Clavien, Pierre-Alain; Kokudo, Norihiro; Barkun, Jeffrey; Strasberg, Steven M.			Recommendations for Laparoscopic Liver Resection A Report From the Second International Consensus Conference Held in Morioka	ANNALS OF SURGERY			English	Article						anatomical resection; colorectal liver metastasis; donor hepatectomy; hepatocellular carcinoma; liver resection; laparoscopic; pneumoperitoneum; robotic	INTERNATIONAL CONSENSUS CONFERENCE; LIVING DONOR HEPATECTOMY; HEPATOCELLULAR-CARCINOMA; HANGING MANEUVER; POSTOPERATIVE COMPLICATIONS; SURGICAL TECHNOLOGY; INITIAL-EXPERIENCE; COLORECTAL-CANCER; CIRRHOTIC LIVER; SURGERY	The use of laparoscopy for liver surgery is increasing rapidly. The Second International Consensus Conference on Laparoscopic Liver Resections (LLR) was held in Morioka, Japan, from October 4 to 6, 2014 to evaluate the current status of laparoscopic liver surgery and to provide recommendations to aid its future development. Seventeen questions were addressed. The first 7 questions focused on outcomes that reflect the benefits and risks of LLR. These questions were addressed using the Zurich-Danish consensus conference model in which the literature and expert opinion were weighed by a 9-member jury, who evaluated LLR outcomes using GRADE and a list of comparators. The jury also graded LLRs by the Balliol Classification of IDEAL. The jury concluded that MINOR LLRs had become standard practice (IDEAL 3) and that MAJOR liver resections were still innovative procedures in the exploration phase (IDEAL 2b). Continued cautious introduction of MAJOR LLRs was recommended. All of the evidence available for scrutiny was of LOW quality by GRADE, which prompted the recommendation for higher quality evaluative studies. The last 10 questions focused on technical questions and the recommendations were based on literature review and expert panel opinion. Recommendations were made regarding preoperative evaluation, bleeding controls, transection methods, anatomic approaches, and equipment. Both experts and jury recognized the need for a formal structure of education for those interested in performing major laparoscopic LLR because of the steep learning curve.	[Wakabayashi, Go] Iwate Med Univ, Morioka, Iwate 0208505, Japan; [Cherqui, Daniel] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France; [Geller, David A.] Univ Pittsburgh, Pittsburgh, PA USA; [Buell, Joseph E.] Tulane Univ Med Ctr Hosp & Clin, Tulane Transplant Inst, New Orleans, LA USA; [Buell, Joseph E.] Louisiana State Univ, New Orleans, LA USA; [Buell, Joseph E.] Louisiana State Univ, Med Ctr, New Orleans, LA USA; [Kaneko, Hironori] Toho Univ, Sch Med, Tokyo, Japan; [Han, Ho Seong] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Asbun, Horacio] Mayo Clin, Jacksonville, FL USA; [O'Rourke, Nicholas] Royal Brisbane Hosp, Herston, Qld, Australia; [Tanabe, Minoru] Tokyo Med & Dent Univ, Tokyo, Japan; [Koffron, Alan J.] Beaumont Hlth Syst, Troy, MI USA; [Tsung, Allan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Soubrane, Olivier] Beaujon Hosp, Clichy, France; [Machado, Marcel Autran] Hosp Sirio Libanes, Sao Paulo, Brazil; [Gayet, Brice] Inst Mutualiste Montsouris, Paris, France; [Troisi, Roberto I.] Ghent Univ Hosp, Sch Med, Ghent, Belgium; [Pessaux, Patrick] Inst Hosp Univ, Strasbourg, France; [Van Dam, Ronald M.] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Scatton, Olivier] Hop La Pitie Salpetriere, Paris, France; [Abu Hilal, Mohammad] Southampton Univ Hosp Trust, Southampton, Hants, England; [Belli, Giulio] Loreto Nuovo Hosp, Naples, Italy; [Kwon, Choon Hyuck David] Sungkyunkwan Univ, Seoul, South Korea; [Edwin, Bjorn] Univ Oslo, Oslo, Norway; [Choi, Gi Hong] Yonsei Univ, Coll Med, Seoul, South Korea; [Aldrighetti, Luca Antonio] Hosp San Raffaele, I-20132 Milan, Italy; [Cai, Xiujun] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Clemy, Sean] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Chen, Kuo-Hsin] Far Eastern Mem Hosp, New Taipei City, Taiwan; [Schoen, Michael R.] Klinikum Karlsruhe, Karlsruhe, Germany; [Sugioka, Atsushi] Fujita Hlth Univ, Toyoake, Aichi, Japan; [Tang, Chung-Ngai] Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China; [Herman, Paulo] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Pekolj, Juan] Hosp Italian Buenos Aires, Buenos Aires, DF, Argentina; [Chen, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Hosp, Wuhan 430074, Peoples R China; [Dagher, Ibrahim] Paris South Univ Hosp, Orsay, France; [Jarnagin, William] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Yamamoto, Masakazu] Tokyo Womens Med Univ, Tokyo, Japan; [Strong, Russell] Univ Queensland, Brisbane, Qld 4072, Australia; [Jagannath, Palepu] Lilavati Hosp & Res Ctr India, Bombay, Maharashtra, India; [Lo, Chung-Mau] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Clavien, Pierre-Alain] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Kokudo, Norihiro] Univ Tokyo, Tokyo, Japan; [Barkun, Jeffrey] McGill Univ, Ctr Hlth, Quebec City, PQ, Canada; [Barkun, Jeffrey] McGill Univ, Quebec City, PQ, Canada; [Strasberg, Steven M.] Washington Univ, Sch Med, St Louis, MO USA	Wakabayashi, G (reprint author), Iwate Med Univ, Dept Surg, Sch Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	go324@mac.com; stras-bergs@wustl.edu	Troisi, Roberto Ivan/E-8737-2015; Herman, Paulo/J-5457-2013	Herman, Paulo/0000-0003-2859-5846			Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Gayet B, 2007, AM J SURG, V194, P685, DOI 10.1016/j.amjsurg.2006.11.044; Samstein B, 2013, AM J TRANSPLANT, V13, P2462, DOI 10.1111/ajt.12360; Nguyen KT, 2011, ARCH SURG-CHICAGO, V146, P348, DOI 10.1001/archsurg.2010.248; Abu Hilal M, 2010, BRIT J SURG, V97, P927, DOI 10.1002/bjs.7034; Ho CM, 2013, SURG ENDOSC, V27, P732, DOI 10.1007/s00464-012-2547-2; Troisi RI, 2013, AM J TRANSPLANT, V13, P2472, DOI 10.1111/ajt.12362; Dagher I, 2008, J AM COLL SURGEONS, V206, P756, DOI 10.1016/j.jamcollsurg.2007.09.012; Nagai S, 2012, LIVER TRANSPLANT, V18, P1188, DOI 10.1002/lt.23488; Giulianotti PC, 2011, SURGERY, V149, P29, DOI 10.1016/j.surg.2010.04.002; Cho A, 2011, SURG ENDOSC, V25, P1333, DOI 10.1007/s00464-010-1358-6; Strasberg SM, 2003, J AM COLL SURGEONS, V196, P938, DOI 10.1016/S1072-7515(03)00112-1; Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Strasberg SM, 2011, J AM COLL SURGEONS, V213, P616, DOI 10.1016/j.jamcollsurg.2011.07.019; Marubashi S, 2013, WORLD J SURG, V37, P2202, DOI 10.1007/s00268-013-2117-3; Vigano L, 2009, ANN SURG, V250, P772, DOI 10.1097/SLA.0b013e3181bd93b2; Tranchart H, 2013, AM J SURG, V205, P8, DOI 10.1016/j.amjsurg.2012.04.015; Honda G, 2013, J HEPATO-BIL-PAN SCI, V20, P435, DOI 10.1007/s00534-012-0586-7; Cherqui D, 2009, ANN SURG, V250, P738, DOI 10.1097/SLA.0b013e3181bd582b; Belli G, 2013, SURG ENDOSC, V27, P2721, DOI 10.1007/s00464-013-2840-8; McCulloch Peter, 2009, Lancet, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Tranchart H, 2010, SURG ENDOSC, V24, P1170, DOI 10.1007/s00464-009-0745-3; Ishizawa T, 2012, ANN SURG, V256, P959, DOI 10.1097/SLA.0b013e31825ffed3; Wang Y, 2012, DIGEST SURG, V29, P99, DOI 10.1159/000336289; Dagher I, 2009, ANN SURG, V250, P856, DOI 10.1097/SLA.0b013e3181bcaf46; Tsung A, 2014, ANN SURG, V259, P549, DOI 10.1097/SLA.0000000000000250; Soubrane O, 2013, AM J TRANSPLANT, V13, P2467, DOI 10.1111/ajt.12361; Eguchi S, 2011, SURGERY, V150, P1002, DOI 10.1016/j.surg.2011.06.021; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Barkun Jeffrey S, 2009, Lancet, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Lin NC, 2013, ANN SURG, V257, P205, DOI 10.1097/SLA.0b013e31827da7fe; Kaneko H, 2008, HPB, V10, P219, DOI 10.1080/13651820802166831; Wakabayashi G, 2011, J HEPATO-BIL-PAN SCI, V18, P481, DOI 10.1007/s00534-011-0388-3; Parks KR, 2014, HPB, V16, P109, DOI 10.1111/hpb.12117; Imura S, 2014, SURG TODAY, V44, P1214, DOI 10.1007/s00595-013-0668-4; Postriganova N, 2014, HPB, V16, P822, DOI 10.1111/hpb.12204; Huang MT, 2003, ANN SURG, V238, P674, DOI 10.1097/01.sla.0000094301.21038.8d; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Belghiti J, 2001, J AM COLL SURGEONS, V193, P109, DOI 10.1016/S1072-7515(01)00909-7; Sasaki A, 2009, BRIT J SURG, V96, P274, DOI 10.1002/bjs.6472; Ha TY, 2013, TRANSPL P, V45, P2997, DOI 10.1016/j.transproceed.2013.08.053; Cardinal JS, 2013, J HEPATO-BIL-PAN SCI, V20, P114, DOI 10.1007/s00534-012-0553-3; Ikegami T, 2009, J HEPATO-BILIARY-PAN, V16, P394, DOI 10.1007/s00534-008-0039-5; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Bryant R, 2009, ANN SURG, V250, P103, DOI 10.1097/SLA.0b013e3181ad6660; Reddy SK, 2011, WORLD J SURG, V35, P1478, DOI 10.1007/s00268-010-0906-5; Kim SH, 2008, WORLD J SURG, V32, P2701, DOI 10.1007/s00268-008-9761-z; Baker TB, 2009, SURGERY, V146, P817, DOI 10.1016/j.surg.2009.05.022; Ban D, 2014, J HEPATO-BIL-PAN SCI, V21, P745, DOI 10.1002/jhbp.166; Begin A, 2014, SURG ENDOSC, V28, P3408, DOI 10.1007/s00464-014-3611-x; Buell JF, 2013, HPB, V15, P845, DOI 10.1111/hpb.12043; Chao YJ, 2012, SURG ENDOSC, V26, P2681, DOI 10.1007/s00464-012-2210-y; Dagher I, 2014, J HEPATOBILIARY PANC, V21, P120; Farges O, 2014, ANN SURG, V260, P916, DOI 10.1097/SLA.0000000000000950; Han HS, 2015, SURG ENDOSC, V29, P184, DOI 10.1007/s00464-014-3649-9; Hibi T, 2014, J HEPATO-BIL-PAN SCI, V21, P737, DOI 10.1002/jhbp.141; Ho CM, 2013, SURG ENDOSC, V27, P1820, DOI 10.1007/s00464-012-2624-6; Ikeda T, 2013, J HEPATO-BIL-PAN SCI, V20, P145, DOI 10.1007/s00534-012-0558-y; Jayaraman S, 2009, SURG ENDOSC, V23, P2369, DOI 10.1007/s00464-009-0359-9; Kaneko H, 2008, SURG LAPARO ENDO PER, V18, P127; Koffron AJ, 2007, SURGERY, V142, P463, DOI 10.1016/j.surg.2007.08.006; Lee MK, 2015, J AM COLL SURGEONS, V220, P64, DOI 10.1016/j.jamcollsurg.2014.09.017; Lesurtel M, 2014, SURGERY, V155, P390, DOI 10.1016/j.surg.2013.10.003; Machado Marcel Autran C, 2008, Am J Surg, V196, pe38, DOI 10.1016/j.amjsurg.2007.10.027; Machado MAC, 2009, SURG ENDOSC, V23, P2615, DOI 10.1007/s00464-009-0423-5; Mbah NA, 2012, HPB, V14, P126, DOI 10.1111/j.1477-2574.2011.00414.x; Memeo R, 2014, WORLD J SURG, V38, P2919, DOI 10.1007/s00268-014-2659-z; Montalti R, 2015, SURG ENDOSC, V29, P2736, DOI 10.1007/s00464-014-3999-3; Porembka MR, 2010, J AM COLL SURGEONS, V210, P286, DOI 10.1016/j.jamcollsurg.2009.12.004; Schiffman SC, 2015, SURGERY, V157, P211, DOI 10.1016/j.surg.2014.08.036; Slankamenac K, 2013, ANN SURG, V258, P1, DOI 10.1097/SLA.0b013e318296c732; Slim K, 2000, ANZ J SURG, V79, P712; Soubrane O, 2014, ANN SURG, DOI [10.1097/SLA.0000000000000737, DOI 10.1097/SLA.0000000000000737]; Takahara T, 2015, ANN SURG, V261, pE3, DOI 10.1097/SLA.0000000000000898; Takahashi M, 2013, SURG ENDOSC, V27, P4732, DOI 10.1007/s00464-013-3202-2; Takasaki K, 2011, VENOUS EMBOLIZATION OF THE LIVER: RADIOLOGIC AND SURGICAL PRACTICE, P23, DOI 10.1007/978-1-84882-122-4_4; Teramoto K, 2003, WORLD J SURG, V27, P1131, DOI 10.1007/s00268-003-6936-5; Tomishige Hirokazu, 2013, World J Gastrointest Surg, V5, P173, DOI 10.4240/wjgs.v5.i6.173; Topal B, 2007, Surg Endosc, V21, P2111, DOI 10.1007/s00464-007-9303-z; Troisi RI, 2012, DIGEST SURG, V29, P463, DOI 10.1159/000345996; Wakabayashi G, 2014, J HEPATO-BIL-PAN SCI, V21, P723, DOI 10.1002/jhbp.139; Wilson CB, 2006, BRIT MED J, V332, P112, DOI 10.1136/bmj.332.7533.112; Yoon YS, 2013, SURGERY, V153, P502, DOI 10.1016/j.surg.2012.10.004	84	23	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	APR	2015	261	4					619	629		10.1097/SLA.0000000000001180		11	Surgery	Surgery	CE2VV	WOS:000351679500025		
J	Mazaki, T; Ishii, Y; Murai, I				Mazaki, Takero; Ishii, Yukimoto; Murai, Ichiro			Immunoenhancing Enteral and Parenteral Nutrition for Gastrointestinal Surgery A Multiple-treatments Meta-analysis	ANNALS OF SURGERY			English	Article						Bayesian meta-analysis; complication; gastrointestinal surgery; immunonutrition; mixed treatment comparison	RANDOMIZED CONTROLLED-TRIALS; CRITICALLY-ILL PATIENTS; ESPEN GUIDELINES; METAANALYSIS; IMMUNONUTRITION; INCONSISTENCY; INTERVENTIONS; NUTRIENTS; NETWORKS; EFFICACY	Objective: Frequentist meta-analyses have demonstrated that immunoenhancing parenteral nutrition (IMPN) and enteral nutrition (IMEN) reduce the incidence of infection and shorten the length of hospital stays compared with standard parenteral nutrition (SPN) and enteral nutrition (SEN). The aim of this study was to evaluate which kind of nutrition-SPN, SEN, IMPN, and IMEN-is most efficacious for reducing the incidence of complications after gastrointestinal surgery. Methods: An English literature search was carried out for randomized controlled trials published from January 1990 to February 2013 that evaluated the clinical efficacy of 4 kinds of nutrition after gastrointestinal surgery. A Bayesian framework was used to calculate the odds ratio between each treatment and the rank order. Results: Seventy-four studies (7572 participants) were included. According to the surface below the cumulative ranking curve (SUCRA) ordering from the best to the worst, IMEN was ranked first for reducing the incidence of 7 complications-any infection (SUCRA = 0.86), overall complication (SUCRA = 0.88), mortality (SUCRA = 0.81), wound infection (SUCRA = 0.79), intra-abdominal abscess (SUCRA = 0.98), anastomotic leak (SUCRA = 0.79), and sepsis (SUCRA = 0.92). Also, IMEN was ranked second for pneumonia and urinary tract infection. IMPN was ranked first for pneumonia (SUCRA = 0.81) and urinary tract infection (SUCRA = 0.86), third for mortality, and fourth for both intra-abdominal abscess and anastomotic leak. SPN showed an inferior efficacy for almost all outcomes. Conclusions: This study suggests that IMEN outperformed other nutrition types for reducing complications and IMEN should be considered the best available option.	[Mazaki, Takero; Ishii, Yukimoto; Murai, Ichiro] Nihon Univ, Sch Med, Div Res Planning & Dev, Tokyo 1738610, Japan; [Mazaki, Takero] Nihon Univ, Grad Sch Med, Div Surg Oncol, Tokyo, Japan; [Ishii, Yukimoto] Nihon Univ, Grad Sch Med, Div Physiol, Tokyo, Japan	Mazaki, T (reprint author), Nihon Univ, Sch Med, Div Res Planning & Dev, Itabashi Ku, 30-1 Oyaguchikami Machi, Tokyo 1738610, Japan.	mazaki.takero@nihon-u.ac.jp					Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Caldwell DM, 2005, BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Zhang Y, 2012, SURG ONCOL, V21, pE87, DOI 10.1016/j.suronc.2012.01.002; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Weimann A, 2006, CLIN NUTR, V25, P224, DOI 10.1016/j.clnu.2006.01.015; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Heller AR, 2006, CRIT CARE MED, V34, P972, DOI 10.1097/01.CCM.0000206309.83570.45; Osland E, 2014, JPEN-PARENTER ENTER, V38, P53, DOI 10.1177/0148607112474825; Heys SD, 1999, ANN SURG, V229, P467, DOI 10.1097/00000658-199904000-00004; Marimuthu K, 2012, ANN SURG, V255, P1060, DOI 10.1097/SLA.0b013e318252edf8; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; Gelman A, 1996, STAT SINICA, V6, P733; Li NN, 2014, CLIN NUTR, V33, P226, DOI 10.1016/j.clnu.2013.08.013; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MCWHIRTER JP, 1994, BRIT MED J, V308, P945; Stroud M, 2003, GUT, V52, P1; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Cerantola Y, 2011, BRIT J SURG, V98, P37, DOI 10.1002/bjs.7273; Lewis SJ, 2001, BRIT MED J, V323, P773, DOI 10.1136/bmj.323.7316.773; Waitzberg DL, 2006, WORLD J SURG, V30, P1592, DOI 10.1007/s00268-005-0657-x; Wei C, 2010, NUTRITION, V26, P474, DOI 10.1016/j.nut.2009.09.011; Marik PE, 2010, JPEN-PARENTER ENTER, V34, P378, DOI 10.1177/0148607110362692; Wanten GJA, 2007, AM J CLIN NUTR, V85, P1171; Mazaki T, 2013, J AM COLL SURGEONS, V217, P788, DOI 10.1016/j.jamcollsurg.2013.07.386; Zaloga GP, 2006, LANCET, V367, P1101, DOI 10.1016/S0140-6736(06)68307-4; Song F, 2003, BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Yaqoob P, 2010, P NUTR SOC, V69, P311, DOI 10.1017/S0029665110001837; Chen B, 2010, JPEN-PARENTER ENTER, V34, P387, DOI 10.1177/0148607110362532; Dias S, 2 NICE; Dias S, 3 NICE; Drover J W, 2010, J AM COLL SURGEONS, V212, P385; Higgins JP, 2008, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1002/9780470712184.CH8; Lipman TO, 1998, JPEN-PARENTER ENTER, V22, P167, DOI 10.1177/0148607198022003167; Luiking YC, 2004, CRIT CARE MED, V32, P2135, DOI 10.1097/01.CCM.0000142939.81045.AO; Mazaki T, 2007, J GASTROINTEST SURG, V12, P739; Ntzoufras I., 2009, BAYESIAN MODELING US; Pradelli L, 2012, CRIT CARE, V16, DOI 10.1186/cc11668; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES	43	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	APR	2015	261	4					662	669		10.1097/SLA.0000000000000935		8	Surgery	Surgery	CE2VV	WOS:000351679500033		
J	Matsuda, A; Miyashita, M; Matsumoto, S; Takahashi, G; Matsutani, T; Yamada, T; Kishi, T; Uchida, E				Matsuda, Akihisa; Miyashita, Masao; Matsumoto, Satoshi; Takahashi, Goro; Matsutani, Takeshi; Yamada, Takeshi; Kishi, Taro; Uchida, Eiji			Abdominoperineal Resection Provides Better Local Control But Equivalent Overall Survival to Local Excision of Anorectal Malignant Melanoma A Systematic Review	ANNALS OF SURGERY			English	Article						anorectum; local recurrence; malignant melanoma; surgery; survival	QUALITY-OF-LIFE; SURGICAL-MANAGEMENT; RECTAL-CANCER; ANTERIOR RESECTION; MUCOSAL MELANOMA; EXPERIENCE; METAANALYSIS; THERAPY; REGION; PATTERNS	Objective: To determine whether the extent of surgery is associated with survival in anorectal malignant melanoma (ARMM). Background: ARMM is a rare and highly malignant neoplasm with unfavorable prognosis. The optimal surgical management, abdominoperineal resection (APR) or local excision (LE), has been long debated, but conclusive evidence has not been obtained. Methods: A comprehensive electronic literature search was performed to identify studies evaluating survival between APR and LE for ARMM. The main outcome measures were overall survival, relapse-free survival, and local recurrence. A meta-analysis was performed using the random-effects models to calculate the odds ratios (ORs) and 95% confidence intervals (CIs). Results: Thirty-one studies, with a total of 1006 patients [544 (54.1%) APR and 462 (45.9%) LE], were included. Meta-analyses showed that overall survival (OR, 1.14; 95% CI, 0.74-1.76; P = 0.54) and relapse-free survival (OR, 0.95; 95% CI, 0.43-2.09; P = 0.89) did not differ significantly between the APR and LE groups. APR significantly reduced local recurrence compared with LE (OR, 0.18; 95% CI, 0.09-0.36; P < 0.00001). Conclusions: Although several limitations, such as inclusion of only retrospective studies with relatively small sample size and selection biases for surgical procedure, are involved, this meta-analysis suggested that APR has no survival benefit; however, APR confers better local control than LE. Given that local failures after LE could be managed by salvage surgery, minimizing morbidity and maximizing quality of life should be the focus in surgical treatment of ARMM.	[Matsuda, Akihisa; Miyashita, Masao; Matsumoto, Satoshi; Takahashi, Goro] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba 2701694, Japan; [Matsutani, Takeshi; Yamada, Takeshi; Uchida, Eiji] Nippon Med Sch, Dept Surg Gastroenterol, Tokyo 113, Japan; [Kishi, Taro] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan	Matsuda, A (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, 1715 Kamagari, Chiba 2701694, Japan.	a-matsu@nms.ac.jp					ABBAS JS, 1980, INT SURG, V65, P423; Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; ANGERAS U, 1983, J SURG ONCOL, V22, P261, DOI 10.1002/jso.2930220411; Nilsson PJ, 2010, BRIT J SURG, V97, P98, DOI 10.1002/bjs.6784; Ballo MT, 2002, J CLIN ONCOL, V20, P4555, DOI 10.1200/JCO.2002.03.002; Cornish JA, 2007, ANN SURG ONCOL, V14, P2056, DOI 10.1245/s10434-007-9402-z; Thibault C, 1997, DIS COLON RECTUM, V40, P661, DOI 10.1007/BF02140894; Iddings DM, 2010, ANN SURG ONCOL, V17, P40, DOI 10.1245/s10434-009-0705-0; Omholt K, 2011, CLIN CANCER RES, V17, P3933, DOI 10.1158/1078-0432.CCR-10-2917; Klas JV, 1999, CANCER, V85, P1686, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7; ROSS M, 1990, ARCH SURG-CHICAGO, V125, P313; WARD MWN, 1986, BRIT J SURG, V73, P68, DOI 10.1002/bjs.1800730127; Egger M, 1997, BRIT MED J, V315, P629; Cagir B, 1999, DIS COLON RECTUM, V42, P1203, DOI 10.1007/BF02238576; Yeh JJ, 2006, ANN SURG, V244, P1012, DOI 10.1097/01.sla.0000225114.56565.f9; Grumann MM, 2001, ANN SURG, V233, P149, DOI 10.1097/00000658-200102000-00001; Gershenwald JE, 1999, J CLIN ONCOL, V17, P976; Belli F, 2009, EJSO-EUR J SURG ONC, V35, P757, DOI 10.1016/j.ejso.2008.05.001; Ni SJ, 2012, HUM PATHOL, V43, P801, DOI 10.1016/j.humpath.2011.08.005; Guren MG, 2005, EJSO, V31, P735, DOI 10.1016/j.ejso.2005.05.004; Aytac B, 2010, KAOHSIUNG J MED SCI, V26, P658, DOI 10.1016/S1607-551X(10)70100-5; Schmidt CE, 2005, ANN SURG ONCOL, V12, P117, DOI 10.1245/ASO.2005.12.036; WANEBO HJ, 1981, CANCER, V47, P1891, DOI 10.1002/1097-0142(19810401)47:7<1891::AID-CNCR2820470730>3.0.CO;2-K; ANTONIUK PM, 1993, INT J COLORECTAL DIS, V8, P81, DOI 10.1007/BF00299333; BOLIVAR JC, 1982, SURG GYNECOL OBSTET, V154, P337; BRADY MS, 1995, DIS COLON RECTUM, V38, P146, DOI 10.1007/BF02052442; Bullard KM, 2003, J AM COLL SURGEONS, V196, P206, DOI 10.1016/S1072-7515(02)01538-7; Carcoforo P, 2012, J CANCER, V3, P449, DOI 10.7150/jca.5187; Che X, 2011, WORLD J GASTROENTERO, V17, P534, DOI 10.3748/wjg.v17.i4.534; Choi Byung Min, 2011, J Korean Soc Coloproctol, V27, P27, DOI 10.3393/jksc.2011.27.1.27; COOPER PH, 1982, DIS COLON RECTUM, V25, P693, DOI 10.1007/BF02629543; GOLDMAN S, 1990, DIS COLON RECTUM, V33, P874, DOI 10.1007/BF02051925; HUSA A, 1974, ACTA CHIR SCAND, V140, P68; Ishizone S, 2008, INT J COLORECTAL DIS, V23, P1257, DOI 10.1007/s00384-008-0529-6; Kim KB, 2004, CANCER, V100, P1478, DOI 10.1002/cncr.20113; KONSTADOULAKIS MM, 1995, J SURG ONCOL, V58, P118, DOI 10.1002/jso.2930580209; LunaPerez P, 1996, SURG ONCOL, V5, P165; Malik A, 2004, INT J COLORECTAL DIS, V19, P121, DOI 10.1007/s00384-003-0526-8; MASON JK, 1966, CANCER, V19, P39, DOI 10.1002/1097-0142(196601)19:1<39::AID-CNCR2820190104>3.0.CO;2-8; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Moore WD., 1857, LANCET, V1, P290; PACK GT, 1967, DIS COLON RECTUM, V10, P161, DOI 10.1007/BF02617173; Perez DR, 2013, ANN SURG ONCOL, V20, P2339, DOI 10.1245/s10434-012-2812-6; Pessaux P, 2004, BRIT J SURG, V91, P1183, DOI 10.1002/bjs.4592; PETITTI DB, 1994, AM J EPIDEMIOL, V140, P779; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rossetti C, 1997, J EXP CLIN CANC RES, V16, P81; Roumen RMH, 1996, EUR J SURG ONCOL, V22, P598, DOI 10.1016/S0748-7983(96)92346-X; Row David, 2009, Clin Colon Rectal Surg, V22, P120, DOI 10.1055/s-0029-1223844; SHAPIRO S, 1994, AM J EPIDEMIOL, V140, P771; SIEGAL B, 1983, AM J SURG, V146, P336, DOI 10.1016/0002-9610(83)90410-5; SLINGLUFF CL, 1990, SURGERY, V107, P1; Wang M, 2013, COLORECTAL DIS, V15, P1086, DOI 10.1111/codi.12250; Weyandt GH, 2003, BRIT J CANCER, V89, P2019, DOI 10.1038/sj.bjc.6601409; Yeh JJ, 2005, LANCET ONCOL, V6, P438, DOI 10.1016/S1470-2045(05)70212-6; Yen CI, 2013, HEPATO-GASTROENTEROL, V60, P89, DOI 10.5754/12453; Zhang S, 2010, MELANOMA RES, V20, P338, DOI 10.1097/CMR.0b013e328339b159	57	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	APR	2015	261	4					670	677		10.1097/SLA.0000000000000862		8	Surgery	Surgery	CE2VV	WOS:000351679500034		
J	Miskovic, D; Foster, J; Agha, A; Delaney, CP; Francis, N; Hasegawa, H; Karachun, A; Kim, SH; Law, WL; Marks, J; Morino, M; Panis, Y; Uriburu, JCP; Wexner, SD; Parvaiz, A				Miskovic, Danilo; Foster, Jake; Agha, Ayman; Delaney, Conor P.; Francis, Nader; Hasegawa, Hirotoshi; Karachun, Alexey; Kim, Seon Hahn; Law, Wai Lun; Marks, John; Morino, Mario; Panis, Yves; Patron Uriburu, Juan Carlos; Wexner, Steven D.; Parvaiz, Amjad			Standardization of Laparoscopic Total Mesorectal Excision for Rectal Cancer A Structured International Expert Consensus	ANNALS OF SURGERY			English	Article						colorectal surgery; consensus; expert; laparoscopic; rectal cancer; total mesorectal excision	COLORECTAL SURGERY; BOWEL PREPARATION; MEDICAL-RESEARCH; CLASICC TRIAL; MULTICENTER; SURVIVAL	Objective: To establish a structured international expert consensus on a detailed technical description of the laparoscopic total mesorectal excision (TME). Background: Laparoscopic TME is a common surgical approach for the treatment of rectal cancer, but there is little agreement on technical details and standards. Methods: Sixty leading surgical experts from 5 different world regions with a median overall experience of 250 laparoscopic TME participated in this study. Four stages of mixed quantitative and qualitative consensus-finding methods were applied. (1) Semistructured expert interviews were independently analyzed by 2 assessors. (2) Consensus on the interview data was reached using reiterating questionnaires (Delphi method). (3) This was further refined in an interactive workshop. (4) Based on this meeting, a comprehensive text was drafted and final approval was sought by all experts. Findings: Three theme categories were identified in 9 detailed interviews (anatomical landmarks, description of tissue retraction, and operating strategies). Following 2 rounds of a 54-item questionnaire, 29 items achieved very high agreement (A* >= 90%), 14 with good agreement (>= 80%), 13 with moderate agreement (>= 50%), and 18 with little or no agreement (<50%). In the workshop, areas of agreement were consolidated and conclusions were sought for those with less agreement. The final document was approved after 2 further rounds of surveys by all respondents. Conclusions: This detailed and agreed technical description of laparoscopic TME may have implications on training, assessment, quality control, and future research.	[Miskovic, Danilo] St James Univ Hosp, John Goligher Dept Colorectal Surg, Leeds LS9 7TF, W Yorkshire, England; [Foster, Jake] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; [Agha, Ayman] Univ Med Ctr Regensburg, Dept Surg, Regensburg, Germany; [Delaney, Conor P.] Case Western Reserve Univ, Div Colorectal Surg, Cleveland, OH 44106 USA; [Francis, Nader] Yeovil Dist Hosp, Dept Surg, Yeovil, England; [Hasegawa, Hirotoshi] Keio Univ, Dept Surg, Tokyo, Japan; [Karachun, Alexey] NN Petrov Oncol Res Inst, St Petersburg, Russia; [Kim, Seon Hahn] Korea Univ, Dept Surg, Seoul, South Korea; [Law, Wai Lun] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Marks, John] Lankenau Med Ctr, Div Colorectal Surg, Wynnewood, PA USA; [Morino, Mario] Univ Turin, Dept Surg Sci, Turin, Italy; [Panis, Yves] Beaujon Hosp, AP HP, Colorectal Dept, Clichy, France; [Panis, Yves] Univ Paris 07, F-75221 Paris 05, France; [Patron Uriburu, Juan Carlos] British Hosp Buenos Aires, Dept Colorectal Surg, Buenos Aires, DF, Argentina; [Wexner, Steven D.] Cleveland Clin Florida, Ctr Digest Dis, Dept Colorectal Surg, Weston, FL USA; [Parvaiz, Amjad] Queen Alexandra Hosp, Minimally Invas Colorectal Unit, Portsmouth, Hants, England	Miskovic, D (reprint author), St James Univ Hosp, John Goligher Colorectal Unit, Becket St, Leeds LS9 7TF, W Yorkshire, England.	d.miskovic@leeds.ac.uk		Morino, Mario/0000-0003-4540-1409			Miskovic D, 2012, DIS COLON RECTUM, V55, P1300, DOI 10.1097/DCR.0b013e31826ab4dd; Bretagnol F, 2010, ANN SURG, V252, P863, DOI 10.1097/SLA.0b013e3181fd8ea9; Cheung YM, 2009, SURG ENDOSC, V23, P2796, DOI 10.1007/s00464-009-0566-4; Slim K, 2004, BRIT J SURG, V91, P1125, DOI 10.1002/bjs.4651; Lange MM, 2008, BRIT J SURG, V95, P1020, DOI 10.1002/bjs.6126; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Cuschieri A, 2001, AM J SURG, V182, P110, DOI 10.1016/S0002-9610(01)00667-5; Lange MM, 2013, ANN SURG ONCOL, V20, P1806, DOI 10.1245/s10434-012-2832-2; Jayne DG, 2010, BRIT J SURG, V97, P1638, DOI 10.1002/bjs.7160; Dahlberg M, 1998, BRIT J SURG, V85, P515; Mackenzie H, 2013, SURG ENDOSC, V27, P2704, DOI 10.1007/s00464-013-2806-x; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Brown G, 2004, AM J ROENTGENOL, V182, P431; HEALD RJ, 1986, LANCET, V1, P1479; Hemandas A, 2011, WORLD J SURG, V35, P409, DOI 10.1007/s00268-010-0837-1; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; BRITTEN N, 1995, BRIT MED J, V311, P251; Dalkey NC., 1968, RM5888PR RAND CORP; HEALD RJ, 1979, BRIT J HOSP MED, V22, P277; Kuhry E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003432.pub2; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Palter VN, 2011, AM J SURG, V201, P251, DOI 10.1016/j.amjsurg.2010.01.031	23	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	APR	2015	261	4					716	722		10.1097/SLA.0000000000000823		7	Surgery	Surgery	CE2VV	WOS:000351679500040		
J	Shindoh, J; de Aretxabala, X; Aloia, TA; Roa, JC; Roa, I; Zimmitti, G; Javle, M; Conrad, C; Maru, DM; Aoki, T; Vigano, L; Ribero, D; Kokudo, N; Capussotti, L; Vauthey, JN				Shindoh, Junichi; de Aretxabala, Xabier; Aloia, Thomas A.; Carlos Roa, Juan; Roa, Ivan; Zimmitti, Giuseppe; Javle, Milind; Conrad, Claudius; Maru, Dipen M.; Aoki, Taku; Vigano, Luca; Ribero, Dario; Kokudo, Norihiro; Capussotti, Lorenzo; Vauthey, Jean-Nicolas			Tumor Location Is a Strong Predictor of Tumor Progression and Survival in T2 Gallbladder Cancer An International Multicenter Study	ANNALS OF SURGERY			English	Article						gallbladder cancer; predictor; staging; tumor location; tumor progression	CARCINOMA; RESECTION; SPREAD; PROGNOSIS; OUTCOMES	Objective: To determine the prognostic impact of tumor location in gallbladder cancer. Background: Depth of tumor is a strong predictor of survival after curative resection of gallbladder cancer. However, the gallbladder has a unique anatomical relationship with the liver, and the clinical significance of tumor location remains unclear. Methods: For 437 patients with gallbladder cancer who underwent resection at 4 international institutions, clinicopathologic characteristics and their association with survival were analyzed. Tumor location was defined as "hepatic side" or "peritoneal side," and the prognostic significance of tumor location was evaluated. Results: Among the 252 patients with T2 disease, patients with tumors on the hepatic side (T2h, n = 99) had higher rates of vascular invasion, neural invasion, and nodal metastasis than patients with tumors on the peritoneal side (T2p, n = 153) (51% vs 19%, 33% vs 8%, and 40% vs 17%, respectively; P < 0.01 for all). After a median follow-up of 58.9 months, 3-year and 5-year survival rates were 52.1% and 42.6%, respectively, for T2h tumors and 73.7% and 64.7%, respectively, for T2p tumors (P = 0.0006). No such differences were observed in T1 or T3 tumors. Multivariate analysis confirmed the independent association of hepatic-side location with survival in T2 tumors (hazard ratio, 2.7; 95% confidence interval, 1.7-4.2; P < 0.001). This subclassification of T2 tumors predicted recurrence in the liver (23% vs 3%; P = 0.003) and distant lymph nodes (16% vs 3%; P = 0.019) even after radical resection. Conclusions: After curative resection of T2 gallbladder cancer, tumor location predicts the pattern of recurrence and survival.	[Shindoh, Junichi; Aloia, Thomas A.; Zimmitti, Giuseppe; Conrad, Claudius; Vauthey, Jean-Nicolas] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Shindoh, Junichi; Aoki, Taku; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [de Aretxabala, Xabier] Clin Alemana Santiago, Dept Surg, Santiago, Chile; [Carlos Roa, Juan] Pontificia Univ Catolica, Dept Pathol, Santiago, Chile; [Roa, Ivan] Creat Biosci, Santiago, Chile; [Zimmitti, Giuseppe; Vigano, Luca; Ribero, Dario; Capussotti, Lorenzo] Osped Mauriziano Umberto 1, Dept HPB & Digest Surg, Turin, Italy; [Javle, Milind] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Maru, Dipen M.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Vauthey, JN (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd,Unit 1484, Houston, TX 77030 USA.	jvauthey@mdanderson.org			National Institutes of Health through Cancer Center Support grant [CA016672]	Supported in part by the National Institutes of Health through Cancer Center Support grant CA016672 to The University of Texas MD Anderson Cancer Center. The authors declare no conflicts of interest.	American Cancer Society, 2013, CANC FACTS FIG 2013; Pilgrim CHC, 2013, DIGEST DIS SCI, V58, P2455, DOI 10.1007/s10620-013-2713-y; Endo I, 2004, WORLD J SURG, V28, P692, DOI 10.1007/s00268-004-7289-4; Miyakawa S, 2009, J HEPATO-BILIARY-PAN, V16, P1, DOI 10.1007/s00534-008-0015-0; Goetze TO, 2008, ANN SURG, V247, P104, DOI 10.1097/SLA.0b013e318154bf5d; Wright BE, 2007, AM J SURG, V194, P820, DOI 10.1016/j.amjsurg.2007.08.032; FAHIM RB, 1962, ANN SURG, V156, P114, DOI 10.1097/00000658-196207000-00021; Wakai T, 2010, AM J SURG PATHOL, V34, P65, DOI 10.1097/PAS.0b013e3181c467d4; Cho SY, 2010, WORLD J SURG, V34, P1572, DOI 10.1007/s00268-010-0522-4; Choi SB, 2010, J GASTROINTEST SURG, V14, P668, DOI 10.1007/s11605-009-1132-z; Edge SB, 2010, AJCC CANC STAGING MA; Karlmark E., 1932, ACTA PATH MICROBIO S, V13, P1; Kohya N, 2010, WORLD J GASTROENTERO, V16, P3567, DOI 10.3748/wjg.v16.i28.3567; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P741, DOI 10.1001/archsurg.138.7.741; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P750; Nagahashi M, 2007, WORLD J GASTROENTERO, V13, P4480; Pawlik T, 2009, ANN SURG ONCOL, V16, P787, DOI 10.1245/s10434-009-0319-6; SHIRAI Y, 1995, CANCER, V75, P2063, DOI 10.1002/1097-0142(19950415)75:8<2063::AID-CNCR2820750806>3.0.CO;2-S; Wright BE, 2007, AM J SURG, V194, P825	19	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	APR	2015	261	4					733	739		10.1097/SLA.0000000000000728		7	Surgery	Surgery	CE2VV	WOS:000351679500042		
J	Cavalli, AR; Higashino, T; Nunez, M				Cavalli, Ana R.; Higashino, Teruo; Nunez, Manuel			Special issue on formal active and passive testing of distributed and networked systems	ANNALS OF TELECOMMUNICATIONS-ANNALES DES TELECOMMUNICATIONS			English	Editorial Material									[Cavalli, Ana R.] Telecom SudParis, F-91000 Evry, France; [Higashino, Teruo] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan; [Nunez, Manuel] Univ Complutense Madrid, Dept Sistemas Informat & Comp, Madrid, Spain	Cavalli, AR (reprint author), Telecom SudParis, 9 Rue Charles Fourier, F-91000 Evry, France.	ana.cavalli@it-sudparis.eu; higashino@ist.osaka-u.ac.jp; mn@sip.ucm.es	Nunez, Manuel/B-6889-2008	Nunez, Manuel/0000-0001-9808-6401				0	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0003-4347	1958-9395		ANN TELECOMMUN	Ann. Telecommun.-Ann Telecommun.	APR	2015	70	3-4					83	84		10.1007/s12243-015-0459-6		2	Telecommunications	Telecommunications	CE3YU	WOS:000351766800001		
J	Cavalli, AR; Higashino, T; Nunez, M				Cavalli, Ana R.; Higashino, Teruo; Nunez, Manuel			A survey on formal active and passive testing with applications to the cloud	ANNALS OF TELECOMMUNICATIONS-ANNALES DES TELECOMMUNICATIONS			English	Article							FINITE-STATE MACHINES; CHECKING APPROACH; TEST-GENERATION; TIMED AUTOMATA; PROTOCOL; SYSTEMS; INFORMATION; DESIGN; MODELS	In this paper we review the main lines of work dealing with formal approaches to testing. This survey is divided into two main parts: active and passive testing. In addition, we overview some of the main approaches to testing (in) the cloud.	[Cavalli, Ana R.] Telecom SudParis, F-91000 Evry, France; [Higashino, Teruo] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan; [Nunez, Manuel] Univ Complutense Madrid, Dept Sistemas Informat & Comp, Madrid, Spain	Cavalli, AR (reprint author), Telecom SudParis, 9 Rue Charles Fourier, F-91000 Evry, France.	ana.cavalli@it-sudparis.eu; higashino@ist.osaka-u.ac.jp; mn@sip.ucm.es	Nunez, Manuel/B-6889-2008	Nunez, Manuel/0000-0001-9808-6401	Spanish MEC project ESTuDIo [TIN2012-36812-C02]; Comunidad de Madrid project SICOMORo-CM [S2013/ICE-3006]; UCM-Santander program [910606]; INTER-TRUST european project (FP7 program);  [26220001]	This research has been partially supported by the Spanish MEC project ESTuDIo (TIN2012-36812-C02), the Comunidad de Madrid project SICOMORo-CM (S2013/ICE-3006), the Japanese Grants-in-Aid for Scientific Research(S) (26220001), the UCM-Santander program to fund research groups (group 910606), and the INTER-TRUST european project (FP7 program).	Alcalde B, 2004, LECT NOTES COMPUT SC, V3235, P150; Andres C, 2010, P 2010 IEEE INT C SE, P610; Andres C, 2008, LECT NOTES COMPUT SC, V5311, P418, DOI 10.1007/978-3-540-88387-6_36; Leucker M, 2009, J LOGIC ALGEBR PROGR, V78, P293, DOI 10.1016/j.jlap.2008.08.004; Dorofeeva R, 2010, INFORM SOFTWARE TECH, V52, P1286, DOI 10.1016/j.infsof.2010.07.001; Casanova H, 2008, 2008 UKSIM TENTH INTERNATIONAL CONFERENCE ON COMPUTER MODELING AND SIMULATION, P126, DOI 10.1109/UKSIM.2008.28; Lee D, 2006, IEEE ACM T NETWORK, V14, P424, DOI 10.1109/TNET.2006.872572; Zeng WX, 2009, FIRST IITA INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P680, DOI 10.1109/JCAI.2009.34; Ural H, 2007, LECT NOTES COMPUT SC, V4581, P335; SABNANI K, 1988, COMPUT NETWORKS ISDN, V15, P285, DOI 10.1016/0169-7552(88)90064-5; Duale AY, 2004, IEEE T COMPUT, V53, P614, DOI 10.1109/TC.2004.1275300; Higashino T, 1999, INT FED INFO PROC, V21, P197; Mouttappa P, 2012, INT CONF QUAL SOFTW, P49, DOI 10.1109/QSIC.2012.33; El-Fakih K, 2004, IEEE T SOFTWARE ENG, V30, P425; Ural H, 2006, FORM ASP COMPUT, V18, P84, DOI 10.1007/s00165-005-0083-8; HIGASHINO T, 1994, IEEE T SOFTWARE ENG, V20, P29, DOI 10.1109/32.263753; Nunez A, 2012, J GRID COMPUT, V10, P185, DOI 10.1007/s10723-012-9208-5; Miller RE, 2001, PROC ANNU SIMUL SYMP, P277, DOI 10.1109/SIMSYM.2001.922142; Benharref A, 2007, LECT NOTES COMPUT SC, V4581, P13; ALUR R, 1994, THEOR COMPUT SCI, V126, P183, DOI 10.1016/0304-3975(94)90010-8; Ladani BT, 2005, LECT NOTES COMPUT SC, V3502, P9; Sun T, 2003, LECT NOTES COMPUT SC, V2767, P319; Joshi P, 2011, ACM SIGPLAN NOTICES, V46, P171, DOI 10.1145/2076021.2048082; Shin KS, 2007, J NETW COMPUT APPL, V30, P331, DOI 10.1016/j.jnca.2005.07.002; CHOW TS, 1978, IEEE T SOFTWARE ENG, V4, P178, DOI 10.1109/TSE.1978.231496; Zhao YX, 2003, J COMPUT SCI TECHNOL, V18, P139, DOI 10.1007/BF02948879; Hierons RM, 2012, DISTRIB COMPUT, V25, P35, DOI 10.1007/s00446-011-0149-1; Cavalli A, 2003, INFORM SOFTWARE TECH, V45, P837, DOI 10.1016/S0950-5849(03)00063-6; Springintveld J, 2001, THEOR COMPUT SCI, V254, P225, DOI 10.1016/S0304-3975(99)00134-6; Lee D, 1996, P IEEE, V84, P1090, DOI 10.1109/5.533956; En-Nouaary A, 1998, REAL TIM SYST SYMP P, P220; Andres C, 2012, SOFTW TEST VERIF REL, V22, P365, DOI 10.1002/stvr.1464; Lalanne F, 2013, IEEE ACM T NETWORK, V21, P788, DOI 10.1109/TNET.2012.2210443; Kliazovich D, 2012, J SUPERCOMPUT, V62, P1263, DOI 10.1007/s11227-010-0504-1; Mouttappa P, 2013, COMPUT NETW, V57, P2992, DOI 10.1016/j.comnet.2013.06.019; Lai R, 2002, J SYST SOFTWARE, V62, P21, DOI 10.1016/S0164-1212(01)00132-7; Tabourier M, 1999, INFORM SOFTWARE TECH, V41, P813, DOI 10.1016/S0950-5849(99)00039-7; Arnedo JA, 2003, LECT NOTES COMPUT SC, V2644, P295; Banzai Takayuki, 2010, Proceedings 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), DOI 10.1109/CCGRID.2010.72; Bayse E, 2005, COMPUT NETW, V48, P247, DOI 10.1016/j.comnet.2004.09.009; Bellard F., 2005, Proceedings of the FREENIX/Open Source Track. 2005 USENIX Annual Technical Conference; Buyya R., 2009, P INT C HIGH PERF CO, V7, P1; Cacciari L, 1999, INFORM SOFTWARE TECH, V41, P767, DOI 10.1016/S0950-5849(99)00036-1; Cavalli A., 2004, Proceedings. 24th International Conference on Distributed Computing System Workshops; Chan W, 2009, P APSCC 2009, P111; Cheung SC, 2001, P 12 INT S SOFTW REL, P210; Corwin Eric H., 2011, Information Security Journal: A Global Perspective, V20, DOI 10.1080/19393555.2011.624162; Dorofeeva M, 2005, P 25 IFIP INT C FORM, P363; FUJIWARA S, 1991, IEEE T SOFTWARE ENG, V17, P591, DOI 10.1109/32.87284; GARCIA A., 2009, P IEEE INT C MECH MA, P1; GONENC G, 1970, IEEE T COMPUT, VC 19, P551, DOI 10.1109/T-C.1970.222975; Halle S, 2009, 2009 ACM S APPL COMP, P2118; Hierons R, 2013, LECT NOTES COMPUTER, V7892, P99; Hierons RM, 2012, IEEE T SOFTWARE ENG, V38, P629, DOI 10.1109/TSE.2011.45; Hiromori A, 2012, P 24 IFIP INT C TEST, P231; Jard C., 1998, P TC6 WG6 1 JOINT IN, V135, P353; Lee D, 1997, 1997 INTERNATIONAL CONFERENCE ON NETWORK PROTOCOLS - PROCEEDINGS, P113, DOI 10.1109/ICNP.1997.643699; Lee D., 2002, Proceedings 10th IEEE International Conference on Network Protocols, DOI 10.1109/ICNP.2002.1181393; Li X., 1994, P 7 INT WORKSH PROT, P225; Luo G, 1993, P 6 IFIP WORKSH PROT, P139; Maag S, 2006, P ACM INT WORKSH PER, P48, DOI 10.1145/1163653.1163663; Mammar A, 2011, LECT NOTES COMPUT SC, V7019, P80, DOI 10.1007/978-3-642-24580-0_7; Mehrotra N, 2010, P 10 INT SOFTW TEST, P1; Mell P, 2007, GUIDE INTRUSION DETE; Miller R, 2000, P IEEE INT PERF COMP, P281; Miller R, 1998, P IEEE INT PERF COMP, P111; Misic V, 1998, P 1998 IEEE INT S SO, P72; Morales G, 2010, P 8 IEEE ICWS, P592; Mouttappa P, 2013, P INT COMP SOFTW APP, P1, DOI 10.1109/COMPSAC.2013.5; Nguyen H, 2012, P 14 IEEE INT S HIGH, P106; Petrenko A, 1993, P IFIP 6 IWPTS FRANC, P363; Rafiq O, 2003, J SUPERCOMPUT, V24, P203, DOI 10.1023/A:1021759127956; Richters M, 2003, 4 INT WORKSH ASP OR; Rumbaugh J., 1991, OBJECT ORIENTED MODE; SIDHU DP, 1989, IEEE T SOFTWARE ENG, V15, P413, DOI 10.1109/32.16602; Simmonds J, 2011, THESIS U TORONTO; Ural H, 2007, P 2 IEEE INT WORKSH, P6; Vuong ST, 1989, P IFIP TC6 2 INT WOR, P161; WANG CJ, 1992, INT CON DISTR COMP S, P252, DOI 10.1109/ICDCS.1992.235085; Wehbi B, 2012, P IEEE 5 INT C SOFTW, P860, DOI DOI 10.1109/ICST.2012.188; Wu J, 2002, 22 IFIP INT C FORM T, P101; Xiaoping Che, 2012, Proceedings of the 7th International Conference on Evaluation of Novel Approaches to Software Engineering (ENASE 2012)	82	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0003-4347	1958-9395		ANN TELECOMMUN	Ann. Telecommun.-Ann Telecommun.	APR	2015	70	3-4					85	93		10.1007/s12243-015-0457-8		9	Telecommunications	Telecommunications	CE3YU	WOS:000351766800002		
J	Koarada, S; Tashiro, S; Tokuda, Y; Ono, Y; Sadanaga, Y; Suematsu, R; Ono, N; Ohta, A; Tada, Y				Koarada, Syuichi; Tashiro, Satoko; Tokuda, Yukiko; Ono, Yukihide; Sadanaga, Yuri; Suematsu, Rie; Ono, Nobuyuki; Ohta, Akihide; Tada, Yoshifumi			Persistent expression of CXCR5 on plasmablasts in IgG4-related disease	ANNALS OF THE RHEUMATIC DISEASES			English	Letter									[Koarada, Syuichi; Tashiro, Satoko; Tokuda, Yukiko; Ono, Yukihide; Sadanaga, Yuri; Suematsu, Rie; Ono, Nobuyuki; Ohta, Akihide; Tada, Yoshifumi] Saga Univ, Fac Med, Div Rheumatol, Saga 8498501, Japan	Koarada, S (reprint author), Saga Univ, Fac Med, Div Rheumatol, 5-1-1 Nabeshima, Saga 8498501, Japan.	koarada@cc.saga-u.ac.jp					Loetscher P, 2002, ARTHRITIS RES, V4, P233, DOI 10.1186/ar412; Fox RI, 2015, ANN RHEUM DIS, V74, P1, DOI 10.1136/annrheumdis-2014-205476; Koarada S, CLIN DEV IMMUNOL; Koarada S, 2013, Open Rheumatol J, V7, P55, DOI 10.2174/1874312901307010055; Koarada S, 2014, ANN RHEUM DIS, V73, pE65, DOI 10.1136/annrheumdis-2014-206179; Wallace ZS, 2015, ANN RHEUM DIS, V74, P190, DOI 10.1136/annrheumdis-2014-205233	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	APR	2015	74	4					E32	U32		10.1136/annrheumdis-2014-207207		2	Rheumatology	Rheumatology	CE2AV	WOS:000351615700002		
J	Ishii, Y; Akasaka, N; Goda, I; Sakoda, H; Fujiwara, S				Ishii, Yuri; Akasaka, Naoki; Goda, Itsuko; Sakoda, Hisao; Fujiwara, Shinsuke			Effective Trapping of Fruit Flies with Cultures of Metabolically Modified Acetic Acid Bacteria	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							SPOTTED-WING DROSOPHILA; SUZUKII DIPTERA DROSOPHILIDAE; GLUCONACETOBACTER-EUROPAEUS; ESCHERICHIA-COLI; GENE-EXPRESSION; UNITED-STATES; VINEGAR; IDENTIFICATION; FERMENTATION; COMBINATIONS	Acetoin in vinegar is an attractant to fruit flies when combined with acetic acid. To make vinegar more effective in attracting fruit flies with increased acetoin production, Komagataeibacter europaeus KGMA0119 was modified by specific gene disruption of the acetohydroxyacid isomeroreductase gene (ilvC). A previously constructed mutant lacking the putative ligand-sensing region in the leucine-responsive regulatory protein (KeLrp, encoded by Kelrp) was also used. The ilvC and Kelrp disruptants (KGMA5511 and KGMA7203, respectively) produced greater amounts of acetoin (KGMA5511, 0.11%; KGMA7203, 0.13%) than the wild-type strain KGMA0119 (0.069%). KGMA7203 produced a trace amount of isobutyric acid (0.007%), but the other strains did not. These strains produced approximately equal amounts of acetic acid (0.7%). The efficiency of fruit fly attraction was investigated with cultured Drosophila melanogaster. D. melanogaster flies (approximately 1,500) were released inside a cage (2.5 m by 2.5 m by 1.5 m) and were trapped with a device containing vinegar and a sticky sheet. The flies trapped on the sticky sheet were counted. The cell-free supernatant from KGMA7203 culture captured significantly more flies (19.36 to 36.96% of released flies) than did KGMA0119 (3.25 to 11.40%) and KGMA5511 (6.87 to 21.50%) cultures. Contrastingly, a 0.7% acetic acid solution containing acetoin (0.13%) and isobutyric acid (0.007%), which mimicked the KGMA7203 supernatant, captured significantly fewer flies (0.88 to 4.57%). Furthermore, the KGMA0119 supernatant with additional acetoin (0.13%) and isobutyric acid (0.007%) captured slightly more flies than the original KGMA0119 supernatant but fewer than the KGMA7203 supernatant, suggesting that the synergistic effects of acetic acid, acetoin, isobutyric acid, and unidentified metabolites achieved the efficient fly trapping of the KGMA7203 supernatant.	[Ishii, Yuri; Goda, Itsuko; Fujiwara, Shinsuke] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Dept Biosci, Sanda, Hyogo, Japan; [Akasaka, Naoki; Sakoda, Hisao] Marukan Vinegar Co Ltd, Inst Appl Microbiol, Kobe, Hyogo, Japan; [Fujiwara, Shinsuke] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Res Ctr Intelligent Biomat, Sanda, Hyogo, Japan	Fujiwara, S (reprint author), Kwansei Gakuin Univ, Grad Sch Sci & Technol, Dept Biosci, Sanda, Hyogo, Japan.	fujiwara-s@kwansei.ac.jp			Senshu Ikeda Bank Ltd.	This study was supported in part by grant of The Senshu Ikeda Bank Ltd.	Adachi O, 2006, BIOSCI BIOTECH BIOCH, V70, P2579, DOI 10.1271/bbb.60259; ADAMS MD, 1990, J BIOL CHEM, V265, P11436; Akasaka N, 2014, J BIOSCI BIOENG, V118, P607, DOI 10.1016/j.jbiosc.2014.05.024; Akasaka N, 2015, J BIOSCI BIOENG; Akasaka N, 2013, APPL ENVIRON MICROB, V79, P7334, DOI 10.1128/AEM.02397-13; Andres-Barrao C, 2011, J BACTERIOL, V193, P2670, DOI 10.1128/JB.00229-11; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351; BOLIVAR F, 1977, GENE, V2, P95; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Cha DH, 2012, J CHEM ECOL, V38, P1419, DOI 10.1007/s10886-012-0196-5; Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10; Landolt PJ, 2012, FLA ENTOMOL, V95, P326; Trcek J, 2007, EXTREMOPHILES, V11, P627, DOI 10.1007/s00792-007-0077-y; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Yamada Y, 2014, INT J SYST EVOL MICR, V64, P1670, DOI 10.1099/ijs.0.054494-0; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Garcia-Quintans N, 2008, APPL ENVIRON MICROB, V74, P1988, DOI 10.1128/AEM.01851-07; Birmingham AL, 2011, J ECON ENTOMOL, V104, P1018, DOI 10.1603/EC10432; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Cha DH, 2014, PEST MANAG SCI, V70, P324, DOI 10.1002/ps.3568; HARWOOD CS, 1981, J BACTERIOL, V148, P117; Hidese R, 2014, MOL MICROBIOL, V93, P331, DOI 10.1111/mmi.12662; Kleiber JR, 2014, ENVIRON ENTOMOL, V43, P439, DOI 10.1603/EN13224; Landolt PJ, 2012, J APPL ENTOMOL, V136, P148, DOI 10.1111/j.1439-0418.2011.01646.x; Lee JC, 2013, ENVIRON ENTOMOL, V42, P1348, DOI 10.1603/EN13148; Lee S, 2004, J BACTERIOL, V186, P5384, DOI 10.1128/JB.186.16.5384-5391.2004; NEWMAN EB, 1995, ANNU REV MICROBIOL, V49, P747; Okada K, 2014, J BACTERIOL, V196, P1866, DOI 10.1128/JB.01515-14; Sambrook J., 2012, MOL CLONING LAB MANU	38	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	7					2265	2273		10.1128/AEM.03678-14		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5AL	WOS:000351842000002		
J	Oide, S; Gunji, W; Moteki, Y; Yamamoto, S; Suda, M; Jojima, T; Yukawa, H; Inui, M				Oide, Shinichi; Gunji, Wataru; Moteki, Yasuhiro; Yamamoto, Shogo; Suda, Masako; Jojima, Toru; Yukawa, Hideaki; Inui, Masayuki			Thermal and Solvent Stress Cross-Tolerance Conferred to Corynebacterium glutamicum by Adaptive Laboratory Evolution	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							OXYGEN-DEPRIVATION CONDITIONS; ESCHERICHIA-COLI; ENVIRONMENTAL-STRESSES; HIGH-TEMPERATURE; OSMOTIC-STRESS; TREHALOSE; ADAPTATION; GROWTH; METABOLISM; RESISTANCE	Reinforcing microbial thermotolerance is a strategy to enable fermentation with flexible temperature settings and thereby to save cooling costs. Here, we report on adaptive laboratory evolution (ALE) of the amino acid-producing bacterium Corynebacterium glutamicum under thermal stress. After 65 days of serial passage of the transgenic strain GLY3, in which the glycolytic pathway is optimized for alanine production under oxygen deprivation, three strains adapted to supraoptimal temperatures were isolated, and all the mutations they acquired were identified by whole-genome resequencing. Of the 21 mutations common to the three strains, one large deletion and two missense mutations were found to promote growth of the parental strain under thermal stress. Additive effects on thermotolerance were observed among these mutations, and the combination of the deletion with the missense mutation on otsA, encoding a trehalose-6-phosphate synthase, allowed the parental strain to overcome the upper limit of growth temperature. Surprisingly, the three evolved strains acquired cross-tolerance for isobutanol, which turned out to be partly attributable to the genomic deletion associated with the enhanced thermotolerance. The deletion involved loss of two transgenes, pfk and pyk, encoding the glycolytic enzymes, in addition to six native genes, and elimination of the transgenes, but not the native genes, was shown to account for the positive effects on thermal and solvent stress tolerance, implying a link between energy-producing metabolism and bacterial stress tolerance. Overall, the present study provides evidence that ALE can be a powerful tool to refine the phenotype of C. glutamicum and to investigate the molecular bases of stress tolerance.	[Oide, Shinichi; Gunji, Wataru; Moteki, Yasuhiro; Yamamoto, Shogo; Suda, Masako; Jojima, Toru; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth, Kizugawa, Kyoto, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, Kizugawa, Kyoto, Japan.	mmg-lab@rite.or.jp					Alcantara-Diaz D, 2004, MUTAGENESIS, V19, P349, DOI 10.1093/mutage/geh039; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; VERTES AA, 1993, RES MICROBIOL, V144, P181, DOI 10.1016/0923-2508(93)90043-2; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001; LEYER GJ, 1993, APPL ENVIRON MICROB, V59, P1842; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x; Jojima T, 2012, FEBS LETT, V586, P4228, DOI 10.1016/j.febslet.2012.10.028; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; Connor MR, 2009, CURR OPIN BIOTECH, V20, P307, DOI 10.1016/j.copbio.2009.04.002; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Tzvetkov M, 2003, MICROBIOL-SGM, V149, P1659, DOI 10.1099/mic.0.26205-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Pope CF, 2008, ANTIMICROB AGENTS CH, V52, P1209, DOI 10.1128/AAC.01152-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Blaby IK, 2012, APPL ENVIRON MICROB, V78, P144, DOI 10.1128/AEM.05773-11; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Bergholz TM, 2010, FOODBORNE PATHOG DIS, V7, P1537, DOI 10.1089/fpd.2010.0624; Jojima T, 2010, APPL MICROBIOL BIOT, V87, P159, DOI 10.1007/s00253-010-2493-7; Tsuchida Y, 2009, APPL MICROBIOL BIOT, V81, P1107, DOI 10.1007/s00253-008-1746-1; Beney L, 2001, APPL MICROBIOL BIOT, V57, P34; Portnoy VA, 2011, CURR OPIN BIOTECH, V22, P590, DOI 10.1016/j.copbio.2011.03.007; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Deng Y, 2011, J BIOL CHEM, V286, P39958, DOI 10.1074/jbc.M111.239616; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Cakar ZP, 2005, FEMS YEAST RES, V5, P569, DOI 10.1016/j.femsyr.2004.10.010; Rudolph B, 2010, J BIOL CHEM, V285, P19029, DOI 10.1074/jbc.M110.103374; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Maughan H, 2011, APPL ENVIRON MICROB, V77, P4105, DOI 10.1128/AEM.00374-11; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; ARMITAGE P, 1952, J ROY STAT SOC B, V14, P1; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; BENNETT AF, 1990, NATURE, V346, P79, DOI 10.1038/346079a0; Canovas D, 2001, J BACTERIOL, V183, P3365, DOI 10.1128/JB.183.11.3365-3371.2001; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Charusanti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033727; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Dragosits M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.76; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Ells TC, 2011, APPL ENVIRON MICROB, V77, P6841, DOI 10.1128/AEM.00757-11; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Izutsu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033288; de Crecy E, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-74; Kinoshita S, 1957, J GEN APPL MICROBIOL, V3, P193, DOI 10.2323/jgam.3.193; Kishimoto T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001164; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Luders S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-36; Machielsen R, 2010, APPL ENVIRON MICROB, V76, P1587, DOI 10.1128/AEM.02595-09; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Okibe N, 2010, MICROBIOL-SGM, V156, P3609, DOI 10.1099/mic.0.043745-0; OZAKI A, 1984, MOL GEN GENET, V196, P175, DOI 10.1007/BF00334113; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Reina-Bueno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033587; Sambrook J., 1989, MOL CLONING LAB MANU; Stoebel DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000671; Wallace-Salinas V, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-151; Wang YH, 2007, J BIOTECHNOL, V129, P510, DOI 10.1016/j.jbiotec.2007.01.011; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	69	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	7					2284	2298		10.1128/AEM.03973-14		15	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5AL	WOS:000351842000004		
J	Lu, J; Zheng, HY; Guo, X; Zhang, Y; Li, H; Liu, L; Zeng, HR; Fang, L; Mo, YL; Yoshida, H; Yi, L; Liu, T; Rutherford, S; Xu, WB; Ke, CW				Lu, Jing; Zheng, Huanying; Guo, Xue; Zhang, Yong; Li, Hui; Liu, Leng; Zeng, Hanri; Fang, Ling; Mo, Yanling; Yoshida, Hiromu; Yi, Lina; Liu, Tao; Rutherford, Shannon; Xu, Wenbo; Ke, Changwen			Elucidation of Echovirus 30's Origin and Transmission during the 2012 Aseptic Meningitis Outbreak in Guangdong, China, through Continuing Environmental Surveillance	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							HEV-B ENTEROVIRUSES; MOLECULAR EPIDEMIOLOGY; DIVERSITY; PROVINCE; IDENTIFICATION; PICORNAVIRUS; SEROTYPES; PROTEIN; SEWAGE; SCHOOL	An aseptic meningitis outbreak occurred in Luoding City of Guangdong, China, in 2012, and echovirus type 30 (ECHO30) was identified as the major causative pathogen. Environmental surveillance indicated that ECHO30 was detected in the sewage of a neighboring city, Guangzhou, from 2010 to 2012 and also in Luoding City sewage samples (6/43, 14%) collected after the outbreak. In order to track the potential origin of the outbreak viral strains, we sequenced the VP1 genes of 29 viral strains from clinical patients and environmental samples. Sequence alignments and phylogenetic analyses based on VP1 gene sequences revealed that virus strains isolated from the sewage of Guangzhou and Luoding cities matched well the clinical strains from the outbreak, with high nucleotide sequence similarity (98.5% to 100%) and similar cluster distribution. Five ECHO30 clinical strains were clustered with the Guangdong environmental strains but diverged from strains from other regions, suggesting that this subcluster of viruses most likely originated from the circulating virus in Guangdong rather than having been more recently imported from other regions. These findings underscore the importance of long-term, continuous environmental surveillance and genetic analysis to monitor circulating enteroviruses.	[Lu, Jing; Zheng, Huanying; Guo, Xue; Li, Hui; Liu, Leng; Zeng, Hanri; Fang, Ling; Mo, Yanling; Yi, Lina; Liu, Tao; Ke, Changwen] Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Yoshida, Hiromu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Lu, Jing; Yi, Lina; Liu, Tao] Guangdong Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Rutherford, Shannon] Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld 4111, Australia	Zheng, HY (reprint author), Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	zhenghy.gdcdc@gmail.com			Sasagawa Medical Awards; Ministry of Health, Labor and Welfare of Japan; Bill and Melinda Gates Foundation [OPP1039272]; Guangdong Nature Science Foundation [S2013040015304]	This project was funded by Sasagawa Medical Awards in Aid for the Japan-China Cooperation Project, a grant for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan, the Bill and Melinda Gates Foundation (OPP1039272), and the Guangdong Nature Science Foundation (S2013040015304).	Akiyoshi K, 2007, JPN J INFECT DIS, V60, P66; Cabrerizo M, 2008, J MED VIROL, V80, P1018, DOI 10.1002/jmv.21197; Zheng HY, 2013, APPL ENVIRON MICROB, V79, P7679, DOI 10.1128/AEM.02058-13; Zhang Y, 2013, BIOMED ENVIRON SCI, V26, P875, DOI 10.3967/bes2013.015; Milia MG, 2013, J CLIN VIROL, V58, P579, DOI 10.1016/j.jcv.2013.08.023; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Wang HY, 2014, APPL ENVIRON MICROB, V80, P4683, DOI 10.1128/AEM.00851-14; Wang HX, 2006, PEPTIDES, V27, P27, DOI 10.1016/j.peptides.2005.06.009; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Mistchenko AS, 2006, J CLIN VIROL, V37, P293, DOI 10.1016/j.jcv.2006.08.009; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Savolainen C, 2001, ARCH VIROL, V146, P521, DOI 10.1007/s007050170160; Faustini A, 2006, INT J INFECT DIS, V10, P291, DOI 10.1016/j.ijid.2005.06.008; Oberste MS, 1999, J VIROL, V73, P1941; Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; dos Santos GPL, 2011, J MED VIROL, V83, P2164, DOI 10.1002/jmv.22235; Dourmashkin RR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-136; Iwai M, 2006, APPL ENVIRON MICROB, V72, P6381, DOI 10.1128/AEM.02621-05; Knowles N. J., 2011, VIRUS TAXONOMY CLASS, P855; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Martinez AA, 2012, J INFECT DEV COUNTR, V6, P836, DOI 10.3855/jidc.2615; Mirand A, 2006, J MED VIROL, V78, P1624, DOI 10.1002/jmv.20747; Mladenova Z, 2014, EPIDEMIOL INFECT, V142, P2159, DOI 10.1017/S0950268813003221; Sedmak G, 2003, APPL ENVIRON MICROB, V69, P7181, DOI 10.1128/AEM.69.12.7181-7187.2003; Tao ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089766; WHO, 2003, GUID ENV SURV POL CI; World Health Organization, 2004, POL LAB MAN; Xiao H, 2014, ARCH VIROL, V159, P379, DOI 10.1007/s00705-013-1818-0; Xiao H, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-263; Yan Ju-ying, 2011, Chinese Journal of Virology, V27, P462; Yang XH, 2013, J MED VIROL, V85, P696, DOI 10.1002/jmv.23503; Zhao YN, 2005, EMERG INFECT DIS, V11, P562	32	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	7					2311	2319		10.1128/AEM.03200-14		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5AL	WOS:000351842000006		
J	Kobayashi, H				Kobayashi, Hideki			Inducible Suppression of Global Translation by Overuse of Rare Codons	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ALKALINE-PHOSPHATASE; TRANSFER-RNAS; PROTEIN; CELLS; OSCILLATOR; SYSTEM; USAGE	Recently, artificial gene networks have been developed in synthetic biology to control gene expression and make organisms as controllable as robots. Here, I present an artificial posttranslational gene-silencing system based on the codon usage bias and low tRNA content corresponding to minor codons. I engineered the green fluorescent protein (GFP) gene to inhibit translation indirectly with the lowest-usage codons to monopolize various minor tRNAs (lgfp). The expression of lgfp interfered nonspecifically with the growth of Escherichia coli, Saccharomyces cerevisiae, human HeLa cervical cancer cells, MCF7 breast cancer cells, and HEK293 kidney cells, as well as phage and adenovirus expansion. Furthermore, insertion of lgfp downstream of a phage response promoter conferred phage resistance on E. coli. Such engineered gene silencers could act as components of biological networks capable of functioning with suitable promoters in E. coli, S. cerevisiae, and human cells to control gene expression. The results presented here show general suppressor artificial genes for live cells and viruses. This robust system provides a gene expression or cell growth control device for artificially synthesized gene networks.	Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan	Kobayashi, H (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan.	hidekik@jamstec.go					Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; SIKORSKI RS, 1989, GENETICS, V122, P19; LISZIEWICZ J, 1993, P NATL ACAD SCI USA, V90, P8000, DOI 10.1073/pnas.90.17.8000; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Cardinale S, 2013, CELL REP, V4, P231, DOI 10.1016/j.celrep.2013.06.023; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; YAMAO F, 1991, NUCLEIC ACIDS RES, V19, P6119, DOI 10.1093/nar/19.22.6119; Gardner TS, 2000, NATURE, V403, P339; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Braun SE, 2012, HUM GENE THER, V23, P917, DOI 10.1089/hum.2011.184; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Birge EA, 2000, BACTERIAL BACTERIOPH; Bishop M., 2003, COMPUTER SECURITY AR; Bosworth S, 2002, COMPUTER SECURITY HD; Cameron DE, 2014, NAT BIOTECHNOL, V32, P1276, DOI 10.1038/nbt.3053; Cormack BP, 1997, CANDIDA ALBICANS, V143, P303, DOI DOI 10.1099/00221287-143-2-303; Csonka LN, 1996, ESCHERICHIA COLI SAL, P13; Csonka LNEW, 1996, ESCHERICHIA COLI SAL, P1210; Flint SJ, 2009, PRINCIPLES VIROLOGY, V2, P52; GURSKY YG, 1994, GENE, V148, P15, DOI 10.1016/0378-1119(94)90228-3; Hoxie JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007179; Lodish H., 2004, MOL CELL BIOL; Sambrook J., 1989, MOL CLONING LAB MANU; SHEN BHP, 1973, P NATL ACAD SCI USA, V70, P1481, DOI 10.1073/pnas.70.5.1481; WILSON IB, 1964, J BIOL CHEM, V239, P4182; Zahn K, 1996, J BACTERIOL, V178, P2926	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	7					2544	2553		10.1128/AEM.03708-14		10	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5AL	WOS:000351842000030		
J	Hayashi, T; Hosokawa, T; Meng, XY; Koga, R; Fukatsu, T				Hayashi, Toshinari; Hosokawa, Takahiro; Meng, Xian-Ying; Koga, Ryuichi; Fukatsu, Takema			Female-Specific Specialization of a Posterior End Region of the Midgut Symbiotic Organ in Plautia splendens and Allied Stinkbugs	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							REDUCTIVE GENOME EVOLUTION; BACTERIAL SYMBIONTS; VERTICAL TRANSMISSION; MEGACOPTA-PUNCTATISSIMA; HEMIPTERA-PENTATOMIDAE; HORIZONTAL TRANSFER; PLATASPID STINKBUG; GUT SYMBIONTS; INSECT; PEST	Many stinkbugs (Insecta: Hemiptera: Heteroptera) are associated with bacterial symbionts in a posterior region of the midgut. In these stinkbugs, adult females excrete symbiont-containing materials from the anus for transmission of the beneficial symbionts to their offspring. For ensuring the vertical symbiont transmission, a variety of female-specific elaborate traits at the cellular, morphological, developmental, and behavioral levels have been reported from diverse stinkbugs of the families Plataspidae, Urostylididae, Parastrachiidae, etc. Meanwhile, such elaborate female-specific traits for vertical symbiont transmission have been poorly characterized for the largest and economically important stinkbug family Pentatomidae. Here, we investigated the midgut symbiotic system of a pentatomid stinkbug, Plautia splendens. A specific gammaproteobacterial symbiont was consistently present extracellularly in the cavity of numerous crypts arranged in four rows on the midgut fourth section. The symbiont was smeared on the egg surface upon oviposition by adult females, orally acquired by newborn nymphs, and thereby transmitted vertically to the next generation and important for growth and survival of the host insects. We found that, specifically in adult females, several rows of crypts at the posterior end region of the symbiotic midgut were morphologically differentiated and conspicuously enlarged, often discharging the symbiotic bacteria from the crypt cavity to the main tract of the symbiotic midgut. The female-specific enlarged end crypts were also found in other pentatomid stinkbugs Plautia stali and Carbula crassiventris. These results suggest that the enlarged end crypts represent a female-specific specialized morphological trait for vertical symbiont transmission commonly found among stinkbugs of the family Pentatomidae.	[Hayashi, Toshinari; Hosokawa, Takahiro; Meng, Xian-Ying; Koga, Ryuichi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Hayashi, Toshinari; Fukatsu, Takema] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Hosokawa, Takahiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Fukatsu, Takema] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Fukatsu, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	t-fukatsu@aist.go.jp			JSPS KAKENHI grant [25221107]	This study was supported by JSPS KAKENHI grant 25221107 to T.F.	Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294x.2001.01189.x; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Weirauch C, 2011, ANNU REV ENTOMOL, V56, P487, DOI 10.1146/annurev-ento-120709-144833; Glasgow H, 1914, BIOL BULL-US, V26, P101, DOI 10.2307/1536004; Fukatsu T, 1999, MOL ECOL, V8, P1935, DOI 10.1046/j.1365-294x.1999.00795.x; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Koga R, 2012, P NATL ACAD SCI USA, V109, pE1230, DOI 10.1073/pnas.1119212109; Matsuura Y, 2014, APPL ENVIRON MICROB, V80, P3769, DOI 10.1128/AEM.00554-14; BIN F, 1993, PHYSIOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-3032.1993.tb00443.x; Fukatsu T, 1998, APPL ENVIRON MICROB, V64, P3599; Hosokawa T, 2005, FEMS MICROBIOL ECOL, V54, P471, DOI 10.1016/j.femsec.2005.06.002; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; Matsuura Y, 2012, APPL ENVIRON MICROB, V78, P4149, DOI 10.1128/AEM.00673-12; Hosokawa T, 2012, APPL ENVIRON MICROB, V78, P4758, DOI 10.1128/AEM.00867-12; Kaiwa N, 2014, CURR BIOL, V24, P2465, DOI 10.1016/j.cub.2014.08.065; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Kikuchi Y, 2012, APPL ENTOMOL ZOOL, V47, P1, DOI 10.1007/s13355-011-0081-7; Attardo GM, 2008, J INSECT PHYSIOL, V54, P1236, DOI 10.1016/j.jinsphys.2008.06.008; Prado SS, 2009, CURR MICROBIOL, V58, P64, DOI 10.1007/s00284-008-9267-9; Hosokawa T, 2007, P R SOC B, V274, P1979, DOI 10.1098/rspb.2007.0620; Tada A, 2011, APPL ENTOMOL ZOOL, V46, P483, DOI 10.1007/s13355-011-0066-6; ABE Y, 1995, JPN J APPL ENTOMOL Z, V39, P109; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Nikoh N, 2011, GENOME BIOL EVOL, V3, P702, DOI 10.1093/gbe/evr064; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Kondorosi E, 2013, ANNU REV MICROBIOL, V67, P611, DOI 10.1146/annurev-micro-092412-155630; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Prado SS, 2009, ENTOMOL EXP APPL, V132, P21, DOI 10.1111/j.1570-7458.2009.00863.x; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Bansal R, 2014, ENVIRON ENTOMOL, V43, P617, DOI 10.1603/EN13341; BISTOLAS KSI, 2014, FRONT MICROBIOL, V5, DOI DOI 10.3389/FMICB.2014; Bourtzis K., 2003, INSECT SYMBIOSIS; Buchner P., 1965, ENDOSYMBIOSIS OF ANI; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Hosokawa T, 2007, MOL ECOL, V16, P5316, DOI 10.1111/j.1365-294X.2007.03592.x; Hosokawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065081; Hosokawa Takahiro, 2015, Zoological Letters, V1, P5, DOI 10.1186/s40851-014-0009-5; Hosokawa T, 2012, ANIM BEHAV, V83, P293, DOI 10.1016/j.anbehav.2011.11.006; Kafil M, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.9901; Kaiwa N, 2011, ZOOL SCI, V28, P169, DOI 10.2108/zsj.28.169; Kikuchi Y, 2008, MICROBIAL ECOLOGY RE, P39; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Kobayashi H, 2011, MICROBIOL RES, V167, P48, DOI 10.1016/j.micres.2011.03.001; Kuskop M, 1924, ARCH PROTISTENKD, V47, P350; Moriyama M, 2012, APPL ENTOMOL ZOOL, V47, P233, DOI 10.1007/s13355-012-0112-z; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSENKRANZ W., 1939, ZEITSCHR MORPH U OKOL TIERS, V36, P279, DOI 10.1007/BF00403148; Salem H, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1838; Schorr H., 1957, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V45, P561, DOI 10.1007/BF00399596; Schuh RT, 1995, TRUE BUGS OF THE WOR; Taylor CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090312	61	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	7					2603	2611		10.1128/AEM.04057-14		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5AL	WOS:000351842000036		
J	Arii, S; Tsuji, K; Tomita, K; Hasegawa, M; Bober, B; Harada, KI				Arii, Suzue; Tsuji, Kiyomi; Tomita, Koji; Hasegawa, Masateru; Bober, Beata; Harada, Ken-Ichi			Cyanobacterial Blue Color Formation during Lysis under Natural Conditions	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							VOLATILE ORGANIC-COMPOUNDS; NOSTOC SP PCC-7120; PHYTOPLANKTON POPULATIONS; MICROCYSTIS-AERUGINOSA; ODOR COMPOUNDS; LAKE; MANAGEMENT; STABILITY; STRESS; BLOOMS	Cyanobacteria produce numerous volatile organic compounds (VOCs), such as beta-cyclocitral, geosmin, and 2-methylisoborneol, which show lytic activity against cyanobacteria. Among these compounds, only beta-cyclocitral causes a characteristic color change from green to blue blue color formation) in the culture broth during the lysis process. In August 2008 and September 2010, the lysis of cyanobacteria involving blue color formation was observed at Lake Tsukui in northern Kanagawa Prefecture, Japan. We collected lake water containing the cyanobacteria and investigated the VOCs, such as beta-cyclocitral, beta-ionone, 1-propanol, 3-methyl-1-butanol, and 2-phenylethanol, as well as the number of cyanobacterial cells and their damage and pH changes. As a result, the following results were confirmed: the detection of several VOCs, including beta-cyclocitral and its oxidation product, 2,2,6-trimethylcyclohexene-1-carboxylic acid; the identification of phycocyanin based on its visible spectrum; the lower pH 6.7 and 5.4) of the lysed samples; and characteristic morphological change in the damaged cyanobacterial cells. We also encountered the same phenomenon on 6 September 2013 in Lake Sagami in northern Kanagawa Prefecture and obtained almost the same results, such as blue color formation, decreasing pH, damaged cells, and detection of VOCs, including the oxidation products of beta-cyclocitral. beta-Cyclocitral derived from Microcystis has lytic activity against Microcystis itself but has stronger inhibitory activity against other cyanobacteria and algae, suggesting that the VOCs play an important role in the ecology of aquatic environments.	[Arii, Suzue; Hasegawa, Masateru; Bober, Beata; Harada, Ken-Ichi] Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi, Japan; [Arii, Suzue; Hasegawa, Masateru; Bober, Beata; Harada, Ken-Ichi] Meijo Univ, Fac Pharm, Nagoya, Aichi 468, Japan; [Tsuji, Kiyomi] Kanagawa Prefectural Inst Publ Hlth, Chigasaki, Kanagawa 2530087, Japan; [Tomita, Koji] Aichi Prefectural Inst Publ Hlth, Kita Ku, Nagoya, Aichi 462, Japan; [Bober, Beata] Jagiellonian Univ, Dept Plant Physiol & Dev, Krakow, Poland	Arii, S (reprint author), Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi, Japan.	takoma@kfx.biglobe.ne.jp					AMEMIYA Y, 1988, PROC INT ASSOC THEOR, V23, P1886; AMEMIYA Y, 1989, Japanese Journal of Phycology, V37, P253; Chang DW, 2011, J HAZARD MATER, V185, P1214, DOI 10.1016/j.jhazmat.2010.10.033; Ozaki K, 2009, J HEALTH SCI, V55, P578, DOI 10.1248/jhs.55.578; Tsuji K, 2006, CHEMOSPHERE, V65, P117, DOI 10.1016/j.chemosphere.2006.02.018; Dickinson JR, 1996, MICROBIOL-UK, V142, P1391; Jancula D, 2011, CHEMOSPHERE, V85, P1415, DOI 10.1016/j.chemosphere.2011.08.036; Sarada R, 1999, PROCESS BIOCHEM, V34, P795, DOI 10.1016/S0032-9592(98)00153-8; FALLON RD, 1979, APPL ENVIRON MICROB, V38, P499; Fujise D, 2010, J CHROMATOGR A, V1217, P6122, DOI 10.1016/j.chroma.2010.07.008; Harada KI, 2009, J CHEM ECOL, V35, P1295, DOI 10.1007/s10886-009-9706-5; Harada K-I, 2010, J RES I MEIJO U, V9, P83; Hasegawa M, 2012, MICROBES ENVIRON, V27, P525, DOI 10.1264/jsme2.ME12099; Hrudey S, 1999, TOXIC CYANOBACTERIA, P278; Huang JJ, 2002, ARCH MICROBIOL, V177, P486, DOI 10.1007/s00203-002-0419-1; Japan Water Works Association, 2011, STAND METH EX WAT; JONES GJ, 1995, WATER SCI TECHNOL, V31, P145, DOI 10.1016/0273-1223(95)00469-4; Juttner F, 2010, J CHEM ECOL, V36, P1387, DOI 10.1007/s10886-010-9877-0; JUTTNER F, 1984, APPL ENVIRON MICROB, V47, P814; JUTTNER F, 1986, J PHYCOL, V22, P169, DOI 10.1111/j.1529-8817.1986.tb04160.x; Marasco EK, 2006, J BIOL CHEM, V281, P31583, DOI 10.1074/jbc.M606299200; Nozawa Y, 2009, J CHROMATOGR A, V1216, P3807, DOI 10.1016/j.chroma.2009.02.037; Ozaki K, 2008, CHEMOSPHERE, V71, P1531, DOI 10.1016/j.chemosphere.2007.11.052; Pastorok RA, 1982, E823 NTIS USA ENG WA; Piehler MF, 2008, ADV EXP MED BIOL, V619, P259; Satchwill T, 2007, WATER SCI TECHNOL, V55, P95, DOI 10.2166/wst.2007.167; Scherzinger D, 2008, MOL MICROBIOL, V69, P231, DOI 10.1111/j.1365-2958.2008.06282.x; Sigee D.C., 2005, FRESHWATER MICROBIOL; Sigee DC, 1999, HYDROBIOLOGIA, V395, P161, DOI 10.1023/A:1017097502124; Simis SGH, 2012, LIMNOL OCEANOGR-METH, V10, P214, DOI 10.4319/lom.2012.10.214; Tucker A, 2005, APPL ENVIRON MICROB, V71, P629; Watson SB, 2003, PHYCOLOGIA, V42, P332, DOI 10.2216/i0031-8884-42-4-332.1; Wood SA, 2008, 1504 CAWTHR I, P1; Wu ZX, 2007, ENVIRON POLLUT, V147, P324, DOI 10.1016/j.envpol.2006.05.022	34	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	8					2667	2675		10.1128/AEM.03729-14		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5BE	WOS:000351843900003		
J	Oura, H; Tashiro, Y; Toyofuku, M; Ueda, K; Kiyokawa, T; Ito, S; Takahashi, Y; Lee, S; Nojiri, H; Nakajima-Kambe, T; Uchiyama, H; Futamata, H; Nomura, N				Oura, Hiromu; Tashiro, Yosuke; Toyofuku, Masanori; Ueda, Kousetsu; Kiyokawa, Tatsunori; Ito, Satoshi; Takahashi, Yurika; Lee, Seunguk; Nojiri, Hideaki; Nakajima-Kambe, Toshiaki; Uchiyama, Hiroo; Futamata, Hiroyuki; Nomura, Nobuhiko			Inhibition of Pseudomonas aeruginosa Swarming Motility by 1-Naphthol and Other Bicyclic Compounds Bearing Hydroxyl Groups	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; MEMBRANE-VESICLES; PLASMID PCAR1; EXPRESSION; BACTERIA; GENES; RESISTANCE; INDOLE; SIGNAL	Many bacteria convert bicyclic compounds, such as indole and naphthalene, to oxidized compounds, including hydroxyindoles and naphthols. Pseudomonas aeruginosa, a ubiquitous bacterium that inhabits diverse environments, shows pathogenicity against animals, plants, and other microorganisms, and increasing evidence has shown that several bicyclic compounds alter the virulence-related phenotypes of P. aeruginosa. Here, we revealed that hydroxyindoles (4- and 5- hydroxyindoles) and naphthalene derivatives bearing hydroxyl groups specifically inhibit swarming motility but have minor effects on other motilities, including swimming and twitching, in P. aeruginosa. Further analyses using 1-naphthol showed that this effect is also associated with clinically isolated hyperswarming P. aeruginosa cells. Swarming motility is associated with the dispersion of cells from biofilms, and the addition of 1-naphthol maintained biofilm biomass without cell dispersion. We showed that this 1-naphthol-dependent swarming inhibition is independent of changes of rhamnolipid production and the intracellular level of signaling molecule cyclic-di-GMP (c-di-GMP). Transcriptome analyses revealed that 1-naphthol increases gene expression associated with multidrug efflux and represses gene expression associated with aerotaxis and with pyochelin, flagellar, and pilus synthesis. In the present study, we showed that several bicyclic compounds bearing hydroxyl groups inhibit the swarming motility of P. aeruginosa, and these results provide new insight into the chemical structures that inhibit the specific phenotypes of P. aeruginosa.	[Oura, Hiromu; Toyofuku, Masanori; Ueda, Kousetsu; Kiyokawa, Tatsunori; Ito, Satoshi; Nakajima-Kambe, Toshiaki; Uchiyama, Hiroo; Nomura, Nobuhiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tashiro, Yosuke; Futamata, Hiroyuki] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Hamamatsu, Shizuoka 4328561, Japan; [Takahashi, Yurika; Lee, Seunguk; Nojiri, Hideaki] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan	Nomura, N (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	nomura.nobuhiko.ge@u.tsukuba.ac.jp		TAKAHASHI, Yurika/0000-0003-2862-4758	Ministry of Education, Culture, Sports, and Technology of Japan [25241020]; Japan Science and Technology Agency; CREST; ALCA	This study was supported in part through funding from Grant-in-aid for Scientific Research (25241020) to N.N. from the Ministry of Education, Culture, Sports, and Technology of Japan. This research was also funded through the Japan Science and Technology Agency, CREST, and ALCA.	Rui LY, 2005, APPL MICROBIOL BIOT, V66, P422, DOI 10.1007/s00253-004-1698-z; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Tashiro Y, 2012, ENVIRON MICROBIOL, V14, P1349, DOI 10.1111/j.1462-2920.2011.02632.x; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x; Garikipati SVBJ, 2009, APPL ENVIRON MICROB, V75, P6545, DOI 10.1128/AEM.00434-09; Samanta SK, 1999, APPL MICROBIOL BIOT, V53, P98; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Cugini C, 2007, MOL MICROBIOL, V65, P896, DOI 10.1111/j.1365-2958.2007.05840.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Tashiro Y, 2009, J BACTERIOL, V191, P7509, DOI 10.1128/JB.00722-09; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Inoue T, 2008, FEMS MICROBIOL LETT, V281, P81, DOI 10.1111/j.1574-6968.2008.01089.x; Lai S, 2009, ENVIRON MICROBIOL, V11, P126, DOI 10.1111/j.1462-2920.2008.01747.x; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; KOCH AK, 1991, J BACTERIOL, V173, P4212; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2395; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Tashiro Y, 2013, MICROBES ENVIRON, V28, P13, DOI 10.1264/jsme2.ME12167; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Tashiro Y, 2010, FEMS MICROBIOL LETT, V304, P123, DOI 10.1111/j.1574-6968.2010.01897.x; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Yawata Y, 2008, APPL ENVIRON MICROB, V74, P5429, DOI 10.1128/AEM.00801-08; Tashiro Y, 2008, J BACTERIOL, V190, P3969, DOI 10.1128/JB.02004-07; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Tashiro Y, 2014, BIOSCI BIOTECH BIOCH, V78, P178, DOI 10.1080/09168451.2014.877828; Toyofuku M, 2007, J BACTERIOL, V189, P4969, DOI 10.1128/JB.00289-07; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI [10.1039/b803796p, 10.1039/16803796p]; Bernier SP, 2011, RES MICROBIOL, V162, P680, DOI 10.1016/j.resmic.2011.04.014; Cao L, 2004, MOL MICROBIOL, V53, P1423, DOI 10.1111/j.1365-2958.2004.04210.x; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8; Ha DG, 2011, J BACTERIOL, V193, P6770, DOI 10.1128/JB.05929-11; Maseda H, 2004, ANTIMICROB AGENTS CH, V48, P1320, DOI 10.1128/AAC.48.4.1320-1328.2004; Miyakoshi M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-12; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Shintani M, 2010, ENVIRON MICROBIOL, V12, P1413, DOI 10.1111/j.1462-2920.2009.02110.x; Takahashi Y, 2015, ENVIRON MICROBIOL, V17, P134, DOI 10.1111/1462-2920.12515; Toyofuku M, 2014, ENVIRON MICROBIOL, V16, P2927, DOI 10.1111/1462-2920.12260; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587	53	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	8					2808	2818		10.1128/AEM.04220-14		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5BE	WOS:000351843900017		
J	Sano, D; Ohta, T; Nakamura, A; Nakagomi, T; Nakagomi, O; Okabe, S				Sano, Daisuke; Ohta, Takatomo; Nakamura, Arata; Nakagomi, Toyoko; Nakagomi, Osamu; Okabe, Satoshi			Culture-Independent Evaluation of Nonenveloped-Virus Infectivity Reduced by Free-Chlorine Disinfection	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							ENVIRONMENTAL WATER SAMPLES; REVERSE TRANSCRIPTION-PCR; HEPATITIS-A VIRUS; ENTERIC VIRUSES; HUMAN NOROVIRUS; MOUTH-DISEASE; WASTE-WATER; MURINE NOROVIRUS; NORWALK VIRUS; CELL-CULTURE	The inability of molecular detection methods to distinguish disinfected virions from infectious ones has hampered the assessment of infectivity for enteric viruses caused by disinfection practices. In the present study, the reduction of infectivity of murine norovirus S7-PP3 and mengovirus vMC0, surrogates of human noroviruses and enteroviruses, respectively, caused by free-chlorine treatment was characterized culture independently by detecting carbonyl groups on viral capsid protein. The amount of carbonyls on viral capsid protein was evaluated by the proportion of biotinylated virions trapped by avidin-immobilized gel (percent adsorbed). This culture-independent approach demonstrated that the percent adsorbed was significantly correlated with the logarithm of the infectious titer of tested viruses. Taken together with the results of previous reports, the result obtained in this study indicates that the amount of carbonyls on viral capsid protein of four important families of waterborne pathogenic viruses, Astroviridae, Reoviridae, Caliciviridae, and Picornaviridae, is increased in proportion to the received oxidative stress of free chlorine. There was also a significant correlation between the percent adsorbed and the logarithm of the ratio of genome copy number to PFU, which enables estimation of the infectious titer of a subject virus by measuring values of the total genome copy number and the percent adsorbed. The proposed method is applicable when the validation of a 4-log reduction of viruses, a requirement in U.S. EPA guidelines for virus removal from water, is needed along with clear evidence of the oxidation of virus particles with chlorine-based disinfectants.	[Sano, Daisuke; Ohta, Takatomo; Nakamura, Arata; Okabe, Satoshi] Hokkaido Univ, Fac Engn, Div Environm Engn, Sapporo, Hokkaido 060, Japan; [Nakagomi, Toyoko; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan	Sano, D (reprint author), Hokkaido Univ, Fac Engn, Div Environm Engn, North 13,West 8, Sapporo, Hokkaido 060, Japan.	dsano@eng.hokudai.ac.jp	Sano, Daisuke/E-5819-2011; Okabe, Satoshi/C-7014-2012	Sano, Daisuke/0000-0001-8075-6972; 	Japan Science and Technology Agency (JST) through Core Research for Evolutionary Science and Technology (CREST); Japan Society for the Promotion of Science [24246089]	This study was supported by the Japan Science and Technology Agency (JST) through Core Research for Evolutionary Science and Technology (CREST) and the Japan Society for the Promotion of Science through a Grant-in-Aid for Scientific Research (A) (24246089).	Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Rodriguez RA, 2009, APPL ENVIRON MICROB, V75, P297, DOI 10.1128/AEM.01150-08; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Lodder WJ, 2005, APPL ENVIRON MICROB, V71, P1453, DOI 10.1128/AEM.71.3.1453-1461.2005; Shin GA, 2003, APPL ENVIRON MICROB, V69, P3975, DOI 10.1128/AEM.69.7.3975-3978.2003; Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Hewitt J, 2007, APPL ENVIRON MICROB, V73, P7853, DOI 10.1128/AEM.00718-07; Kitajima M, 2010, LETT APPL MICROBIOL, V51, P119, DOI 10.1111/j.1472-765X.2010.02869.x; Li JW, 2002, APPL ENVIRON MICROB, V68, P4951, DOI 10.1128/AEM.68.10.4951-4955.2002; Hamza IA, 2011, INT J HYG ENVIR HEAL, V214, P424, DOI 10.1016/j.ijheh.2011.07.014; Nuanualsuwan S, 2002, J VIROL METHODS, V104, P217, DOI 10.1016/S0166-0934(02)00089-7; Kingsley DH, 2014, INT J FOOD MICROBIOL, V171, P94, DOI 10.1016/j.ijfoodmicro.2013.11.018; Pecson BM, 2009, APPL ENVIRON MICROB, V75, P5544, DOI 10.1128/AEM.00425-09; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Sinclair RG, 2012, APPL ENVIRON MICROB, V78, P1969, DOI 10.1128/AEM.06582-11; Kim K, 2011, WATER SCI TECHNOL, V63, P502, DOI 10.2166/wst.2011.249; Ueki Y, 2005, WATER RES, V39, P4271, DOI 10.1016/j.watres.2005.06.035; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05; Nieto-Juarez JI, 2010, ENVIRON SCI TECHNOL, V44, P3351, DOI 10.1021/es903739f; Hosoya M, 2007, J CLIN MICROBIOL, V45, P112, DOI 10.1128/JCM.00718-06; Kitajima M, 2010, J VIROL METHODS, V169, P269, DOI 10.1016/j.jviromet.2010.07.018; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Parshionikar S, 2010, APPL ENVIRON MICROB, V76, P4318, DOI 10.1128/AEM.02800-09; Li D, 2011, J VIROL METHODS, V177, P153, DOI 10.1016/j.jviromet.2011.07.013; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Bosch A, 2008, CURR OPIN BIOTECH, V19, P295, DOI 10.1016/j.copbio.2008.04.006; Aw TG, 2014, J VIROL METHODS, V210, P15, DOI 10.1016/j.jviromet.2014.09.017; Cliver DO, 2009, FOOD ENVIRON VIROL, V1, P123, DOI 10.1007/s12560-009-9020-y; Green K. Y., 2001, FIELDS VIROLOGY, P841; Hwang YC, 2007, APPL ENVIRON MICROB, V73, P2338, DOI 10.1128/AEM.01758-06; INGHIRAMI G, 1988, J VIROL, V62, P2453; Ji Z, 2014, FOOD ENVIRON VIROL, V6, P99, DOI 10.1007/s12560-014-9140-x; Le Guyader FS, 2006, J CLIN MICROBIOL, V44, P3878, DOI 10.1128/JCM.01327-06; Lewis GD, 1989, APPL ENVIRON MICROB, V54, P1980; McGuire KA, 2011, J VIROL, V85, P10806, DOI 10.1128/JVI.00675-11; Pecson BM, 2011, ENVIRON SCI TECHNOL, V45, P2257, DOI 10.1021/es103488e; Sano D, 2010, ENVIRON SCI TECHNOL, V44, P808, DOI 10.1021/es9018964; SHANNON MA, 2008, SCIENCE, V452, P301; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Simonet J, 2006, APPL ENVIRON MICROB, V72, P7671, DOI 10.1128/AEM.01106-06; Svraka S, 2009, J CLIN MICROBIOL, V47, P1674, DOI 10.1128/JCM.00307-09; Tojo K, 2013, WATER SCI TECHNOL, V67, P2236, DOI 10.2166/wst.2013.114; Tu Phan Van, 2007, Emerg Infect Dis, V13, P1733, DOI 10.3201/eid1311.070632; Vasickova P, 2005, VET MED-CZECH, V50, P89	49	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	8					2819	2826		10.1128/AEM.03802-14		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5BE	WOS:000351843900018		
J	Suzuki-Minakuchi, C; Hirotani, R; Shintani, M; Takeda, T; Takahashi, Y; Matsui, K; Vasileva, D; Yun, CS; Okada, K; Yamane, H; Nojiri, H				Suzuki-Minakuchi, Chiho; Hirotani, Ryusuke; Shintani, Masaki; Takeda, Toshiharu; Takahashi, Yurika; Matsui, Kazuhiro; Vasileva, Delyana; Yun, Choong-Soo; Okada, Kazunori; Yamane, Hisakazu; Nojiri, Hideaki			Effects of Three Different Nucleoid-Associated Proteins Encoded on IncP-7 Plasmid pCAR1 on Host Pseudomonas putida KT2440	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							MOBILE GENETIC ELEMENTS; GRAM-NEGATIVE BACTERIA; H-NS; FAMILY PROTEIN; TRANSPOSON TN4676; FLUORESCENS PF0-1; CLONING VECTORS; DNA; CARBAZOLE; SYSTEM	Nucleoid-associated proteins (NAPs), which fold bacterial DNA and influence gene transcription, are considered to be global transcriptional regulators of genes on both plasmids and the host chromosome. Incompatibility P-7 group plasmid pCAR1 carries genes encoding three NAPs: H-NS family protein Pmr, NdpA-like protein Pnd, and HU-like protein Phu. In this study, the effects of single or double disruption of pmr, pnd, and phu were assessed in host Pseudomonas putida KT2440. When pmr and pnd or pmr and phu were simultaneously disrupted, both the segregational stability and the structural stability of pCAR1 were markedly decreased, suggesting that Pmr, Pnd, and Phu act as plasmid-stabilizing factors in addition to their established roles in replication and partition systems. The transfer frequency of pCAR1 was significantly decreased in these double mutants. The segregational and structural instability of pCAR1 in the double mutants was recovered by complementation of pmr, whereas no recovery of transfer deficiency was observed. Comprehensive phenotype comparisons showed that the host metabolism of carbon compounds, which was reduced by pCAR1 carriage, was restored by disruption of the NAP gene(s). Transcriptome analyses of mutants indicated that transcription of genes for energy production, conversion, inorganic ion transport, and metabolism were commonly affected; however, how their products altered the phenotypes of mutants was not clear. The findings of this study indicated that Pmr, Pnd, and Phu act synergistically to affect pCAR1 replication, maintenance, and transfer, as well as to alter the host metabolic phenotype.	[Suzuki-Minakuchi, Chiho; Hirotani, Ryusuke; Shintani, Masaki; Takeda, Toshiharu; Takahashi, Yurika; Matsui, Kazuhiro; Vasileva, Delyana; Yun, Choong-Soo; Okada, Kazunori; Yamane, Hisakazu; Nojiri, Hideaki] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan; [Shintani, Masaki] RIKEN, BioResource Ctr, Japan Collect Microorganisms, Ibaraki, Japan; [Shintani, Masaki] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Hamamatsu, Shizuoka 4328561, Japan; [Takahashi, Yurika] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama, Japan; [Takahashi, Yurika] Toyama Prefectural Univ, Dept Biotechnol, Toyama, Japan; [Yun, Choong-Soo; Nojiri, Hideaki] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan	Nojiri, H (reprint author), Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan.	anojiri@mail.ecc.u-tokyo.ac.jp	Shintani, Masaki/A-3219-2012; 	TAKAHASHI, Yurika/0000-0003-2862-4758	Japan Society for the Promotion of Science; Program for Promotion of Basic Research Activities for Innovative Bio-sciences (PROBRAIN); JSPS KAKENHI [24380043]	C.S.-M. and Y.T. were supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists. The Program for Promotion of Basic Research Activities for Innovative Bio-sciences (PROBRAIN) and JSPS KAKENHI grant 24380043 (to H.N.) also supported this work.	Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dillon SC, 2010, MOL MICROBIOL, V76, P1250, DOI 10.1111/j.1365-2958.2010.07173.x; Swingle B, 2010, APPL ENVIRON MICROB, V76, P4960, DOI 10.1128/AEM.00911-10; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Tendeng C, 2003, MICROBIOL-SGM, V149, P3047, DOI 10.1099/mic.0.C0125-0; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Sukchawalit R, 1999, FEMS MICROBIOL LETT, V181, P217, DOI 10.1016/S0378-1097(99)00541-8; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Top EM, 2003, CURR OPIN BIOTECH, V14, P262, DOI 10.1016/S0958-1669(03)00066-1; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Dorman CJ, 2009, FEMS MICROBIOL REV, V33, P587, DOI 10.1111/j.1574-6976.2008.00155.x; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Nojiri H, 2013, CURR OPIN BIOTECH, V24, P423, DOI 10.1016/j.copbio.2012.09.014; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; CASTAING B, 1995, J BIOL CHEM, V270, P10291; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Dominguez-Cuevas P, 2004, THE PSEUDOMONAS, V2, P319; Forns N, 2005, J BACTERIOL, V187, P3950, DOI 10.1128/JB.187.3950-3959.2005; ITOH N, 1994, BIOSCI BIOTECH BIOCH, V58, P1306; Kouzuma A, 2007, FEMS MICROBIOL LETT, V275, P175, DOI 10.1111/j.1574-6968.2007.00882.x; Maeda K, 2003, J MOL BIOL, V326, P21, DOI 10.1016/S0022-2836(02)01400-6; Miyakoshi M, 2007, J BACTERIOL, V189, P6849, DOI 10.1128/JB.00684-07; Miyakoshi M, 2012, ENVIRON MICROBIOL, V14, P2946, DOI 10.1111/j.1462-2920.2012.02861.x; Nojiri H, 2012, BIOSCI BIOTECH BIOCH, V76, P1, DOI 10.1271/bbb.110620; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Shintani M, 2006, APPL ENVIRON MICROB, V72, P3206, DOI 10.1128/AEM.72.5.3206-3216.2006; Shintani M, 2005, APPL MICROBIOL BIOT, V67, P370, DOI 10.1007/s00253-004-1778-0; Shintani M, 2011, MICROBIOL-SGM, V157, P3405, DOI 10.1099/mic.0.053280-0; Shintani M, 2011, PLASMID, V66, P85, DOI 10.1016/j.plasmid.2011.06.001; Shintani M, 2005, BIOTECHNOL LETT, V27, P1847, DOI 10.1007/s10529-005-3892-1; Shintani M, 2010, ENVIRON MICROBIOL, V12, P1413, DOI 10.1111/j.1462-2920.2009.02110.x; Suzuki C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105656; Takahashi Y, 2015, ENVIRON MICROBIOL, V17, P134, DOI 10.1111/1462-2920.12515; Takahashi Y, 2009, APPL ENVIRON MICROB, V75, P3920, DOI 10.1128/AEM.02373-08; Takahashi Y, 2009, BIOSCI BIOTECH BIOCH, V73, P744, DOI 10.1271/bbb.80665; Takeda T., 2011, INT J EVOL BIOL, V2011, DOI DOI 10.4061/2011/685015; Valls M, 2004, THE PSEUDOMONAS, V2, P289; Yun CS, 2010, J BACTERIOL, V192, P4720, DOI 10.1128/JB.00591-10	45	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	APR	2015	81	8					2869	2880		10.1128/AEM.00023-15		12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE5BE	WOS:000351843900023		
J	Terahara, T; Xu, XD; Kobayashi, T; Imada, C				Terahara, Takeshi; Xu, Xudan; Kobayashi, Takeshi; Imada, Chiaki			Isolation and Characterization of Cr(VI)-Reducing Actinomycetes from Estuarine Sediments	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						Actinomycetes; Estuarine sediments; Hexavalent chromium; NaCl tolerance; Streptomyces	HEXAVALENT CHROMIUM; CHROMATE REDUCTASE; STREPTOMYCES; SOIL; DIVERSITY; BACTERIA; REMOVAL; BIOREMEDIATION; RESISTANCE; WASTE	Bioremediation technologies have strong potential use in the less costly and more environmentally friendly removal of highly toxic hexavalent-chromium (Cr(VI)) compared with physicochemical technologies. Several Cr(VI)-reducing bacteria have been isolated; however, there are few studies on Cr(VI)-resistant and Cr(VI)-reducing actinomycetes. In this study, Cr(VI)-reducing actinomycetes were screened from estuarine, marine, and terrestrial samples on the basis of Cr(VI)-resistant and Cr(VI)-reducing ability. Of the 80 Streptomyces-like strains isolated, 20 strains were found to be resistant to 50 mg/l of Cr(VI). In addition, two strains isolated from the estuarine sediment of Tokyo Bay were found to be resistant to a concentration of 150 mg/l of Cr(VI). Furthermore, one Cr(VI)-reducing strain was found to remove 60 mg/l of Cr(VI) within 1 week and was identified as Streptomyces thermocarboxydus based on 16S rRNA gene analysis. The comparative evaluation with the type strain S. thermocarboxydus NBRC 16323 showed that our isolated strain had higher ability to grow at 27 A degrees C and reduce Cr(VI) at a NaCl concentration of 6.0 % at 27 A degrees C compared with the type strain NBRC 16323. These results indicate that our isolated strain have a potential ability to remove Cr(VI) from contaminated, highly saline sources without heating.	[Terahara, Takeshi; Xu, Xudan; Kobayashi, Takeshi; Imada, Chiaki] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Terahara, T (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	terahara@kaiyodai.ac.jp	TERAHARA, Takeshi/O-1963-2014; KOBAYASHI, Takeshi/O-1953-2014		Faculty of Marine Science, Tokyo Universityof Marine Science and Technology; Cooperative Program of Atmosphere and Ocean Research Institute at the University of Tokyo	We thank the officers and crew members of the research and training vessel "Hiyodori" of Tokyo University of Marine Science and Technology and the members of the International Coastal Research Center, Atmosphere and Ocean Research Institute, University of Tokyo, for supporting sample collection for this study. This research was supported in part by the Grant-in-Aid from the Faculty of Marine Science, Tokyo Universityof Marine Science and Technology and by the Cooperative Program of Atmosphere and Ocean Research Institute at the University of Tokyo.	Alvarez AH, 1999, J BACTERIOL, V181, P7398; Amoroso MJ, 2001, J IND MICROBIOL BIOT, V26, P210, DOI 10.1038/sj.jim.7000112; Cheung KH, 2007, INT BIODETER BIODEGR, V59, P8, DOI 10.1016/j.ibiod.2006.05.002; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; Park CH, 2000, APPL ENVIRON MICROB, V66, P1788, DOI 10.1128/AEM.66.5.1788-1795.2000; Laxman RS, 2002, MINER ENG, V15, P831, DOI 10.1016/S0892-6875(02)00128-0; Pal A, 2005, CURR MICROBIOL, V51, P327, DOI 10.1007/s00284-005-0048-4; Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Kim SB, 1998, INT J SYST BACTERIOL, V48, P59; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; ODONNELL AG, 1993, ANTON LEEUW INT J G, V64, P325; JENSEN PR, 1991, APPL ENVIRON MICROB, V57, P1102; Polti MA, 2007, CHEMOSPHERE, V67, P660, DOI 10.1016/j.chemosphere.2006.11.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; A.P.H.A. A.W.W.A. W.P.C.F., 1981, STANDARD METHODS EXA; BALDI F, 1990, APPL ENVIRON MICROB, V56, P913; Barcina I, 1997, FEMS MICROBIOL ECOL, V23, P1, DOI 10.1111/j.1574-6941.1997.tb00385.x; Beleza VM, 2001, ENVIRON SCI TECHNOL, V35, P4379, DOI 10.1021/es0108786; DAS S, 1990, EXPERIENTIA, V46, P731, DOI 10.1007/BF01939949; Desjardin V, 2002, WASTE MANAGE, V22, P195, DOI 10.1016/S0956-053X(01)00069-1; Desjardin V., 2003, WATER AIR SOIL POLL, V3, P153, DOI 10.1023/A:1023965314747; EPA (Environmental Protection Agency), 1998, 18540299 EPA; Goodfellow M., 1984, BIOL BIOCH BIOMEDICA; Ho WSW, 2001, ENVIRON PROG, V20, P44, DOI 10.1002/ep.670200115; Hodges TW, 2012, MAR BIOTECHNOL, V14, P270, DOI 10.1007/s10126-011-9410-7; Imada C., 2010, ACTINOMYCETOLOGICA, V24, P12; Kwak YH, 2003, APPL ENVIRON MICROB, V69, P4390, DOI 10.1128/AEM.69.8.4390-4395.2003; Marsh TL, 2000, GEOMICROBIOL J, V17, P291, DOI 10.1080/01490450050193351; Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0; Polti MA, 2009, J BASIC MICROB, V49, P285, DOI 10.1002/jobm.200800239; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Shikazono N., 2009, J GEOGR, V118, P1205; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; TAKIZAWA M, 1993, APPL ENVIRON MICROB, V59, P997; Terahara T, 2013, WORLD J MICROB BIOT, V29, P1677, DOI 10.1007/s11274-013-1330-4; Zakir H M, 2008, American Journal of Environmental Sciences, V4	37	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	APR	2015	175	7					3297	3309		10.1007/s12010-015-1501-x		13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CE3YY	WOS:000351767200006		
J	Tanaka, T; Ito, S; Muramatsu, M; Yamada, T; Kamiko, H; Kakimoto, N; Inui, Y				Tanaka, T.; Ito, S.; Muramatsu, M.; Yamada, T.; Kamiko, H.; Kakimoto, N.; Inui, Y.			Accurate and versatile simulation of transient voltage profile of lithium-ion secondary battery employing internal equivalent electric circuit	APPLIED ENERGY			English	Article						Lithium-ion secondary battery; Transient voltage profile; Electromotive force; AC impedance	ENERGY MANAGEMENT; POWER-DENSITY; PERFORMANCE; VEHICLE; STATE; LIFEPO4; CHARGE	This paper presents a new numerical simulation method to calculate transient voltage profiles of lithium-ion secondary batteries. The method employs circuit analysis of an internal equivalent electric circuit composed of an electromotive force, an LR parallel circuit, and eight CR parallel circuits. To demonstrate the accuracy and versatility of this approach, the authors measured the transient voltage responses of three types of test batteries with different output power densities, and compared these experimental data with simulation results. Battery performance was tested using different charge/discharge current patterns and a range of values for state of charge (SOC) and operating temperature. The accuracy of the proposed simulation method was confirmed for all test cases using the three different batteries and charge/discharge current patterns, demonstrating that the method is versatile and applicable to various lithium-ion secondary batteries regardless of type. Since the employed internal equivalent electric circuit is composed of only DC voltage source and linear R, L and C elements, all of general purpose software for electric circuit simulations can easily deal with the circuit. This advantage and the obtained results indicate that the proposed simulation method is a useful technique and offers a powerful tool to develop sophisticated battery control systems for various applications. (C) 2015 Elsevier Ltd. All rights reserved.	[Tanaka, T.; Ito, S.; Muramatsu, M.; Yamada, T.; Kamiko, H.; Kakimoto, N.] Ibaraki Univ, Dept Elect & Elect Engn, Hitachi, Ibaraki 3168511, Japan; [Inui, Y.] Univ Shiga Prefecture, Dept Elect Syst Engn, Hikone 5228533, Japan	Tanaka, T (reprint author), Ibaraki Univ, Dept Elect & Elect Engn, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 3168511, Japan.	tadasi_t@mx.ibaraki.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [25420264]; TEPCO Memorial Federation in Japan	The authors would express their appreciation to the financial support by the Grant-in-Aid for Scientific Research (C) (No. 25420264) provided from The Ministry of Education, Culture, Sports, Science and Technology in Japan. Also, the authors feel grateful for the financial support of Research Grand (General Research) provided from TEPCO Memorial Federation in Japan.	Adams S, 2012, APPL ENERG, V90, P323, DOI 10.1016/j.apenergy.2011.04.053; Chen M, 2006, IEEE T ENERGY CONVER, V21, P504, DOI 10.1109/TEC.2006.874229; Sun FC, 2012, APPL ENERG, V96, P378, DOI 10.1016/j.apenergy.2012.02.061; Waag W, 2013, APPL ENERG, V102, P885, DOI 10.1016/j.apenergy.2012.09.030; Jossen A, 2006, J POWER SOURCES, V154, P530, DOI 10.1016/j.jpowsour.2005.10.041; Capasso C, 2014, APPL ENERG, V136, P921, DOI 10.1016/j.apenergy.2014.04.013; Kermani S, 2012, CONTROL ENG PRACT, V20, P408, DOI 10.1016/j.conengprac.2011.12.001; Jossen A, 2004, SOL ENERGY, V76, P759, DOI 10.1016/j.solener.2003.12.013; Ramadesigan V, 2012, J ELECTROCHEM SOC, V159, pR31, DOI 10.1149/2.018203jes; He HW, 2011, ENERGIES, V4, P582, DOI 10.3390/en4040582; Waag W, 2013, APPL ENERG, V111, P416, DOI 10.1016/j.apenergy.2013.05.001; FULLER TF, 1994, J ELECTROCHEM SOC, V141, P1, DOI 10.1149/1.2054684; Shabbir W, 2014, APPL ENERG, V135, P512, DOI 10.1016/j.apenergy.2014.08.083; Arora P, 2000, J POWER SOURCES, V88, P219, DOI 10.1016/S0378-7753(99)00527-3; Broussely M, 2004, J POWER SOURCES, V136, P386, DOI 10.1016/j.jpowsour.2004.03.031; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; Dokko K, 2007, J POWER SOURCES, V165, P656, DOI 10.1016/j.jpowsour.2006.10.027; Abu-Sharkh S, 2004, J POWER SOURCES, V130, P266, DOI 10.1016/j.jpowsour.2003.12.001; Horiba T, 2005, J POWER SOURCES, V146, P107, DOI 10.1016/j.jpowsour.2005.03.205; Khayyam H, 2013, APPL ENERG, V111, P971, DOI 10.1016/j.apenergy.2013.06.021; Lin B, 2008, J POWER SOURCES, V175, P564, DOI 10.1016/j.jpowsour.2007.09.055; Miranda AG, 2013, APPL ENERG, V111, P681, DOI 10.1016/j.apenergy.2013.05.047; Perez FM, 2010, ENERGY MANAGEMENT; Takeno K, 2005, J POWER SOURCES, V142, P298, DOI 10.1016/j.jpowsour.2004.10.007; Tanaka T., 2012, INT C EL ENG 2012 KA, VIS-1, P198; Veneri O, 2012, INT S POW EL EL DRIV; Wilson AM, 1999, J POWER SOURCES, V81, P642, DOI 10.1016/S0378-7753(99)00236-0	27	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	APR 1	2015	143						200	210		10.1016/j.apenergy.2015.01.028		11	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CE7UY	WOS:000352048500017		
J	Zhang, BJ; Liu, K; Luo, XL; Chen, QL; Li, WK				Zhang, B. J.; Liu, K.; Luo, X. L.; Chen, Q. L.; Li, W. K.			A multi-period mathematical model for simultaneous optimization of materials and energy on the refining site scale	APPLIED ENERGY			English	Article						Integration; Production planning; Mathematical programming; Total site	FLEXIBLE UTILITY SYSTEMS; PLANNING OPTIMIZATION; VARIABLE CONDITIONS; PROCESS INTEGRATION; STEAM-TURBINES; OIL REFINERY; PAPER-MILL; DESIGN; POWER; NETWORKS	A process system is designed for material transformations that produce certain functional chemicals while usually consuming large amounts of energy. Materials in process systems have long been the major focus of investigation to achieve better economic performance. Rising energy prices and stricter limitations on greenhouse gas emissions have also led to greater attention on energy savings. The configuration of process units in a total refining site has a great impact on both material and energy requirements. The simultaneous optimization of materials and energy is highly important for an enterprise. Hence, material and energy integration is proposed in this study for a total refining site to minimize costs. A mixed integer nonlinear programming model is developed that includes four parts: production planning for materials, energy requirements of process units on the basis of pinch analysis, operational planning for utility systems, and balance of utility streams in total sites. An industrial example is studied to demonstrate the performance of the proposed model and the advantages of simultaneous optimization of materials and energy. Significant economic benefits are demonstrated by the simultaneous optimization in this study. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhang, B. J.; Liu, K.; Chen, Q. L.] Sun Yat Sen Univ, Sch Chem & Chem Engn, Key Lab Low Carbon Chem & Energy Conservat Guangd, Guangzhou 510275, Guangdong, Peoples R China; [Luo, X. L.] Guang Dong Univ Technol, Guangzhou Higher Educ Mega Ctr, Sch Mat & Energy, Guangzhou 510006, Guangdong, Peoples R China; [Li, W. K.] Int Univ Japan, Grad Sch Int Management, Niigata 9497277, Japan	Zhang, BJ (reprint author), Sun Yat Sen Univ, Sch Chem & Chem Engn, Key Lab Low Carbon Chem & Energy Conservat Guangd, 135 Xingang West Rd, Guangzhou 510275, Guangdong, Peoples R China.	zhbingj@mail.sysu.edu.cn			National Natural Science Foundation of China [21376277]; Science and Technology Star of Zhujiang of Guangzhou City [2013J2200006]	This research is supported by the National Natural Science Foundation of China (No. 21376277), and the project of the Science and Technology Star of Zhujiang of Guangzhou City (No. 2013J2200006).	Aguilar O, 2007, CHEM ENG RES DES, V85, P1149, DOI 10.1205/cherd06063; Al-Shammari A, 2011, IND ENG CHEM RES, V50, P7065, DOI 10.1021/ie200313r; Anderson JO, 2014, APPL ENERG, V130, P757, DOI 10.1016/j.apenergy.2014.01.092; Shah NK, 2011, IND ENG CHEM RES, V50, P1161, DOI 10.1021/ie1010004; Marechal F, 2003, APPL THERM ENG, V23, P1763, DOI 10.1016/S1359-4311(03)00142-X; Zhang J, 2001, IND ENG CHEM RES, V40, P2640, DOI 10.1021/ie000367c; Varbanov PS, 2004, CHEM ENG RES DES, V82, P561, DOI 10.1205/026387604323142603; Alattas AM, 2011, IND ENG CHEM RES, V50, P6860, DOI 10.1021/ie200151e; Tawarmalani M, 2005, MATH PROGRAM, V103, P225, DOI 10.1007/s10107-005-0581-8; Klemes J, 1997, APPL THERM ENG, V17, P993, DOI 10.1016/S1359-4311(96)00087-7; Zhang BJ, 2007, J CLEAN PROD, V15, P439, DOI 10.1016/j.jclepro.2005.08.004; Klemes JJ, 2013, CURR OPIN CHEM ENG, V2, P461, DOI 10.1016/j.coche.2013.10.003; Liew PY, 2014, APPL ENERG, V135, P778, DOI 10.1016/j.apenergy.2014.03.090; Anderson JO, 2013, APPL ENERG, V111, P791, DOI 10.1016/j.apenergy.2013.05.066; Kim JH, 2001, IND ENG CHEM RES, V40, P1928, DOI 10.1021/ie000344y; Luo XL, 2013, APPL ENERG, V112, P1247, DOI 10.1016/j.apenergy.2012.12.039; Shang ZG, 2005, CHEM ENG SCI, V60, P4431, DOI 10.1016/j.ces.2005.03.015; Zhang BJ, 2013, IND ENG CHEM RES, V52, P14627, DOI 10.1021/ie401952h; Aguilar O, 2008, CHEM ENG SCI, V63, P3569, DOI 10.1016/j.ces.2008.04.010; Al-Mayyahi MA, 2013, APPL ENERG, V104, P783, DOI 10.1016/j.apenergy.2012.11.077; Pan M, 2013, CHEM ENG SCI, V104, P498, DOI 10.1016/j.ces.2013.09.049; Bandyopadhyay S, 2010, APPL THERM ENG, V30, P6, DOI 10.1016/j.applthermaleng.2009.03.007; Luo XL, 2011, ENERGY, V36, P3501, DOI 10.1016/j.energy.2011.03.056; Alattas AM, 2012, IND ENG CHEM RES, V51, P12852, DOI 10.1021/ie3002638; Aguilar O, 2007, CHEM ENG RES DES, V85, P1136, DOI 10.1205/cherd06062; Li WK, 2005, COMPUT CHEM ENG, V29, P2010, DOI 10.1016/j.compchemeng.2005.05.010; Mesfun S, 2013, APPL ENERG, V107, P98, DOI 10.1016/j.apenergy.2013.02.016; Micheletto SR, 2008, COMPUT CHEM ENG, V32, P170, DOI 10.1016/j.compchemeng.2007.05.013; Caballero JA, 2014, APPL ENERG, V124, P256, DOI 10.1016/j.apenergy.2014.03.018; Shang ZG, 2004, COMPUT CHEM ENG, V28, P1673, DOI 10.1016/j.compchemeng.2004.01.010; Vaskan P, 2012, APPL ENERG, V98, P149, DOI 10.1016/j.apenergy.2012.03.018; Mavromatis SP, 1998, CHEM ENG SCI, V53, P1405, DOI 10.1016/S0009-2509(97)00422-3; Pinto JM, 2000, COMPUT CHEM ENG, V24, P2259, DOI 10.1016/S0098-1354(00)00571-8; Mavromatis SP, 1998, CHEM ENG SCI, V53, P1585, DOI 10.1016/S0009-2509(97)00431-4; Agha MH, 2010, ENERGY, V35, P611, DOI 10.1016/j.energy.2009.10.032; Cheung KY, 2004, J CLEAN PROD, V12, P171, DOI 10.1016/S0959-6526(02)00193-2; Dhole V. R., 1992, COMPUT CHEM ENG, V17, pS101; Favennec JP, 2001, PETROLEUM REFINING, V5; Feng XO, 2011, APPL ENERG, V88, P1965, DOI 10.1016/j.apenergy.2010.12.027; Ji XY, 2012, APPL ENERG, V97, P30, DOI 10.1016/j.apenergy.2012.01.014; Kimura M, 2000, IND ENG CHEM RES, V39, P2315; Maravelias CT, 2009, COMPUT CHEM ENG, V33, P1919, DOI 10.1016/j.compchemeng.2009.06.007; Matsuda K, 2009, ENERGY, V34, P687; Medina-Flores JM, 2010, CHEM ENG SCI, V65, P2811, DOI 10.1016/j.ces.2010.01.016; Moita RD, 2005, COMPUT CHEM ENG, V29, P1491, DOI [10.1016/j.compchemeng.2005.02.015, 10.1016/j.compchemmeng.2005.02.015]; Rosenthal R.E., 2013, GAMS USERS GUIDE; Smith R, 2011, 14 C PROC INT MOD OP; Zhang BJ, 2012, IND ENG CHEM RES, V51, P14461, DOI 10.1021/ie301631c; Zhang Q, 2014, AICHE J, V60, P980	49	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	APR 1	2015	143						238	250		10.1016/j.apenergy.2015.01.044		13	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CE7UY	WOS:000352048500020		
J	Teramoto, H; Yukawa, H; Inui, M				Teramoto, Haruhiko; Yukawa, Hideaki; Inui, Masayuki			Copper homeostasis-related genes in three separate transcriptional units regulated by CsoR in Corynebacterium glutamicum	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Corynebacterium; Metal homeostasis; Metal-dependent gene expression; Transcriptional regulation	OXYGEN-DEPRIVATION CONDITIONS; EFFICIENT ISOBUTANOL PRODUCTION; ESCHERICHIA-COLI RCNR; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; REPRESSOR CSOR; CORYNEFORM BACTERIA; ENTEROCOCCUS-HIRAE; ACID PRODUCTION; METAL	In Corynebacterium glutamicum R, CsoR acts as a transcriptional repressor not only of the cognate copA-csoR operon but also of the copZ1-copB-cgR_0126 operon. It is predicted that copA and copB encode P-type ATPases for copper efflux and copZ1 encodes a metallochaperone. Here, a CsoR-binding motif was found upstream of another copZ-like gene, copZ2, and the in vitro binding of the CsoR protein to its promoter was confirmed. The monocistronic copZ2 transcript was upregulated by excess copper in a CsoR-dependent manner. Among the extended CsoR regulon, deletion of copA, but not of copB, copZ1, or copZ2, resulted in decreased resistance to copper, indicating a major role of the CopA copper exporter in the multilayered systems for copper homeostasis. A redundant role of copZ1 and copZ2 in copper resistance was also indicated by double deletion of these genes. The copper-dependent activation of the copA, copZ1, and copZ2 promoters was confirmed by lacZ reporter assays, consistent with the coordinated derepression of the three transcriptional units. The copZ1 promoter activity showed the highest responsiveness to copper and was also induced by excess zinc and nickel. Furthermore, zinc-inducible expression observed for the CsoR-regulated genes was independent of Zur, recently found to uniquely act as a transcriptional repressor of zinc efflux genes. These results implied complicated cross talk between homeostasis of multiple transition metals.	[Teramoto, Haruhiko; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth, Kyoto 6190292, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, 9-2 Kizugawadai, Kyoto 6190292, Japan.	inui@rite.or.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	We thank Crispinus A. Omumasaba (RITE) for critical reading of the manuscript. This work was financially supported in part by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; VERTES AA, 1993, RES MICROBIOL, V144, P181, DOI 10.1016/0923-2508(93)90043-2; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Badarau A, 2013, CHEM COMMUN, V49, P8000, DOI 10.1039/c3cc42709a; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Palumaa P, 2013, FEBS LETT, V587, P1902, DOI 10.1016/j.febslet.2013.05.019; Wieschalka S, 2013, MICROB BIOTECHNOL, V6, P87, DOI 10.1111/1751-7915.12013; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Okino S, 2008, APPL MICROBIOL BIOT, V78, P449, DOI 10.1007/s00253-007-1336-7; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Rademacher C, 2012, MICROBIOL-SGM, V158, P2451, DOI 10.1099/mic.0.058487-0; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Dainty SJ, 2010, J BIOL INORG CHEM, V15, P77, DOI 10.1007/s00775-009-0555-z; Brune I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-21; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; Cobine P, 1999, FEBS LETT, V445, P27, DOI 10.1016/S0014-5793(99)00091-5; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Gaballa A, 2003, BIOMETALS, V16, P497, DOI 10.1023/A:1023425321617; Higgins KA, 2013, BIOCHEMISTRY-US, V52, P84, DOI 10.1021/bi300886q; Ikeda M, 2012, CORYNEBACTERIUM GLUT, V23, P107; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Jojima T, 2012, CORYNEBACTERIUM GLUT, V23, P149; Kinoshita S, 1957, J GEN APPL MICROBIOL, V3, P193, DOI 10.2323/jgam.3.193; Miller J. H., 1972, EXPT MOL GENETICS; Nakata K, 2003, ACS SYM SER, V862, P175; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; Radford DS, 2003, FEMS MICROBIOL LETT, V220, P105, DOI 10.1016/S0378-1097(03)00095-8; Sambrook J., 1989, MOL CLONING; Schelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022143; Schroder J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-12; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Suzuki N, 2006, APPL ENVIRON MICROB, V72, P3750, DOI 10.1128/AEM.72.5.3750-3755.2006; Teramoto H, 2010, APPL ENVIRON MICROB, V76, P5488, DOI 10.1128/AEM.00906-10; Teramoto H, 2008, APPL ENVIRON MICROB, V74, P5290, DOI 10.1128/AEM.00832-08; Teramoto H, 2012, FEBS J, V279, P4385, DOI 10.1111/febs.12028; Teramoto H, 2012, BIOSCI BIOTECH BIOCH, V76, P1952, DOI 10.1271/bbb.120437; Wennerhold J, 2006, J BACTERIOL, V188, P2907, DOI 10.1128/JB.188.8.2907-2918.2006; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	54	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	APR	2015	99	8					3505	3517		10.1007/s00253-015-6373-z		13	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CE3QP	WOS:000351743600016		
J	Oyetibo, GO; Ishola, ST; Ikeda-Ohtsubo, W; Miyauchi, K; Ilori, MO; Endo, G				Oyetibo, Ganiyu Oladunjoye; Ishola, Shakirat Titilayo; Ikeda-Ohtsubo, Wakako; Miyauchi, Keisuke; Ilori, Matthew Olusoji; Endo, Ginro			Mercury bioremoval by Yarrowia strains isolated from sediments of mercury-polluted estuarine water	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Mercury-resistant yeast; Resting and growing cells; Mercury bioremoval; Biosorption; Biovolatilization	HEAVY-METALS; MINAMATA BAY; WASTE-WATER; BIOSORPTION; ADSORPTION; LIPOLYTICA; REMOVAL; CELLS; JAPAN; IONS	Difference in mercuric ion removal by resting and growing cells of two mercury-resistant yeast strains, identified as Yarrowia spp. (strains Idd1 and Idd2), were studied. Resting cells of strain Idd2 exhibited high maximum Hg2+ removal capacity (59 mg mercury per g dry cell weight [gdw(-1)]) by adsorption than those of resting cells of strain Idd1 (32 mg gdw(-1)). The resting cells of strain Idd2 exhibited a higher Hg2+ desorption capacity using CaCl2 (68 %) and EDTA (48 %) than strain Idd1, depicting weaker binding of Hg2+ onto strain Idd2 unlike strain Idd1. The actively growing yeast cells showed opposite Hg removal characteristics to those of the resting cells. Strain Idd1 adsorbed less Hg2+ from culture medium supplemented with Hg2+ than strain Idd2. However, the growing strain Idd1 reduced and vaporized 27 % of supplemented Hg2+ as metallic mercury (Hg-0), while the growing strains Idd2 vaporized 15 % of the supplemented Hg2+. These two yeast strains are potential biotechnological tools for the eventual bioremediation of polluted aquatic systems.	[Oyetibo, Ganiyu Oladunjoye; Ikeda-Ohtsubo, Wakako; Miyauchi, Keisuke; Endo, Ginro] Tohoku Gakuin Univ, Fac Engn, Dept Civil & Environm Engn, Tagajo, Miyagi 9858537, Japan; [Oyetibo, Ganiyu Oladunjoye; Ishola, Shakirat Titilayo; Ilori, Matthew Olusoji] Univ Lagos, Fac Sci, Dept Microbiol, Lagos, Nigeria	Endo, G (reprint author), Tohoku Gakuin Univ, Fac Engn, Dept Civil & Environm Engn, 1-13-1 Chuo, Tagajo, Miyagi 9858537, Japan.	goyetibo@unilag.edu.ng; ishola_titilayo@yahoo.com; wohtsubo@mail.tohoku-gakuin.ac.jp; kmiya@mail.tohoku-gakuin.ac.jp; milori@unilag.edu.ng; gendo@mail.tohoku-gakuin.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS [24-02373]	We thank Dr. Mei-Fang Chien and Toshiki Kurosawa for their useful discussion and assistance during the experiment. GOO and GE appreciate the Japan Society for the Promotion of Science (JSPS) for the awarding of Postdoctoral Research Fellowship FY2012-2013. This work was funded by Grants-in-Aid (No. 24-02373) for Scientific Research from the JSPS.	AMAP/UNEP, 2013, GLOB REL MERC AQ ENV, P263; von Canstein H, 1999, APPL ENVIRON MICROB, V65, P5279; Goyal N, 2003, ADV ENVIRON RES, V7, P311, DOI 10.1016/S1093-0191(02)00004-7; Francois F, 2012, APPL ENVIRON MICROB, V78, P1097, DOI 10.1128/AEM.06522-11; Strouhal M, 2003, BIOELECTROCHEMISTRY, V60, P29, DOI 10.1016/S1567-5394(03)00043-4; Velasquez L, 2009, J HAZARD MATER, V167, P713, DOI 10.1016/j.jhazmat.2009.01.044; Yavuz H, 2006, SEP PURIF TECHNOL, V52, P253, DOI 10.1016/j.seppur.2006.05.001; Hussein H, 2004, ELECTRON J BIOTECHN, V7, P38; Tchounwou PB, 2003, ENVIRON TOXICOL, V18, P149, DOI 10.1002/tox.10116; Puranik PR, 1999, BIOTECHNOL PROGR, V15, P228, DOI 10.1021/bp990002r; Tomiyasu T, 2008, MAR CHEM, V112, P102, DOI 10.1016/j.marchem.2008.07.003; Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1016/0168-6445(94)90046-9; Djeribi R, 2008, DESALINATION, V225, P95, DOI 10.1016/j.desal.2007.04.091; Guzzi G, 2008, TOXICOLOGY, V244, P1, DOI 10.1016/j.tox.2007.11.002; Tomiyasu T, 2006, SCI TOTAL ENVIRON, V368, P283, DOI 10.1016/j.scitotenv.2005.09.090; Bankar AV, 2009, J HAZARD MATER, V170, P487, DOI 10.1016/j.jhazmat.2009.04.070; von Canstein H, 2002, APPL ENVIRON MICROB, V68, P2829, DOI 10.1128/AEM.68.6.2829-2837.2002; Kim EH, 2004, MAR CHEM, V86, P121, DOI 10.1016/j.marchem.2003.12.004; Park EJ, 2007, TOXICOL IN VITRO, V21, P789, DOI 10.1016/j.tiv.2007.01.019; ATSDR, 2008, DIV TOX ENV MED SEPT; Diffels JF, 2006, BIOCHIMIE, V88, P1639, DOI 10.1016/j.biochi.2006.08.008; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; Huang CC, 1999, GENE, V234, P361, DOI 10.1016/S0378-1119(99)00184-5; NAKAMURA K, 1988, APPL ENVIRON MICROB, V54, P2871; Nimick DA, 2013, SCI TOTAL ENVIRON, V443, P40, DOI 10.1016/j.scitotenv.2012.10.080; Rao A, 2013, J CONTAM HYDROL, V146, P63, DOI 10.1016/j.jconhyd.2012.12.008	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	APR	2015	99	8					3651	3657		10.1007/s00253-014-6279-1		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CE3QP	WOS:000351743600028		
J	Kikuchi, N; Yoshida, S; Min, SK; Lee, K; Sakamaki-Sunaga, M; Okamoto, T; Nakazato, K				Kikuchi, Naoki; Yoshida, Shou; Min, Seok-ki; Lee, Kihyuk; Sakamaki-Sunaga, Mikako; Okamoto, Takanobu; Nakazato, Koichi			The ACTN3 R577X genotype is associated with muscle function in a Japanese population	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						alpha-actinin-3; polymorphism; aging; muscle strength; muscle function; test battery	SPINAL MUSCULAR-ATROPHY; ALPHA-ACTININ-3 DEFICIENCY; ATHLETIC PERFORMANCE; ALPHA-ACTININ; OLDER-ADULTS; FIBER TYPES; POLYMORPHISM; STRENGTH; POWER; GENES	Homozygosity for the common nonsense polymorphism R577X in the alpha-actinin-3 gene (ACTN3) causes complete alpha-actinin-3 deficiency in fast-twitch skeletal muscle fibers. This study investigated whether the ACTN3 R577X polymorphism affects fitness status using a battery of tests in a large Japanese cohort. In the present study, 1227 subjects (age: 25-85 years) were genotyped for the ACTN3 R577X polymorphism (rs1815739) using a TaqMan SNP genotyping assay (Applied Biosystems). All subjects were divided into 2 groups based on their age (<55 years and >= 55 years). All subjects completed a questionnaire about exercise habits and were subjected to a battery of tests to assess their fitness status (including grip strength test, chair stand test, and 8-foot walking test). A significant association between the ACTN3 R577X genotype and chair stand test performance was observed in the group of men >= 55 using ANCOVA adjusted for age and exercise habits (p = 0.036). The ACTN3 R577X genotype accounted for 2.5% of the variability in the results of the chair stand test among men in the >= 55 age group. Moreover, for the >= 55 age group, performance in the chair stand test was lower among those with the XX genotype than among those with the RR genotype (p = 0.024) or RX genotype (p = 0.005), unlike results for the <55 age group. No significant difference was noted for hand grip strength or 8-foot walking time. Thus, our results suggest that the ACTN3 R577X genotype is associated with lower-extremity muscle function in the Japanese population.	[Kikuchi, Naoki] Nippon Sport Sci Univ, Sports Training Ctr, Tokyo, Japan; [Yoshida, Shou; Sakamaki-Sunaga, Mikako; Okamoto, Takanobu; Nakazato, Koichi] Nippon Sport Sci Univ, Exercise Physiol Lab, Tokyo, Japan; [Min, Seok-ki] Korea Inst Sport Sci, Seoul, South Korea; [Lee, Kihyuk] Nippon Sport Sci Univ, Grad Sch Hlth & Sport Sci, Tokyo, Japan	Kikuchi, N (reprint author), Nippon Sport Sci Univ, Sports Training Ctr, Tokyo, Japan.	naoki.k@live.jp			Ministry of Education, Culture, Sports, Science and Technology [23500788]; KOZUKI Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (23500788 to K.N.) from the Ministry of Education, Culture, Sports, Science and Technology and by a grant from KOZUKI Foundation (to N.K.).	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Alfred T, 2011, HUM MUTAT, V32, P1008, DOI 10.1002/humu.21526; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Hurley BF, 2000, SPORTS MED, V30, P249, DOI 10.2165/00007256-200030040-00002; Takeshima N, 2007, MED SCI SPORT EXER, V39, P2036, DOI 10.1249/mss.0b013e31814844b7; Daley MJ, 2000, SPORTS MED, V29, P1, DOI 10.2165/00007256-200029010-00001; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Seto JT, 2013, J CLIN INVEST, V123, P4255, DOI 10.1172/JCI67691; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; REED T, 1991, ANN HUM BIOL, V18, P425, DOI 10.1080/03014469100001722; Gomez-Gallego F, 2009, INT J SPORTS MED, V30, P66, DOI 10.1055/s-2008-1038677; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Eynon N, 2013, SPORTS MED, V43, P803, DOI 10.1007/s40279-013-0059-4; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BENHAMIDA C, 1994, MUSCLE NERVE, V17, P400; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Chan S, 2011, MUSCLE NERVE, V43, P37, DOI 10.1002/mus.21778; Delmonico MJ, 2008, J GERONTOL A-BIOL, V63, P1227; Delmonico MJ, 2007, J GERONTOL A-BIOL, V62, P206; Garton FC, 2014, HUM MOL GENET, V23, P1879, DOI 10.1093/hmg/ddt580; Judson RN, 2011, J GERONTOL A-BIOL, V66, P130, DOI 10.1093/gerona/glq189; Kikuchi N, 2014, J STRENGTH COND RES, V28, P1783, DOI 10.1519/JSC.0000000000000338; Kikuchi N, 2013, INT J SPORT PHYSIOL, V8, P57; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; Mikami E, 2014, INT J SPORTS MED, V35, P172, DOI 10.1055/s-0033-1347171; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; North K, 2008, TWIN RES HUM GENET, V11, P384, DOI 10.1375/twin.11.4.384; Pimenta EM, 2012, EUR J APPL PHYSIOL, V112, P1495, DOI 10.1007/s00421-011-2109-7; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; Seto JT, 2011, EXP GERONTOL, V46, P292, DOI 10.1016/j.exger.2010.11.006; Walsh S, 2008, J APPL PHYSIOL, V105, P1486, DOI 10.1152/japplphysiol.90856.2008; Zempo H, 2010, INT J SPORTS MED, V31, P138, DOI 10.1055/s-0029-1242808	38	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	APR	2015	40	4								10.1139/apnm-2014-0346		7	Nutrition & Dietetics; Physiology; Sport Sciences	Nutrition & Dietetics; Physiology; Sport Sciences	CE6ME	WOS:000351949800002		
J	Takahashi, W				Takahashi, Wataru			The split common null point problem in Banach spaces	ARCHIV DER MATHEMATIK			English	Article						Split common null point problem; Maximal monotone operator; Resolvent; Fixed point; Metric projection; Hybrid method; Duality mapping	STRONG-CONVERGENCE THEOREMS; MAXIMAL MONOTONE-OPERATORS; FEASIBILITY PROBLEM; NONEXPANSIVE-MAPPINGS; HILBERT-SPACE	In this paper, we consider the split common null point problem in Banach spaces. Then using the metric resolvents of maximal monotone operators and the metric projections, we prove a strong convergence theorem for finding a solution of the split common null point problem in Banach spaces. The result of this paper seems to be the first one to study it outside Hilbert spaces.	[Takahashi, Wataru] Natl Sun Yat Sen Univ, Dept Appl Math, Kaohsiung 80424, Taiwan; [Takahashi, Wataru] Keio Univ, Keio Res & Educ Ctr Nat Sci, Kouhoku Ku, Yokohama, Kanagawa 2238521, Japan; [Takahashi, Wataru] Tokyo Inst Technol, Dept Math & Comp Sci, Meguro Ku, Tokyo 1528552, Japan	Takahashi, W (reprint author), Natl Sun Yat Sen Univ, Dept Appl Math, Kaohsiung 80424, Taiwan.	wataru@is.titech.ac.jp			Japan Society for the Promotion of Science [23540188]	The author was partially supported by Grant-in-Aid for Scientific Research No. 23540188 from Japan Society for the Promotion of Science.	Alsulami SM, 2014, J NONLINEAR CONVEX A, V15, P793; Xu HK, 2006, INVERSE PROBL, V22, P2021, DOI 10.1088/0266-5611/22/6/007; Byrne C, 2012, J NONLINEAR CONVEX A, V13, P759; Nakajo K, 2003, J MATH ANAL APPL, V279, P372, DOI 10.1016/S0022-247X(02)00458-4; Masad E, 2007, J NONLINEAR CONVEX A, V8, P367; Censor Y, 2009, J CONVEX ANAL, V16, P587; Ohsawa S, 2003, ARCH MATH, V81, P439, DOI 10.1007/s00013-003-0508-7; Solodov MV, 2000, MATH PROGRAM, V87, P189; Aoyama K, 2009, J NONLINEAR CONVEX A, V10, P131; BROWDER FE, 1968, MATH ANN, V175, P89, DOI 10.1007/BF01418765; Censor Y, 1994, NUMER ALGORITHMS, V8, P221, DOI DOI 10.1007/BF02142692; Cioranescu I., 1990, GEOMETRY BANACH SPAC; Kosaka F., 2008, ARCH MATH BASEL, V91, P166; Kosaka F., 2008, SIAM J OPTIMIZ, V19, P824; Moudafi A, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/5/055007; Reich S, 1992, B AM MATH SOC, V26, P367, DOI DOI 10.1090/S0273-0979-1992-00287-2; Takahashi W., 2000, NONLINEAR FUNCTIONAL; Takahashi W, J NONLINEAR IN PRESS; Takahashi W, 2000, CONVEX ANAL APPROXIM; Takahashi W., SET VALUED IN PRESS; Takahashi W, 2014, J NONLINEAR CONVEX A, V15, P1349; Takahashi W., 2009, INTRO NONLINEAR CONV	22	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0003-889X	1420-8938		ARCH MATH	Arch. Math.	APR	2015	104	4					357	365		10.1007/s00013-015-0738-5		9	Mathematics	Mathematics	CE4YU	WOS:000351837300008		
J	Hanai, Y; Sugita, N; Wang, Y; Yoshihara, A; Iwasaki, M; Miyazaki, H; Nakamura, K; Yoshie, H				Hanai, Y.; Sugita, N.; Wang, Y.; Yoshihara, A.; Iwasaki, M.; Miyazaki, H.; Nakamura, K.; Yoshie, H.			Relationships between IL-6 gene polymorphism, low BMD and periodontitis in postmenopausal women	ARCHIVES OF ORAL BIOLOGY			English	Article						IL-6; Polymorphism; Low BMD; Periodontitis	NECROSIS-FACTOR-ALPHA; BONE-MINERAL DENSITY; PROMOTER POLYMORPHISMS; VITAMIN-D; JAPANESE WOMEN; DEFICIENT MICE; INTERLEUKIN-6; DISEASE; ASSOCIATION; EXPRESSION	Objective: IL-6 plays critical roles in bone resorption and the pathogenesis of periodontitis in both inflammation and alveolar bone loss. A negative correlation was observed between periodontitis and truncal bone mineral density (BMD) in postmenopausal women. The C allele carriers of a genetic polymorphism IL-6-572G/C have higher levels of serum IL-6 compared to G allele carriers. We investigated the possible effect of IL-6-572G/C polymorphism on the relationship between low BMD and periodontitis in postmenopausal women. Subjects and methods: A total of 300 postmenopausal Japanese women who lived in Yokogoshi area of Niigata City, Japan, participated in this study. Genomic DNA was extracted from peripheral blood. The IL-6-572G/C genotypes were determined by the restriction fragment length polymorphism method. Bone mineral density (BMD) of right femoral neck and serum bone metabolism markers were measured. Low BMD was defined to have the BMD < 80% of the mean for young adults. Periodontal parameters at two sites per tooth were measured. Results: Serum osteocalcin levels were significantly lower in the IL-6-572G/G genotype (p = 0.025). In the -572G allele non-carriers, percentages of PPD >= 4 mm sites were significantly higher in low BMD group compared with the healthy control group (p = 0.021). Logistic regression analysis revealed low BMD to be associated with periodontitis (Odds ratio = 1.736, p = 0.027) after adjusted with IL-6-572G carriage, age, serum albumin level. Conclusions: IL-6-572G/C polymorphism was not an independent risk factor of low BMD or periodontitis, but may affect the relationship between the two diseases in postmenopausal Japanese women. (C) 2015 Published by Elsevier Ltd.	[Hanai, Y.; Sugita, N.; Wang, Y.; Yoshie, H.] Niigata Univ, Div Periodontol, Dept Oral Biol Sci, Grad Sch Med & Dent Sci, Niigata 9518514, Japan; [Yoshihara, A.] Niigata Univ, Dept Oral Hlth & Welf, Div Oral Sci Hlth Promot, Grad Sch Med & Dent Sci, Niigata 9518514, Japan; [Iwasaki, M.; Miyazaki, H.] Niigata Univ, Dept Oral Hlth Sci, Div Prevent Dent, Grad Sch Med & Dent Sci, Niigata 9518514, Japan; [Nakamura, K.] Niigata Univ, Div Prevent Med, Grad Sch Med & Dent Sci, Niigata 9518514, Japan	Sugita, N (reprint author), Niigata Univ, Div Periodontol, Dept Oral Biol Sci, Grad Sch Med & Dent Sci, Niigata 9518514, Japan.	psugita@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [24593121]	The work was supported by Grants in Aid for Scientific. Research (24593121) from Japan Society for the Promotion of Science (JSPS), Tokyo, Japan.	Yamada Y, 2003, J CLIN ENDOCR METAB, V88, P3372, DOI 10.1210/jc.2002-021449; Ferrari SL, 2003, J CLIN ENDOCR METAB, V88, P255, DOI 10.1210/jc.2002-020092; Costa AM, 2010, GERODONTOLOGY, V27, P70, DOI 10.1111/j.1741-2358.2009.00291.x; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; WactawskiWende J, 1996, J PERIODONTOL, V67, P1076; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Song GG, 2013, MOL BIOL REP, V40, P5191, DOI 10.1007/s11033-013-2621-4; YASUKAWA K, 1987, EMBO J, V6, P2939; BELLIDO T, 1995, J CLIN INVEST, V95, P2886, DOI 10.1172/JCI117995; Nakamura K, 2008, BONE, V42, P271, DOI 10.1016/j.bone.2007.09.056; POLI V, 1994, EMBO J, V13, P1189; Famili P, 2005, J PERIODONTOL, V76, P11, DOI 10.1902/jop.2005.76.1.11; Dongari-Bagtzoglou AI, 1998, J PERIODONTOL, V69, P899; ELDERS PJM, 1992, J CLIN PERIODONTOL, V19, P492, DOI 10.1111/j.1600-051X.1992.tb01162.x; Gomes-Filho IS, 2007, J CLIN PERIODONTOL, V34, P957, DOI 10.1111/j.1600-051X.2007.01141.x; HANSON DA, 1992, J BONE MINER RES, V7, P1251; Hirano T, 1998, Int Rev Immunol, V16, P249, DOI 10.3109/08830189809042997; Holla LI, 2004, J PERIODONTOL, V75, P30, DOI 10.1902/jop.2004.75.1.30; Komatsu Y, 2005, TISSUE ANTIGENS, V65, P110, DOI 10.1111/j.1399-0039.2004.00347.x; Manolagas SC, 1998, ANN NY ACAD SCI, V840, P194, DOI 10.1111/j.1749-6632.1998.tb09563.x; Moreira PR, 2007, CLIN EXP IMMUNOL, V148, P119, DOI 10.1111/j.1365-2249.2007.03327.x; Ohmori S, 2001, OCCUP ENVIRON MED, V45, P12; Payne JB, 2011, J DENT RES, V90, P747, DOI 10.1177/0022034511402993; RALSTON SH, 1994, J BONE MINER RES, V9, P883; Robitaille J, 2008, AM J PREV MED, V35, P47, DOI 10.1016/j.amepre.2008.03.027; Saxlin T, 2009, J CLIN PERIODONTOL, V36, P100, DOI 10.1111/j.1600-051X.2008.01350.x; SEHGAL PB, 1986, P NATL ACAD SCI USA, V83, P5219, DOI 10.1073/pnas.83.14.5219; Sugita N, 2012, J REPROD IMMUNOL, V93, P4; TAKAHASHI K, 1994, J PERIODONTOL, V65, P147; TAMM I, 1989, ANN NY ACAD SCI, V557, P478; Tanaka Yoshiya, 2014, Clin Calcium, V24, P911, DOI CliCa1406911917; Uenishi K, 2008, J NUTR SCI VITAMINOL, V54, P25, DOI 10.3177/jnsv.54.25; Wang Y, 2013, ORAL DIS, V19, P501, DOI 10.1111/odi.12032; Yoshihara A, 2014, J CLIN PERIODONTOL, V41, P460, DOI 10.1111/jcpe.12235	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	APR	2015	60	4					533	539		10.1016/j.archoralbio.2014.12.005		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE4GV	WOS:000351790000003		
J	Nakagawa, T; Ohta, K; Kubozono, K; Ishida, Y; Naruse, T; Takechi, M; Kamata, N				Nakagawa, Takayuki; Ohta, Kouji; Kubozono, Kazumi; Ishida, Yoko; Naruse, Takako; Takechi, Masaaki; Kamata, Nobuyuki			Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell cl and carbonic anhydrase 2	ARCHIVES OF ORAL BIOLOGY			English	Article						Bisphosphonate; Zoledronate; DNA microarray; RANKL; NFATc1; CAII	BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; BONE-RESORPTION; IN-VITRO; MEVALONATE PATHWAY; MECHANISM; RANKL; GERANYLGERANYLATION; REGULATOR; ACIDOSIS; NFATC1	Bisphosphonates (BPs) are widely used in the prevention of skeletal-related events (SRE), including osteoporosis, skeletal metastases of malignant tumours, and multiple myeloma. Osteonecrosis of the jaw (ONJ) is frequently reported as a major adverse effect induced by BP treatment. The receptor activator of the nuclear factor kappa-B ligand (RANKL) inhibitor, denosumab, has recently been used to prevent SRE, but the frequency of ONJ induced by denosumab is similar to that by BPs. This finding suggests that the inhibition of RANKL-mediated osteoclastogenesis may have a close relationship with the occurrence of ONJ. We therefore investigated the expression status of RANKL-inducible genes in zoledronate-treated mouse osteoclast precursor cells. The molecular targets of zoledronate in the RANKL signal pathway and additional factors associated with osteoclastogenesis were analysed by genome-wide screening. Microarray analysis identified that among 31 genes on 44 entities of RANKL-inducible genes, the mRNA expression level of two genes, i.e., nuclear factor of activated T-cells c1 (NFATc1) and carbonic anhydrase 2 (CAII), was decreased in zoledronate-treated cells. Subsequent analyses verified that these two genes were significantly silenced by zoledronate treatment and that their expression was restored following inhibition of zoledronate action by geranylgeraniol. Zoledronate inhibited RANKL-induced osteoclast differentiation by suppression of NFATc1 and CAII gene expression. Our results suggest that these genes might be common targets for zoledronate and denosumab in the mechanism underlying RANKL-induced osteoclast differentiation. A clear understanding of the common molecular mechanisms of bone-remodelling agents is thus essential for prevention of ONJ. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakagawa, Takayuki; Ohta, Kouji; Kubozono, Kazumi; Ishida, Yoko; Naruse, Takako; Takechi, Masaaki; Kamata, Nobuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci,Dept Oral & Maxillofacial Surg, Minami Ku, Hiroshima 7348553, Japan	Nakagawa, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci,Dept Oral & Maxillofacial Surg, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	tnakag@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [23792347, 25861940]	This work was supported by Grants-in-Aid for Scientific Research for Young Scientists (B) (numbers 23792347, 25861940) from the Japan Society for the Promotion of Science (JSPS), Japan. The authors would like to thank Enago (www.enago.jp) for the English language review.	Taylor KH, 2010, BRIT J ORAL MAX SURG, V48, P221, DOI 10.1016/j.bjoms.2009.08.030; Ebetino FH, 2011, BONE, V49, P20, DOI 10.1016/j.bone.2011.03.774; David JP, 2001, J CELL PHYSIOL, V188, P89, DOI 10.1002/jcp.1099; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Frith JC, 2001, ARTHRITIS RHEUM, V44, P2201, DOI 10.1002/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E; Aghaloo TL, 2010, J ORAL MAXIL SURG, V68, P959, DOI 10.1016/j.joms.2009.10.010; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Song I, 2009, FEBS LETT, V583, P2435, DOI 10.1016/j.febslet.2009.06.047; Fujisaki K, 2007, LIFE SCI, V80, P1311, DOI 10.1016/j.lfs.2006.12.037; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Lehenkari P, 1998, EXP CELL RES, V242, P128, DOI 10.1006/excr.1998.4071; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Durie BGM, 2005, NEW ENGL J MED, V353, P99; Migliorati CA, 2006, LANCET ONCOL, V7, P508, DOI 10.1016/S1470-2045(06)70726-4; Kwak HB, 2009, BIOL PHARM BULL, V32, P1193; Ruggiero SL, 2011, ANN NY ACAD SCI, V1218, P38, DOI 10.1111/j.1749-6632.2010.05768.x; Virtanen SS, 2002, CANCER RES, V62, P2708; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Epstein MS, 2012, ORAL SURG ORAL MED O, V116, pE437; Gong L, 2011, PHARMACOGENET GENOM, V21, P50, DOI 10.1097/FPC.0b013e328335729c; Itzstein C, 2011, SMALL GTPASES, V2, P117, DOI DOI 10.4161/SGTP.2.3.16453; Leung R, 2010, J BONE MINER RES, V25, P1077, DOI 10.1359/jbmr.091114; van Beek E, 1999, J BONE MINER RES, V14, P722, DOI 10.1359/jbmr.1999.14.5.722; Marcuzzi A, 2010, INT IMMUNOPHARMACOL, V10, P639, DOI 10.1016/j.intimp.2010.03.008; Marx RE, 2007, J ORAL MAXILLOFAC SU, V65, P397; Nakashima T, ANN N Y ACAD SCI; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	APR	2015	60	4					557	565		10.1016/j.archoralbio.2014.09.012		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE4GV	WOS:000351790000006		
J	Khunkar, SJ; Utaka, S; Hariri, I; Sadr, A; Ikeda, M; Nakashima, S; Nikaido, T; Tagami, J				Khunkar, Sahar J.; Utaka, Sachiko; Hariri, Ilnaz; Sadr, Alireza; Ikeda, Masaomi; Nakashima, Syozi; Nikaido, Toru; Tagami, Junji			Formation and characterization of hypermineralized zone beneath dentine lesion body induced by topical fluoride in-vitro	ARCHIVES OF ORAL BIOLOGY			English	Article						Dentine; Hypermineralization; Fluoride; Demineralization; Remineralization	MINERAL INDUCTION; CARIOUS LESIONS; REMINERALIZATION; MAGNESIUM; INVITRO; CARIES; VIVO; PROTEINS; MATRIX; SITU	Objective: This in-vitro study aimed to evaluate and characterize the hypermineralized zone (Hyper-zone) formed beneath the remineralized dentine lesion body by transverse microradiography (TMR), scanning electron microscopy (SEM) and energy dispersive X-ray analysis (EDS). Design: Demineralized bovine dentine specimens were treated with fluoride solutions (APP, NaF) and remineralized for 2-4 weeks. Then thin sections were prepared to characterize the Hyper-zone by TMR, EDS. Fractured specimen surfaces were observed by SEM. Results: TMR analysis revealed a higher mineral density at Hyper-zone than that of sound dentine (48 vol%) ranging from 50 up to 61 vol% and the thickness ranging from.197 to 344 mu m for 4-week specimens, while specimens without fluoride treatment did not show Hyper-zone. SEM pictures at Hyper-zone showed no evident crystal-like deposits in dentinal tubules and no notable difference when compared to that in sound dentine. EDS analysis demonstrated higher concentrations of Ca and P at Hyper-zone than those in sound dentine, which corresponded to the TMR profile, while the magnesium (Mg) concentration was low at this zone. Conclusions: Demineralized dentine lesions exposed to fluoride and remineralization treatments exhibited Hyper-zone beneath the lesion body, in which the mineral density was higher than that of sound dentine. Possible mechanism for the formation of Hyper-zone was discussed by assuming removal of mineral regulators such as Mg and other organic substances from sound dentine during de-/remineralization processes. (C) 2015 Elsevier Ltd. All rights reserved.	[Khunkar, Sahar J.; Utaka, Sachiko; Hariri, Ilnaz; Nakashima, Syozi; Nikaido, Toru; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Bunkyo Ku, Tokyo 1138549, Japan; [Sadr, Alireza] Tokyo Med & Dent Univ, Int Exchange Ctr, Bunkyo Ku, Tokyo 1138549, Japan; [Ikeda, Masaomi] Tokyo Med & Dent Univ, Clin Oral Sci, Dept Oral Hlth Care Sci, Bunkyo Ku, Tokyo 1138549, Japan	Nakashima, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cariol & Operat Dent, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	dr.sahar_40@hotmail.com; sachiko_utaka@yahoo.co.jp; ilnazhariri@gmail.com; arireza@gmail.com; ikeda.csoe@tmd.ac.jp; nakashima_japanjp@yahoo.co.jp; nikaido.ope@trnd.ac.jp; tagami.ope@tmd.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [25462949]; Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases at Tokyo Medical and Dental University	This study was supported partly by a Grant-in Aid from the JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 25462949 and partly by the Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases at Tokyo Medical and Dental University.	Altenburger MJ, 2009, EUR J ORAL SCI, V117, P458; Kawasaki K, 2000, CARIES RES, V34, P395, DOI 10.1159/000016614; Delbem ACB, 2002, AM J DENT, V15, P169; LUSSI A, 1988, ARCH ORAL BIOL, V33, P685, DOI 10.1016/0003-9969(88)90124-0; TOMAZIC B, 1975, ARCH ORAL BIOL, V20, P803, DOI 10.1016/0003-9969(75)90057-6; Saito T, 2003, CARIES RES, V37, P445, DOI 10.1159/000073398; Caiado ACRL, 2010, J PROSTHET DENT, V103, P352, DOI 10.1016/S0022-3913(10)60076-5; AOBA T, 1992, CALCIFIED TISSUE INT, V51, P143, DOI 10.1007/BF00298503; Arends J, 1997, DENT RES, V11, P403; Arnold WH, 2001, CALCIFIED TISSUE INT, V69, P268, DOI 10.1007/s002230020023; Arnold WH, 2007, ARCH ORAL BIOL, V52, P591, DOI 10.1016/j.archoralbio.2006.11.008; EANES ED, 1981, J DENT RES, V60, P1719, DOI 10.1177/00220345810600091401; Featherstone J D B, 2008, Aust Dent J, V53, P286, DOI 10.1111/j.1834-7819.2008.00064.x; Featherstone JD, 1994, FLUORIDE, V7, P271; Fujikawa H, 2008, CARIES RES, V42, P37, DOI 10.1159/000111748; Fure S, 2009, ORAL HLTH PREV DENT, V7, P147; Iijima Y, 2000, CARIES RES, V34, P388, DOI 10.1159/000016613; IIJIMA Y, 1993, CARIES RES, V27, P106; JENKINS J A, 1978, Biochemistry, V17, P5694; KLONT B, 1990, J DENT RES, V69, P896, DOI 10.1177/00220345900690031301; Larsen MJ, 2001, CARIES RES, V35, P457; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; Linde A, 1989, Connect Tissue Res, V21, P197, DOI 10.3109/03008208909050009; LUSSI A, 1993, CARIES RES, V27, P241; Nyvad B, 1997, J DENT RES, V76, P1845; Øgaard B, 1999, Compend Contin Educ Dent, V20, P10; Preston KP, 2008, ARCH ORAL BIOL, V53, P20; SAKAE T, 1988, J DENT RES, V67, P1229, DOI 10.1177/00220345880670091601; Schtipbach P, 1992, CARIES RES, V26, P153; TAKAGI Y, 1986, CONNECT TISSUE RES, V14, P279, DOI 10.3109/03008208609017471; TEFFT H., 1941, Journal of Dental Research, V20, P45, DOI 10.1177/00220345410200010501; Utaka S, 2013, DENT MATER J, V32, P241, DOI 10.4012/dmj.2012-275; Wefel J S, 1994, Am J Dent, V7, P261	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	APR	2015	60	4					574	581		10.1016/j.archoralbio.2015.01.001		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE4GV	WOS:000351790000008		
J	Katsumata-Kato, O; Yokoyama, M; Matsuki-Fukushima, M; Narita, T; Sugiya, H; Fujita-Yoshigaki, J				Katsumata-Kato, Osamu; Yokoyama, Megumi; Matsuki-Fukushima, Miwako; Narita, Takanori; Sugiya, Hiroshi; Fujita-Yoshigaki, Junko			Secretory proteins without a transport signal are retained in secretory granules during maturation in rat parotid acinar cells	ARCHIVES OF ORAL BIOLOGY			English	Article						Salivary gland; Parotid gland; Secretory granules; Secretory vesicles; Granule maturation; Endocytosis	INDUCED AMYLASE SECRETION; CYCLIC-AMP; AGGREGATION; BIOGENESIS; PH; CALCIUM; RAFTS	Objective: The acinar cells of the parotid gland are filled with numerous secretory granules (SGs), which accumulate the digestion enzyme amylase. SGs mature accompanied with membrane remodelling such as fusion and budding of small vesicles. However, little is understood about the mechanism of the condensation of SG contents during maturation. In this study, we examined whether secretory proteins need a specific signal to be retained in SGs. Design: To induce internalization of the luminal membrane after exocytosis, we injected the p.-adrenergic agonist isoproterenol into rats. Acinar cells were then incubated with Lucifer Yellow (LY) dye as a tracer for 3 h for uptake into immature secretory granules (ISGs). To observe whether LY was retained in SGs after maturation, we continued incubating the cultured acinar cells for 2 days. Results: The localization of LY into ISGs was confirmed by the following four methods: (1) colocalization of the fluorescence of LY and amylase by confocal laser microscopy, (2) detection of the fluorescence from purified ISGs, (3) secretion of the fluorescence together with amylase upon stimulation, and (4) observation of the intracellular localization of LY by electron microscopy. Moreover, we observed co-localization of some of the SGs with the fluorescence of LY after cell culture. Conclusions: Although the fusion and budding of small vesicles may contribute to the process of granule maturation, LY remained in the SGs even after maturation. These results suggest that secretory proteins that have no transport signal are not excluded from SGs, and they are retained in SGs during granule maturation in exocrine parotid glands. (C) 2015 Elsevier Ltd. All rights reserved.	[Katsumata-Kato, Osamu; Yokoyama, Megumi; Matsuki-Fukushima, Miwako; Fujita-Yoshigaki, Junko] Nihon Univ, Sch Dent Matsudo, Dept Physiol, Matsudo, Chiba 2718587, Japan; [Katsumata-Kato, Osamu; Yokoyama, Megumi; Matsuki-Fukushima, Miwako; Fujita-Yoshigaki, Junko] Nihon Univ, Sch Dent Matsudo, Res Inst Oral Sci, Matsudo, Chiba 2718587, Japan; [Narita, Takanori; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Vet Biochem Lab, Fujisawa, Kanagawa 2520880, Japan	Katsumata-Kato, O (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Physiol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	katsumata.osamu@nihon-u.ac.jp			JSPS [20791363, 22791803]; Nihon University Multidisciplinary Research Grant; Grant for Supporting Project for Strategic Research from MEXT [S0801032]; Nihon University School of Dentistry at Matsudo	This work was supported by a Grant-in-Aid for Young Scientists (B) of KAKENHI (20791363, 22791803) from JSPS; by a Nihon University Multidisciplinary Research Grant for 2008-2009; by a Grant for Supporting Project for Strategic Research (S0801032) from MEXT, 2008-2012; and by Grant-in-Aid for Young Researchers Scientists Nihon University School of Dentistry at Matsudo (2013, 2014, 2015).	Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Fujita-Yoshigaki J, 2006, BIOCHEM BIOPH RES CO, V344, P283, DOI 10.1016/j.bbrc.2006.03.130; LEBLOND FA, 1993, BIOCHEM J, V291, P289; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Shitara A, 2013, MOL CELL BIOCHEM, V380, P11, DOI 10.1007/s11010-013-1652-4; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; Bonnemaison Mathilde L, 2013, Front Endocrinol (Lausanne), V4, P101, DOI 10.3389/fendo.2013.00101; Dohke Y, 1998, ARCH BIOCHEM BIOPHYS, V357, P147, DOI 10.1006/abbi.1998.0793; Fujita-Yoshigaki J, 2005, CELL TISSUE RES, V320, P455, DOI 10.1007/s00441-005-1076-x; Fujita-Yoshigaki J, 2013, AM J PHYSIOL-GASTR L, V305, pG685, DOI 10.1152/ajpgi.00093.2013; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Katsumata O, 2007, BIOCHEM BIOPH RES CO, V357, P1071, DOI 10.1016/j.bbrc.2007.04.053; Rudolf R, 2001, MOL BIOL CELL, V12, P1353; Satoh K, 2010, J PHYSIOL SCI, V60, pS46; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Urbe S, 1998, J CELL BIOL, V143, P1831, DOI 10.1083/jcb.143.7.1831; Venkatesh SG, 2002, AM J PHYSIOL-CELL PH, V283, pC438, DOI 10.1152/ajpcell.00552.2001; Venkatesh SG, 2004, AM J PHYSIOL-CELL PH, V286, pC365, DOI 10.1152/ajpcell.00338.2003; von Zastrow M, 1987, J CELL BIOL 1, V105; Wouterlood PG, 1993, J NEUROSCI METH, V48, P75; Yoshimura K, 2002, PFLUG ARCH EUR J PHY, V444, P586, DOI 10.1007/s00424-002-0844-7; Yoshimura K, 1998, BBA-MOL CELL RES, V1402, P171, DOI 10.1016/S0167-4889(98)00007-X; YOSHIMURA K, 1991, JPN J PHYSIOL, V41, P443, DOI 10.2170/jjphysiol.41.443	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	APR	2015	60	4					642	649		10.1016/j.archoralbio.2015.01.006		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE4GV	WOS:000351790000016		
J	Sakuraba, K; Fujimura, K; Nakashima, Y; Okazaki, K; Fukushi, J; Ohishi, M; Oyamada, A; Esaki, Y; Miyahara, H; Iwamoto, Y; Yoshikai, Y; Yamada, H				Sakuraba, Koji; Fujimura, Kenjiro; Nakashima, Yasuharu; Okazaki, Ken; Fukushi, Jun-ichi; Ohishi, Masanobu; Oyamada, Akiko; Esaki, Yukio; Miyahara, Hisaaki; Iwamoto, Yukihide; Yoshikai, Yasunobu; Yamada, Hisakata			Successful In Vitro Culture of Rheumatoid Arthritis Synovial Tissue Explants at the Air-Liquid Interface	ARTHRITIS & RHEUMATOLOGY			English	Article							DISEASE-ACTIVITY; MICE; ENGRAFTMENT; VALIDATION; MOUSE; MODEL	Objective. To establish a method to culture synovial tissue explants from patients with rheumatoid arthritis (RA). Methods. Synovial tissue explants obtained from 10 patients with RA were cultured at the air-liquid interface or were submerged in culture medium. As a control, synovial explants were engrafted subcutaneously into SCID mice. The synovial explants were harvested at different time points, and histologic or flow cytometric analysis was performed. Cytokine levels in the culture supernatants were measured by enzyme-linked immunosorbent assay. Infliximab was added to the air-liquid interface culture to evaluate the effect of tumor necrosis factor blockade on inflammatory cytokine production. Results. The histologic features of RA synovitis, including a hyperplastic lining layer and the presence of cellular infiltrate in the sublining layer, were maintained in synovial tissue explants in air-liquid interface culture. In synovial grafts harvested from SCID-HuRAg mice, the cellular infiltrate was well maintained in the sublining, but the lining layer was lost. Viable CD4+ T cells and macrophages were abundant after air-liquid interface culture but were virtually absent after submerged culture. Furthermore, synovial tissue explants in air-liquid interface culture produced interleukin-6 (IL-6) and IL-8 for a prolonged period of time. The addition of infliximab effectively reduced cytokine production. Conclusion. RA synovial explants can be maintained for weeks using an air-liquid interface culture. This simple culture system might be useful for analyzing the pathogenesis of RA synovitis and for developing antirheumatic drugs.	[Sakuraba, Koji; Fujimura, Kenjiro; Nakashima, Yasuharu; Okazaki, Ken; Fukushi, Jun-ichi; Ohishi, Masanobu; Oyamada, Akiko; Iwamoto, Yukihide; Yoshikai, Yasunobu; Yamada, Hisakata] Kyushu Univ, Fukuoka 8128582, Japan; [Sakuraba, Koji; Fujimura, Kenjiro; Esaki, Yukio; Miyahara, Hisaaki] Natl Hosp Org, Kyushu Med Ctr, Fukuoka, Japan	Yamada, H (reprint author), Kyushu Univ, Med Inst Bioregulat, Div Host Def, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hisakata@bioreg.kyushu-u.ac.jp			Japan Society for the Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science, and Technology, Japan	Supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by Grants for Excellent Graduate Schools from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, Japan.	PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Davis LS, 2002, AM J PATHOL, V160, P357, DOI 10.1016/S0002-9440(10)64379-9; BRENNAN FM, 1989, LANCET, V2, P244; Mestas J, 2004, J IMMUNOL, V172, P2731; Thurlings RM, 2008, ARTHRITIS RHEUM, V58, P1582, DOI 10.1002/art.23505; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Fraser A, 2001, ARTHRITIS RHEUM, V44, P2024, DOI 10.1002/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ashton-Rickardt Philip G, 2007, Methods Mol Biol, V380, P171; GEILER T, 1994, ARTHRITIS RHEUM, V37, P1664, DOI 10.1002/art.1780371116; Hitchon Carol A, 2011, Open Rheumatol J, V5, P107, DOI 10.2174/1874312901105010107; Kaibara N, 2008, HISTOPATHOLOGY, V52, P856, DOI 10.1111/j.1365-2559.2008.03050.x; Matsuno H, 2001, MOD RHEUMATOL, V11, P6; McEvoy AN, 2004, ARTHRITIS RHEUM, V50, P1132, DOI 10.1002/art.20157; RENDT KE, 1993, J IMMUNOL, V151, P7324; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; Scire CA, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2302	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	APR	2015	67	4					887	892		10.1002/art.39019		6	Rheumatology	Rheumatology	CE5AJ	WOS:000351841800007		
J	Nishimura, K; Saegusa, J; Matsuki, F; Akashi, K; Kageyama, G; Morinobu, A				Nishimura, Keisuke; Saegusa, Jun; Matsuki, Fumichika; Akashi, Kengo; Kageyama, Goichi; Morinobu, Akio			Tofacitinib Facilitates the Expansion of Myeloid-Derived Suppressor Cells and Ameliorates Arthritis in SKG Mice	ARTHRITIS & RHEUMATOLOGY			English	Article							TUMOR-BEARING MICE; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; IMMUNE-RESPONSE; DENDRITIC CELLS; CANCER-PATIENTS; PROGRESSION; INHIBITION; DIFFERENTIATION; INFLAMMATION	Objective. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells that have the ability to suppress T cell responses. The aim of this study was to evaluate the effects of the JAK inhibitor tofacitinib on MDSCs in a mouse model of rheumatoid arthritis. Methods. Arthritis was induced in SKG mice by zymosan A (ZyA) injection. MDSCs isolated from the bone marrow (BM) of donor SKG mice with arthritis were adoptively transferred to recipient mice with arthritis. In a separate experiment, tofacitinib was administered to arthritic SKG mice subcutaneously via osmotic pump, in some cases followed by injection of an anti-Gr-1 monoclonal antibody (mAb). BM cells from untreated mice were cultured for 5 days with granulocyte-macrophage colony-stimulating factor, with or without tofacitinib, and then analyzed by flow cytometry. Results. The numbers of MDSCs and polymorphonuclear MDSCs (PMN-MDSCs) were significantly increased in the spleens of SKG mice following ZyA injection. Adoptive transfer of MDSCs to recipient arthritic mice reduced the severity of arthritis compared to that in untreated control mice. Treatment with tofacitinib also ameliorated the progression of arthritis in SKG mice and induced significantly higher numbers of MDSCs and PMN-MDSCs in the BM of these animals. Furthermore, administration of an anti-Gr-1 mAb reduced the antiarthritic effect of tofacitinib in SKG mice. In vitro, tofacitinib facilitated the differentiation of BM cells to MDSCs, and inhibited their differentiation to dendritic cells. Conclusion. Tofacitinib facilitates the expansion of MDSCs and ameliorates arthritis in SKG mice.	[Nishimura, Keisuke; Saegusa, Jun; Matsuki, Fumichika; Akashi, Kengo; Kageyama, Goichi; Morinobu, Akio] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Morinobu, A (reprint author), Kobe Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	morinobu@med.kobe-u.ac.jp			Japan Society for Promotion of Science. [24659473]	Supported in part by Grant-in-Aid for Scientific Research 24659473 from the Japan Society for Promotion of Science.	Almand B, 2001, J IMMUNOL, V166, P678; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; Charles JF, 2012, J CLIN INVEST, V122, P4592, DOI 10.1172/JCI60920; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Yan DH, 2013, EUR J IMMUNOL, V43, P2943, DOI 10.1002/eji.201343472; Kusmartsev S, 2004, J IMMUNOL, V172, P989; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Sinha P, 2007, J IMMUNOL, V179, P977; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Kusmartsev S, 2003, J LEUKOCYTE BIOL, V74, P186, DOI 10.1189/jlb.0103010; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Youn JI, 2008, J IMMUNOL, V181, P5791; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20051758; Bronte V, 2003, J IMMUNOL, V170, P270; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; Jiao Z, 2013, SCAND J RHEUMATOL, V42, P85, DOI 10.3109/03009742.2012.716450; Egelston C, 2012, ARTHRITIS RHEUM-US, V64, P3179, DOI 10.1002/art.34494; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1016/jem.20062602; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Grossman WJ, 1999, BLOOD, V94, P932; Kubo S, 2014, ANN RHEUM DIS, V73, P2192, DOI 10.1136/annrheumdis-2013-203756; Li ZY, 2012, INT J CANCER, V131, P2584, DOI 10.1002/ijc.27572; Lutzky V, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2200; Misaki K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3339; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Oh Keunhee, 2013, Immune Netw, V13, P257, DOI 10.4110/in.2013.13.6.257; vansVollenhoven RF, 2012, NEW ENGL J MED, V367, P508; Zhang L, 2014, INFLAMMATION, V37, P670, DOI 10.1007/s10753-013-9783-z	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	APR	2015	67	4					893	902		10.1002/art.39007		10	Rheumatology	Rheumatology	CE5AJ	WOS:000351841800008		
J	Hamaguchi, Y; Kodera, M; Matsushita, T; Hasegawa, M; Inaba, Y; Usuda, T; Kuwana, M; Takehara, K; Fujimoto, M				Hamaguchi, Yasuhito; Kodera, Masanari; Matsushita, Takashi; Hasegawa, Minoru; Inaba, Yuki; Usuda, Toshikazu; Kuwana, Masataka; Takehara, Kazuhiko; Fujimoto, Manabu			Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti-RNA Polymerase III Autoantibodies	ARTHRITIS & RHEUMATOLOGY			English	Article							LINKED-IMMUNOSORBENT-ASSAY; SKIN THICKNESS SCORE; ANTINUCLEAR ANTIBODY; ASSOCIATIONS; SUBSETS; CLASSIFICATION; INVOLVEMENT; SERA	Objective. To identify predictive factors for scleroderma renal crisis (SRC) in patients with anti-RNA polymerase III (anti-RNAP III) antibodies. Methods. A total of 583 adult Japanese patients with systemic sclerosis (SSc) were screened for anti-RNAP III using a commercially available enzyme-linked immunosorbent assay (ELISA) kit. RNAP subsets were further identified by immunoprecipitation (IP) assays. The association of clinical and immunologic factors with SRC was examined by logistic analyses. Results. In this cohort, 37 patients (6%) were positive for anti-RNAP III, as determined by anti-RNAP III-specific ELISA. Further IP assays revealed that 19 patients were positive for anti-RNAP I/III, 17 for anti-RNAP I/II/III, and 1 for anti-RNAP III. SRC occurred in a total of 17 (2.9%) of 583 patients, with a significantly higher frequency in anti-RNAP III-positive SSc patients (9 of 37 [24%]) than those without anti-RNAP III (8 of 546 [1%]) (odds ratio [OR] 21.6 [95% confidence interval (95% CI) 7.8-60.3], P < 0.00001). Our multivariate analyses using the Cox proportional hazards regression model revealed that anti-RNAP I/II/III positivity (OR 11.0 [95% CI 1.6-222.8], P = 0.0118) and an ELISA index for anti-RNAP III of >= 157 (OR 2.4 x 10(9) [95% CI 2.1-uncalculated], P = 0.0093) were independent factors associated with the development of SRC. Conclusion. Our findings indicate that anti-RNAP III is associated with SRC, as reported previously. In addition, the presence of anti-RNAP II in combination with anti-RNAP I/III (anti-RNAP I/II/III) and a higher ELISA index for anti-RNAP III may be associated with the development of SRC in SSc patients with anti-RNAP III.	[Hamaguchi, Yasuhito; Matsushita, Takashi; Hasegawa, Minoru; Takehara, Kazuhiko; Fujimoto, Manabu] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Kodera, Masanari; Inaba, Yuki; Usuda, Toshikazu] Social Insurance Chukyo Hosp, Nagoya, Aichi, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Tokyo, Japan; [Fujimoto, Manabu] Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan	Fujimoto, M (reprint author), Univ Tsukuba, Dept Dermatol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	mfujimoto@md.tsukuba.ac.jp	Matsushita, Takashi /C-4750-2015	Matsushita, Takashi /0000-0002-1617-086X	Ministry of Health, Labor, and Welfare of Japan	Supported by a Research on Intractable Diseases grant from the Ministry of Health, Labor, and Welfare of Japan to Dr. Fujimoto.	LeRoy EC, 2001, J RHEUMATOL, V28, P1573; LEROY EC, 1988, J RHEUMATOL, V15, P202; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; OKANO Y, 1993, ANN INTERN MED, V119, P1005; Hamaguchi Y, 2011, ARCH DERMATOL, V147, P391, DOI 10.1001/archdermatol.2011.52; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Kuwana M, 2005, ARTHRITIS RHEUM, V52, P2425, DOI 10.1002/art.21232; Nguyen B, 2011, ARTHRITIS RHEUM-US, V63, P530, DOI 10.1002/art.30111; Clements PJ, 2000, ARTHRITIS RHEUM, V43, P2445, DOI 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q; STEEN VD, 1984, AM J MED, V76, P779, DOI 10.1016/0002-9343(84)90986-0; KUWANA M, 1994, ARTHRITIS RHEUM, V37, P75, DOI 10.1002/art.1780370111; Steen VD, 1998, ARTHRITIS RHEUM, V41, P1613, DOI 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O; TAN EM, 1989, ADV IMMUNOL, V44, P93; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Harvey GR, 1999, CLIN EXP IMMUNOL, V117, P395; Steen VD, 2003, RHEUM DIS CLIN N AM, V29, P315, DOI 10.1016/S0889-857X(03)00016-4; Fertig N, 2009, ARTHRIT RHEUM-ARTHR, V61, P958, DOI 10.1002/art.24586; SATOH M, 1994, J CLIN INVEST, V94, P1981, DOI 10.1172/JCI117550; HELFRICH DJ, 1989, ARTHRITIS RHEUM, V32, P1128, DOI 10.1002/anr.1780320911; Steen VD, 2000, ANN INTERN MED, V133, P600; Meyer OC, 2007, J RHEUMATOL, V34, P104; Nihtyanova SI, 2009, RHEUMATOLOGY, V48, P1218, DOI 10.1093/rheumatology/kep215; KUWANA M, 1993, J CLIN INVEST, V91, P1399, DOI 10.1172/JCI116343; Denton CP, 2008, RHEUMATOLOGY S5, V47, P54; Harvey GR, 1996, CLIN EXP IMMUNOL, V105, P468, DOI 10.1046/j.1365-2249.1996.d01-798.x; Kaji K, 2014, ARTHRIT CARE RES, V66, P575, DOI 10.1002/acr.22163; Koschik RW II, 2012, CLIN EXP RHEUMATOL, V30, P12; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; Okano Y, 1996, RHEUM DIS CLIN N AM, V22, P709, DOI 10.1016/S0889-857X(05)70297-0; Perera A, 2007, ARTHRITIS RHEUM, V56, P2740, DOI 10.1002/art.22747; Satoh T, 2009, RHEUMATOLOGY, V48, P1570, DOI 10.1093/rheumatology/kep290; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Teixeira L, 2007, ANN NY ACAD SCI, V1108, P249, DOI 10.1196/annals.1422.027	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	APR	2015	67	4					1045	1052		10.1002/art.38994		8	Rheumatology	Rheumatology	CE5AJ	WOS:000351841800023		
J	Nakamura, H; Takahashi, Y; Yamamoto-Fukuda, T; Horai, Y; Nakashima, Y; Arima, K; Nakamura, T; Koji, T; Kawakami, A				Nakamura, Hideki; Takahashi, Yoshiko; Yamamoto-Fukuda, Tomomi; Horai, Yoshiro; Nakashima, Yoshikazu; Arima, Kazuhiko; Nakamura, Tatsufumi; Koji, Takehiko; Kawakami, Atsushi			Direct Infection of Primary Salivary Gland Epithelial Cells by Human T Lymphotropic Virus Type I in Patients With Sjogren's Syndrome	ARTHRITIS & RHEUMATOLOGY			English	Article							NF-KAPPA-B; HTLV-I; TAX GENE; PREVALENCE; MYELOPATHY; ANTIBODIES; EXOCRINOPATHY; ACTIVATION; APOPTOSIS; PROTEINS	Objective. To investigate whether human T lymphotropic virus type I (HTLV-I) directly infects salivary gland epithelial cells (SGECs) and induces the niche of the salivary glands in patients with Sjogren's syndrome (SS). Methods. SGECs were cultured with the HTLV-I-producing CD4+ T cell line HCT-5 or with Jurkat cells. Antibody arrays, immunofluorescence analysis, and enzyme-linked immunosorbent assay (ELISA) were used to determine the profiles of inflammation-related molecules, and the profiles of apoptosis-related molecules were determined by antibody array and immunofluorescence analysis. The presence of HTLV-I-related molecules was assessed by immunofluorescence analysis and in situ polymerase chain reaction. Apoptosis of SGECs was evaluated by TUNEL staining. Results. Among the SGECs, 7.8 1.3% (mean +/- SD) were positive for HTLV-I-related proteins after 96-hour coculture with HCT-5 cells. Nuclear NF-B p65 was also detected in 10% of the SGECs. The presence of HTLV-I proviral DNA in SGECs after coculture with HCT-5 cells was detected by in situ polymerase chain reaction. After coculture of SGECs with HCT-5, the expression of cytokines and chemokines, including soluble intercellular adhesion molecule 1, RANTES, and interferon -induced protein 10 kd (IP-10/CXCL10) was increased in a time-dependent manner. The expression of proapoptotic molecules (e.g., cytochrome c and Fas) and antiapoptotic molecules (e.g., Bcl-2, Heme oxygenase 2, and Hsp27) was increased in the SGECs cocultured with HCT-5, showing that apoptosis of SGECs was not detected after coculture with HCT-5 or Jurkat cells. Conclusion. HTLV-I is thought to infect SGECs and alter their cellular functions. These changes may induce the niche of SS and contribute to the development of SS in anti-HTLV-I antibody-positive individuals.	[Nakamura, Hideki; Takahashi, Yoshiko; Yamamoto-Fukuda, Tomomi; Horai, Yoshiro; Nakashima, Yoshikazu; Arima, Kazuhiko; Koji, Takehiko; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; [Nakamura, Tatsufumi] Nagasaki Int Univ, Nagasaki, Japan	Nakamura, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	nhideki@nagasaki-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan	Supported in part by a grant from the Ministry of Health, Labor, and Welfare, Japan.	TERADA K, 1994, LANCET, V344, P1116, DOI 10.1016/S0140-6736(94)90630-0; Jain P, 2009, J VIROL, V83, P10908, DOI 10.1128/JVI.01054-09; Nakamura H, 1997, ANN RHEUM DIS, V56, P167, DOI 10.1136/ard.56.3.167; Matsuoka E, 1998, ACTA NEUROPATHOL, V96, P340; Ogawa N, 2002, ARTHRITIS RHEUM, V46, P2730, DOI 10.1002/art.10577; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Nakamura H, 2000, J LAB CLIN MED, V135, P139, DOI 10.1067/mlc.2000.103429; CHISHOLM DM, 1968, J CLIN PATHOL, V21, P656, DOI 10.1136/jcp.21.5.656; Nakamura H, 2006, TRANSL RES, V148, P281, DOI 10.1016/j.trsl.2006.07.003; Suri-Payer E, 2006, SPRINGER SEMIN IMMUN, V28, P3, DOI 10.1007/s00281-006-0021-8; Dimitriou ID, 2002, EUR J ORAL SCI, V110, P21, DOI 10.1034/j.1600-0722.2002.00152.x; Furuya T, 1997, P ASSOC AM PHYSICIAN, V109, P228; Ospelt C, 2004, FRONT BIOSCI, V9, P2323, DOI 10.2741/1399; Hida A, 2010, ANN RHEUM DIS, V69, P2056, DOI 10.1136/ard.2010.128736; Nakamura H, 2009, RHEUMATOLOGY, V48, P854, DOI 10.1093/rheumatology/kep072; GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0; Toulza F, 2010, J IMMUNOL, V185, P183, DOI 10.4049/jimmunol.0903846; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Delaleu N, 2008, RHEUM DIS CLIN N AM, V34, P833, DOI 10.1016/j.rdc.2008.08.004; EGUCHI K, 1992, ANN RHEUM DIS, V51, P769, DOI 10.1136/ard.51.6.769; Fukushima N, 2008, INTERVIROLOGY, V51, P123, DOI 10.1159/000139130; GARRY RF, 1990, SCIENCE, V250, P1127, DOI 10.1126/science.1701273; Kulms D, 2006, VITAM HORM, V74, P283, DOI 10.1016/S0083-6729(06)74011-0; Lee SJ, 2012, J RHEUMATOL, V39, P809, DOI 10.3899/jrheum.111075; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; LINDHOLM PF, 1992, J VIROL, V66, P1294; Liu BY, 2006, INVEST OPHTH VIS SCI, V47, P1510, DOI 10.1167/iovs.05-1277; MARIETTE X, 1993, ARTHRITIS RHEUM, V36, P1423, DOI 10.1002/art.1780361015; Mariette X, 2000, CLIN EXP RHEUMATOL, V18, P341; Nakamura H, 2007, CLIN EXP RHEUMATOL, V25, P831; Nakamura H, 2008, APOPTOSIS, V13, P1322, DOI 10.1007/s10495-008-0261-2; Nakamura H, 2008, CLIN EXP RHEUMATOL, V26, P653; Ohyama Y, 1998, ARTHRITIS RHEUM, V41, P1972, DOI 10.1002/1529-0131(199811)41:11<1972::AID-ART12>3.0.CO;2-M; SAKAI M, 1993, J CLIN INVEST, V92, P1957, DOI 10.1172/JCI116789; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; TALAL N, 1990, ARTHRITIS RHEUM, V33, P774, DOI 10.1002/art.1780330603; Yamano S, 1997, J CLIN PATHOL, V50, P223, DOI 10.1136/jcp.50.3.223; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	APR	2015	67	4					1096	1106		10.1002/art.39009		11	Rheumatology	Rheumatology	CE5AJ	WOS:000351841800029		
J	Kimura, N; Hirata, S; Miyasaka, N; Kawahata, K; Kohsaka, H				Kimura, Naoki; Hirata, Shinya; Miyasaka, Nobuyuki; Kawahata, Kimito; Kohsaka, Hitoshi			Injury and Subsequent Regeneration of Muscles for Activation of Local Innate Immunity to Facilitate the Development and Relapse of Autoimmune Myositis in C57BL/6 Mice	ARTHRITIS & RHEUMATOLOGY			English	Article							T-CELLS; MURINE MODEL; TNF-ALPHA; POLYMYOSITIS; DERMATOMYOSITIS; EXPRESSION; LYMPHOCYTES; CARDIOTOXIN; MYOGENESIS; MONOCYTES	Objective. To determine whether injury and regeneration of the skeletal muscles induce an inflammatory milieu that facilitates the development and relapse of autoimmune myositis. Methods. The quadriceps of C57BL/6 mice were injured with bupivacaine hydrochloride (BPVC) and evaluated histologically. Macrophages and regenerating myofibers in the treated muscles and differentiating C2C12 myotubes were examined for cytokine expression. Mice were immunized with C protein fragments at the base of the tail and in the right hind footpads (day 0) to evoke systemic anti-C protein immunity and to induce local myositis in the right hind limbs. The contralateral quadriceps muscles were injured with BPVC or phosphate buffered saline (PBS) on day 7 or after spontaneous regression of myositis (day 42). The quadriceps muscle in nonimmunized mice was injured with BPVC on day 7. The muscles were examined histologically 14 days after treatment. Results. The BPVC-injured muscles had macrophage infiltration most abundantly at 3 days after the injection, with emergence of regenerating fibers from day 5. The macrophages expressed inflammatory cytokines, including tumor necrosis factor , interleukin-1, and CCL2. Regenerating myofibers and C2C12 myotubes also expressed the cytokines. The BPVC-injected muscles from nonimmunized mice had regenerating myofibers with resolved cell infiltration 14 days after treatment. In mice preimmunized with C protein fragments, the muscles injected with BPVC on day 7 as well as on day 42, but not those injected with PBS, had myositis accompanied by CD8+ T cell infiltration. Conclusion. Injury and regeneration could set up an inflammatory milieu in the muscles and facilitate the development and relapse of autoimmune myositis.	[Kimura, Naoki; Hirata, Shinya; Miyasaka, Nobuyuki; Kawahata, Kimito; Kohsaka, Hitoshi] Tokyo Med & Dent Univ, Tokyo 1138519, Japan	Kohsaka, H (reprint author), Tokyo Med & Dent Univ, Dept Rheumatol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	kohsaka.rheu@tmd.ac.jp			Ministry of Health, Labor, and Welfare, Japan; Global Centers of Excellence Program grant from the Japan Society for the Promotion of Science to the International Research Center for Molecular Science in Tooth and Bone Diseases at Tokyo Medical and Dental University; Abbott Japan; Bristol-Myers Squibb Japan; Janssen Japan; Otsuka Japan; Chugai Pharmaceutical Japan; Takeda Pharmaceutical Japan; Astellas Pharma Japan; Eisai Japan; Mitsubishi Tanabe Pharma Japan; Teijin Pharma Japan; AbbVie Japan; Ono Pharmaceutical Japan; UCB Japan; Japan Blood Products Organization; Asahi Kasei Pharma Japan	Supported by a grant-in-aid from the Ministry of Health, Labor, and Welfare, Japan, and by a Global Centers of Excellence Program grant from the Japan Society for the Promotion of Science to the International Research Center for Molecular Science in Tooth and Bone Diseases at Tokyo Medical and Dental University.; Dr. Miyasaka has received consulting fees, speaking fees, and/or honoraria from Abbott Japan, Bristol-Myers Squibb Japan, Janssen Japan, and Otsuka Japan (less than $10,000 each) and grants from Chugai Pharmaceutical Japan, Abbott Japan, Takeda Pharmaceutical Japan, Bristol-Myers Squibb Japan, Astellas Pharma Japan, Eisai Japan, and Mitsubishi Tanabe Pharma Japan. Dr. Kohsaka has received consulting fees and/or speaking fees from Teijin Pharma Japan, Chugai Pharmaceutical Japan, Mitsubishi Tanabe Pharma Japan, Takeda Pharmaceutical Japan, AbbVie Japan, Ono Pharmaceutical Japan, UCB Japan, Astellas Pharma Japan, Japan Blood Products Organization, and Asahi Kasei Pharma Japan (less than $10,000 each).	Albayda J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0433-8; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Liao H, 2012, ARTHRITIS RHEUM-US, V64, P3441, DOI 10.1002/art.34551; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Sugihara T, 2007, ARTHRITIS RHEUM, V56, P1304, DOI 10.1002/art.22521; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003; Vignaud A, 2007, NEUROSCI RES, V58, P317, DOI 10.1016/j.neures.2007.04.001; Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749; Mammen AL, 2010, CURR OPIN RHEUMATOL, V22, P644, DOI 10.1097/BOR.0b013e32833f0fc7; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Sugihara T, 2010, ARTHRITIS RHEUM-US, V62, P3088, DOI 10.1002/art.27625; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Nishimura M, 2002, J IMMUNOL, V168, P6173; Nagaraju K, 1998, CLIN EXP IMMUNOL, V113, P407; Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005; CHRISTENSEN ML, 1986, ARTHRITIS RHEUM, V29, P1365, DOI 10.1002/art.1780291109; DESBLEECKER JL, 1994, J NEUROPATHOL EXP NE, V53, P369; LYON MG, 1989, J RHEUMATOL, V16, P1218; Nagaraju K, 2009, KELLEYS TXB RHEUMATO, P1353; Nishio J, 2001, J IMMUNOL, V167, P4051; NONAKA I, 1983, ACTA NEUROPATHOL, V60, P167; Okiyama N, 2012, ARTHRITIS RHEUM-US, V64, P3741, DOI 10.1002/art.34629; Zador E, 2001, MUSCLE NERVE, V24, P1058, DOI 10.1002/mus.1110	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	APR	2015	67	4					1107	1116		10.1002/art.39017		10	Rheumatology	Rheumatology	CE5AJ	WOS:000351841800030		
J	Aleksic, J; Ansoldi, S; Antonelli, LA; Antoranz, P; Babic, A; Bangale, P; Barrio, JA; Gonzalez, JB; Bednarek, W; Bernardini, E; Biasuzzi, B; Biland, A; Blanch, O; Bonnefoy, S; Bonnoli, G; Borracci, F; Bretz, T; Carmona, E; Carosi, A; Colin, P; Colombo, E; Contreras, JL; Cortina, J; Covino, S; Da Vela, P; Dazzi, F; De Angelis, A; De Caneva, G; De Lotto, B; Wilhelmi, ED; Mendez, CD; Prester, DD; Dorner, D; Doro, M; Einecke, S; Eisenacher, D; Elsaesser, D; Fidalgo, D; Fonseca, MV; Font, L; Frantzen, K; Fruck, C; Galindo, D; Lopez, RJG; Garczarczyk, M; Terrats, DG; Gaug, M; Godinovic, N; Munoz, AG; Gozzini, SR; Hadasch, D; Hanabata, Y; Hayashida, M; Herrera, J; Hildebrand, D; Hose, J; Hrupec, D; Idec, W; Kadenius, V; Kellermann, H; Knoetig, ML; Kodani, K; Konno, Y; Krause, J; Kubo, H; Kushida, J; La Barbera, A; Lelas, D; Lewandowska, N; Lindfors, E; Lombardi, S; Longo, F; Lopez, M; Lopez-Coto, R; Lopez-Oramas, A; Lorenz, E; Lozano, I; Makariev, M; Mallot, K; Maneva, G; Mankuzhiyil, N; Mannheim, K; Maraschi, L; Marcote, B; Mariotti, M; Martinez, M; Mazin, D; Menzel, U; Miranda, JM; Mirzoyan, R; Moralejo, A; Munar-Adrover, P; Nakajima, D; Neustroev, V; Niedzwiecki, A; Nilsson, K; Nishijima, K; Noda, K; Orito, R; Overkemping, A; Paiano, S; Palatiello, M; Paneque, D; Paoletti, R; Paredes, JM; Paredes-Fortuny, X; Persic, M; Poutanen, J; Moroni, PGP; Prandini, E; Puljak, I; Puljak, I; Rhode, W; Ribo, M; Rico, J; Garcia, JR; Rugamer, S; Saito, T; Saito, K; Satalecka, K; Scalzotto, V; Scapin, V; Schultz, C; Schweizer, T; Sillanpaa, A; Sitarek, J; Snidaric, I; Sobczynska, D; Spanier, F; Stamerra, A; Steinbring, T; Storz, J; Strzys, M; Takalo, L; Takami, H; Tavecchio, F; Temnikov, P; Terzic, T; Tescaro, D; Teshima, M; Thaele, J; Tibolla, O; Torres, DF; Toyama, T; Treves, A; Vogler, P; Will, M; Zanin, R; Casares, J; Moldon, J				Aleksic, J.; Ansoldi, S.; Antonelli, L. A.; Antoranz, P.; Babic, A.; Bangale, P.; Barrio, J. A.; Becerra Gonzalez, J.; Bednarek, W.; Bernardini, E.; Biasuzzi, B.; Biland, A.; Blanch, O.; Bonnefoy, S.; Bonnoli, G.; Borracci, F.; Bretz, T.; Carmona, E.; Carosi, A.; Colin, P.; Colombo, E.; Contreras, J. L.; Cortina, J.; Covino, S.; Da Vela, P.; Dazzi, F.; De Angelis, A.; De Caneva, G.; De Lotto, B.; de Ona Wilhelmi, E.; Delgado Mendez, C.; Dominis Prester, D.; Dorner, D.; Doro, M.; Einecke, S.; Eisenacher, D.; Elsaesser, D.; Fidalgo, D.; Fonseca, M. V.; Font, L.; Frantzen, K.; Fruck, C.; Galindo, D.; Garcia Lopez, R. J.; Garczarczyk, M.; Garrido Terrats, D.; Gaug, M.; Godinovic, N.; Gonzalez Munoz, A.; Gozzini, S. R.; Hadasch, D.; Hanabata, Y.; Hayashida, M.; Herrera, J.; Hildebrand, D.; Hose, J.; Hrupec, D.; Idec, W.; Kadenius, V.; Kellermann, H.; Knoetig, M. L.; Kodani, K.; Konno, Y.; Krause, J.; Kubo, H.; Kushida, J.; La Barbera, A.; Lelas, D.; Lewandowska, N.; Lindfors, E.; Lombardi, S.; Longo, F.; Lopez, M.; Lopez-Coto, R.; Lopez-Oramas, A.; Lorenz, E.; Lozano, I.; Makariev, M.; Mallot, K.; Maneva, G.; Mankuzhiyil, N.; Mannheim, K.; Maraschi, L.; Marcote, B.; Mariotti, M.; Martinez, M.; Mazin, D.; Menzel, U.; Miranda, J. M.; Mirzoyan, R.; Moralejo, A.; Munar-Adrover, P.; Nakajima, D.; Neustroev, V.; Niedzwiecki, A.; Nilsson, K.; Nishijima, K.; Noda, K.; Orito, R.; Overkemping, A.; Paiano, S.; Palatiello, M.; Paneque, D.; Paoletti, R.; Paredes, J. M.; Paredes-Fortuny, X.; Persic, M.; Poutanen, J.; Moroni, P. G. Prada; Prandini, E.; Puljak, I.; Reinthal, R.; Rhode, W.; Ribo, M.; Rico, J.; Rodriguez Garcia, J.; Ruegamer, S.; Saito, T.; Saito, K.; Satalecka, K.; Scalzotto, V.; Scapin, V.; Schultz, C.; Schweizer, T.; Sillanpaa, A.; Sitarek, J.; Snidaric, I.; Sobczynska, D.; Spanier, F.; Stamerra, A.; Steinbring, T.; Storz, J.; Strzys, M.; Takalo, L.; Takami, H.; Tavecchio, F.; Temnikov, P.; Terzic, T.; Tescaro, D.; Teshima, M.; Thaele, J.; Tibolla, O.; Torres, D. F.; Toyama, T.; Treves, A.; Vogler, P.; Will, M.; Zanin, R.; Casares, J.; Moldon, J.		MAGIC Collaboration	MAGIC observations of MWC 656, the only known Be/BH system	ASTRONOMY & ASTROPHYSICS			English	Article						astroparticle physics; binaries: general; gamma rays: stars; X-rays: binaries; stars: individual: MWC 656	GAMMA-RAY OBSERVATIONS; LARGE-AREA TELESCOPE; BLACK-HOLE BINARIES; CYGNUS X-1; GX 339-4; EMISSION; FERMI; PERFORMANCE; MISSION; HARD	Context. MWC 656 has recently been established as the first observationally detected high-mass X-ray binary system containing a Be star and a black hole (BH). The system has been associated with a gamma-ray flaring event detected by the AGILE satellite in July 2010. Aims. Our aim is to evaluate whether the MWC 656 gamma-ray emission extends to very high energy (VHE > 100 GeV) gamma rays. Methods. We observed MWC 656 with the MAGIC telescopes for similar to 23 h during two observation periods: between May and June 2012, and in June 2013. During the last period, observations were performed contemporaneously with X-ray (XMM-Newton) and optical (STELLA) instruments. Results. We did not detect the MWC 656 binary system at TeV energies with the MAGIC telescopes in either of the two campaigns. Upper limits (ULs) to the integral flux above 300 GeV have been set, as well as differential ULs at a level of similar to 5% of the Crab nebula flux. The results obtained from the MAGIC observations do not support persistent emission of VHE gamma rays from this system at a level of 2.4% the Crab flux.	[Aleksic, J.; Blanch, O.; Cortina, J.; Gonzalez Munoz, A.; Lopez-Coto, R.; Lopez-Oramas, A.; Martinez, M.; Moralejo, A.; Rico, J.; Sitarek, J.] IFAE, Bellaterra 08193, Spain; [Ansoldi, S.; Biasuzzi, B.; De Angelis, A.; De Lotto, B.; Longo, F.; Mankuzhiyil, N.; Palatiello, M.; Persic, M.] Univ Udine, I-33100 Udine, Italy; [Ansoldi, S.; Biasuzzi, B.; De Angelis, A.; De Lotto, B.; Longo, F.; Mankuzhiyil, N.; Palatiello, M.; Persic, M.] INFN Trieste, I-33100 Udine, Italy; [Antonelli, L. A.; Bonnoli, G.; Carosi, A.; Covino, S.; La Barbera, A.; Lombardi, S.; Maraschi, L.; Stamerra, A.; Tavecchio, F.] INAF Natl Inst Astrophys, I-00136 Rome, Italy; [Antoranz, P.; Da Vela, P.; Miranda, J. M.; Paoletti, R.] Univ Siena, I-53100 Siena, Italy; [Antoranz, P.; Da Vela, P.; Miranda, J. M.; Paoletti, R.] INFN Pisa, I-53100 Siena, Italy; [Babic, A.; Dominis Prester, D.; Godinovic, N.; Hrupec, D.; Lelas, D.; Puljak, I.; Snidaric, I.; Terzic, T.] Univ Rijeka, Rudjer Boskov Inst, Croatian MAG Consortium, Zagreb 10000, Croatia; [Babic, A.; Dominis Prester, D.; Godinovic, N.; Hrupec, D.; Lelas, D.; Puljak, I.; Snidaric, I.; Terzic, T.] Univ Split, Zagreb 10000, Croatia; [Bangale, P.; Borracci, F.; Colin, P.; Dazzi, F.; Fruck, C.; Hose, J.; Kellermann, H.; Krause, J.; Lorenz, E.; Mazin, D.; Menzel, U.; Mirzoyan, R.; Noda, K.; Paneque, D.; Rodriguez Garcia, J.; Schweizer, T.; Strzys, M.; Teshima, M.; Toyama, T.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany; [Barrio, J. A.; Bonnefoy, S.; Contreras, J. L.; Fidalgo, D.; Fonseca, M. V.; Lopez, M.; Lozano, I.; Satalecka, K.; Scapin, V.] Univ Complutense Madrid, E-28040 Madrid, Spain; [Becerra Gonzalez, J.; Colombo, E.; Garcia Lopez, R. J.; Herrera, J.; Tescaro, D.; Will, M.; Casares, J.] Inst Astrofis Canarias, Tenerife 38200, Spain; [Bednarek, W.; Idec, W.; Niedzwiecki, A.; Sobczynska, D.] Univ Lodz, PL-90236 Lodz, Poland; [Bernardini, E.; De Caneva, G.; Garczarczyk, M.; Gozzini, S. R.; Mallot, K.] Deutsch Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany; [Biland, A.; Hildebrand, D.; Knoetig, M. L.; Prandini, E.; Vogler, P.] Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; [Bretz, T.; Dorner, D.; Eisenacher, D.; Elsaesser, D.; Lewandowska, N.; Mannheim, K.; Ruegamer, S.; Spanier, F.; Steinbring, T.; Storz, J.; Tibolla, O.] Univ Wurzburg, D-97074 Wurzburg, Germany; [Carmona, E.; Delgado Mendez, C.] Ctr Invest Energet Medioambient & Tecnol, Madrid 28040, Spain; [de Ona Wilhelmi, E.; Hadasch, D.] Inst Space Sci, Barcelona 08193, Spain; [Doro, M.; Mariotti, M.; Paiano, S.; Scalzotto, V.; Schultz, C.] Univ Padua, I-35131 Padua, Italy; [Doro, M.; Mariotti, M.; Paiano, S.; Scalzotto, V.; Schultz, C.] INFN, I-35131 Padua, Italy; [Einecke, S.; Frantzen, K.; Overkemping, A.; Rhode, W.; Thaele, J.] Tech Univ Dortmund, D-44221 Dortmund, Germany; [Font, L.; Garrido Terrats, D.; Gaug, M.] Univ Autonoma Barcelona, Unitat Fis Radiac, Dept Fis, Bellaterra 08193, Spain; [Font, L.; Garrido Terrats, D.; Gaug, M.] Univ Autonoma Barcelona, CERES IEEC, Bellaterra 08193, Spain; [Galindo, D.; Marcote, B.; Munar-Adrover, P.; Paredes, J. M.; Paredes-Fortuny, X.; Ribo, M.; Zanin, R.; Moldon, J.] Univ Barcelona, IEEC UB, ICC, Barcelona 08028, Spain; [Hanabata, Y.; Hayashida, M.; Kodani, K.; Konno, Y.; Kubo, H.; Kushida, J.; Nakajima, D.; Nishijima, K.; Orito, R.; Saito, T.; Saito, K.; Takami, H.] Kyoto Univ, Japanese MAG Consortium, Div Phys & Astron, Kyoto 6068501, Japan; [Lindfors, E.; Neustroev, V.; Nilsson, K.; Poutanen, J.; Reinthal, R.; Sillanpaa, A.; Takalo, L.] Univ Turku, Tuorla Observ, Finnish MAG Consortium, SF-20500 Turku, Finland; [Lindfors, E.; Neustroev, V.; Nilsson, K.; Poutanen, J.; Reinthal, R.; Sillanpaa, A.; Takalo, L.] Univ Oulu, Dept Phys, Oulun 90014, Finland; [Makariev, M.; Maneva, G.; Temnikov, P.] Bulgarian Acad Sci, Inst Nucl Res & Nucl Energy, BU-1784 Sofia, Bulgaria; [Moroni, P. G. Prada] Univ Pisa, I-56126 Pisa, Italy; [Moroni, P. G. Prada] INFN Pisa, I-56126 Pisa, Italy; [Torres, D. F.] ICREA, Barcelona 08193, Spain; [Torres, D. F.] Inst Space Sci, Barcelona 08193, Spain; [Treves, A.] Univ Insubria, Como D, Italy; [Treves, A.] INFN Milano Bicocca, Como D, Italy	Lopez-Oramas, A (reprint author), IFAE, Campus UAB, Bellaterra 08193, Spain.	alopez@ifae.es; pmunar@am.ub.es	Torres, Diego/F-3009-2015; Neustroev, Vitaly/B-6351-2008; Antoranz, Pedro/H-5095-2015; Miranda, Jose Miguel/F-2913-2013; Font, Lluis/L-4197-2014; Fonseca Gonzalez, Maria Victoria/I-2004-2015; Contreras Gonzalez, Jose Luis/K-7255-2014; Delgado, Carlos/K-7587-2014; de Ona Wilhelmi, Emma/I-2696-2015	Covino, Stefano/0000-0001-9078-5507; LA BARBERA, ANTONINO/0000-0002-5880-8913; Stamerra, Antonio/0000-0002-9430-5264; Persic, Massimo/0000-0003-1853-4900; Palatiello, Michele/0000-0002-4124-5747; Poutanen, Juri/0000-0002-0983-0049; Antonelli, Lucio Angelo/0000-0002-5037-9034; Ansoldi, Stefano/0000-0002-5613-7693; Torres, Diego/0000-0002-1522-9065; Antoranz, Pedro/0000-0002-3015-3601; Miranda, Jose Miguel/0000-0002-1472-9690; Font, Lluis/0000-0003-2109-5961; Fonseca Gonzalez, Maria Victoria/0000-0003-2235-0725; Contreras Gonzalez, Jose Luis/0000-0001-7282-2394; Delgado, Carlos/0000-0002-7014-4101; Temnikov, Petar/0000-0002-9559-3384; de Ona Wilhelmi, Emma/0000-0002-5401-0744	German BMBF; MPG; Italian INFN; Swiss National Fund SNF; ERDF funds under the Spanish MINECO; CPAN project of the Spanish Consolider-Ingenio programme [CSD2007-00042]; MultiDark project of the Spanish Consolider-Ingenio programme [CSD2009-00064]; Academy of Finland [127740]; Croatian Science Foundation (HrZZ) Project [09/176]; DFG Collaborative Research Centers [SFB823/C4, SFB876/C3]; Polish MNiSzW [745/N-HESS-MAGIC/2010/0]; Spanish Ministerio de Economia y Competividad (MINECO) [AYA2010-18080]	We would like to thank the Instituto de Astrofisica de Canarias for the excellent working conditions at the Observatorio del Roque de los Muchachos in La Palma. The support of the German BMBF and MPG, the Italian INFN, the Swiss National Fund SNF, and the ERDF funds under the Spanish MINECO is gratefully acknowledged. This work was also supported by the CPAN CSD2007-00042 and MultiDark CSD2009-00064 projects of the Spanish Consolider-Ingenio 2010 programme, by grant 127740 of the Academy of Finland, by the Croatian Science Foundation (HrZZ) Project 09/176, by the DFG Collaborative Research Centers SFB823/C4 and SFB876/C3, and by the Polish MNiSzW grant 745/N-HESS-MAGIC/2010/0. J.C. acknowledges support by the Spanish Ministerio de Economia y Competividad (MINECO) under grant AYA2010-18080. The authors thank the anonymous referee for a thorough review and a very constructive list of remarks that helped improving the quality and clarity of this manuscript.	Albert J, 2008, NUCL INSTRUM METH A, V588, P424, DOI 10.1016/j.nima.2007.11.068; Aleksic J., 2015, ASTROPART P IN PRESS; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Aliu E, 2009, ASTROPART PHYS, V30, P293, DOI 10.1016/j.astropartphys.2008.10.003; Casares J, 2014, NATURE, V505, P378, DOI 10.1038/nature12916; Aleksic J, 2012, ASTROPART PHYS, V35, P435, DOI 10.1016/j.astropartphys.2011.11.007; Tavani M, 2009, ASTRON ASTROPHYS, V502, P995, DOI 10.1051/0004-6361/200810527; Strassmeier KG, 2004, ASTRON NACHR, V325, P527, DOI 10.1002/asna.200410273; Remillard RA, 2006, ANNU REV ASTRON ASTR, V44, P49, DOI 10.1146/annurev.astro.44.051905.092532; Zdziarski AA, 2014, MON NOT R ASTRON SOC, V440, P2238, DOI 10.1093/mnras/stu420; Abdo AA, 2009, SCIENCE, V326, P1512, DOI 10.1126/science.1182174; Corbel S, 2013, MON NOT R ASTRON SOC, V428, P2500, DOI 10.1093/mnras/sts215; Albert J, 2007, ASTROPHYS J, V665, pL51, DOI 10.1086/521145; Rolke WA, 2005, NUCL INSTRUM METH A, V551, P493, DOI 10.1016/j.nima.2005.05.068; Malyshev D, 2013, MON NOT R ASTRON SOC, V434, P2380, DOI 10.1093/mnras/stt1184; Bodaghee A, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/98; Casares J, 2012, MON NOT R ASTRON SOC, V421, P1103, DOI 10.1111/j.1365-2966.2011.20368.x; Acharya BS, 2013, ASTROPART PHYS, V43, P3, DOI 10.1016/j.astropartphys.2013.01.007; Dubus G, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0064-5; Fender R, 2006, AIP CONF PROC, V856, P23, DOI 10.1063/1.2356382; hillas A.M., 1985, INT COSM RAY C, V3, P445; Li J., 2013, ARXIV13025211; Lucarelli F., 2010, ASTRON TELEGR, V2761, P1; Moldon J., 2012, THESIS U BARCELONA; Mori M., 2013, 2012 FERM S P ECONF; Munar-Adrover P, 2014, ASTROPHYS J LETT, V786, DOI 10.1088/2041-8205/786/2/L11; Paredes-Fortuny X, 2012, AIP CONF PROC, V1505, P390, DOI 10.1063/1.4772279; Plotkin RM, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/59; Sabatini S, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/83; Tavani M, 2009, NATURE, V462, P620, DOI 10.1038/nature08578; Williams SJ, 2010, ASTROPHYS J LETT, V723, pL93, DOI 10.1088/2041-8205/723/1/L93; Zanin R., 2013, P ICRC 2013 INT COSM	32	1	1	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	APR	2015	576								A36	10.1051/0004-6361/201424879		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CE5LT	WOS:000351877600036		
J	Inno, L; Matsunaga, N; Romaniello, M; Bono, G; Monson, A; Ferraro, I; Iannicola, G; Persson, E; Buonanno, R; Freedman, W; Gieren, W; Groenewegen, MAT; Ita, Y; Laney, CD; Lemasle, B; Madore, BF; Nagayama, T; Nakada, Y; Nonino, M; Pietrzynski, G; Primas, F; Scowcroft, V; Soszynski, I; Tanabe, T; Udalski, A				Inno, L.; Matsunaga, N.; Romaniello, M.; Bono, G.; Monson, A.; Ferraro, I.; Iannicola, G.; Persson, E.; Buonanno, R.; Freedman, W.; Gieren, W.; Groenewegen, M. A. T.; Ita, Y.; Laney, C. D.; Lemasle, B.; Madore, B. F.; Nagayama, T.; Nakada, Y.; Nonino, M.; Pietrzynski, G.; Primas, F.; Scowcroft, V.; Soszynski, I.; Tanabe, T.; Udalski, A.			New NIR light-curve templates for classical Cepheids	ASTRONOMY & ASTROPHYSICS			English	Article						stars: variables: Cepheids; stars: distances; stars: oscillations	LARGE-MAGELLANIC-CLOUD; GRAVITATIONAL LENSING EXPERIMENT.; PERIOD-LUMINOSITY RELATIONS; RADIAL-VELOCITY CURVES; OGLE-III CATALOG; RR LYRAE SURVEY; GALACTIC CEPHEIDS; PULSATION MODELS; STELLAR HALO; METALLICITY GRADIENT	Aims. We present new near-infrared (NIR) light-curve templates for fundamental (FU, J, H, K-S) and first overtone (FO, J) classical Cepheids. The new templates together with period-luminosity and period-Wesenheit (PW) relations provide Cepheid distances from single-epoch observations with a precision only limited by the intrinsic accuracy of the method adopted. Methods. The templates rely on a very large set of Galactic and Magellanic Cloud Cepheids (FU, similar to 600; FO, similar to 200) with well-sampled NIR (IRSF data set) and optical (V, I; OGLE data set) light-curves. To properly trace the change in the shape of the light-curve as a function of pulsation period, we split the sample of calibrating Cepheids into ten different period bins. The templates for the first time cover FO Cepheids and the short-period range of FU Cepheids (P <= 5 days). Moreover, the phase zero-point is anchored to the phase of the mean magnitude along the rising branch. The new approach has several advantages in sampling the light-curve of bump Cepheids when compared with the canonical phase of maximum light. We also provide new empirical estimates of the NIR-to-optical amplitude ratios for FU and FO Cepheids. We perform detailed analytical fits using seventh-order Fourier series and multi-Gaussian periodic functions. The latter are characterized by fewer free parameters (nine vs. fifteen). Results. The mean NIR magnitudes based on the new templates are up to 80% more accurate than single-epoch NIR measurements and up to 50% more accurate than the mean magnitudes based on previous NIR templates, with typical associated uncertainties ranging from 0.015 mag (J band) to 0.019 mag (K-S band). Moreover, we find that errors on individual distance estimates for Small Magellanic Cloud Cepheids derived from NIR PW relations are essentially reduced to the intrinsic scatter of the adopted relations. Conclusions. Thus, the new templates are the ultimate tool for estimating precise Cepheid distances from NIR single-epoch observations, which can be safely adopted for future interesting applications, including deriving the 3D structure of the Magellanic Clouds.	[Inno, L.; Bono, G.; Buonanno, R.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Inno, L.; Romaniello, M.; Primas, F.] European So Observ, D-85748 Garching, Germany; [Matsunaga, N.] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Bono, G.; Ferraro, I.; Iannicola, G.] INAF OAR, I-00040 Monte Porzio Catone, Italy; [Monson, A.; Persson, E.; Freedman, W.; Madore, B. F.; Scowcroft, V.] Observ Carnegie Inst Washington, Pasadena, CA 91101 USA; [Buonanno, R.] INAF Osservatorio Astron Collurania, I-64100 Teramo, Italy; [Gieren, W.; Pietrzynski, G.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Groenewegen, M. A. T.] Koninklijke Sterrenwacht van Belgie, B-1180 Brussels, Belgium; [Ita, Y.] Tohoku Univ, Grad Sch Sci, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Laney, C. D.] S African Astron Observ, ZA-7935 Cape Town, South Africa; [Laney, C. D.] Brigham Young Univ, ESC N283, Dept Phys & Astron, Provo, UT 84601 USA; [Lemasle, B.] Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Nagayama, T.] Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nagayama, T.] Kagoshima Univ, Grad Sch Sci & Engn, Dept Phys & Astron, Kagoshima 8900065, Japan; [Nakada, Y.; Tanabe, T.] Univ Tokyo, Sch Sci, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Nonino, M.] Osserv Astron Trieste, INAF, I-34131 Trieste, Italy; [Pietrzynski, G.; Soszynski, I.; Udalski, A.] Univ Warsaw Observ, PL-00478 Warsaw, Poland	Inno, L (reprint author), Univ Roma Tor Vergata, Dipartimento Fis, Via Ric Sci 1, I-00133 Rome, Italy.	laura.inno@roma2.infn.it		Nonino, Mario/0000-0001-6342-9662; Ferraro, Ivan/0000-0001-8514-7957; Iannicola, Giacinto/0000-0001-9816-5484; BUONANNO, Roberto/0000-0002-8255-815X	PRIN-INAF; PRIN-MIUR [2010LY5N2T]; Carnegie Observatories visitor program; Japan Society for the Promotion of Science (JSPS) [23684005, 26287028]; Polish National Science Center [MAESTRO 2012/06/A/ST9/00269]; BASAL Centro de Astrofisica y Tecnologias Afines (CATA) [PFB-06/2007]; Chilean Ministry of Economy, Development and Tourism's Millenium Science Iniciative [IC 120009]	This work was partially supported by PRIN-INAF 2011 "Tracing the formation and evolution of the Galactic halo with VST" (P.I.: M. Marconi) and by PRIN-MIUR (2010LY5N2T) "Chemical and dynamical evolution of the Milky Way and Local Group galaxies" (P.I.: F. Matteucci). One of us (G.B.) thanks The Carnegie Observatories visitor program for support as science visitor. N.M. acknowledges the support by Grants-in-Aid for Scientific Research (Nos. 23684005 and 26287028) from the Japan Society for the Promotion of Science (JSPS). Support from the Polish National Science Center grant MAESTRO 2012/06/A/ST9/00269 is also acknowledged. W.G. gratefully acknowledges support for this work from the BASAL Centro de Astrofisica y Tecnologias Afines (CATA) PFB-06/2007, and from the Chilean Ministry of Economy, Development and Tourism's Millenium Science Iniciative through grant IC 120009 awarded to the Millenium Institute of Astrophysics (MAS). We also acknowledge G. Fiorentino for many useful discussions concerning the theoretical predictions on NIR period Wesenheit relations. It is also a pleasure to thank an anonymous referee for his/her supportive attitude and insightful suggestions that helped us to improve the readability of the paper.	Akhter S, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/23; Kervella P, 2006, ASTRON ASTROPHYS, V448, P623, DOI 10.1051/0004-6361:20053603; Marconi M, 2005, ASTROPHYS J, V632, P590, DOI 10.1086/432790; Fiorentino G, 2007, ASTRON ASTROPHYS, V476, P863, DOI 10.1051/0004-6361:20077587; Kato D, 2007, PUBL ASTRON SOC JPN, V59, P615; Pedicelli S, 2009, ASTRON ASTROPHYS, V504, P81, DOI 10.1051/0004-6361/200912504; Matsunaga N, 2013, MON NOT R ASTRON SOC, V429, P385, DOI 10.1093/mnras/sts343; Bono G, 2010, ASTROPHYS J, V715, P277, DOI 10.1088/0004-637X/715/1/277; Pojmanski G, 2002, ACTA ASTRONOM, V52, P397; Romaniello M, 2008, ASTRON ASTROPHYS, V488, P731, DOI 10.1051/0004-6361:20065661; Bono G, 2000, ASTROPHYS J, V529, P293, DOI 10.1086/308263; Vivas AK, 2004, ASTRON J, V127, P1158, DOI 10.1086/380929; Marengo M, 2010, ASTROPHYS J, V709, P120, DOI 10.1088/0004-637X/709/1/120; Kienzle F, 1999, ASTRON ASTROPHYS, V341, P818; Drake AJ, 2009, ASTROPHYS J, V696, P870, DOI 10.1088/0004-637X/696/1/870; Soszynski I, 2012, ACTA ASTRONOM, V62, P219; Soszynski I, 2010, ACTA ASTRONOM, V60, P17; Freedman WL, 2010, ANNU REV ASTRON ASTR, V48, P673, DOI 10.1146/annurev-astro-082708-101829; Miceli A, 2008, ASTROPHYS J, V678, P865, DOI 10.1086/533484; Minniti D, 2010, NEW ASTRON, V15, P433, DOI 10.1016/j.newast.2009.12.002; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Soszynski I, 2008, ACTA ASTRONOM, V58, P163; Persson SE, 2004, ASTRON J, V128, P2239, DOI 10.1086/424934; Kinemuchi K, 2006, ASTRON J, V132, P1202, DOI 10.1086/506198; Sandage A, 2006, ASTROPHYS J, V653, P843, DOI 10.1086/508853; Barmby P, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/42; Beaulieu J. P., 1998, Memorie della Societa Astronomica Italiana, V69; Berdnikov L. N., 2004, ASTRON ASTROPHYS T, V23, P253; Bono G, 2000, ASTRON ASTROPHYS, V360, P245; Bono G, 2002, ASTROPHYS J, V565, pL83, DOI 10.1086/339420; Carpenter JM, 2001, ASTRON J, V121, P2851, DOI 10.1086/320383; Freedman W., 2012, SPITZER PROPOSAL, P90002; Genovali K, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321650; Genovali K, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201323198; Groenewegen MAT, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220446; Groenewegen MAT, 2000, ASTRON ASTROPHYS, V363, P901; Inno L, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/84; Ita Y, 2004, MON NOT R ASTRON SOC, V347, P720, DOI 10.1111/j.1365-2966.2004.07257.x; Jones RV, 1996, PUBL ASTRON SOC PAC, V108, P877, DOI 10.1086/133809; Kinman TD, 2012, MON NOT R ASTRON SOC, V422, P2116, DOI 10.1111/j.1365-2966.2012.20747.x; Szabados L, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117815; LANEY CD, 1994, MON NOT R ASTRON SOC, V266, P441; LANEY CD, 1992, ASTRON ASTROPHYS SUP, V93, P93; Luck RE, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/136; Luck RE, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/2/51; Marconi M, 2013, MON NOT R ASTRON SOC, V428, P2185, DOI 10.1093/mnras/sts197; Matsunaga N, 2011, MON NOT R ASTRON SOC, V413, P223, DOI 10.1111/j.1365-2966.2010.18126.x; Matthews LD, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/53; Minniti D, 2003, SCIENCE, V301, P1508, DOI 10.1126/science.1088529; Monson AJ, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/1/12; Moskalik P, 2000, ASTR SOC P, V203, P233; MOSKALIK P, 1992, ASTROPHYS J, V385, P685, DOI 10.1086/170975; Palaversa L, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/4/101; Pejcha O, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/107; Paczynski B, 2000, ASTROPHYS J, V533, pL103, DOI 10.1086/312612; Press W. H., 1989, NUMERICAL RECIPES C; Soszynski I, 2005, PUBL ASTRON SOC PAC, V117, P823, DOI 10.1086/431434; Stellingwerf R. F., 2011, RR LYRAE STARS METAL, P47; Storm J, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117154; Storm J, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117155; Szabados L, 2012, MON NOT R ASTRON SOC, V426, P3148, DOI 10.1111/j.1365-2966.2012.21872.x; VANGENDE.AM, 1974, ASTRON ASTROPHYS, V34, P279; Welch D. L., 1997, VARIABLE STARS ASTRO, P205; Zinn R, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/22	64	1	1	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	APR	2015	576								UNSP A30	10.1051/0004-6361/201424396		22	Astronomy & Astrophysics	Astronomy & Astrophysics	CE5LT	WOS:000351877600030		
J	Okura, Y; Futamase, T				Okura, Yuki; Futamase, Toshifumi			A new weak lensing shear analysis method using ellipticity defined by 0th order moments	ASTRONOMY & ASTROPHYSICS			English	Article						gravitational lensing: weak	SPREAD FUNCTION CORRECTION; GALAXY SHAPE MEASUREMENT; HUBBLE-SPACE-TELESCOPE; COSMIC SHEAR; WEIGHTED HOLICS; IMAGE-ANALYSIS; CHALLENGE; COSMOLOGY; SIGMA(8)	We developed a new method that uses ellipticity defined by 0th order moments (0th-ellipticity) for weak gravitational lensing shear analysis. Although there is a strong correlation between the ellipticity calculated using this approach and the usual ellipticity defined by the 2nd order moment, the ellipticity calculated here has a higher signal-to-noise ratio because it is weighted to the central region of the image. These results were confirmed using data for Abell 1689 from the Subaru telescope. For shear analysis, we adopted the ellipticity of re-smeared artificial image method for point spread function correction, and we tested the precision of this 0th-ellipticity with simple simulation, then we obtained the same level of precision with the results of ellipticity defined by quadrupole moments. Thus, we can expect that weak lensing analysis using 0 shear will be improved in proportion to the statistical error.	[Okura, Yuki] Natl Astron Observ Japan, Tokyo 1818588, Japan; [Futamase, Toshifumi] Tohoku Univ, Astron Inst, Sendai, Miyagi 9808578, Japan	Okura, Y (reprint author), Natl Astron Observ Japan, Tokyo 1818588, Japan.	yuki.okura@nao.ac.jp; tof@astr.tohoku.ac.jp					Hoekstra H, 2006, ASTROPHYS J, V647, P116, DOI 10.1086/503249; Hamana T, 2003, ASTROPHYS J, V597, P98, DOI 10.1086/378348; Maoli R, 2001, ASTRON ASTROPHYS, V368, P766, DOI 10.1051/0004-6361:20010058; Refregier A, 2002, ASTROPHYS J, V572, pL131, DOI 10.1086/341666; Massey R, 2005, MON NOT R ASTRON SOC, V359, P1277, DOI 10.1111/j.1365-2966.2005.09011.x; Heymans C, 2006, MON NOT R ASTRON SOC, V368, P1323, DOI 10.1111/j.1365-2966.2006.10198.x; Bacon DJ, 2000, MON NOT R ASTRON SOC, V318, P625, DOI 10.1046/j.1365-8711.2000.03851.x; Bridle S, 2010, MON NOT R ASTRON SOC, V405, P2044, DOI 10.1111/j.1365-2966.2010.16598.x; KAISER N, 1995, ASTROPHYS J, V449, P460, DOI 10.1086/176071; Bernstein GM, 2002, ASTRON J, V123, P583, DOI 10.1086/338085; Casertano S, 2003, ASTROPHYS J, V598, pL71, DOI 10.1086/380814; Van Waerbeke L, 2005, ASTRON ASTROPHYS, V429, P75, DOI 10.1051/0004-6361:20041513; Munshi D, 2008, PHYS REP, V462, P67, DOI 10.1016/j.physrep.2008.02.003; Miller L, 2007, MON NOT R ASTRON SOC, V382, P315, DOI 10.1111/j.1365-2966.2007.12363.x; Massey R, 2007, MON NOT R ASTRON SOC, V376, P13, DOI 10.1111/j.1365-2966.2006.11315.x; Bacon DJ, 2003, MON NOT R ASTRON SOC, V344, P673, DOI 10.1046/j.1365-8711.2003.06877.x; Kitching TD, 2008, MON NOT R ASTRON SOC, V390, P149, DOI 10.1111/j.1365-2966.2008.13628.x; Kitching TD, 2012, MON NOT R ASTRON SOC, V423, P3163, DOI 10.1111/j.1365-2966.2012.21095.x; Kuijken K, 2006, ASTRON ASTROPHYS, V456, P827, DOI 10.1051/0004-6361:20054794; Melchior P, 2011, MON NOT R ASTRON SOC, V412, P1552, DOI 10.1111/j.1365-2966.2010.17875.x; Mellier Y, 1999, ANNU REV ASTRON ASTR, V37, P127, DOI 10.1146/annurev.astro.37.1.127; Okura Y, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/37; Okura Y, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/112; Okura Y, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/9; Okura Y, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/104; Refregier A, 2003, MON NOT R ASTRON SOC, V338, P35, DOI 10.1046/j.1365-8711.2003.05901.x; Schneider P., 2006, GRAVITATIONAL LENS 1, V33, P1, DOI 10.1007/978-3-540-30310-7_1	27	0	0	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	APR	2015	576								A63	10.1051/0004-6361/201425450		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CE5LT	WOS:000351877600063		
J	Yuzawa, S; Kamakura, S; Hayase, J; Sumimoto, H				Yuzawa, Satoru; Kamakura, Sachiko; Hayase, Junya; Sumimoto, Hideki			Structural basis of cofactor-mediated stabilization and substrate recognition of the alpha-tubulin acetyltransferase alpha TAT1	BIOCHEMICAL JOURNAL			English	Article						alpha-tubulin acetyltransferase 1 (alpha TAT1); coenzyme A; crystal structure; mechanosensory (MEC)-17; substrate recognition	COENZYME-A; MOLECULAR-BASIS; N-ACETYLTRANSFERASE; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL COACTIVATOR; MICROTUBULE ACETYLATION; ANGSTROM RESOLUTION; HISTONE; MEC-17; SPECIFICITY	The functions of microtubules are controlled in part by tubulin post-translational modification including acetylation of Lys(40) in alpha-tubulin. alpha TAT1 (alpha-tubulin acetyltransferase 1), an enzyme evolutionarily conserved among eukaryotes, has recently been identified as the major alpha-tubulin Lys(40) acetyltransferase, in which AcCoA (acetyl-CoA) serves as an acetyl group donor. The regulation and substrate recognition of this enzyme, however, have not been fully understood. In the present study, we show that AcCoA and CoA each form a stable complex with human alpha TAT1 to maintain the protein integrity both in vivo and in vitro. The invariant residues Arg(132) and Ser(160) in alpha TAT1 participate in the stable interaction not only with AcCoA but also with CoA, which is supported by analysis of the present crystal structures of the alpha TAT1 catalytic domain in complex with CoA. Alanine substitution for Arg(132) or Ser(160) leads to a drastic misfolding of the isolated aTAT1 catalytic domain in the absence of CoA and AcCoA but not in the presence of excess amounts of either cofactor. A mutant alpha TAT1 carrying the R132A or S160A substitution is degraded much faster than the wild-type protein when expressed in mammalian MadinDarby canine kidney cells. Furthermore, alanine-scanning experiments using Lys40-containing peptides reveal that alpha-tubulin Ser38 is crucial for substrate recognition of aTAT1, whereas Asp39, Ile42, the glycine stretch (amino acid residues 43-45) andAsp46 are also involved. The requirement for substrate selection is totally different from that in various histone acetyltransferases, which appears to be consistent with the inability of aTAT1 to acetylate histones.	[Yuzawa, Satoru; Kamakura, Sachiko; Hayase, Junya; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka 8128582, Japan	Sumimoto, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan, KAKENHI [26440033]; Uehara Memorial Foundation [201320233];  [26111009]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Oxygen Biology: a new criterion for integrated understanding of life [grant number 26111009]; the The Ministry of Education, Culture, Sports, Science and Technology, Japan, KAKENHI Grant [grant number 26440033]; and The Uehara Memorial Foundation [grant number 201320233].	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Ahvazi B, 2000, BIOCHEM J, V349, P853; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mao LS, 2003, J AM CHEM SOC, V125, P14216, DOI 10.1021/ja036096p; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Liszczak G, 2013, P NATL ACAD SCI USA, V110, P14652, DOI 10.1073/pnas.1310365110; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Wu H, 2012, P NATL ACAD SCI USA, V109, P8925, DOI 10.1073/pnas.1114117109; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; HORIE S, 1986, J BIOCHEM-TOKYO, V99, P1345; Montagnac G, 2013, NATURE, V502, P567, DOI 10.1038/nature12571; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Verhey KJ, 2007, CELL CYCLE, V6, P2152; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Vetting MW, 2002, NAT STRUCT BIOL, V9, P653, DOI 10.1038/nsb830; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Davenport AM, 2014, J MOL BIOL, V426, P2605, DOI 10.1016/j.jmb.2014.05.009; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Rojas JR, 1999, NATURE, V401, P93; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Taschner M, 2012, P NATL ACAD SCI USA, V109, P19649, DOI 10.1073/pnas.1209343109; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Angus-Hill ML, 1999, J MOL BIOL, V294, P1311, DOI 10.1006/jmbi.1999.3338; Brinkmann-Chen S, 2013, P NATL ACAD SCI USA, V110, P10946, DOI 10.1073/pnas.1306073110; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; Chishiki K, 2013, BIOCHEM BIOPH RES CO, V435, P414, DOI 10.1016/j.bbrc.2013.04.103; Dambe TR, 2006, BIOCHEMISTRY-US, V45, P10030, DOI 10.1021/bi052589q; Dorfmueller HC, 2012, ACTA CRYSTALLOGR D, V68, P1019, DOI 10.1107/S0907444912019592; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Li WJ, 2012, CELL RES, V22, P1707, DOI 10.1038/cr.2012.154; Maksimoska J, 2014, BIOCHEMISTRY-US, V53, P3415, DOI 10.1021/bi500380f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi.035632n; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/M502401200; Williamson J R, 1979, Methods Enzymol, V55, P200	63	1	1	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0264-6021	1470-8728		BIOCHEM J	Biochem. J.	APR 1	2015	467		1				103	113		10.1042/BJ20141193		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE2YF	WOS:000351687500008		
J	Buchert, F; Konno, H; Hisabori, T				Buchert, Felix; Konno, Hiroki; Hisabori, Toru			Redox regulation of CF1-ATPase involves interplay between the gamma-subunit neck region and the turn region of the beta DELSEED-loop	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						Chloroplast ATP synthase; ATPase redox regulation; beta DELSEED-loop; Subunit interaction; Cysteine-mediated cross-linking; Thiol labeling	CHLOROPLAST ATP SYNTHASE; COUPLING FACTOR-I; ESCHERICHIA-COLI F1-ATPASE; EPSILON-SUBUNIT; CONFORMATIONAL-CHANGE; CATALYTIC SITE; ALPHA(3)BETA(3)GAMMA COMPLEX; CYANOBACTERIAL F-1-ATPASE; ADENOSINE-TRIPHOSPHATASE; SPINACH-CHLOROPLASTS	The soluble F-1 complex of ATP synthase (F0F1) is capable of ATP hydrolysis, accomplished by the minimum catalytic core subunits alpha(3)beta(3)gamma. A special feature of cyanobacterial F-1 and chloroplast F-1 (CF1) is an amino acid sequence inserted in the gamma-subunit. The insertion is extended slightly into the CF1 enzyme containing two additional cysteines for regulation of ATPase activity via thiol modulation. This molecular switch was transferred to a chimeric F-1 by inserting the cysteine-containing fragment from spinach CF1 into a cyanobacterial gamma-subunit [Y. Kim et al., redox regulation of rotation of the cyanobacterial F-1-ATPase containing thiol regulation switch, J Biol Chem, 286 (2011) 9071-9078]. Under oxidizing conditions, the obtained F-1 tends to lapse into an ADP-inhibited state, a common regulation mechanism to prevent wasteful ATP hydrolysis under unfavorable circumstances. However, the information flow between thiol modulation sites on the gamma-subunit and catalytic sites on the beta-subunits remains unclear. Here, we clarified a possible interplay for the CF1-ATPase redox regulation between structural elements of the beta DELSEED-loop and the gamma-subunit neck region, i.e., the most convex part of the alpha-helical gamma-termini. Critical residues were assigned on the beta-subunit, which received the conformation change signal produced by disulfide/dithiol formation on the gamma-subunit. Mutant response to the ATPase redox regulation ranged from lost to hypersensitive. Furthermore, mutant cross-link experiments and inversion of redox regulation indicated that the gamma-redox state might modulate the subunit interface via reorientation of the beta DELSEED motif region. (C) 2015 Elsevier B.V. All rights reserved.	[Buchert, Felix; Konno, Hiroki; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Konno, Hiroki] Kanazawa Univ, Bio AFM Frontier Res Ctr, Imaging Res Div, Kanazawa, Ishikawa 9201192, Japan; [Hisabori, Toru] Japan Sci & Technol Agcy JST, CREST, Tokyo 1020075, Japan	Hisabori, T (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014		Japan Society for the Promotion of Science [P12389]; Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST)	This work was supported in part by a Postdoctoral Fellowship for Foreign Researchers (P12389 to F.B.) from the Japan Society for the Promotion of Science and the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST) (to T. H.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; MILLS JD, 1980, FEBS LETT, V112, P173, DOI 10.1016/0014-5793(80)80173-6; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Sunamura E, 2012, J BIOL CHEM, V287, P38695, DOI 10.1074/jbc.M112.395053; DU ZY, 1990, BIOCHEMISTRY-US, V29, P402, DOI 10.1021/bi00454a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Nichols NN, 1997, J BACTERIOL, V179, P5056; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Jault JM, 1996, J BIOL CHEM, V271, P28818; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; Hisabori T, 2003, FEBS LETT, V545, P71, DOI 10.1016/S0014-5793(03)00395-8; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; BAKKERGR.T, 1974, BIOCHIM BIOPHYS ACTA, V347, P290, DOI 10.1016/0005-2728(74)90052-8; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Buchert F, 2012, BBA-BIOENERGETICS, V1817, P2038, DOI 10.1016/j.bbabio.2012.06.007; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; DUNHAM KR, 1981, J BIOL CHEM, V256, P212; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Hisabori T, 2013, ANTIOXID REDOX SIGN, V19, P1846, DOI 10.1089/ars.2012.5044; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; JUNGE W, 1970, EUR J BIOCHEM, V14, P582, DOI 10.1111/j.1432-1033.1970.tb00327.x; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; Kim Y, 2011, J BIOL CHEM, V286, P9071, DOI 10.1074/jbc.M110.200584; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Konno H, 2012, PLANT CELL PHYSIOL, V53, P626, DOI 10.1093/pcp/pcs018; Ma JP, 2002, STRUCTURE, V10, P921, DOI 10.1016/S0969-2126(02)00789-X; Matsui T, 1997, J BIOL CHEM, V272, P8215; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; MCCARTY RE, 1973, BIOCHEMISTRY-US, V12, P1503, DOI 10.1021/bi00732a006; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MINKOV IB, 1979, BIOCHEM BIOPH RES CO, V89, P1300, DOI 10.1016/0006-291X(79)92150-8; MORONEY JV, 1982, J BIOL CHEM, V257, P5910; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; Ponomarenko S, 1999, FEBS LETT, V443, P136, DOI 10.1016/S0014-5793(98)01681-0; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; SCHUMANN J, 1985, J BIOL CHEM, V260, P1817; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; VASILYEVA EA, 1982, BIOCHEM J, V202, P9; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WERNERGRUNE S, 1994, MOL GEN GENET, V244, P144	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	APR-MAY	2015	1847	4-5					441	450		10.1016/j.bbabio.2015.01.013		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CE4IF	WOS:000351793600006		
J	Eguchi, Y; Ohtori, S; Sekino, M; Ueno, S				Eguchi, Yawara; Ohtori, Seiji; Sekino, Masaki; Ueno, Shoogo			Effectiveness of Magnetically Aligned Collagen for Neural Regeneration In Vitro and In Vivo	BIOELECTROMAGNETICS			English	Article						nerve regeneration; magnetically orientated collagen; Schwann cell; rat sciatic nerve; neurite	PERIPHERAL-NERVE REGENERATION; SCHWANN-CELLS; ORIENTATION; FIELD; GRAFT; POLYMERIZATION; ALLOGRAFTS	We investigated the effectiveness of using magnetically aligned collagen (after exposure to a maximum 8-T magnetic field) for nerve regeneration in both an in vitro and in vivo model. Neurite outgrowth from embryonic chick dorsal root ganglion (DRG) neurons was significantly greater on magnetically aligned collagen gel than on control gel, and was dependent on magnetic field strength. Silicone tubes (15mm length) filled with collagen gel formed bridges between severed rat sciatic nerves. We prepared tubes for four groups: collagen gel only (COL), magnetically aligned collagen gel (M-COL), collagen gel mixed with Schwann cells (S-COL), and magnetically aligned collagen gel mixed with Schwann cells (M-S-COL). The ratio of infiltrating regenerated nerves was higher in the M-COL group compared to the COL group at 8 weeks post-operation. There were no significant differences between the two groups with and without Schwann cells. Compound action potentials showed higher amplitude and shorter latency in the M-COL than COL group at 12 weeks post-operation. The number and diameter of regenerated axons increased significantly in the M-COL compared with the COL group at 12 weeks post-operation. Here we demonstrated that magnetically orientated collagen promoted nerve regeneration using both an in vitro and in vivo model. Bioelectromagnetics. Bioelectromagnetics. 36:233-243, 2015. (c) 2015 Wiley Periodicals, Inc.	[Eguchi, Yawara] Shimoshizu Natl Hosp, Dept Orthopaed Surg, Chiba 2840003, Japan; [Ohtori, Seiji] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chiba, Japan; [Sekino, Masaki] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Dept Bioengn, Tokyo, Japan; [Ueno, Shoogo] Kyushu Univ, Grad Sch Engn, Dept Appl Quantum Phys, Fukuoka 812, Japan	Eguchi, Y (reprint author), Shimoshizu Natl Hosp, Dept Orthopaed Surg, 934-5 Shikawatashi, Chiba 2840003, Japan.	yawara_eguchi@yahoo.co.jp					TORBET J, 1981, NATURE, V289, P91, DOI 10.1038/289091a0; Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111; Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6; Eguchi Y, 2003, NEUROSCI LETT, V351, P130, DOI 10.1016/S0304-3940(03)00719-5; Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517; HIGASHI T, 1993, BLOOD, V82, P1328; Mohammadi R, 2013, INJURY, V44, P1295, DOI 10.1016/j.injury.2013.04.014; Moore AM, 2011, MUSCLE NERVE, V44, P221, DOI 10.1002/mus.22033; TORBET J, 1984, BIOCHEM J, V219, P1057; Kotani H, 2000, J APPL PHYS, V87, P6191, DOI 10.1063/1.372652; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1; ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109; Ide C, 1996, NEUROSCI RES, V25, P101; Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095; Eguchi Y, 2005, IEEE T MAGN, V41, P4146, DOI 10.1109/TMAG.2005.854854; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; UENO S, 1993, IEEE T MAGN, V29, P3352, DOI 10.1109/20.281173; ZALEWSKI AA, 1995, EXP NEUROL, V133, P189, DOI 10.1006/exnr.1995.1021	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-8462	1521-186X		BIOELECTROMAGNETICS	Bioelectromagnetics	APR	2015	36	3					233	243		10.1002/bem.21896		11	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	CE8JS	WOS:000352089000006		
J	Terazawa, K; Yamada, K; Ohno, Y; Sakata, T; Ishizuka, S				Terazawa, Kazuhiko; Yamada, Kenji; Ohno, Yasuyuki; Sakata, Tadashi; Ishizuka, Shigehiro			Spatial and temporal variability in methane emissions from tree stems of Fraxinus mandshurica in a cool-temperate floodplain forest	BIOGEOCHEMISTRY			English	Article						Diurnal and seasonal change; Forested wetland; Fraxinus; Methane emissions; Tree stem	RICE PADDIES; TRANSPORT MECHANISMS; NITROUS-OXIDE; GAS-TRANSPORT; ALDER-TREES; PLANTS; WATER; ATMOSPHERE; VEGETATION; PEATLANDS	We performed field measurements on the spatial and temporal variability in CH4 emissions from stem surfaces of mature Fraxinus mandshurica Rupr. trees in a floodplain forest of northern Japan. Stem CH4 fluxes were measured by a static closed-chamber method at ca. 15 cm above ground on ten selected trees to test among-individual variability, and the diurnal and seasonal changes in three representative trees. Daytime stem CH4 emission rates varied between 81 and 1,305 A mu g CH4 m(-2) h(-1) among individual trees, and showed a spatial gradient apparently corresponding to the difference in water table depth at the experimental site. Stem CH4 fluxes were quite stable throughout a 24 h period for foliated trees in August and were similar for defoliated trees in November. Large differences were observed in the magnitude of seasonal changes in stem CH4 flux among individual trees; one sampled tree showed no clear seasonal changes in stem CH4 flux, while another tree exhibited drastic seasonal changes ranging larger than one order of magnitude. Results demonstrated the high variability in stem CH4 emissions in space and time, and suggested the importance of soil temperature, water table depth and porewater CH4 concentration as possible environmental factors controlling stem CH4 emissions from temperate forested wetlands.	[Terazawa, Kazuhiko] Tokyo Univ Agr, Dept Bioprod, Abashiri, Hokkaido 0992493, Japan; [Terazawa, Kazuhiko; Yamada, Kenji; Ohno, Yasuyuki] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido 0790198, Japan; [Sakata, Tadashi; Ishizuka, Shigehiro] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Terazawa, K (reprint author), Tokyo Univ Agr, Dept Bioprod, Abashiri, Hokkaido 0992493, Japan.	kt204890@bioindustry.nodai.ac.jp	Ishizuka, Shigehiro/A-9975-2011	Ishizuka, Shigehiro/0000-0002-9906-9571	Japan Society for the Promotion of Science (JSPS) [23380090]	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (B) (Grant No. 23380090). We thank the management office of "Domin-no-mori (people's forest in Hokkaido)'' and its local management staff of the Tsukigata Zone for their valuable support for our field measurement efforts. We also thank two anonymous reviewers for their constructive comments designed to improve the manuscript.	YAMAMOTO S, 1976, J CHEM ENG DATA, V21, P78, DOI 10.1021/je60068a029; Whiting GJ, 1996, AQUAT BOT, V54, P237, DOI 10.1016/0304-3770(96)01048-0; SHANNON RD, 1994, BIOGEOCHEMISTRY, V27, P35; Gauci V, 2010, ATMOS ENVIRON, V44, P2157, DOI 10.1016/j.atmosenv.2010.02.034; Terazawa K, 2007, SOIL BIOL BIOCHEM, V39, P2689, DOI 10.1016/j.soilbio.2007.05.013; Kreuzwieser J, 2003, PLANT BIOLOGY, V5, P423, DOI 10.1055/s-2003-42712; King JY, 1998, J GEOPHYS RES-ATMOS, V103, P29083, DOI 10.1029/98JD00052; Carmichael MJ, 2014, BIOGEOCHEMISTRY, V119, P1, DOI 10.1007/s10533-014-9974-1; Joabsson A, 1999, TRENDS ECOL EVOL, V14, P385, DOI 10.1016/S0169-5347(99)01649-3; Vann CD, 2003, BIOGEOCHEMISTRY, V63, P117, DOI 10.1023/A:1023397032331; Waddington JM, 1996, J GEOPHYS RES-ATMOS, V101, P22775, DOI 10.1029/96JD02014; SEILER W, 1984, J ATMOS CHEM, V1, P241; CICERONE RJ, 1981, J GEOPHYS RES-OC ATM, V86, P7203, DOI 10.1029/JC086iC08p07203; Turetsky MR, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000496; ZEIKUS JG, 1974, SCIENCE, V184, P1181, DOI 10.1126/science.184.4142.1181; Rusch H, 1998, PLANT SOIL, V201, P1, DOI 10.1023/A:1004331521059; Treat CC, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000210; SCHUTZ H, 1989, BIOGEOCHEMISTRY, V7, P33; Armstrong W, 1979, ADV BOT RES, V7, P226; CHANTON JP, 1992, J GEOPHYS RES-ATMOS, V97, P16681; Christensen TR, 2010, METHANE CLIMATE CHAN, P27; Ciais P, 2013, CLIMATE CHANGE 2013, P465, DOI DOI 10.1017/CBO9781107415324.014; Covey KR, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052361; DACEY JWH, 1979, SCIENCE, V203, P1253, DOI 10.1126/science.203.4386.1253; De Simone O, 2002, PLANT BIOLOGY, V4, P515, DOI 10.1055/s-2002-34127; Garnet KN, 2005, AQUAT BOT, V81, P141, DOI 10.1016/j.aquabot.2004.10.003; GROSSE W, 1984, Z NATURFORSCH C, V39, P1186; HESSLEIN RH, 1976, LIMNOL OCEANOGR, V21, P912; HOLZAPFELPSCHORN A, 1986, J GEOPHYS RES-ATMOS, V91, P1803, DOI 10.1029/JD091iD11p11803; HOLZAPFELPSCHORN A, 1986, PLANT SOIL, V92, P223, DOI 10.1007/BF02372636; Hook D. D., 1984, Flooding and plant growth, P265; IUSS Working Group WRB, 2006, IUSS WORK GROUP WRB, V103, P128; Japan Meteorological Agency, 2002, MESH CLIM DAT JAP; Machacova K, 2013, PLANT SOIL, V364, P287, DOI 10.1007/s11104-012-1359-4; Matthews E., 1987, GLOBAL BIOGEOCHEMICA, V1, P61, DOI DOI 10.1029/GB001I001P00061; NOUCHI I, 1990, PLANT PHYSIOL, V94, P59, DOI 10.1104/pp.94.1.59; Pangala SR, 2013, NEW PHYTOL, V197, P524, DOI 10.1111/nph.12031; Pangala SR, 2014, NEW PHYTOL, V201, P887, DOI 10.1111/nph.12561; PULLIAM WM, 1992, OECOLOGIA, V91, P126; Purvaja R, 2004, GLOBAL CHANGE BIOL, V10, P1825, DOI 10.1111/j.1365-2486.2004.00834.x; R Core Team, 2014, R LANG ENV STAT COMP; Rice AL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041565; Schutz H., 1991, TRACE GAS EMISSIONS, P29; SEBACHER DI, 1985, J ENVIRON QUAL, V14, P40; Shannon RD, 1996, J ECOL, V84, P239, DOI 10.2307/2261359; Sun XX, 2012, ATMOS ENVIRON, V60, P277, DOI 10.1016/j.atmosenv.2012.06.051; Van der Nat FJWA, 1998, BIOGEOCHEMISTRY, V41, P1, DOI 10.1023/A:1005933100905; Whiting Gary J., 1992, Global Biogeochemical Cycles, V6, P225, DOI 10.1029/92GB00710; WMO, 2013, WMO GREENH GAS B STA; WMO, 2013, WMO WDCGG DAT SUMM W; YAMAMOTO F, 1995, IAWA J, V16, P47; YAMAMOTO F, 1995, TREE PHYSIOL, V15, P713	52	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-2563	1573-515X		BIOGEOCHEMISTRY	Biogeochemistry	APR	2015	123	3					349	362		10.1007/s10533-015-0070-y		14	Environmental Sciences; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Geology	CE1VC	WOS:000351599700003		
J	Kihira, Y; Burentogtokh, A; Itoh, M; Izawa-Ishizawa, Y; Ishizawa, K; Ikeda, Y; Tsuchiya, K; Tamaki, T				Kihira, Yoshitaka; Burentogtokh, Ariunzaya; Itoh, Mari; Izawa-Ishizawa, Yuki; Ishizawa, Keisuke; Ikeda, Yasumasa; Tsuchiya, Koichiro; Tamaki, Toshiaki			Hypoxia Decreases Glucagon-Like Peptide-1 Secretion from the GLUTag Cell Line	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						glucagon-like peptide-1; hypoxia; cAMP; hypoxia-inducible factor-1 alpha; L cell	PROGLUCAGON GENE-EXPRESSION; INTESTINAL BLOOD-FLOW; GLUCOSE; TRANSCRIPTION; ACTIVATION; MICE; RESPONSES; PANCREAS; TENSION; TISSUE	Glucagon-like peptide-1 (GLP-1), an incretin hormone, is secreted from L cells located in the intestinal epithelium. It is known that intestinal oxygen tension is decreased postprandially. In addition, we found that the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha), which accumulates in cells under hypoxic conditions, was significantly increased in the colons of mice with food intake, indicating that the oxygen concentration is likely reduced in the colon after eating. Therefore, we hypothesized that GLP-1 secretion is affected by oxygen tension. We found that forskolin-stimulated GLP-1 secretion from GLUTag cells, a model of intestinal L cells, is suppressed in hypoxia (1% O-2). Forskolin-stimulated elevations of preproglucagon (ppGCG) and proprotein convertase 1/3 (PC1/3) mRNA expression were decreased under hypoxic conditions. The finding that H89, a protein kinase A (PKA) inhibitor, inhibited the forskolin-stimulated increase of ppGCG and PC1/3 indicated that the cAMP-PKA pathway is involved in the hypoxia-induced suppression of the genes. Hypoxia decreased hexokinase 2 mRNA and protein expression and increased lactate dehydrogenase A mRNA and protein expression. Concomitantly, lactate production was increased and ATP production was decreased. Together, the results indicate that hypoxia decreases glucose utilization for ATP production, which probably causes a decrease in cAMP production and in subsequent GLP-1 production. Our findings suggest that the postprandial decrease in oxygen tension in the intestine attenuates GLP-1 secretion.	[Kihira, Yoshitaka; Burentogtokh, Ariunzaya; Itoh, Mari; Izawa-Ishizawa, Yuki; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 7708503, Japan; [Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 7708503, Japan	Kihira, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	kihira@tokushima-u.ac.jp			Kato Memorial Bioscience Foundation; KAKENHI [26870409]	We would like to thank Dr. Daniel Drucker (Mount Sinai Hospital SLRI, Toronto) for permission to use the GLUTag cell line. This work was partially supported by the Kato Memorial Bioscience Foundation, and by KAKENHI (26870409).	Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Matheson PJ, 1997, J SURG RES, V72, P146, DOI 10.1006/jsre.1997.5176; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Matheson PJ, 2000, J SURG RES, V93, P182, DOI 10.1006/jsre.2000.5862; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; CREUTZFELDT W, 1979, DIABETOLOGIA, V16, P75, DOI 10.1007/BF01225454; DRUCKER DJ, 1989, P NATL ACAD SCI USA, V86, P3953, DOI 10.1073/pnas.86.11.3953; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Cox HM, 2010, CELL METAB, V11, P532, DOI 10.1016/j.cmet.2010.04.014; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chou SC, 2004, BRIT J CANCER, V90, P728, DOI 10.1038/sj.bjc.6601585; Beitner-Johnson D, 1998, BIOCHEM BIOPH RES CO, V242, P61, DOI 10.1006/bbrc.1997.7907; BOHLEN HG, 1980, AM J PHYSIOL, V238, pH164; Chepurny OG, 2013, MOL ENDOCRINOL, V27, P1267, DOI 10.1210/me.2013-1029; CHOU CC, 1994, BRIT VET J, V150, P423; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; EVANS GS, 1988, VIRCHOWS ARCH B, V56, P191, DOI 10.1007/BF02890017; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Hurtado V, 2013, HOT TOPICS ENDOCRINE, P165; Jansen E, 1997, J BIOL CHEM, V272, P2500; Marchetti Piero, 2012, Adv Exp Med Biol, V771, P288; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; PINTO HC, 1995, GASTROENTEROLOGY, V108, P967, DOI 10.1016/0016-5085(95)90191-4; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; WOLLBERG P, 1994, J BIOL CHEM, V269, P19719	38	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					514	521				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900003		
J	Inoue, Y; Abe, K; Onozaki, K; Hayashi, H				Inoue, Yasumichi; Abe, Kenji; Onozaki, Kikuo; Hayashi, Hidetoshi			TGF-beta Decreases the Stability of IL-18-Induced IFN-gamma mRNA through the Expression of TGF-beta-Induced Tristetraprolin in KG-1 Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						transforming growth factor-beta (TGF-beta); interleukin-18 (IL-18); interferon-gamma (IFN-gamma); tristetraprolin (TTP)	GROWTH-FACTOR-BETA; AU-RICH ELEMENTS; ZINC-FINGER PROTEINS; HUMAN T-CELLS; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; CYTOKINE PRODUCTION; INTERFERON-GAMMA; NATURAL-KILLER; CYCLOSPORINE-A	We have previously reported that transforming growth factor-beta (TGF-beta) down-regulates interferon-gamma (IFN-gamma) production in an interleukin-18 (IL-18) treated mouse natural killer (NK) cell line, LNK5E6. In LNK5E6 cells, TGF-beta exhibited no inhibition of the IL-18-induced transcription of IFN-gamma, but did stimulate the degradation of IFN-gamma mRNA induced by IL-18. In the present study, we investigated the mechanism of the down-regulatory effects of TGF-beta on IFN-gamma mRNA expression in a human myelomonocytic cell line, KG-1, which produces IFN-gamma in response to IL-18 alone. Interestingly, IL-18 induced the production of the IFN-gamma through the stabilization of IFN-gamma mRNA, but not the enhanced transcription of IFN-gamma gene. The stability of IFN-gamma mRNA was regulated by mRNA destabilizing elements in the 3'untranslated region (UTR) of IFN-gamma mRNA, especially adenylate-uridylate (AU)-rich elements (AREs) in the 5' half of 3'UTR. Tristetraprolin (TTP), one of the ARE-binding proteins, destabilizes IFN-gamma mRNA, and IL-18 repressed the expression of TTP mRNA. Moreover, TGF-beta repressed the IL-18-induced expression of IFN-gamma mRNA through the induction of TTP mRNA to destabilize IFN-gamma mRNA. Our data is the first to reveal that the crosstalk between IL-18 and TGF-beta through the expression of TTP regulates the production of IFN-gamma.	[Inoue, Yasumichi; Hayashi, Hidetoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Drug Metab & Disposit, Nagoya, Aichi 4678603, Japan; [Abe, Kenji; Onozaki, Kikuo] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Hlth Sci, Nagoya, Aichi 4678603, Japan	Hayashi, H (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Drug Metab & Disposit, Nagoya, Aichi 4678603, Japan.	hhayashi@phar.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590085]; JSPS [24700983]; Nagoya City University; Kowa Life Science Foundation; Research Foundation for Pharmaceutical Sciences; Japan Rheumatism Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nakatomi Foundation; Suzuken Memorial Foundation; Hori Sciences & Arts Foundation; Takeda Science Foundation	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 24590085) from Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Young Scientists (B) (No. 24700983) from JSPS and a Grant-in-Aid for Research in Nagoya City University. YI was supported by the Kowa Life Science Foundation, the Research Foundation for Pharmaceutical Sciences, the Japan Rheumatism Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Nakatomi Foundation, the Suzuken Memorial Foundation, the Hori Sciences & Arts Foundation and the Takeda Science Foundation.	Adachi O, 1998, IMMUNITY, V9, P143; ALAM R, 1994, J EXP MED, V179, P1041, DOI 10.1084/jem.179.3.1041; Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Carballo E, 2000, BLOOD, V95, P1891; Kishore R, 1999, J IMMUNOL, V162, P2457; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; Inoue Y, 2004, J INTERF CYTOK RES, V24, P43, DOI 10.1089/107999004772719909; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Ogawa K, 2003, J BIOL CHEM, V278, P30373, DOI 10.1074/jbc.M304856200; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jvc.M110395200; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Stoll S, 1998, EUR J IMMUNOL, V28, P3231, DOI 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q; Matsumura T, 2003, IMMUNOLOGY, V109, P127, DOI 10.1046/j.1365-2567.2003.01627.x; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Kojima H, 1999, J IMMUNOL, V162, P5063; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Gonsky R, 2003, EUR J IMMUNOL, V33, P1152, DOI 10.1002/eji.200322857; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; BRABLETZ T, 1993, MOL CELL BIOL, V13, P1155; Dai YL, 2003, BLOOD, V102, P1178, DOI 10.1182/blood-2002-12-3771; ESPEVIK T, 1987, J EXP MED, V166, P571, DOI 10.1084/jem.166.2.571; Hayashi H, 2003, BIOCHEM BIOPH RES CO, V300, P980, DOI 10.1016/S0006-291X(02)02939-X; Hunter CA, 1997, EUR J IMMUNOL, V27, P2787, DOI 10.1002/eji.1830271107; Powell MJ, 2000, J IMMUNOL, V165, P292; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Tsutsui H, 1996, J IMMUNOL, V157, P3967; ZHANG W, 1993, MOL CELL BIOL, V13, P7652	48	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					536	544				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900006		
J	Narawa, T; Yano, T; Itoh, T				Narawa, Tomoya; Yano, Toshiaki; Itoh, Tomoo			Stereoselective Recognition of Amethopterin Enantiomers by the Rat Proton-Coupled Folate Transporter	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						methotrexate; amethopterin; enantiomer; species difference; stereoselective transport; proton-coupled folate transporter	METHOTREXATE SENSITIVITY; INTESTINAL-ABSORPTION; MEMBRANE-TRANSPORT; CARRIER ACTIVITY; CELLS; MALABSORPTION; CDNA; EXPRESSION; DEFICIENT; MECHANISM	The stereoselective transport of methotrexate (L-amethopterin, L-MTX) and its enantiomer (D-amethopterin, D-MTX) by the rat proton-coupled folate transporter (rPCFT) were examined using rPCFT-expressing HEK293 cells. The initial rate of uptake of [H-3]-L-MTX by the rPCFT followed Michaelis-Menten kinetics, with a K-m value of 2.1 mu m. Dixon plots revealed that the uptake of L-MTX by the rPCFT was inhibited in a competitive manner by unlabeled L-MTX and D-MTX, with K-i values of approximately 1.3 and 150 mu m, respectively. The initial rate of uptake of D-MTX by the rPCFT also followed Michaelis-Menten kinetics, with a K-m value of 190 mu m. The results of the current study demonstrate that the different enantiomers of MTX are transported in a highly stereoselective manner by the rPCFT, with the uptake clearance of L-MTX being approximately 46-fold greater than that of D-MTX. The observed stereoselectivity of the rPCFT was found to be comparable with that of the human PCFT.	[Narawa, Tomoya; Yano, Toshiaki; Itoh, Tomoo] Sch Pharm, Sch Pharm, Minato Ku, Tokyo 1088641, Japan	Narawa, T (reprint author), Sch Pharm, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	narawat@pharm.kitasato-u.ac.jp					Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Menter A, 2012, J PHARMACOL EXP THER, V342, P696, DOI 10.1124/jpet.112.195479; Leslie EM, 2007, J PHARMACOL EXP THER, V321, P1170, DOI 10.1124/jpet.106.119073; PRASAD PD, 1995, BIOCHEM BIOPH RES CO, V206, P681, DOI 10.1006/bbrc.1995.1096; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Qiu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1669, DOI 10.1152/ajpcell.00202.2007; WONG SC, 1995, J BIOL CHEM, V270, P17468; Wang YH, 2004, CLIN CANCER RES, V10, P6256, DOI 10.1158/1078-0432.CCR-04-0645; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; Clark DE, 1999, J PHARM SCI-US, V88, P807, DOI 10.1021/js9804011; DIXON KH, 1994, J BIOL CHEM, V269, P17; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; HENDEL J, 1984, EUR J CLIN PHARMACOL, V26, P103, DOI 10.1007/BF00546716; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; MOSCOW JA, 1995, CANCER RES, V55, P3790; Narawa T, 2010, DRUG METAB PHARMACOK, V25, P283; Narawa T, 2014, BIOL PHARM BULL, V37, P439; Nguyen TT, 1997, GASTROENTEROLOGY, V112, P783, DOI 10.1053/gast.1997.v112.pm9041240; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Takekuma Y, 2007, J PHARM PHARM SCI, V10, P71; Uwai Y, 2012, PHARMACOL RES, V65, P254, DOI 10.1016/j.phrs.2011.11.003; Uwai Yuichi, 2013, Int J Tryptophan Res, V6, P1, DOI 10.4137/IJTR.S11206; WILLIAMS FMR, 1994, J BIOL CHEM, V269, P5810; WILLIAMS FMR, 1995, J BIOL CHEM, V270, P2987; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					545	551				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900007		
J	Kanazawa, T; Yamazaki, M; Fukuda, T; Takashima, Y; Okada, H				Kanazawa, Takanori; Yamazaki, Mamiko; Fukuda, Tsunehiko; Takashima, Yuuki; Okada, Hiroaki			Versatile Nuclear Localization Signal-Based Oligopeptide as a Gene Vector	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						gene delivery system; nuclear localization signal; dendritic cell; disulfide linkage; histidine; functional amino acid	HIV-1 TAT PROTEIN; PLASMID DNA; MAMMALIAN-CELLS; HISTIDINE-RICH; REDOX STATE; DELIVERY; TRANSFECTION; PEPTIDES; ARGININE; GLUTATHIONE	To develop a versatile nuclear-targeted gene vector, nuclear localization signal (NLS) oligopeptides combining cysteine (C), histidine (H), and stearic acid (STR) were investigated in this study. The original SV40 sequence (SV40: Pro-Lys-Lys-Lys-Arg-Lys-Val) was selected as the NLS sequence, and physical characterizations of various NLS-based oligopeptides (CSV40C, STR-CSV40C, and STR-CH(2)SV40H(2)C), including mean diameter, zeta-potential, complex condensation, and decondensation, were evaluated. In addition, cellular and nuclear uptake of plasmid DNA (pDNA) and gene expression in COS7 and dendritic cells (JAWS II) were determined. As a result, C and STR enhanced formation of a smaller and more stable nano-complex with pDNA based on ionic interactions, the disulfide linkage and hydrophobic interactions. STR-CSV40C and STR-CH(2)SV40H(2)C had significantly higher cellular uptake ability and transfection efficiency than SV40 and CSV40C. In particular, STR-CH(2)SV40H(2)C had higher nuclear uptake and gene expression efficiency than STR-CSV40C. Furthermore, STR-CH(2)SV40H(2)C could deliver pDNA to the nuclei and had high gene expression efficiency in dendritic cells. Our results indicate that STR-CH(2)SV40H(2)C is a promising gene delivery system in non- or slow-dividing cells.	[Kanazawa, Takanori; Yamazaki, Mamiko; Takashima, Yuuki; Okada, Hiroaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Pharmaceut Sci, Hachioji, Tokyo 1920392, Japan; [Fukuda, Tsunehiko] Nagahama Inst Biosci & Technol, Nagahama, Shiga 5260829, Japan	Kanazawa, T (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Pharmaceut Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	kanazawa@toyaku.ac.jp			Promotion and Mutual Aid Corporation for Private Schools of Japan	This work was supported in part by a Grant for Private Universities provided by the Promotion and Mutual Aid Corporation for Private Schools of Japan. We thank Ms. Yumiko Suda, Ms. Yuki Hoashi, Ms. Kana Sogabe, and Ms. Asuna Shibano (School of Pharmacy, Tokyo University of Pharmacy and Life Sciences) for their technical assistance.	HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Wang HY, 2011, J CONTROL RELEASE, V155, P26, DOI 10.1016/j.jconrel.2010.12.009; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; Wolfert MA, 1998, GENE THER, V5, P409, DOI 10.1038/sj.gt.3300606; Tanaka K, 2010, INT J PHARMACEUT, V398, P219, DOI 10.1016/j.ijpharm.2010.07.038; Pichon C, 2001, ADV DRUG DELIVER REV, V53, P75, DOI 10.1016/S0169-409X(01)00221-6; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; van der Aa MAEA, 2005, J GENE MED, V7, P208, DOI 10.1002/jgm.643; Branden LJ, 1999, NAT BIOTECHNOL, V17, P784, DOI 10.1038/11726; FEENER EP, 1990, J BIOL CHEM, V265, P18780; Brunner S, 2000, GENE THER, V7, P401, DOI 10.1038/sj.gt.3301102; Hashida H, 2004, BRIT J CANCER, V90, P1252, DOI 10.1038/sj.bjc.6601680; Wiethoff CM, 2003, J PHARM SCI, V92, P203, DOI 10.1002/jps.10286; Khalil IA, 2004, GENE THER, V11, P636, DOI 10.1038/sj.gt.3302128; Kanazawa T, 2013, INT J PHARMACEUT, V447, P70, DOI 10.1016/j.ijpharm.2013.02.018; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Mann A, 2014, MOL PHARMACEUT, V11, P683, DOI 10.1021/mp400353n; Mae M, 2009, J CONTROL RELEASE, V134, P221, DOI 10.1016/j.jconrel.2008.11.025; Lo SL, 2008, BIOMATERIALS, V29, P2408, DOI 10.1016/j.biomaterials.2008.01.031; Aravindan L, 2013, MACROMOL BIOSCI, V13, P1163, DOI 10.1002/mabi.201300103; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; Bravo-Osuna I, 2007, INT J PHARM, V340, P173, DOI 10.1016/j.ijpharm.2007.03.019; Bremner KH, 2004, BIOCONJUGATE CHEM, V15, P152, DOI 10.1021/bc034140k; HWANG C, 1995, METHOD ENZYMOL, V251, P212; Kumar VV, 2003, GENE THER, V10, P1206, DOI 10.1038/sj.gt.3301979; Liu ZH, 2005, J CONTROL RELEASE, V102, P699, DOI 10.1016/j.jconrel.2004.10.013; Manickam DS, 2006, BIOCONJUGATE CHEM, V17, P1395, DOI 10.1021/bc060104k; Nagasaki T, 2003, BIOCONJUGATE CHEM, V14, P282, DOI 10.1021/bc025602h; Tanaka K, 2011, CHEM PHARM BULL, V59, P202, DOI 10.1248/cpb.59.202	31	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					559	565				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900009		
J	Akao, T; Oyanagi, Y; Shiotsuki, S; Ishii, Y; Sasahara, M				Akao, Teruaki; Oyanagi, Yugi; Shiotsuki, Satoshi; Ishii, Yoko; Sasahara, Masakiyo			Metabolism of Dextran Sulfate Sodium by Intestinal Bacteria in Rat Cecum Is Related to Induction of Colitis	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						dextran sulfate; ulcerative colitis; cecum; metabolism; rat	ULCERATIVE-COLITIS; COLONIC SULFIDE; GERM-FREE; MICE; INFLAMMATION; MICROFLORA; DSS	Ulcerative colitis induced by dextran sulfate sodium (DSS) is one of the most widely used experimental animal models. However, the mechanism responsible for the pathogenesis of the colitis is still unclear. The aim of the present study was to clarify the events occurring after administration of DSS to rats focusing on the relationship between the intestinal bacterial metabolism of DSS and the intestinal mucosal lesions in the model. Within 2 d after DSS administration, severe injury of the cecal mucosa was evident, together with bloody feces and blood in the cecum. However, these lesions were repressed by administration of antibiotics. On the other hand, DSS was found to be metabolized under anaerobic conditions upon incubation with cecal content in vitro, first being desulfated and then undergoing carbohydrate moiety degradation. However, no such metabolic process occurred when cecal content from rats that had been administered antibiotics was employed. These results indicate that the initial step of DSS-induced ulcerative colitis is lesioning of the cecal mucosa, which is related to metabolism of DSS by intestinal bacteria.	[Akao, Teruaki; Oyanagi, Yugi; Shiotsuki, Satoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Med Pharmaceut, Toyama 9300194, Japan; [Ishii, Yoko; Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 9300194, Japan	Akao, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Med Pharmaceut, 2630 Sugitani, Toyama 9300194, Japan.	ta0113@pha.u-toyama.ac.jp					Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; ROWLAND IR, 1988, DRUG METAB REV, V19, P243, DOI 10.3109/03602538808994135; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; DREYWOOD R, 1946, IND ENG CHEM, V18, P499, DOI 10.1021/i560156a015; Taniguchi E, 2009, TOXICOLOGY, V264, P96, DOI 10.1016/j.tox.2009.07.018; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; SILVESTRI LJ, 1982, ANAL BIOCHEM, V123, P303, DOI 10.1016/0003-2697(82)90450-X; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; KATSUNUMA T, 1976, Tokai Journal of Experimental and Clinical Medicine, V1, P111; Kitajima S, 2002, EXP ANIM TOKYO, V51, P203, DOI 10.1538/expanim.51.203; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Ohkusa T, 1985, Nihon Shokakibyo Gakkai Zasshi, V82, P1327; Perse M., 2012, J BIOMED BIOTECHNOL, V2012, DOI [DOI 10.1155/2012/718617, 10.1155/2012/718617]	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					566	570				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900010		
J	Ohya, H; Shibayama, Y; Ogura, J; Narumi, K; Kobayashi, M; Iseki, K				Ohya, Hiroki; Shibayama, Yoshihiko; Ogura, Jiro; Narumi, Katsuya; Kobayashi, Masaki; Iseki, Ken			Regorafenib Is Transported by the Organic Anion Transporter 1B1 and the Multidrug Resistance Protein 2	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						regorafenib; IC50; multidrug resistance protein 2; organic anion transporting polypeptide 1B1; vectorial drug transport	TYROSINE KINASE INHIBITORS; ANTITUMOR-ACTIVITY; DRUG-RESISTANCE; EXPRESSION; POLYPEPTIDES; DISPOSITION; OATP-1B3; OATP1B1	Regorafenib is a small molecule inhibitor of tyrosine kinases, and has been shown to improve the outcomes of patients with advanced colorectal cancer and advanced gastrointestinal stromal tumors. The transport profiles of regorafenib by various transporters were evaluated. HEK293/organic anion transporting polypeptide 1B1 (OATP1B1) cells exhibited increased drug sensitivity to regorafenib. Regorafenib inhibited the uptake of H-3-estrone sulfate by HEK293/OATP1B1 cells in a dose-dependent manner, but did not affect its elimination by P-glycoproteins. The concentration of regorafenib was significantly lower in LLC-PK1/multidrug resistance protein 2 (MRP2) cells than in LLC-PK1 cells treated with the MRP2 inhibitor, MK571. MK571 abolished the inhibitory effects of regorafenib on intracellular accumulation in LLC-PK1/MRP2 cells. The uptake of regorafenib was significantly higher in HEK293/0ATP1B1 cells than in OATP1B1-mock cells. Transport kinetics values were estimated to be K-m=15.9,um and V-max =1.24nmol/mg/min. No significant difference was observed in regorafenib concentrations between HEK293/OATP1B3 and OATP1B3-mock cells. These results indicated that regorafenib is a substrate for MRP2 and OATP1B1, and also suggest that the substrate preference of regorafenib may implicate the pharmacokinetic profiles of regorafenib.	[Ohya, Hiroki; Ogura, Jiro; Narumi, Katsuya; Kobayashi, Masaki; Iseki, Ken] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Clin Pharmaceut & Therapeut, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Shibayama, Yoshihiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Educ Res Ctr Clin Pharm, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Iseki, K (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Clin Pharmaceut & Therapeut, Kita Ku, Nishi 6,Kita 12, Sapporo, Hokkaido 0600812, Japan.	ken-i@pharm.hokudai.ac.jp	kobayashi, masaki /B-1638-2015; Ogura, Jiro/F-7260-2012	Ogura, Jiro/0000-0001-5139-137X	Ministry of Education, Culture, Sports, Science and Technology of Japan	The present study was supported by the Oncology Pharmacy Specialists of Oncology Professionals in Hokkaido, who were supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; He M, 2012, CHIN J CANCER, V31, P126, DOI 10.5732/cjc.011.10315; Ito K, 2005, PHARM RES, V22, P1559, DOI 10.1007/s11095-005-6810-2; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Liu LC, 2006, J PHARMACOL EXP THER, V318, P395, DOI 10.1124/jpet.106.103390; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Mukai M, 2003, CANCER SCI, V94, P557, DOI 10.1111/j.1349-7006.2003.tb01482.x; Yamaguchi H, 2011, BIOL PHARM BULL, V34, P389, DOI 10.1248/bpb.34.389; Sunakawa Y, 2014, INVEST NEW DRUG, V32, P104, DOI 10.1007/s10637-013-9953-8; Hu S, 2014, BRIT J CANCER, V110, P894, DOI 10.1038/bjc.2013.811; Gerk PM, 2002, J PHARMACOL EXP THER, V302, P407, DOI 10.1124/jpet.102.035014; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Hu S, 2008, CLIN CANCER RES, V14, P3141, DOI 10.1158/1078-0432.CCR-07-4913; van Erp NP, 2013, J CHROMATOGR B, V937, P33, DOI 10.1016/j.jchromb.2013.08.013; Dietrich CG, 2003, GUT, V52, P1788, DOI 10.1136/gut.52.12.1788; Chen ZS, 1999, MOL PHARMACOL, V56, P1219; Khurana Varun, 2014, Drug Metabolism and Drug Interactions, V29, P179, DOI 10.1515/dmdi-2013-0062; Khurana Varun, 2014, Drug Metabolism and Drug Interactions, V29, P249, DOI 10.1515/dmdi-2014-0014; Pharmaceutical and Medical Devices Agency Japan, 2013, REV REP STIV TABL 40; Shibayama Y, 2011, BIOL PHARM BULL, V34, P433, DOI 10.1248/bpb.34.433; Thomas-Schoemann A, 2014, CRIT REV ONCOL HEMAT, V89, P179, DOI 10.1016/j.critrevonc.2013.08.007	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					582	586				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900012		
J	Machida, M; Miyamura, Y; Machida, T; Koyama, K; Iizuka, K; Hirafuji, M				Machida, Maiko; Miyamura, Yuki; Machida, Takuji; Koyama, Kinuko; Iizuka, Kenji; Hirafuji, Masahiko			Administration of Olanzapine as an Antiemetic Agent Changes Glucose Homeostasis in Cisplatin-Treated Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						chemotherapy-induced nausea and vomiting; olanzapine; cisplatin; pica; glucose homeostasis	CHEMOTHERAPY-INDUCED NAUSEA; PLACEBO-CONTROLLED TRIAL; HIGH-DOSE CISPLATIN; INDUCED EMESIS; DOUBLE-BLIND; INDUCED PICA; WEIGHT-GAIN; ANTIPSYCHOTIC OLANZAPINE; ANTAGONIST APREPITANT; INSULIN-RESISTANCE	We investigated the effects of olanzapine on cisplatin-induced pica (the consumption of non-nutrient materials such as kaolin) and glucose homeostasis in rats to clarify the effects of olanzapine when used as an anti-emetic drug. Rats were injected intraperitoneally (i.p.) with either 5 mg/kg cisplatin or saline. Additionally, 2 or 10 mg/kg olanzapine were administered i.p. to the rats 10 mm before the administration of cisplatin and subsequently administered every 24 h for 3 d. Kaolin and food intake was measured using an automatic monitoring apparatus. Plasma glucose levels were measured by an enzyme electrode method. The plasma levels of insulin and intact proinsulin were measured by enzyme-linked immunosorbent assay (ELISA). The proinsulin-to-insulin (P/I) ratio was calculated. Cisplatin significantly increased kaolin intake, but decreased food intake and body weight up to 72 h. Olanzapine had no effect on these parameters. Neither olanzapine nor cisplatin alone had a significant effect on the plasma levels of glucose, insulin, or proinsulin. However, a combination of olanzapine and cisplatin significantly decreased plasma insulin levels, but increased plasma intact proinsulin levels and the P/I ratio. Our results suggest that an additive deterioration of insulin-secreting beta-cell function and disturbance of glucose homeostasis should be considered during treatment of patients with olanzapine for cisplatin-induced nausea and vomiting.	[Machida, Maiko; Koyama, Kinuko] Hokkaido Pharmaceut Univ, Sch Pharm, Div Pharmacotherapy, Otaru, Hokkaido 0470264, Japan; [Miyamura, Yuki; Machida, Takuji; Iizuka, Kenji; Hirafuji, Masahiko] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, Dept Pharmacol Sci, Ishikari, Hokkaido 0610293, Japan	Machida, T (reprint author), Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, Dept Pharmacol Sci, Ishikari, Hokkaido 0610293, Japan.	tmachida@hoku-iryo-u.ac.jp					Andrews PLR, 1998, SUPPORT CARE CANCER, V6, P197, DOI 10.1007/s005200050154; Poli-Bigelli S, 2003, CANCER, V97, P3090, DOI 10.1002/cncr.11433; Gore L, 2009, PEDIATR BLOOD CANCER, V52, P242, DOI 10.1002/pbc.21811; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; TAKEDA N, 1993, PHARMACOL BIOCHEM BE, V45, P817, DOI 10.1016/0091-3057(93)90126-E; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Cohen L, 2007, SUPPORT CARE CANCER, V15, P497, DOI 10.1007/s00520-006-0173-z; MITCHELL D, 1976, PHYSIOL BEHAV, V17, P691, DOI 10.1016/0031-9384(76)90171-2; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Hocking CM, 2014, SUPPORT CARE CANCER, V22, P1143, DOI 10.1007/s00520-014-2138-y; Yamamoto K, 2014, BRIT J PHARMACOL, V171, P2888, DOI 10.1111/bph.12629; Roila F, 2006, ANN ONCOL, V17, P20, DOI 10.1093/annonc/mdj078; Navari RM, 2013, SUPPORT CARE CANCER, V21, P1655, DOI 10.1007/s00520-012-1710-6; Tatsushima Y, 2011, EUR J PHARMACOL, V661, P57, DOI 10.1016/j.ejphar.2011.04.026; Yamamoto K, 2007, EUR J PHARMACOL, V554, P34, DOI 10.1016/j.ejphar.2006.09.058; Schmoll HJ, 2006, ANN ONCOL, V17, P1000, DOI 10.1093/annonc/mdl019; Egawa-Takata T, 2010, CANCER SCI, V101, P2171, DOI 10.1111/j.1349-7006.2010.01670.x; Baptista T, 1999, ACTA PSYCHIAT SCAND, V100, P3, DOI 10.1111/j.1600-0447.1999.tb10908.x; Couper GW, 1998, BRIT J SURG, V85, P1403; Ebenbichler CF, 2003, J CLIN PSYCHIAT, V64, P1436; Fukunaka N, 1998, GEN PHARMACOL, V31, P775, DOI 10.1016/S0306-3623(98)00102-5; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Herrstedt J, 2008, ANN ONCOL, V19, P110, DOI 10.1093/annonc/mdn105; Koro CE, 2002, BRIT MED J, V325, P243, DOI 10.1136/bmj.325.7358.243; Kris MG, 2005, SUPPORT CARE CANCER, V13, P85, DOI 10.1007/s00520-004-0699-x; Liu Yanxia, 2003, Research Communications in Molecular Pathology and Pharmacology, V113, P97; Minami M, 2003, PHARMACOL THERAPEUT, V99, P149, DOI 10.1016/S0163-7258(03)00057-3; MINER WD, 1986, BRIT J PHARMACOL, V88, P497; Navari Rudolph M, 2011, J Support Oncol, V9, P188, DOI 10.1016/j.suponc.2011.05.002; Ozasa R, 2013, CELL STRUCT FUNCT, V38, P183; Pfutnzner A, 2011, J DIABETES SCI TECH, V5, P784; Pfützner Andreas, 2004, Diabetes Technol Ther, V6, P405, DOI 10.1089/152091504774198124; Pfützner Andreas, 2004, Clin Lab, V50, P567; Rudd JA, 2002, EUR J PHARMACOL, V454, P47, DOI 10.1016/S0014-2999(02)02472-X; Rudd JA, 1996, BRIT J PHARMACOL, V118, P209; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Shobo M, 2011, BEHAV BRAIN RES, V216, P561, DOI 10.1016/j.bbr.2010.08.046; Suttie SA, 2007, BRIT J CANCER, V97, P902, DOI 10.1038/sj.bjc.6603971; Takano Y, 2014, EUR J PHARMACOL, V740, P496, DOI 10.1016/j.ejphar.2014.06.038; Tan LJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-131; Tattersall FD, 2000, NEUROPHARMACOLOGY, V39, P652, DOI 10.1016/S0028-3908(99)00172-0; Yamamoto K, 2011, J PHARMACOL TOX MET, V63, P30, DOI 10.1016/j.vascn.2010.04.011	45	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					587	593				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900013		
J	Ohta, S; Sakaguchi, S; Kobayashi, Y; Mizuno, N; Tago, K; Itoh, H				Ohta, Shigeyuki; Sakaguchi, Sayaka; Kobayashi, Yuki; Mizuno, Norikazu; Tago, Kenji; Itoh, Hiroshi			Agonistic Antibodies Reveal the Function of GPR56 in Human Glioma U87-MG Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						G protein signal; agonistic antibody; adhesion G protein-coupled receptor (GPCR); glioma cell migration	PROTEIN-COUPLED-RECEPTOR; PROTEOLYTIC SITE; TUMOR-GROWTH; INHIBITION; MIGRATION; ADHESION; PATHWAY; RHO; LAMINATION; CLEAVAGE	GPR56 is a member of the adhesion G protein-coupled receptor (GPCR) and is highly expressed in parts of tumor cells. The involvement of GPR56 in tumorigenesis has been reported. We generated agonistic monoclonal antibodies against human GPR56 and analyzed the action and signaling pathway of GPR56. The antibodies inhibited cell migration through the Gq and Rho pathway in human glioma U87-MG cells. Co-immunoprecipitation analysis indicated that the interaction between the GPR56 extracellular domain and transmembrane domain was potentiated by agonistic antibodies. These results demonstrated that functional antibodies are invaluable tools for GPCR research and should open a new avenue for therapeutic treatment of tumors.	[Ohta, Shigeyuki; Sakaguchi, Sayaka; Kobayashi, Yuki; Mizuno, Norikazu; Tago, Kenji; Itoh, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Biomed Sci, Ikoma, Nara 6300192, Japan; [Mizuno, Norikazu] Aomori Univ, Fac Pharmaceut Sci, Aomori 0300943, Japan; [Tago, Kenji] Jichi Med Univ, Sch Med, Dept Biochem, Shimotsuke, Tochigi 3290498, Japan	Mizuno, N (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Biomed Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	nmizuno@aomori-u.ac.jp; hitoh@bs.naist.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24590113, 25121724, 25293013]; Takeda Science Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant numbers: 24590113, 25121724, and 25293013) and by a Grant from the Takeda Science Foundation.	Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Xu L, 2007, CELL CYCLE, V6, P160, DOI 10.4161/cc.6.2.3760; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Latek D, 2012, ACTA BIOCHIM POL, V59, P515; Gray JX, 1996, J IMMUNOL, V157, P5438; Gui P, 2014, J CELL SCI, V127, P4009, DOI 10.1242/jcs.150987; Herda LR, 2012, BRIT J PHARMACOL, V166, P847, DOI 10.1111/j.1476-5381.2012.01828.x; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Smith BR, 2007, THYROID, V17, P923, DOI 10.1089/thy.2007.0239; Takashima S, 2008, CARDIOVASC RES, V79, P689, DOI 10.1093/cvr/cvn118; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					594	600				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900014		
J	Nagai, N; Ito, Y; Tanino, T				Nagai, Noriaki; Ito, Yoshimasa; Tanino, Tadatoshi			Effect of High Glucose Levels on Amyloid beta Production in Retinas of Spontaneous Diabetes Mellitus Otsuka Long-Evans Tokushima Fatty Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						amyloid beta (A beta); retina; diabetes mellitus; glucose; Otsuka Long-Evans Tokushima Fatty (OLETF) rat	NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; INSULIN-RESISTANCE; CATARACT FORMATION; CONVERTING ENZYME; FIBRIL FORMATION; MODEL; INHIBITION; NEPHROPATHY	The accumulation of amyloid beta(1-42) peptide (A beta(1-42)) in retina is implicated in the development of retinal ganglion cell apoptosis and diabetic retinopathy. In this study we demonstrate that spontaneous diabetes mellitus Otsuka Long-Evans Tokushima Fatty (OLETF) rats can be used as an animal model in studies to identify the expression of A(beta) in diabetic retinas. In addition, we investigated the relation between glucose level and A beta production in the retinas of OLETF rats. In the retinas of Long-Evans Tokushima Otsuka (LETO) rats used as normal controls and OLETF rats, no expression of neprilysin (NEP), which degrades A beta, was detected, and the expression levels of genes associated with A beta production (amyloid precursor protein, beta site APP cleaving enzyme, and presenilin) and A beta(1-42) levels in the retinas of 60-week-old OLETF rats with diabetes mellitus were significantly higher than in 60-week-old LETO rat retinas. Furthermore, the increase in the expression levels of genes associated with A beta production was enhanced by administration of glucose (3.0 g/kg; OGT test), and close relations between the retinal A beta(1-42) level and plasma blood glucose and HbA1c were observed. In conclusion, we have found that A beta accumulates easily in the retinas of LETO and OLETF rats due to the absence of NEP. In addition, we determined that the accumulation of A beta(1-42) in the retinas of OLETF rats is promoted by high plasma glucose levels. Therefore OLETF rats may be a suitable model for studies to identify the expression of A beta in diabetic retinas.	[Nagai, Noriaki; Ito, Yoshimasa; Tanino, Tadatoshi] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan	Nagai, N (reprint author), Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan.	nagai_n@phar.kindai.ac.jp					Akagi Y, 1990, MORPHOLOGICAL CLASSI, P157; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; FUKUSHI S, 1980, INVEST OPHTH VIS SCI, V19, P313; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Kaneto H, 1999, DIABETOLOGIA, V42, P1093, DOI 10.1007/s001250051276; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Nagai N, 2009, TOXICOLOGY, V255, P124, DOI 10.1016/j.tox.2008.10.005; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Wakuta M, 2007, INVEST OPHTH VIS SCI, V48, P590, DOI 10.1167/iovs.05-1168; Lin HB, 2009, PSYCHOPHARMACOLOGY, V204, P705, DOI 10.1007/s00213-009-1499-2; Yoneda S, 2005, JPN J OPHTHALMOL, V49, P106, DOI 10.1007/s10384-004-0156-x; Hara H, 2006, MOL VIS, V12, P977; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Hirashima T, 1998, DIABETES FRONTIER, V9, P477; ISHIDA K, 1995, METABOLISM, V44, P940, DOI 10.1016/0026-0495(95)90249-X; Ito A, 2001, J LAB CLIN MED, V138, P177, DOI 10.1067/mlc.2001.116843; KADOR PF, 1986, METABOLISM, V35, P15, DOI 10.1016/0026-0495(86)90181-2; KINOSHITA JIN H., 1965, INVEST OPHTHALMOL, V4, P786; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; Minami A, 2002, BRIT J NUTR, V87, P157, DOI 10.1079/BJN2001496; Miyamura N, 1999, OPHTHALMIC RES, V31, P358, DOI 10.1159/000055559; Nagai N, 2014, TOXICOLOGY, V315, P55, DOI 10.1016/j.tox.2013.08.003; SATO T, 1995, DIABETOLOGIA, V38, P1033; Shimazawa M, 2008, J NEUROCHEM, V107, P279, DOI 10.1111/j.1471-4159.2008.05606.x; Tajiri Y, 1997, ENDOCRINOLOGY, V138, P273, DOI 10.1210/en.138.1.273; Taniguchi M, 2002, HYPERTENS RES, V25, P287, DOI 10.1291/hypres.25.287; Wong PC, 2008, NEURON, V60, P941, DOI 10.1016/j.neuron.2008.12.010; Xiong M, 2008, NEUROBIOL DIS, V32, P433, DOI 10.1016/j.nbd.2008.08.007; Yabuki A, 2006, EXP ANIM TOKYO, V55, P17, DOI 10.1538/expanim.55.17; Yamada A, 2001, J JUZEN MED SOC, V110, P418; Yonemura D, 1977, Nippon Ganka Gakkai Zasshi, V81, P1632; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zhu X, 2009, BIOCHEM BIOPH RES CO, V384, P110, DOI 10.1016/j.bbrc.2009.04.080	46	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					601	610				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900015		
J	Suzuki, K; Otsuka, F; Yamada, H; Koizumi, S				Suzuki, Kaoru; Otsuka, Fuminori; Yamada, Hirotomo; Koizumi, Shinji			Analysis of Cysteine and Histidine Residues Required for Zinc Response of the Transcription Factor Human MTF-1	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						heavy metal; zinc finger; transcription factor; cysteine; metallothionein	FACTOR-I MTF-1; METALLOTHIONEIN-IIA GENE; METAL-RESPONSE; HEAVY-METALS; FUNCTIONAL-HETEROGENEITY; DNA-BINDING; ELEMENT; FINGERS; ACTIVATION; PROTEIN	Metal responsive element (MRE)-binding transcription factor-1 (MTF-1) is a zinc finger (ZF) transcription factor that plays a key role in heavy metal homeostasis by regulating relevant genes in response to metals. MTF-1 is known to be activated by heavy metals such as Zn and Cd, but the mechanism of activation remains unclear. In the present study, Cys and His residues of human MTF-1 (hMTF-1), some of which may be involved in interaction with metals or with each other, were screened for their contribution to Zn-dependent transcription. To avoid poor induction ratios of previous transfection assays, we re-examined experimental conditions to establish an assay able to correctly detect Zn-responsive transcription. Using this assay, a series of Cys and/or His substitution mutants were analyzed over the entire hMTF-1 molecule. In five out of the six ZFs (ZF1 to ZF5), Cys mutations that disrupt the ZF structure abolished response to Zn. Of these, ZF5 was shown for the first time to be essential for Zn-responsive transcription, despite it being unnecessary for Zn-induced DNA binding. These results indicate that Zn activation of hMTF-1 involves an additional process besides induction of DNA binding activity. Our assay also confirmed the importance of Cys in the acidic activation domain, as well as those in the C-terminal Cys cluster, implicated in transcription in other studies. The identified Cys residues might contribute to metal response of hMTF-1 through direct metal binding and/or intramolecular interactions, analysis of which will be helpful in understanding the mechanism of metal response.	[Suzuki, Kaoru; Yamada, Hirotomo; Koizumi, Shinji] NIOSH, Mech Hlth Effect Res Grp, Tama Ku, Kawasaki, Kanagawa 2148585, Japan; [Otsuka, Fuminori] Teikyo Univ, Fac Pharma Sci, Lab Mol Environm Hlth, Itabashi Ku, Tokyo 1738605, Japan	Koizumi, S (reprint author), NIOSH, Mech Hlth Effect Res Grp, Tama Ku, 6-21-1 Nagao, Kawasaki, Kanagawa 2148585, Japan.	koizumi@h.jniosh.go.jp					Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; HEUCHEL R, 1994, EMBO J, V13, P2870; Apuy JL, 2001, BIOCHEMISTRY-US, V40, P15164, DOI 10.1021/bi0112208; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Li Y, 2006, MOL CELL BIOL, V26, P5580, DOI 10.1128/MCB.00471-06; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Gunther V, 2012, BBA-MOL CELL RES, V1823, P476, DOI 10.1016/j.bbamcr.2011.10.006; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Chen XH, 1999, BIOCHEMISTRY-US, V38, P12915, DOI 10.1021/bi9913000; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Lindert U, 2009, MOL CELL BIOL, V29, P6283, DOI 10.1128/MCB.00847-09; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Chen XH, 1998, BIOCHEMISTRY-US, V37, P11152, DOI 10.1021/bi980843r; Chen XH, 2004, J BIOL CHEM, V279, P4515, DOI 10.1074/jbc.M308924200; Dalton TP, 1997, MOL CELL BIOL, V17, P2781; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Koizumi S, 2000, J CELL PHYSIOL, V185, P464, DOI 10.1002/1097-4652(200012)185:3<464::AID-JCP18>3.0.CO;2-4; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; KOIZUMI S, 1992, EUR J BIOCHEM, V210, P555, DOI 10.1111/j.1432-1033.1992.tb17454.x; Lichtlen P, 2001, NUCLEIC ACIDS RES, V29, P1514, DOI 10.1093/nar/29.7.1514; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; Ogra Y, 2001, J BIOL CHEM, V276, P16534, DOI 10.1074/jbc.M100570200; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; Suzuki K, 2009, IND HEALTH, V47, P419; Yamada H, 2009, ENVIRON TOXICOL PHAR, V28, P61, DOI 10.1016/j.etap.2009.02.007	30	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					611	617				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900016		
J	Miyajima, C; Inoue, Y; Hayashi, H				Miyajima, Chiharu; Inoue, Yasumichi; Hayashi, Hidetoshi			Pseudokinase Tribbles 1 (TRB1) Negatively Regulates Tumor-Suppressor Activity of p53 through p53 Deacetylation	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Tribbles 1 (TRB1); p53; histone deacetylase 1 (HDAC1); deacetylation	GENE-EXPRESSION; PATHWAY; CANCER; ACETYLATION; TRIB1; PHOSPHORYLATION; MORPHOGENESIS; DEGRADATION; ACTIVATION; DROSOPHILA	Tribbles 1 (TRB1) is one of the mammalian orthologs of Drosophila Tribbles, which regulates development and cell proliferation. TRB1 is suggested to act as a scaffold protein in signaling pathways for important cellular processes. TRB1 has also been identified as a myeloid oncogenic driver and mediates leuke-mogenesis through the mitogen-activated protein extracellular kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway and CCAAT/enhancer binding protein (C/EBP) transcriptional factors. However, the physiological roles of TRB1 in solid tumors have not been clarified. Here, we show that TRB1 interacts with p53 and suppresses its tumor suppressor activity. TRB1 knockdown enhances transcriptional activity of p53 and decreases cell viability. Interestingly, TRB1 enhances histone deacety lase 1 (HDAC1)-mediated p53 deacetylation and decreases DNA binding of p53. These results suggest that TRB1 is involved in the proliferation of tumor cells by inhibiting the activities of tumor suppressor p53 in solid tumors.	[Miyajima, Chiharu; Inoue, Yasumichi; Hayashi, Hidetoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Drug Metab & Disposit, Nagoya, Aichi 4678603, Japan	Inoue, Y (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Drug Metab & Disposit, Nagoya, Aichi 4678603, Japan.	yainoue@phar.nagoya-cu.ac.jp; hhayashi@phar.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590085]; JSPS [24700983]; Research Foundation for Pharmaceutical Sciences; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Suzuken Memorial Foundation; Nakatomi Foundation; Hori Sciences & Arts Foundation; YOKOYAMA Foundation for Clinical Pharmacology [YRY1408]	The authors thank members of the Hayashi laboratory for helpful discussions. This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 24590085) from Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Young Scientists (B) (No. 24700983) from JSPS. YI was supported by the Research Foundation for Pharmaceutical Sciences, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Takeda Science Foundation, the Suzuken Memorial Foundation, the Nakatomi Foundation, the Hori Sciences & Arts Foundation and the YOKOYAMA Foundation for Clinical Pharmacology (No. YRY1408).	Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Prives C, 1999, J PATHOL, V187, P112; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Lin ZY, 2014, INT J CANCER, V135, P541, DOI 10.1002/ijc.28707; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Dedhia PH, 2010, BLOOD, V116, P1321, DOI 10.1182/blood-2009-07-229450; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Mashima T, 2014, CANCER RES, V74, P4888, DOI 10.1158/0008-5472.CAN-13-3718; Cunard R., 2013, SCIENTIFICA, V2013; Hayashi H, 2003, BIOCHEM BIOPH RES CO, V300, P980, DOI 10.1016/S0006-291X(02)02939-X; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Higashitsuji H, 2007, J BIOL CHEM, V282, P13716, DOI 10.1074/jbc.M609751200; Inoue Y, 2011, J BIOL CHEM, V286, P6311, DOI 10.1074/jbc.M110.177683; Itoh Y, 2007, J IMMUNOL, V178, P3059; Liang JW, 2013, ONCOL REP, V29, P1827, DOI 10.3892/or.2013.2296; Puskas LG, 2005, CELL MOL BIOL, V51, P177, DOI 10.1170/T617	31	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					618	624				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900017		
J	Hamada, Y; Masuda, K; Okubo, M; Nakasa, H; Sekine, Y; Ishii, I				Hamada, Yuhei; Masuda, Kazushi; Okubo, Masato; Nakasa, Hiromitsu; Sekine, Yuko; Ishii, Itsuko			Pharmaceutical Studies of Levothyroxine Sodium Hydrate Suppository Provided as a Hospital Preparation	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						levothyroxine sodium hydrate; suppository; hospital preparation; hypothyroidism; pharmaceutical study; thyroid gland hormone replacement therapy		The levothyroxine sodium hydrate suppository (L-T-4-suppository) is provided as a hospital preparation for the treatment of hypothyroid patients with dysphagia in Japan because only oral preparations of levothyroxine sodium (L-T-4) are approved for the treatment of hypothyroidism. However, it has been found that serum thyroxine and triiodothyronine levels do not increase as expected with the hospital preparation, requiring a higher dosage of L-T, in the L-T-4-suppository than in the oral preparations. In this study, to determine an effective thyroid gland hormone-replacement therapy for patients with dysphagia, the pharmaceutical properties of the L-T-4-suppository were investigated. Suppositories containing 300 mu g L-T-4 in a base of Witepsol H-15 and Witepsol E-75 (ratio of 1:1) were prepared according to Chiba University Hospital's protocol. Content uniformity, stability, and suppository release were tested. The L-T-4-suppository had uniform weight and content. The content and release property were stable over 90d when the L-T-4-suppository was stored at 4 degrees C and protected from light. The release rate of L-T-4 increased as pH increased. However, no L-T-4 was released below pH 7.2. The release rate of L-T-4 decreased as temperature decreased. These findings suggest that the low level of release of L-T-4 in the rectum under physiological conditions may be the cause of the low serum thyroxine and triiodothyronine levels following L-T-4-suppository administration.	[Hamada, Yuhei] Chiba Univ, Fac Pharmaceut Sci, Dept Pract Pharm, Chuo Ku, Chiba 2608675, Japan; [Masuda, Kazushi; Okubo, Masato; Sekine, Yuko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Pract Pharm, Chuo Ku, Chiba 2608675, Japan; [Masuda, Kazushi; Okubo, Masato; Nakasa, Hiromitsu; Ishii, Itsuko] Chiba Univ, Univ Hosp, Sch Med, Div Pharm,Chuo Ku, Chiba 2608677, Japan; [Ishii, Itsuko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol, Chuo Ku, Chiba 2608675, Japan	Ishii, I (reprint author), Chiba Univ, Univ Hosp, Sch Med, Div Pharm,Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	iishii@faculty.chiba-u.jp					Silva JE, 2003, ANN INTERN MED, V139, P205; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Gaitonde DY, 2012, AM FAM PHYSICIAN, V86, P244; ASKA Pharmaceutical Co. Ltd, 2013, THYR S TABL INT FORM; BITTERMA.W, 1969, DIS COLON RECTUM, V12, P96, DOI 10.1007/BF02629003; Honma K, 1992, AM J PHYSIOL, V262, pR855; Itoh S, 2006, EUR J PHARM BIOPHARM, V64, P393, DOI 10.1016/j.ejpb.2006.06.004; Kato Y, 1986, J NIPPON HOSP PHARM, V12, P253; Kurayoshi K, 1991, JPN J GASTROENTEROL, V24, P856; Matsushita H, 1998, J JPN SURG ASS, V59, P2506; Nakajima Y, 2011, JPN J PHARM HLTH CAR, V37, P323; Odani H, 1991, J NIPPON HOSP PHARM, V17, P448; Shikama T, 1992, AKITA J MED, V19, P421; Takimoto T, 1993, PRACTICA OTO RHINO L, V86, P103; YAMAZAKI M, 1993, PHARMACEUT RES, V10, P927, DOI 10.1023/A:1018933916331; Yamazaki Y, 1986, Nihon Shokakibyo Gakkai Zasshi, V83, P165	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					625	628				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900018		
J	Uchida-Maruki, H; Inagaki, H; Ito, R; Kurita, I; Sai, M; Ito, T				Uchida-Maruki, Hiroko; Inagaki, Hiroyuki; Ito, Ryouichi; Kurita, Ikuko; Sai, Masahiko; Ito, Tatsuhiko			Piceatannol Lowers the Blood Glucose Level in Diabetic Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						piceatannol; passion fruit seed; antidiabetic activity; high fat diet; db/db	PASSIFLORA-EDULIS SEEDS; MITOCHONDRIAL-FUNCTION; DB/DB MICE; RESVERATROL; SIRT1; POLYPHENOLS; METABOLISM; ACTIVATION; STILBENE; GRAPES	We previously found that passion fruit (Passiflora edulis) seeds contained a high amount of piceatannol (3,5,3',4'-trans-tetrahydroxystilbene), a natural analog of resveratrol (3,5,4'-trans-trihydroxystilbene). Resveratrol has been proposed as a potential anti-metabolic disorder compound, by its activation of sirtuin and AMP-activated protein kinase. Many reports show that resveratrol Ameliorates diet-induced obesity and insulin resistance. However, it is not known whether piceatannol also affects diet-induced obesity. We explored the effect of piceatannol on high fat diet-fed mice. The results showed that piceatannol did not affect high fat diet-induced body weight gain or visceral fat gain in mice. However, piceatannol did reduce fasting blood glucose levels. Furthermore, to explore the potential of passion fruit seed extract containing piceatannol as a functional food, passion fruit seed extract was administered in a genetic diabetic mouse model (db/db mice). Single administration of passion fruit seed extract, as well as piceatannol reduced the blood glucose levels of these dbldb mice. These results suggest that piceatannol and passion fruit seed extract may have potential application in the prevention of diabetes.	[Uchida-Maruki, Hiroko; Inagaki, Hiroyuki; Ito, Ryouichi; Kurita, Ikuko; Sai, Masahiko; Ito, Tatsuhiko] Morinaga & Co Ltd, Hlth Sci Res Ctr, Tsurumi Ku, Yokohama, Kanagawa 2308504, Japan	Sai, M (reprint author), Morinaga & Co Ltd, Hlth Sci Res Ctr, Tsurumi Ku, 2-1-1 Shimosueyoshi, Yokohama, Kanagawa 2308504, Japan.	m-sai-ia@morinaga.co.jp					Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Matsui Y, 2010, J AGR FOOD CHEM, V58, P11112, DOI 10.1021/jf102650d; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Cho SJ, 2012, BRIT J NUTR, V108, P2166, DOI 10.1017/S0007114512000347; Setoguchi Y, 2014, J AGR FOOD CHEM, V62, P2541, DOI 10.1021/jf404694y; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Qiao Y, 2014, FOOD FUNCT, V5, P1241, DOI 10.1039/c3fo60630a; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Kawakami S, 2014, NUTRIENTS, V6, P4794, DOI 10.3390/nu6114794; Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067; Sano S, 2011, J AGR FOOD CHEM, V59, P6209, DOI 10.1021/jf104959t; Cantos E, 2003, J AGR FOOD CHEM, V51, P1208, DOI 10.1021/jf020939z; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Dragan S, 2015, CURR MED CHEM, V22, P14; Kinoshita Y, 2013, BIOCHEM BIOPH RES CO, V430, P1164, DOI 10.1016/j.bbrc.2012.12.017; Kobayashi K, 2006, BIOL PHARM BULL, V29, P1275, DOI 10.1248/bpb.29.1275; Kunst ADB, 1983, METHOD ENZYMAT AN, P163; Maruki-Uchida H, 2013, BIOL PHARM BULL, V36, P845, DOI 10.1248/bpb.b12-00708; Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	APR	2015	38	4					629	633				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7VV	WOS:000352050900019		
J	Arora, M; Hemmer, MT; Ahn, KW; Klein, JP; Cutler, CS; Urbano-Ispizua, A; Courie, DR; Alousi, AM; Gale, RP; Inamoto, Y; Weisdorf, DJ; Li, P; Antin, JH; Bolwell, BJ; Boyiadzis, M; Cahn, JY; Cairo, MS; Isola, LM; Jacobsohn, DA; Jagasia, M; Klumpp, TR; Petersdorf, EW; Santarone, S; Schouten, HC; Wingard, JR; Spellman, SR; Pavletic, SZ; Lee, SJ; Horowitz, MM; Flowers, MED				Arora, Mukta; Hemmer, Michael T.; Ahn, Kwang Woo; Klein, John P.; Cutler, Corey S.; Urbano-Ispizua, Alvaro; Courie, Daniel R.; Alousi, Amin M.; Gale, Robert Peter; Inamoto, Yoshihiro; Weisdorf, Daniel J.; Li, Peigang; Antin, Joseph H.; Bolwell, Brian J.; Boyiadzis, Michael; Cahn, Jean-Yves; Cairo, Mitchell S.; Isola, Luis M.; Jacobsohn, David A.; Jagasia, Madan; Klumpp, Thomas R.; Petersdorf, Effie W.; Santarone, Stella; Schouten, Harry C.; Wingard, John R.; Spellman, Stephen R.; Pavletic, Steven Z.; Lee, Stephanie J.; Horowitz, Mary M.; Flowers, Mary E. D.			Center for International Blood and Marrow Transplant Research Chronic Graft-versus-Host Disease Risk Score Predicts Mortality in an Independent Validation Cohort	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Chronic graft-versus-host disease (CGVHD); Risk score; Nonrelapse mortality	CHRONIC GVHD; IMMUNOSUPPRESSIVE TREATMENT; CELL TRANSPLANTATION; CONSENSUS CRITERIA; SURVIVAL; OUTCOMES; CLASSIFICATION; PREDNISONE; CONSORTIUM; DURATION	We previously reported a risk score that predicted mortality in patients with chronic graft-versus-host disease (CGVHD) after hematopoietic stem cell transplantation (HCT) between 1995 and 2004 and reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). We sought to validate this risk score in an independent CIBMTR cohort of 1128 patients with CGVHD who underwent transplantation between 2005 and 2007 using the same inclusion criteria and risk score calculations. According to the sum of the overall risk score (range, 1 to 12), patients were assigned to 4 risk groups (RGs): RG1 (0 to 2), RG2 (3 to 6), RG3 (7 to 8), and RG4 (9 to 10). RG3 and RG4 were combined, as RG4 accounted for only 1% of the total cohort. Cumulative incidences of nonrelapse mortality (NRM) and probability of overall survival were significantly different between each RG (all P < .01). NRM and overall survival at 5 years after CGVHD for each RG were 17% and 72% in RG1, 26% and 53% in RG2, and 44% and 25% in RG3, respectively (all P < .01). Our study validates the prognostic value of the CIBMTR CGVHD RGs for overall survival and NRM in a contemporary transplantation population. The CIBMTR CGVHD RGs can be used to predict major outcomes, tailor treatment planning, and enroll patients in clinical trials. (C) 2015 American Society for Blood and Marrow Transplantation.	[Arora, Mukta; Weisdorf, Daniel J.] Univ Minnesota, Med Ctr, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA; [Hemmer, Michael T.; Ahn, Kwang Woo; Klein, John P.; Horowitz, Mary M.] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplantat Res, Dept Med, Milwaukee, WI 53226 USA; [Ahn, Kwang Woo; Klein, John P.] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53226 USA; [Cutler, Corey S.; Antin, Joseph H.] Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Urbano-Ispizua, Alvaro] Univ Barcelona, Dept Hematol, Hosp Clin, IDIBAPS, Barcelona, Spain; [Urbano-Ispizua, Alvaro] Inst Res Josep Carreras, Barcelona, Spain; [Courie, Daniel R.] Univ Michigan, Dept Internal Med, Blood & Marrow Transplant Program, Ann Arbor, MI 48109 USA; [Alousi, Amin M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA; [Gale, Robert Peter] Univ London Imperial Coll Sci Technol & Med, Hematol Res Ctr, Div Expt Med, Dept Med, London, England; [Inamoto, Yoshihiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Bolwell, Brian J.] Cleveland Clin, Leukemia Program, Hematol Oncol & Blood Disorders, Taussig Canc Inst, Cleveland, OH 44106 USA; [Boyiadzis, Michael] Univ Pittsburgh, Dept Med, Ctr Canc, Med Ctr, Pittsburgh, PA USA; [Cahn, Jean-Yves] Univ Hosp, Dept Hematol, Grenoble, France; [Cairo, Mitchell S.] New York Med Coll, Dept Pediat Hematol Oncol, Valhalla, NY 10595 USA; [Isola, Luis M.] Mt Sinai Med Ctr, Div Blood & Marrow Transplantat, New York, NY 10029 USA; [Jacobsohn, David A.] Childrens Natl Med Ctr, Div Blood & Marrow Transplantat, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Jagasia, Madan] Vanderbilt Univ, Div Hematol Oncol, Med Ctr, Nashville, TN 37235 USA; [Klumpp, Thomas R.] Temple Univ, Sch Med, Dept Med, Bone Marrow Transplant Program, Philadelphia, PA 19122 USA; [Petersdorf, Effie W.; Lee, Stephanie J.; Flowers, Mary E. D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Santarone, Stella] Osped Civile, Dept Hematol, BMT Ctr, Pescara, Italy; [Schouten, Harry C.] Acad Ziekenhuis, Dept Hematol, Maastricht, Netherlands; [Wingard, John R.] Shands Canc Ctr, Div Hematol & Oncol, Dept Med, Gainesville, FL USA; [Wingard, John R.] Univ Florida, Gainesville, FL USA; [Spellman, Stephen R.] Ctr Int Blood & Marrow Transplantat Res, Natl Marrow Donor Program, Minneapolis, MN USA; [Pavletic, Steven Z.] NCI, NIH, Ctr Canc Res, Bethesda, MD 20892 USA	Flowers, MED (reprint author), Fred Hutchinson Canc Res Ctr, D5-290,POB 19024, Seattle, WA 98109 USA.	mflowers@fhcrc.org			National Cancer Institute (NCI) [U24-CA076518]; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID); NHLBI [5U10HL069294]; NCI; Health Resources and Services Administration (HRSA/DHHS) [HHSH250201200016C]; Office of Naval Research [N00014-13-1-0039, N00014-14-1-0028]; Actinium Pharmaceuticals; Allos Therapeutics, Inc.; Amgen, Inc.; Ariad; Be the Match Foundation; Blue Cross and Blue Shield Association; Celgene Corporation; Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Fresenius-Biotech North America, Inc.; Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; Gentium SpA; Genzyme Corporation; GlaxoSmithKline; Health Research, Inc. Roswell Park Cancer Institute; HistoGenetics, Inc.; Incyte Corporation; Jeff Gordon Children's Foundation; Kiadis Pharma; The Leukemia & Lymphoma Society; Medac GmbH; The Medical College of Wisconsin; Merck Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Perkin Elmer, Inc.; Remedy Informatics; Sanofi US; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; St. Baldrick's Foundation; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; Tarix Pharmaceuticals; TerumoBCT; Teva Neuroscience, Inc.; THERAKOS, Inc.; University of Minnesota; University of Utah; Wellpoint, Inc.	The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement U24-CA076518 from the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a grant/cooperative agreement 5U10HL069294 from NHLBI and NCI; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS); 2 grants N00014-13-1-0039 and N00014-14-1-0028 from the Office of Naval Research; and grants from *Actinium Pharmaceuticals; Allos Therapeutics, Inc.; *Amgen, Inc.; anonymous donation to the Medical College of Wisconsin; Ariad; Be the Match Foundation; *Blue Cross and Blue Shield Association; *Celgene Corporation; Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Fresenius-Biotech North America, Inc.; *Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; *Gentium SpA; Genzyme Corporation; GlaxoSmithKline; Health Research, Inc. Roswell Park Cancer Institute; HistoGenetics, Inc.; Incyte Corporation; Jeff Gordon Children's Foundation; Kiadis Pharma; The Leukemia & Lymphoma Society; Medac GmbH; The Medical College of Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; *Milliman USA, Inc.; *Miltenyi Biotec, Inc.; National Marrow Donor Program; Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Perkin Elmer, Inc.; *Remedy Informatics; *Sanofi US; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; St. Baldrick's Foundation; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; *Tarix Pharmaceuticals; *TerumoBCT; *Teva Neuroscience, Inc.; *THERAKOS, Inc.; University of Minnesota; University of Utah; and *Wellpoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration, or any other agency of the US Government.	SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Arora M, 2009, BONE MARROW TRANSPL, V43, P149, DOI 10.1038/bmt.2008.305; Akpek G, 2003, BLOOD, V102, P802, DOI 10.1182/blood-2002-10-3141; Jagasia M, 2007, BIOL BLOOD MARROW TR, V13, P1207, DOI 10.1016/j.bbmt.2007.07.001; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; SULLIVAN KM, 1988, BLOOD, V72, P546; Martin PJ, 2011, BIOL BLOOD MARROW TR, V17, P124, DOI 10.1016/j.bbmt.2010.06.018; Akpek G, 2001, BLOOD, V97, P1219, DOI 10.1182/blood.V97.5.1219; Koc S, 2002, BLOOD, V100, P48, DOI 10.1182/blood.V100.1.48; WINGARD JR, 1989, BLOOD, V74, P1428; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Vigorito AC, 2009, BLOOD, V114, P702, DOI 10.1182/blood-2009-03-208983; Arora M, 2007, BIOL BLOOD MARROW TR, V13, P1145, DOI 10.1016/j.bbmt.2007.06.004; Pidala J, 2012, HAEMATOL-HEMATOL J, V97, P451, DOI 10.3324/haematol.2011.055186; COX DR, 1972, J R STAT SOC B, V34, P187; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Jacobsohn DA, 2011, BLOOD, V118, P4472, DOI 10.1182/blood-2011-04-349068; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Arora M, 2011, BLOOD, V117, P6714, DOI 10.1182/blood-2010-12-323824; Weisdorf D, 2008, BIOL BLOOD MARROW TR, V14, P748, DOI 10.1016/j.bbmt.2008.04.003; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Arora M, 2003, BIOL BLOOD MARROW TR, V9, P38, DOI 10.1053/bbmt.2003.50003; Arora M, 2013, LEUKEMIA, V27, P1196, DOI 10.1038/leu.2012.292; Eapen M, 2007, BIOL BLOOD MARROW TR, V13, P1461, DOI 10.1016/j.bbmt.2007.08.006; Inamoto Y, 2014, BLOOD, V123, P453, DOI 10.1182/blood-2013-11-536581; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lee JH, 2003, BRIT J HAEMATOL, V122, P637, DOI 10.1046/j.1365-2141.2003.04472.x; OCHS LA, 1994, BONE MARROW TRANSPL, V13, P455; STORB R, 1983, ANN INTERN MED, V98, P461	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	APR	2015	21	4					640	645		10.1016/j.bbmt.2014.10.022		6	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CE4GY	WOS:000351790300010		
J	Kawada, H; Yoshimitsu, M; Nakamura, D; Arai, A; Hayashida, M; Kamada, Y; Maekawa, K; Fujino, S; Arima, M; Arima, N; Tabuchi, T; Inoue, H; Hamda, H; Suzuki, S; Matsushita, K; Arima, N				Kawada, Hideaki; Yoshimitsu, Makoto; Nakamura, Daisuke; Arai, Akihiko; Hayashida, Maiko; Kamada, Yuhei; Maekawa, Kenichi; Fujino, Satoshi; Arima, Mamiko; Arima, Naosuke; Tabuchi, Tomohisa; Inoue, Hirosaka; Hamda, Heiichiro; Suzuki, Shinsuke; Matsushita, Kakushi; Arima, Naomichi			A Retrospective Analysis of Treatment Outcomes in Adult T Cell Leukemia/Lymphoma Patients with Aggressive Disease Treated with or without Allogeneic Stem Cell Transplantation: A Single-Center Experience	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Adult T cell leukemia/lymphoma; Allogeneic stem cell transplantation	LEUKEMIA-LYMPHOMA; COMBINATION CHEMOTHERAPY; EXPRESSION; GRAFT	Adult T cell leukemia/lymphoma (ATL) is an aggressive peripheral T cell neoplasm with very poor prognosis. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been reported as a curative treatment modality for ATE However, there are no reports comparing chemotherapy alone with allo-HSCT in ATE In this report, we retrospectively analyzed data for patients treated with (n = 29, median age 55 years) or without allo-HSCT (n = 37, median age 58 years) for ATL in Kagoshima University Hospital, located in one of the most endemic areas of human T cell lymphotropic leukemia virus type 1 infection. Forty patients (61%) started coordination for allo-HSCT. Ten patients (34.4%) received allo-HSCT while in complete remission (CR), whereas the others were not in CR. Twenty-five patients (86.2%) received reduced-intensity conditioning, and the others received myeloablative conditioning. With a median follow-up period for survivors of 41 months (range, 5 to 125 months), the 3-year overall survival (OS) rate from first chemotherapy for all patients (with or without allo-HSCT) was 35.2%. The 3-year OS from first chemotherapy for patients who received allo-HSCT or only chemotherapy was 44.9% and 27.7%, respectively. Univariate analyses revealed that high serum soluble IL-2 receptor (sIL-2R) levels (>= 2000 U/mL) just before the conditioning regimen and progressive disease (PD) status at HSCT (according to Japan Clinical Oncology Group Study 0907 criteria) were significant risk factors for OS in the allo-HSCT group. Multivariate analyses revealed that PD status was a significant risk factor for OS in the allo-HSCT group. In the chemotherapy-only group, the 3-year OS rate was 61.5% (95% CI, 30.8% to 81.8%) in patients with serum sIL-2R levels <2000 U/mL for >3 months. In contrast, the 3-year OS rate was 5.7% (95% a, .4% to 22.4%) in patients who did not achieve serum sIL-2R levels <2000 U/mL for >3 months. Our single-center cohort experience indicates that chemosensitivity is the most important prognostic factor for OS in ATL patients and the use of allo-HSCT is limited in chemorefractory patients with aggressive ATL disease. In the chemosensitive patients, allo-HSCT demonstrated a tendency toward better OS. Further clinical studies are warranted to determine optimal treatments for patients who are less sensitive to conventional chemotherapy. (C) 2015 American Society for Blood and Marrow Transplantation.	[Kawada, Hideaki; Yoshimitsu, Makoto; Nakamura, Daisuke; Arai, Akihiko; Hayashida, Maiko; Kamada, Yuhei; Maekawa, Kenichi; Fujino, Satoshi; Arima, Mamiko; Arima, Naosuke; Tabuchi, Tomohisa; Inoue, Hirosaka; Hamda, Heiichiro; Suzuki, Shinsuke; Matsushita, Kakushi; Arima, Naomichi] Kagoshima Univ Hosp, Dept Hematol & Immunol, Kagoshima, Japan; [Yoshimitsu, Makoto; Nakamura, Daisuke; Arai, Akihiko; Arima, Naomichi] Kagoshima Univ, Ctr Chron Viral Dis, Div Hematol & Immunol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	Yoshimitsu, M (reprint author), Kagoshima Univ, Ctr Chron Viral Dis, Div Hematol & Immunol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan.	myoshimi@m.kufm.kagoshima-u.ac.jp					Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Kozako T, 2009, LEUKEMIA, V23, P375, DOI 10.1038/leu.2008.272; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Ishida T, 2012, BLOOD, V120, P1734, DOI 10.1182/blood-2012-03-414490; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Chibueze CE, 2014, BIOCHEM BIOPH RES CO, V453, P379, DOI 10.1016/j.bbrc.2014.09.084; Ezinne CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087631; Fujiwara H, 2008, INT J HEMATOL, V87, P319, DOI 10.1007/s12185-008-0042-2; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Matsushita K, 1999, LEUKEMIA LYMPHOMA, V36, P67, DOI 10.3109/10428199909145950; Shigematsu A, 2014, BIOL BLOOD MARROW TR, V20, P801, DOI 10.1016/j.bbmt.2014.02.014; Shiratori S, 2008, BIOL BLOOD MARROW TR, V14, P817, DOI 10.1016/j.bbmt.2008.04.014	16	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	APR	2015	21	4					696	700		10.1016/j.bbmt.2014.12.020		5	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CE4GY	WOS:000351790300018		
J	Kodani, S; Komaki, H; Suzuki, M; Hemmi, H; Ohnishi-Kameyama, M				Kodani, Shinya; Komaki, Hisayuki; Suzuki, Masahiro; Hemmi, Hikaru; Ohnishi-Kameyama, Mayumi			Isolation and structure determination of new siderophore albachelin from Amycolatopsis alba	BIOMETALS			English	Article						Siderophore; Amycolatopsis alba; Peptide; Biosynthesis	NONRIBOSOMAL PEPTIDE SYNTHETASE; STREPTOMYCES-COELICOLOR GENOME; GENE CLUSTERS; BIOSYNTHESIS; ERYTHROCHELIN; POLYKETIDE; PREDICTION; DISCOVERY; PATHWAYS; SEQUENCE	A new siderophore named albachelin was isolated from iron deficient culture of Amycolatopsis alba. The planar structure of albachelin was elucidated by the combination of ESI-MS/MS experiment and NMR spectroscopic analyses of the gallium (III) complex. The structure of albachelin was determined to be a linear peptide consisting of 6 mol of amino acids including 3 mol of serine, one mol each of N-alpha-acethyl-N-delta-hydroxy-N-delta-formylornithine, N-alpha-methyl-N-delta-hydroxyornithine, and cyclic N-hydroxyornithine. The stereochemistries of amino acids constituting albachelin were analyzed by applying modified Marfey method to the hydrolysate of albachelin. Based on bioinformatics, we deduced and discussed the possible biosynthetic gene cluster involved in albachelin biosynthesis from the genome sequence of A. alba. By prediction of substrates for adenylation domains, a non-ribosomal peptide biosynthetase gene (AMYAL_RS0130210) was proposed to be the main biosynthetic gene for albachelin biosynthesis. The related genes including transporter for siderophore were found near the NRPS gene as a gene cluster.	[Kodani, Shinya; Suzuki, Masahiro] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan; [Komaki, Hisayuki] Natl Inst Technol & Evaluat NBRC, Biol Resource Ctr, Chiba 2920818, Japan; [Hemmi, Hikaru; Ohnishi-Kameyama, Mayumi] Natl Agr & Food Res Org NARO, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Kodani, S (reprint author), Shizuoka Univ, Grad Sch Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	kodani.shinya@shizuoka.ac.jp			Japan Society for the Promotion of Science [25350964]	This study was supported by the Japan Society for the Promotion of Science by Grants-in-aids (Grant Number 25350964).	Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Ochi K, 2013, APPL MICROBIOL BIOT, V97, P87, DOI 10.1007/s00253-012-4551-9; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Komaki H, 2012, J GEN APPL MICROBIOL, V58, P363; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117; Zerikly M, 2009, CHEMBIOCHEM, V10, P625, DOI 10.1002/cbic.200800389; Mercier A, 2010, APPL ENVIRON MICROB, V76, P3806, DOI 10.1128/AEM.00659-10; Seyedsayamdost MR, 2011, J AM CHEM SOC, V133, P11434, DOI 10.1021/ja203577e; Challis GL, 2000, FEMS MICROBIOL LETT, V187, P111, DOI 10.1111/j.1574-6968.2000.tb09145.x; Clardy J, 2006, ACS CHEM BIOL, V1, P17, DOI 10.1021/cb0600029; Harada K, 1996, TETRAHEDRON LETT, V37, P3001, DOI 10.1016/0040-4039(96)00484-4; Kodani S, 2013, NAT PROD RES, V27, P775, DOI 10.1080/14786419.2012.698412; Kodani S, 2013, ORG BIOMOL CHEM, V11, P4686, DOI 10.1039/c3ob40536b; Komaki H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-323; Lazos O, 2010, CHEM BIOL, V17, P160, DOI 10.1016/j.chembiol.2010.01.011; Park HM, 2013, APPL MICROBIOL BIOT, V97, P1213, DOI 10.1007/s00253-012-4268-9; Robbel L, 2010, FEBS J, V277, P663, DOI 10.1111/j.1742-4658.2009.07512.x; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323	23	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	APR	2015	28	2					381	389		10.1007/s10534-015-9842-z		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE3RE	WOS:000351745200012		
J	Takahashi, S; Aizawa, K; Nakamura, S; Nakayama, K; Fujisaki, S; Watanabe, S; Satoh, H				Takahashi, Shigekazu; Aizawa, Kyoko; Nakamura, Saki; Nakayama, Katsumi; Fujisaki, Shingo; Watanabe, Soichiro; Satoh, Hiroyuki			Accumulation of alkaline earth metals by the green macroalga Bryopsis maxima	BIOMETALS			English	Article						Alkaline earth metal; Strontium; Bryopsis maxima; Nuclear accident; Phytoaccumulation; Ulva arasakii	FUKUSHIMA; STRONTIUM; RADIOCESIUM; ACCIDENT; IODINE; BARIUM; PLANTS	Twenty-five days after the disaster at the Fukushima Daiichi nuclear power plant in 2011, we collected samples of the green macroalga Bryopsis maxima from the Pacific coast of Japan. Bryopsis maxima is a unicellular, multinuclear, siphonous green macroalga. Radiation analysis revealed that B. maxima emitted remarkably high gamma radiation of I-131, Cs-134, Cs-137, and Ba-140 as fission products of U-235. Interestingly, B. maxima contained naturally occurring radionuclides derived from Ra-226 and Ra-228. Analysis of element content revealed that B. maxima accumulates many ocean elements, especially high quantities of the alkaline earth metals Sr (15.9 g per dry-kg) and Ba (3.79 g per dry-kg), whereas Ca content (12.5 g per dry-kg) was lower than that of Sr and only 61 % of the mean content of 70 Japanese seaweed species. Time-course analysis determined the rate of radioactive Sr-85 incorporation into thalli to be approximately 0.13 g Sr per dry-kg of thallus per day. Subcellular fractionation of B. maxima cells showed that most of the Sr-85 was localized in the soluble fraction, predominantly in the vacuole or cytosol. Given that Sr-85 radioactivity was permeable through a dialysis membrane, the Sr-85 was considered to be a form of inorganic ion and/or bound with a small molecule. Precipitation analysis with sodium sulfate showed that more than 70 % of the Sr did not precipitate as SrSO4, indicating that a proportion of the Sr may bind with small molecules in B. maxima.	[Takahashi, Shigekazu; Aizawa, Kyoko; Nakamura, Saki; Nakayama, Katsumi; Fujisaki, Shingo; Watanabe, Soichiro; Satoh, Hiroyuki] Toho Univ, Dept Biomol Sci, Chiba 2748510, Japan	Satoh, H (reprint author), Toho Univ, Dept Biomol Sci, 2-2-1 Miyama, Chiba 2748510, Japan.	hsatoh@biomol.sci.toho-u.ac.jp			JSPS KAKENHI [26660009]; Development of New Technology Foundation [22-23]; Grant for Research in Basic Science from Toho University	The authors thank Professor Masashi Takahashi for his kind gamma-ray spectrometry measurement. This work was supported in part by JSPS KAKENHI Grant no. 26660009, a Grant for Plant Research from the Development of New Technology Foundation (no. 22-23), and a Grant for Research in Basic Science from Toho University.	Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Yamashita J, 2014, J PLANT RES, V127, P11, DOI 10.1007/s10265-013-0605-z; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Fukuda S, 2014, J PLANT RES, V127, P79, DOI 10.1007/s10265-013-0596-9; Tanaka S, 2012, P JPN ACAD B-PHYS, V88, P471, DOI 10.2183/pjab.88.471; Sharma S, 2015, ENVIRON SCI POLLUT R, V22, P946, DOI 10.1007/s11356-014-3635-8; Kobayashi D, 2014, J PLANT RES, V127, P51, DOI 10.1007/s10265-013-0607-x; Krejci MR, 2011, J STRUCT BIOL, V176, P192, DOI 10.1016/j.jsb.2011.08.006; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Kupper FC, 1998, PLANTA, V207, P163, DOI 10.1007/s004250050469; Dunn CE, 1998, PLANTS THAT HYPERACCUMULATE HEAVY METALS: THEIR ROLE IN PHYTOREMEDIATION, MICROBIOLOGY, ARCHAEOLOGY, MINERAL EXPLORATION AND PHYTOMINING, P119; Hirose K, 2011, J ENVIRON RADIOACTIV, V111, P13, DOI DOI 10.1016/J; RJG (Report of Japanese Government), 2011, ACC TEPCOS FUK NUCL; Shimura H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044200; WILCOCK JR, 1989, PROC R SOC SER B-BIO, V238, P203, DOI 10.1098/rspb.1989.0077; Yamamoto T, 1995, T RES I OCEANOCHEMIS, V8, P21	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	APR	2015	28	2					391	400		10.1007/s10534-015-9843-y		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE3RE	WOS:000351745200013		
J	Hashimoto, M; Wakana, D; Ueda, M; Kobayashi, D; Goda, Y; Fujii, I				Hashimoto, Makoto; Wakana, Daigo; Ueda, Miki; Kobayashi, Daisuke; Goda, Yukihiro; Fujii, Isao			Product identification of non-reducing polyketide synthases with C-terminus methyltransferase domain from Talaromyces stipitatus using Aspergillus oryzae heterologous expression	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Polyketide; Biosynthesis; Fungi; Non-reducing polyketide synthase; C-Methyltransferase domain	PENICILLIUM-STIPITATUM; GENE-CLUSTER; NIDULANS; REVEAL	Talaromyces stipitatus ATCC 10500 possesses 17 non-reducing polyketide synthase (NR-PKS) genes. During the course of our functional analysis of PKS genes with a C-terminus methyltransferase domain from T. stipitatus, we expressed tspks2, tspks3 and tspks4 genes in the heterologous host Aspergillus oryzae, respectively. Although the tspks4 transformant gave no apparent product in HPLC analysis, a novel azaphilone pentaketide (3) was identified along with two known related products from the tspks2 transformant. Of four hexaketide products from the tspks3 transformant, two new compounds were identified to be 2-acetyl-7-methyl-3,6,8-trihydroxynaphthalene (4) and its derivative fused with alpha-methyl-alpha,beta-unsaturated gamma-lactone (7). (C) 2015 Elsevier Ltd. All rights reserved.	[Hashimoto, Makoto; Ueda, Miki; Kobayashi, Daisuke; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Wakana, Daigo; Goda, Yukihiro] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	Fujii, I (reprint author), Iwate Med Univ, Sch Pharm, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	ifujii@iwate-med.ac.jp					Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Zabala AO, 2012, CHEM BIOL, V19, P1049, DOI 10.1016/j.chembiol.2012.07.004; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; AYER WA, 1990, CAN J CHEM, V68, P2085, DOI 10.1139/v90-318; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Winter JM, 2012, J AM CHEM SOC, V134, P17900, DOI 10.1021/ja3090498; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Liu T, 2011, J AM CHEM SOC, V133, P13314, DOI 10.1021/ja205780g; Davison J, 2012, P NATL ACAD SCI USA, V109, P7642, DOI 10.1073/pnas.1201469109; Chiang YM, 2013, J AM CHEM SOC, V135, P7720, DOI 10.1021/ja401945a; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Ahuja M, 2012, J AM CHEM SOC, V134, P8212, DOI 10.1021/ja3016395; LYNN DG, 1982, J AM CHEM SOC, V104, P7319, DOI 10.1021/ja00389a073; Bailey A. M., 2007, CHEM COMMUN, P4053; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Eijk G. W. V., 1973, EXPERIENTIA, V29, P522, DOI 10.1007/BF01926640; FRISVAD JC, 1990, ANTON LEEUW INT J G, V57, P179, DOI 10.1007/BF00403953; FUSKA J, 1988, FOLIA MICROBIOL, V33, P238, DOI 10.1007/BF02925912; Hosoe T, 2011, J ANTIBIOT, V64, P211, DOI 10.1038/ja.2010.132; Isono F., 2004, Jpn. Pat., Patent No. [JP 2004307426, 2004307426]; KUHR I, 1973, J ANTIBIOT, V26, P535; Watanabe A, 2002, TETRAHEDRON LETT, V43, P843, DOI 10.1016/S0040-4039(01)02251-1	24	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1381	1384		10.1016/j.bmcl.2015.02.057		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700003		
J	Ichimaru, Y; Saito, H; Uchiyama, T; Metori, K; Tabata, K; Suzuki, T; Miyairi, S				Ichimaru, Yoshimi; Saito, Hiroaki; Uchiyama, Taketo; Metori, Koichi; Tabata, Keiichi; Suzuki, Takashi; Miyairi, Shinichi			Indirubin 3 '-(O-oxiran-2-ylmethyl)oxime: A novel anticancer agent	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Indirubin; Epoxide; Anticancer agent; Metabolism; Adduct	GLYCOGEN-SYNTHASE KINASE-3-BETA; CYCLIN-DEPENDENT KINASES; INDUCE APOPTOSIS; TYRIAN PURPLE; DERIVATIVES; CELLS; INHIBITORS; BINDING; SELECTIVITY; METABOLISM	Indirubin is a potent inhibitor of cell cycle-related protein kinases by binding to the ATP-binding site and thus is a promising compound for development as an antitumor drug. We prepared indirubin 3'-(O-oxiran-2-ylmethyl)oxime (Epox/Ind), in which the ATP-binding site orientated part was attached by non-specific alkylating group. The IC50 value of Epox/Ind at 1.7 mu M in HepG2 cells is comparable to that of cisplatin (4.0 mu M). Furthermore, Epox/Ind was shown to be metabolized by a HepG2 cell lysate into indirubin 3'-(O-2,3-dihydroxypropyl)oxime (E804), the sole extractable metabolite. The lower toxicity of this metabolite may explain the lack of cytotoxicity of 1 mu M Epox/Ind observed in HepG2 cells beyond an initial loss of viability in the first 24 h of treatment. (C) 2015 Elsevier Ltd. All rights reserved.	[Ichimaru, Yoshimi; Saito, Hiroaki; Uchiyama, Taketo; Metori, Koichi; Tabata, Keiichi; Suzuki, Takashi; Miyairi, Shinichi] Nihon Univ, Sch Pharm, Funabashi, Chiba 2748555, Japan	Miyairi, S (reprint author), Nihon Univ, Sch Pharm, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	miyairi.shinichi@nihon-u.ac.jp			JST [AS242Z03636Q]; Nihon University (Multidisciplinary Research Grants) [10-041, 11-029, 14-023]; Nihon University School of Pharmacy (Joint Research Grant) [13-01]	The authors are grateful to Ms. Kyoko Hanaoka, Ms. Mina Kaneko, Ms. Junna Kareki, Ms. Yoshino Umehara and Ms. Misaki Anzai for technical assistance in the experimental work. This work was supported by grants from JST (Grant No. AS242Z03636Q), Nihon University (Multidisciplinary Research Grants (Grant Nos. 10-041, 11-029 and 14-023) for 2010, 2011 and 2014), and Nihon University School of Pharmacy (Joint Research Grant (Grant No. 13-01)).	Johnson WW, 1997, CHEM RES TOXICOL, V10, P672, DOI 10.1021/tx960209j; Leclerc S, 2001, J BIOL CHEM, V276, P251; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Saito H, 2011, BIOORG MED CHEM LETT, V21, P5370, DOI 10.1016/j.bmcl.2011.07.011; Abbas T, 2002, J BIOL CHEM, V277, P40513, DOI 10.1074/jbc.M205495200; Schwartz PA, 2014, P NATL ACAD SCI USA, V111, P173, DOI 10.1073/pnas.1313733111; Mok CKP, 2014, ANTIVIR RES, V106, P95, DOI 10.1016/j.antiviral.2014.03.019; Hoessel R, 1999, NAT CELL BIOL, V1, P60; Jautelat R, 2005, CHEMBIOCHEM, V6, P531, DOI 10.1002/cbic.200400108; Cheng XL, 2010, BIOORGAN MED CHEM, V18, P4509, DOI 10.1016/j.bmc.2010.04.066; Adachi J, 2001, J BIOL CHEM, V276, P31475, DOI 10.1074/jbc.C100238200; Nam S, 2012, MOL ONCOL, V6, P276, DOI 10.1016/j.molonc.2012.02.002; Ferandin Y, 2006, J MED CHEM, V49, P4638, DOI 10.1021/jm060314i; Choi SJ, 2010, J MED CHEM, V53, P3696, DOI 10.1021/jm100080z; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Myrianthopoulos V, 2013, ACS MED CHEM LETT, V4, P22, DOI 10.1021/ml300207a; Dominguez JM, 2012, J BIOL CHEM, V287, P893, DOI 10.1074/jbc.M111.306472; BRESNICK E, 1977, ARCH BIOCHEM BIOPHYS, V183, P31, DOI 10.1016/0003-9861(77)90415-5; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, P1; MARSHALL AD, 1992, FOOD CHEM TOXICOL, V30, P467, DOI 10.1016/0278-6915(92)90097-5; Odii B. O., 2012, J CANC THER, V3, P216; Shin EK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-164; Tanaka T, 2014, EUR J PHARMACOL, V741, P83, DOI 10.1016/j.ejphar.2014.07.035; Vougogiannopoulou K, 2012, PLANTA MED, V78, P1515, DOI 10.1055/s-0032-1315261; Vougogiannopoulou K, 2008, J MED CHEM, V51, P6421, DOI 10.1021/jm800648y; Wang TC, 2010, CHINESE CHEM LETT, V21, P1407, DOI 10.1016/j.cclet.2010.05.026	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1403	1406		10.1016/j.bmcl.2015.02.053		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700008		
J	Wakao, M; Obata, R; Miyachi, K; Kaitsubata, Y; Kondo, T; Sakami, C; Suda, Y				Wakao, Masahiro; Obata, Rumi; Miyachi, Kento; Kaitsubata, Yuhei; Kondo, Takao; Sakami, Chiho; Suda, Yasuo			Synthesis of a chondroitin sulfate disaccharide library and a GAG-binding protein interaction analysis	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Synthesis; Chondroitin sulfate; Library; Sugar Chip; Glycosaminoglycan	METHYL GLYCOSIDES; DERMATAN SULFATE; GROWTH-FACTORS; SUGAR CHIPS; GLYCOSAMINOGLYCANS; 4-SULFATE; ACETALS; UNITS	Chondroitin sulfate (CS), which belongs to the glycosaminoglycan (GAG) superfamily, is a linear sulfated polysaccharide involved in various biological processes. CS structure is very heterogeneous and contains various sulfation patterns owing to the multiple and random enzymatic modifications that occur during its biosynthesis. The resultant microdomain structure in the CS chain interacts with specific biomolecules to regulate biological functions. Therefore, an analysis of the structure-activity relationship of CS at the molecular level is necessary to clarify their biofunctions. In this study, we designed the common intermediate possessing an orthogonally removable protective group and systematically synthesized all 16 types of CS disaccharide structure generated by sulfation. In addition, we demonstrated the on-time analysis of the binding properties of GAG-binding proteins using 'Sugar Chip' immobilized CS disaccharide structures by surface plasmon resonance (SPR) imaging, indicating that our chip technology is effective for the evaluation of binding properties. (C) 2015 Elsevier Ltd. All rights reserved.	[Wakao, Masahiro; Obata, Rumi; Miyachi, Kento; Kaitsubata, Yuhei; Kondo, Takao; Sakami, Chiho; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan; [Suda, Yasuo] SUDx Biotec Corp, Kagoshima 8900013, Japan	Wakao, M (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	wakao@eng.kagoshima-u.ac.jp; ysuda@eng.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) [21710233, 23300356]; Japan Science and Technology Agency (JST) [AS2416907P]; Japan Ministry of Health, Labor and Welfare (Nano-Medicine) [H21-nano-ippan-002]	The present research was financially supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) (Grant-in-Aid for Young Scientists B, Kakenhi 21710233 to M.W. and Grant-in-Aid for Scientific Research B, Kakenhi 23300356 to Y.S.), Japan Science and Technology Agency (JST) (A-Step, Post-venture Support, AS2416907P to Y.S.), and Japan Ministry of Health, Labor and Welfare (Nano-Medicine, H21-nano-ippan-002 to Y.S.).	Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540290114450; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Jacquinet JC, 2009, CHEM-EUR J, V15, P9579, DOI 10.1002/chem.200900741; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Eller S, 2013, ANGEW CHEM INT EDIT, V52, P5858, DOI 10.1002/anie.201210132; Ohlin M, 2011, CARBOHYD RES, V346, P1358, DOI 10.1016/j.carres.2011.03.032; Sakagami M, 2000, TETRAHEDRON LETT, V41, P5547, DOI 10.1016/S0040-4039(00)00877-7; Wakao M, 2008, BIOORG MED CHEM LETT, V18, P2499, DOI 10.1016/j.bmcl.2008.01.069; Karst N, 2002, EUR J ORG CHEM, P815; Suda Y, 2006, BIOCONJUGATE CHEM, V17, P1125, DOI 10.1021/bc0600620; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja048045; Bedini E, 2012, CHEM-EUR J, V18, P2123, DOI 10.1002/chem.201102458; Lubineau A, 1999, EUR J ORG CHEM, P2523; Tamura J, 2012, BIOORG MED CHEM LETT, V22, P1371, DOI 10.1016/j.bmcl.2011.12.054; Fujikawa S, 2005, BIOMACROMOLECULES, V6, P2935, DOI 10.1021/bm050364p; FUKASE K, 1990, TETRAHEDRON LETT, V31, P389; Hashiguchi T, 2010, GLYCOCONJUGATE J, V27, P49, DOI 10.1007/s10719-009-9253-x; JACQUINET JC, 1990, CARBOHYD RES, V199, P153, DOI 10.1016/0008-6215(90)84259-W; Maza S., 2013, ORG BIOMOL CHEM, V42, P3510; Mikami T, 2006, TRENDS GLYCOSCI GLYC, V18, P165; Tamura J., 1998, CARBOHYD RES, V305, P43; Volpi N, 2006, ADV PHARMACOL, V53, pXXV; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289, DOI 10.2174/157016308786733564	24	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1407	1411		10.1016/j.bmcl.2015.02.054		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700009		
J	Sakamoto, T; Koga, Y; Hikota, M; Matsuki, K; Mochida, H; Kikkawa, K; Fujishige, K; Kotera, J; Omori, K; Morimoto, H; Yamada, K				Sakamoto, Toshiaki; Koga, Yuichi; Hikota, Masataka; Matsuki, Kenji; Mochida, Hideki; Kikkawa, Kohei; Fujishige, Kotomi; Kotera, Jun; Omori, Kenji; Morimoto, Hiroshi; Yamada, Koichiro			8-(3-Chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						PDE5; PDE6; Erectile dysfunction	ERECTILE DYSFUNCTION; PDE5 INHIBITORS; DISCOVERY; TADALAFIL; ANALOGS	A novel series of highly selective phosphodiesterase 5 (PDE5) inhibitors was found. 8H-Pyrido[2,3-d]pyrimidin-7-one derivatives bearing an (S)-2-(hydroxymethyl)pyrrolidin-1-yl group at the 2-position and a 3-chloro-4-methoxybenzyl group at the 8-position exhibited potent PDE5 inhibitory activities and high PDE5 selectivity over PDE6. Among the synthesized compounds, the 5-methyl analogue (5b) showed the most potent relaxant effect on isolated rabbit corpus cavernosum with an EC30 value of 0.85 nM. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakamoto, Toshiaki; Koga, Yuichi; Hikota, Masataka; Matsuki, Kenji; Morimoto, Hiroshi; Yamada, Koichiro] Mitsubishi Tanabe Pharma Corp, Med Chem Res Labs 2, Toda, Saitama 3358505, Japan; [Mochida, Hideki; Kikkawa, Kohei] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 2, Toda, Saitama 3358505, Japan; [Fujishige, Kotomi; Kotera, Jun; Omori, Kenji] Mitsubishi Tanabe Pharma Corp, Adv Med Res Labs, Toda, Saitama 3358505, Japan; [Omori, Kenji] Nagoya Univ, Grad Sch Pharmaceut Sci, Lab Target & Drug Discovery, Ind & Acad Cooperat Res Project,Chikusa Ku, Nagoya, Aichi 4648601, Japan	Morimoto, H (reprint author), Mitsubishi Tanabe Pharma Corp, Med Chem Res Labs 2, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan.	morimoto.hiroshi@md.mt-pharma.co.jp					Daugan A, 2003, J MED CHEM, V46, P4525, DOI 10.1021/jm030056e; Fiorito J, 2013, EUR J MED CHEM, V60, P285, DOI 10.1016/j.ejmech.2012.12.009; Hughes RO, 2009, BIOORG MED CHEM LETT, V19, P5209, DOI 10.1016/j.bmcl.2009.07.019; Moreland RB, 2001, J PHARMACOL EXP THER, V296, P225; Daugan A, 2003, J MED CHEM, V46, P4533, DOI 10.1021/jm0300577; Giuliano F, 2010, INT J CLIN PRACT, V64, P240, DOI 10.1111/j.1742-1241.2009.02254.x; Choi H, 2010, BIOORG MED CHEM LETT, V20, P383, DOI 10.1016/j.bmcl.2009.10.071; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Gong XD, 2013, BIOORG MED CHEM LETT, V23, P4944, DOI 10.1016/j.bmcl.2013.06.062; Lue TF, 2000, NEW ENGL J MED, V342, P1802; Marmor MF, 1999, SURV OPHTHALMOL, V44, P153, DOI 10.1016/S0039-6257(99)00079-X; PIWINSKI JJ, 1991, J MED CHEM, V34, P457, DOI 10.1021/jm00105a069; Sakamoto T, 2014, BIOORG MED CHEM LETT, V24, P5175, DOI 10.1016/j.bmcl.2014.09.082; Sakamoto T, 2014, BIOORG MED CHEM LETT, V24, P5460, DOI 10.1016/j.bmcl.2014.10.008; Singh T P, 2010, Expert Rev Respir Med, V4, P13, DOI 10.1586/ers.09.71; TAGUCHI H, 1974, B CHEM SOC JPN, V47, P2529, DOI 10.1246/bcsj.47.2529; Watanabe N, 2000, J MED CHEM, V43, P2523, DOI 10.1021/jm9905054; Yu GX, 2001, J MED CHEM, V44, P1025, DOI 10.1021/jm0155042	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1431	1435		10.1016/j.bmcl.2015.02.041		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700014		
J	Kusumi, K; Shinozaki, K; Kanaji, T; Kurata, H; Naganawa, A; Otsuki, K; Matsushita, T; Sekiguchi, T; Kakuuchi, A; Seko, T				Kusumi, Kensuke; Shinozaki, Koji; Kanaji, Toshiya; Kurata, Haruto; Naganawa, Atsushi; Otsuki, Kazuhiro; Matsushita, Takeshi; Sekiguchi, Tetsuya; Kakuuchi, Akito; Seko, Takuya			Discovery of novel S1P2 antagonists. Part 1: Discovery of 1,3-bis(aryloxy)benzene derivatives	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Sphingosine-1-phosphate receptor 2; Antagonist; G protein-coupled receptors	SPHINGOSINE 1-PHOSPHATE RECEPTORS; VASCULAR-PERMEABILITY	The structure-activity relationships of a novel series of sphingosine-1-phosphate receptor antagonists have been examined in detail. The initial hit compound 1 was modified through synthesis to improve its S1P2 activity. The synthesis of a series of analogs revealed that 1,3-bis(aryloxy) benzene derivatives, as represented by 22, are potent and selective S1P2 antagonists. (C) 2015 Elsevier Ltd. All rights reserved.	[Kusumi, Kensuke; Kanaji, Toshiya; Kurata, Haruto; Naganawa, Atsushi; Otsuki, Kazuhiro; Matsushita, Takeshi; Sekiguchi, Tetsuya; Kakuuchi, Akito] Ono Pharmaceut Co Ltd, Minase Res Inst, Mishima, Osaka 6188585, Japan; [Shinozaki, Koji] Ono Pharma UK Ltd, London WC1V 6EA, England; [Seko, Takuya] Ono Pharmaceut Co Ltd, Head Off, Chuo Ku, Osaka 5418564, Japan	Kusumi, K (reprint author), Ono Pharmaceut Co Ltd, Minase Res Inst, 3-1-1 Sakurai, Mishima, Osaka 6188585, Japan.	kusumi@ono.co.jp					Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C220176200; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Osada M, 2002, BIOCHEM BIOPH RES CO, V299, P483, DOI 10.1016/S0006-291X(02)02671-2; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Roviezzo F, 2011, J PHARMACOL EXP THER, V337, P830, DOI 10.1124/jpet.111.179168; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Victoria A. Blaho, 2014, J LIPID RES, V55, P1596; Victoria A. Blaho, 2011, CHEM REV, V111, P6299	10	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1479	1482		10.1016/j.bmcl.2015.02.029		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700024		
J	Wada, K; Ohkoshi, E; Zhao, Y; Goto, M; Morris-Natschke, SL; Lee, KH				Wada, Koji; Ohkoshi, Emika; Zhao, Yu; Goto, Masuo; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung			Evaluation of Aconitum diterpenoid alkaloids as antiproliferative agents	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Diterpenoid alkaloids; Pseudokobusine; Antiproliferative agents	MACROYESOENSE NAKAI TAMURA; IONIZATION MASS-SPECTROMETRY; CUTANEOUS BLOOD-FLOW; YESOENSE VAR. MACROYESOENSE; PSEUDOKOBUSINE DERIVATIVES; NORDITERPENOID ALKALOIDS; SUBCUNEATUM NAKAI; JAPONICUM THUNB; CONSTITUENTS; MICE	Little information has been reported on the antitumor effects of the diterpenoid alkaloid constituents of Aconitum plants, used in the herbal drug 'bushi'. This study was aimed at determining the antitumor activities of Aconitum C-19-and C-20-diterpenoid alkaloids and synthetic derivatives against lung (A549), prostate (DU145), nasopharyngeal (KB), and vincristine-resistant nasopharyngeal (KB-VIN) cancer cell lines. Newly synthesized C-20-diterpenoid alkaloid derivatives showed substantial suppressive effects against all human tumor cell lines tested. In contrast, natural and derivatized C-19-diterpenoid alkaloids showed only a slight or no effect. Most of the active compounds were hetisine-type C-20-diterpenoid alkaloids, specifically kobusine and pseudokobusine analogs with two different substitution patterns, C-11 and C-11,15. Notably, several C-20-diterpenoid alkaloids were more potent against multidrug-resistant KB subline KB-VIN cells. Pseudokobusine 11-3'-trifluoromethylbenzoate (94) is a possible promising new lead meriting additional evaluation against multidrug-resistant tumors. (C) 2015 Elsevier Ltd. All rights reserved.	[Wada, Koji] Hokkaido Pharmaceut Univ, Sch Pharm, Otaru, Hokkaido 0470264, Japan; [Wada, Koji; Ohkoshi, Emika; Zhao, Yu; Goto, Masuo; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	Lee, KH (reprint author), Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA.	khlee@unc.edu			NIH grant from the National Cancer Institute [CA177584]	This work was supported by NIH grant CA177584 from the National Cancer Institute awarded to K. H. Lee.	Amiya T., 1988, ALKALOIDS, V34, P95; Wang FP, 2010, NAT PROD REP, V27, P529, DOI 10.1039/b916679c; PELLETIER SW, 1986, NAT PROD REP, V3, P451, DOI 10.1039/np9860300451; Wang FP, 2010, ALKALOIDS-CHEM BIOL, V69, P1, DOI 10.1016/S1099-4831(10)69001-3; WADA K, 1985, CHEM PHARM BULL, V33, P3658; PELLETIER SW, 1984, NAT PROD REP, V1, P375, DOI 10.1039/np9840100375; WADA K, 1994, BIOL MASS SPECTROM, V23, P97, DOI 10.1002/bms.1200230209; BANDO H, 1981, HETEROCYCLES, V16, P1723; BANDO H, 1988, CHEM PHARM BULL, V36, P1604; BANDO H, 1989, HETEROCYCLES, V29, P1293; BANDO H, 1987, HETEROCYCLES, V26, P2623; Chodoeva A, 2005, BIOORGAN MED CHEM, V13, P6493, DOI 10.1016/j.bmc.2005.07.015; de Ines C, 2006, Z NATURFORSCH C, V61, P11; Hazawa M, 2011, INVEST NEW DRUG, V29, P1, DOI 10.1007/s10637-009-9327-4; Hazawa M, 2009, INVEST NEW DRUG, V27, P111, DOI 10.1007/s10637-008-9141-4; MORI T, 1983, CHEM PHARM BULL, V31, P2884; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Wada K, 1997, BIOL PHARM BULL, V20, P978; Wada K, 2000, CHEM PHARM BULL, V48, P660; WADA K, 1985, HETEROCYCLES, V23, P2473; Wada K, 2011, J NAT MED-TOKYO, V65, P43, DOI 10.1007/s11418-010-0452-3; BANDO H, 1985, CHEM PHARM BULL, V33, P4717; Wada K, 2012, BIOORG MED CHEM LETT, V22, P249, DOI 10.1016/j.bmcl.2011.11.026; Wada K, 2009, HELV CHIM ACTA, V92, P629; WADA K, 1990, HETEROCYCLES, V31, P1081; Wada K, 2000, BIOL PHARM BULL, V23, P607; Wada K, 2007, J NAT PROD, V70, P1854, DOI 10.1021/np070270w; Wada K, 2000, CHEM PHARM BULL, V48, P1065; WADA K, 1989, Shoyakugaku Zasshi, V43, P50; Wada K, 1998, BIOL PHARM BULL, V21, P140; WADA K, 1989, HETEROCYCLES, V29, P2141; WADA K, 1992, PHYTOCHEMISTRY, V31, P2135, DOI 10.1016/0031-9422(92)80380-W	32	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1525	1531		10.1016/j.bmcl.2015.02.018		7	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700032		
J	Miyachi, K; Wakao, M; Suda, Y				Miyachi, Kento; Wakao, Masahiro; Suda, Yasuo			Syntheses of chondroitin sulfate tetrasaccharide structures containing 4,6-disulfate patterns and analysis of their interaction with glycosaminoglycan-binding protein	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Basic fibroblast growth factor; Chondroitin sulfate; Glycosaminoglycan; Sugar chips; Surface plasmon resonance; Synthesis	FIBROBLAST-GROWTH-FACTOR; METHYL GLYCOSIDES; DERMATAN SULFATE; HEPARAN-SULFATE; HYBRID CHAINS; SUGAR CHIPS; DISACCHARIDES; OLIGOSACCHARIDES; 4-SULFATE; MIDKINE	Chondroitin sulfate tetrasaccharide ligand conjugates, namely GlcA-GalNAc6S-GlcA-GalNAc4S6S (CS-C+E) 1, GlcA2S-GalNAc6S-GlcA2S-GalNAc4S6S (CS-D+T) 2, GlcA-GalNAc4S6S-GlcA-GalNAc4S (CS-E+A) 3, GlcA-GalNAc4S6S-GlcA-GalNAc6S (CS-E+C) 4, and GlcA-GalNAc4S6S-GlcA-GalNAc4S6S (CS-E+E) 5, were systematically synthesized using a disaccharide building block 6. Synthesized CS tetrasaccharide structures were immobilized onto gold-coated chips to prepare array-type sugar chips, and the binding properties of protein were evaluated by surface plasmon resonance imaging biosensor. CS-D+T, CS-E+A, CS-E+C, and CS-E+E showed greater affinity for basic fibroblast growth factor than did other tetrasaccharides (CS-C+D, C+E, D+D). (C) 2015 Elsevier Ltd. All rights reserved.	[Miyachi, Kento; Wakao, Masahiro; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan; [Suda, Yasuo] SUDx Biotec Corp, Kagoshima 8900013, Japan	Wakao, M (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, 1-21-40 Kohrimoto, Kagoshima 8900065, Japan.	wakao@eng.kagoshima-u.ac.jp; ysuda@eng.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) [21710233, 23300356]; Japan Science and Technology Agency (JST) [AS2416907P]; Japan Ministry for Health, Labor, and Welfare (Nano-Medicine) [H21-nano-ippan-002]	The present study was financially supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT; Grant-in-Aid for Young Scientists B, Kakenhi 21710233, to M.W. and Grant-in-Aid for Scientific Research B, Kakenhi 23300356, to Y.S.), Japan Science and Technology Agency (JST) (A-Step, Post-venture Support, AS2416907P to Y.S.), and Japan Ministry for Health, Labor, and Welfare (Nano-Medicine, H21-nano-ippan-002 to Y.S.).	Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540290114450; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Jacquinet JC, 2009, CHEM-EUR J, V15, P9579, DOI 10.1002/chem.200900741; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Wakao M, 2008, BIOORG MED CHEM LETT, V18, P2499, DOI 10.1016/j.bmcl.2008.01.069; Karst N, 2002, EUR J ORG CHEM, P815; Suda Y, 2006, BIOCONJUGATE CHEM, V17, P1125, DOI 10.1021/bc0600620; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; TAMURA J, 1995, BIOORG MED CHEM LETT, V5, P1351, DOI 10.1016/0960-894X(95)00222-F; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja048045; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Bedini E, 2012, CHEM-EUR J, V18, P2123, DOI 10.1002/chem.201102458; Lubineau A, 1999, EUR J ORG CHEM, P2523; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; HABUCHI H, 1992, BIOCHEM J, V285, P805; Tamura J, 2012, BIOORG MED CHEM LETT, V22, P1371, DOI 10.1016/j.bmcl.2011.12.054; Fujikawa S, 2005, BIOMACROMOLECULES, V6, P2935, DOI 10.1021/bm050364p; Hashiguchi T, 2010, GLYCOCONJUGATE J, V27, P49, DOI 10.1007/s10719-009-9253-x; Jacquinet JC, 2015, CARBOHYD RES, V402, P35, DOI 10.1016/j.carres.2014.09.007; JACQUINET JC, 1990, CARBOHYD RES, V199, P153, DOI 10.1016/0008-6215(90)84259-W; Macchione G, 2014, EUR J ORG CHEM, V2014, P3868, DOI 10.1002/ejoc.201402222; Maza S., 2013, ORG BIOMOL CHEM, V42, P3510; Miyachi K., 2015, BIOORG MED IN PRESS; Nakamura-Tsuruta S, 2008, J BIOCHEM, V143, P833, DOI 10.1093/jb/mvn038; Takagaki K, 2002, J BIOL CHEM, V277, P8882, DOI 10.1074/jbc.M106479200; Tamura J., 1998, CARBOHYD RES, V305, P43; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Wakao M, 2015, BIOORG MED CHEM LETT, V25, P1407, DOI 10.1016/j.bmcl.2015.02.054	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1552	1555		10.1016/j.bmcl.2015.02.011		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700037		
J	Hamada, Y; Miyamoto, N; Kiso, Y				Hamada, Yoshio; Miyamoto, Naoko; Kiso, Yoshiaki			Novel beta-amyloid aggregation inhibitors possessing a turn mimic	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Alzheimer's disease; Amyloid-beta peptide; Aggregation inhibitor; Turn mimic	PENTAPEPTIDIC BACE1 INHIBITORS; INTRAMOLECULAR ACYL MIGRATION; CARBOXYLIC-ACID BIOISOSTERES; WATER-SOLUBLE PRODRUGS; STRUCTURE-BASED DESIGN; SOLID-STATE NMR; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; HUMAN BRAIN; EXPERIMENTAL CONSTRAINTS	Amyloid beta peptide, the main component of senile plaques found in the brain of Alzheimer disease (AD) patients, is a molecular target for AD therapeutic intervention. A number of potential AD therapeutics have been reported, including inhibitors of beta-secretase, gamma-secretase, and A beta aggregation, and anti-amyloid agents, such as neprilysin, insulin degrading enzyme (IDE), and A beta antibodies. Recently, we reported potent small-sized beta-secretase (BACE1) inhibitors, which could serve as anti-AD drugs. However AD is a progressive disorder, where dementia symptoms gradually worsen over several decades, and therefore may require many years to get cured. One possible way to achieve a greater therapeutic effect is through simultaneous administration of multiple drugs, similar to those used in Highly Active Anti-Retroviral Therapy (HAART) used to treat AIDS. In order to overcome AD, we took a drug discovery approach to evaluate, novel beta-amyloid aggregation inhibitors. Previously, we reported that a tong-type compound possessing a turn mimic as the inhibitor of HIV-1 protease dimerization. Oligomerized amyloid b peptides contain a turn structure within the molecule. Here, we designed and synthesized novel beta-amyloid aggregation inhibitors with a turn-mimic template, based on the turn conformer of the oligomerized amyloid b peptides. (C) 2015 Elsevier Ltd. All rights reserved.	[Hamada, Yoshio] Kobe Pharmaceut Univ, Med Chem Lab, Kobe, Hyogo 6588558, Japan; [Hamada, Yoshio; Miyamoto, Naoko] Kyoto Pharmaceut Univ, Ctr Frontier Res Med Sci, Yamashina Ku, Kyoto 6078412, Japan; [Kiso, Yoshiaki] Nagahama Inst Biosci & Technol, Dept Biosci, Tamura, Nagahama 5260829, Japan	Hamada, Y (reprint author), Kobe Pharmaceut Univ, Med Chem Lab, Kobe, Hyogo 6588558, Japan.	pynden@gmail.com			MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan (KAKENHI) [23590137, 26460163]	This study was supported in part by the Grants-in-Aid for Scientific Research (C) from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan (KAKENHI Nos. 23590137 and 26460163). We thank Dr. A. Taniguchi and Dr. H. Mukai for performing the Th-T assay and preparing the manuscript.	Tagad HD, 2010, BIOORGAN MED CHEM, V18, P3175, DOI 10.1016/j.bmc.2010.03.032; Kimura T, 2004, BIOORG MED CHEM LETT, V14, P1527, DOI 10.1016/j.bmcl.2003.12.088; Ghosh AK, 2001, J MED CHEM, V44, P2865, DOI 10.1021/jm0101803; Hamada Y, 2008, BIOORG MED CHEM LETT, V18, P1649, DOI 10.1016/j.bmcl.2008.01.058; Hamada Y, 2009, EXPERT OPIN DRUG DIS, V4, P391, DOI 10.1517/17460440902806377; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Balbach JJ, 2002, BIOPHYS J, V83, P1205; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Hamada Y, 2009, BIOORG MED CHEM LETT, V19, P2435, DOI 10.1016/j.bmcl.2009.03.049; Hamada Y, 2012, BIOORG MED CHEM LETT, V22, P1130, DOI 10.1016/j.bmcl.2011.11.102; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Hayashi Y, 2003, J MED CHEM, V46, P3782, DOI 10.1021/jm034112n; DIAZ H, 1992, J AM CHEM SOC, V114, P8316, DOI 10.1021/ja00047a068; Selkoe DJ, 1999, NATURE, V399, pA23; Kreft AF, 2009, J MED CHEM, V52, P6169, DOI 10.1021/jm900188z; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Tagad HD, 2011, BIOORGAN MED CHEM, V19, P5238, DOI 10.1016/j.bmc.2011.07.002; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Hamada Y, 2006, BIOORG MED CHEM LETT, V16, P4354, DOI 10.1016/j.bmcl.2006.05.046; Kimura T, 2006, BIOORG MED CHEM LETT, V16, P2380, DOI 10.1016/j.bmcl.2006.01.108; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Shuto D, 2003, BIOORG MED CHEM LETT, V13, P4273, DOI 10.1016/j.bmcl.2003.09.053; Kimura T, 2005, BIOORG MED CHEM LETT, V15, P211, DOI 10.1016/j.bmcl.2004.09.090; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Asai M, 2006, J NEUROCHEM, V96, P533, DOI 10.1111/j.1471-4159.2005.03576.x; Hamada Y, 2008, BIOORG MED CHEM LETT, V18, P1654, DOI 10.1016/j.bmcl.2008.01.056; DIAZ H, 1991, TETRAHEDRON LETT, V32, P5725, DOI 10.1016/S0040-4039(00)93540-8; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Hamada H., 2002, BIOORGAN MED CHEM, V10, P4155; Hamada Y, 2013, EXPERT OPIN DRUG DIS, V8, P709, DOI 10.1517/17460441.2013.784267; Hamada Y, 2012, EXPERT OPIN DRUG DIS, V7, P903, DOI 10.1517/17460441.2012.712513; Hamada Y, 2012, BIOORG MED CHEM LETT, V22, P4640, DOI 10.1016/j.bmcl.2012.05.089; Hamada Y, 2004, BIOORGAN MED CHEM, V12, P159, DOI 10.1016/j.bmc.2003.10.026; Hamada Y, 2003, BIOORG MED CHEM LETT, V13, P2727, DOI 10.1016/S0960-894X(03)00576-6; Hamada Y, 2014, BIOORG MED CHEM LETT, V24, P618, DOI 10.1016/j.bmcl.2013.12.007; HAMADA Y, 2012, BIOORG ACS MED CHEM, V3, P193; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Sohma Y, 2004, BIOPOLYMERS, V76, P344, DOI 10.1002/bip.20136; Song MC, 2001, BIOORG MED CHEM LETT, V11, P2465, DOI 10.1016/S0960-894X(01)00468-1; Suzuki K, 2013, BIOORGAN MED CHEM, V21, P6665, DOI 10.1016/j.bmc.2013.08.016; Taniguchi A, 2009, CHEMBIOCHEM, V10, P710, DOI 10.1002/cbic.200800765	51	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1572	1576		10.1016/j.bmcl.2015.02.016		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700041		
J	Kubo, M; Gima, M; Baba, K; Nakai, M; Harada, K; Suenaga, M; Matsunaga, Y; Kato, E; Hosoda, S; Fukuyama, Y				Kubo, Miwa; Gima, Minori; Baba, Kohei; Nakai, Megumi; Harada, Kenichi; Suenaga, Midori; Matsunaga, Yoichi; Kato, Eishin; Hosoda, Shinya; Fukuyama, Yoshiyasu			Novel neurotrophic phenylbutenoids from Indonesian ginger Bangle, Zingiber purpureum	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Zingiber purpureum; Bangle; Phenylbutenoid; Curcuminoid; Neurite outgrowth-promoting activity; PC12 cells; NGF	AMYLOID FIBRILS; THIOFLAVIN-T; CASSUMUNAR; CURCUMIN; INHIBITORS; MECHANISM; RHIZOMES; DISEASE; DIMERS	Two new curcuminoids 1 and 2, and a new phenylbutenoid dimer 3, were isolated from Bangle (Zingiber purpureum). Their structures were determined on the basis of comprehensive spectroscopic data and their biogenetic pathway. Compounds 1 and 2 are the first example of curcumin coupled with phenylbutenoid. Compounds 1 and 2 promoted neurite outgrowth of NGF-mediated PC12 cells at concentrations ranging from 1 to 10 mu M. In addition, compound 1 was found to accelerate the prevention of A beta 42 aggregation. (C) 2015 Elsevier Ltd. All rights reserved.	[Kubo, Miwa; Gima, Minori; Baba, Kohei; Harada, Kenichi; Suenaga, Midori; Matsunaga, Yoichi; Fukuyama, Yoshiyasu] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan; [Nakai, Megumi] Kochi Med Grad Sch, Dept Pharm, Nankoku, Kochi 7838505, Japan; [Kato, Eishin; Hosoda, Shinya] HOSODA SHC Co Ltd, Fukui 9100854, Japan	Kubo, M (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, 180 Yamashiro Cho, Tokushima 7708514, Japan.	miwa-k@ph.bunri-u.ac.jp; fukuyama@ph.bunri-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23790035]; MEXT-Senryaku	We thank Dr. Masami Tanaka and Dr. Yasuko Okamoto (TBU) for the 600 MHz NMR and mass spectra. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23790035) and a Grant from MEXT-Senryaku.	LeVine H, 1999, METHOD ENZYMOL, V309, P274; Matsui N, 2012, NEUROSCI LETT, V513, P72, DOI 10.1016/j.neulet.2012.02.010; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Nakamura S, 2009, CHEM PHARM BULL, V57, P1267, DOI 10.1248/cpb.57.1267; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Kubo M, 2009, ORG LETT, V11, P5190, DOI 10.1021/ol9021029; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Kubo M, 2010, BIOORG MED CHEM LETT, V20, P2566, DOI 10.1016/j.bmcl.2010.02.085; Backman C, 1996, J NEUROSCI, V16, P5437; Yokoyama R, 2002, J NAT PROD, V65, P527, DOI 10.1021/np010571k; Huang JM, 2000, TETRAHEDRON LETT, V41, P6111, DOI 10.1016/S0040-4039(00)01023-6; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Woodruff RH, 1997, HISTOL HISTOPATHOL, V12, P459; Howard L. W., 2002, NATURE, V420, P879; Irwin B. L., 2002, NEURON CELL MOL BIOL, V3, P410; JITOE A, 1994, TETRAHEDRON LETT, V35, P981, DOI 10.1016/S0040-4039(00)79944-8; JITOE A, 1993, PHYTOCHEMISTRY, V32, P357, DOI 10.1016/S0031-9422(00)94994-X; Kita T, 2008, BIOSCI BIOTECH BIOCH, V72, P1789, DOI 10.1271/bbb.80075; Promjit S., 1996, MED PLANTS THAILAND, VI, P195; Toren F., 2000, NATURE, V408, P239	24	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	APR 1	2015	25	7					1586	1591		10.1016/j.bmcl.2015.02.005		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	CE2YN	WOS:000351688700044		
J	Matsubara, S				Matsubara, S.			Re: Removable uterine compression sutures for postpartum haemorrhage	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Letter									Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Japan.						Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P378, DOI 10.1111/aogs.12077; Hashida O, 2013, KANTO J OBSTET GYNEC, V50, P167; Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P1069, DOI 10.1111/aogs.12451; Zhang Z, 2014, BJOG, V122, P429	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	APR	2015	122	5					755	756		10.1111/1471-0528.13190		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CE2XZ	WOS:000351686700032		
J	Komura, K; Inamoto, T; Takai, T; Uchimoto, T; Saito, K; Tanda, N; Minami, K; Oide, R; Uehara, H; Takahara, K; Hirano, H; Nomi, H; Kiyama, S; Watsuji, T; Azuma, H				Komura, Kazumasa; Inamoto, Teruo; Takai, Tomoaki; Uchimoto, Taizo; Saito, Kenkichi; Tanda, Naoki; Minami, Koichiro; Oide, Rintaro; Uehara, Hirofumi; Takahara, Kiyoshi; Hirano, Hajime; Nomi, Hayahito; Kiyama, Satoshi; Watsuji, Toshikazu; Azuma, Haruhito			Incidence of urethral stricture after bipolar transurethral resection of the prostate using TURis: results from a randomised trial	BJU INTERNATIONAL			English	Article						transurethral resection of the prostate; bipolar; randomised controlled trial	COAGULATION DEPTH; FOLLOW-UP; MONOPOLAR; COMPLICATIONS; STANDARD; SALINE; CLASSIFICATION; VAPORIZATION; OBSTRUCTION; OUTCOMES	Objectives To assess whether bipolar transurethral resection of the prostate (B-TURP) using the TURis (R) system has a similar level of efficacy and safety to that of the traditional monopolar transurethral resection of the prostate (M-TURP), and to evaluate the impact of the TURis system on postoperative urethral stricture rates over a 36-month follow-up period. Patients and Methods A total of 136 patients with benign prostatic obstruction were randomised to undergo either B-TURP using the TURis system or conventional M-TURP, and were regularly followed for 36 months after surgery. The primary endpoint was safety, which included the long-term complication rates of postoperative urethral stricture. The secondary endpoint was the follow-up measurement of efficacy. Results In peri-operative findings, no patient in either treatment group presented with transurethral resection syndrome, and the decline in levels of haemoglobin and hematocrit were similar. The mean operation time was significantly extended in the TURis treatment group compared with the M-TURP group (79.5 vs 68.6 min; P = 0.032) and postoperative clot retention was more likely to be seen after M-TURP (P = 0.044). Similar efficacy findings were maintained throughout 36 months, but a significant difference in postoperative urethral stricture rates between groups was detected (6.6% in M-TURP vs 19.0% in TURis; P = 0.022). After stratifying patients according to prostate volume, there was no significant difference between the two treatment groups with regard to urethral stricture rates in patients with a prostate volume <= 70 mL (3.8% in M-TURP vs 3.8% in TURis), but in the TURis group there was a significantly higher urethral stricture rate compared with the M-TURP group in patients with a prostate volume >70 mL (20% in TURis vs 2.2% in M-TURP; P = 0.012). Furthermore, the mean operation time for TURis was significantly longer than for M-TURP for the subgroup of patients with a prostate volume >70 mL (99.6 vs 77.2 min; P = 0.011), but not for the subgroup of patients with a prostate volume <= 70 mL. Conclusion The TURis system seems to be as efficacious and safe as conventional M-TURP except that there was a higher incidence of urethral stricture in patients with larger preoperative prostate volumes.	[Komura, Kazumasa; Inamoto, Teruo; Takai, Tomoaki; Uchimoto, Taizo; Saito, Kenkichi; Tanda, Naoki; Minami, Koichiro; Uehara, Hirofumi; Takahara, Kiyoshi; Hirano, Hajime; Nomi, Hayahito; Kiyama, Satoshi; Azuma, Haruhito] Osaka Med Coll, Dept Urol, Osaka, Japan; [Oide, Rintaro] Osaka Med Coll, Device Control Biol Fundamental Res, Osaka, Japan; [Watsuji, Toshikazu] Hirakata City Hosp, Dept Urol, Osaka, Japan	Komura, K (reprint author), Osaka Med Coll, Dept Urol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	uro051@poh.osaka-med.ac.jp					Abascal Junquera JM, 2006, ACTAS UROL ESP, V30, P661; Dincel C, 2004, J ENDOUROL, V18, P293, DOI 10.1089/089277904773582921; Singh H, 2005, J ENDOUROL, V19, P333, DOI 10.1089/end.2005.19.333; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Issa MM, 2008, J ENDOUROL, V22, P1587, DOI 10.1089/end.2008.0192; Starkman JS, 2005, BJU INT, V95, P69, DOI 10.1111/j.1464-410X.2005.05253.x; Mamoulakis C, 2009, EUR UROL, V56, P798, DOI 10.1016/j.eururo.2009.06.037; Michielsen DPJ, 2007, J UROLOGY, V178, P2035, DOI 10.1016/j.juro.2007.07.038; Mamoulakis C, 2011, WORLD J UROL, V29, P205, DOI 10.1007/s00345-010-0566-y; Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005; Ho HSS, 2008, CURR OPIN UROL, V18, P50; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Autorino R, 2009, EUR UROL, V55, P922, DOI 10.1016/j.eururo.2009.01.028; Fagerstrom T, 2010, BJU INT, V105, P1560, DOI 10.1111/j.1464-410X.2009.09052.x; Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058; de Sio M, 2006, UROLOGY, V67, P69, DOI 10.1016/j.urology.2005.07.033; Rassweiler J, 2007, MINIM INVASIV THER, V16, P11, DOI 10.1080/13645700601159410; Huang X, 2007, UROLOGY, V70, P180, DOI 10.1016/j.urology.2007.02.051; Sinanoglu O, 2012, UROLOGY, V80, P402, DOI 10.1016/j.urology.2012.02.029; Chen Q, 2010, BJU INT, V106, P1339, DOI 10.1111/j.1464-410X.2010.09401.x; Mamoulakis C, 2013, EUR UROL, V63, P667, DOI 10.1016/j.eururo.2012.10.003; Ho HSS, 2007, EUR UROL, V52, P517, DOI 10.1016/j.eururo.2007.03.038; Burke N, 2010, UROLOGY, V75, P1015, DOI 10.1016/j.urology.2009.08.015; Huang X, 2008, SCAND J UROL NEPHROL, V42, P265, DOI 10.1080/00365590701702168; Huang X, 2012, UROLOGY, V80, P1116, DOI 10.1016/j.urology.2012.07.024; Iori F, 2008, UROLOGY, V71, P252, DOI 10.1016/j.urology.2007.09.064; Qu L, 2007, UROLOGY, V70, P1034, DOI 10.1016/j.urology.2007.09.015; Tefekli A, 2005, J UROLOGY, V174, P1339, DOI 10.1097/01.ju.0000173075.62504.73	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	APR	2015	115	4					644	652		10.1111/bju.12831		9	Urology & Nephrology	Urology & Nephrology	CE6LZ	WOS:000351949200026		
J	Nishihara, S; Hamada, M				Nishihara, S.; Hamada, M.			Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis?	BONE & JOINT JOURNAL			English	Article							REDUCES BLOOD-LOSS; DEEP-VEIN THROMBOSIS; KNEE ARTHROPLASTY; NATURAL-HISTORY; REPLACEMENT SURGERY; VENOUS THROMBOSIS; BLIND; METAANALYSIS; TRANSFUSION; REDUCTION	Tranexamic acid (TXA) has been used to reduce blood loss during total hip arthroplasty (THA), but its use could increase the risk of venous thromboembolic disease (VTE). Several studies have reported that TXA does not increase the prevalence of deep vein thrombosis (DVT), but most of those used routine chemical thromboprophylaxis, thereby masking the potential increased risk of TXA on VTE. We wished to ascertain whether TXA increases the prevalence of VTE in patients undergoing THA without routine chemical thromboprophylaxis. We carried out a retrospective case-control study in 254 patients who underwent a primary THA, 127 of whom received TXA (1 g given pre-operatively) and a control group of 127 who did not. All patients had mechanical but no chemical thomboprophylaxis. Each patient was examined for DVT by bilateral ultrasonography pre-operatively and on post-operative days 1 and 7. TXA was found to statistically significantly increase the incidence of total DVT on post-operative day 7 compared with the control group (24 (18.9%) and 12 (9.4%), respectively; p < 0.05) but most cases of DVT were isolated distal DVT, with the exception of one patient with proximal DVT in each group. One patient in the control group developed a non-fatal symptomatic pulmonary embolism (PE). The use of TXA did not appear to affect the prevalence of either proximal DVT or PE.	[Nishihara, S.; Hamada, M.] Japan Community Healthcare Org, Hoshigaoka Med Ctr, Dept Orthopaed Surg, Hirakata, Osaka 5738511, Japan	Nishihara, S (reprint author), Japan Community Healthcare Org, Hoshigaoka Med Ctr, Dept Orthopaed Surg, 4-8-1 Hoshigaoka, Hirakata, Osaka 5738511, Japan.	shu-nishihara@umin.net					Sukeik M, 2011, J BONE JOINT SURG BR, V93B, P39, DOI 10.1302/0301-620X.93B1.24984; Kagoma YK, 2009, THROMB RES, V123, P687, DOI 10.1016/j.thromres.2008.09.015; Walsh M, 2007, J ARTHROPLASTY, V22, P1162, DOI 10.1016/j.arth.2006.10.014; [Anonymous], 2008, JAPANESE ORTHOPAEDIC; MOSER KM, 1981, ANN INTERN MED, V94, P439; Alshryda S, 2014, BONE JOINT J, V96B, P1005, DOI 10.1302/0301-620X.96B8.33745; Imai N, 2012, J ARTHROPLASTY, V27, P1838, DOI 10.1016/j.arth.2012.04.024; Schwarz T, 2010, J VASC SURG, V52, P1246, DOI 10.1016/j.jvs.2010.05.094; Gillette BP, 2013, CLIN ORTHOP RELAT R, V471, P150, DOI 10.1007/s11999-012-2488-z; Benoni G, 2001, ACTA ORTHOP SCAND, V72, P442, DOI 10.1080/000164701753532754; Ekback G, 2000, ANESTH ANALG, V91, P1124; Niskanen RO, 2005, ACTA ORTHOP, V76, P829, DOI 10.1080/17453670510045444; Palareti G, 2010, THROMB HAEMOSTASIS, V104, P1063, DOI [10.1160/TH10-06-0351, 10.1160/TH10.06.0351]; Johansson T, 2005, ACTA ORTHOP, V76, P314, DOI 10.1080/00016470510030751; Benoni G, 2000, ACTA ORTHOP SCAND, V71, P250, DOI 10.1080/000164700317411834; Rajesparan K, 2009, J BONE JOINT SURG BR, V91B, P776, DOI 10.1302/0301-620X.91B6.22393; Mahdy AM, 2004, BRIT J ANAESTH, V93, P842, DOI 10.1093/bja/aeh227; KAKKAR VV, 1969, LANCET, V2, P230; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; Irwin A, 2013, BONE JOINT J, V95B, P1556, DOI 10.1302/0301-620X.95B11.31055; Garneti N, 2004, J ARTHROPLASTY, V19, P488, DOI 10.1016/j.arth.2003.12.073; Husted H, 2003, ACTA ORTHOP SCAND, V74, P665, DOI 10.1080/00016470310018171; Ho KM, 2003, ANAESTH INTENS CARE, V31, P529; Claeys MA, 2007, ACTA CHIR BELG, V107, P397; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Ryan MG, 2002, J BONE JOINT SURG AM, V84A, P1998; MacDonald PS, 2003, J VASC SURG, V37, P523, DOI 10.1067/mva.2003.149; Lemay E, 2004, CAN J ANAESTH, V51, P31; Dahl OE, 1997, J CARDIOTHOR VASC AN, V11, P322, DOI 10.1016/S1053-0770(97)90102-6; Falck-Ytter Y, 2012, CHEST S, V141, pe278S; Gandhi Rajiv, 2013, BMC Res Notes, V6, P184, DOI 10.1186/1756-0500-6-184; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Kearon C, 2012, CHEST S, V141, pe419S, DOI 10.1378/chest.11-2301; Markel Arie, 2005, Semin Vasc Med, V5, P65, DOI 10.1055/s-2005-871743; Masuda EM, 2010, DM-DIS MON, V56, P601, DOI 10.1016/j.disamonth.2010.06.011; Pellegrini V D Jr, 1993, J Arthroplasty, V8, P449; Reid RW, 1997, ANESTH ANALG, V84, P990, DOI 10.1097/00000539-199705000-00008; Yamasaki S, 2004, INT ORTHOP, V28, P69, DOI 10.1007/s00264-003-0511-4	39	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	APR	2015	97B	4					458	462		10.1302/0301-620X.97B4.34656		5	Orthopedics; Surgery	Orthopedics; Surgery	CE6NI	WOS:000351954000005		
J	Ike, H; Inaba, Y; Kobayashi, N; Yukizawa, Y; Hirata, Y; Tomioka, M; Saito, T				Ike, H.; Inaba, Y.; Kobayashi, N.; Yukizawa, Y.; Hirata, Y.; Tomioka, M.; Saito, T.			Effects of rotational acetabular osteotomy on the mechanical stress within the hip joint in patients with developmental dysplasia of the hip	BONE & JOINT JOURNAL			English	Article							FINITE-ELEMENT-ANALYSIS; PERIACETABULAR OSTEOTOMY; CONTACT STRESS; OSTEOARTHRITIS; VALIDATION; PREDICTION; POSITION; MODEL; RISK	In this study we used subject-specific finite element analysis to investigate the mechanical effects of rotational acetabular osteotomy (RAO) on the hip joint and analysed the correlation between various radiological measurements and mechanical stress in the hip joint. We evaluated 13 hips in 12 patients (two men and ten women, mean age at surgery 32.0 years; 19 to 46) with developmental dysplasia of the hip (DDH) who were treated by RAO. Subject-specific finite element models were constructed from CT data. The centre-edge (CE) angle, acetabular head index (AHI), acetabular angle and acetabular roof angle (ARA) were measured on anteroposterior pelvic radiographs taken before and after RAO. The relationship between equivalent stress in the hip joint and radiological measurements was analysed. The equivalent stress in the acetabulum decreased from 4.1 MPa (2.7 to 6.5) pre-operatively to 2.8 MPa (1.8 to 3.6) post-operatively (p < 0.01). There was a moderate correlation between equivalent stress in the acetabulum and the radiological measurements: CE angle (R = -0.645, p < 0.01); AHI (R = -0.603, p < 0.01); acetabular angle (R = 0.484, p = 0.02); and ARA (R = 0.572, p < 0.01). The equivalent stress in the acetabulum of patients with DDH decreased after RAO. Correction of the CE angle, AHI and ARA was considered to be important in reducing the mechanical stress in the hip joint.	[Ike, H.; Inaba, Y.; Kobayashi, N.; Yukizawa, Y.; Hirata, Y.; Tomioka, M.; Saito, T.] Yokohama City Univ, Dept Orthopaed Surg, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Inaba, Y (reprint author), Yokohama City Univ, Dept Orthopaed Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	yute0131@med.yokohama-cu.ac.jp					Nakahara I, 2014, BONE JOINT J, V96B, P580, DOI 10.1302/0301-620X.96B5.32503; Michaeli DA, 1997, MED ENG PHYS, V19, P180, DOI 10.1016/S1350-4533(96)00051-3; Bessho M, 2007, J BIOMECH, V40, P1745, DOI 10.1016/j.jbiomech.2006.08.003; Jessel RH, 2009, J BONE JOINT SURG AM, V91A, P1120, DOI 10.2106/JBJS.G.00144; Ziebarth K, 2011, CLIN ORTHOP RELAT R, V469, P447, DOI 10.1007/s11999-010-1544-9; Anderson AE, 2010, J BIOMECH, V43, P1351, DOI 10.1016/j.jbiomech.2010.01.010; Zhao X, 2010, J ORTHOP SCI, V15, P632, DOI 10.1007/s00776-010-1511-z; MACIROWSKI T, 1994, J BIOMECH ENG-T ASME, V116, P10, DOI 10.1115/1.2895693; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Anderson AE, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2953472; Reijman M, 2005, ARTHRITIS RHEUM, V52, P787, DOI 10.1002/art.20886; Yasunaga Y, 2004, ACTA ORTHOP SCAND, V75, P10, DOI 10.1080/00016470410001708020; DALSTRA M, 1995, J BIOMECH ENG-T ASME, V117, P272, DOI 10.1115/1.2794181; HEYMAN CH, 1950, J BONE JOINT SURG AM, V32-A, P767; NINOMIYA S, 1984, J BONE JOINT SURG AM, V66A, P430; Anderson AE, 2005, J BIOMECH ENG-T ASME, V127, P364, DOI 10.1115/1.1894148; Okano K, 2009, CLIN ORTHOP RELAT R, V467, P894, DOI 10.1007/s11999-008-0443-9; Nakamura S, 1998, ACTA ORTHOP SCAND, V69, P259, DOI 10.3109/17453679809000926; SHARP IK, 1961, J BONE JOINT SURG BR, V43, P268; MASSIE WK, 1950, J BONE JOINT SURG AM, V32-A, P519; Jacobsen S, 2005, RHEUMATOLOGY, V44, P211, DOI 10.1093/rheumtology/keh436; Aronson J, 1986, Instr Course Lect, V35, P119; Clohisy JC, 2009, CLIN ORTHOP RELAT R, V467, P128, DOI 10.1007/s11999-008-0481-3; Cooperman Daniel, 2013, J Pediatr Orthop, V33 Suppl 1, pS2, DOI 10.1097/BPO.0b013e3182770a8d; Keyak JH, 1998, J BIOMECH, V31, P125; Kosuge D, 2014, BONE JOINT J, V96B, P1155, DOI 10.1302/0301-620X.96B9.34269; Mavcic B, 2002, J ORTHOPAED RES, V20, P1025, DOI 10.1016/S0736-0266(02)00014-1; Recnik G, 2009, J INT MED RES, V37, P1620; Tsumura H, 2005, J ORTHOP SCI, V10, P145, DOI 10.1007/s00776-004-0866-4; Vukasinovic Z, 2013, INT ORTHOP, V37, P95, DOI 10.1007/s00264-012-1727-y; Zou ZM, 2013, J ORTHOP RES, V31, P472, DOI 10.1002/jor.22245; Zupanc O, 2001, INT ORTHOP, V25, P9, DOI 10.1007/s002640000213	32	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	APR	2015	97B	4					492	497		10.1302/0301-620X.97B4.33736		6	Orthopedics; Surgery	Orthopedics; Surgery	CE6NI	WOS:000351954000010		
J	Boeker, EB; Ram, K; Klopotowska, JE; de Boer, M; Creus, MT; de Andres, AL; Sakuma, M; Morimoto, T; Boermeester, MA; Dijkgraaf, MGW				Boeker, Eveline B.; Ram, Kim; Klopotowska, Joanna E.; de Boer, Monica; Tuset Creus, Montse; de Andres, Ana L.; Sakuma, Mio; Morimoto, Takeshi; Boermeester, Marja A.; Dijkgraaf, Marcel G. W.			An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Review						adverse drug events; epidemiology; medication safety; non-surgical patient; surgical patient	RISK-FACTORS; SIGN-OUT; POLYPHARMACY; HOSPITALS; ERRORS; CARE	AimThe incidence of adverse drug events (ADEs) in surgical and non-surgical patients may differ. This individual patient data meta-analysis (IPDMA) identifies patient characteristics and types of medication most associated with patients experiencing ADEs and suggests target areas for reducing harm and implementing focused interventions. MethodsAuthors of eligible studies on preventable ADEs (pADEs) were approached for collaboration. For assessment of differences among (non-)surgical patients and identification of associated factors descriptive statistics, Pearson chi-square, Poisson and logistic regression analyses were performed. For identification of high risk drugs (HRDs), a model was developed based on frequency, severity and preventability of medication related to ADEs. ResultsIncluded were 5367 patients from four studies. Patients aged 77 years experienced more ADEs and pADEs compared with patients aged 52 years (odds ratios (OR) 2.12 (95% CI 1.70, 2.65) and 2.55 (95% CI 1.70, 3.84), respectively, both P < 0.05). Polypharmacy on admission also increased the risk of ADEs (OR 1.21 (95% CI 1.03, 1.44), P < 0.05) and pADEs (OR 1.85 (95% CI 1.34, 2.56), P < 0.05). pADEs were associated with more severe harm than non-preventable ADEs (54% vs. 32%, P < 0.05). The top five HRDs were antibiotics, sedatives, anticoagulants, diuretics and antihypertensives. Events associated with HRDs included diarrhoea or constipation, abnormal liver function test and central nervous system events. Most pADEs resulted from prescribing errors (90%). ConclusionElderly patients with polypharmacy on admission and receiving antibiotics, sedatives, anticoagulants, diuretics or antihypertensives were more prone to experiencing ADEs. Efficiency in prevention of ADEs may be improved by targeted vigilance systems for alertness of physicians and pharmacists.	[Boeker, Eveline B.; Ram, Kim; Boermeester, Marja A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Klopotowska, Joanna E.; de Boer, Monica] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, NL-1105 AZ Amsterdam, Netherlands; [Tuset Creus, Montse; de Andres, Ana L.] Hosp Clin Barcelona, Dept Hosp Pharm, Barcelona, Spain; [Sakuma, Mio; Morimoto, Takeshi] Hyogo Coll Med, Div Gen Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands	Boermeester, MA (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands.	m.a.boermeester@amc.uva.nl					Agency for Healthcare Research and Quality Rockville M, 2001, RED PREV ADV DRUG EV; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; [Anonymous], 2009, FARM HOSP; Morimoto T, 2011, J GEN INTERN MED, V26, P148, DOI 10.1007/s11606-010-1518-3; Veehof LJG, 2000, FAM PRACT, V17, P261, DOI 10.1093/fampra/17.3.261; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Linjakumpu T, 2002, J CLIN EPIDEMIOL, V55, P809, DOI 10.1016/S0895-4356(02)00411-0; Borowitz SM, 2008, QUAL SAF HEALTH CARE, V17, P6, DOI 10.1136/qshc.2006.019273; Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Kale A, 2012, BMJ QUAL SAF, V21, P933, DOI 10.1136/bmjqs-2012-000946; de Boer M, 2013, INT J CLIN PHARM-NET, V35, P744, DOI 10.1007/s11096-013-9797-5; BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Aljadhey H, 2013, INT J QUAL HEALTH C, V25, P648, DOI 10.1093/intqhc/mzt075; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Kennedy JM, 2000, BRIT J CLIN PHARMACO, V49, P353, DOI 10.1046/j.1365-2125.2000.00145.x; Cano FG, 2009, CAD SAUDE PUBLICA, V25, pS360; de Boer M, 2013, J EVAL CLIN PRACT, V19, P1073, DOI 10.1111/jep.12033; Federico Frank, 2007, Jt Comm J Qual Patient Saf, V33, P537; Franklin Bryony Dean, 2010, Int J Pharm Pract, V18, P305, DOI 10.1111/j.2042-7174.2010.00058.x; Griffin F, 2009, IHI INNOV SER WHITE; Klopotowska JE, 2012, EUR J CLIN PHARMACOL, V69, P75; Kohn LT, 1999, ERR IS HUMAN BUILDIN; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; National Cancer Institute, COMM TERM CRIT ADV E; Ramrattan MA, 2014, INT J CLIN PHARM-NET, V36, P581, DOI 10.1007/s11096-014-9941-x; Seden K, 2013, BMJ OPEN, V3, P1	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	APR	2015	79	4					548	557		10.1111/bcp.12504		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE4BO	WOS:000351776000002		
J	Hashimoto, T				Hashimoto, T.			Production of numerous autoantibodies in paraneoplastic pemphigus	BRITISH JOURNAL OF DERMATOLOGY			English	Editorial Material							MYASTHENIA-GRAVIS; ANTIGEN COMPLEX; ANTIBODIES; ENVOPLAKIN; PERIPLAKIN		Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan	Hashimoto, T (reprint author), Kurume Univ, Inst Cutaneous Cell Biol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp					Gallo E, 2014, CLIN EXP DERMATOL, V39, P323, DOI 10.1111/ced.12296; Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Kim SC, 1997, J INVEST DERMATOL, V109, P365, DOI 10.1111/1523-1747.ep12336235; Mahoney MG, 1998, J INVEST DERMATOL, V111, P308, DOI 10.1046/j.1523-1747.1998.00279.x; Numata S, 2013, J INVEST DERMATOL, V133, P1785, DOI 10.1038/jid.2013.65; Chorzelski T, 1999, J AM ACAD DERMATOL, V41, P393, DOI 10.1016/S0190-9622(99)70111-8; HASHIMOTO T, 1995, J INVEST DERMATOL, V104, P829, DOI 10.1111/1523-1747.ep12607012; Hashimoto T, 2001, CLIN DERMATOL, V19, P675, DOI 10.1016/S0738-081X(00)00192-9; Kiyokawa C, 1998, J INVEST DERMATOL, V111, P1236; Lee SE, 2008, BRIT J DERMATOL, V159, P986, DOI 10.1111/j.1365-2133.2008.08763.x; Proby C, 1999, J INVEST DERMATOL, V112, P153, DOI 10.1046/j.1523-1747.1999.00498.x; Tsuchisaka A, 2014, J INVEST DERMATOL, V134, P2283, DOI 10.1038/jid.2014.151; Wang R, 2015, BRIT J DERMATOL, V172, P968, DOI 10.1111/bjd.13525	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	APR	2015	172	4					849	850		10.1111/bjd.13648		4	Dermatology	Dermatology	CE6MV	WOS:000351952100034		
J	Kurokawa, I; Ohyama, M				Kurokawa, I.; Ohyama, M.			Revisiting the dogma of acne pathogenesis	BRITISH JOURNAL OF DERMATOLOGY			English	Editorial Material							EXPRESSION		[Kurokawa, I.] Meiwa Hosp, Acne Clin Res Ctr, Dept Dermatol, Nishinomiya, Hyogo 6638186, Japan; [Ohyama, M.] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Kurokawa, I (reprint author), Meiwa Hosp, Acne Clin Res Ctr, Dept Dermatol, 4-31 Agenaruo Cho, Nishinomiya, Hyogo 6638186, Japan.	kurokawa.i@meiwa-hospital.com					Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Hughes BR, 1996, BRIT J DERMATOL, V134, P247; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Holland KT, 1989, ACNE, P178; Jahns AC, 2015, BRIT J DERMATOL, V172, P981, DOI 10.1111/bjd.13436; KNAGGS HE, 1994, J INVEST DERMATOL, V102, P89, DOI 10.1111/1523-1747.ep12371738; Kurokawa I, 2007, J CUTAN PATHOL, V34, P338, DOI 10.1111/j.1600-0560.2006.00619.x; Nishijima S, 2003, ACNE VULGARIS, P36; Plewig G, 2005, ACNE AND ROSACEA, P83	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	APR	2015	172	4					851	851		10.1111/bjd.13654		1	Dermatology	Dermatology	CE6MV	WOS:000351952100035		
J	Hata, M; Koike, I; Wada, H; Miyagi, E; Kasuya, T; Kaizu, H; Mukai, Y; Inoue, T				Hata, M.; Koike, I.; Wada, H.; Miyagi, E.; Kasuya, T.; Kaizu, H.; Mukai, Y.; Inoue, T.			Postoperative radiation therapy for extramammary Paget's disease	BRITISH JOURNAL OF DERMATOLOGY			English	Article							MOHS MICROGRAPHIC SURGERY; PELVIC IRRADIATION; TREATMENT OUTCOMES; PROGNOSTIC-FACTORS; ONCOLOGY-GROUP; WIDE EXCISION; VULVA; ADENOCARCINOMA; RECONSTRUCTION; RADIOTHERAPY	Background Extramammary Paget's disease (EMPD) is a rare cutaneous malignancy that is usually treated with surgery. Patients with positive surgical margins require adjuvant therapy, but there have been few reports on the use of radiation therapy. Objectives To investigate the effectiveness of postoperative radiation therapy in EMPD. Materials and methods Twenty-one patients with EMPD involving the genitalia underwent radiation therapy as adjuvant therapy after surgery. Ten patients had inguinal lymph node involvement before radiation therapy, but none had distant metastases. A median total dose of 59.4 Gy (range, 45-64.8 Gy) was delivered to the tumour bed in 30 fractions (range, 23-36 fractions). Results At a median follow-up period of 38 months, all patients had local control. However, six patients had developed distant metastases 6-43 months after radiation therapy. The distant metastasis-free rates were 66% at 3 years and 55% at 5 years. Inguinal lymph node involvement was a significant risk factor for distant metastases. Four patients died 33-58 months after irradiation; the causes of death were tumour progression in three patients and infectious pneumonia in one. The overall and cause-specific survival rates were both 92% at 3 years, and 62% and 71% at 5 years, respectively. No therapy-related toxicities of grade >= 3 were observed. Conclusions Postoperative radiation therapy is safe and effective in maintaining local control in patients with EMPD.	[Hata, M.; Koike, I.; Kasuya, T.; Kaizu, H.; Mukai, Y.; Inoue, T.] Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Wada, H.] Yokohama City Univ, Grad Sch Med, Dept Dermatol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Miyagi, E.] Yokohama City Univ, Grad Sch Med, Dept Obstet & Gynecol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Hata, M (reprint author), Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	mhata@syd.odn.ne.jp					Lam C, 2010, DERMATOL CLIN, V28, P807, DOI 10.1016/j.det.2010.08.002; Rotman M, 2006, INT J RADIAT ONCOL, V65, P169, DOI 10.1016/j.ijrobp.2005.10.019; Lawton CA, 2007, INT J RADIAT ONCOL, V69, P646, DOI 10.1016/j.ijrobp.2007.04.003; Hatta N, 2008, BRIT J DERMATOL, V158, P313, DOI 10.1111/j.1365-2133.2007.08314.x; Black D, 2007, GYNECOL ONCOL, V104, P547, DOI 10.1016/j.ygyno.2006.09.017; Wagner G, 2011, J DTSCH DERMATOL GES, V9, P448, DOI 10.1111/j.1610-0387.2010.07581.x; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Hendi A, 2004, J AM ACAD DERMATOL, V51, P767, DOI 10.1016/j.jaad.2004.07.004; Cai YP, 2013, GYNECOL ONCOL, V129, P412, DOI 10.1016/j.ygyno.2013.02.029; Shiomi T, 2013, J EUR ACAD DERMATOL, V27, P589, DOI 10.1111/j.1468-3083.2012.04489.x; Fanning J, 1999, AM J OBSTET GYNECOL, V180, P24, DOI 10.1016/S0002-9378(99)70143-2; Karam A, 2012, GYNECOL ONCOL, V125, P346, DOI 10.1016/j.ygyno.2012.01.032; Pommier P, 2007, J CLIN ONCOL, V25, P5366, DOI 10.1200/JCO.2006.10.5171; Bae JM, 2013, J AM ACAD DERMATOL, V68, P632, DOI 10.1016/j.jaad.2012.12.960; BESA P, 1992, INT J RADIAT ONCOL, V24, P73; Chan JY, 2012, INT J SURG ONCOL, V2012; Hata M, 2014, ANN ONCOL, V25, P291, DOI 10.1093/annonc/mdt478; Hata M, 2012, ANTICANCER RES, V32, P3315; Hata M, 2011, INT J RADIAT ONCOL, V80, P47, DOI 10.1016/j.ijrobp.2010.01.073; Hata M, 2014, J EUR ACAD DERMATOL, V28, P873, DOI 10.1111/jdv.12185; Ito Y, 2012, DERMATOL SURG, V38, P1938, DOI 10.1111/j.1524-4725.2012.02584.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kwan W H, 1995, Clin Oncol (R Coll Radiol), V7, P400, DOI 10.1016/S0936-6555(05)80016-0; Lee JH, 2013, ANN PLAS SURG, V71, P571, DOI 10.1097/SAP.0b013e31824f23e4; Lee KY, 2009, DERMATOL SURG, V35, P34, DOI 10.1111/j.1524-4725.2008.34380.x; Marcos Soraya, 2012, Rep Pract Oncol Radiother, V17, P163, DOI 10.1016/j.rpor.2012.03.006; Murata Y, 2005, Eur J Dermatol, V15, P168; O'Connor WJ, 2003, DERMATOL SURG, V29, P723, DOI 10.1046/j.1524-4725.2003.29184.x; Qin XJ, 2012, BJU INT, V110, pE1121, DOI 10.1111/j.1464-410X.2012.11491.x; STOCK RG, 1995, INT J RADIAT ONCOL, V31, P31, DOI 10.1016/0360-3016(94)00391-W; Tsutsumida A, 2003, DERMATOL SURG, V29, P21, DOI 10.1046/j.1524-4725.2003.29001.x	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	APR	2015	172	4					1014	1020		10.1111/bjd.13357		7	Dermatology	Dermatology	CE6MV	WOS:000351952100062		
J	Takeichi, T; Hsu, CK; Yang, HS; Chen, HY; Wong, TW; Tsai, WL; Chao, SC; Lee, JYY; Akiyama, M; Simpson, MA; McGrath, JA				Takeichi, T.; Hsu, C. -K.; Yang, H. -S.; Chen, H. -Y.; Wong, T. -W.; Tsai, W. -L.; Chao, S. -C.; Lee, J. Y. -Y.; Akiyama, M.; Simpson, M. A.; McGrath, J. A.			Progressive hyperpigmentation in a Taiwanese child due to an inborn error of vitamin B12 metabolism (cblJ)	BRITISH JOURNAL OF DERMATOLOGY			English	Article							DEFICIENCY; MUTATIONS; SYMPTOMS; SIGN; SKIN	The physiology of human skin pigmentation is varied and complex, with an extensive melanogenic paracrine network involving mesenchymal and epithelial cells, contributing to the regulation of melanocyte survival and proliferation and melanogenesis. Mutations in several genes, involving predominantly the KIT ligand/c-Kit and Ras/mitogen-activated protein kinase signalling pathways, have been implicated in a spectrum of diseases in which there is hyperpigmentation, hypopigmentation or both. Here, we report on a 12-year-old girl from Taiwan with a 6-year history of diffuse progressive skin hyperpigmentation resulting from a different aetiology: an inborn metabolic disorder of vitamin B12 (cobalamin), designated cblJ. Using whole-exome sequencing we identified a homozygous mutation in ABCD4 (c.423C>G; p.Asn141Lys), which encodes an ATP-binding cassette transporter with a role in the intracellular processing of cobalamin. The patient had biochemical and haematological evidence of cobalamin deficiency but no other clinical abnormalities apart from a slight lightening of her previously black hair. Of note, she had no neurological symptoms or signs. Treatment with oral cobalamin (3 mg daily) led to metabolic correction and some reduction in the skin hyperpigmentation at the 3-month follow-up. This case demonstrates that defects or deficiencies of cobalamin should be remembered in the differential diagnosis of diffuse hyperpigmentary skin disorders.	[Takeichi, T.; McGrath, J. A.] Kings Coll London, Guys Hosp, St Johns Inst Dermatol, London SE1 9RT, England; [Simpson, M. A.] Kings Coll London, Guys Hosp, Dept Genet & Mol Med, London SE1 9RT, England; [Takeichi, T.; Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Hsu, C. -K.; Yang, H. -S.; Chen, H. -Y.; Wong, T. -W.; Chao, S. -C.; Lee, J. Y. -Y.] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Dermatol, Tainan 704, Taiwan; [Hsu, C. -K.] Natl Cheng Kung Univ, Coll Med & Hosp, Inst Clin Med, Tainan 704, Taiwan; [Wong, T. -W.] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Biochem & Mol Biol, Tainan 704, Taiwan; [Tsai, W. -L.] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Pathol, Tainan 704, Taiwan	McGrath, JA (reprint author), Kings Coll London, Guys Hosp, St Johns Inst Dermatol, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	Department of Health via the U.K. National Institute for Health Research Comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; Great Britain Sasakawa Foundation [4314]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science [S2404]	The authors acknowledge financial support from the Department of Health via the U.K. National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. This study was also supported in part by the Great Britain Sasakawa Foundation no. 4314 and Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (S2404) from the Japan Society for the Promotion of Science.	Kim JC, 2012, MOL GENET METAB, V107, P664, DOI 10.1016/j.ymgme.2012.10.005; Amyere M, 2011, J INVEST DERMATOL, V131, P1234, DOI 10.1038/jid.2011.29; Watkins D, 2011, AM J MED GENET C, V157C, P33, DOI 10.1002/ajmg.c.30288; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Wang ZQ, 2009, AM J HUM GENET, V84, P672, DOI 10.1016/j.ajhg.2009.03.019; BAKER SJ, 1963, BMJ-BRIT MED J, P1713; Demir N, 2014, CUTAN OCUL TOXICOL, V33, P70, DOI 10.3109/15569527.2013.861477; Graells J, 2009, J AM ACAD DERMATOL, V60, P498, DOI 10.1016/j.jaad.2008.09.011; Hoffman CF, 2003, CUTIS, V71, P127; Mori K, 2001, J DERMATOL, V28, P282	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	APR	2015	172	4					1111	1115		10.1111/bjd.13413		5	Dermatology	Dermatology	CE6MV	WOS:000351952100075		
J	Toyonaga, E; Nishie, W; Komine, M; Murata, S; Shinkuma, S; Natsuga, K; Nakamura, H; Ohtsuki, M; Shimizu, H				Toyonaga, E.; Nishie, W.; Komine, M.; Murata, S.; Shinkuma, S.; Natsuga, K.; Nakamura, H.; Ohtsuki, M.; Shimizu, H.			Skipped exon in COL7A1 determines the clinical phenotypes of dystrophic epidermolysis bullosa	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							PRURIGINOSA; DOMINANT		[Toyonaga, E.; Nishie, W.; Shinkuma, S.; Natsuga, K.; Nakamura, H.; Shimizu, H.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Komine, M.; Murata, S.; Ohtsuki, M.] Jichi Med Univ, Dept Dermatol, Shimotsuke, Tochigi, Japan	Nishie, W (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.	nishie@med.hokudai.ac.jp					Cox HE, 1998, BRIT J DERMATOL, V138, P182; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; MCGRATH JA, 1994, BRIT J DERMATOL, V130, P617, DOI 10.1111/j.1365-2133.1994.tb13109.x; Banky JP, 2004, ARCH DERMATOL, V140, P794, DOI 10.1001/archderm.140.7.794; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; Kim J, 2013, J DERMATOL, V40, P562, DOI 10.1111/1346-8138.12167; Mellerio JE, 1999, J INVEST DERMATOL, V112, P984, DOI 10.1046/j.1523-1747.1999.00614.x; Bulic SO, 2005, BRIT J DERMATOL, V152, P1332, DOI 10.1111/j.1365-2133.2005.06492.x; Sakuntabhai A, 1998, AM J HUM GENET, V63, P737, DOI 10.1086/302029; Yamasaki H, 1997, BRIT J DERMATOL, V137, P308	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	APR	2015	172	4					1141	1144		10.1111/bjd.13386		4	Dermatology	Dermatology	CE6MV	WOS:000351952100086		
J	On, HR; Hashimoto, T; Kim, SC				On, H. R.; Hashimoto, T.; Kim, S. -C.			Pemphigus herpetiformis with IgG autoantibodies to desmoglein 1 and desmocollin 1	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							ANTIBODIES		[On, H. R.; Kim, S. -C.] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Dermatol, Seoul 135720, South Korea; [On, H. R.; Kim, S. -C.] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Cutaneous Biol Res Inst, Seoul 135720, South Korea; [Hashimoto, T.] Kurume Univ, Sch Med, Inst Cutaneous Cell Biol, Dept Dermatol, Fukuoka, Japan	Kim, SC (reprint author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Dermatol, Eonjuro 712, Seoul 135720, South Korea.	kimsc@yuhs.ac					Kozlowska A, 2003, J AM ACAD DERMATOL, V48, P117, DOI 10.1067/mjd.2003.23; Ishii K, 1999, ARCH DERMATOL, V135, P943, DOI 10.1001/archderm.135.8.943; Robinson ND, 1999, J AM ACAD DERMATOL, V40, P649, DOI 10.1016/S0190-9622(99)70145-3; Micali G, 1998, INT J DERMATOL, V37, P197, DOI 10.1046/j.1365-4362.1998.00428.x; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Kasperkiewicz M, 2014, J AM ACAD DERMATOL, V70, P780, DOI 10.1016/j.jaad.2013.11.043; Matsukura S, 2014, INT J DERMATOL, V53, P1023, DOI 10.1111/j.1365-4632.2012.05725.x; Ohata C, 2013, JAMA DERMATOL, V149, P502, DOI 10.1001/jamadermatol.2013.1916; Ohata C, 2013, BRIT J DERMATOL, V168, P879, DOI 10.1111/bjd.12019; Tateishi Chiharu, 2010, J Am Acad Dermatol, V63, pe8, DOI 10.1016/j.jaad.2009.09.016	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	APR	2015	172	4					1144	1146		10.1111/bjd.13419		4	Dermatology	Dermatology	CE6MV	WOS:000351952100087		
J	Kobayashi, Y; Yoshida, S; Nakama, T; Zhou, YD; Ishikawa, K; Arita, R; Nakao, S; Miyazaki, M; Sassa, Y; Oshima, Y; Lzuhara, K; Kono, T; Ishibashil, T				Kobayashi, Yoshiyuki; Yoshida, Shigeo; Nakama, Takahito; Zhou, Yedi; Ishikawa, Keijiro; Arita, Ryoichi; Nakao, Shintaro; Miyazaki, Masanori; Sassa, Yukio; Oshima, Yuji; Lzuhara, Kenji; Kono, Toshihiro; Ishibashil, Tatsuro			Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							OXYGEN-INDUCED RETINOPATHY; MOUSE MODEL; RETINAL NEOVASCULARIZATION; EXPRESSION; MACROPHAGES; ANGIOGENESIS; INFLAMMATION; PERSPECTIVE; VITRECTOMY; PROMOTES	Aim To determine whether CD163, a specific marker for M2 macrophages, is involved in the formation of preretinal fibrovascular membranes (FVMs) present in eyes with proliferative diabetic retinopathy (PDR). Methods We measured the levels of soluble (s)CD163, periostin and vascular endothelial growth factor by sandwich ELISA in vitreous samples from 74 eyes of 62 patients with PDR, 20 eyes of 18 patients with proliferative vitreoretinopathy, and 56 eyes of 54 patients with non-diabetic ocular diseases (control group). Immunohistochemical analyses were performed to determine the expressions of CD68, CD163 and periostin in the surgically resected FVMs and idiopathic epiretinal membranes (ERMs). Results The concentrations of sCD163 and periostin in the vitreous were significantly higher in patients with PDR than in non-diabetic controls (p<0.0001). There was a strong correlation between the vitreous concentrations of sCD163 and periostin. The mean vitreous level of sCD163 was significantly higher in eyes with FVMs than in those without FVMs (epicentre only). The number and percentage of CD163+ macrophages were significantly higher in the FVMs than in the idiopathic ERMs. Immunohistochemical analysis showed co-localisation of CD163 and periostin in FVM cells. Conclusions These findings indicate that the overexpression of CD163 by macrophages may be involved in the development of FVMs partly through periostin production.	[Kobayashi, Yoshiyuki; Yoshida, Shigeo; Nakama, Takahito; Zhou, Yedi; Ishikawa, Keijiro; Arita, Ryoichi; Nakao, Shintaro; Miyazaki, Masanori; Sassa, Yukio; Oshima, Yuji; Ishibashil, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Sassa, Yukio; Kono, Toshihiro] Fukuoka Univ, Chikushi Hosp, Dept Ophthalmol, Chikusino, Fukuoka, Japan; [Lzuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga, Japan	Yoshida, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan.	yosida@eye.med.kyushu-u.ac.jp			JSPS KAKENHI [24249083, 26670757, 26293374]; Takeda Science Foundation	JSPS KAKENHI Grant Numbers 24249083, 26670757 and 26293374, and Takeda Science Foundation.	Akila P, 2012, CLIN CHIM ACTA, V413, P669, DOI 10.1016/j.cca.2012.01.028; Hiscott P, 2000, EYE, V14, P549; Ishikawa K, 2012, LAB INVEST, V92, P91, DOI 10.1038/labinvest.2011.141; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; Yamaji Y, 2008, INVEST OPHTH VIS SCI, V49, P3151, DOI 10.1167/iovs.07-1249; Ishikawa K, 2010, INVEST OPHTH VIS SCI, V51, P4307, DOI 10.1167/iovs.09-4605; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; El-Sabagh HA, 2011, OPHTHALMOLOGY, V118, P636, DOI 10.1016/j.ophtha.2010.08.038; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410; Ishikawa K, 2014, FASEB J, V28, P131, DOI 10.1096/fj.13-229740; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yoshida A, 1999, HISTOL HISTOPATHOL, V14, P1287; Asato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054191; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Simó Rafael, 2006, Curr Diabetes Rev, V2, P71, DOI 10.2174/157339906775473671; Yoshida S, 2011, INVEST OPHTH VIS SCI, V52, P5670, DOI 10.1167/iovs.10-6625; Yoshida S, 2012, INVEST OPHTH VIS SCI, V53, P6997, DOI 10.1167/iovs.12-9671	25	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	APR	2015	99	4					451	456		10.1136/bjophthalmo1-2014-305321		6	Ophthalmology	Ophthalmology	CE2YI	WOS:000351687800003		
J	Nakamura, Y; Mitamura, Y; Hagiwara, A; Kumagai, K; Miura, G; Sugawara, T; Egawa, M; Yamamoto, S				Nakamura, Yosuke; Mitamura, Yoshinori; Hagiwara, Akira; Kumagai, Ken; Miura, Gen; Sugawara, Takeshi; Egawa, Mariko; Yamamoto, Shuichi			Relationship between retinal microstructures and visual acuity after cataract surgery in patients with retinitis pigmentosa	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							SEGMENT JUNCTION	Aims To study the relationship between the retinal microstructures and the best-corrected visual acuity (BCVA) after cataract surgery in patients with retinitis pigmentosa (RP). Methods 58 eyes of 43 consecutive RP patients who underwent cataract surgery were studied. The BCVA was measured before and 3 months after the surgery. The appearance of the inner segment/outer segment (IS/OS) line of the photoreceptors in the optical coherence tomographic (OCT) images at the fovea was graded; Grade 1, IS/OS line not visible; Grade 2, IS/OS line abnormal or discontinuous; and Grade 3, IS/OS line normal. The central foveal thickness (CET) and the length of the IS/OS line were measured in the spectral-domain OCT images. Results The postoperative BCVAs in logMAR units (Grade 1, 1.04 +/- 0.36; Grade 2, 0.33 +/- 0.16; Grade 3, 0.08 +/- 0.14) and the improvements in the BCVA in logMAR units (Grade 1, 0.22 +/- 0.28; Grade 2 +/- 0.53 +/- 0.48; Grade 3, 0.54 +/- 0.35) were significantly different among Grade 1, 2 and 3 groups (p<0.0001, p=0.0378; respectively). A postoperative BCVA of <0.2 logMAR units was achieved in 0% in Grade 1, 20% in Grade 2 and 74% in Grade 3 (p<0.0001). There was a significant correlation between the postoperative BCVA and the length of the IS/OS line (r=-0.601 p<0.0001) or the CET (r=-0.510, p<0.0001). Conclusions The presence of normal IS/OS line in the OCT images is associated with good visual recovery after cataract surgery in RP patients. The integrity of the IS/OS line may be important for predicting good postoperative BCVA.	[Nakamura, Yosuke; Hagiwara, Akira; Kumagai, Ken; Miura, Gen; Sugawara, Takeshi; Yamamoto, Shuichi] Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chiba 2608670, Japan; [Mitamura, Yoshinori; Egawa, Mariko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, Tokushima 770, Japan	Nakamura, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nakamura0709atsu@yahoo.co.jp			Ministry of Education, Science, Sports and Culture, Japan [25462717]	This study was supported in part by Grants-in-Aid 25462717 (to YM) from the Ministry of Education, Science, Sports and Culture, Japan.	Aizawa S, 2009, EYE, V23, P304, DOI 10.1038/sj.eye.6703076; Sandberg MA, 2005, INVEST OPHTH VIS SCI, V46, P3349, DOI 10.1167/iovs.04-1383; Aizawa S, 2010, CLIN EXP OPHTHALMOL, V38, P597, DOI 10.1111/j.1442-9071.2010.02321.x; Hagiwara A, 2013, BRIT J OPHTHALMOL, V97, P237, DOI 10.1136/bjophthalmol-2012-302510; Hayashi K, 1998, OPHTHALMOLOGY, V105, P1239, DOI 10.1016/S0161-6420(98)97028-2; Jackson H, 2001, BRIT J OPHTHALMOL, V85, P936, DOI 10.1136/bjo.85.8.936; Mitamura Y, 2009, BRIT J OPHTHALMOL, V93, P126, DOI 10.1136/bjo.2008.141127; Tsujikawa M, 2008, ARCH OPHTHALMOL-CHIC, V126, P337, DOI 10.1001/archopht.126.3.337	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	APR	2015	99	4					508	511		10.1136/bjophthalmol-2013-304819		4	Ophthalmology	Ophthalmology	CE2YI	WOS:000351687800012		
J	Liu, Y; Kimura, K; Orita, T; Teranishi, S; Suzuki, K; Sonoda, KH				Liu, Yang; Kimura, Kazuhiro; Orita, Tomoko; Teranishi, Shinichiro; Suzuki, Katsuyoshi; Sonoda, Koh-Hei			All-trans-retinoic acid inhibition of transforming growth factor-beta-induced collagen gel contraction mediated by human Tenon fibroblasts: role of matrix metalloproteinases	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							TGF-BETA; 13-CIS-RETINOIC ACID; GLAUCOMA FILTRATION; PULMONARY-FIBROSIS; EXPRESSION; MYOFIBROBLAST; SURGERY; TRANSDIFFERENTIATION; SUPPRESSION; MIGRATION	Background/aims Scarring and contraction of the conjunctiva are common complications of many ocular diseases. We investigated the effects of all-trans-retinoic acid (ATRA) on the contractility of human Tenon's capsule fibroblasts (HTFs) cultured in a three-dimensional collagen gel. Methods HTFs were cultured in a three-dimensional gel of type I collagen and in the absence or presence of transforming growth factor (TGF)-beta, ATRA, or an inhibitor of matrix metalloproteinases (MMPs). Collagen gel contraction was evaluated by measurement of gel diameter. The release of MMPs and tissue inhibitors of metalloproteinases (TIMPs) into culture supernatants was assessed by immunoblot analysis and gelatin zymography. The release of lactate dehydrogenase activity from HTFs was measured with a colorimetric assay kit. Results ATRA inhibited TGF-p-induced collagen gel contraction mediated by HTFs in a concentration-and time-dependent manner. TGF-beta induced the release of MMP-1, MMP-2 and MMP-3 by HTFs, and ATRA inhibited these effects of TGF-13 on MMP-1 and MMP-3 release. ATRA also stimulated TIMP-1 release from HTFs in the presence of TGF-13. Furthermore, TGF-p-induced collagen gel contraction was blocked by the MMP inhibitor GM6001. ATRA did not exhibit cytotoxicity for HTFs. Conclusions ATRA inhibited TGF-p-induced collagen gel contraction mediated by HTFs, likely in part by attenuating the production of MMP-1 and MMP-3 and by stimulating the production of TIMP-1. ATRA may therefore prove to be of clinical value for inhibition of scar formation in the conjunctiva.	[Liu, Yang; Kimura, Kazuhiro; Orita, Tomoko; Teranishi, Shinichiro; Suzuki, Katsuyoshi; Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 7558505, Japan; [Liu, Yang] Jilin Univ, Hosp 1, Dept Ophthalmol, Changchun, Jilin, Peoples R China	Kimura, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	k.kimura@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science (JSPS); National Science Foundation of China [81100635]	This study was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS, to KS and YL) and by a grant (no. 81100635) from the National Science Foundation of China (YL).	Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Shin DM, 2001, J CLIN ONCOL, V19, P3010; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Saarialho-Kere UK, 1998, ARCH DERMATOL RES, V290, pS47, DOI 10.1007/PL00007453; Zhu XY, 2012, INVEST OPHTH VIS SCI, V53, P6897, DOI 10.1167/iovs.12-10198; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Yang KL, 2008, BIOCHEM BIOPH RES CO, V373, P219, DOI 10.1016/j.bbrc.2008.05.192; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Meyer-Ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P4895, DOI 10.1167/iovs.06-0118; Mirastschijski U, 2004, EXP CELL RES, V299, P465, DOI 10.1016/j.yexcer.2004.06.007; Axel DI, 2001, CARDIOVASC RES, V49, P851, DOI 10.1016/S0008-6363(00)00312-6; Dong ZX, 2012, EXP LUNG RES, V38, P82, DOI 10.3109/01902148.2011.646052; Fang QH, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/145197; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P4199, DOI 10.1167/iovs.13-13572; Lu Y, 2004, INVEST OPHTH VIS SCI, V45, P2998, DOI 10.1167/iovs.04-0051; Nakamura-Shibasaki M, 2013, CELL BIOCHEM FUNCT, V31, P482, DOI 10.1002/cbf.2923; Piattelli A, 1999, ORAL ONCOL, V35, P314, DOI 10.1016/S1368-8375(98)00095-5; Porter Rebecca A., 1998, Wound Repair and Regeneration, V6, P157, DOI 10.1046/j.1524-475X.1998.60210.x; Reichel MB, 1998, BRIT J OPHTHALMOL, V82, P1072, DOI 10.1136/bjo.82.9.1072; Wong TTL, 2003, INVEST OPHTH VIS SCI, V44, P1097, DOI 10.1167/iovs.02-0366	26	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	APR	2015	99	4					561	565		10.1136/bjophthalmol-2014-306175		5	Ophthalmology	Ophthalmology	CE2YI	WOS:000351687800022		
J	Kikuchi, C; Dosenovic, S; Bienengraeber, M				Kikuchi, C.; Dosenovic, S.; Bienengraeber, M.			Anaesthetics as cardioprotectants: translatability and mechanism	BRITISH JOURNAL OF PHARMACOLOGY			English	Review							MITOCHONDRIAL PERMEABILITY TRANSITION; HEART IN-VIVO; ARTERY-BYPASS SURGERY; K-ATP CHANNELS; PERIOPERATIVE MYOCARDIAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; HOSPITAL CARDIAC-ARREST; KINASE-C-EPSILON; RAT-HEART; VOLATILE ANESTHETICS	The pharmacological conditioning of the heart with anaesthetics, such as volatile anaesthetics or opioids, is a phenomenon whereby a transient exposure to an anaesthetic agent protects the heart from the harmful consequences of myocardial ischaemia and reperfusion injury. The cellular and molecular mechanisms of anaesthetic conditioning appear largely to mimic those of ischaemic pre- and post-conditioning. Progress has been made on the understanding of the underlying mechanisms although the order of events and the specific targets of anaesthetics that trigger protection are not always clear. In the laboratory, the protection afforded by certain anaesthetics against cardiac ischaemia and reperfusion injury is powerful and reproducible but this has not necessarily translated into similarly robust clinical benefits. Indeed, clinical studies and meta-analyses delivered variable results when comparing in the laboratory setting protective and non-protective anaesthetics. Reasons for this include underlying conditions such as age, obesity and diabetes. Animal models for disease or ageing, human cardiomyocytes derived from stem cells of patients and further clinical studies are employed to better understand the underlying causes that prevent a more robust protection in patients. Linked ArticlesThis article is part of a themed section on Conditioning the Heart - Pathways to Translation. To view the other articles in this section visit	[Kikuchi, C.; Dosenovic, S.; Bienengraeber, M.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Kikuchi, C.] Asahikawa Med Univ, Dept Anesthesiol, Asahikawa, Hokkaido, Japan; [Bienengraeber, M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Bienengraeber, M (reprint author), Med Coll Wisconsin, Dept Anesthesiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mbieneng@mcw.edu			National Institutes of Health [R01 HL098490]	This work was supported in part by the National Institutes of Health (R01 HL098490).	Aldakkak Mohammed, 2008, Cardiovasc Res, V77, P406; Alvarez P, 2014, CHEM-BIOL INTERACT, V218, P89, DOI 10.1016/j.cbi.2014.04.019; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Ge ZD, 2010, ANESTHESIOLOGY, V112, P73, DOI 10.1097/ALN.0b013e3181c4a607; Knapp J, 2013, RESUSCITATION, V84, P1450, DOI 10.1016/j.resuscitation.2013.04.012; Ballester M, 2011, EUR J ANAESTH, V28, P874, DOI 10.1097/EJA.0b013e32834bea2a; Weber N. C., 2008, V182, P187; Piriou V, 2004, ANESTHESIOLOGY, V100, P581, DOI 10.1097/00000542-200403000-00018; Xia ZY, 2006, ANESTH ANALG, V103, P527, DOI 10.1213/01.ane.0000230612.29452.a6; Wang C, 2006, ANESTH ANALG, V103, P281, DOI 10.1213/01.ane.0000226094.94877.98; Hasegawa K, 2013, RESUSCITATION, V84, P1099, DOI 10.1016/j.resuscitation.2013.03.007; Landoni G, 2013, BRIT J ANAESTH, V111, P886, DOI 10.1093/bja/aet231; Schultz JEJ, 1996, CIRC RES, V78, P1100; Weihrauch D, 2005, ANESTH ANALG, V101, P942, DOI 10.1213/01.ane.0000171931.08371.a2; Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; MURRY CE, 1986, CIRCULATION, V74, P1124; Weber NC, 2008, EUR J PHARMACOL, V592, P48, DOI 10.1016/j.ejphar.2008.07.010; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Feng JH, 2005, ANESTHESIOLOGY, V103, P987, DOI 10.1097/00000542-200511000-00013; Zhang JL, 2013, CIRCULATION, V127, pE876, DOI 10.1161/CIRCULATIONAHA.112.000832; Conzen PF, 2003, ANESTHESIOLOGY, V99, P826, DOI 10.1097/00000542-200310000-00013; Zaugg M, 2003, BRIT J ANAESTH, V91, P551, DOI 10.1093/bja/aeg205; Toller WG, 2000, ANESTHESIOLOGY, V92, P1731, DOI 10.1097/00000542-200006000-00033; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Kim HS, 2010, PHYSIOL RES, V59, P347; Cope DK, 1997, ANESTHESIOLOGY, V86, P699, DOI 10.1097/00000542-199703000-00023; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Ebel D, 1999, BRIT J ANAESTH, V83, P903; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1706, DOI 10.1111/bph.12450; Kokita N, 1998, ANESTH ANALG, V86, P252, DOI 10.1097/00000539-199802000-00006; Zhu J, 2013, J GERONTOL A-BIOL, V68, P395, DOI 10.1093/gerona/gls205; Pagel PS, 2008, J CARDIOTHOR VASC AN, V22, P753, DOI 10.1053/j.jvca.2008.03.005; Amour J, 2010, ANESTHESIOLOGY, V112, P576, DOI 10.1097/ALN.0b013e3181cded1f; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; Mio Y, 2008, ANESTHESIOLOGY, V108, P612, DOI 10.1097/ALN.0b013e318167af2d; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; Yannopoulos D, 2013, RESUSCITATION, V84, P1143, DOI 10.1016/j.resuscitation.2013.01.024; Yu CH, 2006, CAN J ANAESTH, V53, P906; Symons JA, 2006, BRIT J ANAESTH, V97, P127, DOI 10.1093/bja/ae1149; Yao YT, 2010, MOL BIOL REP, V37, P2439, DOI 10.1007/s11033-009-9755-4; Jang YG, 2008, ANESTHESIOLOGY, V108, P243, DOI 10.1097/01.anes.0000299437.93898.4a; Ludwig LM, 2004, ANESTHESIOLOGY, V100, P532, DOI 10.1097/00000542-200403000-00011; Canfield SG, 2012, ANESTHESIOLOGY, V117, P735, DOI 10.1097/ALN.0b013e3182655e96; Leucker TM, 2011, J MOL CELL CARDIOL, V51, P803, DOI 10.1016/j.yjmcc.2011.06.026; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; Matsumoto S, 2009, CARDIOVASC DRUG THER, V23, P263, DOI 10.1007/s10557-009-6184-5; Chiari PC, 2005, ANESTHESIOLOGY, V102, P102, DOI 10.1097/00000542-200501000-00018; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Pravdic D, 2009, ANESTHESIOLOGY, V111, P267, DOI 10.1097/ALN.0b013e3181a91957; Zhang Y, 2004, ANESTHESIOLOGY, V101, P918, DOI 10.1097/00000542-200410000-00017; Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Pagel PS, 2013, J CARDIOTHOR VASC AN, V27, P972, DOI 10.1053/j.jvca.2012.10.011; Buse GALL, 2012, CIRCULATION, V126, P2696, DOI 10.1161/CIRCULATIONAHA.112.126144; Huhn R, 2008, BRIT J ANAESTH, V100, P465, DOI 10.1093/bja/aen022; Stewart S, 2009, TRANSL RES, V153, P224, DOI 10.1016/j.trsl.2009.02.003; Frassdorf J, 2009, J THORAC CARDIOV SUR, V137, P1436, DOI 10.1016/j.jtcvs.2008.04.034; Feng JH, 2008, CARDIOVASC RES, V80, P20, DOI 10.1093/cvr/cvn161; Tonkovic-Capin M, 2002, AM J PHYSIOL-HEART C, V283, pH61, DOI 10.1152/ajpheart.01040.2001; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Lange M, 2006, ANESTHESIOLOGY, V105, P503, DOI 10.1097/00000542-200609000-00014; Lucchinetti E, 2009, ANESTH ANALG, V109, P1117, DOI 10.1213/ANE.0b013e3181b5a277; Hirata N, 2011, ANESTHESIOLOGY, V115, P531, DOI 10.1097/ALN.0b013e31822a2316; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Miki T, 1998, MOL CELL BIOCHEM, V186, P3, DOI 10.1023/A:1006856124501; Lindholm EE, 2013, ANESTHESIOLOGY, V119, P802, DOI 10.1097/ALN.0b013e31829bd883; Lemoine S, 2011, BRIT J ANAESTH, V107, P510, DOI 10.1093/bja/aer201; Bienengraeber M, 2013, PHYSIOL GENOMICS, V45, P163, DOI 10.1152/physiolgenomics.00117.2012; Bienengraeber M, 2006, ANESTHESIOLOGY, V105, P534, DOI 10.1097/00000542-200609000-00017; Bignami E, 2013, J CARDIOTHOR VASC AN, V27, P50, DOI 10.1053/j.jvca.2012.06.007; BLAND JHL, 1976, ANESTHESIOLOGY, V45, P287; Bonney S, 2014, CURR PHARM DESIGN, V20, P5690; dasSilva R, 2004, ANESTHESIOLOGY, V100, P59; De Hert S G, 2008, Acta Anaesthesiol Belg, V59, P19; De Hert SG, 2005, ANESTH ANALG, V100, P1584, DOI 10.1213/01.ANE.0000153483.61170.OC; Dyballa-Rukes N, 2014, CELL PHYSIOL BIOCHEM, V33, P967, DOI 10.1159/000358668; Forlani S, 2004, J CARDIOVASC SURG, V45, P117; Frädorf Jan, 2010, Anesthesiology, V113, P1289, DOI 10.1097/ALN.0b013e3181f97fec; Fryer RM, 1999, CIRC RES, V84, P846; Ishii H, 2014, CURR PHARM DESIGN, V20, P5794; KANAYA N, 1995, BRIT J ANAESTH, V74, P563, DOI 10.1093/bja/74.5.563; Kortekaas KA, 2014, BRIT J ANAESTH, V112, P1005, DOI 10.1093/bja/aet588; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013; Lemoine S, 2010, DIABETES METAB, V36, P21, DOI 10.1016/j.diabet.2009.06.006; Liang BT, 1999, CIRC RES, V84, P1396; London MJ, 2009, CURR OPIN CRIT CARE, V15, P333, DOI 10.1097/MCC.0b013e32832e4795; Meybohm P, 2011, CRIT CARE, V15, DOI 10.1186/cc10496; Mio Y, 2009, ANESTH ANALG, V108, P858, DOI 10.1213/ane.0b013e318192a520; Mullenheim J, 2001, ANESTHESIOLOGY, V94, P630; Muravyeva M, 2014, ANESTHESIOLOGY, V120, P870, DOI 10.1097/ALN.0000000000000107; Nguyen LT, 2008, ANESTH ANALG, V107, P776, DOI 10.1213/ane.0b013e318180419d; Pagel PS, 2011, J CARDIOTHOR VASC AN, V25, P1125, DOI 10.1053/j.jvca.2010.09.017; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Piriou V, 2002, BRIT J ANAESTH, V89, P486, DOI 10.1093/bja/aef206; Pravdic D, 2012, EUR J PHARMACOL, V690, P149, DOI 10.1016/j.ejphar.2012.07.003; Redel A, 2009, EXP BIOL MED, V234, P1186, DOI 10.3181/0902-RM-58; Riess ML, 2004, ANESTHESIOLOGY, V100, P569, DOI 10.1097/00000542-200403000-00016; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Roth DM, 2011, PEDIATR CARDIOL, V32, P329, DOI 10.1007/s00246-010-9881-8; Sandhu R, 1997, CIRCULATION, V96, P984; Sedlic F, 2010, BBA-BIOENERGETICS, V1797, P1749, DOI 10.1016/j.bbabio.2010.07.009; Sepac A, 2010, ANESTHESIOLOGY, V113, P906, DOI 10.1097/ALN.0b013e3181eff6b7; Sergeev P, 2004, ANESTHESIOLOGY, V100, P474, DOI 10.1097/00000542-200403000-00005; Singh Pooja, 2013, World J Pediatr Congenit Heart Surg, V4, P24, DOI 10.1177/2150135112457580; Smul TM, 2011, J CARDIOTHOR VASC AN, V25, P276, DOI 10.1053/j.jvca.2010.07.018; Toma O, 2004, ANESTHESIOLOGY, V101, P1372; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Tuman K J, 1991, Semin Thorac Cardiovasc Surg, V3, P47; Uecker M, 2003, ANESTHESIOLOGY, V99, P138, DOI 10.1097/00000542-200307000-00023; Van Allen NR, 2012, MED GAS RES, V28, P22, DOI DOI 10.1186/2045-9912-2-22; van den Brom CE, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-42; WARLTIER DC, 1988, ANESTHESIOLOGY, V69, P552, DOI 10.1097/00000542-198810000-00016; Weber NC, 2005, BRIT J PHARMACOL, V144, P123, DOI 10.1038/sj.bjp.0706063; Weber NC, 2005, ANESTHESIOLOGY, V103, P1174, DOI 10.1097/00000542-200512010-00011; Xiao YY, 2011, ANESTH ANALG, V113, P224, DOI 10.1213/ANE.0b013e3182239b71; Zaugg M, 2013, CIRCULATION, V127, pE875, DOI 10.1161/CIRCULATIONAHA.112.000201; Zhang R., 2013, J CARDIOTHORAC SURG, V11, P76	120	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	APR	2015	172	8			SI		2051	2061		10.1111/bph.12981		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7PH	WOS:000352033300010		
J	Takasu, K; Ogawa, K; Nakamura, A; Kanbara, T; Ono, H; Tomii, T; Morioka, Y; Hasegawa, M; Shibasaki, M; Mori, T; Suzuki, T; Sakaguchi, G				Takasu, Keiko; Ogawa, Koichi; Nakamura, Atsushi; Kanbara, Tomoe; Ono, Hiroko; Tomii, Takako; Morioka, Yasuhide; Hasegawa, Minoru; Shibasaki, Masahiro; Mori, Tomohisa; Suzuki, Tsutomu; Sakaguchi, Gaku			Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							MU-OPIOID RECEPTOR; CONTROLLED-RELEASE OXYCODONE; PERIAQUEDUCTAL GRAY NEURONS; RANDOMIZED CONTROLLED-TRIAL; PAIRED-PULSE FACILITATION; LONG-TERM POTENTIATION; NEUROPATHIC PAIN; SPINAL-CORD; PRESYNAPTIC INHIBITION; CONCISE GUIDE	Background and PurposeWe demonstrated previously that oxycodone has potent antinociceptive effects at supraspinal sites. In this study, we investigated changes in neuronal function and antinociceptive mechanisms of oxycodone at ventrolateral periaqueductal gray (VLPAG) neurons, which are a major site of opioid action, in a femur bone cancer (FBC) model with bone cancer-related pain. Experimental ApproachWe characterized the supraspinal antinociceptive profiles of oxycodone and morphine on mechanical hypersensitivity in the FBC model. Based on the disinhibition mechanism underlying supraspinal opioid antinociception, the effects of oxycodone and morphine on GABA(A) receptor-mediated inhibitory postsynaptic currents (IPSCs) in VLPAG neurons were evaluated in slices from the FBC model. Key ResultsThe supraspinal antinociceptive effects of oxycodone, but not morphine, were abolished by blocking G protein-gated inwardly rectifying potassium1 (K(ir)3.1) channels. In slices from the FBC model, GABAergic synaptic transmission at VLPAG neurons was enhanced, as indicated by a leftward shift of the input-output relationship curve of evoked IPSCs, the increased paired-pulse facilitation and the enhancement of miniature IPSC frequency. Following treatment with oxycodone and morphine, IPSCs were reduced in the FBC model, and the inhibition of presynaptic GABA release by oxycodone, but not morphine was enhanced and dependent on K(ir)3.1 channels. Conclusion and ImplicationsOur results demonstrate that K(ir)3.1 channels are important for supraspinal antinociception and presynaptic GABA release inhibition by oxycodone in the FBC model. Enhanced GABAergic synaptic transmission at VLPAG neurons in the FBC model is an important site of supraspinal antinociception by oxycodone via K(ir)3.1 channel activation.	[Takasu, Keiko; Ogawa, Koichi; Nakamura, Atsushi; Kanbara, Tomoe; Ono, Hiroko; Tomii, Takako; Morioka, Yasuhide; Hasegawa, Minoru; Sakaguchi, Gaku] Shionogi & Co Ltd, Discovery Res Labs Core Therapeut Areas, Pain & Neurol, Toyonaka, Osaka 5610825, Japan; [Nakamura, Atsushi; Kanbara, Tomoe; Shibasaki, Masahiro; Mori, Tomohisa; Suzuki, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Toxicol, Tokyo 142, Japan	Sakaguchi, G (reprint author), Shionogi & Co Ltd, Discovery Res Labs Core Therapeut Areas, Pain & Neurol, 1-1 Futaba Cho,3 Chome, Toyonaka, Osaka 5610825, Japan.	gaku.sakaguchi@shionogi.co.jp					Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Park C, 2010, P NATL ACAD SCI USA, V107, P14857, DOI 10.1073/pnas.1009532107; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451; Quigley C, 2005, BRIT MED J, V331, P825, DOI 10.1136/bmj.331.7520.825; Liu ZL, 2012, BRAIN RES BULL, V88, P529, DOI 10.1016/j.brainresbull.2012.05.010; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Herman MA, 2013, NEUROPHARMACOLOGY, V67, P337, DOI 10.1016/j.neuropharm.2012.11.026; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Budai D, 1998, J NEUROPHYSIOL, V79, P677; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Ingram SL, 1998, J NEUROSCI, V18, P10269; Watson CPN, 2003, PAIN, V105, P71, DOI 10.1016/S0304-3959(03)00160-X; Marker CL, 2004, J NEUROSCI, V24, P2806, DOI 10.1523/JNEUROSCI.5251-03.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Hansen MS, 2012, ACTA ANAESTH SCAND, V56, P407, DOI 10.1111/j.1399-6576.2011.02613.x; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Goitia B, 2013, J NEUROCHEM, V124, P602, DOI 10.1111/jnc.12113; Koyyalagunta D, 2012, PAIN PHYSICIAN, V15, pES39; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530; Drew GM, 2009, J NEUROSCI, V29, P7220, DOI 10.1523/JNEUROSCI.4362-08.2009; CHEN Y, 1994, J BIOL CHEM, V269, P7839; Bercovitch Michaela, 2006, J Pain Palliat Care Pharmacother, V20, P33, DOI 10.1300/J354v20n04_06; Nassirpour R, 2010, J NEUROSCI, V30, P13419, DOI 10.1523/JNEUROSCI.2966-10.2010; Kalso E, 2005, J PAIN SYMPTOM MANAG, V29, pS47, DOI 10.1016/j.jpainsymman.2005.01.010; WU LG, 1994, J NEUROSCI, V14, P645; Lemberg KK, 2006, ANESTHESIOLOGY, V105, P801, DOI 10.1097/00000542-200610000-00027; Peckham EM, 2006, J PHARMACOL EXP THER, V316, P1195, DOI 10.1124/jpet.105.094276; Dupen A, 2007, PAIN MANAG NURS, V8, P113, DOI 10.1016/j.pmn.2007.02.004; Gimbel JS, 2003, NEUROLOGY, V60, P927; Mercadante S, 1998, CANCER TREAT REV, V24, P425, DOI 10.1016/S0305-7372(98)90005-6; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1582, DOI 10.1111/bph.12446; Watson CPN, 1998, NEUROLOGY, V50, P1837; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; BANNING A, 1991, PAIN, V45, P45, DOI 10.1016/0304-3959(91)90163-R; Becker R, 2000, STEREOT FUNCT NEUROS, V75, P16, DOI 10.1159/000048379; Bradaia A, 2005, P NATL ACAD SCI USA, V102, P3034, DOI 10.1073/pnas.0406632102; Buvanendran A, 2010, PAIN PHYSICIAN, V13, pE337; Coleman Robert E., 1998, Current Opinion in Oncology, V10, pS7; Hack SP, 2003, NEUROPHARMACOLOGY, V45, P575, DOI 10.1016/S0028-3908(03)00205-3; Hahm ET, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-41; Heiskanen T, 1997, PAIN, V73, P37, DOI 10.1016/S0304-3959(97)00072-9; Jang IS, 2011, NEUROREPORT, V22, P834, DOI 10.1097/WNR.0b013e32834bc733; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Kobayashi M, 2012, J NEUROPHYSIOL, V107, P1431, DOI 10.1152/jn.00813.2011; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; Nakamura A, 2014, BRIT J PHARMACOL, V171, P253, DOI 10.1111/bph.12441; Nakamura A, 2013, BRIT J PHARMACOL, V168, P375, DOI 10.1111/j.1476-5381.2012.02139.x; Nielsen CK, 2007, PAIN, V132, P289, DOI 10.1016/j.pain.2007.03.022; Olkkola KT, 2013, TRENDS PHARMACOL SCI, V34, P206, DOI 10.1016/j.tips.2013.02.001; REICHLING DB, 1988, PROG BRAIN RES, V77, P31, DOI 10.1016/S0079-6123(08)62777-6; Ross FB, 1997, PAIN, V73, P151, DOI 10.1016/S0304-3959(97)00093-6; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SILLAR KT, 1994, J NEUROSCI, V14, P2636; Silvestri B, 2008, CLIN DRUG INVEST, V28, P399, DOI 10.2165/00044011-200828070-00001; Spivak CE, 2000, SYNAPSE, V38, P254; Stell BM, 2011, J NEUROPHYSIOL, V105, P2931, DOI 10.1152/jn.01125.2010; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Vaughan CW, 1997, J PHYSIOL-LONDON, V498, P463; Virk MS, 2008, MOL PHARMACOL, V73, P1301, DOI 10.1124/mol.107.042952; Wu YC, 2011, J NEUROPHYSIOL, V105, P2715, DOI 10.1152/jn.00459.2010; Xu C, 2008, NAT NEUROSCI, V11, P1410, DOI 10.1038/nn.2215; YAKSH TL, 1976, BRAIN RES, V114, P83, DOI 10.1016/0006-8993(76)91009-X; Yanagisawa Y, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-38; Yum DS, 2008, J NEUROCHEM, V106, P361, DOI 10.1111/j.1471-4159.2008.05400.x	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	APR	2015	172	8			SI		2148	2164		10.1111/bph.13039		17	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE7PH	WOS:000352033300018		
J	Ueno, Y; Takahashi, S; Ohno, Y; Kitajima, K; Yui, M; Kassai, Y; Kawakami, F; Miyake, H; Sugimura, K				Ueno, Y.; Takahashi, S.; Ohno, Y.; Kitajima, K.; Yui, M.; Kassai, Y.; Kawakami, F.; Miyake, H.; Sugimura, K.			Computed diffusion-weighted MRI for prostate cancer detection: the influence of the combinations of b-values	BRITISH JOURNAL OF RADIOLOGY			English	Article							BODY; LOCALIZATION; CHALLENGES; PET/CT	Objective: To evaluate the influence of the combinations of b-values on computed diffusion-weighted images (cDWIs) for prostate cancer (PCa) detection at b=2000 smm(-2). Methods: Diffusion-weighted imaging (DWIs) for 31 patients with PCa (65.2 +/- 7.1 years) were obtained pre-operatively at different b-values (0, 100, 500, 1000 and 2000 s mm(-2)) on a 3-T MRI. cDWIs at b=2000 were generated by using six b-value combinations: 0-100 s mm(-2) (cDWI(0-100)); 0-500 smm(-2) (cDWI(0-500)); 100-500 s mm(-2) (cDWI(100-500)); 0-1000 s mm(-2) (cDWI(0-1000)); 100-1000 s mm(-2) (cDWI(100-1000)); and 500-1000 s mm(-2) (cDWI(500-1000)). These cDWIs and measured DWIs with b=2000 s mm(-2) (mDWI(2000)) were evaluated in this setting. To assess image quality for each DWI, contrast ratios (CRs) of cancerous and non-cancerous lesions were evaluated. To compare the detectability of PCa for each DWI, receiver operating characteristic analysis was used. Results: CRs of all cDWIs were significantly higher than those of mDWI(2000) (p < 0.05). Areas under the curve of cDWI(0-100) (0.62) and cDWI(0-500) (0.65) were significantly smaller (p < 0.05) than those of others (cDWI(100-500), 0.72; cDWI(0-1000), 0.73; cDWI(100-1000), 0.71; cDWI(500-1000), 0.74; mDWI(2000), 0.72). Conclusion: The combinations of b-values influenced image quality and diagnostic ability of cDWIs for PCa detection. The combinations of b >= 100 and b >= 500 s mm(-2), as well as b=0 and b=1000 s mm(-2), were optimal in this study. Advances in knowledge: For generating the useful cDWI for PCa detection, radiologists should take care of the combination of b-values when including low b-values.	[Ueno, Y.; Takahashi, S.; Ohno, Y.; Kitajima, K.; Sugimura, K.] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Ohno, Y.] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res, Kobe, Hyogo 657, Japan; [Yui, M.; Kassai, Y.] Toshiba Med Syst Corp, Otawara, Tochigi, Japan; [Kawakami, F.] Kobe Univ, Grad Sch Med, Dept Pathol, Kobe, Hyogo 657, Japan; [Miyake, H.] Kobe Univ, Grad Sch Med, Dept Urol, Kobe, Hyogo 657, Japan	Ueno, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan.	yonu0121@yahoo.co.jp			Toshiba Medical Systems	Co-author Yoshiharu Ohno, MD, PhD, has a research grant from Toshiba Medical Systems.	Blackledge MD, 2011, RADIOLOGY, V261, P573, DOI 10.1148/radiol.11101919; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Hoeks CMA, 2011, RADIOLOGY, V261, P46, DOI 10.1148/radiol.11091822; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Koh DM, 2012, AM J ROENTGENOL, V199, P252, DOI 10.2214/AJR.11.7866; Ohno Y, 2008, RADIOLOGY, V248, P643, DOI 10.1148/radiol.2482072039; Kitajima K, 2010, J MAGN RESON IMAGING, V31, P625, DOI 10.1002/jmri.22075; Katahira K, 2011, EUR RADIOL, V21, P188, DOI 10.1007/s00330-010-1883-7; Akin O, 2006, RADIOLOGY, V239, P784, DOI 10.1148/radiol.2392050949; Metens T, 2012, EUR RADIOL, V22, P703, DOI 10.1007/s00330-011-2298-9; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Ueno Y, 2013, EUR RADIOL, V23, P3509, DOI 10.1007/s00330-013-2958-z; Ueno Y, 2013, J MAGN RESON IMAGING, V38, P154, DOI 10.1002/jmri.23953; Choi EK, 2009, EUR RADIOL, V19, P2024, DOI 10.1007/s00330-009-1350-5; Blackledge M, 2010, P INT SOC MAGN RES M; Blackledge M, 2009, P INT SOC MAGN RES M; Kimura T, 2012, P INT SOC MAGN RES M; Kitajima Kazuhiro, 2008, Magn Reson Med Sci, V7, P93, DOI 10.2463/mrms.7.93; Koh Dow-Mu, 2007, Magn Reson Med Sci, V6, P211, DOI 10.2463/mrms.6.211; Maas MC, 2013, INVEST RADIOL, V48, P779, DOI 10.1097/RLI.0b013e31829705bb; Nilsen LB, 2013, EUR RADIOL, V23, P1027, DOI 10.1007/s00330-012-2687-8	21	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.	APR	2015	88	1048							20140738	10.1259/bjr.20140738		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE5ER	WOS:000351853900016		
J	Padron, E; Perez, NM; Rodriguez, F; Melian, G; Hernandez, PA; Sumino, H; Padilla, G; Barrancos, J; Dionis, S; Notsu, K; Calvo, D				Padron, Eleazar; Perez, Nemesio M.; Rodriguez, Fatima; Melian, Gladys; Hernandez, Pedro A.; Sumino, Hirochika; Padilla, German; Barrancos, Jose; Dionis, Samara; Notsu, Kenji; Calvo, David			Dynamics of diffuse carbon dioxide emissions from Cumbre Vieja volcano, La Palma, Canary Islands	BULLETIN OF VOLCANOLOGY			English	Article						Diffuse degassing; CO2; CumbreVieja; Volcanic activity; He-3/He-4	CO2 EMISSION; MOUNT-ETNA; GEOTHERMAL FLUIDS; KILAUEA VOLCANO; CENTRAL-AMERICA; VULCANO-ISLAND; FOSSA CRATER; GAS-RELEASE; EAST RIFT; SOIL	We report herein the results of 13 soil CO2 efflux surveys at Cumbre Vieja volcano, La Palma Island, the most active basaltic volcano in the Canary Islands. The CO2 efflux measurements were undertaken using the accumulation chamber method between 2001 and 2013 to constrain the total CO2 output from the studied area and to evaluate occasional CO2 efflux surveys as a volcanic surveillance tool for Cumbre Vieja. Soil CO2 efflux values ranged from non-detectable up to 2442 gm(-2) days(-1), with the highest values observed in the south, where the last volcanic eruption took place (Teneguia, 1971). Isotopic analyses of soil gas carbon dioxide suggest an organic origin as the main contribution to the CO2 efflux, with a very small magmatic gas component observed at the southern part of the volcano. Total biogenic and magmatic combined CO2 emission rates showed a high temporal variability, ranging between 320 and 1544 t days(-1) and averaging 1147 t days(-1) over the 220-km(2) region. Two significant increases in the CO2 emission observed in 2011 and 2013 were likely caused by an enhanced magmatic endogenous contribution revealed by significant changes in the He-3/He-4 ratio in a CO2-rich cold spring. The relatively stable emission rate presented in this work defines the background CO2 emission range for Cumbre Vieja during a volcanic quiescence period.	[Padron, Eleazar; Perez, Nemesio M.; Melian, Gladys; Hernandez, Pedro A.; Padilla, German; Barrancos, Jose] ITER, Envirom Res Div, Santa Cruz De Tenerife 38611, Spain; [Padron, Eleazar; Perez, Nemesio M.; Rodriguez, Fatima; Melian, Gladys; Hernandez, Pedro A.; Padilla, German; Barrancos, Jose; Dionis, Samara; Calvo, David] Inst Volcanol Canarias INVOLCAN, Tenerife 38400, Spain; [Sumino, Hirochika] Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Notsu, Kenji] Shizuoka Univ, Ctr Integrated Res & Educ Nat Hazards, Shizuoka 4228529, Japan	Padron, E (reprint author), ITER, Envirom Res Div, Santa Cruz De Tenerife 38611, Spain.	eleazar@iter.es	Dionis, Samara/H-9806-2015; Perez Rodriguez, Nemesio /H-9295-2015; Calvo Fernandez, David/I-1005-2015; Barrancos, Jose/H-7681-2015; Padilla Hernandez, German Domingo/H-7621-2015; Melian, Gladys/H-7196-2015; Padron, Eleazar/L-5506-2013; 	Dionis, Samara/0000-0002-4555-8484; Perez Rodriguez, Nemesio /0000-0003-1410-7717; Calvo Fernandez, David/0000-0001-6170-9038; Barrancos, Jose/0000-0002-6224-5471; Padilla Hernandez, German Domingo/0000-0002-4524-3829; Melian, Gladys/0000-0002-3707-7170; Padron, Eleazar/0000-0003-3907-5766; Sumino, Hirochika/0000-0002-4689-6231	ALERTA; ALERTA II (INTERREG IIIB Azores-Canaries-Madeira); Direccion General de Universidades e Investigacion, Canary Islands Government [PI2001/025]; MAKAVOL by European Union [MAC/3/C161, MAC2007-2013]; Canarian Agency for Research, Innovation and Information Society (Canary Island Government) [ProID20100160]; Cabildo Insular de Tenerife and Cabildo Insular de La Palma	The authors wish to thank A. Alfaya, L. Fuentes, M. Brito, A. Concepcion, A. Mena, R. Delgado, T. Cabrera, S. Vargas, M.D. Peraza, and G. Lopez for their help during the fieldwork. Funds provided by projects ALERTA and ALERTA II (financially supported by INTERREG IIIB Azores-Canaries-Madeira), PI2001/025 (financially supported by Direccion General de Universidades e Investigacion, Canary Islands Government), MAKAVOL (MAC/3/C161) by the European Union MAC2007-2013 Transnational Cooperation Program, ProID20100160 by Canarian Agency for Research, Innovation and Information Society (Canary Island Government) and by Cabildo Insular de Tenerife and Cabildo Insular de La Palma supported this work. We also thank the municipality of Fuencaliente for logistical support.	CLARKE WB, 1976, INT J APPL RADIAT IS, V27, P515, DOI 10.1016/0020-708X(76)90082-X; Frondini F, 2004, B VOLCANOL, V66, P642, DOI 10.1007/s00445-004-0346-x; Day JMD, 2011, EARTH PLANET SC LETT, V305, P226, DOI 10.1016/j.epsl.2011.03.006; SANO Y, 1985, GEOCHEM J, V19, P135; Perez NM, 2013, J GEOL SOC LONDON, V170, P585, DOI 10.1144/jgs2012-125; PAN V, 1991, GEOCHIM COSMOCHIM AC, V55, P1587, DOI 10.1016/0016-7037(91)90130-W; JAVOY M, 1978, CONTRIB MINERAL PETR, V67, P35, DOI 10.1007/BF00371631; CERLING TE, 1991, GEOCHIM COSMOCHIM AC, V55, P3403, DOI 10.1016/0016-7037(91)90498-T; MARTY B, 1987, EARTH PLANET SC LETT, V83, P16, DOI 10.1016/0012-821X(87)90047-1; STAUDIGEL H, 1986, J VOLCANOL GEOTH RES, V27, P299, DOI 10.1016/0377-0273(86)90018-1; Ward SN, 2001, GEOPHYS RES LETT, V28, P3397, DOI 10.1029/2001GL013110; BAUBRON JC, 1990, NATURE, V344, P51, DOI 10.1038/344051a0; CRAIG H, 1953, GEOCHIM COSMOCHIM AC, V3, P53, DOI 10.1016/0016-7037(53)90001-5; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Carapezza ML, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019614; Chiodini G, 1998, APPL GEOCHEM, V13, P543, DOI 10.1016/S0883-2927(97)00076-0; Gerlach TM, 2001, CHEM GEOL, V177, P101, DOI 10.1016/S0009-2541(00)00385-5; Viveiros F, 2008, J VOLCANOL GEOTH RES, V177, P883, DOI 10.1016/j.jvolgeores.2008.07.005; Hernandez P, 2012, B VOLCANOL, V74, P2435, DOI 10.1007/s00445-012-0673-2; Chiodini G, 1996, B VOLCANOL, V58, P41, DOI 10.1007/s004450050124; Hilton DR, 2000, GEOCHIM COSMOCHIM AC, V64, P2119, DOI 10.1016/S0016-7037(00)00358-6; Day SJ, 1999, J VOLCANOL GEOTH RES, V94, P135, DOI 10.1016/S0377-0273(99)00101-8; Burton MR, 2013, REV MINERAL GEOCHEM, V75, P323, DOI 10.2138/rmg.2013.75.11; ALLARD P, 1991, NATURE, V351, P387, DOI 10.1038/351387a0; Cardellini C, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002165; Gonzalez PJ, 2010, EARTH PLANET SC LETT, V297, P545, DOI 10.1016/j.epsl.2010.07.006; Hernandez PA, 2001, CHEM GEOL, V177, P175, DOI 10.1016/S0009-2541(00)00390-9; Matsuda J, 2002, GEOCHEM J, V36, P191; Hernandez PA, 2001, SCIENCE, V292, P83, DOI 10.1126/science.1058450; SANO Y, 1995, CHEM GEOL, V119, P265, DOI 10.1016/0009-2541(94)00097-R; Carracedo JC, 1998, GEOL MAG, V135, P591, DOI 10.1017/S0016756898001447; STOLPER E, 1988, EARTH PLANET SC LETT, V87, P397, DOI 10.1016/0012-821X(88)90004-0; Arpa MC, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0747-9; Barnes I, 1988, APPL GEOCHEM, V3, P281, DOI 10.1016/0883-2927(88)90107-2; Barnes I, 1978, US GEOL SURV WATER R, V78-39, P1; Carracedo JC, 1996, GEOL SOC SP, P125; Deutsch C. V., 1998, GSLIB GEOSTATISTICAL; Giammanco S, 1998, J VOLCANOL GEOTH RES, V81, P297, DOI 10.1016/S0377-0273(98)00012-2; Giammanco S, 1998, B VOLCANOL, V60, P252, DOI 10.1007/s004450050231; Giammanco S, 2006, PURE APPL GEOPHYS, V163, P853, DOI 10.1007/s00024-006-0039-9; Granieri D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026460; Hernández Perez P., 2003, Journal of Geophysical Research, V108, P2210, DOI 10.1029/2002JB001847; Hernandez PA, 2012, APPL GEOCHEM, V27, P2486, DOI 10.1016/j.apgeochem.2012.08.008; Hernandez PA, 2006, PURE APPL GEOPHYS, V163, P869, DOI 10.1007/s00024-006-0038-x; Maljanen M, 2002, SOIL BIOL BIOCHEM, V34, P577, DOI 10.1016/S0038-0717(01)00213-9; Mcgee KA, 2006, PURE APPL GEOPHYS, V163, P837, DOI 10.1007/s00024-006-0036-z; Navarro JM, 1993, AVANCE PLAN HIDROLOG; Notsu K, 2006, PURE APPL GEOPHYS, V163, P825, DOI 10.1007/s00024-006-0051-0; Padilla GD, 2014, PURE APPL GEOPHYS, V171, P1791, DOI 10.1007/s00024-013-0756-9; Padron E, 2012, CHEM GEOL, V312, P138, DOI 10.1016/j.chemgeo.2012.04.018; Padron E, 2008, PURE APPL GEOPHYS, V165, P95, DOI 10.1007/s00024-007-0281-9; Padron E, 2012, B VOLCANOL, V74, P1509, DOI 10.1007/s00445-012-0610-4; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Perez NM, 1994, MINERAL MAG, V58A, P709, DOI 10.1180/minmag.1994.58A.2.107; Perez NM, 1996, GEOGACETA, V20, P1302; Perez NM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052410; Salazar JML, 2002, EARTH PLANET SC LETT, V205, P81, DOI 10.1016/S0012-821X(02)01014-2; Salazar JML, 2001, GEOPHYS RES LETT, V28, P4275, DOI 10.1029/2001GL013709; Sinclair A., 1974, J GEOCHEM EXPLOR, V3, P129, DOI DOI 10.1016/0375-6742(74)90030-2; Sumino H, 2001, J MASS SPECTROM SOC, V49, P61; Tennant C.B., 1959, ECON GEOL, V54, P1281; Veeger AI, 1991, THESIS U ARIZONA; Zar JH, 1984, BIOSTAT ANAL, P663	63	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0258-8900	1432-0819		B VOLCANOL	Bull. Volcanol.	APR	2015	77	4							28	10.1007/s00445-015-0914-2		15	Geosciences, Multidisciplinary	Geology	CE3RK	WOS:000351745800002		
J	Tsuji, Y; Richard, JP				Tsuji, Yutaka; Richard, John P.			Swain-Scott relationships for nucleophile addition to ring-substituted phenonium ions	CANADIAN JOURNAL OF CHEMISTRY			English	Article						solvolysis; nucleophile; reactive intermediate; substitution	AQUEOUS-SOLUTION; BROMONIUM ION; 4-METHOXYBENZYL CARBOCATIONS; QUINONE METHIDE; BOND-LENGTH; 1-PHENYLETHYL CARBOCATIONS; ELECTROPHILIC BROMINATION; THERMODYNAMIC STABILITY; ELIMINATION-REACTIONS; COMBINATION REACTIONS	The products of the reactions of 2-(4-methoxyphenyl)ethyl tosylate (MeO-1-OTs) and 2-(4-methyphenyl)ethyl tosylate (Me-1-OTs) with nucleophilic anions were determined for reactions in 50: 50 (v/v) trifluoroethanol (TFE) / water at 25 degrees C. In many cases, the nucleophile selectivity k(Nu)/k(s) ((mol/L)(-1)) for reactions of nucleophile and solvent, calculated from the ratio of product yields, depends upon [Nu(-)]. This demonstrates the existence of competing reaction pathways, which show different selectivities for reactions with nucleophiles. A C-13 NMR analysis of the products of the reactions of substrate enriched with C-13 at the alpha-carbon, X-1-[alpha-C-13]OTs (X = -OCH3 or -Me), with nucleophilic anions in 50: 50 (v/v) TFE/water at 25 degrees C shows the formation of X-1-[beta-C-13]OH, X-1-[beta-C-13]OCH2CF3, and X-1-[beta-C-13]Nu (Nu = Br, Cl, CH3CO2, or Cl2CHCO2) from the trapping of symmetrical phenonium ion reaction intermediates X-2(+). The observation of excess label in the alpha-position, [alpha-C-13]/[beta-C-13] > 1.0, for both the water and nucleophile adducts, shows that these nucleophiles also react by direct substitution at X-1-[alpha-C-13]OTs. The ratios of product yields, [alpha-C-13]/[beta-C-13], and observed nucleophile selectivity (k(Nu)/k(s))(obs) were used to dissect the contribution of nucleophile addition at Me-1-OTs and trapping of X-2(+) to the product yields. The product yields from partitioning of the intermediate gave the nucleophile selectivity k(Nu)/k(s) for X-2(+). Swain-Scott plots of log(k(Nu)/k(s)) are correlated by slopes of s = 0.78 and s = 0.73 for reactions of MeO-2(+) and Me-2(+), respectively. This shows that the sensitivity of bimolecular substitution at X-2(+) to changes in nucleophile reactivity is smaller than for nucleophilic substitution at the methyl iodide.	[Tsuji, Yutaka] Kurume Natl Coll Technol, Dept Biochem & Appl Chem, Kurume, Fukuoka 8308555, Japan; [Richard, John P.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	Richard, JP (reprint author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.	jrichard@buffalo.edu			US National Institutes of Health [GM39754]	This work was supported by grant GM39754 from the US National Institutes of Health.	AMYES TL, 1991, J CHEM SOC CHEM COMM, P200, DOI 10.1039/c39910000200; AMYES TL, 1989, J AM CHEM SOC, V111, P7888, DOI 10.1021/ja00202a033; AMYES TL, 1990, J AM CHEM SOC, V112, P9507, DOI 10.1021/ja00182a009; McClelland RA, 1996, TETRAHEDRON, V52, P6823, DOI 10.1016/0040-4020(96)00020-8; AMYES TL, 1993, J ORG CHEM, V58, P6057, DOI 10.1021/jo00074a036; BROWN RS, 1994, J AM CHEM SOC, V116, P2448, DOI 10.1021/ja00085a027; JONES PG, 1984, J AM CHEM SOC, V106, P6207, DOI 10.1021/ja00333a015; PEARSON RG, 1968, J AM CHEM SOC, V90, P319, DOI 10.1021/ja01004a021; Richard JP, 2001, ACCOUNTS CHEM RES, V34, P981, DOI 10.1021/ar0000556; BRIGGS AJ, 1984, J AM CHEM SOC, V106, P6200, DOI 10.1021/ja00333a014; Richard JP, 2000, J AM CHEM SOC, V122, P1664, DOI 10.1021/ja9937526; AMYES TL, 1991, J AM CHEM SOC, V113, P1867, DOI 10.1021/ja00005a081; Tsuji Y, 2013, J PHYS ORG CHEM, V26, P970, DOI 10.1002/poc.3145; JENCKS WP, 1985, CHEM REV, V85, P511, DOI 10.1021/cr00070a001; RITCHIE CD, 1986, CAN J CHEM, V64, P2239, DOI 10.1139/v86-370; SWAIN CG, 1953, J AM CHEM SOC, V75, P141, DOI 10.1021/ja01097a041; ALLEN FH, 1984, J AM CHEM SOC, V106, P6197, DOI 10.1021/ja00333a013; Toteva MM, 2003, J AM CHEM SOC, V125, P8814, DOI 10.1021/ja029588v; BENNET AJ, 1991, J AM CHEM SOC, V113, P8532, DOI 10.1021/ja00022a057; BROWN RS, 1990, J AM CHEM SOC, V112, P6310, DOI 10.1021/ja00173a019; DIETZE P, 1989, J AM CHEM SOC, V111, P5880, DOI 10.1021/ja00197a057; EDWARDS MR, 1986, J AM CHEM SOC, V108, P7067, DOI 10.1021/ja00282a036; Jencks W. P., 1976, HDB BIOCH MOL BIOL, P305; KNIER BL, 1980, J AM CHEM SOC, V102, P6789, DOI 10.1021/ja00542a021; MCCLELLAND RA, 1991, J AM CHEM SOC, V113, P1009, DOI 10.1021/ja00003a040; NAGORSKI RW, 1994, J AM CHEM SOC, V116, P419, DOI 10.1021/ja00080a067; NAGORSKI RW, 1992, J AM CHEM SOC, V114, P7773, DOI 10.1021/ja00046a024; O'Ferrall RM, 2010, ADV PHYS ORG CHEM, V44, P19, DOI 10.1016/S0065-3160(08)44002-9; PEARSON RG, 1967, J ORG CHEM, V32, P2899; RICHARD JP, 1982, J AM CHEM SOC, V104, P4689, DOI 10.1021/ja00381a037; RICHARD JP, 1990, J AM CHEM SOC, V112, P9513, DOI 10.1021/ja00182a010; RICHARD JP, 1984, J AM CHEM SOC, V106, P1361, DOI 10.1021/ja00317a031; RICHARD JP, 1995, TETRAHEDRON, V51, P1535, DOI 10.1016/0040-4020(94)01019-V; RICHARD JP, 1984, J AM CHEM SOC, V106, P1373, DOI 10.1021/ja00317a032; Richard JP, 2000, J AM CHEM SOC, V122, P3963, DOI 10.1021/ja994453j; RICHARD JP, 1984, J AM CHEM SOC, V106, P1383, DOI 10.1021/ja00317a033; RICHARD JP, 1989, J AM CHEM SOC, V111, P1455, DOI 10.1021/ja00186a047; Richard JP, 1996, J AM CHEM SOC, V118, P12603, DOI 10.1021/ja9629064; RICHARD JP, 1986, J AM CHEM SOC, V108, P6819, DOI 10.1021/ja00281a068; Richard JP, 2004, ADV PHYS ORG CHEM, V39, P1, DOI 10.1016/S0065-3160(04)39001-5; RICHARD JP, 1991, TETRAHEDRON LETT, V32, P4255, DOI 10.1016/S0040-4039(00)92142-7; RITCHIE CD, 1972, ACCOUNTS CHEM RES, V5, P348, DOI 10.1021/ar50058a005; SLEBOCKATILK H, 1995, J AM CHEM SOC, V117, P8769, DOI 10.1021/ja00139a009; Teshima M, 2010, J PHYS ORG CHEM, V23, P730, DOI 10.1002/poc.1642; Toteva MM, 1996, J AM CHEM SOC, V118, P11434, DOI 10.1021/ja9617451; Tsuji Y, 2003, J PHYS ORG CHEM, V16, P484, DOI 10.1002/poc.611; Tsuji Y, 2011, J ORG CHEM, V76, P9568, DOI 10.1021/jo202118s; ZHENG CY, 1993, J ORG CHEM, V58, P2122, DOI 10.1021/jo00060a031	48	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	APR	2015	93	4					428	434		10.1139/cjc-2014-0337		7	Chemistry, Multidisciplinary	Chemistry	CE4YJ	WOS:000351836100008		
J	Omasa, M; Date, H; Sozu, T; Sato, T; Nagai, K; Yokoi, K; Okamoto, T; Ikeda, N; Tanaka, F; Maniwa, Y				Omasa, Mitsugu; Date, Hiroshi; Sozu, Takashi; Sato, Tosiya; Nagai, Kanji; Yokoi, Kohei; Okamoto, Tatsuro; Ikeda, Norihiko; Tanaka, Fumihiro; Maniwa, Yoshimasa		Japanese Assoc Res Thymus	Postoperative Radiotherapy Is Effective for Thymic Carcinoma but Not for Thymoma in Stage II and III Thymic Epithelial Tumors: The Japanese Association for Research on the Thymus Database Study	CANCER			English	Article						adjuvant radiotherapy; Masaoka stage II; Masaoka stage III; postoperative radiotherapy; relapse-free survival; thymic carcinoma; thymoma	THORACIC SURGEONS DATABASE; ADJUVANT RADIATION; EUROPEAN-SOCIETY; THERAPY; CHEMOTHERAPY; MALIGNANCIES; OUTCOMES; COHORT	BACKGROUNDThe efficacy of postoperative radiotherapy (PORT) for thymic epithelial tumors is still controversial. Using the Japanese Association for Research on the Thymus (JART) database, this study was aimed at clarifying the efficacy of PORT for Masaoka stage II and III thymic carcinoma and thymoma. METHODSThe JART database registered the records of 2835 patients collected from 32 Japanese institutions from 1991 to 2010. Thymic carcinoma and thymoma at stage II or III were extracted. The efficacy of PORT with respect to relapse-free survival (RFS) and overall survival (OS) was evaluated with the Kaplan-Meier method and Cox regression analysis. RESULTSThere were 1265 patients in all: 155 thymic carcinoma cases (12.3%) and 1110 thymoma cases (87.7%). Eight hundred ninety-five (70.8%) were at stage II, and 370 (29.2%) were at stage III. Four hundred three cases (31.9%) underwent PORT. PORT for stage II and III thymic carcinoma was associated with increasing RFS (hazard ratio, 0.48; 95% confidence interval, 0.30-0.78; P=.003) but was not associated with OS (hazard ratio, 0.94; 95% confidence interval, 0.51-1.75; P=.536). PORT for stage II and III thymoma was not associated with RFS or OS (P=.350). A subgroup analysis of stage III thymoma showed no factor associated with the efficacy of PORT. CONCLUSIONSIn this study, PORT did not increase RFS or OS for stage II or III thymoma but increased RFS for stage II and III thymic carcinoma. Cancer 2015;121:1008-1016. (c) 2015 American Cancer Society. Postoperative radiotherapy increases relapse-free survival for stage II and III thymic carcinoma. Postoperative radiotherapy does not increase relapse-free survival or overall survival for stage II or III thymoma.	[Omasa, Mitsugu; Date, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan; [Sozu, Takashi; Sato, Tosiya] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan; [Nagai, Kanji] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Tokyo, Japan; [Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4648601, Japan; [Okamoto, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Kyushu, Japan; [Ikeda, Norihiko] Tokyo Med Univ, Dept Thorac Surg, Tokyo 1608402, Japan; [Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Dept Surg 2, Kitakyushu, Fukuoka 807, Japan; [Maniwa, Yoshimasa] Kobe Univ, Grad Sch Med, Div Thorac Surg, Kobe, Hyogo 657, Japan	Date, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto, Kyoto 6068507, Japan.	hdate@kuhp.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Janssen Pharmaceutical KK; Tokyo University of Science; Mukogawa Women's University; National Cardiovascular Center; Takeda Pharmaceutical Company, Ltd; Kowa Pharmaceutical Company, Ltd; Toa Eiyo, Ltd; Sanwa Kagaku Kenkyusho Company, Ltd; Union of Japanese Scientists and Engineers; National Institute of Health Sciences; Consortium Kansai for Advanced Medical Engineering and Informatics; EPS Corporation; Kobe Pharmaceutical University; SKETCH Research Group; Ishiyaku Publishers, Inc.	Takashi Sozu reports grants and personal fees outside the submitted work from the following: Japanese Ministry of Education, Culture, Sports, Science, and Technology; Janssen Pharmaceutical KK; Tokyo University of Science; Mukogawa Women's University; National Cardiovascular Center; Takeda Pharmaceutical Company, Ltd; Kowa Pharmaceutical Company, Ltd; Toa Eiyo, Ltd; Sanwa Kagaku Kenkyusho Company, Ltd; Union of Japanese Scientists and Engineers; National Institute of Health Sciences; Consortium Kansai for Advanced Medical Engineering and Informatics; EPS Corporation; Kobe Pharmaceutical University; SKETCH Research Group; and Ishiyaku Publishers, Inc.	Zhao Y, 2013, ANN THORAC SURG, V96, P1019, DOI 10.1016/j.athoracsur.2013.04.078; SUSTER S, 1991, CANCER, V67, P1025, DOI 10.1002/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F; Ruffini E, 2014, J THORAC ONCOL, V9, P541, DOI 10.1097/JTO.0000000000000128; Detterbeck FC, 2004, ANN THORAC SURG, V77, P1860, DOI 10.1016/j.athoracsur.2003.10.001; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Korst RJ, 2009, ANN THORAC SURG, V87, P1641, DOI 10.1016/j.athoracsur.2008.11.022; LEVINE GD, 1978, HUM PATHOL, V9, P495; Okuma Y, 2013, LUNG CANCER, V80, P75, DOI 10.1016/j.lungcan.2012.12.012; Mangi AA, 2005, ANN THORAC SURG, V79, P1834, DOI 10.1016/j.athoracsur.2004.12.051; Falkson CB, 2009, J THORAC ONCOL, V4, P911; KOGA K, 1994, PATHOL INT, V44, P359; Ruffini E, 1997, J THORAC CARDIOV SUR, V113, P55, DOI 10.1016/S0022-5223(97)70399-4; Attaran S, 2012, INTERACT CARDIOV TH, V15, P273, DOI 10.1093/icvts/ivs133; Mangi AA, 2002, ANN THORAC SURG, V74, P1033, DOI 10.1016/S0003-4975(02)03828-6; Okereke IC, 2012, ANN THORAC SURG, V93, P1668, DOI 10.1016/j.athoracsur.2012.01.014; Yano M, 2008, J THORAC ONCOL, V3, P265, DOI 10.1097/JTO.0b013e3181653c71; Detterbeck FC, 2013, J THORAC ONCOL, V8, P1467, DOI 10.1097/JTO.0000000000000017; Haniuda M, 1996, ANN SURG, V224, P219, DOI 10.1097/00000658-199608000-00016; Weksler B, 2013, ANN THORAC SURG, V95, P299, DOI 10.1016/j.athoracsur.2012.09.006; Detterbeck FC, 2010, J THORAC ONCOL, V5, pS318, DOI 10.1097/JTO.0b013e3181f20dab; Gomez D, 2011, J THORAC ONCOL, V6, pS1743, DOI 10.1097/JTO.0b013e31821ea60c; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Onuki T, 2008, J THORAC ONCOL, V3, P270, DOI 10.1097/JTO.0b013e3181653c8c; Ruffini E, 2014, EUR J CARDIO-THORAC, V46, P361, DOI 10.1093/ejcts/ezt649; Shields TW, 1989, GEN THORACIC SURG; Song ZB, 2014, J CANCER RES CLIN, V140, P349, DOI 10.1007/s00432-013-1562-6; Weissferdt A, 2012, AM J CLIN PATHOL, V138, P103, DOI 10.1309/AJCP88FZTWANLRCB	27	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0008-543X	1097-0142		CANCER-AM CANCER SOC	Cancer	APR 1	2015	121	7					1008	1016		10.1002/cncr.29166		9	Oncology	Oncology	CE2AW	WOS:000351615800008		
J	Wu, WW; Nishikawa, H; Fukudal, T; Vittal, V; Asano, M; Miyoshi, Y; Klevit, RE; Ohta, T				Wu, Wenwen; Nishikawa, Hiroyuki; Fukudal, Takayo; Vittal, Vinayak; Asano, Masahide; Miyoshi, Yasuo; Klevit, Rachel E.; Ohta, Tomohiko			Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage	CANCER RESEARCH			English	Article							DOUBLE-STRAND BREAKS; UBIQUITIN LIGASE; HETEROCHROMATIN PROTEIN-1; REPAIR PROTEINS; END RESECTION; RECRUITMENT; MAINTENANCE; BRCA1-BARD1; COMPLEX; BINDS	Stable retention of BRCA1/BARD1 complexes at sites of DNA damage is required for the proper response to DNA double-strand breaks (DSB). Here, we demonstrate that the BRCT domain of BARD1 is crucial for its retention through interaction with HP1. In response to DNA damage, BARD1 interacts with Lys9-dimethylated histone H3 (H3K9me2) in an ATM-dependent but RNF168-independent manner. This interaction is mediated primarily by HP1 gamma. A conserved HP1-binding motif in the BARD1 BRCT domain directly interacted with the chromoshadow domain of HP1 in vitro. Mutations in this motif (or simultaneous depletion of all three HP1 isoforms) disrupted retention of BARD1, BRCA1, and CtIP at DSB sites and allowed ectopic accumulation of RIF1, an effector of nonhomologous end-joining, at damaged loci in S-phase. UNC0638, a small-molecule inhibitor of histone lysine methyltransferase (HKMT), abolished retention and cooperated with the PARP inhibitor olaparib to block cancer cell growth. Taken together, our findings show how BARD1 promotes retention of the BRCA1/BARD1 complex at damaged DNA sites and suggest the use of HKMT inhibitors to leverage the application of PARP inhibitors to treat breast cancer. (C)2015 AACR.	[Wu, Wenwen; Fukudal, Takayo; Ohta, Tomohiko] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa, Japan; [Wu, Wenwen; Ohta, Tomohiko] St Marianna Univ, Grad Sch Med, Dept Surg, Div Breast & Endocrine Surg, Kawasaki, Kanagawa, Japan; [Nishikawa, Hiroyuki] St Marianna Univ, Grad Sch Med, Inst Adv Med Sci, Kawasaki, Kanagawa, Japan; [Vittal, Vinayak; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Asano, Masahide] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine Surg, Nishinomiya, Hyogo, Japan	Ohta, T (reprint author), Univ Grad Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	to@marianna-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Science, Sports, Culture and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Private School Promotion Foundation; National Institute of General Medical Sciences grants [R01 GM088055]; PHS NRSA [2T32 GM007270]	This study was supported by grants from Japan Society for the Promotion of Science (T. Ohta and W. Wu), the Ministry of Education, Science, Sports, Culture and Technology of Japan (T. Ohta), the Ministry of Health, Labour and Welfare of Japan (T. Ohta), the Japan Private School Promotion Foundation (T. Ohta), National Institute of General Medical Sciences grants R01 GM088055 (R.E. Klevit) and PHS NRSA 2T32 GM007270 (V. Vittal).	Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Koike A, 2010, CANCER RES, V70, P6746, DOI 10.1158/0008-5472.CAN-10-0382; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/nchembio.599, 10.1038/NCHEMBIO.599]; Laufer M, 2007, J BIOL CHEM, V282, P34325, DOI 10.1074/jbc.M705198200; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Choi JD, 2012, NUCLEIC ACIDS RES, V40, P11321, DOI 10.1093/nar/gks947; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Zhang F, 2012, J CELL SCI, V125, P6049, DOI 10.1242/jcs.111872; Britton S, 2013, J CELL BIOL, V202, P579, DOI 10.1083/jcb.201303073; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Ayoub N, 2009, CELL CYCLE, V8, P2945; Escribano-Diaz C, 2013, MOL CELL, V49, P1; Filipponi D, 2013, CANCER CELL, V24, P528, DOI 10.1016/j.ccr.2013.08.022; Geuting V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003667; Lee Y-H, 2013, NUCLEIC ACIDS RES, V8111, P1; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Zarebski M, 2009, CYTOM PART A, V75A, P619, DOI 10.1002/cyto.a.20734	50	3	3	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	APR 1	2015	75	7					1311	1321		10.1158/0008-5472.CAN-14-2796		11	Oncology	Oncology	CE6LW	WOS:000351948900018		
J	Hirata, H; Hinoda, Y; Shahryari, V; Deng, GR; Nakajima, K; Tabatabai, ZL; Ishii, N; Dahiya, R				Hirata, Hiroshi; Hinoda, Yuji; Shahryari, Varahram; Deng, Guoren; Nakajima, Koichi; Tabatabai, Z. Laura; Ishii, Nobuhisa; Dahiya, Rajvir			Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205	CANCER RESEARCH			English	Article							BLADDER-CANCER METASTASIS; KIDNEY CANCER; TUMOR-SUPPRESSOR; UP-REGULATION; TRANSCRIPTION; EXPRESSION; HOTAIR; REGION; CERNA; EPIMUTATION	Recently, long noncoding RNAs (lncRNA) have emerged as new gene regulators and prognostic markers in several cancers, including renal cell carcinoma (RCC). In this study, we investigated the contributions of the lncRNA MALAT1 in RCC with a specific focus on its transcriptional regulation and its interactions with Ezh2 and miR-205. We found that MALAT1 expression was higher in human RCC tissues, where it was associated with reduced patient survival. MALAT1 silencing decreased RCC cell proliferation and invasion and increased apoptosis. Mechanistic investigations showed that MALAT1 was transcriptionally activated by c-Fos and that it interacted with Ezh2. After MALAT1 silencing, E-cadherin expression was increased, whereas beta-catenin expression was decreased through Ezh2. Reciprocal interaction between MALAT1 and miR-205 was also observed. Lastly, MALAT1 bound Ezh2 and oncogenesis facilitated by MALAT1 was inhibited by Ezh2 depletion, thereby blocking epithelial-mesenchymal transition via E-cadherin recovery and beta-catenin downregulation. Overall, our findings illuminate how overexpression of MALAT1 confers an oncogenic function in RCC that may offer a novel theranostic marker in this disease. (C)2015 AACR.	[Hirata, Hiroshi; Shahryari, Varahram; Deng, Guoren; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Hirata, Hiroshi; Shahryari, Varahram; Deng, Guoren; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Hinoda, Yuji] Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Yamaguchi, Japan; [Nakajima, Koichi; Ishii, Nobuhisa] Toho Univ, Fac Med, Dept Urol, Tokyo, Japan; [Tabatabai, Z. Laura] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA 94121 USA	Dahiya, R (reprint author), San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [RO1CA130860, RO1CA138642, RO1CA160079, 101BX001123]; VA Merit Review; VA Program Project; Yamada Science Foundation	This study was supported by National Center for Research Resources of the National Institutes of Health through grant numbers RO1CA130860, RO1CA138642, RO1CA160079, and 101BX001123, VA Merit Review, VA Program Project (Principal Investigator, R. Dahiya), and Yamada Science Foundation.	Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Wagener N, 2008, INT J CANCER, V123, P1545, DOI 10.1002/ijc.23683; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Linehan WM, 2012, GENOME RES, V22, P2089, DOI 10.1101/gr.131110.111; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Benetatos L, 2013, INT J CANCER, V133, P267, DOI 10.1002/ijc.27859; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Chiesa N, 2012, HUM MOL GENET, V21, P10, DOI 10.1093/hmg/ddr419; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; An JB, 2013, CANCER RES, V73, P1374, DOI 10.1158/0008-5472.CAN-12-2362; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Chiyomaru T, 2014, J BIOL CHEM, V289, P12550, DOI 10.1074/jbc.M113.488593; Han YH, 2013, FEBS LETT, V587, P3875, DOI 10.1016/j.febslet.2013.10.023; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Frevel MAE, 1999, J BIOL CHEM, V274, P29331, DOI 10.1074/jbc.274.41.29331; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Feldstein O, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-131; Gutschner T, 2015, METHODS MOL BIOL, V1239, P241, DOI 10.1007/978-1-4939-1862-1_13; He HY, 2014, ADV ANAT PATHOL, V21, P174, DOI 10.1097/PAP.0000000000000018; Hirata H, 2013, BRIT J CANCER, V108, P2070, DOI 10.1038/bjc.2013.173; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu L, 2014, BJU INT; Liu PY, 2014, J NATL CANC I, V106; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Ma MZ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-156; Olshan AF, 2013, CANCER MED-US, V2, P744, DOI 10.1002/cam4.110; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun NX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100340; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Walsh Naomi, 2009, BMC Urol, V9, P6, DOI 10.1186/1471-2490-9-6; Xu B, 2013, ARCH PATHOL LAB MED, V137, P1326, DOI 10.5858/arpa.2012-0525-OA; Zhou SG, 2014, J CANCER RES CLIN, V140, P1989, DOI 10.1007/s00432-014-1699-y	48	10	10	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	APR 1	2015	75	7					1322	1331		10.1158/0008-5472.CAN-14-2931		10	Oncology	Oncology	CE6LW	WOS:000351948900019		
J	Sakamoto, A; Hino, S; Nagaoka, K; Anan, K; Takase, R; Matsumori, H; Ojima, H; Kanai, Y; Arita, K; Nakao, M				Sakamoto, Akihisa; Hino, Shinjiro; Nagaoka, Katsuya; Anan, Kotaro; Takase, Ryuta; Matsumori, Haruka; Ojima, Hidenori; Kanai, Yae; Arita, Kazunori; Nakao, Mitsuyoshi			Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells	CANCER RESEARCH			English	Article							HYPOXIA-INDUCIBLE FACTORS; HISTONE DEMETHYLASE; GENE-EXPRESSION; STEM-CELLS; CANCER; WARBURG; GROWTH; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; TRANSCRIPTION; PHYSIOLOGY	The hallmark of most cancer cells is the metabolic shift from mitochondrial to glycolytic metabolism for adapting to the surrounding environment. Although epigenetic modification is intimately linked to cancer, the molecular mechanism, by which epigenetic factors regulate cancer metabolism, is poorly understood. Here, we show that lysine-specific demethylase-1 (LSD1, KDM1A) has an essential role in maintaining the metabolic shift in human hepatocellular carcinoma cells. Inhibition of LSD1 reduced glucose uptake and glycolytic activity, with a concurrent activation of mitochondrial respiration. These metabolic changes coexisted with the inactivation of the hypoxia-inducible factor HIF1 alpha, resulting in a decreased expression of GLUT1 and glycolytic enzymes. In contrast, during LSD1 inhibition, a set of mitochondrial metabolism genes was activated with the concomitant increase of methylated histone H3 at lysine 4 in the promoter regions. Consistently, both LSD1 and GLUT1 were significantly overexpressed in carcinoma tissues. These findings demonstrate the epigenetic plasticity of cancer cell metabolism, which involves an LSD1-mediated mechanism. (C)2015 AACR.	[Sakamoto, Akihisa; Hino, Shinjiro; Nagaoka, Katsuya; Anan, Kotaro; Takase, Ryuta; Matsumori, Haruka; Nakao, Mitsuyoshi] Kumamoto Univ, Dept Med Cell Biol, Inst Mol Embryol & Genet, Chuo Ku, Kumamoto 8600811, Japan; [Sakamoto, Akihisa; Arita, Kazunori] Kagoshima Univ, Fac Med, Grad Sch Med & Dent Sci, Dept Neurosurg, Kagoshima 890, Japan; [Ojima, Hidenori; Kanai, Yae] Natl Canc Ctr, Div Mol Pathol, Tokyo, Japan; [Nakao, Mitsuyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Nakao, M (reprint author), Kumamoto Univ, Dept Med Cell Biol, Inst Mol Embryol & Genet, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	s-hino@kumamoto-u.ac.jp; mnakao@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [3307]; Japan Science and Technology Agency (CREST); Uehara Memorial Foundation; Japan Society for the Promotion of Science; Nakatomi Foundation	This work was supported by a Grant in Aid for Scientific Research on Priority Areas and on Innovative Areas (3307) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Japan Science and Technology Agency (CREST), and by a grant from The Uehara Memorial Foundation (M. Nakao). This work was also supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science and by the Nakatomi Foundation (S. Hino).	Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Wang X, 2010, EPIGENETICS-US, V5, P566, DOI 10.4161/epi.5.7.12662; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Semenza GL, 1996, J BIOL CHEM, V271, P32529; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Kondoh H, 2005, CANCER RES, V65, P177; Reid Y, 2009, IN VITRO CELL DEV-AN, V45, P535, DOI 10.1007/s11626-009-9219-0; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Hamaguchi T, 2008, INT J ONCOL, V33, P725, DOI 10.3892/ijo_00000058; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Qin Y, 2014, CANCER LETT, V347, P225, DOI 10.1016/j.canlet.2014.02.013; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Nicholson TB, 2009, EPIGENETICS, V4, P129; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Dang CV, 2011, J MOL MED-JMM, V89, P205, DOI 10.1007/s00109-011-0730-x; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Watanabe T, 2012, MOL CELL BIOL, V32, P1529, DOI 10.1128/MCB.06478-11; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Ueda R, 2009, J AM CHEM SOC, V131, P17536, DOI 10.1021/ja907055q; Duteil D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5093; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Hino S, 2013, J HUM GENET, V58, P410, DOI 10.1038/jhg.2013.57; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Ouyang Jian, 2009, Mol Cell, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Vander Heiden Matthew G, 2009, Science, V324, P1029, DOI 10.1126/science.1160809	50	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	APR 1	2015	75	7					1445	1456		10.1158/0008-5472.CAN-14-1560		12	Oncology	Oncology	CE6LW	WOS:000351948900030		
J	Neskey, DM; Osman, AA; Ow, TJ; Katsonis, P; McDonald, T; Hicks, SC; Hsu, TK; Pickering, CR; Ward, A; Patel, A; Yordy, JS; Skinner, HD; Giri, U; Sano, D; Story, MD; Beadlel, BM; El-Naggar, AK; Kies, MS; William, WN; Caulin, C; Frederick, M; Kimmel, M; Myers, JN; Lichtarge, O				Neskey, David M.; Osman, Abdullah A.; Ow, Thomas J.; Katsonis, Panagiotis; McDonald, Thomas; Hicks, Stephanie C.; Hsu, Teng-Kuei; Pickering, Curtis R.; Ward, Alexandra; Patel, Ameeta; Yordy, John S.; Skinner, Heath D.; Giri, Uma; Sano, Daisuke; Story, Michael D.; Beadlel, Beth M.; El-Naggar, Adel K.; Kies, Merrill S.; William, William N.; Caulin, Carlos; Frederick, Mitchell; Kimmel, Marek; Myers, Jeffrey N.; Lichtarge, Olivier			Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer	CANCER RESEARCH			English	Article							SQUAMOUS-CELL CARCINOMA; MUTANT P53; GENE-EXPRESSION; PROTEIN; GAIN; IMPACT; SUBSTITUTION; STATISTICS; PHENOTYPE; RESIDUES	TP53 is the most frequently altered gene in head and neck squamous cell carcinoma, with mutations occurring in over two-thirds of cases, but the prognostic significance of these mutations remains elusive. In the current study, we evaluated a novel computational approach termed evolutionary action (EAp53) to stratify patients with tumors harboring TP53 mutations as high or low risk, and validated this system in both in vivo and in vitro models. Patients with high-risk TP53 mutations had the poorest survival outcomes and the shortest time to the development of distant metastases. Tumor cells expressing high-risk TP53 mutations were more invasive and tumorigenic and they exhibited a higher incidence of lung metastases. We also documented an association between the presence of high-risk mutations and decreased expression of TP53 target genes, highlighting key cellular pathways that are likely to be dysregulated by this subset of p53 mutations that confer particularly aggressive tumor behavior. Overall, our work validated EAp53 as a novel computational tool that may be useful in clinical prognosis of tumors harboring p53 mutations. (C)2015 AACR.	[Neskey, David M.] Med Univ S Carolina, Hollings Canc Ctr, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA; [Osman, Abdullah A.; Pickering, Curtis R.; Ward, Alexandra; Patel, Ameeta; Caulin, Carlos; Frederick, Mitchell; Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Ow, Thomas J.] Yeshiva Univ, Albert Einstein Sch Med, Dept Otolaryngol Head & Neck Surg, New York, NY 10033 USA; [Katsonis, Panagiotis; Hsu, Teng-Kuei; Lichtarge, Olivier] Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; [McDonald, Thomas; Kimmel, Marek] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Hicks, Stephanie C.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Yordy, John S.; Story, Michael D.] UT Southwestern Med Ctr, Radiat Oncol, Dallas, TX USA; [Skinner, Heath D.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Radiat Oncol, Houston, TX 77030 USA; [Giri, Uma] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Sano, Daisuke] Yokahama Univ, Dept Otolaryngol Head & Neck Surg, Yokohama, Japan; [Beadlel, Beth M.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Radiat Oncol, Houston, TX 77030 USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Kies, Merrill S.; William, William N.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Story, Michael D.] UT Southwestern Med Ctr, Dept Radiat Oncol, Dallas, TX USA	Myers, JN (reprint author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jmyers@mdanderson.org		Hicks, Stephanie/0000-0002-7858-0231	UTMDACC PANTHEON program; UTMDACC Sisters Institution Network Fund; National Institute of Health Specialized Program of Research Excellence Grant [P50CA097007]; NIH [R01 DE14613, R01 GM079656, R01 GM066099]; Cancer Prevention and Research Institute of Texas [RP120258]; National Research Science Award Institutional Research Training Grant [T32CA60374]; National Institute of Health Program Project Grant [CA06294]; Cancer Center Support Grant [CA016672]; NSF [DBI 1356569, DBI 0851393]; Pharmacoinformatics Training Program of the Neck Center of the Gulf Coast Consortia (NIH) [5 R90 DKO71505]	This work was supported by the UTMDACC PANTHEON program, the UTMDACC Sisters Institution Network Fund, the National Institute of Health Specialized Program of Research Excellence Grant (P50CA097007), the NIH (R01 DE14613), Cancer Prevention and Research Institute of Texas (RP120258), National Research Science Award Institutional Research Training Grant (T32CA60374), the National Institute of Health Program Project Grant (CA06294), and the Cancer Center Support Grant (CA016672). O. Lichtarge gratefully acknowledges support from NIH R01 GM079656 and R01 GM066099, and NSF DBI 1356569 and DBI 0851393. P. Katsonis was supported by the Pharmacoinformatics Training Program of the Neck Center of the Gulf Coast Consortia (NIH grant no. 5 R90 DKO71505).	Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Parikh N, 2014, J PATHOL, V232, P522, DOI 10.1002/path.4321; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Amin SR, 2013, P NATL ACAD SCI USA, V110, pE4195, DOI 10.1073/pnas.1305162110; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Koch WM, 1996, J NATL CANCER I, V88, P1580, DOI 10.1093/jnci/88.21.1580; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Kakudo Y, 2005, CANCER RES, V65, P2108, DOI 10.1158/0008-5472.CAN-04-2935; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Erber R, 1998, ONCOGENE, V16, P1671, DOI 10.1038/sj.onc.1201690; Erdin S, 2010, J MOL BIOL, V396, P1451, DOI 10.1016/j.jmb.2009.12.037; Gross AM, 2014, NATURE GENETICS; Hayes D, P ANN M AM ASS CANC; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Katsonis P, 2014, PROTEIN SCI, V23, P1650, DOI 10.1002/pro.2552; Katsonis P, 2014, GENOME RES, V24, P2050, DOI 10.1101/gr.176214.114; KETCHAM AS, 1966, J AMER MED ASSOC, V198, P157, DOI 10.1001/jama.198.2.157; Klein JP, 2004, HANDB STAT, V23, P27; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Lindenbergh-van der Plas M, 2011, CLIN CANCER RES, V17, P3733, DOI 10.1158/1078-0432.CCR-11-0183; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sano D, 2011, HEAD NECK-J SCI SPEC, V33, P349, DOI 10.1002/hed.21455; Vikhanskaya F, 2007, NUCLEIC ACIDS RES, V35, P2093, DOI 10.1093/nar/gkm099; Xie TX, 2013, LARYNGOSCOPE, V123, P1416, DOI 10.1002/lary.23846	36	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	APR 1	2015	75	7					1527	1536		10.1158/0008-5472.CAN-14-2735		10	Oncology	Oncology	CE6LW	WOS:000351948900037		
J	Kobayashi, N; Hirano, K; Nakano, M; Muramatsu, T; Tsukahara, R; Ito, Y; Ishimori, H; Yamawaki, M; Araki, M; Kato, T				Kobayashi, Norihiro; Hirano, Keisuke; Nakano, Masatsugu; Muramatsu, Toshiya; Tsukahara, Reiko; Ito, Yoshiaki; Ishimori, Hiroshi; Yamawaki, Masahiro; Araki, Motoharu; Kato, Tamon			Predictors of Non-Healing in Patients with Critical Limb Ischemia and Tissue Loss Following Successful Endovascular Therapy	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						critical limb ischemia; endovascular therapy; wound healing	PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; INFRAINGUINAL BYPASS GRAFT; CRITICAL LEG ISCHEMIA; SURGICAL REVASCULARIZATION; HEMODIALYSIS-PATIENTS; ELUTING STENTS; OUTCOMES; SURGERY; DISEASE; ANGIOSOME	ObjectivesTo evaluate the predictors of non-healing in patients with critical limb ischemia (CLI) after successful endovascular therapy (EVT). BackgroundOccasionally, wound healing in patients with CLI and tissue loss cannot be achieved even after successful EVT. Patient's co-morbidities, vascular anatomy, wound features, and interventional strategies/outcomes are associated with the probability of wound healing. MethodsBetween April 2007 and October 2012, 182 patients with CLI (220 limbs) with tissue loss were treated with EVT in our institute. Of these, 164 individual wounds (130 patients, 149 limbs) out of 243 individual wounds were successfully treated. Successful EVT was defined as revascularization by achieving visible blood flow to the wounds, as evaluated by digital subtraction angiography performed just after EVT. A Cox proportional hazards model was used to analyze predictors associated with wound healing. ResultsThe mean follow-up period was 2318 months. The wound healing rates were 40.2%, 57.3%, 62.2%, and 70.7% at 3, 6, 9, and 12 months, respectively. Multivariate Cox proportional hazards analysis revealed that insulin use [hazard ratio (HR), 0.541; 95% confidence interval (CI), 0.329-0.890; P=0.016], dependence on hemodialysis [HR, 0.429; 95% CI, 0.272-0.678; P<0.001], and major tissue loss [HR, 0.460; 95% CI, 0.294-0.720; P=0.001] were independent predictors of non-healing after successful EVT. ConclusionsInsulin use, dependence on hemodialysis, and major tissue loss were independent predictors of non-healing after successful EVT. (c) 2014 Wiley Periodicals, Inc.	[Kobayashi, Norihiro; Hirano, Keisuke; Nakano, Masatsugu; Muramatsu, Toshiya; Tsukahara, Reiko; Ito, Yoshiaki; Ishimori, Hiroshi; Yamawaki, Masahiro; Araki, Motoharu; Kato, Tamon] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa 2308765, Japan	Kobayashi, N (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa 2308765, Japan.	ovation17@gmail.com					Acin F, 2014, INT J VASC MED, V2014; Nakano M, 2013, J ENDOVASC THER, V20, P113, DOI 10.1583/11-3782.1; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; O'Hare AM, 2004, J VASC SURG, V39, P709, DOI 10.1016/j.jvs.2003.11.038; Simons JP, 2010, J VASC SURG, V51, P1419, DOI 10.1016/j.jvs.2010.01.083; Kawarada O, 2012, CATHETER CARDIO INTE, V80, P861, DOI 10.1002/ccd.24370; Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321; Iida O, 2010, CATHETER CARDIO INTE, V75, P830, DOI 10.1002/ccd.22319; Virkkunen J, 2004, J VASC SURG, V40, P761, DOI 10.1016/j.jvs.2004.07.040; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; Brosi P, 2005, J ENDOVASC THER, V12, P704, DOI 10.1583/05-1638MR.1; Awad S, 2006, EUR J VASC ENDOVASC, V32, P51, DOI 10.1016/j.ejvs.2005.12.019; Soga Y, 2013, CIRC J, V77, P2102, DOI 10.1253/circj.CJ-13-0020; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Hart CA, 2013, EXP BIOL MED, V238, P1118, DOI 10.1177/1535370213503275; Wallaert JB, 2012, J VASC SURG, V56, P1317, DOI 10.1016/j.jvs.2012.04.011; Liistro F, 2013, CIRCULATION, V128, P615, DOI 10.1161/CIRCULATIONAHA.113.001811; Treiman GS, 2000, J VASC SURG, V31, P1110, DOI 10.1067/mva.2000.106493; Feiring AJ, 2010, J AM COLL CARDIOL, V55, P1580, DOI 10.1016/j.jacc.2009.11.072; Kabra A, 2013, J VASC SURG, V57, P44, DOI 10.1016/j.jvs.2012.07.042; Biancari F, 2007, WORLD J SURG, V31, P217, DOI 10.1007/s00268-006-0242-y; Svensson H, 2011, J WOUND CARE, V20, P261; Soderstrom MI, 2010, ANN SURG, V252, P765, DOI 10.1097/SLA.0b013e3181fc3c73; Fernandez N, 2011, J VASC SURG, V54, P722, DOI 10.1016/j.jvs.2011.03.232; Khan MUN, 2009, J VASC SURG, V49, P1440, DOI 10.1016/j.jvs.2009.02.226; Biancari F, 2007, WORLD J SURG, V31, P226; Meacham PW, 1998, AM SURGEON, V64, P37; Carsten CG, 1998, AM SURGEON, V64, P33; Chung J, 2006, J VASC SURG, V43, P1183, DOI 10.1016/j.jvs.2005.12.068; Dietzek A M, 1990, Eur J Vasc Surg, V4, P413, DOI 10.1016/S0950-821X(05)80877-1; Guntani Atsushi, 2013, Ann Vasc Dis, V6, P596, DOI 10.3400/avd.oa.13-00059; Khan MU, 2009, J VASC SURG, V49, P1445; Kolluru G. K., 2012, INT J VASC MED, V2012, DOI DOI 10.1155/2012/918267; Kumada Y, 2008, NEPHROL DIAL TRANSPL, V23, P3996, DOI 10.1093/ndt/gfn378; Management of peripheral arterial disease ( PAD). TransAtlantic Inter- Society Consensus ( TASC), 2000, EUR J VASC ENDOVA SA, V19, pSi; Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC), 2000, EUR J VASC ENDOVA SA, V19, pS1; Roberts D, 2014, CATHETER CARDIOVASC; Schultz Gregory S, 2004, Int Wound J, V1, P19, DOI 10.1111/j.1742-481x.2004.00008.x; Soderstrom M, 2008, EUR J VASC ENDOVASC, V36, P90, DOI 10.1016/j.ejvs.2008.01.027; Stoner MC, 2007, J VASC SURG, V46, P289, DOI 10.1016/j.jvs.2007.04.019; Svensson H, 2011, J WOUND CARE, V20, P266; Svensson H, 2011, J WOUND CARE, V20, P264; Werner M, 2012, J ENDOVASC THER, V19, P12, DOI 10.1583/11-3665.1	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	APR	2015	85	5					850	858		10.1002/ccd.25625		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE0UU	WOS:000351523800020		
J	Fujihara, M; Kawasaki, D; Shintani, Y; Fukunaga, M; Nakama, T; Koshida, R; Higashimori, A; Yokoi, Y				Fujihara, Masahiko; Kawasaki, Daizo; Shintani, Yoshiaki; Fukunaga, Masashi; Nakama, Tatsuya; Koshida, Ryouji; Higashimori, Akihiro; Yokoi, Yoshiaki		Co2 Angiography Registry	Endovascular Therapy by CO2 Angiography to Prevent Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Prospective Multicenter Trial of CO2 Angiography Registry	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						carbon dioxide angiography; endovascular therapy; chronic kidney disease	CARBON-DIOXIDE; PERCUTANEOUS CORONARY; RENAL-DISEASE; MEDIA; ACETYLCYSTEINE; INTERVENTIONS; STRATEGIES; RISK	ObjectivesTo assess the safety and efficacy of carbon dioxide (CO2) angiography-guided endovascular therapy (EVT) for renal, iliofemoral artery disease. BackgroundPatients with peripheral vascular disease (PVD) often have chronic kidney disease (CKD) and the use of iodinated contrast media may enhance the risk of contrast-induced nephropathy (CIN). Contrast volume reduction is an effective CIN preventive strategy. MethodsA prospective multicenter registry was developed and six clinical centers participated in the study. Patients with an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73 m(2) and stage-3 CKD were recruited between February 2012 and March 2013. CO2 angiography-guided EVT was performed; incomplete CO2 angiograms were supplemented by intravascular ultrasound, pressure wire, and/or minimal iodinated contrast media. The primary endpoint was a composite of freedom from renal events and freedom from major CO2 angiography related complications. ResultsThis study included 98 patients with 109 lesions. The mean eGFR baseline was 35.212.7 ml min(-1). CO2 angiography-guided angioplasty were performed in 16 renal arteries, 31 aortoiliac arteries, and 62 superficial femoral arteries. The technical success rate was 97.9%. Average CO2 consumption was 281.4 +/- 155.8 ml, average dose of iodinated contrast media was 15.0 +/- 18.1 ml. Primary endpoint was 92.8% (91/98). Incidence of CIN was 5.1% (5/98) and CO2 angiography-related complications occurred in 17.3% (17/98). Two cases (2%) developed severe, fatal, nonocclusive mesenteric ischemia (NOMI). ConclusionsThis trial showed that CO2 angiography-guided angioplasty was effective for preventing CIN, however, CO2 angiography related complication was somewhat high. (c) 2014 Wiley Periodicals, Inc.	[Fujihara, Masahiko; Higashimori, Akihiro; Yokoi, Yoshiaki] Kishiwada Tokushukai Hosp, Dept Cardiol, Kishiwada, Japan; [Fujihara, Masahiko] Kyushu Univ Grad, Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Japan; [Kawasaki, Daizo] Morinomiya Hosp, Dept Cardiol, Osaka, Japan; [Shintani, Yoshiaki] Shin Koga Hosp, Dept Cardiol, Kurume, Fukuoka, Japan; [Fukunaga, Masashi] Hyogo Coll Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan; [Nakama, Tatsuya] Miyazaki Med Assoc Hosp, Dept Cardiol, Miyazaki, Japan; [Koshida, Ryouji] Tokeidai Mem Hosp, Dept Cardiol, Sapporo, Hokkaido, Japan	Fujihara, M (reprint author), Kishiwada Tokushukai Hosp, 4-27-1 Kamoricho, Kishiwada, Osaka 5968522, Japan.	masahiko-fujihara@themis.ocn.ne.jp					Ando Yasuhiro, 2009, Clin Exp Nephrol, V13, P191, DOI 10.1007/s10157-009-0163-9; Jaff MR, 2012, CATHETER CARDIO INTE, V80, P343, DOI 10.1002/ccd.24449; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023; Bosiers M, 2009, J ENDOVASC THER, V16, P261, DOI 10.1583/08-2676.1; Thomsen HS, 2003, BRIT J RADIOL, V76, P513, DOI 10.1259/bjr/26964464; Isenbarger DW, 2003, AM J CARDIOL, V92, P1454, DOI 10.1016/j.amjcard.2003.08.059; Rashid ST, 2004, J VASC SURG, V40, P1136, DOI 10.1016/j.jvs.2004.09.026; Hafiz AM, 2012, CATHETER CARDIO INTE, V79, P929, DOI 10.1002/ccd.23148; Waybill MM, 2001, J VASC INTERV RADIOL, V12, P3, DOI 10.1016/S1051-0443(07)61394-3; Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73; CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3; Marenzi G, 2003, NEW ENGL J MED, V349, P1333, DOI 10.1056/NEJMoa023204; Chao A, 2007, J VASC SURG, V45, P451, DOI 10.1016/j.jvs.2006.11.017; HAWKINS IF, 1982, AM J ROENTGENOL, V139, P19; Kawasaki D, 2012, CIRC J, V76, P1722, DOI 10.1253/circj.CJ-11-1382; Beese RC, 2000, BRIT J RADIOL, V73, P3; Kawarada O, 2006, CATHETER CARDIO INTE, V68, P311, DOI 10.1002/ccd.20837; Madhusudhan KS, 2009, J MED IMAG RADIAT ON, V53, P40, DOI 10.1111/j.1754-9485.2009.02035.x; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Rutherford R B, 1991, J Vasc Interv Radiol, V2, P169, DOI 10.1016/S1051-0443(91)72275-6	22	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	APR	2015	85	5					870	877		10.1002/ccd.25722		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE0UU	WOS:000351523800023		
J	Attizzani, GF; Ohno, Y; Capodanno, D; Cannata, S; Dipasqua, F; Imme, S; Mangiafico, S; Barbanti, M; Ministeri, M; Cageggi, A; Pistritto, AM; Giaquinta, S; Farruggio, S; Chiaranda, M; Ronsivalle, G; Scandura, S; Tamburino, C; Capranzano, P; Grasso, C				Attizzani, Guilherme F.; Ohno, Yohei; Capodanno, Davide; Cannata, Stefano; Dipasqua, Fabio; Imme, Sebastiano; Mangiafico, Sarah; Barbanti, Marco; Ministeri, Margherita; Cageggi, Anna; Pistritto, Anna Maria; Giaquinta, Sandra; Farruggio, Silvia; Chiaranda, Marta; Ronsivalle, Giuseppe; Scandura, Salvatore; Tamburino, Corrado; Capranzano, Piera; Grasso, Carmelo			Gender-Related Clinical and Echocardiographic Outcomes at 30-Day and 12-Month Follow up After MitraClip Implantation in the GRASP Registry	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						MitraClip; mitral regurgitation; mitral insufficiency; gender; percutaneous mitral valve repair	LONG-TERM SURVIVAL; NATIVE VALVULAR REGURGITATION; VALVE REPAIR; PERCUTANEOUS REPAIR; SYSTEM; SURGERY; RECOMMENDATIONS; BENEFICIARIES; ASSOCIATION; REPLACEMENT	ObjectivesTo assess the influence of patients' gender on the outcomes of percutaneous edge-to-edge mitral valve repair (PMVR) using the MitraClip system. BackgroundAlthough gender-related differences have been extensively documented in patients who undergo surgery for moderate-to-severe (3+) and severe (4+) mitral regurgitation (MR), studies assessing whether these differences exist after PMVR are lacking. MethodsClinical and echocardiographic data through 12-month follow up from 171 consecutive patients whom underwent MitraClip implantation and were dichotomized by the gender (106 males and 65 females) were obtained. The primary safety endpoint was the incidence of major adverse events at 30 days and the primary efficacy endpoint was freedom from death, surgery for mitral valve dysfunction, or grade3+ MR at 12-month follow up. ResultsThe primary safety endpoint was observed in four males (3.8%) and four females (6.2%) (P=0.358). Remarkable reduction in MR postprocedure was revealed in both groups, and these results were mostly sustained. Furthermore, left ventricle reverse remodeling and New York Heart Association (NYHA) functional class improvement were revealed in both groups, but females tended to demonstrate worse results over time (P=0.083). The primary efficacy endpoint obtained by Kaplan-Meier estimates was observed in 76.3 and 70.2%, respectively (log rank P=0.231). ConclusionsMitraClip implantation in patients with 3+ and 4+ MR is safe and efficacious until mid-term follow up, regardless of patients' gender. Despite improvement in NYHA functional class in both groups, female gender demonstrated a trend toward poorer results. Further validation of our findings is warranted. (c) 2014 Wiley Periodicals, Inc.	[Attizzani, Guilherme F.; Ohno, Yohei; Capodanno, Davide; Cannata, Stefano; Dipasqua, Fabio; Imme, Sebastiano; Mangiafico, Sarah; Barbanti, Marco; Ministeri, Margherita; Cageggi, Anna; Pistritto, Anna Maria; Giaquinta, Sandra; Farruggio, Silvia; Chiaranda, Marta; Ronsivalle, Giuseppe; Scandura, Salvatore; Tamburino, Corrado; Capranzano, Piera; Grasso, Carmelo] Univ Catania, Ferrarotto Hosp, Div Cardiol, I-95100 Catania, Italy; [Attizzani, Guilherme F.] Pitangueiras Hosp, Intervent Cardiol Dept, Jundiai, Brazil; [Attizzani, Guilherme F.] Univ Hosp Cleveland, Harrington Heart & Vasc Inst, Case Med Ctr, Cleveland, OH 44106 USA; [Ohno, Yohei] Tokai Univ, Sch Med, Dept Cardiol, Isehara, Kanagawa 25911, Japan; [Capodanno, Davide; Tamburino, Corrado; Capranzano, Piera] Excellence Newest Adv ETNA Fdn, Catania, Italy	Capodanno, D (reprint author), Univ Catania, Ferrarotto Hosp, Dept Cardiol, Via Citelli 1, I-95100 Catania, Italy.	dcapodanno@gmail.com					Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Feldman T, 2009, J AM COLL CARDIOL, V54, P686, DOI 10.1016/j.jacc.2009.03.077; Grasso C, 2013, AM J CARDIOL, V111, P1482, DOI 10.1016/j.amjcard.2013.01.300; Surder D, 2013, HEART, V99, P1034, DOI 10.1136/heartjnl-2012-303105; Vassileva CM, 2013, CIRCULATION, V127, P1870, DOI 10.1161/CIRCULATIONAHA.113.002200; Tamburino C, 2010, EUR HEART J, V31, P1382, DOI 10.1093/eurheartj/ehq051; Grayburn PA, 2013, CIRCULATION, V128, P1667, DOI 10.1161/CIRCULATIONAHA.112.001039; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105; Lim DS, 2014, J AM COLL CARDIOL, V64, P182, DOI 10.1016/j.jacc.2013.10.021; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Schillinger W, 2013, EUROINTERVENTION, V9, P84, DOI 10.4244/EIJV9I1A13; Thourani VH, 2003, CIRCULATION, V108, P298, DOI 10.1161/01.CIR.0000079169.15862.13; Mauri L, 2013, J AM COLL CARDIOL, V62, P317, DOI 10.1016/j.jacc.2013.04.030; Avierinos JF, 2008, ANN INTERN MED, V149, P787; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; Nishimura Rick A, 2014, J Am Coll Cardiol, V63, pe57, DOI 10.1016/j.jacc.2014.02.536; Ohno Y, 2014, EUR HEART J-CARD IMG, V15, P1246, DOI 10.1093/ehjci/jeu114; Scandura S, 2012, J AM SOC ECHOCARDIOG, V25, P1099, DOI 10.1016/j.echo.2012.07.015; Seeburger J, 2013, THORAC CARDIOV SURG, V61, P42, DOI 10.1055/s-0032-1331583; Vassileva CM, 2013, ANN THORAC SURG, V96, P1367, DOI 10.1016/j.athoracsur.2013.04.055	20	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	APR	2015	85	5					889	897		10.1002/ccd.25715		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE0UU	WOS:000351523800027		
J	Iwamoto, D; Yamagata, K; Kishi, M; Hayashi-Takanaka, Y; Kimura, H; Wakayama, T; Saeki, K				Iwamoto, Daisaku; Yamagata, Kazuo; Kishi, Masao; Hayashi-Takanaka, Yoko; Kimura, Hiroshi; Wakayama, Teruhiko; Saeki, Kazuhiro			Early Development of Cloned Bovine Embryos Produced from Oocytes Enucleated by Fluorescence Metaphase II Imaging Using a Conventional Halogen-Lamp Microscope	CELLULAR REPROGRAMMING			English	Article							HISTONE H3 PHOSPHORYLATION; NUCLEAR TRANSFER EMBRYOS; IN-VITRO; CHROMOSOME CONDENSATION; SERINE 10; TRANSPLANTATION; MAINTENANCE; CELLS; VISUALIZATION; ACETYLATION	Enucleation of a recipient oocyte is one of the key processes in the procedure of somatic cell nuclear transfer (SCNT). However, especially in bovine species, lipid droplets spreading in the ooplasm hamper identification and enucleation of metaphase II (MII) chromosomes, and thereby the success rate of the cloning remains low. In this study we used a new experimental system that enables fluorescent observation of chromosomes in living oocytes without any damage. We succeeded in visualizing and removing the MII chromosome in matured bovine oocytes. This experimental system consists of injecting fluorescence-labeled antibody conjugates that bind to chromosomes and fluorescent observation using a conventional halogen-lamp microscope. The cleavage rates and blastocyst rates of bovine embryos following in vitro fertilization (IVF) decreased as the concentration of the antibody increased (p<0.05). The enucleation rate of the conventional method (blind enucleation) was 86%, whereas all oocytes injected with the antibody conjugates were enucleated successfully. Fusion rates and developmental rates of SCNT embryos produced with the enucleated oocytes were the same as those of the blind enucleation group (p>0.05). For the production of SCNT embryos, the new system can be used as a reliable predictor of the location of metaphase plates in opaque oocytes, such as those in ruminant animals.	[Iwamoto, Daisaku; Kishi, Masao; Saeki, Kazuhiro] Kinki Univ, Dept Genet Engn, Wakayama 6496493, Japan; [Yamagata, Kazuo] RIKEN Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo 6500047, Japan; [Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Saeki, K (reprint author), Kinki Univ, 930 Nishimitani, Wakayama 6496493, Japan.	saeki@waka.kindai.ac.jp			Japan Society for the Promotion of Science [26450461]	We are grateful to Mr. Takaaki Sekito, Ms. Saki Nishioka, Ms. Rio Hamada, and Ms. Risa Yamamoto for their technical assistance and Ms. Naomi Backes Kamimura and Ms. Julia Walhelm-Kimura for English editing. This study was supported by a Grant-in-Aid for Scientific Research (No. 26450461) from the Japan Society for the Promotion of Science.	Van Hooser A, 1998, J CELL SCI, V111, P3497; Fulka J, 2004, TRENDS BIOTECHNOL, V22, P279, DOI 10.1016/j.tibtech.2004.04.002; Peura TT, 1998, MOL REPROD DEV, V50, P185, DOI 10.1002/(SICI)1098-2795(199806)50:2<185::AID-MRD9>3.0.CO;2-G; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; PRATHER RS, 1989, BIOL REPROD, V41, P414, DOI 10.1095/biolreprod41.3.414; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Dominko T, 2000, BIOL REPROD, V62, P150, DOI 10.1095/biolreprod62.1.150; TATHAM BG, 1995, BIOL REPROD, V53, P1088, DOI 10.1095/biolreprod53.5.1088; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Swain JE, 2007, BIOL REPROD, V76, P628, DOI 10.1095/biolreprod.106.055798; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Tani T, 2006, CLONING STEM CELLS, V8, P61, DOI 10.1089/clo.2006.8.61; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Bui Hong-Thuy, 2004, Biol Reprod, V70, P1843, DOI 10.1095/biolreprod.103.026070; CRITSER ES, 1986, STAIN TECHNOL, V61, P1; Han YM, 2003, THERIOGENOLOGY, V59, P33, DOI 10.1016/S0093-691X(02)01271-2; Hua S, 2011, ANIM REPROD SCI, V126, P37, DOI 10.1016/j.anireprosci.2011.05.002; Iwamoto D, 2012, CELL REPROGRAM, V14, P20, DOI 10.1089/cell.2011.0035; Jeon BG, 2011, REPROD DOMEST ANIM, V46, P1035, DOI 10.1111/j.1439-0531.2011.01781.x; Kimura H, 2010, CURR OPIN CELL BIOL, V22, P412, DOI 10.1016/j.ceb.2010.02.004; Li GP, 2004, CLONING STEM CELLS, V6, P5, DOI 10.1089/15362300460743781; Saeki K, 1998, J VET MED SCI, V60, P523, DOI 10.1292/jvms.60.523; SAEKI K, 1994, THERIOGENOLOGY, V42, P1115, DOI 10.1016/0093-691X(94)90859-1; SMITH LC, 1993, J REPROD FERTIL, V99, P39; Terashita Y, 2011, J REPROD DEVELOP, V57, P564, DOI 10.1262/jrd.11-015H; Thouas G. A., 2001, REPROD BIOMED ONLINE, V3, P25, DOI [10.1016/S1472-6483(10)61960-8, DOI 10.1016/S1472-6483(10)61960-8]; Westhusin ME, 1996, THERIOGENOLOGY, V46, P243, DOI 10.1016/0093-691X(96)00181-1; Yamagata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031638	32	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-4971	2152-4998		CELL REPROGRAM	Cell. Reprogramm.	APR 1	2015	17	2					106	114		10.1089/cell.2014.0086		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Genetics & Heredity	Cell Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CE7YR	WOS:000352058400003		
J	Ogawa, H; Watanabe, H; Fukuda, A; Kono, T				Ogawa, Hidehiko; Watanabe, Hiroyuki; Fukuda, Atsushi; Kono, Tomohiro			Deficiency of Genomic Reprogramming in Trophoblast Stem Cells Following Nuclear Transfer	CELLULAR REPROGRAMMING			English	Article							ADULT SOMATIC-CELLS; MOUSE EMBRYOS; TRICHOSTATIN-A; CLONING; MASS; TROPHECTODERM; FETAL; DIFFERENTIATION; BLASTOCYSTS; ACTIVATION	To examine the genomic reprogrammability of trophoblast stem (TS) cells using a nuclear transfer technique, we produced TS cloned embryos using five TS cell lines from three strains of mice (ICR, B6D2F1, and B6CBF1) as donors and observed developmental ability during preimplantation development. The developmental rates of the TS cloned embryos that developed to the two-cell, four- to eight-cell, morula, and blastocyst stages were 58-83%, 0-38.6%, 0-21.3%, and 0-15.9%, respectively, indicating that more than 50% of TS cloned embryos arrested at the two-cell stage. These TS cloned two-cell embryos were expressed low level of Dappa3 (also known as PGC7/Stella), indicating that zygotic gene activation (ZGA) was disrupted in these embryos. However, a small portion of the TS cloned embryos (0-15.9%) reached the blastocyst stage. In these TS cloned blastocysts, the numbers of trophectoderm (TE) and inner cell mass (ICM) cells were 31.9 +/- 4.6 and 12.1 +/- 3.0, respectively, which were not significantly different from those in the fertilized embryos. In addition, the gene expression analysis showed that Oct3/4, and Cdx2, which are ICM- and TE-specific marker genes, respectively, and Dppa3, and Hdac1, which are zygotic gene activation-related genes, were expressed in TS cloned blastocysts at the same levels as in the fertilized blastocysts. These results indicate that although TS cloned embryos are able to differentiate into ICM cells, the genomic reprogrammability of TS cells is very low following nuclear transfer.	[Ogawa, Hidehiko; Watanabe, Hiroyuki; Fukuda, Atsushi; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo 1568502, Japan	Ogawa, H (reprint author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan.	hogawa@nodai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [22658084]	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 22658084).	Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Nakanishi MO, 2012, EPIGENETICS-US, V7, P173, DOI 10.4161/epi.7.2.18962; Kuckenberg P, 2011, MOL CELL BIOL, V31, P1748, DOI 10.1128/MCB.01047-10; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Jincho Y, 2008, BIOL REPROD, V78, P568, DOI 10.1095/biolreprod.107.064634; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Ogawa H, 2009, PLACENTA, V30, P448, DOI 10.1016/j.placenta.2009.02.006; Ono Y, 2006, BIOL REPROD, V75, P210, DOI 10.1095/biolreprod.105.049171; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Tsunoda Y, 1998, J REPROD FERTIL, V113, P181	36	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-4971	2152-4998		CELL REPROGRAM	Cell. Reprogramm.	APR 1	2015	17	2					115	123		10.1089/cell.2014.0073		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Genetics & Heredity	Cell Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CE7YR	WOS:000352058400004		
J	Murai, K; Endo, D; Kawashita, N; Takagi, T; Fujioka, H				Murai, Kenichi; Endo, Daisuke; Kawashita, Norihito; Takagi, Tatsuya; Fujioka, Hiromichi			Oxidative Rearrangement of Cyclobutanone Derived N,O-Ketals Leading to Pyrrolidone Derivatives	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						rearrangement; halogen; oxidation; N,O-ketal; pyrrolidone	ASYMMETRIC SCHMIDT REACTION; N-ALKYL HETEROCYCLES; C-H BONDS; IMINIUM ETHERS; ROOM-TEMPERATURE; DIRECT AMINATION; HYDROXY AZIDES; NITRENIUM IONS; CHLOROAMINES; KETONES	A halogen-induced oxidative rearrangement of N,O-ketals prepared from cyclobutanones, leading to pyrrolidone derivatives, is developed. The reaction proceeds via an iminium ether intermediate and, depending on the reaction medium, two types of pyrrolidone derivative, containing a halogen atom or hydroxyl group, can be obtained.	[Murai, Kenichi; Endo, Daisuke; Kawashita, Norihito; Takagi, Tatsuya; Fujioka, Hiromichi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Kawashita, Norihito; Takagi, Tatsuya] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Murai, K (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	murai@phs.osaka-u.ac.jp; fujioka@phs.osaka-u.ac.jp			JSPS; MEXT	This work was financially supported by Grant-in-Aid for Scientific Research (C) from JSPS and Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT.	Allin SA, 2008, J ORG CHEM, V73, P6448, DOI 10.1021/jo801019h; Qian X, 2013, CHEM-EUR J, V19, P6225, DOI 10.1002/chem.201300229; Fenster E, 2008, J ORG CHEM, V73, P201, DOI 10.1021/jo702193g; Gracias V, 1996, J ORG CHEM, V61, P10, DOI 10.1021/jo951953w; Murai K, 2012, ORG LETT, V14, P772, DOI 10.1021/ol203313n; Barker TJ, 2009, J AM CHEM SOC, V131, P15598, DOI 10.1021/ja907038b; Shen B, 2010, NATURE, V465, P1027, DOI 10.1038/nature09125; Ward SE, 2011, J MED CHEM, V54, P78, DOI 10.1021/jm100679e; Grohmann C, 2012, ORG LETT, V14, P656, DOI 10.1021/ol203353a; PITTMAN CU, 1972, CHEM REV, V72, P357, DOI 10.1021/cr60278a003; Sahasrabudhe K, 2003, J AM CHEM SOC, V125, P7914, DOI 10.1021/ja0348896; Kenda BM, 2004, J MED CHEM, V47, P530, DOI 10.1021/jm030913e; Hatakeyama T, 2010, ORG LETT, V12, P1516, DOI 10.1021/ol100235b; Barker TJ, 2011, ANGEW CHEM INT EDIT, V50, P8325, DOI 10.1002/anie.201103700; Ng KH, 2012, ORG LETT, V14, P272, DOI 10.1021/ol203046n; Kawano T, 2010, J AM CHEM SOC, V132, P6900, DOI 10.1021/ja101939r; Peng B, 2012, CHEM-EUR J, V18, P16292, DOI 10.1002/chem.201203293; Treece JL, 2010, J ORG CHEM, V75, P2028, DOI 10.1021/jo100087h; Miura T, 2012, ORG LETT, V14, P5214, DOI 10.1021/ol302331k; Smith BT, 2000, J ORG CHEM, V65, P3771, DOI 10.1021/jo000056b; Donaruma L. G., 1960, ORG REACTIONS, V11, P1; Forsee JE, 1999, J ORG CHEM, V64, P4381, DOI 10.1021/jo990041h; GASSMAN PG, 1971, TETRAHEDRON LETT, P109; GASSMAN PG, 1970, ACCOUNTS CHEM RES, V3, P26, DOI 10.1021/ar50025a004; Gawley R. E., 1988, ORG REACTIONS, V35, P1; GRACIAS V, 1995, J AM CHEM SOC, V117, P8047, DOI 10.1021/ja00135a036; Grecian S., 2010, ORGANIC AZIDES SYNTH, P191; Liang PH, 2002, BIOORGAN MED CHEM, V10, P3267, DOI 10.1016/S0968-0896(02)00171-2; Lucas BS, 2012, J AM CHEM SOC, V134, P12855, DOI 10.1021/ja305123v; Murai K, 2013, ORG BIOMOL CHEM, V11, P2648, DOI 10.1039/c3ob40132d; SCHELL FM, 1980, J ORG CHEM, V45, P4069, DOI 10.1021/jo01308a033; SCHELL FM, 1983, TETRAHEDRON LETT, V24, P1883, DOI 10.1016/S0040-4039(00)81796-7; Schietroma DMS, 2012, ORG BIOMOL CHEM, V10, P4692, DOI 10.1039/c2ob25595b; WALLIS ES, 1946, ORG REACTIONS, V3, P267; WOLFF H, 1946, ORG REACTIONS, V3, P307	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	APR	2015	63	4					245	247				3	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE7VT	WOS:000352050700001		
J	Takasu, Y; Yoshida, M; Tange, M; Asahara, K; Uchida, T				Takasu, Yuko; Yoshida, Miyako; Tange, Mio; Asahara, Keiichi; Uchida, Takahiro			Prediction of the Stability of Meropenem in Intravenous Mixtures	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						stability prediction; meropenem; pH; sodium bisulfite (SBS); L-cysteine; degradation rate constant	SODIUM BISULFITE; DEGRADATION; ADMIXTURE; MESILATE	The purpose of this study was to predict the stability of meropenem in a mixed infusion. The hydrolysis of meropenem in aqueous solution was found to be accelerated by pH, and by increasing concentrations of sodium bisulfite (SBS) and L-cysteine. Equations were derived for the degradation rate constants (k(obs)) of pH, SBS and L-cysteine, and fractional rate constants were estimated by the nonlinear least-squares method (quasi-Newton method using the solver in Microsoft Excel) at 25 degrees C. The activation energy (E-a) and frequency factor (A) were calculated using the Arrhenius equation. The pH of the mixed infusion was estimated using the characteristic pH curve. From these results, an equation was derived giving the residual ratio (%) of meropenem at any time after mixing an infusion containing SBS and/or L-cysteine at any temperature, and in the pH range 4.0-10.0. A high correlation was shown to exist between the estimated and determined residual ratios (%).	[Takasu, Yuko; Yoshida, Miyako; Tange, Mio; Asahara, Keiichi; Uchida, Takahiro] Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan	Uchida, T (reprint author), Mukogawa Womens Univ, Sch Pharmaceut Sci, 11-68 Koshien 9 Bancho, Nishinomiya, Hyogo 6638179, Japan.	takahiro@mukogawa-u.ac.jp					ASAHARA K, 1990, CHEM PHARM BULL, V38, P492; Asahara K., 1983, JPN J HOSP PHARM, V9, P431; ASAHARA K, 1990, CHEM PHARM BULL, V38, P1675; ASAHARA K, 1989, CHEM PHARM BULL, V37, P1595; Dainippon Sumitomo Pharma Co. Ltd., 2014, INT FORM MER; Dawson R. M. C., 1966, DATA BIOCH RES, P1; Hamazume Y., 1994, JPN J HOSP PHARM, V20, P139; Hirouchi Y., 1985, J PHARM SCI TECHNOLO, V45, P312; Itagaki F., 2013, JPN J PHARM HLTH CAR, V39, P521; Kameda K, 2010, J CHROMATOGR SCI, V48, P406; Rock G. S., 1975, J PHARM SCI, V64, P216; SCHROETER L, 1961, J PHARM SCI, V50, P891, DOI 10.1002/jps.2600501102; SCHROETER LC, 1958, J AM PHARM ASSOC, V47, P723; TERAO M, 1982, YAKUGAKU ZASSHI, V102, P978; Williams RR, 1935, J AM CHEM SOC, V57, P536, DOI 10.1021/ja01306a044; YEH SY, 1971, J PHARM SCI, V60, P793, DOI 10.1002/jps.2600600530; Yoshida M, 2013, CHEM PHARM BULL, V61, P1; YOSHIOKA M, 2008, JPN J CHEMOTHER, V56, P1	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	APR	2015	63	4					248	254				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE7VT	WOS:000352050700002		
J	Yamamoto, Y; Fukami, T; Koide, T; Onuki, Y; Suzuki, T; Katori, N; Tomonoe, K				Yamamoto, Yoshihisa; Fukami, Toshiro; Koide, Tatsuo; Onuki, Yoshinori; Suzuki, Toyofumi; Katori, Noriko; Tomonoe, Kazuo			Studies on Uniformity of the Active Ingredients in Acetaminophen Suppositories Re-solidified after Melting under High Temperature Conditions	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						suppository; acetaminophen; uniformity; re-solidification; rheology; hard fat	SUSTAINED-RELEASE SUPPOSITORIES; PHARMACEUTICAL EVALUATION; DICLOFENAC; OINTMENTS; DESIGN	The target of the present pharmaceutical study was the antipyretic analgesic, acetaminophen; its suppository form is usually split when used in pediatric patients. We focused on the active ingredient uniformity in these products, which were re-solidified after melting under high temperature condition. When sections of the cut surfaces of the seven acetaminophen suppository products (SUP-A-G) commercially available in Japan were visualized by polarized microscopy, acetaminophen crystals that were dispersed in the base were identified. The results of the quantitative determination of agent concentration for each cut portion (mg/g) suggested uniform dispersion of these crystals in the base of each product. The agent concentration in each portion of the suppositories that was re-solidified after melting at high temperatures was measured. Segregation of the active ingredient was observed in four products at a temperature of 40 degrees C for 1 h, while active ingredient uniformity was maintained in the other three products (SUP-C, SUP-F and SUP-G). The latter three products also showed high viscosity at 40 degrees C. At 50 degrees C for 4h, only the uniformity of the active ingredient in SUP-C was maintained. These results suggest that the uniformity of the active ingredient is lost in some acetaminophen suppositories that were re-solidified after melting under high temperature conditions. The degree of loss varies depending on the product.	[Yamamoto, Yoshihisa] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Fukami, Toshiro] Meiji Pharmaceut Univ, Dept Mol Pharmaceut, Kiyose, Tokyo 2048588, Japan; [Koide, Tatsuo; Katori, Noriko] Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, Tokyo 1588501, Japan; [Onuki, Yoshinori] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan; [Suzuki, Toyofumi; Tomonoe, Kazuo] Nihon Univ, Sch Pharm, Lab Pharmaceut, Funabashi, Chiba 2748555, Japan	Yamamoto, Y (reprint author), Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, 4-21-2 Nakano, Tokyo 1648530, Japan.	y.yamamoto@thu.ac.jp					Miyazaki S, 1998, J CONTROL RELEASE, V56, P75, DOI 10.1016/S0168-3659(98)00079-0; [Anonymous], 2005, VOSC H 15 VOSC E 75; Araki H, 2003, SHOUNI HUKUYAKUSIDO, P33; Azechi Y, 1993, J CONTROL RELEASE, V27, P37; DEBOER AG, 1982, CLIN PHARMACOKINET, V7, P285; DEBOER AG, 1979, CLIN PHARMACOL THER, V26, P701; Fujii T., 1979, JPN J HOSP PHARM, V5, P155; Ishakawa K., 2007, MEMORIES FACULTY E 5, V42, P1; Iwata M, 1999, YAKUGAKU ZASSHI, V119, P170; Janicki S, 2001, EUR J PHARM BIOPHARM, V52, P249, DOI 10.1016/S0939-6411(01)00187-4; MORIMOTO K, 1989, CHEM PHARM BULL, V37, P2491; Muranishi S., 1979, YAKUZAIGAKU, V39, P1; NAKAJIMA T, 1990, CHEM PHARM BULL, V38, P1027; NISHIHATA T, 1985, INT J PHARM, V27, P245, DOI 10.1016/0378-5173(85)90073-0; Realdon N, 2008, PHARMAZIE, V63, P459, DOI 10.1691/ph.2008.7378; Takatori T, 2004, INT J PHARM, V278, P275, DOI 10.1016/j.ijpharm.2004.03.030; Tayama Y., 2006, JPN J PHARM HLTH CAR, V32, P1100; Tazoe K., 2011, J JPN SOC HOSP PHARM, V47, P1417; Walson PD, 2013, CLIN THER, V35, P135, DOI 10.1016/j.clinthera.2012.12.016; Yahagi R, 2000, INT J PHARMACEUT, V193, P205, DOI 10.1016/S0378-5173(99)00338-5; Yamamoto Y, 2014, INT J PHARMACEUT, V463, P62, DOI 10.1016/j.ijpharm.2013.12.054; Yamamoto Y, 2012, INT J PHARMACEUT, V426, P54, DOI 10.1016/j.ijpharm.2012.01.017	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	APR	2015	63	4					263	272				10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE7VT	WOS:000352050700004		
J	Mukai, C; Arima, K; Hirata, S; Yasuda, S				Mukai, Chisato; Arima, Katsuya; Hirata, Shuichi; Yasuda, Shigeo			Synthesis of a Carbon Analogue of Scytonemin	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						scytonemin; allene; [2+2+1] cycloaddition; alkyne; molybdenum; aldol condensation	PAUSON-KHAND REACTION; SUNSCREEN SCYTONEMIN; THERMAL GENERATION; NEOCARZINOSTATIN; PIGMENT; BIOSYNTHESIS; CYCLIZATION; ALKALOIDS; RADIATION	The synthesis of a carbon analogue of scytonemin was accomplished on the basis of molybdenum-mediated intramolecular double Pauson-Khand type reaction of bis(allenyne), followed by the double aldol condensation of the formed double Pauson-Khand type adduct.	[Mukai, Chisato; Arima, Katsuya; Hirata, Shuichi; Yasuda, Shigeo] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan	Mukai, C (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	mukai@p.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, for which we are thankful. We thank Prof. Dr. Akira Odani for UV-visible absorption spectroscopy analysis of 2.	Aburano D, 2007, J ORG CHEM, V72, P6878, DOI 10.1021/jo071137b; Aburano D, 2009, J ORG CHEM, V74, P5590, DOI 10.1021/jo901141t; ALKATHUM.KM, 1972, J INORG NUCL CHEM, V34, P3759, DOI 10.1016/0022-1902(72)80022-8; PROTEAU PJ, 1993, EXPERIENTIA, V49, P825, DOI 10.1007/BF01923559; Mizutani M, 2011, ORG LETT, V13, P1796, DOI 10.1021/ol200320z; MYERS AG, 1987, TETRAHEDRON LETT, V28, P4493, DOI 10.1016/S0040-4039(00)96545-6; Balskus EP, 2008, J AM CHEM SOC, V130, P15260, DOI 10.1021/ja807192u; Movassaghi M, 2007, J ORG CHEM, V72, P1838, DOI 10.1021/jp062325p; Soule T, 2009, J BACTERIOL, V191, P4639, DOI 10.1128/JB.00134-09; Balskus EP, 2009, J AM CHEM SOC, V131, P14648, DOI 10.1021/ja906752u; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; MYERS AG, 1989, J AM CHEM SOC, V111, P8057, DOI 10.1021/ja00202a079; Sashida H, 2010, TETRAHEDRON, V66, P5149, DOI 10.1016/j.tet.2010.04.101; Stevenson CS, 2002, J PHARMACOL EXP THER, V303, P858, DOI 10.1124/jpet.102.036350; Mizutani M, 2014, CHEM COMMUN, V50, P5782, DOI 10.1039/c4cc01843e; Itoh N, 2013, CHEM-EUR J, V19, P8665, DOI 10.1002/chem.201300364; Kashiki T, 2009, ORG LETT, V11, P2473, DOI 10.1021/ol900809w; Cheng X, 2010, MACROMOLECULES, V43, P909, DOI 10.1021/ma902176j; NAGATA R, 1989, TETRAHEDRON LETT, V30, P4995, DOI 10.1016/S0040-4039(01)80564-5; Ekebergh A, 2011, ORG LETT, V13, P4458, DOI 10.1021/ol201812n; Sorrels CM, 2009, APPL ENVIRON MICROB, V75, P4861, DOI 10.1128/AEM.02508-08; Cao H, 2005, J AM CHEM SOC, V127, P933, DOI 10.1021/ja040120x; Cao H, 2003, J AM CHEM SOC, V125, P3230, DOI 10.1021/ja021159+; Datta S, 2005, TETRAHEDRON LETT, V46, P7985, DOI 10.1016/j.tetlet.2005.09.068; GARCIAPICHEL F, 1991, J PHYCOL, V27, P395, DOI 10.1111/j.0022-3646.1991.00395.x; Hayashi Y, 2011, ORG LETT, V13, P1778, DOI 10.1021/ol200311y; Kozaka T, 2007, J ORG CHEM, V72, P10147, DOI 10.1021/jo702136b; Mukai C, 2006, ORG LETT, V8, P83, DOI 10.1021/ol052562z; MYERS AG, 1992, J AM CHEM SOC, V114, P9369, DOI 10.1021/ja00050a017; NAGATA R, 1990, TETRAHEDRON LETT, V31, P2907, DOI 10.1016/0040-4039(90)80181-K; Otsuka Y, 2010, J ORG CHEM, V75, P3420, DOI 10.1021/jo100499h; Stevenson CS, 2002, INFLAMM RES, V51, P112, DOI 10.1007/BF02684014	32	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	APR	2015	63	4					273	277				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE7VT	WOS:000352050700005		
J	Takao, K; Noguchi, K; Hashimoto, Y; Shirahata, A; Sugita, Y				Takao, Koichi; Noguchi, Kaori; Hashimoto, Yosuke; Shirahata, Akira; Sugita, Yoshiaki			Synthesis and Evaluation of Fatty Acid Amides on the N-Oleoylethanolamide-Like Activation of Peroxisome Proliferator Activated Receptor alpha	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						N-oleoylhistamine; fatty acid amide; N-oleoylethanolamide; peroxisome proliferator-activated receptor-alpha; clone 9 cell	FOOD-INTAKE; SIGNALING MOLECULES; PPAR-ALPHA; EXPRESSION; ACYLETHANOLAMINES; HEPATOCYTES	A series of fatty acid amides were synthesized and their peroxisome proliferator-activated receptor alpha (PPAR-alpha) agonistic activities were evaluated in a normal rat liver cell line, clone 9. The mRNAs of the PPAR-alpha downstream genes, carnitine-palmitoyltransferase-1 and mitochondrial 3-hydroxy-3-methylglutarylCoA synthase, were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR) as PPAR-alpha agonistic activities. We prepared nine oleic acid amides. Their PPAR-alpha agonistic activities were, in decreasing order, N-oleoylhistamine (OLHA), N-oleoylglycine, Oleamide, N-oleoyltyramine, N-oleoylsertonin, and Olvanil. The highest activity was found with OLHA. We prepared and evaluated nine N-acylhistamines (N-acyl-HAs). Of these, OLHA, C16:0-HA, and C18:1 Delta(9)-trans-HA showed similar activity. Activity due to the different chain length of the saturated fatty acid peaked at C16:0-HA. The PPAR-alpha antagonist, GW6471, inhibited the induction of the PPAR-alpha downstream genes by OLHA and N-oleoylethanolamide (OEA). These data suggest that N-acyl-HAs could be considered new PPAR-alpha agonists.	[Takao, Koichi; Noguchi, Kaori; Hashimoto, Yosuke; Shirahata, Akira; Sugita, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Takao, K (reprint author), Josai Univ, Fac Pharmaceut Sci, 1-1 Keyaki Dai, Sakado, Saitama 3500295, Japan.	ktakao@josai.ac.jp					Kobayashi M, 2011, EUR J PHARMACOL, V662, P9, DOI 10.1016/j.ejphar.2011.04.043; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Geall AJ, 2000, TETRAHEDRON, V56, P2449, DOI 10.1016/S0040-4020(99)01082-0; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; Ezzili C, 2010, BIOORG MED CHEM LETT, V20, P5959, DOI 10.1016/j.bmcl.2010.08.048; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; Chadwick J, 2010, BIOORGAN MED CHEM, V18, P2586, DOI 10.1016/j.bmc.2010.02.035; Navarro M, 2001, NATURE, V414, P209; Osornio YM, 2012, J ORG CHEM, V77, P10583, DOI 10.1021/jo301659c; Ottria R, 2012, CHEM PHYS LIPIDS, V165, P705, DOI 10.1016/j.chemphyslip.2012.06.010	15	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	APR	2015	63	4					278	285				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE7VT	WOS:000352050700006		
J	Miyamoto, M; Yamashita, T; Yasuhara, Y; Hayasaki, A; Hosokawa, Y; Tsujino, H; Uno, T				Miyamoto, Masayoshi; Yamashita, Taku; Yasuhara, Yuki; Hayasaki, Akinori; Hosokawa, Yukari; Tsujino, Hirofumi; Uno, Tadayuki			Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						cytochrome P450 reductase; membrane anchor; electron transfer; drug metabolism; shunt pathway	NADPH-CYTOCHROME-P-450 REDUCTASE; P450 OXIDOREDUCTASE; P-450 REDUCTASE; CATALYTIC-ACTIVITY; AMINO-ACID; COMPLEX-FORMATION; BINDING DOMAIN; NADPH; METABOLISM; SYSTEM	Cytochrome P450 reductase (CPR) is an important redox partner of microsomal CYPs. CPR is composed of a membrane anchor and a catalytic domain that contains FAD and flavin mononucleotide (FMN) as redox centers and mediates electron transfer to CYP. Although the CPR membrane anchor is believed to be requisite for interaction with CYP, its physiological role is still controversial. To clarify the role of the anchor, we constructed a mutant (Delta 60-CPR) in which the N-terminal membrane anchor was truncated, and studied its effect on binding properties, electron transfer to CYP2C19, and drug metabolism. We found that Delta 60-CPR could bind to and transfer electrons to CYP2C19 as efficiently as WT-CPR, even in the absence of lipid membrane. In accordance with this, Delta 60-CPR could mediate metabolism of amitriptyline (AMT) and imipramine (IMP) in the absence of lipids, although activity was diminished. However, Delta 60-CPR failed to metabolize omeprazole (OPZ) and lansoprazole (LPZ). To clarify the reason for this discrepancy in drug metabolism, we investigated the uncoupling reaction of the CYP catalytic cycle. By measuring the amount of H2O2 by-product, we found that shunt pathways were markedly activated in the presence of OPZ/LPZ in the Delta 60-CPR mutant. Because H2O2 levels varied among the drugs, we conclude that the proton network in the distal pocket of CYP2C19 is perturbed differently by different drugs, and activated oxygen is degraded to become H2O2. Therefore, we propose a novel role for the membrane anchor as a suppressor of the uncoupling reaction in drug metabolism by CYP.	[Miyamoto, Masayoshi; Yasuhara, Yuki; Hayasaki, Akinori; Hosokawa, Yukari; Tsujino, Hirofumi; Uno, Tadayuki] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Yamashita, Taku] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan	Uno, T (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	unot@phs.osaka-u.ac.jp			JSPS, Japan [23390011]	We thank Dr. Noritaka Ariyoshi in Chiba University Hospital for the generous gift of the human CPR gene. This work was financially supported by Grants-in-Aid for Scientific Research (23390011 to TU) from JSPS, Japan.	Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Fang XJ, 1997, FEBS LETT, V416, P77, DOI 10.1016/S0014-5793(97)01173-3; ATKINS WM, 1988, BIOCHEMISTRY-US, V27, P1610, DOI 10.1021/bi00405a033; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Inui H, 2007, BIOCHEMISTRY-US, V46, P10213, DOI 10.1021/bi700164q; Auclair K, 2001, J AM CHEM SOC, V123, P4877, DOI 10.1021/ja0040262; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; PORTER TD, 1985, P NATL ACAD SCI USA, V82, P973, DOI 10.1073/pnas.82.4.973; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Reynald RL, 2012, J BIOL CHEM, V287, P44581, DOI 10.1074/jbc.M112.424895; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; BERNHARDT R, 1988, BIOMED BIOCHIM ACTA, V47, P581; ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; SHEN AL, 1995, J BIOL CHEM, V270, P27475; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Lamb DC, 2001, BIOCHEM BIOPH RES CO, V286, P48, DOI 10.1006/bbrc.2001.5338; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; Das A, 2009, BIOCHEMISTRY-US, V48, P12104, DOI 10.1021/bi9011435; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Attia TZ, 2012, CHEM PHARM BULL, V60, P1544; Attia TZ, 2014, CHEM PHARM BULL, V62, P176; BERNHARDT R, 1987, BIOCHEM INT, V14, P823; BLACK SD, 1979, BIOCHEM BIOPH RES CO, V91, P1528, DOI 10.1016/0006-291X(79)91238-5; Estabrook RW, 1996, ARCH BIOCHEM BIOPHYS, V333, P308, DOI 10.1006/abbi.1996.0395; Gideon DA, 2012, CELL BIOCHEM BIOPHYS, V63, P35, DOI 10.1007/s12013-012-9339-0; Gilep AA, 2001, BIOCHEM BIOPH RES CO, V284, P937, DOI 10.1006/bbrc.2001.5075; GUM JR, 1981, J BIOL CHEM, V256, P7478; HANIU M, 1986, BIOCHEMISTRY-US, V25, P7906, DOI 10.1021/bi00372a018; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Huang R, 2014, BIOPHYS J, V106, P2126, DOI 10.1016/j.bpj.2014.03.051; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Hutzler JM, 2003, ARCH BIOCHEM BIOPHYS, V410, P16; ILAN Z, 1981, J BIOL CHEM, V256, P66; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; INGELMANSUNDBERG M, 1977, BIOCHIM BIOPHYS ACTA, V488, P225, DOI 10.1016/0005-2760(77)90180-1; Iwata H, 1998, BIOCHEM PHARMACOL, V55, P1315, DOI 10.1016/S0006-2952(97)00643-6; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; NADLER SG, 1991, ARCH BIOCHEM BIOPHYS, V290, P277, DOI 10.1016/0003-9861(91)90542-Q; ONO T, 1975, J BIOL CHEM, V250, P1571; Sjodin T, 2001, BIOCHEMISTRY-US, V40, P6852, DOI 10.1021/bi002510b; Sundermann A, 2013, PROTEIN SCI, V22, P1183, DOI 10.1002/pro.2307; Venkateswarlu K, 1998, J BIOL CHEM, V273, P4492, DOI 10.1074/jbc.273.8.4492; Wei L, 2007, MOL PHARMACOL, V72, P1280, DOI 10.1124/mol.107.036178; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; YAMANO S, 1989, MOL PHARMACOL, V36, P83; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	55	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	APR	2015	63	4					286	294				9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CE7VT	WOS:000352050700007		
J	Ozawa, H; Yashiro, K; Yabushita, S				Ozawa, Hitoshi; Yashiro, Kazunori; Yabushita, Satoshi			A two-step electron-driven proton transfer mechanism for the solution-phase nonradiative decay process of squaraine molecule	CHEMICAL PHYSICS LETTERS			English	Article							PICOSECOND LASER PHOTOLYSIS; POTENTIAL-ENERGY SURFACES; CONICAL INTERSECTIONS; FLUORESCENCE EMISSION; SYSTEMS; PHOTOCHEMISTRY; APPROXIMATION; TRANSITIONS; DERIVATIVES; FORMULATION	The strong solvent polarity dependence observed in the nonradiative decay rates of Bis[4-(dimethylamino)phenyl]squaraine (SQ-DMA) had previously been explained by the twisted intramolecular charge transfer mechanism. However, our recent theoretical study did not support this mechanism. We theoretically study the possibility of electron-driven proton transfer (EDPT) processes between an alcohol solvent molecule and the CO- groups of SQ-DMA using a complex model. The results actually support the EDPT mechanism that proceeds via two nonadiabatic transitions: the first from the locally excited (pi -> pi*) state of SQ-DMA to the charge transfer (CT) state, and the second from the CT to So states. (C) 2015 Elsevier B.V. All rights reserved.	[Ozawa, Hitoshi; Yashiro, Kazunori; Yabushita, Satoshi] Keio Univ, Fac Sci & Technol, Dept Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Yabushita, S (reprint author), Keio Univ, Fac Sci & Technol, Dept Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	yabusita@chem.keio.ac.jp			MEXT in Japan [JSPS24550032]	The authors acknowledge Prof. Koji Suzuki and Dr. Keitaro Umezawa of Keio University for their suggestion of a theoretical study on SQ-DMA. This work has been supported by Grants-in-Aid for Scientific Research funded by MEXT (grant no. JSPS24550032) in Japan. The computations were partly carried out using the computer facilities at the Research Center for Computational Science, Okazaki National Institutes.	CornelissenGude C, 1997, J PHYS CHEM A, V101, P9673, DOI 10.1021/jp971577e; Nakajima T, 1999, CHEM PHYS LETT, V300, P1, DOI 10.1016/S0009-2614(98)01363-3; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Borgis D, 1996, J PHYS CHEM-US, V100, P1118, DOI 10.1021/jp9522324; Hattig C, 2000, J CHEM PHYS, V113, P5154, DOI 10.1063/1.1290013; Morita M, 2014, PHYS CHEM CHEM PHYS, V16, P23143, DOI 10.1039/c4cp03623a; ENGLMAN R, 1970, MOL PHYS, V18, P145, DOI 10.1080/00268977000100171; Levine BG, 2008, J PHYS CHEM B, V112, P405, DOI 10.1021/jp0761618; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; MARCUS RA, 1956, J CHEM PHYS, V24, P979, DOI 10.1063/1.1742724; IKEDA N, 1983, J AM CHEM SOC, V105, P5206, DOI 10.1021/ja00354a004; GERMAN ED, 1980, J CHEM SOC FARAD T 2, V76, P1128, DOI 10.1039/f29807601128; Zhao Y, 2007, J PHYS CHEM A, V111, P2047, DOI 10.1021/jp066565k; BORGIS D, 1993, CHEM PHYS, V170, P315, DOI 10.1016/0301-0104(93)85117-Q; REHM D, 1970, ISRAEL J CHEM, V8, P259; Levine BG, 2006, MOL PHYS, V104, P1039, DOI 10.1080/00268970500417762; CHRISTIANSEN O, 1995, CHEM PHYS LETT, V243, P409, DOI 10.1016/0009-2614(95)00841-Q; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; FREED KF, 1970, J CHEM PHYS, V52, P6272, DOI 10.1063/1.1672938; Peng Q, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710274; Simkovitch R, 2015, J PHYS CHEM B, V119, P2253, DOI 10.1021/jp506011e; YABUSHITA S, 1990, CHEM PHYS LETT, V175, P518, DOI 10.1016/0009-2614(90)85574-V; ROOS BO, 1980, CHEM PHYS, V48, P157, DOI 10.1016/0301-0104(80)80045-0; Yarkony DR, 1996, REV MOD PHYS, V68, P985, DOI 10.1103/RevModPhys.68.985; LAW KY, 1994, J PHOTOCH PHOTOBIO A, V84, P123, DOI 10.1016/1010-6030(94)03849-X; ROBB MA, 1995, PURE APPL CHEM, V67, P783, DOI 10.1351/pac199567050783; Sobolewski AL, 2007, J PHYS CHEM A, V111, P11725, DOI 10.1021/jp075803o; Child M. S., 1974, MOL COLLISION THEORY; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GERMAN ED, 1981, J CHEM SOC FARAD T 1, V77, P397, DOI 10.1039/f19817700397; Hammes-Schiffer S, 2001, ACCOUNTS CHEM RES, V34, P273, DOI 10.1021/ar9901117; HERZBERG G, 1963, DISCUSS FARADAY SOC, P77; KAMAT PV, 1992, J PHYS CHEM-US, V96, P195, DOI 10.1021/j100180a038; Kiefer PM, 2010, J PHYS ORG CHEM, V23, P632, DOI 10.1002/poc.1710; LAW KY, 1987, J PHYS CHEM-US, V91, P5184, DOI 10.1021/j100304a012; Levine R. D., 1987, MOL REACTION DYNAMIC; Mataga N., 1970, MOL INTERACTION ELEC; MIYASAKA H, 1993, J PHYS CHEM-US, V97, P8222, DOI 10.1021/j100133a017; Peters KS, 2009, ACCOUNTS CHEM RES, V42, P89, DOI 10.1021/ar8001156; Pham HH, 2014, CHEM PHYS LETT, V610, P141, DOI 10.1016/j.cplett.2014.07.017; TANAKA H, 1984, J PHYS CHEM-US, V88, P1052, DOI 10.1021/j150650a002; WARSHEL A, 1982, J PHYS CHEM-US, V86, P2218, DOI 10.1021/j100209a016; Yesudas K, 2006, J PHYS CHEM A, V110, P11717, DOI 10.1021/jp064074u	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	APR 1	2015	625						78	83		10.1016/j.cplett.2015.02.025		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CE6IP	WOS:000351940400016		
J	Koyama, K; Kudoh, S; Miyajima, K; Mafune, F				Koyama, Kohei; Kudoh, Satoshi; Miyajima, Ken; Mafune, Fumitaka			Dissociation energy for O-2 release from gas-phase iron oxide clusters measured by temperature-programmed desorption experiments	CHEMICAL PHYSICS LETTERS			English	Article							DENSITY-FUNCTIONAL CALCULATIONS; ELECTRONIC-STRUCTURE; INFRARED-SPECTRA; OXYGEN MOLECULES; CO; OXIDATION; ATOMS; IONIZATION; GEOMETRY; MONOXIDE	Thermal dissociation of gas phase iron oxide cluster ions, FenOm' (n = 2-6), was observed by mass spectrometry. The dissociation processes were investigated by temperature-programmed desorption (TPD) measurements for different sized clusters. Oxygen molecules were found to be released from the cluster ions. The threshold energy required for dissociation, determined by analyzing TPD, was compared with the energies obtained by experiments of collision-induced dissociation and by calculations of density functional theory. The agreement of the energies indicates that the oxygen atoms bonded to the terminal site of clusters are more readily released into the gas phase than those in the bridge site. (C) 2015 Elsevier B.V. All rights reserved.	[Koyama, Kohei; Kudoh, Satoshi; Miyajima, Ken; Mafune, Fumitaka] Univ Tokyo, Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Mafune, F (reprint author), Univ Tokyo, Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan.	mafune@cluster.c.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25248004, 24550010]; Genesis Research Institute, Inc.	This work is supported by a Grant-in-Aid for Scientific Research (A) (No. 25248004) and a Grant-in-Aid for Scientific Research (C) (No. 24550010) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and by the Genesis Research Institute, Inc., for the cluster research. The computations were partially performed using Research Center for Computational Science, Okazaki, Japan.	Royer S, 2011, CHEMCATCHEM, V3, P24, DOI 10.1002/cctc.201000378; Chertihin GV, 1996, J PHYS CHEM-US, V100, P5261, DOI 10.1021/jp953198w; Sun Q, 2000, PHYS REV B, V61, P5781, DOI 10.1103/PhysRevB.61.5781; Wang LS, 1996, PHYS REV LETT, V76, P4853, DOI 10.1103/PhysRevLett.76.4853; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Li M, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3246840; CORNEILLE JS, 1995, SURF SCI, V338, P211, DOI 10.1016/0039-6028(95)00567-6; Wang Q, 1999, PHYS REV B, V59, P12672, DOI 10.1103/PhysRevB.59.12672; Andrews L, 1996, J AM CHEM SOC, V118, P467, DOI 10.1021/ja953338f; Sun Q, 2000, PHYS REV B, V62, P8500, DOI 10.1103/PhysRevB.62.8500; Reddy BV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068301; Sakuma K, 2013, J PHYS CHEM A, V117, P3260, DOI 10.1021/jp400850u; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; HAY PJ, 1977, J CHEM PHYS, V66, P4377, DOI 10.1063/1.433731; Morita K, 2013, J PHYS CHEM A, V117, P10145, DOI 10.1021/jp402059y; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Frisch M.J., 2013, GAUSSIAN 09 REVISION; Garcia-Sosa AT, 2000, INT J QUANTUM CHEM, V80, P307, DOI 10.1002/1097-461X(2000)80:3<307::AID-QUA4>3.0.CO;2-8; Glendening E. D., NBO VERSION 3 1; Gutsev GL, 2003, J CHEM PHYS, V119, P11135, DOI 10.1063/1.1621856; Gutsev GL, 1999, J PHYS CHEM A, V103, P5812, DOI 10.1021/jp9909006; Jennings J.R., 1991, CATALYTIC AMMONIA SY; Jones N.O., 2005, PHYS REV B, V72, P2449; McLean D., 1980, J CHEM PHYS, V72, P5639; Reddy BV, 2004, CHEM PHYS LETT, V384, P242, DOI 10.1016/j.cplett.2003.12.023; Reilly NM, 2007, J PHYS CHEM C, V111, P19086, DOI 10.1021/jp0736239; RILEY SJ, 1984, J CHEM PHYS, V80, P1360, DOI 10.1063/1.446817; Schroder D, 2000, EUR J INORG CHEM, P1171; Shin DN, 2004, J CHEM PHYS, V120, P4157, DOI 10.1063/1.1643733; Sun Q, 2000, PHYS REV B, V62, P16176, DOI 10.1103/PhysRevB.62.16176; Wu HB, 1996, J AM CHEM SOC, V118, P5296, DOI 10.1021/ja954153b; Xue W, 2009, J PHYS CHEM A, V113, P5302, DOI 10.1021/jp810426s	32	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	APR 1	2015	625						104	109		10.1016/j.cplett.2015.02.038		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CE6IP	WOS:000351940400020		
J	Honda, T; Minoshima, Y; Yokoi, Y; Takayanagi, T; Shiga, M				Honda, Tomohiro; Minoshima, Yusuke; Yokoi, Yuki; Takayanagi, Toshiyuki; Shiga, Motoyuki			Semiclassical dynamics of electron attachment to guanine-cytosine base pair	CHEMICAL PHYSICS LETTERS			English	Article							POLYMER MOLECULAR-DYNAMICS; DENSITY-FUNCTIONAL THEORY; CHEMICAL-REACTION RATES; PROTON-TRANSFER; ANIONS; BIOMOLECULES; RADICALS; HYDROGEN; SPECTRA; SYSTEMS	Electron attachment dynamics to the guanine-cytosine (G-C) base pair in the gas phase is studied using DFT and molecular dynamics. The potential energy surface of the G-C anion is constructed with the empirical-valence-bond method using force-field information obtained from long-range corrected DFT calculations. Ring-polymer molecular dynamics simulations predict that the initial dipole-bound anion readily converts into the valence-bound anion within 0.1 ps and proton-transfer occurs subsequently within 10 ps. The same process was found in classical simulations, but on a much slower time scale. This result suggests that nuclear quantum effects are important in understanding DNA damage by low-energy electrons. (C) 2015 Elsevier B.V. All rights reserved.	[Honda, Tomohiro; Minoshima, Yusuke; Yokoi, Yuki; Takayanagi, Toshiyuki] Saitama Univ, Dept Chem, Sakura Ku, Saitama 3388570, Japan; [Shiga, Motoyuki] Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Kashiwa, Chiba 2770871, Japan	Takayanagi, T (reprint author), Saitama Univ, Dept Chem, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	tako@mail.saitama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21550005]	This work was supported by the Grant-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant No. 21550005). We thank Dr. Alex Malins in JAEA for proofreading the text.	Alizadeh E, 2012, CHEM REV, V112, P5578, DOI 10.1021/cr300063r; Craig IR, 2004, J CHEM PHYS, V121, P3368, DOI 10.1063/1.1777575; Baccarelli I, 2011, PHYS REP, V508, P1, DOI 10.1016/j.physrep.2011.06.004; Allen JW, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4811329; Habershon S, 2013, ANNU REV PHYS CHEM, V64, P387, DOI 10.1146/annurev-physchem-040412-110122; Sommerfeld T, 2004, J PHYS CHEM A, V108, P9150, DOI 10.1021/jp049082u; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Chen HY, 2009, J AM CHEM SOC, V131, P15930, DOI 10.1021/ja906899p; Witt A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3125009; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Baccarelli I, 2010, EUR PHYS J D, V60, P1, DOI 10.1140/epjd/e2010-00216-3; WARSHEL A, 1980, J AM CHEM SOC, V102, P6218, DOI 10.1021/ja00540a008; Espinosa-Garcia J, 2014, J PHYS CHEM A, V118, P554, DOI 10.1021/jp4118453; CHANG YT, 1990, J PHYS CHEM-US, V94, P5884, DOI 10.1021/j100378a052; Li XF, 2001, J PHYS CHEM B, V105, P10115, DOI 10.1021/jp012364z; Suleimanov YV, 2013, PHYS CHEM CHEM PHYS, V15, P3655, DOI 10.1039/c2cp44364c; Simons J, 2008, J PHYS CHEM A, V112, P6401, DOI 10.1021/jp711490b; Habershon S, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968555; Gu JD, 2012, CHEM REV, V112, P5603, DOI 10.1021/cr3000219; Suleimanov YV, 2012, J PHYS CHEM C, V116, P11141, DOI 10.1021/jp302453z; Smyth M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238108; Chen HY, 2011, PHYS CHEM CHEM PHYS, V13, P2674, DOI 10.1039/c0cp01419b; Craig IR, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1954769; Craig IR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1850093; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gupta A, 2012, J PHYS CHEM B, V116, P5579, DOI 10.1021/jp211608b; Kaczmarek A, 2009, J PHYS CHEM A, V113, P1985, DOI 10.1021/jp8081936; Kumar A, 2008, J PHYS CHEM B, V112, P5189, DOI 10.1021/jp710957p; Li X., 2002, J PHYS CHEM A, V106, P934; Li XF, 2007, ADV QUANTUM CHEM, V52, P59, DOI 10.1016/S0065-3276(06)52004-0; Radisic D, 2005, J AM CHEM SOC, V127, P6443, DOI 10.1021/ja050724g; Shiga M, 2008, CHEM PHYS LETT, V451, P175, DOI 10.1016/j.cplett.2007.11.091; Smets J, 2001, CHEM PHYS LETT, V342, P342, DOI 10.1016/S0009-2614(01)00588-7; Sugioka Y, 2013, J PHYS CHEM A, V117, P11403, DOI 10.1021/jp4067058; Suleimanov YV, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3533275; Szyperska A, 2010, CHEMPHYSCHEM, V11, P880, DOI 10.1002/cphc.200900810; Tian SX, 2005, J PHYS CHEM A, V109, P5153, DOI 10.1021/jp040137h; Yokoi Y, 2014, COMPUT THEOR CHEM, V1046, P99, DOI 10.1016/j.comptc.2014.08.006	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	APR 1	2015	625						174	178		10.1016/j.cplett.2015.03.006		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CE6IP	WOS:000351940400033		
J	Isobe, M; Nishida, A; Choo, YM; Abd Rahman, N; Ploypradith, P; Ruchirawat, S; Lin, GQ; Li, A; Yao, ZJ; Uang, BJ; Liao, CC; Chiu, P; Kim, BM; Loh, TP				Isobe, Minoru; Nishida, Atsushi; Choo, Yeun-Mun; Abd Rahman, Noorsaadah; Ploypradith, Poonsakdi; Ruchirawat, Somsak; Lin, Guo-Qiang; Li, Ang; Yao, Zhu-Jun; Uang, Biing-Jiun; Liao, Chun-Chen; Chiu, Pauline; Kim, Byeong Moon; Loh, Teck Peng			The Last and Next Decades of the Asian Core Program on Cutting-Edge Organic Chemistry in Asia	CHEMISTRY-AN ASIAN JOURNAL			English	Article									[Isobe, Minoru] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Nishida, Atsushi] Chiba Univ, Sch Pharm, Chuo Ku, Chiba 2608675, Japan; [Choo, Yeun-Mun; Abd Rahman, Noorsaadah] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia; [Ploypradith, Poonsakdi; Ruchirawat, Somsak] Chulabhorn Res Inst, Bangkok 10210, Thailand; [Ploypradith, Poonsakdi; Ruchirawat, Somsak] Chulabhorn Grad Inst Laksi, Bangkok 10210, Thailand; [Lin, Guo-Qiang; Li, Ang] Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China; [Yao, Zhu-Jun] Nanjin Univ, Dept Chem, Nanjing 210093, Jiangsu, Peoples R China; [Uang, Biing-Jiun; Liao, Chun-Chen] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan; [Chiu, Pauline] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Kim, Byeong Moon] Seoul Natl Univ, Seoul 151747, South Korea; [Loh, Teck Peng] Nanyang Technol Univ, Singapore 639798, Singapore	Isobe, M (reprint author), Natl Sun Yat Sen Univ, Dept Chem, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan.	minoru@mail.nsysu.edu.tw; anishida@faculty.chiba-u.jp; ymchoo@um.edu.my; noorsaadah@um.edu.my; poonsakdi@cri.or.th; somsak@cri.or.th; lingq@sioc.ac.cn; ali@sioc.ac.cn; yaoz@nju.edu.cn; bjuang@mx.nthu.edu.tw; ccliao@mx.nthu.edu.tw; pchiu@hku.hk; kimbm@snu.ac.kr; teckpeng@ntu.edu.sg	Yao, Zhu-Jun/E-7635-2015; Abd-Rahman, Noorsaadah/B-9291-2010; Loh, Teck Peng/B-7003-2011	Abd-Rahman, Noorsaadah/0000-0001-5847-8961; Loh, Teck Peng/0000-0002-2936-337X			Isobe M., 2006, CHEM-ASIAN J, V1, P18, DOI 10.1002/asia.200600176; Isobe M, 2014, CHEM-ASIAN J, V9, P1689, DOI 10.1002/asia.201402189; Isobe M., 2007, CHEM-ASIAN J, V2, P452, DOI 10.1002/asia.200600423; Isobe Minoru, 2010, Chem Asian J, V5, P660, DOI 10.1002/asia.201000137; Nishida A., 2011, CHEM-ASIAN J, V6, P1300	5	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		790	804		10.1002/asia.201500084		15	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600001		
J	Ma, DH; Kim, D; Akisawa, T; Lee, KH; Kim, KT; Ahn, KH				Ma, Dong Hee; Kim, Dokyoung; Akisawa, Takuya; Lee, Kyung-Ha; Kim, Kyong-Tai; Ahn, Kyo Han			An FITC-BODIPY FRET Couple: Application to Selective, Ratiometric Detection and Bioimaging of Cysteine	CHEMISTRY-AN ASIAN JOURNAL			English	Article						amino-bodipy; bioimaging; cysteine; fluorescence; FRET	RESONANCE ENERGY-TRANSFER; LARGE EMISSION SHIFT; FLUORESCENT-PROBE; LIVING CELLS; HOMOCYSTEINE; GLUTATHIONE; DESIGN; THIOLS; DYES; CHEMODOSIMETER	A novel FRET couple of fluorescein is disclosed, and it was readily constructed by conjugating an amino-BODIPY dye, a new FRET donor, with fluorescein isocyanate. Its potential was demonstrated by a fluorescence sensing system for cysteine, which was prepared by introducing acryloyl groups to the fluorescein moiety. The FRET probe exhibited promising ratiometric response to cysteine with high selectivity and sensitivity in a buffer solution containing acetonitrile at a physiological pH of 7.4, but showed slow reactivity. This slow response was solved by addition of a surfactant, thus allowing ratiometric imaging and determination of the endogenous level of cysteine in cells in HEPES buffer, by confocal fluorescence microscopy. Imaging experiments toward various cells suggested that such aryl acrylate type probes are vulnerable to the ubiquitous esterase activity. For the selected C6 cell line, in which the esterase activity was minimal, the ratiometric quantification of cysteine level was demonstrated. The FRET probe was also applied to determine the level of cysteine in human blood plasma.	[Ma, Dong Hee; Kim, Dokyoung; Ahn, Kyo Han] Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang 790784, South Korea; [Ma, Dong Hee; Kim, Dokyoung; Ahn, Kyo Han] Pohang Univ Sci & Technol POSTECH, Ctr Electrophoto Behav Adv Mol Syst, Pohang 790784, South Korea; [Akisawa, Takuya] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Lee, Kyung-Ha; Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 790784, South Korea	Ahn, KH (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Chem, 77 Cheongam Ro, Pohang 790784, South Korea.	ahn@postech.ac.kr			EPB Center through the National Research Foundation [R11-2008-052-01001]; Ministry of Health Welfare, Korea [HI13C1378]	This work was supported by grants from the EPB Center (R11-2008-052-01001) through the National Research Foundation, and Ministry of Health & Welfare, Korea (HI13C1378).	Albers AE, 2006, J AM CHEM SOC, V128, P9640, DOI 10.1021/ja063308k; Su DD, 2014, BIOMATERIALS, V35, P6078, DOI 10.1016/j.biomaterials.2014.04.035; Shahrokhian S, 2001, ANAL CHEM, V73, P5972, DOI 10.1021/ac010541m; Takakusa H, 2002, J AM CHEM SOC, V124, P1653, DOI 10.1021/ja011251q; Yang XF, 2011, ANGEW CHEM INT EDIT, V50, P10690, DOI 10.1002/anie.201103759; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; Wang XF, 2001, J NEUROSCI, V21, P3322; Lv X, 2011, ORG BIOMOL CHEM, V9, P4954, DOI 10.1039/c1ob05387f; Xuan WM, 2013, CHEM COMMUN, V49, P10474, DOI 10.1039/c3cc46095a; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Guo ZQ, 2012, CHEM SCI, V3, P2760, DOI 10.1039/c2sc20540h; Gomez-Duran CFA, 2010, CHEM COMMUN, V46, P5103, DOI 10.1039/c0cc00397b; Ros-Lis JV, 2004, J AM CHEM SOC, V126, P4064, DOI 10.1021/ja031987i; Long LL, 2011, CHEM COMMUN, V47, P893, DOI 10.1039/c0cc03806g; Lin WY, 2008, ORG LETT, V10, P5577, DOI 10.1021/ol802436j; Dai X, 2014, BIOSENS BIOELECTRON, V59, P35, DOI 10.1016/j.bios.2014.03.018; JACOBSEN DW, 1994, CLIN CHEM, V40, P873; Wang HL, 2012, CHEM COMMUN, V48, P8341, DOI 10.1039/c2cc33932c; Wang L, 2014, SENSOR ACTUAT B-CHEM, V192, P708, DOI 10.1016/j.snb.2013.11.039; Preus S, 2012, CHEMBIOCHEM, V13, P1990, DOI 10.1002/cbic.201200400; Kand D, 2012, CHEM COMMUN, V48, P2722, DOI 10.1039/c2cc16593g; Shiu HY, 2011, CHEM COMMUN, V47, P4367, DOI 10.1039/c0cc04288a; Umezawa K, 2009, CHEM-EUR J, V15, P1096, DOI 10.1002/chem.200801906; Kurishita Y, 2010, J AM CHEM SOC, V132, P13290, DOI 10.1021/ja103615z; Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n; Wang LG, 2012, DYES PIGMENTS, V95, P275, DOI 10.1016/j.dyepig.2012.05.006; Zhao CC, 2014, CHEM-ASIAN J, V9, P1777, DOI 10.1002/asia.201402043; Pires MM, 2008, ORG LETT, V10, P837, DOI 10.1021/ol702769n; Daykin CA, 2002, ANAL BIOCHEM, V304, P220, DOI 10.1006/abio.2002.5637; Tian L, 2012, P NATL ACAD SCI USA, V109, P4756, DOI 10.1073/pnas.1111943109; Yang XF, 2012, ORG BIOMOL CHEM, V10, P2739, DOI 10.1039/c2ob25178g; Shi JM, 2014, DYES PIGMENTS, V100, P255, DOI 10.1016/j.dyepig.2013.09.021; Zhu BC, 2014, BIOSENS BIOELECTRON, V55, P72, DOI 10.1016/j.bios.2013.11.068; Shiu HY, 2010, CHEM-EUR J, V16, P3308, DOI 10.1002/chem.200903121; Goud TV, 2006, TETRAHEDRON, V62, P5084, DOI 10.1016/j.tet.2006.03.036; Shao JY, 2012, CHEM SCI, V3, P1049, DOI 10.1039/c2sc00762b; Yuan L, 2012, CHEM-EUR J, V18, P14520, DOI 10.1002/chem.201201606; Aoyama K, 2008, EUR J NEUROSCI, V27, P20, DOI 10.1111/j.1460-9568.2007.05979.x; Gao F, 2011, ANAL METHODS-UK, V3, P1180, DOI 10.1039/c1ay05073g; Sharma G, 2008, TETRAHEDRON LETT, V49, P4269, DOI 10.1016/j.tetlet.2008.04.146; Sreejith S., 2008, ANGEW CHEM, V120, P8001, DOI 10.1002/ange.200803194; Takakusa H, 2003, CHEM-EUR J, V9, P1479, DOI 10.1002/chem.200390167; WEI L, 1991, LANGMUIR, V7, P1336, DOI 10.1021/la00055a008; Yang X., 2011, ANGEW CHEM, V123, P10878	44	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		894	902		10.1002/asia.201403073		9	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600015		
J	Shibata, H; Tsuchikawa, H; Hayashi, T; Matsumori, N; Murata, M; Usui, T				Shibata, Hajime; Tsuchikawa, Hiroshi; Hayashi, Tatsuru; Matsumori, Nobuaki; Murata, Michio; Usui, Takeo			Modification of Bafilomycin Structure to Efficiently Synthesize Solid-State NMR Probes that Selectively Bind to Vacuolar-Type ATPase	CHEMISTRY-AN ASIAN JOURNAL			English	Article						bafilomycin; chemical synthesis; fluorine label; solid-state NMR; V-ATPase	ECHO DOUBLE-RESONANCE; BETA-HYDROXY KETONES; SACCHAROMYCES-CEREVISIAE; H+-ATPASE; SUBUNIT-C; V-ATPASE; CRYSTAL-STRUCTURE; AMPHOTERICIN-B; STAPHYLOCOCCUS-AUREUS; MACROLIDE ANTIBIOTICS	Bafilomycin (Baf) is one of the most potent inhibitors of vacuolar-type ATPase, which is strongly implicated in age-related diseases. However, the binding site of the antibiotic on the protein remains unclear because of the complexity of the structure of Baf bound to the target subunit in the transmembrane region. For conducting structural studies by applying solid-state NMR, which is one of the most promising methodologies available for structural analysis in membrane system, preparing bioactive fluorinated Baf analogues is essential. In this study two Baf analogues were carefully designed and efficiently synthesized through the convergent coupling of three segments. Biological evaluation revealed that the activity of 24-F-Baf was comparable to that of Baf, indicating its utility as a potential probe for solid-state NMR analysis. By contrast, desmethylated 24-F-Baf exhibited markedly diminished activity. The absence of two methyl groups caused a critical conformational change in the macrocyclic core structure necessary for binding to the target protein.	[Shibata, Hajime; Tsuchikawa, Hiroshi; Hayashi, Tatsuru; Matsumori, Nobuaki; Murata, Michio] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Shibata, Hajime; Murata, Michio] Japan Sci & Technol Agcy, Lipid Act Struct Project, ERATO, Toyonaka, Osaka 5600043, Japan; [Usui, Takeo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Murata, M (reprint author), Osaka Univ, Grad Sch Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	murata@chem.sci.osaka-u.ac.jp			JSPS KA-KENHI [25242073]; Grants for Excellent Graduate Schools, MEXT, Japan; Global COE Programs of Osaka University	We thank Dr. N. Inazumi (Osaka University) for his help in NMR measurements. This work was supported in part by JSPS KA-KENHI 25242073, and Grants for Excellent Graduate Schools, MEXT, Japan. H.S. expresses his special thanks for the supports from Global COE Programs of Osaka University.	Izumi H, 2003, CANCER TREAT REV, V29, P541, DOI 10.1016/S0305-7372(03)00106-3; HANADA H, 1990, BIOCHEM BIOPH RES CO, V170, P873, DOI 10.1016/0006-291X(90)92172-V; Smart BE, 2001, J FLUORINE CHEM, V109, P3, DOI 10.1016/S0022-1139(01)00375-X; Qin A, 2012, INT J BIOCHEM CELL B, V44, P1422, DOI 10.1016/j.biocel.2012.05.014; Yu JX, 2005, CURR MED CHEM, V12, P819, DOI 10.2174/0929867053507342; EVANS DA, 1988, J AM CHEM SOC, V110, P3560, DOI 10.1021/ja00219a035; Farina C, 1999, DRUG DISCOV TODAY, V4, P163, DOI 10.1016/S1359-6446(99)01321-5; PRAKASH GKS, 1989, J AM CHEM SOC, V111, P393, DOI 10.1021/ja00183a073; Yadav JS, 2008, TETRAHEDRON, V64, P1971, DOI 10.1016/j.tet.2007.11.091; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902; Ulrich AS, 2005, PROG NUCL MAG RES SP, V46, P1, DOI 10.1016/j.pnmrs.2004.11.001; Kasai Y, 2008, CHEM-EUR J, V14, P1178, DOI 10.1002/chem.200701256; Scheidt KA, 2002, J AM CHEM SOC, V124, P6981, DOI 10.1021/ja017885e; EVANS DA, 1990, J AM CHEM SOC, V112, P6447, DOI 10.1021/ja00173a071; INANAGA J, 1979, B CHEM SOC JPN, V52, P1989, DOI 10.1246/bcsj.52.1989; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; TAKAI K, 1988, TETRAHEDRON LETT, V29, P5263, DOI 10.1016/S0040-4039(00)80732-7; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; EVANS DA, 1993, TETRAHEDRON LETT, V34, P6871, DOI 10.1016/S0040-4039(00)91817-3; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Nakagawa Y, 2009, J AM CHEM SOC, V131, P7573, DOI 10.1021/ja808447r; Shibata H, 2014, CHEM LETT, V43, P474, DOI 10.1246/cl.131099; WERNER G, 1984, J ANTIBIOT, V37, P110; NEGISHI E, 1985, J AM CHEM SOC, V107, P6639, DOI 10.1021/ja00309a036; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Farina C, 2002, CURR PHARM DESIGN, V8, P2033, DOI 10.2174/1381612023393369; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Kleinbeck F, 2012, CHEM-EUR J, V18, P3598, DOI 10.1002/chem.201102797; SMITH AB, 1995, J AM CHEM SOC, V117, P12011, DOI 10.1021/ja00153a030; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Basak S, 2013, J BIOL CHEM, V288, P11930, DOI 10.1074/jbc.M113.461533; Kim SJ, 2002, BIOCHEMISTRY-US, V41, P6967, DOI 10.1021/bi0121407; KECK GE, 1993, J AM CHEM SOC, V115, P8467, DOI 10.1021/ja00071a074; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Cegelski L, 2006, J MOL BIOL, V357, P1253, DOI 10.1016/j.jmb.2006.01.040; Osteresch C, 2012, J BIOL CHEM, V287, P31866, DOI 10.1074/jbc.M112.372169; BAKER GH, 1987, TETRAHEDRON LETT, V28, P5565, DOI 10.1016/S0040-4039(00)96783-2; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Duer M. J., 2004, INTRO SOLID STATE NM, P349; Gagliardi S, 1998, J MED CHEM, V41, P1883, DOI 10.1021/jm9707838; GEISOW MJ, 1980, EXP CELL RES, V126, P159, DOI 10.1016/0014-4827(80)90481-4; Hanessian S, 2001, J AM CHEM SOC, V123, P10200, DOI 10.1021/ja011452u; Kazami S, 2006, BIOSCI BIOTECH BIOCH, V70, P1364, DOI 10.1271/bbb.50644; Leroux F, 2004, CHEMBIOCHEM, V5, P644, DOI 10.1002/cbic.200300906; Lu CH, 2003, J ANTIBIOT, V56, P415; Ma BY, 2011, CELL SIGNAL, V23, P1244, DOI 10.1016/j.cellsig.2011.03.003; Marshall JA, 2002, J ORG CHEM, V67, P733, DOI 10.1021/jo015864x; Matsuoka S, 2005, BIOCHEMISTRY-US, V44, P704, DOI 10.1021/bi049001k; Mattsson JP, 1996, BBA-BIOMEMBRANES, V1280, P98, DOI 10.1016/0005-2736(95)00285-5; Mehta AK, 2003, J MAGN RESON, V163, P182, DOI 10.1016/S1090-7807(03)00078-8; Ohta E, 2001, TETRAHEDRON, V57, P8463, DOI 10.1016/S0040-4020(01)00843-2; Paterson I, 2002, TETRAHEDRON LETT, V43, P6005, DOI 10.1016/S0040-4039(02)01217-0; Queron E, 2004, TETRAHEDRON LETT, V45, P4539, DOI 10.1016/j.tetlet.2004.04.035; Rauhala V, 2004, TETRAHEDRON, V60, P9199, DOI 10.1016/j.tet.2004.07.059; Toshima K, 1997, J ORG CHEM, V62, P3271, DOI 10.1021/jo970314d; Toshima K, 2001, J ORG CHEM, V66, P1708, DOI 10.1021/jo001377q; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Umegawa Y, 2008, BIOCHEMISTRY-US, V47, P13463, DOI 10.1021/bi801875y; WERNER G, 1983, TETRAHEDRON LETT, V24, P5193, DOI 10.1016/S0040-4039(00)88394-X; WOLF C, 1995, LIEBIGS ANN, P781; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	68	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		915	924		10.1002/asia.201403299		10	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600018		
J	Sasano, Y; Kogure, N; Nishiyama, T; Nagasawa, S; Iwabuchi, Y				Sasano, Yusuke; Kogure, Naoki; Nishiyama, Tomohiro; Nagasawa, Shota; Iwabuchi, Yoshiharu			Highly Efficient Aerobic Oxidation of Alcohols by Using Less-Hindered Nitroxyl-Radical/Copper Catalysis: Optimum Catalyst Combinations and Their Substrate Scope	CHEMISTRY-AN ASIAN JOURNAL			English	Article						alcohols; copper; homogeneous catalysis; oxidation; radicals	ACTIVE ORGANOCATALYST; CARBONYL-COMPOUNDS; CARBOXYLIC-ACIDS; RADICALS; ALDEHYDES; AZADO; MECHANISM; CLEAVAGE; SYSTEMS; AMINES	The oxidation of alcohols into their corresponding carbonyl compounds is one of the most fundamental transformations in organic chemistry. In our recent report, 2-azaadamantane N-oxyl (AZADO)/copper catalysis promoted the highly chemoselective aerobic oxidation of unprotected amino alcohols into amino carbonyl compounds. Herein, we investigated the extension of the promising AZADO/copper-catalyzed aerobic oxidation of alcohols to other types of alcohol. During close optimization of the reaction conditions by using various alcohols, we found that the optimum combination of nitroxyl radical, copper salt, and solution concentration was dependent on the type of substrate. Various alcohols, including highly hindered and heteroatom-rich ones, were efficiently oxidized into their corresponding carbonyl compounds under mild conditions with lower amounts of the catalysts.	[Sasano, Yusuke; Kogure, Naoki; Nishiyama, Tomohiro; Nagasawa, Shota; Iwabuchi, Yoshiharu] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Organ Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Iwabuchi, Y (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Organ Chem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	y-iwabuchi@m.tohoku.ac.jp			MEXT, Japan; JSPS Asian Core Program on Cutting-Edge Organic Chemistry in Asia;  [24390001];  [25860001]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" from MEXT, Japan, by the JSPS Asian Core Program on Cutting-Edge Organic Chemistry in Asia, by a Grant-in-Aid for Scientific Research (B) (24390001), and by a Grant-in-Aid for Young Scientists (B) (25860001).	Geoghegan K, 2013, J ORG CHEM, V78, P3410, DOI 10.1021/jo4000306; Ryland BL, 2014, J AM CHEM SOC, V136, P12166, DOI 10.1021/ja5070137; Hoover JM, 2013, J AM CHEM SOC, V135, P2357, DOI 10.1021/ja3117203; Steves JE, 2013, J AM CHEM SOC, V135, P15742, DOI 10.1021/ja409241h; Hayashi M, 2011, CHEM PHARM BULL, V59, P1570; Hayashi M, 2012, J ORG CHEM, V77, P3005, DOI 10.1021/jo300088b; Cao Q, 2014, CHEM COMMUN, V50, P4524, DOI 10.1039/c3cc47081d; Shibuya M, 2009, J ORG CHEM, V74, P4619, DOI 10.1021/jo900486w; Shibuya M, 2012, TETRAHEDRON LETT, V53, P2070, DOI 10.1016/j.tetlet.2012.02.033; Sasano Y, 2014, ANGEW CHEM INT EDIT, V53, P3236, DOI 10.1002/anie.201309634; Hoover JM, 2011, J AM CHEM SOC, V133, P16901, DOI 10.1021/ja206230h; Ryland BL, 2014, ANGEW CHEM INT EDIT, V53, P8824, DOI 10.1002/anie.201403110; Carey JS, 2006, ORG BIOMOL CHEM, V4, P2337, DOI 10.1039/b602413k; Hoover JM, 2013, ACS CATAL, V3, P2599, DOI 10.1021/cs400689a; Seki Y, 2014, TETRAHEDRON LETT, V55, P3738, DOI 10.1016/j.tetlet.2014.05.085; Caron S, 2006, CHEM REV, V106, P2943, DOI 10.1021/cr040679f; Gamez P, 2004, ADV SYNTH CATAL, V346, P805, DOI 10.1002/adsc.200404063; Sonobe T, 2012, CHEM SCI, V3, P3249, DOI 10.1039/c2sc20699d; Shibuya M, 2014, J ORG CHEM, V79, P10256, DOI 10.1021/jo501862k; Konning D, 2014, CHEM COMMUN, V50, P5014, DOI 10.1039/c4cc01305k; Rogan L, 2014, CATAL SCI TECHNOL, V4, P1720, DOI 10.1039/c4cy00219a; Shibuya M, 2012, ORG LETT, V14, P5006, DOI 10.1021/ol3021429; Shibuya M, 2006, J AM CHEM SOC, V128, P8412, DOI 10.1021/ja0620336; Konning D, 2012, ORG LETT, V14, P5258, DOI 10.1021/ol302420k; SEMMELHACK MF, 1984, J AM CHEM SOC, V106, P3374, DOI 10.1021/ja00323a064; Dugger RW, 2005, ORG PROCESS RES DEV, V9, P253, DOI 10.1021/op050021j; Shibuya M, 2011, J AM CHEM SOC, V133, P6497, DOI 10.1021/ja110940c; Iwabuchi Y, 2013, CHEM PHARM BULL, V61, P1197; Arends I. W. C. E., 2010, MODERN OXIDATION MET, P147; Becker MH, 2007, J AM CHEM SOC, V129, P11987, DOI 10.1021/ja074300t; Tojo G, 2006, BASIC REACT ORG SYNT, P1; Hayashi M, 2012, SYNLETT, P1025, DOI 10.1055/s-0031-1290528; Lin HY, 2012, J ORG CHEM, V77, P7143, DOI 10.1021/jo300353t; Ryland B. L., 2014, ANGEW CHEM, V126, P8968; Sasano Y., 2014, ANGEW CHEM, V126, P3300; Shibuya M, 2011, SYNTHESIS-STUTTGART, P3418, DOI 10.1055/s-0030-1260257; Shibuya M, 2012, ORG LETT, V14, P5010, DOI 10.1021/ol3021435; Shibuya M, 2009, CHEM COMMUN, P1739, DOI 10.1039/b822944a	38	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		1004	1009		10.1002/asia.201403245		6	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600027		
J	Ueno, A; Takimoto, M; Wylie, WNO; Nishiura, M; Ikariya, T; Hou, ZM				Ueno, Atsushi; Takimoto, Masanori; Wylie, W. N. O.; Nishiura, Masayoshi; Ikariya, Takao; Hou, Zhaomin			Copper-Catalyzed Formal C-H Carboxylation of Aromatic Compounds with Carbon Dioxide through Arylaluminum Intermediates	CHEMISTRY-AN ASIAN JOURNAL			English	Article						aromatic compounds; carbon dioxide; carbene ligands; carboxylation; copper	MAGNESIUM 2-ETHOXYETHOXIDE; ORGANOMETALLIC REAGENTS; CRYSTAL-STRUCTURES; CO2; ALKYNES; BONDS; COMPLEXES; BASE; HYDROCARBOXYLATION; TRANSFORMATION	The CH bond carboxylation of various aromatic compounds with CO2 was achieved by the deprotonative alumination with a mixed alkyl amido lithium aluminate compound iBu(3)Al(TMP)Li followed by the NHC-copper-catalyzed carboxylation of the resulting arylaluminum species, which afforded the corresponding carboxylation products in high yield and high selectivity. In addition to benzene derivatives, heteroarenes such as benzofuran, benzothiophene, and indole derivatives are also suitable substrates. Functional groups such as Cl, Br, I, vinyl, amide, and CN could survive the reaction conditions. Some key reaction intermediates such as the copper aryl and isobutyl complexes and their carboxylation products were isolated and structurally characterized by X-ray crystallographic analyses, thus offering important information on the reaction mechanism.	[Ueno, Atsushi; Takimoto, Masanori; Wylie, W. N. O.; Nishiura, Masayoshi; Hou, Zhaomin] RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, Wako, Saitama 3510198, Japan; [Takimoto, Masanori; Nishiura, Masayoshi; Hou, Zhaomin] RIKEN, Organometall Chem Lab, Wako, Saitama 3510198, Japan; [Ikariya, Takao] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Meguro Ku, Tokyo 1528552, Japan	Hou, ZM (reprint author), RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	houz@riken.jp	Hou, Zhaomin/I-5981-2014	Hou, Zhaomin/0000-0003-2841-5120	JSPS [26220802, 26460029]	This work was supported by Grant-in-Aid for Scientific Research (S) (No. 26220802) (to Z.H) and (C) (No. 26460029) (to M.T.) from the JSPS.	Li SH, 2011, ORG LETT, V13, P6046, DOI 10.1021/ol202520x; Leon T, 2013, J AM CHEM SOC, V135, P1221, DOI 10.1021/ja311045f; Naka H, 2008, J AM CHEM SOC, V130, P16193, DOI 10.1021/ja804749y; Cokoja M, 2011, ANGEW CHEM INT EDIT, V50, P8510, DOI 10.1002/anie.201102010; Inomata H, 2012, ORG LETT, V14, P3986, DOI 10.1021/ol301760n; Huang K, 2011, CHEM SOC REV, V40, P2435, DOI 10.1039/c0cs00129e; Ochiai H, 2008, ORG LETT, V10, P2681, DOI 10.1021/ol800764u; Boogaerts IIF, 2010, J AM CHEM SOC, V132, P8858, DOI 10.1021/ja103429q; Boogaerts IIF, 2010, ANGEW CHEM INT EDIT, V49, P8674, DOI 10.1002/anie.201004153; Yeung CS, 2008, J AM CHEM SOC, V130, P7826, DOI 10.1021/ja803435w; Manjolinho F, 2012, ACS CATAL, V2, P2014, DOI 10.1021/cs300448v; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Ohishi T, 2008, ANGEW CHEM INT EDIT, V47, P5792, DOI 10.1002/anie.200801857; Mizuno H, 2011, J AM CHEM SOC, V133, P1251, DOI 10.1021/ja109097z; Fujihara T, 2011, ANGEW CHEM INT EDIT, V50, P523, DOI 10.1002/anie.201006292; Takaya J, 2008, ORG LETT, V10, P2697, DOI 10.1021/ol800829q; Tsuji Y, 2012, CHEM COMMUN, V48, P9956, DOI 10.1039/c2cc33848c; Zhang LA, 2010, ANGEW CHEM INT EDIT, V49, P8670, DOI 10.1002/anie.201003995; Arduengo AJ, 1999, TETRAHEDRON, V55, P14523, DOI 10.1016/S0040-4020(99)00927-8; Fujihara T, 2012, ANGEW CHEM INT EDIT, V51, P11487, DOI 10.1002/anie.201207148; Riduan SN, 2010, DALTON T, V39, P3347, DOI 10.1039/b920163g; Olah GA, 2002, J AM CHEM SOC, V124, P11379, DOI 10.1021/ja020787o; Takimoto M, 2013, CHEM-EUR J, V19, P11439, DOI 10.1002/chem.201301456; Martin R, 2011, CHEMSUSCHEM, V4, P1259, DOI 10.1002/cssc.201100102; Ohmiya H, 2011, ORG LETT, V13, P1086, DOI 10.1021/ol103128x; Zhang L, 2013, CHEM SCI, V4, P3395, DOI 10.1039/c3sc51070k; Correa A, 2009, J AM CHEM SOC, V131, P15974, DOI 10.1021/ja905264a; Uchiyama M, 2004, J AM CHEM SOC, V126, P10526, DOI 10.1021/ja0473236; Jang H, 2011, J AM CHEM SOC, V133, P7859, DOI 10.1021/ja2007643; Zhang WZ, 2010, ORG LETT, V12, P4748, DOI 10.1021/ol102172v; Hou G, 2009, J AM CHEM SOC, V131, P9882, DOI 10.1021/ja903319r; Fujihara T, 2012, J AM CHEM SOC, V134, P9106, DOI 10.1021/ja303514b; Mankad NP, 2004, ORGANOMETALLICS, V23, P3369, DOI 10.1021/om0496380; Correa A, 2009, ANGEW CHEM INT EDIT, V48, P6201, DOI 10.1002/anie.200900667; Sakakura T, 2007, CHEM REV, V107, P2365, DOI 10.1021/cr068357u; Takaya J, 2008, J AM CHEM SOC, V130, P15254, DOI 10.1021/ja806677w; Shintani R, 2013, ORGANOMETALLICS, V32, P2459, DOI 10.1021/om400175h; Kobayashi K, 2009, ORG LETT, V11, P2035, DOI 10.1021/ol900528h; Sasano K, 2013, J AM CHEM SOC, V135, P10954, DOI 10.1021/ja405503y; Li SH, 2011, ANGEW CHEM INT EDIT, V50, P2578, DOI 10.1002/anie.201007128; Armstrong DR, 2013, CHEM-EUR J, V19, P13492, DOI 10.1002/chem.201301180; Ohishi T, 2011, ANGEW CHEM INT EDIT, V50, P8114, DOI 10.1002/anie.201101769; Yoo WJ, 2012, ORG LETT, V14, P5326, DOI 10.1021/ol3025082; BAILEY WF, 1988, J ORGANOMET CHEM, V352, P1, DOI 10.1016/0022-328X(88)83017-1; Liu Y, 2014, J AM CHEM SOC, V136, P11212, DOI [10.1021/ja5064586, 10.1021/ja05064586]; Zhang X, 2012, CHEM COMMUN, V48, P6292, DOI 10.1039/c2cc32045b; Semba K, 2012, ADV SYNTH CATAL, V354, P1542, DOI 10.1002/adsc.201200200; Zhang L, 2013, CHEM COMMUN, V49, P4782, DOI 10.1039/c3cc41838c; Zhang L, 2012, J AM CHEM SOC, V134, P14314, DOI 10.1021/ja3063474; Aresta M., 2010, CARBON DIOXIDE AS CH; BARSKY L, 1976, J ORG CHEM, V41, P3651, DOI 10.1021/jo00884a049; Boogaerts I. I. F., 2010, ANGEW CHEM, V122, P8856, DOI 10.1002/ange.201004153; Bruker, 2007, BRUKER APEX2 V2013 2; CABIDDU S, 1979, J ORGANOMET CHEM, V182, P155, DOI 10.1016/S0022-328X(00)94378-X; Cokoja M., 2011, ANGEW CHEM, V123, P8662, DOI DOI 10.1002/ANGE.201102010; COMINS DL, 1986, J ORG CHEM, V51, P3566, DOI 10.1021/jo00369a002; COOK LS, 1976, TETRAHEDRON LETT, P147; Correa A., 2009, ANGEW CHEM, V721, P6317; Farrugia L. J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI DOI 10.1107/S0021889899006020; Fujihara T., 2011, ANGEW CHEM, V123, P543, DOI 10.1002/ange.201006292; Fujihara T., 2012, ANGEW CHEM, V124, P11655; Gilman H., 1943, ORG SYNTH COLL, V2, P425; Gschwend H. W., 1979, ORG REACTIONS, V26, P195; Gschwend H. W., 1979, ORG REACTIONS, V26, P158; Hou Z., 2007, COMPREHENSIVE ORGANO, V10, P537; Li S., 2011, ANGEW CHEM, V123, P2626, DOI 10.1002/ange.201007128; Mizuno T, 2011, EUR J ORG CHEM, P2606, DOI 10.1002/ejoc.201100147; Nemoto K, 2009, TETRAHEDRON LETT, V50, P4512, DOI 10.1016/j.tetlet.2009.05.076; Ohishi T., 2011, ANGEW CHEM, V123, P8264; Ohishi T., 2008, ANGEW CHEM, V120, P5876, DOI 10.1002/ange.200801857; Omae I, 2012, COORDIN CHEM REV, V256, P1384, DOI 10.1016/j.ccr.2012.03.017; PARHAM WE, 1976, J ORG CHEM, V41, P1268, DOI 10.1021/jo00869a046; Salteris CS, 1999, J ORGANOMET CHEM, V590, P63, DOI 10.1016/S0022-328X(99)00425-8; Sasada T, 2011, CHEM-EUR J, V17, P9385, DOI 10.1002/chem.201100040; SCRETTAS CG, 1989, J ORG CHEM, V54, P1013, DOI 10.1021/jo00266a005; Seyferth D, 2006, ORGANOMETALLICS, V25, P2, DOI 10.1021/om058054a; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tran-Vu H., 2013, ACS CATAL, V3, P2417; Wittig G., 1938, CHEM BER, V71, P1903, DOI DOI 10.1002/CBER.19380710922; Zhang L., 2010, ANGEW CHEM, V122, P8852, DOI 10.1002/ange.201003995	80	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		1010	1016		10.1002/asia.201403247		7	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600028		
J	Kimura, R; Sawayama, Y; Nakazaki, A; Miyamoto, K; Uchiyama, M; Nishikawa, T				Kimura, Rino; Sawayama, Yusuke; Nakazaki, Atsuo; Miyamoto, Kazunori; Uchiyama, Masanobu; Nishikawa, Toshio			Unexpected Metal-Free Transformation of gem-Dibromomethylenes to Ketones under Acetylation Conditions	CHEMISTRY-AN ASIAN JOURNAL			English	Article						dehalogenation; gem-dibromomethylenes; ketones; radical reactions; synthetic methods	PHOTOINDUCED ELECTRON-TRANSFER; RADICAL CYCLIZATION; MOLECULAR-OXYGEN; SYNTHETIC ROUTE; TERTIARY-AMINES; ALKYL-HALIDES; ARYL HALIDES; SAXITOXIN; SKELETON; AUTOXIDATION	Novel conditions for the transformation of gem-dibromomethylenes to ketones are described. gem-Dibromo compounds were treated with acetic anhydride and triethylamine in dichloromethane/water at room temperature under an air atmosphere to give the corresponding ketones in moderate yields. A radical mechanism is proposed based on experimental results.	[Kimura, Rino; Sawayama, Yusuke; Nakazaki, Atsuo; Nishikawa, Toshio] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Miyamoto, Kazunori; Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Miyamoto, Kazunori; Uchiyama, Masanobu] RIKEN, Ctr Sustainable Resource Sci, Adv Elements Chem Res Team, Wako, Saitama 3510198, Japan; [Miyamoto, Kazunori; Uchiyama, Masanobu] RIKEN, Elements Chem Lab, Wako, Saitama 3510198, Japan	Nishikawa, T (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	nisikawa@agr.nagoya-u.ac.jp	Uchiyama, Masanobu/B-7181-2015		MEXT; Daiichi Sankyo Foundation of Life Science; Yamada Science Foundation	This work was supported by Grants-in-Aid on Innovative Areas "Chemical Biology of Natural Products"<SUP>[25]</SUP> from MEXT, the Daiichi Sankyo Foundation of Life Science, and the Yamada Science Foundation. We are grateful to Prof. Yujiro Hayashi (Tohoku Univ. Japan) for invaluable advice on the <SUP>18</SUP>O-labeling experiments.	ALLINGER NL, 1962, J ORG CHEM, V27, P722, DOI 10.1021/jo01050a004; Zhang H, 2012, ANGEW CHEM INT EDIT, V51, P12542, DOI 10.1002/anie.201206518; Sawayama Y, 2011, ANGEW CHEM INT EDIT, V50, P7176, DOI 10.1002/anie.201102494; Studer A, 2014, NAT CHEM, V6, P765, DOI 10.1038/nchem.2031; Umemiya S, 2014, CHEM-EUR J, V20, P15753, DOI 10.1002/chem.201403475; Aitken KM, 2008, TETRAHEDRON, V64, P4384, DOI 10.1016/j.tet.2008.02.064; Muller S, 2011, J AM CHEM SOC, V133, P18534, DOI 10.1021/ja2092163; Lu QQ, 2013, J AM CHEM SOC, V135, P11481, DOI 10.1021/ja4052685; Mehta VP, 2013, RSC ADV, V3, P11957, DOI 10.1039/c3ra40813b; Takeda T, 1997, TETRAHEDRON, V53, P557, DOI 10.1016/S0040-4020(96)00981-7; MAILLARD B, 1983, J AM CHEM SOC, V105, P5095, DOI 10.1021/ja00353a039; Liu W, 2010, J AM CHEM SOC, V132, P16737, DOI 10.1021/ja103050x; Ueda M, 2012, CHEM LETT, V41, P658, DOI 10.1246/cl.2012.658; Ueda H, 2014, ORG LETT, V16, P4194, DOI 10.1021/ol5018883; Shackleford JP, 2012, P NATL ACAD SCI USA, V109, P44, DOI 10.1073/pnas.1113553108; Shirakawa E, 2012, CHEM LETT, V41, P130, DOI 10.1246/cl.2012.130; BECKWITH ALJ, 1983, AUST J CHEM, V36, P719; COSSY J, 1994, TETRAHEDRON LETT, V35, P8161, DOI 10.1016/0040-4039(94)88271-1; COSSY J, 1995, TETRAHEDRON, V51, P11751, DOI 10.1016/0040-4020(95)00727-P; Cossy J, 1996, TETRAHEDRON LETT, V37, P5091, DOI 10.1016/0040-4039(96)01032-5; Farn RD, 2008, J HETEROCYCLIC CHEM, V45, P887; GOLOBISH TD, 1995, J ORG CHEM, V60, P7865, DOI 10.1021/jo00129a028; GROVES JT, 1974, J AM CHEM SOC, V96, P6527, DOI 10.1021/ja00827a053; MATAKA S, 1987, J ORG CHEM, V52, P2653, DOI 10.1021/jo00389a004; MATTAY J, 1989, SYNTHESIS-STUTTGART, P233; NAKAMURA E, 1991, J AM CHEM SOC, V113, P8980, DOI 10.1021/ja00023a076; RILEY DP, 1985, J ORG CHEM, V50, P1563, DOI 10.1021/jo00209a049; Sawamura M, 1997, SYNLETT, P801; Sawayama Y, 2012, J SYN ORG CHEM JPN, V70, P1178; Sawayama Y, 2011, SYNLETT, P651, DOI 10.1055/s-0030-1259546; Sawayama Y., 2011, ANGEW CHEM, V123, P7314; Seyferth D., 1963, J ORG CHEM, V28, P703, DOI 10.1021/jo01038a025; Sha CK, 1998, CHEM COMMUN, P397; Stefane B, 2009, EUR J MED CHEM, V44, P2563, DOI 10.1016/j.ejmech.2009.01.028; TROST BM, 1975, J AM CHEM SOC, V97, P2218, DOI 10.1021/ja00841a037; TURNER WV, 1992, J ORG CHEM, V57, P1610, DOI 10.1021/jo00031a055; Tutar A, 2008, SYNTHETIC COMMUN, V38, P1333, DOI 10.1080/00397910801916223; Zhang H., 2012, ANGEW CHEM, V124, P12710	38	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		1035	1041		10.1002/asia.201403277		7	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600031		
J	Nakajima, M; Arai, S; Nishida, A				Nakajima, Masaya; Arai, Shigeru; Nishida, Atsushi			Asymmetric Total Synthesis of (-)-Lundurine B and Determination of Its Absolute Stereochemistry	CHEMISTRY-AN ASIAN JOURNAL			English	Article						alkaloids; asymmetric synthesis; lundurine; natural products; total synthesis	LAPIDILECTA ALKALOID (+/-)-LAPIDILECTINE-B; SAMARIUM DIIODIDE; CYCLOPROPYL MOIETY; CARBONYL-COMPOUNDS; ALLYLIC AMINATION; KOPSIA ALKALOIDS; INDOLE ALKALOIDS; (+/-)-LUNDURINE; TENUIS; SYSTEM	A total synthesis of the Kopsia tenuis alkaloid (-)-lundurine B has been achieved. A quaternary chiral carbon has been created by an asymmetric deprotonation using a symmetric spiro cyclohexanone intermediate with a chiral lithium amide. The hexacyclic skeleton was sequentially constructed through metal-mediated reactions. The absolute stereochemistry of intermediate 5 has been unambiguously established by X-ray crystallographic analysis. This is the first description of the absolute stereochemistry of Kopsia tenuis alkaloids based on chemical synthesis.	[Nakajima, Masaya; Arai, Shigeru; Nishida, Atsushi] Chiba Univ, Grad Sch Pharmaceut Sci, Chuou ku, Chiba 2608675, Japan	Nishida, A (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuou ku, 1-8-1 Inohana, Chiba 2608675, Japan.				Nanohana Competition Chiba University; Nihon Insight Technologies Corporation; Suzuken Memorial Foundation; Uehara Memorial Foundation; KAKENHI [18790006, 2139002]; JSPS	We thank Prof. Kam for providing NMR charts of the natural products. This study was financially supported by the Nanohana Competition Chiba University 2014, Nihon Insight Technologies Corporation (to M.N.), the Suzuken Memorial Foundation, the Uehara Memorial Foundation, KAKENHI (18790006) (to S.A.) and KAKENHI (2139002) (to A.N.). Funding by JSPS for travel free to Malaysia to A.N. is also acknowledged (Asian Core Program, New Phase of Cutting Edge Organic Chemistry in Asia).	WENKERT E, 1977, J ORG CHEM, V42, P3945, DOI 10.1021/jo00444a034; KAM TS, 1995, TETRAHEDRON LETT, V36, P759, DOI 10.1016/0040-4039(94)02361-E; Yang J, 2006, ORG LETT, V8, P2187, DOI 10.1021/ol0607138; Pearson WH, 2004, J ORG CHEM, V69, P9109, DOI 10.1021/jo048917u; INANAGA J, 1991, TETRAHEDRON LETT, V32, P6557, DOI 10.1016/0040-4039(91)80220-Z; Miller RS, 2000, J AM CHEM SOC, V122, P7718, DOI 10.1021/ja001260j; Ferrer C, 2009, TETRAHEDRON, V65, P9015, DOI 10.1016/j.tet.2009.08.067; You SL, 2001, J AM CHEM SOC, V123, P7471, DOI 10.1021/ja016121w; Szostak M, 2012, J ORG CHEM, V77, P3049, DOI 10.1021/jo300135v; Arai S, 2014, ANGEW CHEM INT EDIT, V53, P5569, DOI 10.1002/anie.201400464; SAKAITANI M, 1990, J ORG CHEM, V55, P870, DOI 10.1021/jo00290a015; Hoshi M, 2014, ORG LETT, V16, P768, DOI 10.1021/ol4034786; Szostak M, 2012, ANGEW CHEM INT EDIT, V51, P9238, DOI 10.1002/anie.201201065; Pearson WH, 2001, J AM CHEM SOC, V123, P6724, DOI 10.1021/ja016007d; Kam TS, 2004, TETRAHEDRON, V60, P10739, DOI 10.1016/j.tet.2004.08.091; ITO Y, 1978, J ORG CHEM, V43, P1011, DOI 10.1021/jo00399a052; Dubovyk I, 2007, J AM CHEM SOC, V129, P14172, DOI 10.1021/ja076659n; Magnus P, 2002, TETRAHEDRON, V58, P3423, DOI 10.1016/S0040-4020(02)00243-0; Aoki K, 1997, TETRAHEDRON LETT, V38, P2505, DOI 10.1016/S0040-4039(97)00378-X; Arai S., 2014, ANGEW CHEM, V126, P5675; Gagnon D, 2009, J ORG CHEM, V74, P6035, DOI 10.1021/jo9009497; Harb HY, 2012, SYNLETT, V23, P6, DOI 10.1055/s-0031-1290093; HAYASHI T, 1990, TETRAHEDRON LETT, V31, P1743, DOI 10.1016/S0040-4039(00)88870-X; Jin S., 2015, ANGEW CHEM INT EDIT, V54, DOI [10.1002/anie.20140996, DOI 10.1002/ANIE.20140996]; Jin S., 2015, ANGEW CHEM, V127, DOI [10.1002/ange.20140996, DOI 10.1002/ANGE.20140996]; Kam TS, 2008, ALKALOIDS-CHEM BIOL, V66, P1, DOI 10.1016/S1099-4831(08)00201-0; Kuehne ME, 2000, J ORG CHEM, V65, P6434, DOI 10.1021/jo000398h; Martin-Fontecha M, 2010, ORG LETT, V12, P4082, DOI 10.1021/ol101666m; Salim M, 2000, TETRAHEDRON, V56, P8063, DOI 10.1016/S0040-4020(00)00725-0; Schultz EE, 2012, ORG LETT, V14, P648, DOI 10.1021/ol203302f; van Eis MJ, 2007, TETRAHEDRON, V63, P1689, DOI 10.1016/j.tet.2006.11.075; WELSTEAD WJ, 1974, J MED CHEM, V17, P544, DOI 10.1021/jm00251a019; Zhang B, 2008, CHEM COMMUN, P4837, DOI 10.1039/b809890e; Zriba R, 2007, TETRAHEDRON LETT, V48, P8234, DOI 10.1016/j.tetlet.2007.09.071	34	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		1065	1070		10.1002/asia.201403407		6	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600034		
J	Yamamoto, T; Aoki, K; Sugiyama, A; Doi, H; Kodama, T; Shimizu, Y; Kanai, M				Yamamoto, Tomohiro; Aoki, Kiyoshi; Sugiyama, Akira; Doi, Hirofumi; Kodama, Tatsuhiko; Shimizu, Yohei; Kanai, Motomu			Design and Synthesis of Biotin Analogues Reversibly Binding with Streptavidin	CHEMISTRY-AN ASIAN JOURNAL			English	Article						biotin; hydrogen bonds; reversible interactions; streptavidin; surface plasmon resonance	CAGED-BIOTIN; CROSS-METATHESIS; SOLID SUPPORTS; AVIDIN; TECHNOLOGY; PROTEINS; IMMOBILIZATION; DISPLACEMENTS; ALDEHYDE; SURFACES	Two new biotin analogues, biotin carbonate 5 and biotin carbamate 6, have been synthesized. These molecules were designed to reversibly bind with streptavidin by replacing the hydrogen-bond donor NH group(s) of biotin's cyclic urea moiety with oxygen. Biotin carbonate 5 was synthesized from L-arabinose (7), which furnishes the desired stereochemistry at the 3,4-cis-dihydroxy groups, in 11% overall yield (over 10steps). Synthesis of biotin carbamate 6 was accomplished from L-cysteine-derived chiral aldehyde 33 in 11% overall yield (over 7steps). Surface plasmon resonance analysis of water-soluble biotin carbonate analogue 46 and biotin carbamate analogue 47 revealed that K-D values of these compounds for binding to streptavidin were 6.7x10(-6)M and 1.7x10(-10)M, respectively. These values were remarkably greater than that of biotin (K-D=10(-15)M), and thus indicate the importance of the nitrogen atoms for the strong binding between biotin and streptavidin.	[Yamamoto, Tomohiro; Aoki, Kiyoshi; Shimizu, Yohei; Kanai, Motomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sugiyama, Akira] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo 1130032, Japan; [Doi, Hirofumi; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Shimizu, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	y-shimizu@mol.f.u-tokyo.ac.jp; kanai@mol.f.u-tokyo.ac.jp			JSPS; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from JSPS	This work was supported by Grant-in-Aid for Scientific Research (B) from JSPS (MK), Grant-in-Aid for Young Scientists (B) from JSPS (YS) and Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from JSPS (TK).	Gilmore K, 2011, CHEM REV, V111, P6513, DOI 10.1021/cr200164y; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Morag E, 1996, ANAL BIOCHEM, V243, P257, DOI 10.1006/abio.1996.0514; Yumura K, 2013, PROTEIN SCI, V22, P213, DOI 10.1002/pro.2203; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; WILCHEK M, 1990, METHOD ENZYMOL, V184, P14; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; Miao XW, 2009, CHEMSUSCHEM, V2, P542, DOI 10.1002/cssc.200900028; Alvarez-Corral M, 2008, CHEM REV, V108, P3174, DOI 10.1021/cr078361l; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Hirsch JD, 2002, ANAL BIOCHEM, V308, P343, DOI 10.1016/S0003-2697(02)00201-4; MULLER W, 1993, SCIENCE, V262, P1706, DOI 10.1126/science.8259513; Clark JS, 2011, ORG BIOMOL CHEM, V9, P4823, DOI 10.1039/c1ob05130j; Chang CW, 2007, TETRAHEDRON, V63, P4310, DOI 10.1016/j.tet.2007.03.047; Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028; DOMINGUEZ JN, 1979, CARBOHYD RES, V75, P101, DOI 10.1016/S0008-6215(00)84630-3; Duthaler RO, 2011, EUR J ORG CHEM, P4667, DOI 10.1002/ejoc.201100247; FUJISAWA T, 1994, J ORG CHEM, V59, P5865, DOI 10.1021/jo00099a009; GASC MB, 1984, SYNTHETIC COMMUN, V14, P465, DOI 10.1080/00397918408059565; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; HOFMANN K, 1976, P NATL ACAD SCI USA, V73, P3516, DOI 10.1073/pnas.73.10.3516; Jeon H, 2011, ORG BIOMOL CHEM, V9, P7237, DOI 10.1039/c1ob05920c; Kan T, 2004, CHEM COMMUN, P353, DOI 10.1039/b311203a; Kim K, 2004, J AM CHEM SOC, V126, P15368, DOI 10.1021/ja0459330; Knoll W, 2000, COLLOID SURFACE A, V161, P115, DOI 10.1016/S0927-7757(99)00331-3; Phaosiri C, 2004, BIOORG MED CHEM LETT, V14, P5309, DOI 10.1016/j.bmcl.2004.08.023; Pirrung MC, 1996, BIOCONJUGATE CHEM, V7, P317, DOI 10.1021/bc960013v; Qureshi M. H., 2001, J BIOL CHEM, V276, P46422; Shimizu T, 2000, TETRAHEDRON LETT, V41, P5099, DOI 10.1016/S0040-4039(00)00781-4; SUNDBERG SA, 1995, J AM CHEM SOC, V117, P12050, DOI 10.1021/ja00154a003; Takikawa H, 1998, TETRAHEDRON LETT, V39, P6931, DOI 10.1016/S0040-4039(98)01456-7; Terai T, 2011, CHEM BIOL, V18, P1261, DOI 10.1016/j.chembiol.2011.09.007; Wang ZJ, 2013, J PEPT SCI, V19, P470, DOI 10.1002/psc.2522; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Yang H, 1999, J ORG CHEM, V64, P242, DOI 10.1021/jo981892c; Ying LQ, 2011, CHEM COMMUN, V47, P8593, DOI 10.1039/c1cc12738a	37	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	APR	2015	10	4			SI		1071	1078		10.1002/asia.201500120		8	Chemistry, Multidisciplinary	Chemistry	CE2DJ	WOS:000351623600035		
J	Mizukoshi, Y; Takeuchi, K; Arutaki, M; Takizawa, T; Hanzawa, H; Takahashi, H; Shimada, I				Mizukoshi, Yumiko; Takeuchi, Koh; Arutaki, Misa; Takizawa, Takeshi; Hanzawa, Hiroyuki; Takahashi, Hideo; Shimada, Ichio			Suppression of Problematic Compound Oligomerization by Cosolubilization of Nondetergent Sulfobetaines	CHEMMEDCHEM			English	Article						artifacts; drug discovery; NMR spectroscopy; nondetergent sulfobetaines; oligomerization	PROMISCUOUS INHIBITORS; MOLECULAR-PROPERTIES; ALPHA-SYNUCLEIN; DRUG DISCOVERY; MAP KINASE; NMR; AGGREGATION; PROTEIN; ASSAY; RELAXATION	Numerous small organic compounds exist in equilibrium among monomers, soluble oligomers, and insoluble aggregates in aqueous solution. Compound aggregation is a major reason for false positives in drug screening, and even soluble oligomers can interfere with structural and biochemical analyses. However, an efficient way to manage the equilibrium of aggregation-prone compounds, especially those involved with soluble oligomers, has not been established. In this study, solution NMR spectroscopy was used as a suitable technique to detect compound oligomers in equilibrium, and it was demonstrated that cosolubilization of nondetergent sulfobetaines (NDSBs) can largely suppress compound oligomerization and aggregation by shifting the equilibrium toward the monomers. The rotational correlation time was obtained from the ratio of the selective and nonselective longitudinal NMR relaxation times, which directly and quantitatively reflected the apparent sizes of the compounds in the equilibrium. The rotational correlation time of the aggregation-prone compound SKF86002 (1mM) was substantially reduced from 0.31 to 0.23ns by cosolubilization of 100mM NDSB195. NDSB cosolubilization allowed us to perform successful structural and biochemical experiments with substantially fewer artifacts, which represents a strategy to directly resolve the problematic oligomerization and aggregation of compounds.	[Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Mizukoshi, Yumiko; Takeuchi, Koh; Arutaki, Misa; Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan; [Mizukoshi, Yumiko; Takeuchi, Koh; Arutaki, Misa; Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Molprof, Koto Ku, Tokyo 1350064, Japan; [Mizukoshi, Yumiko; Arutaki, Misa] JBIC, Koto Ku, Tokyo 1350064, Japan; [Takizawa, Takeshi; Hanzawa, Hiroyuki] Daiichi Sankyo RD Novare, Dept Biol Res, Struct Biol Grp, Drug Discovery & Biomed Technol Unit,Edogawa Ku, Tokyo 1348630, Japan; [Takahashi, Hideo] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Mizukoshi, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.				Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI)	This work was supported by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade and Industry (METI).	LaPlante SR, 2013, J MED CHEM, V56, P5142, DOI 10.1021/jm400535b; Orts J, 2009, J MAGN RESON, V200, P64, DOI 10.1016/j.jmr.2009.06.006; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Bertini I, 2013, CHEMBIOCHEM, V14, P1891, DOI 10.1002/cbic.201300141; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Mizukoshi Y, 2012, ANGEW CHEM INT EDIT, V51, P1362, DOI 10.1002/anie.201104905; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Sanchez-Pedregal VM, 2005, ANGEW CHEM INT EDIT, V44, P4172, DOI 10.1002/anie.200500503; Hagihara M, 2012, FEBS OPEN BIO, V2, P20, DOI 10.1016/j.fob.2012.02.001; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Pellecchia M, 2008, NAT REV DRUG DISCOV, V7, P738, DOI 10.1038/nrd2606; VALENSIN G, 1982, J MAGN RESON, V46, P23, DOI 10.1016/0022-2364(82)90159-7; Smith PES, 2013, CHEMPHYSCHEM, V14, P3138, DOI 10.1002/cphc.201300436; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x; Tarcsay A, 2013, J MED CHEM, V56, P1789, DOI 10.1021/jm301514n; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Ludwig C, 2009, FRONT BIOSCI, V14, P4565, DOI 10.2741/3549; Arakawa T, 2008, INT J PHARM, V355, P220, DOI 10.1016/j.ijpharm.2007.12.009; Chong YC, 2000, BIOTECHNIQUES, V29, P1166; Dalvit Claudio, 2006, Curr Drug Discov Technol, V3, P115, DOI 10.2174/157016306778108875; Ding X, 2004, J PHARM SCI-US, V93, P1351, DOI 10.1002/jps.20034; LaPlante SR, 2013, J MED CHEM, V56, P7073, DOI 10.1021/jm4008714; Mizukoshi Y., 2012, ANGEW CHEM INT EDIT, V124, P1391; Narayanan S, 2005, BIOCHEMISTRY-US, V44, P1444, DOI 10.1021/bi048264b; Ni F., 1994, NMR SPECTROSC, V26, P517; Ono K, 2014, ANGEW CHEM INT EDIT, V53, P2597, DOI 10.1002/anie.201310749; Ono K., 2014, ANGEW CHEM, V126, P2635; PRICHETT W, 1995, J INFLAMM, V45, P97; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Sanchez-Pedregal V.-M., 2005, ANGEW CHEM, V117, P4244, DOI 10.1002/ange.200500503; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Tokunaga Y, 2014, NAT STRUCT MOL BIOL, V21, P704, DOI 10.1038/nsmb.2861; Xiang L, 2008, J MAGN RESON, V194, P147, DOI 10.1016/j.jmr.2008.06.006	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-7179	1860-7187		CHEMMEDCHEM	ChemMedChem	APR	2015	10	4					736	741		10.1002/cmdc.201500057		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE4AR	WOS:000351773300014		
J	Kawamura, K; Ikoma, K; Maruoka, Y; Hisamoto, H				Kawamura, Kunio; Ikoma, Keisuke; Maruoka, Yoshimi; Hisamoto, Hideaki			Separation Behavior of Short Oligonucleotides by Ion-Pair Reversed-Phase Capillary Liquid Chromatography Using a Silica-Based Monolithic Column Applied to Simple Detection of SNPs	CHROMATOGRAPHIA			English	Article						Capillary liquid chromatography; Ion-pair reversed-phase separation; Monolithic column; Oligonucleotide; Single-nucleotide polymorphism	IONIZATION MASS-SPECTROMETRY; THERAPEUTIC OLIGONUCLEOTIDES; ANTISENSE OLIGONUCLEOTIDES; LC-MS/MS; ELECTROPHORESIS; SINGLE; RNAS; HPLC; MONTMORILLONITE; PREDICTION	The separation behaviors of short oligonucleotides using capillary liquid chromatography have been investigated comparatively on an octadecylsilane (ODS) packed column (0.3 mm inner diameter, particle size 3 mu m) and a monolithic ODS column (0.5 mm inner diameter, through pore size 2 mu m). The present paper clearly demonstrates that the resolution obtained using the monolithic ODS packed column is much higher than that using a semi-mu-high-performance liquid chromatography (HPLC) column on a semi-mu-HPLC system. Furthermore, it was surprising that complete baseline resolution of oligonucleotides, typically shorter than 30-mer, with single nucleotide units was achieved using the monolithic column, although this was not possible using the ODS packed column. Good separation of short oligonucleotides was achieved at 40-60 A degrees C with a linear 40-60 % gradient of methanol content. Separation conditions on the monolithic column were optimized regarding the type of counterion, methanol content, temperature, and flow rate. Using the present method, detection of single-nucleotide polymorphisms was achieved without using a mass-spectrometry (MS) detector.	[Kawamura, Kunio; Maruoka, Yoshimi] Hiroshima Shudo Univ, Dept Human Environm Studies, Asaminami Ku, Hiroshima 7313195, Japan; [Ikoma, Keisuke; Hisamoto, Hideaki] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Sakai, Osaka 5998531, Japan	Kawamura, K (reprint author), Hiroshima Shudo Univ, Dept Human Environm Studies, Asaminami Ku, 1-1-1 Ozuka Higashi, Hiroshima 7313195, Japan.	kawamura@shudo-u.ac.jp			MEXT of Japan [21200004]	This research was supported by a Grant-in-Aid for Scientific Research 21200004 (2009-2011) on Innovative Areas from MEXT of Japan.	Apffel A, 1997, ANAL CHEM, V69, P1320, DOI 10.1021/ac960916h; van Dongen WD, 2011, BIOANALYSIS, V3, P541, DOI [10.4155/bio.11.8, 10.4155/BIO.11.8]; Huang WH, 2006, J AM CHEM SOC, V128, P8914, DOI 10.1020/ja061782k; McGinnis AC, 2012, J CHROMATOGR B, V883, P76, DOI 10.1016/j.jchromb.2011.09.007; Gilar M, 2002, J CHROMATOGR A, V958, P167, DOI 10.1016/S0021-9673(02)00306-0; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Cabrera K, 2004, J SEP SCI, V27, P843, DOI 10.1002/jssc.200401827; Sharma VK, 2012, J CHROMATOGR A, V1245, P65, DOI 10.1016/j.chroma.2012.05.003; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Premstaller A, 2000, ANAL CHEM, V72, P4386, DOI 10.1021/ac000283d; Zimmermann A, 2014, J CHROMATOGR A, V1354, P43, DOI 10.1016/j.chroma.2014.05.048; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Verdolino V, 2008, J PHYS CHEM B, V112, P16860, DOI 10.1021/jp8068877; TSUDA T, 1978, ANAL CHEM, V50, P271, DOI 10.1021/ac50024a026; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Holdsvendova P, 2007, J BIOCHEM BIOPH METH, V70, P23, DOI 10.1016/j.jbbm.2006.11.003; Noll B, 2011, J CHROMATOGR A, V1218, P5609, DOI 10.1016/j.chroma.2011.06.057; Huang Z, 2013, ANAL BIOCHEM, V435, P35, DOI 10.1016/j.ab.2012.12.011; Gilar M, 2003, OLIGONUCLEOTIDES, V13, P229, DOI 10.1089/154545703322460612; Azarani A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e7; BABA Y, 1993, J CHROMATOGR-BIOMED, V618, P41, DOI 10.1016/0378-4347(93)80026-Z; Bakry R, 2009, J CHROMATOGR SCI, V47, P418; Beuning PJ, 1999, ANAL BIOCHEM, V273, P284, DOI 10.1006/abio.1999.4223; Biba M, 2013, J PHARMACEUT BIOMED, V72, P25, DOI 10.1016/j.jpba.2012.09.007; Bittova M, 2012, J SEP SCI, V35, P322; Chambers SD, 2007, J SEP SCI, V30, P1628, DOI 10.1002/jssc.200700090; Gelfi C, 1996, ANTISENSE NUCLEIC A, V6, P47, DOI 10.1089/oli.1.1996.6.47; Hemsley M, 2012, BIOANALYSIS, V4, P1457, DOI [10.4155/bio.12.117, 10.4155/BIO.12.117]; Huber CG, 2001, J BIOCHEM BIOPH METH, V47, P5, DOI 10.1016/S0165-022X(00)00147-0; Kawamura K, 1998, J CHROMATOGR A, V802, P167, DOI 10.1016/S0021-9673(97)01092-3; KAWAMURA K, 1994, J AM CHEM SOC, V116, P7564, DOI 10.1021/ja00096a013; Kawamura K, 2000, ENCY ANAL CHEM, V6; Oberacher H, 2003, ANAL BIOANAL CHEM, V376, P292, DOI 10.1007/s00216-003-1888-z; Reyderman L, 1997, ANAL CHEM, V69, P3218, DOI 10.1021/ac970280+; Turnpenny P, 2011, BIOANALYSIS, V3, P1911, DOI [10.4155/bio.11.100, 10.4155/BIO.11.100]	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	APR	2015	78	7-8					487	494		10.1007/s10337-015-2855-5		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CE5FJ	WOS:000351856000005		
J	Takahashi, G; Tabata, M; Taguchi, K; Chikuma, T				Takahashi, Gou; Tabata, Miki; Taguchi, Kyoji; Chikuma, Toshiyuki			Fluorimetric Assay for Measuring Neprilysin Activity Using HPLC	CHROMATOGRAPHIA			English	Article						Assay; High-performance liquid chromatography; MK-801; Neprilysin	PERFORMANCE LIQUID-CHROMATOGRAPHY; BRAIN; ENKEPHALINASE; PURIFICATION; ENZYME; METALLOENDOPEPTIDASE; PEPTIDASE	A rapid and reproducible assay for the determination of neprilysin activity is reported. This method is based on fluorimetric detection of a dansylated dipeptide, 5-dimethylaminonaphthalene-1-sulfonyl-d-Ala-Gly, enzymatically formed from the substrate 5-dimethylaminonaphthalene-1-sulfonyl-d-Ala-Gly-Phe(pNO(2))-Gly after separation by high-performance liquid chromatography using a C-18 reversed-phase column by isocratic elution. The detection limit of this method is at a level as low as 0.2 nmol mL(-1), it yields highly reproducible results and the time consumed for analysis is less than 6.8 min per sample for separation and quantification. By using this assay, the stimulatory effect of (+)MK-801 (dizocilpine maleate)-a noncompetitive N-methyl-[d]-aspartate receptor antagonist-on this enzyme activity was observed in rat brain regions 3 days after the treatment. This new method would be useful for clarification of the physiological role of this enzyme.	[Takahashi, Gou; Tabata, Miki; Chikuma, Toshiyuki] Showa Pharmaceut Univ, Dept Analyt Chem Med, Machida, Tokyo 1948543, Japan; [Taguchi, Kyoji] Showa Pharmaceut Univ, Dept Med Pharmacol, Machida, Tokyo 1948543, Japan	Chikuma, T (reprint author), Showa Pharmaceut Univ, Dept Analyt Chem Med, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	chikuma@ac.shoyaku.ac.jp					RELTON JM, 1983, BIOCHEM J, V215, P519; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Iwata N, 2000, NAT MED, V6, P143; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; Marr RA, 2003, J NEUROSCI, V23, P1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Arif M, 2006, NEUROCHEM INT, V49, P304, DOI 10.1016/j.neuint.2006.01.016; Chikuma T, 2002, ANAL CHIM ACTA, V457, P157, DOI 10.1016/S0003-2670(02)00015-6; Chikuma T, 2004, J CHROMATOGR B, V806, P113, DOI 10.1016/j.jchromb.2004.03.040; FLORENTIN D, 1984, ANAL BIOCHEM, V141, P62, DOI 10.1016/0003-2697(84)90425-1; ICH, 2005, INT C HARM TECH NREQ; ICH, 2006, INT C HARM TECH REQ; James EDM, 2006, BASIC STAT PHARM STA, P229; LI CW, 1995, METHOD ENZYMOL, V248, P253; LLORENS C, 1982, J NEUROCHEM, V39, P1081, DOI 10.1111/j.1471-4159.1982.tb11500.x; MALFROY B, 1978, NATURE, V276, P523, DOI 10.1038/276523a0; Oh-Hashi K, 2008, MOL CELL BIOCHEM, V313, P103, DOI 10.1007/s11010-008-9747-z; ORLOWSKI M, 1981, BIOCHEMISTRY-US, V20, P4942, DOI 10.1021/bi00520a021; VOGEL Z, 1977, FEBS LETT, V80, P332, DOI 10.1016/0014-5793(77)80469-9	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	APR	2015	78	7-8					593	597		10.1007/s10337-015-2856-4		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CE5FJ	WOS:000351856000017		
J	Obayashi, K; Saeki, K; Kurumatani, N				Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio			Light exposure at night is associated with subclinical carotid atherosclerosis in the general elderly population: The HEIJO-KYO cohort	CHRONOBIOLOGY INTERNATIONAL			English	Article						Carotid intima media thickness; circadian rhythm; elderly; epidemiology; light at night	URINARY MELATONIN EXCRETION; HUMAN CIRCADIAN PACEMAKER; CROSS-SECTIONAL ANALYSIS; CORONARY-HEART-DISEASE; SHIFT WORK; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; MEDIA THICKNESS; ARTERY INTIMA	Epidemiological and cellular biological studies indicate the influence of impaired circadian biological rhythmicity on atherosclerosis. Increased exposure to light at night (LAN) is common in modern life, and LAN exposure is the most important environmental cue for circadian misalignment. However, the association between LAN exposure and atherosclerosis has never been explored in humans. In this cross-sectional study, we measured nighttime light intensity in the bedroom along with the intima-media thickness (IMT) of the common carotid artery using ultrasonography in 700 elderly individuals (mean age 71.6 years). Averages of mean and maximal carotid IMT were 0.88 +/- 0.15mm and 1.09 +/- 0.32 mm, respectively. Median intensity of LAN exposure was 0.74 lux (interquartile range, 0.08-3.34). Both mean and maximal carotid IMT significantly increased across quartiles of increasing LAN intensity (p for trend = 0.002 and <0.001, respectively). After adjustment for confounding factors, including age, gender, body mass index, current smoking status, hypertension, diabetes, dyslipidemia, sleep medication, estimated glomerular filtration rate, nocturia, bedtime, duration in bed (scotoperiod), day length (photoperiod), urinary 6-sulfatoxymelatonin excretion and daytime and nighttime physical activity, multivariate linear regression models revealed significant associations of LAN exposure with carotid IMT measurements [mean: beta, 0.032 (fourth versus first quartiles); 95% confidence intervals (CI), 0.002-0.061; p = 0.037; maximal: beta, 0.100 (fourth versus first quartiles); 95% CI, 0.034-0.165; p = 0.003]. In conclusion, these results suggested that LAN exposure in home settings is significantly associated with subclinical carotid atherosclerosis in the general elderly population.	[Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio] Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, Kashihara, Nara 6348521, Japan	Obayashi, K (reprint author), Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, 840 Shijocho, Kashihara, Nara 6348521, Japan.	obayashi@naramed-u.ac.jp			Department of Indoor Environmental Medicine, Nara Medical University; Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; Japan Science and Technology Agency	This work was supported by Grants from the Department of Indoor Environmental Medicine, Nara Medical University; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; and the Japan Science and Technology Agency.	Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Puttonen S, 2009, ATHEROSCLEROSIS, V205, P608, DOI 10.1016/j.atherosclerosis.2009.01.016; Lockley SW, 2006, SLEEP, V29, P161; Heeringa J, 2007, ARCH INTERN MED, V167, P382, DOI 10.1001/archinte.167.4.382; Dumont M, 2001, J BIOL RHYTHM, V16, P502, DOI 10.1177/074873001129002178; Shuboni D, 2010, NEUROSCIENCE, V170, P1172, DOI 10.1016/j.neuroscience.2010.08.009; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; Chang AM, 2012, J PHYSIOL-LONDON, V590, P3103, DOI 10.1113/jphysiol.2011.226555; Simon A, 2007, EUR HEART J, V28, P2967, DOI 10.1093/eurheartj/ehm487; Obayashi K, 2013, J CLIN ENDOCR METAB, V98, P337, DOI 10.1210/jc.2012-2874; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Haupt CM, 2008, ATHEROSCLEROSIS, V201, P205, DOI 10.1016/j.atherosclerosis.2007.12.059; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Scheer FAJL, 1999, J BIOL RHYTHM, V14, P202, DOI 10.1177/074873099129000614; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Bedrosian TA, 2011, PSYCHONEUROENDOCRINO, V36, P1062, DOI 10.1016/j.psyneuen.2011.01.004; Obayashi K, 2014, J CLIN ENDOCR METAB, V99, P3233, DOI 10.1210/jc.2014-1262; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Fonken LK, 2012, J BIOL RHYTHM, V27, P319, DOI 10.1177/0748730412448324; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Obayashi K, 2012, J CLIN ENDOCR METAB, V97, P4166, DOI 10.1210/jc.2012-1873; Obayashi K, 2014, CHRONOBIOL INT, V31, P779, DOI 10.3109/07420528.2014.900501; Yamasaki F, 1998, HYPERTENSION, V32, P417; Anea CB, 2012, CIRC RES, V111, P1157, DOI 10.1161/CIRCRESAHA.111.261750; Spiegel K, 2004, ANN INTERN MED, V141, P846; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Bewick Viv, 2004, Crit Care, V8, P196, DOI 10.1186/cc2857; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Davis S, 2001, AM J EPIDEMIOL, V154, P591, DOI 10.1093/aje/154.7.591; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Law MR, 2004, J MED SCREEN, V11, P3, DOI 10.1258/096914104772950673; Obayashi K, 2014, CHRONOBIOL INT, V31, P976, DOI 10.3109/07420528.2014.937491; Vyas MV, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4800	40	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	APR	2015	32	3					310	317		10.3109/07420528.2014.974809		8	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CE4XM	WOS:000351833600002		
J	Yamamoto, N; Otsuka, K; Kubo, Y; Hayashi, M; Mizuno, K; Ohshima, H; Mukai, C				Yamamoto, Naomune; Otsuka, Kuniaki; Kubo, Yutaka; Hayashi, Mitsutoshi; Mizuno, Koh; Ohshima, Hiroshi; Mukai, Chiaki			Effects of long-term microgravity exposure in space on circadian rhythms of heart rate variability	CHRONOBIOLOGY INTERNATIONAL			English	Article						Circadian period; heart rate variability; long space flight	BAROREFLEX SENSITIVITY; VAGAL; SLEEP; SPACEFLIGHT; ASTRONAUTS; CLOCKS; SYSTEM; TIME	We evaluated their circadian rhythms using data from electrocardiographic records and examined the change in circadian period related to normal RR intervals for astronauts who completed a long-term (>= 6-month) mission in space. The examinees were seven astronauts, five men and two women, from 2009 to 2010. Their mean +/- SD age was 52.0 +/- 4.2 years (47-59 yr). Each stayed in space for more than 160 days; their average length of stay was 172.6 +/- 14.6 days (163-199 days). We conducted a 24-h Holter electrocardiography before launch (Pre), at one month after launch (DF1), at two months after launch (DF2), at two weeks before return (DF3), and at three months after landing (Post), comparing each index of frequency-domain analysis and 24-h biological rhythms of the NN intervals (normal RR intervals). Results show that the mean period of Normal Sinus (NN) intervals was within 24 +/- 4 h at each examination. Inter-individual variability differed among the stages, being significantly smaller at DF3 (Pre versus DF1 versus DF3 versus Post = 22.36 +/- 2.50 versus 25.46 +/- 4.37 versus 22.46 +/- 1.75 versus 26.16 +/- 7.18 h, p<0.0001). The HF component increased in 2 of 7 astronauts, whereas it decreased in 3 of 7 astronauts and 1 was remained almost unchanged at DF1. During DF3, about 6 months after their stay in space, the HF component of 5 of 7 astronauts recovered from the decrease after launch, with prominent improvement to over 20% in 3 astronauts. Although autonomic nervous functions and circadian rhythms were disturbed until one month had passed in space, well-scheduled sleep and wake rhythms and meal times served as synchronizers.	[Yamamoto, Naomune; Kubo, Yutaka; Hayashi, Mitsutoshi] Tokyo Womens Med Univ, Med Ctr East, Dept Med, Tokyo, Japan; [Yamamoto, Naomune; Ohshima, Hiroshi; Mukai, Chiaki] Japan Aerosp Explorat Agcy, Space Biomed Res Off, Tokyo, Japan; [Otsuka, Kuniaki] Tokyo Womens Med Univ, Dept Chron & Gerontol, Tokyo, Japan; [Mizuno, Koh] Tohoku Fukushi Univ, Fac Child & Family Studies, Tokyo, Japan	Yamamoto, N (reprint author), Tokyo Womens Med Univ, Med Ctr East, Dept Med, Tokyo, Japan.	in1195@poh.osaka-med.ac.jp					Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Hurd MW, 1998, J BIOL RHYTHM, V13, P430, DOI 10.1177/074873098129000255; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Hayano J, 1996, CIRCULATION, V94, P842; Monk TH, 2001, PSYCHOSOM MED, V63, P881; Takusagawa M, 1999, HEART, V82, P75; Eckberg DL, 2005, J PHYSIOL-LONDON, V567, P1011, DOI 10.1113/jphysiol.2005.091090; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Aronson D, 2001, J CARDIOVASC ELECTR, V12, P294, DOI 10.1046/j.1540-8167.2001.00294.x; Hirayanagi K, 2004, EUR J APPL PHYSIOL, V92, P160, DOI 10.1007/s00421-004-1067-8; Bernardi L, 1996, CARDIOVASC RES, V32, P234, DOI 10.1016/0008-6363(96)00081-8; BIGGER JT, 1992, AM J CARDIOL, V69, P718, DOI 10.1016/0002-9149(92)90493-I; Bonting S., 1999, ADV SPACE BIOL MED, V7, P103; Busek P, 2005, PHYSIOL RES, V54, P369; Di Rienzo M, 2008, J APPL PHYSIOL, V105, P1569, DOI 10.1152/japplphysiol.90625.2008; Eckberg DL, 2010, J PHYSIOL-LONDON, V588, P1129, DOI 10.1113/jphysiol.2009.186650; GAZENKO O G, 1986, Acta Physiologica Polonica, V37, P53; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Halberg F, 2009, BIOLOGIST, V56, P209; HAYANO J, 1990, AM J PHYSIOL, V258, pH642; Irwin MR, 2006, PSYCHOSOM MED, V68, P159, DOI 10.1097/01.psy.0000195743.60952.00; Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009; LEACH CS, 1991, J CLIN PHARMACOL, V31, P921; Monk TH, 1998, J BIOL RHYTHM, V13, P188, DOI 10.1177/074873098129000039; Otsuka K, 2000, COMPUT CARDIOL, V27, P453; Otsuka K, 1997, COMPUT CARDIOL, V24, P49; Pavy-Le Traon A, 2007, Eur J Appl Physiol, V101, P143, DOI 10.1007/s00421-007-0474-z; Sawada Y, 1997, MED BIOL ENG COMPT, V33, P2821; Schmitt HH, 1985, ANECDOTAL INFORMATIO, P1; Camm AJ, 1996, CIRCULATION, V93, P1043; Verheyden B, 2010, J APPL PHYSIOL, V108, P646, DOI 10.1152/japplphysiol.00883.2009	34	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	APR	2015	32	3					327	340				14	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CE4XM	WOS:000351833600004		
J	Sato, A; Aonuma, K				Sato, Akira; Aonuma, Kazutaka			Role of Cardiac Multidetector Computed Tomography Beyond Coronary Angiography	CIRCULATION JOURNAL			English	Review						Multidetector computed tomography; Myocardial perfusion imaging; Vulnerable plaque	ACUTE MYOCARDIAL-INFARCTION; FRACTIONAL FLOW RESERVE; OPTICAL COHERENCE TOMOGRAPHY; NAPKIN-RING SIGN; ALL-CAUSE MORTALITY; ACUTE CHEST-PAIN; CT ANGIOGRAPHY; ARTERY-DISEASE; DIAGNOSTIC-ACCURACY; PROGNOSTIC VALUE	Cardiac multidetector computed tomography (MDCT) has become a useful noninvasive modality for anatomical imaging of coronary artery disease (CAD). Currently, the main clinical advantage of coronary computed tomography angiography (CCTA) appears to be related to its high negative predictive value at low or intermediate pretest probability for CAD. With the development of technical aspects of MDCT, clinical practice and research are increasingly shifting toward defining the clinical implication of plaque morphology, myocardial perfusion, and patient outcomes. The presence of positive vessel remodeling, low-attenuation plaques, napkin-ring sign, or spotty calcification on CCTA could be useful information on high-risk vulnerable plaques. The napkin-ring sign, especially, showed higher accuracy for the detection of thin-cap fibroatheroma. Recently, it was reported that cardiac 3D single-photon emission tomography/CT fusion imaging, noninvasive fractional flow reserve computed from CT, and integrated CCTA and CT myocardial perfusion were associated with improved diagnostic accuracy for the detection of hemodynamically significant CAD. Furthermore, several randomized, large clinical trials have evaluated the clinical value of CCTA for chest pain triage in the emergency department or long-term reduction in death, myocardial infarction, or hospitalization for unstable angina. In this review we discuss the role of cardiac MDCT beyond coronary angiography, including a comparison with other currently available imaging modalities used to examine atherosclerotic plaque and myocardial perfusion.	[Sato, Akira; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan	Sato, A (reprint author), Univ Tsukuba, Fac Med, Div Cardiovasc, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	asato@md.tsukuba.ac.jp					Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Amanieu C, 2013, EUR RADIOL, V23, P2405, DOI 10.1007/s00330-013-2853-7; Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; Gerber BL, 2006, CIRCULATION, V113, P823, DOI 10.1161/CIRCULATIONAHA.104.529511; Watabe H, 2012, J AM COLL CARDIOL, V59, P1881, DOI 10.1016/j.jacc.2012.01.051; Sato A, 2010, J NUCL CARDIOL, V17, P19, DOI 10.1007/s12350-009-9150-5; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Chao SP, 2010, EUR HEART J, V31, P1916, DOI 10.1093/eurheartj/ehq072; Ito T, 2011, AM J CARDIOL, V107, P1270, DOI 10.1016/j.amjcard.2010.12.036; Sato A, 2010, AM J CARDIOL, V105, P930, DOI 10.1016/j.amjcard.2009.11.028; Muhlestein JB, 2014, JAMA-J AM MED ASSOC, V312, P2234, DOI 10.1001/jama.2014.15825; Westwood ME, 2013, RADIOLOGY, V267, P387, DOI 10.1148/radiol.13121136; Sato A, 2012, J AM COLL CARDIOL, V59, P730, DOI 10.1016/j.jacc.2011.10.890; Seifarth H, 2012, ATHEROSCLEROSIS, V224, P90, DOI 10.1016/j.atherosclerosis.2012.06.021; Petcherski O, 2013, AM J CARDIOL, V111, P510, DOI 10.1016/j.amjcard.2012.10.036; Kashiwagi M, 2009, JACC-CARDIOVASC IMAG, V2, P1412, DOI 10.1016/j.jcmg.2009.09.012; Hachamovitch R, 2012, J AM COLL CARDIOL, V59, P462, DOI 10.1016/j.jacc.2011.09.066; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Otsuka K, 2013, JACC-CARDIOVASC IMAG, V6, P448, DOI [10.1016/j.jcmg.2012.09.016, 10.1016/j.jcmg.2012.12.016]; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Ropers D, 2003, CIRCULATION, V107, P664, DOI 10.1161/01.CIR.0000055738.31551.A9; Yonetsu T, 2013, CIRC J, V77, P1933, DOI 10.1253/circj.CJ-13-0643.1; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396; Hachamovitch R, 1998, CIRCULATION, V97, P535; Voros S, 2011, JACC-CARDIOVASC IMAG, V4, P537, DOI 10.1016/j.jcmg.2011.03.006; Schuijf JD, 2006, J AM COLL CARDIOL, V48, P2508, DOI 10.1016/j.jacc.2006.05.080; Cho I, 2012, CIRCULATION, V126, P304, DOI 10.1161/CIRCULATIONAHA.111.081380; Gaemperli O, 2007, J NUCL MED, V48, P696, DOI 10.2967/jnumed.106.037606; Mueller M, 2013, CIRC J, V77, P1653, DOI 10.1253/circj.CJ-13-0706; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Uetani T, 2010, JACC-CARDIOVASC IMAG, V3, P19, DOI 10.1016/j.jcmg.2009.09.016; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Soeda T, 2011, INT J CARDIOL, V148, P313, DOI 10.1016/j.ijcard.2009.11.019; Litt HI, 2012, NEW ENGL J MED, V366, P1393, DOI 10.1056/NEJMoa1201163; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Ozaki Y, 2011, EUR HEART J, V32, P2814, DOI 10.1093/eurheartj/ehr189; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Lardo AC, 2006, CIRCULATION, V113, P394, DOI 10.1161/CIRCULATIONAHA.105.521450; Nishio M, 2011, HEART, V97, P1397, DOI 10.1136/hrt.2011.227181; Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Pazhenkottil AP, 2011, EUR HEART J, V32, P2824, DOI 10.1093/eurheartj/ehr232; Maurovich-Horvat P, 2010, JACC-CARDIOVASC IMAG, V3, P440, DOI 10.1016/j.jcmg.2010.02.003; Hadamitzky M, 2013, EUR HEART J, V34, P3277, DOI 10.1093/eurheartj/eht293; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Min JK, 2012, J CARDIOVASC COMPUT, V6, P274, DOI 10.1016/j.jcct.2012.06.002; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Kodama T, 2012, JACC-CARDIOVASC INTE, V5, P636, DOI 10.1016/j.jcin.2012.02.016; Nakazawa G, 2008, AM HEART J, V155, P1150, DOI 10.1016/j.ahj.2008.01.006; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Achenbach S, 2004, J AM COLL CARDIOL, V43, P842, DOI 10.1016/j.jacc.2003.09.053; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Ostrom MP, 2008, J AM COLL CARDIOL, V52, P1335, DOI 10.1016/j.jacc.2008.07.027; Kurobe Y, 2014, J CARDIOVASC COMPUT, V8, P289, DOI 10.1016/j.jcct.2014.06.004; Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255; Feldman DN, 2011, CATHETER CARDIO INTE, V77, P1020, DOI 10.1002/ccd.22962; Fujimoto S, 2012, JACC-CARDIOVASC IMAG, V5, P1181, DOI 10.1016/j.jcmg.2012.01.026; Habis M, 2007, J AM COLL CARDIOL, V49, P1178, DOI 10.1016/j.jacc.2006.12.032; Hacker M, 2005, J NUCL MED, V46, P1294; Hlatky Mark A, 2014, J Am Coll Cardiol, V63, P1002, DOI 10.1016/j.jacc.2013.11.038; Hoffmann U, 2012, NEW ENGL J MED, V367, P299, DOI 10.1056/NEJMoa1201161; Kirisli HA, 2014, J NUCL MED, V55, P50, DOI 10.2967/jnumed.113.119842; Koo BK, 2014, CIRC J, V78, P1048, DOI 10.1253/circj.CJ-14-0249; Li SH, 2013, INT J CARDIOL, V168, P5035, DOI 10.1016/j.ijcard.2013.07.222; Motoyama S, 2013, CIRC J, V77, P411, DOI 10.1253/circj.CJ-12-0688; Nishio M, 2014, CIRC J, V78, P2203, DOI 10.1253/circj.CJ-14-0103; Rochitte CE, 2013, EUR HEART J, V35, P1120; Sato A, 2008, EUR HEART J, V29, P490, DOI 10.1093/eurheartj/ehm630; Sato A, 2015, INT J CARDIOL, V182, P419, DOI 10.1016/j.ijcard.2015.01.021; Sato A, 2008, J NUCL MED, V49, P564, DOI 10.2967/jnumed.107.042481	74	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					712	720		10.1253/circj.CJ-15-0102		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100005		
J	Koyama, J; Ikeda, S; Ikeda, U				Koyama, Jun; Ikeda, Shu-ichi; Ikeda, Uichi			Echocardiographic Assessment of the Cardiac Amyloidoses	CIRCULATION JOURNAL			English	Review						Cardiac amyloidosis; Doppler imaging; Echocardiography	SPECKLE-TRACKING ECHOCARDIOGRAPHY; TWO-DIMENSIONAL ECHOCARDIOGRAPHY; VENTRICULAR DIASTOLIC FUNCTION; LIGHT-CHAIN AMYLOIDOSIS; AL PRIMARY AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; DOPPLER-ECHOCARDIOGRAPHY; PROGNOSTIC-SIGNIFICANCE; HEART-DISEASE; INFILTRATIVE CARDIOMYOPATHY	Cardiac amyloidosis is a cardiomyopathy characterized by increased left ventricular (LV) wall thickness and normal or decreased LV cavity size. Congestive heart failure in cardiac amyloidosis is generally considered a predominantly diastolic phenomenon, with systolic dysfunction only occurring in late-stage disease. Echocardiography is a noninvasive, reproducible method of assessing cardiac features and function in cardiac amyloidosis, and some echocardiographic indices are prognostic for the amyloidoses, with M-mode and 2-dimensional echocardiography able to detect increased LV wall thickness. Moreover, Doppler flow measurements can incrementally assess diastolic LV dysfunction, which is characteristic of cardiac amyloidosis, and provide important prognostic information. Additionally, tissue Doppler imaging can detect subtle changes in both systolic and diastolic LV function, which cannot be detected by Doppler flow measurements, and LV longitudinal strain assessed by color tissue Doppler and speckle tracking echocardiography can provide more accurate LV functional and prognostic information than tissue Doppler imaging. This review describes the advances in echocardiography and its crucial role in the diagnosis and management of cardiac amyloidosis.	[Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 3908621, Japan	Koyama, J (reprint author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	jkoyama@shinshu-u.ac.jp					Al-Zahrani GB, 2009, J AM SOC ECHOCARDIOG, V22, P290, DOI 10.1016/j.echo.2008.11.013; Koyama J, 2003, CIRCULATION, V107, P2446, DOI 10.1161/01.CIR.0000068313.67758.4F; Seo Y, 2014, CIRC J, V78, P1290, DOI 10.1253/circj.CJ-14-0360; KLEIN AL, 1990, J AM COLL CARDIOL, V15, P99; Dubrey SW, 1997, HEART, V78, P74; CARROLL JD, 1982, AM J CARDIOL, V49, P9, DOI 10.1016/0002-9149(82)90270-3; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; ROBERTS WC, 1983, AM J CARDIOL, V52, P137, DOI 10.1016/0002-9149(83)90084-X; Ng B, 2005, ARCH INTERN MED, V165, P1425, DOI 10.1001/archinte.165.12.1425; Buss SJ, 2012, J AM COLL CARDIOL, V60, P1067, DOI 10.1016/j.jacc.2012.04.043; Tei CW, 1996, J AM COLL CARDIOL, V28, P658, DOI 10.1016/0735-1097(96)00202-1; FALK RH, 1983, AM J CARDIOL, V51, P826, DOI 10.1016/S0002-9149(83)80140-4; Phelan D, 2014, J AM SOC ECHOCARDIOG, V27, P888, DOI 10.1016/j.echo.2014.04.015; Rapezzi C, 2009, CIRCULATION, V120, P1203, DOI 10.1161/CIRCULATIONAHA.108.843334; Patel AR, 1997, AM J CARDIOL, V80, P486; KLEIN AL, 1990, J AM COLL CARDIOL, V16, P1135; SIMONS M, 1992, AM J CARDIOL, V69, P425, DOI 10.1016/0002-9149(92)90250-3; Quarta CC, 2014, CIRCULATION, V129, P1840, DOI 10.1161/CIRCULATIONAHA.113.006242; Dubrey SW, 1997, AM HEART J, V134, P994, DOI 10.1016/S0002-8703(97)70017-6; Koike H, 2012, AMYLOID, V19, P55, DOI 10.3109/13506129.2012.674580; Rahman JE, 2004, J AM COLL CARDIOL, V43, P410, DOI 10.1016/j.jacc.2003.08.043; KLEIN AL, 1991, CIRCULATION, V83, P808; Bellavia D, 2008, AM J CARDIOL, V101, P1039, DOI 10.1016/j.amjcard.2007.11.047; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Di Bella G, 2011, CIRC J, V75, P1200, DOI 10.1253/circj.CJ-10-0844; Sun JP, 2009, AM J CARDIOL, V103, P411, DOI 10.1016/j.amjcard.2008.09.102; Koike H, 2002, ARCH NEUROL-CHICAGO, V59, P1771, DOI 10.1001/archneur.59.11.1771; FALK RH, 1984, J AM COLL CARDIOL, V3, P107; Koyama J, 2010, JACC-CARDIOVASC IMAG, V3, P333, DOI 10.1016/j.jcmg.2009.11.013; Atsumi A, 2013, CIRC J, V77, P1760, DOI 10.1253/circj.CJ-12-1445; Bellavia D, 2012, EUR HEART J CARDIOVA, V8, P680; Bellavia D, 2007, J AM SOC ECHOCARDIOG, V20, P1194, DOI 10.1016/j.echo.2007.02.025; Bellavia D, 2010, J AM SOC ECHOCARDIOG, V23, P643, DOI 10.1016/j.echo.2010.03.027; BHANDARI AK, 1983, AM J CARDIOL, V51, P817, DOI 10.1016/S0002-9149(83)80139-8; BORER JS, 1977, AM J CARDIOL, V39, P184, DOI 10.1016/S0002-9149(77)80189-6; CHEW C, 1975, AM J CARDIOL, V36, P438, DOI 10.1016/0002-9149(75)90891-7; CHILD JS, 1976, CHEST, V70, P726, DOI 10.1378/chest.70.6.726; CHILD JS, 1981, AM HEART J, V101, P797, DOI 10.1016/0002-8703(81)90618-9; CHILD JS, 1979, AM J CARDIOL, V44, P1391, DOI 10.1016/0002-9149(79)90458-2; CUETOGARCIA L, 1985, J AM COLL CARDIOL, V6, P737; DUBREY S, 1995, BRIT HEART J, V74, P541; ERIKSSON P, 1984, BRIT HEART J, V52, P321; FALK RH, 1987, AM J CARDIOL, V59, P418, DOI 10.1016/0002-9149(87)90948-9; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Feng D, 2007, CIRCULATION, V116, P2420, DOI 10.1161/CIRCULATIONAHA.107.697763; Feng DL, 2009, CIRCULATION, V119, P2490, DOI 10.1161/CIRCULATIONAHA.108.785014; FOURNIER C, 1993, AM J CARDIOL, V72, P854, DOI 10.1016/0002-9149(93)91085-V; HAMER JPM, 1992, EUR HEART J, V13, P623; HONGO M, 1986, CIRCULATION, V73, P249; KINOSHITA O, 1989, BRIT HEART J, V61, P198; KLEIN AL, 1989, J AM COLL CARDIOL, V13, P1017; Koyama J, 2004, J AM SOC ECHOCARDIOG, V17, P36, DOI 10.1067/j.echo.2003.09.014; Koyama J, 2002, AM J CARDIOL, V89, P1067, DOI 10.1016/S0002-9149(02)02277-4; Koyama J, 2002, CIRCULATION, V106, P556, DOI 10.1161/01.CIR.0000023530.86718.B0; Kristen AV, 2007, EUR J HEART FAIL, V9, P617, DOI 10.1016/j.ejheart.2007.01.012; Kusunose K, 2010, CIRC J, V74, P1494, DOI 10.1253/circj.CJ-10-0141; Liu D, 2013, CIRC-CARDIOVASC IMAG, V6, P1066, DOI 10.1161/CIRCIMAGING.113.000683; Liu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056923; Migrino RQ, 2009, J AM SOC ECHOCARDIOG, V22, P1396, DOI 10.1016/j.echo.2009.09.012; Modesto KM, 2006, EUR J ECHOCARDIOGR, V7, P315, DOI 10.1016/j.euje.2005.07.003; Murphy L, 2000, AM J CARDIOL, V86, P244, DOI 10.1016/S0002-9149(00)00870-5; NICOLOSI GL, 1984, CIRCULATION, V70, P432; Ogiwara F, 2005, AM J CARDIOL, V95, P538, DOI 10.1016/j.amjcard.2004.10.029; Oki T, 2004, AM J CARDIOL, V93, P864, DOI 10.1016/j.amjcard.2003.12.025; Palka P, 2002, J AM SOC ECHOCARDIOG, V15, P1353, DOI 10.1067/mje.2002.125285; Perugini E, 2005, AM J CARDIOL, V95, P146, DOI 10.1016/j.amjcard.2004.08.084; PINAMONTI B, 1989, J AM COLL CARDIOL, V14, P666; Pinney JH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000098; Seo Y, 2013, CIRC J, V77, P2481, DOI 10.1253/circj.CJ-13-0380; SIQUEIRAFILHO AG, 1981, CIRCULATION, V63, P188; SUTTON MGS, 1982, CIRCULATION, V66, P790; Tei C, 1995, J Cardiol, V26, P135	72	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					721	734		10.1253/circj.CJ-14-1425		14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100006		
J	Uematsu, M				Uematsu, Masaaki			Speckle Tracking Echocardiography - Quo Vadis?	CIRCULATION JOURNAL			English	Review						Deformation; Eulerian coordinates; Lagrangian coordinates; Myocardial velocity gradient; Stress-strain relationship	MYOCARDIAL VELOCITY-GRADIENT; DOPPLER IMAGING TECHNIQUE; VENTRICULAR SYSTOLIC FUNCTION; GLOBAL LONGITUDINAL STRAIN; DIASTOLIC FUNCTION; TISSUE VELOCITY; 2-DIMENSIONAL STRAIN; ISCHEMIC-MYOCARDIUM; EJECTION FRACTION; NORMAL RANGE	Although echocardiography is a noninvasive means of visualizing the heart, quantitative and reproducible assessment of myocardial motion remains to be established. Tissue Doppler imaging (TDI) emerged in the early 1990 s as a tool to measure tissue motion velocity. For the purpose of analyzing regional myocardial motion quantitatively, the myocardial velocity gradient (MVG) across the myocardial wall was first introduced by using TDI. MVG is mathematically equal to strain rate. Initially, strain was derived as the time integral of the TDI-derived strain rate, but it revealed substantial errors of measurement, which basically arose from the confusion of Eulerian coordinates with Lagrangian coordinates in fluid dynamics. Speckle tracking echocardiography (STE) has subsequently emerged as a technique that analyzes motion by tracking "speckles" on echocardiograms based on Lagrangian coordinates. Although STE-derived strain is a robust parameter of myocardial deformation, the stress-strain relationship has often been overlooked in the assessment of myocardial function. We should consider (1) blood pressure, (2) left ventricular size, and (3) left ventricular wall thickness, as well as strain. Practical means of normalizing strain by stress should be pursued in the quantitative assessment of myocardial function. Consideration of stress-strain relationships is mandatory when interpreting STE-derived strain.	Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo 6608511, Japan	Uematsu, M (reprint author), Kansai Rosai Hosp, Ctr Cardiovasc, 3-1-69 Inabaso, Amagasaki, Hyogo 6608511, Japan.	uematsu@kanrou.net					Abraham TP, 2002, CIRCULATION, V105, P1403, DOI 10.1161/01.CIR.0000013423.33806.77; Koyama J, 2003, CIRCULATION, V107, P2446, DOI 10.1161/01.CIR.0000068313.67758.4F; Seo Y, 2014, CIRC J, V78, P1290, DOI 10.1253/circj.CJ-14-0360; Simmons LA, 2002, J AM SOC ECHOCARDIOG, V15, P768, DOI 10.1067/mje.2002.120504; Edvardsen T, 2002, CIRCULATION, V106, P50, DOI 10.1161/01.CIR.0000019907.77526.75; Edvardsen T, 2002, CIRCULATION, V105, P2071, DOI 10.1161/01.CIR.0000014614.63980.BA; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Chiang SJ, 2014, CIRC J, V78, P419, DOI 10.1253/circj.CJ-13-0513; Kleijn SA, 2012, EUR HEART J-CARD IMG, V13, P159, DOI 10.1093/ejechocard/jer174; Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Stoylen A, 2001, J AM SOC ECHOCARDIOG, V14, P264, DOI 10.1067/mje.2001.110375; Dokainish H, 2011, EUR J ECHOCARDIOGR, V12, P857, DOI 10.1093/ejechocard/jer157; Galderisi M, 2014, EUR HEART J-CARD IMG, V15, P810, DOI 10.1093/ehjci/jeu022; Feigenbaum H, 2012, CIRC J, V76, P1550, DOI 10.1253/circj.CJ-12-0665; D'hooge J, 2002, IEEE T ULTRASON FERR, V49, P281, DOI 10.1109/58.985712; Urheim S, 2000, CIRCULATION, V102, P1158; Shah AM, 2012, CIRCULATION, V125, pE244, DOI 10.1161/CIRCULATIONAHA.111.086348; Skulstad H, 2004, J AM SOC ECHOCARDIOG, V17, P1225, DOI 10.1016/j.echo.2004.07.014; Hashimoto I, 2003, J AM COLL CARDIOL, V42, P1574, DOI 10.1016/S0735-1097(03)01074-X; Edvardsen T, 2001, J AM COLL CARDIOL, V37, P726, DOI 10.1016/S0735-1097(00)01160-8; Kaluzynski K, 2001, IEEE T ULTRASON FERR, V48, P1111, DOI 10.1109/58.935730; MCDICKEN WN, 1992, ULTRASOUND MED BIOL, V18, P651, DOI 10.1016/0301-5629(92)90080-T; Singh GK, 2010, J AM SOC ECHOCARDIOG, V23, P1143, DOI 10.1016/j.echo.2010.08.010; Pislaru C, 2001, J AM COLL CARDIOL, V37, P1141, DOI 10.1016/S0735-1097(01)01113-5; Castro PL, 2000, BIOMED SCI INSTRUM, V395, P197; Kusunose K, 2011, CIRC J, V75, P141, DOI 10.1253/circj.CJ-10-0551; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Hoffmann R, 2002, J AM COLL CARDIOL, V39, P443, DOI 10.1016/S0735-1097(01)01763-6; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Greenberg NL, 2002, CIRCULATION, V105, P99, DOI 10.1161/hc0102.101396; Armstrong WF, 2010, FEIGENBAUMS ECHOCARD; Batchelor G. K., 2000, INTRO FLUID DYNAMICS; Buccheri S, 2013, BIOMED RES INT, DOI 10.1155/2013/297895; FLEMING AD, 1994, BRIT J RADIOL, V67, P679; FLEMING AD, 1994, ULTRASOUND MED BIOL, V20, P937, DOI 10.1016/0301-5629(94)90053-1; Hatle L, 1985, DOPPLER ULTRASOUND C; Kaku K, 2014, J AM SOC ECHOCARDIOG, V27, P55, DOI 10.1016/j.echo.2013.10.002; MCHALE PA, 1973, CIRC RES, V33, P303; MIRSKY I, 1974, CIRCULATION, V50, P128; MIYATAKE K, 1995, J AM COLL CARDIOL, V25, P717, DOI 10.1016/0735-1097(94)00421-L; Mochizuki Y, 2014, CIRC J, V78, P2250, DOI 10.1253/circj.CJ-14-0114; MORIARTY TF, 1980, CIRC RES, V46, P321; Nakamura A, 2014, CIRC J, V78, P1960, DOI 10.1253/circj.CJ-13-1588; Nakayama K, 1998, AM HEART J, V135, P99, DOI 10.1016/S0002-8703(98)70349-7; Palka P, 1995, J Am Soc Echocardiogr, V8, P659, DOI 10.1016/S0894-7317(05)80380-3; Sato K, 2014, CIRC J, V78, P2750, DOI 10.1253/circj.CJ-14-0726; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Shimizu Y, 2003, J AM SOC ECHOCARDIOG, V16, P246, DOI 10.1067/mje.2003.56; Shimizu Y, 1998, J AM COLL CARDIOL, V32, P1418, DOI 10.1016/S0735-1097(98)00394-5; Stoylen A, 2003, SCAND CARDIOVASC J, V37, P253, DOI 10.1080/14017430310015000; Sun JP, 2013, INT J CARDIOL, V167, P495, DOI 10.1016/j.ijcard.2012.01.071; Sutherland GR, 2006, DOPPLER MYOCARDIAL I; Takenaka K, 2001, J Cardiol, V37 Suppl 1, P129; Tsutsui H, 1998, J AM COLL CARDIOL, V31, P89, DOI 10.1016/S0735-1097(97)00430-0; Uematsu M, 1999, ECHOCARDIOGR-J CARD, V16, P465, DOI 10.1111/j.1540-8175.1999.tb00093.x; Uematsu M, 1997, AM J CARDIOL, V79, P237; UEMATSU M, 1995, J AM COLL CARDIOL, V26, P217, DOI 10.1016/0735-1097(95)00158-V	59	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					735	741		10.1253/circj.CJ-15-0049		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100007		
J	Komatsu, S; Ohara, T; Takahashi, S; Takewa, M; Minamiguchi, H; Imai, A; Kobayashi, Y; Iwa, N; Yutani, C; Hirayama, A; Kodama, K				Komatsu, Sei; Ohara, Tomoki; Takahashi, Satoru; Takewa, Mitsuhiko; Minamiguchi, Hitoshi; Imai, Atsuko; Kobayashi, Yasuhiko; Iwa, Nobuzo; Yutani, Chikao; Hirayama, Atsushi; Kodama, Kazuhisa			Early Detection of Vulnerable Atherosclerotic Plaque for Risk Reduction of Acute Aortic Rupture and Thromboemboli and Atheroemboli Using Non-Obstructive Angioscopy	CIRCULATION JOURNAL			English	Review						Aneurysm; Angioscopy; Aorta; Dissection; Vulnerable plaque	ENDOVASCULAR-ANEURYSM-REPAIR; RANDOMIZED CONTROLLED-TRIAL; FOR-VASCULAR-SURGERY; THORACIC AORTA; INTERNATIONAL REGISTRY; MYOCARDIAL-INFARCTION; INTRAMURAL HEMATOMA; CORONARY ANGIOSCOPE; NATURAL-HISTORY; JOINT COUNCIL	The mortality rate due to rupture of aortic dissection and aortic aneurysm is approximately 90%. Acute aortic rupture can be fatal prior to hospitalization and has proven difficult to diagnose correctly or predict. The in-hospital mortality rate of ruptured aortic aneurysm ranges from 53 to 66%. Emergency surgical and endovascular treatments are the only options for ruptured aortic dissection and aortic aneurysm. No method of systematic early detection or inspection of vessel injury is available at the prevention stage. Regardless of the improvement in many imaging modalities, aortic diameter has remained a major criterion for recommending surgery in diagnosed patients. Previous reports have suggested a relationship between vulnerable plaque and atherosclerotic aortic aneurysm. Non-obstructive angioscopy is a new method for evaluating intimal injury over the whole aorta. It has been used to identify many advanced atherosclerotic plaques that were missed on traditional imaging modalities before aneurysm formation. Non-obstructive angioscopy has shown that atherosclerosis of the aorta begins before that of the coronary artery, which had been noted on autopsy "in vivo". Strong or repetitive aortic injuries might cause sudden aortic disruption. Aortic atheroma is also a risk factor of stroke and perivascular embolism. Detecting aortic vulnerable atherosclerotic plaque on non-obstructive angioscopy may not only clarify the pathogenesis of acute aortic rupture and "aortogenic" thromboemboli and atheroemboli but also play a role in the pre-emptive medicine.	[Komatsu, Sei; Ohara, Tomoki; Takahashi, Satoru; Takewa, Mitsuhiko; Minamiguchi, Hitoshi; Imai, Atsuko; Kobayashi, Yasuhiko; Kodama, Kazuhisa] Amagasaki Cent Hosp, Ctr Cardiovasc, Amagasaki, Hyogo 6610976, Japan; [Iwa, Nobuzo; Yutani, Chikao] Amagasaki Cent Hosp, Dept Pathol, Amagasaki, Hyogo 6610976, Japan; [Minamiguchi, Hitoshi; Imai, Atsuko] Osaka Univ, Sch Med, Dept Cardiol, Osaka, Japan; [Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Komatsu, S (reprint author), Amagasaki Cent Hosp, Ctr Cardiovasc, 1-12-1 Shio E, Amagasaki, Hyogo 6610976, Japan.	plaquemap@yahoo.co.jp					ANAGNOST.CE, 1972, AM J CARDIOL, V30, P263, DOI 10.1016/0002-9149(72)90070-7; Saric M, 2011, CURR OPIN CARDIOL, V26, P472, DOI 10.1097/HCO.0b013e32834b7fdd; Ashton HA, 2002, LANCET, V360, P1531; Kurosawa K, 2013, CIRC J, V77, P2860, DOI 10.1253/circj.CJ-13-1252; Brown LC, 1999, ANN SURG, V230, P289; Hansen MS, 2007, AM J CARDIOL, V99, P852, DOI 10.1016/j.amjcard.2006.10.055; FLORY CM, 1945, AM J PATHOL, V21, P549; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Elefteriades JA, 2002, ANN THORAC SURG, V74, pS1877, DOI 10.1016/S0003-4975(02)04147-4; Van Mieghem NM, 2013, CIRCULATION, V127, P2194, DOI 10.1161/CIRCULATIONAHA.112.001091; Kramer CM, 2004, CIRCULATION, V109, P1016, DOI 10.1161/01.CIR.0000116767.95046.C2; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Michel JB, 2012, J CARDIOVASC MED, V13, P628, DOI 10.2459/JCM.0b013e328357face; Elefteriades JA, 2010, J AM COLL CARDIOL, V55, P841, DOI 10.1016/j.jacc.2009.08.084; Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340; Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363; Kronzon I, 2006, CIRCULATION, V114, P63, DOI 10.1161/CIRCULATIONAHA.105.593418; Lee ES, 2009, J VASC SURG, V49, P1107, DOI 10.1016/j.jvs.2008.12.008; Tunick PA, 2000, J AM COLL CARDIOL, V35, P545, DOI 10.1016/S0735-1097(99)00604-X; Chiappini B, 2005, EUR HEART J, V26, P180, DOI 10.1093/eurheartj/ehi024; MASUDA J, 1994, NEUROLOGY, V44, P1231; Sabik JF, 2000, J THORAC CARDIOV SUR, V119, P946, DOI 10.1016/S0022-5223(00)70090-0; Bashur CA, 2013, STEM CELL TRANSL MED, V2, P401, DOI 10.5966/sctm.2012-0185; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; EMANUELSSON H, 1995, J INTERN MED, V238, P111; Guidoux C, 2013, ATHEROSCLEROSIS, V231, P124, DOI 10.1016/j.atherosclerosis.2013.08.025; Handa N, 2014, CIRC J, V78, P1104, DOI 10.1253/circj.CJ-14-0131; HAVERICH A, 1985, CIRCULATION, V72, P22; HIirst Jr AE, 1958, MEDICINE, V37, P217; Hirayama A, 2009, CIRC J, V73, P718; HOLLIER LH, 1992, J VASC SURG, V15, P1046; Ishimaru S, 2013, CIRC J, V77, P789, DOI 10.1253/circj.CJ-66-0057; Kaji S, 2003, CIRCULATION, V108, P307, DOI 10.1161/01.cir.0000087425.86049.74; Karalis DG, 1996, AM HEART J, V131, P1149, DOI 10.1016/S0002-8703(96)90090-3; Karthikesalingam A, 2014, LANCET, V383, P963, DOI 10.1016/S0140-6736(14)60109-4; Katsanos AH, 2014, STROKE, V45, P3352, DOI 10.1161/STROKEAHA.114.007109; Kodama K, 2000, INTERNAL MED, V39, P333, DOI 10.2169/internalmedicine.39.333; Komanapalli CB, 2006, EUR J CARDIO-THORAC, V29, P616, DOI 10.1016/j.ejcts.2006.01.032; Komatsu S, 2006, INT J CARDIOL, V113, P288, DOI 10.1016/j.ijcard.2005.09.049; Komatsu S, 2007, INT J CARDIOL, V123, pE12, DOI 10.1016/j.ijcard.2006.11.106; Komatsu S, 2014, J CARDIOL CASES, V9, P18; Kruger T, 2012, BRIT J SURG, V99, P1331, DOI 10.1002/bjs.8840; Lai DT, 2002, CIRCULATION, V106, pI218, DOI 10.1161/01.cir.000032890.55215.27; Liew YP, 2005, VASC MED, V10, P309, DOI 10.1191/1358863x05vm640ra; LITVACK F, 1985, CLIN CARDIOL, V8, P65; MASUDA Y, 1991, CIRCULATION, V84, P7; Mateo J, 2014, CIRC-CARDIOVASC IMAG, V7, P312, DOI 10.1161/CIRCIMAGING.113.001084; Minami T, 2013, ANN THORAC CARDIOVAS, V19, P461, DOI 10.5761/atcs.oa.12.02077; MIZUNO K, 1989, J AM COLL CARDIOL, V13, P363; Molisse Theresa A, 2007, Curr Treat Options Cardiovasc Med, V9, P137, DOI 10.1007/s11936-007-0007-4; Nagata M, 2013, AM HEART J, V165, P932, DOI 10.1016/j.ahj.2013.02.028; Nakanishi N, 2014, J CARDIOVASC MED HAG, DOI [10.2459/JCM.0000000000000166, DOI 10.2459/JCM.0000000000000166]; NANTO S, 1991, American Journal of Cardiac Imaging, V5, P1; Pansini S, 1998, ANN THORAC SURG, V66, P779, DOI 10.1016/S0003-4975(98)00555-4; Rutledge R, 1996, ANN SURG, V223, P492, DOI 10.1097/00000658-199605000-00005; Saric M, 2012, CURR CARDIOL REP, V14, P342, DOI 10.1007/s11886-012-0261-2; SPEARS JR, 1983, J AM COLL CARDIOL, V1, P1311; Stanson A W, 1986, Ann Vasc Surg, V1, P15, DOI 10.1016/S0890-5096(06)60697-3; Stern A, 1999, AM HEART J, V138, P746, DOI 10.1016/S0002-8703(99)70191-2; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Sullivan PR, 2007, AM J CARDIOL, V99, P852; Sullivan PR, 2000, AM J EMERG MED, V18, P46, DOI 10.1016/S0735-6757(00)90047-0; Tsai TT, 2006, CIRCULATION S1, V114, P350, DOI 10.1161/CIRCULATIONAHA.105.000497; UEDA Y, 1994, J AM COLL CARDIOL, V23, P341; van Heeswijk RB, 2014, RADIOLOGY, DOI [10.1148/radiol.14141371, DOI 10.1148/RADIOL.14141371]; Vilacosta I, 1997, AM HEART J, V134, P495, DOI 10.1016/S0002-8703(97)70087-5; YUTANI C, 1992, MODERN PATHOL, V5, P244; YUTANI C, 1985, ACTA PATHOL JAPON, V35, P789	71	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					742	750		10.1253/circj.CJ-15-0126		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100008		
J	Itoh, T				Itoh, Tomonori			How Can We Predict Reduced Fractional Flow Reserve Using Coronary Lesion Characteristics?	CIRCULATION JOURNAL			English	Editorial Material							ARTERY-DISEASE; FUNCTIONAL SEVERITY; FOLLOW-UP; STENOSIS; INTERVENTION		Iwate Med Univ, Dept Internal Med, Mem Heart Ctr, Div Cardiol, Morioka, Iwate 0208505, Japan	Itoh, T (reprint author), Iwate Med Univ, Dept Internal Med, Mem Heart Ctr, Div Cardiol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	tomoitoh@iwate-med.ac.jp					Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Iguchi T, 2013, CLIN CARDIOL, V36, P172, DOI 10.1002/clc.22076; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; PIJLS NHJ, 1995, CIRCULATION, V92, P3183; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; DEBRUYNE B, 1995, CIRCULATION, V92, P39; PFITZNER J, 1976, ANAESTHESIA, V31, P273, DOI 10.1111/j.1365-2044.1976.tb11804.x; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Koo BK, 2014, CIRC J, V78, P1048, DOI 10.1253/circj.CJ-14-0249; Nakamura Masato, 2014, Cardiovasc Interv Ther, V29, P300, DOI 10.1007/s12928-014-0259-3; Natsumeda M, 2015, CIRC J, V79, P802, DOI 10.1253/circj.CJ-14-0931; Takashima H, 2015, J CARDIOL, V66, P239, DOI 10.1016/j.jjcc.2014.11.004; Yanagisawa H, 2002, CIRC J, V66, P1105, DOI 10.1253/circj.66.1105	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					751	753		10.1253/circj.CJ-15-0209		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100009		
J	Nakagami, H				Nakagami, Hironori			Evaluation of the Genetic Risk of Hypertension-Related Diseases	CIRCULATION JOURNAL			English	Editorial Material							ANGIOTENSIN-CONVERTING-ENZYME; ISCHEMIC-HEART-DISEASE; HYPERTROPHIC CARDIOMYOPATHY; POLYMORPHISM; METAANALYSIS; ASSOCIATION		Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka 5650871, Japan	Nakagami, H (reprint author), Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	nakagami@gts.med.osaka-u.ac.jp					AgerholmLarsen B, 1997, CIRCULATION, V95, P2358; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Shimizu W, 2013, CIRC J, V77, P2867, DOI 10.1253/circj.CJ-13-1217; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Chaudhary J, 2001, AM J PHYSIOL-CELL PH, V280, pC1027; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Funada A, 2010, CIRC J, V74, P2674, DOI 10.1253/circj.CJ-10-0482; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; MARIAN AJ, 1993, LANCET, V342, P1085, DOI 10.1016/0140-6736(93)92064-Z; Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429; Takeuchi F, 2015, CIRC J, V79, P830, DOI 10.1253/circj.CJ-14-0841; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					756	757		10.1253/circj.CJ-15-0178		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100011		
J	Ishihara, M				Ishihara, Masaharu			Takotsubo Cardiomyopathy and Left Ventricular Outflow Tract Obstruction	CIRCULATION JOURNAL			English	Editorial Material							TAKO-TSUBO CARDIOMYOPATHY; CLINICAL PROFILE; PATHOPHYSIOLOGY; PREVALENCE; MANAGEMENT		Hyogo Coll Med, Div Coronary Artery Dis, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Ishihara, M (reprint author), Hyogo Coll Med, Div Coronary Artery Dis, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ma-ishihara@hyo-med.ac.jp					Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Scantlebury DC, 2014, CIRC J, V78, P2129, DOI 10.1253/circj.CJ-14-0859; El Mahmoud R, 2008, AM HEART J, V156, P543, DOI 10.1016/j.ahj.2008.05.002; Kurisu S, 2014, CIRC J, V78, P1559, DOI 10.1253/circj.CJ-14-0382; Izumo M, 2011, CIRC-CARDIOVASC IMAG, V4, P392, DOI 10.1161/CIRCIMAGING.110.962845; Sharkey SW, 2014, CIRC J, V78, P2119, DOI 10.1253/circj.CJ-14-0770; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Redfors B, 2014, INT J CARDIOL, V177, P771, DOI 10.1016/j.ijcard.2014.10.156; De Backer O, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-147; Kawaji T, 2015, CIRC J, V79, P839, DOI 10.1253/circj.CJ-14-1148; Merli E, 2006, EUR J ECHOCARDIOGR, V7, P53, DOI 10.1016/j.euje.2005.08.003; Sato H, 1990, CLIN ASPECT MYOCARDI, P56; Yoshioka T, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.10.042	14	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					758	760		10.1253/circj.CJ-15-0089		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100012		
J	Takahashi, K				Takahashi, Kazuhiro			Fetal Bradycardia Associated With Congenital Heart Defects - Is There a Clinicohistological Correlation?	CIRCULATION JOURNAL			English	Editorial Material							COMPLETE ATRIOVENTRICULAR-BLOCK; CORRECTED TRANSPOSITION; GREAT-ARTERIES; ISOMERISM; TISSUES		Okinawa Childrens Med Ctr, Dept Pediat Cardiol, Haebaru, Okinawa 9011193, Japan	Takahashi, K (reprint author), Okinawa Childrens Med Ctr, Dept Pediat Cardiol, 118-1 Arakawa, Haebaru, Okinawa 9011193, Japan.	bigkaz@mua.biglobe.ne.jp					Anderson RH, 1991, CARDIOL YOUNG, V1, P159; HO SY, 1992, J AM COLL CARDIOL, V20, P904; HO SY, 1986, AM J CARDIOL, V58, P291, DOI 10.1016/0002-9149(86)90064-0; DALIENTO L, 1986, AM J CARDIOL, V58, P314, DOI 10.1016/0002-9149(86)90069-X; Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352; ANDERSON RH, 1974, CIRCULATION, V50, P911; BHARATI S, 1978, AM J CARDIOL, V42, P147, DOI 10.1016/0002-9149(78)91000-7; FOSTER JR, 1976, AM J CARDIOL, V38, P383, DOI 10.1016/0002-9149(76)90181-8; GARCIA OL, 1981, AM J CARDIOL, V48, P1103, DOI 10.1016/0002-9149(81)90327-1; Ho SY, 2003, NOVART FDN SYMP, V250, P221; Ho Siew Yen, 2003, Novartis Found Symp, V250, P210; Ho SY, 2003, NOVART FDN SYMP, V250, P276; Josephson ME, 2008, CLIN CARDIAC ELECTRO, V4th, P93; Miyoshi T, 2015, CIRC J, V79, P854, DOI 10.1253/circj.CJ-14-0978; Suzuki T, 2014, CIRC J, V78, P2848, DOI 10.1253/circj.CJ-14-1137	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					761	762		10.1253/circj.CJ-15-0191		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100013		
J	Yamagami, H; Toyoda, K				Yamagami, Hiroshi; Toyoda, Kazunori			Timing of Anticoagulation Therapy in Patients With Acute Cardioembolic Stroke	CIRCULATION JOURNAL			English	Editorial Material							NONVALVULAR ATRIAL-FIBRILLATION; RANDOMIZED CONTROLLED-TRIALS; HEALTH-CARE PROFESSIONALS; ACUTE ISCHEMIC-STROKE; ORAL ANTICOAGULANTS; WARFARIN; ASSOCIATION; METAANALYSIS; RIVAROXABAN; GUIDELINES		[Yamagami, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan; [Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan	Yamagami, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Neurol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	yamagami-brain@umin.ac.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845			Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.00002546000.92975.1f; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Azoulay L, 2014, EUR HEART J, V35, P1881, DOI 10.1093/eurheartj/eht499; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Whiteley WN, 2013, LANCET NEUROL, V12, P539, DOI 10.1016/S1474-4422(13)70079-6; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Nomura E, 2015, CIRC J, V79, P862, DOI 10.1253/circj.CJ-14-0793; Toyoda K, 2015, INT J STROKE, DOI [10.1111/ijs.12452, DOI 10.1111/IJS.12452]; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					763	765		10.1253/circj.CJ-15-0212		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100014		
J	Amaki, M; Anzai, T				Amaki, Makoto; Anzai, Toshihisa			Does Major Noncardiac Surgery Accelerate the Progression of Aortic Stenosis? - Role of Inflammation	CIRCULATION JOURNAL			English	Editorial Material							C-REACTIVE PROTEIN; LOW-DENSITY-LIPOPROTEIN; VALVE DISEASE; ATHEROSCLEROSIS; ROSUVASTATIN		[Amaki, Makoto; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Div Cardiovasc Med, Dept Heart Failure, Suita, Osaka 5650873, Japan	Amaki, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Cardiovasc Med, Dept Heart Failure, 5-7-1 Fujishirodai, Suita, Osaka 5650873, Japan.	amaki@ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967			Novaro GM, 2007, J AM COLL CARDIOL, V50, P1992, DOI 10.1016/j.jacc.2007.07.064; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Olsson M, 1999, ARTERIOSCL THROM VAS, V19, P1218; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Nohara R, 2013, CIRC J, V77, P1526, DOI 10.1253/circj.CJ-12-1149; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gerber IL, 2003, AM J CARDIOL, V92, P1129, DOI 10.1016/j.amjcard.2003.07.012; Galante A, 2001, J AM COLL CARDIOL, V38, P1078, DOI 10.1016/S0735-1097(01)01484-X; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Carabello BA, 1997, NEW ENGL J MED, V337, P32, DOI 10.1056/NEJM199707033370107; Mizuno R, 2015, CIRC J, V79, P867, DOI 10.1253/circj.CJ-14-1111; Ross R, 1999, NEW ENGL J MED, V340, P115; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Skowasch D, 2006, HEART, V92, P495, DOI 10.1136/hrt.2005.069815	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					766	767		10.1253/circj.CJ-15-0204		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100015		
J	Shinke, T				Shinke, Toshiro			Pioglitazone Revisited to Illuminate Contemporary Vascular Reparative Therapy in the Era of Drug-Eluting Stents	CIRCULATION JOURNAL			English	Editorial Material							ENDOTHELIAL FUNCTION; DIABETES-MELLITUS; RESTENOSIS; CORONARY; IMPLANTATION; PREDICTORS; RESPONSES; MICRORNA		[Shinke, Toshiro] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med, Kobe, Hyogo 6500017, Japan	Shinke, T (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	shinke@med.kobe-u.ac.jp					Santulli G, 2014, J CLIN INVEST, V124, P4102, DOI [10.1172/JCI76069, 10.1172/JCI6069]; Kornowski R, 1997, CIRCULATION, V95, P1366; McDonald RA, 2012, CARDIOVASC RES, V93, P594, DOI 10.1093/cvr/cvr299; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Joner M, 2007, ARTERIOSCL THROM VAS, V27, P182, DOI 10.1161/01.ATV.0000251021.28725.e8; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; West NEJ, 2004, CIRCULATION, V109, P867, DOI 10.1161/01.CIR.0000116750.63158.94; Gilbert RE, 2013, CIRC J, V77, P849, DOI 10.1253/circj.CJ-13-0236; Dohi T, 2011, CIRC J, V75, P1098, DOI 10.1253/circj.CJ-10-0917; Hong SJ, 2015, CIRC J, V79, P880, DOI 10.1253/circj.CJ-14-0964; Iwasaki M, 2014, CIRC J, V78, P2188, DOI 10.1253/circj.CJ-13-1540; Kasai T, 2008, ATHEROSCLEROSIS, V197, P612, DOI 10.1016/j.atherosclerosis.2007.08.030; Patel D, 2011, JACC-CARDIOVASC INTE, V4, P353, DOI 10.1016/j.jcin.2010.10.016; Sourij H, 2006, DIABETES CARE, V29, P1039, DOI 10.2337/dc05-2226	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					768	769		10.1253/circj.CJ-15-0185		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100016		
J	Nakamura, Y; Kunii, H; Yoshihisa, A; Takiguchi, M; Shimizu, T; Yamauchi, H; Iwaya, S; Owada, T; Abe, S; Sato, T; Suzuki, S; Oikawa, M; Kobayashi, A; Yamaki, T; Sugimoto, K; Nakazato, K; Suzuki, H; Saitoh, S; Takeishi, Y				Nakamura, Yuichi; Kunii, Hiroyuki; Yoshihisa, Akiomi; Takiguchi, Mai; Shimizu, Takeshi; Yamauchi, Hiroyuki; Iwaya, Shoji; Owada, Takashi; Abe, Satoshi; Sato, Takamasa; Suzuki, Satoshi; Oikawa, Masayoshi; Kobayashi, Atsushi; Yamaki, Takayoshi; Sugimoto, Koichi; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika			Impact of Peripheral Artery Disease on Prognosis in Hospitalized Heart Failure Patients	CIRCULATION JOURNAL			English	Article						Cardiovascular event; Exercise; Heart failure; Mortality; Peripheral artery disease	ACUTE CORONARY SYNDROME; NECROSIS-FACTOR-ALPHA; EUROPEAN-SOCIETY; CARDIAC TROPONIN; TASK-FORCE; ASSOCIATION; GUIDELINES; OUTCOMES; CARDIOLOGY; PREDICTOR	Background: The impact of peripheral artery disease (PAD) on heart failure (HF) prognosis remains unclear. Methods and Results: A total of 388 consecutive decompensated HF patients were divided into 2 groups based on the presence of PAD: HF with PAD (PAD group, n=101, 26.0%) and HF without PAD (non-PAD group, n=287, 74.0%). We compared clinical features, echocardiographic parameters, cardiopulmonary exercise testing results, laboratory findings, as well as cardiac, non-cardiac, and all-cause mortality between the 2 groups. The PAD group, as compared with the non-PAD group, had (1) higher prevalence of coronary artery disease (40.6 vs. 27.5%, P=0.011) and cerebrovascular disease (34.7 vs. 18.2%, P=0.001); (2) higher tumor necrosis factor-alpha (1.82 vs. 1.49 pg/ml, P=0.023), C-reactive protein (0.32 vs. 0.19 mg/dl, P=0.045), and troponin T (0.039 vs. 0.021 ng/ml, P=0.019); (3) lower LVEF (42.4 vs. 48.5%, P<0.001); (4) lower peak (V) over dotO(2) (13.4 vs. 15.9 ml.kg(-1).min(-1), P=0.001); and (5) higher (V) over dotE/(V) over dotCO(2) slope (38.8 vs. 33.7, P<0.001). On Kaplan-Meier analysis, cardiac, non-cardiac, and all-cause mortality were significantly higher in the PAD group than in the non-PAD group (P<0.05, respectively). On Cox proportional hazard analysis after adjusting for confounding factors, PAD was an independent predictor of cardiac and all-cause mortality (P<0.05, respectively) in HF patients. Conclusions: PAD was common and an independent predictor of cardiac and all-cause mortality in HF patients.	[Nakamura, Yuichi; Kunii, Hiroyuki; Yoshihisa, Akiomi; Takiguchi, Mai; Shimizu, Takeshi; Yamauchi, Hiroyuki; Iwaya, Shoji; Owada, Takashi; Abe, Satoshi; Sato, Takamasa; Suzuki, Satoshi; Oikawa, Masayoshi; Kobayashi, Atsushi; Yamaki, Takayoshi; Sugimoto, Koichi; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan; [Yoshihisa, Akiomi; Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima 9601295, Japan	Yoshihisa, A (reprint author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	yoshihis@fmu.ac.jp			Japan Society for the Promotion of Science [25461061]	The authors thank Ms Kumiko Watanabe, Emiko Kaneda, and Yuko Niimura for their outstanding technical assistance. This study was supported in part by a grant-in-aid for Scientific Research (No. 25461061) from the Japan Society for the Promotion of Science.	McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Ahmed MI, 2010, CIRC-HEART FAIL, V3, P118, DOI 10.1161/CIRCHEARTFAILURE.109.866558; Ponikowski P, 2001, CIRCULATION, V103, P967; Inglis SC, 2013, INT J CARDIOL, V168, P1094, DOI 10.1016/j.ijcard.2012.11.033; Murabito JM, 2009, ATHEROSCLEROSIS, V203, P509, DOI 10.1016/j.atherosclerosis.2008.06.031; O'Neill JO, 2005, CIRCULATION, V111, P2313, DOI 10.1161/01.CIR.0000164270.72123.18; Edelmann F, 2011, CLIN RES CARDIOL, V100, P755, DOI 10.1007/s00392-011-0305-4; Levey AS, 2006, ANN INTERN MED, V145, P247; MANCINI DM, 1992, CIRCULATION, V85, P1364; Meguro T, 2009, CIRC J, V73, P673; Kerr G, 2009, CEREBROVASC DIS, V28, P220, DOI 10.1159/000226773; Perez AV, 2010, INT J CARDIOL, V141, P39, DOI 10.1016/j.ijcard.2008.11.146; Miura M, 2014, CIRC J, V78, P2276, DOI 10.1253/circj.CJ-14-0387; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Kelley WE, 2009, CLIN CHEM, V55, P2098, DOI 10.1373/clinchem.2009.130799; Jones WS, 2011, AM J CARDIOL, V108, P380, DOI 10.1016/j.amjcard.2011.03.057; Ruiz-Canela M, 2014, CIRC J, V78, P553, DOI 10.1253/circj.CJ-14-0062; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Mehta NJ, 2004, INT J CARDIOL, V95, P13, DOI 10.1016/j.ijcard.2003.02.005; Aronow WS, 2009, AM J CARDIOL, V103, P130, DOI 10.1016/j.amjcard.2008.08.037; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Dunlay SM, 2008, CIRCULATION, V118, P625, DOI 10.1161/CIRCULATIONAHA.107.759191; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Katz SD, 2005, CIRCULATION, V111, P310, DOI 10.1161/01.CIR.0000153349.77489.CF; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Arena Ross, 2011, Congest Heart Fail, V17, P115, DOI 10.1111/j.1751-7133.2011.00216.x; Duscha BD, 2002, J AM COLL CARDIOL, V39, P1170, DOI 10.1016/S0735-1097(02)01740-0; Ebisawa S, 2014, CIRC J, V78, P1445, DOI 10.1253/circj.CJ-13-1341; Hebert Kathy, 2010, Congest Heart Fail, V16, P118, DOI 10.1111/j.1751-7133.2010.00140.x; Inglis SC, 2013, HEART FAIL REV, V18, P457, DOI 10.1007/s10741-012-9331-1; Inglis SC, 2010, EUR J HEART FAIL, V12, P698, DOI 10.1093/eurjhf/hfq070; Januszek R, 2014, J CARDIOL, V64, P145, DOI 10.1016/j.jjcc.2013.12.002; Lee WH, 2013, CIRC J, V77, P1046, DOI 10.1253/circj.CJ-12-1122; Morillas P, 2009, AM J CARDIOL, V104, P1494, DOI 10.1016/j.amjcard.2009.07.014; Nakamura Y, 2014, CIRC J, V78, P890, DOI 10.1253/circj.CJ-13-1372; Norgren L, 2007, Eur J Vasc Endovasc Surg, V33 Suppl 1, pS1, DOI 10.1016/j.ejvs.2006.09.024; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, p:, DOI DOI 10.1016/J.ECH0.2010.05.010	37	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					785	+		10.1253/circj.CJ-14-1280		15	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100019		
J	Akiyama, T; Miyazaki, T; Ito, H; Nogami, H; Higurashi, E; Ando, S; Sawada, R				Akiyama, Terukazu; Miyazaki, Tatsuya; Ito, Hiroki; Nogami, Hirofumi; Higurashi, Eiji; Ando, Shin-ichi; Sawada, Renshi			Comparable Accuracy of Micro-Electromechanical Blood Flowmetry-Based Analysis vs. Electrocardiography-Based Analysis in Evaluating Heart Rate Variability	CIRCULATION JOURNAL			English	Article						Autonomic nervous system; Blood flow; Heart rate variability	R-R INTERVAL; SPECTRAL-ANALYSIS; FLOW; HUMANS; POLYNEUROPATHY	Background: Because the conventional evaluation of autonomic nervous system (ANS) function inevitably uses long-lasting uncomfortable electrocardiogram (ECG) recording, a more simplified and comfortable analysis system has been sought for this purpose. The feasibility of using a portable micro-electromechanical system (MEMS) blood flowmeter to analyze heart rate variability (HRV) for evaluating ANS function was thus examined. Methods and Results: Measurements of the R-R interval (TRR) derived from an ECG, simultaneously with the pulse wave interval (TPP) derived from a MEMS blood flowmeter, in 8 healthy subjects was performed and resultant HRV variables in time and frequency domains were compared. The TRR- and TPP-derived variables were strongly correlated (coefficients of regression for low frequency (LF), high frequency (HF), and LF/HF of 1.1, 0.66, and 0.35, respectively; corresponding coefficients of determination of 0.92, 0.63, and 0.91, respectively (P<0.01)). In addition, the values of LF, HF, and LF/HF, as analyzed using TPP, changed significantly from the supine to the standing position in another 6 subjects. Conclusions: Miniaturized-MEMS blood flowmetry can be used to perform HRV analysis for the evaluation of ANS function, which is as accurate as analysis based on ECG within comparable tolerances. As MEMS blood flowmetry can more easily and comfortably record physiological variables for longer durations than ECG recording, and can further capture skin blood flow information, this device has great potential to be used in a wider area of physiological analyses.	[Akiyama, Terukazu; Miyazaki, Tatsuya; Ito, Hiroki; Sawada, Renshi] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan; [Nogami, Hirofumi; Sawada, Renshi] Kyushu Univ, Dept Mech Engn, Fukuoka 8190395, Japan; [Higurashi, Eiji] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Ando, Shin-ichi] Kyushu Univ Hosp, Sleep Apnea Ctr, Fukuoka 812, Japan	Akiyama, T (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	akiyama@nano-micro.mech.kyushu-u.ac.jp					Abe M, 1996, J AUTONOM NERV SYST, V60, P71, DOI 10.1016/0165-1838(96)00033-1; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; American Autonomic Society, 1996, CLIN AUTON RES, V6, P125; ANDO Y, 1992, MUSCLE NERVE, V15, P507, DOI 10.1002/mus.880150416; Higurashi E, 2003, J LIGHTWAVE TECHNOL, V21, P591, DOI 10.1109/JLT.2003.809551; KANO T, 1993, J AUTONOM NERV SYST, V45, P191, DOI 10.1016/0165-1838(93)90051-U; Nogami H, 2011, P I MECH ENG H, V225, P411, DOI 10.1243/09544119JEIM727; Kimura Y, 2010, IEEE T BIO-MED ENG, V57, P2026, DOI 10.1109/TBME.2010.2043842; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; Iwasaki W, 2012, P I MECH ENG H, V226, P759, DOI 10.1177/0954411912452974; Bonner R, 1981, SCATTERING TECHNIQUE, P685; Fredriksson I, 2007, LASER DOPPLER FLOWME; Hess WR, 1954, DIENCEPHALON AUTONOM, V3; Homma S, 1998, NEUROSCI LETT, V247, P25, DOI 10.1016/S0304-3940(98)00274-2; Ide J, 1997, J HAND SURG-BRIT EUR, V22B, P102, DOI 10.1016/S0266-7681(97)80031-9; Ogawa S, 2013, CIRC J, V77, P497, DOI 10.1253/circj.CJ-66-0055; Kainuma M, 2014, CIRC J, V78, P1924, DOI 10.1253/circj.CJ-14-0362; LOW PA, 1995, NEUROLOGY, V45, pS19; Lu Sheng, 2008, J Clin Monit Comput, V22, P23, DOI 10.1007/s10877-007-9103-y; MANO T, 1990, Environmental Medicine (Nagoya), V34, P1; Ogata H, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-24; Ohhashi T, 1998, PHYSIOL MEAS, V19, P449, DOI 10.1088/0967-3334/19/4/001; OKA H, 1995, J AUTONOM NERV SYST, V52, P203, DOI 10.1016/0165-1838(94)00152-A; PENAZ J, 1978, Automedica (London), V2, P135; Rowell LB, 1986, HUMAN CIRCULATION RE; Smith JJ, 1990, CIRCULATORY RESPONSE; Soderstrom T, 2003, AM J PHYSIOL-HEART C, V284, pH1638, DOI 10.1152/ajpheart.00826.2000; Stys A, 1998, CLIN CARDIOL, V21, P719; Takada M, 2008, HEP, V35, P373; Tanaka H, 1999, PEDIATR RES, V46, P691, DOI 10.1203/00006450-199912000-00009; Watanabe S, 2013, CIRC J, V77, P1018, DOI 10.1253/circj.CJ-12-1043; WHEELER T, 1973, BRIT MED J, V4, P584; Wieling W, 1988, AUTONOMIC FAILURE TX, P308	35	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					794	801		10.1253/circj.CJ-14-1199		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100020		
J	Natsumeda, M; Nakazawa, G; Murakami, T; Torii, S; Ijichi, T; Ohno, Y; Masuda, N; Shinozaki, N; Ogata, N; Yoshimachi, F; Ikari, Y				Natsumeda, Makoto; Nakazawa, Gaku; Murakami, Tsutomu; Torii, Sho; Ijichi, Takeshi; Ohno, Yohei; Masuda, Naoki; Shinozaki, Norihiko; Ogata, Nobuhiko; Yoshimachi, Fuminobu; Ikari, Yuji			Coronary Angiographic Characteristics That Influence Fractional Flow Reserve	CIRCULATION JOURNAL			English	Article						Coronary angiography; Flow reserve; Ischemic heart disease	ARTERY-DISEASE; MEDICAL THERAPY; MYOCARDIAL-INFARCTION; FOLLOW-UP; INTERVENTION; STENOSIS; LESIONS; PCI; REVASCULARIZATION; METAANALYSIS	Background: Percutaneous coronary intervention (PCI) guided with fractional flow reserve (FFR) has been shown to improve clinical outcome. Although coronary angiography is the standard method for PCI guidance, the visual severity factors that affect functional ischemia. Methods and Results: To evaluate angiographic predictors of positive FFR in stenotic lesions, angiographic characteristics of 260 consecutive patients (362 lesions) who underwent FFR testing from April 2009 to September 2012 were analyzed. A scoring system (STABLED score) using these predictors was developed and compared with quantitative coronary angiography (QCA). %Diameter stenosis >50% (OR, 8.43; P<0.0001), tandem lesion (OR, 4.00; P<0.0001), true bifurcation (OR, 2.42; P=0.028), lesion length >20 mm (OR, 5.40; P=0.0002), and distance from ostium <20 mm (OR, 1.94; P=0.028) were determined as independent predictors of positive FFR. Area under the ROC curve for probability of positive FFR using the STABLED score (Stenosis 2 points, TAndem lesion 1 point, Bifurcation 1 point, LEsion length 1 point, Distance from ostium 1 point) was 0.85, higher than that for QCA stenosis alone (0.76). STABLED score >= 3 had 72.3% sensitivity and 83.6% specificity for predicting positive FFR, and PPV was 76.7%. Conclusions: Specific angiographic features are applicable for predicting functional ischemia. STABLED score correlates well with FFR.	[Natsumeda, Makoto; Nakazawa, Gaku; Murakami, Tsutomu; Torii, Sho; Ijichi, Takeshi; Ohno, Yohei; Masuda, Naoki; Shinozaki, Norihiko; Ogata, Nobuhiko; Yoshimachi, Fuminobu; Ikari, Yuji] Tokai Univ Hosp, Dept Cardiol, Isehara, Kanagawa 2591193, Japan	Nakazawa, G (reprint author), Tokai Univ Hosp, Dept Cardiol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	gnakazawa@tokai-u.jp					De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Medina A, 2006, REV ESP CARDIOL, V59, P183, DOI 10.1157/13084649; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Morris PD, 2013, JACC-CARDIOVASC INTE, V6, P149, DOI 10.1016/j.jcin.2012.08.024; Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Scanlon PJ, 1999, CIRCULATION, V99, P2345; Wijeysundera HC, 2009, CIRC-CARDIOVASC QUAL, V2, P123, DOI 10.1161/CIRCOUTCOMES.108.834853; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; PIJLS NHJ, 1993, CIRCULATION, V87, P1354; Ribichini F, 2004, PROG CARDIOVASC DIS, V47, P131, DOI 10.1016/j.pcad.2004.07.007; Pijls NHJ, 2013, CIRC J, V77, P561, DOI 10.1253/circj.CJ-13-0161; Hoole SP, 2012, CORONARY ARTERY DIS, V23, P45, DOI 10.1097/MCA.0b013e32834e4f71; Boden WE, 2012, NEW ENGL J MED, V367, P1059, DOI 10.1056/NEJMe1208620; Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; De Bruyne B, 2008, HEART, V94, P949, DOI 10.1136/hrt.2007.122838; Fearon WF, 2007, AM HEART J, V154, P632, DOI 10.1016/j.ahj.2007.06.012; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Ben-Dor Itsik, 2012, Cardiovasc Revasc Med, V13, P177, DOI 10.1016/j.carrev.2011.12.003; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Davies RF, 1997, CIRCULATION, V95, P2037; Nakamura Masato, 2014, Cardiovasc Interv Ther, V29, P300, DOI 10.1007/s12928-014-0259-3; Schomig A, 2008, J AM COLL CARDIOL, V52, P894, DOI 10.1016/j.jacc.2008.05.051; Yamashita J, 2013, CIRC J, V77, P1180, DOI 10.1253/circj.CJ-12-1192	28	4	4	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					802	807		10.1253/circj.CJ-14-0931		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100021		
J	Ozaki, Y; Ohota, M; Ismail, TF; Okumura, M; Ishikawa, M; Muramatsu, T				Ozaki, Yukio; Ohota, Masaya; Ismail, Tevfik F.; Okumura, Masanori; Ishikawa, Masato; Muramatsu, Takashi			Thin Cap Fibroatheroma Defined as Lipid Core Abutting Lumen (LCAL) on Integrated Backscatter Intravascular Ultrasound - Comparison With Optical Coherence Tomography and Correlation With Peri-Procedural Myocardial Infarction	CIRCULATION JOURNAL			English	Article						Intravascular ultrasound; Myocardial infarction; Optical coherence tomography; Plaque; Thin cap fibroatheroma	ELECTIVE STENT IMPLANTATION; ACUTE CORONARY SYNDROME; TISSUE CHARACTERIZATION; BALLOON ANGIOPLASTY; VULNERABLE PLAQUES; IMAGE ACQUISITION; NATURAL-HISTORY; STATIN THERAPY; MULTICENTER; ATHEROSCLEROSIS	Background: This study evaluated the ability of a newly developed integrated backscatter intravascular ultrasound (IB-IVUS) system (VISIWAVE, Terumo, Tokyo, Japan) to detect optical coherence tomography (OCT)-verified thin cap fibroatheroma (TCFA) and assessed the correlation with peri-procedural myocardial infarction (PMI) after percutaneous coronary intervention (PCI). Methods and Results: One hundred culprit lesions in 100 consecutive patients with ischemic heart disease who consented to repeated IVUS and OCT prior to PCI were studied. Of 100 lesions, 48 had OCT-verified TCFA with a cap thickness <65 mu m. Such lesions had larger percentage lipid area and lipid angle >2 quadrants on IB-IVUS. A lipid core abutting lumen (LCAL) was defined as a lipid core pool in the plaque area, directly contacting with the lumen regardless of its circumferential extension. IB-IVUS-identified TCFA defined as a combination of percentage lipid area >= 53.6%, remodeling index >= 1.03, and the presence of LCAL was the best predictor of OCT-verified TCFA with sensitivity, specificity, positive and negative predictive values, and accuracy of 72.9%, 90.4%, 87.5%, 78.3%, and 82.0%, respectively. IB-IVUS-identified TCFA as well as OCT-verified TCFA were significant independent predictors of PMI, after adjusting for other predictors on multivariate analysis. Conclusions: IB-IVUS can be used to identify plaques with a high prevalence of TCFA. Such techniques can therefore potentially be used to identify lesions with an elevated risk of PMI after PCI.	[Ozaki, Yukio; Ohota, Masaya; Okumura, Masanori; Ishikawa, Masato; Muramatsu, Takashi] Fujita Hlth Univ Hosp, Dept Cardiol, Toyoake, Aichi 4701192, Japan; [Ismail, Tevfik F.] Royal Brompton Hosp, London SW3 6LY, England; [Ismail, Tevfik F.] Univ London Imperial Coll Sci Technol & Med, London, England	Ozaki, Y (reprint author), Fujita Hlth Univ Hosp, Cardiol, 1-98 Dengaku, Toyoake, Aichi 4701192, Japan.	ozakiyuk@fujita-hu.ac.jp			Fujita Health University, Toyoake, Japan	This study was supported by an unrestricted grant from Fujita Health University, Toyoake, Japan.	Prati F, 2008, CIRC J, V72, P839, DOI 10.1253/circj.72.839; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; DEFEYTER PJ, 1995, CIRCULATION, V92, P1408; Nakayama N, 2013, CIRC J, V77, P424, DOI 10.1253/circj.CJ-12-0630; Ozaki Y, 2010, EUR HEART J, V31, P1470, DOI 10.1093/eurheartj/ehq066; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Kataiwa H, 2008, CIRC J, V72, P1536, DOI 10.1253/circj.CJ-08-0406; Kawasaki M, 2010, CIRC J, V74, P2641, DOI 10.1253/circj.CJ-10-0547; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Miyamoto Y, 2011, JACC-CARDIOVASC IMAG, V4, P638, DOI 10.1016/j.jcmg.2011.03.014; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Ozaki Y, 2011, EUR HEART J, V32, P2814, DOI 10.1093/eurheartj/ehr189; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Uetani T, 2008, EUR HEART J, V29, P1714, DOI 10.1093/eurheartj/ehn248; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; de Jaegere P, 1998, EUR HEART J, V19, P1214, DOI 10.1053/euhj.1998.1012; Kume T, 2006, AM J CARDIOL, V97, P1713, DOI 10.1016/j.amjcard.2006.01.031; Okumura M, 2007, CIRC J, V71, P1669, DOI 10.1253/circj.71.1669; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gonzalo N, 2009, JACC-CARDIOVASC IMAG, V2, P473, DOI 10.1016/j.jcmg.2008.11.016; Barlis P, 2008, AM J CARDIOL, V102, P391, DOI 10.1016/j.amjcard.2008.03.071; BLAND JM, 1986, LANCET, V1, P307; KEANE D, 1995, CIRCULATION, V91, P2174; Kume T, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.030; Ohota M, 2012, CIRC J, V76, P1678, DOI 10.1253/circj.CJ-11-1157; Ozaki Y, 2007, CIRC J, V71, P1, DOI 10.1253/circj.71.1; Ozaki Y, 1997, CIRCULATION, V96, P491; Ozaki Y, 2012, CIRC J, V76, P922, DOI 10.1253/circj.CJ-11-1122; Ozaki Y, 1996, CIRCULATION, V93, P2114; Rodriguez-Granillo GA, 2007, EUR HEART J, V28, P2326, DOI 10.1093/eurheartj/ehm255; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Yonetsu T, 2011, INT J CARDIOL, V146, P80, DOI 10.1016/j.ijcard.2010.06.010	38	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					808	+		10.1253/circj.CJ-14-0758		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100022		
J	Takeuchi, F; Isono, M; Yamamoto, K; Yokota, M; Akiyama, K; Katsuya, T; Kim, HS; Park, JE; Jang, Y; Lee, JY; Consortium, A; Lee, JY; Kato, N				Takeuchi, Fumihiko; Isono, Masato; Yamamoto, Ken; Yokota, Mitsuhiro; Akiyama, Koichi; Katsuya, Tomohiro; Kim, Hyo-Soo; Park, Jeong Euy; Jang, Yangsoo; Lee, Ji-Young; Consortium, A. G. E. N.; Lee, Jong-Young; Kato, Norihiro			Heterogeneous Effects of Association Between Blood Pressure Loci and Coronary Artery Disease in East Asian Individuals	CIRCULATION JOURNAL			English	Article						Blood pressure; Coronary artery disease; Genetic susceptibility	GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; COMMON VARIANTS; SUSCEPTIBILITY LOCI; JAPANESE MEN; IDENTIFIES 4; METAANALYSIS; HYPERTENSION; RISK; POPULATION	Background: A coronary artery disease (CAD) association study of genetic loci previously identified as being associated with blood pressure (BP) was performed in east Asian populations. Methods and Results: Nine single nucleotide polymorphisms (SNPs) from 9 candidate loci robustly confirmed to be associated with BP in east Asian people, were genotyped. Genotyping was done in up to 17,785 CAD case-control samples (6,522 cases and 11,263 controls). We then tested the associations with other metabolic traits (n <= 17,900) and with type 2 diabetes (931 cases and 1,404 controls), and looked up the datasets in silico in other populations. Significant (adjusted P<0.05) CAD associations were found for 5 BP loci: 3 new CAD associations at FIGN, FGF5 and NPR3, and 2 previously reported ones at ATP2B1 and CNNM2. The strongest CAD association was detected at ATP2B1 rs2681472 (P=1.7x10(-8)), in the direction inverted to what is generally recognized for BP in the epidemiological studies. CNNM2 rs12413409 showed significant association with CAD (P=8.7x10(-7)) and BMI (P=3.5x10(-8), when meta-analyzed with 75,807 east Asian people). The genetic risk score combining BP-raising alleles at each of the SNPs was positively associated with CAD (P=0.011). Conclusions: A substantial proportion of genetic variants associated with BP were also associated with the risk of CAD in east Asian people, and there was some counter-evidence for causal inference.	[Takeuchi, Fumihiko; Isono, Masato; Akiyama, Koichi; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo 1628655, Japan; [Yamamoto, Ken] Kyushu Univ, Dept Mol Genet, Med Inst Bioregulat, Fukuoka 812, Japan; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Ctr Cardiovasc, Dept Internal Med, Seoul 110744, South Korea; [Park, Jeong Euy] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol, Seoul, South Korea; [Jang, Yangsoo] Yonsei Univ, Coll Med, Dept Internal Med, Cardiol Div,Cardiovasc Genome Ctr, Seoul, South Korea; [Lee, Ji-Young; Lee, Jong-Young] KCDC, Ctr Genome Sci, Korea Natl Inst Hlth, Chungcheongbuk Do, South Korea	Kato, N (reprint author), Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nokato@ri.ncgm.go.jp			National Center for Global Health and Medicine; Ministry of Health Labour and Welfare	Grant of National Center for Global Health and Medicine; and the Ministry of Health Labour and Welfare.	Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Kobayashi Y, 2012, HYPERTENSION, V59, P854, DOI 10.1161/HYPERTENSIONAHA.110.165068; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Lewington S, 2002, LANCET, V360, P1903; Nanri A, 2008, AM J CLIN NUTR, V87, P1488; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Miura K, 2009, CIRCULATION, V119, P1892, DOI 10.1161/CIRCULATIONAHA.108.823112; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Lieb W, 2013, HYPERTENSION, V61, P995, DOI 10.1161/HYPERTENSIONAHA.111.00275; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Munroe PB, 2013, CIRC RES, V112, P1365, DOI 10.1161/CIRCRESAHA.112.300387; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155; Lewington S, 2003, J CARDIOVASC RISK, V10, P143, DOI 10.1097/01.hjr.0000060834.46105.3c; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Ehret GB, 2010, CURR HYPERTENS REP, V12, P17, DOI 10.1007/s11906-009-0086-6; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; O'Halloran AM, 2009, J THROMB THROMBOLYS, V27, P175, DOI 10.1007/s11239-008-0196-z; Bangalore S, 2013, HEART, V99, P601, DOI 10.1136/heartjnl-2012-301968; Cho Yoon Shin, 2012, Nat Genet, V44, P67, DOI 10.1038/ng.1019; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Velasquez-Mieyer PA, 2003, INT J OBESITY, V27, P219, DOI 10.1038/sj.ijo.802227; Wang Y, 2013, MOL BIOL REP, V40, P1867, DOI 10.1007/s11033-012-2242-3; Wen WQ, 2014, HUM MOL GENET, V23, P5492, DOI 10.1093/hmg/ddu248	30	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					830	+		10.1253/circj.CJ-14-0841		14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100025		
J	Kawaji, T; Shiomi, H; Morimoto, T; Tazaki, J; Imai, M; Saito, N; Makiyama, T; Shizuta, S; Ono, K; Kimura, T				Kawaji, Tetsuma; Shiomi, Hiroki; Morimoto, Takeshi; Tazaki, Junichi; Imai, Masao; Saito, Naritatsu; Makiyama, Takeru; Shizuta, Satoshi; Ono, Koh; Kimura, Takeshi			Clinical Impact of Left Ventricular Outflow Tract Obstruction in Takotsubo Cardiomyopathy	CIRCULATION JOURNAL			English	Article						Acute coronary syndrome; Left ventricular outflow obstruction; Takotsubo cardiomyopathy	APICAL BALLOONING SYNDROME; ACUTE MYOCARDIAL-INFARCTION; TAKO-TSUBO CARDIOMYOPATHY; AMPULLA CARDIOMYOPATHY; EMOTIONAL-STRESS; PATHOPHYSIOLOGY; DYSFUNCTION; MORTALITY; DIAGNOSIS; FEATURES	Background: A hyperdynamic state of the basal left ventricle sometimes results in obstruction of the left ventricular outflow tract (LVOT). However, the prevalence, clinical presentation, and prognostic effect of LVOT obstruction in takotsubo cardiomyopathy (TC) have not been fully evaluated. Methods and Results: Among 933 consecutive patients who underwent emergency coronary angiography for suspected acute coronary syndrome, 35 patients (3.8%) were diagnosed as TC. The cumulative 3-year incidence of all-cause death, cardiac death, hospitalization for congestive heart failure (CHF), and recurrent TC was 24.2%, 0.0%, 6.5%, and 12.2%, respectively. Among 27 patients with information of a LVOT pressure gradient, LVOT obstruction was present in 9 (33%). The prevalence of moderate to severe mitral regurgitation (67% vs. 11%, P=0.003), CHF (78% vs. 28%, P=0.02), and hypotension (56% vs. 5.6%, P=0.008) was significantly higher in patients with LVOT obstruction than in those without. Nevertheless, the cumulative 3-year incidence of all-cause death was not significantly different between the 2 groups (49.2% vs. 23.0%, P=0.22) with no cardiac deaths in either group. Hospitalization for CHF and recurrent TC were significantly more frequent in patients with LVOT obstruction (25.0% vs. 0.0%, P=0.04, and 25.0% vs. 6.7%, P=0.02). Conclusions: In 35 consecutive patients with TC, those with significant LVOT obstruction (33%) had a more serious clinical presentation such as CHF and hypotension, but had similar 3-year mortality rate as compared with those without.	[Kawaji, Tetsuma; Shiomi, Hiroki; Tazaki, Junichi; Imai, Masao; Saito, Naritatsu; Makiyama, Takeru; Shizuta, Satoshi; Ono, Koh; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Div Gen Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Kimura, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	taketaka@kuhp.kyoto-u.ac.jp					Shah BN, 2011, J AM COLL CARDIOL, V58, P1195, DOI 10.1016/j.jacc.2011.03.062; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Tano A, 2013, J CARDIOL, V61, P428, DOI 10.1016/j.jjcc.2013.01.008; Scantlebury DC, 2014, CIRC J, V78, P2129, DOI 10.1253/circj.CJ-14-0859; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Yoshimura S, 2008, ANN NEUROL, V64, P547, DOI 10.1002/ana.21459; Kawai S, 2007, CIRC J, V71, P990, DOI 10.1253/circj.71.990; Singh K, 2014, AM J CARDIOL, V113, P1420, DOI 10.1016/j.amjcard.2014.01.419; El Mahmoud R, 2008, AM HEART J, V156, P543, DOI 10.1016/j.ahj.2008.05.002; Kurisu S, 2014, CIRC J, V78, P1559, DOI 10.1253/circj.CJ-14-0382; Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; Izumo M, 2011, CIRC-CARDIOVASC IMAG, V4, P392, DOI 10.1161/CIRCIMAGING.110.962845; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Sharkey SW, 2014, CIRC J, V78, P2119, DOI 10.1253/circj.CJ-14-0770; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Haghi D, 2010, CLIN RES CARDIOL, V99, P93, DOI 10.1007/s00392-009-0078-1; Bybee KA, 2004, ANN INTERN MED, V141, P858; Camara EJN, 2009, ECHOCARDIOGR-J CARD, V26, P1195, DOI 10.1111/j.1540-8175.2009.00953.x; Cecchi E, 2013, AM J CARDIOL, V111, P1523, DOI 10.1016/j.amjcard.2013.01.304; Fefer P, 2009, J INTERV CARDIOL, V22, P444, DOI 10.1111/j.1540-8183.2009.00488.x; Kimura K, 2007, CIRCULATION, V115, P620; Kurisu S, 2003, CIRC J, V67, P556; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Owa M, 2001, JPN CIRC J, V65, P349, DOI 10.1253/jcj.65.349; Semba H, 2012, INT HEART J, V53, P230; Wright PT, 2014, CIRC J, V78, P1550, DOI 10.1253/circj.CJ-14-0623	33	3	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					839	+		10.1253/circj.CJ-14-1148		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100026		
J	Kawasaki, T; Harimoto, K; Honda, S; Sato, Y; Yamano, M; Miki, S; Kamitani, T				Kawasaki, Tatsuya; Harimoto, Kuniyasu; Honda, Sakiko; Sato, Yoshimi; Yamano, Michiyo; Miki, Shigeyuki; Kamitani, Tadaaki			Notched QRS for the Assessment of Myocardial Fibrosis in Hypertrophic Cardiomyopathy	CIRCULATION JOURNAL			English	Article						Electrocardiography; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Notch; QRS	LATE GADOLINIUM ENHANCEMENT; CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR SEPTUM; PROGNOSTIC VALUE; SCAR; QUANTIFICATION; ASSOCIATION; CARDIOLOGY; COMMITTEE; DISEASE	Background: Patients with hypertrophic cardiomyopathy (HCM) sometimes develop myocardial fibrosis in association with adverse cardiovascular events. Electrocardiography (ECG) could provide helpful information on myocardial fibrosis in HCM, as in coronary artery disease. Methods and Results: A total of 60 patients with HCM without bundle branch block underwent cardiac magnetic resonance imaging (CMR). The extent or location of late gadolinium enhancement (LGE) was examined in relation to 12-lead ECG. A notch on QRS was defined as at least 2 consecutive spikes in the same polarity with a reversal of direction >= 90 degrees and the initial negative deflection >= 0.05 mV. LGE was associated with notched QRS, leftward QRS axis, and prolonged QRS duration, but not with any other findings such as abnormal Q waves, R-wave amplitude, or ST-T changes. Notched QRS was most useful in determining the presence or absence of myocardial fibrosis, with a sensitivity of 70% and a specificity of 81% using a cut-off of the number of leads with notched QRS >= 2. The number of notched QRS leads was positively correlated with LGE volume (P<0.01) and the lead distribution of notched QRS was informative about the location of LGE. Conclusions: A notch on QRS was useful in estimating myocardial fibrosis as assessed on CMR LGE in HCM patients without bundle branch block.	[Kawasaki, Tatsuya; Harimoto, Kuniyasu; Honda, Sakiko; Sato, Yoshimi; Yamano, Michiyo; Miki, Shigeyuki; Kamitani, Tadaaki] Matsushita Mem Hosp, Dept Cardiol, Moriguchi, Osaka 5708540, Japan	Kamitani, T (reprint author), Matsushita Mem Hosp, Dept Cardiol, 5-55 Sotojima, Moriguchi, Osaka 5708540, Japan.	js-k@wf6.so-net.ne.jp					Maron MS, 2009, J AM COLL CARDIOL, V54, P866, DOI 10.1016/j.jacc.2009.04.072; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; MORRIS JJ, 1964, CIRCULATION, V29, P242; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Hen Y, 2014, CIRC J, V78, P929, DOI 10.1253/circj.CJ-13-0979; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Harimoto K, 2014, J ELECTROCARDIOL, V47, P636, DOI 10.1016/j.jelectrocard.2014.06.010; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONHA.105.595892; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284; Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026; Kawasaki T, 2013, AM J CARDIOL, V112, P867, DOI 10.1016/j.amjcard.2013.04.060; Loring Z, 2011, J ELECTROCARDIOL, V44, P544, DOI 10.1016/j.jelectrocard.2011.06.008; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064; Fonseca-Guzman A, 2011, 2011 COMPUTING IN CARDIOLOGY, P637; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; KURIBAYASHI T, 1992, AM J CARDIOL, V70, P1333, DOI 10.1016/0002-9149(92)90771-P; MARON BJ, 1979, CIRCULATION, V59, P689; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; PERLOFF JK, 1979, CIRCULATION, V60, P12; ROSENBAU.MB, 1969, AM J CARDIOL, V24, P1, DOI 10.1016/0002-9149(69)90044-7; Sakuma H, 2014, CIRC J, V78, P832, DOI 10.1253/circj.CJ-14-0203; Surawicz B, 2008, CHOUS ELECTROCARDIOG; Take Yutaka, 2012, Indian Pacing Electrophysiol J, V12, P213	28	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					847	853		10.1253/circj.CJ-14-1109		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100027		
J	Miyoshi, T; Maeno, Y; Sago, H; Inamura, N; Yasukouchi, S; Kawataki, M; Horigome, H; Yoda, H; Taketazu, M; Shozu, M; Nii, M; Kato, H; Hagiwara, A; Omoto, A; Shimizu, W; Shiraishi, I; Sakaguchi, H; Nishimura, K; Nakai, M; Ueda, K; Katsuragi, S; Ikeda, T				Miyoshi, Takekazu; Maeno, Yasuki; Sago, Haruhiko; Inamura, Noboru; Yasukouchi, Satoshi; Kawataki, Motoyoshi; Horigome, Hitoshi; Yoda, Hitoshi; Taketazu, Mio; Shozu, Makio; Nii, Masaki; Kato, Hitoshi; Hagiwara, Akiko; Omoto, Akiko; Shimizu, Wataru; Shiraishi, Isao; Sakaguchi, Heima; Nishimura, Kunihiro; Nakai, Michikazu; Ueda, Keiko; Katsuragi, Shinji; Ikeda, Tomoaki			Fetal Bradyarrhythmia Associated With Congenital Heart Defects - Nationwide Survey in Japan -	CIRCULATION JOURNAL			English	Article						Atrioventricular block; Bradyarrhythmia; Congenital heart defects; Fetus; Left atrial isomerism	COMPLETE ATRIOVENTRICULAR-BLOCK; HETEROTAXY SYNDROME; MULTICENTER EXPERIENCE; PRENATAL-DIAGNOSIS; CLINICAL-FEATURES; MANAGEMENT; DISEASE; POPULATION; ISOMERISM; GENETICS	Background: Because there is limited information on fetal bradyarrhythmia associated with congenital heart defects (CHD), we investigated its prognosis and risk factors. Methods and Results: In our previous nationwide survey of fetal bradyarrhythmia from 2002 to 2008, 38 fetuses had associated CHD. Detailed clinical data were collected from secondary questionnaires on 29 fetuses from 18 institutions, and were analyzed. The 29 fetuses included 22 with isomerism, 4 with corrected transposition of the great arteries (TGA) and 3 with critical pulmonary stenosis; 14 had complete atrioventricular block (AVB), 8 had second-degree AVB, and 16 had sick sinus syndrome; 5 died before birth, and 10 died after birth (5 in the neonatal period). Neonatal and overall survival rates for fetal bradyarrhythmia with CHD were 66% and 48%, respectively. Pacemaker implantation was needed in 17 cases (89%). Beta-sympathomimetics were administered in utero in 13 cases and were effective in 6, but were not associated with prognosis. All cases of corrected TGA or ventricular rate >= 70 beats/min survived. A ventricular rate <55 beats/min had significant effects on fetal myocardial dysfunction (P=0.02) and fetal hydrops (P=0.04), resulting in high mortality. Conclusions: The prognosis of fetal bradyarrhythmia with CHD is still poor. The type of CHD, fetal myocardial dysfunction, and fetal hydrops were associated with a poor prognosis, depending on the ventricular rate.	[Miyoshi, Takekazu; Shiraishi, Isao; Sakaguchi, Heima; Nishimura, Kunihiro; Nakai, Michikazu; Ueda, Keiko; Katsuragi, Shinji] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka 5658565, Japan; [Maeno, Yasuki] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; [Sago, Haruhiko; Kato, Hitoshi] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Inamura, Noboru] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Izumi, Japan; [Yasukouchi, Satoshi] Nagano Childrens Hosp, Azumino, Japan; [Kawataki, Motoyoshi; Hagiwara, Akiko] Kanagawa Childrens Med Ctr, Yokohama, Kanagawa, Japan; [Horigome, Hitoshi] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Yoda, Hitoshi] Toho Univ, Omori Med Ctr, Tokyo, Japan; [Taketazu, Mio] Saitama Med Univ, Int Med Ctr, Hidaka, Japan; [Shozu, Makio; Omoto, Akiko] Chiba Univ, Chiba, Japan; [Nii, Masaki] Shizuoka Childrens Hosp, Shizuoka, Japan; [Shimizu, Wataru] Nippon Med Sch, Tokyo 113, Japan; [Ikeda, Tomoaki] Mie Univ, Tsu, Mie 514, Japan	Miyoshi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	gomiyoshi0327@yahoo.co.jp			Ministry of Health, Labour and Welfare of Japan	This work was supported by a grant from the Ministry of Health, Labour and Welfare of Japan (Health and Labour Science Research Grants for Clinical Research for New Medicine).	ANDERSON RH, 1977, CIRCULATION, V56, P90; Eliasson H, 2011, CIRCULATION, V124, P1919, DOI 10.1161/CIRCULATIONAHA.111.041970; HO SY, 1992, J AM COLL CARDIOL, V20, P904; Brucato A, 2011, CLIN REV ALLERG IMMU, V40, P27, DOI 10.1007/s12016-009-8190-6; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Pepes S, 2009, HEART, V95, P1974, DOI 10.1136/hrt.2009.165514; Lopes LM, 2008, CIRCULATION, V118, P1268, DOI 10.1161/CIRCULATIONAHA.107.735118; Serraf A, 2010, EUR J CARDIO-THORAC, V38, P721, DOI 10.1016/j.ejcts.2010.02.044; Jaeggi ET, 2004, CIRCULATION, V110, P1542, DOI 10.1161/01.CIR.0000142046.58632.3A; Lim JSL, 2005, CIRCULATION, V112, P2454, DOI 10.1161/CIRCULATIONAHA.105.552364; Khairy P, 2010, J AM COLL CARDIOL, V56, P1149, DOI 10.1016/j.jacc.2010.03.085; Berg C, 2003, ULTRASOUND OBST GYN, V22, P451, DOI 10.1002/uog.904; BUYON JP, 1989, J CLIN INVEST, V84, P627, DOI 10.1172/JCI114208; Cohen MS, 2007, CARDIOL YOUNG, V17, P29, DOI 10.1017/S104795110700114X; Cuneo BF, 2006, CURR OPIN PEDIATR, V18, P490, DOI 10.1097/01.mop.0000245348.52960.11; Fang F, 2013, CIRC J, V77, P1364, DOI 10.1253/circj.CJ-13-0398; GEMBRUCH U, 1989, EUR J OBSTET GYN R B, V31, P9, DOI 10.1016/0028-2243(89)90022-1; Groves AMM, 1996, HEART, V75, P190, DOI 10.1136/hrt.75.2.190; JACOBS JP, 2007, CARDIOL YOUNG S2, V17, P1; Jaeggi ET, 2005, ULTRASOUND OBST GYN, V26, P16, DOI 10.1002/uog.1919; MACHADO MV, 1988, BRIT HEART J, V60, P512; Maeno Y, 2005, HEART, V91, P1075, DOI 10.1136/hrt.2003.033407; Miyoshi T, 2012, CIRC J, V76, P469, DOI 10.1253/circj.CJ-11-1020; Nagel B, 2014, CIRC J, V78, P450, DOI 10.1253/circj.CJ-13-0670; SCHMIDT KG, 1991, J AM COLL CARDIOL, V17, P1360; Sharland G, 2000, TXB FETAL CARDIOLOGY, P335; Shiraishi I, 2012, CIRC J, V76, P2066, DOI 10.1253/circj.CJ-12-0957; Silvetti MS, 2010, EUROPACE, V12, P1316, DOI 10.1093/europace/euq258	28	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					854	861		10.1253/circj.CJ-14-0978		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100028		
J	Nomura, E; Ohshita, T; Imamura, E; Wakabayashi, S; Kajikawa, H; Hosomi, N; Matsumoto, M				Nomura, Eiichi; Ohshita, Tomohiko; Imamura, Eiji; Wakabayashi, Shinichi; Kajikawa, Hiroshi; Hosomi, Naohisa; Matsumoto, Masayasu			Early Administration of Non-Vitamin K Antagonist Oral Anticoagulants for Acute Ischemic Stroke Patients With Atrial Fibrillation in Comparison With Warfarin Mostly Combined With Heparin	CIRCULATION JOURNAL			English	Article						Acute ischemic stroke; Atrial fibrillation; Diffusion-weighted image; Non-vitamin K antagonist oral anticoagulants; Warfarin	INTERNATIONAL NORMALIZED RATIO; RANDOMIZED CONTROLLED-TRIALS; ACUTE CARDIOEMBOLIC STROKE; SECONDARY PREVENTION; LESION RECURRENCE; METAANALYSIS; INITIATION; SILENT; ATTACK; RISK	Background: This study evaluated the rates of new lesions on diffusion-weighted images (DWIs) of magnetic resonance imaging (MRI) and hemorrhagic transformation (HT) during 2 weeks after acute ischemic stroke (AIS) in patients with atrial fibrillation (Af) who were given one of the non-vitamin K antagonist oral anticoagulants (NOACs); this was then compared with those who were given warfarin. Methods and Results: Consecutive AIS patients with Af were enrolled between January 2008 and June 2013, and those selected were patients who had a MRI that included DWIs both on admission and after 2 weeks, and those given only wafrarin (warfarin group) or only one of the NOACs (NOAC group) within 2 weeks of admission. Of all 257 enrolled patients, 50 patients were selected for the NOAC group (median age of 80.0 years) and 125 patients for the warfarin group (median age of 80.0 years). Both NOAC and warfarin were started at a median of the second day after admission. There was no significant difference in the rates of new lesions on DWIs (26.0% vs. 28.0%, P=0.7888) and HT (30.0% vs. 39.2%, P=0.2536) between the NOAC and warfarin groups. The NOAC group had a lower rate of concomitant use of heparin (44.0% vs. 92.8%, P<0.0001) than the warfarin group. Conclusions: This study suggests that NOACs are suitable for AIS patients with Af, perhaps even better than warfarin, given their simplicity.	[Nomura, Eiichi] Hiroshima City Hiroshima Citizens Hosp, Dept Neurol, Hiroshima 7308518, Japan; [Nomura, Eiichi; Ohshita, Tomohiko; Imamura, Eiji] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Wakabayashi, Shinichi; Kajikawa, Hiroshi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan; [Hosomi, Naohisa; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan	Nomura, E (reprint author), Hiroshima City Hiroshima Citizens Hosp, Dept Neurol, Naka Ku, 7-33 Moto Machi, Hiroshima 7308518, Japan.	nomura@mwc.biglobe.ne.jp					Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.00002546000.92975.1f; Ntaios G, 2012, STROKE, V43, P3298, DOI 10.1161/STROKEAHA.112.673558; Hallevi H, 2008, ARCH NEUROL-CHICAGO, V65, P1169, DOI 10.1001/archneur.65.9.noc70105; Hori M, 2014, CIRC J, V78, P1349, DOI 10.1253/circj.CJ-13-1324; Saxena R, 2001, STROKE, V32, P2333, DOI 10.1161/hs1001.097093; Nolte CH, 2012, CEREBROVASC DIS, V33, P248, DOI 10.1159/000334665; Azoulay L, 2014, EUR HEART J, V35, P1881, DOI 10.1093/eurheartj/eht499; Shibazaki K, 2013, J NEUROL SCI, V331, P90, DOI 10.1016/j.jns.2013.05.016; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Pisters R, 2012, CIRC J, V76, P2289, DOI 10.1253/circj.CJ-12-1036; Yasaka M, 2001, INTERNAL MED, V40, P1183, DOI 10.2169/internalmedicine.40.1183; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Berge E, 2000, LANCET, V355, P1205, DOI 10.1016/S0140-6736(00)02085-7; Arboix Adrià, 2011, Expert Rev Cardiovasc Ther, V9, P367, DOI 10.1586/erc.10.192; Arboix Adria, 2012, Curr Cardiol Rev, V8, P54; D'Angelo A, 2002, HAEMATOLOGICA, V87, P1074; Diener HC, 2013, THROMB HAEMOSTASIS, V110, P493, DOI 10.1160/TH13-04-0277; Gomez-Outes A, 2013, THROMBOSIS, V2013, DOI DOI 10.1155/2013/640723; Guedes LC, 2008, STROKE, V39, pE81, DOI 10.1161/STROKEAHA.107.513200; Kang DW, 2006, ARCH NEUROL-CHICAGO, V63, P1730, DOI 10.1001/archneur.63.12.1730; Kim WJ, 2010, J CLIN NEUROL, V6, P19, DOI 10.3988/jcn.2010.6.1.19; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; MacCallum PK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003343; Micheli S, 2008, CEREBROVASC DIS, V25, P289, DOI 10.1159/000118372; Nomura E, 2014, J STROKE CEREBROVASC, V23, P2099, DOI 10.1016/j.jstrokecerebrovasdis.2014.03.016	25	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					862	866		10.1253/circj.CJ-14-0793		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100029		
J	Mizuno, R; Yamagami, S; Higashi, T; Nakada, Y; Takeda, Y; Okayama, S; Fujimoto, S; Saito, Y				Mizuno, Reiko; Yamagami, Shin-taro; Higashi, Tsukimi; Nakada, Yasuki; Takeda, Yukiji; Okayama, Satoshi; Fujimoto, Shinichi; Saito, Yoshihiko			Major Non-Cardiac Surgery Is a Risk Factor for Rapid Hemodynamic Progression of Non-Rheumatic Aortic Stenosis	CIRCULATION JOURNAL			English	Article						Aortic valve stenosis; Echocardiography; Major non-cardiac surgery	C-REACTIVE PROTEIN; VALVE STENOSIS; HEART-FAILURE; DISEASE; ATHEROSCLEROSIS; MORTALITY; CALCIFICATION; INFLAMMATION; PREDICTORS; MODERATE	Background: Inflammatory processes are suggested to play a pathogenic role in the development and progression of non-rheumatic aortic stenosis (AS). Major surgery causes an inflammatory reaction. With the increasing prevalence of non-rheumatic AS, the number of affected patients undergoing major surgery increases. We hypothesized that major non-cardiac surgery (MNCS) could accelerate the progression of non-rheumatic AS. Methods and Results: We enrolled 218 consecutive patients with non-rheumatic AS who underwent transthoracic echocardiography (TTE) at least twice more than 6 months apart. Study patients were divided into the MNCS group and the non-MNCS group. The MNCS group consisted of patients who underwent MNCS during the TTE follow-up interval. At baseline, peak pressure gradient across the aortic valve (AVG) was similar between the groups. Also baseline clinical characteristics and TTE follow-up interval were similar. The annual rate of peak AVG increase was much higher in the MNCS group than in the non-MNCS group. The proportion of patients with rapid hemodynamic progression was much higher in the MNCS group than in the non-MNCS group. Multiple logistic regression analysis showed that MNCS was an independent predictor of rapid hemodynamic progression of non-rheumatic AS. Conclusions: The present study indicates for the first time that MNCS is associated with the rapid progression of non-rheumatic AS.	[Mizuno, Reiko] Nara Med Univ, Cent Clin Lab, Kashihara, Nara 6348522, Japan; [Yamagami, Shin-taro; Higashi, Tsukimi; Nakada, Yasuki; Takeda, Yukiji; Okayama, Satoshi; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6348522, Japan; [Fujimoto, Shinichi] Nara Med Univ, Ctr Educ Dev, Kashihara, Nara 6348522, Japan	Saito, Y (reprint author), Nara Med Univ, Dept Internal Med 1, 840 Shijo, Kashihara, Nara 6348522, Japan.	saitonaramed@gmail.com			Japan Heart Foundation; Naito Foundation; MSD Co, Ltd; Mitsubishi Tanabe Pharma Corporation; Daiichi Sankyo Company Ltd; Takeda Pharmaceutical Co, Ltd; Novartis Pharma K.K.; Shionogi Co, Ltd.; Astellas Pharma Inc; AstraZeneca K.K., Ltd; Otsuka Pharmaceutical Co, Ltd; St. Jude Medical Japan Co, Ltd; Kyowa Hakko Kirin Co Ltd.	Yoshihiko Saito have conflicts of interest to disclose as follows. Honoraria: MSD Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co, Daiichi Sankyo Company Ltd, Otsuka Pharmaceutical Co, Ltd, Pfizer Japan Inc. Research funding: Japan Heart Foundation, The Naito Foundation. Subsidies or donations: MSD Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Co, Ltd, Novartis Pharma K.K., Shionogi & Co, Ltd. Astellas Pharma Inc, AstraZeneca K.K., Ltd, Otsuka Pharmaceutical Co, Ltd, St. Jude Medical Japan Co, Ltd, Kyowa Hakko Kirin Co Ltd. Endowed departments by commercial entities: MSD Co, Ltd.	Pohle K, 2004, MAYO CLIN PROC, V79, P1242; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630; Galante A, 2001, J AM COLL CARDIOL, V38, P1078, DOI 10.1016/S0735-1097(01)01484-X; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Cheitlin MD, 2003, J AM COLL CARDIOL, V42, P954, DOI 10.1016/S0735-1097(03)01065-9; LINDROOS M, 1994, EUR HEART J, V15, P865; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; Iung B, 2012, HEART, V98, pIV7, DOI 10.1136/heartjnl-2012-302395; Takaoka M, 2006, ARTERIOSCL THROM VAS, V26, P2083, DOI 10.1161/01.ATV.0000232528.93786.0a; Ghaisas NK, 2000, J AM COLL CARDIOL, V36, P2257, DOI 10.1016/S0735-1097(00)00998-0; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; Barasch E, 2014, CIRC J, V78, P232, DOI 10.1253/circj.CJ-13-0821; Bonow RO, 2006, J AM COLL CARDIOL, V48, pel, DOI DOI 10.1016/J.JACC.2006.05.021; Holme I, 2012, HEART, V98, P377, DOI 10.1136/heartjnl-2011-300475; Imai K, 2008, AM HEART J, V156, P713, DOI 10.1016/j.ahj.2008.04.011; Kawase Y, 2014, CIRC J, V78, P2455, DOI 10.1253/circj.CJ-14-0712; Min KD, 2014, CIRC J, V78, P2382, DOI 10.1253/circj.CJ-14-0949; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Okayama Satoshi, 2008, J Atheroscler Thromb, V15, P228; Otto CM, 1997, CIRCULATION, V95, P2262; PETER M, 1993, CHEST, V103, P1715, DOI 10.1378/chest.103.6.1715; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Skowasch D, 2006, HEART, V92, P495, DOI 10.1136/hrt.2005.069815	25	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					867	872		10.1253/circj.CJ-14-1111		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100030		
J	Nishi, H; Toda, K; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Kawamura, M; Yoshioka, D; Saito, T; Ueno, T; Kuratani, T; Sawa, Y				Nishi, Hiroyuki; Toda, Koichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Kawamura, Masashi; Yoshioka, Daisuke; Saito, Tetsuya; Ueno, Takayoshi; Kuratani, Toru; Sawa, Yoshiki			Tricuspid Annular Dynamics Before and After Tricuspid Annuloplasty - Three-Dimensional Transesophageal Echocardiography -	CIRCULATION JOURNAL			English	Article						Annular geometry; Echocardiography; Surgery; Valvular disease	MITRAL-VALVE; EUROPEAN ASSOCIATION; RING ANNULOPLASTY; GEOMETRIC CHANGES; REGURGITATION; TIME; RECOMMENDATIONS; DETERMINANTS; DYSFUNCTION; DILATATION	Background: Little is known about the impact of tricuspid annuloplasty (TAP) on annular dynamics. We assessed tricuspid annular dynamics using 3-D transesophageal echocardiography (3D-TEE) before and after TAP with different types of prosthetic ring. Methods and Results: 3D-TEE of the tricuspid valve was acquired in 30 patients (TAP with rigid ring [RR], n=8; TAP with flexible ring [FR], n=10; control, n=12). Tricuspid annular dimensions (circumference, area, annular height, anteroposterior [AP], septolateral [SL] diameter) were measured throughout the cardiac cycle. All postoperative tricuspid annular dimension parameters were significantly reduced by TAP, while the AP/SL ratio was significantly increased (before, 0.96 +/- 0.16; after, 1.03 +/- 0.06; P<0.05). The difference in annular area between diastole and systole was significantly smaller in the TAP groups (11.6%) than in the control (27.9%, P<0.05). Annular height in the FR patients was significantly lower than in the RR group, while the postoperative AP/SL ratio was lower in the RR than the FR and control groups. Change in annular area was not seen in RR patients, while it was seen in the FR and control groups. Conclusions: Annulus motion and shape differ according to the type of prosthetic ring used, although tricuspid regurgitation was well controlled by all types of ring utilized. The present results provide important information for selection of an appropriate prosthetic ring for TAP.	[Nishi, Hiroyuki; Toda, Koichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Kawamura, Masashi; Yoshioka, Daisuke; Saito, Tetsuya; Ueno, Takayoshi; Kuratani, Toru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	sawa-p@surg1.osaka-u.med.ac.jp					Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Grewal J, 2010, CIRCULATION, V121, P1423, DOI 10.1161/CIRCULATIONAHA.109.901181; Fukuda S, 2005, CIRCULATION, V111, P975, DOI 10.1161/01.CIR.0000156449.49998.51; Ton-Nu TT, 2006, CIRCULATION, V114, P143, DOI 10.1161/CIRCULATIONAHA.106.611889; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sonne C, 2009, EUR J ECHOCARDIOGR, V10, P287, DOI 10.1093/ejechocard/jen237; SAGIE A, 1994, J THORAC CARDIOV SUR, V108, P727; Filsoufi F, 2006, ANN THORAC SURG, V81, P2273, DOI 10.1016/j.athoracsur.2005.12.044; Salgo IS, 2002, CIRCULATION, V106, P711, DOI 10.1161/01.CIR.0000025426.39426.83; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Fukuda S, 2006, CIRCULATION, V114, pI582, DOI 10.1161/CIRCULATIONAHA.105.001305; McCarthy PM, 2004, J THORAC CARDIOV SUR, V127, P674, DOI 10.1016/j.jtcvs.2003.11.019; KING RM, 1984, CIRCULATION, V70, P193; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575; Behm CZ, 2004, J HEART VALVE DIS, V13, P784; Fawzy H, 2011, J THORAC CARDIOV SUR, V141, P1037, DOI 10.1016/j.jtcvs.2010.05.039; Fujita S, 2013, CIRC J, V77, P2505, DOI 10.1253/circj.CJ-13-0324; Izutani Hironori, 2010, Asian Cardiovasc Thorac Ann, V18, P489, DOI 10.1177/0218492310379940; Kim HK, 2005, CIRCULATION, V112, pI14, DOI 10.1161/CIRCULATIONAHA.104.524496; Min SY, 2010, EUR HEART J, V31, P2871, DOI 10.1093/eurheartj/ehq227; Murashita T, 2013, CIRC J, V77, P2288, DOI 10.1253/circj.CJ-13-0221; Onoda K, 2000, ANN THORAC SURG, V70, P796, DOI 10.1016/S0003-4975(00)01681-7; Ring L, 2012, EUR HEART J-CARD IMG, V13, P756, DOI 10.1093/ehjci/jes040; Seo HS, 2008, CIRC J, V72, P1645, DOI 10.1253/circj.CJ-08-0237; Spinner EM, 2012, CIRC-CARDIOVASC IMAG, V5, P43, DOI 10.1161/CIRCIMAGING.111.965707; Sukmawan R, 2007, J AM SOC ECHOCARDIOG, V20, P470, DOI 10.1016/j.echo.2006.10.001; Ugaki S, 2013, CIRC J, V77, P2514, DOI 10.1253/circj.CJ-12-1635	28	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					873	879		10.1253/circj.CJ-14-0912		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100031		
J	Mizuno, A; Yamamoto, T; Tanabe, Y; Obayashi, T; Takayama, M; Nagao, K				Mizuno, Atsushi; Yamamoto, Takeshi; Tanabe, Yasuhiro; Obayashi, Toru; Takayama, Morimasa; Nagao, Ken		Tokyo CCU Network Sci Comm	Pulmonary Embolism Severity Index and Simplified Pulmonary Embolism Severity Index Risk Scores Are Useful to Predict Mortality in Japanese Patients With Pulmonary Embolism	CIRCULATION JOURNAL			English	Article						Length of stay; PESI score; Pulmonary embolism; Risk stratification	TOKYO CCU NETWORK; VALIDATION; MANAGEMENT; OUTCOMES; MODEL	Background: The Pulmonary Embolism Severity Index (PESI) and simplified PESI (sPESI) have not been fully evaluated in Japan, so the present study aimed to evaluate these risk stratification models in the prediction of mortality of affected patients in Japan. Methods and Results: We retrospectively analysed 302 PE patients (63.9 +/- 17.2 years of age; 42.4% male) from January 2011 to December 2012 using data from the Tokyo CCU Network. The areas under the receiver-operating characteristic curves were 0.92 (95% confidence interval (CI): 0.88-0.97) for the PESI and 0.88 (95% CI: 0.77-0.98) for the sPESI. Conclusions: Both scores can be used to predict PE mortality in Japan.	[Mizuno, Atsushi; Yamamoto, Takeshi; Tanabe, Yasuhiro; Obayashi, Toru; Takayama, Morimasa; Nagao, Ken] Tokyo CCU Network Sci Comm, Tokyo, Japan; [Mizuno, Atsushi] St Lukes Int Hosp, Dept Cardiol, Tokyo 1048560, Japan	Mizuno, A (reprint author), St Lukes Int Hosp, Dept Cardiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	atmizu@luke.ac.jp					Akutsu K, 2015, CIRC J, V79, P567, DOI 10.1253/circj.CJ-14-0828; Venetz C, 2011, THROMB HAEMOSTASIS, V106, P423, DOI 10.1160/TH11-04-0263; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Tanabe Y, 2014, J CARDIOL, V63, P385, DOI 10.1016/j.jjcc.2013.10.003; Aujesky D, 2006, EUR HEART J, V27, P476, DOI 10.1093/eurheartj/ehi588; Antman EM, 2014, CIRC J, V78, P1267, DOI 10.1253/circj.CJ-14-0459; Aujesky D, 2006, ARCH INTERN MED, V166, P169, DOI 10.1001/archinte.166.2.169; Obayashi T, 2010, CIRC J, V74, P289, DOI 10.1253/circj.CJ-09-0623; Righini M, 2011, J THROMB HAEMOST, V9, P2115, DOI 10.1111/j.1538-7836.2011.04469.x; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720	11	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					889	891		10.1253/circj.CJ-14-1433		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100033		
J	Katayama, Y; Ozawa, T; Iga, A; Hisatake, S; Watanabe, Y				Katayama, Yuzo; Ozawa, Tsukasa; Iga, Atsushi; Hisatake, Shinji; Watanabe, Yoshinori			Surgical Repair of Aorta-Right Atrial Tunnel in an Adult	CIRCULATION JOURNAL			English	Editorial Material							COMPUTED-TOMOGRAPHY; FISTULA		[Katayama, Yuzo; Ozawa, Tsukasa; Watanabe, Yoshinori] Toho Univ, Omori Med Ctr, Div Cardiovasc Surg, Dept Surg, Tokyo 1438541, Japan; [Iga, Atsushi; Hisatake, Shinji] Toho Univ, Omori Med Ctr, Div Cardiovasc Med, Dept Internal Med, Tokyo 1438541, Japan	Katayama, Y (reprint author), Toho Univ, Omori Med Ctr, Div Cardiovasc Surg, Dept Surg,Ota Ku, 6-11 Omori Nishi, Tokyo 1438541, Japan.	yuuzou.katayama@med.toho-u.ac.jp					Coto E O, 1980, J Thorac Cardiovasc Surg, V80, P941; Elwatidy AF, 2003, ANN THORAC SURG, V76, P929, DOI 10.1016/S0003-4975(03)00448-X; Gajjar T, 2005, J THORAC CARDIOV SUR, V130, P1287, DOI 10.1016/j.jtcvs.2005.07.021; Kalangos A, 2000, ANN THORAC SURG, V69, P635, DOI 10.1016/S0003-4975(99)01346-6; Krishna CS, 2010, TEX HEART I J, V37, P480; Mizuno A, 2014, CIRC J, V78, P1002, DOI 10.1253/circj.CJ-13-1279; Motoyama S, 2013, CIRC J, V77, P411, DOI 10.1253/circj.CJ-12-0688; Omeroglu SN, 2014, EUR J CARDIO-THORAC, V45, P580, DOI 10.1093/ejcts/ezt348; ROSENBERG H, 1986, J THORAC CARDIOV SUR, V91, P841; Turkay C, 2003, J THORAC CARDIOV SUR, V125, P1058, DOI 10.1067/mtc.2003.87	10	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					892	893		10.1253/circj.CJ-14-1202		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100034		
J	Hara, H; Matsumoto, Y; Matsumoto, T; Kar, S; Hashimoto, G; Araki, T; Nagashima, Y; Yamazaki, K; Tokue, M; Enomoto, Y; Hayashi, F; Yazaki, Y; Iijima, R; Suzuki, M; Sugi, K; Nakamura, M				Hara, Hidehiko; Matsumoto, Yasushi; Matsumoto, Takashi; Kar, Saibal; Hashimoto, Go; Araki, Tadashi; Nagashima, Yoshinori; Yamazaki, Kenji; Tokue, Masahide; Enomoto, Yoshinari; Hayashi, Fumiyuki; Yazaki, Yoshiyuki; Iijima, Raisuke; Suzuki, Makoto; Sugi, Kaoru; Nakamura, Masato			Percutaneous Antegrade Mitral Paravalvular Leak Closure Through Porcelain Atrial Septum - First Percutaneous Paravalvular Leak Closure in Japan -	CIRCULATION JOURNAL			English	Editorial Material							SEVERE AORTIC-STENOSIS; VALVE		[Hara, Hidehiko; Hashimoto, Go; Araki, Tadashi; Nagashima, Yoshinori; Yamazaki, Kenji; Tokue, Masahide; Enomoto, Yoshinari; Hayashi, Fumiyuki; Yazaki, Yoshiyuki; Iijima, Raisuke; Suzuki, Makoto; Sugi, Kaoru; Nakamura, Masato] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo 1538515, Japan; [Matsumoto, Yasushi] Kanazawa Med Ctr, Natl Hosp Org, Dept Cardiovasc Surg, Kanazawa, Ishikawa, Japan; [Matsumoto, Takashi; Kar, Saibal] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA	Hara, H (reprint author), Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	harahide@oha.toho-u.ac.jp					Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Hara H, 2013, J JCS CARDIOLOGISTS, V21, P256; Hara Hidehiko, 2007, Cardiovasc Revasc Med, V8, P80, DOI 10.1016/j.carrev.2006.10.005; Hara H, 2010, CIRC J, V74, P1513, DOI 10.1253/circj.CJ-10-0557; Krishnaswamy A, 2013, CIRC J, V77, P19, DOI 10.1253/circj.CJ-12-1433; Rihal Charanjit S, 2012, JACC Cardiovasc Interv, V5, P121, DOI 10.1016/j.jcin.2011.11.007	6	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	APR	2015	79	4					894	896		10.1253/circj.CJ-14-0940		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PT	WOS:000351741100035		
J	Aritomi, S; Harada, E; Sugino, K; Nishimura, M; Nakamura, T; Takahara, A				Aritomi, Shizuka; Harada, Eri; Sugino, Kazumi; Nishimura, Mai; Nakamura, Tarou; Takahara, Akira			Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						adriamycin; calcium channel blockers; cilnidipine	N-TYPE; HEART-FAILURE; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ANGIOTENSIN-II; DOXORUBICIN; ALDOSTERONE; MODEL; SYSTEM; AMLODIPINE	Cilnidipine is an L/N-type calcium channel blocker (CCB). The effects of cilnidipine on N-type channels give it unique organ-protective properties via the suppression of hyperactivity in the sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system (RAAS). In the present study, we compared the effects of cilnidipine and amlodipine (an L-type CCB) on cardiac and renal functions in spontaneously-hypertensive rats injected with adriamycin (ADR). After the weekly administration of ADR for 3weeks, spontaneously-hypertensive rats were orally administered cilnidipine (20mg/kg per day), amlodipine (3mg/kg per day), or vehicle once daily for 4weeks. A control group received saline rather than ADR, followed by vehicle for 4weeks. Cilnidipine and amlodipine produced similar reductions in blood pressure after 4weeks. Cilnidipine ameliorated ADR-induced heart and kidney damage, whereas amlodipine slightly improved cardiac echocardiographic parameters, but did not protect against ADR-induced renal damage. Cilnidipine (but not amlodipine) suppressed the reflex SNS and RAAS hyperactivity caused by their antihypertensive effects. Furthermore, cilnidipine and amlodipine treatment decreased the urinary levels of adrenocortical hormones. The protective effects of cilnidipine against ADR-induced renal and cardiac dysfunction might be associated with its blockade of N-type calcium channels, in addition to its pleiotropic actions, which include the inhibition of the RAAS.	[Aritomi, Shizuka; Harada, Eri; Sugino, Kazumi; Nishimura, Mai; Nakamura, Tarou] Ajinomoto Pharmaceut, Res Inst, Kawasaki, Kanagawa 2108681, Japan; [Aritomi, Shizuka; Harada, Eri; Sugino, Kazumi; Takahara, Akira] Toho Univ, Dept Pharmacol & Therapeut, Chiba 2748510, Japan	Harada, E (reprint author), Ajinomoto Pharmaceut, Res Inst, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan.	eri_harada@ajinomoto.com					de Souza RCA, 2006, AM J VET RES, V67, P1319, DOI 10.2460/ajvr.67.8.1319; Takatsu M, 2012, J HYPERTENS, V30, P1845, DOI 10.1097/HJH.0b013e3283567645; Sakata K, 2003, DRUG EXP CLIN RES, V29, P117; Rashikh A, 2012, BIOMED PHARMACOTHER, V66, P138, DOI 10.1016/j.biopha.2011.11.020; Fournier A, 2009, EXPERT REV NEUROTHER, V9, P1413, DOI [10.1586/ern.09.89, 10.1586/ERN.09.89]; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Girerd N, 2013, EUR J HEART FAIL, V15, P1228, DOI 10.1093/eurjhf/hft100; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Klar J, 2005, HYPERTENSION, V46, P1340, DOI 10.1161/01.HYP.0000192025.86189.46; Guerra J, 2005, HEMATOL J, V5, P584, DOI 10.1038/sj.thj.6200573; Ibrahim HN, 2003, CURR OPIN NEPHROL HY, V12, P159, DOI 10.1097/01.mnh.0000058802.51455.ec; Munoz M, 2011, J RENIN-ANGIO-ALDO S, V12, P404, DOI 10.1177/1470320311410092; Zhang J, 1996, J MOL CELL CARDIOL, V28, P1931, DOI 10.1006/jmcc.1996.0186; Sakata K, 1999, HYPERTENSION, V33, P1447; Weir RAP, 2011, EUR J HEART FAIL, V13, P1305, DOI 10.1093/eurjhf/hfr129; Yamaji M, 2009, CIRC-HEART FAIL, V2, P608, DOI 10.1161/CIRCHEARTFAILURE.109.868513; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Lisurek M, 2004, MOL CELL ENDOCRINOL, V215, P149, DOI 10.1016/j.mce.2003.11.008; Rashikh A, 2013, J RENIN-ANGIO-ALDO S, V14, P14, DOI 10.1177/1470320312459980; Souverein PC, 2004, HEART, V90, P859, DOI 10.1136/hrt.2003.020180; Takahara A, 2009, CARDIOVASC THER, V27, P124, DOI 10.1111/j.1755-5922.2009.00079.x; Hazari MS, 2009, TOXICOL SCI, V110, P224, DOI 10.1093/toxsci/kfp092; Aritomi S, 2011, AM J NEPHROL, V33, P168, DOI 10.1159/000323969; Aritomi S, 2012, J HYPERTENS, V1, P102; Aritomi S, 2011, HYPERTENS RES, V34, P193, DOI 10.1038/hr.2010.191; Aritomi S, 2010, HEART VESSELS, V25, P549, DOI 10.1007/s00380-010-0005-4; BRAUNWALD E, 1991, NEW ENGL J MED, V325, P351, DOI 10.1056/NEJM199108013250508; Fardet L, 2007, RHEUMATOLOGY, V46, P1102, DOI 10.1093/rheumatology/kem062; Gnanapragasam A, 2004, LIFE SCI, V76, P585, DOI 10.1016/j.lfs.2004.09.009; Gu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014633; Harada E, 2014, JPN PHARMACOL THER, V42, P413; HOSONO M, 1995, JPN J PHARMACOL, V69, P127, DOI 10.1254/jjp.69.127; Jovanovic D, 2009, BIOMED PHARMACOTHER, V63, P571, DOI 10.1016/j.biopha.2008.10.006; Kojima S, 2004, HYPERTENS RES, V27, P379, DOI 10.1291/hypres.27.379; Konda T, 2005, NEPHRON PHYSIOL, V101, pp1; Konda T, 2009, AM J NEPHROL, V30, P155, DOI 10.1159/000210396; Lai EY, 2011, HYPERTENS RES, V34, P942, DOI 10.1038/hr.2011.65; Mihailovic- Stanojevic N, 2009, NEPHROL DIAL TRANSPL, V24, P1142; Nagai H, 2005, HYPERTENS RES, V28, P361, DOI 10.1291/hypres.28.361; Shiga T, 2007, HEART VESSELS, V22, P404, DOI 10.1007/s00380-007-0984-y; Takahara A, 2009, BRIT J PHARMACOL, V158, P1366, DOI 10.1111/j.1476-5381.2009.00407.x; Takahara A, 2002, EUR J PHARMACOL, V434, P43, DOI 10.1016/S0014-2999(01)01521-7; Takai S, 2013, HYPERTENS RES, V36, P342, DOI 10.1038/hr.2012.187; YUSUF S, 1991, NEW ENGL J MED, V325, P293; Tong J, 1991, AM J PHYSIOL, V260, P909; Tsuchihashi T, 2005, CLIN EXP HYPERTENS, V27, P583, DOI 10.1080/10641960500298558; Tsutamoto T, 2003, J CARDIOVASC PHAR S1, V41, P77; Varagic J, 2002, J HYPERTENS, V20, P317, DOI 10.1097/00004872-200202000-00023; Zhang Shujuan, 2012, J Biomed Res, V26, P425, DOI 10.7555/JBR.26.20120035; Zhou XY, 2002, J HYPERTENS, V20, P993, DOI 10.1097/00004872-200205000-00035; Zucker Irving H, 2002, Heart Fail Monit, V3, P2	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	APR	2015	42	4					344	352		10.1111/1440-1681.12360		9	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CE4WY	WOS:000351832200005		
J	Fujimoto, T; Taniwaki, T; Tahata, S; Nakamura, T; Mizuta, H				Fujimoto, Toru; Taniwaki, Takuya; Tahata, Shogo; Nakamura, Takayuki; Mizuta, Hiroshi			Patient outcomes for a minimally invasive approach to treat lumbar spinal canal stenosis: Is microendoscopic or microscopic decompressive laminotomy the less invasive surgery?	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Lumbar spinal canal stenosis; Microscopic decompressive laminotomy; Microendoscopic decompressive laminotomy; Unilateral approach; Minimally invasive surgery	UNILATERAL LAMINOTOMY; BILATERAL DECOMPRESSION; DISKECTOMY	Objective: We performed a study to compare the severity of surgical stress between microscopic and microendoscopic decompressive laminotomy performed via a unilateral approach in patients with lumbar spinal canal stenosis (LSCS). Materials and methods: A total of 41 patients received decompressive laminotomy for lumbar spinal stenosis. Twenty patients received microscopic decompressive laminotomy (MDL), and 21 patients received microendoscopic decompressive laminotomy (MEDL). The pre- and postoperative Japanese Orthopaedic Association (JOA), and Visual Analogue Scale (VAS) lower leg pain scores were evaluated. The other variables studied were the length of the operation, blood loss, length of hospital stay, the reaction of the CRP and WBC levels, the dosage of non-steroidal anti-inflammatory drugs (NSAIDs) used and surgical. complications. Results: The clinical analyses of the surgical outcomes were evaluated after a minimum two-year follow-up. The pre-and postoperative JOA scores and VAS in the MDL and MEDL groups were statistically similar. There were statistically significant differences found between the lengths of the operation time, blood loss, length of hospital stay, the reaction of CRP, and the pain indicated by the dosage of NSAIDs. The length of the operation time was longer in the MEDL group, and the other variables were greater in the MDL group. Conclusions: The MEDL procedure is less invasive and safer than the MDL procedure. Hence, MEDL is an effective technique for treating symptomatic LSCS patients. (C) 2015 Elsevier B.V. All rights reserved.	[Fujimoto, Toru; Taniwaki, Takuya; Tahata, Shogo; Nakamura, Takayuki; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Kumamoto, Kumamoto 8608556, Japan	Fujimoto, T (reprint author), Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, 1-1-1 Honjyo, Kumamoto, Kumamoto 8608556, Japan.	torufuji@fc.kuh.kumamoto-u.ac.jp					Mannion RJ, 2012, J SPINAL DISORD TECH, V25, P47, DOI 10.1097/BSD.0b013e31820baa1e; Iguchi T, 2000, SPINE, V25, P1754, DOI 10.1097/00007632-200007150-00003; Righesso O, 2007, NEUROSURGERY, V61, P545, DOI 10.1227/01.NEU0000280008.72190.15; Costa F, 2007, J NEUROSURG-SPINE, V7, P579, DOI 10.3171/SPI-07/12/579; Minamide A, 2013, J NEUROSURG-SPINE, V19, P664, DOI 10.3171/2013.8.SPINE13125; Yone K, 1996, SPINE, V21, P242, DOI 10.1097/00007632-199601150-00016; Oertel MF, 2006, NEUROSURGERY, V59, P1264, DOI 10.1227/01.NEU.0000245616.32226.58; Pao JL, 2009, EUR SPINE J, V18, P672, DOI 10.1007/s00586-009-0903-2; Cavusoglu H, 2007, EUR SPINE J, V16, P2133, DOI 10.1007/s00586-007-0471-2; Ikuta K, 2005, J NEUROSURG-SPINE, V2, P624, DOI 10.3171/spi.2005.2.5.0624; Morgalla MH, 2011, J NEUROSURG-SPINE, V14, P305, DOI 10.3171/2010.10.SPINE09708; Foley KT, 1997, TECH NEUROSURG, V3, P301; HERNO A, 1993, SPINE, V18, P1471; JOHNSSON KE, 1986, SPINE, V11, P107, DOI 10.1097/00007632-198603000-00001; McCulloch JA, 1991, ADULT SPINE PRINCIPL, P1821; Mobbs RJ, 2014, J NEUROSURG-SPINE, V21, P176; Muramatsu K, 2001, SPINE, V26, P1599, DOI 10.1097/00007632-200107150-00022; Paravero L, 2009, NEUROSURGERY, V65, P182; POLETTI CE, 1995, NEUROSURGERY, V37, P343; POSTACCHINI F, 1992, J BONE JOINT SURG BR, V74, P862; Toyoda H, 2011, SPINE, V36, P410, DOI 10.1097/BRS.0b013e3181d25829	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2015	131						21	25		10.1016/j.clineuro.2015.01.014		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE4KY	WOS:000351800700005		
J	Mizutani, K; Toda, M; Yoshida, K				Mizutani, Katsuhiro; Toda, Masahiro; Yoshida, Kazunari			Analysis of the intercavernous sinuses using multidetector computed tomography digital subtraction venography (CT-DSV)	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Intercavernous sinus; CT-DSV; Transsphenoidal approach; Anatomy	PITUITARY-GLAND; TRANSSPHENOIDAL SURGERY; AGE; HEIGHT	Purposes: The intercavernous sinuses (ICSs) connect both sides of the cavernous sinus. Knowledge of the ICSs is useful when employing the endoscopic endonasal transsphenoidal approach. Although there were some studies concerning the anatomy of ICSs using cadavers, there is no well-recognized method of the radiological evaluation of the ICSs. Therefore, we evaluate the ICSs using computed tomography digital subtraction venography (CT-DSV) in the cases of unruptured aneurysm that had the normal sellae anatomy. Methods: We retrospectively analyzed 97 cases of unruptured cerebral aneurysm that had normal parasellar and sellar anatomy except for the aneurysms. The analysis was performed using the multi-planar reconstruction images obtained by CT-DSV in these cases. Results: The anterior ICS (AICS), inferior ICS (IICS) and posterior ICS (PICS) were detected in 51 cases (52.6%), 28 cases (28.9%) and 76 cases (78.4%) respectively. In the cases older than 51 years old, the AICS was detected significantly less often than in those younger than 50 years old. Conclusions: The CT-DSV images directly reflected the blood flow. Most of the past research on the ICSs was obtained using cadavers, which could therefore not difectly assess the normal human blood flow. The present study showed the usefulness of CT-DSV for evaluating the ICSs and to understand the normal anatomy of the ICSs. (C) 2015 Published by Elsevier B.V.	[Mizutani, Katsuhiro; Toda, Masahiro; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Shinjuku City, Tokyo, Japan	Mizutani, K (reprint author), Keio Univ, Sch Med, Dept Neurosurg, 35 Shinanomachi, Shinjuku City, Tokyo, Japan.	katsu512@yahoo.co.jp					Tsunoda A, 1997, AM J NEURORADIOL, V18, P551; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; Kim EH, 2009, ACTA NEUROCHIR, V151, P803, DOI 10.1007/s00701-009-0356-8; Liu JK, 2001, J NEUROSURG, V95, P1083, DOI 10.3171/jns.2001.95.6.1083; KAPLAN HA, 1976, J NEUROSURG, V45, P166, DOI 10.3171/jns.1976.45.2.0166; AQUINI MG, 1994, SKULL BASE SURG, V4, P145, DOI 10.1055/s-2008-1058966; ARGYROPOULOU M, 1991, PEDIATR RADIOL, V21, P247, DOI 10.1007/BF02018614; BERGLAND RM, 1968, J NEUROSURG, V28, P93, DOI 10.3171/jns.1968.28.2.0093; DEDIVITIIS E, 1981, SURG NEUROL, V15, P306; DORAISWAMY PM, 1992, AM J NEURORADIOL, V13, P1295; GREEN HT, 1957, AM J ANAT, V100, P435, DOI 10.1002/aja.1001000307; Harris FS, 1976, J NEUROSURG, P45; HAYAKAWA K, 1989, RADIOLOGY, V172, P171; TANABE S, 1984, Neurological Surgery, V12, P815; Tubbs RS, 2013, WORLD NEUROSURG, V2, P5; Winslow JB, 1763, ANATOMICAL EXPOSITIO; XUEREB GP, 1954, Q J EXP PHYSIOL CMS, V39, P199	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2015	131						31	34		10.1016/j.clineuro.2015.01.021		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE4KY	WOS:000351800700007		
J	Lim, SJ; Kim, M; Park, J; Fujita, O; Chung, S				Lim, Seung Jae; Kim, Minkuk; Park, Jeong; Fujita, Osamu; Chung, Sukho			Flame spread over electrical wire with AC electric fields: Internal circulation, fuel vapor-jet, spread rate acceleration, and molten insulator dripping	COMBUSTION AND FLAME			English	Article						Flame spread; Electrical wire; AC electric field; Internal circulation	SUBATMOSPHERIC PRESSURE; TRIBRACHIAL FLAMES; PROPAGATION SPEED; BUNSEN FLAMES; COFLOW JETS; MICROGRAVITY; STABILIZATION; MODEL	The effect of electric field on the characteristics of flame spread along a polyethylene (PE) insulated electrical wire was investigated experimentally by varying the AC frequency and voltage applied to the wire. The results showed that the flame spread rate was accelerated due to the convergence of electric flux near the end of wire, having three distinct regimes depending on applied voltage. In each regime, several subregimes could be identified depending on AC frequency. Flame shape (height and width) and slanted direction of the spreading flame were influenced differently. Fuel-vapor jets were ejected from the molten PE surface even for the baseline case without the application of an electric field; this could be attributed to the bursting of fuel vapor bubbles generated from internal boiling at the molten PE surface. An internal circulation of molten-PE was also observed as a result of non-uniform heating by the spreading flame. In the high voltage regime with a high AC frequency, excessive dripping of molten PE led to flame extinction. (C) 2014 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Lim, Seung Jae; Park, Jeong] Pukyong Natl Univ, Dept Mech Engn, Busan 608737, South Korea; [Kim, Minkuk] Korea Inst Machinery & Mat, Environm & Energy Syst Res Div, Taejon, South Korea; [Fujita, Osamu] Hokkaido Univ, Div Mech & Sci, Sapporo, Hokkaido, Japan; [Chung, Sukho] King Abdullah Univ Sci & Technol, Clean Combust Ctr, Thuwal, Saudi Arabia	Park, J (reprint author), Pukyong Natl Univ, Dept Mech Engn, Busan 608737, South Korea.	jeongpark@pknu.ac.kr		Chung, Suk Ho/0000-0001-8782-312X	AEA Project/KAUST; Space Core Technology Development Project/NRF; JAXA; JAXA Research Working Group	The work was supported by AEA Project/KAUST, by Space Core Technology Development Project/NRF (2011-15), and by JAXA as the candidate experiment for the second phase utilization of JEM/ISS entitled "Quantitative Description of Gravity Impact on Solid Material Flammability as a base of Fire Safety in Space" as well as JAXA Research Working Group to promote space utilization.	Savino R, 2002, J THERMOPHYS HEAT TR, V16, P562, DOI 10.2514/2.6716; FERNANDEZPELLO AC, 1978, COMBUST FLAME, V31, P135, DOI 10.1016/0010-2180(78)90124-4; Kim MK, 2011, P COMBUST INST, V33, P1145, DOI 10.1016/j.proci.2010.06.155; Umemura A, 2002, P COMBUST INST, V29, P2535, DOI 10.1016/S1540-7489(02)80309-1; Fujita O, 2002, P COMBUST INST, V29, P2545, DOI 10.1016/S1540-7489(02)80310-8; Greenberg P.S., 1994, P 3 INT MICR COMB WO, V2, P631; Kikuchi M., 1998, P COMBUST INST, V27, P2507; Kim MK, 2012, COMBUST FLAME, V159, P1151, DOI 10.1016/j.combustflame.2011.10.018; Kim MK, 2011, P COMBUST INST, V33, P1137, DOI 10.1016/j.proci.2010.06.062; Kobayashi H, 2002, P COMBUST INST, V29, P2603, DOI 10.1016/S1540-7489(02)80317-0; Lawton J., 1969, ELECT ASPECTS COMBUS; Nakamura Y, 2009, P COMBUST INST, V32, P2559, DOI 10.1016/j.proci.2008.06.146; Nakamura Y., 2008, PROGR SCALE MODELING, P17, DOI 10.1007/978-1-4020-8682-3_2; Nakamura Y, 2008, J THERM SCI TECH-JPN, V3, P430, DOI 10.1299/jtst.3.430; Orloff L., 1974, P COMBUST INST, V15, P183; Ryu SK, 2010, COMBUST FLAME, V157, P25, DOI 10.1016/j.combustflame.2009.10.001; Takahashi S, 2013, P COMBUST INST, V34, P2657, DOI 10.1016/j.proci.2012.06.158; Weinberg F., 1986, ADV COMBUSTION METHO; Won SH, 2008, COMBUST FLAME, V152, P496, DOI 10.1016/j.combustflame.2007.11.008; Won SH, 2007, P COMBUST INST, V31, P963, DOI 10.1016/j.proci.2006.07.166; Youngblood W.W., 1989, 185147 NASA	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	APR	2015	162	4					1167	1175		10.1016/j.combustflame.2014.10.009		9	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CE4IK	WOS:000351794100024		
J	Nakamura, H; Curran, HJ; Cordoba, AP; Pitz, WJ; Dagaut, P; Togbe, C; Sarathy, SM; Mehl, M; Agudelo, JR; Bustamante, F				Nakamura, Hisashi; Curran, Henry J.; Cordoba, Angel Polo; Pitz, William J.; Dagaut, Philippe; Togbe, Casimir; Sarathy, S. Mani; Mehl, Marco; Agudelo, John R.; Bustamante, Felipe			An experimental and modeling study of diethyl carbonate oxidation	COMBUSTION AND FLAME			English	Article						Ignition delay time; Oxidation; Shock tube; Rapid compression machine; Diethyl carbonate; Jet-stirred reactor	RAPID COMPRESSION MACHINE; JET-STIRRED REACTOR; ATOM ABSTRACTION REACTIONS; ETHYLENE-AIR MIXTURES; FLOW DIFFUSION FLAME; SHOCK-TUBE; RATE CONSTANTS; ELEVATED PRESSURES; THERMAL-DECOMPOSITION; DIMETHYL CARBONATE	Diethyl carbonate (DEC) is an attractive biofuel that can be used to displace petroleum-derived diesel fuel, thereby reducing CO2 and particulate emissions from diesel engines. A better understanding of DEC combustion characteristics is needed to facilitate its use in internal combustion engines. Toward this goal, ignition delay times for DEC were measured at conditions relevant to internal combustion engines using a rapid compression machine (RCM) and a shock tube. The experimental conditions investigated covered a wide range of temperatures (660-1300 K), a pressure of 30 bar, and equivalence ratios of 0.5, 1.0 and 2.0 in air. To provide further understanding of the intermediates formed in DEC oxidation, species concentrations were measured in a jet-stirred reactor at 10 atm over a temperature range of 500-1200 K and at equivalence ratios of 0.5, 1.0 and 2.0. These experimental measurements were used to aid the development and validation of a chemical kinetic model for DEC. The experimental results for ignition in the RCM showed near negative temperature coefficient (NTC) behavior. Six-membered alkylperoxy radical (R(O) over dot(2)) isomerizations are conventionally thought to initiate low-temperature branching reactions responsible for NTC behavior, but DEC has no such possible 6- and 7-membered ring isomerizations. However, its molecular structure allows for 5-, 8- and 9-membered ring R(O) over dot(2) isomerizations. To provide accurate rate constants for these ring structures, ab initio computations for R(O) over dot(2) reversible arrow (Q) over dot OOH isomerization reactions were performed. These new R(O) over dot(2) isomerization rate constants have been implemented in a chemical kinetic model for DEC oxidation. The model simulations have been compared with ignition delay times measured in the RCM near the NTC region. Results of the simulation were also compared with experimental results for ignition in the high-temperature region and for species concentrations in the jet-stirred reactor. Chemical kinetic insights into the oxidation of DEC were made using these experimental and modeling results. (C) 2014 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Nakamura, Hisashi; Curran, Henry J.] Natl Univ Ireland, Combust Chem Ctr, Galway, Ireland; [Nakamura, Hisashi] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan; [Cordoba, Angel Polo; Pitz, William J.; Mehl, Marco] Lawrence Livermore Natl Lab, Livermore, CA USA; [Cordoba, Angel Polo; Agudelo, John R.; Bustamante, Felipe] Univ Antioquia, Medellin, Colombia; [Dagaut, Philippe; Togbe, Casimir] CNRS INSIS, Orleans, France; [Sarathy, S. Mani] King Abdullah Univ Sci & Technol, Clean Combust Res Ctr, Thuwal, Saudi Arabia	Nakamura, H (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	nakamura@edyn.ifs.tohoku.ac.jp	Nakamura, Hisashi/D-9595-2012; Dagaut, Philippe/C-1709-2008; Sarathy, S. Mani/M-5639-2015; AGUDELO, JOHN/K-3041-2014	Nakamura, Hisashi/0000-0002-3158-370X; Sarathy, S. Mani/0000-0002-3975-6206; AGUDELO, JOHN/0000-0003-1304-9375	US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; US Department of Energy, Office of Vehicle Technologies; Office of Basic Energy Sciences; ERC Advanced Grant "2G-CSafe: Combustion of Sustainable Alternative Fuels for Engines used in aeronautics and automotives" [291049]; NSERC of Canada; KAUST Clean Combustion Research Center; Ministry of Agriculture; Government of Cesar; Colciencias; Popular University of Cesar; University of Antioquia in Colombia; "Young Researcher Overseas Visits Program for Vitalizing Brain Circulation" from Japan Society for the Promotion of Science.	This work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. The work at LLNL work was supported by the US Department of Energy, Office of Vehicle Technologies and the Office of Basic Energy Sciences, and the authors thank program managers Gurpreet Singh, Kevin Stork, and Wade Sisk. The work performed at CNRS was funded via the ERC Advanced Grant "2G-CSafe: Combustion of Sustainable Alternative Fuels for Engines used in aeronautics and automotives", Grant Agreement Number 291049 (PI Philippe Dagaut). Co-author SMS acknowledges fellowship support from NSERC of Canada and from the KAUST Clean Combustion Research Center. Co-author ADPC acknowledges the Ministry of Agriculture, the Government of Cesar, Colciencias, Popular University of Cesar and the University of Antioquia in Colombia, for the doctoral scholarship received. Co-author HN acknowledges the financial support "Young Researcher Overseas Visits Program for Vitalizing Brain Circulation" from Japan Society for the Promotion of Science.	Affleck W. S., 1968, P I MECH ENG, V183, P365, DOI 10.1243/PIME_PROC_1968_183_034_02; RITTER ER, 1991, INT J CHEM KINET, V23, P767, DOI 10.1002/kin.550230903; Nakamura H, 2014, COMBUST FLAME, V161, P49, DOI 10.1016/j.combustflame.2013.08.002; Pacheco MA, 1997, ENERG FUEL, V11, P2, DOI 10.1021/ef9600974; McEnally CS, 2011, ENVIRON SCI TECHNOL, V45, P2498, DOI 10.1021/es103733q; DAGAUT P, 1986, J PHYS E SCI INSTRUM, V19, P207, DOI 10.1088/0022-3735/19/3/009; Villano SM, 2011, J PHYS CHEM A, V115, P13425, DOI 10.1021/jp2079204; Dayma G, 2011, P COMBUST INST, V33, P1037, DOI 10.1016/j.proci.2010.05.024; Carstensen HH, 2007, P COMBUST INST, V31, P149, DOI 10.1016/j.proci.2006.08.091; Mendes J, 2013, J PHYS CHEM A, V117, P14006, DOI 10.1021/jp409133x; TEE LS, 1966, IND ENG CHEM FUND, V5, P356, DOI 10.1021/i160019a011; Yasunaga K, 2010, J PHYS CHEM A, V114, P9098, DOI 10.1021/jp104070a; Huynh LK, 2008, J ORG CHEM, V73, P94, DOI 10.1021/jo701824n; Kopp MM, 2014, J PROPUL POWER, V30, P790, DOI 10.2514/1.B34890; Contino F, 2011, P COMBUST INST, V33, P3057, DOI 10.1016/j.proci.2010.08.002; Mittal G, 2014, COMBUST FLAME, V161, P1164, DOI 10.1016/j.combustflame.2013.11.005; [Anonymous], 2001, COMMUNICATION; Ren Y, 2008, FUEL, V87, P2691, DOI 10.1016/j.fuel.2008.02.017; Roh NS, 2003, FUEL PROCESS TECHNOL, V83, P27, DOI 10.1016/S0378-3820(03)00079-1; Kopp MM, 2014, J PROPUL POWER, V30, P799, DOI 10.2514/1.B34891; Saeys M, 2003, J PHYS CHEM A, V107, P9147, DOI 10.1021/jp021706d; Westbrook CK, 2006, J PHYS CHEM A, V110, P6912, DOI 10.1021/jp056362g; Sarathy SM, 2011, COMBUST FLAME, V158, P2338, DOI 10.1016/j.combustflame.2011.05.007; Healy D, 2010, COMBUST FLAME, V157, P1526, DOI 10.1016/j.combustflame.2010.01.016; Barker JR, 2001, INT J CHEM KINET, V33, P232, DOI 10.1002/kin.1017; Glaude PA, 2005, P COMBUST INST, V30, P1111, DOI 10.1016/j.proci.2004.08.096; Darcy D, 2014, COMBUST FLAME, V161, P65, DOI 10.1016/j.combustflame.2013.08.001; [Anonymous], 2013, COMMUNICATION; Gallagher SM, 2008, COMBUST FLAME, V153, P316, DOI 10.1016/j.combustflame.2007.09.004; Dunn BC, 2002, ENERG FUEL, V16, P177, DOI 10.1021/ef0101816; Lenhert DB, 2007, COMBUST SCI TECHNOL, V179, P845, DOI 10.1080/00102200600672011; Farooq A, 2009, P COMBUST INST, V32, P247, DOI 10.1016/j.proci.2008.06.084; Asatryan R, 2010, J PHYS CHEM A, V114, P7693, DOI 10.1021/jp101159h; Barker J. R., 2011, MULTIWELL 2011 3 SOF; Bennadji H, 2011, FUEL, V90, P3237, DOI 10.1016/j.fuel.2011.06.028; Benson S. W., 1976, THERMOCHEMICAL KINET, P272; Frisch M J, 2010, GAUSSIAN 09 REVISION; Harris SJ, 2009, J POWER SOURCES, V193, P855, DOI 10.1016/j.jpowsour.2009.04.030; Herzler J, 1997, J PHYS CHEM A, V101, P5494, DOI 10.1021/jp970653a; Kozak M., 2009, 2009012696 SAE; Liang L, 2010, 2010010178 SAE; Luo ZY, 2012, COMBUST THEOR MODEL, V16, P369, DOI 10.1080/13647830.2011.631034; McNenly M., 2014, COMMUNICATION; Mendes J, 2014, J PHYS CHEM A, V118, P4889, DOI 10.1021/jp5029596; Metcalfe WK, 2009, COMBUST FLAME, V156, P250, DOI 10.1016/j.combustflame.2008.09.007; Metcalfe WK, 2013, INT J CHEM KINET, V45, P638, DOI 10.1002/kin.20802; Morley C, 2004, GASEQ VERSION 0 76; Notario R., 2005, J PHYS ORG CHEM, V18, P134; Pepiot-Desjardins P, 2008, COMBUST FLAME, V154, P191, DOI 10.1016/j.combustflame.2008.03.017; PITZ WJ, 1986, COMBUST FLAME, V63, P113, DOI 10.1016/0010-2180(86)90115-X; Sivaramakrishnan R, 2010, J PHYS CHEM A, V114, P9425, DOI 10.1021/jp104759d; Stranic I, 2014, J PHYS CHEM A, V118, P822, DOI 10.1021/jp410853f; Wijaya CD, 2003, J PHYS CHEM A, V107, P4908, DOI 10.1021/jp027471n; Wurmel J, 2007, INT J VEHICLE DES, V44, P84, DOI 10.1504/IJVD.2007.013220; Yaws C. L., YAWS THERMOPHYSICAL; Zhou CW, 2012, INT J CHEM KINET, V44, P155, DOI 10.1002/kin.20708	56	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	APR	2015	162	4					1395	1405		10.1016/j.combustflame.2014.11.002		11	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CE4IK	WOS:000351794100042		
J	Cai, J; Handa, M; Modest, MF				Cai, Jian; Handa, Masato; Modest, Michael F.			Eulerian-Eulerian multi-fluid methods for pulverized coal flames with nongray radiation	COMBUSTION AND FLAME			English	Article						Coal flames; Radiative heat transfer; Eulerian-Eulerian multiphase flows; Simulations	NARROW-BAND; NUMERICAL-SIMULATION; OPTICAL MEASUREMENT; DETAILED STRUCTURE; K-DISTRIBUTIONS; HEAT-TRANSFER; JET FLAME; COMBUSTION; PARTICLES; DATABASE	A new Favre averaging method based on gas phase density applied to Eulerian-Eulerian simulations of turbulent multiphase reacting flows is proposed. The new Favre averaging method can reproduce turbulent dispersions of mass, momentum, heat and species of solid phases from their averaged transport equations. A new radiation model that can account for nongray gas-solid mixtures is developed for pulverized coal flames. The new models are validated against a pulverized coal ignition flame. Predictions of velocity, temperature and gas major species are found in good agreement with experiments. Pyrometer measurements of temperature are predicted by a radiation transport calculation. It is found that radiation cooling effects can lead to a 500 K temperature decline in solid phases. Radiation also has indirect influence on CO2 predictions through the slow yet strongly temperature-dependent char reaction rates. The consideration of radiation improves predictions of both temperature and CO2 concentrations. Effects of devolatilization model and number of phases are also discussed. (C) 2014 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Cai, Jian; Modest, Michael F.] Univ Calif Merced, Merced, CA 95343 USA; [Handa, Masato] Res & Dev Ctr Mitsubishi Hitachi Power Syst Ltd, Thermal Power Syst Res Dept, Ibaraki, Japan	Cai, J (reprint author), Univ Calif Merced, Merced, CA 95343 USA.	jcai@ucmerced.edu; masato_handa@mhps.com; mmodest@ucmerced.edu			NETL [DE-FE0003801]; Hitachi Research Laboratory, Hitach, Ltd.	The research conducted at University of California at Merced was sponsored by NETL under Grant No. DE-FE0003801. Masato Handa was fully supported by Hitachi Research Laboratory, Hitach, Ltd. during his visit to University of California at Merced.	Luo K, 2012, ENERG FUEL, V26, P6128, DOI 10.1021/ef301253y; Pope SB, 2004, COMBUST FLAME, V139, P222, DOI 10.1016/j.combustflame.2004.07.008; Jackson R, 1997, CHEM ENG SCI, V52, P2457, DOI 10.1016/S0009-2509(97)00065-1; Cai J, 2014, J QUANT SPECTROSC RA, V141, P65, DOI 10.1016/j.jqsrt.2014.02.028; Franchetti BM, 2013, P COMBUST INST, V34, P2419, DOI 10.1016/j.proci.2012.07.056; Wang AQ, 2005, J QUANT SPECTROSC RA, V93, P245, DOI 10.1016/j.jqsrt.2004.08.024; Mashayek F, 2003, PROG ENERG COMBUST, V29, P329, DOI 10.1016/S0360-1285(03)00029-7; BUCKIUS RO, 1980, J HEAT TRANS-T ASME, V102, P99; Hashimoto N, 2012, FUEL, V97, P277, DOI 10.1016/j.fuel.2012.03.005; HAMOR RJ, 1973, COMBUST FLAME, V21, P153, DOI 10.1016/S0010-2180(73)80020-3; Hwang SM, 2005, ENERG FUEL, V19, P382, DOI 10.1021/ef049867z; MERRICK D, 1983, FUEL, V62, P540, DOI 10.1016/0016-2361(83)90223-5; Stein OT, 2013, FLOW TURBUL COMBUST, V90, P859, DOI 10.1007/s10494-012-9423-y; Bermudez A, 2011, COMBUST FLAME, V158, P1852, DOI 10.1016/j.combustflame.2011.02.002; Cai J, 2014, POWDER TECHNOL, V265, P76, DOI 10.1016/j.powtec.2014.01.026; Cai J, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4026169; Crowe CT, 2012, MULTIPHASE FLOWS WITH DROPLETS AND PARTICLES, 2ND EDITION, P1; Hwang SM, 2006, JSME INT J B-FLUID T, V49, P1316, DOI 10.1299/jsmeb.49.1316; Hwang SM, 2006, JSME INT J B-FLUID T, V49, P1328, DOI 10.1299/jsmeb.49.1328; Kobayashi H., 1977, S INT COMBUST, V16, P411, DOI 10.1016/S0082-0784(77)80341-X; Magnussen B. F, 2005, ECCOMAS THEM C COMP, P21; Modest MF, 2003, J QUANT SPECTROSC RA, V76, P69, DOI 10.1016/S0022-4073(02)00046-8; Modest MF, 2013, RADIATIVE HEAT TRANSFER, 3RD EDITION, P1; Pope S. B., 2000, TURBULENT FLOWS; Smoot LD, 1993, FUNDAMENTALS COAL CO; Syamlal M., 1993, DOEMETC941004; Ubhayakar S. K, 1977, S INT COMBUST, V16, P427, DOI 10.1016/S0082-0784(77)80342-1; Veynante D., 2005, THEORETICAL NUMERICA; Viskanta R., 1981, 81HT24 ASME; VISKANTA R, 1987, PROG ENERG COMBUST, V13, P97, DOI 10.1016/0360-1285(87)90008-6; Zhao XY, 2014, COMBUST FLAME, V161, P1866, DOI 10.1016/j.combustflame.2013.12.024; Zhou L. X., 2005, Numerical Heat Transfer, Part B (Fundamentals), V47, DOI 10.1080/10407790590883504	32	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	APR	2015	162	4					1550	1565		10.1016/j.combustflame.2014.11.023		16	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CE4IK	WOS:000351794100056		
J	Dao, HL; Takahashi, R				Dao, Hailong; Takahashi, Ryo			Upper bounds for dimensions of singularity categories	COMPTES RENDUS MATHEMATIQUE			English	Article							TRIANGULATED CATEGORIES; IDEALS	This paper gives upper bounds for the dimension of the singularity category of a Cohen-Macaulay local ring with an isolated singularity. One of them recovers an upper bound given by Ballard, Favero and Katzarkov in the case of a hypersurface. (C) 2015 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.	[Dao, Hailong] Univ Kansas, Dept Math, Lawrence, KS 66045 USA; [Takahashi, Ryo] Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan; [Takahashi, Ryo] Univ Nebraska, Dept Math, Lincoln, NE 68588 USA	Dao, HL (reprint author), Univ Kansas, Dept Math, Lawrence, KS 66045 USA.	hdao@math.ku.edu; takahashi@math.nagoya-u.ac.jp			NSF [DMS 0834050, DMS 1104017]; JSPS [22740008, 22-104]	The first author was partially supported by NSF grants DMS 0834050 and DMS 1104017.; The second author was partially supported by JSPS Grant-in-Aid for Young Scientists (B) 22740008 and by JSPS Postdoctoral Fellowships for Research Abroad (No. 22-104).	Aihara T., 2015, COMMUN ALGE IN PRESS; Rouquier R, 2008, J K-THEORY, V1, P193, DOI 10.1017/is008004024jkt010; Krause H, 2006, CONTEMP MATH, V406, P95; Christensen JD, 1998, ADV MATH, V136, P284, DOI 10.1006/aima.1998.1735; Orlov DO, 2006, SB MATH+, V197, P1827, DOI 10.1070/SM2006v197n12ABEH003824; Bondal A, 2003, MOSC MATH J, V3, P1; Bergh PA, 2010, MATH Z, V265, P849, DOI 10.1007/s00209-009-0545-4; Orlov D, 2009, PROG MATH, V270, P503, DOI 10.1007/978-0-8176-4747-6_16; Ballard M, 2012, INVENT MATH, V189, P359, DOI 10.1007/s00222-011-0367-y; Bruns W., 1998, CAMBRIDGE STUDIES AD, V39; Buchweitz R. -O., 1986, MAXIMAL COHEN MACAUL; Orlov D, 2011, ADV MATH, V226, P206, DOI 10.1016/j.aim.2010.06.016; Orlov D., 2004, P STEKLOV I MATH, V246, P227; WANG HJ, 1994, MICH MATH J, V41, P587; Yoshino Y., 1990, LONDON MATH SOC LECT, V146	15	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1631-073X	1778-3569		CR MATH	C. R. Math.	APR	2015	353	4					297	301		10.1016/j.crma.2015.01.012		5	Mathematics	Mathematics	CE8UX	WOS:000352120700004		
J	Shahadat, MMZ; Mizuno, T; Ishino, Y; Takasaki, M				Shahadat, Mhia Md. Zaglul; Mizuno, Takeshi; Ishino, Yuji; Takasaki, Masaya			Active vibration isolation using negative stiffness and displacement cancellation controls: Comparison based on vibration isolation performance	CONTROL ENGINEERING PRACTICE			English	Article						Zero compliance; Infinite stiffness; Negative stiffness; Displacement cancellation	ISOLATION SYSTEM; SUPPRESSION; PLATFORM	Two vibration control techniques, negative stiffness and displacement cancellation, are characterized and employed to achieve active vibration isolation. A horizontal vibration isolation system is developed and then used to investigate each of these techniques theoretically and experimentally. The respective responses of the developed system are measured separately while closed-loop poles of the system are kept unchanged; these measured responses are compared. The developed system is based on a series combination of two isolators and consists of two moving tables; one of the moving tables is mounted on the series-connected isolators and the other is placed between the isolators. Using the negative stiffness technique, the isolators are controlled so that one of them has a negative stiffness and the other has a positive stiffness of equal absolute magnitude; using the displacement cancellation technique, one isolator is set to cancel displacement while the other behaves as a positive-stiffness isolator. The active negative, positive, and displacement cancellation isolators are created using voice-coil motors guided by a negative stiffness controller, proportional derivative controller and integral-proportional derivative controller, respectively. (C) 2014 Elsevier Ltd. All rights reserved.	[Shahadat, Mhia Md. Zaglul] Saitama Univ, Grad Sch Sci & Engg, Sakura Ku, Saitama 3388570, Japan; [Mizuno, Takeshi; Ishino, Yuji; Takasaki, Masaya] Saitama Univ, Dept Mech Engn, Sakura Ku, Saitama 3388570, Japan	Shahadat, MMZ (reprint author), Saitama Univ, Grad Sch Sci & Engg, Sakura Ku, Shimo Okubo 255, Saitama 3388570, Japan.	shahadat230@yahoo.com			Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors gratefully acknowledge the financial support received from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Scientific Research (B). The authors thank Mr. Takehiko Furushima for his contribution with this study.	Mizuno T, 2003, JSME INT J C-MECH SY, V46, P807, DOI 10.1299/jsmec.46.807; Mohamed Z, 2005, CONTROL ENG PRACT, V13, P267, DOI 10.1016/j.conengprac.2003.11.014; Mizuno T, 2007, CONTROL ENG PRACT, V15, P187, DOI 10.1016/j.conengprac.2006.06.001; Yoshioka H, 2001, J VIB ACOUST, V123, P269, DOI 10.1115/1.1350566; Daley S, 2006, CONTROL ENG PRACT, V14, P991, DOI 10.1016/j.conengprac.2005.05.010; Ho ST, 2000, JSME INT J C-MECH SY, V43, P740; Hogue M. E., 2006, IEEE-ASME T MECH, V11, P462; Hogue M. E., 2010, J VIB ACOUST, V132; Jaensch M, 2007, SMART MATER STRUCT, V16, P409, DOI 10.1088/0964-1726/16/2/020; Long XH, 2013, J MATER PROCESS TECH, V213, P660, DOI 10.1016/j.jmatprotec.2012.11.025; Miyazaki T., 1994, P 2 INT C MOT VIBR C, P29; Mizuno T., 2001, P AS PAC VIBR C 2001, V2, P423; Mizuno T., 2005, IUTAM S MUN; Mizuno T, 2010, J VIB CONTROL, V16, P585, DOI 10.1177/1077546309106151; Rivin E. I., 2003, PASSIVE VIBRATION IS, pix; RIVIN EI, 1995, PRECIS ENG, V17, P41, DOI 10.1016/0141-6359(94)00006-L; Shahadat Mhia Md Zaglul, 2011, Journal of System Design and Dynamics, V5, DOI 10.1299/jsdd.5.1077; Shahadat M. M. Z., 2012, J JAPAN SOC APPL ELE, V20, P619; SHAHADAT MMZ, 2014, IEEE T CONTR SYST T, V23, P1385; Tokhi MO, 1996, MECH SYST SIGNAL PR, V10, P667, DOI 10.1006/mssp.1996.0045; Trumper DL, 2002, MECHATRONICS, V12, P281, DOI 10.1016/S0957-4158(01)00068-X; Watanabe K, 1996, IEEE DECIS CONTR P, P1223, DOI 10.1109/CDC.1996.572661; Yasuda M., 1993, T JPN SOC MECH ENG-C, V59, P1694; Zhang CL, 2002, J MATER PROCESS TECH, V129, P634, DOI 10.1016/S0924-0136(02)00671-4; Zhu WH, 2006, CONTROL ENG PRACT, V14, P863, DOI 10.1016/j.conengprac.2005.04.016	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0661	1873-6939		CONTROL ENG PRACT	Control Eng. Practice	APR	2015	37						55	66		10.1016/j.conengprac.2014.12.004		12	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CE6XA	WOS:000351980300006		
J	Arioka, K				Arioka, Koji			2014 W.R. Whitney Award Lecture: Change in Bonding Strength at Grain Boundaries Before Long-Term SCC Initiation	CORROSION			English	Article						Alloy 800; carbon steel; MA 600; PWR; SCC initiation; TT 690; Type 316	CREEP CRACK-GROWTH; C-MN STEEL; PRESSURIZED-WATER REACTORS; STRESS-CORROSION CRACKING; QUANTITATIVE ASSESSMENT; SECONDARY-SIDE; ENHANCED DIFFUSION; THERMAL DIFFUSION; HYDROGEN PRESSURE; ZIRCONIUM ALLOYS	The purpose of this work is to understand the quantitative processes which are the underlying causes of the initiation of stress corrosion after long-term exposures in high-temperature water. Crack initiation tests were performed using blunt-notched compact-tension type specimens of cold-worked (CW) carbon steel (ASTM A106 [UNS K03006]), CW mill annealed Alloy 600 (UNS N06600, MA600), and CW thermally treated alloy 690 (UNS N06690, TT 690), which were exposed in air, hydrogenated pure water, and in the primary coolant environment in pressurized water reactors (PWR) under static load condition in the range of temperatures between 360 and 465 degrees C. Four important patterns were observed: first, intergranular cracking was observed in all tested materials, even in those exposed in air, under static load conditions when materials had been cold worked. Secondly, 1/T type temperature dependencies of initiation times were observed for CW carbon steel; the crack initiation time in an operating plant (Point Lepreau Nuclear Generating Station, New Brunswick, Canada) seemed to lie in the extrapolated line of the experimental results. Third, cavities in the metal were identified in all of the test materials at the grain boundaries at the bottom of a notch before cracks initiated in both water and air. The cavities seem to result from the condensation of vacancies and affected the bond strength of grain boundaries. Consequently, the bond strength is assumed to be weakened during the incubation period. Judging from the similar apparent activation energy of crack initiation time (145.2KJ/mol) and lattice diffusivity (148.6 KJ/mol) in CW carbon steel, the rate-limiting process of crack initiation caused by cavity formation seems to be lattice diffusion of CW-induced vacancies to grain boundaries. Fourth, the rate of formation of cavities depends on the material, cold work, temperature, grain size, and stress gradient. The rates of cavity formation were examined using 20% CW materials of TT690, MA600, Alloy 800 (UNS N08800), 316 stainless steel (USN S31600, 316), and carbon steel in air. Four important results were obtained: First, 10 to 10,000 times different rates of cavity formation were observed among in the materials. These results suggest that the times of crack initiation that were caused by cavity formation depend strongly on the properties of the materials. Cavities form ten times more rapidly in carbon steel than in TT690 and MA600. The causes of these different rates are more likely because of rapid lattice diffusivities in carbon steel rather than TT690, and the smaller grain size of carbon steel (similar to 20 mu m) when compared to TT690 (similar to 100 mu m). The formation rates of cavities in Alloy 800 and Type 316 are about 100 times slower than TT690. The cause of this difference is assumed to be caused by the effects of grain boundary carbides, judging from the observations that cavities are always nucleated near carbides. This result suggests that crack initiation caused by the formation of cavities will be controlled by lattice diffusivity, grain size, and conditions of nucleation sites, such as grain boundary carbides. As a model for the initiation of stress corrosion cracking (SCC) after long-term operations of CW materials in high-temperature water, the combination of local corrosion and the formation of cavities from the collapse of vacancies seem to dominate the initiation of SCC after long periods of time in high-temperature water.	Inst Nucl Safety Syst Inc, Kyoto, Japan	Arioka, K (reprint author), Inst Nucl Safety Syst Inc, Kyoto, Japan.	arioka@inss.co.jp			Kansai Electric Power Co., Inc.	The author wishes to acknowledge the financial support of this work by Kansai Electric Power Co., Inc. The author specially thanks Prof. Roger W. Staehle for helpful suggestions, discussions, and encouragement. Careful and reliable experimental support by the staff at INSS, Dr. T. Yamada, Mr. T. Miyamoto, Mr. M. Aoki, Mr. K. Murakami, and Mr. M. Hirao is also gratefully acknowledged.	Alexandreanu B., 2009, P 14 INT C ENV DEGR; Andresen PL, 2007, P 13 INT S ENV DEGR; Andresen P.L., 2007, P 2007 AECL COG EPRI; Staehle RW, 2004, CORROSION, V60, P5; HIRTH JP, 1985, ACTA METALL MATER, V33, P359, DOI 10.1016/0001-6160(85)90078-1; FUKAI Y, 1994, PHYS REV LETT, V73, P1640, DOI 10.1103/PhysRevLett.73.1640; VANBUEREN HG, 1955, Z METALLKD, V46, P272; Staehle RW, 2003, CORROSION, V59, P931; Arioka K, 2013, CORROSION, V69, P487, DOI 10.5006/0821; SAWATZKY A, 1967, J NUCL MATER, V22, P304, DOI 10.1016/0022-3115(67)90048-7; WAISMAN JL, 1973, METALL TRANS, V4, P291, DOI 10.1007/BF02649629; SAWATZKY A, 1960, J NUCL MATER, V2, P321, DOI 10.1016/0022-3115(60)90004-0; CHUANG TJ, 1973, ACTA METALL MATER, V21, P1625; Staehle RW, 2004, CORROSION, V60, P115; Arioka K., 2008, J I NUCL SAFETY SYST, V15, P99; Arioka K, 2011, CORROSION, V67, DOI 10.5006/1.3563640; Arioka K., 1997, P TECHN COMM M INFL, P267; Arioka K., 2011, P 15 INT C ENV DEGR; Arioka K., 2011, P 15 INT S ENV DEGR; Arioka K., 2013, QUANTITATIVE MICRONA; Arioka K., 2010, CORROSION, V66; Crank J., MATH DIFFUSION, P47; FUKAI Y, 1993, Z PHYS CHEM, V179, P119; FUKAI Y, 1993, JPN J APPL PHYS 2, V32, pL1256; GONZALEZ OD, 1965, T METALL SOC AIME, V233, P1878; GOOCH DJ, 1986, MATER SCI ENG, V83, P17, DOI 10.1016/0025-5416(86)90170-9; GOOCH DJ, 1984, MATER SCI ENG, V64, P183, DOI 10.1016/0025-5416(84)90102-2; GOOCH DJ, 1987, MATER SCI ENG, V91, P45, DOI 10.1016/0025-5416(87)90282-5; Iida T, 2005, ACTA MATER, V53, P3083, DOI 10.1016/j.actamat.2005.02.049; KOSHIISHI M, 1988, NUCL INSTRUM METH B, V33, P645, DOI 10.1016/0168-583X(88)90650-7; Mizouchi M, 2004, MATER TRANS, V45, P2945, DOI 10.2320/matertrans.45.2945; MOROZUMI S, 1969, J NUCL MATER, V33, P261, DOI 10.1016/0022-3115(69)90020-8; NEATE GJ, 1987, MATER SCI TECH SER, V3, P14; Paraventi D.J., 2007, P 2007 AECL COG EPRI; PULS MP, 1974, ACTA METALL MATER, V22, P639, DOI 10.1016/0001-6160(74)90161-8; RAJ R, 1975, ACTA METALL MATER, V23, P653, DOI 10.1016/0001-6160(75)90047-4; SADANANDA K, 1983, METALL TRANS A, V14, P1467, DOI 10.1007/BF02664831; SAWATZKY A, 1963, J NUCL MATER, V9, P364, DOI 10.1016/0022-3115(63)90154-5; SHIBLI IA, 1987, MATER SCI TECH SER, V3, P110; SHIBLI IA, 1988, MAT SCI ENG A-STRUCT, V104, P29, DOI 10.1016/0025-5416(88)90403-X; SHIBLI IA, 1986, INT J PRES VES PIP, V24, P303, DOI 10.1016/0308-0161(86)90004-9; Slade J.P., 2005, P 12 INT S ENV DEGR; Staehle R.W., 2007, P INT S RES AG MAN L, P29; STEVENS RN, 1971, MATER SCI ENG, V8, P220, DOI 10.1016/0025-5416(71)90076-0; Sugisaki M., 1982, Journal of Nuclear Materials, V104; Toloczko M.B., 2009, P 14 INT C ENV DEGR; VANBUEREN HG, 1955, ACTA METALL MATER, V3, P519, DOI 10.1016/0001-6160(55)90109-7; VITEK V, 1978, ACTA METALL MATER, V26, P1345, DOI 10.1016/0001-6160(78)90150-5; WAISMAN JL, 1977, METALL TRANS A, V8, P1249, DOI 10.1007/BF02643839; Wright M., 2008, SCC IN WORKSH BEAUN; Wright M., 2007, P 2007 AECL COG EPRI; Yamazaki Y, 2004, ACTA MATER, V52, P1247, DOI 10.1016/j.actamat.2003.11.008	52	0	0	NATL ASSOC CORROSION ENG	HOUSTON	1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA	0010-9312	1938-159X		CORROSION-US	Corrosion	APR	2015	71	4					403	419		10.5006/1573		17	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CE5BZ	WOS:000351846400001		
J	Lin, ZYC; Hirano, T; Shibata, S; Seki, NM; Kitajima, R; Sedohara, A; Siomi, MC; Sasaki, E; Siomi, H; Imamura, M; Okano, H				Lin, Zachary Yu-Ching; Hirano, Takamasa; Shibata, Shinsuke; Seki, Naomi M.; Kitajima, Ryunosuke; Sedohara, Ayako; Siomi, Mikiko C.; Sasaki, Erika; Siomi, Haruhiko; Imamura, Masanori; Okano, Hideyuki			Gene expression ontogeny of spermatogenesis in the marmoset uncovers primate characteristics during testicular development	DEVELOPMENTAL BIOLOGY			English	Article						Spermatogenesis; Common marmoset; Spermatogonia; Spermatocyte; Gonocyte; Germ cell	SPERMATOGONIAL STEM-CELLS; DOUBLE-STRAND BREAKS; CALLITHRIX-JACCHUS; COMMON MARMOSET; SEMINIFEROUS EPITHELIUM; GERM-CELLS; NONHUMAN-PRIMATES; NEUROSCIENCE RESEARCH; SYNAPTONEMAL COMPLEX; ACROSOME REACTION	Mammalian spermatogenesis has been investigated extensively in rodents and a strictly controlled developmental process has been defined at cellular and molecular levels. In comparison, primate spermatogenesis has been far less well characterized. However, important differences between primate and rodent spermatogenesis are emerging so it is not always accurate to extrapolate findings in rodents to primate systems. Here, we performed an extensive immunofluorescence study of spermatogenesis in neonatal, juvenile, and adult testes in the common marmoset (Callithrix jacchus) to determine primate-specific patterns of gene expression that underpin primate germ cell development. Initially we characterized adult spermatogonia into two main classes; mitotically active C-KIT(+)Ki67(+) cells and mitotically quiescent SALL4(+)PLZF(+)LIN28(+)DPPA4(+) cells. We then explored the expression of a set of markers, including PIWIL1/MARWI, VASA, DAZL, CLGN, RanBPM, SYCP1 and HAPRIN, during germ cell differentiation from early spermatocytes through round and elongating spermatids, and a clear program of gene expression changes was determined as development proceeded. We then examined the juvenile marmoset testis. Markers of gonocytes demonstrated two populations; one that migrates to the basal membrane where they form the SALL4(+) or C-KIT+ spermatogonia, and another that remains in the lumen of the seminiferous tubule. This later population, historically identified as pre-spermatogonia, expressed meiotic and apoptotic markers and were eliminated because they appear to have failed to correctly migrate. Our findings provide the first platform of gene expression dynamics in adult and developing germ cells of the common marmoset. Although we have characterized a limited number of genes, these results will facilitate primate spermatogenesis research and understanding of human reproduction. (C) 2015 Elsevier Inc. All rights reserved.	[Lin, Zachary Yu-Ching; Shibata, Shinsuke; Sasaki, Erika; Imamura, Masanori; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Hirano, Takamasa; Seki, Naomi M.; Siomi, Mikiko C.; Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Seki, Naomi M.; Siomi, Mikiko C.] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kitajima, Ryunosuke; Imamura, Masanori] Kyoto Univ, Mol Biol Sect, Dept Cellular & Mol Biol, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Sedohara, Ayako; Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki, Kanagawa 2100821, Japan; [Sasaki, Erika] PRESTO Japan Sci & Technol Agcy, Tokyo, Japan	Imamura, M (reprint author), Kyoto Univ, Mol Biol Sect, Dept Cellular & Mol Biol, Primate Res Inst, Inuyama, Aichi 4848506, Japan.	imamura.masanori.2m@kyoto-u.ac.jp; hidokano@a2.keio.jp	Okano, Hideyuki/J-5973-2013; Siomi, Haruhiko/A-7020-2015	Siomi, Haruhiko/0000-0001-8690-3822	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science (JSPS); National Institute of Biomedical Innovation; MEXT; Funding Program for World-Leading Innovative R&D in Science and Technology (FIRST); Keio University; Leave a Nest Grant Life Technologies Japan Award; Interuniversity Bio-Backup Project for Basic Biology; Otsuka Toshimi Foundation	We thank Orie Hikabe, Kimie Ohta, Kazumichi M. Nishida, Miharu K. Kamatani, and Hirotaka James Okano for technical assistance, scientific discussions, and other support. This work was supported by Grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Ministry of Health, Labour and Welfare; the Japan Society for the Promotion of Science (JSPS); the National Institute of Biomedical Innovation; the Strategic Research Program for Brain Sciences and Leading Project for Realization of Regenerative Medicine, MEXT; the Project for Realization of Regenerative Medicine, MEXT; the Funding Program for World-Leading Innovative R&D in Science and Technology (FIRST); a Keio University Grant-in-Aid for the Encouragement of Young Medical Scientists; Leave a Nest Grant Life Technologies Japan Award; Interuniversity Bio-Backup Project for Basic Biology; and Otsuka Toshimi Foundation.	Agarwal A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-143; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mansfield K, 2003, COMPARATIVE MED, V53, P383; CLERMONT Y, 1969, AM J ANAT, V126, P57, DOI 10.1002/aja.1001260106; Dym M, 2009, BIRTH DEFECTS RES C, V87, P27, DOI 10.1002/bdrc.20141; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Ehmcke J, 2005, BIOL REPROD, V72, P293, DOI 10.1095/biolreprod.104.033092; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; Kitamura K, 2003, J BIOL CHEM, V278, P44417, DOI 10.1074/jbc.M304306200; CLERMONT Y, 1966, AM J ANAT, V118, P509, DOI 10.1002/aja.1001180211; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; Hermann BP, 2009, HUM REPROD, V24, P1704, DOI 10.1093/humrep/dep073; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Aeckerle N, 2012, MOL HUM REPROD, V18, P477, DOI 10.1093/molehr/gas025; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Said TM, 2004, HUM REPROD UPDATE, V10, P39, DOI 10.1093/humupd/dmh003; Ruggiu M, 2000, J ANDROL, V21, P470; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Wistuba J, 2003, BIOL REPROD, V69, P582, DOI 10.1095/biolreprod.103.015925; Ehmcke J, 2006, HUM REPROD UPDATE, V12, P275, DOI 10.1093/humupd/dmk001; Hermann BP, 2010, REPRODUCTION, V139, P479, DOI 10.1530/REP-09-0255; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Schlatt S, 2014, SEMIN CELL DEV BIOL, V29, P2, DOI 10.1016/j.semcdb.2014.03.007; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Simorangkir DR, 2009, HUM REPROD, V24, P1596, DOI 10.1093/humrep/dep051; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Albert S, 2010, REPRODUCTION, V140, P733, DOI 10.1530/REP-10-0235; Eildermann K, 2012, CELLS TISSUES ORGANS, V196, P206, DOI 10.1159/000335031; GERDES J, 1984, J IMMUNOL, V133, P1710; CLERMONT Y, 1972, PHYSIOL REV, V52, P198; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; von Kopylow K, 2012, HISTOCHEM CELL BIOL, V138, P759, DOI 10.1007/s00418-012-0991-7; D'Amours D, 2001, J CELL SCI, V114, P3771; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Chemes HE, 2001, INT J ANDROL, V24, P2, DOI 10.1046/j.1365-2605.2001.00260.x; CLERMONT Y, 1973, AM J ANAT, V136, P153, DOI 10.1002/aja.1001360204; Culty M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110544; de Vries M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031485; Dreef HC, 2007, TOXICOL PATHOL, V35, P395, DOI 10.1080/01926230701230346; Ehmcke J, 2005, HUM REPROD, V20, P1185, DOI 10.1093/humrep/deh766; Ehmcke J, 2006, REPRODUCTION, V132, P673, DOI 10.1530/rep.1.01081; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Haruyama E., 2012, TOXICOL PATHOL, V40; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hirano T., 2014, SMALL RNA PROFILING; Imamura M, 2014, MOL REPROD DEV, V81, P2, DOI 10.1002/mrd.22259; Imamura Masanori, 2012, Methods Mol Biol, V925, P21, DOI 10.1007/978-1-62703-011-3_2; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; JACKSON MR, 1984, LAB ANIM, V18, P173, DOI 10.1258/002367784780891262; Kelnar CJH, 2002, HUM REPROD, V17, P1367, DOI 10.1093/humrep/17.5.1367; Kitamura K, 2005, J ANDROL, V26, P511, DOI 10.2164/jandrol.04189; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Li LH, 2005, BIRTH DEFECTS RES B, V74, P450, DOI 10.1002/bdrb.20057; Lin ZYC, 2012, REPRODUCTION, V143, P597, DOI 10.1530/REP-11-0215; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; McKinnell C, 2013, HUM REPROD, V28, P886, DOI 10.1093/humrep/des465; Millar MR, 2000, INT J ANDROL, V23, P266, DOI 10.1046/j.1365-2605.2000.00236.x; Orth JM, 2000, CURR TOP DEV BIOL, V50, P103, DOI 10.1016/S0070-2153(00)50006-4; Pousette A, 1997, HUM REPROD, V12, P2414, DOI 10.1093/humrep/12.11.2414; Puverel S, 2011, DEVELOPMENT, V138, P2511, DOI 10.1242/dev.062505; REY RA, 1993, J CLIN ENDOCR METAB, V76, P1325, DOI 10.1210/jc.76.5.1325; Saunders PTK, 1996, INT J ANDROL, V19, P212, DOI 10.1111/j.1365-2605.1996.tb00465.x; Sharpe RM, 2003, HUM REPROD, V18, P2110, DOI 10.1093/humrep/deg413; Shibata N, 2004, MOL REPROD DEV, V67, P1, DOI 10.1002/mrd.20009; Takahashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095560; Tomioka I, 2012, THERIOGENOLOGY, V78, P1487, DOI 10.1016/j.theriogenology.2012.06.024; Tres LL, 2004, MOL REPROD DEV, V68, P1, DOI 10.1002/mrd.20056; Tres Laura L, 2005, Birth Defects Res C Embryo Today, V75, P130, DOI 10.1002/bdrc.20041; von Schonfedt V, 1999, BIOL REPROD, V61, P582, DOI 10.1095/biolreprod61.3.582; Yamauchi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005338; Yoshinaga K, 1999, ARCH HISTOL CYTOL, V62, P283, DOI 10.1679/aohc.62.283	78	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	APR 1	2015	400	1					43	58		10.1016/j.ydbio.2015.01.014		16	Developmental Biology	Developmental Biology	CE9RQ	WOS:000352181500005		
J	Zhao, W; Ajima, R; Ninomiya, Y; Saga, Y				Zhao, Wei; Ajima, Rieko; Ninomiya, Youichirou; Saga, Yumiko			Segmental border is defined by Ripply2-mediated Tbx6 repression independent of Mesp2	DEVELOPMENTAL BIOLOGY			English	Article						Somitogenesis; Segmentation; Presomitic mesoderm; Tbx6; Ripply2	BOX TRANSCRIPTION FACTORS; PRESOMITIC MESODERM; SOMITE SEGMENTATION; MOUSE; GENE; NOTCH; SOMITOGENESIS; XENOPUS; CLOCK; DIFFERENTIATION	The precise border of somites formed during mouse somitogenesis is defined by a Tbx6 expression domain, which is established by Mesp2-mediated Tbx6 suppression in the anterior part of the presomitic mesoderm (PSM). Ripply2, a target of Mesp2, is proposed to be involved in this down-regulation because Ripply2 deficiency causes an anterior expansion of the Tbx6 domain, resembling the Mesp2-null phenotype. However, it is unclear whether Ripply2 acts on Tbx6 independently or in association with Mesp2. To address this question, we generated three sets of transgenic mice with the following Ripply2 expression patterns: (I) overexpression in the endogenous expression domain, (2) expression instead of Mesp2 (Ripply2-knockin), and (3) ectopic expression in the entire PSM. We found accelerated Tbx6 degradation in the embryos showing Ripply2 overexpression. In the Ripply2-knockin embryos, the anterior limit of Tbx6 domain was generated by Ripply2 even in the absence of Mesp2. Ectopic Ripply2 expression along the entire PSM suppressed Tbx6 and induced Sox2-positive neural tube formation at the bilateral domain, resembling the Tbx6-null phenotype. This phenotype resulted from Tbx6 protein and not mRNA elimination, suggesting the post-translational down-regulation of Tbx6 by Ripply2. Taken together, our results demonstrate that Ripply2 represses Tbx6 in a Mesp2-independent manner, which contributes to the accurate segmental border formation. (C) 2015 Elsevier Inc. All rights reserved.	[Zhao, Wei; Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ajima, Rieko; Saga, Yumiko] SOKENDAI, Dept Genet, Hayama, Kanagawa, Japan; [Ajima, Rieko; Ninomiya, Youichirou; Saga, Yumiko] Res Org Informat & Syst, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan	Saga, Y (reprint author), Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 411, Japan.	ysaga@nig.ac.jp			Transdisciplinary Research Integration Center of the Research Organization of Information and Systems	We are particularly thankful to Noriko Yamatani and Makoto Kiso (National Institute of Genetics, Japan) for generating the transgenic and knockin mice used in this study. We are grateful to Yukuto Yasuhiko for providing reagents. We thank Mark Lewandoski for generously providing the T-Cre mice. This work was supported by funding from the Transdisciplinary Research Integration Center of the Research Organization of Information and Systems.	Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Kawamura A, 2005, DEV CELL, V9, P735, DOI 10.1016/j.devcel.2005.09.021; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Oginuma M, 2008, MECH DEVELOP, V125, P432, DOI 10.1016/j.mod.2008.01.010; WILSON V, 1995, DEVELOPMENT, V121, P877; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Kawamura A, 2008, MOL CELL BIOL, V28, P3236, DOI 10.1128/MCB.01754-07; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Hitachi K, 2009, INT J DEV BIOL, V53, P631, DOI 10.1387/ijdb.082823kh; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Borycki AG, 2000, CURR TOP DEV BIOL, V48, P165; Beddington RSP, 1992, DEV S, V1992, P157; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; Chan T, 2006, ZOOL SCI, V23, P689, DOI 10.2108/zsj.23.689; Chan Techuan, 2007, FEBS Lett, V581, P2691, DOI 10.1016/j.febslet.2007.05.017; Dunty Jr W. C., 2008, DEVELOPMENT, V135, P85; Hubaud A, 2014, NAT REV MOL CELL BIO, V15, P709, DOI 10.1038/nrm3891; Kondow A, 2006, INT J DEV BIOL, V50, P473, DOI 10.1387/ijdb.052138ak; Kondow A, 2007, BIOCHEM BIOPH RES CO, V359, P959, DOI 10.1016/j.bbrc.2007.05.211; Morimoto M, 2007, DEVELOPMENT, V134, P1561, DOI 10.1242/dev.000836; Nomura-Kitabayashi A, 2002, DEVELOPMENT, V129, P2473; Takahashi J, 2010, DEV BIOL, V342, P134, DOI 10.1016/j.ydbio.2010.03.015; Takahashi Y, 2007, DEV BIOL, V304, P593, DOI 10.1016/j.ydbio.2007.01.007; Takahashi Y, 2000, NAT GENET, V25, P390; Takahashi Y, 2003, DEVELOPMENT, V130, P4259, DOI 10.1242/dev.00629; Wanglar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107928; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103	41	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	APR 1	2015	400	1					105	117		10.1016/j.ydbio.2015.01.020		13	Developmental Biology	Developmental Biology	CE9RQ	WOS:000352181500010		
J	Lim, J; Tu, XL; Choi, K; Akiyama, H; Mishina, Y; Long, FX				Lim, Joohyun; Tu, Xiaolin; Choi, Kyunghee; Akiyama, Haruhiko; Mishina, Yuji; Long, Fanxin			BMP-Smad4 signaling is required for precartilaginous mesenchymal condensation independent of Sox9 in the mouse	DEVELOPMENTAL BIOLOGY			English	Article						BMP; Bmpr1a; Bmpr1b; Acvr1; Alk2; Alk3; Alk6; Smad4; Sox9; Cartilage; Mesenchymal condensation; Mouse	CONDITIONAL KNOCKOUT MICE; TGF-BETA; TRANSCRIPTION FACTOR; CARTILAGE FORMATION; CRE RECOMBINASE; BONE-FORMATION; N-CADHERIN; IN-VITRO; CHONDROGENESIS; LIMB	Bone morphogenetic proteins (BMPs) regulate multiple aspects of skeletal development in vertebrates. Although exogenously applied BMPs can induce chondrogenesis de novo, the role and mechanism of physiologic BMP signaling during precartilaginous mesenchymal condensation is not well understood. By deleting the type I BMP receptors or the transcription factor Smad4 in the limb bud mesenchyme, we find that loss of BMP-Smad signaling abolishes skeletal development due to a failure in mesenchymal condensation. In the absence of Smad4, expression of Sox9, an essential transcription factor for chondrogenesis, initiates normally in the proximal mesenchyme of the limb bud, but fails to maintain its level or expand to the more distal territory at the later stages. However, forced-expression of Sox9 does not restore cartilage formation in the Smad4-deficeint embryo. In vitro micromass cultures show that the Smad4-deficient cells fail to condense in a cell-autonomous manner, even though they express several cell adhesion molecules either normally or even at a higher level. Thus, BMP-Smad signaling critically controls mesenchymal condensation to initiate skeletal development likely through a Sox9-independent mechanism. (C) 2015 Elsevier Inc. All rights reserved.	[Lim, Joohyun; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Lim, Joohyun; Long, Fanxin] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Tu, Xiaolin; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Choi, Kyunghee] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Akiyama, Haruhiko] Kyoto Univ, Dept Orthopaed Surg, Kyoto, Japan; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Long, FX (reprint author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA.	flong@wustl.edu			NIH [DK065789, AR055923, P30DK079333]; Kidney translational Research Core at the Washington University School of Medicine; Renal Division at the Washington University School of Medicine [P30DK079333]	This work is supported by NIH Grants DK065789 and AR055923 (FL). The confocal microscopy experiments were supported in part by the NIH funded George O'Brien Center for Kidney Disease Research (P30DK079333), Kidney translational Research Core and the Renal Division at the Washington University School of Medicine (P30DK079333). We thank Masato Hoshi of the Sanjay Jain lab for technical assistance with the confocal microscope.	URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Jones MV, 2007, BIOTECHNIQUES, V42, P569, DOI 10.2144/000112456; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bi WM, 1999, NAT GENET, V22, P85; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Yi SE, 2000, DEVELOPMENT, V127, P621; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Javier AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042566; JIANG TX, 1993, DEV BIOL, V155, P545, DOI 10.1006/dbio.1993.1051; Kaartinen V, 2001, GENESIS, V31, P126, DOI 10.1002/gene.10015; Kim Y, 2011, J BONE MINER METAB, V29, P123, DOI 10.1007/s00774-010-0206-z; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Stott NS, 1999, J CELL PHYSIOL, V180, P314, DOI 10.1002/(SICI)1097-4652(199909)180:3<314::AID-JCP2>3.0.CO;2-Y; Wilkinson D.G., 1998, IN SITU HYBRIDIZATIO	39	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	APR 1	2015	400	1					132	138		10.1016/j.ydbio.2015.01.022		7	Developmental Biology	Developmental Biology	CE9RQ	WOS:000352181500012		
J	Okazawa, M; Murashima, A; Harada, M; Nakagata, N; Noguchi, M; Morimoto, M; Kimura, T; Ornitz, DM; Yamada, G				Okazawa, Mika; Murashima, Aki; Harada, Masayo; Nakagata, Naomi; Noguchi, Masafumi; Morimoto, Mitsuru; Kimura, Tadashi; Ornitz, David M.; Yamada, Gen			Region-specific regulation of cell proliferation by FGF receptor signaling during the Wolffian duct development	DEVELOPMENTAL BIOLOGY			English	Article						Fgfr; Ret; Receptor tyrosine kinase; Cell proliferation; Wolffian duct; Ureteric bud	GROWTH-FACTOR FAMILY; MICE LACKING GDNF; URETERAL BUD DEVELOPMENT; ENTERIC NERVOUS-SYSTEM; KIDNEY DEVELOPMENT; METANEPHRIC MESENCHYME; URINARY-TRACT; DEVELOPMENT SUGGESTS; NEUROTROPHIC FACTOR; EXCRETORY SYSTEM	The Wolffian duct (WD) is a primordium of the male reproductive tract and kidney collecting duct system. Fibroblast growth factor receptors (FGFRs), members of the receptor tyrosine kinase (RTK) family, are essential for kidney development. Although the functions of FGFR signaling in kidney morphogenesis have been analyzed, their function in WD development has not been comprehensively investigated. Here, we demonstrate that Fgfr2 is the major Fgfr gene expressed throughout the WD epithelia and that it is essential for the maintenance of the WD, specifically in the caudal part of the WD. Hoxb7-Cre mediated inactivation of Fgfr2 in the mouse WD epithelia resulted in the regression of the caudal part of the WD and abnormal male reproductive tract development. Cell proliferation and expression of the downstream target genes of RTK signaling (Etv4 and Etv5) were decreased in the caudal part of the WD epithelia in the mutant embryos. Cranial (rostral) WD formation and ureteric budding were not affected. Ret, Etv4, and Etv5 expression were sustained in the ureteric bud of the mutant embryos. Taken together, these data suggest region-specific requirements for FGFR2 signaling in the developing caudal WD epithelia. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Okazawa, Mika; Murashima, Aki; Yamada, Gen] Wakayama Med Univ, Inst Adv Med, Dept Dev Genet, Wakayama 6418509, Japan; [Okazawa, Mika; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Harada, Masayo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Clin Anat, Bunkyo Ku, Tokyo 1138519, Japan; [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Noguchi, Masafumi; Morimoto, Mitsuru] RIKEN Ctr Dev Biol, Lab Lung Dev, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Yamada, G (reprint author), Wakayama Med Univ, Inst Adv Med, Dept Dev Genet, 811-1 Kimiidera, Wakayama 6418509, Japan.	transg8@wakayama-med.ac.jp			National Institutes of Health [R01ES016597, R01HL111190];  [25860771];  [22132006]	We thank Dr. Hideki Enomoto, Dr. Anne M. Moon, Dr. Chuxia Deng, Dr. Ryuichi Nishinakamura, Dr. Nobuyuki Itoh, and Dr. Hideyo Ohuchi for their supports. We also express our appreciation to Dr. Kentaro Suzuki, Dr. Daisuke Matsumaru, Dr. Akiko Omori, Dr. Lerrie A. Ipulan, Dr. Dennis D. Raga, Hiroko Suzuki, Shoko Matsushita, and Yoshitsugu Sakita for their assistance. We thank Tomiko I. Iba for technical help. This work is supported by Grant-in-Aid for Young Scientists B (25860771) and for Scientific Research on Innovative Areas: Molecular mechanisms for establishment of Sex differences (22132006). This work is also supported by National Institutes of Health Grant R01ES016597 (G. Yamada) and R01HL111190 (D. M. Ornitz).	Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Capel B, 2000, MECH DEVELOP, V92, P89, DOI 10.1016/S0925-4773(99)00327-5; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Ornitz DM, 1996, J BIOL CHEM, V271, P15292; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; FINCH PW, 1995, DEV DYNAM, V203, P223; DYCHE WJ, 1979, J MORPHOL, V162, P175, DOI 10.1002/jmor.1051620203; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Batourina E, 2001, NAT GENET, V27, P74; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Paek H, 2009, DEVELOPMENT, V136, P2457, DOI 10.1242/dev.032656; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; PETERS KG, 1992, DEVELOPMENT, V114, P233; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Araki K, 1997, J BIOCHEM-TOKYO, V122, P977; Atsuta Y, 2013, DEV GROWTH DIFFER, V55, P579, DOI 10.1111/dgd.12047; Bates CM, 2011, AM J PHYSIOL-RENAL, V301, pF245, DOI 10.1152/ajprenal.00186.2011; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Brophy RD., 2001, DEVELOPMENT, V128, P4747; Cancilla B, 1999, KIDNEY INT, V56, P2025, DOI 10.1046/j.1523-1755.1999.00781.x; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; Davidson A., 2009, STEMBOOK; Donjacour AA, 2003, DEV BIOL, V261, P39, DOI 10.1016/S0012-1606(03)00250-1; Fimberg N., 2002, DEV BIOL, V247, P237; Haim D., 2008, PEDIATR RES, V64, P592; Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334; Hinton BT, 2000, SERONO SYMP, P163; Hoshi M, 2012, DEVELOPMENT, V139, P2405, DOI 10.1242/dev.078667; Joseph A, 2009, DEV BIOL, V325, P6, DOI 10.1016/j.ydbio.2008.10.012; Kitagaki J, 2011, DEVELOPMENT, V138, P5369, DOI 10.1242/dev.051888; Kume T, 2000, DEVELOPMENT, V127, P1387; Maeshima A, 2007, J AM SOC NEPHROL, V18, P3147, DOI 10.1681/ASN.2007060642; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; Michael L, 2004, J ANAT, V204, P241, DOI 10.1111/j.0021-8782.2004.00285.x; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Mullen RD, 2014, SEX DEV, V8, P281, DOI 10.1159/000364935; Murashima A, 2014, DEV BIOL, V386, P216, DOI 10.1016/j.ydbio.2013.12.026; Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14; Omitz D. M., 2001, GENOME BIOL, V2; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Ozawa K, 1996, MOL BRAIN RES, V41, P279, DOI 10.1016/0169-328X(96)00108-8; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Sainio K, 1997, DEVELOPMENT, V124, P4077; Saxen L, 1987, ORGANOGENESIS KIDNEY; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shakya R, 2005, DEV BIOL, V283, P70, DOI 10.1016/j.ydbio.2005.04.008; Shum WWC, 2011, J ANDROL, V32, P576, DOI 10.2164/jandrol.111.012971; Sims-Lucas S, 2012, J AM SOC NEPHROL, V23, P607, DOI 10.1681/ASN.2011020165; Song R., 2011, J SIGNAL TRANSDUCT, V2011; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tee JB, 2013, BIOL OPEN, V2, P952, DOI 10.1242/bio.20135595; Tong SYC, 1996, J UROLOGY, V155, P2057, DOI 10.1016/S0022-5347(01)66107-X; Walker KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056062; Weiss AC, 2014, DEVELOPMENT, V141, P3420, DOI 10.1242/dev.113928; Yu J, 2004, CURR OPIN GENET DEV, V14, P550, DOI 10.1016/j.gde.2004.07.009; Zhao MR, 2007, BIOL PSYCHIAT, V62, P381, DOI 10.1016/j.biopsych.2006.10.019	82	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	APR 1	2015	400	1					139	147		10.1016/j.ydbio.2015.01.023		9	Developmental Biology	Developmental Biology	CE9RQ	WOS:000352181500013		
J	Lingle, W				Lingle, Will			Contrastive Discourse Analysis: Functional and Corpus Perspectives	DISCOURSE & COMMUNICATION			English	Book Review									[Lingle, Will] Kanda Univ Int Studies, English Language Inst, Chiba, Japan	Lingle, W (reprint author), Kanda Univ Int Studies, English Language Inst, Chiba, Japan.						Halliday M. A. K., 1994, INTRO FUNCTIONAL GRA; Martin James R., 2005, LANGUAGE EVALUATION; Sapir Edward, 1949, LANGUAGE; TABOADA M, 2012, CONTRASTIVE DISCOURS; Whorf B, 1939, LANGUAGE THOUGHT REA, P134	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1750-4813	1750-4821		DISCOURSE COMMUN	Discourse Commun.	APR	2015	9	2					267	269		10.1177/1750481314564857c		3	Communication	Communication	CE8CH	WOS:000352068200010		
J	Das, S; Flocchini, P; Santoro, N; Yamashita, M				Das, Shantanu; Flocchini, Paola; Santoro, Nicola; Yamashita, Masafumi			Forming sequences of geometric patterns with oblivious mobile robots	DISTRIBUTED COMPUTING			English	Article						Distributed coordination; Autonomous mobile robots; Pattern formation; Oblivious; Semi-synchronous; Sequence of patterns	CIRCLE FORMATION; ASYNCHRONOUS ROBOTS; LIMITED VISIBILITY; ALGORITHMS; CONVERGENCE; SYSTEMS	We study the computational power of distributed systems consisting of simple autonomous robots moving on the plane. The robots are endowed with visual perception, allowing them to see each other, but they do not have any means of explicit communication with each other. Further the robots are oblivious, meaning that they always act based on their current perception of the environment, and they have no memory of the past. Such system of simple robots have been studied extensively with the objective of achieving coordinated tasks e.g. arranging the robots in a line or a circle. In fact it has been shown that obliviousness is not a limiting factor to form a single geometric pattern, however arbitrary. This paper aims to understand the computational limits imposed by the obliviousness of the robots by studying the formation of a series of geometric patterns instead of a single pattern. If such a series of patterns could be formed this would create some form of memory in an otherwise memory-less system. We show that, under particular conditions, oblivious robot systems can indeed form a given series of geometric patterns starting from any arbitrary configuration. More precisely, we characterize the series of patterns that can be formed by oblivious robot systems under various additional restrictions such as anonymity, asynchrony and lack of common orientation. These results provide strong indications that oblivious solutions may be obtained also for tasks that intuitively seem to require memory.	[Das, Shantanu] Aix Marseille Univ, LIF, F-13009 Marseille, France; [Das, Shantanu] CNRS, F-13009 Marseille, France; [Flocchini, Paola] Univ Ottawa, Sch Elect Engn & Comp Sci, Ottawa, ON, Canada; [Santoro, Nicola] Carleton Univ, Sch Comp Sci, Ottawa, ON K1S 5B6, Canada; [Yamashita, Masafumi] Kyushu Univ, Dept Comp Sci & Commun Engn, Fukuoka 812, Japan	Das, S (reprint author), Aix Marseille Univ, LIF, 163 Ave Luminy, F-13009 Marseille, France.	shantanu.das@lif.univ-mrs.fr; flocchin@eecs.uottawa.ca; santoro@scs.carleton.ca; mak@csce.kyushu-u.ac.jp			Natural Sciences and Engineering Research Council (Canada) under the Discovery Grant program; Prof. Flocchini's University Research Chair; Ministry of Education, Sports, Culture and Technology of Japan	This research has been supported in part by the Natural Sciences and Engineering Research Council (Canada) under the Discovery Grant program, by Prof. Flocchini's University Research Chair, and by the Scientific Grant in Aid by the Ministry of Education, Sports, Culture and Technology of Japan.	Agmon N, 2006, SIAM J COMPUT, V36, P56, DOI 10.1137/050645221; ANDO H, 1995, PROCEEDINGS OF THE 1995 IEEE INTERNATIONAL SYMPOSIUM ON INTELLIGENT CONTROL, P453, DOI 10.1109/ISIC.1995.525098; Izumi T, 2013, IEEE T PARALL DISTR, V24, P716, DOI 10.1109/TPDS.2012.212; Defago X, 2008, THEOR COMPUT SCI, V396, P97, DOI 10.1016/j.tcs.2008.01.050; Flocchini P, 2005, THEOR COMPUT SCI, V337, P147, DOI 10.1016/j.tcs.2005.01.001; Ando H, 1999, IEEE T ROBOTIC AUTOM, V15, P818, DOI 10.1109/70.795787; Cieliebak M, 2012, SIAM J COMPUT, V41, P829, DOI 10.1137/100796534; Sugihara K, 1996, J ROBOTIC SYST, V13, P127, DOI 10.1002/(SICI)1097-4563(199603)13:3<127::AID-ROB1>3.0.CO;2-U; Flocchini P, 2008, THEOR COMPUT SCI, V407, P412, DOI 10.1016/j.tcs.2008.07.026; Yamashita M, 2010, THEOR COMPUT SCI, V411, P2433, DOI 10.1016/j.tcs.2010.01.037; Cohen R, 2008, THEOR COMPUT SCI, V399, P71, DOI 10.1016/j.tcs.2008.02.007; Suzuki I, 1999, SIAM J COMPUT, V28, P1347, DOI 10.1137/S009753979628292X; Efrima A, 2007, LECT NOTES COMPUT SC, V4362, P70; Lin J, 2007, SIAM J CONTROL OPTIM, V46, P2120, DOI 10.1137/040620564; Asahiro Y, 2008, LECT NOTES COMPUT SC, V5401, P125, DOI 10.1007/978-3-540-92221-6_10; Bouzid Z., 2011, 11055817 ARXIV; Bullo F, 2009, PRINC SER APPL MATH, P1; Chatzigiannakis I, 2004, LECT NOTES COMPUT SC, V3059, P159; Dieudonne Y, 2009, LECT NOTES COMPUT SC, V5923, P71; Dieudonne Y, 2008, ACM T AUTON ADAP SYS, V3, DOI 10.1145/1452001.1452006; Fujinaga N, 2010, LECT NOTES COMPUT SC, V6490, P1, DOI 10.1007/978-3-642-17653-1_1; Fujinaga N, 2012, LECT NOTES COMPUT SC, V7611, P312, DOI 10.1007/978-3-642-33651-5_22; Gervasi V, 2004, DISCRETE APPL MATH, V144, P324, DOI 10.1016/j.dam.2003.11.010; Gordon N, 2003, IEEE/WIC INTERNATIONAL CONFERENCE ON INTELLIGENT AGENT TECHNOLOGY, PROCEEDINGS, P545, DOI 10.1109/IAT.2003.1241141; Izumi T, 2007, LECT NOTES COMPUT SC, V4731, P298; Souissi S, 2011, THEOR COMPUT SCI, V412, P4350, DOI 10.1016/j.tcs.2010.11.011; Yamauchi Y., 2013, 20 INT C STRUCT INF, P201	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-2770	1432-0452		DISTRIB COMPUT	Distrib. Comput.	APR	2015	28	2					131	145		10.1007/s00446-014-0220-9		15	Computer Science, Theory & Methods	Computer Science	CE8HN	WOS:000352082600004		
J	Kawamura, A; Kobayashi, Y				Kawamura, Akitoshi; Kobayashi, Yusuke			Fence patrolling by mobile agents with distinct speeds	DISTRIBUTED COMPUTING			English	Article						Idle time; Mobile robots; Partition-based strategy		Suppose we want to patrol a fence (line segment) using mobile agents with given speeds , ..., so that every point on the fence is visited by an agent at least once in every unit time period. Czyzowicz et al. conjectured that the maximum length of the fence that can be patrolled is , which is achieved by the simple strategy where each agent moves back and forth in a segment of length . We disprove this conjecture by a counterexample involving agents. We also show that the conjecture is true for .	[Kawamura, Akitoshi; Kobayashi, Yusuke] Univ Tokyo, Tokyo, Japan	Kawamura, A (reprint author), Univ Tokyo, Tokyo, Japan.	kawamura@is.s.u-tokyo.ac.jp			KAKENHI (Japan)	A preliminary version of this paper was presented at the 23rd International Symposium on Algorithms and Computation [10]. Supported in part by KAKENHI (Grant-in-Aid for Scientific Research, Japan).	Yanovski V, 2003, ALGORITHMICA, V37, P165, DOI 10.1007/s00453-003-1030-9; Suzuki I, 1999, SIAM J COMPUT, V28, P1347, DOI 10.1137/S009753979628292X; Chen K., 2013, P 25 CAN C COMP GEOM; Chevaleyre Y., 2004, Proceedings. IEEE/WIC/ACM International Conference on Intelligent Agent Technology (IAT 2004), DOI 10.1109/IAT.2004.1342959; Collins A., 2013, P 25 ACM S PAR ALG A, P241; Czyzowicz J, 2012, LECT NOTES COMPUT SC, V7611, P341, DOI 10.1007/978-3-642-33651-5_24; Czyzowicz J., 2014, P 21 INT C STRUCT IN; Czyzowicz J, 2011, LECT NOTES COMPUT SC, V6942, P701, DOI 10.1007/978-3-642-23719-5_59; Dumitrescu A., 2014, ELECTRON J COMB, V21, P3; Elmaliach Y., 2008, P 7 INT JOINT C AUT, P63; Kawamura A., 2012, P 23 INT S ALG COMP, V7676, P598; Pasqualetti F, 2010, IEEE DECIS CONTR P, P7153, DOI 10.1109/CDC.2010.5717873	12	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-2770	1432-0452		DISTRIB COMPUT	Distrib. Comput.	APR	2015	28	2					147	154		10.1007/s00446-014-0226-3		8	Computer Science, Theory & Methods	Computer Science	CE8HN	WOS:000352082600005		
J	Fukkoshi, Y; Akamatsu, R; Shimpo, M				Fukkoshi, Yuko; Akamatsu, Rie; Shimpo, Misa			The relationship of eating until 80% full with types and energy values of food consumed	EATING BEHAVIORS			English	Article						Eating habit; Energy intake; Servings of dishes; Diet; Japanese	PORTION SIZE; CALORIC RESTRICTION; METABOLIC-RATE; MINDFULNESS; ADULTS; INTERVENTION; IMPACT	Objective: Eating until one is 80% full is considered a healthy dietary practice in Japan. This study examined the relationship between this behavior and energy intake and types and quantities of foods consumed to examine its beneficial effects. Methods: This study relied on dietary records and self-administered questionnaires completed by 330 users of a health-management website in November 2012. ANOVA was performed to examine the relationship between eating until one is 80% full and intake. Results: Men who always ate until they were 80% full consumed less energy than those who did not (mean [SD]; always: 1997.3 [356.7] kcal; rarely/never: 2448.9 [637.1] kcal; p < 0.05). Moreover, men who ate until they were 80% full consumed fewer servings of grain dishes (always: 3.7 [0.9] servings; rarely/never: 5.1 [1.9] servings; p < 0.05) and more servings of vegetable dishes (always: 5.9 [2.2] servings; rarely/never: 4.0 [2.3] servings, p < 0.05) than those who did not. Conclusion: Men who ate until they were 80% full consumed less energy and more vegetable dishes than those who did not, suggesting that eating until one is 80% full is associated with healthy dietary habits among men. (C) 2015 Elsevier Ltd. All rights reserved.	[Fukkoshi, Yuko] Sundaigakuen Jr & Senior High Sch, Kita Ku, Tokyo, Japan; [Akamatsu, Rie; Shimpo, Misa] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Shimpo, Misa] Japan Soc Promot Sci, Tokyo, Japan	Akamatsu, R (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Otsuka 2-1-1, Tokyo 1128610, Japan.	fukko4yuko@gmail.com; akamatsu.rie@ocha.ac.jp; g1370511@edu.cc.ocha.ac.jp					Wansink B, 2005, J NUTR EDUC BEHAV, V37, P242, DOI 10.1016/S1499-4046(06)60278-9; Hsieh SD, 2011, PUBLIC HEALTH NUTR, V14, P1266, DOI 10.1017/S1368980010003824; Alberts HJEM, 2012, APPETITE, V58, P847, DOI 10.1016/j.appet.2012.01.009; Siebelink E, 2011, BRIT J NUTR, V106, P274, DOI 10.1017/S0007114511000067; Willcox BJ, 2007, ANN NY ACAD SCI, V1114, P434, DOI 10.1196/annals.1396.037; DEVRIES JHM, 1994, AM J CLIN NUTR, V60, P855; Trudeau E, 1998, J AM DIET ASSOC, V98, P1412, DOI 10.1016/S0002-8223(98)00319-8; Mathieu J, 2009, J AM DIET ASSOC, V109, P1982, DOI 10.1016/j.jada.2009.10.023; Framson C, 2009, J AM DIET ASSOC, V109, P1439, DOI 10.1016/j.jada.2009.05.006; Yoshiike N, 2007, NUTR REV, V65, P149, DOI 10.1301/nr.2007.apr.149-154; Wansink B, 2010, PHYSIOL BEHAV, V100, P454, DOI 10.1016/j.physbeh.2010.05.003; Marchiori D, 2014, APPETITE, V75, P40, DOI 10.1016/j.appet.2013.12.009; Wansink B, 2007, J AM DIET ASSOC, V107, P1103, DOI 10.1016/j.jada.2007.05.019; Beshara M, 2013, APPETITE, V67, P25, DOI 10.1016/j.appet.2013.03.012; Ganpule AA, 2007, EUR J CLIN NUTR, V61, P1256, DOI 10.1038/sj.ejcn.1602645; Gilbert D., 2010, MINDFULNESS, V1, P227, DOI [10.1007/s12671-010-0032-3, DOI 10.1007/S12671-010-0032-3]; Japanese Ministry of Education Culture Sports Science and Technology, 2005, STAND TABL FOOD COMP; Kaibara E., 1982, YOJOKUN; Kimira Y., 2011, ASIA PACIFIC J CLIN, V20, P29; Maruyama K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2002; Miyake R, 2011, J NUTR SCI VITAMINOL, V57, P224, DOI 10.3177/jnsv.57.224; OECD, 2012, OB UPD; Rolls B. J., 2004, NUTR REV, V41291; Tabata I, 2013, J NUTR SCI VITAMINOL, V59, pS26; Wakita Asano Andrea, 2008, J Nutr Sci Vitaminol (Tokyo), V54, P384, DOI 10.3177/jnsv.54.384; Willcox DC, 2006, BIOGERONTOLOGY, V7, P173, DOI 10.1007/s10522-006-9008-z	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1471-0153	1873-7358		EAT BEHAV	Eat. Behav.	APR	2015	17						153	156		10.1016/j.eatbeh.2015.03.001		4	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CE4XP	WOS:000351834000033		
J	Yamamoto, K; Maruyama, T; Kondo, K; Kashiwagi, T				Yamamoto, Kohei; Maruyama, Takashi; Kondo, Keiichiro; Kashiwagi, Takayuki			A Method for Designing a High-Power Contactless Power Transformer Considering Reactive Power	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						contactless high power system; frequency; power transfer system; reactive power; resonance capacitor; self-inductance		Problems in high-power contactless power transmission systems using series and parallel resonance capacitors arise from the maximum voltage limit of the series capacitor due to high reactive power. In this study, the characteristics of the reactive power are analyzed using an equivalent circuit and a contactless power transfer system is designed with the reactive power characteristics taken into consideration. The self-inductance and the frequency can be used to determine the distribution of reactive power on the primary side and the secondary side. In addition, the optimal winding number, size of the coil, and the appropriate frequency are investigated through electromagnetic field analysis. (C) 2015 Wiley Periodicals, Inc.	[Yamamoto, Kohei; Maruyama, Takashi] Chiba Univ, Chiba, Japan; [Kondo, Keiichiro] Chiba Univ, Fac Engn, Chiba 260, Japan; [Kashiwagi, Takayuki] Inst Elect Engineers Japan, Kokubunji, Tokyo, Japan	Yamamoto, K (reprint author), Chiba Univ, Chiba, Japan.						Chigira M, 2012, T IEEJ IA, V132, P9; Fujita T., 2007, Transactions of the Institute of Electrical Engineers of Japan, Part D, V127D, DOI 10.1541/ieejias.127.174; Kaneko Y, 2010, T IEE JAPAN D, V130, P734; Matsuki F, 2011, UNDERSTANDING WIRELE; Yamamoto K, 2012, IEEJ CONV RECORD, P147	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					1	10		10.1002/ecj.11625		10	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700001		
J	Wataya, R; Iwai, D; Sato, K				Wataya, Ryo; Iwai, Daisuke; Sato, Kousuke			Sensing of Audience Excitation and Boredom Emotion Based on the Synchrony of Sitting Body Sway	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						ambient sensing; audience emotion sensing; sensing chair; sitting body sway; synchrony		More and more recent studies of emotion estimation have taken the approach of ambient sensing, where users are monitored without constraining their bodies and without being aware of the sensing system. Few of them, however, focus on audience emotions. We attempted to examine audience emotions, which are difficult to estimate when using only individual data, and which come to be estimated more easily when using ambient sensing of synchrony among multiple users. We developed an ambient sensing chair, which employs wireless sensors to determine the center of force of the seated user, and designed an experiment for an audience watching a soccer game on TV or a technical presentation in order to examine the relationship between audience body sway and emotional states in a natural situation. We found that synchrony could be well correlated with audience excitement and boredom, something not observable in the individual data. These results indicate the possibility of development of service marketing systems that evaluate TV content, and feedback systems that give notice of the emotional state of an audience to a presenter. (C) 2015 Wiley Periodicals, Inc.	[Wataya, Ryo; Iwai, Daisuke] Osaka Univ, Toyonaka, Osaka 560, Japan; [Iwai, Daisuke; Sato, Kousuke] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 560, Japan	Wataya, R (reprint author), Osaka Univ, Toyonaka, Osaka 560, Japan.						Kim J, 2008, IEEE T PATTERN ANAL, V30, P2067, DOI 10.1109/TPAMI.2008.26; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52; Chetouani DE, 2012, IEEE T AFFECT COMPUT, P1; Hamaguchi Nana, 2012, SICE Journal of Control, Measurement, and System Integration, V5, DOI 10.9746/jcmsi.5.2; Hong ZT, 2001, T MECHATRONICS, V6, P261; Matsumoto H, 2011, 2011 INF PROC SOC JA, pC; Mutlu B, 2007, 42 HUM COMP INT I; Wataya R, 2012, P 56 RES C I SYST CO, P615; Wataya R, 2012, P RES PRESENTATIONS, V40, P43; Wataya Ryo, 2012, P IEEE GLOB C CONS E, P29	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					11	19		10.1002/ecj.11627		9	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700002		
J	Harada, S; Sasada, I; Hang, F				Harada, Shoumu; Sasada, Ichiro; Hang, Feng			Development of a One-Dimensional Fluxgate Array and Its Application to Magnetocardiogram Measurements	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						biomagnetic field measurement; fluxgate magnetometer; fundamental mode orthogonal; sensor head interference	ORTHOGONAL FLUXGATE	We have designed an excitation part of the driving circuit of the fundamental mode orthogonal fluxgate (FG) to avoid an interference problem between fluxgates that may occur when individually operating fluxgates are placed closely. In this new design, three sensor heads are driven by a common excitation current while their outputs are processed separately to yield their own outputs. With magnetometers of this design, we have built a 6-channel FG array of a linear arrangement with the spacing of 3 cm, as a step to a 6 x 6 fluxgate array. The excitation frequency was shared by two excitation circuits, each of which provides a set of three sensor heads with the excitation current. A magnetocardiogram (MCG) was measured with the 6-channel FG array by repeatedly sliding the top plate of a bed carrying a healthy volunteer by 3 cm. The distribution of the QRS complex observed on a 5 x 6 of array measurement points resembles with that observed by a SQUID MCG measurement system. (C) 2015 Wiley Periodicals, Inc.	[Harada, Shoumu; Sasada, Ichiro; Hang, Feng] Kyushu Univ, Sasada Labs, Fukuoka 812, Japan	Harada, S (reprint author), Kyushu Univ, Sasada Labs, Fukuoka 812, Japan.				JSPS [2246055]	This study was supported by a JSPS Grant-in-Aid (topic no. 2246055).	Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Bison G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3255041; Knappe S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491548; Dolabdjian C, 1998, SCI INSTRUM, V10, P69; Harada S, 2012, J JPN BIOMAGNETISM B, V25, P182; Nakai K, 2006, INT J CARDIOVAS IMAG, V22, P573, DOI 10.1007/s10554-005-9019-x; Nakashima Y, 2010, IEEE T MAGN, V6, P46; Pannetier-Lecoeur M, 2011, PHYS LETT, V98; Paperno E, 2004, SENSOR ACTUAT A-PHYS, V116, P405, DOI 10.1016/j.sna.2004.05.011; Sasada I, 2012, EUR MAGNET SENSORS A, pT011; Sasada I, 2008, PAPERS TECHNICAL M M, P23; Sasada I, 2011, PAPERS TECHNICAL M M, P17; Sasada I, 2002, J APPL PHYS, V91, P7789, DOI 10.1063/1.1451899; Takahashi R, 2008, J MAGN SOC JPN, V32, P434, DOI 10.3379/msjmag.32.434	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					20	26		10.1002/ecj.11645		7	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700003		
J	Yamashita, M; Honda, T				Yamashita, Maki; Honda, Takashi			Fabrication of Magnetic Microactuators for Cytology Brush Built into Capsule Endoscope	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						capsule endoscope; cytology brush; external magnetic field; magnetic microactuator; permanent magnet		In this paper, we propose two kinds of magnetic microactuators for a cytology brush built into a capsule endoscope. One is a moving-magnet linear actuator, in which the rotational oscillation of a permanent magnet is converted into linear movement through friction. The other is a rotating-magnet actuator with a flexible push-pull wire. Both actuators can be driven by an external magnetic field and can rub the brush back and forth. As in operational testing, we successfully pushed and pulled the brush back and forth along the surface of raw meat. We have also added a new angular positioning function to the capsule by using a DC magnetic field perpendicular to the magnetic field for rubbing the brush. (C) 2015 Wiley Periodicals, Inc.	[Yamashita, Maki] Kyushu Inst Technol, Kitakyushu, Fukuoka 804, Japan; [Honda, Takashi] Kyushu Inst Technol, Fac Engn, Kitakyushu, Fukuoka 804, Japan	Yamashita, M (reprint author), Kyushu Inst Technol, Kitakyushu, Fukuoka 804, Japan.				Japan Society for the Promotion of Science [22560279]	This research was supported in part by a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (topic number 22560279).	[Anonymous], 2010, Siemens Press Release: Magnetically Guided Capsule Endoscope System from Siemens and Olympus for Comfortable Examination of the Stomach, Patent No. 8084898; Chiba A., 2007, J MAGN, V12, P89; Honda T, 1999, IEEE T MAGN, V35, P4004, DOI 10.1109/20.800736; Ito H, 2008, J JPN SOC PRECIS ENG, V74, P1152; Miyazaki N, 2000, PAPERS TECHNICAL M M; Moglia Andrea, 2008, Recent Patents on Biomedical Engineering, V1, DOI 10.2174/1874764710801010024	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					27	34		10.1002/ecj.11648		8	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700004		
J	Mabuchi, R; Yamada, K				Mabuchi, Ryuki; Yamada, Keiichi			Estimation of Driver's Intention to Stop or Pass Through at Yellow Traffic Signal	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						dilemma zone; driver; intent recognition		At signalized intersections, a driver is forced to decide whether to stop or pass through when the signal turns yellow from green. It has been pointed out that this dilemma sometimes leads to accidents at intersections. This paper proposes two methods based on vehicle behavior for predicting whether a driver approaching a signalized intersection decides to stop or pass through the intersection when the signal turns yellow, in order to support the drivers' decision-making to prevent accidents at and near intersections. The first method predicts whether a driver will decide to stop when the signal turns yellow, based on the idea that whether a driver decides to stop should depend on the situation and the vehicle behavior at the moment the signal turns yellow. The second method estimates whether a driver has decided to stop, in other words, whether the driver has the intention to stop, based on the idea that the driver's intention will appear in the vehicle behavior when the driver has decided to stop at the intersection. This method can detect the driver's oversight or neglect of traffic signals on the way to the intersection. The effectiveness of these two methods is demonstrated with experiments using real-world data. (C) 2015Wiley Periodicals, Inc.	[Mabuchi, Ryuki; Yamada, Keiichi] Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi, Japan; [Mabuchi, Ryuki; Yamada, Keiichi] Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi, Japan	Mabuchi, R (reprint author), Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi, Japan.						Akamatsu M, 2003, J SOC AUTOMOTIVE ENG, V57, P34; McCall JC, 2007, IEEE T INTELL TRANSP, V8, P431, DOI 10.1109/TITS.2007.902640; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Rakha H, 2007, IEEE T INTELL TRANSP, V8, P630, DOI 10.1109/TITS.2007.908146; Aoude GS, 2012, IEEE T INTELL TRANSP, V13, P724, DOI 10.1109/TITS.2011.2179537; GAZIS D, 1960, OPER RES, V8, P112, DOI 10.1287/opre.8.1.112; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Liu C, 1996, TRANSPORT RES A-POL, V30, P333, DOI 10.1016/0965-8564(96)00001-8; Mahalel D, 1987, TRANSPORT RES REC, V1114, P96; Mezaki D, 2007, 2007013678 SAE; Michitsuji Y, 2008, T SOC AUTOMOTIVE ENG, V39, P277; National Police Agency Traffic Bureau, 2011, 2011 ANN STAT ROAD T; Neale VL, 2006, 06CR10 VTRC; Oliver N, 2000, PROCEEDINGS OF THE IEEE INTELLIGENT VEHICLES SYMPOSIUM 2000, P7, DOI 10.1109/IVS.2000.898310; Salvucci DD, 2004, P HUM FACT ERG SOC 4, P2228; Wakasugi T, 1999, J JAPAN AUTOMOBILE R, V21, P574; Zegeer C, 1977, EFFECTIVENESS GREEN, P472	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					35	43		10.1002/ecj.11649		9	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700005		
J	Yamauchi, S; Kawamura, H; Suzuki, K				Yamauchi, Sho; Kawamura, Hidenori; Suzuki, Keiji			Extended Flocking Algorithm for Self-parameter Tuning	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						autonomous system; flocking algorithm; self-parameter tuning		Flocking algorithms for a multiagent system are distributed algorithms that only have simple rules for each agent but generate complex formational movement. These algorithms are known as swarm intelligence and are robust and disaster tolerant for most cases. We consider that flocking algorithms that have these characteristics are the way to generate homeostasis in a system. We expect that by making use of this algorithm the system can tune its self-parameters and thus maintain a high performance. First, to apply a flocking algorithm to a system, we extended the flocking algorithm to form an arbitrary lattice for further flexibility. We then applied the extended flocking algorithm to position tracking camera system as an example. (C) 2015 Wiley Periodicals, Inc.	[Yamauchi, Sho; Kawamura, Hidenori; Suzuki, Keiji] Hokkaido Univ, Grad Sch Informat Sci, Sapporo, Hokkaido 060, Japan	Yamauchi, S (reprint author), Hokkaido Univ, Grad Sch Informat Sci, Sapporo, Hokkaido 060, Japan.						Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Olfati-Saber R, 2006, IEEE T AUTOMAT CONTR, V51, P401, DOI 10.1109/TAC.2005.864190; Bonabeau E., 1999, SWARM INTELLIGENCE N; Jakimovski B, 2009, INT C AUT ROB CONTR; Mondada F, 2004, AUTON ROBOT, V17, P193, DOI 10.1023/B:AURO.0000033972.50769.1c; Reynolds C.W., 1987, COMPUT GRAPH, V2, P25, DOI DOI 10.1145/37402.37406; Williams A, 2004, P 2004 AM CONTR C BO	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					44	51		10.1002/ecj.11650		8	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700006		
J	Otsuka, T; Higashiguchi, T; Yugami, N				Otsuka, Takamitsu; Higashiguchi, Takeshi; Yugami, Noboru			Rare-Earth Plasma Beyond Extreme Ultraviolet (BEUV) Sources at 6.x nm	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						extreme ultraviolet lithography (EUVL); extreme ultraviolet (EUV); laser-produced plasma (LPP)	ISOELECTRONIC SEQUENCE; RESONANCE LINES	We have studied self-absorption effects of a laser-produced plasma (LPP) source at 6.x nm as a function of laser pulse duration and viewing angle. The spectral profiles are shown to have a strong dependence on the viewing angle. Absorption effects are less pronounced when a 150-ps pulse duration is used due to reduced opacity resulting from plasma expansion. Conversion efficiencies and ion energies are also measured as a function of laser pulse duration and laser power density. A maximum conversion efficiency of 0.4% within a 0.6% bandwidth was measured, and lower ion kinetic energy was observed. It is concluded that in order to reduce self-absorption effects and ion yields, and increase conversion efficiencies, a short pulse duration should be used. (C) 2015 Wiley Periodicals, Inc.	[Otsuka, Takamitsu; Higashiguchi, Takeshi; Yugami, Noboru] Utsunomiya Univ, Fac Engn, Utsunomiya, Tochigi, Japan	Otsuka, T (reprint author), Utsunomiya Univ, Fac Engn, Utsunomiya, Tochigi, Japan.				Canon Foundation; TEPCO Memorial Foundation	This study was assisted by grants from the Canon Foundation and the TEPCO Memorial Foundation. Assistance was also obtained from the Utsunomiya University Individuation Project, the Utsunomiya University Center for Optical Research and Education, Gigaphoton, Inc., and Intel Corporation.	Churilov SS, 2009, PHYS SCRIPTA, V80, DOI 10.1088/0031-8949/80/04/045303; SUGAR J, 1993, J OPT SOC AM B, V10, P799, DOI 10.1364/JOSAB.10.000799; BAUCHE J, 1988, PHYS SCRIPTA, V37, P659, DOI 10.1088/0031-8949/37/5/002; OSULLIVAN G, 1981, J OPT SOC AM, V71, P227, DOI 10.1364/JOSA.71.000227; Attwood DT, 2000, SOFT XRAYS EXTREME U; Bakshi V, 2006, EUV SOURCES LITHOGRA; Banine V, 2011, P 2011 INT WORKSH EU; Banine VY, 2011, J PHYS D, V44; Benschop J, 2010, P 2010 INT WORKSH EU; Cummins T, 2012, APPL PHYS LETT, V100; Filevich J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056409; Fujioka S, 2008, APPL PHYS LETT, V92; Hayden P, 2006, MICROELECTRON ENG, V83, P699, DOI 10.1016/j.mee.2005.12.032; Higashiguchi T, 2011, APPL PHYS LETT, V99; Kilbane D, 2010, J APPL PHYS, V108; Kutluk G, 2009, J ELECTRON SPECTROSC, V169, P67, DOI 10.1016/j.elspec.2008.11.004; Louis E., 2011, P 2011 INT WORKSH EU; O'Gorman C, 2012, APPL PHYS LETT, V100; Okazaki Shinji, 2010, Review of Laser Engineering, V38; Okuno T, 2006, APPL PHYS LETT, V88; O'Sullivan G, 2012, J MOD OPTIC, V59, P855, DOI 10.1080/09500340.2012.678399; Otsuka T, 2010, APPL PHYS LETT, V97; Otsuka T, 2010, APPL PHYS LETT, V97; Sasaki A, 2010, APPL PHYS LETT, V97; SUGAR J, 1993, J OPT SOC AM B, V10, P1321, DOI 10.1364/JOSAB.10.001321; SUGAR J, 1982, PHYS SCRIPTA, V26, P419, DOI 10.1088/0031-8949/26/6/002; Suzuki C, 2012, J PHYS B ATOM MOL PH, V45; Tanaka H, 2005, APPL PHYS LETT, V87; White J, 2005, J APPL PHYS, V98; Zang GM, 1994, J APPL PHYS, V75, P1923	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					52	58		10.1002/ecj.11690		7	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700007		
J	Seino, Y; Kato, H; Yonemitsu, H; Sato, H; Kanno, M; Kobayashi, K; Kawanishi, A; Azuma, T				Seino, Yuriko; Kato, Hirokazu; Yonemitsu, Hiroki; Sato, Hironobu; Kanno, Masahiro; Kobayashi, Katsutoshi; Kawanishi, Ayako; Azuma, Tsukasa			Application of Directed Self-Assembly Lithography to Semiconductor Device Manufacturing Process	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						directed self-assembly; graphoepitaxy; block copolymer; PS-b-PMMA; contact hole shrinking; wet development		Directed self-assembly (DSA) lithography has recently entered the spotlight as one of the most promising new generation lithography candidates, with the potential for fabrication of semiconductor device patterns down to sub-30 nm. In this report, the latest experimental and simulation results on the contact hole shrinking process using DSA are demonstrated. (C) 2015 Wiley Periodicals, Inc.	[Seino, Yuriko; Kato, Hirokazu; Yonemitsu, Hiroki; Sato, Hironobu; Kanno, Masahiro; Kobayashi, Katsutoshi; Kawanishi, Ayako; Azuma, Tsukasa] Toshiba Co Ltd, Ctr Semicond Res & Dev, Tokyo, Japan	Seino, Y (reprint author), Toshiba Co Ltd, Ctr Semicond Res & Dev, Tokyo, Japan.						Muramatsu M, 2012, J MICRO-NANOLITH MEM, V11, DOI 10.1117/1.JMM.11.3.031305; Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784; Aoyagi T, 2002, J SOC RHEOL JPN, V30, P247; Kato H, MICROELECTR IN PRESS; Seino Y, 2012, PROC SPIE, V8323, DOI 10.1117/12.915652; Yonemitsu H, 2012, 2012 MRS FALL M EXH; Yonemitsu H, 2012, 25 INT MICR NAN C MN	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	APR	2015	98	4					59	64		10.1002/ecj.11691		6	Engineering, Electrical & Electronic	Engineering	CE1TK	WOS:000351594700008		
J	Fukushima, H; Imanishi, M; Iwami, T; Seki, T; Kawai, Y; Norimoto, K; Urisono, Y; Hata, M; Nishio, K; Saeki, K; Kurumatani, N; Okuchi, K				Fukushima, Hidetada; Imanishi, Masami; Iwami, Taku; Seki, Tadahiko; Kawai, Yasuyuki; Norimoto, Kazunobu; Urisono, Yasuyuki; Hata, Michiaki; Nishio, Kenji; Saeki, Keigo; Kurumatani, Norio; Okuchi, Kazuo			Abnormal breathing of sudden cardiac arrest victims described by laypersons and its association with emergency medical service dispatcher-assisted cardiopulmonary resuscitation instruction	EMERGENCY MEDICINE JOURNAL			English	Article							SURVIVAL; IMPROVE; CALL	Background Current guidelines for cardiopulmonary resuscitation (CPR) emphasise that emergency medical service (EMS) dispatchers should identify sudden cardiac arrest (CA) with abnormal breathing and assist lay rescuers performing CPR. However, lay rescuers description of abnormal breathing may be inconsistent, and it is unclear how EMS dispatchers provide instruction for CPR based on the breathing status of the CA victims described by laypersons. Methods and results To investigate the incidence of abnormal breathing and the association between the EMS dispatcher-assisted CPR instruction and layperson CPR, we retrospectively analysed 283 witnessed CA cases whose information regarding breathing status of CA victims was available from population-based prospective cohort data. In 169 cases (59.7%), laypersons described that the CA victims were breathing in various ways, and that the victims were 'not breathing' in 114 cases (40.3%). Victims described as breathing in various ways were provided EMS dispatch-instruction for CPR less frequently than victims described as 'not breathing' (27.8% (47/169) vs 84.2% (96/114); p<0.001). Multivariate logistic regression showed that EMS dispatch-instruction for CPR was associated significantly with layperson CPR (adjusted OR, 11.0; 95% CI, 5.72 to 21.2). Conclusions This population-based study indicates that 60% of CA victims showed agonal respiration, which was described as breathing in various ways at the time of EMS call. Although EMS dispatch-instruction was associated significantly with an increase in layperson CPR, abnormal breathing was associated with a much lower rate of CPR instruction and, in turn, was related to a much lower rate of bystander CPR.	[Fukushima, Hidetada; Seki, Tadahiko; Kawai, Yasuyuki; Norimoto, Kazunobu; Urisono, Yasuyuki; Hata, Michiaki; Okuchi, Kazuo] Nara Med Univ, Dept Emergency & Crit Care Med, Kashihara, Nara 634, Japan; [Imanishi, Masami] Nara Saiseikai Gose Hosp, Dept Neurosurg, Gose, Nara, Japan; [Iwami, Taku] Kyoto Univ Hlth Serv, Dept Hlth Serv, Kyoto, Japan; [Nishio, Kenji] Nara Med Univ, Dept Gen Med, Kashihara, Nara 634, Japan; [Saeki, Keigo; Kurumatani, Norio] Nara Med Univ, Dept Epidemiol & Community Hlth, Kashihara, Nara 634, Japan	Fukushima, H (reprint author), Nara Med Univ, Dept Emergency & Crit Care Med, Shijo Cho 840, Kashihara, Nara 634, Japan.	hidetakarina@gmail.com			Foundation for Ambulance Service Development (Tokyo, Japan)	This study was supported by the Foundation for Ambulance Service Development (Tokyo, Japan).	Berdowski J, 2009, CIRCULATION, V119, P2096, DOI 10.1161/CIRCULATIONAHA.108.768325; Bang A, 2003, RESUSCITATION, V56, P25, DOI 10.1016/S0300-9572(02)00278-2; Kuisma M, 2005, RESUSCITATION, V67, P89, DOI 10.1016/j.resuscitation.2005.04.008; Hauff SR, 2003, ANN EMERG MED, V42, P731, DOI 10.1016/mem.2003.294; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Hallstrom AP, 2003, RESUSCITATION, V57, P123, DOI 10.1016/S0300-9572(03)00005-4; Holmberg M, 1998, RESUSCITATION, V36, P29, DOI 10.1016/S0300-9572(97)00089-0; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Vaillancourt C, 2011, RESUSCITATION, V82, P1483, DOI 10.1016/j.resuscitation.2011.05.020; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Bobrow BJ, 2008, CIRCULATION, V118, P2550, DOI 10.1161/CIRCULATIONAHA.108.799940; Ma MHM, 2007, RESUSCITATION, V73, P236, DOI 10.1016/j.resuscitation.2006.09.005; Roppolo LP, 2009, RESUSCITATION, V80, P769, DOI 10.1016/j.resuscitation.2009.04.013; White L, 2010, CIRCULATION, V121, P91, DOI 10.1161/CIRCULATIONAHA.109.872366; CLARK JJ, 1992, ANN EMERG MED, V21, P1464, DOI 10.1016/S0196-0644(05)80062-9; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Bang A, 2008, RESUSCITATION, V78, P116, DOI 10.1016/j.resuscitation.2008.02.027; Billittier A J 4th, 2000, Prehosp Emerg Care, V4, P234, DOI 10.1080/10903120090941254; Bohm K, 2007, EUR J EMERG MED, V14, P256, DOI 10.1097/MEJ.0b013e32823a3cd1; Coons SJ, 2009, RESUSCITATION, V80, P334, DOI 10.1016/j.resuscitation.2008.11.024; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Flynn Julie, 2006, Prehosp Disaster Med, V21, P72; Haley KB, 2011, PREHOSP EMERG CARE, V15, P282, DOI 10.3109/10903127.2010.541981; Kuisma M, 2005, ACTA ANAESTH SCAND, V49, P1527, DOI 10.1111/j.1399-6576.2005.00761.x	25	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	APR	2015	32	4					314	317		10.1136/emermed-2013-203112		4	Emergency Medicine	Emergency Medicine	CE2ZG	WOS:000351691400015		
J	Shrestha, A; Lama, TK; Karki, S; Sigdel, DR; Rai, U; Rauniyar, SK; Al-Mahtab, M; Takahashi, K; Arai, M; Akbar, SMF; Mishiro, S				Shrestha, Ananta; Lama, Thupten K.; Karki, Sneha; Sigdel, Deepak R.; Rai, Utsav; Rauniyar, Shyam K.; Al-Mahtab, Mamun; Takahashi, Kazuaki; Arai, Masahiro; Akbar, Sheikh M. F.; Mishiro, Shunji			Hepatitis E Epidemic, Biratnagar, Nepal, 2014	EMERGING INFECTIOUS DISEASES			English	Letter									[Shrestha, Ananta] Liver Fdn Nepal, Kathmandu, Nepal; [Lama, Thupten K.; Karki, Sneha] Civil Serv Hosp, Kathmandu, Nepal; [Sigdel, Deepak R.; Rai, Utsav; Rauniyar, Shyam K.] Koshi Zonal Hosp, Biratnagar, Nepal; [Al-Mahtab, Mamun] Bangbandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh; [Takahashi, Kazuaki; Arai, Masahiro; Akbar, Sheikh M. F.; Mishiro, Shunji] Toshiba Gen Hosp, Tokyo, Japan	Akbar, SMF (reprint author), Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, 6-3-22 Higashi Oi, Tokyo 1408522, Japan.	sheikh.akbar@po.toshiba.co.jp					Takahashi K, 2009, EMERG INFECT DIS, V15, P704, DOI 10.3201/eid1505.081100; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Gautam M, JAUNDICE OUTBREAK EX; Ghimeri B, ALERT ISSUED JAUNDIC; Kantipur E, JAUNDICE OUTBREAK BI; Shrestha S M, 2006, Kathmandu Univ Med J (KUMJ), V4, P530	6	2	2	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	APR	2015	21	4					711	713		10.3201/eid2104.141512		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CE2NK	WOS:000351652100030		
J	Yahiro, T; Wangchuk, S; Wada, T; Dorji, C; Matsumoto, T; Mynak, ML; Tshering, KP; Nishizono, A; Ahmed, K				Yahiro, Takaaki; Wangchuk, Sonam; Wada, Takeshi; Dorji, Chimmi; Matsumoto, Takashi; Mynak, Mimi Lhamo; Tshering, Kunzang Pem; Nishizono, Akira; Ahmed, Kamruddin			Norovirus GII.21 in Children with Diarrhea, Bhutan	EMERGING INFECTIOUS DISEASES			English	Letter							GASTROENTERITIS		[Yahiro, Takaaki; Wada, Takeshi; Matsumoto, Takashi; Nishizono, Akira; Ahmed, Kamruddin] Oita Univ, Yufu, Oita 8795593, Japan; [Wangchuk, Sonam; Dorji, Chimmi] Royal Govt Bhutan, Minist Hlth, Thimphu, Bhutan; [Mynak, Mimi Lhamo] Jigme Dorji Wangchuk Natl Referral Hosp, Thimphu, Bhutan; [Tshering, Kunzang Pem] Royal Govt Bhutan, Univ Med Sci, Thimphu, Bhutan	Ahmed, K (reprint author), Oita Univ, Res Promot Inst, Fac Med, Dept Microbiol, Yufu, Oita 8795593, Japan.	ahmed@oita-u.ac.jp					Huynen P, 2013, J CLIN VIROL, V58, P515, DOI 10.1016/j.jcv.2013.08.013; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Haramoto E, 2005, APPL ENVIRON MICROB, V71, P2403, DOI 10.1128/AEM.71.5.2403-2411.2005; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Kittigul L, 2010, J MED VIROL, V82, P854, DOI 10.1002/jmv.21746; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Nahar S, 2013, VIRUS GENES, V46, P538, DOI 10.1007/s11262-013-0895-1; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Yahiro T, 2014, EMERG INFECT DIS, V20, P1037, DOI 10.3201/eid2006.131430	9	1	1	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	APR	2015	21	4					732	734		10.3201/eid2104.141856		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CE2NK	WOS:000351652100041		
J	Kawamoto, R; Kohara, K; Katoh, T; Kusunoki, T; Ohtsuka, N; Abe, M; Kumagi, T; Miki, T				Kawamoto, Ryuichi; Kohara, Katsuhiko; Katoh, Tateaki; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Abe, Masanori; Kumagi, Teru; Miki, Tetsuro			Changes in oxidized low-density lipoprotein cholesterol are associated with changes in handgrip strength in Japanese community-dwelling persons	ENDOCRINE			English	Article						Oxidized LDL-cholesterol; MDL-LDL; Handgrip strength; Nordic walking exercise	NORDIC WALKING; GRIP STRENGTH; METABOLIC SYNDROME; OXIDATIVE STRESS; BODY-COMPOSITION; OLD-AGE; SARCOPENIA; MORTALITY; EXERCISE; MUSCLE	Nordic walking (NW), characterized by the use of two walking poles, has positive effects on several muscle groups. Muscle strength and mass decrease with age, and recently, this decrease is defined as sarcopenia. Sarcopenia may be triggered by oxidative stress. We investigated whether changes in the oxidative stress marker, malondialdehyde-modified low-density lipoprotein (MDA-LDL)/LDLcholesterol (LDL-C) ratio are associated with change in handgrip strength (HGS), which is a useful indicator of sarcopenia, by a 12-week NW exercise among Japanese community-dwelling persons. The present study included 65 women aged 67 +/- 7 years and 9 men aged 71 +/- 8 years from a rural village. NW exercise of 120 min per week was performed for 12 weeks. Before and at the end of the 12-week intervention, various confounding factors and HGS were measured. 12-week changes in various factors were calculated by subtracting the baseline values from the 12-week values. Changes in HGS and follow-up HGS increased progressively with decreased changes in the MDA-LDL/LDL-C ratio after the 12-week walking exercise (r = -0.32, P = 0.006 and r = -0.35, P = 0.002, respectively). Multiple linear regression analysis showed that changes in HDL-C (beta = 0.26, P = 0.019) and MDALDL/LDL-C ratio (beta = -0.32, P = 0.004) were significantly and independently associated with changes in HGS. When the data were further stratified by gender, change in the MDA-LDL/LDL-C ratio was significantly and similarly associated with change in HGS in women only. These results suggest that change in MDA-LDL/LDL-C ratio may be a predictor for HGS after a 12-week NW exercise in community-dwelling persons.	[Kawamoto, Ryuichi; Kusunoki, Tomo; Abe, Masanori; Kumagi, Teru] Ehime Univ, Grad Sch Med, Dept Community Med, Toon City, Ehime 7910295, Japan; [Kawamoto, Ryuichi; Katoh, Tateaki; Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Seiyo City, Ehime 7971212, Japan; [Kohara, Katsuhiko; Katoh, Tateaki; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon City, Ehime 7910295, Japan	Kawamoto, R (reprint author), Seiyo Municipal Nomura Hosp, Dept Internal Med, 9-53 Nomura,Nomura Cho, Seiyo City, Ehime 7971212, Japan.	rykawamo@m.ehime-u.ac.jp; koharak@m.ehime-u.ac.jp; takeaki.katoh@gmail.com; kusunoki.tomo.mm@ehime-u.ac.jp; ohtsukan@hotmail.com; masaben@m.ehime-u.ac.jp; terukuma@m.ehime-u.ac.jp; tmiki@m.ehime-u.ac.jp			Foundation for Development of Community	This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2013).	Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Church TS, 2002, RES Q EXERCISE SPORT, V73, P296; Kohara K, 2014, ENDOCRINE, V45, P15, DOI 10.1007/s12020-013-9992-0; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Doria E, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/830257; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Tschentscher M, 2013, AM J PREV MED, V44, P76, DOI 10.1016/j.amepre.2012.09.043; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Kawamoto R, 2013, ENDOCRINE, V44, P132, DOI 10.1007/s12020-013-9912-3; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Ji LL, 2006, ANN NY ACAD SCI, V1067, P425, DOI 10.1196/annals.1354.061; Cesari M, 2005, ARCH INTERN MED, V165, P2148, DOI 10.1001/archinte.165.18.2148; Hansen EA, 2009, J STRENGTH COND RES, V23, P1187, DOI 10.1519/JSC.0b013e31819f1e2b; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Collins PF, 2013, RESPIROLOGY, V18, P616, DOI 10.1111/resp.12070; Ji LL, 2001, ANN NY ACAD SCI, V928, P236; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Schwameder H, 1999, J SPORT SCI, V17, P969, DOI 10.1080/026404199365362; Buonocore D., 2012, MUSCLES LIGAMENTS J, V1, P85; Derbre F, 2014, EUR J SPORT SCI, V14, pS98, DOI 10.1080/17461391.2011.654268; Kim Tae Nyun, 2013, J Bone Metab, V20, P1, DOI 10.11005/jbm.2013.20.1.1; Matsuda M, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-77; Pansarasa O, 2000, FREE RADICAL RES, V33, P287, DOI 10.1080/10715760000301451; Shim JM, 2013, J PHYS THER SCI, V25, P1553, DOI 10.1589/jpts.25.1553; Song MS, 2013, ASIAN NURS RES, V7, P1, DOI 10.1016/j.anr.2012.11.001; Sugiyama K, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-2; Walter P R, 1996, J Cardiopulm Rehabil, V16, P245, DOI 10.1097/00008483-199607000-00006	28	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	APR	2015	48	3					871	877		10.1007/s12020-014-0360-5		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CE2QT	WOS:000351661100018		
J	Kakuda, H; Kobayashi, J; Kakuda, M; Yamakawa, J; Takekoshi, N				Kakuda, Hirokazu; Kobayashi, Junji; Kakuda, Masahiro; Yamakawa, Junichi; Takekoshi, Noboru			The effect of anagliptin treatment on glucose metabolism and lipid metabolism, and oxidative stress in fasting and postprandial states using a test meal in Japanese men with type 2 diabetes	ENDOCRINE			English	Article						Anagliptin; Test meal; Adiponectin; Remnant; Renal function; 8-OHdG	GLUCAGON-LIKE PEPTIDE-1; ATHEROSCLEROSIS; TRIGLYCERIDES; INHIBITOR; THERAPY; MICE		[Kakuda, Hirokazu; Kakuda, Masahiro] Kakuda Clin, Kahoku, Ishikawa 9291215, Japan; [Kobayashi, Junji; Yamakawa, Junichi] Kanazawa Med Univ, Dept Gen Med, Kahoku, Ishikawa 9200293, Japan; [Takekoshi, Noboru] Kanazawa Med Univ, Kahoku, Ishikawa 9200293, Japan	Kobayashi, J (reprint author), Kanazawa Med Univ, Dept Gen Med, 1-1 Daigaku Uchinada, Kahoku, Ishikawa 9200293, Japan.	mary@kanazawa-med.ac.jp	Kobayashi, Junjiro/J-8547-2015				Annuzzi G, 2010, METABOLISM, V59, P567, DOI 10.1016/j.metabol.2009.08.020; Tremblay AJ, 2011, DIABETES OBES METAB, V13, P366, DOI 10.1111/j.1463-1326.2011.01362.x; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Hsieh J, 2010, DIABETOLOGIA, V53, P552, DOI 10.1007/s00125-009-1611-5; Nakaya K, 2013, METABOLISM, V62, P939, DOI 10.1016/j.metabol.2013.01.010; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; Wojdemann M, 1998, DIGEST DIS SCI, V43, P799, DOI 10.1023/A:1018874300026; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473; Chan DC, 2005, CLIN CHEM, V51, P578, DOI 10.1373/clinchem.2004.045120; Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855; Aronson D, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186/1475-2840-1-1; Eglit T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073273; Kakuda H., 2013, CHOLESTEROL, V2013; Qin X., 2005, AM J PHYSIOL-GASTR L, V288, P943; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397; Twicker TB, 2004, CIRCULATION, V109, P1918, DOI 10.1161/01.CIR.0000125278.58527.F3; van Oostrom AJHHM, 2003, J LIPID RES, V44, P576, DOI 10.1194/jlr.M200419-JLR200; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335	20	3	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	APR	2015	48	3					1005	1009		10.1007/s12020-014-0376-x		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CE2QT	WOS:000351661100036		
J	Iwata, K; Katayama, H; Arimura, TH				Iwata, Kazuyuki; Katayama, Hajime; Arimura, Toshi H.			Do households misperceive the benefits of energy-saving actions? Evidence from a Japanese household survey	ENERGY FOR SUSTAINABLE DEVELOPMENT			English	Article						Household; Perception; Energy-saving actions	CONSERVATION BEHAVIORS; CLIMATE-CHANGE; REQUIREMENTS; INCENTIVES; REDUCTION; OPTIONS	Using a household survey conducted in a suburb of Tokyo, we examine whether individuals properly perceive the benefits of energy-saving actions. A bivariate regression shows that, on average, individuals overestimate the benefits. The tendency to overestimate is robust to controlling for individual and home characteristics. Our results are contrary to those of Attari et al. (2011), who found that individuals in the U.S. tended to underestimate the benefits of energy-saving activities. The difference in our results suggests that the provision of information about the benefits of energy saving may be an effective policy to address global warming issues in one country but not necessarily in all countries. We also find that the magnitude of overestimation is greatest among young single males, whereas the benefits perceived by older married females are the smallest. This result suggests that the provision of tailored information (i.e., highly personalized and specific information) can be an effective intervention even in Japan. (C) 2014 International Energy Initiative. Published by Elsevier Inc. All rights reserved.	[Iwata, Kazuyuki] Takasaki City Univ Econ, Fac Reg Policy, Takasaki, Gumma, Japan; [Katayama, Hajime] Waseda Univ, Fac Commerce, Tokyo, Japan; [Arimura, Toshi H.] Waseda Univ, Fac Polit Sci & Econ, Tokyo, Japan	Iwata, K (reprint author), Kaminamie Cho 1300, Takasaki, Gunma 3700801, Japan.	iwata.kazuyu@gmail.com	Iwata, Kazuyuki/M-6836-2015	Iwata, Kazuyuki/0000-0002-2712-9133	Japanese Ministry of the Environment; Japan Society for the Promotion of Science [24530267]	We are grateful to the editor and reviewers for insightful comments as well as suggestions. All remaining errors are ours. This study was supported by "An economic analysis of the impact of linking domestic ETS's among on the Japanese economy: a computable general equilibrium analysis approach" by the Japanese Ministry of the Environment and Grant-in-Aid for Scientific Research (C: 24530267) by the Japan Society for the Promotion of Science.	Lokshin M, 2006, STATA J, V6, P377; VRINGER K, 1995, ENERG POLICY, V23, P893, DOI 10.1016/0301-4215(95)00072-Q; Scherbaum CA, 2008, J APPL SOC PSYCHOL, V38, P818, DOI 10.1111/j.1559-1816.2007.00328.x; Carlsson-Kanyama A, 2005, J IND ECOL, V9, P221, DOI 10.1162/1088198054084590; Alfredsson EC, 2004, ENERGY, V29, P513, DOI 10.1016/j.energy.2003.10.013; Truelove HB, 2012, J ENVIRON PSYCHOL, V32, P246, DOI 10.1016/j.jenvp.2012.04.002; Steg L, 2006, ENVIRON BEHAV, V38, P92, DOI 10.1177/0013916505278519; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Galvin R, 2013, ENERG BUILDINGS, V67, P596, DOI 10.1016/j.enbuild.2013.08.065; Larrick RP, 2008, SCIENCE, V320, P1593, DOI 10.1126/science.1154983; Staats HJ, 1996, J ENVIRON MANAGE, V46, P189, DOI 10.1006/jema.1996.0015; GELLER ES, 1981, J CONSUM RES, V8, P331, DOI 10.1086/208872; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; GONZALES MH, 1988, J APPL SOC PSYCHOL, V18, P1049, DOI 10.1111/j.1559-1816.1988.tb01192.x; McMakin AH, 2002, ENVIRON BEHAV, V34, P848, DOI 10.1177/001391602237252; Yue T, 2013, ENERG POLICY, V62, P665, DOI 10.1016/j.enpol.2013.07.051; Yatchew A, 1997, ECON LETT, V57, P135, DOI 10.1016/S0165-1765(97)00218-8; Urban J, 2012, ENERG POLICY, V47, P69, DOI 10.1016/j.enpol.2012.04.018; Silva JMCS, 2006, REV ECON STAT, V88, P641, DOI 10.1162/rest.88.4.641; BAIRD JC, 1981, J APPL PSYCHOL, V66, P90; Barr S, 2005, ENERG POLICY, V33, P1425, DOI 10.1016/j.enpol.2003.12.016; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Arbrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273; Arbrahamse W, 2007, J ENVIRON PSYCHOL, V27, P265; Attari SZ, 2011, P NATL ACAD SCI US P, V107, P16054; Benders RMT, 2006, ENERG POLICY, V34, P3612, DOI 10.1016/j.enpol.2005.08.005; Ecofys, 2013, WORLD GHG EM FLOW CH; Eurobarometer, 2007, ATT ISS REL EU EN PO; Griod B, 2009, ENERG POLICY, V37, P5650; HIRST E, 1983, J ENVIRON SYST, V12, P303; HUTTON RB, 1981, J CONSUM RES, V8, P291, DOI 10.1086/208867; LUYBEN PD, 1982, ENVIRON BEHAV, V14, P113, DOI 10.1177/0013916582141007; U.S. global change research program, 2014, OV CLIM CHANG IMP US; WINETT RA, 1982, J ENVIRON SYST, V12, P61; Yohanis YG, 2012, ENERG POLICY, V41, P654, DOI 10.1016/j.enpol.2011.11.028	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0973-0826			ENERGY SUSTAIN DEV	Energy Sustain Dev.	APR	2015	25						27	33		10.1016/j.esd.2014.12.005		7	Energy & Fuels	Energy & Fuels	CE8UO	WOS:000352119800004		
J	Muzembo, BA; Deguchi, Y; Ngatu, NR; Eitoku, M; Hirota, R; Suganuma, N				Muzembo, Basilua Andre; Deguchi, Yoji; Ngatu, Nlandu Roger; Eitoku, Masamitsu; Hirota, Ryoji; Suganuma, Narufumi			Selenium and exposure to fibrogenic mineral dust: A mini-review	ENVIRONMENT INTERNATIONAL			English	Review						Selenium; Selenoproteins; Pneumoconiosis; Silicosis; Asbestosis; Coal miner's pneumoconiosis	COAL-WORKERS PNEUMOCONIOSIS; ASBESTOS-INDUCED DISEASES; PREVENTION TRIAL SELECT; LUNG-CANCER; SERUM SELENIUM; GLUTATHIONE-PEROXIDASE; HUMAN HEALTH; ANTIOXIDANT ENZYMES; DIETARY-SUPPLEMENT; PULMONARY-FIBROSIS	Individuals exposed to fibrogenic mineral dust may exhibit an impaired antioxidant system and produce high levels of reactive oxygen and nitrogen species through immune cells, contributing to the perturbation of immune cell function, inflammation, fibrosis and lung cancer. The lung diseases which are caused by inhalation of fibrogenic mineral dust, known as pneumoconioses, develop progressively and irreversibly over decades. At the moment there is no known cure. The Mace element selenium has potent antioxidant and anti-inflammatory properties mediated mainly through selenoproteins. Research has demonstrated that selenium has the ability to protect against cardiovascular diseases; to kill cancer cells in vitro and reduce cancer incidence; and to immunomodulate various cellular signaling pathways. For these reasons, selenium has been proposed as a promising therapeutic agent in oxidative stress associated pathology that in theory would be beneficial for the prevention or treatment of pneumoconioses such as silicosis, asbestosis, and coal worker's pneumoconiosis. However, studies regarding selenium and occupational lung diseases are rare. The purpose of this study is to conduct a mini-review regarding the relationship between selenium and exposure to fibrogenic mineral dust with emphasis on epidemiological studies. We carried out a systematic literature search of English published studies on selenium and exposure to fibrogenic mineral dust. We found four epidemiological studies. Reviewed studies show that selenium is lower in individuals exposed to fibrogenic mineral dust. However, three out of the four reviewed studies could not confirm cause-and-effect relationships between low selenium status and exposure to fibrogenic mineral dust. This mini-review underscores the need for large follow-up and mechanistic studies for selenium to further elucidate its therapeutic effects. (C) 2015 Elsevier Ltd. All rights reserved.	[Muzembo, Basilua Andre; Ngatu, Nlandu Roger; Eitoku, Masamitsu; Hirota, Ryoji; Suganuma, Narufumi] Kochi Univ, Kochi Med Sch, Dept Environm Med, Div Social Med, Kochi 7838505, Japan; [Deguchi, Yoji] Univ Fukui, Fac Med Sci, Sch Nursing, Fukui 910, Japan; [Ngatu, Nlandu Roger] Kochi Univ, Disaster Grad Sch Hlth & Nursing Sci, Disaster Nursing Global Leader Program DNGL, Kochi 7838505, Japan; [Muzembo, Basilua Andre] Japan Soc Promot Sci, Tokyo, Japan	Muzembo, BA (reprint author), Kochi Univ, Kochi Med Sch, Dept Environm Med, Div Social Med, Kochi 7838505, Japan.	andersonbasilua@yahoo.fr			Japan Society for the Promotion of Science (JSPS)	The authors thank the Japan Society for the Promotion of Science (JSPS) for providing financial support during the preparation of this article. The authors also thank Mr Peter Duveen, Mr Danien Ribble, Mr Mugo Andrew and Mrs Mansongi Biyela Carine for helpful suggestions on the draft of this manuscript.	American Thoracic Society, 1986, AM REV RESPIR DIS, V134, P363; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; El-Bayoumy K, 2001, MUTAT RES-FUND MOL M, V475, P123, DOI 10.1016/S0027-5107(01)00075-6; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Pelclova D, 2008, IND HEALTH, V46, P484, DOI 10.2486/indhealth.46.484; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Sinha R, 2004, CURR CANCER DRUG TAR, V4, P13, DOI 10.2174/1568009043481614; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Coudray C, 1997, J AM COLL NUTR, V16, P584; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Zou K, 2009, OSTEOARTHR CARTILAGE, V17, P144, DOI 10.1016/j.joca.2008.06.011; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Shukla A, 2003, FREE RADICAL BIO MED, V34, P1117, DOI 10.1016/S0891-5849(03)00060-1; Maeda M, 2010, J IMMUNOTOXICOL, V7, P268, DOI 10.3109/1547691X.2010.512579; Nogueira CW, 2011, ARCH TOXICOL, V85, P1313, DOI 10.1007/s00204-011-0720-3; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; QUINLAN T, 1994, ENVIRON HEALTH PERSP, V102, P79, DOI 10.2307/3431823; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Cullinan P, 2013, PRIM CARE RESP J, V22, P249, DOI 10.4104/pcrj.2013.00055; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771; Hoffmann FW, 2010, J NUTR, V140, P1155, DOI 10.3945/jn.109.120725; Roach HD, 2002, RADIOGRAPHICS, V22, pS167; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Longnecker MP, 1996, EPIDEMIOLOGY, V7, P384, DOI 10.1097/00001648-199607000-00008; Chen XH, 2003, J CLIN ENDOCR METAB, V88, P5963, DOI 10.1210/jc.2003-030544; Kanarek MS, 2011, ANN EPIDEMIOL, V21, P688, DOI 10.1016/j.annepidem.2011.05.010; Johnson CC, 2010, P NUTR SOC, V69, P119, DOI 10.1017/S0029665109991807; Jablonska E, 2008, EUR J NUTR, V47, P47, DOI 10.1007/s00394-008-0696-9; Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301; Aldosary BM, 2012, CLIN TOXICOL, V50, P57, DOI 10.3109/15563650.2011.641560; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; GE KY, 1983, VIRCHOWS ARCH A, V401, P1, DOI 10.1007/BF00644785; Dunn B, 2012, NATURE, V483, pS2, DOI 10.1038/483S2a; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; McKenzie RC, 1998, IMMUNOL TODAY, V19, P342, DOI 10.1016/S0167-5699(98)01294-8; Look MP, 1997, EUR J CLIN NUTR, V51, P266, DOI 10.1038/sj.ejcn.1600401; Bera S, 2013, MUTAGENESIS, V28, P127, DOI 10.1093/mutage/ges064; Duffield-Lillico AJ, 2003, J NATL CANCER I, V95, P1477, DOI 10.1093/jnci/djg061; Chong S, 2006, RADIOGRAPHICS, V26, P59, DOI 10.1148/rg.261055070; WILBER CG, 1980, CLIN TOXICOL, V17, P171; Rayman MP, 2008, BRIT J NUTR, V100, P238, DOI 10.1017/S0007114508922522; Hatfield DL, 2009, MOL INTERV, V9, P18, DOI 10.1124/mi.9.1.6; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123; Apostolou S, 2004, ONCOGENE, V23, P5032, DOI 10.1038/sj.onc.1207683; MacFarquhar JK, 2010, ARCH INTERN MED, V170, P256, DOI 10.1001/archinternmed.2009.495; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; Suadicani P, 2012, EUR RESPIR J, V39, P1443, DOI 10.1183/09031936.00102711; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; ROY M, 1994, BIOL TRACE ELEM RES, V41, P103, DOI 10.1007/BF02917221; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Bargagli E, 2009, RESP MED, V103, P1245, DOI 10.1016/j.rmed.2009.04.014; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; ANTMAN KH, 1993, CHEST, V103, pS373, DOI 10.1378/chest.103.4_Supplement.373S; Attfield MD, 2003, ANN OCCUP HYG, V47, P525, DOI 10.1093/annhyg/meg084; Bargagli E, 2008, BIOL TRACE ELEM RES, V124, P225, DOI 10.1007/s12011-008-8143-6; Bartz RR, 2010, CRIT CARE, V14, DOI 10.1186/cc9185; Burk RF, 2003, J NUTR, V133, p1517S; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S; Ciofu O, 2014, COCHRANE DB SYST REV, V8; DAVIS JMG, 1983, AM REV RESPIR DIS, V128, P118; Day BJ, 2008, ANTIOXID REDOX SIGN, V10, P355, DOI 10.1089/ars.2007.1916; Delgado Diemen, 2012, Saf Health Work, V3, P140; ENGELEN JJM, 1990, ENVIRON HEALTH PERSP, V84, P165; Franke KW, 1934, J NUTR, V8, P597; Fritz H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026259; GABOR S, 1985, ENVIRON RES, V37, P293, DOI 10.1016/0013-9351(85)90109-4; Goodman GE, 2001, CANCER EPIDEM BIOMAR, V10, P1069; Gottschall EB, 2004, CHEST, V125, p83S, DOI 10.1378/chest.125.5_suppl.83S; Halliwell B, 1999, FREE RADICAL BIO MED, P246; JANSSEN YMW, 1992, J BIOL CHEM, V267, P10625; JANSSEN YMW, 1990, FREE RADICAL RES COM, V11, P53, DOI 10.3109/10715769009109667; KAMP DW, 1992, FREE RADICAL BIO MED, V12, P293, DOI 10.1016/0891-5849(92)90117-Y; Kinnula Vuokko L., 2005, Current Drug Targets - Inflammation and Allergy, V4, P465, DOI 10.2174/1568010054526368; Knekt P, 1998, AM J EPIDEMIOL, V148, P975; Laclaustra M, 2009, CIRC-CARDIOVASC QUAL, V2, P369, DOI 10.1161/CIRCOUTCOMES.108.831552; Longtin R, 2003, J NATL CANCER I, V95, P98; MCLOUD TC, 1991, RADIOL CLIN N AM, V29, P931; Morris JS, 2013, NUTRIENTS, V5, P1024, DOI 10.3390/nu5041024; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Moxon AL, 1943, PHYSIOL REV, V23, P305; Muller D, 2010, HUM EXP TOXICOL, V29, P431, DOI 10.1177/0960327109360046; Muzembo BA, 2013, J TRACE ELEM MED BIO, V27, P40, DOI 10.1016/j.jtemb.2012.05.003; Nadif R, 2001, OCCUP ENVIRON MED, V58, P239, DOI 10.1136/oem.58.4.239; Naghadehi MZ, 2014, ATMOS ENVIRON, V83, P1, DOI 10.1016/j.atmosenv.2013.10.053; Norton RL, 2012, MOL ASPECTS MED, V33, P98, DOI 10.1016/j.mam.2011.10.003; Oryszczyn MP, 1996, AM J IND MED, V30, P281, DOI 10.1002/(SICI)1097-0274(199609)30:3<281::AID-AJIM5>3.0.CO;2-1; Prazakova S, 2014, CLIN RESPIR J, V8, P1, DOI 10.1111/crj.12028; Robinson C, 2012, NUTR CANCER, V64, P315, DOI 10.1080/01635581.2012.649100; Rose AH, 2014, AM J PATHOL, V184, P1041, DOI 10.1016/j.ajpath.2013.12.008; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; SOUTAR CA, 1984, BRIT J IND MED, V41, P334; Spiller HA, 2007, FORENSIC SCI INT, V171, P67, DOI 10.1016/j.forsciint.2006.06.077; Steenland K, 2014, CA-CANCER J CLIN, V64, P63, DOI 10.3322/caac.21214; Thomson CD, 2008, AM J CLIN NUTR, V87, P379; THOMSON CD, 1980, AM J CLIN NUTR, V33, P303; THOMSON CD, 1993, BRIT J NUTR, V69, P577, DOI 10.1079/BJN19930057; Todd Nevins W, 2012, Fibrogenesis Tissue Repair, V5, P11, DOI 10.1186/1755-1536-5-11; Tsuda T, 2002, ANN EPIDEMIOL, V12, P288, DOI 10.1016/S1047-2797(01)00271-X; Wang XR, 2000, J OCCUP ENVIRON MED, V42, P1076, DOI 10.1097/00043764-200011000-00009; Wojewoda M, 2010, BBA-BIOENERGETICS, V1797, P890, DOI 10.1016/j.bbabio.2010.01.035; Xia Y, 2014, INT J ENV RES PUB HE, V11, P8612, DOI 10.3390/ijerph110908612; Yoneyama S, 2008, EUR J CLIN NUTR, V62, P1187, DOI 10.1038/sj.ejcn.1602842; Yoo MH, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P325, DOI 10.1007/978-1-4614-1025-6_25; YOUNG RC, 1992, J NATL MED ASSOC, V84, P41; Zhang JW, 2010, J INT MED RES, V38, P884	121	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	APR	2015	77						16	24		10.1016/j.envint.2015.01.002		9	Environmental Sciences	Environmental Sciences & Ecology	CE4FP	WOS:000351786800003		
J	Zeiger, E; Gollapudi, B; Aardema, MJ; Auerbach, S; Boverhof, D; Custer, L; Dedon, P; Honma, M; Ishida, S; Kasinski, AL; Kim, JH; Manjanatha, MG; Marlowe, J; Pfuhler, S; Pogribny, I; Slikker, W; Stankowski, LF; Tanir, JY; Tice, R; van Benthem, J; White, P; Witt, KL; Thybaud, V				Zeiger, Errol; Gollapudi, Bhaskar; Aardema, Marilyn J.; Auerbach, Scott; Boverhof, Darrell; Custer, Laura; Dedon, Peter; Honma, Masamitsu; Ishida, Seiichi; Kasinski, Andrea L.; Kim, James H.; Manjanatha, Mugimane G.; Marlowe, Jennifer; Pfuhler, Stefan; Pogribny, Igor; Slikker, William; Stankowski, Leon F., Jr.; Tanir, Jennifer Y.; Tice, Raymond; van Benthem, Jan; White, Paul; Witt, Kristine L.; Thybaud, Veronique			Opportunities to Integrate New Approaches in Genetic Toxicology: An ILSI-HESI Workshop Report	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Review						genetic toxicity; mutation; epigenetics; genomics		Genetic toxicity tests currently used to identify and characterize potential human mutagens and carcinogens rely on measurements of primary DNA damage, gene mutation, and chromosome damage in vitro and in rodents. The International Life Sciences Institute Health and Environmental Sciences Institute (ILSI-HESI) Committee on the Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity Testing held an April 2012 Workshop in Washington, DC, to consider the impact of new understanding of biology and new technologies on the identification and characterization of genotoxic substances, and to identify new approaches to inform more accurate human risk assessment for genetic and carcinogenic effects. Workshop organizers and speakers were from industry, academe, and government. The Workshop focused on biological effects and technologies that would potentially yield the most useful information for evaluating human risk of genetic damage. Also addressed was the impact that improved understanding of biology and availability of new techniques might have on genetic toxicology practices. Workshop topics included (1) alternative experimental models to improve genetic toxicity testing, (2) Biomarkers of epigenetic changes and their applicability to genetic toxicology, and (3) new technologies and approaches. The ability of these new tests and technologies to be developed into tests to identify and characterize genotoxic agents; to serve as a bridge between in vitro and in vivo rodent, or preferably human, data; or to be used to provide dose response information for quantitative risk assessment was also addressed. A summary of the workshop and links to the scientific presentations are provided. Environ. Mol. Mutagen. 56:277-285, 2015. (c) 2014 Wiley Periodicals, Inc.	[Zeiger, Errol] Errol Zeiger Consulting, Chapel Hill, NC 27514 USA; [Gollapudi, Bhaskar; Boverhof, Darrell] Dow Chem Co USA, Midland, MI 48674 USA; [Aardema, Marilyn J.] BioReliance Corp, Marilyn Aardema Consulting LLC, Rockville, MD USA; [Auerbach, Scott; Tice, Raymond; Witt, Kristine L.] NIEHS, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Custer, Laura] Bristol Myers Squibb Co, Dept Genet Toxicol, New York, NY 10154 USA; [Dedon, Peter] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Honma, Masamitsu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Tokyo, Japan; [Ishida, Seiichi] Natl Inst Hlth Sci, Div Pharmacol, Tokyo, Japan; [Kasinski, Andrea L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Kim, James H.; Tanir, Jennifer Y.] ILSI Hlth & Environm Sci Inst, Washington, DC USA; [Manjanatha, Mugimane G.; Pogribny, Igor; Slikker, William] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Marlowe, Jennifer] Novartis, Cambridge, MA USA; [Pfuhler, Stefan] Procter & Gamble Co, Cincinnati, OH USA; [Stankowski, Leon F., Jr.] BioReliance Corp, Rockville, MD USA; [van Benthem, Jan] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [White, Paul] Hlth Canada, Environm Hlth Sci & Res Div, Ottawa, ON K1A 0L2, Canada; [Thybaud, Veronique] Sanofi, Vitry Alfortville Res Ctr, Vitry Sur Seine, France	Zeiger, E (reprint author), Errol Zeiger Consulting, Chapel Hill, NC 27514 USA.	zeiger@nc.rr.com	Kasinski, Andrea/E-7951-2014; 	Dedon, Peter/0000-0003-0011-3067	ILSI/HESI IVGT committee	The organizing committee is grateful to the researchers who agreed to participate in this Workshop. In addition, the support of the ILSI/HESI staff, particularly Eric Moore, was invaluable for the organization, logistics, and day-to-day running of the Workshop. The authors also thank the ILSI/HESI IVGT committee for its financial and intellectual support.	Gollapudi BB, 2013, ENVIRON MOL MUTAGEN, V54, P8, DOI 10.1002/em.21727; Johnson GE, 2014, ENVIRON MOL MUTAGEN, V55, P609, DOI 10.1002/em.21870; Lynch AM, 2011, ENVIRON MOL MUTAGEN, V52, DOI 10.1002/em.20614	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	APR	2015	56	3					277	285		10.1002/em.21923		9	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CE4BZ	WOS:000351777100001		
J	Fujii, Y; Sakurada, T; Harada, KH; Koizumi, A; Kimura, O; Endo, T; Haraguchi, K				Fujii, Yukiko; Sakurada, Tsukasa; Harada, Kouji H.; Koizumi, Akio; Kimura, Osamu; Endo, Tetsuya; Haraguchi, Koichi			Long-chain perfluoroalkyl carboxylic acids in Pacific cods from coastal areas in northern Japan: A major source of human dietary exposure	ENVIRONMENTAL POLLUTION			English	Article						Perfluoroalkyl carboxylic acids; Perfluorooctanoic acid; Sea fish; Japan; Human dietary intake	PERFLUORINATED COMPOUNDS; TEMPORAL TRENDS; TISSUE DISTRIBUTION; BREAST-MILK; FRESH-WATER; SERUM; SAMPLES; FISH; SUBSTANCES; CONSUMPTION	This study investigates perfluoroalkyl carboxylic acids (PFCAs) contamination of edible fish muscle from Japanese coastal waters. The concentrations of PFCAs with 8-14 carbon atoms (C8-C14) in Pacific cods in Hokkaido, Japan were 51 (median: pg/g-wet weight) for C8, 93 for C9, 99 for C10, 746 for 01, 416 for C12, 404 for C13, and 93 for C14. The levels of C9-C14 PFCAs in fish were strongly correlated to each other, but not to C8 and the other chlorinated persistent organic pollutants, indicating that C9-C14 PFCAs have a different emission source and/or bioaccumulation mechanism. The relative ratios between estimated PFCAs intake through fish consumption and the reported total dietary exposure of PFCAs were less than 1 for C8 to C9, but were more than 1 for C10 to C14. This result strongly suggests that fish consumption is a significant source of human dietary exposure to C10-C14 PFCAs. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujii, Yukiko; Sakurada, Tsukasa; Haraguchi, Koichi] Daiichi Univ Pharm, Minami Ku, Fukuoka 8158511, Japan; [Harada, Kouji H.; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kimura, Osamu; Endo, Tetsuya] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, Ishikari, Hokkaido 0610293, Japan	Haraguchi, K (reprint author), Daiichi Univ Pharm, Minami Ku, Fukuoka 8158511, Japan.	k-haraguti@daiichi-cps.ac.jp			JSPS KAKENHI [26881008, 24310049]	This work was supported by JSPS KAKENHI Grant Numbers 26881008 (Y. F.) and 24310049 (K.H.). The funding bodies had no role in the study design, data collection or analysis, or in decisions concerning the preparation and publication of the manuscript. The authors have no financial conflicts of interest.	Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P196; Lau C, 2004, TOXICOL APPL PHARM, V198, P231, DOI 10.1016/j.taap.2003.11.031; Harada KH, 2011, ENVIRON INT, V37, P1183, DOI 10.1016/j.envint.2011.04.011; Fujii Y, 2012, CHEMOSPHERE, V86, P315, DOI 10.1016/j.chemosphere.2011.10.035; Jones PD, 2003, ENVIRON TOXICOL CHEM, V22, P2639, DOI 10.1897/02-553; Berger U, 2009, CHEMOSPHERE, V76, P799, DOI 10.1016/j.chemosphere.2009.04.044; Fujii Y, 2012, ENVIRON SCI TECHNOL, V46, P11235, DOI 10.1021/es302536g; Okada E, 2013, ENVIRON INT, V60, P89, DOI 10.1016/j.envint.2013.07.013; Reiner JL, 2012, ANAL BIOANAL CHEM, V404, P2683, DOI 10.1007/s00216-012-5943-5; Wu YN, 2012, ENVIRON INT, V42, P67, DOI 10.1016/j.envint.2011.04.007; Fujii Y, 2013, CHEMOSPHERE, V93, P538, DOI 10.1016/j.chemosphere.2013.06.049; Zhao YG, 2011, CHEMOSPHERE, V85, P277, DOI 10.1016/j.chemosphere.2011.06.002; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Haraguchi K, 2009, ENVIRON INT, V35, P1072, DOI 10.1016/j.envint.2009.06.003; Haug LS, 2009, ENVIRON SCI TECHNOL, V43, P2131, DOI 10.1021/es802827u; Murakami M, 2011, ARCH ENVIRON CON TOX, V61, P631, DOI 10.1007/s00244-011-9660-4; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Vestergren R, 2012, J CHROMATOGR A, V1237, P64, DOI 10.1016/j.chroma.2012.03.023; Corsini E, 2012, TOXICOL APPL PHARM, V258, P248, DOI 10.1016/j.taap.2011.11.004; Hart K, 2008, SCI TOTAL ENVIRON, V403, P215, DOI 10.1016/j.scitotenv.2008.05.035; Hlouskova V, 2013, SCI TOTAL ENVIRON, V461, P88, DOI 10.1016/j.scitotenv.2013.04.081; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Olsen GW, 2007, CHEMOSPHERE, V68, P105, DOI 10.1016/j.chemosphere.2006.12.031; Zhang LY, 2013, ENVIRON SCI TECHNOL, V47, P11293, DOI 10.1021/es4026722; Chimura M., 2014, MARINE FISHERIES STO, P868; Fujii Y, 2014, ENVIRON POLLUT, V185, P228, DOI 10.1016/j.envpol.2013.11.002; Fujii Y., 2015, J OCCUP HLTH; Hattori T., 1994, HOKKAIDO U COLLECTIO; Ministry of Health Labour and Welfare, 2012, NAT HLTH NUTR SURV; Mishima S., 1989, N PAC FISH COMMUN B, V42, P180; Renner R, 2001, SCI AM, P284	31	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	APR	2015	199						35	41		10.1016/j.envpol.2015.01.007		7	Environmental Sciences	Environmental Sciences & Ecology	CE6UE	WOS:000351972900005		
J	Takahara, T; Endo, S; Takada, M; Oba, Y; Nursal, WI; Igawa, T; Doi, H; Yamada, T; Okuda, T				Takahara, Teruhiko; Endo, Satoru; Takada, Momo; Oba, Yurika; Nursal, Wim Ikbal; Igawa, Takeshi; Doi, Hideyuki; Yamada, Toshihiro; Okuda, Toshinori			Radiocesium accumulation in the anuran frog, Rana tagoi tagoi, in forest ecosystems after the Fukushima Nuclear Power Plant accident	ENVIRONMENTAL POLLUTION			English	Article						Contamination; FNPP; Forest floor; Radioactivity; Tago's brown frog	CONTAMINATION; FISH	Amphibians are key components in forest food webs. When examining radioactive contamination in anurans, it is important to understand how radiocesium transfer occurs from lower to higher trophic levels in forest ecosystems. We investigated the activity concentration of radiocesium (Cs-134 and Cs-137) in Tago's brown frog (Rana tagoi tagoi) captured on the forest floor approximately 2.5 years after the Fukushima Nuclear Power Plant (FNPP) accident. We collected 66 R. tagoi tagoi at different distances from the FNPP. Radiocesium accumulation showed positive correlations with the air radiation dose rate and litter contamination but not with distance from the FNPP. Whole-body radioactivity showed no correlation with body mass or length. Our results suggest that differences in the available food items result in large variability in individual contamination. Contamination level monitoring in terrestrial and aquatic amphibian is necessary for clarifying the processes and mechanisms of radiocesium transfer through forest food webs. (C) 2015 Elsevier Ltd. All rights reserved.	[Takahara, Teruhiko; Takada, Momo; Oba, Yurika; Nursal, Wim Ikbal; Yamada, Toshihiro; Okuda, Toshinori] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima, Hiroshima 7398521, Japan; [Endo, Satoru] Hiroshima Univ, Grad Sch Engn, Higashihiroshima, Hiroshima 7398527, Japan; [Igawa, Takeshi] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima, Hiroshima 7398529, Japan; [Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Hiroshima 7398530, Japan	Takahara, T (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Higashihiroshima, Hiroshima 7398521, Japan.	takahara@hiroshima-u.ac.jp	Igawa, Takeshi/E-2881-2014	Igawa, Takeshi/0000-0001-6880-6180	Phoenix Leader Education Program (Hiroshima Initiative) for Renaissance from Radiation Disaster, Organization of the Leading Graduate Education Program	We thank the Iwaki District Forest Office for supporting our field survey. We thank Drs. T. Gomi and M. Sakai at Tokyo University of Agriculture and Technology for their useful comments for sample treatments. We are also grateful to Drs. H. Deguchi, E. Oguri, M. Ishitani, and H. Hanada at Hiroshima University for their kind advice regarding the study topic. This study was supported by Phoenix Leader Education Program (Hiroshima Initiative) for Renaissance from Radiation Disaster, Organization of the Leading Graduate Education Program.	Metts BS, 2013, ENVIRON SCI TECHNOL, V47, P2846, DOI 10.1021/es303989u; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Ayabe Y, 2014, J ENVIRON RADIOACTIV, V127, P105, DOI 10.1016/j.jenvrad.2013.10.010; Fukushima T, 2014, INLAND WATERS, V4, P204, DOI 10.5268/IW-4.2.689; Goris RC, 2004, GUIDE AMPHIBIANS REP; Hasegawa M, 2013, J ENVIRON RADIOACTIV, V126, P8, DOI 10.1016/j.jenvrad.2013.06.006; Hayama S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068530; Igawa T., 2015, CURR HERPETOL, V34, P1; Iguchi K, 2013, FISHERIES SCI, V79, P983, DOI 10.1007/s12562-013-0666-x; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; R Core Team, 2014, R LANG ENV STAT COMP; Regester KJ, 2006, OECOLOGIA, V147, P303, DOI 10.1007/s00442-005-0266-2; Sakai M, 2014, ENVIRON POLLUT, V187, P112, DOI 10.1016/j.envpol.2014.01.002; SHIZUMA K, 1992, NUCL INSTRUM METH B, V66, P459, DOI 10.1016/0168-583X(92)95419-R; Stark K, 2004, J ENVIRON RADIOACTIV, V75, P1, DOI 10.1016/j.jenvrad.2003.12.011; Sumida M, 2002, MOL PHYLOGENET EVOL, V25, P293, DOI 10.1016/S1055-7903(02)00243-9; Unrine JM, 2007, ENVIRON POLLUT, V149, P182, DOI 10.1016/j.envpol.2007.01.039; Venables W.N., 2002, STAT COMPLEMENTS MOD; Yamamoto S, 2014, J FISH BIOL, V84, P1607, DOI 10.1111/jfb.12368; Yoshimura M, 2014, HYDROBIOLOGIA, V722, P19, DOI 10.1007/s10750-013-1672-9	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	APR	2015	199						89	94		10.1016/j.envpol.2015.01.018		6	Environmental Sciences	Environmental Sciences & Ecology	CE6UE	WOS:000351972900012		
J	Septiningrum, K; Ohi, H; Waeonukul, R; Pason, P; Tachaapaikoon, C; Ratanakhanokchai, K; Sermsathanaswadi, J; Deng, L; Prawitwong, P; Kosugi, A				Septiningrum, Krisna; Ohi, Hiroshi; Waeonukul, Rattiya; Pason, Patthra; Tachaapaikoon, Chakrit; Ratanakhanokchai, Khanok; Sermsathanaswadi, Junjarus; Deng, Lan; Prawitwong, Panida; Kosugi, Akihiko			The GH67 alpha-glucuronidase of Paenibacillus curdlanolyticus B-6 removes hexenuronic acid groups and facilitates biodegradation of the model xylooligosaccharide hexenuronosyl xylotriose	ENZYME AND MICROBIAL TECHNOLOGY			English	Article						Hexenuronic acid; alpha-Glucuronidase; GH67; Hexenuronosyl xylotriose; Paenibacillus curdlanolyticus	KRAFT PULPS; GEOBACILLUS-STEAROTHERMOPHILUS; ASPERGILLUS-TUBINGENSIS; DELIGNIFICATION; DEGRADATION; SUBSTRATE; GLCA67A; ECF	4-O-Methylglucuronic acid (MeGlcA) side groups attached to the xylan backbone through alpha-1,2 linkages are converted to hexenuronic acid (HexA) during alkaline pulping. alpha-Glucuronidase (EC 3.2.1.139) hydrolyzes 1,2-linked MeGlcA from xylooligosaccharides. To determine whether alpha-glucuronidase can also hydrolyze HexA-decorated xylooligosaccharides, a gene encoding alpha-glucuronidase (AguA) was cloned from Paenibacillus curdlanolyticus B-6. The purified protein degraded hexenuronosyl xylotriose (Delta X3), a model substrate prepared from kraft pulp. AguA released xylotriose and HexA from Delta X3, but the V-max and k(cat) values for Delta X3 were lower than those for MeGlcA, indicating that HexA side groups may affect the hydrolytic activity. To explore the potential for biological bleaching, Delta X3 degradation was performed using intracellular extract from P. curdlanolyticus B-6. The intracellular extract, with synergistic a-glucuronidase and beta-xylosidase activities, degraded Delta X3 to xylose and HexA. These results indicate that a-glucuronidase can be used to remove HexA from Delta X3 derived from pulp, reducing the need for chemical treatments in the pulping process. (C) 2015 Elsevier Inc. All rights reserved.	[Septiningrum, Krisna; Ohi, Hiroshi; Kosugi, Akihiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Septiningrum, Krisna; Deng, Lan; Prawitwong, Panida; Kosugi, Akihiko] Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki 3058686, Japan; [Waeonukul, Rattiya; Pason, Patthra; Tachaapaikoon, Chakrit] King Mongkuts Univ Technol Thonburi, Pilot Plant Dev & Training Inst, Bangkok 10150, Thailand; [Ratanakhanokchai, Khanok] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok 10150, Thailand; [Sermsathanaswadi, Junjarus] Suan Dusit Rajabhat Univ, Fac Sci & Technol, Dept Chem Technol, Bangkok 10300, Thailand	Kosugi, A (reprint author), Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan.	akosugi@affrc.go.jp			Japan Educational Exchanges and Services Sponsored Scholarship (JEES) from Mitsubishi Cooperation [MITUS1306]	We would like to thank Dr. Shigeki Yoshida (University of Tsukuba, Ibaraki, Japan) for providing authentic Delta X3. K. Septiningrum was supported by a Japan Educational Exchanges and Services Sponsored Scholarship (JEES) (MITUS1306) from Mitsubishi Cooperation.	Nelson N, 1944, J BIOL CHEM, V153, P375; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; [Anonymous], 2003, TAPPI J; [Anonymous], 1988, METHOD ENZYMOL; Cadena EM, 2010, BIORESOURCE TECHNOL, V101, P3554, DOI 10.1016/j.biortech.2009.11.105; Valls C, 2010, BIOCHEM ENG J, V49, P401, DOI 10.1016/j.bej.2010.02.002; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; BERG B, 1972, J APPL BACTERIOL, V35, P201, DOI 10.1111/j.1365-2672.1972.tb03691.x; Valls C, 2009, BIORESOURCE TECHNOL, V100, P2032, DOI 10.1016/j.biortech.2008.10.009; Shatalov AA, 2004, CELLULOSE, V11, P109, DOI 10.1023/B:CELL.0000014770.83387.75; Zaide G, 2001, EUR J BIOCHEM, V268, P3006, DOI 10.1046/j.1432-1327.2001.02193.x; Shallom D, 2004, J BACTERIOL, V186, P6928, DOI 10.1128/JB.186.20.6928-6937.2004; Nagy T, 2003, J BIOL CHEM, V278, P20286, DOI 10.1074/jbc.M302205200; Takahashi S, 2011, J WOOD SCI, V57, P27, DOI 10.1007/s10086-010-1143-0; Biely P, 2000, BBA-GEN SUBJECTS, V1474, P360, DOI 10.1016/S0304-4165(00)00029-5; Valls C, 2010, PROCESS BIOCHEM, V45, P425, DOI 10.1016/j.procbio.2009.10.015; Vuorinen T, 1999, J PULP PAP SCI, V25, P155; BRONNENMEIER K, 1995, MICROBIOL-SGM, V141, P2033; BUCHERT J, 1995, TAPPI J, V78, P125; de Vries RP, 1998, J BACTERIOL, V180, P243; Granstrom A, 2001, NORD PULP PAP RES J, V16, P18; JOHANSSON MH, 1977, CARBOHYD RES, V54, P295, DOI 10.1016/S0008-6215(00)84821-1; Li J, 1988, NORD PULP PAP RES J, V13, P153; Milner Y., 1967, CARBOHYD RES, V4, P359, DOI DOI 10.1016/S0008-6215(00)80191-3; Nagy T, 2002, J BACTERIOL, V184, P4925, DOI 10.1128/JB.184.17.4925-4929.2002; Pason P, 2006, APPL ENVIRON MICROB, V72, P2483, DOI 10.1128/AEM.72.4.2483-2490.2006; Pason P, 2010, APPL MICROBIOL BIOT, V85, P573, DOI 10.1007/s00253-009-2117-2; Simao JPF, 2005, IND ENG CHEM RES, V44, P2990, DOI 10.1021/ie049062e; SIMKOVIC I, 1986, CARBOHYD RES, V152, P131, DOI 10.1016/S0008-6215(00)90293-3; WARREN L, 1960, NATURE, V186, P237, DOI 10.1038/186237a0; Winyasuk W., 2012, International Journal of Agricultural Technology, V8, P103	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-0229	1879-0909		ENZYME MICROB TECH	Enzyme Microb. Technol.	APR	2015	71						28	35		10.1016/j.enzmictec.2015.01.006		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CE4IL	WOS:000351794200005		
J	Bosch, M; Esteban-Pretel, J				Bosch, Mariano; Esteban-Pretel, Julen			The labor market effects of introducing unemployment benefits in an economy with high informality	EUROPEAN ECONOMIC REVIEW			English	Article						Informal economy; Search models; Labor markets; Unemployment benefits; Mexico	EQUILIBRIUM UNEMPLOYMENT; CYCLICAL BEHAVIOR; JOB DESTRUCTION; ENFORCEMENT; VACANCIES; INSURANCE; CREATION; COSTS	Unemployment benefit systems are nonexistent in many developing economies. Introducing such systems poses many challenges which are partly due to the high level of informality in the labor markets of these economies. This paper studies the consequences on the labor market of implementing an unemployment benefit system in economies with large informal sectors and high flows of workers between formality and informality. We build a search and matching model with endogenous destruction, on-the-job search, and intersectoral flows, where agents in the economy decide optimally whether or not to formalize jobs. We calibrate the model for Mexico, and show that the introduction of an unemployment benefit system, where workers contribute when employed in the formal market and collect benefits when they lose their jobs, even if they obtain informal jobs, can lead to an increase in formality in the economy, while also producing small increases in unemployment. The exact impact of incorporating such benefits depends on the relative strength of two opposing effects: the generosity of the benefits and the level of the contributions that finance those benefits. We also show important policy complementarities with other interventions in the labor market. In particular, combining the unemployment benefit program with policies that reduce the cost of formality, such as lower employment taxes and firing costs, can produce greater decreases in informality and lower impacts on unemployment than when the program is applied in isolation. (C) 2014 Elsevier B.V. All rights reserved.	[Bosch, Mariano] Interamer Dev Bank, Labor Markets & Social Secur Unit, Washington, DC USA; [Esteban-Pretel, Julen] CUNY Queens Coll, Dept Econ, Queens, NY 11367 USA; [Esteban-Pretel, Julen] Natl Grad Inst Policy Studies GRIPS, Tokyo, Japan	Esteban-Pretel, J (reprint author), CUNY Queens Coll, Dept Econ, Powdermaker Hall,65-30 Kissena Blvd, Queens, NY 11367 USA.	mbosch@iadb.org; julen.esteban@qc.cuny.edu			Japanese Ministry of Education [24330063]; Policy Research Center at the National Graduate Institute for Policy Studies; IDB Economic and Sector Work [RG-1248]	We thank Veronica Alaimo, James Albrecht, Jesus Fernandez-Villaverde, Hugo Hopenhayn and David Kaplan, participants at the Experts workshop on unemployment protection systems in high informality countries at the Inter-American Development Bank (IDB), and two anonymous referees, for comments and suggestions. We respectively acknowledge financial support for this project by the Japanese Ministry of Education through the Grant-in-Aid for Scientific Research (Grant no. 24330063), from the Policy Research Center at the National Graduate Institute for Policy Studies, and the IDB Economic and Sector Work RG-1248. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the Inter-American Development Bank, its Board of Directors, or the countries they represent.	Alvarez-Parra F, 2009, J MONETARY ECON, V56, P954, DOI 10.1016/j.jmoneco.2009.09.006; Kugler AD, 1999, INT TAX PUBLIC FINAN, V6, P389, DOI 10.1023/A:1008711819429; MORTENSEN DT, 1994, REV ECON STUD, V61, P397, DOI 10.2307/2297896; Petrongolo B, 2001, J ECON LIT, V39, P390, DOI 10.1257/jel.39.2.390; Fiess NM, 2010, J DEV ECON, V91, P211, DOI 10.1016/j.jdeveco.2009.09.009; Albrecht J, 2009, ECON J, V119, P1105; Acemoglu D, 1999, J POLIT ECON, V107, P893, DOI 10.1086/250084; Bosch M, 2012, J DEV ECON, V98, P270, DOI 10.1016/j.jdeveco.2011.08.004; Cahuc P, 2000, J PUBLIC ECON, V77, P135, DOI 10.1016/S0047-2727(99)00063-8; Almeida R, 2009, J COMP ECON, V37, P28, DOI 10.1016/j.jce.2008.09.004; Antunes AR, 2007, EUR ECON REV, V51, P203, DOI 10.1016/j.euroecorev.2005.11.008; Shimer R, 2005, AM ECON REV, V95, P25, DOI 10.1257/0002828053828572; Zenou Y, 2008, J DEV ECON, V86, P336, DOI 10.1016/j.jdeveco.2007.06.009; Hagedorn M, 2008, AM ECON REV, V98, P1692, DOI 10.1257/aer.98.4.1692; Anton A., 2012, WORKING PAPER SERIES; Boeri T., 2006, CEPR DISCUSSION PAPE; Bosch, 2006, CEP DISC PAP; Bosch M., 2012, MEASURING COST UNPUB; Bosch M., 2004, START COSTS IN UNPUB; Bosch M., 2008, 3514 IZA; Finkelstein-Shapiro A., 2012, WORKING PAPER SERIES, VWP-385; Fugazza M, 2004, J PUBLIC ECON, V88, P395, DOI 10.1016/S0047-2727(02)00079-8; ILO, 2000, WORLD LAB REP 2000 I; Loayza N.V., 2006, POLICY RESEARCH WORK, V4078; Margolis D.N., 2012, IZA DISCUSSION PAPER; Meghir C, 2012, NBER WORKING PAPERS; Pages C, 2009, J COMP ECON, V37, P387, DOI 10.1016/j.jce.2009.05.002; PISSARIDES CA, 1983, REV ECON STUD, V50, P57, DOI 10.2307/2296954; Ulyssea G, 2010, J DEV ECON, V91, P87, DOI 10.1016/j.jdeveco.2009.07.001	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2921	1873-572X		EUR ECON REV	Eur. Econ. Rev.	APR	2015	75						1	17		10.1016/j.euroecorev.2014.10.010		17	Economics	Business & Economics	CE7QX	WOS:000352038000001		
J	Sato, Y; Zenou, Y				Sato, Yasuhiro; Zenou, Yves			How urbanization affect employment and social interactions	EUROPEAN ECONOMIC REVIEW			English	Article						Weak ties; Strong ties; Urban Economics; Labor market	RESIDENTIAL SEGREGATION; DYNAMIC-MODELS; LABOR-MARKETS; WEAK TIES; NETWORKS; SECTOR; UNEMPLOYMENT; GEOGRAPHY; CREATION; URBANISM	We develop a model where the unemployed workers in the city can find a job either directly or through weak or strong ties. We show that, in denser areas, individuals choose to interact with more people and meet more random encounters (weak ties) than in sparsely populated areas. We also demonstrate that, for a low urbanization level, there is a unique steady-state equilibrium where workers do not interact with weak ties, while, for a high level of urbanization, there is a unique steady-state equilibrium with full social interactions. We show that these equilibria are usually not socially efficient when the urban population has an intermediate size because there are too few social interactions compared to the social optimum. Finally, even when social interactions are optimal, we show that there is over-urbanization in equilibrium. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Yasuhiro] Osaka Univ, Suita, Osaka 565, Japan; [Zenou, Yves] Univ Stockholm, IFN, S-10691 Stockholm, Sweden; [Zenou, Yves] CEPR, London, England	Zenou, Y (reprint author), Univ Stockholm, IFN, S-10691 Stockholm, Sweden.	ysato@econ.osaka-u.ac.jp; yves.zenou@ne.su.se			Japan Society for the Promotion of Science; French National Research Agency [ANR-2011-BSH1-014-01]	We thank the editor, Joerg Oechssler, an associate editor, two anonymous referees, Keisuke Kawata, Akihiko Matsui, Hiroshi Ohashi, Pascal Mossay, Yasuyuki Sawada, Takatoshi Tabuchi, Kenichi Ueda, Noriyuki Yanagawa, and the participants of various seminars and conferences for very useful comments and discussions. This study was conducted as a part of the Project "Spatial Economic Analysis on Regional Growth" undertaken at the Research Institute of Economy, Trade and Industry (RIETI). We acknowledge the financial support from the Japan Society for the Promotion of Science through a Grant-in-Aid for Young Scientists (B). Yves Zenou gratefully acknowledges the financial support from the French National Research Agency grant ANR-2011-BSH1-014-01.	AMATO PR, 1993, SOC PSYCHOL QUART, V56, P249, DOI 10.2307/2786662; Ciccone A, 1996, AM ECON REV, V86, P54; Hellerstein JK, 2011, J LABOR ECON, V29, P659, DOI 10.1086/660776; Zenou Y, 2013, J URBAN ECON, V74, P113, DOI 10.1016/j.jue.2012.11.002; Topa G, 2001, REV ECON STUD, V68, P261, DOI 10.1111/1467-937X.00169; Desmond M, 2012, AM J SOCIOL, V117, P1295, DOI 10.1086/663574; Cattell V, 2001, SOC SCI MED, V52, P1501, DOI 10.1016/S0277-9536(00)00259-8; Brueckner JK, 2008, J URBAN ECON, V64, P18, DOI 10.1016/j.jue.2007.08.002; WELLMAN B, 1979, AM J SOCIOL, V84, P1201, DOI 10.1086/226906; Zenou Y, 2011, J DEV ECON, V96, P174, DOI 10.1016/j.jdeveco.2010.11.001; Ballester C, 2006, ECONOMETRICA, V74, P1403, DOI 10.1111/j.1468-0262.2006.00709.x; Marcouiller D, 1997, ECON DEV CULT CHANGE, V45, P367, DOI 10.1086/452278; Calvo-Armengol A, 2004, AM ECON REV, V94, P426, DOI 10.1257/0002828041464542; Mossay P, 2011, J ECON THEORY, V146, P2455, DOI 10.1016/j.jet.2011.06.009; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143; Patacchini E, 2012, REG SCI URBAN ECON, V42, P938, DOI 10.1016/j.regsciurbeco.2012.01.004; Akerlof GA, 1997, ECONOMETRICA, V65, P1005, DOI 10.2307/2171877; Calvo-Armengol A, 2007, J PUBLIC ECON, V91, P203, DOI 10.1016/j.jpubeco.2006.05.011; Calvo-Armengol A, 2009, REV ECON STUD, V76, P1239, DOI 10.1111/j.1467-937X.2009.00550.x; Wahba J, 2005, J DEV ECON, V78, P443, DOI 10.1016/jj.deveco.2004.11.006; Zhang JF, 2004, J ECON BEHAV ORGAN, V54, P533, DOI 10.1016/j.jebo.2003.03.005; Helsley RW, 2007, J ECON GEOGR, V7, P119, DOI 10.1093/jeg/lbl027; Wirth L, 1938, AM J SOCIOL, V44, P1, DOI 10.1086/217913; Maloney WF, 1999, WORLD BANK ECON REV, V13, P275; Helsley RW, 2014, J ECON THEORY, V150, P426, DOI 10.1016/j.jet.2013.09.009; HARRIS JR, 1970, AM ECON REV, V60, P126; Bayer P., 2008, J POLITICAL EC, V116, P1150; Beckmann M.J., 1976, MATH LAND USE THEORY, P117; Blien U, 2006, LABOUR ECON, V13, P445, DOI 10.1016/j.labeco.2006.02.004; Brueckner JK, 2002, INT ECON REV, V43, P155, DOI 10.1111/1468-2354.t01-1-00007; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Combes P. -P., 2010, AGGLOMERATION EC, P15; Combes P.-P., 2015, HDB REGIONAL URBAN E, V5; Essletzbichler J, 2007, EUR URBAN REG STUD, V14, P7, DOI 10.1177/0969776406068589; Essletzbichler J, 2004, ANN ASSOC AM GEOGR, V94, P602, DOI 10.1111/j.1467-8306.2004.00416.x; Faberman J., 2005, 386 US BUR LAB STAT; Fischer Claude S., 1982, DWELL FRIENDS PERSON; Fujita M, 2013, EC AGGLOMERATION CIT; Ghiglino C., 2012, VEBLEN MEETS K UNPUB; Glaeser E., 2010, AGGLOMERATION EC; Glaeser E.L., 1996, Q J ECON, V111, P508; Granovetter M., 1974, GETTING JOB STUDY CO; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI DOI 10.2307/202051; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Grauwin S, 2012, J PUBLIC ECON, V96, P124, DOI 10.1016/j.jpubeco.2011.08.011; Yamada G, 1996, ECON DEV CULT CHANGE, V44, P289, DOI 10.1086/452214; Hilber C.A.L., 2009, REG STUD, V44, P355; Ioannides Y. M., 2004, J ECON LIT, V42, P1056; Jacobs J, 1969, EC CITIES; KORTE C, 1980, J SOC ISSUES, V36, P29; LIN N, 1986, SOC NETWORKS, V8, P365, DOI 10.1016/0378-8733(86)90003-1; loannides Y. M., 2012, NEIGHBORHOODS NATION; Marshall A., 1890, PRINCIPLES EC; Micucci G, 2009, SPAT ECON ANAL, V4, P391, DOI 10.1080/17421770903317637; Mitra A., 2007, REV URBAN REGIONAL D, V19, P197, DOI [10.1111/j.1467-940X.2007.00136.x, DOI 10.1111/J.1467-940X.2007.00136.X]; Mossay P., 2013, SPATIAL SEGREG UNPUB; PALISI BJ, 1986, SOCIOL SPECTRUM, V6, P361; Pissarides C., 2000, EQUILIBRIUM UNEMPLOY; Putnam R. D., 2001, BOWLING ALONE; Putnam RD, 1993, MAKING DEMOCRACY WOR; Rosenthal S., 2004, HDB URBAN REGIONAL E, V4, P2119; Simmel G., 1995, METROPOLIS CTR SYMBO, P30; Tonnies F., 1957, COMMUNITY SOC; Ioannides YM, 2010, J REGIONAL SCI, V50, P343, DOI 10.1111/j.1467-9787.2009.00638.x; Tops G., 2015, HDB REGIONAL URBAN E, V5; Zenou Y., 2015, J LABOR EC IN PRESS	66	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2921	1873-572X		EUR ECON REV	Eur. Econ. Rev.	APR	2015	75						131	155		10.1016/j.euroecorev.2015.01.011		25	Economics	Business & Economics	CE7QX	WOS:000352038000008		
J	Nakanuma, S; Miyashita, T; Hayashi, H; Tajima, H; Takamura, H; Tsukada, T; Okamoto, K; Sakai, S; Makino, I; Kinoshita, J; Nakamura, K; Oyama, K; Inokuchi, M; Nakagawara, H; Ninomiya, I; Kitagawa, H; Fushida, S; Fujimura, T; Ohta, T				Nakanuma, Shinichi; Miyashita, Tomoharu; Hayashi, Hironori; Tajima, Hidehiro; Takamura, Hiroyuki; Tsukada, Tomoya; Okamoto, Koichi; Sakai, Seisho; Makino, Isamu; Kinoshita, Jun; Nakamura, Keishi; Oyama, Katsunobu; Inokuchi, Masafumi; Nakagawara, Hisatoshi; Ninomiya, Itasu; Kitagawa, Hirohisa; Fushida, Sachio; Fujimura, Takashi; Ohta, Tetsuo			Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						platelet; aggregation; cluster of differentiation 42b; sinusoidal obstruction syndrome; veno-occlusive disease; liver transplantation	HEPATIC VENOOCCLUSIVE DISEASE; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; OF-THE-LITERATURE; GROWTH-FACTOR; SIALIC-ACID; REGENERATION; HEPATOCYTES; CILOSTAZOL; REJECTION	Sinusoidal obstruction syndrome (SOS), previously known as veno-occlusive disease, is relatively rare subsequent to liver transplantation (LT). SOS refractory to medical therapy, however, can result in centrilobular fibrosis, portal hypertension and liver failure. Although sinusoidal endothelial cell damage around central venules (zone 3) occurs early in the development of SOS, the detailed mechanism of SOS development and its association with thrombocytopenia are not yet completely understood. The present report describes a patient who experienced SOS with unexplained thrombocytopenia following living donor LT. The progression of SOS resulted in graft dysfunction and the patient succumbed. The presence of platelets in the liver allograft was assayed immunohistochemically using antibody to the platelet marker cluster of differentiation 42b (platelet glycoprotein Ib). Platelet aggregates were found attached to hepatocytes along the sinusoid and within the cytoplasm of hepatocytes, particularly in zone 3. By contrast, no staining was observed in zone 1. These findings suggested that extravasated platelet aggregation in the space of Disse and the phagocytosis of platelets by hepatocytes were initiated by sinusoidal endothelial cell damage due to the toxicity of the immunosuppressant tacrolimus or a corticosteroid pulse, and that platelet activation and degranulation may be at least partially involved in the mechanism responsible for SOS.	[Nakanuma, Shinichi; Miyashita, Tomoharu; Hayashi, Hironori; Tajima, Hidehiro; Takamura, Hiroyuki; Tsukada, Tomoya; Okamoto, Koichi; Sakai, Seisho; Makino, Isamu; Kinoshita, Jun; Nakamura, Keishi; Oyama, Katsunobu; Inokuchi, Masafumi; Nakagawara, Hisatoshi; Ninomiya, Itasu; Kitagawa, Hirohisa; Fushida, Sachio; Fujimura, Takashi; Ohta, Tetsuo] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Nakanuma, S (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Surg Gastroenterol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	n_shin@gj8.so-net.ne.jp					Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001; Iba T, 2006, SHOCK, V26, P522, DOI 10.1097/01.shk.0000228800.56223.db; MARS WM, 1993, AM J PATHOL, V143, P949; Zhang LF, 2012, CLIN TRANSPLANT, V26, P511, DOI 10.1111/j.1399-0012.2012.01604.x; Salat C, 1997, BLOOD, V89, P2184; Ribero D, 2007, CANCER, V110, P2761, DOI 10.1002/cncr.23099; Campos-Varela I, 2012, LIVER TRANSPLANT, V18, P201, DOI 10.1002/lt.22351; SHULMAN HM, 1987, AM J PATHOL, V127, P549; Ueda S, 2003, LAB INVEST, V83, P1595, DOI 10.1097/01.LAB.0000095686.10639.C8; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Coppell JA, 2003, BLOOD REV, V17, P63, DOI 10.1016/S0268-960X(03)00002-X; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; Brech A, 1998, BBA-BIOMEMBRANES, V1373, P195, DOI 10.1016/S0005-2736(98)00104-7; Chen H, 2014, EXP THER MED, V7, P141, DOI 10.3892/etm.2013.1401; Golebiewska EM, 2014, BLOOD REV, DOI [10.1016/j.blre.2014.10.003, DOI 10.1016/J.BLRE.2014.10.003, 10.1016/j.blre.2014.10.00325468720]; Jung SM, 2008, PLATELETS, V19, P32, DOI 10.1080/09537100701609027; Kitajima K, 2010, CLIN TRANSPLANT, V24, P139, DOI 10.1111/j.1399-0012.2009.00971.x; MAK KM, 1984, HEPATOLOGY, V4, P386, DOI 10.1002/hep.1840040306; Membreno FE, 2008, CLIN TRANSPLANT, V22, P397, DOI 10.1111/j.1399-0012.2008.00814.x; MOHAMMAD SF, 1981, AM J PATHOL, V104, P132; Oh H, 1998, BONE MARROW TRANSPL, V22, P675, DOI 10.1038/sj.bmt.1701402; Parenti A, 2002, CARDIOVASC RES, V55, P201, DOI 10.1016/S0008-6363(02)00326-7; Pihusch V, 2005, THROMB RES, V116, P233, DOI 10.1016/j.thromres.2004.12.010; Ruan ZH, 2004, PROSTAG OTH LIPID M, V73, P73, DOI 10.1016/j.prpostaglandins.2003.11.002; Sebagh M, 1999, HEPATOLOGY, V30, P1144, DOI 10.1002/hep.510300514; Wang SE, 2013, J CHIN MED ASSOC, V76, P358, DOI 10.1016/j.jcma.2013.03.001; Wang SL, 2010, NEUROREPORT, V21, P629, DOI 10.1097/WNR.0b013e32833a4d4d; Watanabe K, 2007, J SURG RES, V143, P13, DOI 10.1016/j.jss.2007.04.041; Watanabe T, 2011, INT J MOL MED, V28, P919, DOI 10.3892/ijmm.2011.768; Yamada N, 2012, TRANSPL P, V44, P810, DOI 10.1016/j.transproceed.2012.01.008; YAMAMOTO M, 1984, ACTA PATHOL JAPON, V34, P77	33	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	APR	2015	9	4					1119	1124		10.3892/etm.2015.2245		6	Medicine, Research & Experimental	Research & Experimental Medicine	CE3FJ	WOS:000351711600006		
J	Kasuya, N; Ohta, S; Takanami, Y; Kawai, Y; Inoue, Y; Murata, I; Kanamoto, I				Kasuya, Noriaki; Ohta, Shoichiro; Takanami, Yoshikazu; Kawai, Yukari; Inoue, Yutaka; Murata, Isamu; Kanamoto, Ikuo			Effect of low glycemic index food and postprandial exercise on blood glucose level, oxidative stress and antioxidant capacity	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						glycemic index; blood glucose level; oxidative stress; antioxidant capacity	TYPE-2 DIABETIC-PATIENTS; CORONARY-HEART-DISEASE; CARDIOVASCULAR MORTALITY; HEALTHY-SUBJECTS; IN-VIVO; HYPERGLYCEMIA; MEAL; HUMANS; METAANALYSIS; RESPONSES	Low glycemic index (GI) food and postprandial exercise are non-drug therapies for improving postprandial hyperglycemia. The present randomized, crossover study investigated the effect of low GI food combined with postprandial exercise on postprandial blood glucose level, oxidative stress and antioxidant capacity. A total of 13 healthy subjects were each used in four experiments: i) rice only (control), ii) salad prior to rice (LGI), iii) exercise following rice (EX) and iv) salad prior to rice and exercise following rice (MIX). The blood glucose level, oxidative stress and antioxidant capacity were then measured. At 60 min after the meal, the blood glucose level was observed to be increased in the MIX group compared with that in the LGI group. Furthermore, at 180 min, the antioxidant capacity was found to be reduced in the MIX group compared with those of the LGI and EX groups. These findings suggest that low GI food combined with postprandial exercise does not improve postprandial hyperglycemia. It may be necessary to establish optimal timing and intensity when combining low GI food with postprandial exercise to improve postprandial hyperglycemia.	[Kasuya, Noriaki; Inoue, Yutaka; Murata, Isamu; Kanamoto, Ikuo] Josai Univ, Div Pharmaceut Sci, Lab Drug Safety Management, Sakado, Saitama 3500295, Japan; [Ohta, Shoichiro] Kan Etsu Hosp, Dept Urol, Tsurugashima, Saitama 3502213, Japan; [Takanami, Yoshikazu] Otsuma Womens Univ, Dept Food Sci, Tokyo 1028357, Japan; [Kawai, Yukari] Louis Pasteur Ctr Med Res, Kyoto 6068225, Japan	Ohta, S (reprint author), Kan Etsu Hosp, Dept Urol, 145-1 Suneori, Tsurugashima, Saitama 3502213, Japan.	d11494@hotmail.co.jp			Kao Research Council for the Study of Healthcare Science [B-22002]	The present study was supported by a grant (no. B-22002) from the Kao Research Council for the Study of Healthcare Science.	Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Viollet B, 2009, FRONT BIOSCI, V14, P3380, DOI 10.2741/4060; Weickert MO, 2006, DIABETES CARE, V29, P775, DOI 10.2337/diacare.29.04.06.dc05-2374; Niskanen L, 1998, DIABETES CARE, V21, P1861, DOI 10.2337/diacare.21.11.1861; Poirier P, 2000, J CLIN ENDOCR METAB, V85, P2860, DOI 10.1210/jc.85.8.2860; Paniagua JA, 2007, J AM COLL NUTR, V26, P434; Larsen JJS, 1997, DIABETOLOGIA, V40, P447, DOI 10.1007/s001250050699; Huxley R, 2006, BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Lu ZX, 2000, AM J CLIN NUTR, V71, P1123; Williams SB, 1998, CIRCULATION, V97, P1695; Opperman AM, 2004, BRIT J NUTR, V92, P367, DOI 10.1079/BJN20041203; Marfella R, 2001, J CLIN INVEST, V108, P635, DOI 10.1172/JCI13727; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Castaner O, 2012, AM J CLIN NUTR, V95, P1238, DOI 10.3945/ajcn.111.029207; Ceriello A, 1998, HORM METAB RES, V30, P146, DOI 10.1055/s-2007-978854; Ceriello A, 1998, DIABETES CARE, V21, P1529, DOI 10.2337/diacare.21.9.1529; Kanamoto Ikuo, 2010, Journal of the Japan Diabetes Society, V53, P96; Ostman E, 2005, EUR J CLIN NUTR, V59, P983, DOI 10.1038/sj.ejcn.1602197; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397	21	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	APR	2015	9	4					1201	1204		10.3892/etm.2015.2228		4	Medicine, Research & Experimental	Research & Experimental Medicine	CE3FJ	WOS:000351711600018		
J	Ikeda, K; Tsujimoto, K; Suzuki, Y; Koyama, AH				Ikeda, Keiko; Tsujimoto, Kazuko; Suzuki, Yukiko; Koyama, Augustine Hajime			Survival of influenza A virus on contaminated student clothing	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						influenza virus; virus inactivation; contaminated clothes; indirect transmission; viral epidemics	INFECTION; TRANSMISSION; INACTIVATION	The role of contaminated clothing in the transmission of influenza A virus during an epidemic period was investigated by examining the recovery of infectious influenza virus from experimentally virus-contaminated clothing, which had been subejected to routine wearing and washing for several months or years. The amount of infectious virus recovered from the nine types of clothing decreased with time and was shown to differ widely between clothing samples, when the contaminated clothing samples were maintained in uncovered glass Petri dishes in a safety cabinet under air blowing. These results indicate a dependence of virus transmissibility on the nature of the contaminated clothes. The difference in recovery was shown to have no significant correlation with the thickness or the materials of the clothing; however, a correlation was observed with the residual amount of water in the deposited virus preparation on the test clothing.	[Ikeda, Keiko; Suzuki, Yukiko] Wakayama Med Univ, Sch Hlth & Nursing Sci, Wakayama 6410011, Japan; [Tsujimoto, Kazuko; Koyama, Augustine Hajime] Wakayama Shin Ai Womens Jr Coll, Wakayama 6400341, Japan	Ikeda, K (reprint author), Wakayama Med Univ, Sch Hlth & Nursing Sci, 580 Mikazura, Wakayama 6410011, Japan.	keiko-i-nc@wakayama-med.ac.jp			Japan Society for the Promotion of Science [23660017, 25463335]	The study was supported in part by a Grant-in-Aid for Challenging Exploratory Research (no. 23660017) and for Scientific Research (C) (no. 25463335) from the Japan Society for the Promotion of Science. The authors thank Dr Tsutomu Arakawa (Alliance Protein Laboratories, Inc., Camerillo, CA, USA) for his helpful discussion.	American Medical Association, 1994, AM MED ASS FAMILY ME, P597; Uozaki M, 2007, ANTIVIR RES, V73, P85, DOI 10.1016/j.antivrial.2006.07.010; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Arakawa T, 2009, CURR MED CHEM, V16, P2485; Ikeda K, 2010, EXP THER MED, V1, P251, DOI 10.3892/etm_00000039; Ikeda K, 2012, INT J MOL MED, V30, P1307, DOI 10.3892/ijmm.2012.1149; Kurokawa M, 1999, INT J MOL MED, V3, P527; Laevens H, 1999, VET REC, V145, P243; Lai MYY, 2005, CLIN INFECT DIS, V41, pE67, DOI 10.1086/433186; Nishide M, 2011, INT J MOL MED, V27, P803, DOI 10.3892/ijmm.2011.668; Sakaguchi Hiroko, 2010, Environmental Health and Preventive Medicine, V15, P344, DOI 10.1007/s12199-010-0149-y; Uozaki M, 2010, EXP THER MED, V1, P983, DOI 10.3892/etm.2010.139; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Yamasaki H, 2008, J PHARM SCI-US, V97, P3067, DOI 10.1002/jps.21224	14	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	APR	2015	9	4					1205	1208		10.3892/etm.2015.2278		4	Medicine, Research & Experimental	Research & Experimental Medicine	CE3FJ	WOS:000351711600019		
J	Toyokawa, T; Inaba, T; Omote, S; Okamoto, A; Miyasaka, R; Watanabe, K; Izumikawa, K; Fujita, I; Horii, J; Ishikawa, S; Morikawa, T; Murakami, T; Tomoda, J				Toyokawa, Tatsuya; Inaba, Tomoki; Omote, Shizuma; Okamoto, Akiko; Miyasaka, Rika; Watanabe, Kazuo; Izumikawa, Koichi; Fujita, Isao; Horii, Joichiro; Ishikawa, Shigenao; Morikawa, Tamiya; Murakami, Takako; Tomoda, Jun			Risk factors for non-curative resection of early gastric neoplasms with endoscopic submucosal dissection: Analysis of 1,123 lesions	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						endoscopic submucosal dissection; early gastric neoplasms; non-curative resection; risk factors	CANCER; EXPERIENCE	Although the frequency of residual disease and recurrence following endoscopic submucosal dissection (ESD) has markedly decreased, a few cases of residual disease and recurrence following ESD are still observed. The aims of the present study were to clarify the causes of non-curative resection and to investigate the risk factors. A total of 1,123 early gastric neoplasm lesions treated by ESD were investigated. Non-curative resection was defined as histological positivity of the resected margins, vascular invasion or failure of en bloc resection. Cases of non-curative resection were classified as being caused by one of three reasons: Inadequate technique, pre-procedural misdiagnosis or problems in the histological diagnosis. Following classification, the cases of non-curative and curative resection were compared based on a range of patient characteristics: Procedure time, and size, type and location of the lesions. The frequency of non-curative resection was 16% (182 lesions). Non-curative resection occurred due to inadequate technique in 59 cases, pre-procedural misdiagnosis in 88 cases and problems in the histological diagnosis in 35 cases. Multivariate analysis revealed that a large lesion size, long procedure time and inexperienced endoscopist were associated with a significantly higher risk of non-curative resection due to an inadequate technique. Furthermore, it was found that lesions located in the upper area of the stomach and cancer with submucosal invasion were associated with a significantly higher risk of non-curative resection due to pre-procedural misdiagnosis. In conclusion, the present study has shown that the major reasons for non-curative resection are an inadequate technique and pre-procedural misdiagnosis. The risk factors for these problems have been clarified.	[Toyokawa, Tatsuya; Omote, Shizuma; Okamoto, Akiko; Miyasaka, Rika; Watanabe, Kazuo; Fujita, Isao; Horii, Joichiro; Morikawa, Tamiya; Murakami, Takako; Tomoda, Jun] Natl Hosp Org, Fukuyama Med Ctr, Dept Gastroenterol, Fukuyama, Hiroshima 34207, Japan; [Inaba, Tomoki; Izumikawa, Koichi; Ishikawa, Shigenao] Kagawa Prefectural Cent Hosp, Dept Gastroenterol, Takamatsu, Kagawa, Japan	Toyokawa, T (reprint author), Natl Hosp Org, Fukuyama Med Ctr, Dept Gastroenterol, 4-14-17 Okinogami Cho, Fukuyama, Hiroshima 34207, Japan.	toyotatu@kmail.plala.or.jp					Abe N, 2012, GASTRIC CANCER, V15, P70, DOI 10.1007/s10120-011-0067-8; Suzuki H, 2013, ENDOSCOPY, V45, P93, DOI 10.1055/s-0032-1325929; Kawahara Y, 2009, DIGEST ENDOSC, V21, P14, DOI 10.1111/j.1443-1661.2008.00824.x; Toyokawa T, 2011, EUR J CLIN INVEST, V41, P474, DOI 10.1111/j.1365-2362.2010.02428.x; Tanaka M, 2008, DIGESTION, V77, P23, DOI 10.1159/000111484; Ono H, 2008, GASTRIC CANCER, V11, P47, DOI 10.1007/s10120-008-0452-0; Park JC, 2010, SURG ENDOSC, V24, P2842, DOI 10.1007/s00464-010-1060-8; Park YM, 2011, SURG ENDOSC, V25, P2666, DOI 10.1007/s00464-011-1627-z; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Kakushima N, 2011, DIGEST ENDOSC, V23, P227, DOI 10.1111/j.1443-1661.2010.01092.x; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Kato M, 2011, J GASTROENTEROL, V46, P325, DOI 10.1007/s00535-010-0350-1; Dinis-Ribeiro M, 2009, GASTROINTEST ENDOSC, V69, P350, DOI 10.1016/j.gie.2008.08.035; Nonaka S, 2011, GASTRIC CANCER, V14, P56, DOI 10.1007/s10120-011-0008-6; Toyokawa T, 2012, J GASTROEN HEPATOL, V27, P907, DOI 10.1111/j.1440-1746.2011.07039.x; Choi J, 2010, ENDOSKOPIE HEUTE, V23, P275, DOI 10.1055/s-0030-1255617; Fernandez-Esparrach G, 2010, GASTROINTEST ENDOSC, V71, P615, DOI 10.1016/j.gie.2009.10.013; Hirasawa K, 2011, GASTROINTEST ENDOSC, V74, P1268, DOI 10.1016/j.gie.2011.07.067; Jang JS, 2009, SCAND J GASTROENTERO, V44, P1370, DOI 10.3109/00365520903194609; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Nagano Hideki, 2005, Gastric Cancer, V8, P149, DOI 10.1007/s10120-005-0328-5; Ohnita K, 2009, SURG ENDOSC, V23, P2713, DOI 10.1007/s00464-009-0473-8; Takenaka R, 2008, GASTROINTEST ENDOSC, V67, P359, DOI 10.1016/j.gie.2007.10.021	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	APR	2015	9	4					1209	1214		10.3892/etm.2015.2265		6	Medicine, Research & Experimental	Research & Experimental Medicine	CE3FJ	WOS:000351711600020		
J	Tamaka, K; Seike, M; Hagiwara, T; Sato, A; Ohtsu, H				Tamaka, Kyoko; Seike, Masahiro; Hagiwara, Tamio; Sato, Atsushi; Ohtsu, Hiroshi			Histamine suppresses regulatory T cells mediated by TGF-beta in murine chronic allergic contact dermatitis	EXPERIMENTAL DERMATOLOGY			English	Article						chronic allergic contact dermatitis; histamine; regulatory T cell; TGF-beta	TRANSCRIPTION FACTOR FOXP3; RECEPTOR ANTAGONIST; CUTTING EDGE; MICE; HYPERSENSITIVITY; INDUCTION; SKIN; INFLAMMATION; TOLERANCE; LESIONS	Regulatory T cells (Tregs) suppress effector T cells and ameliorate contact hypersensitivity (CH); however, the role of Tregs in chronic allergic contact dermatitis (CACD) has not been assessed. Repeated elicitation of CH has been used to produce CACD models in mice. We previously showed that the presence of histamine facilitates the creation of eczematous lesions in this model using histidine decarboxylase (HDC) (-/-) mice. Therefore, the effects of histamine on Tregs in the CACD model were investigated in this study. CACD was developed by repeated epicutaneous application of 2, 4, 6-trinitro-1-chlorobenzene (TNCB) on HDC (+/+) and HDC (-/-) murine skin to assess the effects of histamine in CACD. Histamine aggravated CACD in the murine model and suppressed the number of Tregs in the skin. Histamine also suppressed the level of TGF-1 in this model. Recombinant TGF-1 or anti-TGF-1 antibody was injected into the dorsal dermis of HDC (+/+) mice daily just before TNCB challenge to determine the effects of histamine-regulated TGF- on the Treg population in CACD. Recombinant TGF-1 injection promoted the infiltration of Tregs in the skin and the production of IL-10; however, anti-TGF-1 antibody injection suppressed the number of Tregs in the skin and the production of IL-10. Histamine suppresses the number of Tregs in CACD, and this effect is mediated by TGF-beta.	[Tamaka, Kyoko; Seike, Masahiro; Hagiwara, Tamio] Sagami Womens Jr Coll, Dept Food & Nutr Sci, Minami Ku, Sagamihara, Kanagawa 2520383, Japan; [Sato, Atsushi; Ohtsu, Hiroshi] Tohoku Univ, Dept Quantum Sci & Energy Engn, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 980, Japan	Seike, M (reprint author), Sagami Womens Jr Coll, Dept Food & Nutr Sci, Minami Ku, 2-1-1 Bunkyo, Sagamihara, Kanagawa 2520383, Japan.	m-seike@star.sagami-wu.ac.jp			Sagami Women's University	Masahiro Seike, Kyoko Tanaka and Tamio Hagiwara performed the research. Masahiro Seike, Tamio Hagiwara, Atsushi Sato and Hiroshi Ohtsu designed the research study and analysed the data. Masahiro Seike and Hiroshi Ohtsu wrote the paper. We thank Kyowa Hakko Kirin for providing olopatadine and Johnson & Johnson Pharmaceutical Research & Development for donating JNJ7777120. This study was supported by grants from Sagami Women's University.	Ring S, 2006, EUR J IMMUNOL, V36, P2981, DOI 10.1002/eji.200636207; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Sakaguchi S, 2009, EUR J IMMUNOL, V39, P2331, DOI 10.1002/eji.200939688; Wing JB, 2014, INT IMMUNOL, V26, P61, DOI 10.1093/intimm/dxt060; Seike M, 2005, ARCH DERMATOL RES, V297, P68, DOI 10.1007/s00403-005-0569-5; Ohtsu H, 2002, EUR J IMMUNOL, V32, P1698, DOI 10.1002/1521-4141(200206)32:6<1698::AID-IMMU1698>3.0.CO;2-7; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Kitagaki H, 1997, J IMMUNOL, V159, P2484; Davidson TS, 2007, J IMMUNOL, V178, P4022; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Seike M, 2010, ALLERGY, V65, P319, DOI 10.1111/j.1398-9995.2009.02240.x; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Wang G, 2007, CLIN EXP ALLERGY, V37, P151, DOI 10.1111/j.1365-2222.2006.02621.x; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Cavani A, 2003, J IMMUNOL, V171, P5760; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fantini MC, 2004, J IMMUNOL, V172, P5149; Honda T, 2011, J DERMATOL SCI, V61, P144, DOI 10.1016/j.jdermsci.2010.11.001; Wang L F, 1996, J Immunol, V156, P4077; Matsushita A, 2012, EXP DERMATOL, V21, P714, DOI 10.1111/j.1600-0625.2012.01559.x; Nakajima S, 2010, J IMMUNOL, V184, P5595, DOI 10.4049/jimmunol.0903260; Ohsawa Y, 2012, ALLERGY, V67, P1014, DOI 10.1111/j.1398-9995.2012.02854.x; Park JM, 2012, EXP DERMATOL, V21, P969, DOI 10.1111/exd.12044; Seike M, 2005, EXP DERMATOL, V14, P169, DOI 10.1111/j.0906-6705.2005.00247.x; Su WR, 2012, J ALLERGY CLIN IMMUN, V130, P444, DOI 10.1016/j.jaci.2012.05.011; Tamura T, 2004, BRIT J DERMATOL, V151, P1133, DOI 10.1111/j.1365-2133.2004.06172.x	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	APR	2015	24	4					280	284		10.1111/exd.12644		5	Dermatology	Dermatology	CE6GZ	WOS:000351936100012		
J	Inoue, K; Takei, K; Denda, M				Inoue, Kaori; Takei, Kentaro; Denda, Mitsuhiro			Functional glycine receptor in cultured human keratinocytes	EXPERIMENTAL DERMATOLOGY			English	Letter						chloride ion; epidermis; inward current; stratum corneum	EPIDERMAL-KERATINOCYTES; SKIN; ADULT	We previously demonstrated that a series of neural receptors, those play a crucial role in nerve system, also expressed in epidermal keratinocytes. We also demonstrated that topical application of glycine on hairless mice skin after the barrier disruption also accelerated the barrier recovery and it was blocked by the strychnine. Glycine is known as one of the most important inhibitory neurotransmitters in the mammalian central nervous system. Thus, we hypothesized that glycine receptor also functionally expressed in the epidermal keratinocytes. In the present study, we first studied the expression of glycine receptor message in cultured human keratinocytes. Then we demonstrate for the first time the existence of a functional receptor with electrophysiological properties of glycine receptors in cultured human epidermal keratinocytes. Finally, we demonstrated immune-histochemical study against anti-glycine receptor subunits in human skin. Results of the present study might indicate new target of the clinical dermatology.	[Inoue, Kaori; Denda, Mitsuhiro] Shiseido Res Ctr, Yokohama, Kanagawa 2248558, Japan; [Takei, Kentaro] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Takei, Kentaro; Denda, Mitsuhiro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Denda, M (reprint author), Shiseido Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	mitsuhiro.denda@to.shiseido.co.jp					BECKER CM, 1988, EMBO J, V7, P3717; Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x; MALOSIO ML, 1991, EMBO J, V10, P2401; PRIBILLA I, 1992, EMBO J, V11, P4305; Aprison M H, 1978, ADV NEUROCHEM, V3, P203; DENDA M, 1992, ARCH DERMATOL RES, V284, P363, DOI 10.1007/BF00372041; Denda M, 2003, J INVEST DERMATOL, V121, P362, DOI 10.1046/j.1523-1747.2003.12367.x; Denda M, 2007, EXP DERMATOL, V16, P157, DOI 10.1111/j.1600-0625.2006.00529.x; SCHMIEDEN V, 1992, EMBO J, V11, P2025	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	APR	2015	24	4					307	309		10.1111/exd.12651		3	Dermatology	Dermatology	CE6GZ	WOS:000351936100020		
J	Miura, K; Satoh, M; Kinouchi, M; Yamamoto, K; Hasegawa, Y; Kakugawa, Y; Kawai, M; Uchimi, K; Aizawa, H; Ohnuma, S; Kajiwara, T; Sakurai, H; Fujiya, T				Miura, Koh; Satoh, Masayuki; Kinouchi, Makoto; Yamamoto, Kuniharu; Hasegawa, Yasuhiro; Kakugawa, Yoichiro; Kawai, Masaaki; Uchimi, Kiyoshi; Aizawa, Hiroki; Ohnuma, Shinobu; Kajiwara, Taiki; Sakurai, Hiroto; Fujiya, Tsuneaki			The use of natural products in colorectal cancer drug discovery	EXPERT OPINION ON DRUG DISCOVERY			English	Review						anti-cancer agent; cancer prevention; colorectal cancer; drug discovery; natural products	FAMILIAL ADENOMATOUS POLYPOSIS; RANDOMIZED CONTROLLED-TRIAL; REFRACTORY SOLID TUMORS; FREE FATTY-ACID; EICOSAPENTAENOIC ACID; PHASE-II; CHEMOPREVENTIVE AGENT; HEALTHY-VOLUNTEERS; BLACK-RASPBERRIES; TALAPORFIN SODIUM	Introduction: Natural products (NPs) are evolutionarily designed and contain more complex and challenging structures than synthetic compounds. Since the 1980s, the pharmaceutical industry has gradually shifted to a strategy of developing targeted agents by screening libraries of synthetic compounds. However, NPs have recently received renewed focus as a rich repository for drug discovery. Irinotecan was developed as a derivative of camptothecin and was applied in standard regimens for metastatic colorectal cancer (CRC) worldwide. Additionally, polysaccharide K is approved for CRC in Japan and Taiwan in combination with cytotoxic agents. However, after the approval of irinotecan in 1996, no anti-cancer agents derived from NPs have been approved for CRC. Areas covered: This review discusses NPs that are currently under investigation for the treatment of CRC. In addition, other NPs derived as purified ingredients and crude extracts are listed and also discussed. Expert opinion: The use of NPs for the discovery of anti-cancer agents has not been fully investigated. New technologies that are currently applied for synthetic compounds may be utilized for anti-cancer drug discovery including NPs for CRC.	[Miura, Koh; Satoh, Masayuki; Kinouchi, Makoto; Yamamoto, Kuniharu; Hasegawa, Yasuhiro; Kakugawa, Yoichiro; Kawai, Masaaki; Uchimi, Kiyoshi; Aizawa, Hiroki; Sakurai, Hiroto; Fujiya, Tsuneaki] Miyagi Canc Ctr, Dept Surg, Natori, Miyagi 9811293, Japan; [Ohnuma, Shinobu; Kajiwara, Taiki] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 9808574, Japan	Miura, K (reprint author), Miyagi Canc Ctr, Dept Surg, 47-1 Nodayama, Natori, Miyagi 9811293, Japan.	k-miura@surg1.med.tohoku.ac.jp					Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; Zick SM, 2011, CANCER PREV RES, V4, P1929, DOI 10.1158/1940-6207.CAPR-11-0224; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Li YH, 2014, BIOCHEM PHARMACOL, V88, P150, DOI 10.1016/j.bcp.2014.01.018; HSIANG YH, 1988, CANCER RES, V48, P1722; West NJ, 2010, GUT, V59, P918, DOI 10.1136/gut.2009.200642; Bravo L, 1998, NUTR REV, V56, P317; Vosooghi M, 2014, EXPERT OPIN DRUG DIS, V9, P255, DOI 10.1517/17460441.2014.883377; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Shimizu M, 2011, MOL NUTR FOOD RES, V55, P832, DOI 10.1002/mnfr.201000622; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Sandur SK, 2009, INT J RADIAT ONCOL, V75, P534, DOI 10.1016/j.ijrobp.2009.06.034; Lustig RA, 2003, CANCER-AM CANCER SOC, V98, P1767, DOI 10.1002/cncr.11708; Fini L, 2010, CLIN CANCER RES, V16, P5703, DOI 10.1158/1078-0432.CCR-10-1990; Chicca A, 2008, BRIT J PHARMACOL, V153, P879, DOI 10.1038/sj.bjp.0707639; Lee SJ, 2014, BRIT J CANCER, V111, P497, DOI 10.1038/bjc.2014.283; Zhang RW, 2014, J BIOL CHEM, V289, P6394, DOI 10.1074/jbc.M113.513960; Reyes-Zurita FJ, 2009, CANCER LETT, V273, P44, DOI 10.1016/j.canlet.2008.07.033; Larrosa M, 2010, J NUTR BIOCHEM, V21, P717, DOI 10.1016/j.jnutbio.2009.04.012; Suh Y, 2009, CARCINOGENESIS, V30, P300, DOI 10.1093/carcin/bgn269; Thomas GL, 2011, CURR OPIN CHEM BIOL, V15, P516, DOI 10.1016/j.cbpa.2011.05.022; Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g; Lim S, 2013, MOL NUTR FOOD RES, V57, P1908, DOI 10.1002/mnfr.201300040; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Mohr JT, 2008, NATURE, V455, P323, DOI 10.1038/nature07370; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Wang LS, 2014, CANCER PREV RES, V7, P666, DOI 10.1158/1940-6207.CAPR-14-0052; Kirschning A, 2012, ANGEW CHEM INT EDIT, V51, P4012, DOI 10.1002/anie.201107386; Kim SP, 2012, MOL NUTR FOOD RES, V56, P935, DOI 10.1002/mnfr.201200057; Bi XL, 2010, CANCER PREV RES, V3, P1443, DOI 10.1158/1940-6207.CAPR-10-0124; Skropeta D, 2014, NAT PROD REP, V31, P999, DOI 10.1039/c3np70118b; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Bailly C, 2009, BIOCHEM PHARMACOL, V77, P1447, DOI 10.1016/j.bcp.2008.12.013; Howells LM, 2011, INT J CANCER, V129, P476, DOI 10.1002/ijc.25670; Kang YJ, 2012, MOL PHARMACOL, V82, P168, DOI 10.1124/mol.112.078535; Prada CF, 2013, BIOCHEM PHARMACOL, V85, P1433, DOI 10.1016/j.bcp.2013.02.024; Shoichet BK, 2013, NAT CHEM, V5, P9, DOI 10.1038/nchem.1537; Liu W, 2014, INT IMMUNOPHARMACOL, V20, P337, DOI 10.1016/j.intimp.2014.03.015; Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Kroep JR, 2009, EXPERT OPIN INV DRUG, V18, P69, DOI 10.1517/13543780802571674 ; Over B, 2013, NAT CHEM, V5, P21, DOI [10.1038/nchem.1506, 10.1038/NCHEM.1506]; Yang XM, 2011, J MED CHEM, V54, P5097, DOI 10.1021/jm200330s; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Luo XJ, 2011, EUR J CANCER, V47, P316, DOI 10.1016/j.ejca.2010.09.021; Cockbain AJ, 2014, GUT, V63, P1760, DOI 10.1136/gutjnl-2013-306445; Kunnumakkara AB, 2008, CLIN CANCER RES, V14, P2128, DOI 10.1158/1078-0432.CCR-07-4722; Howells LM, 2011, CANCER PREV RES, V4, P1419, DOI 10.1158/1940-6207.CAPR-11-0148; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Zhang W, 2011, J MED CHEM, V54, P1288, DOI 10.1021/jm101248v; Min HY, 2010, BIOCHEM PHARMACOL, V80, P1356, DOI 10.1016/j.bcp.2010.07.026; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Chitchumroonchokchai C, 2013, MOL NUTR FOOD RES, V57, P203, DOI 10.1002/mnfr.201200539; Ciombor KK, 2015, ANNU REV MED, V66, P83, DOI 10.1146/annurev-med-051513-102539; Citronberg J, 2013, CANCER PREV RES, V6, P271, DOI 10.1158/1940-6207.CAPR-12-0327; Dancik V, 2010, J AM CHEM SOC, V132, P9259, DOI 10.1021/ja102798t; D'Angelo L, 2014, CARCINOGENESIS, V35, P2314, DOI 10.1093/carcin/bgu173; Deng S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-128; Femia AP, 2012, MOL NUTR FOOD RES, V56, P1353, DOI 10.1002/mnfr.201200122; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frank E, 2013, KOEHN NATURAL PRODUC; Gonzalez-Vallinas M, 2013, PHARMACOL RES, V72, P61, DOI 10.1016/j.phrs.2013.03.010; GOTTLIEB JA, 1972, CANCER CHEMOTH REP 1, V56, P103; Hope C., 2008, MOL NUTR FOOD RES, V52, P52; Hull MA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-237; Imai M, 2009, CANCER LETT, V276, P74, DOI 10.1016/j.canlet.2008.10.036; Jiang Y, 2013, EUR J CANCER PREV, V22, P455, DOI 10.1097/CEJ.0b013e32835c829b; Kujundzic M, 2007, J SURG ONCOL, V96, P518, DOI 10.1002/jso.20832; Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Liu L, 2010, CARCINOGENESIS, V31, P22; Liu L, 2010, CARCINOGENESIS, V31, P18; Macone A, 2009, BIOORGAN MED CHEM, V17, P6003, DOI 10.1016/j.bmc.2009.06.061; Maehara Y, 2012, SURG TODAY, V42, P8, DOI 10.1007/s00595-011-0075-7; Mitchell W, 2011, CURR OPIN CHEM BIOL, V15, P553, DOI 10.1016/j.cbpa.2011.06.005; Mitchell W, 2011, CURR OPIN CHEM BIOL, V15, P505, DOI 10.1016/j.cbpa.2011.05.017; Morrison KC, 2014, NAT PROD REP, V31, P6, DOI 10.1039/c3np70063a; Murff HJ, 2009, CANCER EPIDEM BIOMAR, V18, P2283, DOI 10.1158/1055-9965.EPI-08-1196; Nguyen Anthony V, 2009, Cancer Manag Res, V1, P25; Piazzi G, 2014, INT J CANCER, V135, P2004, DOI 10.1002/ijc.28853; Puangpraphant S, 2013, BIOFACTORS, V39, P430, DOI 10.1002/biof.1083; Rusconi M, 2010, PHARMACOL RES, V61, P5, DOI 10.1016/j.phrs.2009.08.008; Schmitt EK, 2011, CURR OPIN CHEM BIOL, V15, P497, DOI 10.1016/j.cbpa.2011.05.018; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stingl JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-360; Thomasset S, 2009, CANCER PREV RES, V2, P625, DOI 10.1158/1940-6207.CAPR-08-0201; Tung NH, 2013, PHYTOTHER RES, V27, P66, DOI 10.1002/ptr.4680; Ueberschaar N, 2013, J AM CHEM SOC, V135, P17408, DOI 10.1021/ja4080024; Weber W, 2009, DRUG DISCOV TODAY, V14, P956, DOI 10.1016/j.drudis.2009.06.010; Yamazaki H, 2012, MAR DRUGS, V10, P2691, DOI 10.3390/md10122691; Yuan JH, 2008, MOL MED, V14, P590, DOI 10.2119/2007-00050.Yuan; Zick SM, 2014, MOL CARCINOG; Zurbriggen MD, 2012, J BIOTECHNOL, V160, P80	97	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1746-0441	1746-045X		EXPERT OPIN DRUG DIS	Expert. Opin. Drug Discov.	APR	2015	10	4					411	426		10.1517/17460441.2015.1018174		16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE2CQ	WOS:000351621200008		
J	Lee, M; Hong, GE; Zhang, HP; Yang, CY; Han, KH; Mandal, PK; Lee, CH				Lee, Miyeon; Hong, Go-Eun; Zhang, Heping; Yang, Cheul-Young; Han, Kyu-Ho; Mandal, Prabhat Kumar; Lee, Chi-Ho			Production of the isoflavone aglycone and antioxidant activities in black soymilk using fermentation with Streptococcus thermophilus S10	FOOD SCIENCE AND BIOTECHNOLOGY			English	Article						black bean; soymilk; fermentation; isoflavone; aglycone	LACTIC-ACID BACTERIA; PHYTO-ESTROGENS; HYDROLYZE DAIDZIN; BETA-GLUCOSIDASES; SOY; SOYBEANS; GROWTH; CANCER; HEALTH; BIFIDOBACTERIA	The best starter culture for fermented black soymilk was determined. Black soymilk was fermented using Lactobacillus acidophilus ATCC 4356 (LA), Lactobacillus plantarum P8 (LP), and Streptococcus thermophilus S10 (ST). An ST single culture exhibited higher beta-glucosidase activities than LAST (LA:ST=1:1, v/v), LPST (LP:ST=1:1, v/v), and LALPST (LA:LP:ST=1:1:1, v/v) mixed cultures. The pH of fermented black soymilk was significantly (p < 0.05) decreased during fermentation due to an increase in lactic acid formed by lactic acid bacteria. The beta-glucosidase activity of the ST single culture was significantly (p < 0.05) higher than for mixed cultures. Black soymilk fermented with ST alone showed significantly (p < 0.05) more bioconversion of the isoflavone glycoside to aglycone, compared with controls. Black soymilk fermented with ST resulted in the best antioxidant effect. The ST single culture was best for production of health functional fermented black soymilk.	[Lee, Miyeon; Hong, Go-Eun; Lee, Chi-Ho] Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 143701, South Korea; [Zhang, Heping] Inner Mongolia Agr Univ, Dept Food Sci & Engn, Hohhot 010018, Peoples R China; [Yang, Cheul-Young] Eulji Univ, Dept Food Sci & Serv, Songnam 461713, Gyeonggi, South Korea; [Han, Kyu-Ho] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan; [Mandal, Prabhat Kumar] Rajuv Gandhi Coll Vet & Anim Sci, Dept Livestock Prod Technol, Pondicherry 605009, India	Lee, CH (reprint author), Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 143701, South Korea.	leech@konkuk.ac.kr			Konkuk University	This paper was supported by Konkuk University in 2014.	ANGELES AG, 1971, J MILK FOOD TECHNOL, V34, P30; Cederroth CR, 2012, MOL CELL ENDOCRINOL, V355, P192, DOI 10.1016/j.mce.2011.05.049; Pyo YH, 2005, J FOOD SCI, V70, pS215; Izumi T, 2000, J NUTR, V130, P1695; Brouns F, 2002, FOOD RES INT, V35, P187, DOI 10.1016/S0963-9969(01)00182-X; Lee BH, 2013, J FUNCT FOODS, V5, P905, DOI 10.1016/j.jff.2013.01.040; Scalabrini P, 1998, INT J FOOD MICROBIOL, V39, P213, DOI 10.1016/S0168-1605(98)00005-1; Marazza JA, 2013, J FUNCT FOODS, V5, P1848, DOI 10.1016/j.jff.2013.09.005; MATSUURA M, 1993, J FOOD SCI, V58, P144, DOI 10.1111/j.1365-2621.1993.tb03231.x; Onozawa M, 1998, JPN J CLIN ONCOL, V28, P360, DOI 10.1093/jjco/28.6.360; Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Takahashi R, 2005, J AGR FOOD CHEM, V53, P4578, DOI 10.1021/jf048062m; WANG HJ, 1994, J AGR FOOD CHEM, V42, P1666, DOI 10.1021/jf00044a016; PRATT DE, 1979, J FOOD SCI, V44, P1720, DOI 10.1111/j.1365-2621.1979.tb09125.x; MEIR S, 1995, J AGR FOOD CHEM, V43, P1813, DOI 10.1021/jf00055a012; Chien HL, 2006, FOOD MICROBIOL, V23, P772, DOI 10.1016/j.fm.2006.01.002; MITAL BK, 1974, J FOOD SCI, V39, P1018, DOI 10.1111/j.1365-2621.1974.tb07300.x; XU X, 1994, J NUTR, V124, P825; Cassidy A, 1996, P NUTR SOC, V55, P399, DOI 10.1079/PNS19960038; AOAC, 2000, 92039 AOAC; AOAC, 2000, 94205 AOAC; AOAC, 2000, 98413 AOAC; AOAC, 2000, 94705 AOAC; Blois MS, 1958, NATURE, V181, P1198; Chung WY, 2008, J KOREAN SOC FOOD SC, V37, P141, DOI 10.3746/jkfn.2008.37.2.141; Hong GE, 2012, ASIAN J ANIM VET ADV, V7, P502, DOI 10.3923/ajava.2012.502.511; Hwang JS, 2012, KOREAN J MICROBIOL, V48, P216; MATSUURA M, 1995, BIOSCI BIOTECH BIOCH, V59, P1623; Messina M, 2000, EUR J CANCER, V36, pS71; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Park JW, 2007, KOREAN J FOOD CULTUR, V22, P353; PINTHONG R, 1980, J FOOD TECHNOL, V15, P647, DOI 10.1191/0269215501cr438oa; Potter SM, 1998, AM J CLIN NUTR, V68, p1375S; Shon MY, 2000, KOREAN J FOOD SCI TE, V32, P936; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Toda T., 2001, FOOD SCI TECHNOL RES, V6, P314; Tsangalis D, 2003, J FOOD SCI, V68, P623, DOI 10.1111/j.1365-2621.2003.tb05721.x; Wang ZL, 2013, FOOD BIOPHYS, V8, P43, DOI 10.1007/s11483-012-9282-z	38	0	0	KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST	SEOUL	#605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-7708	2092-6456		FOOD SCI BIOTECHNOL	Food Sci. Biotechnol.	APR	2015	24	2					537	544		10.1007/s10068-015-0070-7		8	Food Science & Technology	Food Science & Technology	CE5HO	WOS:000351862100020		
J	Mikuma, T; Iwata, YT; Miyaguchi, H; Kuwayama, K; Tsujikawa, K; Kanamori, T; Inoue, H				Mikuma, Toshiyasu; Iwata, Yuko T.; Miyaguchi, Hajime; Kuwayama, Kenji; Tsujikawa, Kenji; Kanamori, Tatsuyuki; Inoue, Hiroyuki			The use of a sulfonated capillary on chiral capillary electrophoresis/mass spectrometry of amphetamine-type stimulants for methamphetamine impurity profiling	FORENSIC SCIENCE INTERNATIONAL			English	Article						Capillary electrophoresis; Mass spectrometry; Chiral analysis; Methamphetamine; Chemically modified capillary	MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PARTIAL FILLING TECHNIQUE; TANDEM MASS-SPECTROMETRY; MACROCYCLIC POLYAMINE; AMINO-GROUPS; SEPARATION; CYCLODEXTRIN; COLUMN; MS; ELECTROCHROMATOGRAPHY	Chiral capillary electrophoresis/tandem mass spectrometry (CE/MS/MS) using a chemically modified capillary containing sulfonated groups was developed for the following 8 amphetamine-type stimulants (ATS): amphetamine, methamphetamine (MA), norephedrine, norpseudoephedrine, ephedrine (EP), pseudoephedrine (pEP), dimethylamphetamine and methylephedrine. The running buffer was 10 mM formic acid containing 20 mM highly sulfated gamma-cyclodextrin (pH 2.5) as the chiral selector. All 16 enantiomers were well resolved within 60 min, and precisely identified due to their characteristic mass spectra. Further, the RSDs of the migration times of the analytes were no more than 0.3% without any standardization. (1R,2S)-(-)-EP and (1S,2S)-(+)-pEP, which are important ATS impurities originating in the precursors, were added to a highly concentrated MA solution (1 mg/mL) and analyzed as mock samples for MA impurity analysis. Acceptable repeatability of the migration times of ()-EP and (+)-pEP (ca. 0.3% RSDs) was still observed without interference from the large amount of MA. The limits of detection (LOD) of (-)-EP and (+)-pEP were approximately 2 mu g/mL, therefore, their LOD as the impurity concentrations were calculated at about 0.2%. Seized MA samples were dissolved in water at a high concentration (1 mg/mL) and analyzed by this method. (-)-EP and (+)-pEP were clearly detected as impurities. Although these compounds had similar migration times and mass spectral patterns, the fine repeatability allowed easy identification of the impurities by a simple comparison of the absolute migration times of the specimens and those of authentic standards. This study is the first to report the use of a chemically modified capillary for the impurity profiling on CE/MS/MS. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Mikuma, Toshiyasu; Iwata, Yuko T.; Miyaguchi, Hajime; Kuwayama, Kenji; Tsujikawa, Kenji; Kanamori, Tatsuyuki; Inoue, Hiroyuki] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan	Mikuma, T (reprint author), Chiba Prefectural Police HQ, Forens Sci Lab, Chuo Ku, 1-71-1 Chuoko, Chiba 2600024, Japan.	tosh.mikuma@gmail.com					Tanaka Y, 2000, J CHROMATOGR A, V875, P323, DOI 10.1016/S0021-9673(99)01334-5; Schulte G, 1998, J CHROMATOGR A, V800, P77, DOI 10.1016/S0021-9673(97)01002-9; Kodama S, 2009, ELECTROPHORESIS, V30, P349, DOI 10.1002/elps.200800340; Righetti PG, 2001, ELECTROPHORESIS, V22, P603, DOI 10.1002/1522-2683(200102)22:4<603::AID-ELPS603>3.3.CO;2-E; Lu MH, 2009, ELECTROPHORESIS, V30, P2273, DOI 10.1002/elps.200800683; Horvath J, 2001, ELECTROPHORESIS, V22, P644, DOI 10.1002/1522-2683(200102)22:4<644::AID-ELPS644>3.3.CO;2-V; Schappler J, 2006, ELECTROPHORESIS, V27, P1537, DOI 10.1002/elps.200500805; Iwamuro Y, 2010, FORENSIC TOXICOL, V28, P19, DOI 10.1007/s11419-009-0086-x; Liu CY, 2001, ELECTROPHORESIS, V22, P612, DOI 10.1002/1522-2683(200102)22:4<612::AID-ELPS612>3.0.CO;2-N; Iwata YT, 2003, ELECTROPHORESIS, V24, P1770, DOI 10.1002/elps.200305431; Iwata YT, 2013, FORENSIC SCI INT, V226, P235, DOI 10.1016/j.forsciint.2013.01.033; Iwata YT, 2006, FORENSIC SCI INT, V161, P92, DOI 10.1016/j.forsciint.2006.01.018; Liau AS, 2003, FORENSIC SCI INT, V134, P17, DOI 10.1016/S0379-0738(03)00096-3; Fanali S, 1998, J CHROMATOGR A, V800, P69, DOI 10.1016/S0021-9673(97)00978-3; [Anonymous], 2000, AG CAP EL SYST US GU; Chen WH, 1999, J CHROMATOGR A, V848, P401, DOI 10.1016/S0021-9673(99)00444-6; Fritz JS, 2000, J CHROMATOGR A, V884, P261, DOI 10.1016/S0021-9673(00)00186-2; Harada K, 2008, J BIOSCI BIOENG, V105, P249, DOI 10.1263/jbb.105.249; Hsu JC, 1997, ANALYST, V122, P1393, DOI 10.1039/a700739f; Iio R, 2003, ANALYST, V128, P646, DOI 10.1039/b212820a; Inoue H, 2003, FORENSIC SCI INT, V135, P42, DOI 10.1016/S0379-0738(03)00176-2; Inoue H, 2008, J HEALTH SCI, V54, P615, DOI 10.1248/jhs.54.615; Inoue T., 1983, REP NATL RES I POLIC, V36, P92; INOUE T, 1994, FORENSIC SCI INT, V69, P97, DOI 10.1016/0379-0738(94)90053-1; Iwamuro Y, 2010, J HEALTH SCI, V56, P606, DOI 10.1248/jhs.56.606; Iwata YT, 2002, ELECTROPHORESIS, V23, P1328, DOI 10.1002/1522-2683(200205)23:9<1328::AID-ELPS1328>3.0.CO;2-Z; Kodama S, 2005, ELECTROPHORESIS, V26, P4070, DOI 10.1002/elps.200500445; Molina M, 2001, J CHROMATOGR A, V927, P191, DOI 10.1016/S0021-9673(01)01053-6; Nagai N., 1893, YAKUGAKU ZASHI, V13, P901; National Police Agency Government of Japan, 2014, WHIT PAP POL 2013; PFANZ H, 1955, Arch Pharm Ber Dtsch Pharm Ges, V288, P563, DOI 10.1002/ardp.19552881114; Rudaz S, 2005, ELECTROPHORESIS, V26, P3910, DOI 10.1002/elps.200500177; Schmitt-Kopplin P, 2001, ELECTROPHORESIS, V22, P77, DOI 10.1002/1522-2683(200101)22:1<77::AID-ELPS77>3.0.CO;2-1; SWGDRUG Committee, 2001, REC ED TRAIN QUAL AS; Taga A, 2008, J SEP SCI, V31, P853, DOI 10.1002/jssc.200700500; Taga Atsushi, 2007, J Oleo Sci, V56, P429; TANAKA K, 1994, J FORENSIC SCI, V39, P500; Wang XC, 2013, ELECTROPHORESIS, V34, P1828, DOI 10.1002/elps.201200679; Wongwan S, 2010, ELECTROPHORESIS, V31, P1475, DOI 10.1002/elps.200900724; Xu L, 2004, J CHROMATOGR A, V1033, P161, DOI 10.1016/j.chroma.2004.01.020	40	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	APR	2015	249						59	65		10.1016/j.forsciint.2015.01.015		7	Medicine, Legal	Legal Medicine	CE6LG	WOS:000351947300016		
J	Torimitsu, S; Nishida, Y; Takano, T; Koizumi, Y; Hayakawa, M; Yajima, D; Inokuchi, G; Makino, Y; Motomura, A; Chiba, F; Iwase, H				Torimitsu, Suguru; Nishida, Yoshifumi; Takano, Tachio; Koizumi, Yoshinori; Hayakawa, Mutsumi; Yajima, Daisuke; Inokuchi, Go; Makino, Yohsuke; Motomura, Ayumi; Chiba, Fumiko; Iwase, Hirotaro			Statistical analysis of biomechanical properties of the adult sagittal suture using a bending method in a Japanese forensic sample	FORENSIC SCIENCE INTERNATIONAL			English	Article						Mechanical properties; Bending strength; Suture; Cranial bone; Fracture; Adult	CRANIAL SUTURES; CRANIOFACIAL SUTURES; MECHANICAL-PROPERTIES; INFANT SKULL; BONE; STRAIN; HEAD; RAT; INJURIES; FONTANEL	This study examined the mechanical properties of the adult sagittal suture compared with surrounding parietal bones using bending tests and investigated the association between the mechanical properties of the suture and age. We used the heads of 116 Japanese cadavers (76 male cadavers and 40 female cadavers) of known age and sex. A total of 1160 cranial samples, 10 from each skull, were collected. The samples were imaged using multidetector computed tomography, and the sample thickness at the center of each sample (ST) was measured. The failure stress of each sample (FS) was measured by a bending test, and the ratio of failure stress to the square of sample thickness (FS/ST2) was calculated. Statistical analyses revealed that the FS and FS/ST2 values were significantly lower at all suture sites than at all bone sites regardless of sex. There were not significant but slight positive correlations between age and FS and FS/ST2 values at any suture site in male samples. In female samples, age had significant positive correlations with FS and FS/ST2 values at the middle suture sites, whereas there were not significant but slight positive correlations between age and FS and FS/ST2 values at the edges of the suture. Statistical analyses also demonstrated that FS and FS/ST2 values were significantly greater in male samples than in female samples at the middle suture sites. These findings suggest that the bending strength of the adult sagittal suture is significantly lower than that of surrounding parietal bones. Therefore, avoiding direct impact on cranial sutures may be important for preventing skull fractures and severe complications that can cause death. The results of this study also revealed that the bending strength of the middle sagittal suture significantly increases with age in only female samples, whereas the bending strength is significantly higher in male samples than in female samples at the middle suture sites, indicating the possibility of sex difference in the bony interdigitation of the sutures during childhood. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Torimitsu, Suguru; Hayakawa, Mutsumi; Yajima, Daisuke; Inokuchi, Go; Makino, Yohsuke; Motomura, Ayumi; Chiba, Fumiko; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan; [Nishida, Yoshifumi; Takano, Tachio; Koizumi, Yoshinori] Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Designing Everyday Life Funct & Social Syst Team, Koto Ku, Tokyo 1350064, Japan	Torimitsu, S (reprint author), Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	number60188@chiba-u.jp; y.nishida@aist.go.jp; t.takano@amail.plala.or.jp; y.koizumi@aist.go.jp; moo600@faculty.chiba-u.jp; yajima.d@faculty.chiba-u.jp; goinokuchi@chiba-u.jp; ymakino-tky@umin.ac.jp; tsunetoa@graduate.chiba-u.jp; chibafumico@chiba-u.jp; iwase@faculty.chiba-u.jp			Designing Everyday Life Function and Social System Team; Digital Human Research Center; National Institute of Advanced Industrial Science and Technology (AIST); JSPS KAKENHI [26860462]	This work was supported by Designing Everyday Life Function and Social System Team, Digital Human Research Center, National Institute of Advanced Industrial Science and Technology (AIST), and JSPS KAKENHI Grant Number 26860462.	PRITCHARD JJ, 1956, J ANAT, V90, P73; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.0.CO;2-1; Kiesler J, 2003, AM FAM PHYSICIAN, V67, P2547; DUC G, 1986, PEDIATRICS, V78, P904; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Mao JJ, 2002, J DENT RES, V81, P810; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; HUBBARD RP, 1971, J BIOMECH, V4, P491, DOI 10.1016/0021-9290(71)90039-X; Jasinoski SC, 2010, J BIOMECH, V43, P3104, DOI 10.1016/j.jbiomech.2010.08.007; Malli N, 2013, INT J LEGAL MED, V127, P195, DOI 10.1007/s00414-012-0690-x; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Henderson JH, 2005, J BIOMECH, V38, P2294, DOI 10.1016/j.jbiomech.2004.07.037; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; JASLOW CR, 1995, J ZOOL, V235, P193; Sun ZY, 2004, ANAT REC PART A, V276A, P150, DOI 10.1002/ar.a.20002; Chiba F, 2013, INT J LEGAL MED, V127, P1005, DOI 10.1007/s00414-013-0883-y; Delille C., 2003, MEC IND, V4, P119, DOI DOI 10.1016/S1296-2139(03)00029-0; Delille R, 2007, INT J CRASHWORTHINES, V12, P101, DOI 10.1080/13588260701433081; EVANS FG, 1957, J APPL PHYSIOL, V10, P493; Henderson JH, 2004, BONE, V34, P271, DOI 10.1016/j.bone.2003.10.007; Herring S. W., 2000, CRANIOSYNOSTOSIS, P3; Herring S W, 2005, Orthod Craniofac Res, V8, P174, DOI 10.1111/j.1601-6343.2005.00328.x; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Kikugawa H, 2004, MATER TRANS, V45, P3060, DOI 10.2320/matertrans.45.3060; Mao JJ, 2003, ANGLE ORTHOD, V73, P128; MCELHANE.JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; McLaughlin E, 2000, CLEFT PALATE-CRAN J, V37, P590, DOI 10.1597/1545-1569(2000)037<0590:TLDCON>2.0.CO;2; Nishimoto T., 1995, T JPN SOC MECH ENG, V61, P2386; PERSSON M, 1973, Odontologisk Revy, V24, P1; Popowics TE, 2007, J BIOMECH, V40, P837, DOI 10.1016/j.jbiomech.2006.03.011; Rice David P., 2008, V12, P1, DOI 10.1159/0000115028; Russell Anthony P., 1993, P345; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; Tada H., 2000, STRESS ANAL CRACKS H, P58; Torimitsu S., 2014, FORENSIC SCI INT, V234; Vaananen H.K., 1996, MATURITAS, V23, P65; Yamada H., 1970, STRENGTH BIOL MAT; Yu Jack C, 2004, Semin Pediatr Neurol, V11, P249, DOI 10.1016/j.spen.2004.10.002	41	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	APR	2015	249						101	106		10.1016/j.forsciint.2015.01.030		6	Medicine, Legal	Legal Medicine	CE6LG	WOS:000351947300021		
J	Makino, Y; Yamamoto, S; Shiotani, S; Hayakawa, H; Fujimoto, H; Yokota, H; Horikoshi, T; Iwase, H; Uno, T				Makino, Yohsuke; Yamamoto, Seiji; Shiotani, Seiji; Hayakawa, Hideyuki; Fujimoto, Hajime; Yokota, Hajime; Horikoshi, Takuro; Iwase, Hirotaro; Uno, Takashi			Can ruptured abdominal aortic aneurysm be accurately diagnosed as the cause of death without postmortem computed tomography when autopsies cannot be performed?	FORENSIC SCIENCE INTERNATIONAL			English	Article						Cause of death; Multidetector computed tomography; Abdominal aortic aneurysm; Ruptured aortic aneurysm; Autopsy	HIGH-ATTENUATING CRESCENT; IMPENDING RUPTURE; CT FINDINGS; SIGN; TRIAL; MEN	Purpose: This study aimed to conduct a multicentre retrospective review of cases to clarify how many ruptured abdominal aortic aneurysms (RAAAs) as the cause of death could be diagnosed without postmortem computed tomography (PMCT) when autopsies cannot be performed. Methods: We collected consecutive PMCT data from January 2002 to December 2009 from three institutes where PMCT examinations are performed on a routine basis for deceased patients with unknown causes of death. A total of 19 cases were identified where PMCT revealed RAAAs. Ante-mortem clinical presentations, post-mortem external examinations, and peri-mortem ultrasonography findings were assessed for their diagnostic accuracy. Results: The correct diagnosis based on the classic triad of shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%) patients. Shock, acute abdominal pain, and abdominal swelling were found in five of 19 (26%) patients. Shock and acute abdominal pain or abdominal swelling were found in two of 19 (10%) patients. Ten of 19 (53%) patients only had shock. Peri-mortem ultrasonography was performed in seven of 19 patients; one was diagnosed with RAAA (14%). No patients had pre-mortem CT examinations. Conclusions: Post-mortem diagnosis of RAAA is difficult to make based on ante-mortem clinical presentation, post-mortem external examinations, or peri-mortem ultrasonography. PMCT is recommended for diagnosing RAAA as the cause of death if pre-mortem CT examinations are not carried out when autopsies cannot be performed. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Makino, Yohsuke; Yokota, Hajime; Uno, Takashi] Chiba Univ Hosp, Dept Radiol, Chuo Ku, Chiba 2608677, Japan; [Makino, Yohsuke; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan; [Yamamoto, Seiji] Autopsy Imaging Informat Ctr, Chuo Ku, Tokyo 1040061, Japan; [Shiotani, Seiji] Tsukuba Med Ctr, Dept Radiol, Tsukuba, Ibaraki 3058558, Japan; [Hayakawa, Hideyuki] Tsukuba Med Examiners Off, Dept Forens Med, Tsukuba, Ibaraki 3058558, Japan; [Fujimoto, Hajime] Numazu City Hosp, Dept Radiol, Numazu, Shizuoka 4100302, Japan; [Horikoshi, Takuro; Uno, Takashi] Chiba Univ, Dept Diagnost Radiol & Radiat Oncol, Chuo Ku, Chiba 2608670, Japan; [Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan	Makino, Y (reprint author), Chiba Univ Hosp, Dept Radiol, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	ymakino-tky@umin.ac.jp; seikichi@autopsyimaging.com; shiotani@tmch.or.jp; hayakawa@tmch.or.jp; hfujimot@lilac.ocn.ne.jp; rd8h-ykt@radio.ne.jp; taku_steelfish@yahoo.co.jp; iwase@faculty.chiba-u.jp; unotakas@faculty.chiba-u.jp					Aghayev E, 2007, FORENSIC SCI INT, V166, P199, DOI 10.1016/j.forsciint.2006.05.035; Arita T, 1997, RADIOLOGY, V204, P765; Ashton HA, 2002, LANCET, V360, P1531; Takahashi N, 2012, EUR RADIOL, V22, P152, DOI 10.1007/s00330-011-2248-6; Flach PM, 2010, ARCH PATHOL LAB MED, V134, P115, DOI 10.1043/2008-0503-CRR3.1; Hayakawa M, 2006, INT J LEGAL MED, V120, P24, DOI 10.1007/s00414-005-0038-x; Rakita D, 2007, RADIOGRAPHICS, V27, P497, DOI 10.1148/rg.272065026; SIEGEL CL, 1994, AM J ROENTGENOL, V163, P1123; Schwartz SA, 2007, AM J ROENTGENOL, V188, pW57, DOI 10.2214/AJR.05.1554; Shojania KG, 2008, NEW ENGL J MED, V358, P873, DOI 10.1056/NEJMp0707996; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Leth PM, 2009, AM J FOREN MED PATH, V30, P219, DOI 10.1097/PAF.0b013e318187e0af; Kasahara S, 2012, LEGAL MED-TOKYO, V14, P239, DOI 10.1016/j.legalmed.2012.03.007; Gonsalves CF, 1999, RADIOLOGY, V211, P37; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; MEHARD WB, 1994, RADIOLOGY, V192, P359; Arai Akiko, 2006, Radiat Med, V24, P147, DOI 10.1007/BF02493283; Blanc-Louvry I., 2013, EUR RADIOL, V23, P1829; DONALDSON MC, 1985, J VASC SURG, V2, P564; Loughrey MB, 2000, ULSTER MED J, V69, P83; Proisy M., 2012, EUROPEAN RADIOLOGY, V23, P1711; Saukko P., 1997, KNIGHTS FORENSIC PAT; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; Shiotani Seiji, 2004, Radiat Med, V22, P405; Takahashi N, 2009, JPN J RADIOL, V27, P264, DOI 10.1007/s11604-009-0337-0; Uchigasaki S, 2004, FORENSIC SCI INT, V140, P33, DOI 10.1016/j.forsciint.2003.11.029; Vardulaki KA, 1999, J MED SCREEN, V6, P50	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	APR	2015	249						107	111		10.1016/j.forsciint.2015.01.022		5	Medicine, Legal	Legal Medicine	CE6LG	WOS:000351947300022		
J	Amino, K; Osanai, T				Amino, Kanae; Osanai, Takashi			Cross-language differences of articulation rate and its transfer into Japanese as a second language	FORENSIC SCIENCE INTERNATIONAL			English	Article						Forensic phonetics; Foreign accents; Speech tempo; Accent identification	DIALECT; ACCENT; SPEECH	Recently, the articulation rate has been attracting attention in forensic speech investigation as an acoustic feature that varies across speakers, dialects, and languages. The present study investigates how cross-language differences in the articulation rate are transferred into Japanese as a second language. Participants were speakers of Japanese, Chinese, Korean, and Thai. They were recorded while they read a passage in their native language and in Japanese. Local and global articulation rates were calculated based on the number of syllables as well as the number of morae for Japanese speech. When we compared the articulation rate of the native languages, Japanese was the fastest, then Korean, Chinese, and Thai in that order. Also, a significant positive correlation was observed between the articulation rate of the native language and that of the second language. A gender difference was found in the articulation rate of some languages, with males speaking faster than females. The effect of age was limited to Thai speakers only. Accent discrimination and identification experiments were conducted and the results revealed that native and non-native accents could be correctly discriminated just by the articulation rate. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Amino, Kanae; Osanai, Takashi] Natl Res Inst Police Sci, Sect Forens Sci 4, Kashiwa, Chiba 2770882, Japan	Amino, K (reprint author), Natl Res Inst Police Sci, Sect Forens Sci 4, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	amino@nrips.go.jp			JSPS [26870865, 25350488, 24810034]	This study was supported by Grants-in-Aid for Scientific Research KAKENHI by JSPS (26870865, 25350488, 24810034).	Neuhauser S, 2008, INT J SPEECH LANG LA, V15, P131, DOI 10.1558/ijsll.v15i2.131; BYRD D, 1994, SPEECH COMMUN, V15, P39, DOI 10.1016/0167-6393(94)90039-6; Jacewicz E, 2009, LANG VAR CHANGE, V21, P233, DOI 10.1017/S0954394509990093; Boersma Paul, 2001, GLOT INT, V5.9-10, P341; Cao H., 2011, P ICPHS, P396; Flege James Emil, 1982, STUDIES 2 LANGUAGE A, V5, P1, DOI 10.1017/S0272263100004563; Gonzalez-Rodriguez J., 2014, P OD, P33; Gut Ulrike, 2007, Speaker Classification I. Fundamentals, Features, and Methods. (Lecture Notes in Artificial Intelligence vol. 4343), DOI 10.1007/978-3-540-74200-5_4; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI DOI 10.1145/1656274.1656278; Hollien H., 2002, FORENSIC VOICE IDENT; International Phonetic Association, 1999, HDB INT PHON ASS GUI; Jessen M, 2007, SCI JUSTICE, V47, P50, DOI 10.1016/j.scijus.2007.03.003; Jessen Michael, 2007, Speaker Classification I. Fundamentals, Features, and Methods. (Lecture Notes in Artificial Intelligence vol. 4343), DOI 10.1007/978-3-540-74200-5_10; Koester O., 2012, INT J SPEECH LANG LA, V19, P51; Kuenzel H. J., 1995, Science and Justice, V35, P291; Munro MJ, 1995, LANG SPEECH, V38, P289; Quene H, 2008, J ACOUST SOC AM, V123, P1104, DOI 10.1121/1.2821762; Rogers H., 1998, FORENSIC LINGUIST, V5, P203, DOI DOI 10.1558/SLL.1998.5.2.203; Rose P., 2002, FORENSIC SPEAKER IDE; Simpson AP, 2001, J ACOUST SOC AM, V109, P2153, DOI 10.1121/1.1356020; Vance Timothy J., 2008, SOUNDS JAPANESE; Yuan JH, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P541	22	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	APR	2015	249						116	122		10.1016/j.forsciint.2015.01.029		7	Medicine, Legal	Legal Medicine	CE6LG	WOS:000351947300024		
J	Uekusa, K; Hayashida, M; Ohno, Y				Uekusa, Kyoko; Hayashida, Makiko; Ohno, Youkichi			Forensic toxicological analyses of drugs in tissues in formalin solutions and in fixatives	FORENSIC SCIENCE INTERNATIONAL			English	Article						Forensic-toxicology; Analysis; Formalin; Tissue; GC-MS; Sulfoxide	FIXED LIVER-TISSUE; MASS-SPECTROMETRY; METHAMPHETAMINE; QUANTITATION; METHYLATION; STABILITY	Forensic toxicological drug analyses of human specimens are usually performed immediately after autopsy or on frozen preserved tissues. Occasionally, cases require analysis of drugs from tissues fixed in formalin solution. To improve the estimation of the level of drug in tissues following formalin fixation, we studied drug concentrations in human tissues, liver and kidney, that were collected from a drug-positive autopsy case. Parts of tissues were preserved in formalin solution for 1, 3, 6 and 13 months. Tissues obtained before and after preservation, along with tissue-exposed fixatives, were assayed using gas chromatography-mass spectrometry; all of the samples were assayed for the presence of drugs and changes in the drug concentrations both before and after preservation in formalin. Concentrations of assayed drugs decreased upon fixation in formalin; levels of these drugs did not necessarily show further decreases during subsequent storage in fixative, up to 13 months. Distinct trends in drug levels were found in liver and kidney. In liver, the levels of chlorpromazine, levomepromazine, and promethazine decreased to 23-39% at 1 month after preservation; all 3 of these drugs were detected at all tested time points of preservation. Bromazepam was not detected at 13 months after preservation. Milnacipran was the most unstable after preservation in formalin solution among all of the assayed drugs. In kidney, all assayed drugs exhibited reduced stability during preservation compared to levels in liver. Methamphetamine and methylenedioxymethamphetamine were not detected in any time points of tissues. The proportions of the drugs that remained within the tissues differed between liver and kidney. Also, S-oxide compounds of chlorpromazine and levomepromazine, which were not observed before preservation, were detected in fixed liver tissues and their fixatives at 3, 6 and 13 months of preservation. These results suggest that analyses in formalin-fixed tissues need to include analysis of various organ-tissues and their fixatives at multiple time points for the duration of preservation. These analyses should include detection of chemical degradation/denaturation products, such as S-oxides of chlorpromazine and levomepromazine. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Uekusa, Kyoko; Hayashida, Makiko; Ohno, Youkichi] Nippon Med Sch, Dept Legal Med, Tokyo 1138602, Japan	Uekusa, K (reprint author), Nippon Med Sch, Dept Legal Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	uekusa@nms.ac.jp			Japan Society for the Promotion of Science (JSPS) [23590859, 26460891]	The authors thank Dr. Makoto Nihira (Nippon Medical School, Tokyo, Japan) for his advice and support. The authors are grateful to Dr. Kenji Hara (Fukuoka University, Fukuoka, Japan) for donating methamphetamine-d<INF>4</INF>, to Dr. Yukari Tomita (Nippon Medical School, Tokyo, Japan) for her excellence assistance. A portion of this work was supported by Grants-in-Aid for Scientific Research (No. 23590859, No. 26460891) from the Japan Society for the Promotion of Science (JSPS).	Kudo K, 2009, FORENSIC TOXICOL, V27, P21, DOI 10.1007/s11419-009-0066-1; Baselt R.C., 2011, DISPOSITION TOXIC DR, P333; CASHMAN JR, 1993, DRUG METAB DISPOS, V21, P492; Cingolani M, 2004, J ANAL TOXICOL, V28, P16; Cingolani M, 2001, J ANAL TOXICOL, V25, P31; Hayashida Makiko, 2009, Leg Med (Tokyo), V11 Suppl 1, pS423, DOI 10.1016/j.legalmed.2009.02.078; Maskell PD, 2013, J ANAL TOXICOL, V37, P440, DOI 10.1093/jat/bkt051; Nikolaou P, 2013, FORENSIC SCI INT, V233, P312, DOI 10.1016/j.forsciint.2013.10.006; NISHIGAMI J, 1995, INT J LEGAL MED, V107, P165, DOI 10.1007/BF01428398; O'Neil M.J., 2006, MERCK INDEX, P726; Shakleya DM, 2005, J ANAL TOXICOL, V29, P715; Shakleya DM, 2006, FORENSIC SCI INT, V157, P87, DOI 10.1016/j.forsciint.2005.04.012; Suzuki Y., 2009, JPN J FORENSIC SCI T, V14, P99; Takayasu T, 2013, J ANAL TOXICOL, V37, P615, DOI 10.1093/jat/bkt055; Tirumalai PS, 2005, J ANAL TOXICOL, V29, P48; Tracy TS, 2001, J ANAL TOXICOL, V25, P166; TSOUKALIPAPADOPOULOU H, 1987, FORENSIC SCI INT, V34, P63, DOI 10.1016/0379-0738(87)90084-3; Uekusa K, 2013, FORENSIC SCI INT, V227, P45, DOI 10.1016/j.forsciint.2012.10.005; Viel G, 2009, FORENSIC SCI INT, V193, P79, DOI 10.1016/j.forsciint.2009.09.010; WINEK CL, 1993, FORENSIC SCI INT, V61, P175, DOI 10.1016/0379-0738(93)90224-X	20	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	APR	2015	249						165	172		10.1016/j.forsciint.2015.01.028		8	Medicine, Legal	Legal Medicine	CE6LG	WOS:000351947300029		
J	Matsuta, S; Shima, N; Kamata, H; Kakehashi, H; Nakano, S; Sasaki, K; Kamata, T; Nishioka, H; Miki, A; Katagi, M; Zaitsu, K; Sato, T; Tsuchihashi, H; Suzuki, K				Matsuta, Shuntaro; Shima, Noriaki; Kamata, Hiroe; Kakehashi, Hidenao; Nakano, Shihoko; Sasaki, Keiko; Kamata, Tooru; Nishioka, Hiroshi; Miki, Akihiro; Katagi, Munehiro; Zaitsu, Kei; Sato, Takako; Tsuchihashi, Hitoshi; Suzuki, Koichi			Metabolism of the designer drug alpha-pyrrolidinobutiophenone (alpha-PBP) in humans: Identification and quantification of the phase I metabolites in urine	FORENSIC SCIENCE INTERNATIONAL			English	Article						alpha-PBP; Cathinone; Human phase I metabolism; Urine; LC-MS/MS; GC-MS	CHROMATOGRAPHY-MASS-SPECTROMETRY; TOXICOLOGICAL DETECTION; RABBIT LIVER; RAT; PYROVALERONE; REDUCTION	Urinary phase I metabolites of alpha-pyrrolidinobutiophenone (alpha-PBP) in humans were investigated by analyzing urine specimens obtained from drug abusers. Unequivocal identification and accurate quantification of major metabolites were realized using gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry with newly synthesized authentic standards. Two major phase I metabolic pathways were revealed: (1) reduction of the ketone group to 1-phenyl-2-(pyrrolidin-1-yl)butan-1-ol (OH-alpha-PBP, diastereomers) partly followed by conjugation to its glucuronide and (2) oxidation at the 2 ''-position of the pyrrolidine ring to alpha-(2 ''-oxo-pyrrolidino)butiophenone (2 ''-oxo-alpha-PBP) via the putative intermediate alpha-(2 ''-hydroxypyrrolidino)butiophenone (2 ''-OH-alpha-PBP). Of the phase I metabolites retaining the structural characteristics of the parent drug, OH-alpha-PBP was the most abundant in all specimens examined. Comparison of the phase I metabolism of alpha-PBP and alpha-pyrrolidinovalerophenone (alpha-PVP) suggested a relationship between the aliphatic side chain length and the metabolic pathways in alpha-pyrrolidinophenones: the shorter aliphatic side chain (1) led to more extensive metabolism via reduction of the ketone group than via the oxidation at the 2 ''-position of the pyrrolidine ring and (2) influenced the isomeric ratio of a pair of diastereomers. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Matsuta, Shuntaro; Shima, Noriaki; Kamata, Hiroe; Kakehashi, Hidenao; Nakano, Shihoko; Sasaki, Keiko; Kamata, Tooru; Nishioka, Hiroshi; Miki, Akihiro; Katagi, Munehiro] Osaka Prefectural Police Headquarters, Forens Sci Lab, Chuo Ku, Osaka 5410053, Japan; [Zaitsu, Kei] Nagoya Univ, Grad Sch Med, Dept Legal Med & Bioeth, Showa Ku, Nagoya, Aichi 4668550, Japan; [Sato, Takako; Tsuchihashi, Hitoshi; Suzuki, Koichi] Osaka Med Coll, Dept Legal Med, Div Prevent & Social Med, Takatsuki, Osaka 5698686, Japan	Matsuta, S (reprint author), Osaka Prefectural Police Headquarters, Forens Sci Lab, Chuo Ku, 1-3-18 Hommachi, Osaka 5410053, Japan.	matsutash@gmail.com					Ammann D, 2012, J ANAL TOXICOL, V36, P381, DOI 10.1093/jat/bks049; Meltzer PC, 2006, J MED CHEM, V49, P1420, DOI 10.1021/jm050797a; Meyer MR, 2010, J MASS SPECTROM, V45, P1426, DOI 10.1002/jms.1859; Springer D, 2002, J CHROMATOGR B, V773, P25, DOI 10.1016/S1570-0232(01)00578-5; Shin HS, 1996, J ANAL TOXICOL, V20, P568; Springer D, 2003, J CHROMATOGR B, V796, P253, DOI 10.1016/j.jchromb.2003.07.008; IMAMURA Y, 1989, J PHARMACOBIO-DYNAM, V12, P731; Jane MP, 2012, J MED TOXICOL, V8, P33; Kobana K, 2000, BIOL PHARM BULL, V23, P917; Matsuta S, 2014, JPN J FORENSIC SCI T, V19, P77; Peters FT, 2005, J CHROMATOGR B, V824, P81, DOI 10.1016/j.jchromb.2005.07.003; Sauer S, 2009, J MASS SPECTROM, V44, P952; Shima N, 2013, FORENSIC TOXICOL, V31, P101, DOI 10.1007/s11419-012-0172-3; Shima N, 2014, FORENSIC TOXICOL, V32, P59, DOI 10.1007/s11419-013-0202-9	14	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	APR	2015	249						181	188		10.1016/j.forsciint.2015.02.004		8	Medicine, Legal	Legal Medicine	CE6LG	WOS:000351947300031		
J	Sato, H; Inoue, H; Hayee, B; Ikeda, H; Sato, C; Phalanusitthepha, C; Santi, EGR; Kobayashi, Y; Kudo, S				Sato, Hiroki; Inoue, Haruhiro; Hayee, Bu'Hussain; Ikeda, Haruo; Sato, Chiaki; Phalanusitthepha, Chainarong; Santi, Esperanza Grace R.; Kobayashi, Yasutoshi; Kudo, Shin-ei			In vivo histopathology using endocytoscopy for non-neoplastic changes in the gastric mucosa: a prospective pilot study (with video)	GASTROINTESTINAL ENDOSCOPY			English	Article							HELICOBACTER-PYLORI INFECTION; SQUAMOUS-CELL CARCINOMA; INTESTINAL METAPLASIA; MAGNIFYING ENDOSCOPY; CANCER; CLASSIFICATION; DIAGNOSIS; TRIAL; ANTIBODIES; PATHOLOGY	Background: Endocytoscopy (EC), as a novel ultrahigh magnification technology, enables in vivo histopathological diagnoses of the GI tract. EC is particularly exceptional when comparing dysplastic and neoplastic tissue with normal tissue. There are, however, no detailed data for minute or minimal changes in the gastric mucosa. Objective: To describe non-neoplastic EC patterns of the gastric mucosa correlated with histopathological findings and to determine any relationship with Helicobacter pylori (HP) infection. Design: A pilot prospective study. Setting: Tertiary care referral center. Patients: Sixty-four participants undergoing upper endoscopy for various indications. Methods: Antral mucosal patterns on EC were divided into 4 categories: type 1 (normal), each papilla/pit has round smooth structure; type 2 (gastritis), extended, notched, and distorted structure with some necrotic tissue; type 3(atrophy), neighboring papilla/pit take on a lobulated appearance; type 4 (intestinal metaplasia [IM]), goblet cells are identified in a completely stained crypt. Target biopsy specimens were obtained from the region identified with these patterns, and multiple HP tests were performed. Results: HP positivity was 0%, 40.9%, 50.0%, and 58.3% in types 1, 2, 3, and 4, respectively. The sensitivity and specificity of types 2+3+4 for HP positivity were 100% and 42.5%, respectively. The positive predictive values of type 1 for normal, type 2 for chronic gastritis, type 3 for atrophic gastritis, and type 4 for IM were 100%, 62.5%, 40.0%, and 100%, respectively. The sensitivity and specificity of types 3+4 for atrophic gastritis to IM were 87.0% and 95.1%, respectively. Limitations: Small, single-center, pilot study. Conclusions: EC can differentiate gastric mucosal patterns of minimal, non-neoplastic change and appears to reliably exclude HP infection.	[Sato, Hiroki; Inoue, Haruhiro; Ikeda, Haruo; Sato, Chiaki; Phalanusitthepha, Chainarong; Kudo, Shin-ei] Showa Univ, Ctr Digest Dis, Nothern Yokohama Hosp, Yokohama, Kanagawa 2248503, Japan; [Hayee, Bu'Hussain] Kings Coll Hosp NHS Fdn Trust, Dept Gastroenterol, London, England; [Santi, Esperanza Grace R.] De La Salle Univ, Med Ctr, Dept Gastroenterol, Dasmarinas City, Cavite, Philippines; [Kobayashi, Yasutoshi] Kobayashi Internal Med Clin, Kobe, Hyogo, Japan	Sato, H (reprint author), Showa Univ, Ctr Digest Dis, Nothern Yokohama Hosp, Tsuzuki Ku, 35-1 Chigasakichuo, Yokohama, Kanagawa 2248503, Japan.						Hayee B, 2013, GASTROINTEST ENDOSC, V78, P452, DOI 10.1016/j.gie.2013.03.1333; Uedo N, 2006, ENDOSCOPY, V38, P819, DOI 10.1055/s-2006-944632; Neumann H, 2011, ALIMENT PHARM THER, V33, P1183, DOI 10.1111/j.1365-2036.2011.04647.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Tahara T, 2009, GASTROINTEST ENDOSC, V70, P246, DOI 10.1016/j.gie.2008.11.046; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Inoue H, 2006, ENDOSCOPY, V38, P891, DOI 10.1055/s-2006-944667; Kaise M, 2009, ENDOSCOPY, V41, P310, DOI 10.1055/s-0028-1119639; BAH A, 1995, ENDOSCOPY, V27, P593, DOI 10.1055/s-2007-1005764; Minami H, 2012, DIS ESOPHAGUS, V25, P235, DOI 10.1111/j.1442-2050.2011.01241.x; Yagi K, 2005, ENDOSCOPY, V37, P660, DOI 10.1055/s-861423; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Redeen S, 2003, ENDOSCOPY, V35, P946; Kudo SE, 2011, ENDOSCOPY, V43, P869, DOI 10.1055/s-0030-1256663; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Kokkola A, 2003, APMIS, V111, P619, DOI 10.1034/j.1600-0463.2003.1110604.x; MARSHALL BJ, 1984, LANCET, V1, P1311; Kitahara F, 1999, GUT, V44, P693; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Shimizu Y, 2013, GASTROINTEST ENDOSC, V78, P351, DOI 10.1016/j.gie.2013.03.1336; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Chiu PWY, 2014, DIGEST ENDOSC, V26, P52, DOI 10.1111/den.12050; ASAKA M, 1994, J GASTROENTEROL, V29, P100; Bansal A, 2008, GASTROINTEST ENDOSC, V67, P210, DOI 10.1016/j.gie.2007.06.009; Chandrasoma PT, 2003, AM J SURG PATHOL, V27, P929, DOI 10.1097/00000478-200307000-00008; IDA K, 1975, ENDOSCOPY, V7, P18; Inoue Haruhiro, 2005, Clin Gastroenterol Hepatol, V3, pS61, DOI 10.1016/S1542-3565(05)00282-X; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; Kumagai Y, 2009, DIS ESOPHAGUS, V22, P505, DOI 10.1111/j.1442-2050.2009.00952.x; RUGGE M, 1993, HISTOPATHOLOGY, V22, P9, DOI 10.1111/j.1365-2559.1993.tb00062.x; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Suzuki S, 1979, Int Adv Surg Oncol, V2, P223; Tao Guo, 2014, Gastric Cancer, V17, P122, DOI 10.1007/s10120-013-0250-1; Yagi K, 2002, J GASTROEN HEPATOL, V17, P39, DOI 10.1046/j.1440-1746.2002.02665.x	35	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					875	881		10.1016/j.gie.2014.08.019		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700009		
J	Tsuji, Y; Fujishiro, M; Kodashima, S; Ono, S; Niimi, K; Mochizuki, S; Asada-Hirayama, I; Matsuda, R; Minatsuki, C; Nakayama, C; Takahashi, Y; Sakaguchi, Y; Yamamichi, N; Koike, K				Tsuji, Yosuke; Fujishiro, Mitsuhiro; Kodashima, Shinya; Ono, Satoshi; Niimi, Keiko; Mochizuki, Satoshi; Asada-Hirayama, Itsuko; Matsuda, Rie; Minatsuki, Chihiro; Nakayama, Chiemi; Takahashi, Yu; Sakaguchi, Yoshiki; Yamamichi, Nobutake; Koike, Kazuhiko			Polyglycolic acid sheets and fibrin glue decrease the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms (with video)	GASTROINTESTINAL ENDOSCOPY			English	Article							RANDOMIZED CONTROLLED-TRIAL; CANCER; RESECTION; OUTCOMES; ULCER; FEASIBILITY; GASTRECTOMY; PREVENTION; INCREASE; STOMACH	Background: The prevention of bleeding after endoscopic submucosal dissection (ESD) for gastric neoplasms is still an important problem. Objective: To investigate the efficacy and safety of a shielding method that uses polyglycolic acid (PGA) sheets and fibrin glue to prevent post-ESD bleeding in high-risk patients. Design: A nonrandomized trial with historical control subjects. Setting: A single academic hospital in Japan. Patients: From July 2013 to February 2014, 45 ESD-induced ulcers in 41 patients with a high risk of bleeding were enrolled in a study group. Forty-one consecutive ESD-induced ulcers in 37 control subjects with a high risk of bleeding were treated in 2013 before the first enrollment. Interventions: We placed PGA sheets on the mucosal defect and fixed with fibrin glue in the study group. Main Outcome Measurements: The post-ESD bleeding rate. Results: The post-ESD bleeding occurred at a rate of 6.7% in the study group (3/45 lesions) and 22.0% in the historical control group (9/41 lesions). There was a significant difference in the post-ESD bleeding rate between the 2 groups (P Z.041). Limitations: A nonrandomized trial with historical control subjects; a single-center analysis; small sample size. Conclusions: The endoscopic tissue shielding method with PGA sheets and fibrin glue appears to be promising for the prevention of post-ESD bleeding.	[Tsuji, Yosuke; Fujishiro, Mitsuhiro; Kodashima, Shinya; Ono, Satoshi; Mochizuki, Satoshi; Asada-Hirayama, Itsuko; Matsuda, Rie; Minatsuki, Chihiro; Nakayama, Chiemi; Takahashi, Yu; Sakaguchi, Yoshiki; Yamamichi, Nobutake; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo 1138655, Japan; [Tsuji, Yosuke; Fujishiro, Mitsuhiro] Univ Tokyo, Dept Endoscopy & Endoscop Surg, Grad Sch Med, Tokyo 1138655, Japan; [Niimi, Keiko] Univ Tokyo, Ctr Epidemiol & Prevent Med, Grad Sch Med, Tokyo 1138655, Japan	Fujishiro, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Takahashi, Yu/I-4665-2015	Takahashi, Yu/0000-0002-3066-9501	BoehringerIngelheim; Otsuka Pharmaceutical; Astrazeneca Pharmaceutical; DaiichiSankyo Pharmaceutical; Eisai Corporation; Aska Pharmaceutical; Nihon Pharmaceutical; Pentax; Mitsubishi Tanabe Pharma Corporation; Amco Corporation; Takeda Pharmaceutical; Zeria Pharmaceutical; Astellas Pharmaceutical; Dainihon-Sumitomo Pharmaceutical; Taiho Pharmaceutical; Ajinomoto Pharmaceutical; Eisai	The following author disclosed financial relationships relevant to this publication: M. Fujishiro: Speaker for Olympus, BoehringerIngelheim, Otsuka Pharmaceutical, Astrazeneca Pharmaceutical, DaiichiSankyo Pharmaceutical, Eisai Corporation, Aska Pharmaceutical, Nihon Pharmaceutical, Pentax, Mitsubishi Tanabe Pharma Corporation, Amco Corporation, and Takeda Pharmaceutical; Unrestricted Research Grants from Astellas Pharmaceutical, Takeda Pharmaceutical, Zeria Pharmaceutical, Otsuka Pharmaceutical, Astrazeneca Pharmaceutical, Dainihon-Sumitomo Pharmaceutical, Taiho Pharmaceutical, Ajinomoto Pharmaceutical, and Eisai; Nonfinancial Support from HOYA Pentax, Olympus Medical Systems, and Fujifilm; and Honoraria from Olympus Medical Systems, HOYA Pentax, Eisai, MSD, Daiichi-Sankyo Pharmaceutical, Astrazeneca Pharmaceutical, Aska Pharmaceutical, Taisho-Toyama Pharmaceutical, Otsuka Pharmaceutical, Zeria Pharmaceutical, Takeda Pharmaceutical, Astellas Pharmaceutical, Seikagaku Corp, Johnson & Johnson, Ajinomoto Pharmaceutical, Amco, Novartis Pharmaceutical, Boston Scientific, and, Boehringer-Ingelheim. All other authors disclosed no financial relationships relevant to this publication.	Higashiyama M, 2011, DIGEST ENDOSC, V23, P290, DOI 10.1111/j.1443-1661.2011.01151.x; Ono S, 2014, ENDOSCOPY, V46, pE44, DOI 10.1055/s-0033-1359125; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Tokioka S, 2012, J GASTROEN HEPATOL, V27, P63, DOI 10.1111/j.1440-1746.2012.07075.x; Sanomura Y, 2014, GASTRIC CANCER, V17, P489, DOI 10.1007/s10120-013-0305-3; Tsuji Y, 2014, GASTROINTEST ENDOSC, V79, P151, DOI 10.1016/j.gie.2013.08.041; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Niimi K, 2012, DIGEST ENDOSC, V24, P110, DOI 10.1111/j.1443-1661.2011.01178.x; Sekiguchi M, 2013, ENDOSCOPY, V45, P708, DOI 10.1055/s-0033-1344332; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Goto O, 2009, ENDOSCOPY, V41, P118, DOI 10.1055/s-0028-1119452; Tsuji Y, 2010, WORLD J GASTROENTERO, V16, P2913, DOI 10.3748/wjg.v16.i23.2913; Koh R, 2013, GASTROINTEST ENDOSC, V78, P476, DOI 10.1016/j.gie.2013.03.008; Choi CW, 2014, SURG ENDOSC, V28, P2213, DOI 10.1007/s00464-014-3457-2; Fujishiro M, 2006, WORLD J GASTROENTERO, V12, P5108; Okada K, 2011, SURG ENDOSC, V25, P98, DOI 10.1007/s00464-010-1137-4; Lim JH, 2012, GASTROINTEST ENDOSC, V75, P719, DOI 10.1016/j.gie.2011.11.034; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Takizawa K, 2008, ENDOSCOPY, V40, P179, DOI 10.1055/s-2007-995530; Cho SJ, 2012, ENDOSCOPY, V44, P114, DOI 10.1055/s-0031-1291459; Goto O, 2012, DIGEST DIS SCI, V57, P435, DOI 10.1007/s10620-011-1886-5; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Hiura Y, 2013, SURG TODAY, V43, P527, DOI 10.1007/s00595-012-0253-2; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Mukai S, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/875323; Nonaka S, 2013, GASTROINTEST ENDOSC, V78, P63, DOI 10.1016/j.gie.2013.02.006; Nonaka S, 2014, GASTROINTEST ENDOSC, V79, P260, DOI 10.1016/j.gie.2013.07.059; Takeuchi J, 2013, J ORAL MAXIL SURG, V71, pE126, DOI 10.1016/j.joms.2012.08.012; Takeuchi T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-136; Takimoto K, 2012, Endoscopy, V44 Suppl 2 UCTN, pE414, DOI 10.1055/s-0032-1325739; Tomita T, 2012, J GASTROEN HEPATOL, V27, P1441, DOI 10.1111/j.1440-1746.2012.07144.x; Ueda K, 2011, J SURG RES, V167, pE71, DOI 10.1016/j.jss.2009.11.009; Uedo N, 2007, AM J GASTROENTEROL, V102, P1610, DOI 10.1111/j.1572-0241.2007.01197.x; Uemura K, 2009, HEPATO-GASTROENTEROL, V56, P1538	35	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					906	912		10.1016/j.gie.2014.08.028		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700014		
J	Dhir, V; Itoi, T; Khashab, MA; Park, DH; Teoh, AYB; Attam, R; Messallam, A; Varadarajulu, S; Maydeo, A				Dhir, Vinay; Itoi, Takao; Khashab, Mouen A.; Park, Do Hyun; Teoh, Anthony Yuen Bun; Attam, Rajeev; Messallam, Ahmed; Varadarajulu, Shyam; Maydeo, Amit			Multicenter comparative evaluation of endoscopic placement of expandable metal stents for malignant distal common bile duct obstruction by ERCP or EUS-guided approach	GASTROINTESTINAL ENDOSCOPY			English	Article							DIFFICULT BILIARY CANNULATION; ADVERSE EVENTS; FAILED ERCP; DRAINAGE; PANCREATITIS; CHOLEDOCHODUODENOSTOMY; PREVENTION; INSERTION; ACCESS; VIDEOS	Background: A single session of EUS-guided biliary drainage (EUS-BD) may be a viable alternative to ERCP in patients with malignant distal common bile duct (CBD) obstruction. There is no study comparing EUS-BD and ERCP for the relief of distal malignant biliary obstruction. Objective: To compare the outcomes of self-expandable metal stent (SEMS) placement for malignant distal biliary obstruction by using ERCP and EUS-BD. Study Design: Multicenter, retrospective analysis. Setting: Tertiary referral centers. Patients: Patients with malignant distal CBD obstruction requiring SEMS placement. Interventions: Patients in the EUS-BD group underwent EUS-guided choledochoduodenostomy (EUS-CDS) or EUS-guided antegrade (EUS-AG) procedures after 1 or more failed ERCP attempts. Patients in the ERCP group underwent retrograde SEMS placement. Main Outcome Measurements: Composite success (the ability to complete the intended therapeutic procedure in a single session and resulting in a greater than 50% decrease in bilirubin over 2 weeks). Results: The study included 208 patients, 104 treated with ERCP and 104 treated with EUS-BD (68 EUS-CDS, 36 EUS-AG). SEMS placement was successful in 98 patients in the ERCP group and 97 in the EUS-BD group (94.23% vs 93.26%, P = 1.00). The frequency of adverse events in the ERCP and EUS-BD groups was 8.65% and 8.65%, respectively. Postprocedure pancreatitis rates were higher in the ERCP group (4.8% vs 0, P = .059). The mean procedure times in the ERCP and EUS-BD groups were similar (30.10 and 35.95 minutes, P = .05). Limitations: Retrospective analysis. Conclusions: In patients with malignant distal CBD obstruction requiring SEMS placement, the short-term outcome of EUS-BD is comparable to that of ERCP.	[Dhir, Vinay; Maydeo, Amit] Baldota Inst Digest Sci, Dept Endoscopy & Endosonog, Mumbai 400012, Maharashtra, India; [Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Khashab, Mouen A.; Messallam, Ahmed] Johns Hopkins Univ Hosp, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA; [Park, Do Hyun] Asan Med Ctr, Dept Gastroenterol & Hepatol, Seoul, South Korea; [Teoh, Anthony Yuen Bun] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Attam, Rajeev] Univ Minnesota, Med Ctr, Dept Gastroenterol & Hepatol, Minneapolis, MN 55455 USA; [Varadarajulu, Shyam] Florida Hosp, Ctr Intervent Endoscopy, Orlando, FL USA	Dhir, V (reprint author), Baldota Inst Digest Sci, Mumbai 400012, Maharashtra, India.	vinaydhir@gmail.com					Das A, 2007, GASTROINTEST ENDOSC, V65, P960, DOI 10.1016/j.gie.2006.07.031; Khashab MA, 2013, GASTROINTEST ENDOSC, V78, P734, DOI 10.1016/j.gie.2013.05.013; Artifon ELA, 2012, J CLIN GASTROENTEROL, V46, P768, DOI 10.1097/MCG.0b013e31825f264c; Bailey AA, 2008, ENDOSCOPY, V40, P296, DOI 10.1055/s-2007-995566; Park DH, 2011, GASTROINTEST ENDOSC, V74, P1276, DOI 10.1016/j.gie.2011.07.054; Dhir V, 2012, GASTROINTEST ENDOSC, V75, P354, DOI 10.1016/j.gie.2011.07.075; Park DH, 2013, GASTROINTEST ENDOSC, V78, P91, DOI 10.1016/j.gie.2013.01.042; Maydeo A, 2011, GASTROINTEST ENDOSC, V74, P1308, DOI 10.1016/j.gie.2011.08.047; Hara K, 2011, AM J GASTROENTEROL, V106, P1239, DOI 10.1038/ajg.2011.84; Halttunen J, 2014, SCAND J GASTROENTERO, V49, P752, DOI 10.3109/00365521.2014.894120; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Hara K, 2013, ENDOSCOPY, V45, P392, DOI 10.1055/s-0032-1326076; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Dhir V, 2014, DIGEST ENDOSC, V26, P430, DOI 10.1111/den.12153; Swan MP, 2013, CLIN GASTROENTEROL H, V11, P430, DOI 10.1016/j.cgh.2012.12.017; Castano R, 2010, SURG ENDOSC, V24, P2092, DOI 10.1007/s00464-010-0903-7; Das A, 2000, Cancer Control, V7, P452; Dhir V, 1999, GASTROINTEST ENDOSC, V50, P143; Kaffes AJ, 2005, GASTROINTEST ENDOSC, V62, P669, DOI 10.1016/j.gie.2005.05.022; Mutignani M, 2007, ENDOSCOPY, V39, P440, DOI 10.1055/s-2007-966327; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Tuca Albert, 2012, Cancer Manag Res, V4, P159, DOI 10.2147/CMAR.S29297; Uchino R, 2013, GASTROINTEST ENDOSC, V78, P842, DOI 10.1016/j.gie.2013.06.028	23	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					913	923		10.1016/j.gie.2014.09.054		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700015		
J	Ogura, T; Imoto, A; Masuda, D; Sano, T; Onda, S; Yamamoto, K; Kitano, M; Takeuchi, T; Inoue, T; Higuchi, K				Ogura, Takeshi; Imoto, Akira; Masuda, Daisuke; Sano, Tatsushi; Onda, Saori; Yamamoto, Kazuhiro; Kitano, Masayuki; Takeuchi, Toshihisa; Inoue, Takuya; Higuchi, Kazuhide			Antegrade biopsy by using a trans-catheter technique through EUS-guided hepaticojejunostomy	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Ogura, Takeshi; Imoto, Akira; Masuda, Daisuke; Sano, Tatsushi; Onda, Saori; Takeuchi, Toshihisa; Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Osaka, Japan; [Yamamoto, Kazuhiro] Osaka Med Coll, Dept Radiol, Osaka, Japan; [Kitano, Masayuki] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan	Ogura, T (reprint author), Osaka Med Coll, Dept Internal Med 2, Osaka, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					1007	1008		10.1016/j.gie.2014.06.032		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700036		
J	Mizutani, Y; Hirooka, Y; Watanabe, O; Nakamura, M; Yamamura, T; Ando, T; Goto, H				Mizutani, Yasuyuki; Hirooka, Yoshiki; Watanabe, Osamu; Nakamura, Masanao; Yamamura, Takeshi; Ando, Takafumi; Goto, Hidemi			Pyogenic granuloma of the small bowel treated by double-balloon enteroscopy	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Mizutani, Yasuyuki; Watanabe, Osamu; Nakamura, Masanao; Ando, Takafumi; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Hirooka, Yoshiki; Yamamura, Takeshi] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan	Mizutani, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					1023	1024		10.1016/j.gie.2014.11.005		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700052		
J	Nakamura, M; Hirooka, Y; Watanabe, O; Yamamura, T; Nagura, A; Ando, T; Goto, H				Nakamura, Masanao; Hirooka, Yoshiki; Watanabe, Osamu; Yamamura, Takeshi; Nagura, Asuka; Ando, Takafumi; Goto, Hidemi			Submucosal tumor in the small bowel resected by EMR at double-balloon endoscopy	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Nakamura, Masanao; Watanabe, Osamu; Ando, Takafumi; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Hirooka, Yoshiki; Yamamura, Takeshi; Nagura, Asuka] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan	Nakamura, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					1024	1025		10.1016/j.gie.2014.11.024		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700053		
J	Mori, H; Kobara, H; Rafiq, K; Fujihara, S; Nishiyama, N; Matsunaga, T; Ayaki, M; Yachida, T; Chiyo, T; Masaki, T				Mori, Hirohito; Kobara, Hideki; Rafiq, Kazi; Fujihara, Shintaro; Nishiyama, Noriko; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Chiyo, Taiga; Masaki, Tsutomu			Preclipping fixation EMR to achieve sufficient surgical margin and negative resection	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Mori, Hirohito] Kagawa Univ, Fac Med, Dept Gastroenterol, Dept Gastroenterol Surg,Ehime Rosai Hosp, Kagawa, Japan; [Mori, Hirohito] Kagawa Univ, Fac Med, Dept Neurol, Dept Gastroenterol Surg,Ehime Rosai Hosp, Kagawa, Japan; [Kobara, Hideki; Fujihara, Shintaro; Nishiyama, Noriko; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Chiyo, Taiga; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol, Kagawa, Japan; [Kobara, Hideki; Fujihara, Shintaro; Nishiyama, Noriko; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Chiyo, Taiga; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Neurol, Kagawa, Japan; [Rafiq, Kazi] Kagawa Univ, Fac Med, Dept Pharmacol, Kagawa, Japan	Mori, H (reprint author), Kagawa Univ, Fac Med, Dept Gastroenterol, Dept Gastroenterol Surg,Ehime Rosai Hosp, Kagawa, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					1025	1026		10.1016/j.gie.2014.10.022		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700054		
J	Nishikawa, T; Tsuyuguchi, T; Ishigami, H; Sakai, Y; Sugiyama, H; Nakatani, Y; Ohtsuka, M; Miyazaki, M; Yokosuka, O				Nishikawa, Takao; Tsuyuguchi, Toshio; Ishigami, Hideaki; Sakai, Yuji; Sugiyama, Harutoshi; Nakatani, Yukio; Ohtsuka, Masayuki; Miyazaki, Masaru; Yokosuka, Osamu			Peroral cholangioscopy-guided forceps biopsy to evaluate a cicatricial stricture of the biliary duct (with video)	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Nishikawa, Takao; Tsuyuguchi, Toshio; Ishigami, Hideaki; Sakai, Yuji; Sugiyama, Harutoshi; Ohtsuka, Masayuki; Miyazaki, Masaru; Yokosuka, Osamu] Chiba Univ, Dept Gastroenterol & Nephrol, Grad Sch Med, Chiba, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Basic Pathol, Chiba, Japan	Nishikawa, T (reprint author), Chiba Univ, Dept Gastroenterol & Nephrol, Grad Sch Med, Chiba, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					1030	1031		10.1016/j.gie.2014.10.008		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700058		
J	Sasajima, K; Chinzei, R; Takahashi, M; Koushima, Y; Watanabe, H				Sasajima, Keita; Chinzei, Ryo; Takahashi, Masanori; Koushima, Youhei; Watanabe, Hidenobu			Endoscopic submucosal dissection for an early ileal cancer	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Sasajima, Keita; Chinzei, Ryo; Takahashi, Masanori; Koushima, Youhei] Saitama Red Cross Hosp, Dept Gastroenterol, Saitama, Japan; [Watanabe, Hidenobu] PCL Japan, Dept Pathol, Tokyo, Japan	Sasajima, K (reprint author), Saitama Red Cross Hosp, Dept Gastroenterol, Saitama, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					1031	1032		10.1016/j.gie.2014.11.050		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700060		
J	Ishizu, Y; Ishigami, M; Suzuki, N; Kuzuya, T; Honda, T; Hayashi, K; Katano, Y; Hirooka, Y; Ishikawa, T; Matsushita, T				Ishizu, Yoji; Ishigami, Masatoshi; Suzuki, Nobuaki; Kuzuya, Teiji; Honda, Takashi; Hayashi, Kazuhiko; Katano, Yoshiaki; Hirooka, Yoshiki; Ishikawa, Tetsuya; Matsushita, Tadashi			Endoscopic treatment of esophageal varices in hemophiliac patients with liver cirrhosis	GASTROINTESTINAL ENDOSCOPY			English	Letter									[Ishizu, Yoji; Ishigami, Masatoshi; Kuzuya, Teiji; Honda, Takashi; Hayashi, Kazuhiko] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Suzuki, Nobuaki] Nagoya Univ Hosp, Dept Clin Lab Med, Nagoya, Aichi, Japan; [Katano, Yoshiaki] Fujita Hlth Univ, Sch Med, Banbuntane Hotokukai Hosp, Dept Internal Med, Toyoake, Aichi, Japan; [Hirooka, Yoshiki] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan; [Ishikawa, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Div Med Lab Sci, Nagoya, Aichi 4648601, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan	Ishizu, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan.						Monroe DM, 2012, HAEMOPHILIA, V18, P11, DOI 10.1111/j.1365-2516.2012.02889.x; Yamada M, 1998, EUR J GASTROEN HEPAT, V10, P151, DOI 10.1097/00042737-199802000-00010	2	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	APR	2015	81	4					1059	1060		10.1016/j.gie.2014.11.043		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SV	WOS:000351668700084		
J	Nishio, SY; Hayashi, Y; Watanabe, M; Usami, SI				Nishio, Shin-Ya; Hayashi, Yoshiharu; Watanabe, Manabu; Usami, Shin-Ichi			Clinical Application of a Custom AmpliSeq Library and Ion Torrent PGM Sequencing to Comprehensive Mutation Screening for Deafness Genes	GENETIC TESTING AND MOLECULAR BIOMARKERS			English	Article							GENOTYPE-PHENOTYPE CORRELATION; NONSYNDROMIC HEARING-LOSS; LARGE COHORT; IDENTIFICATION; IMPAIRMENT; DFNA20/26; VARIANTS; FAMILIES; SPECTRUM; JAPANESE	Background: Congenital hearing loss is one of the most common sensory disorders, with 50-70% of cases attributable to genetic causes. Although recent advances in the identification of deafness genes have resulted in more accurate molecular diagnosis, leading to the better determination of suitable clinical interventions, difficulties remain with regard to clinical applications due to the extreme genetic heterogeneity of deafness. Aim: Toward more effective genetic testing, we adopted Massively Parallel DNA Sequencing (MPS) of target genes using an Ion PGM (TM) system and an Ion AmpliSeq (TM) panel to diagnose common mutations responsible for deafness and discover rare causative gene mutations. Before its clinical application, we investigated the accuracy of MPS-based genetic testing. Results: We compared the results of Invader assay-based genetic screening, the accuracy of which has already been verified in previous studies, with those of MPS-based genetic testing for a large population of Japanese deafness patients and revealed that over 99.98% of the results were the same for each genetic testing system. Conclusion: The Ion Personal Genome Machine system had sufficient uniformity and accuracy for application to the clinical diagnosis of common causative mutations and efficiently identified rare causative mutations and/or mutation candidates.	[Nishio, Shin-Ya; Usami, Shin-Ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 3908621, Japan; [Nishio, Shin-Ya; Usami, Shin-Ichi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 3908621, Japan; [Hayashi, Yoshiharu; Watanabe, Manabu] Life Technol Japan Ltd, Tokyo, Japan	Usami, SI (reprint author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	usami@shinshu-u.ac.jp			Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan; Life Technologies Japan Ltd.	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (http://mhlw.go.jp/english/) (S.-I.U.) and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://mext.go.jp/english/) (S.-I.U.). This study was also supported by Life Technologies Japan Ltd. as collaborative study (S.-I.U.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Tsongalis GJ, 2014, CLIN CHEM LAB MED, V52, P707, DOI 10.1515/cclm-2013-0883; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002; Nal N, 2007, HUM MUTAT, V28, P1014, DOI 10.1002/humu.20556; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Sagong B, 2010, ANN CLIN LAB SCI, V40, P380; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Miyagawa M, 2014, J HUM GENET, V59, P262, DOI 10.1038/jhg.2014.12; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Domenech E, 2002, EUR J HUM GENET, V10, P421, DOI 10.1038/sj/ejhg.5200823; Dong F, 2005, BRIT J HAEMATOL, V130, P620, DOI 10.1111/j.1365-2141.2005.05658.x; Liu Yu-he, 2005, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V40, P764; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Oshima A, 2006, HUM MUTAT, V29, pE37; Su CC, 2007, AUDIOL NEURO-OTOL, V12, P20, DOI 10.1159/000096154; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yuan Yong-yi, 2009, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V44, P449; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	26	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1945-0265	1945-0257		GENET TEST MOL BIOMA	Genet. Test. Mol. Biomark.	APR 1	2015	19	4					209	217		10.1089/gtmb.2014.0252		9	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CF1YQ	WOS:000352344400009		
J	Sakashita, T; Hayashi, R; Homma, A; Matsuura, K; Kato, K; Kawabata, K; Monden, N; Hasegawa, Y; Onitsuka, T; Fujimoto, Y; Iwae, S; Okami, K; Matsuzuka, T; Yoshino, K; Fujii, M				Sakashita, Tomohiro; Hayashi, Ryuichi; Homma, Akihiro; Matsuura, Kazuto; Kato, Kengo; Kawabata, Kazuyoshi; Monden, Nobuya; Hasegawa, Yasuhisa; Onitsuka, Tetsuro; Fujimoto, Yasushi; Iwae, Shigemichi; Okami, Kenji; Matsuzuka, Takashi; Yoshino, Kunitoshi; Fujii, Masato			Multi-institutional retrospective study for the evaluation of ocular function-preservation rates in maxillary sinus squamous cell carcinomas with orbital invasion	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						maxillary sinus cancer; orbital invasion; ocular function; squamous cell carcinoma; chemoradiotherapy	CISPLATIN INFUSION; PARANASAL SINUSES; RADIOTHERAPY; MANAGEMENT; CANCER; NASAL	BackgroundThe purpose of this retrospective analysis was to evaluate ocular function and survival rates among treatment modalities in patients with maxillary sinus cancer with orbital invasion. MethodsEighty-seven patients were classified according to the main treatment modality. Ocular function preservation rates and survival rates were evaluated for each therapeutic modality. ResultsThe 5-year overall survival rate for the en bloc resection, conservative surgery, superselective intra-arterial chemotherapy, and radiotherapy (RADPLAT), intravenous chemoradiotherapy (IV-CRT) was 70%, 35%, 49%, and 31%, respectively. The ocular function preservation rate for each group was 15%, 27%, 30%, and 17%, respectively. In the en bloc resection group, there was no significant difference in the 5-year overall survival rate between patients with orbital exenteration and those without orbital exenteration (72% vs 71%; p=.9321). ConclusionThe en bloc resection group showed a favorable survival rate but a low preservation rate. Preservation of orbital contents did not reduce the survival rate. (c) 2014 Wiley Periodicals, Inc. Head Neck37: 537-542, 2015	[Sakashita, Tomohiro; Homma, Akihiro] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido 0608638, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Div Head & Neck Surg, Kashiwa, Chiba, Japan; [Matsuura, Kazuto] Miyagi Canc Ctr, Div Head & Neck Surg, Sendai, Miyagi, Japan; [Kato, Kengo] Tohoku Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan; [Kawabata, Kazuyoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Head & Neck Oncol, Tokyo, Japan; [Monden, Nobuya] Natl Shikoku Canc Ctr, Dept Otorhinolaryngol Head & Neck Surg, Matsuyama, Ehime, Japan; [Hasegawa, Yasuhisa] Aichi Canc Ctr, Dept Head & Neck Surg, Nagoya, Aichi 464, Japan; [Onitsuka, Tetsuro] Shizuoka Canc Ctr, Dept Head & Neck Surg, Shizuoka, Japan; [Fujimoto, Yasushi] Nagoya Univ, Grad Sch Med, Dept Otolaryngol, Nagoya, Aichi 4648601, Japan; [Iwae, Shigemichi] Hyogo Canc Ctr, Dept Head & Neck Surg, Akashi, Hyogo, Japan; [Okami, Kenji] Tokai Univ, Dept Otolaryngol, Isehara, Kanagawa, Japan; [Matsuzuka, Takashi] Fukushima Med Univ, Dept Otolaryngol, Fukushima, Japan; [Yoshino, Kunitoshi] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Otolaryngol Head & Neck Surg, Osaka, Japan; [Fujii, Masato] Natl Tokyo Med Ctr, Dept Otorhinolaryngol, Tokyo, Japan	Homma, A (reprint author), Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	ak-homma@med.hokudai.ac.jp			Health and Labor Sciences Research Grant for Clinical Cancer Research from the Ministry of Health, Labor, and Welfare of Japan [H22-Gannrinshou-Ippan-017]; National Cancer Center Research and Development Fund of Japan [23-A-21]	Contract grant sponsor: This study was supported in part by a Health and Labor Sciences Research Grant for Clinical Cancer Research (H22-Gannrinshou-Ippan-017) from the Ministry of Health, Labor, and Welfare of Japan, and the National Cancer Center Research and Development Fund (23-A-21) of Japan.	Homma A, 2009, CANCER, V115, P4705, DOI 10.1002/cncr.24515; Imola MJ, 2002, LARYNGOSCOPE, V112, P1357, DOI 10.1097/00005537-200208000-00007; Rasch CRN, 2010, CANCER-AM CANCER SOC, V116, P2159, DOI 10.1002/cncr.24916; Dulguerov P, 2001, CANCER, V92, P3012, DOI 10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E; Carrau RL, 1999, LARYNGOSCOPE, V109, P230, DOI 10.1097/00005537-199902000-00012; Nishino H, 2003, LARYNGOSCOPE, V113, P1064, DOI 10.1097/00005537-200306000-00028; Nishino H, 2013, HEAD NECK; Paulino AC, 1998, CANCER, V83, P457, DOI 10.1002/(SICI)1097-0142(19980801)83:3<457::AID-CNCR14>3.0.CO;2-V; SAKAI S, 1976, ACTA OTO-LARYNGOL, V82, P172, DOI 10.3109/00016487609120878; SATO Y, 1970, CANCER, V25, P571, DOI 10.1002/1097-0142(197003)25:3<571::AID-CNCR2820250312>3.0.CO;2-N; Segi M, 1981, GANN MONOGR CANCER R, P121; Shiga K, 2007, OTOLARYNG HEAD NECK, V136, P1003, DOI 10.1016/j.otohns.2006.12.018; STERN SJ, 1993, ARCH OTOLARYNGOL, V119, P964; STPIERRE S, 1983, HEAD NECK SURG, V5, P508, DOI 10.1002/hed.2890050610; TSUJII H, 1986, CANCER, V57, P2261, DOI 10.1002/1097-0142(19860615)57:12<2261::AID-CNCR2820571204>3.0.CO;2-X	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	APR	2015	37	4					537	542		10.1002/hed.23639		6	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CE2ZB	WOS:000351690800015		
J	Motegi, A; Kawashima, M; Arahira, S; Zenda, S; Toshima, M; Onozawa, M; Hayashi, R; Akimoto, T				Motegi, Atsushi; Kawashima, Mitsuhiko; Arahira, Satoko; Zenda, Sadamoto; Toshima, Masamichi; Onozawa, Masakatsu; Hayashi, Ryuichi; Akimoto, Tetsuo			Accelerated radiotherapy for T1 to T2 glottic cancer	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						early glottic cancer; accelerated fractionation radiotherapy; local control; laryngeal preservation; adverse events	SQUAMOUS-CELL CARCINOMA; LOCAL-CONTROL; NECK-CANCER; RADIATION-THERAPY; FRACTION SIZE; PROGNOSTIC-FACTORS; ISCHEMIC-STROKE; INCREASED RISK; TREATMENT TIME; HEAD	BackgroundAccelerated fractionation radiotherapy (RT) was administered in an attempt to improve the local control rates in patients with T1/T2 N0 glottic cancer. MethodsMedical charts of 148 consecutive patients who had undergone RT using 2.4 Gray (Gy) once-daily fractionation between July 1999 and April 2007 were reviewed. ResultsOf 104 patients with T1 disease treated by RT, 82 received 60 Gy/25 fractions, and the remaining 22 with large tumor volumes and/or slow response to RT received 64.8 Gy/27 fractions. All 44 patients with T2 disease received 64.8 Gy/27 fractions. The 5-year local control and overall survival (OS) rates were 93% and 96%, respectively, in patients with T1 disease, and 77% and 91%, respectively, in patients with T2 disease. No severe acute toxicities were observed, although 2 patients (1%) developed severe late toxicity. ConclusionAccelerated RT for early glottic cancer is feasible, with encouraging local control rates. (c) 2014 Wiley Periodicals, Inc. Head Neck37: 579-584, 2015	[Motegi, Atsushi; Kawashima, Mitsuhiko; Arahira, Satoko; Zenda, Sadamoto; Toshima, Masamichi; Onozawa, Masakatsu; Akimoto, Tetsuo] Natl Canc Ctr Hosp East, Div Radiat Oncol, Kashiwa, Chiba 2778577, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Div Head & Neck Surg, Kashiwa, Chiba 2778577, Japan	Motegi, A (reprint author), Natl Canc Ctr Hosp East, Div Radiat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	amotegi@east.ncc.go.jp			National Cancer Center Research and Development Fund [25-A-10]; Ministry of Education, Science and Culture of Japan [24591863, 24791341]; Ministry of Health and Welfare	This study was supported in part by the National Cancer Center Research and Development Fund (25-A-10), and also was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (24591863 & 24791341), and by Health Science Research Grants from the Ministry of Health and Welfare.	Garden AS, 2003, INT J RADIAT ONCOL, V55, P322, DOI 10.1016/S0360-3016(02)03938-X; Marshak G, 1999, INT J RADIAT ONCOL, V43, P1009, DOI 10.1016/S0360-3016(98)00547-1; Le QTX, 1997, INT J RADIAT ONCOL, V39, P115, DOI 10.1016/S0360-3016(97)00284-8; Hartl DM, 2011, HEAD NECK-J SCI SPEC, V33, P1638, DOI 10.1002/hed.21528; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Mendenhall WM, 2004, CANCER, V100, P1786, DOI 10.1002/cncr.20181; Huang YS, 2011, ORAL ONCOL, V47, P1092, DOI 10.1016/j.oraloncology.2011.07.024; Dorresteijn LDA, 2002, J CLIN ONCOL, V20, P282, DOI 10.1200/JCO.20.1.282; Plummer C, 2011, STROKE, V42, P2410, DOI 10.1161/STROKEAHA.111.615203; Gultekin M, 2012, HEAD NECK-J SCI SPEC, V34, P1009, DOI 10.1002/hed.21860; Chu CN, 2011, BRIT J CANCER, V105, P1419, DOI 10.1038/bjc.2011.361; van der Voet JCM, 1998, INT J RADIAT ONCOL, V42, P247, DOI 10.1016/S0360-3016(98)00226-0; Haynes JC, 2002, LARYNGOSCOPE, V112, P1883, DOI 10.1097/00005537-200210000-00034; Warde P, 1998, INT J RADIAT ONCOL, V41, P347, DOI 10.1016/S0360-3016(98)00062-5; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Smith GL, 2008, J CLIN ONCOL, V26, P5119, DOI 10.1200/JCO.2008.16.6546; Yamazaki H, 2006, INT J RADIAT ONCOL, V64, P77, DOI 10.1016/j.ijrobp.2005.06.014; Furusaka T, 2012, ACTA OTO-LARYNGOL, V132, P546, DOI 10.3109/00016489.2011.646008; Hall EJ, 2012, RADIOBIOLOGY RADIOLO, P391; Kagami Y, 2004, NIPPON IGAKU HOUSHAS, V64, pS148; Narayana A, 2000, INT J RADIAT ONCOL, V46, P21, DOI 10.1016/S0360-3016(99)00348-X; Reddy SP, 1998, RADIOTHER ONCOL, V47, P161, DOI 10.1016/S0167-8140(97)00196-5; Rosenthal DI, 2010, INT J RADIAT ONCOL, V77, P455, DOI 10.1016/j.ijrobp.2009.04.061; Rosenthal DI, 2004, SEMIN RADIAT ONCOL, V14, P153, DOI 10.1053/j.semradonc.2004.01.001; Saarilahti K, 1998, RADIOTHER ONCOL, V47, P155, DOI 10.1016/S0167-8140(97)00222-3; Scott AS, 2009, RADIOTHER ONCOL, V90, P163, DOI 10.1016/j.radonc.2008.12.019; Smee RI, 2013, LARYNGOSCOPE, V123, P171, DOI 10.1002/lary.23663; Thariat J, 2004, Cancer Radiother, V8, P288, DOI 10.1016/S1278-3218(04)00088-5; Yu E, 1997, INT J RADIAT ONCOL, V37, P587, DOI 10.1016/S0360-3016(96)00578-0	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	APR	2015	37	4					579	584		10.1002/hed.23641		6	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CE2ZB	WOS:000351690800021		
J	Sato, S; Hasegawa, A; Semboshi, S; Wagatsuma, K				Sato, Shigeo; Hasegawa, Akifumi; Semboshi, Satoshi; Wagatsuma, Kazuaki			Effect of Dislocations on Spinodal Decomposition, Precipitation, and Age-hardening of Cu-Ti Alloy	HIGH TEMPERATURE MATERIALS AND PROCESSES			English	Article						copper-titanium alloy; spinodal decomposition; dislocation; precipitation; X-ray diffraction; small-angle X-ray scattering	COPPER-TITANIUM ALLOYS; X-RAY; COLD WORK; STRENGTH; CONTRAST	In age-hardenable Cu-Ti alloys, cold work before aging enhances their mechanical properties and shortens the aging time for obtaining the maximum hardness. In order to discuss hardening behaviors, microstructural evolutions such as dislocation rearrangements, progress of spinodal decomposition, and subsequent precipitation from the spinodal region during aging need to be analyzed precisely. Therefore, we employed a probing method combining the small-and the wide-angle X-ray scattering methods to characterize the precipitate size and the progress of spinodal decomposition, respectively. Sideband peaks appearing adjacent to Bragg reflection peaks in the X-ray diffraction patterns of a copper matrix were analyzed to estimate the development of compositional modulations of titanium accompanied by spinodal decomposition. The results of these analytical procedures revealed that the growth rates of the spinodal region and nanometer-scales precipitates in Cu-Ti alloys are less susceptible to dislocations introduced during cold working before aging, and that dislocations introduced during prior cold working annihilate in the initial aging stage. Consequently, overaging, which is mainly induced by dislocation annihilation, in a cold-worked Cu-Ti alloy occurs after a shorter aging time than in an unworked alloy.	[Sato, Shigeo; Hasegawa, Akifumi; Wagatsuma, Kazuaki] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Semboshi, Satoshi] Tohoku Univ, Kansai Ctr, Inst Mat Res, Naka Ku, Sakai, Osaka 5998531, Japan	Sato, S (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	s.sato@imr.tohoku.ac.jp	Wagatsuma, Kazuaki/B-3079-2012		Japan Institute of Copper; Japan Society for the Promotion of Science [22760572]	This work was financially supported by the research program of the Japan Institute of Copper, and by the Japan Society for the Promotion of Science via a Grant-in-Aid for Young Scientists (B) (22760572).	DATTA A, 1976, ACTA METALL MATER, V24, P987, DOI 10.1016/0001-6160(76)90129-2; Daniel V, 1943, PROC R SOC LON SER-A, V181, P0368, DOI 10.1098/rspa.1943.0014; Ungar T, 1996, APPL PHYS LETT, V69, P3173; Ungar T, 1999, J APPL CRYSTALLOGR, V32, P992, DOI 10.1107/S0021889899009334; LAUGHLIN DE, 1975, ACTA METALL MATER, V23, P329, DOI 10.1016/0001-6160(75)90125-X; NAGARJUNA S, 1995, MATER T JIM, V36, P1058; Markandeya R, 2005, MAT SCI ENG A-STRUCT, V404, P305, DOI 10.1016/j.msea.2005.05.072; Ungar T, 1999, PHYS STATUS SOLIDI A, V171, P425, DOI 10.1002/(SICI)1521-396X(199902)171:2<425::AID-PSSA425>3.0.CO;2-W; Soffa WA, 2004, PROG MATER SCI, V49, P347, DOI 10.1016/S0079-6425(03)00029-X; Sato S, 2009, J ALLOY COMPD, V477, P846, DOI 10.1016/j.jallcom.2008.10.158; Zhang P, 2011, MAT SCI ENG A-STRUCT, V529, P62, DOI 10.1016/j.msea.2011.08.061; CORNIE JA, 1973, METALL TRANS, V4, P727, DOI 10.1007/BF02643081; Glatter O., 1982, SMALL ANGLE XRAY SCA; Nagarjuna S., 2001, MAT SCI ENG A-STRUCT, V313, P261; Ribarik G, 2004, MAT SCI ENG A-STRUCT, V387, P343, DOI 10.1016/j.msea.2004.01.089; Sanders PG, 1997, MAT SCI ENG A-STRUCT, V234, P77, DOI 10.1016/S0921-5093(97)00185-8; Sato S., 2009, ADV XRAY ANAL, V52, P9; Sato S, 2010, POWDER DIFFR, V25, P104, DOI 10.1154/1.3416942; Sato S, 2010, HIGH TEMP MAT PR-ISR, V29, P405; Semboshi S, 2013, MATER CHARACT, V82, P23, DOI 10.1016/j.matchar.2013.04.016; Semboshi S., 2013, J JRI CU, V52, P30; Tsujimoto T., 1973, Journal of the Japan Institute of Metals, V37; Tsujimoto T., 1975, Journal of the Japan Institute of Metals, V39; UNGAR T, 1991, MAT SCI ENG A-STRUCT, V138, P147, DOI 10.1016/0921-5093(91)90684-F	24	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-6455	2191-0324		HIGH TEMP MAT PR-ISR	High Temp. Mater. Process.	APR	2015	34	2					123	130		10.1515/htmp-2014-0038		8	Materials Science, Multidisciplinary	Materials Science	CE2RY	WOS:000351665200003		
J	Kanbayashi, T; Miyafuji, H				Kanbayashi, Toru; Miyafuji, Hisashi			Raman microscopic analysis of wood after treatment with the ionic liquid, 1-ethyl-3-methylimidazolium chloride	HOLZFORSCHUNG			English	Article						cellulose; cell wall; 1-ethyl-3-methylimidazolium chloride; ionic liquid (IL); Japanese cedar (Cryptomeria japonica); lignin; Raman microscopy; wood	MORPHOLOGICAL-CHANGES; JAPANESE BEECH; SPECTROSCOPY; SPRUCE; DISSOLUTION; LIGNIN; CELLULOSE; BEHAVIOR; BAND	Japanese cedar (Cryptomeria japonica) was treated with the ionic liquid (IL) 1-ethyl-3-methylimidazolium chloride ([C2mim][Cl]), which is a solvent for cellulose, and the changes in the chemical components and their distribution in wood cell walls have been investigated by Raman microscopy. Raman spectra, recorded from various areas of the cell walls, showed that lignin in the compound middle lamellae (CML) and cell corners (CC) was resistant to the reaction with [C2mim][Cl], but its molecular structure changed partially. The reactivity of cellulose and hemicelluloses with [C2mim][Cl] was higher than that of lignin in the cell wall, and the cell wall structure was maintained even in an advanced state of the reactions. The effects of [C2mim][Cl] on cellulose and hemicelluloses in the cell wall were homogeneous, whereas that of lignin was inhomogeneous.	[Miyafuji, Hisashi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan; [Kanbayashi, Toru] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan	Miyafuji, H (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan.	miyafuji@kpu.ac.jp			JSPS [25450246]	The authors wish to thank the Kyoto Municipal Institute of Industrial Technology and Culture for its assistance with the Raman microscopic analysis. This research was partly supported by a Grant-in-Aid for Scientific Research (c) (25450246) from JSPS, for which the authors are grateful.	Agarwal U. P., 1999, ADV LIGNOCELLULOSICS, P201; Agarwal UP, 2000, ACS SYM SER, V742, P250; Miyafuji H, 2012, J WOOD SCI, V58, P222, DOI 10.1007/s10086-011-1245-3; WHITING P, 1982, WOOD SCI TECHNOL, V16, P261; Kanbayashi T, 2013, J WOOD SCI, V59, P410, DOI 10.1007/s10086-013-1343-5; Agarwal UP, 1997, APPL SPECTROSC, V51, P1648, DOI 10.1366/0003702971939316; Ohno E, 2013, J WOOD SCI, V59, P221, DOI 10.1007/s10086-013-1322-x; Nakamura A, 2010, J WOOD SCI, V56, P256, DOI 10.1007/s10086-009-1081-x; TERASHIMA N, 1988, WOOD SCI TECHNOL, V22, P259; Nakamura A, 2010, HOLZFORSCHUNG, V64, P289, DOI 10.1515/HF.2010.042; Miyafuji H, 2009, J WOOD SCI, V55, P215, DOI 10.1007/s10086-009-1020-x; Viell J, 2011, HOLZFORSCHUNG, V65, P519, DOI 10.1515/HF.2011.072; Agarwal UP, 2008, HOLZFORSCHUNG, V62, P667, DOI 10.1515/HF.2008.112; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Zhang H, 2005, MACROMOLECULES, V38, P8272, DOI 10.1021/ma0505676; Agarwal UP, 2011, J WOOD CHEM TECHNOL, V31, P324, DOI 10.1080/02773813.2011.562338; WILEY JH, 1987, CARBOHYD RES, V160, P113, DOI 10.1016/0008-6215(87)80306-3; Fort DA, 2007, GREEN CHEM, V9, P63, DOI 10.1039/b607614a; Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e; Agarwal UP, 1998, J WOOD CHEM TECHNOL, V18, P381, DOI 10.1080/02773819809349587; Kanbayashi T, 2014, J WOOD SCI, V60, P152, DOI 10.1007/s10086-014-1389-z; Edwards HGM, 1997, SPECTROCHIM ACTA A, V53, P2383, DOI 10.1016/S1386-1425(97)00178-9; Honglu X., 2006, HOLZFORSCHUNG, V60, P509, DOI 10.1515/HF.2006.084; Ou R., 2013, HOLZFORSCHUNG, V68, P555; Qu C, 2013, HOLZFORSCHUNG, V67, P25, DOI 10.1515/hf-2012-0037; Schenzel K, 2001, CELLULOSE, V8, P49, DOI 10.1023/A:1016616920539; Schrems M, 2011, HOLZFORSCHUNG, V65, P527, DOI 10.1515/HF.2011.099	27	3	3	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	APR	2015	69	3					273	279		10.1515/hf-2014-0060		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CE6EC	WOS:000351928400004		
J	Yanase, Y; Sakamoto, K; Imai, T				Yanase, Yu; Sakamoto, Kazuyuki; Imai, Takanori			Isolation and structural elucidation of norlignan polymers from the heartwood of Cryptomeria japonica	HOLZFORSCHUNG			English	Article						Cryptomeria japonica; heartwood extractives; heartwood formation; MALDI-TOF-MS; norlignans; peroxidase; polymeric norlignans; polymerization; sugi wood	BLACKING PHENOMENON; JAPANESE CEDAR	The norlignan (NorL) is a class of secondary metabolites, which occurs in the heartwood (hW) of certain softwood species. Although the NorL is often assumed to be secondarily altered (e.g., oxidized and/or polymerized in the hW over time), the formation and the chemical structure of oxidized/polymerized products remained unclear. In this study, we focused on the question whether an NorL oligomer/polymer exists in the hW of Cryptomeria japonica. First, NorL model polymers were prepared by horseradish peroxidase-catalyzed oxidation and their chemical structures were investigated by size exclusion chromatography-high-performance liquid chromatography (SEC-HPLC), nuclear magnetic resonance (NMR), and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Second, methanol (MeOH) extracted from the hW of Cryptomeria japonica was fractionated, and one of the fractions contained NorL polymers as demonstrated by its chromatographic and spectrometric data in comparison with those of model polymers. Third, five kinds of agatharesinol (AGA) model dimers were synthesized and their chemical structures were determined. C-13-NMR signals corresponding to the model dimer structures were observed in the NMR spectrum of the natural polymer fraction. In summary, an NorL polymer was found in the hW of Cryptomeria japonica, and its preliminary chemical structure was proposed for the first time.	[Yanase, Yu; Sakamoto, Kazuyuki; Imai, Takanori] Nagoya Univ, Grad Sch Bioagr Sci, Lab Biomass Resources Utilizat, Nagoya, Aichi 4648601, Japan	Imai, T (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Biomass Resources Utilizat, Nagoya, Aichi 4648601, Japan.	takaimai@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [20248018, 25450240]	This work was supported by the Grant-in-Aid for Scientific Research (Nos. 20248018 and 25450240) from the Japan Society for the Promotion of Science (JSPS). The authors thank technical personnel Mr. Kazushi Koga for his technical help with NMR analyses as well as Ms. Ruka Takama for her technical support with MS analyses.	Bito N, 2011, ANN FOREST SCI, V68, P1049, DOI 10.1007/s13595-011-0118-7; Chen XH, 2001, Z NATURFORSCH C, V56, P249; Higuchi T., 1967, MOKUZAI GAKKAISHI, V13, P274; Hishiyama S., 1999, 49 ANN M JAP WOOD RE, p2P13; Hishiyama S., 2006, 56 ANN M JAP WOOD RE, pPP012; Imai T., 2005, NAGOYA U FOR SCI, V24, P1; Imai T, 2009, PHYTOCHEM LETT, V2, P196, DOI 10.1016/j.phytol.2009.07.002; Imai T, 2012, MOKUZAI GAKKAISHI, V58, P11; Kai Y., 1972, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V18, P315; Kano H, 2004, MOKUZAI GAKKAISHI, V50, P91; HOCH JC, 1985, BIOCHEMISTRY-US, V24, P3831, DOI 10.1021/bi00336a003; KURODA H, 1983, HOLZFORSCHUNG, V37, P225, DOI 10.1515/hfsg.1983.37.5.225; Lukmandaru G., 2009, ANN FOREST SCI, V66, p605p1; Matsukuma N., 1965, MOKUZAI GAKKAISHI, V11, P227; Muraoka O., 1995, J CHEM SOC P1, V1995, P405; Nagasaki T, 2002, PHYTOCHEMISTRY, V60, P461, DOI 10.1016/S0031-9422(02)00141-3; NAULT J, 1988, WOOD SCI TECHNOL, V22, P73; OHASHI H, 1990, HOLZFORSCHUNG, V44, P79, DOI 10.1515/hfsg.1990.44.2.79; Ohtani Y, 2009, MOKUZAI GAKKAISHI, V55, P92; Saito K., 2008, ANAL CHEM, V80, P552; Takahashi K, 1996, MOKUZAI GAKKAISHI, V42, P998; Takahashi K, 2006, J WOOD SCI, V52, P134, DOI 10.1007/s10086-005-0733-8; Takahashi K., 1981, MOKUZAI GAKKAISHI, V27, P654	23	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	APR	2015	69	3					281	296		10.1515/hf-2013-0251		16	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CE6EC	WOS:000351928400005		
J	Kobori, H; Inagaki, T; Fujimoto, T; Okura, T; Tsuchikawa, S				Kobori, Hikaru; Inagaki, Tetsuya; Fujimoto, Takaaki; Okura, Tsutomu; Tsuchikawa, Satoru			Fast online NIR technique to predict MOE and moisture content of sawn lumber	HOLZFORSCHUNG			English	Article						modulus of elasticity (MOE); moisture content (MC); near-infrared spectroscopy (NIR); online quality control	NEAR-INFRARED SPECTROSCOPY; UNSTABLE TEMPERATURE CONDITIONS; WOOD MECHANICAL-PROPERTIES; YOUNGS MODULUS; CHEMICAL-COMPOSITION; SHEAR MODULUS; SOLID WOOD; SCOTS PINE; DENSITY; STIFFNESS	A fast online grading apparatus for sawn lumber based on near-infrared (NIR) spectroscopy has been developed. The method is based on a novel wavelength dispersive NIR spectrophotometer equipped with a diffraction grating linear sensor and high-intensity lighting. It was possible to acquire spectra from the entire surface of Hinoki cypress lumber sections traveling on a conveyor belt at a speed of 120 m min(-1). Additionally, predictive models for moisture content (MC) and modulus of elasticity (MOE) under various MC conditions were developed from the NIR spectra with the aid of partial least squares regression (PLSR) analysis. Both the MC and MOE predictive models demonstrated sufficient levels of prediction accuracy for use on high-speed conveyor belts, and the results of various experiments indicate that the developed device could be applied for the online quality certification of sawn lumber in commercial sawmills.	[Tsuchikawa, Satoru] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Aichi 4648601, Japan; [Kobori, Hikaru] Shizuoka Univ, Grad Sch Agr, Shizuoka 4228529, Japan; [Inagaki, Tetsuya] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Fujimoto, Takaaki] Tottori Univ, Fac Agr, Tottori 6808553, Japan; [Okura, Tsutomu] Soma Opt Ltd, Hinode 1900182, Japan	Tsuchikawa, S (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Aichi 4648601, Japan.	st3842@agr.nagoya-u.ac.jp			Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries, Japan [22003]; Ministry of Education, Science, Sports and Culture (MEXT) [22248020]	This research was partly supported by the Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries, Japan (No. 22003) and the Ministry of Education, Science, Sports and Culture (MEXT), Grant-in-Aid for Scientific Research (No. 22248020).	Watanabe A, 2006, APPL SPECTROSC, V60, P1054, DOI 10.1366/000370206778397452; Fujimoto T, 2007, APPL SPECTROSC, V61, P882, DOI 10.1366/000370207781540150; Lundgren N, 2006, J WOOD SCI, V52, P39, DOI 10.1007/s10086-005-0724-9; Kobori H, 2013, HOLZFORSCHUNG, V67, P307, DOI 10.1515/hf-2012-0054; Pastore TCM, 2011, HOLZFORSCHUNG, V65, P73, DOI 10.1515/HF.2011.010; Hein PRG, 2010, HOLZFORSCHUNG, V64, P45, DOI 10.1515/HF.2010.011; Windeisen E, 2009, HOLZFORSCHUNG, V63, P773, DOI 10.1515/HF.2009.084; Fujimoto T, 2008, J NEAR INFRARED SPEC, V16, P529, DOI [10.1255/jnirs.813, 10.1255/jnirs.818]; Thygesen LG, 2000, J NEAR INFRARED SPEC, V8, P183; Tsuchikawa S, 2013, APPL SPECTROSC REV, V48, P560, DOI 10.1080/05704928.2011.621079; Thumm A, 2001, J NEAR INFRARED SPEC, V9, P117; Defo M, 2007, FOREST PROD J, V57, P68; Adedipe OE, 2008, FOREST PROD J, V58, P28; Schajer GS, 2006, HOLZ ROH WERKST, V64, P483, DOI 10.1007/s00107-006-0109-9; Via BK, 2003, J NEAR INFRARED SPEC, V11, P365; Sun BL, 2011, HOLZFORSCHUNG, V65, P689, DOI 10.1515/HF.2011.075; Schwanninger M, 2011, J NEAR INFRARED SPEC, V19, P287, DOI 10.1255/jnirs.955; Tsuchikawa S, 2007, APPL SPECTROSC REV, V42, P43, DOI 10.1080/05704920601036707; Kelley SS, 2004, WOOD SCI TECHNOL, V38, P257, DOI 10.1007/s00226-003-0213-5; Haines DW, 1996, WOOD SCI TECHNOL, V30, P253; Fujimoto T, 2012, J NEAR INFRARED SPEC, V20, P353, DOI 10.1255/jnirs.994; Fernandes A, 2013, HOLZFORSCHUNG, V67, P59, DOI 10.1515/hf-2011-0258; Fujimoto T, 2010, APPL SPECTROSC, V64, P92; Fujimoto T, 2010, J WOOD SCI, V56, P452, DOI 10.1007/s10086-010-1122-5; GERHARDS CC, 1982, WOOD FIBER SCI, V14, P4; Gindl W, 2001, J NEAR INFRARED SPEC, V9, P255; Hein PRG, 2010, J NEAR INFRARED SPEC, V18, P443, DOI 10.1255/jnirs.907; HOFFMEYER P, 1995, HOLZ ROH WERKST, V53, P165, DOI 10.1007/BF02716418; Ilic J, 2001, HOLZ ROH WERKST, V59, P169, DOI 10.1007/s001070100198; Jones PD, 2006, WOOD SCI TECHNOL, V40, P709, DOI 10.1007/s00226-006-0085-6; Leinonen A, 2008, HOLZFORSCHUNG, V62, P284, DOI 10.1515/HF.2008.033; Meder R, 2003, J NEAR INFRARED SPEC, V11, P137; Mora CR, 2011, J NEAR INFRARED SPEC, V19, P391, DOI 10.1255/jnirs.947; Murata K, 2007, HOLZFORSCHUNG, V61, P589, DOI 10.1515/HF2007.082; Schimleck LR, 2009, HOLZFORSCHUNG, V63, P457, DOI 10.1515/HF.2009.082; Schimleck LR, 2003, CAN J FOREST RES, V33, P2297, DOI 10.1139/X03-173; So CL, 2004, FOREST PROD J, V54, P6; Taylor AM, 2011, HOLZFORSCHUNG, V65, P185, DOI 10.1515/HF.2011.026; Thygesen LG, 2000, J NEAR INFRARED SPEC, V8, P191; Tsuchikawa S, 2005, APPL SPECTROSC, V59, P86, DOI 10.1366/0003702052940413; Yoshihara H, 2012, HOLZFORSCHUNG, V66, P207, DOI 10.1515/HF.2011.118; Zahri S, 2008, HOLZFORSCHUNG, V62, P679, DOI 10.1515/HF.2008.114	42	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	APR	2015	69	3					329	335		10.1515/hf-2014-0021		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CE6EC	WOS:000351928400011		
J	Ojima, A; Matsui, T; Nakamura, N; Higashimoto, Y; Ueda, S; Fukami, K; Okuda, S; Yamagishi, S				Ojima, A.; Matsui, T.; Nakamura, N.; Higashimoto, Y.; Ueda, S.; Fukami, K.; Okuda, S.; Yamagishi, S.			DNA Aptamer Raised Against Advanced Glycation End Products (AGEs) Improves Glycemic Control and Decreases Adipocyte Size in Fructose-Fed Rats by Suppressing AGE-RAGE Axis	HORMONE AND METABOLIC RESEARCH			English	Article						AGEs; RAGE; oxidative stress; adiponectin; adipocytes; aptamer	INSULIN-RESISTANCE; RECEPTOR; OBESITY; MICE; DYSREGULATION; INFLAMMATION; ADIPONECTIN; PROGRESSION; EXPRESSION; GENERATION	Advanced glycation end products (AGEs) decrease adiponectin expression and suppress insulin signaling in cultured adipocytes through the interaction with a receptor for AGEs (RAGE) via oxidative stress generation. We have recently found that high-affinity DNA aptamer directed against AGE (AGE-aptamer) prevents the progression of experimental diabetic nephropathy by blocking the harmful actions of AGEs in the kidney. This study examined the effects of AGE-aptamer on adipocyte remodeling, AGE-RAGE-oxidative stress axis, and adiponectin expression in fructose-fed rats. Although AGE-aptamer treatment by an osmotic mini pump for 8 weeks did not affect serum insulin levels, it significantly decreased average fasting blood glucose and had a tendency to inhibit body weight gain in fructose-fed rats. Furthermore, AGE-aptamer significantly suppressed the increase in adipocyte size and prevented the elevation in AGEs, RAGE, and an oxidative stress marker, 8-hydroxydeoxyguanosine (8-OHdG), levels in adipose tissues of fructose-fed rats at 14-week-old, while it restored the decrease in adiponectin mRNA levels. Our present study suggests that AGE-aptamer could improve glycemic control and prevent adipocyte remodeling in fructose-fed rats partly by suppressing the AGE-RAGE-mediated oxidative stress generation. AGE-aptamer might be a novel therapeutic strategy for fructose-induced metabolic derangements.	[Ojima, A.; Matsui, T.; Nakamura, N.; Yamagishi, S.] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut, Diabet Vasc Complicat, Kurume, Fukuoka 8300011, Japan; [Higashimoto, Y.] Kurume Univ, Sch Med, Dept Chem, Kurume, Fukuoka 8300011, Japan; [Ueda, S.; Fukami, K.; Okuda, S.] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 8300011, Japan	Yamagishi, S (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut, Diabet Vasc Complicat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This study was supported in part by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to S.Y.), and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to S.Y.).	Yamagishi S, 2011, CURR DRUG TARGETS, V12, P2096; Yamagishi S, 2005, CURR PHARM DESIGN, V11, P2279, DOI 10.2174/1381612054367300; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Song F, 2014, DIABETES, V63, P1948, DOI 10.2337/db13-1636; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; HWANG IS, 1987, HYPERTENSION, V10, P512; Takeuchi M, 2000, MOL MED, V6, P114; Ward MS, 2013, CURR OPIN PHARMACOL, V13, P654, DOI 10.1016/j.coph.2013.06.009; Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Matsui T, 2014, AM J PATHOL, V184, P1094, DOI 10.1016/j.ajpath.2013.12.032; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Takeuchi M, 2008, CURR PHARM DESIGN, V14, P973, DOI 10.2174/138161208784139693; Stitt AW, 1997, ANN NY ACAD SCI, V811, P115, DOI 10.1111/j.1749-6632.1997.tb51994.x; Ojima A, 2014, INT J CARDIOL, V171, P443, DOI 10.1016/j.ijcard.2013.12.143; Gaens KHJ, 2014, ARTERIOSCL THROM VAS, V34, P1199, DOI 10.1161/ATVBAHA.113.302281; Jia XM, 2007, MOL CELL BIOCHEM, V306, P133, DOI 10.1007/s11010-007-9563-x; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Rahbar S, 2007, CELL BIOCHEM BIOPHYS, V48, P147, DOI 10.1007/s12013-07-0021-x; Jilma-Stohlawetz P, 2011, THROMB HAEMOSTASIS, V106, P539, DOI 10.1160/TH11-02-0069; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Unoki H, 2008, CURR PHARM DESIGN, V14, P987, DOI 10.2174/138161208784139747; DAgati V, 2010, TRENDS ENDOCRIN MET, V21, P50, DOI 10.1016/j.tem.2009.07.003; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Cruciani-Guglielmacci C, 2005, AM J PHYSIOL-ENDOC M, V288, pE148, DOI 10.1152/ajpendo.00225.2004; Feinman RD, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-45; Maeda S, 2011, INT J CARDIOL, V152, P408, DOI 10.1016/j.ijcard.2011.08.043; Maeda S, 2011, INT J CARDIOL, V146, P264, DOI 10.1016/j.ijcard.2010.10.073; Mangge H, 2010, CURR MED CHEM, V17, P4511, DOI 10.2174/092986710794183006; Ojima A, 2014, LAB INVEST, V94, P422, DOI 10.1038/labinvest.2014.5; Unoki H, 2007, DIABETES RES CLIN PR, V76, P236, DOI 10.1016/j.diabres.2006.09.016; Unoki-Kubota H, 2010, PROTEIN PEPTIDE LETT, V17, P1177	34	3	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0018-5043	1439-4286		HORM METAB RES	Horm. Metab. Res.	APR	2015	47	4					253	258		10.1055/s-0034-1385904		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CE6CK	WOS:000351923300003		
J	Zhang, LC; Yang, JJ; Inai, Y; Huang, Q; Wu, JL				Zhang, Liancun; Yang, Jiajia; Inai, Yoshinobu; Huang, Qiang; Wu, Jinglong			Effects of aging on pointing movements under restricted visual feedback conditions	HUMAN MOVEMENT SCIENCE			English	Article						Pointing movement; Aging; Visual restriction; Fitts' law; Movement time	DISCRETE MOTOR-RESPONSES; INFORMATION CAPACITY; AIMING MOVEMENTS; ARM MOVEMENTS; REACHING MOVEMENTS; TEMPORAL FEATURES; HAND MOVEMENTS; ONLINE CONTROL; DOUBLE-STEP; LAW HOLDS	The goal of this study was to investigate the effects of aging on pointing movements under restricted visual feedback of hand movement and target location. Fifteen young subjects and fifteen elderly subjects performed pointing movements under four restricted visual feedback conditions that included full visual feedback of hand movement and target location (FV), no visual feedback of hand movement and target location condition (NV), no visual feedback of hand movement (NM) and no visual feedback of target location (NT). This study suggested that Fitts' law applied for pointing movements of the elderly adults under different visual restriction conditions. Moreover, significant main effect of aging on movement times has been found in all four tasks. The peripheral and central changes may be the key factors for these different characteristics. Furthermore, no significant main effects of age on the mean accuracy rate under condition of restricted visual feedback were found. The present study suggested that the elderly subjects made a very similar use of the available sensory information as young subjects under restricted visual feedback conditions. In addition, during the pointing movement, information about the hand's movement was more useful than information about the target location for young and elderly subjects. (C) 2014 Elsevier B.V. All rights reserved.	[Zhang, Liancun; Huang, Qiang; Wu, Jinglong] Beijing Inst Technol, Intelligent Robot Inst, Sch Mechatron Engn, Beijing 100081, Peoples R China; [Zhang, Liancun; Huang, Qiang; Wu, Jinglong] Beijing Inst Technol, State Key Lab Intelligent Control & Decis Complex, Key Lab Biomimet Robots & Syst, Minist Educ, Beijing 100081, Peoples R China; [Zhang, Liancun; Yang, Jiajia; Inai, Yoshinobu; Wu, Jinglong] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Huang, Q (reprint author), Beijing Inst Technol, State Key Lab Intelligent Control & Decis Complex, Key Lab Biomimet Robots & Syst, Intelligent Robot Inst,Sch Mechatron Engn,Minist, Beijing 100081, Peoples R China.	qhuang@bit.edu.cn; wu@mech.okayama-u.ac.jp			National Key Technologies R&D Program of China [2013BAK03B03]; National Natural Science Foundation of China [61473043];  [21404002];  [24686034]	We would like to thank the individuals who participated in this study and the staff of the Wu Laboratory for their assistance with data collection. This study received financial support from Grant-in-Aid for Scientific Research (B) 21404002, Japan and Grant-in-Aid for Young Scientists (A) 24686034, National Key Technologies R&D Program of China (2013BAK03B03) and National Natural Science Foundation of China (61473043).	ANNETT J, 1958, Q J EXP PSYCHOL, V10, P1, DOI 10.1080/17470215808416248; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Sarlegna F, 2003, EXP BRAIN RES, V151, P524, DOI 10.1007/s00221-003-1504-7; WELFORD AT, 1969, ACTA PSYCHOL, V30, P3, DOI 10.1016/0001-6918(69)90034-1; Sarlegna FR, 2006, NEUROSCI LETT, V403, P309, DOI 10.1016/j.neulet.2006.05.003; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; PELISSON D, 1986, EXP BRAIN RES, V62, P303; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; Klein CS, 2001, J APPL PHYSIOL, V91, P1341; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Wu JL, 2010, HUM MOVEMENT SCI, V29, P882, DOI 10.1016/j.humov.2010.03.009; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; GOGGIN NL, 1992, RES Q EXERCISE SPORT, V63, P366; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; Harridge SDR, 1999, MUSCLE NERVE, V22, P831, DOI 10.1002/(SICI)1097-4598(199907)22:7<831::AID-MUS4>3.0.CO;2-3; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54; SCHEIBEL ME, 1975, EXP NEUROL, V47, P392, DOI 10.1016/0014-4886(75)90072-2; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Briggs SD, 1999, PSYCHOL AGING, V14, P427, DOI 10.1037//0882-7974.14.3.427; DORFMAN LJ, 1979, NEUROLOGY, V29, P38; CARLTON LG, 1981, Q J EXP PSYCHOL-A, V33, P87; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Zhai SM, 2004, INT J HUM-COMPUT ST, V61, P791, DOI 10.1016/j.ijhcs.2004.09.006; Yan JH, 2000, J MOTOR BEHAV, V32, P121; HOFFMANN ER, 1991, ERGONOMICS, V34, P397, DOI 10.1080/00140139108967324; Bauer J. A., 1968, BEHAV RES METHODS, V1, P157, DOI 10.3758/BF03209898; Brouwer AM, 2007, J VISION, V7, DOI 10.1167/7.5.6; Chaput S, 1996, J GERONTOL B-PSYCHOL, V51, pP346; Desmurget M, 1997, EXP BRAIN RES, V115, P180, DOI 10.1007/PL00005680; FITTS PM, 1966, J EXP PSYCHOL, V71, P475, DOI 10.1037/h0022970; Brouwer AM, 2009, J VISION, V9, DOI 10.1167/9.1.24; Giuffrida CG, 2008, TOP GERIATR REHABIL, V24, P253; HAALAND KY, 1993, PSYCHOL AGING, V8, P617, DOI 10.1037/0882-7974.8.4.617; Held R., 1958, PERCEPT MOTOR SKILL, V8, P83, DOI DOI 10.2466/PMS.1958.8.3.83; MacKenzie I. S., 1992, Human-Computer Interaction, V7, DOI 10.1207/s15327051hci0701_3; Medina J, 2009, NEUROSCI LETT, V451, P222, DOI 10.1016/j.neulet.2009.01.002; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Pratt J, 1996, J MOTOR BEHAV, V28, P149; Romero DH, 2003, HUM MOVEMENT SCI, V22, P207, DOI 10.1016/S0167-9457(02)00160-4; Rosenbaum DA, 2006, PSYCHON B REV, V13, P918, DOI 10.3758/BF03194019; SALTHOUSE TA, 1988, ANN NY ACAD SCI, V515, P33, DOI 10.1111/j.1749-6632.1988.tb32962.x; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; STELMACH GE, 1986, AGE, V9, P99, DOI 10.1007/BF02432281; Temprado JJ, 2013, EXP BRAIN RES, V228, P105, DOI 10.1007/s00221-013-3542-0; WELFORD AT, 1984, EXP AGING RES, V10, P73; WELFORD AT, 1988, ANN NY ACAD SCI, V515, P1, DOI 10.1111/j.1749-6632.1988.tb32958.x; Yang JJ, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-7, CONFERENCE PROCEEDINGS, P129, DOI 10.1109/ICMA.2009.5246017; Yen H., 1998, EXPT AGING RES, V24, P155	58	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2015	40						1	13		10.1016/j.humov.2014.11.009		13	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CE6WF	WOS:000351978200001		
J	Saito, A; Watanabe, K; Akima, H				Saito, Akira; Watanabe, Kohei; Akima, Hiroshi			Coordination among thigh muscles including the vastus intermedius and adductor magnus at different cycling intensities	HUMAN MOVEMENT SCIENCE			English	Article						Synergy; Surface electromyogram; Pedaling; Power output; Quadriceps lemons; Hip adductor muscles	DYNAMIC KNEE EXTENSIONS; LOWER-LIMB MUSCLES; INTERINDIVIDUAL VARIABILITY; ELECTROMYOGRAPHIC ANALYSIS; NEUROMUSCULAR SYNERGIES; TRAINED CYCLISTS; JOINT ANGLE; ACTIVATION; QUADRICEPS; FORCE	Although many studies have been focused on muscle synergies in the lower limbs, synergies of the thigh muscles during cycling have not been investigated in detail. We examined synergies of the thigh muscles including the vastus intermedius (VI) and adductor magnus (AM) while cycling. Eight healthy men pedaled at 20%, 40%, 60%, 80% and 100% of maximal aerobic power output at a constant cadence of 60 rpm. Surface electromyography (EMG) recorded signals from the deep VI and the three superficial quadriceps femoris (QF) muscles, the two hamstrings and the AM. The root mean square of the EMG signal was averaged every 2 degrees of crank rotation and normalized by the peak value for each muscle. We used factor analysis to assess normalized EMG recordings while cycling and to identify thigh muscle synergies. The VI, the superficial QF muscles and the AM dominated the first muscle synergy at all power output levels. The AM also formed a second synergy with the two hamstrings at all power output levels. These results suggest that the VI coordinates with the other QF and AM muscles, and that the AM coordinates with the QF and hamstring muscles while cycling. (C) 2014 Elsevier B.V. All rights reserved.	[Saito, Akira; Akima, Hiroshi] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Saito, Akira] Japan Soc Promot Sci, Nagoya, Aichi, Japan; [Watanabe, Kohei] Chukyo Univ, Sch Int Liberal Studies, Nagoya, Aichi, Japan; [Akima, Hiroshi] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan	Saito, A (reprint author), Nagoya Univ, Grad Sch Educ & Human Dev, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	a-saito@nagoya-u.jp			Ministry of Education, Culture, Sports, Science, and Technology Grant [23300239];  [25-860]	This study was supported in part by a Grant-in-Aid for Japan Society for the Promotion of Science (#25-860) to AS, and a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology Grant (#23300239) to HA. We appreciate the assistance of Dr. Koji Ishida, Dr. Keisho Katayama and Mr. Shin Yamashita in monitoring heart rate. We also thank Dr. Taian M.M. Vieira from Universidade Federal do Rio de Janeiro in Brazil for valuable comments regarding the final version of this manuscript.	Akima H, 2007, ACTA ASTRONAUT, V60, P728, DOI 10.1016/j.actaastro.2006.10.006; Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2005-821000; Akima H, 2013, EUR J APPL PHYSIOL, V113, P2829, DOI 10.1007/s00421-013-2721-9; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Hug F, 2009, J ELECTROMYOGR KINES, V19, P182, DOI 10.1016/j.jelekin.2007.10.010; Hug F, 2011, J NEUROPHYSIOL, V106, P91, DOI 10.1152/jn.01096.2010; Saito A, 2013, J ELECTROMYOGR KINES, V23, P831, DOI 10.1016/j.jelekin.2013.02.005; Watanabe K, 2009, EUR J APPL PHYSIOL, V106, P815, DOI 10.1007/s00421-009-1086-6; Shiavi R, 1998, MED BIOL ENG COMPUT, V36, P171, DOI 10.1007/BF02510739; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Watanabe K, 2011, J NEUROSCI METH, V198, P332, DOI 10.1016/j.jneumeth.2011.03.014; Hug F, 2008, EUR J APPL PHYSIOL, V104, P667, DOI 10.1007/s00421-008-0810-y; Neumann DA, 2010, J ORTHOP SPORT PHYS, V40, P82, DOI 10.2519/jospt.2010.3025; Ting LH, 2007, CURR OPIN NEUROBIOL, V17, P622, DOI 10.1016/j.conb.2008.01.002; Farina D, 2004, J APPL PHYSIOL, V97, P2035, DOI 10.1152/japplphysiol.00606.2004; Akima H, 2013, MUSCLE NERVE, V47, P682, DOI 10.1002/mus.23647; ADAMS GR, 1992, J APPL PHYSIOL, V73, P1578; Rouffet DM, 2008, J ELECTROMYOGR KINES, V18, P866, DOI 10.1016/j.jelekin.2007.03.008; Dorel S, 2008, J ELECTROMYOGR KINES, V18, P857, DOI 10.1016/j.jelekin.2007.03.002; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Takizawa M, 2014, SCAND J MED SCI SPOR, V24, P197, DOI 10.1111/j.1600-0838.2012.01466.x; Raasch CC, 1999, J NEUROPHYSIOL, V82, P515; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; Saito A, 2013, J ELECTROMYOGR KINES, V23, P1406, DOI 10.1016/j.jelekin.2013.08.009; Barroso Filipe, 2013, Conf Proc IEEE Eng Med Biol Soc, V2013, P6933, DOI 10.1109/EMBC.2013.6611152; Basmajian J., 1985, MUSCLES ALIVE; Bernstein N, 1967, COORDINATION REGULAT; DAVIS BL, 1993, J ELECTROMYOGR KINES, V3, P51, DOI 10.1016/1050-6411(93)90023-P; de Groot G, 1992, NEUROSCIENCE, V46, P197; De Marchis C, 2013, HUM MOVEMENT SCI, V32, P1480, DOI 10.1016/j.humov.2013.07.018; Enders H, 2013, MED SCI SPORT EXER, V45, P2298, DOI 10.1249/MSS.0b013e31829e49aa; Fukunaga T., 2001, ACTA PHYSL SCANDINAV, V172, P249; Hug F, 2006, INT J SPORTS MED, V27, P456, DOI 10.1055/s-2005-865787; Ivanenko Y. P., 2004, J PHYSL, V556, P267; Merkle LA, 1998, J NEUROSCI METH, V82, P207, DOI 10.1016/S0165-0270(98)00054-5; MONTGOMERY WH, 1994, AM J SPORT MED, V22, P272, DOI 10.1177/036354659402200220; Sabatini AM, 2002, BIOL CYBERN, V86, P253, DOI 10.1007/s00422-001-0297-7; Sarre G, 2003, EUR J APPL PHYSIOL, V88, P476, DOI 10.1007/s00421-002-0738-6; Wakeling JM, 2009, J NEUROPHYSIOL, V101, P843, DOI 10.1152/jn.90679.2008; Watanabe Kohei, 2009, J Electromyogr Kinesiol, V19, pe280, DOI 10.1016/j.jelekin.2008.06.002; Watanabe K, 2011, SCAND J MED SCI SPOR, V21, pE412, DOI 10.1111/j.1600-0838.2011.01347.x	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2015	40						14	23		10.1016/j.humov.2014.11.010		10	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CE6WF	WOS:000351978200002		
J	Kitamura, D; Saruwatari, H; Kameoka, H; Takahashi, Y; Kondo, K; Nakamura, S				Kitamura, Daichi; Saruwatari, Hiroshi; Kameoka, Hirokazu; Takahashi, Yu; Kondo, Kazunobu; Nakamura, Satoshi			Multichannel Signal Separation Combining Directional Clustering and Nonnegative Matrix Factorization with Spectrogram Restoration	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Multichannel signal separation; music signal processing; nonnegative matrix factorization (NMF); spectrogram restoration	AUDIO SOURCE SEPARATION; TIME-FREQUENCY MASKS; SPEECH RECOGNITION; MIXTURES; BINARY	In this paper, to address problems in multichannel music signal separation, we propose a new hybrid method that combines directional clustering and advanced nonnegative matrix factorization (NMF). The aims of multichannel music signal separation technology is to extract a specific target signal from observed multichannel signals that contain multiple instrumental sounds. In previous studies, various methods using NMF have been proposed, but many problems remain including poor separation accuracy and lack of robustness. To solve these problems, we propose a new supervised NMF (SNMF) with spectrogram restoration and a hybrid method that concatenates the proposed SNMF after directional clustering. Via the extrapolation of supervised spectral bases, the proposed SNMF attempts both target signal separation and reconstruction of the lost target components, which are generated by preceding directional clustering. In addition, we experimentally reveal the trade-off between separation and extrapolation abilities and propose a new scheme for adaptive divergence, where the optimal divergence can be automatically changed in each time frame according to the local spatial conditions. The results of an evaluation experiment show that our proposed hybrid method outperforms the conventional music signal separation methods.	[Kitamura, Daichi] Grad Univ Adv Studies, Sch Multidisciplinary Sci, Dept Informat, Tokyo 1018430, Japan; [Saruwatari, Hiroshi; Kameoka, Hirokazu] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Takahashi, Yu; Kondo, Kazunobu] Yamaha Corp, Res & Dev 1, Shizuoka 4380192, Japan; [Nakamura, Satoshi] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan	Kitamura, D (reprint author), Grad Univ Adv Studies, Sch Multidisciplinary Sci, Dept Informat, Tokyo 1018430, Japan.	d-kitamura@nii.ac.jp; hiroshi_saruwatari@ipc.i.u-tokyo.ac.jp; kameoka@hil.t.u-tokyo.ac.jp; yu.takahashi@music.yamaha.com; kazunobu.kondo@music.yamaha.com; s-nakamura@is.naist.jp					Ozerov A, 2010, IEEE T AUDIO SPEECH, V18, P550, DOI 10.1109/TASL.2009.2031510; Harding S, 2006, IEEE T AUDIO SPEECH, V14, P58, DOI 10.1109/TSA.2005.860354; Araki S, 2007, SIGNAL PROCESS, V87, P1833, DOI 10.1016/j.sigpro.2007.02.003; Mohammadiha N, 2013, IEEE T AUDIO SPEECH, V21, P2140, DOI 10.1109/TASL.2013.2270369; Vincent E, 2006, IEEE T AUDIO SPEECH, V14, P1462, DOI 10.1109/TSA.2005.858005; Sawada H, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P261; Li YP, 2009, SPEECH COMMUN, V51, P230, DOI 10.1016/j.specom.2008.09.001; Smaragdis P, 2007, IEEE T AUDIO SPEECH, V15, P1, DOI 10.1109/TASL.2006.876726; Mandel MI, 2010, IEEE T AUDIO SPEECH, V18, P382, DOI 10.1109/TASL.2009.2029711; Cemgil A. T., 2009, COMPUTATIONAL INTELL, V17, DOI DOI 10.1155/2009/785152; Eguchi S., 2001, ROBUSTIFYING MAXIMUM; FitzGerald D., 2009, P IR SIGN SYST C; Kameoka H, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P5365; Kitamura D., 2013, P 3D SYST APPL, pS10; Kitamura D., 2014, P JOINT WORKSH HANDS, P92; Kitamura D, 2014, IEICE T FUND ELECTR, VE97A, P1113, DOI 10.1587/transfun.E97.A.1113; Kitamura D., 2013, P DIG SIGN PROC; Madhu N., 2010, P 4 INT S COMM CONTR; Mesaros A., 2007, P 8 INT C MUS INF RE, P375; Nakano Masahiro, 2010, Proceedings of the 2010 IEEE International Workshop on Machine Learning for Signal Processing (MLSP), DOI 10.1109/MLSP.2010.5589233; Ono N., 2008, P 16 EUR SIGN PROC C; Ozerov A., 2009, P WASPAA MOH NY US, P121; Lee DD, 2001, ADV NEUR IN, V13, P556; Smaragdis P, 2007, LECT NOTES COMPUT SC, V4666, P414; Smaragdis P., 2007, P IEEE WORKSH APPL S, P135; Srinivasan S, 2006, SPEECH COMMUN, V48, P1486, DOI 10.1016/j.specom.2006.09.003; Virtanen T, 2007, IEEE T AUDIO SPEECH, V15, P1066, DOI 10.1109/TASL.2006.885253	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	APR	2015	23	4					654	669		10.1109/TASLP.2015.2401425		16	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	CE4ZY	WOS:000351840600005		
J	Kobayashi, Y; Matsubayashi, D; Hondo, S; Yamamoto, T; Okazaki, Y; Nagai, M; Sasagawa, S; Ito, D; Hata, Y; Hamada, T; Arasawa, R; Sakakura, M; Suzawa, H; Yamamoto, Y; Yamazaki, S				Kobayashi, Yoshiyuki; Matsubayashi, Daisuke; Hondo, Suguru; Yamamoto, Tsutomu; Okazaki, Yutaka; Nagai, Masaharu; Sasagawa, Shinya; Ito, Daigo; Hata, Yuki; Hamada, Takashi; Arasawa, Ryo; Sakakura, Masayuki; Suzawa, Hideomi; Yamamoto, Yoshitaka; Yamazaki, Shunpei			Effect of Surrounded-Channel Structure on Electrical Characteristics of c-Axis Aligned Crystalline In-Ga-Zn-O Field-Effect Transistor	IEEE ELECTRON DEVICE LETTERS			English	Article						Crystalline oxide semiconductor (OS); c-axis aligned crystalline (CAAC); In-Ga-Zn-O (IGZO); surrounded channel (S-ch); field-effect transistor (FET)		In this letter, we report the electrical characteristics of a crystalline oxide semiconductor, especially c-axis aligned crystalline In-Ga-Zn-O (CAAC-IGZO) field-effect transistors (FETs) having a surrounded-channel structure with 51-nm channel lengths, 11-nm equivalent oxide thicknesses of the gate insulating films, and various channel widths. The results show that the influence of the gate electrode on the sides of the channel increases as the channel width is reduced, which leads to excellent OFF-state and ON-state current characteristics of the FET with a 51-nm channel length and a 50-nm channel width. By exploiting these characteristics, low-power large-scale integration (LSI) applications become possible that would not be possible with conventional Si-LSI techniques.	[Kobayashi, Yoshiyuki; Matsubayashi, Daisuke; Hondo, Suguru; Yamamoto, Tsutomu; Okazaki, Yutaka; Nagai, Masaharu; Sasagawa, Shinya; Ito, Daigo; Hata, Yuki; Hamada, Takashi; Arasawa, Ryo; Sakakura, Masayuki; Suzawa, Hideomi; Yamamoto, Yoshitaka; Yamazaki, Shunpei] Semicond Energy Lab Co Ltd, Atsugi, Kanagawa 2430036, Japan	Kobayashi, Y (reprint author), Semicond Energy Lab Co Ltd, Atsugi, Kanagawa 2430036, Japan.	dm1141@sel.co.jp					Jeon S, 2011, ACS APPL MATER INTER, V3, P1, DOI 10.1021/am1009088; Jeon S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3623426; KIMIZUKA N, 1995, J SOLID STATE CHEM, V116, P170, DOI 10.1006/jssc.1995.1198; Lee CW, 2007, SOLID STATE ELECTRON, V51, P505, DOI 10.1016/j.sse.2006.11.013; Kim H, 2011, IEEE T ELECTRON DEV, V58, P3820, DOI 10.1109/TED.2011.2165286; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; KIMIZUKA N, 1985, J SOLID STATE CHEM, V60, P382, DOI 10.1016/0022-4596(85)90290-7; Aoki T., 2014, P IEEE ISSCC FEB, P502; Aoyama T, 2013, PROCEEDINGS OF 2013 TWENTIETH INTERNATIONAL WORKSHOP ON ACTIVE-MATRIX FLATPANEL DISPLAYS AND DEVICES (AM-FPD 13): TFT TECHNOLOGIES AND FPD MATERIALS, P223; Hatsumi R., 2013, SID S DIG TECH PAPER, V44, P338; Jeon S., 2012, P S VLSI TECHN, P125; Jeon S., 2010, IEDM; Keshavarzi A, 1997, INT TEST CONF P, P146; Kobayashi Y., 2014, S VLSI, P1; Kobayashi Y., 2014, JPN J APPL PHYS, V53; Nagatsuka S, 2013, 2013 5TH IEEE INTERNATIONAL MEMORY WORKSHOP (IMW), P188, DOI 10.1109/IMW.2013.6582131; Ohshima K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EE02; Song I, 2008, IEEE ELECTR DEVICE L, V29, P549, DOI 10.1109/LED.2008.920965; Yamazaki S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ED18; Yamazaki S., 2012, SID S, V43, P183	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	APR	2015	36	4					309	311		10.1109/LED.2015.2399911		3	Engineering, Electrical & Electronic	Engineering	CE3QS	WOS:000351743900007		
J	Kang, S; Fallahazad, B; Lee, K; Movva, H; Kim, K; Corbet, CM; Taniguchi, T; Watanabe, K; Colombo, L; Register, LF; Tutuc, E; Banerjee, SK				Kang, Sangwoo; Fallahazad, Babak; Lee, Kayoung; Movva, Hema; Kim, Kyounghwan; Corbet, Chris M.; Taniguchi, Takashi; Watanabe, Kenji; Colombo, Luigi; Register, Leonard F.; Tutuc, Emanuel; Banerjee, Sanjay K.			Bilayer Graphene-Hexagonal Boron Nitride Heterostructure Negative Differential Resistance Interlayer Tunnel FET	IEEE ELECTRON DEVICE LETTERS			English	Article						Negative differential resistance; resonant tunneling; tunneling field effect transistor; bilayer graphene; hexagonal boron nitride; static random access memory; latch		We present the room temperature operation of a vertical tunneling field-effect transistor using a stacked double bilayer graphene (BLG) and hexagonal boron nitride heterostructure. The device shows two tunneling resonances with negative differential resistance (NDR). An analysis of the electrostatic potential drop across the heterostructure indicates the resonances are associated with the relative alignment of the lower or upper bands of the two BLG. Using the NDR characteristic of the device, one-transistor latch or SRAM operation is demonstrated. The device characteristics are largely insensitive to temperature from 1.5 to 300 K.	[Kang, Sangwoo; Fallahazad, Babak; Lee, Kayoung; Movva, Hema; Kim, Kyounghwan; Corbet, Chris M.; Register, Leonard F.; Tutuc, Emanuel; Banerjee, Sanjay K.] Univ Texas Austin, Microelect Res Ctr, Austin, TX 78712 USA; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Colombo, Luigi] Texas Instruments Inc, Dallas, TX 75266 USA	Tutuc, E (reprint author), Univ Texas Austin, Microelect Res Ctr, Austin, TX 78712 USA.	etutuc@mer.utexas.edu; banerjee@ece.utexas.edu	WATANABE, Kenji/H-2825-2011	WATANABE, Kenji/0000-0003-3701-8119	Semiconductor Research Corporation through the Nanoelectronics Research Initiative-South West Academy of Nanoelectronics; Intel Corporation, Santa Clara, CA, USA	This work was supported in part by the Semiconductor Research Corporation through the Nanoelectronics Research Initiative-South West Academy of Nanoelectronics and in part by the Intel Corporation, Santa Clara, CA, USA. The review of this letter was arranged by Editor S. J. Koester.	Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Feenstra RM, 2012, J APPL PHYS, V111, DOI 10.1063/1.3686639; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Lee K, 2014, SCIENCE, V345, P58, DOI 10.1126/science.1251003; Fallahazad B, 2015, NANO LETT, V15, P428, DOI 10.1021/nl503756y; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; Britnell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2817; de la Barrera S. C., 2015, THEORY RESONANT TUNN; Mishchenko A, 2014, NAT NANOTECHNOL, V9, P808, DOI [10.1038/nnano.2014.187, 10.1038/NNANO.2014.187]; Reddy D., 2012, P 70 ANN DEV RES C, P73; Zhang LM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.235408; Zhao P, 2013, IEEE T ELECTRON DEV, V60, P951, DOI 10.1109/TED.2013.2238238	15	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	APR	2015	36	4					405	407		10.1109/LED.2015.2398737		3	Engineering, Electrical & Electronic	Engineering	CE3QS	WOS:000351743900039		
J	Cheung, G; Florencio, D; Le Callet, P; Lin, CW; Magli, E				Cheung, Gene; Florencio, Dinei; Le Callet, Patrick; Lin, Chia-Wen; Magli, Enrico			Introduction to the Issue on Interactive Media Processing for Immersive Communication	IEEE JOURNAL OF SELECTED TOPICS IN SIGNAL PROCESSING			English	Editorial Material									[Cheung, Gene] Natl Inst Informat, Tokyo 1018430, Japan; [Florencio, Dinei] Microsoft Res, Redmond, WA 98052 USA; [Le Callet, Patrick] Univ Nantes, F-44306 Nantes, France; [Lin, Chia-Wen] Natl Tsing Hwa Univ, Nantes 30013, Taiwan; [Magli, Enrico] Politecn Torino, I-10129 Turin, Italy	Cheung, G (reprint author), Natl Inst Informat, Tokyo 1018430, Japan.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4553	1941-0484		IEEE J-STSP	IEEE J. Sel. Top. Signal Process.	APR	2015	9	3					381	383		10.1109/JSTSP.2015.2406092		3	Engineering, Electrical & Electronic	Engineering	CE3SU	WOS:000351749800001		
J	Ishizaki, T; Sandberg, H; Kashima, K; Imura, J; Aihara, K				Ishizaki, Takayuki; Sandberg, Henrik; Kashima, Kenji; Imura, Jun-ichi; Aihara, Kazuyuki			Dissipativity-Preserving Model Reduction for Large-Scale Distributed Control Systems	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						Dissipativity preservation; distributed control systems; singular perturbation approximation; structured model reduction	SINGULAR PERTURBATION; LYAPUNOV EQUATIONS; VIBRATION SUPPRESSION; DYNAMICAL-SYSTEMS; LINEAR-SYSTEMS; PASSIVITY; APPROXIMATION; INTERPOLATION; ROBUSTNESS; STABILITY	We propose a dissipativity-preserving structured model reduction method for distributed control systems. As a fundamental tool to develop structured model reduction, we first establish dissipativity-preserving model reduction for general linear systems on the basis of a singular perturbation approximation. To this end, by deriving a tractable expression of singular perturbation models, we characterize dissipativity preservation in terms of a projection-like transformation of storage functions, and we show that the resultant approximation error is relevant to the sum of neglected eigenvalues of an index matrix. Next, utilizing this dissipativity-preserving model reduction, we develop a structured controller reduction method for distributed control systems. The major significance of this method is to preserve the spatial distribution of dissipative controllers and to provide an a priori bound for the performance degradation of closed-loop systems in terms of the H-2-norm. The efficiency of the proposed method is verified through a numerical example of vibration suppression control for interconnected second-order systems.	[Ishizaki, Takayuki; Imura, Jun-ichi] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Tokyo 1528552, Japan; [Sandberg, Henrik] Royal Inst Technol KTH, Automat Control, Sch Elect Engn, SE-10044 Stockholm, Sweden; [Kashima, Kenji] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	Ishizaki, T (reprint author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Tokyo 1528552, Japan.	ishizaki@mei.titech.ac.jp; hsan@kth.se; kashima@ieee.org; imura@mei.titech.ac.jp; aihara@sat.t.u-tokyo.ac.jp			Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Japan Science and Technology Agency, CREST	Manuscript received February 14, 2013; revised March 4, 2014 and October 14, 2014; accepted October 25, 2014. Date of publication November 12, 2014; date of current version March 20, 2015. This work was supported in part by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP), and by Japan Science and Technology Agency, CREST. Recommended by Associate Editor A. Nedich.	Sztipanovits J, 2012, P IEEE, V100, P29, DOI 10.1109/JPROC.2011.2161529; Sandberg H, 2009, OPTIM CONTR APPL MET, V30, P225, DOI 10.1002/oca.854; Reis T, 2011, SIAM J APPL DYN SYST, V10, P1, DOI 10.1137/090779802; Arcak M, 2007, IEEE T AUTOMAT CONTR, V52, P1380, DOI 10.1109/TAC.2007.902733; WILLEMS JC, 1972, ARCH RATION MECH AN, V45, P352, DOI 10.1007/BF00276494; Gugercin S, 2003, NUMER ALGORITHMS, V32, P27, DOI 10.1023/A:1022205420182; GEORGIOU TT, 1990, IEEE T AUTOMAT CONTR, V35, P673, DOI 10.1109/9.53546; Odabasioglu A, 1998, IEEE T COMPUT AID D, V17, P645, DOI 10.1109/43.712097; Shames I, 2011, AUTOMATICA, V47, P2757, DOI 10.1016/j.automatica.2011.09.011; Sinopoli B, 2003, P IEEE, V91, P1235, DOI 10.1109/JPROC.2003.814926; Sorensen DC, 2005, SYST CONTROL LETT, V54, P347, DOI 10.1016/j.sysconle.2004.07.006; JAIMOUKHA IM, 1994, SIAM J NUMER ANAL, V31, P227, DOI 10.1137/0731012; Kim KD, 2012, P IEEE, V100, P1287, DOI 10.1109/JPROC.2012.2189792; MOYLAN PJ, 1978, IEEE T AUTOMAT CONTR, V23, P143, DOI 10.1109/TAC.1978.1101721; Antoulas A.C., 2005, APPROXIMATION LARGE; AOKI M, 1968, IEEE T AUTOMAT CONTR, VAC13, P246, DOI 10.1109/TAC.1968.1098900; Bai H, 2011, COMMUN CONTROL ENG, P1, DOI 10.1007/978-1-4614-0014-1; Casella F, 2000, IEEE DECIS CONTR P, P4491, DOI 10.1109/CDC.2001.914616; CHOW JH, 1985, IEEE T AUTOMAT CONTR, V30, P714, DOI 10.1109/TAC.1985.1104055; Chu B, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P7782; CLAPPERTON B, 1994, IEEE DECIS CONTR P, P3737, DOI 10.1109/CDC.1994.411739; Emami-Naeini A, 2003, IEEE T CONTR SYST T, V11, P668, DOI 10.1109/TCST.2003.816411; Goddard PJ, 1998, IEEE T AUTOMAT CONTR, V43, P858, DOI 10.1109/9.701085; GUDMUNDSSON T, 1994, IEEE T AUTOMAT CONTR, V39, P1110, DOI 10.1109/9.284905; HADDAD WM, 1994, IEEE T AUTOMAT CONTR, V39, P827, DOI 10.1109/9.286262; Ionutiu R, 2008, IEEE T COMPUT AID D, V27, P2250, DOI 10.1109/TCAD.2008.2006160; Ishizaki T., 2013, P IEEE ACC, P5544; Ishizaki T, 2012, IEEE DECIS CONTR P, P4175, DOI 10.1109/CDC.2012.6426793; Ishizaki T, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P7837; Ishizaki T, 2012, P AMER CONTR CONF, P2301; Khalil H K, 1996, NONLINEAR SYSTEMS, V3; KOKOTOVI.PV, 1972, IEEE T AUTOMAT CONTR, VAC17, P29, DOI 10.1109/TAC.1972.1099851; Kokotovic P., 1987, SINGULAR PERTURBATIO, V25; Kong LL, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P7771; Lall S, 2003, PHYSICA D, V184, P304, DOI 10.1016/S0167-2789(03)00227-6; Li L, 2005, AUTOMATICA, V41, P145, DOI 10.1016/j.automatica.2004.09.003; LIU Y, 1989, INT J CONTROL, V50, P1379, DOI 10.1080/00207178908953437; Lozano-Leal R., 1988, Proceedings of the 27th IEEE Conference on Decision and Control (IEEE Cat. No.88CH2531-2), DOI 10.1109/CDC.1988.194606; Newman M., 2009, NETWORKS INTRO; Obinata G., 2001, MODEL REDUCTION CONT; Zhou J, 2009, IEEE T CIRCUITS-I, V56, P200, DOI 10.1109/TCSI.2008.924895; Polyuga RV, 2010, AUTOMATICA, V46, P665, DOI 10.1016/j.automatica.2010.01.018; Samar S, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P5271, DOI 10.1109/CDC.2003.1272475; Sou KC, 2012, AUTOMATICA, V48, P1069, DOI 10.1016/j.automatica.2012.03.011; VIDYASAGAR M, 1984, IEEE T AUTOMAT CONTR, V29, P403, DOI 10.1109/TAC.1984.1103547; VINNICOMBE G, 1993, IEEE T AUTOMAT CONTR, V38, P1371, DOI 10.1109/9.237648; Wang JF, 2003, INT J SOLIDS STRUCT, V40, P465, DOI 10.1016/S0020-7683(02)00589-9; WILLEMS JC, 1972, ARCH RATION MECH AN, V45, P321, DOI 10.1007/BF00276493	48	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	APR	2015	60	4					1023	1037		10.1109/TAC.2014.2370271		15	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CE3MW	WOS:000351731600010		
J	Mukaidani, H; Xu, H; Dragan, V				Mukaidani, Hiroaki; Xu, Hua; Dragan, Vasile			Decentralized H-2 Control for Multi-Channel Stochastic Systems	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						H-2 control problem; linear matrix inequality (LMI); multi-channel stochastic systems; static output feedback; stochastic algebraic Riccati equation (SARE)	STATE-DEPENDENT NOISE; FIELD LQG CONTROL; MATRIX INEQUALITIES; NASH	This technical note investigates a decentralized H-2 control problem for multi-channel linear time-invariant stochastic systems governed by Ito's differential equation. After using a stochastic algebraic Riccati equation (SARE) to establish the necessary conditions for the existence of the optimal strategy set that minimizes an H-2 norm, we show that the necessary conditions can also be expressed using a linear matrix inequality (LMI). The equivalence between the solvability of the SARE and the feasibility of the LMI is proved for the first time using a Karush-Kuhn-Tucker (KKT) condition. Furthermore, the static output feedback solution was also studied. A numerical example is given to demonstrate the usefulness of the obtained features.	[Mukaidani, Hiroaki] Hiroshima Univ, Inst Engn, Hiroshima 7398521, Japan; [Xu, Hua] Univ Tsukuba, Grad Sch Business Sci, Tokyo 1120012, Japan; [Dragan, Vasile] Acad Romana, Inst Math, Bucharest, Romania	Mukaidani, H (reprint author), Hiroshima Univ, Inst Engn, Hiroshima 7398521, Japan.	mukaida@hiroshima-u.ac.jp	Mukaidani, Hiroaki/D-8442-2012	Mukaidani, Hiroaki/0000-0001-6740-7102	Research Foundation for the Electrotechnology of Chubu (REFEC); Ministry of Education, Culture, Sports, Science and Technology of Japan [23500017]	Manuscript received August 13, 2012; revised February 12, 2013, September 11, 2013, and April 5, 2014; accepted June 17, 2014. Date of publication July 8, 2014; date of current version March 20, 2015. This work was supported in part by the Research Foundation for the Electrotechnology of Chubu (REFEC) and the Grant-in-Aid for Scientific Research (C)-23500017 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Recommended by Associate Editor T. Zhou.	Abou-Kandil H., 2003, MATRIX RICCATI EQUAT; Afanas'ev V. N., 1996, MATH THEORY CONTROL; Zhang WH, 2004, AUTOMATICA, V40, P87, DOI 10.1016/j.automatica.2003.07.002; Chen BS, 2004, IEEE T AUTOMAT CONTR, V49, P45, DOI 10.1109/TAC.2003.821400; Nourian M, 2012, IEEE T AUTOMAT CONTR, V57, P2801, DOI 10.1109/TAC.2012.2195797; Zhai GS, 2001, AUTOMATICA, V37, P565, DOI 10.1016/S0005-1098(00)00190-4; Huang M, 2007, IEEE T AUTOMAT CONTR, V52, P1560, DOI 10.1109/TAC.2007.904450; VanAntwerp JG, 2000, J PROCESS CONTR, V10, P363, DOI 10.1016/S0959-1524(99)00056-6; Jungers M, 2008, AUTOMATICA, V44, P1874, DOI 10.1016/j.automatica.2007.10.035; Boyd S, 2004, CONVEX OPTIMIZATION; Dragan V., 2006, MATH METHODS ROBUST; Dragan V, 2004, AUTOMATICA, V40, P1103, DOI 10.1016/j.automatica.2004.01.023; Gajic Z, 1999, AUTOMATICA, V35, P951, DOI 10.1016/S0005-1098(98)00232-5; Guo CH, 2002, OPER THEOR, V130, P209; Huang MY, 2012, IEEE T AUTOMAT CONTR, V57, P1736, DOI 10.1109/TAC.2012.2183439; Lavaei J, 2009, AUTOMATICA, V45, P1326, DOI 10.1016/j.automatica.2009.01.007; Li X, 2003, J GLOBAL OPTIM, V27, P149, DOI 10.1023/A:1024887007165; Mukaidani H, 2009, AUTOMATICA, V45, P1272, DOI 10.1016/j.automatica.2008.12.020; Mukaidani H, 2012, P AMER CONTR CONF, P50; Mukaidani H, 2009, IEEE T AUTOMAT CONTR, V54, P2244, DOI 10.1109/TAC.2009.2026854; Nourian M, 2013, IEEE T AUTOMAT CONTR, V58, P639, DOI 10.1109/TAC.2012.2215399; Rami MA, 2000, IEEE T AUTOMAT CONTR, V45, P1131, DOI 10.1109/9.863597; Siljak Dragoslav D, 1991, DECENTRALIZED CONTRO; STANKOVIC SS, 1989, AUTOMATICA, V25, P545, DOI 10.1016/0005-1098(89)90097-6; van den Broek WA, 2003, AUTOMATICA, V39, P355, DOI 10.1016/S0005-1098(02)00228-5; Wang L., 2008, P IEEE GLOB COMM C N	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	APR	2015	60	4					1080	1086		10.1109/TAC.2014.2336354		7	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CE3MW	WOS:000351731600016		
J	Morris, S; Hirata, M; Sugata, H; Goto, T; Matsushita, K; Yanagisawa, T; Saitoh, Y; Kishima, H; Yoshimine, T				Morris, Shayne; Hirata, Masayuki; Sugata, Hisato; Goto, Tetsu; Matsushita, Kojiro; Yanagisawa, Takufumi; Saitoh, Youichi; Kishima, Haruhiko; Yoshimine, Toshiki			Patient-Specific Cortical Electrodes for Sulcal and Gyral Implantation	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Amyotrophic lateral sclerosis (ALS); brain-machine interface (BMI); brain sulcus; cortical electrodes; personalized	BRAIN-MACHINE INTERFACES; COMPUTER INTERFACE; ARRAY; CORTEX; SYSTEM; ARM	Purpose: Noninvasive localization of certain brain functions may be mapped on a millimetre level. However, the inter-electrode spacing of common clinical brain surface electrodes still remains around 10 mm. Here, we present details on development of electrodes for attaining higher quality electrocorticographic signals for use in functional brain mapping and brain-machine interface (BMI) technologies. Methods: We used platinum-plate-electrodes of 1-mm diameter to produce sheet electrodes after the creation of individualized molds using a 3-D printer and a press system that sandwiched the electrodes between personalized silicone sheets. Results: We created arrays to fit the surface curvature of the brain and inside the central sulcus, with interelectrode distances of 2.5 mm (a density of 16 times previous standard types). Rat experiments undertaken indicated no long term toxicity. We were also able to custom design, rapidly manufacture, safely implant, and confirm the efficacy of personalized electrodes, including the capability to attain meaningful high-gamma-band information in an amyotrophic lateral sclerosis patient. Conclusion: We developed cortical sheet electrodes with a high-spatial resolution, tailor-made to match an individual's brain. Significance: This sheet electrode may contribute to the higher performance of BMI's.	[Morris, Shayne; Hirata, Masayuki; Sugata, Hisato; Goto, Tetsu; Matsushita, Kojiro; Yanagisawa, Takufumi; Kishima, Haruhiko; Yoshimine, Toshiki] Osaka Univ, Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan; [Saitoh, Youichi] Osaka Univ, Dept Neuromodulat & Neurosurg, Suita, Osaka 5650871, Japan	Hirata, M (reprint author), Osaka Univ, Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	morris.shayne@gmail.com; mhirata@nsurg.med.osaka-u.ac.jp; hsugata@nsurg.med.osaka-u.ac.jp; t-goto@nsurg.med.osaka-u.ac.jp; matsushita@nsurg.med.osaka-u.ac.jp; takufumiy@gmail.com; neurosaitoh@mbk.nifty.com; hkishima@nsurg.med.osaka-u.ac.jp; yoshimine@nsurg.med.osaka-u.ac.jp			BMI Development and Development of BMI Technologies for Clinical Application Grant carried out under the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); KAKENHI - Japan Society for the Promotion of Science (JSPS) [23390347, 26282165]; Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare [23100101]	This work was supported in part by a BMI Development and Development of BMI Technologies for Clinical Application Grant carried out under the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), by a KAKENHI (23390347, 26282165) grant funded by the Japan Society for the Promotion of Science (JSPS), and through a Health Labour Sciences Research Grant 23100101 from the Ministry of Health Labour and Welfare.	McFarland DJ, 2008, J NEURAL ENG, V5, P101, DOI 10.1088/1741-2560/5/2/001; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Li Z, 2011, NEURAL COMPUT, V23, P3162, DOI 10.1162/NECO_a_00207; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Iturrate I, 2009, IEEE T ROBOT, V25, P614, DOI 10.1109/TRO.2009.2020347; Hirata M, 2011, IEICE T COMMUN, VE94B, P2448, DOI 10.1587/transcom.E94.B.2448; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Cincotti F, 2008, BRAIN RES BULL, V75, P796, DOI 10.1016/j.brainresbull.2008.01.007; Rubehn B, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036003; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Galan F., 2007, P IEEE INT S INT SIG, P1; Mak Joseph N, 2009, IEEE Reviews in Biomedical Engineering, V2, DOI 10.1109/RBME.2009.2035356; Orsborn AL, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00157; Stieglitz T, 2001, SENSOR ACTUAT A-PHYS, V90, P203, DOI 10.1016/S0924-4247(01)00520-9; Yanagisawa T., 2011, J NEUROSURG, V114, P1	22	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	APR	2015	62	4					1034	1041		10.1109/TBME.2014.2329812		8	Engineering, Biomedical	Engineering	CE3ZR	WOS:000351769700003		
J	Dinh, TA; Yamashita, S; Ho, TY				Dinh, Trung Anh; Yamashita, Shigeru; Ho, Tsung-Yi			An Optimal Pin-Count Design With Logic Optimization for Digital Microfluidic Biochips	IEEE TRANSACTIONS ON COMPUTER-AIDED DESIGN OF INTEGRATED CIRCUITS AND SYSTEMS			English	Article						Digital microfluidics; logic optimization; pin-count reduction	ON-A-CHIP; IMPLEMENTATION	Digital microfluidic biochips have become one of the most promising technologies for biomedical experiments. In modern microfluidic technology, reducing the number of independent control pins that reflects most of the fabrication cost, power consumption, and reliability of a microfluidic system, is a key challenge for every digital microfluidic biochip design. However, all the previous chip designs sacrifice the optimality of the problem, and only limited reduction on the number of control pins is observed. Moreover, most existing designs cannot satisfy high-throughput demand for bioassays, and thus inapplicable in practical contexts. In this paper, we propose the first optimal pin-count design scheme for digital microfluidic biochips. By integrating a very simple combinational logic circuit into the original chip, the proposed scheme can provide high-throughput for bioassays with an information-theoretic minimum number of control pins. Furthermore, to cope with the rapid growth of the chip's scale, we also propose a scalable and efficient heuristics to reduce the number of control pins. A logic optimization technique, which can be used to reduce the complexity of the integrated combinational logic circuit, is also presented in this paper. Experiments demonstrate that the proposed scheme can obtain much fewer number of control pins compared with the previous state-of-the-art works.	[Dinh, Trung Anh] Ritsumeikan Univ, Grad Sch Informat Sci & Engn, Kusatsu 5258577, Japan; [Yamashita, Shigeru] Ritsumeikan Univ, Dept Comp Sci, Kusatsu 5258577, Japan; [Ho, Tsung-Yi] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu 30010, Taiwan	Dinh, TA (reprint author), Ritsumeikan Univ, Grad Sch Informat Sci & Engn, Kusatsu 5258577, Japan.	trungda@ngc.is.ritsumei.ac.jp			Japan Society for the Promotion of Science KAKENHI [23300019]; Taiwan Ministry of Science and Technology [MOST 102-2221-E-009-194-MY3, 103-2220-E-009-029, 103-2923-E-009-006-MY3]	Manuscript received May 29, 2014; revised September 14, 2014 and December 2, 2014; accepted December 17, 2014. Date of publication January 29, 2015; date of current version March 17, 2015. The work of S. Yamashita was supported by the Japan Society for the Promotion of Science KAKENHI under Grant 23300019. The work of T.-Y. Ho was supported by the Taiwan Ministry of Science and Technology under Grant MOST 102-2221-E-009-194-MY3, Grant 103-2220-E-009-029, and Grant 103-2923-E-009-006-MY3. A preliminary version of this paper was published in the proceedings of the IEEE/ACM Design, Automation and Test in Europe in 2014 [1]. This paper was recommended by Associate Editor Y. Wang.	Lin CCY, 2010, IEEE T COMPUT AID D, V29, P1315, DOI 10.1109/TCAD.2010.2049157; Hadwen B, 2012, LAB CHIP, V12, P3305, DOI 10.1039/c2lc40273d; Srinivasan V, 2004, LAB CHIP, V4, P310, DOI 10.1039/b403341h; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; Su F, 2006, IEEE T COMPUT AID D, V25, P211, DOI 10.1109/TCAD.2005.855956; Xu T, 2008, DES AUT CON, P173; Pollack MG, 2002, LAB CHIP, V2, P96, DOI 10.1039/b110474h; Li Y, 2007, PROC EUR S-STATE DEV, P446, DOI 10.1109/ESSDERC.2007.4430974; Luo Y, 2012, DES AUT CON, P18; Gong J, 2008, J MICROELECTROMECH S, V17, P257, DOI 10.1109/JMEMS.2007.912698; Dinh T. A., 2014, P IEEE ACM DES AUT T, P1; Evans Randall, 2007, P IEEE SENS C ATL GA, P423; Grissom D., 2013, P 50 ACM EDAC IEEE D, P1; Gros J., 1999, GRAPH THEORY ITS APP; Huang XW, 2015, INTEGRATION, V51, P208, DOI 10.1016/j.vlsi.2014.07.004; Huang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104539; Hwang WL, 2006, DES AUT CON, P925; Li Y., 2006, P IET SEM MEMS SENS, P23; Luo Yan, 2012, P DATE, P1239; Phan S. K., 2003, P IEEE 16 ANN INT C, P694; Sasao T, 2001, INT SYM MVL, P207; VILLA T, 1990, IEEE T COMPUT AID D, V9, P905, DOI 10.1109/43.59068; Xu T., 2006, P IEEE ACM INT C HAR, P112, DOI 10.1145/1176254.1176283	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0070	1937-4151		IEEE T COMPUT AID D	IEEE Trans. Comput-Aided Des. Integr. Circuits Syst.	APR	2015	34	4					629	641		10.1109/TCAD.2015.2394502		13	Computer Science, Hardware & Architecture; Computer Science, Interdisciplinary Applications; Engineering, Electrical & Electronic	Computer Science; Engineering	CE3YC	WOS:000351765000012		
J	Ichii, M; Ishida, R; Tsuchiya, H; Kamakura, Y; Mori, N; Ogawa, M				Ichii, Masato; Ishida, Ryoma; Tsuchiya, Hideaki; Kamakura, Yoshinari; Mori, Nobuya; Ogawa, Matsuto			Computational Study of Effects of Surface Roughness and Impurity Scattering in Si Double-Gate Junctionless Transistors	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Backscattering coefficient; ionized impurity (II) scattering; junctionless transistor (JLT); Monte Carlo method; screening effect; surface roughness (SR) scattering	MONTE-CARLO; ELECTRON-TRANSPORT; MOBILITY	Electron transport in Si double-gate junctionless transistors (JLTs) is simulated on the basis of the multisubband Monte Carlo method, considering acoustic phonons, intervalley phonons, ionized impurities (IIs), and surface roughness (SR) scattering. It is demonstrated that JLTs can actually minimize the mobility degradation caused by SR scattering and improve the current drivability. On the other hand, II scattering is confirmed to degrade the current drivability compared with conventional MOSFETs with an intrinsic channel. However, the performance degradation in JLTs due to II scattering is shown to be insignificant, owing to the screening effect of free carriers and the forward scattering properties of high-speed carriers. Furthermore, by extracting a backscattering coefficient, the screening effect and the forward scattering properties are shown to more mitigate II scattering as the gate voltage increases.	[Ichii, Masato; Ishida, Ryoma; Tsuchiya, Hideaki; Ogawa, Matsuto] Kobe Univ, Dept Elect & Elect Engn, Kobe, Hyogo 6570013, Japan; [Tsuchiya, Hideaki; Kamakura, Yoshinari; Mori, Nobuya] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1028666, Japan; [Kamakura, Yoshinari; Mori, Nobuya] Osaka Univ, Div Elect Elect & Informat Engn, Osaka 5650871, Japan	Ichii, M (reprint author), Kobe Univ, Dept Elect & Elect Engn, Kobe, Hyogo 6570013, Japan.	146t207t@stu.kobe-u.ac.jp; 137t204t@stu.kobe-u.ac.jp; tsuchiya@eedept.kobe-u.ac.jp; kamakura@si.eei.eng.osaka-u.ac.jp; nobuya.mori@eei.eng.osaka-u.ac.jp; ogawa@eedept.kobe-u.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency/Core Research for Evolutional Science and Technology	This work was supported in part by the Japan Society for the Promotion of Science through the Grant-in-Aid for Scientific Research and in part by the Japan Science and Technology Agency/Core Research for Evolutional Science and Technology. The review of this paper was arranged by Editor R. M. Todi.	Colinge JP, 2010, NAT NANOTECHNOL, V5, P225, DOI [10.1038/nnano.2010.15, 10.1038/NNANO.2010.15]; Gnani E, 2011, IEEE T ELECTRON DEV, V58, P2903, DOI 10.1109/TED.2011.2159608; Rios R, 2011, IEEE ELECTR DEVICE L, V32, P1170, DOI 10.1109/LED.2011.2158978; Takagi SI, 1996, J APPL PHYS, V80, P1567, DOI 10.1063/1.362953; PRANGE RE, 1968, PHYS REV, V168, P779, DOI 10.1103/PhysRev.168.779; Fischetti MV, 1996, J APPL PHYS, V80, P2234, DOI 10.1063/1.363052; JACOBONI C, 1983, REV MOD PHYS, V55, P645, DOI 10.1103/RevModPhys.55.645; Duarte JP, 2011, IEEE T ELECTRON DEV, V58, P4219, DOI 10.1109/TED.2011.2169266; FISCHETTI MV, 1993, PHYS REV B, V48, P2244, DOI 10.1103/PhysRevB.48.2244; Barraud S, 2012, IEEE ELECTR DEVICE L, V33, P1225, DOI 10.1109/LED.2012.2203091; Fischetti MV, 2001, J APPL PHYS, V89, P1232, DOI 10.1063/1.1332424; Chen ZJ, 2012, IEEE T ELECTRON DEV, V59, P3292, DOI 10.1109/TED.2012.2221164; Choi J., 2012, APPL PHYS EXP, V5; Dollfus P., 2010, WIGNER MONTE CARLO M; Esseni D., 2011, NANOSCALE MOS TRANSI; Goto K. -I., 2012, APPL PHYS LETT, V101, P073503; Hess K., 2000, ADV THEORY SEMICONDU; Kadotani N, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.094101; Koba S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.114301; Koba S., 2013, P IEEE IEDM DEC; Lee C.-W., 2009, APPL PHYS LETT, V94; Monsef F, 2004, J APPL PHYS, V95, P3587, DOI 10.1063/1.1650885; Nagai K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.044302; Rudenko T., 2012, APPL PHYS LETT, V101; Soree B., 2011, APPL PHYS LETT, V99; Uchida K., 2002, P IEDM, P47; Wei KL, 2014, IEEE ELECTR DEVICE L, V35, P817, DOI 10.1109/LED.2014.2331326	27	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	APR	2015	62	4					1255	1261		10.1109/TED.2015.2399954		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CE3UF	WOS:000351753900027		
J	Li, N; Okada, K; Inoue, T; Hirano, T; Bu, QH; Narayanan, AT; Siriburanon, T; Sakane, H; Matsuzawa, A				Li, Ning; Okada, Kenichi; Inoue, Takeshi; Hirano, Takuichi; Bu, Qinghong; Narayanan, Aravind Tharayil; Siriburanon, Teerachot; Sakane, Hitoshi; Matsuzawa, Akira			High-Q Inductors on Locally Semi-Insulated Si Substrate by Helium-3 Bombardment for RF CMOS Integrated Circuits	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						CMOS; helium-3 bombardment; high-Q inductor	ON-CHIP INDUCTORS; SPIRAL INDUCTORS; SILICON; TECHNOLOGY; WAFERS; ICS	A helium-3 ion bombardment technique is proposed to realize high-Q inductors by creating locally semi-insulating substrate areas. A dose of 1.0 x 10(13) cm(-2) helium-3 increases a Si substrate resistivity from 4 Omega . cm to above 1 k Omega . cm, which improves the quality factor of a 2-nH inductor with a 140-mu m diameter by 38% (Q = 16.3). An aluminum mask is used for covering active areas, and at least 15-mu m distance from the mask edge is required to avoid the p-n junction leakage. The proposed technique is applied to an 8-GHz oscillator, and an 8.5 dB improvement of the measured phase noise has been achieved.	[Li, Ning; Okada, Kenichi; Hirano, Takuichi; Bu, Qinghong; Narayanan, Aravind Tharayil; Siriburanon, Teerachot; Matsuzawa, Akira] Tokyo Inst Technol, Tokyo 1528550, Japan; [Inoue, Takeshi; Sakane, Hitoshi] SHI Examinat & Inspect Ltd, Saijo, Ehime 7991393, Japan	Li, N (reprint author), Tokyo Inst Technol, Tokyo 1528550, Japan.	lining@ssc.pe.titech.ac.jp; okada@ssc.pe.titech.ac.jp; tki_inoue@shi.co.jp; hira@antenna.ee.titech.ac.jp; buqh@ssc.pe.titech.ac.jp; aravind@ssc.pe.titech.ac.jp; tee@ssc.pe.titech.ac.jp; hts_sakane@shi.co.jp; matsu@ssc.pe.titech.ac.jp			IEEE; MIC; SCOPE; VDEC; Cadence Design Systems, Inc.; Agilent Technologies Japan, Ltd.; Mentor Graphics, Inc.	This work was supported in part by the IEEE, in part by MIC, in part by SCOPE, and in part by VDEC in collaboration with Cadence Design Systems, Inc., Agilent Technologies Japan, Ltd., and Mentor Graphics, Inc. The review of this paper was arranged by Editor R. M. Todi.	Long JR, 1997, IEEE J SOLID-ST CIRC, V32, P357, DOI 10.1109/4.557634; Choi YS, 2004, IEEE ELECTR DEVICE L, V25, P76, DOI 10.1109/LED.2003.822652; Yue CP, 2000, IEEE T ELECTRON DEV, V47, P560, DOI 10.1109/16.824729; Musa A, 2011, IEEE J SOLID-ST CIRC, V46, P2635, DOI 10.1109/JSSC.2011.2166336; Burghartz JN, 2011, ULTRA-THIN CHIP TECHNOLOGY AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7276-7; Carchon G., 2005, IEEE INT SOL STAT CI, P398, DOI 10.1109/ISSCC.2005.1494037; Carchon G, 2003, IEEE MTT S INT MICR, P1287, DOI 10.1109/MWSYM.2003.1212605; Carchon GJ, 2004, IEEE T MICROW THEORY, V52, P1244, DOI 10.1109/TMTT.2004.825656; Hara S., 2010, P IEEE VLSI CIRC S M, P51; Kim J, 2003, IEEE RAD FREQ INTEGR, P591; Lee LS, 2001, IEEE T ELECTRON DEV, V48, P928; Li N., 2014, S VLSI TECHN JUN, P1; Liao CP, 1998, IEEE ELECTR DEVICE L, V19, P461, DOI 10.1109/55.735746; Liu C. C., 2012, IEDM, P323; Tang D. D., 2003, IEDM TECH, P673; Wu R., 2014, P IEEE RAD FREQ INT, P381; Ziegler J.F., PARTICLE INTERACTION	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	APR	2015	62	4					1269	1275		10.1109/TED.2015.2403873		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CE3UF	WOS:000351753900029		
J	Shah, ASBM; Yokoyama, H; Kakimoto, N				Shah, Ahmad Syahiman Bin Mohd; Yokoyama, Hiroki; Kakimoto, Naoto			High-Precision Forecasting Model of Solar Irradiance Based on Grid Point Value Data Analysis for an Efficient Photovoltaic System	IEEE TRANSACTIONS ON SUSTAINABLE ENERGY			English	Article						Correlation coefficient; grid point value (GPV); irradiance; liquid water path; solar relative humidity	RELATIVE-HUMIDITY; RADIATION; TEMPERATURE; JMA	An accurate forecasting system is extremely crucial in order to simulate an optimum output level of photovoltaic (PV) power production for the next day. In this study, a relatively high-precision model of solar irradiance forecasting based on grid point value (GPV) datasets using relative humidity, precipitation, and three-level cloud covers parameterization has been conducted in Hitachi and four main cities in Japan. In the case of cloudy/rainy/snowy days, the influence of liquid water path is further introduced to the model. As a result, correlation coefficient r of 0.94, 0.91, 0.91, 0.89, and 0.92 have been obtained using 21UTC forecast version in 2012 datasets for Hitachi, Tokyo, Nagoya, Osaka, and Fukuoka, respectively. Surprisingly, although the earlier forecast version, using 9UTC datasets, was later applied to the model, there was no significant change to the r for these five locations as their values reduced by only approximately 0.01 at most. Furthermore, a similar trend has also been observed for the 2013 datasets from a comparison of 21UTC and 9UTC versions, which highly supports the fact that this model is reliable, since it still remains in a high-precision state even in the case where the earlier datasets of previous day are used.	[Shah, Ahmad Syahiman Bin Mohd] Ibaraki Univ, Grad Sch Sci & Engn, Ibaraki, Japan; [Yokoyama, Hiroki] Ibaraki Univ, Dept Elect & Elect Engn, Ibaraki 3168511, Japan; [Kakimoto, Naoto] Ibaraki Univ, Ibaraki 3168511, Japan	Shah, ASBM (reprint author), Ibaraki Univ, Grad Sch Sci & Engn, Ibaraki, Japan.	13nd206a@hcs.ibaraki.ac.jp; ykyn.2-sgy-eb5@ezweb.ne.jp; kakimoto@mx.ibaraki.ac.jp					Almorox Javier, 2011, Turkish Journal of Physics, V35, DOI 10.3906/fiz-0912-20; Eissa Y, 2013, SOL ENERGY, V89, P1, DOI 10.1016/j.solener.2012.12.008; Mellit A, 2010, SOL ENERGY, V84, P807, DOI 10.1016/j.solener.2010.02.006; Thornton PE, 2000, AGR FOREST METEOROL, V104, P255, DOI 10.1016/S0168-1923(00)00170-2; Rehman S, 2008, ENERG POLICY, V36, P571, DOI 10.1016/j.enpol.2007.09.033; Diagne M, 2014, SOL ENERGY, V105, P99, DOI 10.1016/j.solener.2014.03.016; Saito K, 2007, J METEOROL SOC JPN, V85B, P271, DOI 10.2151/jmsj.85B.271; Yang HT, 2014, IEEE T SUSTAIN ENERG, V5, P917, DOI 10.1109/TSTE.2014.2313600; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; Badescu V, 1997, SOL ENERGY, V61, P251, DOI 10.1016/S0038-092X(97)00057-1; Mathiesen P, 2013, IEEE T SUSTAIN ENERG, V4, P510, DOI 10.1109/TSTE.2012.2200704; Lorenz E, 2009, IEEE J-STARS, V2, P2, DOI 10.1109/JSTARS.2009.2020300; Dambreville R., 2014, SCIENCEDIRECT RENEW, V72, P291; Geraldi E., 2009, IEEE T GEOSCI REMOTE, V2, P2; Hitachi City Hall, 2014, IND OBS WEATH DAT HI; Japan Map. Facts.co, 2013, JAP MAP JAP OUTL MAP; Japan Meteorology Agency (JMA), 2014, IND WEATH DAT BAS GP; JMA, 2014, WEATH DAT; Khan M. M., 2012, J ENG SCI TECH REV, V5, P12; Lengfeld K, 2010, METEOROL Z, V19, P25, DOI 10.1127/0941-2948/2010/0423; National Aeronautics and Space Administration (NASA), 1999, REL SOL RAD PHYS EAR; National Center for Atmospheric Research Staff, 2013, CLIM DAT GUID LIQ WA; Ohtake H, 2013, SOL ENERGY, V98, P138, DOI 10.1016/j.solener.2012.10.007; Reno M. J., 2012, SAND20122389 SAND NA; SAITO K, 1988, J METEOROL SOC JPN, V66, P187; Spencer J., 1971, SEARCH, V2, P172; Teixeira J, 2001, MON WEATHER REV, V129, P1750, DOI 10.1175/1520-0493(2001)129<1750:CFARHI>2.0.CO;2; Tetens V. O., 1930, Z GEOPHYS, V6, P297; Yoshikado H., 1987, J METEOROL SOC JPN, V2, P109; Zhang HL, 2013, IEEE J-STARS, V6, P180, DOI 10.1109/JSTARS.2012.2211000	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-3029			IEEE T SUSTAIN ENERG	IEEE Trans. Sustain. Energy	APR	2015	6	2					474	481		10.1109/TSTE.2014.2383398		8	Energy & Fuels; Engineering, Electrical & Electronic	Energy & Fuels; Engineering	CE4WG	WOS:000351830300018		
J	Xia, ZF; Hariyama, M; Kameyama, M				Xia, Zhengfan; Hariyama, Masanori; Kameyama, Michitaka			Asynchronous Domino Logic Pipeline Design Based on Constructed Critical Data Path	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						Asynchronous pipeline; critical data path; dual-rail domino gate; single-rail domino gate	ARCHITECTURE; CIRCUITS; GATES	This paper presents a high-throughput and ultralow-power asynchronous domino logic pipeline design method, targeting to latch-free and extremely fine-grain or gate-level design. The data paths are composed of a mixture of dual-rail and single-rail domino gates. Dual-rail domino gates are limited to construct a stable critical data path. Based on this critical data path, the handshake circuits are greatly simplified, which offers the pipeline high throughput as well as low power consumption. Moreover, the stable critical data path enables the adoption of single-rail domino gates in the noncritical data paths. This further saves a lot of power by reducing the overhead of logic circuits. An 8 x 8 array style multiplier is used for evaluating the proposed pipeline method. Compared with a bundled-data asynchronous domino logic pipeline, the proposed pipeline, respectively, saves up to 60.2% and 24.5% of energy in the best case and the worst case when processing different data patterns.	[Xia, Zhengfan; Hariyama, Masanori; Kameyama, Michitaka] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan	Xia, ZF (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan.	xiazhengfan@ecei.tohoku.ac.jp; hariyama@ecei.tohoku.ac.jp; kameyama@ecei.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology KAKENHI [12020735]; Ministry of Economy, Trade and Industry, through the Research and Development Subsidiary Program for Promotion of Academia-industry Cooperation; VLSI Design and Education Center; University of Tokyo through STARC; University of Tokyo through e-Shuttle Inc.; University of Tokyo through Fujitsu Ltd.; University of Tokyo through Cadence Design Systems Inc.; University of Tokyo through Synopsys Inc.; University of Tokyo through Mentor Graphics Inc.	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology KAKENHI under Grant 12020735, in part by the Ministry of Economy, Trade and Industry, through the Research and Development Subsidiary Program for Promotion of Academia-industry Cooperation, in part by VLSI Design and Education Center, and in part by the University of Tokyo through STARC, e-Shuttle Inc., Fujitsu Ltd., Cadence Design Systems Inc., Synopsys Inc., and Mentor Graphics Inc. This paper was presented at the dual-rail/single-rail hybrid logic design concept appeared in the 2012 IEEE International Symposium on Circuits and Systems, May 2012, pp. 3017-3020, as dual-rail/single-rail hybrid logic design for high-performance asynchronous circuit and the construction of the critical data path using synchronizing logic gates appeared in the 2012 IEICE Transaction on Electronics, Vol. E95-C, no. 8, pp. 1434-1443, Aug. 2012, as design of high-performance asynchronous pipeline using synchronizing logic gates.	Ahuja S, 2009, 2009 IEEE INTERNATIONAL HIGH LEVEL DESIGN VALIDATION AND TEST WORKSHOP, P20, DOI 10.1109/HLDVT.2009.5340181; Teifel J, 2004, IEEE T COMPUT, V53, P1376, DOI 10.1109/TC.2004.88; Martin AJ, 2006, P IEEE, V94, P1089, DOI 10.1109/JPROC.2006.875789; Calhoun BH, 2008, P IEEE, V96, P343, DOI 10.1109/JPROC.2007.911072; Nowick SM, 2011, IEEE DES TEST COMPUT, V28, P8, DOI 10.1109/MDT.2011.71; Singh M, 2010, IEEE T VLSI SYST, V18, P1043, DOI 10.1109/TVLSI.2009.2019660; Hariyama M, 2008, IEICE T ELECTRON, VE91C, P1419, DOI 10.1093/ietele/e91-c.9.1419; Harris D., 2004, LECT NOTES SUBJECT; Krstic M, 2007, IEEE DES TEST COMPUT, V24, P430, DOI 10.1109/MDT.2007.164; Li L.J., 2010, P IEEE CONS COMM NET, P1; Lines A. M., 1998, PIPELINED ASYNCHRONO; Low HS, 2011, INT SYMP ASYNCHRON C, P77, DOI 10.1109/ASYNC.2011.17; Singh M, 2007, IEEE T VLSI SYST, V15, P1256, DOI 10.1109/TVLSI.2007.902205; Sparso J., 2001, PRINCIPLES ASYNCHRON; Srivastava P, 1998, PR GR LAK SYMP VLSI, P108, DOI 10.1109/GLSV.1998.665208; Sutherland I., 1999, LOGICAL EFFORT DESIG; Taubin Alexander, 2007, Foundations and Trends in Electronic Design Automation, V2, DOI 10.1561/1000000006; Williams T. E., 1991, THESIS STANFORD U ST; Xia Z, 2010, ELECTRON LETT, V46, P1116, DOI 10.1049/el.2010.1602; Xia Z., 2012, P IEEE ISCAS, P3017; Xia ZF, 2012, IEICE T ELECTRON, VE95C, P1434, DOI 10.1587/transele.E95.C.1434	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	APR	2015	23	4					619	630		10.1109/TVLSI.2014.2314685		12	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CE3TI	WOS:000351751400002		
J	Jarollahi, H; Gripon, V; Onizawa, N; Gross, WJ				Jarollahi, Hooman; Gripon, Vincent; Onizawa, Naoya; Gross, Warren J.			Algorithm and Architecture for a Low-Power Content-Addressable Memory Based on Sparse Clustered Networks	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						Associative memory; content-addressable memory (CAM); low-power computing; recurrent neural networks; sparse clustered networks (SCNs)	NEURAL-NETWORKS; CAM; DESIGN	We propose a low-power content-addressable memory (CAM) employing a new algorithm for associativity between the input tag and the corresponding address of the output data. The proposed architecture is based on a recently developed sparse clustered network using binary connections that on-average eliminates most of the parallel comparisons performed during a search. Therefore, the dynamic energy consumption of the proposed design is significantly lower compared with that of a conventional low-power CAM design. Given an input tag, the proposed architecture computes a few possibilities for the location of the matched tag and performs the comparisons on them to locate a single valid match. TSMC 65-nm CMOS technology was used for simulation purposes. Following a selection of design parameters, such as the number of CAM entries, the energy consumption and the search delay of the proposed design are 8%, and 26% of that of the conventional NAND architecture, respectively, with a 10% area overhead. A design methodology based on the silicon area and power budgets, and performance requirements is discussed.	[Jarollahi, Hooman; Gross, Warren J.] McGill Univ, Dept Elect & Comp Engn, Montreal, PQ H3A 2A7, Canada; [Gripon, Vincent] Telecom Bretagne, Dept Elect, F-29238 Brest, France; [Onizawa, Naoya] Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan	Jarollahi, H (reprint author), McGill Univ, Dept Elect & Comp Engn, Montreal, PQ H3A 2A7, Canada.	hooman.jarollahi@mail.mcgill.ca; vincent.gripon@telecom-bretagne.eu; naoya.onizawa@mail.mcgill.ca; warren.gross@mcgill.ca					Agarwal A., 2011, P ESSCIRC 2011 SEPT, P83; Lin CS, 2003, IEEE J SOLID-ST CIRC, V38, P654, DOI 10.1109/JSSC.2003.809515; Chang YJ, 2008, IEEE T VLSI SYST, V16, P965, DOI 10.1109/TVLSI.2008.2000595; Wang CC, 2009, IEEE J SOLID-ST CIRC, V44, P1571, DOI 10.1109/JSSC.2009.2017009; Pagiamtzis K, 2004, IEEE J SOLID-ST CIRC, V39, P1512, DOI 10.1109/JSSC.2004.831433; Huang PT, 2011, IEEE J SOLID-ST CIRC, V46, P507, DOI 10.1109/JSSC.2010.2082270; Chao HJ, 2002, P IEEE, V90, P1518, DOI 10.1109/JPROC.2002.802001; Pagiamtzis K, 2006, IEEE J SOLID-ST CIRC, V41, P712, DOI 10.1109/JSSC.2005.864128; Gripon V, 2011, IEEE T NEURAL NETWOR, V22, P1087, DOI 10.1109/TNN.2011.2146789; Noda H, 2005, IEEE J SOLID-ST CIRC, V40, P245, DOI 10.1109/JSSC.2004.838016; Chang YJ, 2007, IEEE T VLSI SYST, V15, P13, DOI 10.1109/TVLSI.2006.887813; Gripon V., 2012, P INF THEOR APPL WOR, P269; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huang NF, 2001, GLOB TELECOMM CONF, P1877; Jarollahi H, 2013, P IEEE INT C APPL, P305; Jarollahi H., 2013, P IEEE GLOB C SIGN I, P1270; Jarollahi H, 2013, INT CONF ACOUST SPEE, P2523, DOI 10.1109/ICASSP.2013.6638110; Jarollahi H., 2012, P ISCAS, P2901; Juan T., 1997, Proceedings 1997 International Symposium on Low Power Electronics and Design (IEEE Cat. No.97TH8332), DOI 10.1109/LPE.1997.621281; Lei Z., 2010, P INT GREEN COMP C A, P477; LIU LY, 1994, IEEE T CONSUM ELECTR, V40, P282; Meribout M, 2000, IEEE T IMAGE PROCESS, V9, P2126, DOI 10.1109/83.887981; MOTOMURA M, 1990, IEEE J SOLID-ST CIRC, V25, P1158, DOI 10.1109/4.62138; Nakanishi M., 1996, P 13 INT C PATT REC, V2, P516, DOI 10.1109/ICPR.1996.546878; Noda H., 2004, P IEEE ISSCC FEB, V1, P208; Onizawa N, 2012, INT SYMP ASYNCHRON C, P41, DOI 10.1109/ASYNC.2012.25; Pagiamtzis K, 2003, PROCEEDINGS OF THE IEEE 2003 CUSTOM INTEGRATED CIRCUITS CONFERENCE, P383, DOI 10.1109/CICC.2003.1249423; PANCHANATHAN S, 1991, IEEE T SIGNAL PROCES, V39, P2066, DOI 10.1109/78.134438; Ruan SJ, 2008, IEEE T VLSI SYST, V16, P331, DOI 10.1109/TVLSI.2007.915514; Schultz KJ, 1996, IEEE J SOLID-ST CIRC, V31, P689, DOI 10.1109/4.509851; Wang J.-S., 2005, IEEE INT SOL STAT CI, V1, P464; WEI BWY, 1993, 1993 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS : PROCEEDINGS, VOLS 1-4 ( ISCAS 93 ), P1953; Yang SH, 2012, IEEE T VLSI SYST, V20, P1909, DOI 10.1109/TVLSI.2011.2163205; Zukowski CA, 1997, REC IEEE INT WKSHP M, P64, DOI 10.1109/MTDT.1997.619397	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	APR	2015	23	4					642	653		10.1109/TVLSI.2014.2316733		12	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CE3TI	WOS:000351751400004		
J	Iwai, D; Mihara, S; Sato, K				Iwai, Daisuke; Mihara, Shoichiro; Sato, Kosuke			Extended Depth-of-Field Projector by Fast Focal Sweep Projection	IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS			English	Article						Projection display; extended depth-of-field projector; focal sweep; immersive virtual reality; spatial augmented reality	FLEXIBLE DEPTH; PHOTOGRAPHY; SYSTEMS	A simple and cost-efficient method for extending a projector's depth-of-field (DOF) is proposed. By leveraging liquid lens technology, we can periodically modulate the focal length of a projector at a frequency that is higher than the critical flicker fusion (CFF) frequency. Fast periodic focal length modulation results in forward and backward sweeping of focusing distance. Fast focal sweep projection makes the point spread function (PSF) of each projected pixel integrated over a sweep period (IPSF; integrated PSF) nearly invariant to the distance from the projector to the projection surface as long as it is positioned within sweep range. This modulation is not perceivable by human observers. Once we compensate projection images for the IPSF, the projected results can be focused at any point within the range. Consequently, the proposed method requires only a single offline PSF measurement; thus, it is an open-loop process. We have proved the approximate invariance of the projector's IPSF both numerically and experimentally. Through experiments using a prototype system, we have confirmed that the image quality of the proposed method is superior to that of normal projection with fixed focal length. In addition, we demonstrate that a structured light pattern projection technique using the proposed method can measure the shape of an object with large depth variances more accurately than normal projection techniques.	[Iwai, Daisuke; Mihara, Shoichiro; Sato, Kosuke] Osaka Univ, Suita, Osaka 565, Japan	Iwai, D (reprint author), Osaka Univ, Suita, Osaka 565, Japan.	daisuke.iwai@sys.es.osaka-u.ac.jp; mihara@sens.sys.es.osaka-u.ac.jp; sato@sys.es.osaka-u.ac.jp			MEXT, Japan [22135003]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Shitsukan" (No. 22135003) from MEXT, Japan.	Salvi J, 2004, PATTERN RECOGN, V37, P827, DOI 10.1016/j.patcog.2003.10.002; Nagase M, 2011, VIRTUAL REAL-LONDON, V15, P119, DOI 10.1007/s10055-010-0168-4; Bimber O, 2006, IEEE T VIS COMPUT GR, V12, P658, DOI 10.1109/TVCG.2006.75; Bimber O, 2008, COMPUT GRAPH FORUM, V27, P2219, DOI 10.1111/j.1467-8659.2008.01175.x; Nagahara H, 2008, LECT NOTES COMPUT SC, V5305, P60, DOI 10.1007/978-3-540-88693-8_5; [Anonymous], 2014, BIG BUCK BUNNY; Bandyopadhyay D., 2001, Proceedings IEEE and ACM International Symposium on Augmented Reality, DOI 10.1109/ISAR.2001.970539; Bermano A., 2013, ACM T GRAPHIC, V32; Bimber O., 2005, SPATIAL AUGMENTED RE; Brown M., 2006, P IEEE C COMP VIS PA, V2, P1956; Grosse M., 2010, ACM T GRAPHIC, V29, P22; Hausler G., 1972, Optics Communications, V6, DOI 10.1016/0030-4018(72)90243-X; Ji Y., 2014, P IEEE C COMP VIS PA; Kalloniatis M., 2014, WEBVISION ORG RETINA; Kuthirummal S, 2011, IEEE T PATTERN ANAL, V33, P58, DOI 10.1109/TPAMI.2010.66; Liu S, 2011, OPT EXPRESS, V19, P353, DOI 10.1364/OE.19.000353; Miau D., 2013, P IEEE INT C COMP PH, P1; Minsky M, 1961, US Pat., Patent No. 3013467; Sato K., 1987, Proceedings of the First International Conference on Computer Vision (Cat. No.87CH2465-3); Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang L, 2006, ACM T GRAPHIC, V25, P907, DOI 10.1145/1141911.1141974	21	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1077-2626	1941-0506		IEEE T VIS COMPUT GR	IEEE Trans. Vis. Comput. Graph.	APR	2015	21	4					462	470		10.1109/TVCG.2015.2391861		9	Computer Science, Software Engineering	Computer Science	CE3VG	WOS:000351757000006		
J	Plopski, A; Itoh, Y; Nitschke, C; Kiyokawa, K; Klinker, G; Takemura, H				Plopski, Alexander; Itoh, Yuta; Nitschke, Christian; Kiyokawa, Kiyoshi; Klinker, Gudrun; Takemura, Haruo			Corneal-Imaging Calibration for Optical See-Through Head-Mounted Displays	IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS			English	Article						OST-HMD calibration; eye pose estimation; corneal imaging; optical see-through	AUGMENTED REALITY; COMPROMISING REFLECTIONS; SYSTEM; ALIGNMENT; CAMERA; POINT; EYES	In recent years optical see-through head-mounted displays (OST-HMDs) have moved from conceptual research to a market of mass-produced devices with new models and applications being released continuously. It remains challenging to deploy augmented reality (AR) applications that require consistent spatial visualization. Examples include maintenance, training and medical tasks, as the view of the attached scene camera is shifted from the user's view. A calibration step can compute the relationship between the HMD-screen and the user's eye to align the digital content. However, this alignment is only viable as long as the display does not move, an assumption that rarely holds for an extended period of time. As a consequence, continuous recalibration is necessary. Manual calibration methods are tedious and rarely support practical applications. Existing automated methods do not account for user-specific parameters and are error prone. We propose the combination of a pre-calibrated display with a per-frame estimation of the user's cornea position to estimate the individual eye center and continuously recalibrate the system. With this, we also obtain the gaze direction, which allows for instantaneous uncalibrated eye gaze tracking, without the need for additional hardware and complex illumination. Contrary to existing methods, we use simple image processing and do not rely on iris tracking, which is typically noisy and can be ambiguous. Evaluation with simulated and real data shows that our approach achieves a more accurate and stable eye pose estimation, which results in an improved and practical calibration with a largely improved distribution of projection error.	[Plopski, Alexander; Kiyokawa, Kiyoshi; Takemura, Haruo] Osaka Univ, Suita, Osaka 565, Japan; [Itoh, Yuta; Klinker, Gudrun] Tech Univ Munich, D-80290 Munich, Germany; [Nitschke, Christian] Kyoto Univ, Kyoto 6068501, Japan	Plopski, A (reprint author), Osaka Univ, Suita, Osaka 565, Japan.	plopski@ime.cmc.osaka-u.ac.jp; itoh@in.tum.de; christian.nitschke@i.kyoto-u.ac.jp; kiyo@cmc.osaka-u.ac.jp; klinker@in.tum.de; takemura@cmc.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [24300048]; European Union [PITN-GA-2012-316919-EDUSAFE]	This research is funded in part by Grant-in-Aid for Scientific Research(B), #24300048 from Japan Society for the Promotion of Science (JSPS), Japan and by the European Union's Seventh Frame-work Programme for Research and Technological Development under PITN-GA-2012-316919-EDUSAFE.	Hansen DW, 2010, IEEE T PATTERN ANAL, V32, P478, DOI 10.1109/TPAMI.2009.30; Tuceryan M, 2002, PRESENCE-TELEOP VIRT, V11, P259, DOI 10.1162/105474602317473213; [Anonymous], 2012, P IEEE INT C ROB AUT; Wong KYK, 2008, LECT NOTES COMPUT SC, V5302, P631, DOI 10.1007/978-3-540-88682-2_48; Nishino K, 2005, IEEE I CONF COMP VIS, P519; Backes M, 2009, P IEEE S SECUR PRIV, P315, DOI 10.1109/SP.2009.20; Nishino K, 2004, ACM T GRAPHIC, V23, P704, DOI 10.1145/1015706.1015783; Park HM, 2008, INT SYM MIX AUGMENT, P175; Nishino K, 2006, INT J COMPUT VISION, V70, P23, DOI 10.1007/s11263-006-6274-9; Schnieders D, 2010, PROC CVPR IEEE, P1442, DOI 10.1109/CVPR.2010.5539799; Agrawal A, 2013, PROC CVPR IEEE, P1399, DOI 10.1109/CVPR.2013.184; Villanueva A, 2008, IEEE T SYST MAN CY B, V38, P1123, DOI 10.1109/TSMCB.2008.926606; Guestrin ED, 2006, IEEE T BIO-MED ENG, V53, P1124, DOI 10.1109/TBME.2005.863952; Schneider E, 2009, ANN NY ACAD SCI, V1164, P461, DOI 10.1111/j.1749-6632.2009.03858.x; Backes M, 2008, P IEEE S SECUR PRIV, P158, DOI 10.1109/SP.2008.25; Shih SW, 2000, INT C PATT RECOG, P201, DOI 10.1109/ICPR.2000.902895; Axholt M, 2011, P IEEE VIRT REAL ANN, P27, DOI 10.1109/VR.2011.5759432; Azuma R., 1995, THESIS U N CAROLINA; Bulling A, 2009, J AMB INTEL SMART EN, V1, P157, DOI 10.3233/AIS-2009-0020; Caudell T. P., 1992, P IEEE HAW INT C SYS, V2, P659; Genc Y., 2002, Proceedings of the IEEE and ACM International Symposium on Mixed and Augmented Reality, DOI 10.1109/ISMAR.2002.1115086; Genc Y, 2000, IEEE AND ACM INTERNATIONAL SYMPOSIUM ON AUGMENTED REALITY, PROCEEDING, P165, DOI 10.1109/ISAR.2000.880940; Halstead M.A., 1996, P ACM SIGGRAPH, P335, DOI 10.1145/237170.237272; Holloway RL, 1997, PRESENCE-TELEOP VIRT, V6, P413; Ishiguro Y., 2010, P 1 AUGM HUM INT C, P25; Itoh Y., 2014, P IEEE INT S MIX AUG, P171; Itoh Y., 2014, P IEEE S 3D US INT 3, P75; Itoh Y, 2015, IEEE T VIS COMPUT GR, V21, P471, DOI 10.1109/TVCG.2015.2391859; Kishishita N., 2014, P IEEE ACM INT S MIX, P177; Klemm M., 2014, P IEEE INT S MIX AUG, P273; Liestol G, 2013, INT SYM MIX AUGMENT, P23, DOI 10.1109/ISMAR-AMH.2013.6671263; Maier P., 2011, P IEEE INT S MIX AUG, P267; Nakazawa A., 2012, P EUR C COMP VIS ECC, P159; Navab N, 2004, P IEEE VIRT REAL ANN, P245, DOI 10.1109/VR.2004.1310091; Nitschke C., 2012, P 23 BRIT MACH VIS C, P221; Nitschke C., 2013, COMPUTER VISION, V5, P1; Nitschke C, 2011, COMPUT VIS IMAGE UND, V115, P835, DOI 10.1016/j.cviu.2011.02.008; Owen C. B., 2004, P IEEE ACM INT S MIX, P70; Rolland J. P., 1995, P PHOT IND APPL SPIE, P293; Tsukada A., 2012, P S EYE TRACK RES AP, P213; Tsukada A., 2011, P INT C COMP VIS, P2084; Tsumura N., 2003, P IS T SIDS 11 COL I, P77; Wu HY, 2005, IEICE T INF SYST, VE88D, P2277, DOI 10.1093/ietisy/e88-d.10.2277	43	2	2	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1077-2626	1941-0506		IEEE T VIS COMPUT GR	IEEE Trans. Vis. Comput. Graph.	APR	2015	21	4					481	490		10.1109/TVCG.2015.2391857		10	Computer Science, Software Engineering	Computer Science	CE3VG	WOS:000351757000008		
J	Moser, K; Itoh, Y; Oshima, K; Swan, JE; Klinker, G; Sandor, C				Moser, Kenneth; Itoh, Yuta; Oshima, Kohei; Swan, J. Edward, II; Klinker, Gudrun; Sandor, Christian			Subjective Evaluation of a Semi-Automatic Optical See-Through Head-Mounted Display Calibration Technique	IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS			English	Article						Calibration; user study; OST HMD; INDICA; SPAAM; eye tracking	AUGMENTED REALITY	With the growing availability of optical see-through (OST) head-mounted displays (HMDs), there is a present need for robust, uncomplicated, and automatic calibration methods suited for non-expert users. This work presents the results of a user study which both objectively and subjectively examines registration accuracy produced by three OST HMD calibration methods: (1) SPAAM, (2) Degraded SPAAM, and (3) Recycled INDICA, a recently developed semi-automatic calibration method. Accuracy metrics used for evaluation include subject provided quality values and error between perceived and absolute registration coordinates. Our results show all three calibration methods produce very accurate registration in the horizontal direction but caused subjects to perceive the distance of virtual objects to be closer than intended. Surprisingly, the semi-automatic calibration method produced more accurate registration vertically and in perceived object distance overall. User assessed quality values were also the highest for Recycled INDICA, particularly when objects were shown at distance. The results of this study confirm that Recycled INDICA is capable of producing equal or superior on-screen registration compared to common OST HMD calibration methods. We also identify a potential hazard in using reprojection error as a quantitative analysis technique to predict registration accuracy. We conclude with discussing the further need for examining INDICA calibration in binocular HMD systems, and the present possibility for creation of a closed-loop continuous calibration method for OST Augmented Reality.	[Moser, Kenneth] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Itoh, Yuta; Klinker, Gudrun] Tech Univ Munich, Dept Informat, D-80290 Munich, Germany; [Oshima, Kohei; Sandor, Christian] Nara Inst Sci & Technol, Dept Informat Sci, Interact Media Design Lab, Nara, Japan; [Swan, J. Edward, II] Mississippi State Univ, Dept Comp Sci, Mississippi State, MS 39762 USA	Moser, K (reprint author), Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA.	moserk@acm.org; itoh@in.tum.de; oshima.kohei.of0@is.naist.jp; swan@acm.org; klinker@in.tum.de; sandor@is.naist.jp			National Scince foundation (NSF); Japan Society for the Promotion of Science (JSPS) [IIA-1414772]; NASA Mississippi Space Grant Consortium; NSF [IIS-1320909, IIS-1018413]; European Union [PITN-GA-2012-316919-EDUSAFE]	This material is based upon work supported in part by the National Scince foundation (NSF) and the Japan Society for the Promotion of Science (JSPS) through an East Asia and Pacific Summer Institutes Fellowship, award IIA-1414772, to K. Moser. Funding was also provided through the NASA Mississippi Space Grant Consortium, to K. Moser, as well as NSF awards IIS-1320909 and IIS-1018413, to J. E. Swan II. The project also received funding from the European Union's Seventh Framework Programme for Research and Technological Development under PITN-GA-2012-316919-EDUSAFE awarded to Y. Itoh. The authors would like to especially thank Dr. Hirokazu Kato and Dr. Goshiro Yamamoto, the members of the Interactive Media Design Lab and staff of the Nara Institute of Science and Technology, as well as all of the anonymous subjects.	Gilson SJ, 2011, J NEUROSCI METH, V199, P328, DOI 10.1016/j.jneumeth.2011.05.011; Gabbard JL, 2008, IEEE T VIS COMPUT GR, V14, P513, DOI 10.1109/TVCG.2008.24; Axholt M, 2011, P IEEE VIRT REAL ANN, P27, DOI 10.1109/VR.2011.5759432; Axholt M., 2010, P HUM FACT ERG SOC A, V54, P2427; Azuma R, 1995, THESIS; Boud A., 1999, P 1999 IEEE INT C IN, P32, DOI DOI 10.1109/IV.1999.781532; Caudell T. P., 1992, P IEEE HAW INT C SYS, V2, P659; Genc Y., 2002, Proceedings of the IEEE and ACM International Symposium on Mixed and Augmented Reality, DOI 10.1109/ISMAR.2002.1115086; Genc Y, 2000, IEEE AND ACM INTERNATIONAL SYMPOSIUM ON AUGMENTED REALITY, PROCEEDING, P165, DOI 10.1109/ISAR.2000.880940; Grubert J., 2010, P IEEE VIRT REAL C M, P269; Howell D. C., 2002, STAT METHODS PSYCHOL; Huber M., 2007, P 6 IEEE ACM INT S M, P1, DOI 10.1145/1329125.1329340; Itoh Y., 2014, P IEEE INT S MIX AUG, P171; Itoh Y., 2014, P IEEE S 3D US INT 3, P75; JANIN AL, 1993, P IEEE VIRT REAL ANN, P246, DOI 10.1109/VRAIS.1993.380772; Kato H., 1999, Proceedings 2nd IEEE and ACM International Workshop on Augmented Reality (IWAR'99), DOI 10.1109/IWAR.1999.803809; Klinker G., 1999, AUGMENTED REALITY BA; Livingston M. A., 2002, INT IND TRAIN SIM ED, V2002, P89; Livingston MA, 2008, INT SYM MIX AUGMENT, P77, DOI 10.1109/ISMAR.2008.4637329; Maier P., 2011, P 10 IEEE INT S MIX, P267; McGarrity E., 2001, Proceedings IEEE and ACM International Symposium on Augmented Reality, DOI 10.1109/ISAR.2001.970525; Navab N, 2004, P IEEE VIRT REAL ANN, P245, DOI 10.1109/VR.2004.1310091; Nitschke A. N. C., 2013, INFORM MEDIA TECHNOL, V8, P389; Owen C. B., 2004, P IEEE ACM INT S MIX, P70; Swirski L., 2012, P S EYE TRACK RES AP, P173; Tang A., 2003, P 2 IEEE ACM INT S M, P161; Tuceryan M, 2000, IEEE AND ACM INTERNATIONAL SYMPOSIUM ON AUGMENTED REALITY, PROCEEDING, P149, DOI 10.1109/ISAR.2000.880938	27	1	1	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1077-2626	1941-0506		IEEE T VIS COMPUT GR	IEEE Trans. Vis. Comput. Graph.	APR	2015	21	4					491	500		10.1109/TVCG.2015.2391856		10	Computer Science, Software Engineering	Computer Science	CE3VG	WOS:000351757000009		
J	Tsunori, K; Sato, S; Hasuike, A; Manaka, S; Shino, H; Sato, N; Kubota, T; Arai, Y; Ito, K; Miyazaki, M				Tsunori, Katsuyoshi; Sato, Shuichi; Hasuike, Akira; Manaka, Soichiro; Shino, Hiromichi; Sato, Nobuaki; Kubota, Tatsuya; Arai, Yoshinori; Ito, Koichi; Miyazaki, Masashi			Effects of Intermittent Administration of Parathyroid Hormone on Bone Augmentation in Rat Calvarium	IMPLANT DENTISTRY			English	Article						PTH; plastic cap; micro-CT	ORTHOPEDIC-SURGERY; RABBIT CALVARIUM; TITANIUM CAP; REGENERATION; OSTEOPOROSIS; ENHANCEMENT; EXPRESSION; MATRIX; CELLS; DRUG	Objectives: This study examined the effects of parathyroid hormone (PTH) on bone augmentation beyond the skeletal envelope within a plastic cap in rat calvaria. Materials and Methods: The calvaria of 30 rats were exposed, and 2 plastic caps were placed on each. Each of the 10 rats was treated with 35 or 105 mg/kg (PTH-35, PTH-105) PTH 3 times per week. The control group was injected with sterile saline 3 times per week. Micro-computed tomography (CT) imaging was performed every 2 weeks for 12 weeks. Micro-CT and histological sections were used to determine the amount of bone augmentation within the plastic caps. Bone volume (BV) was calculated using BV-measuring software. Results: The histomorphometric and histological analyses showed that the amount of bone augmentation was increased significantly in the PTH groups compared with the controls at 12 weeks. The PTH-105 group showed significantly more bone augmentation and osteoblasts compared with the PTH-35 group. Conclusions: These results indicate that the higher the dose of intermittent PTH administered, the greater the amount of bone formation beyond the skeletal envelop in the rat calvarium.	[Tsunori, Katsuyoshi; Manaka, Soichiro; Shino, Hiromichi; Sato, Nobuaki; Kubota, Tatsuya] Nihon Univ, Div Appl Oral Sci, Grad Sch Dent, Tokyo 1018310, Japan; [Sato, Shuichi; Hasuike, Akira; Miyazaki, Masashi] Nihon Univ, Sch Dent, Dept Periodontol, Tokyo 1018310, Japan; [Sato, Shuichi] Nihon Univ, Div Adv Dent Treatment, Dent Res Ctr, Sch Dent, Tokyo 1018310, Japan; [Arai, Yoshinori; Ito, Koichi] Nihon Univ, Sch Dent, Tokyo 1018310, Japan; [Miyazaki, Masashi] Nihon Univ, Sch Dent, Dept Operat Dent, Tokyo 1018310, Japan; [Miyazaki, Masashi] Nihon Univ, Sch Dent, Div Biomat Sci, Dent Res Ctr, Tokyo 1018310, Japan	Sato, S (reprint author), Nihon Univ, Sch Dent, Dept Periodontol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	satou.shuuichi@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25463056]; Dental Research Center, Nihon University School of Dentistry	This work was supported by a Grant-in-Aid for Scientific Research (C) (No.25463056 to S.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a grant from the Dental Research Center, Nihon University School of Dentistry (2013). We express appreciation to Asahi Kasei Pharma, Tokyo, Japan which provided PTH (1-34).	Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115; Jung RE, 2007, INT J ORAL MAX IMPL, V22, P258; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Kuchler U, 2011, J DENT RES, V90, P1001, DOI 10.1177/0022034511407920; Yun JI, 2010, J CLIN PERIODONTOL, V37, P419, DOI 10.1111/j.1600-051X.2010.01547.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Kuroshima S, 2013, J DENT RES, V92, P553, DOI 10.1177/0022034513487558; Chalidis B, 2007, EXPERT OPIN INV DRUG, V16, P441, DOI 10.1517/13543784.16.4.441; Skripitz R, 2004, ACTA ORTHOP SCAND, V75, P654, DOI 10.1080/00016470410004012; Deal C, 2003, CLEV CLIN J MED, V70, P585; Marx J, 2004, SCIENCE, V305, P1420, DOI 10.1126/science.305.5689.1420; Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; EJERSTED C, 1993, J BONE MINER RES, V8, P1097; Roberts MD, 2009, J BIOMECH, V42, P2431, DOI 10.1016/j.jbiomech.2009.08.030; Min S, 2008, ORAL SURG ORAL MED O, V106, P892, DOI 10.1016/j.tripleo.2008.04.012; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; Barnes GL, 2008, J BONE JOINT SURG AM, V90A, P120, DOI 10.2106/JBJS.G.01443; UZAWA T, 1995, BONE, V16, P477; Chen H, 2003, Clin Orthop Relat Res, P291, DOI 10.1097/01.blo.0000079443.64912.18; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Hasegawa Y, 2008, J PERIODONTOL, V79, P348, DOI 10.1902/jop.2008.070305 ; Kochi Go, 2010, J Oral Sci, V52, P203; Kuemmerle JF, 2005, AM J PHYSIOL-GASTR L, V288, P101; Lotinun S, 2002, ENDOCRINE, V17, P29, DOI 10.1385/ENDO:17:1:29; Madore GR, 2004, J AM ACAD ORTHOP SUR, V12, P67; Miloro M, 2010, J ORAL MAXIL SURG, V68, P1225, DOI 10.1016/j.joms.2009.09.090; Whitfield James F, 2003, Curr Osteoporos Rep, V1, P32, DOI 10.1007/s11914-003-0006-7	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	APR	2015	24	2					142	148		10.1097/ID.0000000000000228		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE6AB	WOS:000351916700003		
J	Ito, T; Hashimoto, Y; Baba, S; Iseki, T; Morita, S				Ito, Tomohiko; Hashimoto, Yoshiya; Baba, Shunsuke; Iseki, Tomio; Morita, Shosuke			Bone Regeneration With a Collagen Model Polypeptides/alpha-Tricalcium Phosphate Sponge in a Canine Tibia Defect Model	IMPLANT DENTISTRY			English	Article						bone regeneration; synthesized collagen model polypeptides; porous alpha-tricalcium phosphate	CALCIUM-PHOSPHATE; PARTICLE-SIZE; ALPHA-TCP; COMPOSITE; HYDROXYAPATITE; SCAFFOLDS; CERAMICS; CELLS	Introduction: We evaluated the effects of synthesized collagen model polypeptides consisting of a proline-hydroxyproline-glycine (poly(PHG)) sequence combined with porous alpha-tricalcium phosphate (alpha-TCP) particles on bone formation in a canine tibia defect model. Materials and Methods: The porous alpha-TCP particles were mixed with a poly(PHG) solution, and the obtained sponge was then crosslinked and characterized by x-ray diffraction and scanning electron microscopy. Tibia defects were analyzed in 12 healthy beagles using microcomputed tomography and histological evaluation. Results: At 2 and 4 weeks, the volume density of new bone was higher in the poly(PHG)/alpha-TCP group than in poly(PHG) alone group (P < 0.05); however, there was no difference at 8 weeks (P > 0.05). Histological evaluation at 4 weeks after implantation revealed that the poly(PHG) had degraded, and newly formed bone was present on the surface of the alpha-TCP particles. At 8 weeks, continuous cortical bone formation with a Haversian structure covered the top of the bone defects in both groups. Conclusion: This study demonstrates that the composite created using porous alpha-TCP particles and poly(PHG) is sufficiently adaptable for treating bone defects.	[Ito, Tomohiko; Iseki, Tomio; Morita, Shosuke] Osaka Dent Univ, Dept Oral & Maxillofacial Surg 1, Osaka, Japan; [Hashimoto, Yoshiya] Osaka Dent Univ, Dept Biomat, Osaka, Japan; [Baba, Shunsuke] Osaka Dent Univ, Dept Oral Implantol, Osaka, Japan	Hashimoto, Y (reprint author), Osaka Dent Univ, Dept Biomat, 8-1 Kuzuha Hanazono Cho, Hirakata, Osaka 5731121, Japan.	yoshiya@cc.osaka-dent.ac.jp					Kitamura M, 2005, J AM CERAM SOC, V88, P822, DOI 10.1111/j.1551-2916.2005.00164.x; Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x; Matsuno T, 2006, DENT MATER J, V25, P138; Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016; Rojbani H, 2011, J BIOMED MATER RES A, V98A, P488, DOI 10.1002/jbm.a.33117; Kihara H, 2006, J BIOMED MATER RES B, V79B, P284, DOI 10.1002/jbm.b.30540; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Baba S, 2010, DENT MATER J, V29, P673, DOI 10.4012/dmj.2009-123; Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084; Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6; SHAPOFF CA, 1980, J PERIODONTOL, V51, P625; Arima Y, 2013, ORTHOD WAVES, V72, P23, DOI [10.1016/j.odw.2012.11.001, DOI 10.1016/J.ODW.2012.11.001]; COHEN M, 1993, CLIN PLAST SURG, V20, P691; Kitamura M, 2004, J MATER SCI-MATER M, V15, P1153, DOI 10.1023/B:JMSM.0000046399.40310.47; Knabe C, 2004, BIOMATERIALS, V25, P335, DOI 10.1016/S0142-9612(03)00525-8; Sakai K, 2011, DENT MATER J, V30, P913, DOI 10.4012/dmj.2011-126; Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L; Tanihara M, 2008, J BIOMED MATER RES A, V85A, P133, DOI 10.1002/jbm.a.31496; Tobita K, 2011, J BONE JOINT SURG BR, V93B, P525, DOI 10.1302/0301-620X.93B4.25449; Uchino T, 2006, KEY ENG MAT, V309-311, P251; Yamamoto Y, 1999, J THORAC CARDIOV SUR, V118, P276, DOI 10.1016/S0022-5223(99)70218-7; ZANER DJ, 1984, J PERIODONTOL, V55, P406	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	APR	2015	24	2					197	203		10.1097/ID.0000000000000210		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE6AB	WOS:000351916700012		
J	Yamasaki, S; Wang, LY; Hirata, T; Hayashi-Nishino, M; Nishino, K				Yamasaki, Seiji; Wang, Li-Yuan; Hirata, Takahiro; Hayashi-Nishino, Mitsuko; Nishino, Kunihiko			Multidrug efflux pumps contribute to Escherichia coli biofilm maintenance	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Letter							RESISTANCE; EXPRESSION		[Yamasaki, Seiji; Wang, Li-Yuan] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Hirata, Takahiro] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka, Japan; [Hayashi-Nishino, Mitsuko; Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Lab Microbiol & Infect Dis, Osaka, Japan	Nishino, K (reprint author), Osaka Univ, Inst Sci & Ind Res, Lab Microbiol & Infect Dis, Osaka, Japan.	nishino@sanken.osaka-u.ac.jp					Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Link AJ, 1997, J BACTERIOL, V179, P6228; Maira-Litran T, 2000, J APPL MICROBIOL, V88, P243, DOI 10.1046/j.1365-2672.2000.00963.x; Matsumura K, 2011, BIOCONTROL SCI, V16, P69; Nishino K, 2004, J BACTERIOL, V186, P1423, DOI 10.1128/JB.186.5.1423-1429.2004	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	APR	2015	45	4					439	441		10.1016/j.ijantimicag.2014.12.005		4	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CE2WK	WOS:000351681600020		
J	Fukushima, Y; Takahashi, Y; Hori, Y; Kishimoto, Y; Shiga, K; Tanaka, Y; Masunaga, E; Tani, M; Yokoyama, M; Kondo, K				Fukushima, Yoichi; Takahashi, Yoshinari; Hori, Yusuke; Kishimoto, Yoshimi; Shiga, Kaedeko; Tanaka, Yuiko; Masunaga, Erika; Tani, Mariko; Yokoyama, Mihoko; Kondo, Kazuo			Skin photoprotection and consumption of coffee and polyphenols in healthy middle-aged Japanese females	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Article							CHLOROGENIC ACID; FERULIC ACID; QUANTITATIVE-EVALUATION; VITAMIN-C; GREEN TEA; CARDIOVASCULAR-DISEASES; DECAFFEINATED COFFEE; LENTIGO SENILIS; DAMAGE; HUMANS	BackgroundReactive oxygen species are known to mediate skin photoaging, which results in the formation of pigmented spots and wrinkles. Coffee is the largest source of polyphenols, which supplies a large number of antioxidants in one's daily life. However, little is known about how much coffee and polyphenol consumption influences skin health. In this study, a cross-sectional survey of the diet, environmental factors, and skin conditions was conducted in healthy Japanese females to explore the influence of coffee and polyphenol consumption on skin conditions. Materials and methodsNon-smoking, healthy female subjects with moderate sun exposure in their daily lives were recruited for this study (n=131, age range: 30-60years old) and recorded their food and beverage intake and life circumstances using questionnaires. The skin water content, transepidermal water loss, and elasticity were measured on the cheek of each subject using non-invasive methods: a Corneometer, a Tewameter, and a Cutometer, respectively. Wrinkles and pigmented spots were evaluated using digital photograph images. ResultsConsumption of coffee and total polyphenols from all sources and from coffee showed a statistically significant correlation towards a decrease in pigmented spot scores (P<0.05). Subjects with high total polyphenol consumption from coffee or chlorogenic acids (the third tertile group) showed the lowest score of ultraviolet pigmented spots (P<0.05). ConclusionCoffee and polyphenol consumption was associated with low facial pigmented spots in Japanese middle-aged females. We speculated that coffee helps protect human skin from photoaging, and polyphenols, including chlorogenic acids, may contribute to the decreased hyperpigmentation of pigmented spots.	[Fukushima, Yoichi] Nestle Japan Ltd, Wellness Commun Sect, Tokyo 1400002, Japan; [Takahashi, Yoshinari; Hori, Yusuke] TES Holdings Ltd, Dept Clin Res, Tokyo, Japan; [Kishimoto, Yoshimi; Shiga, Kaedeko; Tanaka, Yuiko; Masunaga, Erika; Tani, Mariko; Kondo, Kazuo] Ochanomizu Univ, Inst Environm Sci Human Life, Tokyo 112, Japan; [Yokoyama, Mihoko] Yokoyama Skin Clin, Tokyo, Japan	Fukushima, Y (reprint author), Nestle Japan Ltd, Wellness Commun Sect, Shinagawa Ku, NYK Tennoz Bldg,2-2-20 Higashi Shinagawa, Tokyo 1400002, Japan.	yoichi.fukushima@jp.nestle.com					Ahn Eun Hee, 2011, Exp Neurobiol, V20, P169, DOI 10.5607/en.2011.20.4.169; Ahn S, 2007, SKIN RES TECHNOL, V13, P280, DOI 10.1111/j.1600-0846.2007.00224.x; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888; Honjo S, 2001, J CLIN EPIDEMIOL, V54, P823, DOI 10.1016/S0895-4356(01)00344-4; Maurya DK, 2013, CANCER BIOTHER RADIO, V28, P51, DOI 10.1089/cbr.2012.1263; Kennedy C, 2003, J INVEST DERMATOL, V120, P548, DOI 10.1046/j.1523-1747.2003.12092.x; Boelsma E, 2003, AM J CLIN NUTR, V77, P348; Andersen LF, 2006, AM J CLIN NUTR, V83, P1039; Zhang W, 2009, DIABETES CARE, V32, P1043, DOI 10.2337/dc08-2251; Pellegrini N, 2003, J NUTR, V133, P2812; Murray JC, 2008, J AM ACAD DERMATOL, V59, P418, DOI 10.1016/j.jaad.2008.05.004; Je YJ, 2009, INT J CANCER, V124, P1662, DOI 10.1002/ijc.24124; Kadono S, 2001, J INVEST DERMATOL, V116, P571, DOI 10.1046/j.1523-1747.2001.01296.x; Hattori H, 2004, J INVEST DERMATOL, V122, P1256, DOI 10.1111/j.0022-202X.2004.22503.x; Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T; Heinrich U, 2006, J NUTR, V136, P1565; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Guyuron B, 2009, PLAST RECONSTR SURG, V123, P1321, DOI 10.1097/PRS.0b013e31819c4d42; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708; Vardi N, 2012, J CHEM NEUROANAT, V43, P43, DOI 10.1016/j.jchemneu.2011.09.003; Lin JY, 2003, J AM ACAD DERMATOL, V48, P866, DOI 10.1067/mjd.2003.425; Ando H, 2010, INT J MOL SCI, V11, P2566, DOI 10.3390/ijms11062566; Hillebrand GG, 2001, J DERMATOL SCI, V27, pS42; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j; Heinrich U, 2006, SKIN PHARMACOL PHYS, V19, P224, DOI 10.1159/000093118; Svilaas A, 2004, J NUTR, V134, P562; Lin FH, 2005, J INVEST DERMATOL, V125, P826, DOI 10.1111/j.0022-202X.2005.23768.x; Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004; Benavente CA, 2009, CURR PHARM DESIGN, V15, P29, DOI 10.2174/138161209787185760; Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048; Maki T, 2010, CLIN CHEM LAB MED, V48, P849, DOI 10.1515/CCLM.2010.161; Black HS, 1997, J PHOTOCH PHOTOBIO B, V40, P29, DOI 10.1016/S1011-1344(97)00021-3; Chang WC, 2010, EUR J NUTR, V49, P267, DOI 10.1007/s00394-009-0083-1; Chu YF, 2011, FOOD CHEM, V124, P914, DOI 10.1016/j.foodchem.2010.07.019; Cinkilic N, 2012, FOOD CHEM TOXICOL, V53, P359; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u; Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939; Haywood R, 2011, PHOTOCHEM PHOTOBIOL, V87, P117, DOI 10.1111/j.1751-1097.2010.00850.x; Ichihashi M., 2009, J ANTI-AGING MED, V6, P46; Jen M, 2010, CLIN DERMATOL, V28, P669, DOI 10.1016/j.clindermatol.2010.03.029; Keller KL, 1998, J AM ACAD DERMATOL, V39, P611, DOI 10.1016/S0190-9622(98)70011-8; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1; Miik M, 2010, MUTAT RES, V692, P42; Miyamoto K, 2002, J COSMET SCI, V53, P62; MURATA M, 1995, BIOSCI BIOTECH BIOCH, V59, P1887; Nagata C, 2010, BRIT J NUTR, V103, P1493, DOI 10.1017/S0007114509993461; Pillai S., 2005, International Journal of Cosmetic Science, V27, P17, DOI 10.1111/j.1467-2494.2004.00241.x; Purba MB, 2001, J AM COLL NUTR, V20, P71; Renouf M, 2010, BRIT J NUTR, V104, P1635, DOI 10.1017/S0007114510002709; RICHARD S, 1994, PHOTODERMATOL PHOTO, V10, P164; Rosado C., 2005, International Journal of Cosmetic Science, V27, P237, DOI 10.1111/j.1467-2494.2005.00270.x; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Shekar SN, 2005, J INVEST DERMATOL, V125, P1119, DOI 10.1111/j.0022-202X.2005.23961.x; Stahl W, 2006, PHOTOCH PHOTOBIO SCI, V5, P238, DOI 10.1039/b505312a; Tang YZ, 2008, J AGR FOOD CHEM, V56, P11025, DOI 10.1021/jf802462h; Tournas JA, 2006, J INVEST DERMATOL, V126, P1185, DOI 10.1038/sj.jid.5700232; vansDam RM, 2005, JAMA-J AM MED ASSOC, V294, P97; Young AR, 2007, J INVEST DERMATOL, V127, P975, DOI 10.1038/sj.jid.5700606	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	APR	2015	54	4					410	418		10.1111/ijd.12399		9	Dermatology	Dermatology	CE3RV	WOS:000351747000014		
J	Ohashi, A; Kiniwa, Y; Okuyama, R; Kosho, T; Suga, T; Has, C; Kubo, H				Ohashi, Atsuko; Kiniwa, Yukiko; Okuyama, Ryuhei; Kosho, Tomoki; Suga, Tomoaki; Has, Cristina; Kubo, Hitomi			A case of Kindler syndrome with severe esophageal stenosis	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							ADHESION; PROTEIN		[Ohashi, Atsuko; Kiniwa, Yukiko; Okuyama, Ryuhei] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan; [Kosho, Tomoki] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 390, Japan; [Suga, Tomoaki] Shinshu Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Matsumoto, Nagano 390, Japan; [Has, Cristina] Univ Freiburg, Dept Dermatol, Freiburg, Germany; [Kubo, Hitomi] Nagano Red Cross Hosp, Div Dermatol, Nagano, Japan	Ohashi, A (reprint author), Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan.	ykiniwa@shinshu-u.ac.jp					Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Lai-Cheong JE, 2009, BRIT J DERMATOL, V160, P233, DOI 10.1111/j.1365-2133.2008.08976.x; Has C, 2011, HUM MUTAT, V32, P1204, DOI 10.1002/humu.21576; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Natsuga K, 2011, J DERMATOL SCI, V61, P38, DOI 10.1016/j.jdermsci.2010.11.008; Piccinni E, 2013, BRIT J DERMATOL, V168, P1019, DOI 10.1111/bjd.12184	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	APR	2015	54	4					E106	E108		10.1111/ijd.12715		3	Dermatology	Dermatology	CE3RV	WOS:000351747000008		
J	Matsuzaki, T; Iwasa, T; Tungalagsuvd, A; Munkhzaya, M; Kawami, T; Yamasaki, M; Murakami, M; Kato, T; Kuwahara, A; Yasui, T; Irahara, M				Matsuzaki, Toshiya; Iwasa, Takeshi; Tungalagsuvd, Altankhuu; Munkhzaya, Munkhsaikhan; Kawami, Takako; Yamasaki, Mikio; Murakami, Masahiro; Kato, Takeshi; Kuwahara, Akira; Yasui, Toshiyuki; Irahara, Minoru			The responses of hypothalamic NPY and OBRb mRNA expression to food deprivation develop during the neonatal-prepubertal period and exhibit gender differences in rats	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						NPY; Leptin; OBRb; Hypothalamus; Sex difference	SERUM LEPTIN LEVELS; Y GENE-EXPRESSION; ARCUATE NUCLEUS; FEMALE RATS; RESPONSIVENESS; SENSITIVITY; EXPOSURE; WEIGHT; MICE	Neuropeptide Y (NPY) is an important hypothalamic orexigenic neuropeptide that acts in the brain. It has been established that the fasting-induced up-regulation of NPY expression is mainly caused by a reduction in the activity of leptin, which is a hormone secreted by adipose tissue. We have reported that in female rats hypothalamic NPY mRNA expression does not respond to fasting during the early neonatal period, but subsequently becomes sensitive to it later in the neonatal period. In this study, we compared the developmental changes in the responses of NPY and leptin expression to fasting between male and female rats during the neonatal to pre-pubertal period. Fasting was induced by maternal deprivation during the pre-weaning period (postnatal days 10 and 20) and by food deprivation during the post-weaning period (postnatal day 30). Hypothalamic NPY mRNA expression was not affected by fasting on postnatal day 10, whereas it was increased by fasting on postnatal day 20 and 30 in both males and females. On the other hand, the serum leptin level was decreased by fasting at all examined ages in both sexes. Namely, hypothalamic NPY mRNA expression was not correlated with the reduction in the serum leptin level at postnatal day 10 in either sex. Under the fasted conditions, the hypothalamic NPY mRNA levels of the males were higher than those of the females on postnatal days 20 and 30, whereas no such differences were observed under the normal nourishment conditions. The serum leptin levels observed under the fasted conditions did not differ between males and females at any examined age. These results suggest that some hypothalamic NPY functions develop during the neonatal period and that there is no major difference between the sexes with regard to the time when NPY neurons become sensitive to fasting. They also indicate that hypothalamic NPY expression is more sensitive to under-nutrition in male rats than in female rats, at least during the pre-pubertal period. (C) 2015 Published by Elsevier Ltd. on behalf of ISDN.	[Matsuzaki, Toshiya; Iwasa, Takeshi; Tungalagsuvd, Altankhuu; Munkhzaya, Munkhsaikhan; Kawami, Takako; Yamasaki, Mikio; Kato, Takeshi; Kuwahara, Akira; Irahara, Minoru] Univ Tokushima, Grad Sch, Dept Obstet & Gynecol, Inst Hlth Biosci, Tokushima 7708503, Japan; [Murakami, Masahiro] Shikoku Med Ctr Children & Adults, Dept Obstet & Gynecol, Zentsuji, Kagawa 7658507, Japan; [Yasui, Toshiyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Reprod Technol, Tokushima 7708503, Japan	Matsuzaki, T (reprint author), Univ Tokushima, Grad Sch, Dept Obstet & Gynecol, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	mat@tokushima-u.ac.jp					Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Adam CL, 2013, INT J DEV NEUROSCI, V31, P608, DOI 10.1016/j.ijdevneu.2013.07.005; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Iwasa T, 2014, INT J DEV NEUROSCI, V34, P76, DOI 10.1016/j.ijdevneu.2014.02.001; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Mistry AM, 1999, AM J PHYSIOL-REG I, V277, pR742; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Iwasa T, 2011, INT J DEV NEUROSCI, V29, P377, DOI 10.1016/j.ijdevneu.2011.03.006; Iwasa T, 2014, INT J DEV NEUROSCI, V36, P1, DOI 10.1016/j.ijdevneu.2014.03.011; Carlo AS, 2007, ENDOCRINOLOGY, V148, P6073, DOI 10.1210/en.2007-0822; Iwasa T, 2014, INT J DEV NEUROSCI, V35, P52, DOI 10.1016/j.ijdevneu.2014.03.007; Konieczna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081906; Li H, 1998, AM J PHYSIOL-ENDOC M, V275, pE405; Iwasa T, 2013, NEUROENDOCRINOL LETT, V34, P543; Priego T, 2009, HORM BEHAV, V55, P33, DOI 10.1016/j.yhbeh.2008.07.010; White J. D., 1989, MOL CELL NEUROSCI, V1, P41, DOI 10.1016/1044-743190040-B	18	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	APR	2015	41						63	67		10.1016/j.ijdevneu.2014.11.006		5	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CE4IJ	WOS:000351794000007		
J	Matsuzaki, T; Iwasa, T; Munkhzaya, M; Tungalagsuvd, A; Kawami, T; Murakami, M; Yamasaki, M; Yamamoto, Y; Kato, T; Kuwahara, A; Yasui, T; Irahara, M				Matsuzaki, Toshiya; Iwasa, Takeshi; Munkhzaya, Munkhsaikhan; Tungalagsuvd, Altankhuu; Kawami, Takako; Murakami, Masahiro; Yamasaki, Mikio; Yamamoto, Yuri; Kato, Takeshi; Kuwahara, Akira; Yasui, Toshiyuki; Irahara, Minoru			Developmental changes in hypothalamic oxytocin and oxytocin receptor mRNA expression and their sensitivity to fasting in male and female rats	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Oxytocin; Estrogen receptor-alpha; Hypothalamus	PITUITARY-ADRENAL AXIS; SERUM LEPTIN LEVELS; ESTROGEN-RECEPTOR; PARAVENTRICULAR NUCLEUS; MATERNAL-DEPRIVATION; FOOD-DEPRIVATION; INFANT RAT; EXPOSURE; UNDERNUTRITION; RESPONSIVENESS	Oxytocin (OT) affects the central nervous system and is involved in a variety of social and non-social behaviors. Recently, the role played by OT in energy metabolism and its organizational effects on estrogen receptor alpha (ER-alpha) during the neonatal period have gained attention. In this study, the developmental changes in the hypothalamic mRNA levels of OT, the OT receptor (OTR), and ER-alpha were evaluated in male and female rats. In addition, the fasting-induced changes in the hypothalamic mRNA levels of OT and the OTR were evaluated. Hypothalamic explants were taken from postnatal day (PND) 10, 20, and 30 rats, and the mRNA level of each molecule was measured. Hypothalamic OT mRNA expression increased throughout the developmental period in both sexes. The rats' hypothalamic OTR mRNA levels were highest on PND 10 and decreased throughout the developmental period. In the male rats, the hypothalamic mRNA levels of ER-alpha were higher on PND 30 than on PND 10. On the other hand, no significant differences in hypothalamic ER-alpha mRNA expression were detected among the examined time points in the female rats, although hypothalamic ER-alpha mRNA expression tended to be higher on PND 30 than on PND 10. Significant positive correlations were detected between hypothalamic OT and ER-alpha mRNA expression in both the male and female rats. Hypothalamic OT mRNA expression was not affected by fasting at any of the examined time points in either sex. These results indicate that hypothalamic OT expression is not sensitive to fasting during the developmental period. In addition, as a positive correlation was detected between hypothalamic OT and ER-alpha mRNA expression, these two molecules might interact with each other to induce appropriate neuronal development. (C) 2015 Elsevier Ltd. All rights reserved.	[Matsuzaki, Toshiya; Iwasa, Takeshi; Munkhzaya, Munkhsaikhan; Tungalagsuvd, Altankhuu; Kawami, Takako; Murakami, Masahiro; Yamasaki, Mikio; Yamamoto, Yuri; Kato, Takeshi; Kuwahara, Akira; Yasui, Toshiyuki; Irahara, Minoru] Univ Tokushima, Dept Obstet & Gynecol, Grad Sch, Inst Hlth Biosci, Tokushima 7708503, Japan	Matsuzaki, T (reprint author), Univ Tokushima, Dept Obstet & Gynecol, Grad Sch, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	mat@tokushima-u.ac.jp					LEVINE S, 1991, DEV PSYCHOBIOL, V24, P547, DOI 10.1002/dev.420240803; Maejima Y, 2011, AGING-US, V3, P1169; Yamamoto Y, 2006, NEUROSCIENCE, V137, P157, DOI 10.1016/j.neuroscience.2005.08.065; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Iwasa T, 2014, INT J DEV NEUROSCI, V34, P76, DOI 10.1016/j.ijdevneu.2014.02.001; Tung YCL, 2008, J NEUROSCI, V28, P12419, DOI 10.1523/JNEUROSCI.3412-08.2008; Cassoni P, 2002, INT J ONCOL, V21, P375; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Perry AN, 2009, BEHAV BRAIN RES, V205, P154, DOI 10.1016/j.bbr.2009.08.021; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; Smith MA, 1997, ENDOCRINOLOGY, V138, P4622, DOI 10.1210/en.138.11.4622; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Iwasa T, 2011, INT J DEV NEUROSCI, V29, P377, DOI 10.1016/j.ijdevneu.2011.03.006; Iwasa T, 2014, INT J DEV NEUROSCI, V36, P1, DOI 10.1016/j.ijdevneu.2014.03.011; Cushing BS, 1999, J NEUROENDOCRINOL, V11, P765; Iwasa T, 2014, INT J DEV NEUROSCI, V35, P52, DOI 10.1016/j.ijdevneu.2014.03.007; Iwasa T, 2010, J PHYSIOL-LONDON, V588, P821, DOI 10.1113/jphysiol.2009.183558; Kiss Alexander, 2005, Endocr Regul, V39, P97; Matsuzaki T., 2015, INT J DEV N IN PRESS; Withuhn TF, 2003, PHYSIOL BEHAV, V80, P135, DOI 10.1016/S0031-9384(03)00222-1; Yang H. P., 2013, ISRN NEUROSCIENCE; Zhang G, 2011, AM J PHYSIOL-ENDOC M, V301, pE1004, DOI 10.1152/ajpendo.00196.2011	22	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	APR	2015	41						105	109		10.1016/j.ijdevneu.2015.01.001		5	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CE4IJ	WOS:000351794000013		
J	Katsura, A; Morishita, A; Iwama, H; Tani, J; Sakamoto, T; Tatsuta, M; Toyota, Y; Fujita, K; Kato, K; Maeda, E; Nomura, T; Miyoshi, H; Yoneyama, H; Himoto, T; Fujiwara, S; Kobara, H; Mori, H; Niki, T; Ono, M; Hirashima, M; Masaki, T				Katsura, Akiko; Morishita, Asahiro; Iwama, Hisakazu; Tani, Joji; Sakamoto, Teppei; Tatsuta, Miwa; Toyota, Yuka; Fujita, Koji; Kato, Kiyohito; Maeda, Emiko; Nomura, Takako; Miyoshi, Hisaaki; Yoneyama, Hirohito; Himoto, Takashi; Fujiwara, Shintaro; Kobara, Hideki; Mori, Hirohito; Niki, Toshiro; Ono, Masafumi; Hirashima, Mitsuomi; Masaki, Tsutomu			MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						MCD; hepatic steatosis; liver fibrosis	FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; EXPRESSION; MICE; MIR-194; CANCER; CELLS; ACID; HEPATOCARCINOGENESIS; DEFICIENT	Non-alcoholic steatohepatitis (NASH) is one of the most common causes of chronic liver disease and is considered to be a causative factor of cryptogenic cirrhosis and hepatocellular carcinoma. microRNAs (miRNAs) are small non-coding RNAs that negatively regulate messenger RNA (mRNA). Recently, it was demonstrated that the aberrant expression of certain miRNAs plays a pivotal role in liver disease. The aim of the present study was to evaluate changes in miRNA profiles associated with metformin treatment in a NASH model. Eight-week-old male mice were fed a methionine-and choline-deficient (MCD) diet alone or with 0.08% metformin for 15 weeks. Metformin significantly downregulated the level of plasma transaminases and attenuated hepatic steatosis and liver fibrosis. The expression of miRNA-376a, miRNA-127, miRNA-34a, miRNA-300 and miRNA-342-3p was enhanced among the 71 upregulated miRNAs, and the expression of miRNA-122, miRNA-194, miRNA-101b and miRNA-705 was decreased among 60 downregulated miRNAs in the liver of MCD-fed mice when compared with control mice. Of note, miRNA profiles were altered following treatment with metformin in MCD-fed mice. miRNA-376a, miRNA-127, miRNA-34a, miRNA-300 and miRNA-342-3p were downregulated, but miRNA-122, miRNA-194, miRNA-101b and miRNA-705 were significantly upregulated in MCD-fed mice treated with metformin. miRNA profiles were altered in MCD-fed mice and metformin attenuated this effect on miRNA expression. Therefore, miRNA profiles are a potential tool that may be utilized to clarify the mechanism behind the metformin-induced improvement of hepatic steatosis and liver fibrosis. Furthermore, identification of targetable miRNAs may be used as a novel therapy in human NASH.	[Katsura, Akiko; Morishita, Asahiro; Tani, Joji; Sakamoto, Teppei; Tatsuta, Miwa; Toyota, Yuka; Fujita, Koji; Kato, Kiyohito; Maeda, Emiko; Nomura, Takako; Miyoshi, Hisaaki; Yoneyama, Hirohito; Himoto, Takashi; Fujiwara, Shintaro; Kobara, Hideki; Mori, Hirohito; Hirashima, Mitsuomi; Masaki, Tsutomu] Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, Miki, Kagawa 7610793, Japan; [Iwama, Hisakazu] Kagawa Univ, Sch Med, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Niki, Toshiro] Kagawa Univ, Sch Med, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan; [Ono, Masafumi] Kochi Med Sch, Dept Gastroenterol & Hepatol, Koichi, Japan	Morishita, A (reprint author), Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	asahiro@med.kagawa-u.ac.jp					Xu J, 2012, LIVER INT, V32, P752, DOI 10.1111/j.1478-3231.2011.02750.x; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Dong PX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-99; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Castro RE, 2013, J HEPATOL, V58, P119, DOI 10.1016/j.jhep.2012.08.008; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Chiang YP, 2012, EXP THER MED, V3, P560, DOI 10.3892/etm.2011.436; Lin HZ, 2000, NAT MED, V6, P998; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Moore KJ, 2010, TRENDS ENDOCRIN MET, V21, P699, DOI 10.1016/j.tem.2010.08.008; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI14178; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Braconi C, 2008, HEPATOLOGY, V47, P1807, DOI 10.1002/hep.22326; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Krutzfeldt J, 2012, HEPATOLOGY, V55, P98, DOI 10.1002/hep.24658; Loomba R, 2009, ALIMENT PHARM THER, V29, P172, DOI 10.1111/j.1365-2036.2008.03869.x; Pan CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039151; Song YX, 2012, ANN SURG ONCOL, V19, pS509, DOI 10.1245/s10434-011-1999-2; Zhai H, 2013, BIOMARKER RES, V1, P12; Zhang Y, 2013, NEOPLASMA, V60, P247, DOI 10.4149/neo_2013_033	32	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	APR	2015	35	4					877	884		10.3892/ijmm.2015.2092		8	Medicine, Research & Experimental	Research & Experimental Medicine	CE3YA	WOS:000351764800003		
J	Uechi, J; Tsuji, Y; Konno, M; Hayashi, K; Shibata, T; Nakayama, E; Mizoguchi, I				Uechi, J.; Tsuji, Y.; Konno, M.; Hayashi, K.; Shibata, T.; Nakayama, E.; Mizoguchi, I.			Generation of virtual models for planning orthognathic surgery using a modified multimodal image fusion technique	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						three-dimensional (3D); orthognathic surgery; metal artefact; multimodal image fusion; registration accuracy; virtual model	SCAN PROCEDURE; SKULL MODEL; SIMULATION; ARTIFACTS; DENTITION; ACCURATE; SPLINT	Streak artefacts caused by dental metals deteriorate the quality of computed tomography (CT) images. We developed and evaluated a method for generating three-dimensional virtual models to plan orthognathic surgery in patients with multiple dental materials, to avoid the adverse effects of metal artefacts in image fusion. The method basically consists of four procedures: (1) fabrication of a splint in the open-mouth position with fiducial markers, (2) reconstruction of a virtual skull model in the open-mouth position from CT scanning, (3) reconstruction of two virtual dental models in the open-mouth position and either the intercuspal position (ICP) or centric relation (CR) from surface scanning, and (4) three serial steps of image registration and subsequent repositioning of the mandible to the ICP or CR. This method allows for the registration of skull and dental models under artefact-free conditions. To validate the method, CT and dental cast data from 30 patients were used. The registration accuracy was 0.080 nun for the initial registration, 0.033 mm for the second registration, and 0.028 mm for the third registration. The present method can be used to determine the occlusal relationships and craniofacial morphology of patients with dental metals and can be applied to computer-assisted diagnosis and surgery.	[Uechi, J.; Konno, M.; Hayashi, K.; Mizoguchi, I.] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthopaed, Ishikari, Hokkaido 0610293, Japan; [Tsuji, Y.; Shibata, T.] Hlth Sci Univ Hokkaido, Div Reconstruct Surg Oral & Maxillofacial Reg, Dept Human Biol & Pathophysiol, Ishikari, Hokkaido 0610293, Japan; [Nakayama, E.] Hlth Sci Univ Hokkaido, Div Oral & Maxillofacial Radiol, Dept Human Biol & Pathophysiol, Ishikari, Hokkaido 0610293, Japan	Uechi, J (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthopaed, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.	juechi@hoku-iryo-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [17791540, 22792006, 23593040, 24659915]	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (numbers 17791540, 22792006, 23593040 and 24659915).	Kim BC, 2010, ORAL SURG ORAL MED O, V110, P370, DOI 10.1016/j.tripleo.2010.03.036; Swennen GRJ, 2009, INT J ORAL MAX SURG, V38, P48, DOI 10.1016/j.ijom.2008.11.006; Hernandez-Alfaro F, 2013, INT J ORAL MAX SURG, V42, P1547, DOI 10.1016/j.ijom.2013.03.025; Gateno J, 2003, J CRANIOFAC SURG, V14, P833, DOI 10.1097/00001665-200311000-00004; Hassfeld S, 2001, INT J ORAL MAX SURG, V30, P2, DOI 10.1054/ijom.2000.0024; Troulis MJ, 2002, INT J ORAL MAX SURG, V31, P349, DOI 10.1054/ijom.2002.0278; Rangel FA, 2008, AM J ORTHOD DENTOFAC, V134, P820, DOI 10.1016/j.ajodo.2007.11.026; Swennen GRJ, 2007, INT J ORAL MAX SURG, V36, P146, DOI 10.1016/j.ijom.2006.09.019; Gateno J, 2007, J ORAL MAXIL SURG, V65, P728, DOI 10.1016/j.joms.2006.04.001; Plooij JM, 2011, INT J ORAL MAX SURG, V40, P341, DOI 10.1016/j.ijom.2010.10.013; Lemmens C, 2009, IEEE T MED IMAGING, V28, P250, DOI 10.1109/TMI.2008.929103; HARAMATI N, 1994, COMPUT MED IMAG GRAP, V18, P429, DOI 10.1016/0895-6111(94)90080-9; Swennen GRJ, 2009, J CRANIOFAC SURG, V20, P297, DOI 10.1097/SCS.0b013e3181996803; Swennen GRJ, 2007, J CRANIOFAC SURG, V18, P533, DOI 10.1097/scs.0b013e31805343df; Nkenke E, 2004, DENTOMAXILLOFAC RAD, V33, P226, DOI 10.1259/dmfr/27071199; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bechtold TE, 2012, J OROFAC ORTHOP, V73, P126, DOI 10.1007/s00056-011-0060-1; Goshtasby AA, 2005, 2-D AND 3-D IMAGE REGISTRATION FOR MEDICAL, REMOTE SENSING, AND INDUSTRIAL APPLICATIONS, P155; Hamm KD, 2004, PERSPECTIVE IN IMAGE-GUIDED SURGERY, P3, DOI 10.1142/9789812702678_0001; Klinke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031766; Nishii Y, 1998, ORTHOD WAVES, V57, P189; Nkenke E, 2007, Int J Comput Dent, V10, P11; O'Neil M, 2012, BRIT J ORAL MAX SURG, V50, P49, DOI 10.1016/j.bjoms.2010.11.009; Sachdeva Rohit, 2005, J Clin Orthod, V39, P297; Sagawa R, 2002, IEEE RSJ INT C INT R, P79; Schutyser F, 2005, LECT NOTES COMPUT SC, V3749, P368; Sohmura T, 2005, CLIN ORAL IMPLAN RES, V16, P728, DOI 10.1111/j.1600-0501.2005.01139.x; Uechi J, 2006, AM J ORTHOD DENTOFAC, V130, P786, DOI 10.1016/j.ajodo.2006.03.025; Varga E, 2013, INT J ORAL MAX SURG, V42, P1159, DOI 10.1016/j.ijom.2013.02.006; Xia J, 2001, IEEE T INF TECHNOL B, V5, P97	30	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	APR	2015	44	4					462	469		10.1016/j.ijom.2014.11.007		8	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CE6RQ	WOS:000351966100009		
J	Matsumoto, K; Tsukimura, N; Ishizuka, T; Kohinata, K; Yonehara, Y; Honda, K				Matsumoto, K.; Tsukimura, N.; Ishizuka, T.; Kohinata, K.; Yonehara, Y.; Honda, K.			Local application of Aqua Titan improves symptoms of temporomandibular joint muscle disorder: a preliminary study	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						Aqua Titan; temporomandibular disorder; muscle pain; masseter muscle	DIAGNOSTIC-CRITERIA; PAIN; COATINGS; OXIDE	Aqua Titan (AT), comprising microscopic titanium particles dispersed in water, has been reported to have beneficial effects on muscle tissue. This study investigated the effects of local application of AT on symptoms in patients with muscle disorders of the temporomanclibular joint (TMJ) compared to patients with joint disorders of the TMJ. Sixteen patients with unilateral masseter muscle pain during motion (muscle disorder group) and six patients with unilateral TMJ pain during motion (joint disorder group) applied an AT-permeated patch over the painful area every night for 2 weeks. Symptoms were evaluated clinically at the initial visit and 1 and 2 weeks later. Clinical symptoms in the joint disorder group showed no tendency towards improvement after 2 weeks. In contrast, mouth opening range with/without pain, visual analogue scale (VAS) scores for pain during mouth opening and eating, and activities of daily living (ADL) scores in the muscle disorder group were improved significantly after 2 weeks. Multiple comparison tests in the muscle disorder group showed significant improvements in the VAS for eating and ADL score after 1 week. These results suggest that the AT patch has a potential supplementary role in the treatment of patients with muscle disorders of the TMJ.	[Matsumoto, K.; Ishizuka, T.; Kohinata, K.; Honda, K.] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Tokyo 1018310, Japan; [Matsumoto, K.; Tsukimura, N.; Ishizuka, T.; Yonehara, Y.; Honda, K.] Nihon Univ, Sch Dent, Dept Temporomandibular Disorders, Dent Hosp, Tokyo 1018310, Japan; [Tsukimura, N.] Nihon Univ, Sch Dent, Dept Partial Denture Prosthodont, Tokyo 1018310, Japan; [Yonehara, Y.] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Tokyo 1018310, Japan	Matsumoto, K (reprint author), Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	matsumoto.kunihito@nihon-u.ac.jp			Sato Fund; Uemura Fund; Dental Research Centre at Nihon University School of Dentistry; Phiten Co., Ltd.	This study was supported by the Sato Fund, the Uemura Fund, a grant from the Dental Research Centre at Nihon University School of Dentistry, and a research fund from Phiten Co., Ltd.	Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Haroutiunian S, 2010, PAIN MED, V11, P535, DOI 10.1111/j.1526-4637.2010.00809.x; Kostova I, 2009, ANTI-CANCER AGENT ME, V9, P827; Manfredini D, 2011, ORAL SURG ORAL MED O, V112, P453, DOI 10.1016/j.tripleo.2011.04.021; Suzuki R, 2003, J BIOMED MATER RES A, V66A, P396, DOI 10.1002/jbm.a.10001; Aoi W, 2012, PHYSIOL BEHAV, V108, P13, DOI 10.1016/j.physbeh.2012.09.009; Carballo-Vila M, 2009, J BIOMED MATER RES A, V90A, P94, DOI 10.1002/jbm.a.32058; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Hughes JD, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-653; Liu Frederick, 2013, Dent Clin North Am, V57, P465, DOI 10.1016/j.cden.2013.04.006; Nishiyama A, 2014, ACTA ODONTOL SCAND, V72, P428, DOI 10.3109/00016357.2013.850173; Oral Koray, 2009, Agri, V21, P89; Rowlands DS, 2014, J SCI MED SPORT, V17, P134, DOI 10.1016/j.jsams.2013.03.003; Sahlin H, 2006, J BIOMED MATER RES A, V77A, P43, DOI 10.1002/jbm.a.30642; Schiffman EL, 2014, INT J ORAL MAX SURG, V43, P217, DOI 10.1016/j.ijom.2013.07.744; Wadsworth DP, 2010, MED SCI SPORT EXER, V42, P2273, DOI 10.1249/MSS.0b013e3181e397a6	16	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	APR	2015	44	4					483	487		10.1016/j.ijom.2014.11.005		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CE6RQ	WOS:000351966100011		
J	Sakaguchi, O; Kokuryo, S; Tsurushima, H; Tanaka, J; Habu, M; Uehara, M; Nishihara, T; Tominaga, K				Sakaguchi, O.; Kokuryo, S.; Tsurushima, H.; Tanaka, J.; Habu, M.; Uehara, M.; Nishihara, T.; Tominaga, K.			Lipopolysaccharide aggravates bisphosphonate-induced osteonecrosis in rats	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						bisphosphonate; bisphosphonate-related osteonecrosis of the jaw (BRONJ); rat; model; lipopolysaccharide; LPS	ZOLEDRONIC ACID; DENTAL EXTRACTION; ANIMAL-MODEL; BEAGLE DOGS; JAW; DEXAMETHASONE; PREVENTION; ENDOTOXIN; LESIONS; CELLS	The pathogenesis of bisphosphonate-related osteonecrosis of the jaw. (BRONJ) is highly controversial. We have previously reported the development of osteonecrosis by periodontal pathogenic stimulation in the jaw and femur of rats treated with bisphosphonate. Since the major toxicity factor of Gram-negative bacteria is lipopolysaccharide (LPS), the present study aimed to evaluate the relationship between osteonecrosis and LPS in a rat model of BRON-like lesions. Seventeen male rats were injected subcutaneously with zoledronic acid weekly for 4 weeks and divided into three groups: LPS (LPS administered into the bone marrow of the mandible and femur) and LPS plus polymyxin B (PMB) and saline groups (given neutralized LPS with PMB or saline, respectively, using the same protocol). At 4 weeks after the procedure, harvested specimens were analyzed using histomorphology (n = 5 from each group) and histochemistry (n = 1 each from LPS and LPS plus PMB groups). There was a significantly wider area of osteonecrosis in the LPS group as compared to the saline and LPS plus PMB groups in both the mandible (P = 0.030 and P = 0.009, respectively) and femur (P = 0.002 and P = 0.020, respectively). Our results indicate that LPS stimulation is deeply involved in the development and promotion of BRON.	[Sakaguchi, O.; Tanaka, J.; Habu, M.; Uehara, M.; Tominaga, K.] Kyushu Dent Univ, Div Maxillofacial Surg, Dept Sci Phys Funct, Kitakyushu, Fukuoka, Japan; [Kokuryo, S.; Tsurushima, H.] Kyushu Dent Univ, Div Oral Med, Dept Sci Phys Funct, Kitakyushu, Fukuoka, Japan; [Nishihara, T.] Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan	Kokuryo, S (reprint author), Dept Sci Phys Funct, Div Maxillofacial Surg, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r08kokuryo@fa.kyu-dent.ac.jp					Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Tsurushima H, 2013, INT J ORAL MAX SURG, V42, P1481, DOI 10.1016/j.ijom.2013.06.011; Lopez-Jornet P, 2011, J ORAL MAXIL SURG, V69, P2488, DOI 10.1016/j.joms.2011.02.059; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; Cankaya M, 2013, INT J ORAL MAX SURG, V42, P1134, DOI 10.1016/j.ijom.2013.02.008; Abtahi J, 2013, J DENT RES, V92, P279, DOI 10.1177/0022034512472335; JACOBS DM, 1977, J IMMUNOL, V118, P21; Aguirre JI, 2012, J BONE MINER RES, V27, P2130, DOI 10.1002/jbmr.1669; Allen MR, 2008, J ORAL MAXIL SURG, V66, P987, DOI 10.1016/j.joms.2008.01.038; Pautke C, 2012, BONE, V51, P592, DOI 10.1016/j.bone.2012.04.020; Mawardi H, 2011, J DENT RES, V90, P1339, DOI 10.1177/0022034511420430; Allen MR, 2011, OSTEOPOROSIS INT, V22, P693, DOI 10.1007/s00198-010-1268-4; Abtahi J, 2013, INT J ORAL MAX SURG, V42, P632, DOI 10.1016/j.ijom.2013.02.007; Allen MR, 2013, J ORAL MAXIL SURG, V71, P1017, DOI 10.1016/j.joms.2012.11.016; Neto NC, 2013, INT J EXP PATHOL, V94, P65, DOI 10.1111/iep.12007; GERY I, 1972, J IMMUNOL, V108, P1088; Holcugo A, 2010, J BONE MINER RES, V25, P1337; Huja SS, 2009, ARCH ORAL BIOL, V54, P851, DOI 10.1016/j.archoralbio.2009.06.002; Labrinidis A, 2009, CLIN CANCER RES, V15, P3451, DOI 10.1158/1078-0432.CCR-08-1616; Maahs MP, 2011, HEAD NECK-J SCI SPEC, V33, P199, DOI 10.1002/hed.21422; NISHIHARA T, 1986, J PERIODONTAL RES, V21, P521, DOI 10.1111/j.1600-0765.1986.tb01488.x; RIFKIND D, 1966, J BACTERIOL, V92, P815; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI [10.1002/jcp.22201, 10.1002/jcp.2220]; Yamashita J, 2010, CLIN CANCER RES, V17, P1405	26	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	APR	2015	44	4					528	534		10.1016/j.ijom.2014.08.011		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CE6RQ	WOS:000351966100018		
J	Inohara, H; Takenaka, Y; Yoshii, T; Nakahara, S; Yamamoto, Y; Tomiyama, Y; Seo, Y; Isohashi, F; Suzuki, O; Yoshioka, Y; Sumida, I; Ogawa, K				Inohara, Hidenori; Takenaka, Yukinori; Yoshii, Tadashi; Nakahara, Susumu; Yamamoto, Yoshifumi; Tomiyama, Yoichiro; Seo, Yuji; Isohashi, Fumiaki; Suzuki, Osamu; Yoshioka, Yasuo; Sumida, Iori; Ogawa, Kazuhiko			Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							LOCALLY ADVANCED HEAD; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; CHEMOTHERAPY; CHEMORADIOTHERAPY; TRIAL; RADIOTHERAPY; MUTATIONS; SURVIVAL; TOXICITY	Purpose: We investigated the efficacy and safety of weekly low- dose docetaxel and cisplatin therapy concurrent with conventionally fractionated radiation in patients with technically resectable stage III- IV squamous cell carcinoma of the head and neck. Methods and Materials: Between March 2004 and October 2011, we enrolled 117 patients, of whom 116 were analyzable ( 43 had oropharyngeal cancer, 54 had hypopharyngeal cancer, and 19 had laryngeal cancer), and 85 ( 73%) had stage IV disease. Radiation consisted of 66 Gy in 33 fractions. Docetaxel, 10 mg/ m 2, followed by cisplatin, 20 mg/ m 2, administered on the same day were given once a week for 6 cycles. The primary endpoint was overall complete response ( CR) rate after chemoradiation therapy. Human papillomavirus ( HPV) DNA in oropharyngeal cancer was examined by PCR. Results: Of 116 patients, 82 ( 71%) completed treatment per protocol; 102 ( 88%) received the full radiation therapy dose; and 90 ( 78%) and 12 ( 10%) patients received 6 and 5 chemotherapy cycles, respectively. Overall CR rate was 71%. After median follow- up of 50.9 months ( range: 15.6- 113.9 months for surviving patients), 2- year and 4- year overall survival rates were 82% and 68%, respectively. Cumulative 2- year and 4- year local failure rates were 27% and 28%, respectively, whereas distant metastasis rates were 15% and 22%, respectively. HPV status in oropharyngeal cancer was not associated with treatment efficacy. Acute toxicity included grade 3 and 4 infield mucositis in 73% and 5% of patients, respectively, whereas myelosuppression and renal injury were minimal. No patients died of toxicity. Feeding tube dependence in 8% and tracheostomy in 1% of patients were evident at 2 years postchemoradiation therapy in patients who survived without local treatment failure. Conclusions: Local control and survival with this regimen were satisfactory. Although acute toxicity, such as mucositis, was common, late toxicity, such as laryngoesophageal dysfunction, was minimal. Therapy using weekly low- dose docetaxel and cisplatin concurrent with radiation warrants further evaluation. 2015 Elsevier Inc. All rights reserved.	[Inohara, Hidenori; Takenaka, Yukinori; Yoshii, Tadashi; Nakahara, Susumu; Yamamoto, Yoshifumi; Tomiyama, Yoichiro] Osaka Univ, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka 5650871, Japan; [Seo, Yuji; Isohashi, Fumiaki; Suzuki, Osamu; Yoshioka, Yasuo; Sumida, Iori; Ogawa, Kazuhiko] Osaka Univ, Fac Med, Dept Radiat Oncol, Suita, Osaka 5650871, Japan	Inohara, H (reprint author), Osaka Univ, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hinohara@ent.med.osaka-u.ac.jp					Adelstein DJ, 1997, HEAD NECK-J SCI SPEC, V19, P567, DOI 10.1002/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5; Allen CT, 2010, LARYNGOSCOPE, V120, P1756, DOI 10.1002/lary.20936; Lefebvre JL, 2013, J CLIN ONCOL, V31, P853, DOI 10.1200/JCO.2012.42.3988; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Garden AS, 2004, J CLIN ONCOL, V22, P2856, DOI 10.1200/JCO.2004.12.012; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Dignam JJ, 2008, J CLIN ONCOL, V26, P4027, DOI 10.1200/JCO.2007.12.9866; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Inohara H, 2004, ANTICANCER RES, V24, P4135; Maeda S, 2004, CANCER SCI, V95, P679, DOI 10.1111/j.1349-7006.2004.tb03329.x; Maruyama H, 2014, CANCER SCI, V105, P409, DOI 10.1111/cas.12369; Milas L, 2003, HEAD NECK-J SCI SPEC, V25, P152, DOI 10.1002/hed.10232; Nguyen-Tan P, 2013, INT J RADIAT ONCOL, V87, pS56; Sobin LH, 2002, TNM CLASSIFICATION M; Tsao AS, 2006, J CLIN ONCOL, V24, P4163, DOI 10.1200/JCO.2006.05.7851	20	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	APR 1	2015	91	5					934	941		10.1016/j.ijrobp.2014.12.032		8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CE3NR	WOS:000351734000009		
J	Inoue, K; Hanaoka, Y; Nishijima, T; Okamoto, M; Chang, H; Saito, T; Soya, H				Inoue, K.; Hanaoka, Y.; Nishijima, T.; Okamoto, M.; Chang, H.; Saito, T.; Soya, H.			Long-term Mild Exercise Training Enhances Hippocampus-dependent Memory in Rats	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						hippocampal function; Morris water maze; exercise intensity; lactate threshold; stress	SPATIAL MEMORY; ADULT NEUROGENESIS; IMPROVES MEMORY; C57BL/6J MICE; STRESS; BRAIN; ACTIVATION; PROLIFERATION; PERFORMANCE; PLASTICITY	Although exercise training improves hippocampus-related cognition, the optimum exercise intensity is still disputed. Based on the lactate threshold (LT, approximately 20 m/min on treadmill) of rats, we have shown that 2 weeks of training with stress-free mild exercise (ME, <LT), but not intense exercise (IE, >LT), comprising exercise stress, promotes adult hippocampal neurogenesis (Okamoto et al., PNAS, 2012), a potential substrate for memory improvement. These results led us to postulate that long-term ME, but not IE, training leads to improved hippocampal function as assessed with a Morris water maze (MWM) task. To test this hypothesis, we investigated the changes in physiological stress levels and MWM task performance in rats assigned to 6 weeks of sedentary control (CONT), ME-training or IE-training conditions. Results showed that, compared to the other conditions, only IE causes general adaptive syndrome (GAS), including adrenal hypertrophy, thymic atrophy and hypercorticosteronemia. In the MWM, ME led to enhanced memory, but not learning, compared with CONT, while IE produced no change in either capacity, probably due to GAS. These findings support the hypothesis that 6 weeks of continuous ME training leads to enhanced hippocampus-related memory, which may have implications for both healthy adults and subjects with low physical capacity.	[Inoue, K.; Hanaoka, Y.; Nishijima, T.; Okamoto, M.; Chang, H.; Saito, T.; Soya, H.] Univ Tsukuba, Fac Hlth & Sport Sci, Lab Exercise Biochem & Neuroendocrinol, Tsukuba, Ibaraki 3058574, Japan; [Inoue, K.] Hlth Sci Univ Hokkaido, Sch Rehabil Sci, Ishikari, Hokkaido 06102, Japan; [Chang, H.] Seoul Womens Univ, Dept Human Movement Sci, Seoul, South Korea	Soya, H (reprint author), Univ Tsukuba, Fac Hlth & Sport Sci, Lab Exercise Biochem & Neuroendocrinol, 1-1-1 Tennnoudai, Tsukuba, Ibaraki 3058574, Japan.	hsoya@taiiku.tsukuba.ac.jp			Japan Society for the Promotion of Science [20300214, 23240091]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Japan Society for the Promotion of Science (Grants-in-aid for Scientific Research B 20300214 and A 23240091) and for the Body and Mind Integrated Sports Sciences Project (2010-2013) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Alaei HojjatAllah, 2008, J Bodyw Mov Ther, V12, P72, DOI 10.1016/j.jbmt.2007.05.004; SUTANTO W, 1994, LAB ANIM, V28, P293, DOI 10.1258/002367794780745092; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Uysal N, 2005, NEUROSCI LETT, V383, P241, DOI 10.1016/j.neulet.2005.04.054; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Spina RJ, 1996, J APPL PHYSIOL, V80, P2250; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023; Okamoto M, 2012, P NATL ACAD SCI USA, V109, P13100, DOI 10.1073/pnas.1210023109; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; FORDYCE DE, 1991, BEHAV BRAIN RES, V46, P123, DOI 10.1016/S0166-4328(05)80105-6; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Aguiar AS, 2010, NEUROSCIENCE, V171, P1216, DOI 10.1016/j.neuroscience.2010.09.053; Hoveida R, 2011, BEHAV BRAIN RES, V216, P270, DOI 10.1016/j.bbr.2010.08.003; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Ang ET, 2006, BRAIN RES, V1113, P186, DOI 10.1016/j.brainres.2006.07.023; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Nishijima T, 2006, NEUROSCI RES, V54, P186, DOI 10.1016/j.neures.2005.11.005; Shaw KN, 2003, EUR J NEUROSCI, V17, P2438, DOI 10.1046/j.1460-9568.2003.02643.x; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Hyodo K, 2012, NEUROBIOL AGING, V33, P2621, DOI 10.1016/j.neurobiolaging.2011.12.022; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1046/j.1460-9568.2003.03041.x; Joëls Marian, 2008, Prog Brain Res, V167, P3; Kawashima H, 2004, LIFE SCI, V76, P763, DOI 10.1016/j.lfs.2004.09.014; Kim YP, 2003, INT J SPORTS MED, V24, P114, DOI 10.1055/s-2003-38202; soya Hideaki, 2011, Journal of Exercise Nutrition & Biochemistry, V15, P1; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Soya H., 2001, EXERCISE NUTR ENV ST, P21; Soya H, 2007, NEUROSCI RES, V58, P341, DOI 10.1016/j.neures.2007.04.004; Srere PA, 1969, METHOD ENZYMOL, P3; Valor LM, 2012, HIPPOCAMPUS, V22, P929, DOI 10.1002/hipo.20888	42	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	APR	2015	36	4					280	285		10.1055/s-0034-1390465		6	Sport Sciences	Sport Sciences	CE4YY	WOS:000351837700002		
J	You, J; Yamasaki, M				You, J.; Yamasaki, M.			Effect of Range of Motion on Aerobic Capacity in Adults with Cerebral Palsy	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						cerebral palsy; range of motion; aerobic capacity	CERVICAL DYSTONIA; SURGICAL-TREATMENT; YOUNG-PEOPLE; LOWER-LIMB; CHILDREN; RELIABILITY; PERFORMANCE; MYELOPATHY; HEALTH; VALIDITY	The aim of the study was to examine the relationship between whole body range of motion (ROM) and aerobic capacity based on the fact that motor ability is closely related to ROM in adults with cerebral palsy (CP). The subjects were ambulant adults with CP (N = 56). Their age, height, weight, and BMI were 36.4 +/- 9.2 years, 162.6 +/- 9.5 cm, 58.9 +/- 11.0 kg, and 22.2 +/- 3.4 kg.m(-2), respectively. Active ROM (AROM) was measured in this study. Measurements included 25 AROMs of the cervical spine, shoulder, elbow, wrist, hip, knee, and ankle. Peak oxygen uptake (VO2peak) was measured during a maximal treadmill test. Correlation analysis revealed that shoulder abduction and hip abduction were significantly associated with many other AROMs. Many AROMs including the cervical spine (rotation), shoulder (flexion, extension, and abduction), hip (internal rotation, external rotation, abduction and adduction), knee (flexion) and ankle (dorsiflexion and plantarflexion) were significantly correlated with VO2peak (p < 0.05). The highest correlation coefficient was observed in the relationship between ankle dorsiflexion and VO2peak (p < 0.01). Ankle dorsiflexion and cervical rotation of AROMs were maintained within the regression model of factors associated with VO2peak. The present study demonstrated a strong relationship between ankle dorsiflexion and cervical rotation of AROMs and VO2peak in ambulant adults with CP.	[You, J.; Yamasaki, M.] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima 7398521, Japan	You, J (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Higashihiroshima 7398521, Japan.	rocggi@hanmail.net					American Academy of Orthopaedic Surgeons, 1965, JOINT MOT METH MEAS; American Medical Association, 1990, GUIDES EVALUATION PE; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Kessler KR, 1999, J NEUROL, V246, P265, DOI 10.1007/s004150050345; Brashear A, 2001, SEMIN NEUROL, V21, P85, DOI 10.1055/s-2001-13123; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; Trockel MT, 2000, J AM COLL HEALTH, V49, P125; Bell KJ, 2002, J PEDIATR ORTHOPED, V22, P677, DOI 10.1097/01.BPO.0000023143.69745.A9; Nieuwenhuijsen C, 2009, J REHABIL MED, V41, P375, DOI 10.2340/16501977-0340; Liptak GS, 2001, DEV MED CHILD NEUROL, V43, P364, DOI 10.1017/S001216220100069X; Tobimatsu Y, 1998, ARCH PHYS MED REHAB, V79, P991, DOI 10.1016/S0003-9993(98)90099-5; Fosang AL, 2003, DEV MED CHILD NEUROL, V45, P664, DOI 10.1017/S0012162203001245; GAJDOSIK RL, 1987, PHYS THER, V67, P1867; Sandstrom K, 2004, DISABIL REHABIL, V26, P1023, DOI 10.1080/09638280410001703503; JANKOVIC J, 1990, NEUROLOGY, V40, P277; Balemans ACJ, 2013, MED SCI SPORT EXER, V45, P561, DOI 10.1249/MSS.0b013e3182732b2f; Bartlett DJ, 2010, DEV MED CHILD NEUROL, V52, P155; Boyd RN, 1999, EUR J NEUROL, V6, P523; Braendvik SM, 2010, DEV MED CHILD NEUROL, V52, pe29, DOI 10.1111/j.1469-8749.2009.03490.x; Fernandez J, 1990, HUM FACTORS, V4, P457; FUJI T, 1987, J BONE JOINT SURG AM, V69A, P815; Harada T, 1996, J BONE JOINT SURG BR, V78B, P613; HIROSE G, 1984, J NEUROL NEUROSUR PS, V47, P775, DOI 10.1136/jnnp.47.8.775; HOOFWIJK M, 1995, PEDIATR EXERC SCI, V7, P305; Jahnsen R, 2004, CLIN REHABIL, V18, P309, DOI 10.1191/0269215504cr735oa; Kawarada S, 2011, JPN J COMPR REHABIL, V2, P82; Kilgour Gaela M, 2005, Phys Occup Ther Pediatr, V25, P61, DOI 10.1300/J006v25n03_05; Kusano S, 2001, J PHYS THER SCI, V13, P49, DOI 10.1589/jpts.13.49; Nordmark E, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-65; Lokan C., 2006, P ISESE 06, P75, DOI 10.1145/1159733.1159747; LUNDBERG A, 1978, DEV MED CHILD NEUROL, V20, P205; LUNDBERG A, 1984, DEV MED CHILD NEUROL, V26, P328; LUNDBERG A, 1976, J APPL PHYSIOL, V40, P873; Macedo Osmair Gomes de, 2008, Clinics (Sao Paulo), V63, P601; MCCLUER S, 1982, PARAPLEGIA, V20, P308; McDowell BC, 2012, PHYS OCCUP THER PEDI, V32, P139, DOI 10.3109/01942638.2011.644032; NISHIHARA N, 1984, J BONE JOINT SURG BR, V66, P504; Nitta O, 1993, PHYS THERAPY JAPAN, V20, P347; Norkin CC, 2011, MEASUREMENT JOINT MO; PANDYA S, 1985, PHYS THER, V65, P1339; Silver D, 1923, J BONE JOINT SURG, V5, P569; van der Slot WMA, 2007, DISABIL REHABIL, V29, P179, DOI 10.1080/09638280600747686; van Meeteren J, 2007, J REHABIL MED, V39, P598, DOI 10.2340/16501977-0095; Verschuren O, 2006, PHYS THER, V86, P1107; Verschuren O, 2010, RES DEV DISABIL, V31, P1352, DOI 10.1016/j.ridd.2010.07.005	45	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	APR	2015	36	4					315	320		10.1055/s-0034-1390431		6	Sport Sciences	Sport Sciences	CE4YY	WOS:000351837700008		
J	Sugino, Y; O'Malley, KJ; Wang, Z; Tyagi, P; Birder, LA; Ogawa, O; Yoshimura, N				Sugino, Yoshio; O'Malley, Katherine J.; Wang, Zhou; Tyagi, Pradeep; Birder, Lori A.; Ogawa, Osamu; Yoshimura, Naoki			Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						Chronic cystitis; Laser-capture microdissection; Real-time PCR; Urothelial cells; Detrusor cells	IDIOPATHIC DETRUSOR OVERACTIVITY; MOLECULAR CHARACTERIZATION; URINARY-BLADDER; MUSCLE LAYER; UROTHELIUM; ACTIVATION; PROTEIN; TISSUE	This study examined whether the laser-capture microdissection (LCM) method can achieve separation of urothelial cells from detrusor cells or superficial urothelial cells from intermediate/basal urothelial cells, using alpha-smooth muscle actin (SMA) and cytokeratin 20 (CK20). In addition, we investigated the changes in expression of muscarinic receptors in laser-captured urothelial and detrusor cells in rats with chronic cystitis. Female SD rats were injected with cyclophosphamide (75 mg/kg) intraperitoneally at day 1, 4, 7 and 10 to induce chronic cystitis. Saline was injected in the same protocol for controls. Bladder specimens were cut at 8 mu m thickness, fixed in 70 % ethanol and lightly stained by hematoxylin and eosin, and then superficial urothelium, intermediate/basal urothelium and detrusor muscles were laser-captured separately. Real-time PCR was performed to examine expressions of alpha-SMA, CK20, muscarinic 2 receptors (M2R) and muscarinic 3 receptors (M3R). The expression of alpha-SMA mRNA in detrusor muscle cells was 200 times higher than that in urothelial cells in controls. CK20 mRNA expression in apical urothelial cells was 55 times more than that in detrusor muscle and four times more than that in intermediate/basal urothelial cells. Expressions of M2R and M3R mRNA were increased in urothelial cells and decreased in detrusor muscles following chronic cystitis. The LCM could be useful for tissue collection of detrusor muscle and different layers of urothelial cells with minimal contamination of other cell types, and cell type-specific changes in molecular expression could accurately be analyzed. Increased expression of urothelial MR might enhance urothelial-afferent interactions to induce bladder overactivity/pain conditions associated with bladder inflammation.	[Sugino, Yoshio] Kobe City Med Ctr Gen Hosp, Dept Urol, Chuo Ku, Kobe, Hyogo, Japan; [O'Malley, Katherine J.; Wang, Zhou] Univ Pittsburgh, Dept Urol, Shadyside Med Ctr, Sch Med, Pittsburgh, PA 15232 USA; [Tyagi, Pradeep; Yoshimura, Naoki] Univ Pittsburgh, Dept Urol, Sch Med, Pittsburgh, PA 15213 USA; [Birder, Lori A.] Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Ogawa, Osamu] Kyoto Univ Hosp, Dept Urol, Sakyo Ku, Kyoto 606, Japan	Yoshimura, N (reprint author), Univ Pittsburgh, Dept Urol, Sch Med, Suite 700,3470 Fifth Ave, Pittsburgh, PA 15213 USA.	suginoy@kcho.jp; omalleykj@upmc.edu; wangz2@upmc.edu; tyagip@upmc.edu; lbirder@pitt.edu; ogawao@kuhp.kyoto-u.ac.jp; nyos@pitt.edu			National Institute of Health [DK088836, P01DK093424, P20DK090919]; Department of Defense [W81XWH-12-1-0565]	This work was supported by grants from the National Institute of Health (Grant No. DK088836, P01DK093424 and P20DK090919) and the Department of Defense (Grant No. W81XWH-12-1-0565).	Bschleipfer T, 2007, LIFE SCI, V80, P2303, DOI 10.1016/j.lfs.2007.01.053; Pradidarcheep W, 2008, J HISTOCHEM CYTOCHEM, V56, P1099, DOI 10.1369/jhc.2008.952101; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Dugan C, 2014, J MOL NEUROSCI, V54, P360, DOI 10.1007/s12031-014-0308-5; Grol S, 2009, BJU INT, V104, P398, DOI 10.1111/j.1464-410X.2009.08423.x; Yoshimura N, 1999, J NEUROSCI, V19, P4644; Tong YC, 2006, NEUROSCI LETT, V406, P216, DOI 10.1016/j.neulet.2006.07.065; O'Malley KJ, 2009, PROSTATE, V69, P1716, DOI 10.1002/pros.21034; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; Birder LA, 2010, AUTON NEUROSCI-BASIC, V153, P33, DOI 10.1016/j.autneu.2009.07.005; Cheng JT, 2007, NEUROSCI LETT, V423, P1, DOI 10.1016/j.neulet.2007.05.062; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Giglio D, 2005, AUTON NEUROSCI-BASIC, V122, P9, DOI 10.1016/j.autneu.2005.07.005; Kim JC, 2008, BJU INT, V101, P371, DOI 10.1111/j.1464-410X.2007.07251.x; Kullmann FA, 2008, J NEUROSCI, V28, P1977, DOI 10.1523/JNEUROSCI.4694-07.2008; Liu HT, 2007, BJU INT, V100, P1086, DOI 10.1111/j.1464-410X.2007.07151.x; Mansfield KJ, 2007, BJU INT, V99, P1433, DOI 10.1111/j.1464-410X.2007.06866.x; Matsumoto Y, 2012, UROLOGY, V79, pe1184; Matsumoto Y, 2010, UROLOGY, V75, P862, DOI 10.1016/j.urology.2009.12.013; Neuhaus J, 2012, WORLD J UROL, V30, P693, DOI 10.1007/s00345-011-0774-0; Romih R, 2002, APPL IMMUNOHISTO M M, V10, P339, DOI 10.1097/00022744-200212000-00009; Vizzard MA, 1996, J COMP NEUROL, V370, P191; Zarghooni S, 2007, LIFE SCI, V80, P2308, DOI 10.1016/j.lfs.2007.01.046; Zheng XY, 2008, SPINAL CORD, V46, P574, DOI 10.1038/sc.2008.39	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	APR	2015	47	4					637	642		10.1007/s11255-015-0926-z		6	Urology & Nephrology	Urology & Nephrology	CE5FI	WOS:000351855900010		
J	Ioku, N; Ishige, K; Yanagida, E				Ioku, Norisuke; Ishige, Kazuhiro; Yanagida, Eiji			Sharp decay estimates in Lorentz spaces for nonnegative Schrodinger heat semigroups	JOURNAL DE MATHEMATIQUES PURES ET APPLIQUEES			English	Article						Schrodinger heat semigroups; Lorentz spaces; Quadratically decaying potential	2ND-ORDER ELLIPTIC-EQUATIONS; LARGE TIME BEHAVIOR; POSITIVE SOLUTIONS; GROUND-STATES; CRITICALITY; OPERATOR; NORMS; SUBCRITICALITY; GAUGEABILITY; BOUNDS	Let H : = -Delta + V be a nonnegative Schrodinger operator on L-2 (R-N), where N >= 2 and V be a radially symmetric function decaying quadratically at the space infinity. In this paper we consider the Schrodinger heat semigroup e(-tH) and make a complete table of the decay rates of the operator norms of e(-tH) in the Lorentz spaces as t -> infinity. (C) 2014 Published by Elsevier Masson SAS.	[Ioku, Norisuke] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Ishige, Kazuhiro] Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan; [Yanagida, Eiji] Tokyo Inst Technol, Dept Math, Meguro Ku, Tokyo 1528551, Japan	Yanagida, E (reprint author), Tokyo Inst Technol, Dept Math, Meguro Ku, Tokyo 1528551, Japan.	yanagida@math.titech.ac.jp			Japan Society for the Promotion of Science [23340035, 24244012]	The second author was supported in part by the Grant-in-Aid for Scientific Research (B) (No. 23340035) from Japan Society for the Promotion of Science. The third author was supported in part by Grant-in-Aid for Scientific Research (A) (No. 24244012) from Japan Society for the Promotion of Science.	Alvino A., 1991, DIFFERENTIAL INTEGRA, V4, P25; Milman PD, 2004, J FUNCT ANAL, V212, P373, DOI 10.1016/j.jfa.2003.12.008; SIMON B, 1981, J FUNCT ANAL, V40, P66, DOI 10.1016/0022-1236(81)90073-2; Ioku N, 2013, J FUNCT ANAL, V264, P2764, DOI 10.1016/j.jfa.2013.03.009; MURATA M, 1984, J FUNCT ANAL, V56, P300, DOI 10.1016/0022-1236(84)90079-X; Ishige K, 2012, J FUNCT ANAL, V262, P2695, DOI 10.1016/j.jfa.2011.12.024; DAVIES EB, 1991, J FUNCT ANAL, V102, P95, DOI 10.1016/0022-1236(91)90137-T; MURATA M, 1986, DUKE MATH J, V53, P869, DOI 10.1215/S0012-7094-86-05347-0; SIMON B, 1982, B AM MATH SOC, V7, P447, DOI 10.1090/S0273-0979-1982-15041-8; Aronson D., 1968, ANNALI DELLA SCUOLA, V22, P607; BENNETT C, 1988, PURE APPL MATH, V129; BERGH J., 1976, INTERPOLATION SPACES; Ishige K., 2013, SPRINGER INDAM SERIE, V2, P165; Ladyzenskaja O. A., 1968, LINEAR QUASILINEAR E; Moschini L., 2005, Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti Lincei. Matematica e Applicazioni, V16; Moschini L, 2007, FORUM MATH, V19, P407, DOI 10.1515/FORUM.2007.017; MURATA M, 1985, TOHOKU MATH J, V37, P151, DOI 10.2748/tmj/1178228678; Pinchover Y, 1996, DUKE MATH J, V85, P431, DOI 10.1215/S0012-7094-96-08518-X; PINCHOVER Y, 1989, J DIFFER EQUATIONS, V80, P237, DOI 10.1016/0022-0396(89)90083-1; PINCHOVER Y, 1990, J DIFFER EQUATIONS, V87, P353, DOI 10.1016/0022-0396(90)90007-C; PINCHOVER Y, 1988, DUKE MATH J, V57, P955, DOI 10.1215/S0012-7094-88-05743-2; Zhang QS, 2001, J FUNCT ANAL, V182, P344, DOI 10.1006/jfan.2000.3737; ZHAO Z, 1992, T AM MATH SOC, V334, P75, DOI 10.2307/2153973; ZHAO Z, 1990, B AM MATH SOC, V23, P513, DOI 10.1090/S0273-0979-1990-15965-8	24	1	1	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	0021-7824	1776-3371		J MATH PURE APPL	J. Math. Pures Appl.	APR	2015	103	4					900	923		10.1016/j.matpur.2014.09.006		24	Mathematics, Applied; Mathematics	Mathematics	CE6RE	WOS:000351964800003		
J	Umezawa, K; Takeda, K; Ishida, T; Sunagawa, N; Makabe, A; Isobe, K; Koba, K; Ohno, H; Samejima, M; Nakamura, N; Igarashi, K; Yoshida, M				Umezawa, Kiwamu; Takeda, Kouta; Ishida, Takuya; Sunagawa, Naoki; Makabe, Akiko; Isobe, Kazuo; Koba, Keisuke; Ohno, Hiroyuki; Samejima, Masahiro; Nakamura, Nobuhumi; Igarashi, Kiyohiko; Yoshida, Makoto			A Novel Pyrroloquinoline Quinone-Dependent 2-Keto-D-Glucose Dehydrogenase from Pseudomonas aureofaciens	JOURNAL OF BACTERIOLOGY			English	Article							QUINOHEMOPROTEIN ALCOHOL-DEHYDROGENASE; QUINOPROTEIN GLUCOSE-DEHYDROGENASE; D-GLUCONATE DEHYDROGENASE; ACINETOBACTER-CALCOACETICUS; SEQUENCE ALIGNMENT; CARBOHYDRATE OXIDATION; SUBSTRATE-SPECIFICITY; ELECTRON-TRANSPORT; AERUGINOSA; PURIFICATION	A gene encoding an enzyme similar to a pyrroloquinoline quinone (PQQ)-dependent sugar dehydrogenase from filamentous fungi, which belongs to new auxiliary activities (AA) family 12 in the CAZy database, was cloned from Pseudomonas aureofaciens. The deduced amino acid sequence of the cloned enzyme showed only low homology to previously characterized PQQ-dependent enzymes, and multiple-sequence alignment analysis showed that the enzyme lacks one of the three conserved arginine residues that function as PQQ-binding residues in known PQQ-dependent enzymes. The recombinant enzyme was heterologously expressed in an Escherichia coli expression system for further characterization. The UV-visible (UV-Vis) absorption spectrum of the oxidized form of the holoenzyme, prepared by incubating the apoenzyme with PQQ and CaCl2, revealed a broad peak at approximately 350 nm, indicating that the enzyme binds PQQ. With the addition of 2-keto-D-glucose (2KG) to the holoenzyme solution, a sharp peak appeared at 331 nm, attributed to the reduction of PQQ bound to the enzyme, whereas no effect was observed upon 2KG addition to authentic PQQ. Enzymatic assay showed that the recombinant enzyme specifically reacted with 2KG in the presence of an appropriate electron acceptor, such as 2,6-dichlorophenol indophenol, when PQQ and CaCl2 were added. 1H nuclear magnetic resonance (H-1-NMR) analysis of reaction products revealed 2-keto-D-gluconic acid (2KGA) as the main product, clearly indicating that the recombinant enzyme oxidizes the C-1 position of 2KG. Therefore, the enzyme was identified as a PQQ-dependent 2KG dehydrogenase (Pa2KGDH). Considering the high substrate specificity, the physiological function of Pa2KGDH may be for production of 2KGA.	[Umezawa, Kiwamu; Makabe, Akiko; Koba, Keisuke; Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Fuchu, Tokyo, Japan; [Takeda, Kouta; Ohno, Hiroyuki; Nakamura, Nobuhumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Ishida, Takuya; Sunagawa, Naoki; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo, Japan; [Isobe, Kazuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	Yoshida, M (reprint author), Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Fuchu, Tokyo, Japan.	ymakoto@cc.tuat.ac.jp	Ohno, Hiroyuki/F-6459-2012; Nakamura, Nobuhumi/C-1972-2013	Ohno, Hiroyuki/0000-0001-9716-3495; Nakamura, Nobuhumi/0000-0002-5373-2972	Japan Society for the Promotion of Science [26-8518]; Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) [24114001, 24114008]	This research was financially supported by a grant-in-aid for JSPS fellows (grant 26-8518 to K. Umezawa) from the Japan Society for the Promotion of Science and by grants-in-aid for innovative areas (grants 24114001 and 24114008 to K. Igarashi) from the Japanese Ministry of Education, Culture, Sports, and Technology (MEXT).	Agbanyo F, 1985, J BIOCH, V228, P257; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; AMEYAMA M, 1981, FEBS LETT, V130, P179, DOI 10.1016/0014-5793(81)81114-3; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; DOKTER P, 1986, BIOCHEM J, V239, P163; Miyazaki T, 2006, APPL ENVIRON MICROB, V72, P1487, DOI 10.1128/AEM.72.2.1487-1495.2006; JANSSEN FW, 1968, BIOCHIM BIOPHYS ACTA, V167, P501, DOI 10.1016/0005-2744(68)90040-5; MATSUSHITA K, 1980, AGR BIOL CHEM TOKYO, V44, P1505; Volc J, 1997, ARCH MICROBIOL, V167, P119, DOI 10.1007/s002030050424; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; ROBERTS BK, 1973, J GEN MICROBIOL, V78, P319; WHITING PH, 1976, J GEN MICROBIOL, V92, P304; SHINAGAWA E, 1983, J FERMENT TECHNOL, V61, P359; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104851; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; Chen ZW, 2002, STRUCTURE, V10, P837, DOI 10.1016/S0969-2126(02)00774-8; FRAMPTON EW, 1961, J BIOL CHEM, V236, P2571; GUYMON LF, 1974, J BACTERIOL, V117, P1261; Keitel T, 2000, J MOL BIOL, V297, P961, DOI 10.1006/jmbi.2000.3603; Lockwood LB, 1941, J BACTERIOL, V42, P51; Matsushita K, 1996, J BIOL CHEM, V271, P4850; MATSUSHITA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1548; Matsushita Kazunobu, 2004, V16, P81; MATSUSHITA K, 1979, J BIOCHEM-TOKYO, V86, P249; MATSUSHITA K, 1979, J BIOCHEM-TOKYO, V85, P1173; NARROD SA, 1956, J BIOL CHEM, V220, P45; Nei M., 1987, BIOL EVOL, V4, P406; Oubrie A, 2002, J BIOL CHEM, V277, P3727, DOI 10.1074/jbc.M109403200; Oubrie A, 1999, P NATL ACAD SCI USA, V96, P11787, DOI 10.1073/pnas.96.21.11787; Sakuraba H, 2010, ARCH BIOCHEM BIOPHYS, V502, P81, DOI 10.1016/j.abb.2010.08.002; Southall SM, 2006, J BIOL CHEM, V281, P30650, DOI 10.1074/jbc.M601783200	37	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	APR	2015	197	8					1322	1329		10.1128/JB.02376-14		8	Microbiology	Microbiology	CE3PC	WOS:000351738600002		
J	Saika, A; Ushimaru, K; Mizuno, S; Tsuge, T				Saika, Azusa; Ushimaru, Kazunori; Mizuno, Shoji; Tsuge, Takeharu			Genome-Based Analysis and Gene Dosage Studies Provide New Insight into 3-Hydroxy-4-Methylvalerate Biosynthesis in Ralstonia eutropha	JOURNAL OF BACTERIOLOGY			English	Article							ALCALIGENES SP SH-69; PSEUDOMONAS SP 61-3; POLYHYDROXYALKANOATE SYNTHASE; 3-HYDROXYBUTYRIC ACID; AMINO-ACIDS; H16; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); 3-HYDROXYVALERATE; COPOLYMER; MUTANTS	Recombinant Ralstonia eutropha strain PHB(-)4 expressing the broad-substrate-specificity polyhydroxyalkanoate (PHA) synthase 1 from Pseudomonas sp. strain 61-3 (PhaCl(Ps)) synthesizes a PHA copolymer containing the branched side-chain unit 3-hydroxy-4-methylvalerate (3H4MV), which has a carbon backbone identical to that of leucine. Mutant strain 1F2 was derived from R. eutropha strain PHB(-)4 by chemical mutagenesis and shows higher levels of 3H4MV production than does the parent strain. In this study, to understand the mechanisms underlying the enhanced production of 3H4MV, whole-genome sequencing of strain 1F2 was performed, and the draft genome sequence was compared to that of parent strain PHB(-)4. This analysis uncovered four point mutations in the 1F2 genome. One point mutation was found in the ilvH gene at amino acid position 36 (A36T) of IlvH. ilvH encodes a subunit protein that regulates acetohydroxy acid synthase III (AHAS III). AHAS catalyzes the conversion of pyruvate to 2-acetolactate, which is the first reaction in the biosynthesis of branched amino acids such as leucine and valine. Thus, the A36T IlvH mutation may show AHAS tolerance to feedback inhibition by branched amino acids, thereby increasing carbon flux toward branched amino acid and 3H4MV biosynthesis. Furthermore, a gene dosage study and an isotope tracer study were conducted to investigate the 3H4MV biosynthesis pathway. Based on the observations in these studies, we propose a 3H4MV biosynthesis pathway in R. eutropha that involves a condensation reaction between isobutyryl coenzyme A (isobutyryl-CoA) and acetyl-CoA to form the 3H4MV carbon backbone.	[Saika, Azusa; Ushimaru, Kazunori; Mizuno, Shoji; Tsuge, Takeharu] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 227, Japan	Saika, A (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Higashi Ku, Tsukuba, Ibaraki, Japan.	azusa-saika@aist.go.jp; tsuge.t.aa@m.titech.ac.jp	Tsuge, Takeharu/F-6618-2011	Tsuge, Takeharu/0000-0002-6296-6500	Research for Promoting Technological Seeds of the Japan Science and Technology Agency (JST); JSPS young scientist fellowship [12J07871]	This work was supported by funding from the Research for Promoting Technological Seeds of the Japan Science and Technology Agency (JST) to T.T. A.S. is a recipient of a JSPS young scientist fellowship (12J07871).	Matsusaki H, 2000, BIOMACROMOLECULES, V1, P17, DOI 10.1021/bm9900040; HAYWOOD GW, 1991, INT J BIOL MACROMOL, V13, P83, DOI 10.1016/0141-8130(91)90053-W; Sudesh K, 2002, INT J BIOL MACROMOL, V30, P97, DOI 10.1016/S0141-8130(02)00010-7; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; Watanabe Y, 2012, J BIOSCI BIOENG, V113, P286, DOI 10.1016/j.jbiosc.2011.10.015; Tajima K, 2003, J BIOSCI BIOENG, V95, P77, DOI 10.1016/S1389-1723(03)80152-4; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Saika A, 2014, J BIOSCI BIOENG, V117, P670, DOI 10.1016/j.jbiosc.2013.12.006; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Tsuge T, 2005, MACROMOL BIOSCI, V5, P112, DOI 10.1002/mabi.200400152; MASSEY LK, 1976, BACTERIOL REV, V40, P42; Fukui T, 1997, J BACTERIOL, V179, P4821; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Mifune J, 2008, CAN J CHEM, V86, P621, DOI 10.1139/V08-047; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; SCHLEGEL HG, 1970, ARCH MIKROBIOL, V71, P283, DOI 10.1007/BF00410161; BANNERJE.D, 1970, J BIOL CHEM, V245, P1828; Bramer CO, 2001, INT J SYST EVOL MICR, V51, P1709; Choi GG, 2003, BIOTECHNOL LETT, V25, P665, DOI 10.1023/A:1023437013044; FUJITA M, 1993, INT J BIOL MACROMOL, V15, P253, DOI 10.1016/0141-8130(93)90046-O; Fukui T, 2011, APPL MICROBIOL BIOT, V89, P1527, DOI 10.1007/s00253-011-3100-2; Gusyatiner MM, 2002, US patent, Patent No. [6,403,342 B1, 6403342]; Lu JN, 2015, APPL MICROBIOL BIOT, V99, P761, DOI 10.1007/s00253-014-5965-3; Martin CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2418; Mendel S, 2001, J MOL BIOL, V307, P465, DOI 10.1006/jmbi.2000.4413; NAKAMURA K, 1992, INT J BIOL MACROMOL, V14, P321, DOI 10.1016/S0141-8130(05)80072-8; Park JH, 2010, APPL MICROBIOL BIOT, V85, P491, DOI 10.1007/s00253-009-2307-y; Raberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095907; RHEE YH, 1993, BIOTECHNOL LETT, V15, P377, DOI 10.1007/BF00128280; Saika A, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-6; Shimizu R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-169; STEINBUCHEL A, 1989, APPL MICROBIOL BIOT, V31, P168, DOI 10.1007/BF00262457; STEINBUCHEL A, 1992, APPL MICROBIOL BIOT, V37, P1; Tanadchangsaeng N, 2010, BIOMACROMOLECULES, V11, P1615, DOI 10.1021/bm100267k; Tanadchangsaeng N, 2009, BIOMACROMOLECULES, V10, P2866, DOI 10.1021/bm900696c; Tsuge T, 2004, FEMS MICROBIOL LETT, V231, P77, DOI 10.1016/S0378-1097(03)00930-3; WIEGEL J, 1977, ARCH MICROBIOL, V114, P203, DOI 10.1007/BF00446863	40	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	APR	2015	197	8					1350	1359		10.1128/JB.02474-14		10	Microbiology	Microbiology	CE3PC	WOS:000351738600005		
J	Liu, JK; Shirosaki, Y; Miyazaki, T				Liu, Jinkun; Shirosaki, Yuki; Miyazaki, Toshiki			Bioactive polymethylmethacrylate bone cement modified with combinations of phosphate group-containing monomers and calcium acetate	JOURNAL OF BIOMATERIALS APPLICATIONS			English	Article						Bioactive polymethylmethacrylate bone cement; phosphate group-containing monomers; calcium acetate; compressive strength; simulated body fluid	APATITE FORMATION; GLASS; METHACRYLOXYPROPYLTRIMETHOXYSILANE; COMPOSITES	Bone cement from polymethylmethacrylate powder and methylmethacrylate liquid has been successfully demonstrated as artificial material to anchor joint replacements in bone. However, it lacks the capability to bond directly to bone, so long-term implantation leads to an increased risk of loosening. Bioactive materials show better performance in fixation to bone, and the chemical bonding depends on bone-like apatite formation. This is triggered by surface reactions with body fluid. For these reactions, superficial functional groups like silanol (Si-OH) are ideal sites to induce apatite nucleation and the release of Ca2+ ions accelerates the apatite growth. Therefore, incorporation of materials containing these key components may provide the cement with apatite-forming ability. In this study, phosphoric acid 2-hydroxyethyl methacrylate ester or bis[2-(methacryloyloxy)ethyl] phosphate supplying a phosphate group (PO4H2) was added into methylmethacrylate liquid, while calcium acetate as a source of Ca2+ ions was mixed into polymethylmethacrylate powder. The influences of the combinations on the setting time and compressive strength were also investigated. Apatite was formed on the cements modified with 30 mass% of phosphoric acid 2-hydroxyethyl methacrylate ester or bis[2-(methacryloyloxy)ethyl] phosphate. The induction period was shortened with increased amounts of Ca(CH3COO)(2). The setting time could be controlled by the Ca(CH3COO)(2)/monomer mass ratio. Faster setting was achieved at a ratio close to the mixing ratio of the powder/liquid (2:1), and both increases and decreases in the amount of Ca(CH3COO)(2) prolonged the setting time based on this ratio. The highest compressive strength was 88.8 +/- 2.6MPa, higher than the lowest limit of ISO 5833 but was lower than that of the simulated body fluid-soaked reference. The increase of additives caused the decline in compressive strength. In view of balancing apatite formation and clinical standard, bis[2-(methacryloyloxy)ethyl] phosphate is more suitable as an additive, and the optimal modification is a combination of 30 mass% of bis[2-(methacryloyloxy)ethyl] phosphate and 20 mass% of Ca(CH3COO)(2).	[Liu, Jinkun; Miyazaki, Toshiki] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan; [Shirosaki, Yuki] Kyushu Inst Technol, Frontier Res Acad Young Researchers, Kitakyushu, Fukuoka 8080196, Japan	Miyazaki, T (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	tmiya@life.kyutech.ac.jp			Japan Society for the Promotion of Science [24550234]	This study was supported by a Grant-in-Aid for Scientific Research ((C) 24550234) from the Japan Society for the Promotion of Science.	Abd Samad H, 2011, BIO-MED MATER ENG, V21, P247, DOI 10.3233/BME-2011-0673; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Kasuga T, 2005, ACTA BIOMATER, V1, P55, DOI 10.1016/j.actbio.2004.08.001; KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Tanahashi M, 1997, J BIOMED MATER RES, V34, P305; Macarie L, 2010, PROG POLYM SCI, V35, P1078, DOI 10.1016/j.progpolymsci.2010.04.001; Corchon MAG, 2006, BIOMATERIALS, V27, P1778, DOI 10.1016/j.biomaterials.2005.10.015; ISO, 1992, ORTHOPAEDIC APPLICAT; Kokubo T, 2006, BIOMATERIALS, V27, P2097; Kuhn KD, 2000, BONE CEMENTS; Li P, 1994, J BIOMED MATER RES, V24, P7, DOI DOI 10.1002/JBM.820280103; Miyazaki T, 2003, J BIOMED MATER RES A, V67A, P1417, DOI 10.1002/jbm.a.20042; Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368; Mori A, 2003, J CERAM SOC JPN, V111, P739; Mori A, 2005, J MATER SCI-MATER M, V16, P713, DOI 10.1007/s10856-005-2607-4; Plewinski M, 2013, DENT MATER, V29, P1256, DOI 10.1016/j.dental.2013.09.016; Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.0.CO;2-O; Skripitz R, 1999, BIOMATERIALS, V20, P351, DOI 10.1016/S0142-9612(98)00175-6; Wolf-Brandstetter C, 2013, J BIOMED MATER RES B, V101B, P599, DOI 10.1002/jbm.b.32862; Yamauchi J, 1986, J JPN DENT MATER, V5, P144	22	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0885-3282	1530-8022		J BIOMATER APPL	J. Biomater. Appl.	APR	2015	29	9					1296	1303		10.1177/0885328214562436		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CE3EE	WOS:000351707600008		
J	Akita, T; Maeda, Y; Kohyama, M				Akita, Tomoki; Maeda, Yasushi; Kohyama, Masanori			Low-temperature CO oxidation properties and TEM/STEM observation of Au/gamma-Fe2O3 catalysts	JOURNAL OF CATALYSIS			English	Article						Au; TEM/STEM; Interface; gamma-Fe2O3; Catalyst; CO oxidation	CARBON-MONOXIDE; FE3O4(111) SURFACE; GOLD NANOPARTICLES; AU/FE2O3 CATALYSTS; SUPPORTED GOLD; HAADF-STEM; AU; AU/TIO2; OXIDE; TIO2	Au/gamma-Fe2O3 catalysts with Au nanoparticles on gamma-Fe2O3 supports were prepared by the solid grinding and deposition-precipitation methods. The prepared catalysts exhibit high activity for low-temperature CO oxidation. Their catalytic activity is proportional to the total length of the perimeters of all the Au particles on the supports, indicating that the active site is located on the perimeter. The fine structure of the prepared catalysts was investigated by aberration-corrected TEM and STEM. A preferential orientation relationship was observed between Au and the gamma-Fe2O3 crystals. STEM observation revealed the atomic-scale structure of the Au(111)/gamma-Fe2O3(111) interface. (C) 2015 Elsevier Inc. All rights reserved.	[Akita, Tomoki; Maeda, Yasushi; Kohyama, Masanori] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan	Akita, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Midorigaoka 1-8-31, Ikeda, Osaka 5638577, Japan.	t-akita@aist.go.jp	Maeda, Yasushi/M-3417-2015		Japan Society for the Promotion of Science (JSPS) [26286054]	This work was supported by the Japan Society for the Promotion of Science (JSPS Grant-in-Aid for Scientific Research (B) 26286054). The authors are grateful to Ms. F. Arai, Ms. C. Fukada, and Ms. M. Makino for their assistance with sample preparation and measurement of catalytic activities.	Akita T, 2008, J MATER SCI, V43, P3917, DOI 10.1007/s10853-007-2401-4; Visco AM, 1997, REACT KINET CATAL L, V61, P219, DOI 10.1007/BF02478376; Fujitani T, 2011, ANGEW CHEM INT EDIT, V50, P10144, DOI 10.1002/anie.201104694; Li N, 2013, APPL CATAL B-ENVIRON, V142, P523, DOI 10.1016/j.apcatb.2013.05.068; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Kotobuki M, 2009, J CATAL, V264, P67, DOI 10.1016/j.jcat.2009.03.013; Daniells ST, 2005, J CATAL, V230, P52, DOI 10.1016/j.jcat.2004.11.020; Ritter M, 1999, SURF SCI, V432, P81, DOI 10.1016/S0039-6028(99)00518-X; Yan T, 2012, J CATAL, V294, P216, DOI 10.1016/j.jcat.2012.07.024; Haruta M, 2011, FARADAY DISCUSS, V152, P11, DOI 10.1039/c1fd00107h; Deng WL, 2007, TOP CATAL, V44, P199, DOI 10.1007/S11244-007-0293-9; Gatel C, 2007, SURF SCI, V601, P1031, DOI 10.1016/j.susc.2006.11.045; Akita T, 2008, SURF INTERFACE ANAL, V40, P1760, DOI 10.1002/sia.2999; Khoudiakov M, 2005, APPL CATAL A-GEN, V291, P151, DOI 10.1016/j.apcata.2005.01.042; Fujitani T, 2009, ANGEW CHEM INT EDIT, V48, P9515, DOI 10.1002/anie.200905380; Ishida T, 2008, CHEM-EUR J, V14, P8456, DOI 10.1002/chem.200800980; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; Tsubota S, 1998, CATAL LETT, V56, P131, DOI 10.1023/A:1019069315071; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Overbury SH, 2006, J CATAL, V241, P56, DOI 10.1016/j.jcat.2006.04.018; Akita T, 2013, ACCOUNTS CHEM RES, V46, P1773, DOI 10.1021/ar300259n; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; Mou XL, 2012, ANGEW CHEM INT EDIT, V51, P2989, DOI 10.1002/anie.201107113; Schubert MM, 2001, J CATAL, V197, P113, DOI 10.1006/jcat.2000.3069; Hutchings GJ, 2006, J CATAL, V242, P71, DOI 10.1016/j.jcat.2006.06.001; Mizera J., 2012, CATAL TODAY, V187, P20; Mizukoshi Y, 2006, SCRIPTA MATER, V54, P609, DOI 10.1016/j.scriptamat.2005.10.038; Okunishi E, 2009, MICROSC MICROANAL, V15, P164, DOI 10.1017/S1431927609093891; Seino S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2151826; Smit G, 2003, CROAT CHEM ACTA, V76, P269; Tsubota S., 1995, PREPARATION CATALYST, P227	31	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	APR	2015	324						127	132		10.1016/j.jcat.2015.02.006		6	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CE4OG	WOS:000351809300015		
J	Shibagaki, K; Amano, Y; Ishimura, N; Yuki, T; Taniguchi, H; Fujita, H; Kobayashi, K; Kinoshita, Y				Shibagaki, Kotaro; Amano, Yuji; Ishimura, Norihisa; Yuki, Takafumi; Taniguchi, Hideaki; Fujita, Hiraku; Kobayashi, Keita; Kinoshita, Yoshikazu			Magnification Endoscopy With Acetic Acid Enhancement and a Narrow-Band Imaging System for Pit Pattern Diagnosis of Colorectal Neoplasms	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						pit pattern; narrow-band imaging; acetic acid; magnification endoscopy; colorectal neoplasm	EARLY GASTRIC-CANCER; SPECIALIZED INTESTINAL METAPLASIA; MAGNIFYING ENDOSCOPY; BARRETTS-ESOPHAGUS; INVASION DEPTH; GOBLET CELLS; CHROMOENDOSCOPY; COLONOSCOPY; LESIONS; CHROMOSCOPY	Background and Goals: Pit pattern (PP) analysis of colorectal neoplasms using magnification chromoendoscopy with crystal violet (CV-MCE) is useful for predicting histologic features, but it is time consuming. Capillary pattern analysis by magnification endoscopy with narrow-band imaging (NBIME) is a useful and simpler procedure, but its diagnostic accuracy may be inferior to CV-MCE. NBIME with acetic acid enhancement (A-NBIME) is effective for rapid visualization of gastric mucosal microstructures. We performed a prospective study to compare the diagnostic reliability and feasibility of A-NBIME and CV-MCE in PP diagnosis of colorectal neoplasms. Study: The present study consisted of 3 protocols: Study-1 assessed 56 colorectal lesions photographed with A-NBIME and CV-MCE, and the endoscopic images were reviewed by 3 experts to compare the diagnostic concordance; study-2 assessed 202 colorectal lesions photographed with A-NBIME in 116 consecutive patients and the correlation between PP and histologic findings; study-3 randomly allocated 100 patients with colorectal lesions equally to A-NBIME and CV-MCE, and compared the procedure time and visible ratio of PP. Results: The k value for interobserver agreement for A-NBIME and CV-MCE was 0.71 (0.66 to 0.75) and 0.80 (0.75 to 0.85), respectively. Intraobserver agreement between modalities for each reviewer was 0.79 (0.70 to 0.88), 0.80 (0.71 to 0.90), and 0.74 (0.67 to 0.82). Non-neoplastic polyps and massively invasive submucosal adenocarcinomas were statistically related to type II and type VI-H/V-N. The procedure time was statistically shorter with A-NBIME than with CV-MCE (31 vs. 81 s), and the visible ratio of PP was equivalent (98.9% vs. 98.3%). Conclusions: A-NBIME is comparable with CV-MCE in PP diagnosis of colorectal neoplasms and is a simpler technique.	[Shibagaki, Kotaro; Taniguchi, Hideaki; Fujita, Hiraku] Tottori Municipal Hosp, Dept Gastroenterol, Tottori, Japan; [Kobayashi, Keita] Tottori Municipal Hosp, Dept Pathol, Tottori, Japan; [Amano, Yuji] Int Univ Hlth & Welf, Kaken Hosp, Dept Endoscopy, Ichikawa, Japan; [Ishimura, Norihisa; Kinoshita, Yoshikazu] Shimane Univ, Fac Med, Dept Gastroenterol, Matsue, Shimane, Japan; [Yuki, Takafumi] Shimane Univ Hosp, Div Endoscopy, Izumo, Shimane, Japan	Amano, Y (reprint author), Int Univ Hlth & Welf, Kaken Hosp, Dept Endoscopy, 6-1-14 Konodai, Ichikawa, Japan.	amano@kaken-hp.or.jp					Hoffman A, 2006, GASTROINTEST ENDOSC, V64, P1, DOI 10.1016/j.gie.2005.09.031; Fujii T, 2001, ENDOSCOPY, V33, P1036; Machida H, 2004, ENDOSCOPY, V36, P1094, DOI 10.1055/s-2004-826040; Hirata M, 2007, GASTROINTEST ENDOSC, V65, P988, DOI 10.1016/j.gie.2006.07.046; Tanaka S, 2006, GASTROINTEST ENDOSC, V64, P604, DOI 10.1016/j.gie.2006.06.007; Kanao H, 2009, GASTROINTEST ENDOSC, V69, P631, DOI 10.1016/j.gie.2008.08.028; Lacy S, 1996, JOURNALISM MASS COMM, V73, P963; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Kudo S, 2000, WORLD J SURG, V24, P1081; Wada Y, 2010, DIGEST ENDOSC, V22, P192, DOI 10.1111/j.1443-1661.2010.00983.x; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183; Tobaru T, 2008, INT J ONCOL, V33, P503, DOI 10.3892/ijo_00000033; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Sakamoto T, 2011, DIGEST ENDOSC, V23, P118, DOI 10.1111/j.1443-1661.2010.01049.x; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Tischendorf JJW, 2007, ENDOSCOPY, V39, P1092, DOI 10.1055/s-2007-966781; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; Chiu HM, 2007, GUT, V56, P373, DOI 10.1136/gut.2006.099614; Lambert R, 2003, ENDOSCOPY, V35, P437, DOI 10.1055/s-2003-38766; Rey JF, 2005, ENDOSCOPY, V37, P583, DOI 10.1055/s-2005-861321; Tanaka K, 2006, J GASTROENTEROL, V41, P332, DOI 10.1007/s00535-005-1760-3; Tanaka K, 2008, GASTROINTEST ENDOSC, V67, P430, DOI 10.1016/j.gie.2007.10.042; Kanao H, 2008, WORLD J GASTROENTERO, V14, P211, DOI 10.3748/wjg.14.211; Guelrud M, 2001, GASTROINTEST ENDOSC, V53, P559, DOI 10.1067/mge.2001.114059; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Yagi K, 2005, GASTROINTEST ENDOSC, V62, P963, DOI 10.1016/j.gie.2005.08.050; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Fortun PJ, 2006, ALIMENT PHARM THERAP, V23, P735, DOI 10.1111/j.1365-2036.2006.02823.x; Hurlstone DP, 2004, GUT, V53, P376, DOI 10.1136/gut.2003.029868; Imai Y, 2001, EARLY COLORECTAL CAN, V5, P595; Japanese Society for Cancer of the Colon and Rectum, 2006, GEN RUL CLIN PATH ST; Kadowaki S, 2009, J GASTROEN HEPATOL, V24, P1625, DOI 10.1111/j.1440-1746.2009.05918.x; Kaid LL, 1988, MEASUREMENT COMMUNIC; Kashida H, 2009, COLONOSCOPY PRINCIPL, V2nd, P412, DOI 10.1002/9781444316902.ch31; Kim JH, 2008, WORLD J GASTROENTERO, V14, P1903, DOI 10.3748/wjg.14.1903; Kudo S, 2010, GASTROENTEROLOGICAL, V2nd, P197; Reaud S, 2006, GASTROEN CLIN BIOL, V30, P217, DOI 10.1016/S0399-8320(06)73156-6; Sano Y, 2006, DIGEST ENDOSC, V18, P544; Smith W. F., 2004, FDN MAT SCI ENG; Tanaka K, 2008, DIGEST ENDOSC, V20, P150, DOI 10.1111/j.1443-1661.2008.00795.x; Tanaka S, 2000, ONCOL REP, V7, P783; Togashi K, 2006, ENDOSCOPY, V38, P613, DOI 10.1055/s-2006-925001; Toyoda H, 2004, GASTROINTEST ENDOSC, V59, P15, DOI 10.1016/S0016-5107(03)02527-6; Toyoda H, 2006, DIGEST ENDOSC, V18, pS41, DOI 10.1111/j.1443-1661.2006.00639.x; Wimmer DR, 2011, MASS MEDIA RES INTRO, V9th	45	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	APR	2015	49	4					306	312				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2GJ	WOS:000351632400008		
J	Nomura, T; Iwakiri, K; Matsutani, T; Hagiwara, N; Fujita, I; Nakamura, Y; Kawami, N; Miyashita, M; Uchida, E				Nomura, Tsutomu; Iwakiri, Katsuhiko; Matsutani, Takeshi; Hagiwara, Nobutoshi; Fujita, Itsuro; Nakamura, Yoshiharu; Kawami, Noriyuki; Miyashita, Masao; Uchida, Eiji			Thoracoscopic Long Myotomy in the Prone Position to Treat Rapid Esophageal Contractions With Normal Latency	JOURNAL OF CLINICAL GASTROENTEROLOGY			English	Article						high-resolution manometry; prone thoracoscopic long myotomy; rapid contractions with normal latency	MOTILITY DISORDERS	A 56-year-old woman with an 8-year history of dysphagia and chest pain received a diagnosis of diffuse esophageal spasm by esophageal high-resolution manometry (HRM). Approximately 2 years of medical therapy was ineffective, and the patient's symptoms were worsening. Therefore, surgery was considered to be the most optimal treatment for this patient. The right thoracoscopic approach was selected because a long myotomy from the distal to proximal level of the esophagus was needed based on the HRM findings. The operation was performed in the prone position with establishment of pneumothorax. The total length of the myotomy was 16 cm, and the operation was finished within 2 hours. After the operation, the symptoms were considerably improved and no contractions were detected by HRM. The HRM findings before the operation were classified as rapid contractions with normal latency based on the 2012 Chicago classification of esophageal motility. Treatment for patients with rapid esophageal contractions with normal latency has not been previously described; however, treatment for diffuse esophageal spasm was considered to be pertinent to this patient. In conclusion, right thoracoscopic esophageal long myotomy in the prone position with establishment of pneumothorax may be useful when a proximal-level esophagomyotomy is required based on preoperative mapping by HRM.	[Nomura, Tsutomu; Matsutani, Takeshi; Hagiwara, Nobutoshi; Fujita, Itsuro; Nakamura, Yoshiharu; Miyashita, Masao; Uchida, Eiji] Nippon Med Sch, Dept Digest Surg, Div Gastroenterol, Bunkyo Ku, Tokyo 1138603, Japan; [Iwakiri, Katsuhiko; Kawami, Noriyuki] Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Bunkyo Ku, Tokyo 1138603, Japan	Nomura, T (reprint author), Nippon Med Sch, Dept Med, Div Digest Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	nomura-t@nms.ac.jp					Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Herbella FA, 2008, J GASTROINTEST SURG, V12, P604, DOI 10.1007/s11605-007-0379-5; Leconte M, 2007, BRIT J SURG, V94, P1113, DOI 10.1002/bjs.5761; Patti MG, 2005, ARCH SURG-CHICAGO, V140, P442, DOI 10.1001/archsurg.140.5.442; Salvador R, 2012, DIS ESOPHAGUS, V25, P311, DOI 10.1111/j.1442-2050.2010.01172.x	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0192-0790	1539-2031		J CLIN GASTROENTEROL	J. Clin. Gastroenterol.	APR	2015	49	4					320	322				3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2GJ	WOS:000351632400010		
J	Gomi, A; Iino, T; Nonaka, C; Miyazaki, K; Ishikawa, F				Gomi, A.; Iino, T.; Nonaka, C.; Miyazaki, K.; Ishikawa, F.			Health benefits of fermented milk containing Bifidobacterium bifidum YIT 10347 on gastric symptoms in adults	JOURNAL OF DAIRY SCIENCE			English	Article						Bifidobacterium bifidum; fermented milk; gastric symptoms; questionnaire	IRRITABLE-BOWEL-SYNDROME; CASEI STRAIN SHIROTA; HELICOBACTER-PYLORI; FUNCTIONAL DYSPEPSIA; GASTROINTESTINAL SYMPTOMS; PROBIOTICS; DISORDERS; DISEASE; BF-1; MANAGEMENT	We conducted a preliminary open trial (trial 1) and a double-blind, placebo-controlled, crossover trial (trial 2) to examine how fermented milk containing the probiotic Bifidobacterium bifidum YIT 10347 affects gastric and lower abdominal symptoms in adults taking no medication. In trial 1, subjects with or without gastric and lower abdominal symptoms ingested fermented milk containing B. bifidum YIT 10347 daily for 2 wk. In trial 2, subjects with gastric symptoms ingested fermented milk containing B. bifidum YIT 10347 (active preparation) or placebo daily for 2 wk, followed by crossover for 3 wk after a washout period. Before (baseline) and 1 and 2 wk after ingestion, subjects completed a questionnaire. In trial 1 (305 subjects), the prevalence of gastric and lower abdominal symptoms was 46 and 58%, respectively, at baseline. Ingestion of B. bifidum YIT 10347 significantly decreased the prevalence of gastric and lower abdominal symptoms from 45 to 33% at 1 wk and to 28% at 2 wk, and from 57 to 40% at 2 wk, respectively. In subjects with gastric symptoms at baseline, the average gastric symptom score per subject significantly decreased by 0.9 at 1 wk and 1.2 at 2 wk. In trial 2 (27 subjects), ingestion of the active preparation significantly decreased the average gastric symptoms score per subject by 1.0 at 1 wk and 1.1 at 2 wk, but ingestion of placebo milk had no effect. No side effects were reported by any subjects in either trial. We conclude that fermented milk containing B. bifidum YIT 10347 has the potential to provide health benefits by alleviating gastric symptoms in subjects taking no medication.	[Gomi, A.; Iino, T.; Miyazaki, K.; Ishikawa, F.] Yakult Cent Inst, Kunitachi, Tokyo 1868650, Japan; [Nonaka, C.] Yakult Honsha, Fac Res & Dev, Tokyo 1058660, Japan	Gomi, A (reprint author), Yakult Cent Inst, Kunitachi, Tokyo 1868650, Japan.	atsushi-gomi@yakult.co.jp					Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Matsumoto Y, 2008, J GASTROENTEROL, V43, P332, DOI 10.1007/s00535-008-2172-y; Sykora J, 2005, J CLIN GASTROENTEROL, V39, P692; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; Horvath A, 2011, ALIMENT PHARM THER, V33, P1302, DOI 10.1111/j.1365-2036.2011.04665.x; Quigley EMM, 2006, ALIMENT PHARM THERAP, V24, P411, DOI 10.1111/j.1365-2036.2006.02989.x; Waller PA, 2011, SCAND J GASTROENTERO, V46, P1057, DOI 10.3109/00365521.2011.584895; Kamino D, 2008, J CLIN BIOCHEM NUTR, V42, P144, DOI 10.3164/jcbn.2008021; Sgouras D, 2004, APPL ENVIRON MICROB, V70, P518, DOI 10.1128/AEM.70.1.518-526.2004; Agrawal A, 2009, ALIMENT PHARM THER, V29, P104, DOI 10.1111/j.1365-2036.2008.03853.x; Fujimoto J, 2013, APPL ENVIRON MICROB, V79, P2182, DOI 10.1128/AEM.03294-12; Miki K, 2007, J DAIRY SCI, V90, P2630, DOI 10.3168/jds.2006-803; Sakamoto I, 2001, J ANTIMICROB CHEMOTH, V47, P709, DOI 10.1093/jac/47.5.709; Saad RJ, 2006, ALIMENT PHARM THERAP, V24, P475, DOI 10.1111/j.1365-2037.2006.03005.x; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Cain AM, 2011, ALTERN THER HEALTH M, V17, P72; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Watanabe T, 2007, WORLD J GASTROENTERO, V13, P4219; Boivin M, 2001, Can J Gastroenterol, V15 Suppl B, p8B; FULLER R, 1991, GUT, V32, P439, DOI 10.1136/gut.32.4.439; Gomi A, 2013, J DAIRY SCI, V96, P832, DOI 10.3168/jds.2012-5950; Isolauri E., 2001, AM J CLIN NUTR S2, V73, P444; Mayer EA, 2008, NEW ENGL J MED, V358, P1692, DOI 10.1056/NEJMcp0801447; Miyazaki K, 2008, FUNCT FOOD NUTRA SER, P165; NAGAOKA M, 1994, BIOL PHARM BULL, V17, P1012; Reid G, 2005, CAN FAM PHYSICIAN, V51, P1487; Shirasawa Y, 2010, J DAIRY SCI, V93, P4526, DOI 10.3168/jds.2010-3274; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Umesaki Y., 2012, ADV SCI BIFIDOBACTER, P145; Urita Y., 2008, CLIN NUTR S, V1, P19; Yamamoto Y., 1994, JPN PHARMACOL THER, V22, P4743	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	APR	2015	98	4					2277	2283		10.3168/jds.2014-9158		7	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CD8AN	WOS:000351317700020		
J	Teramura, M; Nakai, T; Itoh, M; Sato, T; Ohtani, M; Kawashima, C; Hanada, M				Teramura, M.; Nakai, T.; Itoh, M.; Sato, T.; Ohtani, M.; Kawashima, C.; Hanada, M.			Short communication: Difructose anhydride III promotes calcium absorption from the duodenum in cattle	JOURNAL OF DAIRY SCIENCE			English	Article						difructose anhydride (DFA) III; calcium duodenum	DFA-III; INTESTINAL EPITHELIUM; CACO-2 CELLS; DAIRY-COWS; PASSAGE; METABOLISM; INDUCTION; TRANSPORT; DIGESTA; HUMANS	Difructose anhydride (DFA) III promotes the intestinal absorption of calcium via a paracellular pathway in rats. In dairy cows, DFA III reaches the duodenum without being degraded by ruminal bacteria and hence could be used to control hypocalcemia. The aims of the present study were to investigate the percentage of DFA III that appears in the duodenum of cows and to determine the effect of DFA III on calcium absorption from duodenal fluid. The first experiment was performed in 3 ruminally and duodenally cannulated dry Holstein cows in a 3 x 3 Latin square design. Each experimental period lasted 7 d. On the first day, the cows were ruminally fed one of the following treatments: 0 (DFA0), 50 (DFA50), or 100 (DFA100) g/d of DFA III, using cobalt-EDTA as a liquid phase marker. Difructose anhydride III was detected in duodenal fluid 1 h after feeding, and its concentration peaked 4 h after feeding, in a dose-dependent manner. The percentages of DFA III that appeared in the duodenum after the DFA50 and DFA100 treatments were 69.1 +/- 7.0% and 67.9 +/- 5.6%, respectively. The second experiment used the everted duodenal sacs of cattle (n = 7 in each group). Sacs were incubated in artificial mucosal fluid containing 1 mM DFA III or no DFA III (control) for 60 min with 100% O-2 in a water bath at 37 degrees C. After incubation, the calcium concentration of the artificial serosal fluid in the everted sacs was measured. Calcium absorption was higher in the DFA III-treated group than in the control group (803 +/- 161 and 456 +/- 74 nmol/cm of sac, respectively). The above results demonstrate that approximately 70% of administered DFA III reached the duodenum of cows intact. Moreover, similar to its effects on calcium absorption in rats, DFA III promoted calcium absorption via a paracellular pathway in the duodenum of cows.	[Teramura, M.] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Teramura, M.; Nakai, T.; Sato, T.; Ohtani, M.] Nippon Beet Sugar Mfg Co Ltd, Obihiro, Hokkaido 0800831, Japan; [Itoh, M.] Hokkaido Res Org, Agr Res Dept, Anim Res Ctr, Shintoku, Hokkaido 0810031, Japan; [Kawashima, C.; Hanada, M.] Obihiro Univ Agr & Vet Med, Obihiro, Hokkaido 0808555, Japan	Teramura, M (reprint author), Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan.	teramu@nitten.co.jp					Sakurai H, 1997, BIOSCI BIOTECH BIOCH, V61, P989; HORST RL, 1990, ENDOCRINOLOGY, V126, P1053; Mineo H, 2002, J NUTR, V132, P3394; BALLARD ST, 1995, ANNU REV NUTR, V15, P35; Saito K, 2000, BIOSCI BIOTECH BIOCH, V64, P1321, DOI 10.1271/bbb.64.1321; Shigematsu N, 2004, BIOSCI BIOTECH BIOCH, V68, P1011, DOI 10.1271/bbb.68.1011; Suzuki T, 2004, J NUTR, V134, P1935; UDEN P, 1980, J SCI FOOD AGR, V31, P625, DOI 10.1002/jsfa.2740310702; Bronner F, 1998, J NUTR, V128, P917; Suzuki T, 2006, LIFE SCI, V79, P401, DOI 10.1016/j.lfs.2006.01.044; HOWARD A, 1993, AM J PHYSIOL, V265, pG917; Mitamura R, 2005, BRIT J NUTR, V94, P268, DOI 10.1079/BJN20051483; Suzuki T, 1998, BIOSCI BIOTECH BIOCH, V62, P837, DOI 10.1271/bbb.62.837; Ray PP, 2013, J DAIRY SCI, V96, P1156, DOI 10.3168/jds.2012-5851; Bronner F, 1987, PHYSL GASTROINTESTIN, P1419; Kishi K, 1996, LIFE SCI, V59, P1133, DOI 10.1016/0024-3205(96)00430-4; Koenig KM, 2002, J DAIRY SCI, V85, P930; Kozakai Takaharu, 1999, Animal Science Journal, V70, P526; Minamida K, 2006, J BIOSCI BIOENG, V101, P149, DOI 10.1263/jbb.101.149; Minamida K, 2005, J BIOSCI BIOENG, V99, P548, DOI 10.1263/jbb.99.548; Nakai T., 2007, NIHON CHIKUSAN GAKKA, V78, P57, DOI 10.2508/chikusan.78.57; PERRET C, 1985, EUR J BIOCHEM, V150, P211, DOI 10.1111/j.1432-1033.1985.tb09009.x; Sato T., 2007, ANIM SCI J, V78, P37; Sato T., 2006, NIHON CHIKUSAN GAKKA, V77, P395, DOI 10.2508/chikusan.77.395; Yamagishi N, 2002, J VET MED A, V49, P461, DOI 10.1046/j.1439-0442.2002.00483.x; Yang WZ, 2001, J DAIRY SCI, V84, P2709	26	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	APR	2015	98	4					2533	2538		10.3168/jds.2014-9004		6	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CD8AN	WOS:000351317700045		
J	Kilic, AM; Plasencia, P; Ishida, K; Hirsch, F				Kilic, Ali Murat; Plasencia, Pablo; Ishida, Keisuke; Hirsch, Francis			The Case of the Carnian (Triassic) Conodont Genus Metapolygnathus Hayashi	JOURNAL OF EARTH SCIENCE			English	Article						Carnian; conodont; phylogeny; evolutionary trend		Successive evolutionary trends control the genera Paragondolella Mosher and Metapolygnathus Hayashi over the about 20 Ma long Aegean-Tuvalian timespan. In consideration of their evolutionary criteria, these genera have been retained together with Carnepigondolella Kozur and the two new genera proposed herein, Mazzaella (type species M. carnica) and Hayashiella (type species H. nodosa). Mazzaella n. gen. represents a Late Julian side branch of Metapolygnathus, harbouring a platform ornamentation similar to the several million years younger Tuvalian lineage of Carnepigondolella, issued from Hayashiella n. gen. that is intermediary between Metapolygnathus and Carnepigondolella, based on appearance and platform ornamentation.	[Kilic, Ali Murat] Balikesir Univ, Dept Geol Engn, TR-10145 Balikesir, Turkey; [Plasencia, Pablo] Univ Valencia, Dept Geol, Burjassot 46100, Spain; [Plasencia, Pablo] Univ Valencia, ICBIBE, Burjassot 46100, Spain; [Ishida, Keisuke] Univ Tokushima, Fac Sci, Geol Lab, Tokushima 7708502, Japan; [Hirsch, Francis] Naruto Univ, Fac Sci, Geol Lab, Naruto 7728502, Japan	Kilic, AM (reprint author), Balikesir Univ, Dept Geol Engn, TR-10145 Balikesir, Turkey.	alimurat@balikesir.edu.tr					Mazza M, 2012, RIV ITAL PALEONTOL S, V118, P85; Mazza M, 2010, PALAEOGEOGR PALAEOCL, V290, P120, DOI 10.1016/j.palaeo.2009.07.006; Budurov K., 1965, TRAV GEOL BULG SER P, P115; Budurov K., 1972, Mitteilungen Ges Geol Bergbaust, V21, P853; Budurov K.J., 1990, Courier Forschungsinstitut Senckenberg, V118, P203; BUDUROV K, 1977, Geologica Balcanica, V7, P31; Buryi G. I., 1996, Acta Micropalaeontologica Sinica, V13, P135; Carter E., 2013, NEW MEXICO MUSEUM NA, V61, P67; Hayashi S., 1968, EARTH SCI TOKYO, V22, P63; Hayashi S., 1987, GEOSCIENCE MAGAZINE, V37, P1; Kozur H. W., 1989, PAPERS ORDOVICIAN TR, V117, P409; Kozur Heinz W., 2003, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V25, P49; Krystyn L., 1975, OESTERREICHISCH SA 1, V184, P259; Mazza M, 2012, J SYST PALAEONTOL, V10, P401, DOI 10.1080/14772019.2011.573584; Mock R., 1979, GEOL PALAONT MITT IN, P171; MOSHER L C, 1968, Journal of Paleontology, V42, P895; MOSHER L C, 1973, Geological Survey of Canada Bulletin, V222, P141; Orchard M.J., 1991, Geological Survey of Canada Paper, V90, P173; Orchard M.J., 2007, Albertiana, V36, P130; Orchard M. J., 2007, NEW MEXICO MUSEUM NA, V41, P331; Orchard M. J., 2013, NEW MEXICO MUSEUM NA, V61, P445; Orchard M. J., 1991, GEOLOGICAL SURVEY CA, V335, P299; Orchard M. J., 1983, FOSSILS STRATA, V15, P177	23	0	0	CHINA UNIV GEOSCIENCES	BEIJING	29 XUEYUAN RD, BEIJING, 100083, PEOPLES R CHINA	1674-487X	1867-111X		J EARTH SCI-CHINA	J. Earth Sci.	APR	2015	26	2					219	223		10.1007/s12583-015-0534-y		5	Geosciences, Multidisciplinary	Geology	CE5QU	WOS:000351891500007		
J	Yoshikawa, H				Yoshikawa, Hiroshi			Stochastic macro-equilibrium: a microfoundation for the Keynesian economics	JOURNAL OF ECONOMIC INTERACTION AND COORDINATION			English	Article						Heterogeneous agents; Microeconomic foundations; Unemployment; Productivity; Entropy; Keynes' Principle of effective demand	LABOR PRODUCTIVITY DISTRIBUTION; DEMAND; MACROECONOMICS; UNEMPLOYMENT; MARKETS; TIME	In place of the standard search equilibrium, this paper presents an alternative concept of stochastic macro-equilibrium based on the principle of statistical physics. This concept of equilibrium is motivated by unspecifiable differences of economic agents and the presence of all kinds of micro shocks facing them. Our model mimics the empirically observed distribution of labor productivity. The distribution of productivity resulting from the matching of workers and firms depends crucially on aggregate demand. When aggregate demand rises, not only the unemployment rate declines, but more workers are employed by firms with higher productivity. The effect of the reservation wage on unemployment also depends on aggregate demand so that the distinction between cyclical and structural unemployment is ambiguous. The model, a general equilibrium model of monopolistic competition with friction and uncertainty provides a micro-foundation for Keynes' principle of effective demand.	Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan	Yoshikawa, H (reprint author), Univ Tokyo, Fac Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yoshikawa@e.u-tokyo.ac.jp			JSPS [24243027]	This work is supported by the Grant-in Aid for Scientific Research (KAKENHI) Grant Number 24243027 by JSPS. The empirical work and simulation presented in the paper were carried out by Professor Hiroshi Iyetomi and Mr. Yoshiyuki Arata. The author is grateful to them for their assistance. He is indebted to CRD Association for the Credit Risk Database used. He is also grateful to Professors Hideaki Aoyama, Jean-Philippe Bouchaud, Nobuyuki Hanaki, Hiroshi Iyetomi, Alan P. Kirman, Takashi Negishi, Makoto Nirei, Bertrand Roehner, Robert M. Solow and seminar participants at Ecole Normale Superieure, Ecole Politechnique, University of Marseille and University of Tokyo for their useful comments. He is also grateful to an anonymous referee and Editor professor Thomas Lux for constructive suggestions.	Sweezy PM, 1939, J POLIT ECON, V47, P568, DOI 10.1086/255420; Caballero RJ, 2010, J ECON PERSPECT, V24, P85, DOI 10.1257/jep.24.4.85; TOBIN J, 1993, J ECON PERSPECT, V7, P45; Marsili M, 1998, PHYS REV LETT, V80, P2741, DOI 10.1103/PhysRevLett.80.2741; Syverson C, 2011, J ECON LIT, V49, P326, DOI 10.1257/jel.49.2.326; FOLEY DK, 1994, J ECON THEORY, V62, P321, DOI 10.1006/jeth.1994.1018; Rogerson R, 2005, J ECON LIT, V43, P959, DOI 10.1257/002205105775362014; Aoyama H, 2010, J ECON INTERACT COOR, V5, P27, DOI 10.1007/s11403-010-0063-9; Diamond P, 2011, AM ECON REV, V101, P1045, DOI 10.1257/aer.101.4.1045; DREZE JH, 1979, ECON LETT, V4, P1, DOI 10.1016/0165-1765(79)90081-8; Fabien Postel-Vinay, 2002, ECONOMETRICA, V70, P2295, DOI 6; Feynman RP, 1964, PRINCIPLE LEAST ACTI, VII; FRIEDMAN M, 1968, AM ECON REV, V58, P1; Gatti DD, 2008, NEW ECON WINDOWS, P1; Galibaldi U, 2010, FINITARY PROBABILIST; Ikeda Y, 2009, PROG THEOR PHYS SUPP, P93, DOI 10.1143/PTPS.179.93; Iyetomi H, 2011, J JPN INT ECON, V25, P246, DOI 10.1016/j.jjie.2011.06.002; Iyetomi H, 2012, PROG THEOR PHYS SUPP, P135; Keynes JM, 1936, GEN THEORY EMPLOYMEN; Kittel C, 1980, THERMAL PHYS; Mortensen DT, 2011, AM ECON REV, V101, P1073, DOI 10.1257/aer.101.4.1073; NEGISHI T, 1960, REV ECON STUD, V28, P196; Negishi T., 1979, MICROECONOMIC FDN KE; Okun A, 1963, P BUS EC STAT SECT A, P98; Okun Arthur M., 1973, BPEA, V4, P207; Pissarides CA, 2011, AM ECON REV, V101, P1092, DOI 10.1257/aer.101.4.1092; KYDLAND FE, 1982, ECONOMETRICA, V50, P1345, DOI 10.2307/1913386; Solow RM, 1986, ECONOMICA, V53, pS23, DOI 10.2307/2554372; TOBIN J, 1972, AM ECON REV, V62, P1; Yoshikawa H, 2007, RECONSTRUCTING MACRO; Yoshikawa H, 2013, CIRJEF827 U TOK FAC; Yoshikawa H, 2003, JPN ECON REV, V54, P1, DOI 10.1111/1468-5876.00242	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1860-711X	1860-7128		J ECON INTERACT COOR	J. Econ. Interact. Coord.	APR	2015	10	1					31	55		10.1007/s11403-014-0142-4		25	Economics	Business & Economics	CE3ZX	WOS:000351770700003		
J	Aoyama, H; Iyetomi, H; Yoshikawa, H				Aoyama, Hideaki; Iyetomi, Hiroshi; Yoshikawa, Hiroshi			Equilibrium distribution of labor productivity: a theoretical model	JOURNAL OF ECONOMIC INTERACTION AND COORDINATION			English	Article						Labor productivity; Equilibrium; Detailed balance; Firm theory	MARKETS	We construct a theoretical model for equilibrium distribution of workers across sectors with different labor productivity, assuming that a sector can accommodate a limited number of workers which depends only on its productivity. A general formula for such distribution of productivity is obtained, using the detail-balance condition necessary for equilibrium in the Ehrenfest-Brillouin model. We also carry out an empirical analysis on the average number of workers in given productivity sectors on the basis of an exhaustive dataset in Japan. The theoretical formula succeeds in explaining the two distinctive observational facts in a unified way, that is, a Boltzmann distribution with negative temperature on low-to-medium productivity side and a decreasing part in a power-law form on high productivity side.	[Aoyama, Hideaki] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Iyetomi, Hiroshi; Yoshikawa, Hiroshi] Univ Tokyo, Grad Sch Econ, Tokyo, Japan	Aoyama, H (reprint author), Kyoto Univ, Grad Sch Sci, Kyoto, Japan.	hideaki.aoyama@gmail.com			Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the Japan Society for the Promotion of Science	The authors would like to thank Yoshi Fujiwara, Yuichi Ikeda and Wataru Souma for helpful discussions and comments during the course of this work. and Toshiyuki Masuda, Chairman of The Kyoto Shinkin Bank for his comments on Japanese small to medium firms. We would also thank the Credit Risk Database for the data used in this paper. This work is supported in part by the Program for Promoting Methodological Innovation in Humanities and Social Sciences by Cross-Disciplinary Fusing of the Japan Society for the Promotion of Science.	FOLEY DK, 1994, J ECON THEORY, V62, P321, DOI 10.1006/jeth.1994.1018; Arrow KJ, 1954, ECONOMETRICA, V22, P265, DOI 10.2307/1907353; Aoki M, 2002, MODELING AGGREGATE B; Aoki M, 1996, NEW APPROACHES MACRO; Aoyama H, 2010, PROGR THEOR PHYS SUP, V179, P80; Aoyama H, 2010, J ECON INTERACT COOR, V5, P27, DOI 10.1007/s11403-010-0063-9; COSTANTINI D, 1989, FOUND PHYS, V19, P743, DOI 10.1007/BF00731910; Diamond P, 2011, AM ECON REV, V101, P1045, DOI 10.1257/aer.101.4.1045; Fujiwara Y, 2009, ECONOMICS, V3, P1; Garibaldi U., 2010, FINITARY PROBABILIST; Iyetomi H, 2012, PROGR THEOR IN PRESS; Kittel C, 1980, THERMAL PHYS; Mortensen DT, 2011, AM ECON REV, V101, P1073, DOI 10.1257/aer.101.4.1073; Pissarides CA, 2011, AM ECON REV, V101, P1092, DOI 10.1257/aer.101.4.1092; Scalas E., 2009, ECONOMICS-KIEL, V3, P1; Souma W, 2009, EC E J, V3, P14; Yoshikawa H, 2007, RECONSTRUCTING MACRO; Yoshikawa H, 2011, CIRJE DISCUSSION PAP; Yoshikawa H, 2003, JPN ECON REV, V54, P1, DOI 10.1111/1468-5876.00242	19	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1860-711X	1860-7128		J ECON INTERACT COOR	J. Econ. Interact. Coord.	APR	2015	10	1					57	66		10.1007/s11403-013-0118-9		10	Economics	Business & Economics	CE3ZX	WOS:000351770700004		
J	Aoyama, H; Fujiwara, Y; Gallegati, M				Aoyama, Hideaki; Fujiwara, Yoshi; Gallegati, Mauro			Micro-macro relation of production: double scaling law for statistical physics of economy	JOURNAL OF ECONOMIC INTERACTION AND COORDINATION			English	Article						Labor productivity; Scaling law; Stochastic process		We show that an economic system populated by multiple agents generates an equilibrium distribution in the form of multiple scaling laws of conditional probability density functions, which are sufficient for characterizing the probability distribution. The existence of the double scaling law is demonstrated empirically for the sales and the labor of one million Japanese firms. Theoretical study of the scaling laws suggests lognormal joint distributions of sales and labor and a scaling law for labor productivity, both of which are confirmed empirically. This framework offers characterization of the equilibrium distribution with a small number of scaling indices, which determine macroscopic quantities, thus setting the stage for an equivalence with statistical physics, bridging micro- and macro-economics.	[Aoyama, Hideaki] Kyoto Univ, Grad Sch Sci, Dept Phys, Kyoto 6068501, Japan; [Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500047, Japan; [Gallegati, Mauro] Univ Politecn Marche, Dept Econ, I-62100 Ancona, Italy	Fujiwara, Y (reprint author), Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500047, Japan.	hideaki.aoyama@gmail.com; yoshi.fujiwara@gmail.com; mauro.gallegati@gmail.com			Program for Promoting Methodological Innovation in Humanities and Social Sciences; Cross -Disciplinary Fusing of the Japan Society for the Promotion of Science [20330060]; Ministry of Education, Science, Sports and Culture, Japan [S-09132]	We would like to thank H. Iyetomi, Y. Ikeda, W. Souma and H. Yoshikawa for discussions, support and encouragements. We also would like to thank the CRD Association for providing us with their database. The present work was supported in part by the Program for Promoting Methodological Innovation in Humanities and Social Sciences, and by Cross -Disciplinary Fusing of the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (B) 20330060 (2008-10), and Invitation Fellowship Program for Research in Japan (Short term) ID No. S-09132 of the Ministry of Education, Science, Sports and Culture, Japan.	Aoyama H, 2010, J ECON INTERACT COOR, V5, P27, DOI 10.1007/s11403-010-0063-9; Aoyama H, 2009, PROG THEOR PHYS SUPP, P80, DOI 10.1143/PTPS.179.80; Aoyama H., 2010, ECONOPHYSICS CO STAT; Blume Lawrence E., 2006, EC EVOLVING COMPLEX; Foley KD, 1994, J ECON THEORY, V62, P321; Gatti DD, 2008, NEW ECON WINDOWS, P1; Gali J, 2008, MONETARY POLICY, INFLATION, AND THE BUSINESS CYCLE: AN INTRODUCTION TO THE NEW KEYNESIAN FRAMEWORK, P1; Hayfield T., 2008, J STAT SOFTW, V27; Ikeda Y, 2009, PROG THEOR PHYS SUPP, P93, DOI 10.1143/PTPS.179.93; Keynes J. M., 1936, THE GEN THEORY; Kydland F, 1982, J EC SOC, P1345; Racine Jeffrey, 2007, NONPARAMETRIC ECONOM; Yoshikawa H, 2007, RECONSTRUCTING MACRO	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1860-711X	1860-7128		J ECON INTERACT COOR	J. Econ. Interact. Coord.	APR	2015	10	1					67	78		10.1007/s11403-014-0124-6		12	Economics	Business & Economics	CE3ZX	WOS:000351770700005		
J	Jantanasakulwong, K; Rohindra, D; Mori, K; Kuboyama, K; Ougizawa, T				Jantanasakulwong, Kittisak; Rohindra, David; Mori, Keisuke; Kuboyama, Keiichi; Ougizawa, Toshiaki			Thermoplastic elastomer by reactive blending of poly(butylene succinate) with ethylene-propylenediene terpolymer and ethylene-1-butene rubbers	JOURNAL OF ELASTOMERS AND PLASTICS			English	Article						Thermoplastic elastomer; poly(butylene succinate); reactive blending; maleic anhydride; ethylene-propylene-diene terpolymer; ethylene-1-butene	MALEATED NATURAL-RUBBER; IN-SITU COMPATIBILIZATION; MALEIC-ANHYDRIDE; RHEOLOGICAL PROPERTIES; EPDM; TEREPHTHALATE); POLYPROPYLENE; BEHAVIOR; COPOLYMER; STYRENE	Poly(butylene succinate) (PBS) was melt blended with maleic anhydride-grafted ethylene-propylene-diene terpolymer (EPDM-MAH) and maleic anhydride-grafted ethylene-1-butene copolymer (EB-MAH) to obtain thermoplastic elastomers (TPEs) containing a biodegradable polyester. PBS/EB-MAH blend showed lower modulus and excellent strain recovery compared to PBS/EPDM-MAH blend due to the smaller rubber particle size. Tensile strength of PBS/EPDM-MAH blend was found to be significantly improved by annealing because of the increased interfacial reaction between PBS matrix phase and EPDM dispersed phase and the increased cross-linking in EPDM. As the result, it was found that the annealing process is effective for the improvement of the mechanical properties of PBS/MAH-grafted rubber blends.	[Jantanasakulwong, Kittisak; Rohindra, David; Mori, Keisuke; Kuboyama, Keiichi; Ougizawa, Toshiaki] Tokyo Inst Technol, Dept Organ & Polymer Mat, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528552, Japan	Kuboyama, K (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Grad Sch Sci & Engn, Meguro Ku, 2-12-1-S8-33 O Okayama, Tokyo 1528552, Japan.	kkuboyam@o.cc.titech.ac.jp					Li Y, 2001, POLYMER, V42, P3419, DOI 10.1016/S0032-3861(00)00767-9; Li YJ, 2006, MACROMOLECULES, V39, P4195, DOI 10.1021/ma060181a; Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W; Shi Q, 2008, J APPL POLYM SCI, V110, P3963, DOI 10.1002/app.28989; Willke T, 2004, APPL MICROBIOL BIOT, V66, P131, DOI 10.1007/s00253-004-1733-0; Aravind I, 2004, POLYMER, V45, P4925, DOI 10.1016/j.polymer.2004.04.063; Saelao J, 2005, J APPL POLYM SCI, V95, P28, DOI 10.1002/app.20810; Ho CH, 2008, POLYMER, V49, P3902, DOI 10.1016/j.polymer.2008.06.054; Liu HZ, 2012, POLYMER, V53, P272, DOI 10.1016/j.polymer.2011.12.036; Barra GMO, 1999, J BRAZIL CHEM SOC, V10, P31, DOI 10.1590/S0103-50531999000100006; Wanamaker CL, 2009, BIOMACROMOLECULES, V10, P2904, DOI 10.1021/bm900721p; Phan TTM, 1998, J APPL POLYM SCI, V68, P1451, DOI 10.1002/(SICI)1097-4628(19980531)68:9<1451::AID-APP9>3.0.CO;2-A; Wang RY, 2009, POLYM ENG SCI, V49, P26, DOI 10.1002/pen.21210; Kim SJ, 2001, POLYMER, V42, P4073, DOI 10.1016/S0032-3861(00)00810-7; Bevington JC, 1966, EUR POLYM J, V2, P185, DOI 10.1016/0014-3057(66)90040-1; Carone E, 2000, POLYMER, V41, P5929, DOI 10.1016/S0032-3861(99)00800-9; DEURI AS, 1987, J APPL POLYM SCI, V34, P2205, DOI 10.1002/app.1987.070340613; Eynde S. V., 2000, Polymer, V41; Grigoryeva OP, 2000, EUR POLYM J, V36, P1419, DOI 10.1016/S0014-3057(99)00205-0; Han YK, 2002, MACROMOL RES, V10, P108; Jen T, 2009, J APPL POLYM SCI, V114, P2806; Jha A, 2000, J APPL POLYM SCI, V78, P1001, DOI 10.1002/1097-4628(20001031)78:5<1001::AID-APP90>3.0.CO;2-G; KIKUCHI Y, 1991, POLYM ENG SCI, V31, P1029, DOI 10.1002/pen.760311406; Kim JH, 2002, POLYM J, V34, P203, DOI 10.1295/polymj.34.203; Li CQ, 2003, POLYM TEST, V22, P191, DOI 10.1016/S0142-9418(02)00079-X; Li HM, 2002, POLYMER, V43, P5455, DOI 10.1016/S0032-3861(02)00369-5; Li TQ, 2001, J APPL POLYM SCI, V81, P1420, DOI 10.1002/app.1567; Lui Y, 2002, J BIOACTIVE COMPAT P, V17, P209; Mehrabzadeh M, 1999, J APPL POLYM SCI, V72, P1257, DOI 10.1002/(SICI)1097-4628(19990606)72:10<1257::AID-APP4>3.0.CO;2-7; Mishra JK, 2004, MATER LETT, V58, P3477; Mishra JK, 2007, MATER LETT, V61, P3551, DOI 10.1016/j.matlet.2006.11.119; Nakason C, 2002, POLYM TEST, V21, P449, DOI 10.1016/S0142-9418(01)00109-X; Nakason C, 2001, J APPL POLYM SCI, V81, P2803, DOI 10.1002/app.1728; Nakason C, 2006, POLYM TEST, V25, P656, DOI 10.1016/j.polymertesting.2006.03.011; Palmlof M, 1999, J APPL POLYM SCI, V72, P521; Rao HX, 2008, POLYM ADVAN TECHNOL, V19, P770, DOI 10.1002/pat.1032; Roy MAI, 2010, SOFT MATTER, V6, P1758; Sen A, 2000, POLYMER, V41, P9177, DOI 10.1016/S0032-3861(00)00300-1; Shujun W, 2005, POLYM DEGRAD STABIL, V87, P395, DOI DOI 10.1016/J.P0LYMDEGRADSTAB.2004.08.012; Sichina WJ, THERMAL ANAL APPL NO; Soares BG, 2008, J APPL POLYM SCI, V110, P3566, DOI 10.1002/app.28946; Tasdemir M, 2006, INT J POLYM MATER, V55, P1065, DOI 10.1080/00986440600643023; Zhao Y, 2007, POLYM-PLAST TECHNOL, V46, P175, DOI 10.1080/03602550601153034	43	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0095-2443	1530-8006		J ELASTOM PLAST	J. Elastomer Plast.	APR	2015	47	3					215	231		10.1177/0095244313507805		17	Materials Science, Multidisciplinary; Polymer Science	Materials Science; Polymer Science	CE8ES	WOS:000352074900002		
J	Inoue, T; Tsuchiya, N; Narita, S; Tsuruta, H; Akihama, S; Saito, M; Satoh, S; Habuchi, T				Inoue, Takamitsu; Tsuchiya, Norihiko; Narita, Shintaro; Tsuruta, Hiroshi; Akihama, Susumu; Saito, Mitsuru; Satoh, Shigeru; Habuchi, Tomonori			Successful Introduction of Laparoendoscopic Single-Site Donor Nephrectomy After Experience with Laparoscopic Single-Site Plus-One Trocar Donor Nephrectomy	JOURNAL OF ENDOUROLOGY			English	Article							INITIAL CLINICAL-EXPERIENCE; COMPLICATIONS; INSTITUTION; SURGERY; PORT	Purpose: To assess the feasibility, safety, and efficacy of the laparoendoscopic single-site (LESS) donor nephrectomy (LESSDN) procedure after experience with the LESS-plus-one-trocar donor nephrectomy (LEPODN) procedure. Patients and Methods: From 2009 to 2014, 126 left laparoscopic donor nephrectomies (LDNs) were performed, including 59 Standard (Std)-LDN, 30 LEPODN, and 37 LESSDN. In the LEPODN procedure, a 5-mm trocar was added as a right-hand working trocar to the LESSDN procedure. A GelPOINT((R)) platform was applied on a pararectal single incision in both LEPODN and LESSDN procedures. After performing the LEPODN procedure several times, each surgeon performed the LESSDN procedure. Results: Std-LDN, LEPODN, and LESSDN procedures were performed by 10, 10, and 7 surgeons, respectively. The mean operative time, estimated blood loss, warm ischemia time, time to ambulation, and length of postoperative hospital stay were the shortest for the LESSDN procedure (P<0.012, P=0.007, P<0.001, P=0.027, and P=0.001, respectively). No significant difference in the complication rate, delayed graft function rate, and mean 7-day post-transplant serum creatinine levels was observed among the three procedures. Individual results of the operative time and estimated blood loss for the LESSDN procedure were not significantly inferior to those of Std-LDN and LEPODN procedures for each surgeon. Conclusions: The LESSDN procedure can be introduced safely and effectively without compromising the operative time, complication rate, and graft function after experience with the LEPODN procedure among multiple surgeons. The LEPODN procedure may be an effective bridge from standard multiport LDN to LESSDN.	[Inoue, Takamitsu; Tsuchiya, Norihiko; Narita, Shintaro; Tsuruta, Hiroshi; Akihama, Susumu; Saito, Mitsuru; Satoh, Shigeru; Habuchi, Tomonori] Akita Univ Grad Sch Med, Dept Urol, Akita, Japan; [Satoh, Shigeru] Akita Univ Grad Sch Med, Ctr Kidney Dis & Transplantat, Akita, Japan	Habuchi, T (reprint author), Akita Univ Sch Med, Dept Urol, 1-1-1 Hondo, Akita 0108543, Japan.	thabuchi@doc.med.akita-u.ac.jp					Andonian S, 2010, J ENDOUROL, V24, P429, DOI 10.1089/end.2009.0185; Dols LFC, 2010, TRANSPL INT, V23, P121, DOI 10.1111/j.1432-2277.2009.01027.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Wang GJ, 2011, J UROLOGY, V186, P2333, DOI 10.1016/j.juro.2011.07.071; Ganpule AP, 2009, UROLOGY, V74, P1238, DOI 10.1016/j.urology.2009.03.048; Afaneh C, 2011, UROLOGY, V78, P1332, DOI 10.1016/j.urology.2011.04.077; Raman JD, 2007, UROLOGY, V70, P1039, DOI 10.1016/j.urology.2007.10.001; Kurien A, 2011, J ENDOUROL, V25, P365, DOI 10.1089/end.2010.0250; Stamatakis L, 2013, BJU INT, V112, P198, DOI 10.1111/j.1464-410X.2012.11763.x; Canes D, 2010, EUR UROL, V57, P95, DOI 10.1016/j.eururo.2009.07.023; Ramasamy R, 2011, J UROLOGY, V186, P1386, DOI 10.1016/j.juro.2011.05.053; Chueh SCJ, 2013, UROLOGY, V82, P352, DOI 10.1016/j.urology.2013.03.045; Fan XX, 2012, EUR UROL, V62, P601, DOI 10.1016/j.eururo.2012.05.055; Gill IS, 2008, J UROLOGY, V180, P637, DOI 10.1016/j.juro.2008.04.028; Gimenez E, 2010, J UROLOGY, V184, P2049, DOI 10.1016/j.juro.2010.06.138; Inoue T, 2013, UROLOGY, V81, P308, DOI 10.1016/j.urology.2012.09.048; Narita S, 2006, UROLOGY, V67, P496, DOI 10.1016/j.urology.2005.09.064; Ponsky LE, 2008, J ENDOUROL, V22, P663, DOI 10.1089/end.2007.0427; Rane A, 2008, UROLOGY, V72, P260, DOI 10.1016/j.urology.2008.01.078; Ratner LE, 2010, AM J TRANSPLANT, V10, P2577, DOI 10.1111/j.1600-6143.2010.03341.x; Saito M, 2012, J ENDOUROL, V26, P1038, DOI 10.1089/end.2012.0015; Symes A, 2011, J MINIM ACCESS SURG, V7, P90, DOI 10.4103/0972-9941.72394; Tracy CR, 2008, NAT CLIN PRACT UROL, V5, P561, DOI 10.1038/ncpuro1215; Tsuchiya N, 2004, UROLOGY, V64, P250, DOI 10.1016/j.urology.2004.03.043; Tsuchiya N, 2006, J UROLOGY, V175, P230, DOI 10.1016/S0022-5347(05)00043-1	25	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790	1557-900X		J ENDOUROL	J. Endourol.	APR 1	2015	29	4					435	442		10.1089/end.2014.0509		8	Urology & Nephrology	Urology & Nephrology	CF1YD	WOS:000352343000013		
J	Hishikari, K; Hikita, H; Sugiyama, T; Oumi, T; Kimura, S; Takahashi, A; Isobe, M				Hishikari, Keiichi; Hikita, Hiroyuki; Sugiyama, Tomoyo; Oumi, Tetsuo; Kimura, Shigeki; Takahashi, Atsushi; Isobe, Mitsuaki			Intravenous Intravascular Ultrasound Using the AcuNav Ultrasound Catheter for Guiding Recanalization of Aortoiliac Chronic Total Occlusions	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						AcuNav ultrasound catheter; chronic total occlusion; endovascular therapy; intravenous intravascular ultrasound imaging; peripheral artery disease	GUIDED BALLOON ANGIOPLASTY; ARTERIAL VISUALIZATION		[Hishikari, Keiichi; Hikita, Hiroyuki; Sugiyama, Tomoyo; Oumi, Tetsuo; Kimura, Shigeki; Takahashi, Atsushi] Yokosuka Kyosai Hosp, Yokosuka, Kanagawa, Japan; [Hishikari, Keiichi; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Tokyo, Japan	Hikita, H (reprint author), Yokosuka Kyosai Hosp, Ctr Cardiovasc, 1-16 Yonegahama Dori, Yokosuka, Kanagawa, Japan.	hihikita2000@yahoo.co.jp					Al-Ameri H, 2009, J INVASIVE CARDIOL, V21, P468; Gallagher KA, 2011, J ENDOVASC THER, V18, P624, DOI 10.1583/11-3539.1; Ascher E, 2005, J VASC SURG, V42, P1114, DOI 10.1016/j.jvs.2005.08.025; Ascher E, 2008, J CARDIOVASC SURG, V49, P151; Beebe HG, 1998, J ENDOVASC SURG, V5, P101, DOI 10.1583/1074-6218(1998)005<0101:BCFDII>2.0.CO;2; CLULEY SR, 1993, J VASC SURG, V17, P23; CLULEY SR, 1991, AM J SURG, V162, P117, DOI 10.1016/0002-9610(91)90171-9; Gandini R, 2009, J ENDOVASC THER, V16, P23, DOI 10.1583/08-2520.1; Katzenschlager R, 1996, RADIOLOGY, V199, P331; Kawarada O, 2005, CATHETER CARDIO INTE, V65, P187, DOI 10.1002/ccd.20368; Kawarada O, 2010, J VASC SURG, V52, P475, DOI 10.1016/j.jvs.2010.03.025; Kriegel AV, 1996, J ENDOVASC SURG, V3, P429, DOI 10.1583/1074-6218(1996)003<0429:IIUFAV>2.0.CO;2; Reid DB, 1996, J ENDOVASC SURG, V3, P435, DOI 10.1583/1074-6218(1996)003<0435:IIRWAV>2.0.CO;2	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	APR	2015	22	2					269	271		10.1177/1526602815575486		3	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CE6OQ	WOS:000351958000023		
J	Gramlich-Oka, B				Gramlich-Oka, Bettina			Mabiki: Infanticide and Population Growth in Eastern Japan, 1660-1950	JOURNAL OF FAMILY HISTORY			English	Book Review									[Gramlich-Oka, Bettina] Sophia Univ, Tokyo 102, Japan	Gramlich-Oka, B (reprint author), Sophia Univ, Tokyo 102, Japan.						Akira Hayami, 2010, POPULATION FAMILY EA, P10; Akira Hayami, 1988, JAPAN TRANSITION, P315; Cullen Louis, 2006, JAPAN REV, V18, P129; Drixler F, 2013, ASIA-LOCAL STUD GLOB, V25, P1; Droppers Garrett, 1894, T ASIATIC SOC JAPAN, Vxxii, p[258, 280]; Osamu Saito, 1992, JAPAN FORUM, V4, p[369, 379], DOI 10.1080/09555809208721469	6	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-1990	1552-5473		J FAM HIST	J. Fam. Hist.	APR	2015	40	2					250	252		10.1177/0363199015572307		3	Anthropology; Family Studies; History; History Of Social Sciences	Anthropology; Family Studies; History; Social Sciences - Other Topics	CE3UM	WOS:000351754800007		
J	Toffoli, A; Waseda, T; Houtani, H; Cavaleri, L; Greaves, D; Onorato, M				Toffoli, A.; Waseda, T.; Houtani, H.; Cavaleri, L.; Greaves, D.; Onorato, M.			Rogue waves in opposing currents: an experimental study on deterministic and stochastic wave trains	JOURNAL OF FLUID MECHANICS			English	Article						ocean processes; surface gravity waves	NONLINEAR SCHRODINGER-EQUATION; SURFACE GRAVITY-WAVES; FREAK-WAVES; LABORATORY OBSERVATIONS; NONUNIFORM CURRENT; EVOLUTION; INSTABILITY; MODULATION; SEA	Interaction with an opposing current amplifies wave modulation and accelerates nonlinear wave focusing in regular wavepackets. This results in large-amplitude waves, usually known as rogue waves, even if the wave conditions are less prone to extremes. Laboratory experiments in three independent facilities are presented here to assess the role of opposing currents in changing the statistical properties of unidirectional and directional mechanically generated random wavefields. The results demonstrate in a consistent and robust manner that opposing currents induce a sharp and rapid transition from weakly to strongly non-Gaussian properties. This is associated with a substantial increase in the probability of occurrence of rogue waves for unidirectional and directional sea states, for which the occurrence of extreme and rogue waves is normally the least expected.	[Toffoli, A.] Swinburne Univ Technol, Ctr Ocean Engn Sci & Technol, Hawthorn, Vic 3122, Australia; [Waseda, T.; Houtani, H.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan; [Houtani, H.] Natl Maritime Res Inst, Mitaka, Tokyo 1810004, Japan; [Cavaleri, L.] Inst Marine Sci, I-30122 Venice, Italy; [Greaves, D.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Onorato, M.] Univ Turin, Dept Phys, I-10125 Turin, Italy; [Onorato, M.] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy	Toffoli, A (reprint author), Swinburne Univ Technol, Ctr Ocean Engn Sci & Technol, POB 218, Hawthorn, Vic 3122, Australia.	toffoli.alessandro@gmail.com	Onorato, Miguel/G-7104-2012; 	Onorato, Miguel/0000-0001-9141-2147; Toffoli, Alessandro/0000-0003-3112-6856	JSPS Fellowship for Research in Japan Program; JSPS; International Science Linkages (ISL) Program of the Australian Academy of Science; EU [FP7-SPACE-2011-1/CP-FP]; JSPS KAKENHI; VDRS grant from Swinburne University of Technology; MIUR [PRIN 2012BFNWZ2]; ONR [N000141010991]	The experiments were supported by the JSPS Fellowship for Research in Japan Program, Grants-in-Aid for Scientific Research of the JSPS and the International Science Linkages (ISL) Program of the Australian Academy of Science. L.C. has contributed under the EU-funded My Wave FP7-SPACE-2011-1/CP-FP project. A.T. and D.G. acknowledge Dr K. Collins and Dr M. Hann for providing velocity measurements in the wave flume and ocean wave basin at Plymouth University. T.W. was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research and Grant-in-Aid for Young Scientists. M.O. and A.T. acknowledge the VDRS grant from Swinburne University of Technology. M.O. was supported by MIUR Grant PRIN 2012BFNWZ2 and ONR grant N000141010991. M.O. also acknowledges Dr B. GiuliNico for interesting discussions.	Akhmediev N, 2009, PHYS LETT A, V373, P2137, DOI 10.1016/j.physleta.2009.04.023; Shrira VI, 2010, J ENG MATH, V67, P11, DOI 10.1007/s10665-009-9347-2; Hjelmervik KB, 2009, J FLUID MECH, V637, P267, DOI 10.1017/S0022112009990607; Onorato M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.184502; Onorato M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.114502; Mori N, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004024; Toffoli A, 2005, APPL OCEAN RES, V27, P281, DOI 10.1016/j-apor.2006.03.003; Janssen PAEM, 2003, J PHYS OCEANOGR, V33, P863, DOI 10.1175/1520-0485(2003)33<863:NFIAFW>2.0.CO;2; Zakharov VE, 2009, PHYSICA D, V238, P540, DOI 10.1016/j.physd.2008.12.002; AKHMEDIEV NN, 1987, THEOR MATH PHYS+, V72, P809, DOI 10.1007/BF01017105; SMITH R, 1976, J FLUID MECH, V77, P417, DOI 10.1017/S002211207600219X; Lavrenov IV, 1998, NAT HAZARDS, V17, P117, DOI 10.1023/A:1007978326982; Onorato M, 2006, EUR J MECH B-FLUID, V25, P586, DOI 10.1016/j.euromechflu.2006.01.002; Waseda T, 2009, J PHYS OCEANOGR, V39, P621, DOI 10.1175/2008JPO4031.1; Onorato M, 2001, PHYS REV LETT, V86, P5831, DOI 10.1103/PhysRevLett.86.5831; Ma Y, 2010, J FLUID MECH, V661, P108, DOI 10.1017/S0022112010002880; Chabchoub A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.204502; LONGUETHIGGINS MS, 1961, J FLUID MECH, V10, P529, DOI 10.1017/S0022112061000342; Babanin A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029135; Dias F, 1999, ANNU REV FLUID MECH, V31, P301, DOI 10.1146/annurev.fluid.31.1.301; Tulin MP, 1999, J FLUID MECH, V378, P197, DOI 10.1017/S0022112098003255; Toffoli A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.051201; Dysthe KB, 2003, J FLUID MECH, V478, P1, DOI 10.1017/S0022112002002616; Onorato M, 2009, J FLUID MECH, V627, P235, DOI 10.1017/S002211200900603X; Onorato M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.067302; Socquet-Juglard H, 2005, J FLUID MECH, V542, P195, DOI 10.1017/S0022112005006312; White BS, 1998, J FLUID MECH, V355, P113, DOI 10.1017/S0022112097007751; Chabchoub A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056601; Chawla A., 2000, THESIS U DELAWARE US; GERBER M, 1987, J FLUID MECH, V176, P311, DOI 10.1017/S0022112087000697; Hauser D., 2005, MEASURING ANAL DIREC; Johnson R.S., 1997, MODERN INTRO MATH TH; Kharif C, 2009, ADV GEOPHYS ENV MECH, P1, DOI 10.1007/978-3-540-88419-4_1; Kirby J.T., 2002, J GEOPHYS RES, V107, P4; Komen G.J., 1994, DYNAMICS MODELING OC; LAI RJ, 1989, J GEOPHYS RES-OCEANS, V94, P16201, DOI 10.1029/JC094iC11p16201; Lavrenov IV, 2006, EUR J MECH B-FLUID, V25, P574, DOI [10.1016/j.euromechflu.2006.02.009, 10.1016/j.euromechflu.2006.02-009]; Ma YX, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4832715; Moreira RM, 2012, J FLUID MECH, V691, P1, DOI 10.1017/jfm.2011.436; Ochi MK, 1998, OCEAN WAVES STOCHAST; Stocker JR, 1999, J FLUID MECH, V399, P335, DOI 10.1017/S0022112099006618; Peregrine D. H., 1976, ADV APPL MECH, P9; Ruban VP, 2012, JETP LETT+, V95, P486, DOI 10.1134/S002136401209010X; Shrira VI, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.041002; Suastika I. K., 2004, THESIS TU DELFT NETH; Thomas R, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4768530; Toffoli A., 2011, NAT HAZARD EARTH SYS, V11, P1; Dysthe KB, 1999, PHYS SCRIPTA, VT82, P48, DOI 10.1238/Physica.Topical.082a00048; Waseda T., 2005, P 15 ISOPE SEOUL KOR, P19; Yuen H. C., 1982, ADV APPL MECH, V22, P20	50	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	APR	2015	769						277	297		10.1017/jfm.2015.132		21	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CE5JP	WOS:000351869100014		
J	Zhang, W; Li, W; Nakayama, A				Zhang, W.; Li, W.; Nakayama, A.			An analytical consideration of steady-state forced convection within a nanofluid-saturated metal foam	JOURNAL OF FLUID MECHANICS			English	Article						convection; convection in porous media	EFFECTIVE THERMAL-CONDUCTIVITY; HEAT-TRANSFER; POROUS-MEDIA; FLUID-FLOW; MACRODISPERSION; DISPERSION; TRANSPORT	An analytical consideration has been made to explore the velocity, temperature and nanoparticle distributions and heat transfer characteristics associated with thermal dispersion and nanoparticle mechanical dispersion within a nanofluid-saturated homogeneous metal foam. A volume-averaging theory was rigorously applied to integrate locally a set of governing equations based on the modified Buongiorno model at the pore scale. Thus, a macroscopic set of volume-averaged governing equations were derived allowing interstitial heat transfer between the nanofluid and metal phases. Unknown terms were modelled mathematically to obtain a closed set of volume-averaged governing equations. Subsequently, a pore-scale analysis was carried out to find possible functional forms for describing thermal dispersion and nanoparticle mechanical dispersion in a nanofluid-saturated metal foam. Using the resulting set of volume-averaged governing equations, forced convective flows in nanofluid-saturated metal foams were analytically investigated for the steady-state case. Eventually, it has been predicted that an unconventionally high level of the heat transfer rate (about 80 times more than the case of base fluid convection without a metal foam) may be achieved by combination of metal foam and nanofluid.	[Zhang, W.; Li, W.; Nakayama, A.] Shizuoka Univ, Dept Mech Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Nakayama, A.] Wuhan Polytech Univ, Sch Civil Engn & Architecture, Wuhan 430023, Hubei, Peoples R China	Nakayama, A (reprint author), Shizuoka Univ, Dept Mech Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	tmanaka@ipc.shizuoka.ac.jp					GELHAR LW, 1983, WATER RESOUR RES, V19, P161, DOI 10.1029/WR019i001p00161; Bianco V, 2009, APPL THERM ENG, V29, P3632, DOI 10.1016/j.applthermaleng.2009.06.019; Lee S, 1999, J HEAT TRANS-T ASME, V121, P280, DOI 10.1115/1.2825978; Nakayama A, 2004, J FLUID MECH, V498, P139, DOI 10.1017/S0022112003006712; Heris SZ, 2007, INT J HEAT FLUID FL, V28, P203, DOI 10.1016/j.ijheatfluidflow.2006.05.001; Calmidi VV, 1999, J HEAT TRANS-T ASME, V121, P466, DOI 10.1115/1.2826001; Pak BC, 1998, EXP HEAT TRANSFER, V11, P151, DOI 10.1080/08916159808946559; Yang C, 2013, INT J THERM SCI, V71, P249, DOI 10.1016/j.ijthermalsci.2013.04.007; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Maiga SE, 2005, INT J HEAT FLUID FL, V26, P530, DOI 10.1016/j.ijheatfluidflow.2005.02.004; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; Nakayama A, 2009, HEAT MASS TRANSFER, V45, P1365, DOI 10.1007/s00231-009-0513-x; Yang C, 2011, TRANSPORT POROUS MED, V89, P237, DOI 10.1007/s11242-011-9766-1; Wang J, 1999, STOCH ENV RES RISK A, V13, P66, DOI 10.1007/s004770050032; Yang C, 2010, INT J HEAT MASS TRAN, V53, P3222, DOI 10.1016/j.ijheatmasstransfer.2010.03.004; Nakayama A, 2006, J FLUID MECH, V563, P81, DOI 10.1017/S0022112006001078; Calmidi VV, 2000, J HEAT TRANS-T ASME, V122, P557, DOI 10.1115/1.1287793; Cheng P, 1978, ADV HEAT TRANSFER, V14, P1; Chien R., 2007, INT J THERM SCI, V46, P57; Choi S. U. S., 1996, INT MECH ENG C EXH A, P1; Dukhan N, 2013, METAL FOAMS FUNDAMEN; Fried J.J., 1971, ADV HYDROSCI, V7, P169; Kuwahara F, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4004354; Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, DOI 10.1016/0045-7825(74)90029-2; Li W., 2015, J THERMOPHY IN PRESS, V29; LIANG CY, 1975, J HEAT TRANS-T ASME, V97, P16; Nakayama A., 1995, PC AIDED NUMERICAL H, p[49, 103]; Ohsawa S., 2015, THESIS SHIZUOKA U JA; QUINTARD M, 1995, INT J HEAT MASS TRAN, V38, P2779, DOI 10.1016/0017-9310(95)00028-8; Quintard M., 1993, ADV HEAT TRANSFER, V23, P369, DOI 10.1016/S0065-2717(08)70009-1; Sakai F., 2014, P INT HEAT TRANSF C; TAYLOR G, 1954, PROC R SOC LON SER-A, V223, P446, DOI 10.1098/rspa.1954.0130; Xuan YM, 2000, INT J HEAT MASS TRAN, V43, P3701, DOI 10.1016/S0017-9310(99)00369-5; Yang C., 2009, OPEN TRANSPORT PHENO, V1, P1; Yang C, 2013, J HEAT TRANS-T ASME, V135, DOI 10.1115/1.4023539; Zhukauskas A., 1987, ADV HEAT TRANSFER, V18, P87	36	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	APR	2015	769						590	620		10.1017/jfm.2015.131		31	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CE5JP	WOS:000351869100025		
J	Kataoka, T; Akylas, TR				Kataoka, T.; Akylas, T. R.			On three-dimensional internal gravity wave beams and induced large-scale mean flows	JOURNAL OF FLUID MECHANICS			English	Article						geophysical and geological flows; internal waves	INSTABILITY	The three-dimensional propagation of internal gravity wave beams in a uniformly stratified Boussinesq fluid is discussed, assuming that variations in the along-beam and transverse directions are of long length scale relative to the beam width. This situation applies, for instance, to the far-field behaviour of a wave beam generated by a horizontal line source with weak transverse dependence. In contrast to the two-dimensional case of purely along-beam variations, where nonlinear effects are minor even for beams of finite amplitude, three-dimensional nonlinear interactions trigger the transfer of energy to a circulating horizontal time-mean flow. This resonant beam mean-flow coupling is analysed, and a system of two evolution equations is derived for the propagation of a small-amplitude beam along with the induced mean flow. This model explains the salient features of the experimental observations of Bordes et al. (Phys. Fluids, vol. 24, 2012, 086602).	[Kataoka, T.] Kobe Univ, Grad Sch Engn, Dept Mech Engn, Kobe, Hyogo 6578501, Japan; [Akylas, T. R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Akylas, TR (reprint author), MIT, Dept Mech Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	trakylas@mit.edu			US National Science Foundation [DMS-1107335]	This work was supported in part by the US National Science Foundation under grant DMS-1107335.	Koudella CR, 2006, J FLUID MECH, V548, P165, DOI 10.1017/S0022112005007524; Staquet C, 2002, ANNU REV FLUID MECH, V34, P559, DOI 10.1146/annurev.fluid.34.090601.130953; Mercier MJ, 2010, J FLUID MECH, V657, P308, DOI 10.1017/S0022112010002454; Gostiaux L, 2007, EXP FLUIDS, V42, P123, DOI 10.1007/s00348-006-0225-7; MOWBRAY DE, 1967, J FLUID MECH, V28, P1, DOI 10.1017/S0022112067001867; THOMAS NH, 1972, J FLUID MECH, V54, P495, DOI 10.1017/S0022112072000837; Bordes G, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4745880; Grisouarda N, 2013, PROC IUTAM, V8, P119, DOI 10.1016/j.piutam.2013.04.016; Grisouard N, 2012, J FLUID MECH, V708, P250, DOI 10.1017/jfm.2012.303; Karimi HH, 2014, J FLUID MECH, V757, P381, DOI 10.1017/jfm.2014.509; Kataoka T, 2013, J FLUID MECH, V736, P67, DOI 10.1017/jfm.2013.527; Lighthill M. J., 1978, WAVES FLUIDS; Lighthill M. J., 1996, DYNAM ATMOS OCEANS, V23, P3; McEwan A. D., 1973, Boundary-Layer Meteorology, V5, DOI 10.1007/BF02188317; Tabaei A, 2003, J FLUID MECH, V482, P141, DOI 10.1017/S0022112003003902; Tabaei A, 2007, STUD APPL MATH, V119, P271, DOI 10.1111/j.1467-9590.2007.00389.x	16	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	APR	2015	769						621	634		10.1017/jfm.2015.143		14	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CE5JP	WOS:000351869100026		
J	Nagai, T; Tanoue, Y; Kai, N; Suzuki, N				Nagai, Takeshi; Tanoue, Yasuhiro; Kai, Norihisa; Suzuki, Nobutaka			Characterization of collagen from emu (Dromaius novaehollandiae) skins	JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE			English	Article						Alternative source of collagen; By-product; Collagen; Emu; Skin	ACID-SOLUBLE COLLAGEN; OUTER SKIN; WASTE MATERIAL; SPECTROSCOPY; GELATIN; BONE	Collagen from emu skins as a by-product was prepared. The skins were hardly solubilized in acetic acid, however were successfully solubilized on digestion with 10% pepsin (w/w) for 4 days. The yield of pepsin-solubilized collagen (PSC) was about 27.3 %, on a raw weight basis. By SDS-PAGE and CM-Toyopearl 650 M column chromatography, the presence of a fourth subunit that was previously designated alpha 4 was confirmed. The denaturation temperature of the PSC was 31.5 degrees C, about 6-7 degrees C lower than that from the porcine skins. ATR-FTIR analysis indicated that the helical arrangements of the PSC from emu skins existed and its structures of PSC were changed slightly due to the loss of N- and C-terminus domains in similar to that from the porcine skins. That is, the PSC from emu skins did not possess telopeptide chains as major portion of antigenic sites in collagen. The present study indicates that a large quantity of emu skins as by-products have potential as a good alternative source of high-quality collagen for industrial purposes in the foods, cosmetics, and pharmaceutical and biomedical fields.	[Nagai, Takeshi] Yamagata Univ, Grad Sch Agr Sci, Tsuruoka, Yamagata 9978555, Japan; [Nagai, Takeshi] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Nagai, Takeshi] Prince Songkla Univ, Grad Sch, Hat Yai 90112, Thailand; [Tanoue, Yasuhiro; Kai, Norihisa] Natl Fisheries Univ, Shimonoseki, Yamaguchi 7596595, Japan; [Suzuki, Nobutaka] Nagoya Res Inst, Nagoya, Aichi 4701131, Japan	Nagai, T (reprint author), Yamagata Univ, Grad Sch Agr Sci, Tsuruoka, Yamagata 9978555, Japan.	tnagai@tds1.tr.yamagata-u.ac.jp					Zhang M, 2009, FOOD CHEM, V115, P826, DOI 10.1016/j.foodchem.2009.01.006; Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006; Liu H, 2007, FOOD CHEM, V101, P621, DOI 10.1016/j.foodchem.2006.01.059; Zhang Y, 2007, FOOD CHEM, V103, P906, DOI 10.1016/j.foodchem.2006.09.053; Nagai T, 2008, FOOD CHEM, V111, P296, DOI 10.1016/j.foodchem.2008.03.087; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505; Nagai T, 2002, FOOD CHEM, V76, P149, DOI 10.1016/S0308-8146(01)00255-2; Li H, 2004, FOOD CHEM, V84, P65, DOI 10.1016/S0308-8146(03)00167-5; Nagai T, 2002, FOOD CHEM, V78, P173, DOI 10.1016/S0308-8146(01)00396-X; Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8; Singh P, 2011, FOOD CHEM, V124, P97, DOI 10.1016/j.foodchem.2010.05.111; PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105; Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0; Senaratne LS, 2006, BIORESOURCE TECHNOL, V97, P191, DOI 10.1016/j.biortech.2005.02.024; Nagai T, 1999, J SCI FOOD AGR, V79, P855, DOI 10.1002/(SICI)1097-0010(19990501)79:6<855::AID-JSFA299>3.3.CO;2-E; Zhang ZK, 2006, J SOC LEATH TECH CH, V90, P23; Cliche S, 2003, POULTRY SCI, V82, P503; Jaroenviriyapap T., 2009, Asian Journal of Food and Agro-Industry, V2, P974; Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026; KIMURA S, 1987, COMP BIOCHEM PHYS B, V88, P27, DOI 10.1016/0305-0491(87)90074-5; Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042; Nagai T, 2000, FOOD CHEM, V70, P205, DOI 10.1016/S0308-8146(00)00081-9; Nagai T, 2004, Z NATURFORSCH C, V59, P271; Nagai T, 2011, FOOD NUTR SCI, V1, P59; Nagai T, 2001, FOOD CHEM, V72, P425, DOI 10.1016/S0308-8146(00)00249-1; Owusu-Apenten RK, 2002, FOOD PROTEIN ANAL QU, P1; Sarver Jr RW, 1991, ANAL BIOCHEM, V194, P39; Shao CH, 1999, J FOOD SCI, V64, P1052, DOI 10.1111/j.1365-2621.1999.tb12280.x; Snowden J. M., 1997, Inflammopharmacology, V5, P127, DOI 10.1007/s10787-997-0021-x; Wang L, 2007, J FOOD SCI, V72, pE450, DOI 10.1111/j.1750-3841.2007.00478.x	31	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0022-1155	0975-8402		J FOOD SCI TECH MYS	J. Food Sci. Technol.-Mysore	APR	2015	52	4					2344	2351		10.1007/s13197-014-1266-1		8	Food Science & Technology	Food Science & Technology	CE5LU	WOS:000351877700052		
J	Erihemu; Hironaka, K; Koaze, H; Oda, Y; Shimada, K				Erihemu; Hironaka, Kazunori; Koaze, Hiroshi; Oda, Yuji; Shimada, Kenichiro			Zinc enrichment of whole potato tuber by vacuum impregnation	JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE			English	Article						Whole potatoes; Vacuum impregnation; Zinc enrichment; Steam-cooking; Storage	FUNCTIONAL FOOD TRENDS; OSMOTIC DEHYDRATION; RESPIRATION RATE; TEMPERATURE; VEGETABLES; FRUITS	Zinc is a nutritionally essential truce element, and thus zinc deficiency (ZD) severely affects human health. More than 25% of the world's population is at risk of ZD. This study was initiated to examine the use of the vacuum impregnation (VI) technique for enriching zinc content of whole potatoes; the effect of vacuum time, restoration time, steam-cooking and storage at 4 degrees C on the zinc content of VI whole potatoes was evaluated. Whole potato tubers were immersed in a 9 g/100 g zinc (zinc gluconate) solution. Vacuum pressure of 1, 000 Pa was applied for 0-120 min, and atmospheric pressure restoration for 0-4 h. Experimental results showed that the zinc content of VI potatoes increased with vacuum and restoration time. Moreover, VI-cooked unpeeled or peeled potatoes had 63-94 times and 47-75 times higher zinc contents than un-VI-cooked unpeeled or peeled potatoes, respectively. The world daily potato consumption (86 g) of the VI-cooked unpeeled and peeled potatoes provided adult men with 130-148% and 100-135% of the recommended daily allowance (RDA) of zinc, respectively. Also, the daily potato consumption of the unpeeled and peeled potatoes supplied adult women with 178-203% and 137-185% of the RDA level, respectively. In addition, the VI potatoes had 40 times higher zinc contents through 30 days of storage at 4 degrees C, compared with un-VI-treated potatoes. This study indicated that VI treatment of whole potatoes was useful for enriching the zinc content.	[Erihemu; Koaze, Hiroshi; Oda, Yuji; Shimada, Kenichiro] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan; [Hironaka, Kazunori] Univ Ryukyus, Dept Reg Agr Engn, Nishihara, Okinawa 9030213, Japan	Hironaka, K (reprint author), Univ Ryukyus, Dept Reg Agr Engn, Nishihara, Okinawa 9030213, Japan.	kazuhiro@agr.u-ryukyu.ac.jp					Abong G. O., 2009, Journal of Animal and Plant Sciences (JAPS), V2, P76; Aguilera JM, 1990, MICROSTRUCTURAL PRIN; Alzamora SM, 2000, TRENDS FOOD ENG, P205; Hironaka K, 2011, FOOD CHEM, V127, P1114, DOI 10.1016/j.foodchem.2011.01.111; Salvatori D, 1998, J FOOD PROCESS ENG, V21, P59, DOI 10.1111/j.1745-4530.1998.tb00439.x; Faller ALK, 2009, FOOD RES INT, V42, P210, DOI 10.1016/j.foodres.2008.10.009; Chan S, 1998, CLIN LAB MED, V18, P673; Tompkins TA, 2007, BIOL TRACE ELEM RES, V120, P28, DOI 10.1007/s12011-007-0072-2; Mujica-Paz H, 2003, J FOOD ENG, V57, P305, DOI 10.1016/S0260-8774(02)00344-8; Zhao YY, 2004, TRENDS FOOD SCI TECH, V15, P434, DOI 10.1016/j.rifs.2004.01.008; FITO P, 1994, J FOOD ENG, V22, P313, DOI 10.1016/0260-8774(94)90037-X; Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Murniece I, 2011, J FOOD COMPOS ANAL, V24, P699, DOI 10.1016/j.jfca.2010.09.005; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P494, DOI 10.1016/j.jfca.2009.09.001; Sun DW, 2003, J FOOD ENG, V57, P337, DOI 10.1016/S0260-8774(02)00354-0; Menrad K, 2003, J FOOD ENG, V56, P181, DOI 10.1016/S0260-8774(02)00247-9; Chiralt A, 2001, J FOOD ENG, V49, P141, DOI 10.1016/S0260-8774(00)00219-3; AOAC, 1970, OFF METH AN ASS OFF, V11<SUP>th</SUP>; Bistrom M, 2002, TRENDS FOOD SCI TECH, V13, P372, DOI 10.1016/S0924-2244(02)00187-5; Burgos G, 2009, J FOOD COMPOS ANAL, V22, P533, DOI 10.1016/j.jfca.2008.05.013; Castro L, 2001, NUTRITION, V17, p[161, 163]; Chiralt A, 1999, FOOD ENGN MFG, P341; Chiralt A, 1997, FOOD ENG 2000, P214; Fito P, 1997, FOOD ENG 2000, P231; Fito P, 1996, J FOOD ENG, V27, P229, DOI 10.1016/0260-8774(95)00005-4; Fito P, 2000, MINIMALLY PROCESSED, P185; Fito P, 2000, TRENDS FOOD ENG, P149; [Food and Nutrition Board (FNB) Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes], 2001, STAND COMM SCI EV DI, P422; Gonzalez C, 1999, INT DAIRY J, V9, P143, DOI 10.1016/S0958-6946(99)00035-7; Gras M., 2002, Innovative Food Science & Emerging Technologies, V3, P263, DOI 10.1016/S1466-8564(02)00032-2; Gras ML, 2003, J FOOD ENG, V56, P279, DOI 10.1016/S0260-8774(02)00269-8; Igual M, 2008, J FOOD ENG, V86, P315, DOI 10.1016/j.jfoodeng.2007.06.002; International Year of Potato (IYP), 2008, IYP POT NUTR DIET; Mazza G., 1998, FUNCTIONAL FOODS BIO, P460; Menrad M, 2000, 372000 TA; MONDY NI, 1992, FOOD RES INT, V25, P375, DOI 10.1016/0963-9969(92)90112-I; Peterson RL, 1985, POTATO PHSYL; Ruerez P, 2002, FOOD CHEM, V79, P23; Sanzana S, 2011, PROC FOOD SCI, V1, P1528, DOI 10.1016/j.profoo.2011.09.227; Sibbel A, 2007, SOC SCI MED, V64, P554, DOI 10.1016/j.socscimed.006.08.042; Sloan AE, 2000, FOOD TECHNOL-CHICAGO, V54, P33; Sloan AE, 2002, FOOD TECHNOL-CHICAGO, V56, P32; Sormani A, 1999, FOOD SCI TECHNOL INT, V5, P479, DOI 10.1177/108201329900500605; Stauffer JE, 1999, CEREAL FOOD WORLD, V44, P115; Tapia MS, 1999, FOOD SCI TECHNOLOGY, V1, P43; WEAVER ML, 1983, AM POTATO J, V60, P735, DOI 10.1007/BF02856893; Whittaker P, 1998, AM J CLIN NUTR, V68, p442S; Wustman R., 2007, Potato Research, V50, P351, DOI 10.1007/s11540-008-9079-0	49	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0022-1155	0975-8402		J FOOD SCI TECH MYS	J. Food Sci. Technol.-Mysore	APR	2015	52	4					2352	2358		10.1007/s13197-013-1194-5		7	Food Science & Technology	Food Science & Technology	CE5LU	WOS:000351877700053		
J	Berthier, C; Kutchukian, C; Bouvard, C; Okamura, Y; Jacquemond, V				Berthier, Christine; Kutchukian, Candice; Bouvard, Clement; Okamura, Yasushi; Jacquemond, Vincent			Depression of voltage-activated Ca2+ release in skeletal muscle by activation of a voltage-sensing phosphatase	JOURNAL OF GENERAL PHYSIOLOGY			English	Article							SARCOPLASMIC-RETICULUM; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CALCIUM-RELEASE; RYANODINE RECEPTOR; CHARGE MOVEMENT; FIBERS; MEMBRANE; MOUSE; PHOSPHOINOSITIDES; MYOTUBULARIN	Phosphoinositides act as signaling molecules in numerous cellular transduction processes, and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5) P-2) regulates the function of several types of plasma membrane ion channels. We investigated the potential role of PtdIns(4,5) P-2 in Ca2+ homeostasis and excitation-contraction (E-C) coupling of mouse muscle fibers using in vivo expression of the voltage-sensing phosphatases (VSPs) Ciona intestinalis VSP (Ci-VSP) or Danio rerio VSP (Dr-VSP). Confocal images of enhanced green fluorescent protein-tagged Dr-VSP revealed a banded pattern consistent with VSP localization within the transverse tubule membrane. Rhod-2 Ca2+ transients generated by 0.5-s-long voltage-clamp depolarizing pulses sufficient to elicit Ca2+ release from the sarcoplasmic reticulum (SR) but below the range at which VSPs are activated were unaffected by the presence of the VSPs. However, in Ci-VSP-expressing fibers challenged by 5-s-long depolarizing pulses, the Ca2+ level late in the pulse (3 s after initiation) was significantly lower at 120 mV than at 20 mV. Furthermore, Ci-VSP-expressing fibers showed a reversible depression of Ca2+ release during trains, with the peak Ca2+ transient being reduced by similar to 30% after the application of 10 200-ms-long pulses to 100 mV. A similar depression was observed in Dr-VSP-expressing fibers. Cav1.1 Ca2+ channel-mediated current was unaffected by Ci-VSP activation. In fibers expressing Ci-VSP and a pleckstrin homology domain fused with monomeric red fluorescent protein (PLC delta 1PH-mRFP), depolarizing pulses elicited transient changes in mRFP fluorescence consistent with release of transverse tubule-bound PLC delta 1PH domain into the cytosol; the voltage sensitivity of these changes was consistent with that of Ci-VSP activation, and recovery occurred with a time constant in the 10-s range. Our results indicate that the PtdIns(4,5) P-2 level is tightly maintained in the transverse tubule membrane of the muscle fibers, and that VSP-induced depletion of PtdIns(4,5) P-2 impairs voltage-activated Ca2+ release from the SR. Because Ca2+ release is thought to be independent from InsP(3) signaling, the effect likely results from an interaction between PtdIns(4,5) P-2 and a protein partner of the E-C coupling machinery.	[Berthier, Christine; Kutchukian, Candice; Bouvard, Clement; Jacquemond, Vincent] Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaire, Ctr Natl Rech Sci, UMR 5534, F-69100 Villeurbanne, France; [Okamura, Yasushi] Osaka Univ, Grad Sch Med, Lab Integrat Physiol, Suita, Osaka 5650871, Japan	Jacquemond, V (reprint author), Univ Lyon 1, Ctr Genet & Physiol Mol & Cellulaire, Ctr Natl Rech Sci, UMR 5534, F-69100 Villeurbanne, France.	vincent.jacquemond@univ-lyon1.fr			Centre National de la Recherche Scientifique; Universite Lyon 1; Association Francaise contre les Myopathies (AFM) [15677]	This work was supported by grants from Centre National de la Recherche Scientifique and Universite Lyon 1 to Centre de Genetique et de Physiologie Moleculaire et Cellulaire, and by a grant from Association Francaise contre les Myopathies to V. Jacquemond (AFM no. 15677).	Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Casas M, 2010, J GEN PHYSIOL, V136, P455, DOI 10.1085/jgp.200910397; Tjondrokoesoemo A, 2013, J BIOL CHEM, V288, P2103, DOI 10.1074/jbc.M112.425975; Blaauw B, 2012, J GEN PHYSIOL, V140, P235, DOI 10.1085/jgp.201110747; Jacquemond V, 1997, BIOPHYS J, V73, P920; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Dulhunty AF, 2006, CLIN EXP PHARMACOL P, V33, P763, DOI 10.1111/j.1440-1681.2006.04441.x; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Suh BC, 2012, P NATL ACAD SCI USA, V109, P3161, DOI 10.1073/pnas.1121434109; Jorquera G, 2013, J CELL SCI, V126, P1189, DOI 10.1242/jcs.116855; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Kurokawa T, 2012, P NATL ACAD SCI USA, V109, P10089, DOI 10.1073/pnas.1203799109; Collet C, 2003, BIOPHYS J, V84, P251; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Barrientos G, 2002, J MEMBRANE BIOL, V188, P163, DOI 10.1007/s00232-001-0179-x; CHU A, 1991, J BIOL CHEM, V266, P7699; Collet C, 2004, CELL BIOCHEM BIOPHYS, V40, P225, DOI 10.1385/CBB:40:2:225; FOSTER PS, 1994, INT J BIOCHEM, V26, P449, DOI 10.1016/0020-711X(94)90001-9; KOBAYASHI M, 1989, BIOCHEM BIOPH RES CO, V163, P1487, DOI 10.1016/0006-291X(89)91147-9; Lefebvre R, 2011, J PHYSIOL-LONDON, V589, P5361, DOI 10.1113/jphysiol.2011.216408; Lefebvre R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054042; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; LINDINGER MI, 1992, AM J PHYSIOL, V262, pR126; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; OGAWA Y, 1989, J BIOCHEM-TOKYO, V106, P864; Ohizumi Y, 1999, CAN J PHYSIOL PHARM, V77, P276, DOI 10.1139/cjpp-77-4-276; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; Pouvreau S, 2005, J PHYSIOL-LONDON, V567, P815, DOI 10.1113/jphysiol.2005.089599; RIOS E, 1992, ANNU REV PHYSIOL, V54, P109, DOI 10.1146/annurev.ph.54.030192.000545; Rodriguez EG, 2014, PFLUG ARCH EUR J PHY, V466, P973, DOI 10.1007/s00424-013-1346-5; Sakata S, 2011, J PHYSIOL-LONDON, V589, P2687, DOI 10.1113/jphysiol.2011.208165; Treves S, 2009, J PHYSIOL-LONDON, V587, P3071, DOI 10.1113/jphysiol.2009.171876; Weiss N, 2010, J PHYSIOL-LONDON, V588, P2945, DOI 10.1113/jphysiol.2010.191593; Yamaguchi S, 2014, J CELL PHYSIOL, V229, P422, DOI 10.1002/jcp.24463	42	3	3	ROCKEFELLER UNIV PRESS	NEW YORK	950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA	0022-1295	1540-7748		J GEN PHYSIOL	J. Gen. Physiol.	APR	2015	145	4					315	330		10.1085/jgp.201411309		16	Physiology	Physiology	CE6IH	WOS:000351939600006		
J	Hirase, T; Inokuchi, S; Matsusaka, N; Okita, M				Hirase, Tatsuya; Inokuchi, Shigeru; Matsusaka, Nobuou; Okita, Minoru			Effects of a Balance Training Program Using a Foam Rubber Pad in Community-Based Older Adults: A Randomized Controlled Trial	JOURNAL OF GERIATRIC PHYSICAL THERAPY			English	Article						balance; foam rubber; older adults; randomized controlled trial	WOMEN AGED 75; ELDERLY-PEOPLE; FALL RISK; POSTURAL REFLEXES; PREVENTING FALLS; TAI-CHI; EXERCISE; STRENGTH; FRAIL; RESISTANCE	Background and Purpose: Exercise programs aimed at improving balance are effective in fall prevention for older adults. Guidelines indicate that unstable elements should be integrated in balance training with this population. Balance training on an unstable surface facilitates proprioception mediated by skin receptors in the soles of the feet and by mechano-receptors in the joints and muscles. This randomized controlled trial examined whether balance training performed using a foam rubber pad was more beneficial than balance training performed on a stable flat surface in older adults. Methods: Older adults using Japanese community day centers once or twice per week were enrolled in this trial. In total, 93 participants were randomized to 1 of 3 groups: foam rubber exercise group (n = 32), stable surface exercise group (n = 31), and control group (n = 30). Participants in the foam rubber and stable surface exercise groups attended a 60-minute exercise class once a week for 4 months and followed a home-based exercise routine. Outcome measures were the following performance tests: the one-leg standing test (OLST), the chair standing test, the timed up-and-go test (TUGT), and the tandem-stance test (TST). These assessments were conducted before the intervention, and at 1, 2, 3, and 4 months after starting the intervention. Results: There were group x time interactions (P < 0.001) for all performance tests. The foam rubber exercise group showed significant improvements in the OLST, TST, and TUGT at 1 to 4 months compared with the control group (P < 0.02). The foam rubber exercise group also showed significant improvements in the OLST and TST at 2 and 3 months compared with the stable surface exercise group (P < 0.02). Within the foam rubber exercise group, the OLST, TUGT, and TST, at 1 to 4 months, were significantly improved compared with before the intervention (P < 0.01). Within the stable surface exercise group, the TUGT and TST, at 3 and 4 months, were significantly improved compared with before the intervention (P < 0.01). Conclusions: This study confirms that balance training in older adults performed using a foam rubber pad is effective for improving balance ability, and that this improvement occurs 2 months earlier compared with balance training performed on a stable surface. These findings suggest that balance training performed using a foam rubber pad is beneficial to clients and service providers because the programs improve physical functioning with a reduced number of exercise sessions.	[Hirase, Tatsuya; Okita, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Locomot Rehabil Sci, Unit Rehabil Sci, Nagasaki 8528520, Japan; [Inokuchi, Shigeru; Matsusaka, Nobuou] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hlth Sci, Nagasaki 8528520, Japan	Inokuchi, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Hlth Sci, 1-7-1 Sakamoto, Nagasaki 8528520, Japan.	shigeru@nagasaki-u.ac.jp					Seidler RD, 1997, GAIT POSTURE, V6, P224, DOI 10.1016/S0966-6362(97)00012-X; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Wu G, 1997, EXP BRAIN RES, V114, P163, DOI 10.1007/PL00005616; TINETTI ME, 1994, J GERONTOL, V49, pM140; HOFFMAN MA, 1995, BRAIN RES, V700, P303, DOI 10.1016/0006-8993(95)01082-7; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Granacher U, 2011, SPORTS MED, V41, P377, DOI 10.2165/11539920-000000000-00000; McIlroy WE, 2003, BRAIN RES, V961, P73, DOI 10.1016/S0006-8993(02)03845-3; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218; Taylor-Piliae RE, 2006, ALTERN THER HEALTH M, V12, P50; Gardner MM, 2000, BRIT J SPORT MED, V34, P7, DOI 10.1136/bjsm.34.1.7; Madureira MM, 2007, OSTEOPOROSIS INT, V18, P419, DOI 10.1007/s00198-006-0252-5; Vellas BJ, 1997, J AM GERIATR SOC, V45, P735; Cyarto EV, 2008, GERONTOLOGY, V54, P272, DOI 10.1159/000155653; Doig GS, 2005, J CRIT CARE, V20, P187, DOI 10.1016/j.crc.2005.04.005; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Hess JA, 2005, J MANIP PHYSIOL THER, V28, P582, DOI 10.1016/j.jmpt.2005.08.013; Taaffe DR, 1999, J AM GERIATR SOC, V47, P1208; Rubenstein LZ, 2006, MED CLIN N AM, V90, P807, DOI 10.1016/j.mcna.2006.05.013; Audette JF, 2006, AGE AGEING, V35, P388, DOI 10.1093/ageing/afl006; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Bernier JN, 1998, J ORTHOP SPORT PHYS, V27, P264; Cho BL, 2004, J AM GERIATR SOC, V52, P1168, DOI 10.1111/j.1532-5415.2004.52317.x; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Inokuchi S, 2007, J REHABIL MED, V39, P479, DOI 10.2340/16501977-0080; Chalmers GR, 2002, J GERONTOL A-BIOL, V57, pB321; De Amici D, 2000, CONTROL CLIN TRIALS, V21, P103, DOI 10.1016/S0197-2456(99)00054-9; Demura S, 2012, ARCH GERONTOL GERIAT, V54, P370, DOI 10.1016/j.archger.2011.04.010; Earles DR, 2000, INT J NEUROSCI, V105, P1, DOI 10.3109/00207450009003261; Gardner MM, 2001, AGE AGEING, V30, P77, DOI 10.1093/ageing/30.1.77; Granacher U, 2006, GAIT POSTURE, V24, P459, DOI 10.1016/j.gaitpost.2005.12.007; Hitkamp HC, 2001, INT J SPORTS MED, V22, P285; Inokuchi S, 2003, RIGAKU RYOHOGAKU S1, V30, P358; Jacobson BH, 2011, CLIN REHABIL, V25, P549, DOI 10.1177/0269215510392390; Jeka J, 2004, J NEUROPHYSIOL, V92, P2369; Kuptniratsaikul V, 2011, CLIN INTERV AGING, V6, P111, DOI 10.2147/CIA.S17851; Liu-Ambrose T, 2004, J AM GERIATR SOC, V52, P657, DOI 10.1111/j.1532-5415.2004.52200.x; Mastusaka N, 2001, AM J SPORTS MED, V29, P25; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Rubenstein Laurence Z, 2006, Age Ageing, V35 Suppl 2, pii37, DOI 10.1093/ageing/afl084; Shimada H, 2003, CLIN REHABIL, V17, P472, DOI 10.1191/0269215503cr638oa; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081; Suzuki T, 2000, HLTH ASSESSMENT MANU, P142; Tinetti ME, 1990, J GERONTOL MED SCI, V45, pM239; WILKERSON GB, 1994, J SPORT REHABIL, V3, P43	47	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1539-8412	2152-0895		J GERIATR PHYS THER	J. Geriatr. Phys. Ther.	APR-JUN	2015	38	2					62	70		10.1519/JPT.0000000000000023		9	Geriatrics & Gerontology; Rehabilitation	Geriatrics & Gerontology; Rehabilitation	CE3ZO	WOS:000351769300002		
J	Tiefenbach, T; Kohlbacher, F				Tiefenbach, Tim; Kohlbacher, Florian			Happiness in Japan in Times of Upheaval: Empirical Evidence from the National Survey on Lifestyle Preferences	JOURNAL OF HAPPINESS STUDIES			English	Article						Happiness economics; Japan; Disaster; March 11; 3-11; Great East Japan Earthquake; Life satisfaction; Fukushima	EASTERLIN PARADOX; ECONOMIC-GROWTH; SATISFACTION; EMPLOYMENT; UNHAPPINESS; MARRIAGE; IMPACT; INCOME	Happiness economics has become an established field of research, and happiness and life satisfaction are increasingly considered important policy goals by governments around the globe. The Japanese government has recently started to follow this trend by regularly collecting data on personal happiness and its determinants through nationwide surveys since 2010. Analyzing data from the 2011 National Survey on Lifestyle Preferences, this paper has three aims: first, we use the Japanese happiness data to check for similarities and differences compared to well-known findings established in the international literature. Second, from a Japanese perspective we contribute to ongoing debates regarding inconclusive findings. Third, we analyze the happiness effects of the impact of the Great East Japan Earthquake of March 11. Overall, our results confirm the majority of determinants established by previous studies in the field of happiness economics, such as income, unemployment and marriage. But we find significant differences regarding the effects of entrepreneurship and political participation. Finally, we do not find a statistically significant nation-wide drop in happiness after the disaster of 11 March 2011, but we observe a spatial effect indicating that respondents living closer to the Fukushima prefecture are less happy after the disaster.	[Tiefenbach, Tim; Kohlbacher, Florian] German Inst Japanese Studies DIJ, Chiyoda Ku, Tokyo 1020094, Japan	Tiefenbach, T (reprint author), German Inst Japanese Studies DIJ, Chiyoda Ku, Jochi Kioizaka Bldg 2F,7-1 Kioicho, Tokyo 1020094, Japan.	tiefenbach@dijtokyo.org					Alois Stutzer, 2002, HAPPINESS EC EC I AF; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Hu F, 2013, SOC INDIC RES, V110, P951, DOI 10.1007/s11205-011-9967-6; Blanchflower DG, 2004, J PUBLIC ECON, V88, P1359, DOI 10.1016/S0047-2727(02)00168-8; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Oswald AJ, 1997, ECON J, V107, P1815, DOI 10.1111/1468-0297.00260; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Leung A, 2011, J HAPPINESS STUD, V12, P443, DOI 10.1007/s10902-010-9208-8; Oshio T, 2010, SOC SCI MED, V70, P1358, DOI 10.1016/j.socscimed.2010.01.010; Easterlin R, 2005, SOC INDIC RES, V74, P429, DOI 10.1007/s11205-004-6170-z; De Cuyper N, 2008, INT J MANAG REV, V10, P25, DOI 10.1111/j.1468-2370.2007.00221.x; DIENER E, 1995, SOC INDIC RES, V34, P7, DOI 10.1007/BF01078966; Luechinger S, 2009, J PUBLIC ECON, V93, P620, DOI 10.1016/j.jpubeco.2008.10.003; Stevenson B, 2008, BROOKINGS PAP ECO AC, P1; Uchida Y, 2014, J HAPPINESS STUD, V15, P207, DOI 10.1007/s10902-013-9463-6; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037/0033-2909.125.2.276; Meier S, 2008, ECONOMICA, V75, P39, DOI 10.1111/j.1468-0335.2007.00597.x; Hagerty MR, 2003, SOC INDIC RES, V64, P1, DOI 10.1023/A:1024790530822; Myers DG, 2000, AM PSYCHOL, V55, P56, DOI 10.1037/0003-066X.55.1.56; Benz M, 2008, ECONOMICA, V75, P362, DOI 10.1111/j.1468-0335.2007.00594.x; Blanchflower DG, 2011, ACAD MANAGE PERSPECT, V25, P6; Aknin LB, 2012, J HAPPINESS STUD, V13, P347, DOI 10.1007/s10902-011-9267-5; Tafarodi RW, 2012, J HAPPINESS STUD, V13, P783, DOI 10.1007/s10902-011-9290-6; Tokuda Y, 2008, SOC INDIC RES, V89, P349, DOI 10.1007/s11205-007-9235-y; Carroll N, 2009, J POPUL ECON, V22, P445, DOI 10.1007/s00148-007-0174-3; Easterlin RA, 2006, J ECON PSYCHOL, V27, P463, DOI 10.1016/j.joep.2006.05.002; Bardasi E, 2004, SOC SCI MED, V58, P1671, DOI 10.1016/S0277-9536(03)00400-3; Sianesi B, 2004, REV ECON STAT, V86, P133, DOI 10.1162/003465304323023723; Neria Y, 2011, AM PSYCHOL, V66, P429, DOI [10.1037/a0024791, 10.1037/0024791]; Berger EM, 2010, KYKLOS, V63, P1; Winkelmann L, 1998, ECONOMICA, V65, P1, DOI 10.1111/1468-0335.00111; Aknin LB, 2013, J PERS SOC PSYCHOL, V104, P635, DOI 10.1037/a0031578; Haller M, 2006, SOC INDIC RES, V75, P169, DOI 10.1007/s11205-004-6297-y; Kountouris Y, 2011, KYKLOS, V64, P556, DOI 10.1111/j.1467-6435.2011.00520.x; Applbaum K., 1996, URBAN ANTHROP, V25, P1; Argyle M., 1999, WELL BEING FDN HEDON, P353; Asano H., 2011, RIETI DISCUSSION PAP, V11-J-037; Benz M, 2007, EC PSYCHOL PROMISING, P199; Blanchflower D. G., 1998, J LABOUR EC, V16, P20; Clark AE, 2008, J ECON LIT, V46, P95, DOI 10.1257/jel.46.1.95; Cuyper N., 2006, J OCCUPATIONAL ORG P, DOI [10.1348/096317905X53660, DOI 10.1348/096317905X53660]; Davey G., 2012, SCI CULTURES, V6; Diaz-Serrano L, 2009, J ECON PSYCHOL, V30, P745, DOI 10.1016/j.joep.2009.06.006; Ferrer-i-Carbonell A., 2004, ECON J, V114, P641, DOI DOI 10.1111/J.1468-0297.2004.00235.X; Flavin P, 2012, J HAPPINESS STUD, V13, P63, DOI 10.1007/s10902-011-9250-1; Frey B., 2008, HAPPINESS REVOLUTION; Frey BS, 2009, HAPPINESS, ECONOMICS AND POLITICS: TOWARDS A MULTI-DISCIPLINARY APPROACH, P301; Frey BS, 2007, J ECON SURV, V21, P1, DOI 10.1111/j.1467-6419.2007.00505.x; Goebel J., 2013, 7691 IZA; Hayo B, 2003, J ECON PSYCHOL, V24, P329, DOI 10.1016/S0167-4870(02)00173-3; Higuchi Y., 2011, KYOTO KEIO GLOBAL CO, VDP2011-016; Inoguchi T, 2009, SOC INDIC RES, V92, P227, DOI 10.1007/s11205-008-9351-3; Ishino T., 2012, DYNAMISM HOUSEHOLD B, P255; Ishino T., 2013, DYNAMICS EMPLOYMENT, P157; Kimball M., 2006, 12062 NBER; Kingston J., 2012, NATURAL DISASTER NUC, P1; Kitamura Y., 2012, DYNAMISM HOUSEHOLD B, P233; Kobayashi M., 2009, REGIONAL INCOME INEQ; Kume K., 2009, SEIKATSU KEZEIGAKU K, V29, P33; Kume K., 2011, RIETI DISCUSSION PAP, V11-J-061, P1; Kusago T., 2008, THAMMASAT EC J, V26, P88; Kusago T, 2007, SOC INDIC RES, V81, P79, DOI 10.1007/s11205-006-0016-9; Layard R., 2011, HAPPINESS LESSONS NE; Lee KS, 2012, J MARRIAGE FAM, V74, P953, DOI 10.1111/j.1741-3737.2012.01001.x; Lee KS, 2008, SOC SCI RES, V37, P1216, DOI 10.1016/j.ssresearch.2008.02.005; Lucas R. E., 2006, J HAPPINESS STUD, V7, P405, DOI DOI 10.1007/S10902-006-9001-X; Metcalfe R, 2011, ECON J, V121, pF81, DOI 10.1111/j.1468-0297.2010.02416.x; Morikawa M., 2010, RIETI DISCUSSION PAP, V10-J-043, P1; Ochsen C, 2012, J ECON PSYCHOL, V33, P112, DOI 10.1016/j.joep.2011.08.007; Ohtake F., 2004, NIHON RODO KENKYU ZA, V528, P59; Ohtake F., 2007, NIHON RODO KENKYU ZA, V558, P4; Ohtake F., 2012, JAPAN LABOR REV, V9, P59; Oshio T, 2011, SOC INDIC RES, V104, P351, DOI 10.1007/s11205-010-9754-9; Oshio T, 2011, J HAPPINESS STUD, V12, P633, DOI 10.1007/s10902-010-9220-z; Praag B. M. Sv, 2008, HAPPINESS QUANTIFIED; Rehdanz K., 2013, WELL BEING EFFECTS M; Remler D. K., 2011, RES METHODS PRACTICE; Rojas M, 2007, J ECON PSYCHOL, V28, P1, DOI 10.1016/j.joep.2005.10.002; Romanov D, 2012, ECONOMICA, V79, P183, DOI 10.1111/j.1468-0335.2010.00868.x; Ruprah I., 2010, OVEWP0210 INT DEV BA; Shiraishi K., 2007, ESRI DISCUSSION PAPE, V181; Sugimoto Y., 2010, INTRO JAPANESE SOC; Suzuki K, 2009, SOC INDIC RES, V92, P81, DOI 10.1007/s11205-008-9290-z; Tafarodi RW, 2012, J HAPPINESS STUD, V13, P969, DOI 10.1007/s10902-011-9299-x; Thranhardt A. M., 1990, 3 SECTOR COMP STUDIE, V21, P347; Tiefenbach T., 2014, GENDER LIFESPAN QUAL, P183; Tokuda Y, 2010, J APPL SOC PSYCHOL, V40, P2574, DOI 10.1111/j.1559-1816.2010.00671.x; Tsuji T., 2011, KOJINSHOTOKU KOFUKUK; Tsutsui Y., 2010, NIHON KOFUKUDO KAKUS, P33; Uchida Y., 2004, J HAPPINESS STUD, V5, P223, DOI DOI 10.1007/S10902-004-8785-9; Ueda A., 2010, SHAKAI HOSHO KENKYU, V46, P139; Ueda M., 2013, ESRI DISCUSSION PAPE, V295; Urakawa K., 2007, EFFECT EC DISPARITY, V26, P13; Urakawa K., 2007, IMPACT RELATIVE INEQ, V73, P61; Veenhoven R, 2006, SOC INDIC RES, V79, P421, DOI 10.1007/s11205-005-5074-x; Weitz-Shapiro R., 2008, 638 RES DEP INT DEV, V638; Yamane S., 2008, GCOE DISCUSSION PAPE, V7	99	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-4978	1573-7780		J HAPPINESS STUD	J. Happiness Stud.	APR	2015	16	2					333	366		10.1007/s10902-014-9512-9		34	Psychology, Multidisciplinary; Social Sciences, Interdisciplinary	Psychology; Social Sciences - Other Topics	CE1YI	WOS:000351608500004		
J	Rahman, MM; Lu, MJ; Kyi, KH				Rahman, Mohammad Mahfuzur; Lu, Minjiao; Kyi, Khin Htay			Variability of soil moisture memory for wet and dry basins	JOURNAL OF HYDROLOGY			English	Article						Soil moisture autocorrelation; Soil moisture memory; Soil moisture persistence; Soil moisture memory timescale; Aridity; XinAnJiang model	STREAMFLOW FORECASTS; CLIMATE; SURFACE; MODEL; PRECIPITATION; SCALES; SIMULATIONS; CIRCULATION; PERSISTENCE; FEEDBACK	Soil moisture memory (SMM) is not only important for atmospheric weather/climate forecasting, but may also be useful in flood and drought prediction. Despite their importance, SMM studies are restricted in certain regions due to the scarcity of soil moisture data. To overcome this limitation, this study explains the variability of SMM in wet and dry basins, and shows an alternative way to predict the basin scale SMM using observed precipitation and potential evapotranspiration information only. This study presents the basin average SMM in the form of a timescale that indicates the duration of significant auto-correlations at 95% confidence intervals. The soil moisture autocorrelations were calculated using observed precipitation, potential evapotranspiration, streamflow and soil moisture data sets simulated using the XinAnJiang (XAJ) model, for 26 river basins across the USA. The XAJ model's capability to simulate seasonal cycles (temporal anomalies) of soil moisture was validated against cycles from the observed data set of the Spoon River basin of Illinois State, USA. Based on the validation experience, the XAJ model was thereafter used to simulate soil moisture data for the analysed basins. Basin scale SMM timescale ranges were computed from 11 to 133 days. The SMM timescale is highly influenced by precipitation variability and exhibits strong seasonality. Dry basins tend to show the highest memory during the winter months (December to February) and lowest in late spring (May). In contrast, wet basins have the lowest memory during winter and early spring (December to April) and highest in the late summer and early autumn (July to September). The SMM timescale displayed an exponential relationship with the basin aridity index, with an r(2) value of 0.9. This relationship could be a cheap source of basin scale SMM prediction from widely available observed data sets (actual precipitation and potential evapotranspiration), and thus, could afford some knowledge of SMM under no knowledge conditions. (C) 2015 Elsevier B.V. All rights reserved.	[Rahman, Mohammad Mahfuzur; Lu, Minjiao; Kyi, Khin Htay] Nagaoka Univ Technol, Dept Civil & Environm Engn, Nagaoka, Niigata 9402188, Japan; [Lu, Minjiao] Chongqing Jiaotong Univ, Chongqing, Peoples R China	Rahman, MM (reprint author), Nagaoka Univ Technol, Dept Civil & Environm Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	romelku22@yahoo.com					Mueller B, 2012, P NATL ACAD SCI USA, V109, P12398, DOI 10.1073/pnas.1204330109; Robock A, 2000, B AM METEOROL SOC, V81, P1281, DOI 10.1175/1520-0477(2000)081<1281:TGSMDB>2.3.CO;2; Dirmeyer PA, 2009, J HYDROMETEOROL, V10, P278, DOI 10.1175/2008JHM1016.1; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Koster RD, 2001, J HYDROMETEOROL, V2, P558, DOI 10.1175/1525-7541(2001)002<0558:SMMICM>2.0.CO;2; Schlosser CA, 2002, J HYDROMETEOROL, V3, P483, DOI 10.1175/1525-7541(2002)003<0483:AMBIOS>2.0.CO;2; Nicholson S, 2000, REV GEOPHYS, V38, P117, DOI 10.1029/1999RG900014; Wu WR, 2004, J CLIMATE, V17, P2752, DOI 10.1175/1520-0442(2004)017<2752:TSOLSM>2.0.CO;2; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Entin JK, 1999, J METEOROL SOC JPN, V77, P183; Koster RD, 2010, NAT GEOSCI, V3, P613, DOI 10.1038/NGEO944; Liu YQ, 1999, J CLIMATE, V12, P2139, DOI 10.1175/1520-0442(1999)012<2139:ASOPIT>2.0.CO;2; Vinnikov KY, 1996, J GEOPHYS RES-ATMOS, V101, P7163, DOI 10.1029/95JD02753; VINNIKOV KY, 1991, J CLIMATE, V4, P66, DOI 10.1175/1520-0442(1991)004<0066:SMEDAM>2.0.CO;2; Entin JK, 2000, J GEOPHYS RES-ATMOS, V105, P11865, DOI 10.1029/2000JD900051; GEORGAKAKOS KP, 1995, WATER RESOUR RES, V31, P655, DOI 10.1029/94WR02375; Yao H, 2001, J HYDROL, V249, P176, DOI 10.1016/S0022-1694(01)00418-8; Hong SY, 2000, NATURE, V408, P842, DOI 10.1038/35048548; Seneviratne SI, 2006, J HYDROMETEOROL, V7, P1090, DOI 10.1175/JHM533.1; Seneviratne SI, 2012, J HYDROMETEOROL, V13, P404, DOI 10.1175/JHM-D-11-044.1; Bonan GB, 1998, WATER RESOUR RES, V34, P2693, DOI 10.1029/98WR02073; Delworth T. L., 1988, Journal of Climate, V1, DOI 10.1175/1520-0442(1988)001<0523:TIOPEO>2.0.CO;2; Gudmundsson L, 2011, HYDROL EARTH SYST SC, V15, P2853, DOI 10.5194/hess-15-2853-2011; HOLLINGER SE, 1994, J CLIMATE, V7, P822, DOI 10.1175/1520-0442(1994)007<0822:ASMCOI>2.0.CO;2; Hurk B., 2012, CLIM DYNAM, V38, P149; Koster RD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041677; Koster RD, 1997, J CLIMATE, V10, P1578, DOI 10.1175/1520-0442(1997)010<1578:TIBTAR>2.0.CO;2; Kyi K.H., 2014, THESIS NAGAOKA U TEC; Li X., 2014, ANN J HYDRAUL ENG JS, V58, P163; Lu M., 2014, HYDROL RES LETT, V8, P51; Mahanama S, 2012, J HYDROMETEOROL, V13, P189, DOI 10.1175/JHM-D-11-046.1; Mahanama SPP, 2003, J HYDROMETEOROL, V4, P1134, DOI 10.1175/1525-7541(2003)004<1134:IOSMMI>2.0.CO;2; Mahanama SPP, 2005, J HYDROMETEOROL, V6, P656, DOI 10.1175/JHM446.1; MANABE S, 1969, MON WEATHER REV, V97, P739, DOI 10.1175/1520-0493(1969)097<0739:CATOC>2.3.CO;2; Mitchell J.M., 1966, CLIMATIC CHANGE WMO, P79; Nash J. E., 1970, J HYDROL, V10, P282, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Orth R, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017366; Orth R, 2013, THESIS I ATMOSPHERIC; Orth R., 2012, HYDROL EARTH SYST SC, V17, P3895; Schaake J., 2006, IAHS PUBLICATION; Wu ZY, 2007, ATMOS OCEAN, V45, P37; ZHAO RJ, 1992, J HYDROL, V135, P371	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	APR	2015	523						107	118		10.1016/j.jhydrol.2015.01.033		12	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CE6TS	WOS:000351971700010		
J	Kamtchueng, BT; Fantong, WY; Wirmvem, MJ; Tiodjio, RE; Takounjou, AF; Asai, K; Djomou, SLB; Kusakabe, M; Ohba, T; Tanyileke, G; Hell, JV; Ueda, A				Kamtchueng, Brice Tchakam; Fantong, Wilson Yetoh; Wirmvem, Mengnjo Jude; Tiodjio, Rosine Edwige; Takounjou, Alain Fouepe; Asai, Kazuyoshi; Djomou, Serges L. Bopda; Kusakabe, Minoru; Ohba, Takeshi; Tanyileke, Gregory; Hell, Joseph Victor; Ueda, Akira			A multi-tracer approach for assessing the origin, apparent age and recharge mechanism of shallow groundwater in the Lake Nyos catchment, Northwest, Cameroon	JOURNAL OF HYDROLOGY			English	Article						Stable isotopes (delta O-18 and delta D); CFCs and SF6; Shallow groundwater origin and age; Shallow groundwater recharge; Lake Nyos - Cameroon	WEST-AFRICA IMPLICATIONS; STABLE-ISOTOPES; CHLOROFLUOROCARBONS CFCS; SULFUR-HEXAFLUORIDE; YOUNG GROUNDWATER; RESIDENCE TIMES; TERRIGENIC SF6; GAS DISASTER; HYDROCHEMISTRY; AQUIFER	The shallow aquifer in the vicinity of Lake Nyos (Northwest, Cameroon) is one of the main water supply sources to meet the water needs of the inhabitants to be resettled after 1986s tragedy. Unfortunately, there is a lack of knowledge on the groundwater recharge and flow systems in the area. Multiple environmental tracers (delta O-18, ED, Cl-, CFCs and SF6) and a yearly record of rainfall, surface waters and groundwater were employed to characterize the recharge mechanism of the shallow groundwater seeping in the fractured rock of the Lake Nyos catchment (LNC). The delta O-18-delta D relationship of the rainfall events gave the Nyos Meteoric Water Line: delta D = 8.28 delta O-18 + 11.87. Inland moisture vapor may have impacted the isotopic composition of original vapor masses from Gulf of Guinea prior to precipitation. Shallow groundwater in the LNC shows a similar trend of enrichment in O-18 and D as surface waters indicating a well-mixed aquifer. The proportions of surface waters and rainfall in the groundwater reservoir were 87% and 13%, respectively. The high annual recharge rate (941 mm/yr) and the seasonal variability in the isotopic signatures of groundwater indicate a renewable aquifer system. CFCs apparent ages-based piston flow model revealed a young age (average of 24 a.) of the groundwater in the LNC. SF6-based ages were biased young as compared to relatively younger than CFCs-based ages, implying an additional terrigenic production of SF6. The conceptual model for groundwater flow suggests that three main flow regimes, mainly controlled by the physical properties of the rock heterogeneities govern the movement of water in the aquifer. The piston flow model appears, however, to be the better model to explain the flow regime in the highly faulted and fissured area where recharge occurs (similar to 1200-1600 masl). The rapid circulation and the low solubility lead to low mineralization. In the middle-lower area where waters circulate more in the weathered layer, exponential mixing model dominates, yielding more mineralized water. Downward to the valley, with prevailing gentle slope, interaction between surface and recently infiltrated groundwater better explain the observed similarity in the isotopic compositions and the mineralization of water. (C) 2015 Elsevier B.V. All rights reserved.	[Kamtchueng, Brice Tchakam; Tiodjio, Rosine Edwige; Kusakabe, Minoru; Ueda, Akira] Toyama Univ, Dept Environm Biol & Chem, Toyama 9308555, Japan; [Fantong, Wilson Yetoh; Takounjou, Alain Fouepe; Djomou, Serges L. Bopda; Tanyileke, Gregory; Hell, Joseph Victor] Inst Min & Geol Res IRGM, Yaounde 4110, Cameroon; [Wirmvem, Mengnjo Jude; Ohba, Takeshi] Tokai Univ, Sch Sci, Dept Chem, Hiratsuka, Kanagawa 2591211, Japan; [Asai, Kazuyoshi] Geosci Lab Co Ltd, Nagoya, Aichi 4680007, Japan	Kamtchueng, BT (reprint author), Toyama Univ, Dept Environm Biol & Chem, Toyama 9308555, Japan.	d1271305@ems.u-toyama.ac.jp			Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA) under the Science and Technology Research Partnership for Sustainable Development (SATREPS) project	This study was funded by the Grant from Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA) under the Science and Technology Research Partnership for Sustainable Development (SATREPS) project entitled: Magmatic Fluid Supply into Lakes Nyos and Monoun, and Mitigation of Natural Disasters in Cameroon. Institute of Geological and Mining Research (IRGM) of Cameroon is also acknowledged for providing logistics during sampling campaigns. Special thanks go to two anonymous reviewers and the editors for their critical reviews and helpful comments.	Aka FT, 2008, J VOLCANOL GEOTH RES, V176, P212, DOI 10.1016/j.jvolgeores.2008.04.009; Ako AA, 2013, J HYDROL, V502, P156, DOI 10.1016/j.jhydrol.2013.08.032; Plummer LN, 2001, CHEM GEOL, V179, P93, DOI 10.1016/S0009-2541(01)00317-5; Njitchoua R, 1999, J HYDROL, V223, P17, DOI 10.1016/S0022-1694(99)00087-6; Lapworth DJ, 2013, HYDROGEOL J, V21, P673, DOI 10.1007/s10040-012-0925-4; Koh DC, 2007, J HYDROL, V339, P93, DOI 10.1016/j.jhydrol.2007.03.011; Gooddy DC, 2006, J HYDROL, V330, P44, DOI 10.1016/j.jhydrol.2006.04.011; Kusakabe M, 2008, GEOCHEM J, V42, P93; Nicholson SE, 2000, GLOBAL PLANET CHANGE, V26, P137, DOI 10.1016/S0921-8181(00)00040-0; Gonfiantini R, 2001, CHEM GEOL, V181, P147, DOI 10.1016/S0009-2541(01)00279-0; DANSGAARD W, 1964, TELLUS, V16, P436; FITTON JG, 1985, EARTH PLANET SC LETT, V72, P23, DOI 10.1016/0012-821X(85)90114-1; Manning AH, 2005, GROUND WATER, V43, P353, DOI 10.1111/j.1745-6584.2005.0028.x; Negrel P, 2011, J HYDROL, V397, P55, DOI 10.1016/j.jhydrol.2010.11.033; Busenberg E, 2000, WATER RESOUR RES, V36, P3011, DOI 10.1029/2000WR900151; KLING GW, 1987, SCIENCE, V236, P169, DOI 10.1126/science.236.4798.169; [Anonymous], 1993, GEOPHYS MONOGR SER, DOI DOI 10.1029/GM078P0001; Wilson GB, 1997, APPL GEOCHEM, V12, P747, DOI 10.1016/S0883-2927(97)00035-8; Temdjim R, 2012, CHEM ERDE-GEOCHEM, V72, P39, DOI 10.1016/j.chemer.2011.07.002; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Ako AA, 2010, WATER RESOUR MANAG, V24, P871, DOI 10.1007/s11269-009-9476-4; Qin DJ, 2011, J HYDROL, V405, P194, DOI 10.1016/j.jhydrol.2011.05.023; Garcin Y, 2012, GEOCHIM COSMOCHIM AC, V79, P106, DOI 10.1016/j.gca.2011.11.039; Darling WG, 2012, APPL GEOCHEM, V27, P1688, DOI 10.1016/j.apgeochem.2012.02.005; Zuber A, 2005, HYDROL PROCESS, V19, P2247, DOI 10.1002/hyp.5669; Asai Kazuyoshi, 2011, Hydrological Research Letters, V5, DOI 10.3178/HRL.5.42; Cappa CD, 2003, J GEOPHYS RES, V108, P1; Clark I., 1997, ENV ISOTOPES HYDROGE, P328; EVANS WC, 1994, GEOCHEM J, V28, P139; Fantong WY, 2010, ENVIRON EARTH SCI, V60, P107, DOI 10.1007/s12665-009-0173-7; Fantong W.Y., 2015, J AFR EARTH SC, V10, P42; Fontes J.C., 1977, COMPOSITION ISOTOPIQ, P28; Friedrich R, 2013, APPL GEOCHEM, V33, P318, DOI 10.1016/j.apgeochem.2013.03.002; Gat J.R., 2010, SERIES ENV SCI MANAG, V6, P189; GIGGENBACH WF, 1990, J VOLCANOL GEOTH RES, V42, P337, DOI 10.1016/0377-0273(90)90031-A; Hem J.D., 1985, 2254 US GEOL SURV; IAEA (International Atomic Energy Agency), 2006, STIPUB1238 IAEA; Jaunat J, 2012, APPL GEOCHEM, V27, P2053, DOI 10.1016/j.apgeochem.2012.06.009; Kamtchueng BT, 2014, ENVIRON EARTH SCI, V72, P3663, DOI 10.1007/s12665-014-3278-6; Katz BG, 2001, CHEM GEOL, V179, P167, DOI 10.1016/S0009-2541(01)00321-7; Kazemi G.A., 2006, GROUNDWATER AGE, P325; Kendall C., 2011, ISOTOPE GEOCHEMISTRY, P181; Kusakabe M., 1992, INT MONOGRAPH SERIES, P83; KUSAKABE M, 1989, J VOLCANOL GEOTH RES, V39, P167, DOI 10.1016/0377-0273(89)90056-5; La Salle CL, 2012, APPL GEOCHEM, V27, P1304, DOI 10.1016/j.apgeochem.2011.12.006; LOCKWOOD JP, 1989, J VOLCANOL GEOTH RES, V39, P117, DOI 10.1016/0377-0273(89)90052-8; LOCKWOOD JP, 1988, B VOLCANOL, V50, P340, DOI 10.1007/BF01073590; Marechal JC, 2009, J HYDROL, V364, P272, DOI 10.1016/j.jhydrol.2008.11.006; Molenat J, 2013, J HYDROL, V480, P1, DOI 10.1016/j.jhydrol.2012.11.043; Molua E.L., 2006, CLIMATE HYDROLOGY WA, P37; Nagao K, 2010, GEOCHEM J, V44, P519; Plummer L. N., 2000, ENV TRACERS SUBSURFA, P441; Plummer L.N., 2006, USE CHLOROFLUOROCARB, P17; Plummer L.N., 2003, RESIDENCE TIMES NITR, P12; Santella N, 2008, J HYDROL, V349, P139, DOI 10.1016/j.jhydrol.2007.10.031; Stadler S, 2010, J HYDROL, V388, P291, DOI 10.1016/j.jhydrol.2010.05.008; Stute M., 2000, ENV TRACERS SUBSURFA, P349; Takaaki I., 2004, GEOCHEM J, V38, P435; Takounjou AF, 2011, ENVIRON EARTH SCI, V64, P107, DOI 10.1007/s12665-010-0822-x; Tanyileke G., 1994, THESIS OKAYAMA U JAP, P193; Tuttle M.L., 1987, 90691 US GEOL SURV; Tuttle M.L., 1992, P 7 WAT ROCKS INT S; WHO/UNICEF, 2008, COV EST IMPR SAN CAM; Wirmvem M.J., 2014, THESIS TOKAI U JAPAN, P162; Yeh HF, 2014, WATER-SUI, V6, P2849, DOI 10.3390/w6102849; Yurtsever Y., 1981, IAEA TECHNICAL REPOR, V210, P339	66	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	APR	2015	523						790	803		10.1016/j.jhydrol.2015.02.008		14	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CE6TS	WOS:000351971700065		
J	Katsuki, M; Hirooka, Y; Kishi, T; Sunagawa, K				Katsuki, Masato; Hirooka, Yoshitaka; Kishi, Takuya; Sunagawa, Kenji			Decreased proportion of Foxp3(+)CD4(+) regulatory T cells contributes to the development of hypertension in genetically hypertensive rats	JOURNAL OF HYPERTENSION			English	Article						blood pressure; hypertension; regulatory T cells; spleen; sympathetic nervous system	ANGIOTENSIN-II; NERVOUS-SYSTEM; IMMUNE-SYSTEM; NEURAL REGULATION; BLOOD-PRESSURE; IN-VIVO; SPLEEN; INNERVATION; MECHANISMS; COMPLEXES	Objective: Dysregulation of the sympathetic nervous system and the immune system has been highlighted in the pathogenesis of hypertension. Foxp3(+) regulatory T (Treg) cells, which maintain immune homeostasis, have potent antihypertensive properties. We systematically explored whether Treg cells proportions are altered in stroke-prone spontaneously hypertensive rats (SHRSP) with increased sympathetic activity. Then, we focused on Treg cells in the spleen and determined whether Treg cells proportion in the spleen could be affected by splenic sympathetic input associated with the progression of hypertension. We also investigated effects of Treg cell induction on hypertension development and cardiac hypertrophy in SHRSP. Methods and Results: We evaluated Treg cells in SHRSP. Compared with normotensive Wistar-Kyoto (WKY) rats, SHRSP exhibited decreased proportions of CD4(+)CD25(+)Foxp3(+) cells (Treg cells) in the spleen before the onset of hypertension. Splenic sympathetic denervation in prehypertensive SHRSP attenuated the reduction of Treg cells at 4 weeks after denervation (P < 0.05) and delayed the development of hypertension in SHRSP. Interleukin (IL)-2 and anti-IL-2 mAb complex selectively induced Treg cells in vivo (P<0.01), delayed the development of hypertension and decreased the heart weight/body weight ratio (4.64 +/- 0.06 vs. 4.25 +/- 0.05 mg/g, P<0.01) and the cross-sectional area of cardiac myocytes in SHRSP compared with vehicle-treated SHRSP (580 +/- 3.91 vs. 438 +/- 4.43 mm(2), P<0.0001). Conclusion: Our findings indicate that a decrease in Treg cell proportion is crucial for the development of hypertension and cardiac hypertrophy in SHRSP, which is involved in sympathetic neural input to the spleen.	[Katsuki, Masato; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 8128582, Japan; [Kishi, Takuya] Kyushu Univ, Grad Sch Med Sci, Dept Adv Therapeut Cardiovasc Dis, Fukuoka 8128582, Japan	Hirooka, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyoshi@cardiol.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24390198]	This work was supported by a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science (24390198). We are grateful for the technical supports from the Research Support Center, Graduate School of Medical Sciences, Kyushu University.	Andrew PS, 2001, AM J PHYSIOL-REG I, V280, pR1564; Kishi T, 2010, HYPERTENSION, V55, P291, DOI 10.1161/HYPERTENSIONAHA.109.138636; Mancia G, 2014, CIRC RES, V114, P1804, DOI 10.1161/CIRCRESAHA.114.302524; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Bhowmick S, 2009, J LEUKOCYTE BIOL, V86, P1275, DOI 10.1189/jlb.0209107; Matrougui K, 2011, AM J PATHOL, V178, P434, DOI 10.1016/j.ajpath.2010.11.034; Rodriguez-Iturbe B, 2014, NAT REV NEPHROL, V10, P56, DOI 10.1038/nrneph.2013.248; Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782; Zubcevic J, 2011, HYPERTENSION, V57, P1026, DOI 10.1161/HYPERTENSIONAHA.111.169748; Martelli D, 2014, J PHYSIOL-LONDON, V592, P1677, DOI 10.1113/jphysiol.2013.268573; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Abboud FM, 2012, HYPERTENSION, V59, P755, DOI 10.1161/HYPERTENSIONAHA.111.186833; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Marvar PJ, 2011, CURR OPIN PHARMACOL, V11, P156, DOI 10.1016/j.coph.2010.12.001; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; ACKERMAN KD, 1987, J NEUROSCI RES, V18, P49, DOI 10.1002/jnr.490180109; Grassi G, 2010, EXP PHYSIOL, V95, P581, DOI 10.1113/expphysiol.2009.047381; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Ganta CK, 2005, AM J PHYSIOL-HEART C, V289, pH1683, DOI 10.1152/ajpheart.00125.2005; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Dinh TN, 2012, CIRCULATION, V126, P1256, DOI 10.1161/CIRCULATIONAHA.112.099044; Cano G, 2001, J COMP NEUROL, V439, P1, DOI 10.1002/cne.1331; BELLINGER D L, 1989, Brain Behavior and Immunity, V3, P291, DOI 10.1016/0889-1591(89)90029-9; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; Cabassi A, 1998, LIFE SCI, V62, P1111, DOI 10.1016/S0024-3205(98)00034-4; Felten DL, 1987, J NEUROSCI RES, V18, P118; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Hirooka Y, 2013, HYPERTENSION, V62, P995, DOI 10.1161/HYPERTENSIONAHA.113.00801; Huang BS, 1996, HYPERTENSION, V28, P1005; Idris-Khodja N, 2014, EUR HEART J, V35, P1238, DOI 10.1093/eurheartj/ehu119; Jouda J, 2012, ANN NY ACAD SCI, V1261, P18, DOI 10.1111/j.1749-6632.2012.06642.x; KAWANO Y, 1994, AM J HYPERTENS, V7, P536; MADDEN K S, 1989, Brain Behavior and Immunity, V3, P72, DOI 10.1016/0889-1591(89)90007-X; Muller DN, 2011, CURR OPIN NEPHROL HY, V20, P113, DOI 10.1097/MNH.0b013e3283436f88; Quiroz Y, 2012, NEPHROL DIAL TRANSPL, V27, P2; Sakai K, 2000, HYPERTENSION, V36, P1023; Xiao B, 2011, J HYPERTENS, V29, P257, DOI 10.1097/HJH.0b013e32834137cd; YAMORI Y, 1985, J HYPERTENS, V3, P63, DOI 10.1097/00004872-198502000-00010; Zhang WG, 1999, AM J PHYSIOL-HEART C, V276, pH1608	48	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	APR	2015	33	4					773	783		10.1097/HJH.0000000000000469		11	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CE6OD	WOS:000351956700016		
J	Fukazawa, T; Hiraiwa, N; Umemura, T; Mise-Omata, S; Obata, Y; Doi, T				Fukazawa, Taro; Hiraiwa, Noriko; Umemura, Takeshi; Mise-Omata, Setsuko; Obata, Yuichi; Doi, Takahiro			Egress of Mature Murine Regulatory T Cells from the Thymus Requires RelA	JOURNAL OF IMMUNOLOGY			English	Article							NF-KAPPA-B; CHEMOKINE RECEPTOR CXCR3; REG CELLS; FOXP3 EXPRESSION; IMMUNE-RESPONSE; EMIGRATION; TOLERANCE; MIGRATION; THYMOCYTE; LIGANDS	The mechanism of egress of mature regulatory T cells (Tregs) from the thymus to the periphery remains enigmatic, as does the nature of those factors expressed in the thymic environment. In this study, we examined the fate of thymic Tregs in TNF-alpha/RelA double-knockout (TA-KO) mice, because TA-KO mice retain a Treg population in the thymus but have only a small Treg population at the periphery. Transplantation of whole TA-KO thymus to under the kidney capsule of Rag1-null mice failed to induce the production of donor-derived splenic Tregs expressing neuropilin-1, which is reported to be a marker of naturally occurring Tregs, indicating that TA-KO thymic Tregs either do not leave the thymus or are lost at the periphery. We next transplanted enriched TA-KO thymic Tregs to the peripheries of TA-KO mice and traced mouse survival. Transplantation of TA-KO thymic Tregs rescued the lethality in TA-KO mice, demonstrating that TA-KO thymic Tregs remained functional at the periphery. The TA-KO thymic Treg population had highly demethylated CpG motifs in the foxp3 locus, indicating that the cells were arrested at a late mature stage. Also, the population included a large subpopulation of Tregs expressing IL-7R alpha, which is a possible marker of late-stage mature Tregs. Finally, TA-KO fetal liver chimeric mice developed a neuropilin-1(+) splenic Treg population from TA-KO cells, suggesting that Treg arrest was caused by a lack of RelA in the thymic environment. Taken together, these results suggest that egress of mature Tregs from the thymus depends on RelA in the thymic environment.	[Fukazawa, Taro; Mise-Omata, Setsuko; Obata, Yuichi; Doi, Takahiro] RIKEN BioResource Ctr, Technol & Dev Team, BioSignal Program, Ibaraki 3050074, Japan; [Fukazawa, Taro] Kochi Univ, Kochi Med Sch, Dept Immunol, Kochi 7838505, Japan; [Hiraiwa, Noriko] RIKEN BioResource Ctr, Expt Anim Div, Ibaraki 3050074, Japan; [Umemura, Takeshi] Kochi Univ, Kochi Med Sch, Ctr Innovat & Translat Med, Kochi 7838505, Japan	Doi, T (reprint author), Ohtsuka Clin, Toshima Ku, MOA 401,3-34-6 Minamiotsuka, Tokyo 1700005, Japan.	godtak@gmail.com			Japan Society for the Promotion of Science [24790488, 25111515]	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI Grants 24790488 and 25111515).	Bennett CL, 2001, NAT GENET, V27, P20; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI200422325; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Weinreich MA, 2008, J IMMUNOL, V181, P2265; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Dilek N, 2012, J IMMUNOL, V188, P4209, DOI 10.4049/jimmunol.1101512; Wysocki CA, 2005, BLOOD, V106, P3300, DOI 10.1182/blood-2005-04-1632; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Tani-ichi S, 2013, P NATL ACAD SCI USA, V110, P612, DOI 10.1073/pnas.1219242110; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Rudensky A, 2005, PHILOS T ROY SOC B, V360, P1645, DOI 10.1098/rstb.2005.1731; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Moreira AP, 2008, J IMMUNOL, V180, P3049; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Drennan MB, 2009, J IMMUNOL, V183, P2213, DOI 10.4049/jimmunol.0901213; Drennan MB, 2009, EUR J IMMUNOL, V39, P925, DOI 10.1002/eji.200838912; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gerondakis S, 2012, IMMUNOL REV, V246, P272, DOI 10.1111/j.1600-065X.2011.01090.x; Kroetz DN, 2011, J IMMUNOL, V186, P5949, DOI 10.4049/jimmunol.1003876; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI13853; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Soligo M, 2011, EUR J IMMUNOL, V41, P503, DOI 10.1002/eji.201040712; Venturi GM, 2007, J IMMUNOL, V178, P291; Vianello F, 2005, J IMMUNOL, V175, P5115	41	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	APR 1	2015	194	7					3020	3028		10.4049/jimmunol.1302756		9	Immunology	Immunology	CE2RK	WOS:000351663400008		
J	Ouchida, R; Lu, Q; Liu, J; Li, YQ; Chu, YW; Tsubata, T; Wang, JY				Ouchida, Rika; Lu, Qing; Liu, Jun; Li, Yingqian; Chu, Yiwei; Tsubata, Takeshi; Wang, Ji-Yang			Fc mu R Interacts and Cooperates with the B Cell Receptor To Promote B Cell Survival	JOURNAL OF IMMUNOLOGY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IMMUNE-RESPONSES; BAFF; ACTIVATION; IGM; MICE; APOPTOSIS; TRANSCRIPTION; NF-KAPPA-B2; HOMEOSTASIS	The IgM FcR (Fc mu R) promotes B cell survival, but the molecular mechanism remains largely unknown. We show using Fc mu R-/- and wild-type mice that Fc mu R specifically enhanced B cell survival induced by BCR cross-linking with F(ab ')(2)-anti-IgM Abs while having no effect on survival when the B cells were activated by CD40 ligation or LPS stimulation. Fc mu R expression was markedly upregulated by anti-IgM stimulation, which may promote enhanced Fc mu R signaling in these cells. Immunofluorescence and confocal microscopy analyses demonstrated that Fc mu R colocalized with the BCR on the plasma membrane of primary B cells. Coimmunoprecipitation analysis further revealed that Fc mu R physically interacted with the BCR complex. Because NF-kappa B plays a prominent role in B cell survival, we analyzed whether Fc mu R was involved in BCR-triggered NF-kappa B activation. Fc mu R did not affect BCR-triggered I kappa B alpha phosphorylation characteristic of the canonical NF-kappa B activation pathway but promoted the production of the noncanonical NF-kappa B pathway component p52. Consistent with the elevated p52 levels, Fc mu R enhanced BCR-triggered expression of the antiapoptotic protein BCL-xL. Importantly, Fc mu R stimulation alone in the absence of BCR signaling had no effect on either IkBa phosphorylation or the expression of p52 and BCL-xL. Therefore, Fc mu R relied on the BCR signal to activate the noncanonical NF-kappa B pathway and enhance B cell survival. These results reveal a cross-talk downstream of Fc mu R and BCR signaling and provide mechanistic insight into Fc mu R-mediated enhancement of B cell survival after BCR stimulation.	[Ouchida, Rika] RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Immune Div, Yokohama, Kanagawa 2300045, Japan; [Lu, Qing; Liu, Jun; Li, Yingqian; Chu, Yiwei; Wang, Ji-Yang] Fudan Univ, Dept Immunol, Sch Basic Med Sci, Shanghai 200032, Peoples R China; [Tsubata, Takeshi; Wang, Ji-Yang] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan; [Wang, Ji-Yang] Fudan Univ, Biotherapy Res Ctr, Shanghai 200032, Peoples R China; [Wang, Ji-Yang] Fudan Univ, Inst Immunobiol, Shanghai 200032, Peoples R China	Wang, JY (reprint author), Fudan Univ, Dept Immunol, Sch Basic Med Sci, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	wang@fudan.edu.cn			Major National Scientific Research Projects of China [2015CB943300]; National Natural Science Foundation of China [81373129, 81330080]; Japan Society for the Promotion of Science [25460604]	This work was supported in part by the Major National Scientific Research Projects of China (2015CB943300 to J.-Y. W.), the National Natural Science Foundation of China (81373129 to J.-Y. W.), a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (25460604 to J.-Y. W.), and the National Natural Science Foundation of China (81330080 to Q. L.).	Agathangelidis A, 2013, ADV EXP MED BIOL, V792, P1, DOI 10.1007/978-1-4614-8051-8_1; Li FJ, 2011, BLOOD, V118, P4902, DOI 10.1182/blood-2011-04-350793; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Sasaki Y, 2004, J IMMUNOL, V173, P2245; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Burger JA, 2013, TRENDS IMMUNOL, V34, P592, DOI 10.1016/j.it.2013.07.002; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Honjo K, 2012, P NATL ACAD SCI USA, V109, P15882, DOI 10.1073/pnas.1206567109; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107; Hatada EN, 2003, J IMMUNOL, V171, P761; Cancro MP, 2009, NAT REV IMMUNOL, V9, P657, DOI 10.1038/nri2621; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Ouchida R, 2012, P NATL ACAD SCI USA, V109, pE2699, DOI 10.1073/pnas.1210706109; Shima H, 2010, INT IMMUNOL, V22, P149, DOI 10.1093/intimm/dxp121; Choi SC, 2013, J IMMUNOL, V190, P987, DOI 10.4049/jimmunol.1202227; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Shinners NP, 2007, J IMMUNOL, V179, P3872; Brink R, 2014, CURR OPIN IMMUNOL, V28, P97, DOI 10.1016/j.coi.2014.03.001; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Hancer VS, 2012, MED ONCOL, V29, P1068, DOI 10.1007/s12032-011-9821-3; Honjo K, 2014, INT IMMUNOL, V26, P659, DOI 10.1093/intimm/dxu070; Lopes-Carvalho Thiago, 2005, V8, P91; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408	33	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	APR 1	2015	194	7					3096	3101		10.4049/jimmunol.1402352		6	Immunology	Immunology	CE2RK	WOS:000351663400016		
J	Shimizu, K; Nakajima, A; Sudo, K; Liu, Y; Mizoroki, A; Ikarashi, T; Horai, R; Kakuta, S; Watanabe, T; Iwakura, Y				Shimizu, Kenji; Nakajima, Akiko; Sudo, Katsuko; Liu, Yang; Mizoroki, Atsuhiko; Ikarashi, Tetsuro; Horai, Reiko; Kakuta, Shigeru; Watanabe, Toshiki; Iwakura, Yoichiro			IL-1 Receptor Type 2 Suppresses Collagen-Induced Arthritis by Inhibiting IL-1 Signal on Macrophages	JOURNAL OF IMMUNOLOGY			English	Article							AUTOANTIBODY-MEDIATED ARTHRITIS; RHEUMATOID-ARTHRITIS; T-CELLS; PHYSIOLOGICAL CONDITIONS; ARTICULAR-CARTILAGE; JOINT INFLAMMATION; DECOY RECEPTOR; II RECEPTOR; CD40 LIGAND; INTERLEUKIN-1	IL-1 alpha and IL-1 beta (in this article referred to as IL-1) play important roles in host defense against infection and inflammatory diseases. IL-1R1 is the receptor for IL-1, and IL-1R2 is suggested to be a decoy receptor, because it lacks the signal-transducing TIR domain in the cytoplasmic part. However, the roles of IL-1R2 in health and disease remain largely unknown. In this study, we generated EGFP-knock-in Il1r2(-/-) mice and showed that they were highly susceptible to collagen-induced arthritis, an animal model for rheumatoid arthritis in which the expression of IL-1R2 is augmented in inflammatory joints. Il1r2 was highly expressed in neutrophils but had only low expression in other cells, including monocytes and macrophages. Ab production and T cell responses against type II collagen were normal in Il1r2(-/-) mice. Despite the high expression in neutrophils, no effects of Il1r2 deficiency were observed; however, we found that production of inflammatory mediators in response to IL-1 was greatly enhanced in Il1r2(-/-) macrophages. These results suggest that IL-1R2 is an important regulator of arthritis by acting specifically on macrophages as a decoy receptor for IL-1.	[Shimizu, Kenji; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Noda, Chiba 2780022, Japan; [Shimizu, Kenji; Nakajima, Akiko; Sudo, Katsuko; Liu, Yang; Mizoroki, Atsuhiko; Horai, Reiko; Kakuta, Shigeru; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo 1088639, Japan; [Ikarashi, Tetsuro; Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Tokyo 1138657, Japan; [Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tumor Cell Biol Lab, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; [Iwakura, Yoichiro] Chiba Univ, Med Mycol Res Ctr, Chiba 2508673, Japan	Iwakura, Y (reprint author), Tokyo Univ Sci, Res Inst Biomed Sci, 2669 Yamazaki, Noda, Chiba 2780022, Japan.	iwakura@rs.tus.ac.jp			Core Research for Evolutional Science and Technology funds from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This work was supported by Core Research for Evolutional Science and Technology funds from the Japan Science and Technology Agency, grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to Y.I.).	Alten R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-153; Alten R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2438; Yamaki M, 2010, EXP DERMATOL, V19, P730, DOI 10.1111/j.1600-0625.2010.01108.x; Luross JA, 2001, IMMUNOLOGY, V103, P407, DOI 10.1046/j.1365-2567.2001.01267.x; Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clin.2004.12.009; COLOTTA F, 1995, J EXP MED, V181, P2181, DOI 10.1084/jem.181.6.2181; Bourke E, 2003, J IMMUNOL, V170, P5999; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; LICHTMAN AH, 1988, P NATL ACAD SCI USA, V85, P9699, DOI 10.1073/pnas.85.24.9699; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Neumann D, 2000, J IMMUNOL, V165, P3350; Jouvenne P, 1998, ARTHRITIS RHEUM, V41, P1083, DOI 10.1002/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Nakae S, 2001, J IMMUNOL, V167, P90; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Iwakura Y, 2002, CYTOKINE GROWTH F R, V13, P341, DOI 10.1016/S1359-6101(02)00021-7; Park MJ, 2012, EXP MOL MED, V44, P694, DOI 10.3858/emm.2012.44.11.078; Re F, 1996, J EXP MED, V183, P1841, DOI 10.1084/jem.183.4.1841; Li J, 2012, ARTHRITIS RHEUM-US, V64, P1098, DOI 10.1002/art.33423; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Furst DE, 2004, CLIN THER, V26, P1960, DOI 10.1016/j.clinthera.2004.12.019; AREND WP, 1994, J IMMUNOL, V153, P4766; Sasai M, 1999, ARTHRITIS RHEUM, V42, P1635, DOI 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; Chida D, 2008, DIABETOLOGIA, V51, P1698, DOI 10.1007/s00125-008-1075-z; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Alvarez-Garcia O, 2014, ARTHRITIS RHEUMATOL, V66, P1779, DOI 10.1002/art.38399; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Martin P, 2013, J LEUKOCYTE BIOL, V94, P791, DOI 10.1189/jlb.0113035; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Chou LW, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3365; Jhun JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078843; Kagiwada K, 2004, ENDOCRINOLOGY, V145, P5044, DOI 10.1210/en.2004-0054; Kato H, 2003, J RHEUMATOL, V30, P247; Lin SY, 2012, GENES IMMUN, V13, P214, DOI 10.1038/gene.2011.74; Mercer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008639; Ryu JH, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001881; Saijo S, 2002, ARTHRITIS RHEUM, V46, P533, DOI 10.1002/art.10172; SEKI N, 1988, J IMMUNOL, V140, P1477; Stahl N, 2009, ANN NY ACAD SCI, V1182, P124, DOI 10.1111/j.1749-6632.2009.05074.x; Sunaga S, 1997, MOL REPROD DEV, V46, P109, DOI 10.1002/(SICI)1098-2795(199702)46:2<109::AID-MRD1>3.0.CO;2-U; Zhang X., 2008, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1401S83	55	3	3	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	APR 1	2015	194	7					3156	3168		10.4049/jimmunol.1402155		13	Immunology	Immunology	CE2RK	WOS:000351663400022		
J	Suryawanshi, A; Manoharan, I; Hong, Y; Swafford, D; Majumdar, T; Taketo, MM; Manicassamy, B; Koni, PA; Thangaraju, M; Sun, ZM; Mellor, AL; Munn, DH; Manicassamy, S				Suryawanshi, Amol; Manoharan, Indumathi; Hong, Yuan; Swafford, Daniel; Majumdar, Tanmay; Taketo, M. Mark; Manicassamy, Balaji; Koni, Pandelakis A.; Thangaraju, Muthusamy; Sun, Zuoming; Mellor, Andrew L.; Munn, David H.; Manicassamy, Santhakumar			Canonical Wnt Signaling in Dendritic Cells Regulates Th1/Th17 Responses and Suppresses Autoimmune Neuroinflammation	JOURNAL OF IMMUNOLOGY			English	Article							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN GENE; CYTOKINE GM-CSF; TOLEROGENIC RESPONSES; EFFECTOR PHASE; T-H-17 CELLS; ENCEPHALOMYELITIS; INFLAMMATION; ACTIVATION	Breakdown in immunological tolerance to self-Ags or uncontrolled inflammation results in autoimmune disorders. Dendritic cells (DCs) play an important role in regulating the balance between inflammatory and regulatory responses in the periphery. However, factors in the tissue microenvironment and the signaling networks critical for programming DCs to control chronic inflammation and promote tolerance are unknown. In this study, we show that wnt ligand-mediated activation of beta-catenin signaling in DCs is critical for promoting tolerance and limiting neuroinflammation. DC-specific deletion of key upstream (lipoprotein receptorrelated protein [LRP]5/6) or downstream (beta-catenin) mediators of canonical wnt signaling in mice exacerbated experimental autoimmune encephalomyelitis pathology. Mechanistically, loss of LRP5/6-beta-catenin-mediated signaling in DCs led to an increased Th1/Th17 cell differentiation but reduced regulatory T cell response. This was due to increased production of proinflammatory cytokines and decreased production of anti-inflammatory cytokines such as IL-10 and IL-27 by DCs lacking LRP5/6-beta-catenin signaling. Consistent with these findings, pharmacological activation of canonical wnt/beta-catenin signaling delayed experimental autoimmune encephalomyelitis onset and diminished CNS pathology. Thus, the activation of canonical wnt signaling in DCs limits effector T cell responses and represents a potential therapeutic approach to control autoimmune neuroinflammation.	[Suryawanshi, Amol; Manoharan, Indumathi; Hong, Yuan; Swafford, Daniel; Majumdar, Tanmay; Koni, Pandelakis A.; Mellor, Andrew L.; Munn, David H.; Manicassamy, Santhakumar] Georgia Regents Univ, Ctr Canc, Canc Immunol Inflammat & Tolerance Program, Augusta, GA 30912 USA; [Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; [Manicassamy, Balaji] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Koni, Pandelakis A.; Mellor, Andrew L.; Manicassamy, Santhakumar] Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Thangaraju, Muthusamy] Georgia Regents Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30912 USA; [Sun, Zuoming] Beckman Res Inst City Hope, Div Immunol, Duarte, CA 91010 USA; [Munn, David H.] Georgia Regents Univ, Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA	Manicassamy, S (reprint author), Georgia Regents Univ, 1120 15th St,CN 4153, Augusta, GA 30912 USA.	smanicassamy@gru.edu			National Institutes of Health [DK097271, AI04875]	This work was supported by National Institutes of Health Grants DK097271 and AI04875 (to S.M.).	Fitzgerald DC, 2007, J IMMUNOL, V179, P3268; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Valencia J, 2011, J IMMUNOL, V187, P4129, DOI 10.4049/jimmunol.1101243; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Oderup C, 2013, J IMMUNOL, V190, P6126, DOI 10.4049/jimmunol.1203002; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Marinou K, 2012, TRENDS ENDOCRIN MET, V23, P628, DOI 10.1016/j.tem.2012.06.001; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Marchetti B, 2013, TRENDS MOL MED, V19, P144, DOI 10.1016/j.molmed.2012.12.001; Ponomarev ED, 2007, J IMMUNOL, V178, P39; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Brault V, 2001, DEVELOPMENT, V128, P1253; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Bettelli E, 2003, J AUTOIMMUN, V20, P265, DOI 10.1016/S0896-8411(03)00048-9; Harvey K, 2014, J MOL CELL BIOL, V6, P1, DOI 10.1093/jmcb/mju002; Heneka M, 2014, J EXP MED, V211, P1500, DOI 10.1084/jem.2118insight1; Ji QY, 2007, ANN NY ACAD SCI, V1103, P157, DOI 10.1196/annals.1394.017; Liang XJ, 2014, J LEUKOCYTE BIOL, V95, P179, DOI 10.1189/jlb.0613330; Manoharan I., 2015, CANC RES; Manoharan I, 2014, J IMMUNOL, V193, P4203, DOI 10.4049/jimmunol.1400614; Rabelo, 2010, AUTOIMMUN REV, V9, P207; Terry R. L., 2014, METHODS MOL BIOL; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324	47	4	4	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	APR 1	2015	194	7					3295	3304		10.4049/jimmunol.1402691		10	Immunology	Immunology	CE2RK	WOS:000351663400035		
J	Nakatsugawa, M; Yamashita, Y; Ochi, T; Tanaka, S; Chamoto, K; Guo, TX; Butler, MO; Hirano, N				Nakatsugawa, Munehide; Yamashita, Yuki; Ochi, Toshiki; Tanaka, Shinya; Chamoto, Kenji; Guo, Tingxi; Butler, Marcus O.; Hirano, Naoto			Specific Roles of Each TCR Hemichain in Generating Functional Chain-Centric TCR	JOURNAL OF IMMUNOLOGY			English	Article							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; ENHANCED ANTITUMOR-ACTIVITY; ANTIGEN-PRESENTING CELLS; TUMOR-REACTIVE CTL; GENE-TRANSFER; METASTATIC MELANOMA; CANCER REGRESSION; PHAGE DISPLAY; DIRECTED EVOLUTION	TCR alpha- and beta-chains cooperatively recognize peptide -MHC complexes. It has been shown that a "chain-centric" TCR hemichain can, by itself, dictate MHC-restricted Ag specificity without requiring major contributions from the paired TCR counterchain. Little is known, however, regarding the relative contributions and roles of chain-centric and its counter, non chain-centric, hemichains in determining T cell avidity. We comprehensively analyzed a thymically unselected T cell repertoire generated by transducing the a-chain centric HLA-A*02:01(A2)/MART1(27-35) TCR alpha, clone SIG35 alpha, into A2-matched and unmatched post-thymic T cells. Regardless of their HLA-A2 positivity, a substantial subset of peripheral T cells transduced with SIG35 alpha gained reactivity for A2/MART1(27-35). Although the generated A2/MART1(27-35) specific T cells used various TRBV genes, TRBV27 predominated with >10(2) highly diverse and unique clonotypic CDR3 beta sequences. T cells individually reconstituted with various A2/MART1(27-35) TRBV27 TCR beta genes along with SIG35a possessed a wide range (>2 log orders) of avidity. Approximately half possessed avidity higher than T cells expressing clone DMF5, a naturally occurring A2/MART1(27-35) TCR with one of the highest affinities. Importantly, similar findings were recapitulated with other self-Ags. Our results indicate that, although a chain-centric TCR hemichain determines Ag specificity, the paired counterchain can regulate avidity over a broad range (>2 log orders) without compromising Ag specificity. TCR chain centricity can be exploited to generate a thymically unselected Ag-specific T cell repertoire, which can be used to isolate high-avidity antitumor T cells and their uniquely encoded TCRs rarely found in the periphery because of tolerance.	[Nakatsugawa, Munehide; Yamashita, Yuki; Ochi, Toshiki; Tanaka, Shinya; Chamoto, Kenji; Guo, Tingxi; Butler, Marcus O.; Hirano, Naoto] Univ Hlth Network, Princess Margaret Canc Ctr, Immune Therapy Program, Toronto, ON M5G 2M9, Canada; [Nakatsugawa, Munehide; Yamashita, Yuki; Ochi, Toshiki; Tanaka, Shinya; Chamoto, Kenji; Guo, Tingxi; Butler, Marcus O.; Hirano, Naoto] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; [Nakatsugawa, Munehide; Yamashita, Yuki; Ochi, Toshiki; Tanaka, Shinya; Chamoto, Kenji; Guo, Tingxi; Butler, Marcus O.; Hirano, Naoto] Univ Hlth Network, Campbell Family Canc Res Inst, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Tanaka, Shinya] Takara Bio Inc, Otsu, Shiga 5202193, Japan; [Guo, Tingxi; Hirano, Naoto] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Butler, Marcus O.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	Hirano, N (reprint author), Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	naoto.hirano@utoronto.ca			Takara Bio, Inc., National Institutes of Health Grant [R01 CA148673]; Ontario Institute for Cancer Research Clinical Investigator Award [IA-039]; Princess Margaret Cancer Foundation; Guglietti Fellowship Award; Knudson Postdoctoral Fellowship; Frederick Banting and Charles Best Canada Graduate Scholarship	This work was supported by Takara Bio, Inc., National Institutes of Health Grant R01 CA148673 (to NB.), Ontario Institute for Cancer Research Clinical Investigator Award IA-039 (to N.H.), The Princess Margaret Cancer Foundation (to M.O.B. and N.H.), a Guglietti Fellowship Award (to T.O.), a Knudson Postdoctoral Fellowship (to KC), and a Frederick Banting and Charles Best Canada Graduate Scholarship (to T.G).	Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Aggen DH, 2012, GENE THER, V19, P365, DOI 10.1038/gt.2011.104; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; Imataki O, 2012, J IMMUNOL, V188, P1609, DOI 10.4049/jimmunol.1003446; Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; van Loenen MM, 2010, P NATL ACAD SCI USA, V107, P10972, DOI 10.1073/pnas.1005802107; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; Tanaka M, 2011, CLIN CANCER RES, V17, P5392, DOI 10.1158/1078-0432.CCR-10-3083; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Robbins PF, 2008, J IMMUNOL, V180, P6116; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Thomas S, 2010, IMMUNOLOGY, V129, P170, DOI 10.1111/j.1365-2567.2009.03227.x; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Cormier JN, 1997, CANCER J SCI AM, V3, P37; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Hirano N, 2006, CLIN CANCER RES, V12, P2967, DOI 10.1158/1078-0432.CCR-05-2791; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Butler MO, 2014, IMMUNOL REV, V257, P191, DOI 10.1111/imr.12129; Chen JL, 2000, J IMMUNOL, V165, P948; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Li LP, 2010, NAT MED, V16, P1029, DOI 10.1038/nm.2197; Zhao Y, 2007, J IMMUNOL, V179, P5845; Yokosuka T, 2002, J EXP MED, V195, P991, DOI 10.1084/jem.20010809; Heemskerk MHM, 2003, BLOOD, V102, P3530, DOI 10.1182/blood-2003-05-1524; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Johnson LA, 2006, J IMMUNOL, V177, P6548; Haidar JN, 2009, PROTEINS, V74, P948, DOI 10.1002/prot.22203; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Khammari A, 2009, J INVEST DERMATOL, V129, P2835, DOI 10.1038/jid.2009.144; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Dietrich PY, 2003, J IMMUNOL, V170, P5103; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; Ansen S, 2008, CLIN CANCER RES, V14, P6125, DOI 10.1158/1078-0432.CCR-08-1146; Brennan RM, 2012, J IMMUNOL, V188, P2742, DOI 10.4049/jimmunol.1102675; Butler MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030229; Butler MO, 2010, INT IMMUNOL, V22, P863, DOI 10.1093/intimm/dxq440; Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905; Butler MO, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002207; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Carrasco YR, 2001, J EXP MED, V193, P1045, DOI 10.1084/jem.193.9.1045; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Dong LC, 2010, J IMMUNOL, V184, P3063, DOI 10.4049/jimmunol.0903622; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Hirano N, 2006, BLOOD, V108, P2662, DOI 10.1182/blood-2006-04-017566; Jager E, 2002, INT J CANCER, V98, P376, DOI 10.1002/ijc.10165; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kitamura T, 1998, INT J HEMATOL, V67, P351; Pierce B.G., 2014, PLOS COMPUT BIOL, V10; Pittet M. J., 2001, CLIN CANCER RES, V7, p796s; Rimoldi D, 2000, J IMMUNOL, V165, P7253; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; SENSI M, 1995, P NATL ACAD SCI USA, V92, P5674, DOI 10.1073/pnas.92.12.5674; Valmori D, 2000, J IMMUNOL, V165, P533; Weber J, 2008, J IMMUNOTHER, V31, P215, DOI 10.1097/CJI.0b013e3181611420; Wieckowski S, 2009, J IMMUNOL, V183, P5397, DOI 10.4049/jimmunol.0901460; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658	85	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	APR 1	2015	194	7					3487	3500		10.4049/jimmunol.1401717		14	Immunology	Immunology	CE2RK	WOS:000351663400053		
J	Katano, I; Takahashi, T; Ito, R; Kamisako, T; Mizusawa, T; Ka, Y; Ogura, T; Suemizu, H; Kawakami, Y; Ito, M				Katano, Ikumi; Takahashi, Takeshi; Ito, Ryoji; Kamisako, Tsutomu; Mizusawa, Takuma; Ka, Yuyo; Ogura, Tomoyuki; Suemizu, Hiroshi; Kawakami, Yutaka; Ito, Mamoru			Predominant Development of Mature and Functional Human NK Cells in a Novel Human IL-2-Producing Transgenic NOG Mouse	JOURNAL OF IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; DIFFERENTIATION IN-VIVO; HUMAN-LYMPHOCYTES; MICE; TRANSPLANTATION; EXPRESSION; SUBSET; RECONSTITUTION; INTERLEUKIN-2; RESPONSIVENESS	We generated a severe immunodeficient NOD/Shi-scid-IL-2R gamma(nun) (NOG) mouse substrain expressing the transgenic human IL-2 gene (NOG IL-2 Tg). Upon transfer of human cord blood derived hematopoietic stem cells (HSCs), CD3(-)CD56(high)CD16(+/-) cells developed unexpectedly, predominantly in the NOG IL-2 Tg (hu-HSC NOG IL-2 Tg). These cells expressed various NK receptors, including NKp30, NKp44, NKp46, NKG2D, and CD94, as well as a diverse set of killer cell Ig-like receptor molecules at levels comparable to normal human NK cells from the peripheral blood, which is evidence of their maturity. They produced levels of granzyme A as high as in human peripheral blood derived NK cells, and a considerable amount of perforM protein was detected in the plasma. Human NK cells in hu-HSC NOG IL-2 Tg produced IFN-gamma upon stimulation, and IL-2, IL-15, or IL-12 treatment augmented the in vitro cytotoxicity. Inoculation of K562 leukemia cells into hu-HSC NOG IL-2 Tg caused complete rejection of the tumor cells, whereas inoculation into hu-HSC NOG fully reconstituted with human B, T, and some NK cells did not. Moreover, when a CCR4(+) Hodgkin's lymphoma cell line was inoculated s.c. into hu-HSC NOG IL-2 Tg, the tumor growth was significantly suppressed by treatment with a therapeutic humanized anti-CCR4 Ab (mogamulizumab), suggesting that the human NK cells in the mice exerted active Ab-dependent cellular cytotoxicity in vivo. Taken together, these data suggest that the new NOG IL-2 Tg strain is a unique model that can be used to investigate the biological and pathological functions of human NK cells in vivo.	[Katano, Ikumi; Takahashi, Takeshi; Ito, Ryoji; Kamisako, Tsutomu; Mizusawa, Takuma; Ka, Yuyo; Ogura, Tomoyuki; Suemizu, Hiroshi; Ito, Mamoru] Cent Inst Expt Anim, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan; [Katano, Ikumi; Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res,Shinjuku Ku, Tokyo 1608582, Japan	Takahashi, T (reprint author), Cent Inst Expt Anim, Kawasaki Ku, 3-25-12 Tono Machi, Kawasaki, Kanagawa 2100821, Japan.	takeshi-takahashi@ciea.or.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25871075]; RIKEN BioResource Center through the National Bio-Resource Project of MEXT, Japan [MTA CM00134];  [22220007]	This work was supported by Grant-in-Aid for Scientific Research (S) 22220007 (to M.L) and Grant-in-Aid for Young Scientists 25871075 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Japanese cord blood derived CD34<SUP>+</SUP> stem cells were provided by RIKEN BioResource Center through the National Bio-Resource Project of MEXT, Japan (MTA CM00134).	TRINCHIERI G, 1984, J EXP MED, V160, P1147, DOI 10.1084/jem.160.4.1147; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; LANIER LL, 1988, J EXP MED, V167, P1572, DOI 10.1084/jem.167.5.1572; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Ferlazzo G, 2004, J IMMUNOL, V172, P1455; Chklovskaia E, 2004, BLOOD, V103, P3860, DOI 10.1182/blood-2003-04-1200; JACOBS R, 1992, BLOOD, V79, P3239; NAGLER A, 1989, J IMMUNOL, V143, P3183; CALIGIURI MA, 1993, J CLIN INVEST, V91, P123, DOI 10.1172/JCI116161; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; LANIER LL, 1983, J IMMUNOL, V131, P1789; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Dulphy N, 2008, J IMMUNOL, V181, P2227; Ito A, 2009, CANCER IMMUNOL IMMUN, V58, P1195, DOI 10.1007/s00262-008-0632-0; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Vukicevic M, 2010, EUR J IMMUNOL, V40, P3246, DOI 10.1002/eji.200940016; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Klimosch SN, 2013, BLOOD, V122, P2380, DOI 10.1182/blood-2013-01-479790; MILLER JS, 1992, BLOOD, V80, P2182; Shiokawa M, 2010, BIOCHEM BIOPH RES CO, V399, P733, DOI 10.1016/j.bbrc.2010.07.145; Strowig T, 2010, BLOOD, V116, P4158, DOI 10.1182/blood-2010-02-270678; Timonen T, 1997, J LEUKOCYTE BIOL, V62, P693	35	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	APR 1	2015	194	7					3513	3525		10.4049/jimmunol.1401323		13	Immunology	Immunology	CE2RK	WOS:000351663400055		
J	Funakoshi, Y; Ishimura, K; Ogi, Y; Iwasa, T				Funakoshi, Yusuke; Ishimura, Kosei; Ogi, Yoshiro; Iwasa, Takashi			Application of preview information to pointing control of truss structure using artificial thermal expansion on orbit	JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES			English	Article						Pointing control; large space telescope; thermal expansion; preview information; model predictive control	SPACE STRUCTURES	The pointing performance of a truss structure on orbit that is used for a large space telescope is discussed. To achieve advanced science missions, large and precise support structures such as truss structures are needed. However, the preciseness of the structure might be lost due to various disturbances on orbit. Therefore, to realize ultra-large and precise support structures, active shape control of the structures is needed. To control the shape, we use artificial thermal expansion caused by heaters instead of mechanical actuators. Control systems without mechanical mechanisms have high reliability, which is very attractive for use on orbit. However, there are some constraints regarding the usage of heaters. The control input is restricted to positive inputs because heaters can give off heat but cannot dissipate heat actively, and there will be upper limits on the heat input. To improve the control performance under such constraints, we apply model predictive control as a feedforward control method with preview information. In this article, we mainly show the effectiveness of model predictive control compared with proportional-integral control, which is one of the typical feedback control methods. We developed a structural mathematical model and a thermal mathematical model in order to evaluate the performance of the control system. It is confirmed through numerical simulations that the total error is reduced by model predictive control compared with proportional-integral control.	[Funakoshi, Yusuke] Univ Tokyo, Dept Aeronaut & Astronaut, Tokyo, Japan; [Ishimura, Kosei] Japan Aerosp Explorat Agcy ISAS JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Ogi, Yoshiro] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Iwasa, Takashi] Tottori Univ, Dept Mech Engn, Tottori 680, Japan	Funakoshi, Y (reprint author), Japan Aerosp Explorat Agcy ISAS JAXA, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	funakoshi.yusuke@jaxa.jp			Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency	A part of this study was supported by "Study on Development of High-Precision Large Space Structural System" in the "Science and Engineering Experiments of Strategic Development and Research" of Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency.	Agnes GS, 2004, SPAC 2004 C EXH SAN; HAFTKA RT, 1985, AIAA J, V23, P450, DOI 10.2514/3.8934; Puig L, 2010, ACTA ASTRONAUT, V67, P12, DOI 10.1016/j.actaastro.2010.02.021; Korkmaz S, 2011, COMPUT STRUCT, V89, P2113, DOI 10.1016/j.compstruc.2011.07.010; EDBERG DL, 1987, AIAA J, V25, P877, DOI 10.2514/3.9715; Franklin G. F., 2009, FEEDBACK CONTROL DYN; GIVOLI D, 1995, J SPACECRAFT ROCKETS, V32, P662, DOI 10.2514/3.26667; Ishimura K, 2010, 61 INT ASTR C PRAG 2, P6116; Ishimura K, 2011, 19 SPAC ENG C KUM JA; Lake MS, 1998, AIP CONF PROC, P188; Maciejowski J. M., 2002, PREDICTIVE CONTROL C; Miura K, 1992, J INTEL MAT SYST STR, V3, P54, DOI 10.1177/1045389X9200300104; Pichler U, 2001, J THERMAL STRESSES, V24, P565; Takahashi T, 2010, SPAC TEL INSTR 2010; TOLSON RH, 1992, J GUID CONTROL DYNAM, V15, P605, DOI 10.2514/3.20881; Utku S., 1993, Journal of Intelligent Material Systems and Structures, V4, DOI 10.1177/1045389X9300400401; Wada B.K., 1990, J INTELLIGENT MATERI, V1, P157, DOI DOI 10.1177/1045389X9000100202	17	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1045-389X	1530-8138		J INTEL MAT SYST STR	J. Intell. Mater. Syst. Struct.	APR	2015	26	6			SI		730	739		10.1177/1045389X14560360		10	Materials Science, Multidisciplinary	Materials Science	CE8CK	WOS:000352068500011		
J	Miyano, G; Yamoto, M; Kaneshiro, M; Miyake, H; Morita, K; Nouso, H; Koyama, M; Okawada, M; Doi, T; Koga, H; Fukumoto, K; Lane, GJ; Yamataka, A; Urushihara, N				Miyano, Go; Yamoto, Masaya; Kaneshiro, Masakatsu; Miyake, Hiromu; Morita, Keiichi; Nouso, Hiroshi; Koyama, Mariko; Okawada, Manabu; Doi, Takashi; Koga, Hiroyuki; Fukumoto, Koji; Lane, Geoffrey J.; Yamataka, Atsuyuki; Urushihara, Naoto			Diaphragmatic Eventration in Children: Laparoscopy Versus Thoracoscopic Plication	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							PHRENIC-NERVE; INFANTS; INSUFFLATION; HEMODYNAMICS; INJURY	Aim: To determine the best way to perform diaphragmatic plication for diaphragmatic eventration (DE) using minimally invasive surgery. Materials and Methods: We conducted a retrospective review of pediatric cases of DE treated between 2007 and 2012. Thoracoscopic plication (TP) is performed using single-lung ventilation with three 5-mm ports; laparoscopic plication (LP) is performed using three or four 5-mm ports. The choice of technique was determined preferentially by the treating surgeon. Results: There were 20 subjects (13 treated by LP and 7 treated by TP). Etiology of DE was phrenic nerve injury (LP, n=11; TP, n=1) and muscular deficiency (LP, n=2; TP, n=6). Mean age (LP, 18 months; TP, 25 months) and weight (LP, 8.0 kg; TP, 9.7 kg) at surgery were not significantly different. Mean operating time was 155.6 minutes in LP and 167.0 minutes in TP (P=not significant). Mean intraoperative end-tidal CO2 was 41.9 mm Hg (range, 35-52 mm Hg) in LP and 36.9 mm Hg (range, 33-41 mm Hg) in TP (P=.01). Mean duration of postoperative ventilation was 1.2 days in LP and 1.3 days in TP (P=not significant). Mean time taken to recommence feeding postoperatively was 1.6 days in both groups (P=not significant). Complications were one conversion to thoracotomy in TP, 1 case of atelectasis in each group (P=not significant), and 6 cases of recurrence in LP versus none in TP (P=.04). Conclusions: Both TP and LP are beneficial for treating small children with DE. However, there is a higher incidence of recurrence after LP, and the role of TP in cardiac patients requiring subsequent surgery is debatable.	[Miyano, Go; Yamoto, Masaya; Kaneshiro, Masakatsu; Miyake, Hiromu; Morita, Keiichi; Nouso, Hiroshi; Koyama, Mariko; Fukumoto, Koji; Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka 4208660, Japan; [Okawada, Manabu; Doi, Takashi; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ Sch Med, Dept Pediat Gen & Urogenital Surg, Tokyo, Japan	Miyano, G (reprint author), Shizuoka Childrens Hosp, Dept Pediat Surg, Aoi Ku, 860 Urushiyama, Shizuoka 4208660, Japan.	go1993@hotmail.co.jp					Abraham Mohan K, 2003, Indian Pediatr, V40, P1088; Huttl TP, 2004, SURG ENDOSC, V18, P547, DOI 10.1007/s00464-003-8127-8; Hill RC, 1996, ANN THORAC SURG, V61, P945, DOI 10.1016/0003-4975(95)01150-1; Becmeur F, 2005, J PEDIATR SURG, V40, P1712, DOI 10.1016/j.jpedsurg.2005.07.008; GHARAGOZLOO F, 1995, SURG ENDOSC-ULTRAS, V9, P1204; Hines MH, 2003, ANN THORAC SURG, V76, P234, DOI 10.1016/S0003-4975(03)00177-2; JONES DR, 1993, ANN THORAC SURG, V55, P1379; MEARNS AJ, 1977, BRIT J SURG, V64, P558, DOI 10.1002/bjs.1800640809; MOK Q, 1991, BRIT HEART J, V65, P287; Sato M, 2005, PEDIATR SURG INT, V21, P34, DOI 10.1007/s00383-004-1259-7; SMITH CD, 1986, J THORAC CARDIOV SUR, V91, P490; Takahashi T, 2013, ANN THORAC CARDIOVAS, V19, P243, DOI 10.5761/atcs.cr.12.01907; Van Smith C, 1998, ANN THORAC SURG, V65, P842, DOI 10.1016/S0003-4975(98)00008-3; WAYNE ER, 1974, J PEDIATR SURG, V9, P643, DOI 10.1016/0022-3468(74)90101-8	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	APR 1	2015	25	4					331	334		10.1089/lap.2014.0237		4	Surgery	Surgery	CF3UC	WOS:000352473200014		
J	Fujishiro, J; Ishimaru, T; Sugiyama, M; Arai, M; Uotani, C; Yoshida, M; Miyakawa, K; Kakihara, T; Iwanaka, T				Fujishiro, Jun; Ishimaru, Tetsuya; Sugiyama, Masahiko; Arai, Mari; Uotani, Chizue; Yoshida, Mariko; Miyakawa, Kyohei; Kakihara, Tomo; Iwanaka, Tadashi			Thoracoscopic Plication for Diaphragmatic Eventration After Surgery for Congenital Heart Disease in Children	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							PEDIATRIC CARDIAC-SURGERY; PHRENIC-NERVE PALSY; CLINICAL-IMPLICATIONS; PARALYSIS; MANAGEMENT; INFANTS; REPAIR	Objective: The aim of this study was to clarify the role of thoracoscopic plication for diaphragmatic eventration after surgery for congenital heart disease (CHD) in children. Patients and Methods: We retrospectively reviewed the medical charts of pediatric patients who had undergone thoracoscopic plication of diaphragmatic eventration after surgery for CHD between 2008 and 2013 at our department. Results: Five patients were identified during the study period. The median age and body weight of the patients were 7.6 months and 6.6 kg, respectively. The associated CHDs were pulmonary artery atresia in 3 patients, truncus arteriosus in 1 patient, and double-outlet right ventricle in 1 patient. Four patients needed preoperative mechanical respiratory support. At operation, all the patients received CO2 insufflation (4 mm Hg), and single-lung ventilation was attempted in 3 patients using a bronchial blocker. A sufficient operative field was maintained by CO2 insufflation in all the patients regardless of single-lung ventilation. The procedure was not converted to open operation in any patient. Postoperative extubation was performed in the operating room in 1 patient, on the day of operation in 2 patients, and on postoperative Days 1 and 2 in 2 patients. Air embolism was not observed in any of the patients. Diaphragmatic eventration did not recur in any of the patients after thoracoscopic plication. Conclusions: Thoracoscopic plication is a safe and effective procedure for pediatric diaphragmatic eventration after surgery for CHD. Considering the sufficient operative field maintained by CO2 insufflation, single-lung ventilation using a bronchial blocker would be unnecessary for this procedure. With its safety and good outcome, early thoracoscopic plication is a good treatment option for pediatric patients with symptomatic diaphragmatic eventration after surgery for CHD.	[Fujishiro, Jun; Ishimaru, Tetsuya; Sugiyama, Masahiko; Arai, Mari; Uotani, Chizue; Yoshida, Mariko; Miyakawa, Kyohei; Kakihara, Tomo; Iwanaka, Tadashi] Univ Tokyo, Fac Med, Dept Pediat Surg, Tokyo 1138655, Japan	Fujishiro, J (reprint author), Univ Tokyo, Fac Med, Dept Pediat Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	jfujishi-tky@umin.ac.jp					Abraham Mohan K, 2003, Indian Pediatr, V40, P1088; Amin Z, 2001, J THORAC CARDIOV SUR, V122, P856, DOI 10.1067/mtc.2001.118506; KUNOVSKY P, 1993, EUR J CARDIO-THORAC, V7, P342, DOI 10.1016/1010-7940(93)90063-H; Lemmer J, 2007, INTENS CARE MED, V33, P1985, DOI 10.1007/s00134-007-0717-9; Lemmer J, 2006, INTENS CARE MED, V32, P1227, DOI 10.1007/s00134-006-0208-4; Becmeur F, 2005, J PEDIATR SURG, V40, P1712, DOI 10.1016/j.jpedsurg.2005.07.008; Cherian A, 2004, PEDIATR SURG INT, V20, P872, DOI 10.1007/s00383-004-1154-2; de Leeuw M, 1999, J THORAC CARDIOV SUR, V118, P510, DOI 10.1016/S0022-5223(99)70190-X; Guvenc BH, 2004, J LAPAROENDOSC ADV A, V14, P302, DOI 10.1089/lap.2004.14.302; HALLER JA, 1979, J PEDIATR SURG, V14, P779; Hines MH, 2003, ANN THORAC SURG, V76, P234, DOI 10.1016/S0003-4975(03)00177-2; Joho-Arreola AL, 2005, EUR J CARDIO-THORAC, V27, P53, DOI 10.1016/j.ejcts.2004.10.002; Knight S R, 1998, Ann Thorac Cardiovasc Surg, V4, P240; Ovroutski S, 2005, EUR J CARDIO-THORAC, V27, P561, DOI 10.1016/j.ejcts.2004.12.0044; Takahashi T, 2013, ANN THORAC CARDIOVAS, V19, P243, DOI 10.5761/atcs.cr.12.01907; Talwar Sachin, 2010, Ann Pediatr Cardiol, V3, P50, DOI 10.4103/0974-2069.64370; Tanaka Y, 2011, ASIAN J ENDOSC SURG, V3, P169; Tonz M, 1996, J PEDIATR SURG, V31, P1265, DOI 10.1016/S0022-3468(96)90247-X; van Onna IEW, 1998, EUR J CARDIO-THORAC, V14, P179, DOI 10.1016/S1010-7940(98)00147-X; WATANABE T, 1987, J THORAC CARDIOV SUR, V94, P383	20	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	APR 1	2015	25	4					348	351		10.1089/lap.2014.0260		4	Surgery	Surgery	CF3UC	WOS:000352473200017		
J	Ikeo, R				Ikeo, Reiko			'Like'-similes in a 1st-person narrative: Kazuo Ishiguro's Never Let Me Go	JOURNAL OF LITERARY SEMANTICS			English	Article						like-similes; Ishiguro; blending; human clones; point of view	METAPHORS	Kathy's 1st-person narrative in Kazuo Ishiguro's Never Let Me Go depicts the relationships among three leading characters, Kathy, Ruth and Tommy, who live in a near-contemporary world, where (we slowly grasp) some human clones are raised to be a source of replacement organs for non-cloned humans in ill health. Kathy and her friends are three such clones. Figurative expressions in Kathy's narrative tend to appear in the form of similes or with explicit markers of similitude such as 'like' and 'the sort', and the frequency of 'like' is particularly high. The primary focus of this paper is to examine the effects which are achieved by 'like'-similes and how they contribute to constructing the fictional world of the novel. 'Like' is used here with syntactic flexibility and semantic versatility and these 'like'-similes are predominantly used to describe the characters' actions, intentions, emotions and the situations in which they act. As the three friends grow older and approach the final phase of their lives, when they will be organ donors, the characters' viewpoints and the narrator's presentation of them shift. Through an array of 'like'-similes, the 1st-person narrator consistently interprets other characters' internal states and signals the way she is making assumptions about them and the surrounding environments.	Senshu Univ, Tama Ku, Kawasaki, Kanagawa 2148580, Japan	Ikeo, R (reprint author), Senshu Univ, Tama Ku, 2-1-1 Higashimita, Kawasaki, Kanagawa 2148580, Japan.	rikeo0919@gmail.com					Adams Tim, 2005, THE OBSERVER; Andersen G, 2000, PRAG BEYOND NEW SER, V79, P17; Chiappe D, 2003, METAPHOR SYMBOL, V18, P85, DOI 10.1207/S15327868MS1802_2; Aristotle, 1959, THE ART OF RHETORIC; BENPORAT Z, 1992, POETICS TODAY, V13, P737, DOI 10.2307/1773297; BETHLEHEM LS, 1996, POETICS TODAY, V17, P203, DOI 10.2307/1773356; BLACKBURN MJ, 1993, MATER DESIGN, V14, P19, DOI 10.1016/0261-3069(93)90041-S; Cameron L, 2003, METAPHOR SYMBOL, V18, P149, DOI 10.1207/S15327868MS1803_02; Dancygier Barbara, 2005, MENTAL SPACES IN GRA; Darian Steven G., 1973, LANG STYLE, V6, P48; Fauconnier Gilles, 2002, THE WAY WE THINK CON; Genette Gerard, 1982, FIGURES LIT DISCOURS, P103; Glucksberg S, 2008, CAMB HANDB PSYCHOL, P67; Glucksberg S., 1993, METAPHOR THOUGHT, P401; Glucksberg Sam, 2001, UNDERSTANDING FIGURA; Goatly Andrew, 2011, THE LANGUAGE OF META; Ishiguro K, 2005, NEVER LET ME GO; Israel Michael, 2004, LANGUAGE CULTURE MIN, P123; Lakoff G, 1980, METAPHORS WE LIVE BY; Lakoff George, 1989, MORE THAN COOL REASO; Leech G., 2007, STYLE IN FICTION; Leech G, 1969, LINGUISTIC GUIDE ENG; Lewis Barry, 2011, K ISHIGURO NEW CRITI, P199; Mack Dorothy, 1975, POETICS, V4, P251; Miller George A., 1993, METAPHOR THOUGHT, P357; MILLER J, 1995, J PRAGMATICS, V23, P365, DOI 10.1016/0378-2166(94)00044-F; Mullan John, 2006, THE GUARDIAN CULTURE; NPR, 2011, NEVER LET ME GO; Ortony A., 1993, METAPHOR THOUGHT, P342; Quirk R., 1985, COMPREHENSIVE GRAMMA; Sawyer Andy, 2011, KAZUO ISHIGURO NEW C, P236; Semino E, 2008, METAPHOR IN DISCOURSE, P1; Shen Y, 2008, CAMB HANDB PSYCHOL, P295; Shen Yeshayahu, 1997, COGN LINGUIST, V8, P37; Spiegel Online International, 2005, COMMUNICATION; Turner Mark, 1996, THE LITERARY MIND TH; UNDERHILL R, 1988, AM SPEECH, V63, P234, DOI 10.2307/454820	37	0	0	DE GRUYTER MOUTON	BERLIN	GENTHINER STRASSE 13, 10785 BERLIN, GERMANY	0341-7638	1613-3838		J LITERARY SEMANTICS	J. Lit. Sem.	APR	2015	44	1					45	68		10.1515/jls-2015-0004		24	Language & Linguistics; Literature	Linguistics; Literature	CE5DD	WOS:000351849600003		
J	Nomura, H; Matoda, M; Okamoto, S; Kondo, E; Omatsu, K; Kato, K; Takeshima, N				Nomura, Hidetaka; Matoda, Maki; Okamoto, Sanshiro; Kondo, Eiji; Omatsu, Kohei; Kato, Kazuyoshi; Takeshima, Nobuhiro			Clinicopathologic Features and Treatment Outcomes of Primary Extramammary Paget Disease of the Vulva	JOURNAL OF LOWER GENITAL TRACT DISEASE			English	Article						extramammary; treatment outcome; Paget disease; rare tumors	EXCISION; RADIOTHERAPY; RECURRENCE	Objective: The aim of this study was to identify the clinicopathologic features and treatment outcome of primary extramammary Paget disease of the vulva (EMPDV). Materials and Methods: We performed a retrospective analysis of 14 patients who were treated at our center from April 1994 to November 2010. Results: The mean age of patients in our sample was 64.4 years (range = 47-83 y). We observed intraepithelial and invasive EMPDV in 11 (78.6%) and 3 (21.4%) patients, respectively. Moreover, we observed a positive incision margin in 9 patients (64.3%). During a median follow-up period of 69.5 months (range = 32-221 mo), we observed recurrence in 3 patients (21.4%), 2 of whom had invasive EMPDV and 1 had intraepithelial EMPDV. Time to recurrence was 16 and 18 months for patients with invasive EMPDV and 98 months for patients with intraepithelial EMPDV. The recurrence rate of intraepithelial EMPDV and invasive EMPDV was significantly different (9.1% and 66.7%, respectively, p < .028). Local recurrence occurred in all 3 patients, necessitating further surgical resection. One patient with recurrence of invasive EMPDV received adjuvant radiotherapy but died 101 months after the initial treatment. The other 2 patients remained alive without recurrence. We did not observe distant recurrence. Conclusions: The recurrence rate of invasive EMPDV was high. However, because distant metastasis is rare, repeat surgical excision for recurrent EMPDV and long-term observation are necessary for a good prognosis.	[Nomura, Hidetaka; Matoda, Maki; Okamoto, Sanshiro; Kondo, Eiji; Omatsu, Kohei; Kato, Kazuyoshi; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Tokyo 1358550, Japan	Nomura, H (reprint author), Canc Inst Hosp, Dept Gynecol, Koto Ku, Ariake 3-8-31, Tokyo 1358550, Japan.	hidetaka.nomura@jfcr.or.jp					Black D, 2007, GYNECOL ONCOL, V104, P547, DOI 10.1016/j.ygyno.2006.09.017; Yanagi T, 2007, CLIN EXP DERMATOL, V32, P506, DOI 10.1111/j.1365-2230.2007.02425.x; Cai YP, 2013, GYNECOL ONCOL, V129, P412, DOI 10.1016/j.ygyno.2013.02.029; KODAMA S, 1995, GYNECOL ONCOL, V56, P63, DOI 10.1006/gyno.1995.1010; Tebes S, 2002, AM J OBSTET GYNECOL, V187, P281, DOI 10.1067/mob.2002.125700; Fanning J, 1999, AM J OBSTET GYNECOL, V180, P24, DOI 10.1016/S0002-9378(99)70143-2; Parker LP, 2000, GYNECOL ONCOL, V77, P183, DOI 10.1006/gyno.2000.5741; Karam A, 2012, GYNECOL ONCOL, V125, P346, DOI 10.1016/j.ygyno.2012.01.032; FISHMAN DA, 1995, GYNECOL ONCOL, V56, P266, DOI 10.1006/gyno.1995.1044; Guerrieri Mario, 2002, Australas Radiol, V46, P204, DOI 10.1046/j.1440-1673.2001.01039.x; Jones ISC, 2011, GYNECOL ONCOL, V122, P42, DOI 10.1016/j.ygyno.2011.03.033; Lee CW, 2011, EUR J GYNAECOL ONCOL, V32, P34; Luk NM, 2003, CLIN EXP DERMATOL, V28, P360, DOI 10.1046/j.1365-2230.2003.01301.x; Roh HJ, 2010, ACTA OBSTET GYN SCAN, V89, P962, DOI 10.3109/00016341003674905; Shaco-Levy R, 2010, EUR J OBSTET GYN R B, V149, P86, DOI 10.1016/j.ejogrb.2009.11.003; Wilkinson EJ, 2002, HUM PATHOL, V33, P549, DOI 10.1053/hupa.2002.124788	16	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1089-2591	1526-0976		J LOW GENIT TRACT DI	J. Low. Genit. Tract. Dis.	APR	2015	19	2					145	148				4	Obstetrics & Gynecology	Obstetrics & Gynecology	CE5OB	WOS:000351883900031		
J	Kusaka, Y; Koutake, M; Ushijima, H				Kusaka, Yasuyuki; Koutake, Masayoshi; Ushijima, Hirobumi			Fabrication of embedded electrodes by reverse offset printing	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						printed electronics; embedded electrode; thin film transistor; interconnect; patterning	THIN-FILM TRANSISTORS; CHARGE-TRANSPORT; PERFORMANCE; INKJET; ANTHRADITHIOPHENE; SEMICONDUCTOR; PATTERNS	We developed a novel offset-printing process that permits the fabrication of silver-nanoparticle electrodes embedded in a dielectric layer. We succeeded in embedding approximately 1 mu m thick silver electrodes to a dielectric layer with thickness ratio of 1:1.4. The surface-height difference between the embedded electrode and the surrounded dielectric layer was less than 80 nm. By virtue of the surface uniformity of this embedding process, the interconnect breakage of orthogonal wires printed on top of the underlying wire was drastically reduced to 4%, compared to 41% for non-embedded wires. The electric conductivity of embedded electrodes with thickness approximate to 110 nm was about 10 mu Omega cm(-1), which was comparable to that of a silver pattern formed on a glass substrate alone. We also examined the characteristics of fully printed thin-film transistors composed of the embedded electrodes, and measured an average mobility of 0.07 cm(2) V(-1)s(-1). These results demonstrate the applicability of the proposed technique to the fabrication of printed circuits and devices including active elements.	[Kusaka, Yasuyuki; Ushijima, Hirobumi] Natl Inst Adv Ind Sci & Technol, Flexible Elect Res Ctr, Tsukuba Cent 5, Tsukuba, Ibaraki 3058565, Japan; [Koutake, Masayoshi] DIC Corp, Sakura, Chiba 2858668, Japan	Kusaka, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Flexible Elect Res Ctr, Tsukuba Cent 5, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	y-kusaka@aist.go.jp			 [26889075]	This research was financially supported for a part by Grant-in-Aid for Research Activity Start-up (Project No. 26889075). The authors gratefully acknowledge the technical assistance of M Fujita.	Diaz E, 2013, LANGMUIR, V29, P12608, DOI 10.1021/la402101d; Leufgen M, 2004, APPL PHYS LETT, V84, P1582, DOI 10.1063/1.1652233; Subramanian S, 2008, J AM CHEM SOC, V130, P2706, DOI 10.1021/ja073235k; Gundlach DJ, 2008, NAT MATER, V7, P216, DOI 10.1038/nmat2122; Salmeron JF, 2014, J ELECTRON MATER, V43, P604, DOI 10.1007/s11664-013-2893-4; Jang Y, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/15/155103; Dickey KC, 2006, ADV MATER, V18, P1721, DOI 10.1002/adma.200600188; Kim SJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742324; Zhang L, 2010, J MATER CHEM, V20, P7059, DOI 10.1039/c0jm00331j; Hambsch M, 2010, MATER SCI ENG B-ADV, V170, P93, DOI 10.1016/j.mseb.2010.02.035; Zuliani C, 2014, ELECTROCHIM ACTA, V132, P292, DOI 10.1016/j.electacta.2014.03.140; Minari T, 2014, ADV FUNCT MATER, V24, P4886, DOI 10.1002/adfm.201400169; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Lee TM, 2010, THIN SOLID FILMS, V518, P3355, DOI 10.1016/j.tsf.2009.10.017; Kusaka Y, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035020; Nomura K, 2014, MICROELECTRON ENG, V123, P58, DOI 10.1016/j.mee.2014.05.009; Galagan Y, 2011, SOL ENERG MAT SOL C, V95, P1339, DOI 10.1016/j.solmat.2010.08.011; Chen JH, 2014, NANOSCALE, V6, P449, DOI 10.1039/c3nr04341j; Pudas M, 2005, PROG ORG COAT, V54, P310, DOI 10.1016/j.porgcoat.2005.07.008; Azarova NA, 2010, ORG ELECTRON, V11, P1960, DOI 10.1016/j.orgel.2010.09.008; Madaria AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245201; Kim M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4755878; Hamilton R, 2009, ADV MATER, V21, P1166, DOI 10.1002/adma.200801725; Kang JS, 2010, J MATER SCI-MATER EL, V21, P1213, DOI 10.1007/s10854-009-0049-3; Singh M, 2010, ADV MATER, V22, P673, DOI 10.1002/adma.200901141; Jung Y, 2008, ADV FUNCT MATER, V18, P742, DOI 10.1002/adfm.200701089; Cho SY, 2012, ORG ELECTRON, V13, P1329, DOI 10.1016/j.orgel.2012.04.007; Kang D, 2014, J APPL PHYS, V115, DOI 10.1063/1.4882020; Kina O, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.01AB07; Kumatani A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01026; Leppaniemi J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/30/305204; Li Y, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/2/024203; Martinez-Olmos A, 2013, ANAL CHEM, V85, P11098, DOI 10.1021/ac4028802; Park SK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2952769; Singh KB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218302; Takamatsu S, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/7/075017; Whiting GL, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3276913	37	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	APR	2015	25	4							045017	10.1088/0960-1317/25/4/045017		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CE5AF	WOS:000351841400018		
J	Pal, P; Gosalvez, MA; Sato, K; Hida, H; Xing, Y				Pal, Prem; Gosalvez, Miguel A.; Sato, Kazuo; Hida, H.; Xing, Yan			Anisotropic etching on Si{1 1 0}: experiment and simulation for the formation of microstructures with convex corners (vol 24, 125001, 2014)	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Correction									[Pal, Prem] Indian Inst Technol, MEMS, Hyderabad, Andhra Pradesh, India; [Pal, Prem] Indian Inst Technol, Dept Phys, Micronano Syst Lab, Hyderabad, Andhra Pradesh, India; [Gosalvez, Miguel A.] Univ Basque Country, UPV EHU, Dept Mat Phys, Donostia San Sebastian 20018, Spain; [Gosalvez, Miguel A.] Univ Basque Country, CSIC, Ctr Mixto, Ctr Fis Mat, Donostia San Sebastian 20018, Spain; [Gosalvez, Miguel A.] DIPC, Donostia San Sebastian 20018, Spain; [Sato, Kazuo] Aichi Inst Technol, Dept Mech Engn, Aichi, Japan; [Hida, H.] Kobe Univ, Dept Engn, Machine Dynam Lab, Kobe, Hyogo, Japan; [Xing, Yan] Southeast Univ, Dept Mech Engn, Lab Micronano Med Devices, Nanjing, Jiangsu, Peoples R China	Pal, P (reprint author), Indian Inst Technol, MEMS, Hyderabad, Andhra Pradesh, India.	prem@iith.ac.in	Hida, Hirotaka/J-2100-2014; DONOSTIA INTERNATIONAL PHYSICS CTR., DIPC/C-3171-2014; CSIC-UPV/EHU, CFM/F-4867-2012	Hida, Hirotaka/0000-0002-4749-1893; 			Pal P, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/12/125001	1	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	APR	2015	25	4							049601	10.1088/0960-1317/25/4/049601		1	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CE5AF	WOS:000351841400023		
J	Seo, YJ; Toda, M; Ono, T				Seo, Yong-Jun; Toda, Masaya; Ono, Takahito			Si nanowire probe with Nd-Fe-B magnet for attonewton-scale force detection	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						silicon nanowire; magnetic resonance force microscopy; force detection	SILICON CANTILEVERS; RESONANCE; MICROSCOPY; RESOLUTION; OSCILLATOR	In this study, we have developed a 210 nm-wide and 32 mu m-long silicon nanowire probe with a silicon mirror using a silicon-on-insulator wafer in order to improve sensitivity of force detection for magnetic resonance force microscopy (MRFM). Additionally, a Nd-Fe-B magnet has been integrated at the end of the nanowire. The fabricated nanowire probe shows a resonance frequency of 11.256 kHz and a factor of 12 800 after annealing at 800 degrees C for 2 h in forming gas. The probe exhibits attonewton sensitivity, and the measurement of force mapping based on electron spin resonance is demonstrated for 3D imaging of radicals. The detected force and magnetic field gradient are approximately 82 aN and similar to 70.1 G mu m(-1) at room temperature. The radical density is calculated as 4.6 x 10(18) spins cm(-3).	[Seo, Yong-Jun; Toda, Masaya; Ono, Takahito] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan	Seo, YJ (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan.	seo@nme.mech.tohoku.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS)	Parts of this work were performed in the Micro/Nanoma-chining Research Education Center (MNC) and Micro System Integration Center (mu SIC) of Tohoku University. This work was supported in part by Special Coordination Funds for Promoting Science and Technology, Formation of Innovation Center for Fusion of Advanced Technologies from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), also supported in part by Grant- in Aid for Young Scientists from Japan Society for the Promotion of Science (JSPS).	SIDLES JA, 1991, APPL PHYS LETT, V58, P2854, DOI 10.1063/1.104757; Gil-Santos E, 2010, NAT NANOTECHNOL, V5, P641, DOI [10.1038/nnano.2010.151, 10.1038/NNANO.2010.151]; Nichol JM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054414; Stowe TD, 1997, APPL PHYS LETT, V71, P288, DOI 10.1063/1.119522; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Poggio M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/34/342001; Mamin HJ, 2007, NAT NANOTECHNOL, V2, P301, DOI 10.1038/nnano.2007.105; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Schwab KC, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2012461; Mouaziz S, 2006, MICROELECTRON ENG, V83, P1306, DOI 10.1016/j.mee.2006.01.218; Lee SC, 2001, J MAGN RESON, V150, P207, DOI 10.1006/jmre.2001.2319; BRULAND KJ, 1995, REV SCI INSTRUM, V66, P2853, DOI 10.1063/1.1145567; Chaste J, 2012, NAT NANOTECHNOL, V7, P300, DOI [10.1038/nnano.2012.42, 10.1038/NNANO.2012.42]; Cleland A. N., 2003, FDN NANOMECHANICS SO; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Golriz AA, 2011, NANOSCALE, V3, P5049, DOI 10.1039/c1nr10917k; Minard KR, 2002, J MAGN RESON, V154, P336, DOI 10.1006/jmre.2001.2494; Seeber DA, 2002, APPL MAGN RESON, V22, P139, DOI 10.1007/BF03166098; SIDLES JA, 1992, REV SCI INSTRUM, V63, P3881, DOI 10.1063/1.1143837; Tsuji S, 2004, J MAGN RESON, V167, P211, DOI 10.1016/j.jmr.2003.12.011; ZUGER O, 1993, APPL PHYS LETT, V63, P2496	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	APR	2015	25	4							045015	10.1088/0960-1317/25/4/045015		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CE5AF	WOS:000351841400016		
J	Dallai, R; Thipaksorn, A; Gottardo, M; Mercati, D; Machida, R; Beutel, RG				Dallai, Romano; Thipaksorn, Apisit; Gottardo, Marco; Mercati, David; Machida, Ryuichiro; Beutel, Rolf Georg			The Sperm Structure of Cryptocercus punctulatus Scudder (Blattodea) and Sperm Evolution in Dictyoptera	JOURNAL OF MORPHOLOGY			English	Article						insect sperm structure; termite sperm; polyneopteran sperm; insect phylogeny	PHYLOGENETIC IMPLICATIONS; MASTOTERMES-DARWINIENSIS; WING BASE; INSECTA; SPERMATOZOON; ARTHROPODA; ZORAPTERA; MANTOPHASMATODEA; TERMITES; COCKROACHES	Sperm of the dictyopteran key taxon Cryptocercus punctulatus was examined. It has largely maintained a blattodean groundplan condition, with a three-layered acrosome, an elongate nucleus, a single centriole, a conspicuous centriole adjunct material, two connecting bands (=accessory bodies), and a long functional flagellum with a 9+9+2 axoneme provided with accessory tubules with 16 protofilaments and intertubular material. These sperm characters are shared with several other polyneopterans. The sperm of C. punctulatus is very similar to what is found in Periplaneta americana and species of other groups of roaches, including the sperm of Loboptera decipiens described here for the first time. The general sperm organization here described can be assumed for the groundplan of Insecta and Pterygota. The following evolutionary path can be suggested: after the split between Cryptocercidae and the common ancestor of Isoptera, the typical pattern of sperm formation was altered very distinctly, resulting in a duplication or multiplication (Mastotermitidae) of the centrioles. Mastotermes has maintained a certain sperm motility, but with a very unusual apparatus of multiple flagella with a 9+0 axoneme pattern. After the split into Mastotermitidae and the remaining Isoptera, sperm motility was completely abandoned, and different modifications of sperm components occurred, and even the loss of the sperm flagellum. (C) 2014 Wiley Periodicals, Inc.	[Dallai, Romano; Gottardo, Marco; Mercati, David] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Thipaksorn, Apisit; Machida, Ryuichiro] Univ Tsukuba, Sugadaira Montane Res Ctr, Nagano 3862204, Japan; [Thipaksorn, Apisit] Kasetsart Univ, Dept Zool, ASESRU, Fac Sci, Bangkok 10900, Thailand; [Beutel, Rolf Georg] Univ Jena, Phyletischem Museum, Inst Spezielle Zool & Evolut Biol, Entomol Grp, D-07743 Jena, Germany	Dallai, R (reprint author), Univ Siena, Dept Life Sci, Via A Moro 2, I-53100 Siena, Italy.	romano.dallai@unisi.it		Dallai, Romano/0000-0002-2258-8891			Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Dallai R, 2012, ARTHROPOD STRUCT DEV, V41, P337, DOI 10.1016/j.asd.2012.01.003; Klass Klaus-Dieter, 2006, Entomologische Abhandlungen (Dresden), V63, P3; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; Mashimo Y, 2014, J MORPHOL, V275, P295, DOI 10.1002/jmor.20215; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Yoshizawa K, 2005, MOL PHYLOGENET EVOL, V37, P572, DOI 10.1016/j.ympev.2005.05.008; Letsch HO, 2012, P ROY SOC B-BIOL SCI, V279, P3282, DOI 10.1098/rspb.2012.0744; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Dallai R, 2003, ZOOMORPHOLOGY, V122, P67, DOI 10.1007/s00435-002-0070-z; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Jarvis KJ, 2005, SYST ENTOMOL, V30, P442, DOI 10.1111/j.1365-3113.2004.00276.x; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; Letsch H, 2013, SYST ENTOMOL, V38, P783, DOI 10.1111/syen.12028; Riparbelli MG, 2009, CELL MOTIL CYTOSKEL, V66, P248, DOI 10.1002/cm.20352; Yoshizawa K, 2007, SYST ENTOMOL, V32, P197, DOI 10.1111/j.1365-3113.2007.00379.x; Inward D, 2007, BIOLOGY LETT, V3, P331, DOI 10.1098/rsbl.2007.0102; BACCETTI B, 1981, INT J INVER REP DEV, V3, P87; BACCETTI B, 1978, J CELL BIOL, V76, P569, DOI 10.1083/jcb.76.3.569; BACCETTI B, 1974, J MICROSC-OXFORD, V21, P159; BACCETTI B, 1977, J ULTRA MOL STRUCT R, V61, P260, DOI 10.1016/S0022-5320(77)80051-8; Beutel RG, 2013, ATTI ACCADEMIA NAZL, VLXI, P133; Beutel RG, 2013, INSECT MORPHOLOGY PH, P516; BRELAND OP, 1968, ANN ENTOMOL SOC AM, V61, P1037; Callaini G, 1999, BIOL CELL, V91, P355, DOI 10.1016/S0248-4900(99)80096-3; Cameron Stephen L., 2006, Arthropod Systematics & Phylogeny, V64, P27; Costa JT, 2006, OTHER INSECT SOC; DALLAI R, 1990, J STRUCT BIOL, V103, P164, DOI 10.1016/1047-8477(90)90020-D; Dallai R, 2007, ZOOMORPHOLOGY, V126, P53, DOI 10.1007/s00435-007-0030-8; Dallai R, 1999, MALE GAMETE: FROM BASIC SCIENCE TO CLINICAL APPLICATIONS, P333; Dallai R, 2005, ZOOMORPHOLOGY, V124, P205, DOI 10.1007/s00435-005-0007-4; Deitz Lewis L., 2003, Entomologische Abhandlungen (Dresden), V61, P69; DESALLE R, 1992, SCIENCE, V257, P1933, DOI 10.1126/science.1411508; Djernaes M, 2014, MOL PHYLOGE IN PRESS, DOI [10.1016/ j. ympev. 2014.08.019, DOI 10.1016/J.YMPEV.2014.08.019]; Gonzalez C, 1998, J CELL SCI, V111, P2697; Hennig W., 1969, STAMMESGESCHICHTE IN, P436; Jamieson BGM, 1999, INSECTS THEIR SPERMA, P555; Kristensen N. P., 1975, J ZOOL SYST EVOL RES, V13, P1, DOI DOI 10.1111/J.1439-0469.1975.TB00226.X; Kristensen NP., 1991, INSECTS AUSTR, V2, P125; Matsuura K., 2011, BIOL TERMITES MODERN, P321; Ohkuma M, 2009, P R SOC B, V276, P239, DOI 10.1098/rspb.2008.1094; Rosati F., 1967, Bollettino di Zoologia, V34, P167; Shahaney DM, 1972, INT J INSECT MORPHOL, V1, P121, DOI 10.1016/0020-7322(72)90018-9; THORNE BL, 1992, SYST ENTOMOL, V17, P253, DOI 10.1111/j.1365-3113.1992.tb00336.x; Wang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053679; Wipfler B, 2014, CLADISTICS IN PRESS, DOI [10. 1111/ cla. 12068, DOI 10.1111/CLA.12068]	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-2525	1097-4687		J MORPHOL	J. Morphol.	APR	2015	276	4					361	369		10.1002/jmor.20345		9	Anatomy & Morphology	Anatomy & Morphology	CE3OJ	WOS:000351735900001		
J	Miyazaki, T; Kobayashi, M				Miyazaki, Taeko; Kobayashi, Masashi			Morphological Characteristics of Eyes and Retinas of Two Sardines (Sardinops melanostictus and Etrumeus sadina, Clupeidae) and an anchovy (Engraulis japonicus, Engraulididae)	JOURNAL OF MORPHOLOGY			English	Article						black-pigmented lens muscle; retinal ganglion cell; scattered light blocking; visual ecology	GANGLION-CELLS; REEF TELEOSTS; SPECTRAL SENSITIVITY; SOUTHERN BENGUELA; FISH SCHOOLS; PHOTORECEPTORS; TOPOGRAPHY; CONES; ENCRASICOLUS; SAGAX	The morphology of the eyes and distribution of retinal ganglion cells in two sardine species (Sardinops melanostictus and Etrumeus sadina, Clupeidae) and the Japanese anchovy (Engraulis japonicus, Engraulididae) were investigated anatomically and histologically. The eyes of the sardines faced a slightly dorsolateral direction with the visual field extended obliquely upward. In contrast, the eyes in the anchovy were almost laterally directed. It was hypothesized that the sardines may have an advantage in receiving more downward irradiance compared with the anchovy. The lens muscle was larger in these three species than in many other teleosts, and its surface was entirely melanin-pigmented. Also, the lens muscle directly and tightly adhered to the backside surface of the iris. The relative area of the lens muscle to the area of the lens, a referential value of the relative power of visual accommodation were notably larger in the species studied than in other teleost values that have been previously reported. A higher M/L% value of these clupeid fishes could facilitate fast and wide ranging visual accommodation and was considered to be associated with maintaining and/or re-establishing school formations quickly. Analysis of topographical distributions of cells in the ganglion cell layer showed that cell density was highest in the ventrotemporal quadrant of the retina (temporal of the optic cleft) in all three species. Another potentially important role for the black-pigmented lens muscle may be to block the specialized retinal area from intense sunlight that scatters and irradiates upward or laterally in the surface waters that they inhabit. Thus, the sardine and anchovy may take advantage of efficient detection of visual signals in the frontal-upward direction and further improve visibility of the target in this direction. (C) 2014 Wiley Periodicals, Inc.	[Miyazaki, Taeko; Kobayashi, Masashi] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie 5148507, Japan	Miyazaki, T (reprint author), Mie Univ, Grad Sch Bioresources, Kurima Machiya Cho, Tsu, Mie 5148507, Japan.	taeko@bio.mie-u.ac.jp			Japan Society for the Promotion of Science [23570113]; Kakushin Educational Foundation from Kakuda Pearl Co. Ltd.	Contract grant sponsor: the Japan Society for the Promotion of Science; Grant number: 23570113; Contract grant sponsor: Kakushin Educational Foundation from Kakuda Pearl Co. Ltd.	Van der Lingen CD, 2002, S AFR J MARINE SCI, V24, P301; Kondrashev SL, 2012, VISION RES, V68, P19, DOI 10.1016/j.visres.2012.07.005; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; NEILL SRS, 1974, J ZOOL, V172, P549; van der Lingen CD, 2006, AFR J MAR SCI, V28, P465, DOI 10.2989/18142320609504199; PARTRIDGE BL, 1980, J COMP PHYSIOL, V135, P315; FINERAN BA, 1978, PHILOS T ROY SOC B, V283, P25, DOI 10.1098/rstb.1978.0017; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P283, DOI 10.1159/000116595; COLLIN SP, 1988, EXP BIOL, V47, P195; COLLIN SP, 1989, BRAIN BEHAV EVOLUT, V34, P184, DOI 10.1159/000116504; Kino M, 2009, ENVIRON BIOL FISH, V85, P33, DOI 10.1007/s10641-009-9453-z; MAGURRAN AE, 1990, ANN ZOOL FENN, V27, P51; FINERAN BA, 1976, J ULTRA MOL STRUCT R, V54, P296, DOI 10.1016/S0022-5320(76)80158-X; Hess M, 2006, J MORPHOL, V267, P1356, DOI 10.1002/jmor.10482; Miyazaki T, 2002, ZOOL SCI, V19, P1223, DOI 10.2108/zsj.19.1223; Beer T., 1894, PFLUGERS ARCH GES PH, V58, P523, DOI 10.1007/BF01671307; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P269, DOI 10.1159/000116594; HANYU ISAO, 1959, BULL JAPANESE SOC SCI FISH, V25, P595; Hess M, 2009, VISION RES, V49, P1569, DOI 10.1016/j.visres.2009.03.016; ITO H, 1984, J COMP NEUROL, V229, P80, DOI 10.1002/cne.902290107; JANSSEN J, 1981, LIMNOL OCEANOGR, V26, P1168; Kaltenberg AM, 2009, MAR ECOL PROG SER, V394, P247, DOI 10.3354/meps08252; Koch PC, 2011, J NEUROSCI RES, V89, P1316, DOI 10.1002/jnr.22651; Koch PC, 2010, J NEUROSCI METH, V188, P127, DOI 10.1016/j.jneumeth.2010.01.030; Konchina Y. V., 1991, J ICHTHYOLOGY, V31, P59; Kondrashev SL, 2013, J EXP BIOL, V216, P1041, DOI 10.1242/jeb.078980; Kondrashev SL, 2011, RUSS J MAR BIOL+, V37, P143, DOI 10.1134/S1063074011020064; Louw GG, 1998, S AFR J MARINE SCI, V19, P227; Makino A, 2010, J MOLLUS STUD, V76, P180, DOI 10.1093/mollus/eyp055; Matsuoka M, 1999, FISHERIES SCI, V65, P224; Matthiessen L, 1886, PFLUGERS ARCH, V38, P521, DOI 10.1007/BF01654675; Miyazaki T., 2013, FISH PHYSIOL BIOCHEM, V40, P23; O'Connell, 1963, J MORPHOL, V113, P287; PARTRIDGE BL, 1982, SCI AM, V246, P114; Pitcher T. J., 1993, BEHAV TELEOST FISHES, P363; Reckel F, 2001, ACTA ZOOL-STOCKHOLM, V82, P89, DOI 10.1046/j.1463-6395.2001.00071.x; Reckel F, 2004, J MORPHOL, V260, P13, DOI 10.1002/jmor.10215; SOMIYA H, 1987, PROC R SOC SER B-BIO, V230, P77, DOI 10.1098/rspb.1987.0010; SOMIYA H, 1973, Japanese Journal of Ichthyology, V20, P193; Strandburg-Peshkin A, 2013, CURR BIOL, V23, pR709, DOI 10.1016/j.cub.2013.07.059	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-2525	1097-4687		J MORPHOL	J. Morphol.	APR	2015	276	4					415	424		10.1002/jmor.20350		10	Anatomy & Morphology	Anatomy & Morphology	CE3OJ	WOS:000351735900006		
J	Sakata, A; Okada, T; Yamamoto, A; Kanagaki, M; Fushimi, Y; Okada, T; Dodo, T; Arakawa, Y; Schmitt, B; Miyamoto, S; Togashi, K				Sakata, Akihiko; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Fushimi, Yasutaka; Okada, Tsutomu; Dodo, Toshiki; Arakawa, Yoshiki; Schmitt, Benjamin; Miyamoto, Susumu; Togashi, Kaori			Grading glial tumors with amide proton transfer MR imaging: different analytical approaches	JOURNAL OF NEURO-ONCOLOGY			English	Article						Magnetic resonance imaging; Amide proton transfer imaging; Chemical exchange saturation transfer; Glioma grading	EXCHANGE SATURATION-TRANSFER; HUMAN BRAIN-TUMORS; INTRATUMOR HETEROGENEITY; RADIATION NECROSIS; CONTRAST AGENTS; TRANSFER CEST; WEIGHTED MRI; GLIOMAS; GLIOBLASTOMA; ENHANCEMENT	Amide proton transfer (APT) magnetic resonance imaging is gaining attention for its capability for grading glial tumors. Usually, a representative slice is analyzed. Different definitions of tumor areas have been employed in previous studies. We hypothesized that the accuracy of APT imaging for brain tumor grading may depend upon the analytical methodology used, such as selection of regions of interest (ROIs), single or multiple tumor slices, and whether or not there is normalization to the contralateral white matter. This study was approved by the institutional review board, and written informed consent was waived. Twenty-six patients with histologically proven glial tumors underwent preoperative APT imaging with a three-dimensional gradient-echo sequence. Two neuroradiologists independently analyzed APT asymmetry (APTasym) images by placing ROIs on both a single representative slice (RS) and all slices including tumor (i.e. whole tumor: WT). ROIs indicating tumor extent were separately defined on both FLAIR and, if applicable, contrast-enhanced T1-weighted images (CE-T1WI), yielding four mean APTasym values (RS-FLAIR, WT-FLAIR, RS-CE-T1WI, and WT-CE-T1WI). The maximum values were also measured using small ROIs, and their differences among grades were evaluated. Receiver operating characteristic (ROC) curve analysis was also conducted on mean and maximum values. Intra-class correlation coefficients for inter-observer agreement were excellent. Significant differences were observed between high- and low-grade gliomas for all five methods (P < 0.01). ROC curve analysis found no statistically significant difference among them. This study clarifies that single-slice APT analysis is robust despite tumor heterogeneity, and can grade glial tumors with or without the use of contrast material.	[Sakata, Akihiko; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Fushimi, Yasutaka; Okada, Tsutomu; Dodo, Toshiki; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, Kyoto 6068507, Japan; [Arakawa, Yoshiki; Miyamoto, Susumu] Kyoto Univ, Dept Neurosurg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Schmitt, Benjamin] Siemens Ltd, Healthcare Sect, Melbourne, Vic, Australia	Okada, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tomokada@kuhp.kyoto-u.ac.jp					Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Jia GA, 2011, J MAGN RESON IMAGING, V33, P647, DOI 10.1002/jmri.22480; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Ward KM, 2000, MAGNET RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Sagiyama K, 2014, P NATL ACAD SCI USA, V111, P4542, DOI 10.1073/pnas.1323855111; Essig M, 2012, AM J NEURORADIOL, V33, P803, DOI 10.3174/ajnr.A2640; Zhou JY, 2012, APPL MAGN RESON, V42, P393, DOI 10.1007/s00723-011-0306-5; Lam WWM, 2002, CLIN RADIOL, V57, P219, DOI 10.1053/crad.2001.0741; Hong XH, 2014, NEURO-ONCOLOGY, V16, P856, DOI 10.1093/neuonc/not245; Agarwal S, 2013, NEURO-ONCOLOGY, V15, P718, DOI 10.1093/neuonc/not015; Cha S, 2006, AM J NEURORADIOL, V27, P475; Zhou JY, 2013, J MAGN RESON IMAGING, V38, P1119, DOI 10.1002/jmri.24067; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Sherry AD, 2008, ANNU REV BIOMED ENG, V10, P391, DOI 10.1146/annurev.bioeng.9.060906.151929; Schmitt B, 2011, MAGN RESON MED, V65, P1620, DOI 10.1002/mrm.22750; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gerigk L, 2012, J MAGN RESON IMAGING, V35, P1207, DOI 10.1002/jmri.23534; Schmitt B, 2011, RADIOLOGY, V260, P257, DOI 10.1148/radiol.11101841; EARNEST F, 1988, RADIOLOGY, V166, P823; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Dula AN, 2013, MAGN RESON MED, V70, P216, DOI 10.1002/mrm.24450; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hobbs SK, 2003, J MAGN RESON IMAGING, V18, P530, DOI 10.1002/jmri.10395; Kleihues P, 2007, WHO CLASSIFICATION T, P10; Paech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104181; Palumbo B, 2009, Q J NUCL MED MOL IM, V53, P17; Sun PZ, 2010, STROKE, V41, pS147, DOI 10.1161/STROKEAHA.110.595777; Togao O, 2014, NEURO-ONCOLOGY, V16, P441, DOI 10.1093/neuonc/not158; TOVI M, 1994, ACTA RADIOL, V35, P495; Vargas HA, 2013, J MAGN RESON IMAGING, V37, P1160, DOI 10.1002/jmri.23899; Zhao XN, 2013, MOL IMAGING BIOL, V15, P114, DOI 10.1007/s11307-012-0563-1	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	APR	2015	122	2					339	348		10.1007/s11060-014-1715-8		10	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CE5FL	WOS:000351856300013		
J	Hasegawa, H; Inoue, T; Tamura, A; Saito, I				Hasegawa, Hirotaka; Inoue, Tomohiro; Tamura, Akira; Saito, Isamu			Emergent intracranial surgical embolectomy in conjunction with carotid endarterectomy for acute internal carotid artery terminus embolic occlusion and tandem occlusion of the cervical carotid artery due to plaque rupture	JOURNAL OF NEUROSURGERY			English	Article						carotid artery stenosis; carotid endarterectomy; carotid terminus occlusion; embolectomy; plaque rupture; vascular disorders	ACUTE ISCHEMIC-STROKE; SINGLE-CENTER EXPERIENCE; MECHANICAL THROMBECTOMY; ENDOVASCULAR THERAPY; ANTERIOR CIRCULATION; PENUMBRA SYSTEM; MERCI; REVASCULARIZATION; RECANALIZATION; DEVICE	Acute internal carotid artery (ICA) terminus occlusion is associated with extremely poor functional outcomes or mortality, especially when it is caused by plaque rupture of the cervical ICA with engrafted thrombus that elongates and extends into the ICA terminus. The goal of this study was to evaluate the efficacy and safety of surgical embolectomy in conjunction with carotid endarterectomy (CEA) for acute ICA terminus occlusion associated with cervical plaque rupture resulting in tandem occlusion. A retrospective review of medical records was performed. Clinical and radiographic characteristics were evaluated, including details of surgical technique, recanalization grade, recanalization time, complications, modified Rankin Scale (mRS) score at 3 months, and National Institutes of Health Stroke Scale (NIHSS) score improvement at 1 month. Three patients (mean age 77.3 years; median presenting NIHSS Score 22, range 19-26) presented with abrupt tandem occlusion of the cervical ICA and ICA terminus and were selected for surgery after confirmation of embolic high-density signal at the ICA terminus on CT and diffusion-weighted imaging (DWI)/magnetic resonance angiography (MRA) mismatch. All patients underwent craniotomy for surgical embolectomy of the ICA terminus embolus followed by cervical exposure, aspiration of long residual proximal embolus ranging from the cervical to cavernous ICA, and removal of ruptured unstable plaque by CEA. Postoperative MRA demonstrated Thrombolysis In Myocardial Infarction (TIMI) 3 recanalization in all patients (100%) without evidence of additional infarction according to DWI. Mean recanalization time from hospital arrival was 234 minutes and from start of surgery, 151 minutes. Serial postoperative CT and MRI studies showed no symptomatic hemorrhage, brain edema, or progression of infarction. The patients' mRS scores at 3 months were 3, 3, and 1. All 3 patients demonstrated marked improvements in NIHSS scores (median 17 points; range 13-23 points) at 1 month. Considering the dismal prognosis associated with ICA terminus occlusion, especially when accompanied by cervical plaque rupture, emergent surgical embolectomy in conjunction with CEA might be an effective and decisive treatment option with a high complete recanalization rate and acceptable safety profile.	[Hasegawa, Hirotaka; Inoue, Tomohiro; Tamura, Akira; Saito, Isamu] Fuji Brain Inst & Hosp, Dept Neurosurg, Shizuoka 4180021, Japan	Hasegawa, H (reprint author), Fuji Brain Inst & Hosp, Dept Neurosurg, 270-12 Sugita, Shizuoka 4180021, Japan.	ayhi_hase_dani@yahoo.co.jp					Davalos A, 2012, STROKE, V43, P2699, DOI 10.1161/STROKEAHA.112.663328; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Inoue T, 2013, BRIT J NEUROSURG, V27, P783, DOI 10.3109/02688697.2013.793286; Olivot JM, 2013, STROKE, V44, P2205, DOI 10.1161/STROKEAHA.113.000911; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Malik AM, 2011, STROKE, V42, P1653, DOI 10.1161/STROKEAHA.110.595520; Fischer U, 2013, EUR J NEUROL, V20, P1017, DOI 10.1111/ene.12094; Jovin TG, 2005, STROKE, V36, P2426, DOI 10.1161/01.STR.0000185924.22918.51; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Psychogios MN, 2012, AM J NEURORADIOL, V33, P1488, DOI 10.3174/ajnr.A2990; Dababneh H, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11350; FURUI T, 1984, J NEUROSURG, V60, P861, DOI 10.3171/jns.1984.60.4.0861; Kim DJ, 2008, CEREBROVASC DIS, V26, P184, DOI 10.1159/000145326; Kulcsar Z, 2010, AM J NEURORADIOL, V31, P628, DOI 10.3174/ajnr.A1924; MCCORMICK PW, 1992, J NEUROSURG, V76, P752, DOI 10.3171/jns.1992.76.5.0752; Murata T, 2010, NEUROSURG REV, V33, P341, DOI 10.1007/s10143-010-0252-y; Pereira VM, 2013, STROKE, V44, pE239, DOI 10.1161/01.str.0000437193.20049.36; Shi ZS, 2010, STROKE, V41, P953, DOI 10.1161/STROKEAHA.109.571943; Thomalla Götz, 2008, Stroke, V39, P1616, DOI 10.1161/STROKEAHA.107.504951; TIMI Study Group, 1985, NEW ENGL J MED, V312, P932	21	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2015	122	4					939	947		10.3171/2014.11.JNS132855		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE2PW	WOS:000351658500028		
J	Miyake, Y; Ito, S; Tanaka, M; Tanaka, Y				Miyake, Yohei; Ito, Susumu; Tanaka, Mio; Tanaka, Yukichi			Spontaneous regression of infantile dural-based non-Langerhans cell histiocytosis after surgery: case report	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						non-Langerhans cell histiocytosis; dural-based lesion; spontaneous regression; infant; oncology	SOLITARY JUVENILE XANTHOGRANULOMA; UPPER CERVICAL-SPINE; OF-THE-LITERATURE; NERVOUS-SYSTEM; FIBROUS XANTHOMA; LESION; ADULT; TUMOR; FIBROXANTHOMA; CHILDHOOD	The authors report the case of a large left occipital mass lesion in an 8-month-old boy who presented with seizure. Neu-roimaging demonstrated an approximately 5-cm extraaxial tumor, and the patient underwent partial resection. The tumor was strongly attached to the tentorium and falx. In the postoperative course the residual lesion regressed spontaneously, and after 5 years only a slight residual tumor remained along the teritorium. Histopathological examination of the tumor revealed non-Langerhans cell histiocytosis (non-LCH). However, the tumor was not diagnosed as juvenile xanthogranuloma (JXG) because it lacked Touton giant cells. Hence, the authors described this lesion as a fibroxanthogranuloma. Most intracraniospinal non-LCHs have been reported as JXG; however, several cases of xanthomatous tumors with histopathological features resembling those of JXG have been described as fibrous xanthoma, xanthoma, fibroxanthoma, and xanthogranuloma. Among JXG and the xanthomatous tumors, a review of the literature revealed several cases of dural-based tumors; these dural-based tumors have had favorable courses, including the case described in this report. In addition, the patient in the present case experienced spontaneous regression of the residual tumor. The authors report this unique case and review the literature on isolated intracraniospinal non-LCHs, especially in cases of dural-based lesion.	[Miyake, Yohei; Ito, Susumu] Kanagawa Childrens Med Ctr, Dept Neurosurg, Yokohama, Kanagawa 2328555, Japan; [Tanaka, Mio; Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Dept Pathol, Yokohama, Kanagawa 2328555, Japan	Miyake, Y (reprint author), Kanagawa Childrens Med Ctr, Dept Neurosurg, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	ymiyaken@gmail.com					ABIKO S, 1981, Neurologia Medico-Chirurgica, V21, P979; Ernemann U, 2002, NEURORADIOLOGY, V44, P759, DOI 10.1007/s00234-002-0819-6; Orsey A, 2008, PEDIATR BLOOD CANCER, V50, P927, DOI 10.1002/pbc.21252; Deisch JK, 2013, NEUROPATHOLOGY, V33, P39, DOI 10.1111/j.1440-1789.2012.01323.x; PAULUS W, 1992, AM J SURG PATHOL, V16, P76, DOI 10.1097/00000478-199201000-00012; Dehner LP, 2003, AM J SURG PATHOL, V27, P579, DOI 10.1097/00000478-200305000-00003; Janssen D, 2005, AM J SURG PATHOL, V29, P21, DOI 10.1097/01.pas.0000147395.01229.06; Abla O, 2013, PEDIATR BLOOD CANCER, V60, P342, DOI 10.1002/pbc.24379; Johnson TE, 2010, OPHTHAL PLAST RECONS, V26, P133, DOI 10.1097/IOP.0b013e3181b8f2b6; WERTZ FD, 1982, OPHTHALMOLOGY, V89, P1331; Ashley WW, 2005, J NEUROSURG, V102, P307; BENJAMIN B, 1995, INT J PEDIATR OTORHI, V32, P77, DOI 10.1016/0165-5876(94)01107-9; Bostrom J, 2000, J NEUROSURG, V93, P335, DOI 10.3171/jns.2000.93.2.0335; Cao D, 2008, EUR SPINE J, V17, pS318, DOI 10.1007/s00586-008-0606-0; Castro-Gago M, 2009, PEDIATR NEUROL, V40, P123, DOI 10.1016/j.pediatrneurol.2008.10.014; Chiba K, 2013, CHILD NERV SYST, V29, P1039, DOI 10.1007/s00381-013-2100-1; Chung IH, 2009, KOREAN J RADIOL, V10, P402, DOI 10.3348/kjr.2009.10.4.402; Fulkerson DH, 2008, PEDIATR NEUROSURG, V44, P480, DOI 10.1159/000180303; Gressot LV, 2013, J NEUROSURG-PEDIATR, V12, P187, DOI 10.3171/2013.5.PEDS1332; Gutnik H, 2001, BRAIN PATHOL, V11, P123; Husain S, 2012, BRAIN PATHOL, V22, P433, DOI 10.1111/j.1750-3639.2012.00591.x; Inoue H, 2011, EUR SPINE J, V20, pS343, DOI 10.1007/s00586-011-1786-6; Jain D, 2013, NEUROPATHOLOGY, V33, P324, DOI 10.1111/j.1440-1789.2012.01353.x; KAMIRYO T, 1988, SURG NEUROL, V29, P27, DOI 10.1016/0090-3019(88)90119-X; Kim DS, 1996, NEUROSURGERY, V39, P182, DOI 10.1097/00006123-199607000-00042; KIMURA H, 1991, SURG NEUROL, V35, P317, DOI 10.1016/0090-3019(91)90012-X; KITCHEN ND, 1995, BRIT J NEUROSURG, V9, P233, DOI 10.1080/02688699550041629; Konar S, 2014, TURK NEUROSURG, V24, P102, DOI 10.5137/1019-5149.JTN.7712-13.0; Lee SJ, 2012, J KOREAN NEUROSURG S, V51, P54, DOI 10.3340/jkns.2012.51.1.54; Miyazono M, 1999, NEUROSURG REV, V22, P215, DOI 10.1007/s101430050019; MORIMURA T, 1986, NEUROSURGERY, V19, P139; Nakasu S, 2007, J NEURO-ONCOL, V84, P99, DOI 10.1007/s11060-007-9351-1; Naren N, 2011, BRIT J NEUROSURG, V25, P744, DOI 10.3109/02688697.2011.562992; Oyama H, 1997, NEUROL SURG TOKYO, V25, P745; PD, 2001, HEAD NECK, V23, P426; Rajaram S, 2010, PEDIATR RADIOL, V40, P145, DOI 10.1007/s00247-010-1768-6; Rampini PM, 2001, SPINE, V26, P1392, DOI 10.1097/00007632-200106150-00026; Schultz KD, 1997, PEDIATR NEUROSURG, V26, P315; SHIMOSAWA S, 1993, SURG NEUROL, V39, P138, DOI 10.1016/0090-3019(93)90092-F; Sun LP, 2009, WORLD J PEDIATR, V5, P71, DOI 10.1007/s12519-009-0015-4; Tamir I, 2013, J CLIN NEUROSCI, V20, P183, DOI 10.1016/j.jocn.2012.05.019; Vijapura CA, 2012, PEDIATR HEMAT ONCOL, V29, P440, DOI 10.3109/08880018.2012.691151; Wille DA, 2013, NEUROPEDIATRICS, V44, P171, DOI 10.1055/s-0032-1329908; YAMATAKI A, 1990, Neurologia Medico-Chirurgica, V30, P759, DOI 10.2176/nmc.30.759	44	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2015	15	4					372	379		10.3171/2014.10.PEDS14378		8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CE2QA	WOS:000351658900007		
J	Fahey, FH; Bom, HHS; Chiti, A; Choi, YY; Huang, G; Lassmann, M; Laurin, N; Mut, F; Nunez-Miller, R; O'Keeffe, D; Pradhan, P; Scott, AM; Song, SL; Soni, N; Uchiyama, M; Vargas, L				Fahey, Frederic H.; Bom, Henry Hee-Seong; Chiti, Arturo; Choi, Yun Young; Huang, Gang; Lassmann, Michael; Laurin, Norman; Mut, Fernando; Nunez-Miller, Rodolfo; O'Keeffe, Darin; Pradhan, Prasanta; Scott, Andrew M.; Song, Shaoli; Soni, Nischal; Uchiyama, Mayuki; Vargas, Luis			Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 1-Statement of the Issue and a Review of Available Resources	JOURNAL OF NUCLEAR MEDICINE			English	Article							ATOMIC-BOMB SURVIVORS; SOLID CANCER; RADIATION; CHILDREN; RISK; MORTALITY; DIAGNOSIS; DOSIMETRY; EPILEPSY	The Nuclear Medicine Global Initiative (NMGI) was formed in 2012 and consists of 13 international organizations with direct involvement in nuclear medicine. The underlying objectives of the NMGI were to promote human health by advancing the field of nuclear medicine and molecular imaging, encourage global collaboration in education, and harmonize procedure guidelines and other policies that ultimately lead to improvements in quality and safety in the field throughout the world. For its first project, the NMGI decided to consider the issues involved in the standardization of administered activities in pediatric nuclear medicine. This article presents part 1 of the final report of this initial project of the NMGI. It provides a review of the value of pediatric nuclear medicine, the current understanding of the carcinogenic risk of radiation as it pertains to the administration of radiopharmacarticals in children, and the application of dosimetric models in children. A listing of pertinent educational and reference resources available in print and online is also provided. The forthcoming part 2 report will discuss current standards for administered activities in children and adolescents that have been developed by various organizations and an evaluation of the current practice of pediatric nuclear medicine specifically with regard to administered activities as determined by an international survey of nuclear medicine clinics and centers. Lastly, the part 2 report will recommend a path forward toward global standardization of the administration of radiopharmaceuticals in children.	[Fahey, Frederic H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Bom, Henry Hee-Seong] Chonnam Natl Univ, Hwasun Hosp, Hwasun, Jeonnam, South Korea; [Chiti, Arturo] Humanitas Res Hosp, Rozzano, Italy; [Choi, Yun Young] Hanyang Univ Hosp, Seoul, South Korea; [Huang, Gang; Song, Shaoli] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China; [Lassmann, Michael] Univ Wurzburg, D-97070 Wurzburg, Germany; [Laurin, Norman] Ctr Hosp Affilie Univ Reg Trois Rivieres, Montreal, PQ, Canada; [Mut, Fernando] Spanish Assoc Hosp, Montevideo, Uruguay; [Nunez-Miller, Rodolfo] IAEA, A-1400 Vienna, Austria; [O'Keeffe, Darin] Christchurch Hosp, Christchurch, New Zealand; [Pradhan, Prasanta] Sanjay Gandhi Post Grad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Scott, Andrew M.] Austin Hosp, Melbourne, Vic 3084, Australia; [Scott, Andrew M.] Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; [Soni, Nischal] Inkosi Albert Luthuli Cent Hosp, Dept Nucl Med, Durbankwazulu Natal, South Africa; [Uchiyama, Mayuki] Jikei Univ, Sch Med, Dept Radiol, Minato Ku, Tokyo, Japan; [Vargas, Luis] Xalapa Med Ctr, Xalapa, Veracruz, Mexico	Fahey, FH (reprint author), Boston Childrens Hosp, Div Nucl Med, 300 Longwood Ave, Boston, MA 02115 USA.	Frederic.Fahey@childrens.harvard.edu		Chiti, Arturo/0000-0002-5806-1856			Ann ICRP, 2008, ANN ICRP, V38, P1, DOI DOI 10.1016/J.ICRP.2008.08.003; Ann ICRP, 1998, ANN ICRP, V28, P1; Annex B, 2013, UNSCEAR 2013 REP; Mueller WP, 2013, PEDIATR RADIOL, V43, P418, DOI 10.1007/s00247-012-2512-1; Treves ST, 2014, SEMIN NUCL MED, V44, P202, DOI 10.1053/j.semnuclmed.2014.03.009; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Dorfman AL, 2011, ARCH PEDIAT ADOL MED, V165, P458, DOI 10.1001/archpediatrics.2010.270; Kumar A, 2013, J NUCL MED, V54, P1775, DOI 10.2967/jnumed.112.114397; Shammas A, 2013, SEMIN NUCL MED, V43, P139, DOI 10.1053/j.semnuclmed.2012.10.001; Ma JJ, 2007, SEMIN MUSCULOSKEL R, V11, P322, DOI 10.1055/s-2008-1060335; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; Preston DL, 2008, J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Hendrick RE, 2010, RADIOLOGY, V257, P246, DOI 10.1148/radiol.10100570; [Anonymous], 2007, ANN ICRP, V37, P1, DOI 10.1016/j.icrp.2007.09.001; Martin CJ, 2007, BRIT J RADIOL, V80, P639, DOI 10.1259/bjr/25922439; Little MP, 2009, RADIAT ENVIRON BIOPH, V48, P253, DOI 10.1007/s00411-009-0228-x; Charon M, 2006, PEDIAT PET IMAGING; Committee to Assess, 2006, HLTH RISKS EXP LOW L; Conway JJ, 2007, SEMIN NUCL MED, V37, P242, DOI 10.1053/j.semnuclmed.2007.02.004; Craig JC, 2000, EUR J NUCL MED, V27, P1610, DOI 10.1007/s002590000349; Eberlein U, 2011, EUR J NUCL MED MOL I, V38, P2269, DOI 10.1007/s00259-011-1904-z; EBERLEIN U, 2011, EUR J NUCL MED MO S2, V38, pS438; Edefonti A, 2014, SEMIN NUCL MED, V44, P123, DOI 10.1053/j.semnuclmed.2013.10.004; Fahey FH, 2011, J NUCL MED, V52, P1240, DOI 10.2967/jnumed.109.069609; ICRP, 1991, ANN ICRP, V21, P1; International Commission on Radiological Protection (ICRP), 1988, ANN ICRP, P18; Kumar R, 2010, EXPERT REV ANTICANC, V10, P755, DOI [10.1586/era.10.12, 10.1586/ERA.10.12]; Menzel Hans-Georg, 2009, Ann ICRP, V39, P1, DOI 10.1016/j.icrp.2009.09.001; Nadel HR, 2010, SEMIN NUCL MED, V40, P31, DOI 10.1053/j.semnuclmed.2009.10.001; Nadel HR, 2014, UR J NUCL MED MOL S1, V41, pS104; Packard AB, 1996, J NUCL MED, V37, P1101; Piepsz A, 2006, SEMIN NUCL MED, V36, P16, DOI 10.1053/j.semnuclmed.2005.08.002; Sgouros G, 2011, J NUCL MED, V52, P1923, DOI 10.2967/jnumed.111.092221; Shammas A, 2009, SEMIN MUSCULOSKEL R, V13, P159, DOI 10.1055/s-0029-1237687; Treves ST, 2014, PEDIAT NUCL MED MOL, V4th; Zucchetta P, 2010, Q J NUCL MED MOL IM, V54, P363	37	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	APR	2015	56	4					646	651		10.2967/jnumed.114.152249		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE9NL	WOS:000352170600053		
J	Yoshida, Y; Umeno, A; Akazawa, Y; Shichiri, M; Murotomi, K; Hone, M				Yoshida, Yasukazu; Umeno, Aya; Akazawa, Yoko; Shichiri, Mototada; Murotomi, Kazutoshi; Hone, Masanori			Chemistry of Lipid Peroxidation Products and Their Use as Biomarkers in Early Detection of Diseases	JOURNAL OF OLEO SCIENCE			English	Review						lipid peroxidation; oxidative stress; HODE; oxycholesterol; HETE	FREE-RADICAL OXIDATION; IN-VIVO; ALZHEIMERS-DISEASE; REACTIVE OXYGEN; HYDROXYOCTADECADIENOIC ACID; BIOLOGICAL SAMPLES; MASS-SPECTROMETRY; ARACHIDONIC-ACID; STRESS; METABOLISM	We developed a novel method to measure hydroxyoctadecadienoic acid (HODE) levels in biological fluids and tissue samples. This method can be used to measure the oxidation products of linoleic acid. Reduction and saponification enabled us to measure hydroperoxides and hydroxides of both free and esterified forms of linoleic acid as total HODE, which includes the enzymatic and non-enzymatic products 9- and 13-(Z, E)-HODEs; the non-enzymatic free radical-mediated products 9- and 13-(E, E)-HODEs; and the specific non-enzymatic singlet oxygen-mediated products 10- and 12-(Z, E)-HODEs. We have recently reported HODE levels in plasma and erythrocytes from healthy volunteers and patients with several diseases and determined that its levels are much higher in patients with lifestyle-related diseases than in healthy volunteers. Furthermore, 10- and 12-(Z, E)-HODE plasma levels can serve as promising biomarkers for the early detection of diabetes. Thus, HODE is a useful biomarker for the assessment of oxidative status, and its efficiency as a biomarker can be improved by using it in combination with other typical biomarkers. This review article focuses on lipid peroxidation biomarkers, including HODE, and discusses their potential in practical and clinical applications in disease prediction.	[Yoshida, Yasukazu; Umeno, Aya; Akazawa, Yoko; Shichiri, Mototada; Murotomi, Kazutoshi; Hone, Masanori] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Yoshida, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.	yoshida-ya@aist.go.jp			Foundation, Oil & Fat Industry Kaikan	This work was partially supported by Grant-in-Aid of Foundation, Oil & Fat Industry Kaikan. We thank Prof. Niki and our colleagues for their invaluable contribution.	Akazawa Ogawa Y., FREE RAD BI IN PRESS; Mesaros C, 2009, J CHROMATOGR B, V877, P2736, DOI 10.1016/j.jchromb.2009.03.011; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Renic M, 2009, J CEREBR BLOOD F MET, V29, P629, DOI 10.1038/jcbfm.2008.156; Liu W, 2010, CHEM RES TOXICOL, V23, P986, DOI 10.1021/tx1000943; Diczfalusy U, 2004, J AOAC INT, V87, P467; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; [Anonymous], 2004, BIOCH SOC S; Montine TJ, 2002, FREE RADICAL BIO MED, V33, P620, DOI 10.1016/S0891-5849(02)00807-9; Roberts LJ, 2005, BRAIN PATHOL, V15, P143; Yoshida Y, 2009, NEUROBIOL AGING, V30, P174, DOI 10.1016/j.neurobiolaging.2007.06.012; Noguchi N, 2008, J CLIN BIOCHEM NUTR, V43, P131, DOI 10.3164/jcbn.2008068; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Cracowski JL, 2004, CHEM PHYS LIPIDS, V128, P75, DOI 10.1016/j.chemphyslip.2003.10.006; Pratt DA, 2011, ACCOUNTS CHEM RES, V44, P458, DOI 10.1021/ar200024c; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Forman HJ, 2008, ARCH BIOCHEM BIOPHYS, V477, P183, DOI 10.1016/j.abb.2008.06.011; Bachi A, 1996, FREE RADICAL BIO MED, V20, P619, DOI 10.1016/0891-5849(95)02087-X; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; Nishimura T, 2005, GENES CELLS, V10, P793, DOI 10.1111/j.1365-2443.2005.00879.x; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; Porter NA, 2013, J ORG CHEM, V78, P3511, DOI 10.1021/jo4001433; GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623; Niki E, 2012, FEBS LETT, V586, P3767, DOI 10.1016/j.febslet.2012.09.025; Ward NC, 2011, CLIN SCI, V121, P501, DOI 10.1042/CS20110215; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Poli G, 2004, CURR MED CHEM, V11, P1163; Levonen AL, 2001, ARTERIOSCL THROM VAS, V21, P1846, DOI 10.1161/hq1101.098488; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Su B, 2008, CURR ALZHEIMER RES, V5, P525; Brown HA, 2011, CHEM REV, V111, P5817, DOI 10.1021/cr200363s; ERICKSON SK, 1977, J BIOL CHEM, V252, P5186; Gniwotta C, 1997, ARTERIOSCL THROM VAS, V17, P3236; Gutteridge J.M.C., 2007, FREE RADICALS BIOL M; Harman D., 1956, J GERONTOL, V119, P283; Hirashima Y., 2011, NEUROSRGERY, V70, P602; Horie M, 2011, J OCCUP HEALTH, V53, P64, DOI 10.1539/joh.L10121; Lee SH, 2007, CHEM RES TOXICOL, V20, P1665, DOI 10.1021/tx700130p; Murotomi K., FREE RADIC IN PRESS; Musiek E.S., 2005, BRAIN PATHOL, V15, P149; Nakagawa K, 2007, J LIPID RES, V48, P2779, DOI 10.1194/jlr.D700016-JLR200; Niki E, 2014, BBA-GEN SUBJECTS, V1840, P809, DOI 10.1016/j.bbagen.2013.03.020; Noguchi N, 2002, BIOL CHEM, V383, P619, DOI 10.1515/BC.2002.064; Roman RJ, 2006, NEUROL RES, V28, P738, DOI 10.1179/016164106X152016; Song W, 1996, ARCH BIOCHEM BIOPHYS, V328, P272, DOI 10.1006/abbi.1996.0173; Tallman KA, 2001, J AM CHEM SOC, V123, P11827, DOI 10.1021/ja0169724; Terao J, 2014, SUBCELL BIOCHEM, V77, P83, DOI 10.1007/978-94-007-7920-4_7; Umeno A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063542; Xu LB, 2014, J AM CHEM SOC, V136, P5443, DOI 10.1021/ja5011674; Yoshida Y, 2006, BBA-GEN SUBJECTS, V1760, P1558, DOI 10.1016/j.bbagen.2006.06.007; Yoshida Y, 2010, J GASTROEN HEPATOL, V25, P107, DOI 10.1111/j.1440-1746.2009.05928.x; Zmijewski JW, 2005, BIOCHEM SOC T, V33, P1385	58	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	APR	2015	64	4					347	356		10.5650/jos.ess14281		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CE6VC	WOS:000351975300001		
J	Zhang, H; Ma, JK; Miao, YL; Tuchiya, T; Chen, JY				Zhang, Han; Ma, Jinkui; Miao, Yelian; Tuchiya, Tomohiro; Chen, Jie Yu			Analysis of Carbonyl Value of Frying Oil by Fourier Transform Infrared Spectroscopy	JOURNAL OF OLEO SCIENCE			English	Article						frying oil; carbonyl value; degradation; Fourier-transform infrared spectroscopy; partial least squares regression	VIRGIN OLIVE OIL; EDIBLE OILS; ACID-COMPOSITION; LEAST-SQUARES; AUTHENTICATION; CHEMISTRY; FTIR; FATS; NIR	A rapid method for determining the carbonyl value of frying oils has been developed using Fourier-transform infrared (FTIR) spectroscopy and chemometrics. One hundred and fifty-six frying oils with different carbonyl values were collected from an actual potato frying process. FTIR spectra in the range of 4000-650 cm(-1) were scanned with a FTIR spectroscopy apparatus using the attenuated total reflectance (ATR) method. A good calibration model was obtained using the partial least-squares (PLS) regression method with full cross validation for predicting the carbonyl value of frying oils. For the model, the coefficients of determination (R-2), standard errors of cross validation (SECV) and standard errors of prediction (SEP) were 0.99, 1.87 mu mol g(-1) and 1.93 mu mol g(-1), respectively. Moreover, standard deviation ratios of reference data in the validation sample set to the SEP were higher than 3. This study shows that the carbonyl value of frying oils can be successfully determined to a high accuracy using FTIR spectroscopy combined with PLS regression.	[Zhang, Han; Tuchiya, Tomohiro; Chen, Jie Yu] Akita Prefectural Univ, Akita 0100195, Japan; [Ma, Jinkui] Zhaoqing Univ, Zhaoqing 526061, Guangdong, Peoples R China; [Miao, Yelian] Nanjing Univ Technol, Nanjing 211816, Jiangsu, Peoples R China	Chen, JY (reprint author), Akita Prefectural Univ, Fac Bioresource Sci, 241-438 Kaidobata Nishi Nakano Shimoshinjo, Akita 0100195, Japan.	jiey_chen@akita-pu.ac.jp					Al-Degs YS, 2011, FOOD ANAL METHOD, V4, P540, DOI 10.1007/s12161-011-9201-9; Lerma-Garcia MJ, 2010, FOOD CHEM, V118, P78, DOI 10.1016/j.foodchem.2009.04.092; Vlachos N, 2006, ANAL CHIM ACTA, V573, P459, DOI 10.1016/j.aca.2006.05.034; FRANKEL EN, 1987, CHEM PHYS LIPIDS, V44, P73, DOI 10.1016/0009-3084(87)90045-4; Chen JY, 2006, J AGR FOOD CHEM, V54, P9652, DOI 10.1021/jf061461s; Maggio RM, 2009, FOOD CHEM, V114, P1549, DOI 10.1016/j.foodchem.2008.11.029; Wang L, 2006, FOOD CHEM, V95, P529, DOI 10.1016/j.foodchem.2005.04.015; Rohman A, 2010, FOOD RES INT, V43, P886, DOI 10.1016/j.foodres.2009.12.006; Zhang Q, 2012, FOOD CHEM, V132, P1607, DOI 10.1016/j.foodchem.2011.11.129; MADDEN HH, 1978, ANAL CHEM, V50, P1383, DOI 10.1021/ac50031a048; Lerma-Garcia MJ, 2011, FOOD CHEM, V124, P679, DOI 10.1016/j.foodchem.2010.06.054; Guillen MD, 1997, J AM OIL CHEM SOC, V74, P1281, DOI 10.1007/s11746-997-0058-4; Permanyer A, 2005, FUEL, V84, P159, DOI 10.1016/j.fuel.2004.06.027; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Endo Y, 2001, J AM OIL CHEM SOC, V78, P1021, DOI 10.1007/s11746-001-0381-1; Chen JY, 2005, FOOD SCI TECHNOL RES, V11, P26, DOI 10.3136/fstr.11.26; Nunes CA, 2014, FOOD RES INT, V60, P255, DOI 10.1016/j.foodres.2013.08.041; HENICK AS, 1954, J AM OIL CHEM SOC, V31, P88, DOI 10.1007/BF02612488; BLUMENTHAL MM, 1991, FOOD TECHNOL-CHICAGO, V45, P68; Chen JY, 2004, J NEAR INFRARED SPEC, V12, P311; Chen Jie Yu, 2003, Appl Spectrosc, V57, P1399, DOI 10.1366/000370203322554572; Chen JY, 2007, FOOD SCI TECHNOL RES, V13, P291, DOI 10.3136/fstr.13.291; Chen JY, 2008, FOOD SCI TECHNOL RES, V14, P132, DOI 10.3136/fstr.14.132; CHIBA T, 1989, J AM OIL CHEM SOC, V66, P1588, DOI 10.1007/BF02636182; CLARK WL, 1991, FOOD TECHNOL-CHICAGO, V45, P84; Duckworth J, 2004, NEAR INFRARED SPECTR, P115; Endo Y., 2003, Journal of Oleo Science, V52, P353; Hocevar H., 2012, J AM OIL CHEM SOC, V89, P781; JOCS, 2003, STANDARD METHODS ANA; Kumazawa H, 1965, J AM OIL CHEM SOC, V14, P167; Li-Chan E., 2002, HDB VIBRATIONAL SPEC, P3629; Martens H., 1989, MULTIVARIATE CALIBRA; Tyagi VK, 1996, J AM OIL CHEM SOC, V73, P499, DOI 10.1007/BF02523926; WHITE PJ, 1991, FOOD TECHNOL-CHICAGO, V45, P75; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145; Yang H, 2000, J AM OIL CHEM SOC, V77, P291, DOI 10.1007/s11746-000-0048-y	36	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	APR	2015	64	4					375	380		10.5650/jos.ess14201		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CE6VC	WOS:000351975300004		
J	Wakisaka, S; Nishimura, T; Gohtani, S				Wakisaka, Satoshi; Nishimura, Takahisa; Gohtani, Shoichi			O/W Nano-Emulsion Formation Using an Isothermal Low-Energy Emulsification Method in a Mixture of Polyglycerol Polyricinoleate and Hexaglycerol Monolaurate with Glycerol System	JOURNAL OF OLEO SCIENCE			English	Article						nano-emulsion; isothermal low-energy emulsification; sponge phase; liquid crystalline; glycerol	NANOEMULSION FORMATION; NONIONIC SURFACTANT; PHASE-BEHAVIOR; OPTIMIZATION; OIL; TEMPERATURE; MICROEMULSIONS; SOLUBILIZATION; INVERSION; STABILITY	We investigated how phase behavior changes by replacing water with glycerol in water/mixture of polyglycerol polyricinoleate (PGPR) and hexaglycerol monolaurate (HGML)/vegetable oil system, and studied the effect of glycerol on o/w nano-emulsion formation using an isothermal low-energy method. In the phase behavior study, the liquid crystalline phase (Lc) + the sponge phase (L-3) expanded toward lower surfactant concentration when water was replaced with glycerol in a system containing surfactant HLP (a mixture of PGPR and HGML). O/W nano-emulsions were formed by emulsification of samples in a region of Lc + L-3. In the glycerol/surfactant HLP/vegetable oil system, replacing water with glycerol was responsible for the expansion of a region containing Lc + L-3 toward lower surfactant concentration, and as a result, in the glycerol/surfactant HLP/vegetable oil system, the region where o/w nano-emulsions or o/w emulsions could be prepared using an isothermal low-energy emulsification method was wide, and the droplet diameter of the prepared o/w emulsions was also smaller than that in the water/surfactant HLP/vegetable oil system. Therefore, glycerol was confirmed to facilitate the preparation of nano-emulsions from a system of surfactant HLP. Moreover, in this study, we could prepare o/w nano-emulsions with a simple one-step addition of water at room temperature without using a stirrer. Thus, the present technique is highly valuable for applications in several industries.	[Wakisaka, Satoshi] Ehime Univ, United Grad Sch Agr Sci, Dept Food Sci, Miki, Kagawa 7610795, Japan; [Wakisaka, Satoshi; Nishimura, Takahisa] Glico Nutr Co Ltd, Div Res & Dev, Nishiyodogawa Ku, Osaka 5558502, Japan; [Gohtani, Shoichi] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Gohtani, S (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Ikenobe, Miki, Kagawa 7610795, Japan.	gohtani@ag.kagawa-u.ac.jp					Patel H, 2010, BIOPHYS CHEM, V150, P119, DOI 10.1016/j.bpc.2010.03.015; Garti N, 2001, J AGR FOOD CHEM, V49, P2552, DOI 10.1021/jf001390b; Silva HD, 2012, FOOD BIOPROCESS TECH, V5, P854, DOI 10.1007/s11947-011-0683-7; Sajjadi S, 2006, LANGMUIR, V22, P5597, DOI 10.1021/la060043e; Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004; Miyanoshita M, 2011, J OLEO SCI, V60, P355, DOI 10.5650/jos.60.355; Komaiko J, 2014, J COLLOID INTERF SCI, V425, P59, DOI 10.1016/j.jcis.2014.03.035; Aramaki K, 1999, LANGMUIR, V15, P6226, DOI 10.1021/la9900573; Sole I, 2006, LANGMUIR, V22, P8326, DOI 10.1021/la0613676; Saberi AH, 2013, J COLLOID INTERF SCI, V411, P105, DOI 10.1016/j.jcis.2013.08.041; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Yaghmur A, 2002, COLLOID SURFACE A, V209, P71, DOI 10.1016/S0927-7757(02)00168-1; Izquierdo P, 2004, LANGMUIR, V20, P6594, DOI 10.1021/la049566h; D'Errico G, 2005, J COLLOID INTERF SCI, V286, P747, DOI 10.1016/j.jcis.2005.01.030; Wakisaka S, 2014, J OLEO SCI, V63, P229, DOI 10.5650/jos.ess13139; Saberi AH, 2013, J COLLOID INTERF SCI, V391, P95, DOI 10.1016/j.jcis.2012.08.069; Pey CM, 2006, COLLOID SURFACE A, V288, P144, DOI 10.1016/j.colsurfa.2006.02.026; Sole I, 2010, J COLLOID INTERF SCI, V344, P417, DOI 10.1016/j.jcis.2009.11.046; Chang YH, 2014, J AGR FOOD CHEM, V62, P2306, DOI 10.1021/jf500160y; Gohtani S., 2014, JPN J FOOD ENG, V15, P119; Ikeda S., 2013, J FOOD SCI, V78, P1017; Li X, 1999, LANGMUIR, V15, P2278, DOI 10.1021/la9804076; Maldonado A, 2007, J COLLOID INTERF SCI, V308, P485, DOI 10.1016/j.jcis.2007.01.012; Murakami A., 2005, J OLEO SCI, V54, P633; SAGITANI H, 1988, J DISPER SCI TECHNOL, V9, P115, DOI 10.1080/01932698808943980; Sagitani H., 1986, J JPN OIL CHEM SOC, V35, P102; SUZUKI T, 1989, J COLLOID INTERF SCI, V129, P491, DOI 10.1016/0021-9797(89)90463-3	27	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	APR	2015	64	4					405	413		10.5650/jos.ess14229		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CE6VC	WOS:000351975300007		
J	Ishizawa, R; Masuda, K; Sakata, S; Nakatani, A				Ishizawa, Rie; Masuda, Kazumi; Sakata, Susumu; Nakatani, Akira			Effects of Different Fatty Acid Chain Lengths on Fatty Acid Oxidation-Related Protein Expression Levels in Rat Skeletal Muscles	JOURNAL OF OLEO SCIENCE			English	Article						MCFA diet; H-FABP; mitochondrial enzyme; rat skeletal muscle	INSULIN-RESISTANCE; BINDING PROTEIN; ENERGY-EXPENDITURE; GENE-EXPRESSION; WEIGHT-LOSS; MITOCHONDRIA; DIET; TRIGLYCERIDES; METABOLISM; RECEPTORS	Skeletal muscles can adapt to dietary interventions that affect energy metabolism. Dietary intake of medium-chain fatty acids (MCFAs) enhances mitochondrial oxidation of fatty acids (FAO) in type Ha skeletal muscle fibers. However, the effect of MCFAs diet on mitochondrial or cytoplasmic FAO-related protein expression levels in different types of muscle fibers remains unclear. This study aims to examine the effects of a high-fat diet, containing MCFAs, on mitochondrial enzyme activities and heart-type fatty acid-binding protein (H-FABP) levels in different types of skeletal muscle fibers. Five-week-old male Wistar rats were assigned to one of the following three dietary conditions: standard chow (SC, 12% of calories from fat), high-fat MCFA, or high-fat long-chain fatty acids (LCFAs) diet (60% of calories from fat for both). The animals were provided food and water ad libitum for 4 weeks, following which citrate synthase (CS) activity and H-FABP concentration were analyzed. The epididymal fat pads (EFP) were significantly smaller in the MCFA group than in the LCFA group (p < 0.05). MCFA-fed group displayed an increase in CS activity compared with that observed in SC-fed controls in all types of skeletal muscle fibers (triceps, surface portion of gastrocnemius (gasS), deep portion of gastrocnemius (gasD), and soleus; p < 0.05,). H-FABP concentration was significantly higher in the LCFA group than in both the SC-fed and MCFA-fed groups (triceps, gasS, gasD, and soleus; p < 0.05,). However, no significant difference was observed in the H-FABP concentrations between the SC-fed and MCFA-fed groups. The results of this study showed that the MCFA diet can increase the expression of the mitochondrial enzyme CS, but not that of H-FABP, in both fast- and slow-twitch muscle fibers, suggesting that H-FABP expression is dependent on the chain length of fatty acids in the cytoplasm of skeletal muscles cells.	[Ishizawa, Rie] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Ishizawa, Rie; Nakatani, Akira] Nara Univ Educ, Dept Exercise Physiol, Nara 6308528, Japan; [Masuda, Kazumi] Kanazawa Univ, Fac Human Sci, Kanazawa, Ishikawa 9201192, Japan; [Sakata, Susumu] Kio Univ, Grad Sch Hlth Sci, Nara 6300832, Japan	Nakatani, A (reprint author), Nara Univ Educ, Dept Exercise Physiol, Takabatake Cho, Nara 6308528, Japan.	akira@nara-edu.ac.jp	Masuda, Kazumi/C-4198-2015		Japanese Ministry of Education, Science, Sports, and Culture [18500624]	This research was supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (18500624, AN)	Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Bach AC, 1996, J LIPID RES, V37, P708; BASS NM, 1988, INT REV CYTOL, V111, P143, DOI 10.1016/S0074-7696(08)61733-7; Clavel S, 2002, EUR J APPL PHYSIOL, V87, P193, DOI 10.1007/s00421-002-0612-6; ARIANO MA, 1973, J HISTOCHEM CYTOCHEM, V21, P51; BACH AC, 1982, AM J CLIN NUTR, V36, P950; Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Chilliard Y, 2001, DOMEST ANIM ENDOCRIN, V21, P271, DOI 10.1016/S0739-7240(01)00124-2; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Chmurzynska A, 2006, J APPL GENETICS, V47, P39, DOI 10.1007/BF03194597; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359; St-Onge MP, 2008, AM J CLIN NUTR, V87, P621; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Chang W, 2001, MOL CELL BIOCHEM, V221, P127, DOI 10.1023/A:1010990129038; Collatos T. C., 1977, NEUROPHYSIOLOGY, V49, P1292; Han DH, 1997, DIABETES, V46, P1761, DOI 10.2337/diabetes.46.11.1761; Miller W. C., 1983, J APPL PHYSL RESP EN, V26, P78; Poirier H, 1997, FEBS LETT, V412, P480, DOI 10.1016/S0014-5793(97)00830-2; REICHMANN H, 1985, PFLUG ARCH EUR J PHY, V404, P1, DOI 10.1007/BF00581484; Shinohara H, 2005, BIOSCI BIOTECH BIOCH, V69, P1811, DOI 10.1271/bbb.69.1811; Srere P., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0; VANBREDA E, 1992, PFLUG ARCH EUR J PHY, V421, P274; VEERKAMP JH, 1993, MOL CELL BIOCHEM, V123, P101, DOI 10.1007/BF01076480	30	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	APR	2015	64	4					415	421		10.5650/jos.ess14199		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CE6VC	WOS:000351975300008		
J	Koyanagi, Y; Hamada, T; Lwagawa, T; Okamura, H				Koyanagi, Yuji; Hamada, Toshiyuki; Lwagawa, Tetsuo; Okamura, Hiroaki			Asymmetric Synthesis of Ampelomin A and ent-Epiampelomin A	JOURNAL OF OLEO SCIENCE			English	Article						ampelomin family; carbasugar; asymmetric synthesis; base-catalyzed Diels-Alder reaction	DIELS-ALDER REACTION; 3-HYDROXY-2-PYRONE; (+)-EPIEPOFORMIN; INTERMEDIATE; INHIBITORS	We synthesized the naturally occurring carbasugar ampelomin A and its epimer from a common starting material. The enantiomerically pure starting material was obtained by base-catalyzed asymmetric Diels Alder reaction of 3-hydroxy-2-pyrone and chiral acrylate. The total yield of ampelomin A was 14% in seven synthetic steps. The key step of the synthesis of ampelomin A was inversion of the stereochemistry at the C-6 position, which was achieved by stereoselective catalytic hydrogenation of the corresponding methylidene group. Further synthesis of the epimer was straightforward, because all stereogenic centers had already been introduced on the starting material; the total yield was 44% in four synthetic steps. Both the final products were obtained in pure form without contamination with undesired isomers. The reported 111 NMR chemical shift of the C-7 methyl protons and the H-5(axial), coupling pattern of natural ampelomin A were inconsistent with those of our synthetic product. After careful comparison of the spectra and examination of the stable conformation obtained through MM2 calculations, we present revised NMR data for ampelomin A.	[Koyanagi, Yuji; Hamada, Toshiyuki; Lwagawa, Tetsuo; Okamura, Hiroaki] Kagoshima Univ, Grad Sch, Dept Chem & Biosci, Kagoshima 8900065, Japan	Okamura, H (reprint author), Kagoshima Univ, Grad Sch, Dept Chem & Biosci, Korimoto 1-21-35, Kagoshima 8900065, Japan.	okam@sci.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23550160, 26410096]; Cooperative Research Program of the "Network Joint Research Centre for Materials and Devices [2011287, 2014440]	We are grateful to Professor Xiaoyi Wei, South China Botanical Garden, for providing the <SUP>1</SUP>H NMR spectrum chart of natural ampelomin A. We thank Professor Junji Inanaga and Associate Professor Hiroshi Furuno, Kyushu University, for HRMS measurements. This work was supported by a Grant-in-Aid for Scientific Research (No. 23550160 and No. 26410096) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Cooperative Research Program of the "Network Joint Research Centre for Materials and Devices (No. 2011287 and 2014440).	Zhang HY, 2009, J NAT PROD, V72, P265, DOI 10.1021/np800667e; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345; AFARINKIA K, 1992, TETRAHEDRON, V48, P9111, DOI 10.1016/S0040-4020(01)85607-6; Righi G, 2000, TETRAHEDRON, V56, P1733, DOI 10.1016/S0040-4020(99)01083-2; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Shan M, 2008, ORG LETT, V10, P3381, DOI 10.1021/ol801106r; de Melo EB, 2006, TETRAHEDRON, V62, P10277, DOI 10.1016/j.tet.2006.08.055; Compain P, 2001, BIOORGAN MED CHEM, V9, P3077, DOI 10.1016/S0968-0896(01)00176-6; Edwards MG, 2008, ANGEW CHEM INT EDIT, V47, P1935, DOI 10.1002/anie.200705329; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Carreno MC, 2002, ANGEW CHEM INT EDIT, V41, P2755, DOI 10.1002/1521-3773(20020802)41:15<2755::AID-ANIE2755>3.0.CO;2-A; HUTCHINS RO, 1971, J CHEM SOC CHEM COMM, P1097, DOI 10.1039/c29710001097; JEFFORD CW, 1972, J AM CHEM SOC, V94, P8905, DOI 10.1021/ja00780a044; Kipassa NT, 2008, ORG LETT, V10, P815, DOI 10.1021/ol7029646; Lagreca ME, 2014, TETRAHEDRON LETT, V55, P853, DOI 10.1016/j.tetlet.2013.12.036; Li P., 2007, PHYTOCHEMISTRY, V68, P891; Meister AC, 2013, EUR J ORG CHEM, V2013, P7110, DOI 10.1002/ejoc.201300752; Meister AC, 2012, EUR J ORG CHEM, P5373, DOI 10.1002/ejoc.201200704; OKAMURA H, 1995, TETRAHEDRON LETT, V36, P5939, DOI 10.1016/0040-4039(95)01200-2; Okamura H, 2012, B CHEM SOC JPN, V85, P631, DOI 10.1246/bcsj.20110257; Okamura H, 2000, TETRAHEDRON LETT, V41, P8317, DOI 10.1016/S0040-4039(00)01444-1; Okamura H, 2009, TETRAHEDRON, V65, P10709, DOI 10.1016/j.tet.2009.10.036; Okamura H, 2003, TETRAHEDRON, V59, P10159, DOI 10.1016/j.tet.2003.10.065; Okamura H, 2000, TETRAHEDRON LETT, V41, P4147, DOI 10.1016/S0040-4039(00)00555-4; Okamura H, 2006, HETEROCYCLES, V68, P2587; Okamura H, 1998, TETRAHEDRON LETT, V39, P1211, DOI 10.1016/S0040-4039(97)10843-7; Shimizu H, 2001, TETRAHEDRON, V57, P1903, DOI 10.1016/S0040-4020(01)00032-1; Shimizu H, 2001, TETRAHEDRON LETT, V42, P8649, DOI 10.1016/S0040-4039(01)01871-8	28	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	APR	2015	64	4					449	454		10.5650/jos.ess14212		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CE6VC	WOS:000351975300012		
J	Oura, K; Oka, K; Kawanishi, Y; Sugamoto, K; Yoshikawa, H; Murase, T				Oura, Keiichiro; Oka, Kunihiro; Kawanishi, Yohei; Sugamoto, Kazuomi; Yoshikawa, Hideki; Murase, Tsuyoshi			Volar Morphology of the Distal Radius in Axial Planes: A Quantitative Analysis	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						volar locking plate; rupture of the flexor pollicis longus; three-dimensional evaluation; morphology of the distal radius	POLLICIS LONGUS TENDON; CORRECTIVE OSTEOTOMY; COMPUTED-TOMOGRAPHY; CONTACT PRESSURE; PLATE FIXATION; FRACTURES; RUPTURE; COMPLICATIONS; POSITION; SYSTEM	To investigate the cause of rupture of the flexor pollicis longus (FPL) after volar plate fixation of distal radius fractures, previous studies have examined the shape of the distal radius in the sagittal plane or in the lateral view. However, there are no reports on the anatomical shape of the volar surface concavity of the distal radius in the axial plane. We hypothesized that this concavity might contribute to the mismatch between the plate and the surface of the radius. To test this hypothesis, we constructed three-dimensional models of the radius and FPL based on computed tomography scans of 70 normal forearms. We analyzed axial cross-sectional views with 2mm intervals. In all cases, the volar surface of the distal radius was concave in the axial plane. The concavity depth was maximum at 6mm proximal to the palmar edge of the lunate fossa and progressively decreased toward the proximal radius. FPL was closest to the radius at 2mm proximal to the palmar edge of the lunate fossa. The volar surface of the distal radius was externally rotated from proximal to distal. These results may help to develop new implants which fit better to the radius and decrease tendon irritation. (c) 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:496-503, 2015.	[Oura, Keiichiro; Oka, Kunihiro; Kawanishi, Yohei; Yoshikawa, Hideki; Murase, Tsuyoshi] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Sugamoto, Kazuomi] Osaka Univ, Dept Orthopaed Biomat Sci, Grad Sch Med, Suita, Osaka 5650871, Japan	Murase, T (reprint author), Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tmurase-osk@umin.ac.jp			Japan Society for the Promotion of Science	This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. We thank Ryoji Nakao for computer programming.	Soong M, 2011, J BONE JOINT SURG AM, V93A, P328, DOI [10.2106/JBJS.J.00193, 10.2106/JBJSJ.00193]; Rozental TD, 2006, J HAND SURG-AM, V31A, P359, DOI 10.1016/j.jhsa.2005.10.010; Drobetz H, 2003, INT ORTHOP, V27, P1, DOI 10.1007/s00264-002-0393-x; Kitay A, 2013, J HAND SURG-AM, V38A, P1091, DOI 10.1016/j.jhsa.2013.03.011; Bell JSP, 1998, J BONE JOINT SURG BR, V80B, P225, DOI 10.1302/0301-620X.80B2.8351; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Murase T, 2008, J BONE JOINT SURG AM, V90A, P2375, DOI 10.2106/JBJS.G.01299; Crisco JJ, 2007, J ORTHOP RES, V25, P547, DOI 10.1002/jor.20322; Tanaka Y, 2011, J HAND SURG-AM, V36A, P1790, DOI 10.1016/j.jhsa.2011.08.027; Andermahr J, 2006, J HAND SURG-AM, V31A, P892, DOI 10.1016/j.jhsa.2006.03.01; Berglund LM, 2009, J AM ACAD ORTHOP SUR, V17, P369; Arora R, 2007, J ORTHOP TRAUMA, V21, P316, DOI 10.1097/BOT.0b013e318059b993; Miyake J, 2011, CLIN ORTHOP RELAT R, V469, P1766, DOI 10.1007/s11999-010-1748-z; Cross AW, 2008, J HAND SURG-AM, V33A, P164, DOI 10.1016/j.jhsa.2007.11.011; Chen NC, 2007, J BONE JOINT SURG AM, V89A, P2051, DOI 10.2106/JBJS.G.00020; Orbay JL, 2006, CLIN ORTHOP RELAT R, P58, DOI 10.1097/01.blo.0000205891.96575.0f; Gasse N, 2011, SURG RADIOL ANAT, V33, P485, DOI 10.1007/s00276-010-0754-x; Bolton NRM, 2005, CLIN BIOMECH, V20, P540; Cho Chul-Hyun, 2012, Clin Orthop Surg, V4, P325, DOI 10.4055/cios.2012.4.4.325; Duncan Scott F M, 2007, Am J Orthop (Belle Mead NJ), V36, P669; Kikuchi Y, 2004, PRIMATES, V45, P129, DOI 10.1007/s10329-003-0068-2; Klug RA, 2007, J HAND SURG-AM, V32A, P984, DOI 10.1016/j.jhsa.2007.05.006; Koo Siu Cheong, 2006, Hand Surg, V11, P67, DOI 10.1142/S0218810406003048; Lorensen W. E., 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422; Matityahu AM, 2013, J HAND SURG-EUR VOL, V38E, P144, DOI 10.1177/1753193412453436; Mitsuhiko N, 2013, J JPN SOC SURG HAND, V30, P12; Oka K, 2012, J SHOULDER ELB SURG, V21, pE1, DOI 10.1016/j.jse.2012.05.035; Orbay J, 2005, HAND CLIN, V21, P347, DOI 10.1016/j.hcl.2005.02.003; Orbay J L, 2000, Hand Surg, V5, P103, DOI 10.1142/S0218810400000223; Pichler W, 2008, ORTHOPEDICS, V31, P1; STEINMETZ A, 1988, ATHEROSCLEROSIS, V74, P231, DOI 10.1016/0021-9150(88)90242-0; Valbuena SE, 2010, CHIR MAIN, V29, P109, DOI 10.1016/j.main.2009.12.005	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	APR	2015	33	4					496	503		10.1002/jor.22780		8	Orthopedics	Orthopedics	CE2YE	WOS:000351687400008		
J	Kumar, D; Wyatt, C; Chiba, K; Lee, S; Nardo, L; Link, TM; Majumdar, S; Souza, RB				Kumar, Deepak; Wyatt, Cory; Chiba, Ko; Lee, Sonia; Nardo, Lorenzo; Link, Thomas M.; Majumdar, Sharmila; Souza, Richard B.			Anatomic Correlates of Reduced Hip Extension During Walking in Individuals With Mild-Moderate Radiographic Hip Osteoarthritis	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						gait; cartilage; Labrum; HOOS; 6 minute walk test	FEMOROACETABULAR IMPINGEMENT; REPLACEMENT PATIENTS; KNEE OSTEOARTHRITIS; HEALTHY CONTROLS; SYMPTOMATIC HIP; GAIT ANALYSIS; ASSOCIATION; PAIN; MRI; METAANALYSIS	To identify radiographic and MR features of hip osteoarthritis (OA) related to reduced hip extension during walking. Sixty six subjects, were stratified into those with (n=36, KL=2, 3) and without (n=30, KL=0, 1) radiographic hip OA. Cartilage and labrum lesions were graded semi-quantitatively on hip MRI. Alpha angle and lateral center edge (LCE) angle were measured. Sagittal kinematics and kinetics were calculated during walking at speed of 1.35m/s using 3-D motion capture. All subjects completed Hip disability and Osteoarthritis Outcome Score (HOOS), timed up and go, and 6min walk tests. Variables were compared between the two groups using one-way ANOVA (adjusting for age). Correlations of radiographic and MR parameters with peak hip extension were calculated. The OA group was older, had greater pain, and limitation of function. They also had lower peak hip extension and higher peak hip flexion; and worse acetabular and femoral cartilage lesions. Peak hip extension and flexion correlated with KL grade, cartilage lesions in the inferior and posterior femur. Reduced hip extension and greater hip flexion during walking are present in high functioning (HOOS>85%) individuals with mild-moderate hip OA, and are associated with cartilage lesions. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:527-534, 2015.	[Kumar, Deepak; Wyatt, Cory; Lee, Sonia; Nardo, Lorenzo; Link, Thomas M.; Majumdar, Sharmila; Souza, Richard B.] Univ Calif San Francisco, Musculoskeletal Quantitat Imaging Res Grp, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Chiba, Ko] Nagasaki Univ, Sch Med, Dept Orthoped Surg, Nagasaki, Japan; [Souza, Richard B.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA	Kumar, D (reprint author), Univ Calif San Francisco, Musculoskeletal Quantitat Imaging Res Grp, Dept Radiol & Biomed Imaging, 1700 4th St,Suite 203 Byers Hall, San Francisco, CA 94143 USA.	deepak.kumar@ucsf.edu			NIH-NIAMS [P50 AR060752]	Grant sponsor: NIH-NIAMS; Grant number: P50 AR060752.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Gold SL, 2012, CLIN ORTHOP RELAT R, V470, P3321, DOI 10.1007/s11999-012-2403-7; Foucher KC, 2012, J BIOMECH, V45, P1360, DOI 10.1016/j.jbiomech.2012.03.008; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Hurwitz DE, 1997, J ORTHOPAED RES, V15, P629, DOI 10.1002/jor.1100150421; Lenaerts G, 2009, GAIT POSTURE, V30, P296, DOI 10.1016/j.gaitpost.2009.05.016; Harris MD, 2012, J ORTHOP RES, V30, P1133, DOI 10.1002/jor.22040; Schmitz MR, 2012, AM J SPORT MED, V40, P1337, DOI 10.1177/0363546512439991; Ganz R, 2008, CLIN ORTHOP RELAT R, V466, P264, DOI 10.1007/s11999-007-0060-z; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Nilsdotter AK, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-10; Murphy LB, 2010, OSTEOARTHR CARTILAGE, V18, P1372, DOI 10.1016/j.joca.2010.08.005; Beaulieu ML, 2010, GAIT POSTURE, V32, P269, DOI 10.1016/j.gaitpost.2010.05.007; Roemer FW, 2011, OSTEOARTHR CARTILAGE, V19, P946, DOI 10.1016/j.joca.2011.04.003; Kubota M, 2007, J ORTHOP SCI, V12, P451, DOI 10.1007/s00776-007-1160-z; Register B, 2012, AM J SPORT MED, V40, P2720, DOI 10.1177/0363546512462124; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Watelain E, 2001, ARCH PHYS MED REHAB, V82, P1705, DOI 10.1053/apmr.2001.26812; Block JA, 2010, CURR OPIN RHEUMATOL, V22, P544, DOI 10.1097/BOR.0b013e32833bd81f; Kumar D, 2013, OSTEOARTHR CARTILAGE, V21, P1685, DOI 10.1016/j.joca.2013.08.009; Foucher KC, 2007, J BIOMECH, V40, P3432, DOI 10.1016/j.jbiomech.2007.05.020; Salaffi F, 2005, AGING CLIN EXP RES, V17, P255; Ewen AM, 2012, GAIT POSTURE, V36, P1, DOI 10.1016/j.gaitpost.2011.12.024; Polkowski GG, 2010, SPORTS MED ARTHROSC, V18, P56, DOI 10.1097/JSA.0b013e3181dc5774; Stratford PW, 2006, PHYS THER, V86, P1489, DOI 10.2522/ptj.20060002; Mintz DN, 2005, ARTHROSCOPY, V21, P385, DOI 10.1016/j.arthro.2004.12.011; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Kumar D, 2014, PM&R, V6, P681, DOI 10.1016/j.pmrj.2014.02.002; Eitzen I, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-258; Guermazi A, 2012, NAT REV RHEUMATOL; Lee S, 2014, J MAGN RESON IMAGING, DOI [10.1002/jmri.24722, DOI 10.1002/JMRI.24722]; Mamisch TC, 2009, MAGN RESON IMAGING C, V18, P111; Nho SJ, 2013, J AM ACAD ORTHOP SUR, V21, pS1, DOI 10.5435/JAAOS-21-07-S1; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Rydevik K, 2010, J ORTHOP SPORT PHYS, V40, P616, DOI 10.2519/jospt.2010.3346; Smith TO, 2011, EUR RADIOL, V21, P863, DOI 10.1007/s00330-010-1956-7	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	APR	2015	33	4					527	534		10.1002/jor.22781		8	Orthopedics	Orthopedics	CE2YE	WOS:000351687400012		
J	Tamura, S; Miki, H; Tsuda, K; Takao, M; Hattori, A; Suzuki, N; Yonenobu, K; Sugano, N				Tamura, Satoru; Miki, Hidenobu; Tsuda, Kosuke; Takao, Masaki; Hattori, Asaki; Suzuki, Naoki; Yonenobu, Kazuo; Sugano, Nobuhiko			Hip Range of Motion During Daily Activities in Patients with Posterior Pelvic Tilt from Supine to Standing Position	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						pelvic tilt; total hip arthroplasty; motion analysis	LOWER-EXTREMITY; ARTHROPLASTY; REPLACEMENT; NAVIGATION; SYSTEM; SPONDYLOLISTHESIS; IMPLANTATION; IMPINGEMENT; INCLINATION; MOVEMENT	In most patients with hip disorders, the anterior pelvic plane (APP) sagittal tilt does not change from supine to standing position. However, in some patients, APP sagittal tilt changes more than 10 degrees posteriorly from supine to standing position. The purpose of this study was to both examine APP sagittal tilt and investigate the hip flexion and extension range of motion (ROM) required during daily activities in these atypical patients. Patient-specific 4-dimensional (4D) motion analysis was performed for 50 hips from 44 patients who had undergone total hip arthroplasty. All patients divided into two categories, such as atypical patients for whom the pelvis tilted more than 10 degrees posteriorly from supine to standing position preoperatively (19 hips from 18 patients) and the remaining typical patients (31 hips from 26 patients). The required hip flexion and extension angles did not differ significantly between atypical patients and typical patients. In conclusion, the hip flexion ROM during deep bending activities and hip extension ROM during extension activities required in those atypical patients with pelvic tilt more than 10 degrees backward from supine to standing position did not shift in the direction of extension. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:542-547, 2015.	[Tamura, Satoru; Tsuda, Kosuke; Sugano, Nobuhiko] Osaka Univ, Dept Orthopaed Med Engn, Grad Sch Med, Suita, Osaka, Japan; [Miki, Hidenobu] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka, Japan; [Takao, Masaki] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka, Japan; [Hattori, Asaki; Suzuki, Naoki] Jikei Univ, Inst High Dimens Med Imaging, Sch Med, Tokyo, Japan; [Yonenobu, Kazuo] Jikei Inst, Grad Sch Hlth Care Sci, Osaka, Japan	Tamura, S (reprint author), 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	n-sugano@umin.net					Sugano N, 2012, J ARTHROPLASTY, V27, P1562, DOI 10.1016/j.arth.2012.01.029; Bader R, 2004, J MATER SCI-MATER M, V15, P711, DOI 10.1023/B:JMSM.0000030214.79180.13; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217; Ishida T, 2011, J ORTHOP SCI, V16, P682, DOI 10.1007/s00776-011-0153-0; Babisch JW, 2008, J BONE JOINT SURG AM, V90A, P357, DOI 10.2106/JBJS.F.00628; Nishihara S, 2003, CLIN ORTHOP RELAT R, P140, DOI 10.1097/01.blo.0000069891.31220.fd; Taki N, 2012, J ARTHROPLASTY, V27, P940, DOI 10.1016/j.arth.2011.10.003; Miki H, 2007, J ARTHROPLASTY, V22, P946, DOI 10.1016/j.arth.2007.02.004; Shon WY, 2005, J ARTHROPLASTY, V20, P427, DOI 10.1016/j.arth.2004.09.058; Murphy WS, 2013, CLIN ORTHOP RELAT R, V471, P417, DOI 10.1007/s11999-012-2581-3; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; Hagio K, 2004, J ORTHOPAED RES, V22, P665, DOI 10.1016/j.orthres.2003.10.009; Miki H, 2012, J ARTHROPLASTY, V27, P1641, DOI 10.1016/j.arth.2012.03.002; Miki H, 2004, J BIOMECH, V37, P443, DOI 10.1016/j.jbiomech.2003.09.009; Sugano N, 2007, J BONE JOINT SURG BR, V89B, P455, DOI 10.1302/0301-620X.89B4.18458; Barrack Robert L, 2003, J Am Acad Orthop Surg, V11, P89; Barrey C, 2007, NEUROSURGERY, V61, P981, DOI 10.1227/01.NEU.0000280112.98151.6D; Labelle H, 2005, SPINE, V30, pS27, DOI 10.1097/01.brs.0000155560.92580.90; Otake Y, 2005, J BIOMECH, V38, P2397, DOI 10.1016/j.jbiomech.2004.10.023; Tamura S, 2014, J ARTHROPLASTY, V29, P2294, DOI 10.1016/j.arth.2013.11.014; WOOLSON ST, 1985, J BONE JOINT SURG AM, V67A, P1251; Yamamura M, 2007, J ORTHOP RES, V25, P1582, DOI 10.1002/jor.20448	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	APR	2015	33	4					542	547		10.1002/jor.22799		6	Orthopedics	Orthopedics	CE2YE	WOS:000351687400014		
J	Hoshiyama, Y; Otsuki, S; Oda, S; Kurokawa, Y; Nakajima, M; Jotoku, T; Tamura, R; Okamoto, Y; Lotz, MK; Neo, M				Hoshiyama, Yoshiaki; Otsuki, Shuhei; Oda, Shuhei; Kurokawa, Yoshitaka; Nakajima, Mikio; Jotoku, Tsuyoshi; Tamura, Ryuichi; Okamoto, Yoshinori; Lotz, Martin K.; Neo, Masashi			Chondrocyte Clusters Adjacent to Sites of Cartilage Degeneration have Characteristics of Progenitor Cells	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						osteoarthritis; chondrocyte cluster; STRO-1	FIBROBLAST GROWTH FACTOR-2; CONTINUOUS PASSIVE MOTION; ARTHRITIC HUMAN HIPS; ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; METABOLIC ABNORMALITIES; DISEASE PROGRESSION; BONE; EXPRESSION; APOPTOSIS	The purpose of this study was to investigate the site-specific characteristics and roles of chondrocyte clusters in human knee osteoarthritis. Cartilage explants were obtained from 45 knees undergoing total knee replacement surgery. The explants were taken from 4 locations in the knee: the medial femoral condyle, the medial posterior femoral condyle (MPC), the lateral femoral condyle, and the lateral posterior femoral condyle (LPC). Cartilage degeneration, cell density, and cell arrangement were compared histologically. A live/dead cell viability assay and immunohistochemical analyses using antibodies against STRO-1, FGF2, and Ki-67 were performed. Cell proliferation and cartilaginous nodule production in MPC and LPC explants in monolayer culture were compared. Finally, MPC cartilage explants were cultured to observe histological changes. The cell density of the MPC explants was higher than that of the LPC because of clustering. MPC explants contained more live cells than the LPC did, and the expression of IHC markers in MPC explants was higher than that in LPC. Chondrocytes from MPC proliferated faster and produced more nodules in monolayer culture than those from the LPC and MPC explants were repaired during organ culture. In conclusion, chondrocyte clusters adjacent to severe cartilage degeneration have specific characteristics, with progenitor and proliferative potential. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:548-555, 2015.	[Hoshiyama, Yoshiaki; Otsuki, Shuhei; Oda, Shuhei; Kurokawa, Yoshitaka; Nakajima, Mikio; Jotoku, Tsuyoshi; Okamoto, Yoshinori; Neo, Masashi] Osaka Med Coll, Dept Orthoped Surg, Osaka 5698686, Japan; [Tamura, Ryuichi] Rakusai Shimizu Hosp, Dept Orthoped Surg, Nishikyo Ku, Kyoto 6101106, Japan; [Lotz, Martin K.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Otsuki, S (reprint author), Osaka Med Coll, Dept Orthoped Surg, 2-7 Daigakumachi, Osaka 5698686, Japan.	ort182@poh.osaka-med.ac.jp		Neo, Masashi/0000-0001-9208-6419	Japan Society for the Promotion of Science KAKENHI [24791571]; Nakatomi Foundation	Grant sponsor: Japan Society for the Promotion of Science KAKENHI; Grant number: 24791571; Grant sponsor: The Nakatomi Foundation.	Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; Tetlow LC, 2001, ARTHRITIS RHEUM, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Pauli C, 2011, OSTEOARTHR CARTILAGE, V19, P1132, DOI 10.1016/j.joca.2011.05.008; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424; Jones EA, 2002, ARTHRITIS RHEUM, V46, P3349, DOI 10.1002/art.10696; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Khan IM, 2010, OSTEOARTHR CARTILAGE, V18, P208, DOI 10.1016/j.joca.2009.08.011; Nugent-Derfus GE, 2007, OSTEOARTHR CARTILAGE, V15, P566, DOI 10.1016/j.joca.2006.10.015; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Guilak F, 2004, CLIN ORTHOP RELAT R, P17, DOI 10.1097/01.blo.0000131233.83640.91; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; D'Lima DD, 2001, OSTEOARTHR CARTILAGE, V9, P712, DOI 10.1053/joca.2001.0468; Chang C, 2003, OSTEOARTHR CARTILAGE, V11, P603, DOI 10.1016/S1063-4584(03)00087-6; Intema F, 2011, ANN RHEUM DIS, V70, P1441, DOI 10.1136/ard.2010.142364; Neumann K, 2008, J ORTHOP RES, V26, P1449, DOI 10.1002/jor.20635; Englund M, 2010, ANN RHEUM DIS, V69, P1796, DOI 10.1136/ard.2009.121681; Hashimoto S, 1998, ARTHRITIS RHEUM, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Lane NE, 2011, OSTEOARTHR CARTILAGE, V19, P478, DOI 10.1016/j.joca.2010.09.013; Vincent T, 2002, P NATL ACAD SCI USA, V99, P8259, DOI 10.1073/pnas.122033199; Felson DT, 2012, OSTEOARTHR CARTILAGE, V21, P10; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; HIRSCHMA.A, 1967, HISTOCHEMISTRY, V10, P369, DOI 10.1007/BF00304320; KETTELKA.DB, 1972, CLIN ORTHOP RELAT R, P202; Koshino T., 1982, J BONE JOINT SURG AM, V64, P42; Lee GM, 2000, OSTEOARTHR CARTILAGE, V8, P44, DOI 10.1053/joca.1999.0269; Malko AV, 2013, STEM CELL REV REP, V9, P121, DOI 10.1007/s12015-013-9434-7; Otsuki S, 2010, J ORTHOP RES, V28, P96, DOI 10.1002/jor.20944; Otsuki S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2432; Otsuki S, 2008, J ORTHOP RES, V26, P1194, DOI 10.1002/jor.20571; Schumacher BL, 2002, ANAT REC, V266, P241, DOI 10.1002/ar.10063; SHIMIZU T, 1987, J ORTHOPAED RES, V5, P187, DOI 10.1002/jor.1100050205; Thomas S, 2000, J CELL PHYSL, V182, P311; Yen CN, 2008, BIOTECHNOL PROGR, V24, P452, DOI 10.1021/bp0702828	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	APR	2015	33	4					548	555		10.1002/jor.22782		8	Orthopedics	Orthopedics	CE2YE	WOS:000351687400015		
J	Ikemura, S; Hasegawa, M; Iino, T; Miyamoto, K; Imanaka-Yoshida, K; Yoshida, T; Sudo, A				Ikemura, Shigeto; Hasegawa, Masahiro; Iino, Takahiro; Miyamoto, Keiichi; Imanaka-Yoshida, Kyoko; Yoshida, Toshimichi; Sudo, Akihiro			Effect of Tenascin-C on the Repair of Full-Thickness Osteochondral Defects of Articular Cartilage in Rabbits	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						cartilage repair; tenascin-C; gellan-gellan-sulfate; animal model	FIBROBLAST-GROWTH-FACTOR; GELLAN GUM; OSTEOARTHRITIC CARTILAGE; MATRIX DEGRADATION; PERIOSTEAL GRAFTS; BONE INDUCTION; CELLS; PROLIFERATION; CHONDROCYTES; JOINT	The purpose of this study was to examine the effect of tenascin-C (TNC) on the repair of full-thickness osteochondral defects of articular cartilage in vivo. We used a gellan-gellan-sulfate sponge (Gellan-GS) to maintain a TNC-rich environment in the cartilage defects. We implanted Gellan-GS soaked in PBS only (Group 1), Gellan-GS soaked in 10 mu g/ml of TNC (Group 2), and Gellan-GS soaked in 100 mu g/ml of TNC (Group 3) into a full-thickness osteochondral defect of the patellar groove of rabbits. The defect area was examined grossly and histologically 4-12 weeks after surgery. Sections of synovium were also immunohistochemically investigated. Histologically as well as macroscopically, the defects in Group 2 showed better repair than the other groups at 8 and 12 weeks after surgery. Inflammation of the synovium tended to diminish over time in all groups, and the degree of synovitis was the same for all three groups at each time point. In conclusion, Gellan-GS soaked in TNC can be used as a novel scaffold for the repair of articular cartilage defects. This study also indicates that TNC promotes the repair of full-thickness osteochondral defects in vivo. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:563-571, 2015.	[Ikemura, Shigeto; Hasegawa, Masahiro; Iino, Takahiro; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan; [Miyamoto, Keiichi] Mie Univ, Grad Sch Med, Dept Chem Mat, Tsu, Mie, Japan; [Imanaka-Yoshida, Kyoko; Yoshida, Toshimichi] Mie Univ, Grad Sch Med, Dept Pathol & Matrix Biol, Tsu, Mie, Japan	Hasegawa, M (reprint author), Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan.	masahase@clin.medic.mie-u.ac.jp	Yoshida, Toshimichi/H-6204-2013	Yoshida, Toshimichi/0000-0001-8935-8217			Goh FG, 2010, J IMMUNOL, V184, P2655, DOI 10.4049/jimmunol.0903359; Li YC, 2010, TISSUE ENG PART C-ME, V16, P1267, DOI 10.1089/ten.TEC.2009.0682; GRANDE DA, 1989, J ORTHOPAED RES, V7, P208, DOI 10.1002/jor.1100070208; Jenniskens YM, 2006, OSTEOARTHR CARTILAGE, V14, P1136, DOI 10.1016/j.joca.2006.04.002; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579; JANSSON PE, 1983, CARBOHYD RES, V124, P135, DOI 10.1016/0008-6215(83)88361-X; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532; Wang CM, 2008, ACTA BIOMATER, V4, P1226, DOI 10.1016/j.actbio.2008.03.008; MOSCATELLI D, 1994, J CELL PHYSIOL, V160, P555, DOI 10.1002/jcp.1041600319; Okamura N, 2010, OSTEOARTHR CARTILAGE, V18, P839, DOI 10.1016/j.joca.2009.08.013; Power J, 2014, J ORTHOP RES, V32, P669, DOI 10.1002/jor.22580; Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K; Brittberg M, 1996, CLIN ORTHOP RELAT R, P270; Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45; Sofat N, 2012, RHEUMATOL INT, V32, P2809, DOI 10.1007/s00296-011-2067-8; Smith AM, 2007, J BIOMATER APPL, V22, P241, DOI 10.1177/0885328207076522; ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017; Pfander D, 2004, ANN RHEUM DIS, V63, P240, DOI 10.1136/ard.2002.003749; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; ASPENBERG P, 1991, ACTA ORTHOP SCAND, V62, P481, DOI 10.3109/17453679108996650; BILLINGS E, 1990, ACTA ORTHOP SCAND, V61, P201; ENGKVIST O, 1979, SCAND J PLAST RECONS, V13, P361; Hasegawa M, 2004, J RHEUMATOL, V31, P2021; Mackie EJ, 1998, MICROSC RES TECHNIQ, V43, P102; Miyamoto K, 2001, INT J BIOL MACROMOL, V28, P381, DOI 10.1016/S0141-8130(01)00135-0; MOORHOUSE R, 1977, J MOL BIOL, V109, P373, DOI 10.1016/S0022-2836(77)80018-1; Nakoshi Y, 2010, J ORTHOP SCI, V15, P666, DOI 10.1007/s00776-010-1513-x; Oliveira JT, 2010, J ORTHOP SCI, V15, P1; Patel L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-164; RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P175, DOI 10.3109/17453678208992197; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SALTER DM, 1993, BRIT J RHEUMATOL, V32, P780; Schmidt-Rohlfing B, 2002, SCAND J RHEUMATOL, V31, P151; Tanaka H, 2004, TISSUE ENG, V10, P633, DOI 10.1089/107632704323061988; Toma N, 2005, J NEUROSURG, V103, P681, DOI 10.3171/jns.2005.103.4.0681; Wakitani S, 1997, ACTA ORTHOP SCAND, V68, P474, DOI 10.3109/17453679708996266; WANG JS, 1993, ACTA ORTHOP SCAND, V64, P557, DOI 10.3109/17453679308993692; Yoshida T, 1999, VIRCHOWS ARCH, V435, P496, DOI 10.1007/s004280050433; Yoshimura E, 1999, HISTOCHEM CELL BIOL, V111, P259, DOI 10.1007/s004180050356	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	APR	2015	33	4					563	571		10.1002/jor.22794		9	Orthopedics	Orthopedics	CE2YE	WOS:000351687400017		
J	Hatakeyama, N; Hori, T; Yamamoto, M; Igarashi, K; Iesato, K; Takebayashi, A; Kaneda, M; Sarashina, T; Toriumi, N; Tsutsumi, H				Hatakeyama, Naoki; Hori, Tsukasa; Yamamoto, Masaki; Igarashi, Keita; Iesato, Kotoe; Takebayashi, Akira; Kaneda, Makoto; Sarashina, Takeo; Toriumi, Naohisa; Tsutsumi, Hiroyuki			Extramedullary Tumor of Cerebral Falx: An Unusual Presentation of Acute Megakaryocytic Leukemia	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						acute megakaryocytic leukemia; extramedullary tumor; PET	ACUTE MYELOID-LEUKEMIA; CHILDREN; DIAGNOSIS	In childhood acute myelogenous leukemia, extramedullary tumor is an occasional clinical symptom. However, extramedullary acute megakaryocytic leukemia is extremely rare. Here, we report an extremely rare case of acute megakaryocytic leukemia in a patient who presented with extramedullary tumor of cerebral falx as a first manifestation before the diagnosis of systemic bone marrow leukemia.	[Hatakeyama, Naoki; Hori, Tsukasa; Yamamoto, Masaki; Igarashi, Keita; Iesato, Kotoe; Takebayashi, Akira; Tsutsumi, Hiroyuki] Sapporo Med Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 0608543, Japan; [Kaneda, Makoto; Sarashina, Takeo; Toriumi, Naohisa] Asahikawa Med Univ, Sch Med, Dept Pediat, Asahikawa, Hokkaido, Japan	Hatakeyama, N (reprint author), Sapporo Med Univ, Sch Med, Dept Pediat, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	nhatake@sapmed.ac.jp					BYRD JC, 1995, J CLIN ONCOL, V13, P1800; Bakst RL, 2011, BLOOD, V118, P3785, DOI 10.1182/blood-2011-04-347229; Bisschop MM, 2001, LEUKEMIA, V15, P46, DOI 10.1038/sj.leu.2401971; CREUTZIG U, 1995, BLOOD, V86, P3097; Cribe ASWI, 2013, EUR J HAEMATOL, V90, P273, DOI 10.1111/ejh.12085; Dusenbery KE, 2003, J PEDIAT HEMATOL ONC, V25, P760, DOI 10.1097/00043426-200310000-00004; Kobayashi R, 2007, PEDIATR BLOOD CANCER, V48, P393, DOI 10.1002/pbc.20824; KRAUSE JR, 1979, CANCER, V44, P1017, DOI 10.1002/1097-0142(197909)44:3<1017::AID-CNCR2820440333>3.0.CO;2-I; Liang C, 2012, PEDIATR DEVEL PATHOL, V15, P385, DOI 10.2350/11-12-1124-CR.1; RAVINDRANATH Y, 1991, J CLIN ONCOL, V9, P572; Stolzel F, 2011, HAEMATOL-HEMATOL J, V96, P1552, DOI 10.3324/haematol.2011.045047	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	APR	2015	37	3					E170	E172				3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CE3EK	WOS:000351708300007		
J	Miura, Y; Saito, J; Shimanuki, Y; Takeyama, J; Murotsuki, J				Miura, Yuichiro; Saito, Junko; Shimanuki, Yoshihisa; Takeyama, Junji; Murotsuki, Jun			Diagnosis and Treatment of a Preterm Infant With Inoperable Congenital Hepatoblastoma-A Case Report	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						hepatoblastoma; preterm infant; image diagnosis; treatment	INTERNATIONAL SOCIETY; CHILDREN; HEMANGIOENDOTHELIOMA; SURVIVAL; FETAL	Reports of hepatoblastoma (HB) in preterm infants are quite rare. Herein, we report the clinical management of a preterm infant with inoperable congenital HB. A female fetus that had been diagnosed with a large liver tumor consistent with hemangioma was delivered by emergency cesarean section at 33 weeks of gestation because of fetal distress. Effective antitumor therapy could not be performed, resulting in rapid deterioration and death. The postmortem histopathologic analysis confirmed the tumor as a HB. This report demonstrates the difficulties inherent in both the image diagnosis of HB and in providing efficacious treatments for preterm infants with HB.	[Miura, Yuichiro; Saito, Junko] Miyagi Childrens Hosp, Dept Neonatol, Sendai, Miyagi, Japan; [Shimanuki, Yoshihisa] Miyagi Childrens Hosp, Dept Radiol, Sendai, Miyagi, Japan; [Takeyama, Junji] Miyagi Childrens Hosp, Dept Clin Pathol, Sendai, Miyagi, Japan; [Murotsuki, Jun] Miyagi Childrens Hosp, Dept Maternal & Fetal Med, Sendai, Miyagi, Japan; [Murotsuki, Jun] Tohoku Univ, Grad Sch Med, Dept Maternal & Fetal Med, Sendai, Miyagi 980, Japan	Miura, Y (reprint author), Univ Western Australia, Sch Womens & Infants Hlth, 35 Stirling Highway, Crawley, WA 6009, Australia.	yuichiro.miura@uwa.edu.au					Allan BJ, 2013, HPB, V15, P741, DOI 10.1111/hpb.12112; Ammann RA, 1999, MED PEDIATR ONCOL, V32, P466, DOI 10.1002/(SICI)1096-911X(199906)32:6<466::AID-MPO20>3.0.CO;2-1; Brown J, 2000, EUR J CANCER, V36, P1418, DOI 10.1016/S0959-8049(00)00074-5; Isaacs H, 2007, J PEDIATR SURG, V42, P1797, DOI 10.1016/j.jpedsurg.2007.07.047; Hou JY, 2009, J PEDIAT HEMATOL ONC, V31, P718, DOI 10.1097/MPH.0b013e3181b6db88; Darbari A, 2003, HEPATOLOGY, V38, P560, DOI 10.1053/jhep.2003.50375; Horton JD, 2009, PEDIATR SURG INT, V25, P407, DOI 10.1007/s00383-009-2349-3; Bartelink IH, 2006, CLIN PHARMACOKINET, V45, P1077, DOI 10.2165/00003088-200645110-00003; Ergin H, 2008, PATHOL ONCOL RES, V14, P97, DOI 10.1007/s12253-008-9001-8; Huang LC, 2011, PEDIATR HEMAT ONCOL, V28, P150, DOI 10.3109/08880018.2010.536299; Ingram JD, 2000, PEDIATR RADIOL, V30, P794, DOI 10.1007/s002470000320; Lu M, 2007, PEDIATR RADIOL, V37, P587, DOI 10.1007/s00247-007-0460-y; Picton SV, 2009, CANCER CHEMOTH PHARM, V63, P749, DOI 10.1007/s00280-008-0787-6; Schnater JM, 2002, CANCER, V94, P1111, DOI 10.1002/cncr.10282; Shih JC, 2000, ULTRASOUND OBST GYN, V16, P94, DOI 10.1046/j.1469-0705.2000.00168.x; Stones DK, 2009, PEDIATR BLOOD CANCER, V52, P883, DOI 10.1002/pbc.21945; Trobaugh-Lotrario AD, 2013, PEDIATR BLOOD CANCER, V60, P1817, DOI 10.1002/pbc.24655; Veal GJ, 2012, SEMIN FETAL NEONAT M, V17, P243, DOI 10.1016/j.siny.2012.03.002; von Schweinitz Dietrich, 2003, Semin Neonatol, V8, P403, DOI 10.1016/S1084-2756(03)00092-7	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	APR	2015	37	3					E188	E190				3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CE3EK	WOS:000351708300012		
J	Nishimura, M; Kodama, Y; Fukano, R; Okamura, J; Ogaki, K; Sakaguchi, Y; Migita, M; Inagaki, J				Nishimura, Miho; Kodama, Yuichi; Fukano, Reiji; Okamura, Jun; Ogaki, Kippei; Sakaguchi, Yoshihisa; Migita, Masahiro; Inagaki, Jiro			Meralgia Paresthetica as a Presentation of Acute Appendicitis in a Girl With Acute Lymphoblastic Leukemia	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						appendicitis; meralgia paresthetica; leukemia	HEMATOLOGIC MALIGNANCIES; CHILDREN; MANAGEMENT	A 7-year-old girl with Philadelphia chromosome-positive acute lymphoblastic leukemia developed recurrent fever and meralgia paresthetica (MP) during chemotherapy, which resolved after administration of antibiotics. Five months after the onset of these symptoms, enhanced computed tomography showed a periappendiceal abscess extending into the psoas muscle. The cause of her fever and MP was thought to be appendicitis, which probably developed during induction chemotherapy but did not result in typical abdominal pain. Patients with recurrent fever and MP should be evaluated by imaging examinations including computed tomography to search for appendicitis.	[Nishimura, Miho; Kodama, Yuichi; Fukano, Reiji; Okamura, Jun; Inagaki, Jiro] Kyushu Natl Canc Ctr, Dept Pediat, Fukuoka 8111395, Japan; [Ogaki, Kippei; Sakaguchi, Yoshihisa] Kyushu Natl Canc Ctr, Dept Gastrointestinal Surg, Fukuoka 8111395, Japan; [Migita, Masahiro] Japanese Red Cross Kumamoto Hosp, Dept Pediat, Kumamoto, Japan	Kodama, Y (reprint author), Kyushu Natl Canc Ctr, Dept Pediat, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	yuichik@m.kufm.kagoshima-u.ac.jp					Alioglu B, 2007, INT J HEMATOL, V86, P364, DOI 10.1532/IJH97.E0739; ANGEL CA, 1992, J PEDIATR SURG, V27, P476, DOI 10.1016/0022-3468(92)90342-5; Hobson MJ, 2005, J PEDIATR SURG, V40, P214, DOI 10.1016/j.jpedsurg.2004.09.048; Parisi TJ, 2011, NEUROLOGY, V77, P1538, DOI 10.1212/WNL.0b013e318233b356; Wiegering VA, 2008, J PEDIAT HEMATOL ONC, V30, P464, DOI 10.1097/MPH.0b013e318168e7cb; CHIRLETTI P, 1993, LEUKEMIA LYMPHOMA, V9, P237, DOI 10.3109/10428199309147376; EXELBY PR, 1975, CANCER, V35, P826, DOI 10.1002/1097-0142(197503)35:3<826::AID-CNCR2820350339>3.0.CO;2-B; Ghavanini MRA, 2001, AM J PHYS MED REHAB, V80, P703, DOI 10.1097/00002060-200109000-00012; Kim EY, 2012, YONSEI MED J, V53, P781, DOI 10.3349/ymj.2012.53.4.781; Yi Tae Im, 2012, Ann Rehabil Med, V36, P273, DOI 10.5535/arm.2012.36.2.273	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	APR	2015	37	3					E182	E183				2	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CE3EK	WOS:000351708300010		
J	Himuro, N; Miyagishima, S; Kozuka, N; Tsutsumi, H; Mori, M				Himuro, N.; Miyagishima, S.; Kozuka, N.; Tsutsumi, H.; Mori, M.			Measurement of family-centered care in the neonatal intensive care unit and professional background	JOURNAL OF PERINATOLOGY			English	Article							PEDIATRIC SERVICE PROVIDERS; PARENTS PERCEPTIONS; ADAPTATION; VALIDATION; CHILDREN; INFANTS	OBJECTIVE: The aims of this study were to examine the validity and reliability of the Measure of Processes of Care for Service Providers (MPOC-SP) for multidisciplinary teams in neonatal intensive care units (NICUs) and to examine differences among professions. STUDY DESIGN: A Japanese language version of the MPOC-SP questionnaire was distributed among the professionals employed at three perinatal medical centers. RESULT: A total of 83 multidisciplinary team members completed the questionnaire. The construct validity was examined by a confirmative analysis of each scale structure. The MPOC-SP showed adequate internal consistency. The test-retest analysis showed that the MPOC-SP, except the 'providing general information' scale, is a reliable tool. The results suggest that professional background affects the attitude and behavior of professionals involved in family-centered care. CONCLUSION: The MPOC-SP has good psychometric properties and can be used to identify areas for improvement in the family-centered care provided by multidisciplinary teams in the NICUs.	[Himuro, N.; Mori, M.] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 0608556, Japan; [Miyagishima, S.] Sapporo Med Univ, Dept Pediat, Grad Sch, Sapporo, Hokkaido 0608556, Japan; [Miyagishima, S.] Sapporo Med Univ Hosp, Div Rehabil Med, Sapporo, Hokkaido, Japan; [Kozuka, N.] Sapporo Med Univ, Dept Div Phys Therapy 1, Sch Hlth Sci, Sapporo, Hokkaido 0608556, Japan; [Tsutsumi, H.] Sapporo Med Univ, Dept Pediat, Sapporo, Hokkaido 0608556, Japan	Himuro, N (reprint author), Sapporo Med Univ, Sch Med, Dept Publ Hlth, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	himuro@sapmed.ac.jp					Ahmann E, 2006, PEDIAT NURS, V20, P98; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Kowalski WJ, 2006, J PERINATOL, V26, P44, DOI 10.1038/sj.jp.7211409; McGrath JM, 2011, J PERINAT NEONAT NUR, V25, P165, DOI 10.1097/JPN.0b013e31821a6706; Gooding JS, 2011, SEMIN PERINATOL, V35, P20, DOI 10.1053/j.semperi.2010.10.004; King S, 2004, CHILD HEALTH CARE, V33, P35, DOI 10.1207/s15326888chc3301_3; Siebes RC, 2006, CLIN REHABIL, V20, P502, DOI 10.1191/0269215506cr979oa; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Woodside JM, 2001, CHILD HEALTH CARE, V30, P237, DOI 10.1207/S15326888CHC3003_5; BLAND JM, 1986, LANCET, V1, P307; Cunningham BJ, 2014, DEV MED CHILD NEUROL, V56, P445, DOI 10.1111/dmcn.12347; Himuro N, 2013, CHILD CARE HLTH DEV, V39, P358, DOI 10.1111/j.1365-2214.2012.01371.x; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; King GA, 1997, CHILD CARE HLTH DEV, V23, P47, DOI 10.1046/j.1365-2214.1997.840840.x; King SM, 1996, DEV MED CHILD NEUROL, V38, P757; King S., 1995, MEASURE PROCESSES CA; Portney LG, 2009, FDN CLIN RES APPL PR; Rosenbaum P, 1998, PHYS OCCUPATIONAL TH, V18, P1, DOI DOI 10.1300/J006V18N01_01; Streiner DL, 2008, HLTH MEASUREMENT SCA; Van Riper M, 2001, HEART LUNG, V30, P74, DOI 10.1067/mhl.2001.110625	20	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0743-8346	1476-5543		J PERINATOL	J. Perinatol.	APR	2015	35	4					284	289		10.1038/jp.2014.204		6	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CE5JJ	WOS:000351868300010		
J	Igami, K; Shimojo, Y; Ito, H; Miyazaki, T; Kashiwada, Y				Igami, Kentaro; Shimojo, Yosuke; Ito, Hisatomi; Miyazaki, Toshitsugu; Kashiwada, Yoshiki			Hepatoprotective effect of fermented ginseng and its major constituent compound K in a rat model of paracetamol (acetaminophen)-induced liver injury	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						acetaminophen; compound K; DNA microarray; fermented ginseng; JNK phosphorylation	HEPATIC-INJURY; ACETAMINOPHEN; HEPATOTOXICITY; ACTIVATION; SAPONIN; CELLS; MICE; PROTOPANAXADIOL; INHIBITION; EXPRESSION	ObjectivesThis work aimed at evaluating the effect of fermented ginseng (FG) and fermented red ginseng (FRG) against rat liver injury caused by paracetamol (acetaminophen (APAP)). MethodsAspartate aminotransferase (AST) and alanine aminotransferase (ALT) in the serum and histopathological changes in the liver were analysed to determine the degree of liver injury. Deoxyribonucleic acid (DNA) microarray analysis was performed to compare gene expression levels altered in the rat livers. Phosphorylated Jun-N-terminal kinase (JNK) in human hepatocellular carcinoma (HepG2) cells were detected using western blot analysis to investigate the anti-inflammatory activity of compound K. Key findingsPretreatment with FG, containing compound K at high concentration, attenuated AST as well as ALT levels in rats, while no obvious effect was observed in the group that received FRG, whose content of compound K was lower than that of FG. In addition, the results of our histopathological analysis were consistent with changes in the serum biochemical analysis. DNA microarray analysis indicated that JNK- and glutathione S-transferase (GST)-related genes were involved in the hepatotoxicity. Notably, compound K, a major ginsenoside in FG, inhibited the phosphorylation of JNK in HepG2 cells. ConclusionsFG was shown to possess hepatoprotective activity against paracetamol (APAP)-induced liver injury better than FRG. Compound K might play an important role for an anti-inflammatory activity of FG by inhibiting JNK signalling in the liver.	[Igami, Kentaro; Shimojo, Yosuke; Ito, Hisatomi; Miyazaki, Toshitsugu] Nagase & CO LTD, Ctr Res & Dev, Kobe, Hyogo, Japan; [Kashiwada, Yoshiki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 770, Japan	Kashiwada, Y (reprint author), Univ Tokushima, Grad Sch Pharmaceut Sci, 1-78 Shomachi, Tokushima 7708505, Japan.	kasiwada@tokushima-u.ac.jp					Ahmed MME, 2011, HEPATOLOGY, V54, P1322, DOI 10.1002/hep.24493; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Zuber R, 2002, PHYTOTHER RES, V16, P632, DOI 10.1002/ptr.1000; Gum SI, 2013, LIVER INT, V33, P1071, DOI 10.1111/liv.12046; Jung SH, 2006, INT J CANCER, V118, P490, DOI 10.1002/ijc.21356; Hasegawa H, 2004, J PHARMACOL SCI, V95, P153, DOI 10.1254/jphs.FMJ04001X4; Bond GR, 2012, DRUG SAFETY, V35, P149, DOI 10.2165/11595890-000000000-00000; COLES B, 1988, ARCH BIOCHEM BIOPHYS, V264, P253, DOI 10.1016/0003-9861(88)90592-9; Choi K, 2007, NEUROSCI LETT, V421, P37, DOI 10.1016/j.neulet.2007.05.017; THUMMEL KE, 1993, BIOCHEM PHARMACOL, V45, P1563, DOI 10.1016/0006-2952(93)90295-8; Park JS, 2012, J PHARMACOL EXP THER, V341, P59, DOI 10.1124/jpet.111.189035; Tew KD, 2011, DRUG METAB REV, V43, P179, DOI 10.3109/03602532.2011.552912; Li W, 2011, MOLECULES, V16, P10093, DOI 10.3390/molecules161210093; Hau DKP, 2010, FORSCH KOMPLEMENTMED, V17, P209, DOI 10.1159/000319317; Ho AS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-58; Kim HJ, 1997, PLANTA MED, V63, P415, DOI 10.1055/s-2006-957724; Kitaoka K, 2009, SLEEP, V32, P413; Lee HU, 2005, LIVER INT, V25, P1069, DOI 10.1111/j.1478-3231.2005.01068.x; Liang GS, 1996, J BIOL CHEM, V271, P1695; Wang SD, 2014, LIVER INT, V34, P1068, DOI 10.1111/liv.12329; Waring WS, 2012, EXPERT REV CLIN PHAR, V5, P311, DOI [10.1586/ecp.12.15, 10.1586/ECP.12.15]; Zira A, 2009, J APPL TOXICOL, V29, P395, DOI 10.1002/jat.1425	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	APR	2015	67	4					565	572		10.1111/jphp.12342		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE4XF	WOS:000351832900010		
J	Kohri, Y; Takebe, T; Minami, Y; Kanai, T; Takarada, W; Kikutani, T				Kohri, Youhei; Takebe, Tomoaki; Minami, Yutaka; Kanai, Toshitaka; Takarada, Wataru; Kikutani, Takeshi			Structure and properties of low-isotacticity polypropylene elastomeric fibers prepared by sheath-core bicomponent spinning: effect of localization of high-isotacticity component near the fiber surface	JOURNAL OF POLYMER ENGINEERING			English	Article						bicomponent fiber; elastic recovery; elastomeric fiber; isotacticity; polypropylene	ETHYLENE-PROPYLENE COPOLYMER; ISOTHERMAL CRYSTALLIZATION; MORPHOLOGY DEVELOPMENT; MECHANICAL-PROPERTIES; UNIAXIAL DEFORMATION; BLOCK-COPOLYMERS; CATALYSTS; BLENDS	Sheath-core type bicomponent melt-spun fibers were produced by extruding the melts of low-isotacticity polypropylene (LPP) as the core component and the blend of LPP and high-isotacticity PP (IPP) as the sheath component. IPP content in the sheath was changed from 8 wt% to 40 wt% while sheath/core composition was varied from 50/50 to 10/90. Accordingly overall IPP content was kept constant at 4 wt%. Even though the overall IPP content was intact, bicomponent fibers with lower contraction ratio after spinning, higher elastic recovery and slightly higher modulus and strength were obtained by increasing the IPP content in the sheath and decreasing the sheath layer composition, i.e., localizing the IPP to the region near the surface in the fiber cross-section. Structure analysis of the as-spun fibers suggested the suppression of crystallization of LPP in the sheath by blending IPP. By contrast, enhancement of molecular orientation and crystallization of the sheath component were found to occur by localizing the IPP to the region near the fiber surface. It was speculated that this behavior was caused by the kinematic mutual interaction of the sheath and core components in the melt spinning process.	[Kohri, Youhei; Takebe, Tomoaki; Minami, Yutaka] Idemitsu Kosan Co Ltd, Performance Mat Labs, Chiba, Japan; [Kohri, Youhei; Takarada, Wataru; Kikutani, Takeshi] Tokyo Inst Technol, Organ & Polymer Mat, Tokyo 152, Japan; [Kanai, Toshitaka] KT Polymer, Chiba, Japan	Kohri, Y (reprint author), Idemitsu Kosan Co Ltd, Performance Mat Labs, Chiba, Japan.	yohei.koori@idemitsu.com					Toki S, 2006, MACROMOLECULES, V39, P3588, DOI 10.1021/ma0600106; De Rosa C, 2011, POLYM CHEM-UK, V2, P2155, DOI 10.1039/c1py00129a; Kikutani T, 1996, J APPL POLYM SCI, V62, P1913, DOI 10.1002/(SICI)1097-4628(19961212)62:11<1913::AID-APP16>3.0.CO;2-Z; Bensason S, 1997, MACROMOLECULES, V30, P2436, DOI 10.1021/ma961685j; Liu LZ, 2003, MACROMOLECULES, V36, P1920, DOI 10.1021/ma020771i; Zuo F, 2011, MACROMOLECULES, V44, P3670, DOI 10.1021/ma102512p; Deplace F, 2010, J POLYM SCI POL PHYS, V48, P1428, DOI 10.1002/polb.21969; Chum PS, 2008, PROG POLYM SCI, V33, P797, DOI 10.1016/j.progpolymsci.2008.05.003; Stephens CH, 2006, J APPL POLYM SCI, V100, P1651, DOI 10.1002/app.23788; Auriemma F, 2011, MACROMOLECULES, V44, P6026, DOI 10.1021/ma201420f; Brandrup J, 1975, POLYM HDB 5, V24; De Rosa C, 2007, MACROMOLECULES, V40, P6600, DOI 10.1021/ma070409+; De Rosa C, 2004, J AM CHEM SOC, V126, P17040, DOI 10.1021/ja045684f; Jeon K, 2008, MACROMOLECULES, V41, P95, DOI 10.1021/ma070757b; Kikutani T, 1995, SEN-I GAKKAISHI, V51, P408; Kohri Y, 2014, SEN-I GAKKAISHI, V70, P203; Okamoto K, 2012, SEIK KAK ANN M, P259; Poon BC, 2007, J APPL POLYM SCI, V104, P489, DOI 10.1002/app.25243; Rana S, 2003, POLYMER, V44, P2385; Tajima T, 2006, [No title captured], Patent No. [WO2006/051708 A1, 2006051708]; Takebe T, 2009, JP2009-62667A, Patent No. 200962667; Takebe T, 2010, POLYMERS, V59, P853; Takebe T, 2009, [No title captured], Patent No. [JP2009-209506A, 2009209506]; Takebe T, 2009, SEIKEI KAKOU, V21, P202; Wang ZG, 2001, J POLYM SCI POL PHYS, V39, P1876, DOI 10.1002/polb.1162; Wang ZG, 2000, J POLYM SCI POL PHYS, V38, P2580, DOI 10.1002/1099-0488(20001001)38:19<2580::AID-POLB100>3.3.CO;2-2	26	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-6447	2191-0340		J POLYM ENG	J. Polym. Eng.	APR	2015	35	3					277	285		10.1515/polyeng-2014-0195		9	Polymer Science	Polymer Science	CE7JL	WOS:000352015300009		
J	Kikawada, Y; Hirose, M; Tsukamoto, A; Nakamachi, K; Oi, T; Honda, T; Takahashi, H; Hirose, K				Kikawada, Yoshikazu; Hirose, Masaaki; Tsukamoto, Atsushi; Nakamachi, Ko; Oi, Takao; Honda, Teruyuki; Takahashi, Hiroaki; Hirose, Katsumi			Mobility of radioactive cesium in soil originated from the Fukushima Daiichi nuclear disaster: application of extraction experiments	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radioactive cesium; Fukushima Daiichi Nuclear Power Plant; Fukushima disaster; Contaminated soil; Extraction experiment	POWER-PLANT ACCIDENT; CONTAMINATION; RADIOCESIUM; DEPOSITION; CATIONS; CHARGE	Extraction experiments on soil radioactively contaminated by the Fukushima Daiichi Nuclear Power Plant accident were conducted by using a variety of extractants to acquire knowledge on the mobility of radioactive cesium in soil. The experimental results revealed that cesium is tightly bound with soil particles and that radioactive cesium newly deposited on soil due to the accident had apparently a higher mobility than stable cesium commonly existing in soil. The results suggested that radioactive cesium deposited on soil hardly migrates via aqueous processes, although chemical and mineralogical conditions of soil affect their mobility.	[Kikawada, Yoshikazu; Oi, Takao; Hirose, Katsumi] Sophia Univ, Fac Sci & Technol, Chiyoda Ku, Tokyo 1028554, Japan; [Hirose, Katsumi] Sophia Univ, Grad Sch Sci & Technol, Chiyoda Ku, Tokyo 1028554, Japan; [Tsukamoto, Atsushi; Nakamachi, Ko; Honda, Teruyuki] Tokyo City Univ, Grad Sch Engn, Setagaya Ku, Tokyo 1588557, Japan; [Takahashi, Hiroaki] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Kikawada, Y (reprint author), Sophia Univ, Fac Sci & Technol, Chiyoda Ku, 7-1 Kioicho, Tokyo 1028554, Japan.	y-kikawa@sophia.ac.jp					SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; BARROW NJ, 1985, ADV AGRON, V38, P183, DOI 10.1016/S0065-2113(08)60676-8; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Wuddivira MN, 2007, EUR J SOIL SCI, V58, P722, DOI 10.1111/j.1365-2389.2006.00861.x; Qin HB, 2012, GEOCHEM J, V46, P297; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; Kozai N, 2012, J NUCL SCI TECHNOL, V49, P473, DOI [10.1080/002231312012677131, 10.1080/00223131.2012.677131]; Bolan NS, 1999, ADV AGRON, V67, P87, DOI 10.1016/S0065-2113(08)60514-3; Kumada K., 1987, CHEM SOIL ORGANIC MA; Sensi N, 1991, SOIL SCI, V152, P259; Yamaguchi Noriko, 2012, Bulletin of the National Institute of Agro-Environmental Sciences, V31, P75; Yoshida N, 2012, ELEMENTS, V8, P201, DOI 10.2113/gselements.8.3.201	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	APR	2015	304	1					27	31		10.1007/s10967-014-3713-x		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CE3UP	WOS:000351755200006		
J	Mendoza-Hernandez, OS; Ishikawa, H; Nishikawa, Y; Maruyama, Y; Sone, Y; Umeda, M				Mendoza-Hernandez, Omar Samuel; Ishikawa, Hiroaki; Nishikawa, Yuuki; Maruyama, Yuki; Sone, Yoshitsugu; Umeda, Minoru			Electrochemical impedance study of LiCoO2 cathode reactions in a lithium ion cell incorporating a reference electrode	JOURNAL OF SOLID STATE ELECTROCHEMISTRY			English	Article						Li-ion secondary cell; Electrochemical impedance spectroscopy; dQ/dE vs. E; LiCoO2	AC-IMPEDANCE; INTERCALATION; BATTERIES; CARBON; SPECTROSCOPY; PARTICLES; LI4TI5O12; INSERTION; LIXCOO2	Kinetic characteristics of LiCoO2 cathode materials are studied using a Li-ion secondary cell incorporating a reference electrode. By carrying out electrochemical impedance spectroscopy (EIS) measurements at different state of charges (SOCs) and temperatures and obtaining dQ/dE vs. E curves, the activation energy, pre-exponential factor, and reaction rate constant of Li-ion insertion/deinsertion reactions are analyzed as a function of cathode potential. The kinetic behavior of Li-ion conduction, Li-ion solvation/desolvation, and charge transfer reactions of LiCoO2 and its dependency on the structural changes of LiCoO2 are studied. The charge transfer, Li-ion conduction, and Li-ion solvation/desolvation reactions exhibited a dependency on the structural changes of the cathode material.	[Mendoza-Hernandez, Omar Samuel; Ishikawa, Hiroaki; Nishikawa, Yuuki; Maruyama, Yuki; Umeda, Minoru] Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, Nagaoka, Ibaraki 3113195, Japan; [Ishikawa, Hiroaki] Ind Technol Inst Ibaraki Prefecture, Nagaoka, Ibaraki 3113195, Japan; [Sone, Yoshitsugu] Japan Aerosapce Explorat Agcy, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Sone, Yoshitsugu] Grad Univ Adv Studies, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	Umeda, M (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, Fac Engn, 1603-1 Kamitomioka, Nagaoka, Ibaraki 3113195, Japan.	mumeda@vos.nagaokaut.ac.jp					Whittingham MS, 2008, MRS BULL, V33, P411, DOI 10.1557/mrs2008.82; Hang T, 2013, J POWER SOURCES, V222, P442, DOI 10.1016/j.jpowsour.2012.09.010; Fergus JW, 2010, J POWER SOURCES, V195, P939, DOI 10.1016/j.jpowsour.2009.08.089; Chen ZH, 2002, J ELECTROCHEM SOC, V149, pA1604, DOI 10.1149/1.1519850; REIMERS JN, 1992, J ELECTROCHEM SOC, V139, P2091, DOI 10.1149/1.2221184; Gomez J, 2011, J POWER SOURCES, V196, P4826, DOI 10.1016/j.jpowsour.2010.12.107; Andre D, 2011, J POWER SOURCES, V196, P5334, DOI 10.1016/j.jpowsour.2010.12.102; BOUKAMP BA, 1986, SOLID STATE IONICS, V20, P31, DOI 10.1016/0167-2738(86)90031-7; Patil A, 2008, MATER RES BULL, V43, P1913, DOI 10.1016/j.materresbull.2007.08.031; Zhang SS, 2001, ELECTROCHEM SOLID ST, V4, pA206, DOI 10.1149/1.1414946; Dolle M, 2001, J ELECTROCHEM SOC, V148, pA851, DOI 10.1149/1.1381071; Woodford WH, 2010, J ELECTROCHEM SOC, V157, pA1052, DOI 10.1149/1.3464773; Umeda M, 2001, ELECTROCHIM ACTA, V47, P885, DOI 10.1016/S0013-4686(01)00799-X; Ishikawa H, 2012, J POWER SOURCES, V198, P236, DOI 10.1016/j.jpowsour.2011.09.067; Lei JL, 2005, J ELECTROCHEM SOC, V152, pA774, DOI 10.1149/1.1867652; Ogumi Z, 2010, ELECTROCHEMISTRY, V78, P319; Bard AJ, 2001, ELECTROCHEMICAL METH; Dokko K, 2001, ELECTROCHIM ACTA, V47, P933, DOI 10.1016/S0013-4686(01)00809-X; Dokko K, 2001, J ELECTROCHEM SOC, V148, pA422, DOI 10.1149/1.1359197; Hong JS, 2000, J ELECTROCHEM SOC, V147, P3183, DOI 10.1149/1.1393881; Itakagi M., 2004, J POWER SOURCES, V135, P255; LI GB, 1995, SOLID STATE IONICS, V81, P15, DOI 10.1016/0167-2738(95)00166-4; Manjunatha H, 2011, ELECTROCHIM ACTA, V56, P1439, DOI 10.1016/j.electacta.2010.08.107; Meyers JP, 2000, J ELECTROCHEM SOC, V147, P2930, DOI 10.1149/1.1393627; Schweikert N, 2012, SOLID STATE IONICS, V226, P15, DOI 10.1016/j.ssi.2012.08.002; Suresh P, 2002, J APPL ELECTROCHEM, V32, P267, DOI 10.1023/A:1015565404343; Wang CS, 2003, J ELECTROCHEM SOC, V150, pA143, DOI 10.1149/1.1530150	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-8488	1433-0768		J SOLID STATE ELECTR	J. Solid State Electrochem.	APR	2015	19	4					1203	1210		10.1007/s10008-015-2741-y		8	Electrochemistry	Electrochemistry	CE3CS	WOS:000351702700027		
J	Saitoh, H; Watanabe, H; Kakuda, S; Takimoto-Kamimura, M; Takagi, K; Takeuchi, A; Takenouchi, K				Saitoh, Hiroshi; Watanabe, Hidekazu; Kakuda, Shinji; Takimoto-Kamimura, Midori; Takagi, Kenichiro; Takeuchi, Akiko; Takenouchi, Kazuya			Synthesis and biological activities of vitamin D-3 derivatives with cyanoalkyl side chain at C-2 position	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Review						Vitamin D-3; 2 alpha-Functionalized vitamin D; Vitamin D receptor; Binding affinity; Transactivation; X-ray co-crystallographic analysis		We synthesized and evaluated novel vitamin D-3 derivatives with cyanoalkyl side chain at C-2 position on the basis of our previous research for 2 alpha side chain which bears nitrogen atom-containing functional group. Through a study of X-ray co-crystal structures of human VDR and compound 3, we demonstrated that the 2 alpha alkyl side chain in compound 3 shows a novel interaction in the complex of hVDR-LBD and ligand. This article is part of a Special Issue entitled '17th Vitamin D Workshop'. (C) 2014 Elsevier Ltd. All rights reserved.	[Saitoh, Hiroshi; Watanabe, Hidekazu; Kakuda, Shinji; Takimoto-Kamimura, Midori; Takagi, Kenichiro; Takeuchi, Akiko; Takenouchi, Kazuya] Teijin Pharma Ltd, Teijin Inst Biomed Res, Hino, Tokyo 1918512, Japan	Saitoh, H (reprint author), Teijin Pharma Ltd, Teijin Inst Biomed Res, 4-3-2 Asahigaoka, Hino, Tokyo 1918512, Japan.	hi.saitou@teijin.co.jp					Hatakeyama S, 2001, STEROIDS, V66, P267, DOI 10.1016/S0039-128X(00)00149-5; Matsuo Miki, 2013, ACS Med Chem Lett, V4, P671, DOI 10.1021/ml400098w; Saito N, 2004, J ORG CHEM, V69, P7463, DOI 10.1021/jo0491051; Saitoh H, 2011, ORG BIOMOL CHEM, V9, P3954, DOI 10.1039/c1ob05142c	4	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	APR	2015	148				SI		27	30		10.1016/j.jsbmb.2014.12.004		4	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CE4FJ	WOS:000351786200005		
J	Takano, M; Sawada, D; Yasuda, K; Nishikawa, M; Takeuchi, A; Takagi, K; Horie, K; Reddy, GS; Chen, TC; Sakaki, T; Kittaka, A				Takano, Masashi; Sawada, Daisuke; Yasuda, Kaori; Nishikawa, Miyu; Takeuchi, Akiko; Takagi, Ken-ichiro; Horie, Kyohei; Reddy, G. Satyanarayana; Chen, Tai C.; Sakaki, Toshiyuki; Kittaka, Atsushi			Synthesis and metabolic studies of 1 alpha,2 alpha,25-, 1 alpha,4 alpha,25-and 1 alpha,4 beta,25-trihydroxyvitamin D-3	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Review						Vitamin D-3; Trihydroxyvitamin D-3; Vitamin D receptor; CYP3A4; CYP24A1; UGT	A-RING; BIOLOGICAL-ACTIVITIES; VITAMIN-D; 1-ALPHA,25-DIHYDROXY-19-NORVITAMIN D-3; 2-ALPHA-SUBSTITUTED ANALOGS; EFFICIENT SYNTHESIS; CYP24A1; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; DIFFERENTIATION; DESIGN	Three different A-ring perhydroxylated trihydroxyvitamin D-3 metabolites were synthesized from their appropriate A-ring precursors and CD-ring for their potential therapeutic applications. We first chemically synthesized 1 alpha,2 alpha,25-trihydroxyvitamin D-3 [1 alpha,2 alpha,25(OH)(3)D-3] to study its VDR binding affinity because this metabolite is a product of recombinant human CYP3A4 catalysis when 2 alpha-(3-hydroxypropoxy)-1 alpha,25-dihydroxyvitamin D-3 (O2C3), a more potent vitamin D receptor (VDR) binder than 1 alpha,25-dihydroxyvitamin D-3 [1 alpha,25(OH)(2)D-3], is used as the substrate. We found that this metabolite retained 27.3% of the VDR binding affinity compared to 1 alpha,25(OH)(2)D-3. The k(cat)/K-m value of CYP24A1 for 1 alpha,2 alpha,25(OH)(3)D-3 is 60% of that for 1 alpha,25(OH)(2)D-3. Since the biological activity and the metabolic fate of a naturally occurring C4-hydroxylated vitamin D-2 metabolite found in the serum of rats treated with pharmacological doses of vitamin D-2 have never been described, we next synthesized 1 alpha,4 alpha,25-trihydroxyvitamin D-3 and its diastereoisomer, 1 alpha,4 beta,25-trihydroxyvitamin D-3, to study their metabolism and biological activities. Both 4-hydroxylated isomers showed weaker VDR binding affinity than 1 alpha,25(OH)(2)D-3. Although either 4-hydroxylated isomer can be metabolized by CYP24A1 almost at the same level as 1 alpha,25(OH)(2)D-3, their metabolic patterns catalyzed by uridine 5'-diphosphoglucuronosyltransferase (UGT) are different; only the 4 alpha-hydroxylated analog can be metabolized by UGT to produce a glucuronate conjugate. The results provide important information for the synthesis of new novel chemotherapeutic vitamin D analogs which would be less subjective to degradation and therefore more bioavailable than 1 alpha,25(OH)(2)D-3. This article is part of a Special Issue entitled '17th Vitamin D Workshop'. (C) 2014 Elsevier Ltd. All rights reserved.	[Takano, Masashi; Sawada, Daisuke; Kittaka, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Tokyo 1738605, Japan; [Yasuda, Kaori; Nishikawa, Miyu; Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Imizu, Toyama 9390398, Japan; [Takeuchi, Akiko; Takagi, Ken-ichiro; Horie, Kyohei] Teijin Pharma Ltd, Teijin Inst Biomed Res, Tokyo 1918512, Japan; [Reddy, G. Satyanarayana] Epimer LLC, North Smithfield, RI 02906 USA; [Chen, Tai C.] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA	Kittaka, A (reprint author), Teikyo Univ, Fac Pharmaceut Sci, 2-11-1 Kaga, Tokyo 1738605, Japan.	akittaka@pharm.teikyo-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25860011]; Japan Society for the Promotion of Science [23590015, 24590021]	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (No. 25860011 to M.T.) as well as Grants-in-Aid from the Japan Society for the Promotion of Science (No. 23590015 to D.S. and 24590021 to A.K.).	Abe D, 2005, DRUG METAB DISPOS, V33, P778, DOI 10.1124/dmd.104.003038; Yasuda K, 2013, J STEROID BIOCHEM, V133, P84, DOI 10.1016/j.jsbmb.2012.09.006; Sakaki T, 2014, ANTI-CANCER AGENT ME, V14, P97, DOI 10.2174/18715206113139990307; Zhu JG, 2012, ARCH BIOCHEM BIOPHYS, V523, P30, DOI 10.1016/j.abb.2012.01.013; TROST BM, 1992, J AM CHEM SOC, V114, P9836, DOI 10.1021/ja00051a016; Hourai S, 2006, J MED CHEM, V49, P5199, DOI 10.1021/jm0604070; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Ono K, 2003, J ORG CHEM, V68, P7407, DOI 10.1021/jo034787y; Krishnan AV, 2011, VITAMIN D AND CANCER, P53, DOI 10.1007/978-1-4419-7188-3_3; Kusudo T, 2004, BIOCHEM BIOPH RES CO, V321, P774, DOI 10.1016/j.bbrc.2004.07.040; Matsuo Miki, 2013, ACS Med Chem Lett, V4, P671, DOI 10.1021/ml400098w; Ono Y, 2014, J STEROID BIOCHEM, V139, P88, DOI 10.1016/j.jsbmb.2013.10.007; POSNER GH, 1991, J ORG CHEM, V56, P4339, DOI 10.1021/jo00014a003; Rao DS, 1999, J STEROID BIOCHEM, V71, P63, DOI 10.1016/S0960-0760(99)00125-9; Saito N, 2006, CURR TOP MED CHEM, V6, P1273, DOI 10.2174/156802606777864953; Saito N, 2004, J ORG CHEM, V69, P7463, DOI 10.1021/jo0491051; Sawada D, 2009, CHEM PHARM BULL, V57, P1431, DOI 10.1248/cpb.57.1431; Sawada D, 2012, CHEM PHARM BULL, V60, P1343; Shimizu M, 2003, BIOORG MED CHEM LETT, V13, P809, DOI 10.1016/S0960-894X(03)00005-2; SICINSKI RR, 1994, J MED CHEM, V37, P3730, DOI 10.1021/jm00048a009; Takahashi E, 2006, BIOL PHARM BULL, V29, P2246, DOI 10.1248/bpb.29.2246; Takano M, 2014, CHEM PHARM BULL, V62, P182; Tsugawa N, 2000, BIOL PHARM BULL, V23, P66	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	APR	2015	148				SI		34	37		10.1016/j.jsbmb.2014.09.021		4	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CE4FJ	WOS:000351786200007		
J	Kondo, S; Takano, T; Ono, Y; Saito, H; Matsumoto, T				Kondo, Satoshi; Takano, Toshiyuki; Ono, Yoshiyuki; Saito, Hitoshi; Matsumoto, Toshio			Eldecalcitol reduces osteoporotic fractures by unique mechanisms	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Vitamin D-binding protein (DBP); Vitamin D receptor (VDR); Vitamin D 24-hydroxylase (CYP24A1); Hypercalcemia; Hypercalciuria; Renal function	DOUBLE-BLIND; VITAMIN-D; ED-71; ANALOG	Eldecalcitol shows higher binding affinity for vitamin D-binding protein (DBP), tighter binding to vitamin D receptor (VDR), and resistance to metabolic degradation via 24-hydroxylation. In silico analysis of the mode of binding demonstrated that the 3-hydroxypropyloxy (3-HP) group of eldecalcitol offers additional hydrogen bond and CH-pi interaction for the binding to DBP and VDR. However, the 3-HP group interferes with the binding of eldecalcitol to CYP24A1, causing poor metabolic clearance of eldecalcitol by this enzyme. These characteristics may contribute to the stronger effect of eldecalcitol than calcitriol. The present post-hoc analysis also demonstrate that the incidence of hypercalcemia and hypercalciuria is slightly higher in eldecalcitol than in alfacalcidol group especially in patients with CKD stage 3B, that both serum and urinary calcium return to the baseline levels shortly after cessation of the treatment in both treatment groups, that the incidence of urolithiasis is higher in patients with higher eGFR and is similar between alfacalcidol and eldecalcitol groups, and that eGFR is transiently reduced by both alfacalcidol and eldecalcitol treatment especially among patients with higher eGFR but recovers after the end of both treatment. Eldecalcitol can be used for the treatment of osteoporosis without Ca supplementation to reduce the incidence of hypercalcemia and hypercalciuria, and enough hydration is recommended in order to avoid hypercalcemia, urolithiasis and deterioration of renal function. (C) 2015 Elsevier Ltd. All rights reserved.	[Kondo, Satoshi; Takano, Toshiyuki; Ono, Yoshiyuki; Saito, Hitoshi] Chugai Pharmaceut Co Ltd, Tokyo 1038324, Japan; [Matsumoto, Toshio] Univ Tokushima, Fujii Mem Inst Med Res, Tokushima 7708503, Japan	Matsumoto, T (reprint author), Univ Tokushima, Fujii Mem Inst Med Res, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	toshio.matsumoto@tolcushima-u.ac.jp			Chugai Pharmaceutical Co., Ltd.; Chugai; Daiichi-Sankyo; Eli Lilly Japan; Asahi Kasei Pharm; Teijin Pharm	The studies are supported by Chugai Pharmaceutical Co., Ltd.; T. Matsumoto receives consulting fees from Chugai, Daiichi-Sankyo, Eli Lilly Japan, Asahi Kasei Pharm, Teijin Pharm.	Abe M., 2011, JPN PHARMACOL THER, V39, P261; PAYNE RB, 1973, BRIT MED J, V4, P643; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; Hatakeyama S, 2007, J STEROID BIOCHEM, V103, P222, DOI 10.1016/j.jsbmb.2006.12.025; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Levey AS, 1999, ANN INTERN MED, V130, P461; Mitchell DM, 2012, J CLIN ENDOCR METAB, V97, P4507, DOI 10.1210/jc.2012-1808; Furuichi Tatsuya, 1998, Life Sciences, V62, P453; Matsumoto T, 2010, J STEROID BIOCHEM, V121, P261, DOI 10.1016/j.jsbmb.2010.03.035; Ono Y, 2014, J STEROID BIOCHEM, V139, P88, DOI 10.1016/j.jsbmb.2013.10.007; Ritter CS, 2011, J CELL BIOCHEM, V112, P1348, DOI 10.1002/jcb.23051; Uchiyama Y, 2002, BONE, V30, P582, DOI 10.1016/S8756-3282(02)00682-8	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	APR	2015	148				SI		232	238		10.1016/j.jsbmb.2015.01.016		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CE4FJ	WOS:000351786200035		
J	Kanazawa, Y; Morioka, T; Arakawa, S; Furuta, Y; Nakanishi, A; Kitazono, T				Kanazawa, Yuka; Morioka, Takato; Arakawa, Shuji; Furuta, Yoshihiko; Nakanishi, Asako; Kitazono, Takanari			Nonconvulsive Partial Status Epilepticus Mimicking Recurrent Infarction Revealed by Diffusion-weighted and Arterial Spin Labeling Perfusion Magnetic Resonance Images	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Stroke mimics; ictal hyperperfusion; nonconvulsive status epilepticus; diffusion-weighted image; arterial spin labeling	MRI; EPILEPSY; SEIZURE; ANASTOMOSIS	"Non-convulsive'' partial status epilepticus (SE) is an important pathologic condition that should be differentiated from cerebral infarction. Herein, we reported 2 patients who had partial SE associated with old infarction in the right parietal lobe. Each patient had 2 episodes of left hemiparesis and hemisensory disturbance without convulsion. On diffusion-weighted magnetic resonance images (DW-MRI), a hyperintense lesion was noted in the cortex around the old infarction lesion, and recurrent infarction was suspected. Although electroencephalography (EEG) failed to reveal ictal discharges or interictal paroxysmal activities in 3 of 4 episodes, perfusion images with arterial spin labeling (ASL) clearly demonstrated ictal hyperperfusion in the area corresponding to the cortical hyperintense lesion on DW-MRI. After appropriate anticonvulsant treatment based on the diagnosis of partial SE, clinical symptoms were completely improved. These data stress the importance of cortical hyperintensity on DW-MRI and ictal ASL hyperperfusion, even when SE cannot be determined from EEG.	[Kanazawa, Yuka; Arakawa, Shuji; Furuta, Yoshihiko] Kyushu Rosai Hosp, Dept Cerebrovasc Dis, Kitakyushu, Fukuoka 8000296, Japan; [Morioka, Takato] Kyushu Rosai Hosp, Dept Neurosurg, Kitakyushu, Fukuoka 8000296, Japan; [Nakanishi, Asako] Kyushu Rosai Hosp, Dept Radiol, Kitakyushu, Fukuoka 8000296, Japan; [Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan	Kanazawa, Y (reprint author), Kyushu Rosai Hosp, Dept Cerebrovasc Dis, Kokuraminami Ku, 1-1 Sonekitamachi, Kitakyushu, Fukuoka 8000296, Japan.	yuka8850@gmail.com					Pollock JM, 2008, J COMPUT ASSIST TOMO, V32, P291, DOI 10.1097/RCT.0b013e31814cf81f; Pizzini F, 2008, EPILEPSY RES, V81, P225, DOI 10.1016/j.eplepsyres.2008.06.009; Calistri V, 2003, AM J NEURORADIOL, V24, P671; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; Wieshmann UC, 1997, LANCET, V350, P493, DOI 10.1016/S0140-6736(05)63083-8; Kim JA, 2001, AM J NEURORADIOL, V22, P1149; Di Bonaventura C, 2009, EPILEPSIA, V50, P45, DOI 10.1111/j.1528-1167.2008.01970.x; Oishi M, 2012, NEURORADIOLOGY, V54, P653, DOI 10.1007/s00234-012-1027-7; Winkler DT, 2009, STROKE, V40, P1522, DOI 10.1161/STROKEAHA.108.530352; Toledo M, 2011, EPILEPTIC DISORD, V13, P336, DOI 10.1684/epd.2011.0445; Pizzini FB, 2013, MAGN RESON IMAGING, V31, P1001, DOI 10.1016/j.mri.2013.03.023; De Reuck J, 2009, EUR NEUROL, V62, P344, DOI 10.1159/000240647; Diehl B, 1999, EPILEPSIA, V40, P1667, DOI 10.1111/j.1528-1157.1999.tb02056.x; Flacke S, 2000, NEURORADIOLOGY, V42, P92; Hamamura T, 2010, NEUROL MED-CHIR, V50, P1099, DOI 10.2176/nmc.50.1099; Kesavadas C, 2009, NEURORADIOLOGY, V51, P293, DOI 10.1007/s00234-009-0497-8; Krumholz A, 2007, NEUROLOGY, V69, P1996, DOI 10.1212/01.wnl.0000285084.93652.43; Lansberg MG, 1999, NEUROLOGY, V52, P1021; Lee DS, 2000, NEUROLOGY, V55, P835; Lovblad KO, 2004, NEURORADIOLOGY, V46, P175, DOI 10.1007/s00234-003-1133-7; Morioka T, 2011, NEUROL MED-CHIR, V51, P171; Morioka T, 2013, NEUROL MED-CHIR, V53, P388	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					731	738		10.1016/j.jstrokecerebrovasdis.2014.09.026		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700009		
J	Kato, Y; Hayashi, T; Tanahashi, N; Kobayashi, S				Kato, Yuji; Hayashi, Takeshi; Tanahashi, Norio; Kobayashi, Shotai		Japan Stand Stroke Registry Study	Cardioembolic Stroke Is the Most Serious Problem in the Aging Society: Japan Standard Stroke Registry Study	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Age stratification; ischemic stroke; epidemiology; Japanese	ACUTE ISCHEMIC-STROKE; ATRIAL-FIBRILLATION; CLINICAL-FEATURES; RISK-FACTORS; EARLY DEATH; OLD; PREDICTORS; REDUCTION; DISEASE	Background: Japan has the fastest aging society in the world. Older patients have a different stroke risk profile and different stroke features compared with younger patients. The aim of the present study was to examine the stroke subtypes, risk factor profiles, stroke severities, and functional outcomes in the different age groups. Methods: A total of 78,096 patients with acute ischemic stroke, including transient ischemic attacks, were included in a multicenter, hospital-based registration study based on a computerized database involving 95 Japanese institutes between 2000 and 2012. Results: The frequency of atrial fibrillation increased even after the age of 90 years; consequently, the proportion of patients experiencing cardioembolic stroke also increased in the same age group. Furthermore, more severe symptoms on arrival and worse functional outcomes were observed with increasing age. The frequency of hypertension increased with age, peaking in patients in their 70s, and decreasing slightly thereafter. The frequency of diabetes mellitus and hyperlipidemia peaked in patients in their 50s or 60s and gradually decreased thereafter. Conclusion: The findings of the present study suggest that in the currently aging society, cardioembolic stroke is the most important stroke subtype. The roles of hypertension, diabetes mellitus, and hyperlipidemia are greatest in stroke patients in their 50s to 60s. In older patients, the role of atrial fibrillation is more significant. (C) 2015 by National Stroke Association	[Kato, Yuji; Hayashi, Takeshi; Tanahashi, Norio] Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, Saitama, Japan; [Kobayashi, Shotai] Shimane Univ, Dept Neurol, Matsue, Shimane, Japan	Kato, Y (reprint author), Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	yujik@saitama-med.ac.jp			Japanese Ministry of Welfare	JSSRS was developed with support ("21st Century Type Promoting Development of Clinical Research Fund'') from the Japanese Ministry of Welfare during 1999 to 2001.	Rojas JI, 2007, EUR J NEUROL, V14, P895, DOI 10.1111/j.1468-1331.2007.01841.x; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; Kammersgaard LP, 2004, AGE AGEING, V33, P149, DOI 10.1093/ageing/afh052; Arboix A, 2000, J AM GERIATR SOC, V48, P36; Toyoda K, 2007, CEREBROVASC DIS, V24, P289, DOI 10.1159/000105682; Bentsen L, 2014, J STROKE CEREBROVASC, V23, P1944, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.002; Saxena R, 2001, STROKE, V32, P2333, DOI 10.1161/hs1001.097093; Kobayashi S, 2006, AM J PREV MED, V31, pS240, DOI 10.1016/j.amepre.2006.08.011; [Anonymous], 1990, STROKE, V21, P637; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Chalmers J, 2012, J HYPERTENS, V30, P1706, DOI 10.1097/HJH.0b013e32835789ff; Gur AY, 2012, NEUROEPIDEMIOLOGY, V39, P57, DOI 10.1159/000339362; Hosomi N, 2009, CEREBROVASC DIS, V27, P67, DOI 10.1159/000172636; Inoue H, 2004, CIRC J, V68, P417, DOI 10.1253/circj.68.417; Kimura K, 2005, J NEUROL NEUROSUR PS, V76, P679, DOI 10.1136/jnnp.2004.048827; Maeda K, 2013, J STROKE CEREBROVASC, V22, P1070, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.006; Pohjasvaara T, 1997, STROKE, V28, P729; Wu Chih-Ying, 2010, Neurol India, V58, P863, DOI 10.4103/0028-3886.73747; Yates Scott W, 2013, Int J Gen Med, V6, P167, DOI 10.2147/IJGM.S39379	19	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					811	814		10.1016/j.jstrokecerebrovasdis.2014.11.019		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700021		
J	Sone, T; Nakaya, N; Iokawa, K; Hasegawa, K; Tsukada, T; Kaneda, M; Hamaguchi, T; Suzuki, K				Sone, Toshimasa; Nakaya, Naoki; Iokawa, Kazuaki; Hasegawa, Keiichi; Tsukada, Tetsu; Kaneda, Mariko; Hamaguchi, Toyohiro; Suzuki, Kenji			Prediction of Upper Limb Recovery in the Acute Phase of Cerebrovascular Disease: Evaluation of "Functional Hand'' Using the Manual Function Test	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebrovascular disease; functional recovery; prediction statistics; upper limb function; rehabilitation	ACUTE STROKE; ARM FUNCTION; PERFORMANCE; RELIABILITY; DEXTERITY; MOVEMENT	Background: Prediction of upper limb function recovery in the acute phase of cerebrovascular disease can help clarify goal setting in rehabilitation and subsequently shorten hospital stay. The present study aimed to develop regression equations that can be used to predict the Manual Function Test (MFT) score 3 weeks after onset and to determine the optimal cutoff MFT score for the identification of "Functional Hand.'' Methods: In all, 190 patients with cerebrovascular disease were included in this study. The baseline survey performed within 1 week after onset assessed sociodemographic profiles, medical profiles, and acute symptoms. MFT was performed to determine the cutoff score to indicate Functional Hand. We used stepwise multiple regression analysis to establish the prediction equations with the best fit for the MFT score 3 weeks after onset. In addition, the sensitivity and specificity of the MFT as an indicator of Functional Hand with cutoff values were determined. Results: The multiple regression analysis showed that the following factors had a significant influence on the MFT: Brunnstrom recovery stage, cognitive function, range of motion, age, and sensation. The area under the curve was .93 for the MFT score as an indicator of Functional Hand. The cutoff MFT score to identify Functional Hand was 22/21 points, with a sensitivity and specificity of 91.1% and 82.1%, respectively. Conclusions: Our findings helped develop regression equations that can be used to predict the MFT score 3 weeks after onset of cerebrovascular disease by evaluating factors reportedly associated with upper limb function recovery. (C) 2015 by National Stroke Association	[Sone, Toshimasa; Iokawa, Kazuaki; Suzuki, Kenji] Tohoku Fukushi Univ, Fac Hlth Sci, Dept Rehabil, Sendai, Miyagi 9818522, Japan; [Nakaya, Naoki] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 980, Japan; [Hasegawa, Keiichi; Tsukada, Tetsu; Kaneda, Mariko] Takeda Gen Hosp, Dept Rehabil, Aizu Wakamatsu, Fukushima, Japan; [Hamaguchi, Toyohiro] Saitama Prefectural Univ, Sch Hlth & Social Serv, Dept Occupat Therapy, Koshigaya, Japan	Sone, T (reprint author), Tohoku Fukushi Univ, Fac Hlth Sci, Dept Rehabil, Aoba Ku, 1-8-1 Kunimi, Sendai, Miyagi 9818522, Japan.	sone-t@umin.ac.jp			Japan Health Foundation	This study was supported by The Japan Health Foundation (2009).	HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; BOHANNON RW, 1987, PHYS THER, V67, P206; PRESCOTT RJ, 1982, STROKE, V13, P641; Coupar F, 2012, CLIN REHABIL, V26, P291, DOI 10.1177/0269215511420305; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Beebe JA, 2009, STROKE, V40, P1772, DOI 10.1161/STROKEAHA.108.536763; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; Smania N, 2007, STROKE, V38, P1088, DOI 10.1161/01.STR.0000258077.88064.a3; Miyamoto S, 2009, AM J PHYS MED REHAB, V88, P247, DOI 10.1097/PHM.0b013e3181951133; Wolf SL, 2001, STROKE, V32, P1635; Cioncoloni D, 2013, NEUROREHABILITATION, V33, P217, DOI 10.3233/NRE-130948; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; BOHANNON RW, 1991, ARCH PHYS MED REHAB, V72, P682; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Katrak P, 1998, ARCH PHYS MED REHAB, V79, P758, DOI 10.1016/S0003-9993(98)90352-5; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Feys H, 2000, ACTA NEUROL SCAND, V102, P371, DOI 10.1034/j.1600-0404.2000.102006371.x; Harris JE, 2007, PHYS THER, V87, P88, DOI 10.2522/ptj.20060065; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Chino N, 1994, JPN J REHABIL MED, V31, P119; Feys H, 2000, Physiother Res Int, V5, P1, DOI 10.1002/pri.180; Katoh S, 1991, JPN J GERIATR PSYCHI, V11, P1339; MAHONEY F I, 1965, Md State Med J, V14, P61; Michimata A, 2008, TOHOKU J EXP MED, V214, P257, DOI 10.1620/tjem.214.257; Moriyama S, 1987, P JOINT JAP CHIN STR, P114; Nakamura R, 1999, RECOVERY EVALUATING; Ohta T, 1974, No Shinkei Geka, V2, P623; Sone Toshimasa, 2015, Nihon Eiseigaku Zasshi, V70, P62, DOI 10.1265/jjh.70.62; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2011, 2011 SUMM PAT SURV; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2007, COMPR SURV LIV COND; Ueda S, 1996, CYCLOPAEDIA REHABILI; WALKER MF, 1991, J NEUROL NEUROSUR PS, V54, P699, DOI 10.1136/jnnp.54.8.699	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					815	822		10.1016/j.jstrokecerebrovasdis.2014.11.018		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700022		
J	Usui, H; Nishida, Y				Usui, Harunobu; Nishida, Yuusuke			Relationship between Physical Activity and the Very Low-Frequency Component of Heart Rate Variability after Stroke	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Physical activity; autonomic nervous system; heart rate variability; very low frequency; stroke	INFLAMMATORY MARKERS; METABOLIC SYNDROME; VAGUS NERVE; ASSOCIATION; PREDICTOR; SURVIVORS; EXERCISE; FAILURE; DISEASE; HEALTH	Background: The present study aimed to clarify the relationship between high physical activity (PA) and function of the autonomic nervous system, which is important in the prognosis after stroke. We hypothesized a positive association between PA and the very low-frequency (VLF) component of heart rate variability (HRV). Methods: Eight patients participated in this study. PA was measured using an accelerometer, and HRV was measured using a heart rate monitor. Results: A significant and positive relationship was observed between the VLF component of HRV and PA. A significant negative relationship was observed between the VLF component of HRV and the duration of inactivity. No significant relationship was identified between the low-to-high frequency ratio of HRV and between the high-frequency component of HRV and PA. Conclusions: A positive correlation was observed between the VLF component of HRV and PA in stroke patients. Therefore, the VLF component of HRV links PA to cardiovascular prognosis.	[Usui, Harunobu; Nishida, Yuusuke] Seirei Christopher Univ, Dept Rehabil Sci, Hamamatsu, Shizuoka 4338558, Japan	Usui, H (reprint author), Seirei Christopher Univ, Rehabil Sci, Kita Ku, 3453 Mikatabarachou, Hamamatsu, Shizuoka 4338558, Japan.	13dr01@g.seirei.ac.jp					Ada T, 2014, J STROKE CEREBROVASC, V23, P259; Gordon NF, 2004, STROKE, V35, P1230, DOI 10.1161/01.STR.0000127303.19261.19; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649; Assoumou HGN, 2010, REJUV RES, V13, P653, DOI 10.1089/rej.2010.1019; Gando Y, 2010, HYPERTENSION, V56, P540, DOI 10.1161/HYPERTENSIONAHA.110.156331; Whiteley W, 2011, STROKE, V42, P10, DOI 10.1161/STROKEAHA.110.588954; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Hadase M, 2004, CIRC J, V68, P343, DOI 10.1253/circj.68.343; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Wannamethee SG, 2007, J THROMB HAEMOST, V5, P1637, DOI 10.1111/j.1538-7836.2007.02643.x; Guzzetti S, 2005, EUR HEART J, V26, P357, DOI 10.1093/eurheartj/ehi067; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Kes VB, 2008, CLIN BIOCHEM, V41, P1330, DOI 10.1016/j.clinbiochem.2008.08.080; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Gunther A, 2012, ACTA NEUROL SCAND, V126, P189, DOI 10.1111/j.1600-0404.2011.01626.x; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Gujjar AR, 2004, NEUROCRIT CARE, V1, P347, DOI 10.1385/NCC:1:3:347; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Birgit V, 2013, J STROKE CEREBROVASC, V22, pe426; Carroll SL, 2012, ARCH PHYS MED REHAB, V93, P466, DOI 10.1016/j.apmr.2011.08.047; Force Task, 1996, EUROPEAN HEART J, V17, P354, DOI DOI 10.1093/OXFORDJOURNAL-S.EURHEARTJ.A014868; Janszky I, 2004, J INTERN MED, V256, P421, DOI 10.1111/j.1365-2796.2004.01403.x; Kanel RV, 2007, J WOMENS HEALTH, V17, P1331; Lampert R., 2008, AM HEART J, V156, p759e1; Stein PK, 2008, J AM GERIATR SOC, V56, P315, DOI 10.1111/j.1532-5415.2007.01564.x; Tanya W, 2012, STROKE RES TREATMENT, V13; Thayer JF, 2010, BRAIN BEHAV IMMUN, V24, P1223, DOI 10.1016/j.bbi.2010.07.247; Ulrika P, 2012, J STROKE CEREBROVASC, V21, P652	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					840	843		10.1016/j.jstrokecerebrovasdis.2014.11.026		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700026		
J	Meguro, T; Kuwahara, K; Tomita, Y; Okuma, Y; Tanabe, T; Muraoka, K; Terada, K; Hirotsune, N; Nishino, S				Meguro, Toshinari; Kuwahara, Ken; Tomita, Yusuke; Okuma, Yu; Tanabe, Tomoyuki; Muraoka, Kenichiro; Terada, Kinya; Hirotsune, Nobuyuki; Nishino, Shigeki			Primary Pontine Hemorrhage in the Acute Stage: Clinical Features and a Proposed New Simple Scoring System	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Primary pontine hemorrhage; outcome; prognosis; mortality	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; GRADING SCALE; OXIDATIVE STRESS; 30-DAY MORTALITY; HYPERGLYCEMIA; PREDICTORS; STROKE; DYSFUNCTION; VALIDATION; HEMATOMA	Background: It is important to evaluate the likelihood of fatality in patients with acute primary pontine hemorrhage (PPH) in emergency departments. We aimed to evaluate the clinical symptoms and computed tomography findings of PPH to develop a simple grading scale for predicting the mortality of PPH. Methods: Records of 101 consecutive patients admitted to our hospital with acute PPH between June 1, 2006, and January 31, 2014, were retrospectively reviewed. Independent predictors of 30-day mortality were identified by univariate and multivariate logistic regression analyses. A simple and easy clinical score (PPH score) was developed from independent factors to predict mortality in acute PPH. The PPH score was compared with the established intracerebral hemorrhage (ICH) score, which served as the reference scoring system. Results: Overall mortality rate 30 days after onset was 58.4% (59 of 101). Factors independently associated with 30-day mortality were Glasgow Coma Scale (GCS) score of 6 or less (P = .0051), absence of pupillary light reflex (P = .0003), and blood glucose of 180 mg/dL or greater (P = .0312). The PPH score was the sum of independent factors, which were assigned 1 point each. The area under the receiver operating characteristic curve for predicting 30-day mortality was .90 (95% confidence interval [CI], .84-.95) for PPH score and .86 (95% CI, .78-.93) for ICH score. Conclusions: GCS score of 6 or less, absence of pupillary light reflex, and plasma glucose of 10 mmol/L or greater are independent mortality predictors of PPH. The PPH score is a simple and reliable clinical grading scale for predicting 30-day mortality.	[Meguro, Toshinari; Kuwahara, Ken; Tomita, Yusuke; Okuma, Yu; Tanabe, Tomoyuki; Muraoka, Kenichiro; Terada, Kinya; Hirotsune, Nobuyuki; Nishino, Shigeki] Hiroshima City Hosp, Dept Neurol Surg, Hiroshima 7308518, Japan	Meguro, T (reprint author), Hiroshima City Hosp, Dept Neurol Surg, Naka Ku, 7-33 Motomachi, Hiroshima 7308518, Japan.	tmeguron@hotmail.com					Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; BRODERICK JP, 1993, STROKE, V24, P987; Hemphill JC, 2001, STROKE, V32, P891; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Kamada H, 2007, STROKE, V38, P1044, DOI 10.1161/01.STR.0000258041.75739.cb; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Liu J, 2011, NAT MED, V17, P206, DOI 10.1038/nm.2295; Martini SR, 2007, J CEREBR BLOOD F MET, V27, P435, DOI 10.1038/sj.jcbfm.9600355; Weimar C, 2006, J NEUROL NEUROSUR PS, V77, P601, DOI 10.1136/jnnp.2005.081117; Allen CL, 2009, DIABETES OBES METAB, V11, P480, DOI 10.1111/j.1463-1326.2008.00987.x; Kruyt ND, 2010, J CEREBR BLOOD F MET, V30, P1577, DOI 10.1038/jcbfm.2010.102; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Ruiz-Sandoval JL, 2007, STROKE, V38, P1641, DOI 10.1161/STROKEAHA.106.478222; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Balci K, 2005, CLIN NEUROL NEUROSUR, V108, P36, DOI 10.1016/j.clineuro.2005.02.007; Beslow LA, 2014, STROKE, V45, P66, DOI 10.1161/STROKEAHA.113.003448; Del Brutto OH, 2004, NEUROLOGY, V62, P515; Dziewas R, 2003, CEREBROVASC DIS, V16, P224, DOI 10.1159/000071120; Jang JH, 2011, J KOREAN MED SCI, V26, P100, DOI 10.3346/jkms.2011.26.1.100; Jung DS, 2007, J KOREAN NEUROSURG S, V41, P82; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Murata Y, 1999, J NEUROL SCI, V167, P107, DOI 10.1016/S0022-510X(99)00150-1; NAKAJIMA K, 1983, STROKE, V14, P485; Rabinstein AA, 2004, CEREBROVASC DIS, V17, P66, DOI 10.1159/000073900; Shaya M, 2005, SURG NEUROL, V63, P343, DOI 10.1016/j.surneu.2004.06.019; Stead LG, 2010, NEUROCRIT CARE, V13, P67, DOI 10.1007/s12028-010-9355-0; Tetri S, 2009, J NEUROSURG, V110, P411, DOI 10.3171/2008.8.JNS08445; Wessels T, 2004, AM J NEURORADIOL, V25, P257; Wijdicks EFM, 1997, NEUROLOGY, V49, P1342	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					860	865		10.1016/j.jstrokecerebrovasdis.2014.12.006		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700029		
J	Koyama, T; Marumoto, K; Uchiyama, Y; Miyake, H; Domen, K				Koyama, Tetsuo; Marumoto, Kohei; Uchiyama, Yuki; Miyake, Hiroji; Domen, Kazuhisa			Outcome Assessment of Hemiparesis due to Intracerebral Hemorrhage Using Diffusion Tensor Fractional Anisotropy	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Hematoma; paresis; probability; prognosis; recovery; stroke	FUNCTIONAL INDEPENDENCE MEASURE; MODIFIED RANKIN SCALE; BARTHEL INDEX; STROKE; DISABILITY; INFARCTION; RECOVERY; REHABILITATION; TRACTOGRAPHY; FSL	Background: This study aimed to evaluate the prognostic efficacy of magnetic resonance diffusion tensor fractional anisotropy (FA) for patients with hemiparesis due to intracerebral hemorrhage. Methods: Diffusion tensor FA brain images were acquired 14-21 days after putaminal and/or thalamic hemorrhage. The ratio of FA values within the cerebral peduncles of the affected and unaffected hemispheres (rFA) was calculated for each patient (n = 40) and assessed for correlation with Brunnstrom stage (BRS, 1-6), motor component of the functional independence measure (FIM-motor, 13-91), and the total length of stay (LOS) until discharge from rehabilitation (P < .05). Ordinal logistic regression analyses were conducted to determine the relationships between rFA and specific outcomes as measured by BRS range (poor, BRS 1 or 2; moderate, BRS 3 or 4; and good, BRS 5 or 6; P < .05). Results: The rFA values were .571-1.043 (median, .856) and BRS scores were 1-6 (median, 4) for shoulder/elbow/forearm, 1-6 (median, 4) for hand, and 2-6 (median, 4) for lower extremities. FIM-motor scores were 58-86 (median, 78) and LOS ranged from 42 to 225 days (median, 175.5 days). Correlation coefficients were statistically significant between rFA and shoulder/elbow/forearm BRS (. 696), hand BRS (. 779), lower extremity BRS (. 631), FIM-motor (. 442), and LOS (-.598). Logistic model fit was moderate for shoulder/elbow/forearm BRS (R-2 = .221) and lower extremity BRS (R-2 = .277), but was much higher for hand BRS (R-2 = .441). Conclusions: Diffusion tensor FA values are predictive of clinical outcome from hemiparesis due to putaminal and/or thalamic hemorrhage, particularly hand function recovery. (C) 2015 by National Stroke Association	[Koyama, Tetsuo] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Rehabil Med, Nishinomiya, Hyogo 6638211, Japan; [Koyama, Tetsuo; Marumoto, Kohei; Uchiyama, Yuki; Domen, Kazuhisa] Hyogo Coll Med, Dept Rehabil Med, Nishinomiya, Hyogo 6638501, Japan; [Miyake, Hiroji] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Neurosurg, Nishinomiya, Hyogo 6638211, Japan	Koyama, T (reprint author), Nishinomiya Kyoritsu Neurosurg Hosp, Dept Rehabil Med, 11-1 Imazu Yamanaka Cho, Nishinomiya, Hyogo 6638211, Japan.	ytkoyama@bd6.so-net.ne.jp			Japan Society for the Promotion of Science (KAKENHI) [25282168]; Medical Research Fund of Hyogo Medical Association [MRF-H-08-12]	Grand-in-Aid for Scientific Research (B), the Japan Society for the Promotion of Science (KAKENHI), 25282168 and the Medical Research Fund of Hyogo Medical Association, MRF-H-08-12.	Kusano Y, 2009, AM J NEURORADIOL, V30, P1561, DOI 10.3174/ajnr.A1639; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Koyama T, 2013, NEUROREHABILITATION, V32, P87, DOI 10.3233/NRE-130825; BRODERICK JP, 1993, STROKE, V24, P987; DAVERAT P, 1991, STROKE, V22, P1; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Koyama T, 2012, J STROKE CEREBROVASC, V21, P704, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.004; Yamada K, 2009, MAGN RESON MED SCI, V8, P165; Sulter G, 1999, STROKE, V30, P1538; Stineman MG, 1998, ARCH PHYS MED REHAB, V79, P497, DOI 10.1016/S0003-9993(98)90062-4; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Safaz I, 2009, INT J REHABIL RES, V32, P228, DOI 10.1097/MRR.0b013e32832a62ad; Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24; Wang DM, 2012, CEREBROVASC DIS, V34, P199, DOI 10.1159/000341857; Naghdi S, 2010, BRAIN INJURY, V24, P1372, DOI 10.3109/02699052.2010.506860; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JORGENSEN HS, 1995, ANN NEUROL, V38, P45, DOI 10.1002/ana.410380110; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Kuzu Y, 2012, CEREBROVASC DIS, V33, P566, DOI 10.1159/000338904; Yoshioka H, 2008, NEUROSURGERY, V62, P97, DOI [10.1227/01.NEU.0000311066.03121.B8, 10.1227/01.NEU.0000296979.08546.79]; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Kwon S, 2004, STROKE, V35, P918, DOI 10.1161/01.STR.0000119385.56094.32; Brunnstrom S, 1966, Phys Ther, V46, P357; Katrak PH, 2009, PM&R, V1, P427, DOI 10.1016/j.pmrj.2009.03.002; Koyama T, 2014, J STROKE CEREBROVASC, V23, P2397, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.017; Koyama T, 2006, J REHABIL MED, V38, P280, DOI 10.1080/16501970600731420; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS145, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.014	28	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					881	889		10.1016/j.jstrokecerebrovasdis.2014.12.011		9	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700032		
J	Kato, Y; Hayashi, T; Sehara, Y; Deguchi, I; Fukuoka, T; Maruyama, H; Horiuchi, Y; Nagamine, Y; Sano, H; Tanahashi, N				Kato, Yuji; Hayashi, Takeshi; Sehara, Yoshihide; Deguchi, Ichiro; Fukuoka, Takuya; Maruyama, Hajime; Horiuchi, Yohsuke; Nagamine, Yuito; Sano, Hiroyasu; Tanahashi, Norio			Ischemic Stroke with Essential Thrombocythemia: A Case Series	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Ischemic stroke; essential thrombocythemia; JAK2 V617F mutation; antiplatelet therapy; cytoreductive therapy	POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; RISK-FACTORS; THROMBOSIS; CRITERIA	Background: Essential thrombocythemia (ET) is considered a rare cause of stroke partly because it is not detected if the platelet count is not elevated. However, early detection of ET is important because thrombosis can recur frequently, unless adequately treated. Methods: We retrospectively collected data from 10 stroke cases with ET. Clinical characteristics, location of stroke, laboratory data (platelet and leukocyte count, hemoglobin, and JAK2 V617F mutation), and treatment were reviewed. Results: The population consisted of 7 women and 3 men aged 18-83 years. Most patients had atherosclerotic risk factors. Half of the patients had a history of ischemic stroke. In 8 patients, ischemic stroke was the first manifestation of ET. Of 13 acute cerebrovascular events, 4 were transient ischemic attacks and 9 were cerebral infarctions. Three patients presented with watershed-type infarcts without large artery stenosis. Two patients had atherosclerotic stenosis of the large artery and experienced atherothrombotic infarction. The mean platelet count was 966 +/- 383 x 10(9)/L. JAK2 V617F mutation was found in 5 of 7 patients. Despite treatment with combined antiplatelet and cytoreductive therapy in all patients, 3 experienced recurrent ischemic stroke. Conclusions: These findings suggest that ET is an adjunctive risk factor for stroke and the patients with ET are subject to watershed-type infarcts even in the absence of large artery stenosis. Early diagnosis of ET and strict management of vascular risk factors may help prevent additional cerebrovascular events. (C) 2015 by National Stroke Association	[Kato, Yuji; Hayashi, Takeshi; Sehara, Yoshihide; Deguchi, Ichiro; Fukuoka, Takuya; Maruyama, Hajime; Horiuchi, Yohsuke; Nagamine, Yuito; Sano, Hiroyasu; Tanahashi, Norio] Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, Hidaka, Hidaka, Saitama 3501298, Japan	Kato, Y (reprint author), Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, Hidaka, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	yujik@saitama-med.ac.jp					VANGENDEREN PJJ, 1994, PRESSE MED, V23, P73; Falanga A, 2012, HEMATOL-AM SOC HEMAT, P571, DOI 10.1182/asheducation-2012.1.571; Palandri F, 2011, ANN HEMATOL, V90, P933, DOI 10.1007/s00277-010-1154-3; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Richard S, 2011, EUR J NEUROL, V18, P995, DOI 10.1111/j.1468-1331.2010.03183.x; Landolfi R, 2006, BEST PRACT RES CL HA, V19, P617, DOI 10.1016/j.beha.2005.07.011; Carobbio A, 2007, BLOOD, V109, P2310, DOI 10.1182/blood-2006-09-046342; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; De Stefano V, 2008, HAEMATOL-HEMATOL J, V93, P372, DOI 10.3324/haematol.12053; ARBOIX A, 1995, STROKE, V26, P1463; Arellano-Rodrigo E, 2009, AM J HEMATOL, V84, P102, DOI 10.1002/ajh.21338; D'Ambrosio Daniele, 2008, Cases J, V1, P354, DOI 10.1186/1757-1626-1-354; Posfai E, 2014, J NEUROL SCI, V336, P260, DOI 10.1016/j.jns.2013.10.016; Tefferi Ayalew, 2013, Am J Hematol, V88, P507, DOI 10.1002/ajh.23417	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					890	893		10.1016/j.jstrokecerebrovasdis.2014.12.012		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700033		
J	Ito, Y; Nakajima, M; Watari, M; Sakamoto, T; Hashimoto, Y; Tajiri, S; Takada, A; Ando, Y				Ito, Yasuyuki; Nakajima, Makoto; Watari, Mari; Sakamoto, Tetsuro; Hashimoto, Yoichiro; Tajiri, Seiji; Takada, Akira; Ando, Yukio			Intratumoral Hemorrhage in a Patient with Malignant Meningioma under Anticoagulant Therapy	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Intratumoral hemorrhage; meningioma; nonvalvular atrial fibrillation; novel oral anticoagulants; warfarin		We report the case of an elderly woman with malignant meningioma and atrial fibrillation who started taking anticoagulants after an ischemic stroke and subsequently developed intratumoral hemorrhage. Further studies are required to confirm whether a particular anticoagulant agent is suitable for patients with brain tumor and atrial fibrillation.	[Ito, Yasuyuki; Watari, Mari; Sakamoto, Tetsuro; Hashimoto, Yoichiro] Kumamoto City Hosp, Dept Neurol, Kumamoto 8628505, Japan; [Nakajima, Makoto; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto 860, Japan; [Tajiri, Seiji; Takada, Akira] Kumamoto City Hosp, Dept Neurosurg, Kumamoto 8628505, Japan	Ito, Y (reprint author), Kumamoto City Hosp, Dept Neurol, Higashi Ku, 1-1-60 Koto, Kumamoto 8628505, Japan.	yasito1973@gmail.com					Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Gerber DE, 2006, J CLIN ONCOL, V24, P1310, DOI 10.1200/JCO.2005.04.6656; Bosnjak R, 2005, J NEUROSURG, V103, P473, DOI 10.3171/jns.2005.103.3.0473; Bruno MC, 2003, J NEUROSURG SCI, V47, P227; Bruno M C, 2003, J Neurosurg Sci, V47, P215; JONES N R, 1989, British Journal of Neurosurgery, V3, P691, DOI 10.3109/02688698908992693; Kuzeyli K, 2004, J CLIN NEUROSCI, V11, P490, DOI 10.1016/j.jocn.2003.10.012	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					E90	E91		10.1016/j.jstrokecerebrovasdis.2014.11.008		2	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700002		
J	Ohyagi, M; Nakamura, K; Watanabe, M; Fujigasaki, H				Ohyagi, Masaki; Nakamura, Kazuha; Watanabe, Mutsufusa; Fujigasaki, Hiroto			Embolic Stroke during Apixaban Therapy for Left Atrial Appendage Thrombus	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Novel oral anticoagulants; atrial fibrillation; thrombolysis; echocardiography	FIBRILLATION; PATIENT	Left atrial appendage (LAA) thrombus is associated with atrial fibrillation (AF) and is a powerful predictor of cardiogenic thromboembolism. Warfarin is an established anticoagulant therapy for patients with LAA thrombus to prevent thromboembolic complications. Apixaban is superior to warfarin in the prevention of thromboembolic complications in patients with AF, and there are case reports showing apixaban-associated resolution of LAA thrombus; however, the efficacy and safety of apixaban for the treatment of LAA thrombus remains unproven. Here we report a patient who experienced embolic stroke while taking apixaban for the treatment of LAA thrombus. Thrombolysis therapy was initiated at the onset of stroke and the patient recovered remarkably. Apixaban is known to make thrombi mobile and/ or fragile by shifting the coagulation/fibrinolysis balance to a relative predominance of fibrinolytic activity; therefore, it is necessary to monitor for thromboembolic complications after the initiation of apixaban for the treatment of pre-existing LAA thrombus.	[Ohyagi, Masaki; Nakamura, Kazuha; Watanabe, Mutsufusa; Fujigasaki, Hiroto] Tokyo Metropolitan Bokutoh Hosp, Dept Internal Med, Tokyo 1308575, Japan	Ohyagi, M (reprint author), Tokyo Metropolitan Bokutoh Hosp, Dept Internal Med, Sumida Ku, 4-23-15 Koutoubashi, Tokyo 1308575, Japan.	ohyanuro@tmd.ac.jp					Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; YASAKA M, 1990, STROKE, V21, P1540; Dobashi S, 2014, BMJ CASE REP; Fang BR, 2001, ECHOCARDIOGR-J CARD, V18, P527, DOI 10.1046/j.1540-8175.2001.00527.x; Kawakami Tohru, 2013, Thromb J, V11, P26, DOI 10.1186/1477-9560-11-26; Saito S, 2014, J STROKE CEREBROVASC, V23, P1747, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.014	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	APR	2015	24	4					E99	E100		10.1016/j.jstrokecerebrovasdis.2014.11.031		2	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FP	WOS:000351856700005		
J	Lee, S; Shimada, H; Park, H; Makizako, H; Lee, S; Doi, T; Yoshida, D; Tsutsumimoto, K; Anan, Y; Suzuki, T				Lee, SungChul; Shimada, Hiroyuki; Park, Hyuntae; Makizako, Hyuma; Lee, Sangyoon; Doi, Takehiko; Yoshida, Daisuke; Tsutsumimoto, Kota; Anan, Yuya; Suzuki, Takao			The Association Between Kidney Function and Cognitive Decline in Community-Dwelling, Elderly Japanese People	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Chronic kidney disease; creatinine; decline in cognitive function	BODY-COMPOSITION; OLDER-ADULTS; RISK-FACTORS; DISEASE; IMPAIRMENT; PREVALENCE; DEMENTIA; POPULATION; HEALTH; PERFORMANCE	Objectives: The aim of this study was to evaluate the relationship between chronic kidney disease (CKD) and cognitive decline in community-dwelling older adults without dementia. Design: Cross-sectional. Setting: Obu Study of Health Promotion for the Elderly in Japan. Participants: The participants were 4686 residents (community-dwelling older adults without dementia) who completed baseline assessments. Measurements: The estimated glomerular filtration rate (eGFR, mL/min/1.73 m(2)) was determined according to the creatinine level, and participants were classified into three mutually exclusive categories: normal (>60.0 mL/min/1.73 m(2)), mild CKD (45.0-59.9 mL/min/1.73 m(2)), or moderate to severe CKD (<45.0 mL/min/1.73 m(2)). Cognitive function was assessed using the National Center for Geriatrics and Gerontology-Functional Assessment Tool. Multivariate logistic regression was used to examine the relationships between eGFR and cognitive decline. Results: After multivariate adjustment, participants with lower eGFR had lower cognitive function scores on most domains (P < .05). In particular, participants with advanced CKD (eGFR < 45 mL/min/1.73 m2) were more likely to have significant cognitive decline on the Trail Making Test part A (odds ratio = 2.347, 95% confidence interval = 1.525-3.614) and the Symbol Digit Substitution Task (odds ratio = 2.308, 95% confidence interval = 1.486-3.585) than those with normal and mild CKD. Conclusions: A lower level of kidney function was associated with lower cognitive performance in attention and processing speed. These results suggest that eGFR might be an effective method to screen for cognitive decline in community-dwelling older adults. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Lee, SungChul; Shimada, Hiroyuki; Park, Hyuntae; Makizako, Hyuma; Lee, Sangyoon; Doi, Takehiko; Yoshida, Daisuke; Tsutsumimoto, Kota; Anan, Yuya] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, Obu, Aichi 4748511, Japan; [Doi, Takehiko] Japan Soc Promot Sci, Tokyo, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi 4748511, Japan	Lee, S (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, 35 Gengo, Obu, Aichi 4748511, Japan.	leesuykr@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Shahinian VB, 2013, AM J KIDNEY DIS, V61, P930, DOI 10.1053/j.ajkd.2013.01.018; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Etgen T, 2012, AM J NEPHROL, V35, P474, DOI 10.1159/000338135; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Seliger SL, 2004, J AM SOC NEPHROL, V15, P1904, DOI 10.1097/01.asn.0000131529.60019.fa; GURALNIK JM, 1994, J GERONTOL, V49, pM85; Kuriyama N, 2013, ARCH GERONTOL GERIAT, V56, P55, DOI 10.1016/j.archger.2011.11.009; Levey AS, 2003, ANN INTERN MED, V139, P137; Desmond DW, 2000, NEUROLOGY, V54, P1124; Arismendi-Morillo G, 2010, ULTRASTRUCT PATHOL, V34, P214, DOI 10.3109/01913121003743690; Etgen T, 2009, NEPHROL DIAL TRANSPL, V24, P3144, DOI 10.1093/ndt/gfp230; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Kearns B, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-49; Kurella M, 2005, AM J KIDNEY DIS, V45, P66, DOI 10.1053/j.ajkd.2004.08.044; Tamura MK, 2011, CLIN J AM SOC NEPHRO, V6, P248, DOI 10.2215/CJN.02660310; Seidel UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091176; Slinin Y, 2008, J AM GERIATR SOC, V56, P2082, DOI 10.1111/j.1532-5415.2008.01936.x; Thornton WL, 2007, J INT NEUROPSYCH SOC, V13, P344, DOI 10.1017/S1355617707070361; Yang AC, 2011, J AM GERIATR SOC, V58, P2046	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	APR 1	2015	16	4							UNSP 349.e1	10.1016/j.jamda.2014.12.009		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CE6KT	WOS:000351946000016		
J	Sawamura, K; Sano, H; Nakanishi, M				Sawamura, Kanae; Sano, Hiroshi; Nakanishi, Miharu			Japanese Public Long-Term Care Insured: Preferences for Future Long-Term Care Facilities, Including Relocation, Waiting Times, and Individualized Care	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Preferences; long-term care; discrete choice experiment; Japan; general population	NURSING-HOMES; DEMENTIA; PEOPLE	Objectives: Expenditures on long-term care insurance (LTCI) in Japan have been increasing with the aging of the population, which has led to an increase in premiums. To optimize resource allocation, we aim to clarify the priorities of the functions of long-term care facilities from the viewpoint of future beneficiaries. Design: The present study was conducted using a cross-sectional study design. Setting/Participants: We conducted a mail-in survey targeting 2400 adults aged 50-65 in 8 cities in Japan, and 371 persons responded. Measurements: Conjoint analysis was applied to measure participants' preferences for long-term care facility services. Participants read 1 of 2 vignettes of an 80-year-old person with either dementia or a fracture, and were asked to envision it as a possible future scenario for themselves. Participants then completed 8 or 9 tasks to select suitable long-term care facilities for the person described. The questionnaire also contained common questions on participants' personal profiles: age, gender, family situation, education, approximate yearly family income, experience as a family caregiver, dwelling status, present health status, and possibility of requiring long-term care services in the future. Results: The results focused mainly on (1) possibilities of individual choice for daily schedules/meals; (2) availability of regular care staff; (3) room; (4) main daily interactions; (5) necessity of relocation associated with medical deterioration; 6) Waiting time; 7) distance from present residence; and (8) monthly fees. Necessity of relocation associated with medical deterioration was consistently given the greatest importance. Participants with experience as a family caregiver showed significantly greater preference for individualized care and communication. Conclusions: The option of avoiding relocation was highly valued by participants compared with private rooms and individualized care. The present situation of high demand for intensive care homes for the elderly, provoked by anxiety about future residence, will not change unless a robust system is built to support residents even when their health has deteriorated. Individualized care has been promoted by long-term care insurance policies, but further advances will require efforts to obtain the understanding of the insured. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Sawamura, Kanae] Japan Res Inst, Ctr Strategy Emergence, Tokyo 1410022, Japan; [Sano, Hiroshi] Shiga Univ, Fac Econ, Dept Econ, Hikone, Shiga, Japan; [Nakanishi, Miharu] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 113, Japan	Sawamura, K (reprint author), Japan Res Inst, Ctr Strategy Emergence, Shinagawa Ku, 2-18-1 Higashi Gotanda, Tokyo 1410022, Japan.	sawa-tky@umin.ac.jp			internally funded projects of the Institute for Health Economics and Policy, Tokyo, Japan [PJ12402, PJ13402]	This study was one of the internally funded projects of the Institute for Health Economics and Policy (grant numbers PJ12402, PJ13402), Tokyo, Japan.	Nieboer AP, 2010, SOC SCI MED, V70, P1317, DOI 10.1016/j.socscimed.2009.12.027; KROES EP, 1988, J TRANSP ECON POLICY, V22, P11; Nakanishi M, 2012, J AM MED DIR ASSOC, V13, P794, DOI 10.1016/j.jamda.2012.08.010; Brannelly T, 2011, NURS ETHICS, V18, P662, DOI 10.1177/0969733011408049; Chappell N. L., 2007, DEMENTIA, V6, P527, DOI 10.1177/1471301207084372; Division of the Support for the Elderly Ministry of Health Labor and Welfare, 2014, SIT APPL APPL INT CA; Edvardsson D, 2011, J CLIN NURS, V20, P2890, DOI 10.1111/j.1365-2702.2011.03706.x; Japanese Association of Retirement housing, 2013, SURV ACT SIT FEE BAS; Ministry of Health Labor and Welfare, 2011, FUT PROJ COSTS REQ S; Ministry of Health Labor and Welfare, 2013, CURR SIT FUT DIR LON; Ministry of Health Labor and Welfare, 2014, OV MED SERV REG JAP; Nakanishi M, 2013, J AM MED DIR ASSOC, V15; Netten A, 2011, ASCOT ADULT SOCIAL C; Nomura Research Institute, 2010, STUD APPL SPEC NURS; Organization for Economic Co-operation and Development, 2013, ED GLANC 2013 IND AN; Sanko N, 2001, THESIS ECOLE NATL PO; Sawamura K, 2013, ARCH GERONTOL GERIAT, V56, P416, DOI 10.1016/j.archger.2012.11.009; Statistics and Information Department Ministry of Health Labor and Welfare, 2014, SURV I EST LONG TERM; Statistics and Information Department Ministry of Health Labor and Welfare, 2012, SURV LONG TERM CAR B; Statistics Bureau Ministry of Internal Affairs and Communication, 2010, POP CENS 2010; Terada S, 2013, PSYCHIAT RES, V205, P103, DOI 10.1016/j.psychres.2012.08.028; The Institute for Health Economics and Policy, 2011, STUD APPL URG MOT SP; van Bilsen PMA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-39	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	APR 1	2015	16	4							UNSP 350.e9	10.1016/j.jamda.2015.01.082		12	Geriatrics & Gerontology	Geriatrics & Gerontology	CE6KT	WOS:000351946000019		
J	Mizuno, O; Nomura, T; Ohguchi, Y; Suzuki, S; Nomura, Y; Hamade, Y; Hoshina, D; Sandilands, A; Akiyama, M; McLean, WHI; Abe, R; Shimizu, H				Mizuno, O.; Nomura, T.; Ohguchi, Y.; Suzuki, S.; Nomura, Y.; Hamade, Y.; Hoshina, D.; Sandilands, A.; Akiyama, M.; McLean, W. H. I.; Abe, R.; Shimizu, H.			Loss-of-function mutations in the gene encoding filaggrin underlie a Japanese family with food-dependent exercise-induced anaphylaxis	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							ICHTHYOSIS VULGARIS; ATOPIC ECZEMA; RARE MUTATIONS; DERMATITIS; PREVALENT; ALLERGY; DISEASE; ASTHMA	BackgroundFood-dependent exercise-induced anaphylaxis (FDEIA) is a serious food allergy in which anaphylaxis develops when exercise is performed within several hours after food intake. The precise mechanism underlying allergic sensitization in FDEIA has been an important issue but remains poorly understood. ObjectivesWe aimed to elucidate the pathomechanism including the route of allergen sensitization involved in FDEIA. MethodsA Japanese family with wheat-dependent exercise-induced anaphylaxis (WDEIA), a specific form of FDEIA, were clinically examined. Mutation analysis of the gene encoding filaggrin (FLG) was also performed. ResultsTwo of the family members were confirmed as WDEIA on the basis of their medical history and positive provocation test results. Notably, the two affected individuals in the family had concomitant ichthyosis vulgaris. Mutation analysis of FLG revealed that they carry one or more loss-of-function mutations that have not been described in the Japanese population. ConclusionThese results indicate that FLG mutations might be involved in the pathogenesis of WDEIA in the present case.	[Mizuno, O.; Nomura, T.; Ohguchi, Y.; Suzuki, S.; Nomura, Y.; Hamade, Y.; Hoshina, D.; Abe, R.; Shimizu, H.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Sandilands, A.; McLean, W. H. I.] Univ Dundee, Coll Life Sci, Dermatol & Genet Med, Dundee, Scotland; [Sandilands, A.; McLean, W. H. I.] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland; [Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan	Nomura, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.	nomura@huhp.hokudai.ac.jp			Japan Society for the Promotion of Science [25860925]	This work was supported by Grant-in-Aid for Young Scientists (B) 25860925 (to T. Nomura) from the Japan Society for the Promotion of Science.	Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Nemoto-Hasebe I, 2009, BRIT J DERMATOL, V161, P1387, DOI [10.1111/j.1365-2133.2009.09406.x, 10.1111/j.1365-2133.2009.09406]; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Fukutomi Y, 2011, J ALLERGY CLIN IMMUN, V127, P531, DOI 10.1016/j.jaci.2010.09.035; Chinuki Y, 2012, ALLERGOL INT, V61, P529, DOI 10.2332/allergolint.12-RAI-0494; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Li M, 2013, BRIT J DERMATOL, V168, P1335, DOI 10.1111/bjd.12206; Nomura T, 2009, J INVEST DERMATOL, V129, P1302, DOI 10.1038/jid.2008.372; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	APR	2015	29	4					805	808		10.1111/jdv.12441		4	Dermatology	Dermatology	CE2XH	WOS:000351684500027		
J	Yatabe, Y				Yatabe, Yasushi			ALK FISH and IHC You Cannot Have One without the Other	JOURNAL OF THORACIC ONCOLOGY			English	Editorial Material							POSITIVE LUNG-CANCER; CHEMOTHERAPY; CRIZOTINIB		[Yatabe, Yasushi] Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan	Yatabe, Y (reprint author), Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	yyatabe@aichi-cc.jp					Ali G, 2014, ARCH PATHOL LAB MED, V138, P1449, DOI 10.5858/arpa.2013-0388-OA; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Cabillic F, 2014, J THORAC ONCOL, V9, P295, DOI 10.1097/JTO.0000000000000072; Biomarker Committee tJLCS, 2 NOT RES IHC FISH D; Blackhall FH, 2014, J CLIN ONCOL, V32, P2780, DOI 10.1200/JCO.2013.54.5921; Ilie MI, 2015, ANN ONCOL, V26, P238, DOI 10.1093/annonc/mdu484; Martin V, 2014, J THORAC ON IN PRESS; Mitsudomi T, GUIDANCE ALK GENE TE; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI 10.1056/NEJMoa1311107; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI 10.1056/NEJMoa1408440; Tsao SM, IASLC ATLAS ALK TEST	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	APR	2015	10	4					548	550		10.1097/JTO.0000000000000461		3	Oncology; Respiratory System	Oncology; Respiratory System	CE2UQ	WOS:000351675400005		
J	Kohno, T; Saito, M				Kohno, Takashi; Saito, Motonobu			Comparisons between Mouse and Human Studies Will Help the Prevention, Diagnosis, and Treatment of the Deadliest Type of Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Editorial Material							COMPREHENSIVE GENOMIC ANALYSIS		[Kohno, Takashi; Saito, Motonobu] Natl Canc Ctr, Div Genome Biol, Tokyo 1040045, Japan	Kohno, T (reprint author), Natl Canc Ctr, Div Genome Biol, Tokyo 1040045, Japan.	tkkohno@ncc.go.jp					Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Umemura S, 2014, J THORAC ONCOL, V9, P1324, DOI 10.1097/JTO.0000000000000250; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Gazdar AF, 2015, J THORAC ONCOL, V10, P553, DOI 10.1097/JTO.0000000000000459; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	APR	2015	10	4					551	552		10.1097/JTO.0000000000000477		2	Oncology; Respiratory System	Oncology; Respiratory System	CE2UQ	WOS:000351675400006		
J	Kinoshita, T; Ohtsuka, T; Yotsukura, M; Asakura, K; Goto, T; Kamiyama, I; Otake, S; Tajima, A; Emoto, K; Hayashi, Y; Kohno, M				Kinoshita, Tomonari; Ohtsuka, Takashi; Yotsukura, Masaya; Asakura, Keisuke; Goto, Taichiro; Kamiyama, Ikuo; Otake, Sotaro; Tajima, Atsushi; Emoto, Katsura; Hayashi, Yuichiro; Kohno, Mitsutomo			Prognostic Impact of Preoperative Tumor Marker Levels and Lymphovascular Invasion in Pathological Stage I Adenocarcinoma and Squamous Cell Carcinoma of the Lung	JOURNAL OF THORACIC ONCOLOGY			English	Article						Adenocarcinoma; Squamous cell carcinoma; Pathological stage I	SERUM CARCINOEMBRYONIC ANTIGEN; ADJUVANT CHEMOTHERAPY; CANCER REGISTRY; GENE-MUTATIONS; CLASSIFICATION; ASSOCIATION; RECURRENCE; TEGAFUR; URACIL; TRIAL	Introduction: Some unfavorable prognostic factors for stage I non-small-cell lung cancers have been reported; however, they are not reflected in the current Tumor-Node-Metastasis classification. Methods: We retrospectively reviewed 629 patients who underwent complete resection of pathological stage I adenocarcinomas (ADs) or squamous cell carcinomas (SQs) at two institutes between 1996 and 2011. The correlation between clinicopathological characteristics and survival rates was analyzed to identify prognostic factors. Results: Multivariate analysis indicated that among ADs, high serum carcinoembryonic antigen levels (p = 0.04 for overall survival [OS]; p < 0.01 for recurrence-free survival [RFS]; p = 0.02 for disease-specific survival [DSS]), lymphatic permeation (p < 0.01 for RFS and DSS), and vascular invasion (p < 0.01 for OS and RFS; p = 0.03 for DSS) were independent prognostic factors. Among SQs, high squamous cell carcinoma antigen (SCC) (p < 0.05 for OS), and vascular invasion (p < 0.05 for RFS and DSS) were independently prognostic. We suggest that among completely resected tumors less than or equal to 5 cm without lymph node metastasis, the current stages IA and IB AD with high serum carcinoembryonic antigen levels, lymphatic permeation, or vascular invasion should be upgraded to stage IB and IIA, respectively. The current stage IA SQ with high SCC antigen levels or vascular invasion should be upgraded to stage IB. These reclassifications accurately reflect survival status (p < 0.04 in all comparisons). Conclusions: Some important differences in prognostic factors were observed between AD and SQ. High preoperative serum tumor marker levels and lymphovascular invasion should be included as additional criteria in the forthcoming Tumor-Node-Metastasis staging.	[Kinoshita, Tomonari; Ohtsuka, Takashi; Yotsukura, Masaya; Asakura, Keisuke; Goto, Taichiro; Kamiyama, Ikuo; Kohno, Mitsutomo] Keio Univ Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 1608582, Japan; [Otake, Sotaro; Tajima, Atsushi] Saiseikai Utsunomiya Hosp, Dept Gen Thorac Surg, Utsunomiya, Tochigi, Japan; [Emoto, Katsura; Hayashi, Yuichiro] Keio Univ Sch Med, Dept Pathol, Tokyo 1608582, Japan	Kinoshita, T (reprint author), Keio Univ Sch Med, Dept Surg, Div Gen Thorac Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	t.kinoshita@a7.keio.jp					Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Poleri C, 2003, CHEST, V123, P1858, DOI 10.1378/chest.123.6.1858; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Sawabata N, 2010, J THORAC ONCOL, V5, P1369, DOI 10.1097/JTO.0b013e3181e452b9; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Darling GE, 2011, CHEST, V139, P1124, DOI 10.1378/chest.10-0859; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Matsuguma H, 2008, J THORAC CARDIOV SUR, V135, P44, DOI 10.1016/j.jtcvs.2007.09.032; Butts CA, 2010, J CLIN ONCOL, V28, P29, DOI 10.1200/JCO.2009.24.0333; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Sonobe M, 2012, ANN SURG ONCOL, V19, pS347, DOI 10.1245/s10434-011-1799-8; Kadota K, 2014, AM J SURG PATHOL, V38, P448, DOI 10.1097/PAS.0000000000000134; Kagohashi K, 2008, MED ONCOL, V25, P187, DOI 10.1007/s12032-007-9021-3; Kawase A, 2012, JPN J CLIN ONCOL, V42, P189, DOI 10.1093/jjco/hyr188; Maeda R, 2010, THORAX, V65, P1092, DOI 10.1136/thx.2010.141861; Miyoshi K, 2009, J THORAC CARDIOV SUR, V137, P429, DOI 10.1016/j.jtcvs.2008.07.007; Okada M, 2003, CANCER, V98, P535, DOI 10.1002/cncr.11530; Okada M, 2004, ANN THORAC SURG, V78, P1004, DOI 10.1016/j.athorascur.2004.03.019; Shimada Y, 2010, J THORAC ONCOL, V5, P970, DOI 10.1097/JTO.0b013e3181dd1803; Takeuchi Susumu, 2003, Ann Thorac Cardiovasc Surg, V9, P98	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	APR	2015	10	4					619	628		10.1097/JTO.0000000000000480		10	Oncology; Respiratory System	Oncology; Respiratory System	CE2UQ	WOS:000351675400014		
J	Norii, T; Crandall, C; Terasaka, Y				Norii, Tatsuya; Crandall, Cameron; Terasaka, Yusuke			Survival of severe blunt trauma patients treated with resuscitative endovascular balloon occlusion of the aorta compared with propensity score-adjusted untreated patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Balloon occlusion; resuscitation/method; trauma centers; blunt trauma; aortic diseases/therapy	ABBREVIATED INJURY SCALE; HEMORRHAGIC-SHOCK; MODEL; THORACOTOMY; CARE; MORTALITY; SYSTEM; AGE	BACKGROUND: Despite a growing call for use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for critically uncontrolled hemorrhagic shock, there is limited evidence of treatment efficacy. We compared the mortality between patients who received a REBOA with those who did not, adjusting for the likelihood of treatment and injury severity, to measure efficacy. METHODS: We analyzed observational prospective data from the Japan Trauma Data Bank (2004-2011) to compare the mortality between adult patients who received a REBOA with those who did not. To adjust for potential treatment bias, we calculated the likelihood of REBOA treatment via a propensity score (PS) using available pretreatment variables (vital signs, age, sex, as well as anatomic and physiologic injury severity) and matched treated patients to up to five similar PS untreated patients. We compared survival to discharge between treated and untreated groups using conditional logistic regression and Cox proportional hazards regression. RESULTS: Of 45,153 patients who met inclusion, 452 patients (1.0%) received REBOA placement. These patients were seriously injured (median Injury Severity Score [ISS], 35) and had high mortality (76%). Patients who did not receive a REBOA had significantly lower injury severity (median ISS, 13; p < 0.0001) and lower mortality (16%). After matching REBOA patients with controls with similar PSs for treatment, the crude conditional odds ratio of survival by REBOA treatment was 0.30 (95% confidence interval, 0.23-0.40). CONCLUSION: REBOA treatment is associated with higher mortality compared with similarly ill trauma patients who did not receive a REBOA. The higher observed mortality among REBOA-treated patients may signal "last ditch" efforts for severity not otherwise identified in the trauma registry. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Norii, Tatsuya; Crandall, Cameron] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA; [Terasaka, Yusuke] Kenwakai Otemachi Hosp, Dept Emergency Med, Kitakyushu, Fukuoka, Japan	Norii, T (reprint author), Dept Emergency Med, MSC 11 6025 Lomas Blvd NE, Albuquerque, NM 87131 USA.	TaNorii@salud.unm.edu					Markov NP, 2013, SURGERY, V153, P848, DOI 10.1016/j.surg.2012.12.001; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Scott DJ, 2013, J TRAUMA ACUTE CARE, V75, P122, DOI 10.1097/TA.0b013e3182946746; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Burlew CC, 2012, J TRAUMA ACUTE CARE, V73, P1359, DOI 10.1097/TA.0b013e318270d2df; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; LEDGERWOOD AM, 1976, J TRAUMA, V16, P610, DOI 10.1097/00005373-197608000-00004; Powell DW, 2004, J AM COLL SURGEONS, V199, P211, DOI 10.1016/j.jamcollsurg.2004.04.004; Harma M, 2004, AUST NZ J OBSTET GYN, V44, P170, DOI 10.1111/j.1479-828X.2004.00181.x; Martinelli T, 2010, J TRAUMA, V68, P942, DOI 10.1097/TA.0b013e3181c40579; Nakahara S, 2008, INJURY PREV, V14, P106, DOI 10.1136/ip.2007.016824; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Avaro JP, 2011, J TRAUMA, V71, P720, DOI 10.1097/TA.0b013e318221a94a; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Nakahara S, 2011, WORLD J SURG, V35, P512, DOI 10.1007/s00268-010-0865-x; HUGHES CW, 1954, SURGERY, V36, P65; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Arthurs Zachary, 2006, Vasc Endovascular Surg, V40, P149, DOI 10.1177/153857440604000210; Assar AN, 2009, J CARDIOVASC SURG, V50, P381; Bergstralh EJ, GMATCH SAS MACRO COM; Gennarelli TA, 2008, ABBREVIATED INJURY S; Karkos CD, 2001, ANN EMERG MED, V38, P328, DOI 10.1067/mem.2001.114408; Kauvar DS, 2006, J TRAUMA, V60, P3; Kimura A, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-9; Kimura A, 2012, WORLD J SURG, V36, P813, DOI 10.1007/s00268-012-1498-z; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Nobuyuki H, 2011, KYUKYU SHINRYO SHISH, P233; R Core Team, 2014, R LANG ENV STAT COMP; Shoko T, 2010, J AM COLL SURGEONS, V211, P338, DOI 10.1016/j.jamcollsurg.2010.04.010; Tohira H, 2012, INJURY, V43, P1924, DOI 10.1016/j.injury.2012.08.024; Tohira H, 2011, J TRAUMA, V71, P56, DOI 10.1097/TA.0b013e31821e5a25; Villamaria CY, 2014, J TRAUMA ACUTE CARE, V76, P92; White JM, 2011, J TRAUMA, V71, P1278, DOI 10.1097/TA.0b013e318225052f	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2015	78	4					721	728		10.1097/TA.0000000000000578		8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CE8EJ	WOS:000352074000010		
J	Shirotake, S; Kikuchi, E; Tanaka, N; Matsumoto, K; Miyazaki, Y; Kobayashi, H; Ide, H; Obata, J; Hoshino, K; Kaneko, G; Hagiwara, M; Kosaka, T; Kanao, K; Kodaira, K; Hara, S; Oyama, M; Momma, T; Miyajima, A; Nakagawa, K; Hasegawa, S; Nakajima, Y; Oya, M				Shirotake, Suguru; Kikuchi, Eiji; Tanaka, Nobuyuki; Matsumoto, Kazuhiro; Miyazaki, Yasumasa; Kobayashi, Hiroaki; Ide, Hiroki; Obata, Jun; Hoshino, Katsura; Kaneko, Gou; Hagiwara, Masayuki; Kosaka, Takeo; Kanao, Kent; Kodaira, Kiichiro; Hara, Satoshi; Oyama, Masafumi; Momma, Tetsuo; Miyajima, Akira; Nakagawa, Ken; Hasegawa, Shintaro; Nakajima, Yosuke; Oya, Mototsugu			Impact of an Adjuvant Chemotherapeutic Regimen on the Clinical Outcome in High Risk Patients with Upper Tract Urothelial Carcinoma: A Japanese Multi-Institution Experience	JOURNAL OF UROLOGY			English	Article						urinary tract; carcinoma, transitional cell; chemotherapy, adjuvant; treatment outcome	UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; NEOADJUVANT CHEMOTHERAPY; BLADDER-CANCER; SURVIVAL; METAANALYSIS; MANAGEMENT; RECURRENCE; TUMORS	Purpose: Current guidelines do not yet provide any recommendations for adjuvant chemotherapy in patients with upper tract urothelial carcinoma managed with radical nephroureterectomy. We evaluated whether an adjuvant chemotherapeutic regimen would affect the clinical outcome in patients with high risk upper tract urothelial carcinoma. Materials and Methods: We identified 873 patients who had undergone radical nephrouretectomy for localized upper tract urothelial carcinoma at 14 Japanese institutions between 1993 and 2011. We assessed whether the type of regimen, such as methotrexate, vinblastine, doxorubicin and cisplatin, and gemcitabine and cisplatin, in an adjuvant setting, could affect the subsequent clinical outcome of patients with upper tract urothelial carcinoma. Results: On multivariate analysis pathological T stage, tumor grade, lymphovascular invasion and lymph node involvement were prognostic factors for recurrence-free survival and cancer specific survival. We defined 229 patients with 3 or more of these factors as the high risk group. In an analysis according to adjuvant regimen, Kaplan-Meier curves showed that the 1 and 2-year recurrence-free survival rates in the methotrexate, vinblastine, doxorubicin and cisplatin treated group were 71.4% and 47.9%, which were significantly higher than in the gemcitabine and cisplatin treated group (48.2% and not reached, p = 0.022) or those not treated with adjuvant chemotherapy (53.4% and 39.6%, p = 0.039). Similar results were observed in terms of cancer specific survival. Conclusions: Our study showed that pT3-4, tumor grade 3, positive lymphovascular invasion and lymph node involvement were independent risk factors for disease mortality in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. In the high risk group methotrexate, vinblastine, doxorubicin and cisplatin adjuvant chemotherapy contributed to improve subsequent mortality compared to gemcitabine and cisplatin or no adjuvant chemotherapy.	[Shirotake, Suguru; Kikuchi, Eiji; Tanaka, Nobuyuki; Matsumoto, Kazuhiro; Miyazaki, Yasumasa; Kobayashi, Hiroaki; Ide, Hiroki; Obata, Jun; Hoshino, Katsura; Kaneko, Gou; Hagiwara, Masayuki; Kosaka, Takeo; Kanao, Kent; Miyajima, Akira; Oya, Mototsugu] Keio Univ, Dept Urol, Sch Med, Tokyo 1608582, Japan; [Matsumoto, Kazuhiro] Saiseikai Cent Hosp, Tokyo, Japan; [Kobayashi, Hiroaki] Kyosai Tachikawa Hosp, Tokyo, Japan; [Kaneko, Gou; Hara, Satoshi] Kawasaki City Hosp, Tokyo, Japan; [Tanaka, Nobuyuki] Musashino Yowakai Hosp, Tokyo, Japan; [Miyazaki, Yasumasa] Ogikubo Hosp, Tokyo, Japan; [Ide, Hiroki] Inagi City Hosp, Tokyo, Japan; [Momma, Tetsuo] Natl Hosp Org Saitama Hosp, Saitama, Japan; [Kosaka, Takeo] Irumagawa Hosp, Saitama, Japan; [Hara, Satoshi] Natl Hosp Org, Tochigi Med Ctr, Shimotsuke, Tochigi, Japan; [Nakajima, Yosuke] Saiseikai Yokohamashi Tobu Hosp, Kanagawa, Japan; [Hagiwara, Masayuki; Nakagawa, Ken] Ichikawa Gen Hosp, Tokyo Dent Coll, Chiba, Japan	Kikuchi, E (reprint author), Keio Univ, Dept Urol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	eiji-k@kb3.so-net.ne.jp					Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Vassilakopoulou M, 2011, CANCER-AM CANCER SOC, V117, P5500, DOI 10.1002/cncr.26172; Gandaglia G, 2014, INT J UROL, V21, P249, DOI 10.1111/iju.12267; Novara G, 2010, EUR UROL, V57, P1064, DOI 10.1016/j.eururo.2009.12.029; Kikuchi E, 2009, J CLIN ONCOL, V27, P612, DOI 10.1200/JCO.2008.17.2361; Leow JJ, 2014, EUR UROL, V66, P529, DOI 10.1016/j.eururo.2014.03.003; Porten S, 2014, CANCER-AM CANCER SOC, V120, P1794, DOI 10.1002/cncr.28655; Yates DR, 2012, BRIT J CANCER, V106, P1083, DOI 10.1038/bjc.2012.64; Cha EK, 2012, EUR UROL, V61, P818, DOI 10.1016/j.eururo.2012.01.021; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Langner C, 2006, MODERN PATHOL, V19, P272, DOI 10.1038/modpathol.3800529; Kamihira O, 2009, EUR UROL, V55, P1397, DOI 10.1016/j.eururo.2009.03.003; Colin P, 2012, ANN SURG ONCOL, V19, P3613, DOI 10.1245/s10434-012-2453-9; Soga N, 2008, INT J UROL, V15, P800, DOI 10.1111/j.1442-2042.2008.02114.x; Leow JJ, 2014, EUR UROL, V66, P42, DOI 10.1016/j.eururo.2013.08.033; Ouzzane A, 2011, EUR UROL, V60, P1258, DOI 10.1016/j.eururo.2011.05.049; Margulis V, 2009, CANCER, V115, P1224, DOI 10.1002/cncr.24135; Hellenthal NJ, 2009, J UROLOGY, V182, P900, DOI 10.1016/j.juro.2009.05.011; Fujimoto H, 2014, INT J UROL, V21, P527, DOI 10.1111/iju.12367; Gayed BA, 2013, CURR UROL REP, V14, P94, DOI 10.1007/s11934-013-0307-z; Lee SE, 2006, UROL INT, V77, P22, DOI 10.1159/000092930; Lucca I, 2014, BJU INT; Michael M, 1998, BRIT J UROL, V82, P366; Oya M, 2014, INT J UROL; Tanaka N, 2014, ANN SURG ONCOL, V21, P3151, DOI 10.1245/s10434-014-3657-y; Yafi FA, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.11.014; zYafi FA, 2012, BJU INT, V1102, pE7	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	APR	2015	193	4					1122	1128		10.1016/j.juro.2014.10.022		7	Urology & Nephrology	Urology & Nephrology	CE8OO	WOS:000352102900010		
J	Aizawa, N; Ito, H; Sugiyama, R; Fujimura, T; Suzuki, M; Fukuhara, H; Homma, Y; Igawa, Y				Aizawa, Naoki; Ito, Hiroki; Sugiyama, Rino; Fujimura, Tetsuya; Suzuki, Motofumi; Fukuhara, Hiroshi; Homma, Yukio; Igawa, Yasuhiko			Selective Inhibitory Effect of Imidafenacin and 5-Hydroxymethyl Tolterodine on Capsaicin Sensitive C Fibers of the Primary Bladder Mechanosensitive Afferent Nerves in the Rat	JOURNAL OF UROLOGY			English	Article						urinary bladder; neurons; afferent; capsaicin; imidafenacin; 5-hydroxymethyl tolterodine	URINARY-BLADDER; MUSCARINIC RECEPTORS; PELVIC NERVE; OVERACTIVE BLADDER; ANTIMUSCARINIC AGENT; IN-VITRO; ACETYLCHOLINE; FESOTERODINE; ACTIVATION; MECHANISM	Purpose: Imidafenacin and fesoterodine are used to treat overactive bladder. Imidafenacin, fesoterodine and its active metabolite 5-hydroxymethyl tolterodine are muscarinic receptor antagonists. It is believed that these agents act on afferent nerves in addition to smooth muscle. We investigated the effects of imidafenacin and 5-hydroxymethyl tolterodine on single unit afferent activity of mechanosensitive capsaicin sensitive and insensitive primary bladder afferent nerve fibers in rats. Materials and Methods: Female Sprague Dawley (R) rats were anesthetized. Single unit afferent activity was recorded from the L6 dorsal roots and classified by conduction velocity as that of A delta or C fibers. After measuring control single afferent activity during constant filling cystometry the procedure was repeated with intravenous administration of imidafenacin (0.3 to 30 mu g/kg) or 5-hydroxymethyl tolterodine (0.01 to 1 mg/kg) at cumulative doses with or without intravesical capsaicin or oxotremorine-M instillation. Results: A total of 139 single unit afferent fibers were isolated from 111 rats, including 19 Ad and 120 C fibers. Neither imidafenacin nor 5-hydroxymethyl tolterodine significantly affected the overall single unit afferent activity of A delta or C fibers. Based on capsaicin sensitivity C fibers were divided into capsaicin sensitive and insensitive groups. Each antimuscarinic inhibited the single unit afferent activity of capsaicin sensitive C fibers but not of capsaicin insensitive C fibers at the highest dose. Moreover, oxotremorine-M facilitated single unit afferent activity in a proportion of C fibers. The facilitated single unit afferent activity was significantly attenuated by the highest dose of imidafenacin. Conclusions: These findings demonstrate that imidafenacin and 5-hydroxymethyl tolterodine can selectively inhibit capsaicin sensitive C fibers among mechanosensitive bladder afferents by antagonizing bladder muscarinic receptors.	[Fujimura, Tetsuya; Suzuki, Motofumi; Fukuhara, Hiroshi; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138655, Japan; [Fujimura, Tetsuya; Suzuki, Motofumi; Fukuhara, Hiroshi; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan	Igawa, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Continence Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yigawa-jua@umin.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of the Japanese Government [40159588, 80595257]; Kyorin Pharmaceutical research grant; Pfizer research grant	Supported by Ministry of Education, Culture, Sport, Science and Technology of the Japanese Government Grants-in-Aid for Scientific Research 40159588 (YI) and 80595257 (NA), and Kyorin Pharmaceutical and Pfizer research grants.	Aizawa N, 2012, NEUROUROL URODYNAM, V31, P148, DOI 10.1002/nau.21212; De Laet K, 2006, NEUROUROL URODYNAM, V25, P156, DOI 10.1002/nau.20208; Andersson KE, 2003, EUR UROL, V43, P1, DOI 10.1016/S0302-2838(02)00540-7; Yamada S, 2011, J PHARMACOL EXP THER, V336, P365, DOI 10.1124/jpet.110.172288; Andersson KE, 2004, LANCET NEUROL, V3, P46, DOI 10.1016/S1474-4422(03)00622-7; Jiang CH, 2002, J PHYSIOL-LONDON, V543, P211, DOI 10.1113/jphysiol.2002.019042; Iijima K, 2007, EUR UROL, V52, P842, DOI 10.1016/j.eururo.2007.02.057; Aizawa N, 2011, NEUROUROL URODYNAM, V30, P163, DOI 10.1002/nau.20940; Kullmann FA, 2008, AM J PHYSIOL-RENAL, V294, pF971, DOI 10.1152/ajprenal.00313.2007; Aizawa N, 2010, NEUROUROL URODYNAM, V29, P771, DOI 10.1002/nau.20826; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Yamazaki T, 2011, N-S ARCH PHARMACOL, V384, P319, DOI 10.1007/s00210-011-0675-1; Fullhase C, 2010, BJU INT, V106, P287, DOI 10.1111/j.1464-410X.2009.09008.x; Yoshida M, 2004, UROLOGY, V63, P17, DOI 10.1016/j.urology.2003.11.003; Daly DM, 2010, EUR UROL, V58, P22, DOI 10.1016/j.eururo.2009.12.030; Jiang W, 1996, J AUTONOM NERV SYST, V58, P181; Kobayashi F, 2007, ARZNEIMITTEL-FORSCH, V57, P92; Kullmann FA, 2008, J NEUROSCI, V28, P1977, DOI 10.1523/JNEUROSCI.4694-07.2008; Ney P, 2008, BJU INT, V101, P1036, DOI 10.1111/j.1464-410X.2007.07358.x; SENGUPTA JN, 1994, J NEUROPHYSIOL, V72, P2420; Shea VK, 2000, J NEUROPHYSIOL, V84, P1924; Watanabe N, 2013, BJU INT, V112, P131, DOI 10.1111/j.1464-410X.2012.11747.x; Yokoyama O, 2011, J UROLOGY, V185, P2392, DOI 10.1016/j.juro.2011.02.048; Yokoyama O, 2005, J UROLOGY, V174, P2032, DOI 10.1097/01.ju.0000176793.50410.9e; Yu YB, 2010, BRAIN RES, V1361, P43, DOI 10.1016/j.brainres.2010.09.018	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	APR	2015	193	4					1423	1432		10.1016/j.juro.2014.09.005		10	Urology & Nephrology	Urology & Nephrology	CE8OO	WOS:000352102900114		
J	Valsecchi, ME; Terai, M; Eschelman, DJ; Gonsalves, CF; Chervoneva, I; Shields, JA; Shields, CL; Yamamoto, A; Sullivan, KL; Laudadio, M; Berd, D; Mastrangelo, MJ; Sato, T				Valsecchi, Matias E.; Terai, Mizue; Eschelman, David J.; Gonsalves, Carin F.; Chervoneva, Irina; Shields, Jerry A.; Shields, Carol L.; Yamamoto, Akira; Sullivan, Kevin L.; Laudadio, MaryAnn; Berd, David; Mastrangelo, Michael J.; Sato, Takami			Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte-Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							GEMCITABINE PLUS TREOSULFAN; OCULAR MELANOMA; CLINICAL-TRIAL; DACARBAZINE BOLD; 2-STAGE DESIGNS; LIVER; CHEMOTHERAPY; IMMUNOEMBOLIZATION; CHEMOEMBOLIZATION; VINCRISTINE	Purpose: To investigate the effects of immunoembolization with granulocyte macrophage colony-stimulating factor (GM-CSF) in patients With uveal melanoma (UM) with liver-only metastasis. Materials and Methods: In this double-blind phase II clinical trial, patients were randomized to undergo immunoembolization or bland embolization (BE). Lobar treatment was performed with GM-CSF or nottual saline solution mixed with ethiodized oil followed by embolization with gelatin sponge emulsified with iodinated contrast medium. Fifty-two patients (immunoembolization, n = 25; BE, n 27) were enrolled. Response was assessed after every two treatments. The primary endpoint was overall response rate (ORR) of liver metastases. Progression-free survival (PFS); overall survival (OS), and immunologic responses were secondary endpoints. Results: There were five partial responses in the immutoembolization group (ORR, 21.2%; 90% confidence interval [CI], 10.3%- 30.5%) and three in the BE group (ORR, 16.7%; 90% CI, 6.3%-26.9%). Stable disease Was seen in 12 patients in the immunoembolization group and 19 in the BE group. OS times were 21.5 months (95% CI, 18.5-24.8 mo) with immunoembolization and 17.2 months (95% CI, 11.9-22.4 mo) with BE. The degree of proinflammatory cytokine production was more robust after immunoembolization and correlated with time to "systemic" extrahepatic progression. In the immunoembolization group, interleukin (IL)-6 levels at 1 hour (P =.001) and IL-8 levels at. 18 hours after the procedure (P <.001) were Significant predictors of longer systemic PFS. Moreover, a dose response pattern was evident between posttreatment serum cytokine concentrations and systemic PFS. Conclusions: Immunoembolization induced more robust inflammatory responses, which correlated with the delayed progression of extrahepatic systemic metastases.	[Valsecchi, Matias E.; Terai, Mizue; Laudadio, MaryAnn; Berd, David; Mastrangelo, Michael J.; Sato, Takami] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med Oncol, Philadelphia, PA 19107 USA; [Eschelman, David J.; Gonsalves, Carin F.] Thomas Jefferson Univ, Div Intervent Radiol, Dept Radiol, Philadelphia, PA 19107 USA; [Chervoneva, Irina] Thomas Jefferson Univ, Div Biostat, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Shields, Jerry A.; Shields, Carol L.] Thomas Jefferson Univ, Ocular Oncol Serv, Wills Eye Hosp, Philadelphia, PA 19107 USA; [Sullivan, Kevin L.] Fresenius Vasc Care, Decatur, GA USA; [Yamamoto, Akira] Osaka City Univ, Grad Sch Med, Dept Radiol, Osaka 558, Japan	Sato, T (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Med Oncol, Philadelphia, PA 19107 USA.	takami.sato@jefferson.edu			NCI [5R21CA103250-02]	This study was approved by the IRB of Thomas Jefferson University and the FDA (BB-IND 8260). It was partially supported by an NCI grant (5R21CA103250-02, PI: T.S.).	Sato T, 2010, SEMIN ONCOL, V37, P127, DOI 10.1053/j.seminoncol.2010.03.014; Jung SH, 2004, STAT MED, V23, P881, DOI 10.1002/sim.1653; Fiorentini G, 2009, IN VIVO, V23, P131; Gray R, 2006, CLIN CANCER RES, V12, P1966, DOI 10.1158/1078-0432.CCR-05-1136; Carvajal RD, 2014, JAMA-J AM MED ASSOC, V311, P2397, DOI 10.1001/jama.2014.6096; Schmittel A, 2005, MELANOMA RES, V15, P205, DOI 10.1097/00008390-200506000-00010; [Anonymous], 1999, J IMMUNOLOGY, V163, P2314; Sato T, 2008, J CLIN ONCOL, V26, P5436, DOI 10.1200/JCO.2008.16.0705; Sato T, 2008, CURR ONCOL REP, V10, P431, DOI 10.1007/s11912-008-0066-z; Patel K, 2005, MELANOMA RES, V15, P297, DOI 10.1097/00008390-200508000-00011; Yamamoto A, 2009, RADIOLOGY, V252, P290, DOI 10.1148/radiol.2521081252; Bedikian AY, 2003, MELANOMA RES, V13, P303, DOI 10.1097/01.cmr.0000056231.78713.e2; Leyvraz S, 1997, J CLIN ONCOL, V15, P2589; Kivela T, 2003, EUR J CANCER, V39, P1115, DOI 10.1016/S0959-8049(03)00132-1; Koyama T, 2008, STAT MED, V27, P3145, DOI 10.1002/sim.3123; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; CANTORE M, 1994, TUMORI, V80, P37; Gonsalves CF, 2011, AM J ROENTGENOL, V196, P468, DOI 10.2214/AJR.10.4881; Scher HI, 2002, CLIN CANCER RES, V8, P400; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P989, DOI 10.1001/archophthalmol.2009.208; Dranoff G, 2002, IMMUNOL REV, V188, P147, DOI 10.1034/j.1600-065X.2002.18813.x; Bhatia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048787; Homsi J, 2010, MELANOMA RES, V20, P507, DOI 10.1097/CMR.0b013e3283403ce9; Mavligit GM, 1988, JAMA-J AM MED ASSOC, V260, P947; Nathan FE, 1994, P AN M AM SOC CLIN, V13, P394; Noter SL, 2004, MELANOMA RES, V14, P67, DOI 10.1097/01.cmr.0000113340.53882.af; O'Neill PA, 2006, MELANOMA RES, V16, P245, DOI 10.1097/01.cmr.0000205017.38859.07; Osada S, 2007, J SURG ONCOL, V95, P491, DOI 10.1002/jso.20712; Penel N, 2008, INVEST NEW DRUG, V26, P561, DOI 10.1007/s10637-008-9143-2; Pyrhonen S, 2002, CANCER, V95, P2366, DOI 10.1002/cncr.10996; Schell SR, 2002, J AM COLL SURGEONS, V195, P774, DOI 10.1016/S1072-7515(02)01333-9; Schmittel A, 2005, MELANOMA RES, V15, P447, DOI 10.1097/00008390-200510000-00014; Schmittel A, 2006, ANN ONCOL, V17, P1826, DOI 10.1093/annonc/mdl309; Shields CL, 2012, RETINA-J RET VIT DIS, V32, P1363, DOI 10.1097/IAE.0b013e31824d09a8; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9	35	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	APR	2015	26	4					523	532		10.1016/j.jvir.2014.11.037		10	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CE5OE	WOS:000351884200008		
J	Sato, Y; Inaba, Y; Murata, S; Yamaura, H; Kato, M; Kawada, H; Shimizu, Y; Ishiguchi, T				Sato, Yozo; Inaba, Yoshitaka; Murata, Shinichi; Yamaura, Hidekazu; Kato, Mina; Kawada, Hiroshi; Shimizu, Yasuhiro; Ishiguchi, Tsuneo			Percutaneous Drainage for Afferent Limb Syndrome and Pancreatic Fistula via the Blind End of the Jejunal Limb after Pancreatoduodenectomy or Bile Duct Resection	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							LOOP SYNDROME; CANCER; OBSTRUCTION; JAUNDICE; CHOLANGIOCARCINOMA; PLACEMENT; STENT; TUBE	Purpose: To investigate the feasibility of percutaneous drainage via the blind end of the jejunal limb (BEJL) for afferent limb syndrome and pancreatic fistula. Materials and Methods: Per Cutaneous drainage via the BEJL was performed in eight Patients, (seven Men and one woman; mean age,. 63 y; range, 42-71 y) presenting with afferent limb syndrome (n = 6) or pancreatic fistula (n following pancreatoduodenectomy or bile duct resection with reconstruction at. our institute from March 2005 to June 2013. Reconstruction was performed by using a modified Child method or the Roux-en-Y method, and the BEJL was surgically fixed to the abdominal wall. Afferent limb syndrome was caused by tumor recurrence or postoperative complications. Technical success, clinical success, and complications were evaluated retrospectively. Results: Technical success of drainage via BEJL was achieved in. all patients. Drainage catheters (5-10 F) were inserted into the afferent limbs Of six patients, into the pancreatic duct Of one patient, and into the pancreatic fistula of one patient Metallic stents were subsequently placed. to address malignant afferent limb obstruction in-two patients. Clinical success was achieved in seven patients (87.5%), and no patients developed major complications. Drainage catheters were removed from four patients. The mean catheter indwelling period in all patients Was 143 days (range, 21-292 d). Conclusions: Percutaneous drainage via BEJL after pancreatoduodenectomy or bile duct resection may be a feasible treatment for afferent limb syndrome and pancreatic fistula.	[Sato, Yozo; Ishiguchi, Tsuneo] Aichi Med Univ, Dept Radiol, Nagakute, Aichi 48011, Japan; [Sato, Yozo; Inaba, Yoshitaka; Murata, Shinichi; Yamaura, Hidekazu; Kato, Mina; Kawada, Hiroshi] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi 4648681, Japan; [Shimizu, Yasuhiro] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 4648681, Japan	Sato, Y (reprint author), Aichi Med Univ, Dept Radiol, Nagakute, Aichi 48011, Japan.	ysato@aichi-cc.jp					Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Pannala R, 2011, GASTROINTEST ENDOSC, V74, P295, DOI 10.1016/j.gie.2011.04.029; Burdick JS, 2002, GASTROINTEST ENDOSC, V55, P602, DOI 10.1067/mge.2002.122584; Wallace MJ, 2010, J VASC INTERV RADIOL, V21, P431, DOI 10.1016/j.jvir.2009.12.398; Castellanos JA, 2014, ANN SURG ONCOL, V21, P747, DOI 10.1245/s10434-013-3289-7; D'Angelica MI, 2004, SURG TODAY, V34, P885, DOI 10.1007/s00595-004-2832-3; Eckel F, 2011, ANN ONCOL, V22, P40, DOI DOI 10.1093/ANN0NC/MDR375; Gwon DI, 2007, J VASC INTERV RADIOL, V18, P157, DOI 10.1016/j.jvir.2006.10.017; Han K, 2012, AM J ROENTGENOL, V199, P761; Igami T, 2009, J HEPATO-BILIARY-PAN, V16, P661, DOI 10.1007/s00534-009-0104-8; Ke S, 2013, SURGERY, V153, P743, DOI 10.1016/j.surg.2013.02.008; Kim YH, 2002, J VASC INTERV RADIOL, V13, P845; Kim YJ, 2013, EUR RADIOL, V23, P2747, DOI 10.1007/s00330-013-2883-1; MORITA S, 1989, CARDIOVASC INTER RAD, V12, P66, DOI 10.1007/BF02577389; Moriura S, 1999, SURG TODAY, V29, P1098; Sacks D, 2003, J VASC INTERV RADIOL, V14, pS199; Song HY, 2007, J VASC INTERV RADIOL, V18, P1538, DOI 10.1016/j.jvir.2007.08.037; Yao NS, 1998, CARDIOVASC INTER RAD, V21, P350, DOI 10.1007/s002709900277; Yoshida H, 2008, SURG TODAY, V38, P285, DOI 10.1007/s00595-007-3604-7	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	APR	2015	26	4					566	572		10.1016/j.jvir.2014.11.010		7	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CE5OE	WOS:000351884200013		
J	Matsubara, Y; Matsumoto, T; Aoyagi, Y; Tanaka, S; Okadome, J; Morisaki, K; Shirabe, K; Maehara, Y				Matsubara, Yutaka; Matsumoto, Takuya; Aoyagi, Yukihiko; Tanaka, Shinichi; Okadome, Jun; Morisaki, Koichi; Shirabe, Ken; Maehara, Yoshihiko			Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia	JOURNAL OF VASCULAR SURGERY			English	Article							PERIPHERAL ARTERIAL-DISEASE; RANDOMIZED CONTROLLED-TRIAL; INFRAINGUINAL BYPASS; SKELETAL-MUSCLE; REVASCULARIZATION; RECONSTRUCTION; ANGIOPLASTY; MULTICENTER; MORTALITY	Background: Sarcopenia has been proposed as a prognostic factor for various diseases. Patients with critical limb ischemia (CLI) have a very poor prognosis, but sarcopenia has not been reported as a prognostic factor for CLI patients. If sarcopenia is associated with the prognosis of CLI patients, it could help select the treatment plan. Therefore, we examined whether sarcopenia is a prognostic factor for CLI patients. Methods: We performed a retrospective study of CLI patients diagnosed with Fontaine III or IV peripheral artery disease who underwent preoperative computed tomography imaging and revascularization between January 2002 and December 2009. The presence of sarcopenia was defined as skeletal muscle area of <114.0 cm(2) for men or <89.8 cm2 for women using transverse computed tomography scans at the third lumbar vertebra. We compared the 5-year survival rate and clinical characteristics between patients with or without sarcopenia. We also screened possible prognostic factors for overall survival using hazard ratios (HRs) with 95% confidence intervals (CIs). Results: Of 64 eligible patients, 28 patients had sarcopenia and 36 did not. There were significant differences in age, skeletal muscle area, body mass index, and the presence of smoking, cerebrovascular disease, and hemodialysis between patients with and without sarcopenia (all P < .05). The 5-year survival rate was significantly lower in patients with sarcopenia (23.5% vs 77.5%, P = .001). Prognostic factors for overall survival were the presence of sarcopenia (HR, 3.22; 95% CI, 1.24-9.11; P = .02), requirement for hemodialysis (HR, 4.30; 95% CI, 1.60-12.2; P = . 004), and postoperative complications (HR, 5.02; 95% CI, 1.90-13.7; P = .001). Conclusions: Our results suggest that sarcopenia is a prognostic factor for CLI patients. Exercise and nutritional interventions focusing on improving sarcopenia might be useful treatment options for CLI patients.	[Matsubara, Yutaka; Matsumoto, Takuya; Aoyagi, Yukihiko; Tanaka, Shinichi; Okadome, Jun; Morisaki, Koichi; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Matsumoto, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takum@surg2.med.kyushu-u.ac.jp					Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Bauer JM, 2008, EXP GERONTOL, V43, P674, DOI 10.1016/j.exger.2008.03.007; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Genton L, 2011, CLIN NUTR, V30, P436, DOI 10.1016/j.clnu.2011.01.009; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Meyerson SL, 2001, J VASC SURG, V34, P27, DOI 10.1067/mva.2001.116350; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Arvela E, 2010, J VASC SURG, V52, P1218, DOI 10.1016/j.jvs.2010.06.101; Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811; Ramdev P, 2002, J VASC SURG, V36, P969, DOI 10.1067/mva.2002.128297; Antoun S, 2013, CURR OPIN SUPPORT PA, V7, P383, DOI 10.1097/SPC.0000000000000011; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Kimura H, 2003, EUR J VASC ENDOVASC, V25, P29, DOI 10.1053/ejvs.2002.1767; Albers M, 2005, J VASC SURG, V42, P449, DOI 10.1016/j.jvs.2005.05.031; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; van der Zaag ES, 2004, EUR J VASC ENDOVASC, V28, P132, DOI 10.1016/j.ejvs.2004.04.003; McPhee JT, 2013, J VASC SURG, V57, P1481, DOI 10.1016/j.jvs.2012.11.074; BREVETTI G, 1991, CIRCULATION, V84, P1490; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Dormandy J A, 1991, Eur J Vasc Surg, V5, P131, DOI 10.1016/S0950-821X(05)80676-0; Fowkes F, 2005, CIRCULATION, V112, P3704; Hakaim AG, 2003, J VASC SURG, V27, P29; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hoshino J, 2010, CIRC J, V74, P2426, DOI 10.1253/circj.CJ-09-0910; Norgren L, 2007, Eur J Vasc Endovasc Surg, V33 Suppl 1, pS1, DOI 10.1016/j.ejvs.2006.09.024; Sakuma Kunihiro, 2010, Curr Aging Sci, V3, P90; Shigematsu H, 2010, INT ANGIOL, V29, P2; Vesser M, 2013, NUTR METAB CARDIOVAS, V23, P511; Wolfle KD, 2003, EUR J VASC ENDOVASC, V25, P229, DOI 10.1053/ejvs.2002.1849; Yoshizumi T, 2014, HEPATOL RES, V44, P313, DOI 10.1111/hepr.12119	33	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	APR	2015	61	4					945	950		10.1016/j.jvs.2014.10.094		6	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CE4BP	WOS:000351776100016		
J	Kobayashi, N; Hirano, K; Nakano, M; Ito, Y; Ishimori, H; Yamawaki, M; Tsukahara, R; Muramatsu, T				Kobayashi, Norihiro; Hirano, Keisuke; Nakano, Masatsugu; Ito, Yoshiaki; Ishimori, Hiroshi; Yamawaki, Masahiro; Tsukahara, Reiko; Muramatsu, Toshiya			Prognosis of critical limb ischemia patients with tissue loss after achievement of complete wound healing by endovascular therapy	JOURNAL OF VASCULAR SURGERY			English	Article							INFRAINGUINAL BYPASS GRAFT; DRUG-ELUTING STENTS; ANGIOPLASTY; MANAGEMENT; DISEASE; SURGERY; MULTICENTER; PREDICTORS; AMPUTATION; ARTERY	Objective: Critical limb ischemia (CLI) patients with tissue loss have been recognized to have a poor survival rate. In this study, we aimed to determine whether the prognosis of CLI patients with tissue loss improves after complete wound healing is achieved by endovascular therapy. Methods: We treated 187 CLI patients with tissue loss by endovascular therapy from April 2007 to December 2012. Among these patients, 113 patients who achieved complete wound healing were enrolled. The primary end point was survival rate at 3 years. The secondary end points were limb salvage rate and recurrence rate of CLI at 3 years. Results: The mean follow-up period after achievement of complete wound healing was 32 6 18 months. At 1 year, 2 years, and 3 years, the survival rates were 86%, 79%, and 74%; the limb salvage rates were 100%, 100%, and 100%; the recurrence rates of CLI were 2%, 6%, and 9%, respectively. On multivariate Cox proportional hazard analysis, age >75 years (hazard ratio, 3.18; 95% confidence interval, 1.23-8.24; P = .017) and nonambulatory status (hazard ratio, 2.46; 95% confidence interval, 1.08-5.65; P = .035) were identified as independent predictors of death for CLI patients with tissue loss even after complete wound healing was achieved. The Kaplan-Meier curve for the overall survival rate at 3 years showed that CLI patients of older age (>75 years) had a significantly decreased survival rate compared with CLI patients of younger age (<= 75 years) (58% vs 87%; log-rank test, P < .001). In addition, nonambulatory CLI patients had a significantly poor survival rate relative to ambulatory CLI patients (40% vs 93%; log-rank test, P < .001). Conclusions: The overall survival rate of CLI patients was acceptable and the recurrence rate of CLI was extremely low once complete wound healing was achieved. Nonambulatory status and age >75 years can serve as predictors of death even after complete wound healing is achieved.	[Kobayashi, Norihiro; Hirano, Keisuke; Nakano, Masatsugu; Ito, Yoshiaki; Ishimori, Hiroshi; Yamawaki, Masahiro; Tsukahara, Reiko; Muramatsu, Toshiya] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa 2308765, Japan	Kobayashi, N (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa 2308765, Japan.	ovation17@gmail.com					Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Simons JP, 2010, J VASC SURG, V51, P1419, DOI 10.1016/j.jvs.2010.01.083; Kawarada O, 2012, CATHETER CARDIO INTE, V80, P861, DOI 10.1002/ccd.24370; Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; LARSSON J, 1995, DIABETIC MED, V12, P770; Soga Y, 2014, J ATHEROSCLER THROMB, V21, P691; Soga Y, 2013, CIRC J, V77, P2102, DOI 10.1253/circj.CJ-13-0020; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Bailey CMH, 2003, EUR J VASC ENDOVASC, V25, P131, DOI 10.1053/ejvs.2002.1817; Hart CA, 2013, EXP BIOL MED, V238, P1118, DOI 10.1177/1535370213503275; Liistro F, 2013, CIRCULATION, V128, P615, DOI 10.1161/CIRCULATIONAHA.113.001811; Roberts D, 2014, CATHETER CARDIO INTE, V84, P236, DOI 10.1002/ccd.25384; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Feiring AJ, 2010, J AM COLL CARDIOL, V55, P1580, DOI 10.1016/j.jacc.2009.11.072; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Chung J, 2013, J VASC SURG, V58, P972, DOI 10.1016/j.jvs.2013.03.050; Soderstrom MI, 2010, ANN SURG, V252, P765, DOI 10.1097/SLA.0b013e3181fc3c73; Khan MUN, 2009, J VASC SURG, V49, P1440, DOI 10.1016/j.jvs.2009.02.226; Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005; Canaud L, 2014, J VASC SURG, V59, P1721, DOI 10.1016/j.jvs.2014.03.235; Meacham PW, 1998, AM SURGEON, V64, P37; Carsten CG, 1998, AM SURGEON, V64, P33; Chung J, 2014, J VASC SURG; Conte MS, 2009, J VASC SURG, V50; Hioki H., 2014, ANGIOLOGY; Khan MU, 2009, J VASC SURG, V49, P1445; Kobayashi N, 2014, CIRC J, V78, P1746, DOI 10.1253/circj.CJ-14-0171; Kobayashi N, CATHETER CARDIOVASC; Mills Sr JL, 2014, J VASC SURG, V59; Schultz Gregory S, 2004, Int Wound J, V1, P19, DOI 10.1111/j.1742-481x.2004.00008.x; Shumkov O A, 2013, Khirurgiia (Mosk), P9; Singh GD, 2014, J VASC SURG, V59, P1300, DOI 10.1016/j.jvs.2013.11.061; Tomoi Yusuke, 2013, Cardiovasc Interv Ther, V28, P374, DOI 10.1007/s12928-013-0188-6	34	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	APR	2015	61	4					951	959		10.1016/j.jvs.2014.11.065		9	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CE4BP	WOS:000351776100017		
J	Kato, K; Yamamoto, K; Yoshii, S; Suzuki, T				Kato, Kaori; Yamamoto, Kazuo; Yoshii, Shinpei; Suzuki, Toshimitsu			Aortic fibrosarcoma presenting as rupture of an abdominal aortic aneurysm	JOURNAL OF VASCULAR SURGERY			English	Editorial Material									[Kato, Kaori; Yamamoto, Kazuo; Yoshii, Shinpei] Tachikawa Med Ctr, Dept Cardiovasc Surg, Nagaoka, Niigata, Japan; [Suzuki, Toshimitsu] Tachikawa Med Ctr, Dept Pathol, Nagaoka, Niigata, Japan	Kato, K (reprint author), Tachikawa Med Ctr, Dept Cardiovasc Surg, Nagaoka, Niigata, Japan.	kaorik@yamanashi.ac.jp					Naughton PA, 2011, J VASC SURG, V53, P818, DOI 10.1016/j.jvs.2010.10.090; Thalheimer A, 2004, J VASC SURG, V40, P548, DOI 10.1016/j.jvs.2004.06.035	2	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	APR	2015	61	4					1066	1066		10.1016/j.jvs.2014.05.004		1	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CE4BP	WOS:000351776100036		
J	Doh, J; McGuire, S; Ozaki, T				Doh, Jonathan; McGuire, Steven; Ozaki, Toshiya			The Journal of World Business Special Issue: Global governance and international nonmarket strategies: Introduction to the special issue	JOURNAL OF WORLD BUSINESS			English	Article							CORPORATE SOCIAL-RESPONSIBILITY; INTEGRATED STRATEGY; POLITICAL STRATEGY; RESEARCH AGENDA; NGOS; MULTINATIONALS; GOVERNMENTS; ENVIRONMENT; COMPETITION; INVESTMENT	Global governance and nonmarket strategy are two important and interconnected subjects of international business scholarship. In this article, we introduce the special issue by first providing a brief review of recent trends in global governance and nonmarket strategy and summarizing some of the important research contributions that have shed light on them. We then present an overview of the contributions to the special issue and their contributions to global governance and international nonmarket strategy research. We conclude with some observations about this scholarship and provide suggestions for future research directions. (C) 2014 Elsevier Inc. All rights reserved.	[Doh, Jonathan] Villanova Univ, Villanova Sch Business, Villanova, PA 19085 USA; [McGuire, Steven] Aberystwyth Univ, Sch Business & Management, Aberystwyth SY23 3AL, Dyfed, Wales; [Ozaki, Toshiya] Rikkyo Univ, Coll Business, Tokyo 171, Japan	Doh, J (reprint author), Villanova Univ, Villanova Sch Business, Villanova, PA 19085 USA.	jonathan.doh@villanova.edu; sbm@aber.ac.uk; ozakit@rikkyo.ac.jp					Amsden A. H, 1989, ASIAS NEXT GIANT S K; Dahan NM, 2013, BUS SOC, V52, P365, DOI 10.1177/0007650313491470; Teegen H, 2004, J INT BUS STUD, V35, P463, DOI 10.1057/palgrave.jibs.8400112; Hiatt SR, 2013, ACAD MANAGE J, V56, P923, DOI 10.5465/amj.2011.0128; Doh JP, 2012, ACAD MANAGE PERSPECT, V26, P22, DOI 10.5465/amp.2012.0041; Lucea R, 2010, BUS SOC, V49, P116, DOI 10.1177/0007650309345459; Kostova T, 2002, ACAD MANAGE J, V45, P215, DOI 10.2307/3069293; FAGRE N, 1982, J INT BUS STUD, V13, P9, DOI 10.1057/palgrave.jibs.8490547; McWilliams A, 2006, J MANAGE STUD, V43, P1, DOI 10.1111/j.1467-6486.2006.00580.x; Hillman AJ, 1999, ACAD MANAGE REV, V24, P825, DOI 10.2307/259357; BODDEWYN JJ, 1994, ACAD MANAGE REV, V19, P119, DOI 10.2307/258837; Baron DP, 2001, J ECON MANAGE STRAT, V10, P7, DOI 10.1162/105864001300122548; Lawton T, 2013, INT J MANAG REV, V15, P86, DOI 10.1111/j.1468-2370.2012.00337.x; Prakash A, 2002, REV INT POLIT ECON, V9, P513, DOI 10.1080/09692290210150707; Buckley PJ, 1998, J INT BUS STUD, V29, P539, DOI 10.1057/palgrave.jibs.8490006; Ramamurti R, 2001, J INT BUS STUD, V32, P23, DOI 10.1057/palgrave.jibs.8490936; Oliver C, 2008, ACAD MANAGE REV, V33, P496; Jackson G, 2008, J INT BUS STUD, V39, P540, DOI 10.1057/paigrave.jibs.8400375; Baron DP, 1997, CALIF MANAGE REV, V39, P145; Bemhagen P., 2013, BUSINESS POLITICS, V15, P63; Bendor J., 1987, AM POLIT SCI REV, V81, P129, DOI 10.2307/1960782; Berger S., 1996, NATL DIVERSITY GLOBA; Boddewyn J, 2011, GLOB STRATEG J, V1, P345, DOI 10.1111/j.2042-5805.2011.00026.x; Dasai R., 2011, Q J POLIT SCI, V6, P137; Dore R., 1973, JAPANESE FACTORY ORI; Friedmann T., 2005, WORLD IS FLAT BRIEF; Frynas J. G., 2006, STRATEGIC MANAGEMENT, V27, P145; Hall P. A., 2001, VARIETIES CAPITALISM; Henisz WJ, 2000, J LAW ECON ORGAN, V16, P334, DOI 10.1093/jleo/16.2.334; Hillman A. J., 2004, J MANAGE, V30, P387; Johnston C, 1982, MITI JAPANESE MIRACL; Khanna T., 2014, HARVARD BUS REV, V92, P58; Khanna T., 2005, 106014 HARV BUS SCH; KOBRIN SJ, 1979, J INT BUS STUD, V10, P67, DOI 10.1057/palgrave.jibs.8490631; KOBRIN SJ, 1987, INT ORGAN, V41, P609; Kobrin S. J., 1998, J INT AFF, V51, P361; KOBRIN SJ, 1998, FOREIGN POLICY FAL, P97; KOBRIN SJ, 1978, COLUMBIA J WORLD BUS, V13, P113; Kobrin SJ, 2004, REV INT STUD, V30, P111, DOI 10.1017/S0260210504005856; Kobrin SJ, 2009, BUS ETHICS Q, V19, P349; Koppell Jonathan G. S., 2010, WORLD RULE ACCOUNTAB; Lawton T. C, 2013, ALIGNING ADVANTAGE C; McGuire S, 2012, OXFORD HDB WTO, P320; McGuire S, 2013, INT AFF, V89, P695, DOI 10.1111/1468-2346.12040; Ohmae K., 1990, BORDERLESS WORLD POW; Rehbein K A, 1999, BUSINESS SOC, V38, P144, DOI 10.1177/000765039903800202; Schuler DA, 1996, ACAD MANAGE J, V39, P720, DOI 10.2307/256661; Vernon R, 1971, SOVEREIGNTY BAY MULT; Wade R., 2004, GOVERNING MARKET EC; Weymouth Stephen, 2012, BUS POLITICS, V14, P1; Whittington R, 2012, STRATEG ORGAN, V10, P263, DOI 10.1177/1476127012452828; ZAHEER S, 1995, ACAD MANAGE J, V38, P341, DOI 10.2307/256683	52	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1090-9516	1878-5573		J WORLD BUS	J. World Bus.	APR	2015	50	2					256	261		10.1016/j.jwb.2014.10.002		6	Business	Business & Economics	CE2OO	WOS:000351655100002		
J	Nishimura, A; Fukuda, A; Kato, K; Fujisawa, K; Uchida, A; Sudo, A				Nishimura, Akinobu; Fukuda, Aki; Kato, Ko; Fujisawa, Kohzo; Uchida, Atsumasa; Sudo, Akihiro			Vascular safety during arthroscopic all-inside meniscus suture	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Magnetic resonance image; Knee arthroscopy; Meniscus suture; All-inside suture; Vascular position	CRUCIATE LIGAMENT RECONSTRUCTION; HIGH TIBIAL OSTEOTOMY; POPLITEAL ARTERY; REPAIR SYSTEM; ARROW	The purpose of the study is to assess the orientation and distance of the popliteal artery (PA) from both the anteromedial and anterolateral portals. The records of 97 patients (100 knees) who underwent knee arthroscopy were reviewed. The shortest distance from the posterior tibial cortex to the PA on the lines from both the medial and lateral borders of the patellar tendon to the PA was evaluated by magnetic resonance imaging at full knee extension. The figure-of-four position was compared between patients with intact and deficient anterior cruciate ligaments (ACLs). The shortest distances from the posterior cruciate ligament (PCL) to the lines running from the medial and lateral borders of the patellar tendon to the PA were also measured. The shortest distances from the posterior tibial cortex to the PA were significantly longer in the figure-of-four position than at full knee extension and during extension in the ACL-deficient than intact group. Distances did not significantly differ in the figure-of-four position. The PA was hidden from the anteromedial portal by the PCL, but remained vulnerable from the anterolateral portal. All-inside meniscus suturing of the posterior horn of the lateral meniscus inserted through the anteromedial portal is safer when the knee is in the figure-of-four position than fully extended. Meniscus repairs should be completed before ACL reconstruction due to vascular positions and the ease of approach.	[Nishimura, Akinobu; Kato, Ko] Mie Univ, Grad Sch Med, Dept Orthopaed & Sports Med, Tsu, Mie 5148507, Japan; [Nishimura, Akinobu; Uchida, Atsumasa; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; [Fukuda, Aki; Fujisawa, Kohzo] Suzuka Kaisei Hosp, Dept Orthopaed Surg, Tsu, Mie, Japan	Nishimura, A (reprint author), Mie Univ, Grad Sch Med, Dept Orthopaed & Sports Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	meiten@clin.medic.mie-u.ac.jp					Jones HP, 2002, ARTHROSCOPY, V18, P64, DOI 10.1053/jars.2002.25343; Smith PN, 1999, CLIN ORTHOP RELAT R, P158; Abouheif MM, 2011, KNEE SURG SPORT TR A, V19, P1868, DOI 10.1007/s00167-011-1489-x; Kotsovolos ES, 2006, ARTHROSCOPY, V22, P3, DOI 10.1016/j.arthro.2005.10.017; Shetty AA, 2003, J BONE JOINT SURG BR, V85B, P218, DOI 10.1302/0301-620X.85B2.13559; Miller MD, 2002, ARTHROSCOPY, V18, P939, DOI 10.1053/jars.2002.36146; Kim J, 2010, AM J SPORT MED, V38, P810, DOI 10.1177/0363546510363664; Haas AL, 2005, ARTHROSCOPY, V21, P167, DOI 10.1016/j.arthro.2004.10.012; Barrett GR, 1998, ARTHROSCOPY, V14, P824, DOI 10.1016/S0749-8063(98)70018-0; Bellabarba C, 1997, Am J Orthop (Belle Mead NJ), V26, P18; Cohen Steven B, 2007, J Knee Surg, V20, P235; Delee JC, 1985, ARTHROSCOPY, V1, P214, DOI 10.1016/S0749-8063(85)80086-4; Gill SS, 2002, ARTHROSCOPY, V18, P569, DOI 10.1053/jars.2002.29897; Kalliakmanis A, 2008, ARTHROSCOPY, V24, P810, DOI 10.1016/j.arthro.2008.03.003; Likes Rickland L, 2011, Orthop Surg, V3, P259, DOI 10.1111/j.1757-7861.2011.00151.x; ZAIDI SHA, 1995, J BONE JOINT SURG BR, V77B, P384	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					975	980		10.1007/s00167-013-2774-7		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700007		
J	Horie, M; Muneta, T; Yamazaki, J; Nakamura, T; Koga, H; Watanabe, T; Sekiya, I				Horie, Masafumi; Muneta, Takeshi; Yamazaki, Junya; Nakamura, Tomomasa; Koga, Hideyuki; Watanabe, Toshifumi; Sekiya, Ichiro			A modified quadrant method for describing the femoral tunnel aperture positions in ACL reconstruction using two-view plain radiographs	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Femoral tunnel position; Anterior cruciate ligament reconstruction; Quadrant method; 45-degree-flexion posterior-anterior standing view; Measurement reproducibility; Image analysis	ANTERIOR CRUCIATE LIGAMENT; ANATOMIC RECONSTRUCTION; POSTEROLATERAL BUNDLES; TRANSTIBIAL TECHNIQUE; COMPUTED-TOMOGRAPHY; GRAFT ORIENTATION; KNEE LAXITY; PLACEMENT; ATTACHMENT; FLEXION	A modified quadrant method was developed for description of femoral tunnel aperture positions on the sagittal plane after double-bundle anterior cruciate ligament (ACL) reconstruction, which can be measured by using two-view radiographs. The purpose of the study is to provide a new measurement method and to evaluate the reproducibility and accuracy of the method. Forty-one patients who had undergone a double-bundle ACL reconstruction were investigated. Two-view plain radiographs, a 45-degree-flexion posterior-anterior standing (Rosenberg) and a lateral view, were taken at 1 year postoperatively, and the femoral tunnel positions were measured. Intra- and inter-observer reproducibility was calculated by means of intra-class correlation coefficient (ICC). Also, the accuracy of the method was evaluated by comparing the measurement from three-dimensional computed tomography (3D-CT). Intra-observer reproducibility was excellent (ICC > 0.9). Inter-observer reproducibility of antero-medial (AM) tunnel position was almost perfect (ICC > 0.8) and that of postero-lateral (PL) tunnel was substantial (ICC > 0.7). The accuracy of the method was assessed by comparing the measurement from 3D-CT and was found to be almost perfect (ICC > 0.8). With the modified quadrant method, the average height of AM and PL tunnels were 17.8 and 44.4 %, respectively, and the depth of AM and PL tunnels were 25.5 and 36.7 %, respectively. A modified quadrant method was found to have acceptable reproducibility and accuracy. The method is useful for describing the femoral tunnel aperture positions in ACL reconstruction because of its easiness and simplicity. By using this method, it is possible to analyse the femoral tunnel position even in the cases without CT analysis.	[Horie, Masafumi; Muneta, Takeshi; Yamazaki, Junya; Nakamura, Tomomasa; Koga, Hideyuki; Watanabe, Toshifumi; Sekiya, Ichiro] Tokyo Med & Dent Univ Hosp, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138519, Japan	Muneta, T (reprint author), Tokyo Med & Dent Univ Hosp, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	muneta.orj@tmd.ac.jp					Basdekis G, 2009, KNEE SURG SPORT TR A, V17, P1089, DOI 10.1007/s00167-009-0829-6; Kawaguchi Y, 2011, KNEE SURG SPORT TR A, V19, P1249, DOI 10.1007/s00167-011-1455-7; Abebe ES, 2011, J BIOMECH, V44, P1914, DOI 10.1016/j.jbiomech.2011.04.030; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Hosseini A, 2012, INT ORTHOP, V36, P845, DOI 10.1007/s00264-011-1333-4; Kawakami Y, 2012, KNEE SURG SPORT TR A, V20, P1503, DOI 10.1007/s00167-011-1726-3; Zantop T, 2008, AM J SPORT MED, V36, P65, DOI 10.1177/0363546507308361; Yasuda K, 2004, ARTHROSCOPY, V20, P1015, DOI 10.1016/j.arthro.2004.08.010; Steckel H, 2010, KNEE SURG SPORT TR A, V18, P52, DOI 10.1007/s00167-009-0852-7; van Eck CF, 2010, ARTHROSCOPY, V26, pS2, DOI 10.1016/j.arthro.2010.03.005; Piasecki DP, 2011, AM J SPORT MED, V39, P1306, DOI 10.1177/0363546510397170; Zavras TD, 2005, KNEE SURG SPORT TR A, V13, P92, DOI 10.1007/s00167-004-0541-5; Iriuchishima T, 2010, KNEE SURG SPORT TR A, V18, P1226, DOI 10.1007/s00167-010-1128-y; ROSENBERG TD, 1988, J BONE JOINT SURG AM, V70A, P1479; Shino K, 2008, ARTHROSCOPY, V24, P1178, DOI 10.1016/j.arthro.2008.06.010; Inoue M, 2010, KNEE SURG SPORT TR A, V18, P1176, DOI 10.1007/s00167-009-0989-4; Strauss EJ, 2011, AM J SPORT MED, V39, P1263, DOI 10.1177/0363546510395488; Colombet P, 2006, ARTHROSCOPY, V22, P984, DOI 10.1016/j.arthro.2006.04.102; Markolf KL, 2002, J ORTHOPAED RES, V20, P1016, DOI 10.1016/S0736-0266(02)00035-9; Bernard M, 1997, AM J KNEE SURG, V10, P21; Bernard M, 1997, Am J Knee Surg, V10, P14; Giron F, 2006, KNEE SURG SPORT TR A, V14, P250, DOI 10.1007/s00167-005-0685-y; Hoser C, 2005, KNEE SURG SPORT TR A, V13, P256, DOI 10.1007/s00167-004-0548-y; Lorenz S, 2009, AM J SPORT MED, V37, P2368, DOI 10.1177/0363546509341577; MUNETA T, 1993, AM J SPORT MED, V21, P299, DOI 10.1177/036354659302100222; Muneta T, 1996, AM J SPORT MED, V24, P603, DOI 10.1177/036354659602400507; Xu Yan, 2011, Arthroscopy, V27, P923, DOI 10.1016/j.arthro.2011.02.020	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					981	985		10.1007/s00167-013-2781-8		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700008		
J	Fujino, K; Tajima, G; Yan, J; Kamei, Y; Maruyama, M; Takeda, S; Kikuchi, S; Shimamura, T				Fujino, Kotaro; Tajima, Goro; Yan, Jun; Kamei, Youichi; Maruyama, Moritaka; Takeda, Sanjuro; Kikuchi, Shuhei; Shimamura, Tadashi			Morphology of the femoral insertion site of the medial patellofemoral ligament	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Medial patellofemoral ligament; Insertion; Femur; Morphology; Apex of adductor tubercle	LATERAL PATELLAR TRANSLATION; SOFT-TISSUE RESTRAINTS; ANATOMICAL RECONSTRUCTION; RADIOGRAPHIC LANDMARKS; TUNNEL PLACEMENT; NATURAL-HISTORY; DISLOCATION; KNEE; ATTACHMENT; CHILDREN	The purpose of this study was to identify the femoral insertion of the medial patellofemoral ligament (MPFL) and related osseous landmarks. A total of 31 unpaired human cadaveric knees were studied. The MPFL was identified, and the site of its femoral insertion was marked. Three-dimensional images were created, and the location and morphology of the femoral insertion of the MPFL and related osseous structures were analyzed. The MPFL was identified in all knees. The femoral insertion of the MPFL was elliptical in shape, and the mean surface area was 56.5 +/- A 16.9 mm(2). The characteristic features of the femoral insertion of the MPFL could not be identified, but the adductor tubercle was clearly identified in all knees. The centre of the femoral insertion of the MPFL was 10.6 +/- A 2.5 mm distal to the apex of the adductor tubercle on the long axis of the femur, and the position of the insertion site was consistent in all knees. The adductor tubercle was clearly identified as an osseous landmark. The femoral insertion of the MPFL was approximately 10 mm distal to the adductor tubercle. These findings may improve understanding of the anatomy of the femoral insertion of the MPFL and may assist surgeons in performing anatomical reconstruction.	[Fujino, Kotaro; Tajima, Goro; Kamei, Youichi; Maruyama, Moritaka; Takeda, Sanjuro; Kikuchi, Shuhei; Shimamura, Tadashi] Iwate Med Univ, Dept Orthopaed Surg, Morioka, Iwate 0208505, Japan; [Yan, Jun] Iwate Med Univ, Dept Anat, Morioka, Iwate 0208505, Japan	Tajima, G (reprint author), Iwate Med Univ, Dept Orthopaed Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	nqi45560@nifty.com; gorot56jp@mac.com					LaPrade RE, 2007, J BONE JOINT SURG AM, V89A, P2000, DOI 10.2106/JBJS.F.01176; Kepler CK, 2011, AM J SPORT MED, V39, P1444, DOI 10.1177/0363546510397174; Barnett AJ, 2012, KNEE SURG SPORT TR A, V20, P2380, DOI 10.1007/s00167-011-1871-8; Fithian DC, 2004, AM J SPORT MED, V32, P1114, DOI 10.1177/0363546503260788; Desio SM, 1998, AM J SPORT MED, V26, P59; Philippot R, 2009, KNEE SURG SPORT TR A, V17, P475, DOI 10.1007/s00167-009-0722-3; HAWKINS RJ, 1986, AM J SPORT MED, V14, P117, DOI 10.1177/036354658601400204; Nomura E, 2005, KNEE SURG SPORT TR A, V13, P510, DOI 10.1007/s00167-004-0607-4; Aragao JA, 2008, CLINICS, V63, P541, DOI 10.1590/S1807-59322008000400021; Gelaude F, 2008, COMPUT AIDED SURG, V13, P188, DOI [10.3109/10929080802195783, 10.1080/10929080802195783]; Sanders TG, 2001, J COMPUT ASSIST TOMO, V25, P957, DOI 10.1097/00004728-200111000-00021; Baldwin JL, 2009, AM J SPORT MED, V37, P2355, DOI 10.1177/0363546509339909; Philippot R, 2012, KNEE SURG SPORT TR A, V20, P331, DOI 10.1007/s00167-011-1598-6; Schottle P, 2009, ARCH ORTHOP TRAUM SU, V129, P305, DOI 10.1007/s00402-008-0712-9; Higuchi T, 2010, KNEE SURG SPORT TR A, V18, P1470, DOI 10.1007/s00167-010-1043-2; Nakagawa K, 2002, J BONE JOINT SURG BR, V84B, P861, DOI 10.1302/0301-620X.84B6.12804; Schottle PB, 2007, AM J SPORT MED, V35, P801, DOI 10.1177/0363546506296415; Redfern J, 2010, AM J SPORT MED, V38, P293, DOI 10.1177/0363546509347602; Panagiotopoulos E, 2006, KNEE SURG SPORT TR A, V14, P7, DOI 10.1007/s00167-005-0631-z; Amis AA, 2003, KNEE, V10, P215, DOI 10.1016/S0968-0160(03)00006-1; Tuxoe JI, 2002, KNEE SURG SPORT TR A, V10, P138, DOI 10.1007/s00167-001-0261-z; Sallay PI, 1996, AM J SPORT MED, V24, P52, DOI 10.1177/036354659602400110; Victor J, 2009, AM J SPORT MED, V37, P2028, DOI 10.1177/0363546509337407; Nomura E, 2000, KNEE, V7, P121, DOI 10.1016/S0968-0160(00)00038-7; CONLAN T, 1993, J BONE JOINT SURG AM, V75A, P682; Dejour H, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P19, DOI 10.1007/BF01552649; Farr Jack, 2006, J Knee Surg, V19, P307; Feller J A, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P184, DOI 10.1007/BF01560202; Maenpaa H, 1997, AM J SPORT MED, V25, P213, DOI 10.1177/036354659702500213; Nelitz M, 2012, ARCH ORTHOP TRAUM SU, V132, P1647, DOI 10.1007/s00402-012-1593-5; Nelitz M, 2011, KNEE SURG SPORT TR A, V19, P2067, DOI 10.1007/s00167-011-1548-3; Steensen RN, 2004, AM J SPORT MED, V32, P1509, DOI 10.1177/0363546503261505; Tateishi T, 2011, KNEE SURG SPORT TR A, V19, P400, DOI 10.1007/s00167-010-1235-9; Yercan HS, 2011, ARCH ORTHOP TRAUM SU, V131, P1059, DOI 10.1007/s00402-011-1305-6; Yoo YS, 2012, AM J SPORT MED, V40, P2142, DOI 10.1177/0363546512453301	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					998	1003		10.1007/s00167-013-2797-0		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700011		
J	Ishida, T; Yamanaka, M; Takeda, N; Homan, K; Koshino, Y; Kobayashi, T; Matsumoto, H; Aoki, Y				Ishida, Tomoya; Yamanaka, Masanori; Takeda, Naoki; Homan, Kentaro; Koshino, Yuta; Kobayashi, Takumi; Matsumoto, Hisashi; Aoki, Yoshimitsu			The effect of changing toe direction on knee kinematics during drop vertical jump: a possible risk factor for anterior cruciate ligament injury	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Anterior cruciate ligament injury; Injury prevention; Knee biomechanics; Landing; Motion analysis	RANDOMIZED CONTROLLED-TRIAL; TEAM HANDBALL; MECHANISMS; BASKETBALL; ACL; PREVENTION; SYSTEM; SOCCER	The purpose of this study was to examine the effect of changing toe direction on knee kinetics and kinematics associated with anterior cruciate ligament injury during drop vertical jumps. Fourteen females performed drop vertical jumps under three toe conditions (natural, toe-in, and toe-out). The knee kinetics and kinematics during landing were evaluated using a motion analysis system. Results under three toe conditions were compared using a one-way repeated measures analysis of variance and a post hoc Bonferroni test. Toe-in landing was associated with a significantly greater knee abduction angle, tibial internal rotation angle, and knee abduction moment than the natural and toe-out conditions. Toe-out landing was associated with significantly greater tibial internal rotational angular velocity. Changing toe direction significantly affects knee kinetics and kinematics during landing. It is important to avoid changing toe direction excessively inward or outward during landing to prevent the increases in knee abduction and tibial internal rotation which might increase the risk of ACL injury.	[Ishida, Tomoya; Homan, Kentaro; Koshino, Yuta] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Ishida, Tomoya; Matsumoto, Hisashi] Hokushin Orthoped Hosp, Dept Rehabil, Sapporo, Hokkaido, Japan; [Yamanaka, Masanori; Takeda, Naoki] Hokkaido Univ, Div Hlth Sci, Dept Rehabil Sci, Fac Hlth Sci,Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yamanaka, Masanori; Takeda, Naoki; Kobayashi, Takumi] Hokkaido Univ, Prevent Joint Dis, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Koshino, Yuta] NTT East Japan Sapporo Hosp, Rehabil Ctr, Sapporo, Hokkaido, Japan; [Aoki, Yoshimitsu] Hokushin Orthoped Hosp, Dept Orthoped Surg, Sapporo, Hokkaido, Japan	Yamanaka, M (reprint author), Hokkaido Univ, Div Hlth Sci, Dept Rehabil Sci, Fac Hlth Sci,Kita Ku, West 5,North 12, Sapporo, Hokkaido 0600812, Japan.	yamanaka@hs.hokudai.ac.jp					Hewett TE, 1999, AM J SPORT MED, V27, P699; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Nagano Y, 2007, KNEE, V14, P218, DOI 10.1016/j.knee.2006.11.008; Pioletti DP, 1999, MED ENG PHYS, V21, P95, DOI 10.1016/S1350-4533(99)00028-4; Viskontas DG, 2008, AM J SPORT MED, V36, P927, DOI 10.1177/0363546508314791; Ford KR, 2010, MED SCI SPORT EXER, V42, P1923, DOI 10.1249/MSS.0b013e3181dc99b1; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Shin CS, 2011, MED SCI SPORT EXER, V43, P1484, DOI 10.1249/MSS.0b013e31820f8395; Boden BP, 2000, ORTHOPEDICS, V23, P573; Myer GD, 2004, J ATHL TRAINING, V39, P352; Padua DA, 2009, AM J SPORT MED, V37, P1996, DOI 10.1177/0363546509343200; Shimokochi Y, 2008, J ATHL TRAINING, V43, P396, DOI 10.4085/1062-6050-43.4.396; Ishida T, 2014, KNEE, V21, P563, DOI 10.1016/j.knee.2012.12.002; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Fleiss J. L, 1986, DESIGN ANAL CLIN EXP; Griffin LY, 2006, AM J SPORT MED, V34, P1512, DOI 10.1177/0363546506286866; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Myklebust Grethe, 2007, Instr Course Lect, V56, P407; Walden M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3042	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					1004	1009		10.1007/s00167-013-2815-2		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700012		
J	Oohashi, Y				Oohashi, Yoshikazu			Developmental anomaly of ossification type patella partita	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Patella partita; Bipartite patella; Developmental anomaly of ossification type; Current concepts; Review	PAINFUL BIPARTITE PATELLA; BONE-SCINTIGRAPHY; SURGICAL EXCISION; SEPARATION; FRACTURE; RELEASE; TOPHUS; GOUT	Bipartite patella has been recognized as an incidental radiographic finding. However, symptomatic bipartite patella is occasionally diagnosed in adolescents and young athletes. The incidence of bipartite patella has been reported at 0.2-1.7, and 1-2 % of these cases are symptomatic. The purpose of this review article was to discuss current concepts relevant to developmental anomaly of ossification type patella partita. A PubMed database search using the key words "bipartite patella" was performed. Clinical papers reporting the bipartite patella were included. Four German-language studies were also included, three for incidence of bipartite patella and one for classification. A new classification of developmental anomaly of ossification type patella partita based on location and number of fragment was recently proposed. It is simple and useful and applicable to all types of bipartite or tripartite patella. Several imaging studies have reportedly been used to evaluate symptomatic bipartite patella. MRI is currently the most appropriate method used to assess patients with bipartite patella. Although surgical procedures have been developed that reduce excessive traction force by the vastus lateralis muscle on the bipartite fragment, there is not sufficient evidence to support their use for routine treatment of painful bipartite patella. In most symptomatic cases, movement at the interface between the bipartite fragment and the body of the patella presumably causes the pain. Therefore, the existence of apparent motion at the interface should be confirmed by specific imaging studies before surgery. Magnetic resonance imaging findings may provide such evidence by demonstrating a fluid bright signal across the segmentation, typical of pseudoarthrosis.	Oohashi Orthopaed Clin, Fukui, Fukui 9100015, Japan	Oohashi, Y (reprint author), Oohashi Orthopaed Clin, 38-20 Ninomiya 3 Choume, Fukui, Fukui 9100015, Japan.	oohashiy@lilac.ocn.ne.jp					Adachi N, 2002, ARTHROSCOPY, V18, P404, DOI 10.1053/jars.2002.30645; O'Brien J, 2011, EUR J RADIOL, V78, P425, DOI 10.1016/j.ejrad.2009.11.001; Kavanagh EC, 2007, SKELETAL RADIOL, V36, P209, DOI 10.1007/s00256-006-0232-z; Oohashi Y, 2010, KNEE SURG SPORT TR A, V18, P1465, DOI 10.1007/s00167-010-1047-y; Reber P, 1996, ARCH ORTHOP TRAUM SU, V115, P297, DOI 10.1007/BF00439058; OGATA K, 1994, J BONE JOINT SURG AM, V76A, P573; ISHIKAWA H, 1994, CLIN ORTHOP RELAT R, P223; Blumensaat C, 1932, ARCH ORTHOP CHIR, V32, P263; BOURNE MH, 1990, J PEDIATR ORTHOPED, V10, P69; Canizares GH, 2003, ARTHROSCOPY, V19, P215, DOI 10.1053/jars.2003.50055; Carney Joseph, 2010, Am J Orthop (Belle Mead NJ), V39, P40; CARTER SR, 1989, INJURY, V20, P244, DOI 10.1016/0020-1383(89)90128-9; COLLINGS CL, 1994, CLIN NUCL MED, V19, P865, DOI 10.1097/00003072-199410000-00004; Enomoto H, 2006, KNEE, V13, P474, DOI 10.1016/j.knee.2006.09.001; Felli L, 2011, KNEE SURG SPORT TR A, V19, P398, DOI 10.1007/s00167-010-1229-7; George R, 1935, BRIT J SURG, V22, P555, DOI 10.1002/bjs.1800228717; Gorva AD, 2006, EUR J TRAUMA, V4, P411; GREEN WT, 1975, CLIN ORTHOP RELAT R, P197; HALPERN AA, 1978, CLIN ORTHOP RELAT R, P180; IOSSIFIDIS A, 1995, INJURY, V26, P175, DOI 10.1016/0020-1383(95)93496-5; IOSSIFIDIS A, 1995, EUR J NUCL MED, V22, P1212; IRELAND ML, 1995, MED SCI SPORT EXER, V27, P299; Kobayashi K, 2005, J Orthop Surg (Hong Kong), V13, P199; MORI Y, 1995, AM J SPORT MED, V23, P13, DOI 10.1177/036354659502300103; OGDEN JA, 1982, J PEDIATR ORTHOPED, V2, P263; OGDEN JA, 1984, SKELETAL RADIOL, V11, P246; Oohashi Y, 2006, KNEE, V13, P189, DOI 10.1016/j.knee.2006.01.008; Oohashi Y, 2010, J ORTHOP, V7, pe5; Oohashi Y, 2007, KNEE SURG SPORT TR A, V15, P1395, DOI 10.1007/s00167-007-0311-2; Paas H. R., 1931, DTSCH Z CHIR, V230, P261; Puddu G, 1978, Ital J Orthop Traumatol, V4, P197; ROSENTHAL RK, 1977, J BONE JOINT SURG AM, V59, P934; Saupe E., 1921, ROFO FORTSCHR RONTG, V28, P37; Siemens W., 1931, DTSCH Z CHIR, V233, P727; Sinding-Larsen MF, 1921, ACTA RADIOL, V1, P171; Tashiro S, 2002, ORTHOPEDICS, V25, P1295; Thomas AL, 2007, ORTHOPEDICS, V30, P491; Tonotsuka H, 2008, KNEE, V15, P64, DOI 10.1016/j.knee.2007.09.005; Weaver J K, 1977, Am J Sports Med, V5, P137, DOI 10.1177/036354657700500401; Weckstrom M, 2008, CLIN ORTHOP RELAT R, V466, P2848, DOI 10.1007/s11999-008-0367-4; Woods G William, 2007, J Knee Surg, V20, P293	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					1071	1076		10.1007/s00167-014-2887-7		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700022		
J	Fujii, M; Furumatsu, T; Miyazawa, S; Okada, Y; Tanaka, T; Ozaki, T; Abe, N				Fujii, Masataka; Furumatsu, Takayuki; Miyazawa, Shinichi; Okada, Yukimasa; Tanaka, Takaaki; Ozaki, Toshifumi; Abe, Nobuhiro			Intercondylar notch size influences cyclops formation after anterior cruciate ligament reconstruction	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Cyclops lesion; Cyclops syndrome; Anterior cruciate ligament reconstruction; Intercondylar notch; Cross-sectional area; Bone tunnel	CROSS-SECTIONAL AREA; DOUBLE-BUNDLE; SINGLE-BUNDLE; ANTHROPOMETRIC MEASUREMENTS; INJURIES; KNEE; DIMENSIONS; STENOSIS; LESION; WIDTH	The purpose of this study was to investigate the incidence of cyclops lesions and its relationship with the cross-sectional area of the intercondylar notch. For this study, 55 patients (24 male and 31 female) underwent follow-up arthroscopy after bi-socket anterior cruciate ligament reconstruction with hamstring tendon grafts were included. All patients underwent magnetic resonance imaging measurements of intercondylar notch dimensions. We compared the femoral intercondylar notch sizes and bone tunnel sizes between knees with cyclops lesions (cyclops group) and those without cyclops lesions (no-cyclops group). The mean percentage of the tunnel size to the cross-sectional area of the femoral intercondylar notch was also compared between the groups. The median follow-up duration was 3.8 years. Cyclops lesions were found in 15 of the 55 knees (27.3 %) on second-look arthroscopy (cyclops group). Only 6 of the 55 knees (10.9 %) had extension loss (cyclops syndrome). The cyclops group included 3 men and 12 women. The two groups showed a statistical difference in sex variation (P = 0.04). No significant differences were found in the femoral and tibial tunnel sizes between the two groups. The cross-sectional area of the femoral intercondylar notch was significantly smaller in the cyclops group (251.7 +/- A 63.2 mm(2)) than in the no-cyclops group (335.6 +/- A 77.6 mm(2)) (P < 0.001). The percentage of the total femoral tunnel size to the cross-sectional area of the femoral intercondylar notch was significantly higher in the cyclops group (18.6 +/- A 5.3 %) than in the no-cyclops group (13.2 +/- A 3.6 %) (P = 0.02). A smaller intercondylar notch size may be a potential risk factor for cyclops lesion formation.	[Fujii, Masataka; Furumatsu, Takayuki; Miyazawa, Shinichi; Okada, Yukimasa; Tanaka, Takaaki; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg Sci Funct Recovery & Reconstr, Kita Ku, Okayama 7008558, Japan; [Abe, Nobuhiro] Kawasaki Med Univ, Dept Orthopaed Surg & Sport Med, Kita Ku, Okayama 7008505, Japan	Furumatsu, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg Sci Funct Recovery & Reconstr, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	matino@md.okayama-u.ac.jp	FURUMATSU, Takayuki/B-2233-2011		Japan Society for the Promotion of Science [24791546]	We thank Ms. Aki Yoshida, Ms. Reina Tanaka, and Ms. Emi Matsumoto for their technical cooperation. This work was supported by the grant from Japan Society for the Promotion of Science (No. 24791546, T.F.).	Ahn Jin Hwan, 2007, Knee Surg Sports Traumatol Arthrosc, V15, P242, DOI 10.1007/s00167-006-0177-8; van Eck CF, 2010, KNEE SURG SPORT TR A, V18, P1239, DOI [10.1007/s00167-010-1131-3, 10.1007/s00167-010-1135-z]; Hamada M, 2005, ARTHROSCOPY, V21, P917, DOI 10.1016/j.arthro.2005.05.006; Hamada M, 2001, ARTHROSCOPY, V17, P801, DOI 10.1053/jars.2001.25251; SOURYAL TO, 1988, AM J SPORT MED, V16, P449, DOI 10.1177/036354658801600504; Taketomi S, 2011, KNEE SURG SPORT TR A, V19, P424, DOI 10.1007/s00167-010-1246-6; SOURYAL TO, 1993, AM J SPORT MED, V21, P535, DOI 10.1177/036354659302100410; Anderson AF, 2001, AM J SPORT MED, V29, P58; Uhorchak JM, 2003, AM J SPORT MED, V31, P831; Shelbourne KD, 1998, AM J SPORT MED, V26, P402; Kondo E, 2008, AM J SPORT MED, V36, P1675, DOI 10.1177/0363546508317123; Muneta T, 1997, AM J SPORT MED, V25, P69, DOI 10.1177/036354659702500113; Domzalski M, 2010, INT ORTHOP, V34, P703, DOI 10.1007/s00264-010-0987-7; Dienst M, 2007, ARCH ORTHOP TRAUM SU, V127, P253, DOI 10.1007/s00402-006-0177-7; Kawakami Y, 2012, KNEE SURG SPORT TR A, V20, P1503, DOI 10.1007/s00167-011-1726-3; Tsukada H, 2008, J ORTHOP SCI, V13, P122, DOI 10.1007/s00776-007-1203-5; Siebold R, 2008, ARTHROSCOPY, V24, P137, DOI 10.1016/j.arthro.2007.11.013; Zeng C, 2013, KNEE SURG SPORT TR A, V21, P804, DOI 10.1007/s00167-012-2166-4; Simon RA, 2010, J BIOMECH, V43, P1702, DOI 10.1016/j.jbiomech.2010.02.033; Araki D, 2011, INT ORTHOP, V35, P439, DOI 10.1007/s00264-010-1110-9; Baker SJ, 1995, SKELETON ATTRIBUTION, P91; Bernard M, 1997, Am J Knee Surg, V10, P14; Bradley DM, 2000, AM J ROENTGENOL, V174, P719; Cha J, 2012, SKELETAL RADIOL, V41, P997, DOI 10.1007/s00256-011-1347-4; Charlton WPH, 2002, AM J SPORT MED, V30, P329; Dandy D J, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P76, DOI 10.1007/BF01476476; Delcogliano A, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P194, DOI 10.1007/BF01567962; Delince P, 1998, ARTHROSCOPY, V14, P869, DOI 10.1016/S0749-8063(98)70025-8; Fung DT, 2007, CLIN ORTHOP RELAT R, P210, DOI 10.1097/BLO.0b013e31804d2339; Gohil S, 2014, KNEE SURG SPORT TR A, V22, P1090, DOI 10.1007/s00167-013-2480-5; JACKSON D W, 1990, Arthroscopy, V6, P171, DOI 10.1016/0749-8063(90)90072-L; Kropf EJ, 2013, KNEE SURG SPORT TR A, V21, P720, DOI 10.1007/s00167-012-2052-0; LAPRADE RF, 1994, AM J SPORT MED, V22, P198, DOI 10.1177/036354659402200208; MARZO J M, 1992, Arthroscopy, V8, P10, DOI 10.1016/0749-8063(92)90129-Y; Muellner T, 1999, KNEE SURG SPORT TR A, V7, P284, DOI 10.1007/s001670050165; Rosenberg TD, 1994, TECHNIQUES ACL RECON; Sonnery-Cottet B, 2010, ARTHROSCOPY, V26, P1483, DOI 10.1016/j.arthro.2010.02.034; Tonin M, 2001, AM J SPORT MED, V29, P545; Vaidya SV, 2000, J ARTHROPLASTY, V15, P79, DOI 10.1016/S0883-5403(00)91285-3; van Dijck RAHE, 2008, ARTHROSCOPY, V24, P88, DOI 10.1016/j.arthro.2007.08.012; Wang J, 2009, ARTHROSCOPY, V25, P626, DOI 10.1016/j.arthro.2008.12.006	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					1092	1099		10.1007/s00167-014-2891-y		8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700025		
J	Iriuchishima, T; Ryu, K; Aizawa, S; Fu, FH				Iriuchishima, Takanori; Ryu, Keinosuke; Aizawa, Shin; Fu, Freddie H.			Size correlation between the tibial anterior cruciate ligament footprint and the tibia plateau	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Anterior cruciate ligament; Anatomy; Double bundle; Tibia plateau	ANATOMIC DOUBLE-BUNDLE; INTERCONDYLAR NOTCH WIDTH; BONE TUNNEL PLACEMENT; PATELLAR TENDON-BONE; POSTEROLATERAL BUNDLES; SINGLE-BUNDLE; RECONSTRUCTION; INSERTIONS; GRAFT; ACL	The purpose of this study was to reveal the correlation between the size of the native anterior cruciate ligament (ACL) footprint and the size of the tibia plateau. Twenty-four non-paired human cadaver knees were used. All soft tissues around the knee were resected except the ACL. The ACL was cut in the middle, and the femoral bone was cut at the most proximal point of the femoral notch. The ACL was carefully dissected, and the periphery of the ACL insertion site was outlined on both the femoral and tibial sides. An accurate lateral view of the femoral condyle and the tibial plateau was photographed with a digital camera, and the images were downloaded to a personal computer. The size of the femoral and tibial ACL footprints, and anterior-posterior (AP) and medial-lateral (ML), lengths of the tibia plateau and area of tibia plateau were measured with Image J software (National Institution of Health). The sizes of the native femoral and tibial ACL footprints were 72.3 +/- A 24.4 and 134.1 +/- A 32.4 mm(2), respectively. The AP lengths of the whole, medial and lateral facet of the tibia plateau were as follows: 44.5 +/- A 4.1, 40.8 +/- A 4.1 and 36.8 +/- A 4 mm, respectively. The ML length of the tibia plateau was 68.3 +/- A 5.5 mm. Total area of tibia plateau was 2,282.9 +/- A 378.7 mm(2). The AP length of the lateral facet of the tibia plateau (Pearson's correlation coefficient = 0.508, p = 0.011) and the total area of tibia plateau (Pearson's correlation coefficient = 0.442, p = 0.031) were significantly correlated with the size of the tibial ACL footprint. For clinical relevance, the AP length of lateral facet of the tibia plateau and total area of tibia plateau are significantly correlated with the size of the tibial ACL footprint. It might be possible to predict the size of the ACL measuring these parameters.	[Iriuchishima, Takanori] Kamimoku Hot Springs Hosp, Dept Orthopaed Surg, Minakami, Gunma, Japan; [Ryu, Keinosuke] Surugadai Nihon Univ Hosp, Dept Orthopaed Surg, Tokyo, Japan; [Aizawa, Shin] Nihon Univ, Sch Med, Dept Funct Morphol, Tokyo, Japan; [Fu, Freddie H.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA	Iriuchishima, T (reprint author), Kamimoku Hot Springs Hosp, Dept Orthopaed Surg, 198-2 Ishikura, Minakami, Gunma, Japan.	sekaiwoseisu@yahoo.co.jp					Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Harner CD, 1999, ARTHROSCOPY, V15, P741, DOI 10.1016/S0749-8063(99)70006-X; Siebold R, 2008, ARTHROSCOPY, V24, P154, DOI 10.1016/j.arthro.2007.08.006; Shin SH, 2010, J HAND SURG-AM, V35A, P1120, DOI 10.1016/j.jhsa.2010.04.002; van Eck CF, 2011, ARTHROSCOPY, V27, P1235, DOI 10.1016/j.arthro.2011.03.085; van Eck CF, 2010, KNEE SURG SPORT TR A, V18, P1257, DOI [10.1007/s00167-010-1135-z, 10.1007/s00167-009-1038-z]; Davis TJ, 1999, KNEE SURG SPORT TR A, V7, P209, DOI 10.1007/s001670050150; Siebold R, 2008, ARTHROSCOPY, V24, P585, DOI 10.1016/j.arthro.2007.12.008; Fu FH, 2011, ORTHOPEDICS, V34, P281, DOI 10.3928/01477447-20110228-15; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Okada E, 2011, EUR SPINE J, V20, P1567, DOI 10.1007/s00586-011-1774-x; Iriuchishima T, 2009, KNEE SURG SPORT TR A, V17, P590, DOI 10.1007/s00167-008-0691-y; Darcy SP, 2006, J BIOMECH, V39, P2371, DOI 10.1016/j.jbiomech.2005.08.009; Kondo E, 2008, AM J SPORT MED, V36, P1675, DOI 10.1177/0363546508317123; Muneta T, 1997, AM J SPORT MED, V25, P69, DOI 10.1177/036354659702500113; Yagi M, 2002, AM J SPORT MED, V30, P660; Kopf S, 2009, KNEE SURG SPORT TR A, V17, P213, DOI 10.1007/s00167-008-0709-5; Kopf S, 2011, AM J SPORT MED, V39, P108, DOI 10.1177/0363546510377399; Steiner ME, 2008, AM J SPORT MED, V36, P176, DOI 10.1177/0363546507311690; Zantop T, 2008, AM J SPORT MED, V36, P65, DOI 10.1177/0363546507308361; Niki Y, 2011, ARTHROSCOPY, V27, P1242, DOI 10.1016/j.arthro.2011.03.086; Dargel J, 2006, SURG RADIOL ANAT, V28, P398, DOI 10.1007/s00276-006-0107-y; Luites JWH, 2007, KNEE SURG SPORT TR A, V15, P1422, DOI 10.1007/s00167-007-0402-0; Yasuda K, 2006, ARTHROSCOPY, V22, P240, DOI 10.1016/j.arthro.2005.12.017; Takahashi M, 2006, AM J SPORT MED, V34, P787, DOI 10.1177/0363546505282625; Iriuchishima T, 2011, ARCH ORTHOP TRAUM SU, V131, P1085, DOI 10.1007/s00402-011-1308-3; Stijak L, 2009, KNEE SURG SPORT TR A, V17, P812, DOI 10.1007/s00167-009-0807-z; Brophy RH, 2006, ARTHROSCOPY, V22, DOI 10.1016/j.arthro.2005.08.051; Loh JC, 2003, ARTHROSCOPY, V19, P297, DOI 10.1053/jars.2003.50084; Wolters F, 2011, KNEE SURG SPORT TR A, V19, pS17, DOI 10.1007/s00167-011-1503-3; Iriuchishima T, 2010, KNEE SURG SPORT TR A, V18, P1226, DOI 10.1007/s00167-010-1128-y; Shino K, 2008, ARTHROSCOPY, V24, P1178, DOI 10.1016/j.arthro.2008.06.010; Maeyama A, 2011, KNEE SURG SPORT TR A, V19, P1233, DOI 10.1007/s00167-010-1382-z; Karlsson J, 2011, AM J SPORT MED, V39, P2016, DOI 10.1177/0363546511402660; Iriuchishima T, 2011, KNEE SURG SPORT TR A, V19, P674, DOI 10.1007/s00167-010-1331-x; Iriuchishima T, 2010, AM J SPORT MED, V38, P1611, DOI 10.1177/0363546510363461; Tompkins Marc, 2011, J Bone Joint Surg Am, V93, P789, DOI 10.2106/JBJS.J.01723; Wu Eileen, 2011, J Knee Surg, V24, P39; Yasuda K, 2011, DIGEST ENDOSC, V23, P1, DOI 10.1111/j.1443-1661.2011.01157.x	39	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					1147	1152		10.1007/s00167-014-2927-3		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700033		
J	Amano, H; Iwahashi, T; Suzuki, T; Mae, T; Nakamura, N; Sugamoto, K; Shino, K; Yoshikawa, H; Nakata, K				Amano, Hiroshi; Iwahashi, Takehiko; Suzuki, Tomoyuki; Mae, Tatsuo; Nakamura, Norimasa; Sugamoto, Kazuomi; Shino, Konsei; Yoshikawa, Hideki; Nakata, Ken			Analysis of displacement and deformation of the medial meniscus with a horizontal tear using a three-dimensional computer model	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Horizontally torn medial meniscus; MRI; 3-D computer model; Movement and deformation	KNEE FLEXION; CONTACT; JOINT; MRI	The displacement and deformation of the knee meniscus significantly affect its roles; however, little is known about the displacement and deformation patterns of a torn medial meniscus. The objective of this study was to evaluate quantitatively the patterns of displacement and deformation in horizontally torn medial menisci during knee flexion. Twenty patients with horizontally torn medial menisci underwent three-dimensional (3-D) magnetic resonance imaging at varying degrees of knee flexion, and 3-D computer models of the tibia, tibial articular cartilage, and meniscus were generated. Based on these, the size of the horizontal tear (% tear) was evaluated and defined as the circumferential ratio between the length of the horizontal tear and that of the entire meniscus. The 3-D meniscus models were automatically superimposed over images taken at 0, 20, 40, and 60A degrees of knee flexion by the voxel-based registration method. Meniscal motion and deformation during knee flexion were visualized and quantitatively calculated on the mid-sagittal plane. Correlations between the size of horizontal tear, displacement/deformation of torn menisci, and clinical symptoms were evaluated after conservative treatment for 3 months. The % tear was 35.7 +/- A 12.5 % (range 13.7-55.5 %). During knee flexion, all torn menisci moved posteriorly, with gradual widening of horizontal and vertical gaps (p < 0.05). A direct correlation was observed between % tear and change in the vertical tear gap during knee flexion (p < 0.05). There was an inverse correlation between Lysholm score and % tear (p < 0.05). Medial meniscal horizontal tears widen and deform during knee flexion, and % tear correlates with the change in the vertical gap. Patients with a lower % tear are more capable of performing activities of daily living after conservative treatment. This method may help clarify the cause of pain in patients with medial meniscus tears as well as facilitate the selection of an appropriate treatment plan.	[Amano, Hiroshi] Osaka Rosai Hosp, Dept Sports Orthoped, Kita Ku, Sakai, Osaka 5918025, Japan; [Amano, Hiroshi; Iwahashi, Takehiko; Mae, Tatsuo; Yoshikawa, Hideki] Osaka Univ, Dept Orthoped, Grad Sch Med, Suita, Osaka 5650871, Japan; [Suzuki, Tomoyuki] Sapporo Med Univ, Dept Orthoped Surg, Chu Ou Ku, Sapporo, Hokkaido 0608543, Japan; [Nakamura, Norimasa] Osaka Hlth Sci Univ, Fac Rehabil Sci, Kita Ku, Osaka 5300043, Japan; [Sugamoto, Kazuomi] Osaka Univ, Locomotor Biomat Ltd Joint Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Shino, Konsei] Osaka Yukioka Coll Hlth Sci, Osaka 5670801, Japan; [Nakata, Ken] Osaka Univ, Grad Sch Med, Dept Hlth & Sport Sci, Toyonaka, Osaka 5600043, Japan	Amano, H (reprint author), Osaka Rosai Hosp, Dept Sports Orthoped, Kita Ku, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.	h-amano@umin.ac.jp					Goto A, 2005, J ORTHOP RES, V23, P750, DOI 10.1016/j.orthres.2004.10.001; [Anonymous], 1992, ACM COMPUT SURV, DOI DOI 10.1145/146370.146374; Shefelbine SJ, 2006, J ORTHOP RES, V24, P1208, DOI 10.1002/jor.20139; MARKOLF KL, 1976, J BONE JOINT SURG AM, V58, P583; Yao J, 2008, J ORTHOP RES, V26, P673, DOI 10.1002/jor.20553; Duc SR, 2007, RADIOLOGY, V245, P216, DOI 10.1148/radiol.2451060990; STOLLER DW, 1987, RADIOLOGY, V163, P731; HSIEH HH, 1976, J BONE JOINT SURG AM, V58, P87; Vasanawala SS, 2005, AM J ROENTGENOL, V184, P1450; BESSETTE GC, 1992, ORTHOPEDICS, V15, P35; Bao HRC, 2013, J ORTHOP SCI, V18, P256, DOI 10.1007/s00776-012-0334-5; Boxheimer L, 2004, INVEST RADIOL, V39, P254, DOI 10.1097/01.rli.0000116895.04239.84; Boxheimer L, 2006, RADIOLOGY, V238, P221; Hauger O, 2000, RADIOLOGY, V217, P193; Jang KM, 2012, ORTHOPEDICS, V35, P430; Kawahara Y, 1999, ACTA RADIOL, V40, P610; Kim YM, 2013, KNEE SURG SPORT TR A, V21, P1546, DOI 10.1007/s00167-012-2131-2; Lorensen W. E., 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422; MCBRIDE ID, 1988, CAN J SPORT SCI, V13, P175; Moritomo H, 2003, J HAND SURG-AM, V28A, P797, DOI 10.1053/S0363-5023(03)00259-4; Scholes C, 2015, KNEE SURG SPORT TR A, V23, P32, DOI 10.1007/s00167-013-2482-3; Seedhom B. B., 1979, Engineering in Medicine, V8; Yamada Y, 2007, J BONE JOINT SURG BR, V89B, P746, DOI 10.1302/0301-620X.89B6.18514	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					1153	1160		10.1007/s00167-014-2931-7		8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700034		
J	Amano, H; Toritsuka, Y; Uchida, R; Mae, T; Ohzono, K; Shino, K				Amano, Hiroshi; Toritsuka, Yukiyoshi; Uchida, Ryohei; Mae, Tatsuo; Ohzono, Kenji; Shino, Konsei			Outcome of anatomical double-bundle ACL reconstruction using hamstring tendons via an outside-in approach	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						The anatomical double-bundle ACL reconstruction; Clinical results; Outside-in approach; Short-term results	ANTERIOR CRUCIATE LIGAMENT; 2-YEAR FOLLOW-UP; SINGLE-BUNDLE; GRAFT FIXATION; BIOMECHANICAL ANALYSIS; FEMORAL ATTACHMENT; INITIAL TENSION; SOCKET; KNEE; PLACEMENT	To evaluate the clinical outcome of anatomical double-bundle anterior cruciate ligament (ACL) reconstruction using multistranded hamstring tendons via an outside-in approach. One hundred and twenty-one patients (mean age 28 +/- A 10 years) who underwent ACL reconstruction were examined. Using an outside-in femoral drill guide, an upper femoral tunnel for the anteromedial (AM) graft was created just below the superior articular cartilage margin of the medial wall of the lateral condyle through a small incision. A lower femoral tunnel for the posterolateral (PL) graft was drilled in the centre of the inferior-posterior half of the attachment area behind the resident's ridge in the same manner. Two tibial tunnels were created at the centre of the AM and PL bundle footprints of a normal ACL. Patients were evaluated at 24 months postoperatively. According to the IKDC form, 52 knees (43 %) were graded as normal, 64 (53 %) as nearly normal, 1 (1 %) as abnormal and 4 (3 %) as graft rupture due to re-injury. Loss of knee extension of < 5A degrees was observed in one patient (1 %). Among 111 patients who were directly evaluated, none showed loss of flexion of < 5A degrees. Lachman sign was negative in 103 patients (93 %), while the pivot shift test result was negative or equivalent to that of the contralateral healthy knee in 103 patients (93 %). The mean side-to-side difference in anterior laxity at manual maximum force with the KT-2000 arthrometer(A (R)) was 0.9 +/- A 1.1 mm, and 94 % of patients showed a range between -1 and +2 mm. The anatomical double-bundle outside-in ACL reconstruction provided a satisfactory short-term outcome. Case series, Level IV.	[Amano, Hiroshi] Osaka Rosai Hosp, Dept Orthopaed, Kita Ku, Sakai, Osaka 5918025, Japan; [Toritsuka, Yukiyoshi; Uchida, Ryohei; Ohzono, Kenji] Kansai Rosai Hosp, Dept Orthopaed Sports Med, Amagasaki, Hyogo 6600064, Japan; [Mae, Tatsuo] Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan; [Shino, Konsei] Osaka Yukioka Coll Hlth Sci, Osaka 5670801, Japan	Toritsuka, Y (reprint author), Kansai Rosai Hosp, Dept Orthopaed Sports Med, 3-1-69 Inabaso, Amagasaki, Hyogo 6600064, Japan.	toritsuka@kanrou.net					Aglietti P, 2007, CLIN ORTHOP RELAT R, P108, DOI 10.1097/BLO.0b013e31802baaf4; Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Mae T, 2010, ARTHROSCOPY, V26, P1289, DOI 10.1016/j.arthro.2010.02.017; Park SJ, 2010, ARTHROSCOPY, V26, P630, DOI 10.1016/j.arthro.2009.09.006; Hamada M, 2001, ARTHROSCOPY, V17, P801, DOI 10.1053/jars.2001.25251; Buoncristiani AM, 2006, ARTHROSCOPY, V22, P1000, DOI 10.1016/j.arthro.2006.06.005; Kawaguchi Y, 2011, KNEE SURG SPORT TR A, V19, P1249, DOI 10.1007/s00167-011-1455-7; Aglietti P, 2010, AM J SPORT MED, V38, P25, DOI 10.1177/0363546509347096; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Kondo E, 2008, AM J SPORT MED, V36, P1675, DOI 10.1177/0363546508317123; Yagi M, 2002, AM J SPORT MED, V30, P660; Niki Y, 2011, ARTHROSCOPY, V27, P1242, DOI 10.1016/j.arthro.2011.03.086; Mae T, 2008, AM J SPORT MED, V36, P1087, DOI 10.1177/0363546508314433; Yasuda K, 2004, ARTHROSCOPY, V20, P1015, DOI 10.1016/j.arthro.2004.08.010; Shelbourne KD, 2009, AM J SPORT MED, V37, P246, DOI 10.1177/0363546508325665; Hussein M, 2012, AM J SPORT MED, V40, P1781, DOI 10.1177/0363546512446928; Streich NA, 2008, KNEE SURG SPORT TR A, V16, P232, DOI 10.1007/s00167-007-0480-z; Salmon L, 2005, ARTHROSCOPY, V21, P948, DOI 10.1016/j.arthro.2005.04.110; Yasuda K, 2006, ARTHROSCOPY, V22, P240, DOI 10.1016/j.arthro.2005.12.017; Iwahashi T, 2008, KNEE SURG SPORT TR A, V16, P167, DOI 10.1007/s00167-007-0456-z; Zaffagnini S, 2012, KNEE SURG SPORT TR A, V20, P153, DOI 10.1007/s00167-011-1589-7; Shino K, 2010, KNEE SURG SPORT TR A, V18, P1164, DOI 10.1007/s00167-009-0979-6; Loh JC, 2003, ARTHROSCOPY, V19, P297, DOI 10.1053/jars.2003.50084; Fujie H, 2011, KNEE SURG SPORT TR A, V19, pS47, DOI 10.1007/s00167-011-1513-1; Yagi M, 2007, CLIN ORTHOP RELAT R, P100, DOI 10.1097/BLO.0b013e31802ba45c; AMIS AA, 1991, J BONE JOINT SURG BR, V73, P260; Gabriel MT, 2004, J ORTHOPAED RES, V22, P85, DOI 10.1016/S0736-0266(03)00133-5; ROSENBERG TD, 1988, J BONE JOINT SURG AM, V70A, P1479; Suomalainen P, 2011, AM J SPORT MED, V39, P1615, DOI 10.1177/0363546511405024; Mae T, 2007, KNEE SURG SPORT TR A, V15, P328, DOI 10.1007/s00167-006-0172-0; Mae T, 2001, ARTHROSCOPY, V17, P708, DOI 10.1053/jars.2001.25250; Bellier G, 2004, ARTHROSCOPY, V20, P890, DOI 10.1016/j.arthro.2004.06.019; Giron F, 2006, KNEE SURG SPORT TR A, V14, P250, DOI 10.1007/s00167-005-0685-y; Iwahashi T, 2010, ARTHROSCOPY, V26, pS13, DOI 10.1016/j.arthro.2010.01.023; Jarvela T, 2008, AM J SPORT MED, V36, P290, DOI 10.1177/0363546507308360; Kim SJ, 2006, ARTHROSCOPY, V22; Mae T, 2008, AM J SPORT MED, V36, P1094, DOI 10.1177/0363546508317412; OMEARA PM, 1992, CLIN ORTHOP RELAT R, P201; Ohkawa S, 2012, KNEE SURG SPORT TR A, V20, P778, DOI 10.1007/s00167-012-1900-2; Shino K, 2002, TECH KNEE SURG, V1, P78; Shino K, 2002, ARTHROSCOPY, V18, P908, DOI 10.1053/jars.2002.35267; Toritsuka Y, 2009, KNEE SURG SPORT TR A, V17, P456, DOI 10.1007/s00167-008-0707-7; Toritsuka Y, 2007, KNEE SURG SPORT TR A, V15, P835, DOI 10.1007/s00167-007-0304-1	43	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2015	23	4					1222	1230		10.1007/s00167-014-2950-4		9	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CE1ZM	WOS:000351611700044		
J	Huang, XD				Huang, Xiangdi			On formation of singularity of spherically symmetric nonbarotropic flows	KYOTO JOURNAL OF MATHEMATICS			English	Article							NAVIER-STOKES EQUATIONS; HEAT-CONDUCTIVE FLUIDS; ONE-DIMENSIONAL MOTION; BLOW-UP CRITERION; CLASSICAL-SOLUTIONS; COMPRESSIBLE FLOWS; EXISTENCE; BOUNDARY	We study an initial boundary value problem on a ball for the heat-conductive system of compressible Navier-Stokes-Fourier equations, in particular, a criterion for the breakdown of the classical solution. For smooth initial data away from vacuum, we prove that the classical solution which is spherically symmetric loses its regularity in a finite time if and only if the density concentrates or vanishes or the velocity becomes unbounded around the center. One possible situation is that a vacuum ball appears around the center and the density may concentrate on the boundary of the vacuum ball simultaneously.	[Huang, Xiangdi] Chinese Acad Sci, Acad Math & Syst Sci, Beijing 100190, Peoples R China; [Huang, Xiangdi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Pure & Appl Math, Toyonaka, Osaka 5600043, Japan	Huang, XD (reprint author), Chinese Acad Sci, Acad Math & Syst Sci, Beijing 100190, Peoples R China.	xdhuang@amss.ac.cn			Natural Science Foundation of China [11101392];  [23-01320]	Author's work partially supported by Grant-in-Aid for Japan Society for the Promotion of Science Fellows 23-01320 and Natural Science Foundation of China 11101392	Huang XD, 2013, COMMUN MATH PHYS, V324, P147, DOI 10.1007/s00220-013-1791-1; Cho YG, 2006, J MATH ANAL APPL, V320, P819, DOI 10.1016/j.jmaa.2005.08.005; MATSUMURA A, 1979, P JPN ACAD A-MATH, V55, P337; Cho Y, 2006, J DIFFER EQUATIONS, V228, P377, DOI 10.1016/j.jde.2006.05.001; Huang XD, 2010, SCI CHINA MATH, V53, P671, DOI 10.1007/s11425-010-0042-6; Huang XD, 2011, COMMUN MATH PHYS, V301, P23, DOI 10.1007/s00220-010-1148-y; Hoff D, 2004, ARCH RATION MECH AN, V173, P297, DOI 10.1007/s00205-004-0318-5; Huang XD, 2011, SIAM J MATH ANAL, V43, P1872, DOI 10.1137/100814639; Xin ZP, 2013, COMMUN MATH PHYS, V321, P529, DOI 10.1007/s00220-012-1610-0; Sun YZ, 2011, ARCH RATION MECH AN, V201, P727, DOI 10.1007/s00205-011-0407-1; DAVEIGA HB, 1989, ARCH RATION MECH AN, V108, P141, DOI 10.1007/BF01053460; Cho YG, 2006, MANUSCRIPTA MATH, V120, P91, DOI 10.1007/s00229-006-0637-y; Fang DY, 2012, NONLINEAR ANAL-THEOR, V75, P3130, DOI 10.1016/j.na.2011.12.011; Huang X., PREPRINT; Itaya N, 1971, KODAI MATH SEM REP, V23, P60, DOI 10.2996/kmj/1138846265; Kaihov A. V., 1979, DIFFER EQU, V15, P662; Choe HJ, 2005, MATH METHOD APPL SCI, V28, P1, DOI 10.1002/mma.545; MATSUMURA A, 1983, COMMUN MATH PHYS, V89, P445, DOI 10.1007/BF01214738; Matsumura A., 1980, J MATH KYOTO U, V200, P67; NAGASAWA T, 1986, J DIFFER EQUATIONS, V65, P49, DOI 10.1016/0022-0396(86)90041-0; Nash J., 1962, B SOC MATH FRANCE, V90, P487; Solonnikov V. A., 1980, J SOVIET MATH, V14, P1120, DOI 10.1007/BF01562053; Straskraba I., 1993, J FAC SCI U TOKYO 1A, V40, P17; Tani A, 1977, PUBL RES I MATH SCI, V13, P193, DOI 10.2977/prims/1195190106; Vaigant V. A., 1995, MATH J, V36, P1108, DOI [10.1007/BF02106835, DOI 10.1007/BF02106835]; VALLI A, 1982, ANN MAT PUR APPL, V130, P197, DOI 10.1007/BF01761495; Valli A., 1983, ANN SCUOLA NORM SUP, V10, P607; Xin ZP, 1998, COMMUN PUR APPL MATH, V51, P229, DOI 10.1002/(SICI)1097-0312(199803)51:3<229::AID-CPA1>3.0.CO;2-C; Zhang T, 2010, SIAM J MATH ANAL, V41, P2453, DOI 10.1137/090758878	29	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	APR	2015	55	1					1	15		10.1215/21562261-2801813		15	Mathematics	Mathematics	CE8SR	WOS:000352114900001		
J	Moriya, S				Moriya, Syunji			Multiplicative formality of operads and Sinha's spectral sequence for long knots	KYOTO JOURNAL OF MATHEMATICS			English	Article							HOMOTOPY-THEORY; SPACES	Lambrechts, Turchin, and Voilc proved the Bousfield-Kan-type rational homology spectral sequence associated to the dth Kontsevich operad collapses at E-2-page if d >= 4. The key of their proof is formality of the operad. In this paper, we simplify their proof by using a model category of operads. As by-products we obtain two new consequences. One is collapse of the spectral sequence in the case of d = 3 (and the coefficients being rational numbers). The other says there is no nontrivial extension for the Gerstenhaber algebra structure on the spectral sequence.	Kyoto Univ, Dept Math, Kyoto 6068502, Japan	Moriya, S (reprint author), Kyoto Univ, Dept Math, Kyoto 6068502, Japan.	moriyasy@math.kyoto-u.ac.jp					Tamarkin DE, 2003, LETT MATH PHYS, V66, P65, DOI 10.1023/B:MATH.0000017651.12703.a1; Kontsevich M, 1999, LETT MATH PHYS, V48, P35, DOI 10.1023/A:1007555725247; Volic I, 2006, COMPOS MATH, V142, P222, DOI 10.1112/S0010437X05001648; Sinha DP, 2006, J AM MATH SOC, V19, P461, DOI 10.1090/S0894-0347-05-00510-2; Muro F, 2011, ALGEBR GEOM TOPOL, V11, P1541, DOI 10.2140/agt.2011.11.1541; Berger C, 2003, COMMENT MATH HELV, V78, P805, DOI 10.1007/s00014-003-0772-y; Gerstenhaber M., 1995, INT MATH RES NOTICES, V3, P141; Hardt R, 2011, ALGEBR GEOM TOPOL, V11, P2477, DOI 10.2140/agt.2011.11.2477; Hinich V, 1997, COMMUN ALGEBRA, V25, P3291, DOI 10.1080/00927879708826055; Hovey M., 1999, MATH SURVEYS MONOGRA, V63; Lambrechts P, 2010, GEOM TOPOL, V14, P2151, DOI 10.2140/gt.2010.14.2151; Lambrechts P., 2013, MEM AM MATH SOC, V230; McClure JE, 2004, AM J MATH, V126, P1109, DOI 10.1353/ajm.2004.0038; Sakai K., 2008, GEOM TOPOL MONOGR, V13, P463, DOI [10.2140/gtm.2008.13.463, DOI 10.2140/GTM.2008.13.463]; Salvatore P, 2006, INT MATH RES NOTICES; Songhafouo Tsopmene P. A., ARXIV12102561V3MATHA; Spitzweck M., ARXIVMATH0101102V1MA; Turchin Tourtchine V., 2004, NATO SCI SERIES 2, V179, P23, DOI 10.1007/978-1-4020-2772-7_2	18	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	APR	2015	55	1					17	27		10.1215/21562261-2801858		11	Mathematics	Mathematics	CE8SR	WOS:000352114900002		
J	Taniguchi, K				Taniguchi, Kenji			Socle filtrations of the standard Whittaker (g, K)-modules of Spin(r, 1)	KYOTO JOURNAL OF MATHEMATICS			English	Article								Studied are the composition series of the standard Whittaker (g, K)-modules. For a generic infinitesimal character, the structures of these modules are completely understood, but if the infinitesimal character is integral, then there are not so many cases in which the structures of them are known. In this paper, as an example of the integral case, we determine the socle filtrations of the standard Whittaker (g, K)-modules when G is the group Spin(r, 1) and the infinitesimal character is regular integral.	Aoyama Gakuin Univ, Dept Math & Phys, Chou Ku, Sagamihara, Kanagawa 2525258, Japan	Taniguchi, K (reprint author), Aoyama Gakuin Univ, Dept Math & Phys, Chou Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	taniken@gem.aoyama.ac.jp			Japan Society for the Promotion of Science [24540027]	The author expresses sincere gratitude to the referees, whose advice was very useful to improve this paper. Author's research partially supported by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) # 24540027.	GELFAND IM, 1950, DOKL AKAD NAUK SSSR+, V71, P1017; Collingwood D. H., 1985, RES NOTES MATH, V137; MATUMOTO H, 1988, ACTA MATH-DJURSHOLM, V161, P183, DOI 10.1007/BF02392298; Taniguchi K., 2013, JOSAI MATH MONOGRAPH, V6, P93; Taniguchi K, 2013, T AM MATH SOC, V365, P3899; Taniguchi K., 1996, J MATH SCI-U TOKYO, V3, P331; Vogan D. A., 1981, PROGR MATH, V15; WALLACH NR, 1983, LECT NOTES MATH, V1024, P287, DOI 10.1007/BFb0071436; Yamashita H., 1990, JAPAN J MATH NS, V16, P31	9	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	APR	2015	55	1					43	61		10.1215/21562261-2848115		19	Mathematics	Mathematics	CE8SR	WOS:000352114900004		
J	Cuong, NT; Goto, S; Hoang, NV				Nguyen Tu Cuong; Goto, Shiro; Nguyen Van Hoang			On the cofiniteness of generalized local cohomology modules	KYOTO JOURNAL OF MATHEMATICS			English	Article							SMALL DIMENSION; PRIMES; IDEALS; FINITENESS; DUALITY	Let R be a commutative Noetherian ring, let I be an ideal of R, and let M, N be two finitely generated R-modules. The aim of this paper is to investigate the I-cofiniteness of generalized local cohomology modules H-I(j)(M, N) = lim(-> n) Ext(R)(j)(M/I-n M, N) of M and N with respect to I. We first prove that if I is a principal ideal, then H-I(j)(M, N) is I-cofinite for all M, N and all j. Secondly, let t be a nonnegative integer such that dim Supp(H-I(j)(M, N)) <= 1 for all j < t. Then H-I(j)(M, N) is I-cofinite for all j < t and Hom(R/I, H-I(j)(M, N)) is finitely generated. Finally, we show that if dim(M) <= 2 or dim(N) <= 2, then H-I(j)(M, N) is I-cofinite for all j.	[Nguyen Tu Cuong] Vietnam Acad Sci & Technol, Inst Math, Hanoi, Vietnam; [Goto, Shiro] Meiji Univ, Sch Sci & Technol, Dept Math, Tokyo 101, Japan; [Nguyen Van Hoang] Meiji Univ, Meiji Inst Adv Study Math Sci MIMS, Tokyo 101, Japan; [Nguyen Van Hoang] Thai Nguyen Univ Educ, Thai Nguyen City, Vietnam	Cuong, NT (reprint author), Vietnam Acad Sci & Technol, Inst Math, Hanoi, Vietnam.	ntcuong@math.ac.vn; goto@math.meiji.ac.jp; nguyenvanhoang1976@yahoo.com					Bahmanpour K, 2008, P AM MATH SOC, V136, P2359, DOI 10.1090/S0002-9939-08-09260-5; ZOSCHINGER H, 1986, J ALGEBRA, V102, P1, DOI 10.1016/0021-8693(86)90125-0; Divaani-Aazar K, 2005, P AM MATH SOC, V133, P655, DOI 10.1090/S0002-9939-04-07728-7; Brodmann MP, 2000, P AM MATH SOC, V128, P2851, DOI 10.1090/S0002-9939-00-05328-4; Melkersson L, 2005, J ALGEBRA, V285, P649, DOI 10.1016/j.jalgebra.2004.08.037; Bahmanpour K, 2009, J ALGEBRA, V321, P1997, DOI 10.1016/j.jalgebra.2008.12.020; Bijan-Zadeh M. H., 1980, GLASGOW MATH J, V21, P173, DOI 10.1017/S0017089500004158; Borna K, 2011, B AUST MATH SOC, V83, P382, DOI 10.1017/S0004972711002073; Chardin M, 2008, J ALGEBRA, V319, P4780, DOI 10.1016/j.jalgebra.2007.11.032; Chardin M, 2008, P AM MATH SOC, V136, P2749, DOI 10.1090/S0002-9939-08-09400-8; Cuong N. T., 2005, E W J MATH, V7, P107; Cuong N. T., 2002, VIETNAM J MATH, V30, P121; Cuong NT, 2008, MANUSCRIPTA MATH, V126, P59, DOI 10.1007/s00229-007-0162-7; Delfino D, 1997, J PURE APPL ALGEBRA, V121, P45, DOI 10.1016/S0022-4049(96)00044-8; Divaani-Aazar K., 2004, C MATH, V99, P283, DOI [10.4064/cm99-2-12, DOI 10.4064/CM99-2-12]; Grothendieck A., 1968, SEM GEOM ALG BOIS MA; HARTSHOR.R, 1970, INVENT MATH, V9, P145, DOI 10.1007/BF01404554; Herzog J., 1970, THESIS U REGENSBURG; Herzog J, 2003, ARCH MATH, V81, P512, DOI 10.1002/s00013-050512-08; Hoang N. V., 2008, ACTA MATH VIETNAMICA, V33, P163; Kawakami S., 2006, TOYAMA MATH J, V29, P59; Kawasaki K, 1996, P AM MATH SOC, V124, P3275, DOI 10.1090/S0002-9939-96-03399-0; Kawasaki K, 1998, B LOND MATH SOC, V30, P241, DOI 10.1112/S0024609397004347; Kawasaki K, 2011, MATH Z, V269, P587, DOI 10.1007/s00209-010-0751-0; Macdonald I. G., 1973, S MATEMATICA, VXI, P23; Marley T, 2001, MANUSCRIPTA MATH, V104, P519, DOI 10.1007/s002290170024; Marley T, 2002, J ALGEBRA, V256, P180, DOI 10.1016/S0021-8693(02)00151-5; MELKERSSON L, 1995, J PURE APPL ALGEBRA, V101, P291, DOI 10.1016/0022-4049(94)00059-R; MELKERSSON L, 1990, MATH PROC CAMBRIDGE, V107, P267, DOI 10.1017/S0305004100068535; Melkersson L, 1999, MATH PROC CAMBRIDGE, V125, P417, DOI 10.1017/S0305004198003041; Sharp R. Y., 1998, CAMBRIDGE STUDIES AD, V60, DOI [10.1017/CB09780511629204, DOI 10.1017/CB09780511629204]; Suzuki N., 1978, J MATH KYOTO U, V18, P71; YASSEMI S, 1994, J PURE APPL ALGEBRA, V95, P103, DOI 10.1016/0022-4049(94)90121-X; Yoshida KI, 1997, NAGOYA MATH J, V147, P179	34	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	2156-2261	2154-3321		KYOTO J MATH	Kyoto J. Math.	APR	2015	55	1					169	185		10.1215/21562261-2848151		17	Mathematics	Mathematics	CE8SR	WOS:000352114900008		
J	Bar-Zen, N; Kapanda, L; Tate, JE; Jere, KC; Iturriza-Gomara, M; Nakagomi, O; Mwansambo, C; Costello, A; Parashar, UD; Heyderman, RS; French, N; Cunliffe, NA				Bar-Zen, Naor; Kapanda, Lester; Tate, Jacqueline E.; Jere, Khuzwayo C.; Iturriza-Gomara, Miren; Nakagomi, Osamu; Mwansambo, Charles; Costello, Anthony; Parashar, Umesh D.; Heyderman, Robert S.; French, Neil; Cunliffe, Nigel A.		VacSurv Consortium	Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study	LANCET INFECTIOUS DISEASES			English	Article							UNITED-STATES; INDIRECT PROTECTION; AFRICAN INFANTS; SEVERE DIARRHEA; CHILDREN; GASTROENTERITIS; IMPACT; MORTALITY; BLANTYRE; STRAINS	Background Rotavirus is the main cause of severe acute gastroenteritis in children in Africa. Monovalent human rotavirus vaccine (RV1) was added into Malawi's infant immunisation schedule on Oct 29, 2012. We aimed to assess the impact and effectiveness of RV1 on rotavirus gastroenteritis in the 2 years after introduction. Methods From Jan 1, 2012, to June 30, 2014, we recruited children younger than 5 years who were admitted into Queen Elizabeth Central Hospital, Blantyre, Malawi, with acute gastroenteritis. We assessed stool samples from these children for presence of rotavirus with use of ELISA and we genotyped rotaviruses with use of RT-PCR. We compared rotavirus detection rates in stool samples and incidence of hospital admittance for rotavirus in children from Jan 1 to June 30, in the year before vaccination (2012) with the same months in the 2 years after vaccination was introduced (2013 and 2014). In the case-control portion of our study, we recruited eligible rotavirus-positive children from the surveillance platform and calculated vaccine effectiveness (one minus the odds ratio of vaccination) by comparing infants with rotavirus gastroenteritis with infants who tested negative for rotavirus, and with community age-matched and neighbourhood-matched controls. Findings We enrolled 1431 children, from whom we obtained 1417 stool samples (99%). We detected rotavirus in 79 of 157 infants (50%) before the vaccine, compared with 57 of 219 (40%) and 52 of 170 (31%) in successive calendar years after vaccine introduction (p=0.0002). In the first half of 2012, incidence of rotavirus hospital admission was 269 per 100 000 infants compared with 284 in the same months of 2013 (rise of 5.8%, 95% CI -23.1 to 45.4; p=0.73) and 153 in these months in 2014 (a reduction from the prevaccine period of 43.2%, 18.0-60-7; p=0.003). We recruited 118 vaccine-eligible rotavirus cases (median age 8.9 months; IQR 6.6-11.1), 317 rotavirus-test-negative controls (9.4 months; 6.9-11.9), and 380 community controls (8.8 months; 6.5-11.1). Vaccine effectiveness for two doses of RV1 in rotavirus-negative individuals was 64% (95% CI 24-83) and community controls was 63% (23-83). The point estimate of effectiveness was higher against genotype G1 than against G2 and G12. Interpretation Routine use of RV1 reduced hospital admissions for several genotypes of rotavirus in children younger than 5 years, especially in infants younger than 1 year. Our data support introduction of rotavirus vaccination at the WHO recommended schedule, with continuing surveillance in high-mortality countries. Copyright (C) Bar-Zeev, et al. Open Access article distributed under the terms of CC BY.	[Bar-Zen, Naor; Kapanda, Lester; Jere, Khuzwayo C.; Heyderman, Robert S.; French, Neil] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Bar-Zen, Naor; Jere, Khuzwayo C.; Iturriza-Gomara, Miren; French, Neil; Cunliffe, Nigel A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Tate, Jacqueline E.; Parashar, Umesh D.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Epidemiol Branch, Atlanta, GA USA; [Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Mwansambo, Charles] Minist Hlth & Populat, Lilongwe, Malawi; [Costello, Anthony] UCL, Inst Global Hlth, London, England; [Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Cunliffe, NA (reprint author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	n.a.cunliffe@liv.ac.uk			Wellcome Trust; GlaxoSmithKline Biologicals	Wellcome Trust, GlaxoSmithKline Biologicals.	Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; Bayard V, 2012, INT J INFECT DIS, V16, pE94, DOI 10.1016/j.ijid.2011.09.003; Groome MJ, 2014, LANCET INFECT DIS, V14, P1096, DOI 10.1016/S1473-3099(14)70940-5; Gurgel RG, 2009, GASTROENTEROLOGY, V137, P1970, DOI 10.1053/j.gastro.2009.07.046; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Anderson EJ, 2013, CLIN INFECT DIS, V56, P755, DOI 10.1093/cid/cis1010; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Hanquet G, 2013, VACCINE, V31, P5634, DOI 10.1016/j.vaccine.2013.07.006; Braeckman T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4752; Cunliffe NA, 2010, J INFECT DIS, V202, pS168, DOI 10.1086/653577; Expanded Programme on Immunization, 2009, MAN ROT DET CHAR MET; Hothorn Ludwig A, 2009, Epidemiol Perspect Innov, V6, P1, DOI 10.1186/1742-5573-6-1; Malawi Ministry of Health, 2011, MAL INT GUID PROV HI; Matthijnssens J, 2014, CLIN MICROBIOL INFEC, V20; Molto Y, 2011, PEDIAT INFECT DIS S, V30, pS16; National Statistics Office, 2009, MAL CENS POP HOUS 20; Pagel C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-151; PATH, 2014, ROT VACC ACC DEL; Quintanar-Solares M, 2011, PEDIATR INFECT DIS J, V30, pS11; Steele AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-213; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0; Turner A, 2013, PAEDIATR INT CHILD H, V33, P42, DOI 10.1179/2046905512Y.0000000015; World Bank, 2013, GINI IND DAT TABL; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P220; Yen C, 2011, PEDIATR INFECT DIS J, V30, pS6, DOI 10.1097/INF.0b013e3181fefa05	32	6	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1473-3099	1474-4457		LANCET INFECT DIS	Lancet Infect. Dis.	APR	2015	15	4					422	428		10.1016/S1473-3099(14)71060-6		7	Infectious Diseases	Infectious Diseases	CE6WA	WOS:000351977700038		
J	Heneka, MT; Carson, MJ; El Khoury, J; Landreth, GE; Brosseron, F; Feinstein, DL; Jacobs, AH; Wyss-Coray, T; Vitorica, J; Ransohoff, RM; Herrup, K; Frautschy, SA; Finsen, B; Brown, GC; Verkhratsky, A; Yamanaka, K; Koistinaho, J; Latz, E; Halle, A; Petzold, GC; Town, T; Morgan, D; Shinohara, ML; Perry, VH; Holmes, C; Bazan, NG; Brooks, DJ; Hunot, S; Joseph, B; Deigendesch, N; Garaschuk, O; Boddeke, E; Dinarello, CA; Breitner, JC; Cole, GM; Golenbock, DT; Kummer, MP				Heneka, Michael T.; Carson, Monica J.; El Khoury, Joseph; Landreth, Gary E.; Brosseron, Frederic; Feinstein, Douglas L.; Jacobs, Andreas H.; Wyss-Coray, Tony; Vitorica, Javier; Ransohoff, Richard M.; Herrup, Karl; Frautschy, Sally A.; Finsen, Bente; Brown, Guy C.; Verkhratsky, Alexei; Yamanaka, Koji; Koistinaho, Jari; Latz, Eicke; Halle, Annett; Petzold, Gabor C.; Town, Terrence; Morgan, Dave; Shinohara, Mari L.; Perry, V. Hugh; Holmes, Clive; Bazan, Nicolas G.; Brooks, David J.; Hunot, Stephane; Joseph, Bertrand; Deigendesch, Nikolaus; Garaschuk, Olga; Boddeke, Erik; Dinarello, Charles A.; Breitner, John C.; Cole, Greg M.; Golenbock, Douglas T.; Kummer, Markus P.			Neuroinflammation in Alzheimer's disease	LANCET NEUROLOGY			English	Review							MILD COGNITIVE IMPAIRMENT; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; ANTIINFLAMMATORY PREVENTION TRIAL; NITRIC-OXIDE SYNTHASE; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL AMYLOID ANGIOPATHY; GENOME-WIDE ASSOCIATION; CENTRAL-NERVOUS-SYSTEM	Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to pattern recognition receptors on microglia and astroglia, and trigger an innate immune response characterised by release of inflammatory mediators, which contribute to disease progression and severity. Genome-wide analysis suggests that several genes that increase the risk for sporadic Alzheimer's disease encode factors that regulate glial clearance of misfolded proteins and the inflammatory reaction. External factors, including systemic inflammation and obesity, are likely to interfere with immunological processes of the brain and further promote disease progression. Modulation of risk factors and targeting of these immune mechanisms could lead to future therapeutic or preventive strategies for Alzheimer's disease.	[Heneka, Michael T.; Petzold, Gabor C.] Univ Bonn, Dept Neurol, Univ Hosp Bonn, D-53127 Bonn, Germany; [Heneka, Michael T.; Brosseron, Frederic; Latz, Eicke; Petzold, Gabor C.] German Ctr Neurodegnerat Dis DZNE, Bonn, Germany; [Carson, Monica J.] Univ Calif Riverside, Div Biomed Sci, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [El Khoury, Joseph] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Charlestown, MA USA; [Landreth, Gary E.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Alzheimer Res Lab, Cleveland, OH 44106 USA; [Feinstein, Douglas L.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Jacobs, Andreas H.] Johanniter Hosp, Dept Geriatr, Bonn, Germany; [Jacobs, Andreas H.] Westfalian Wilhelms Univ WWU, European Inst Mol Imaging EIMI, Munster, Germany; [Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Wyss-Coray, Tony] VA Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA USA; [Vitorica, Javier] Univ Seville, Inst Biomed Sevilla IBIS, Hosp Univ Virgen del Rocio, Consejo Super Invest Cient, Seville, Spain; [Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA; [Herrup, Karl] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Frautschy, Sally A.; Cole, Greg M.] Univ Calif Los Angeles, David Geffen Sch Med, Geriatr Res & Clin Ctr, Dept Neurol,Greater Los Angeles Vet Affairs Healt, Los Angeles, CA 90095 USA; [Finsen, Bente] Univ Southern Denmark, Inst Mol Med, Odense, Denmark; [Brown, Guy C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Verkhratsky, Alexei] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Verkhratsky, Alexei] Basque Fdn Sci IKERBASQUE, Achucarro Ctr Neurosci, Bilbao, Spain; [Verkhratsky, Alexei] Univ Basque Country, Univ Basque Country UPV, Dept Neurosci,EHU Euskal Herriko Unibertsitatea, CIBERNED Ctr Invest Biomed Red Enfermedades Neuro, Leioa, Spain; [Yamanaka, Koji] Nagoya Univ, RIKEN Brain Sci Inst, Environm Med Res Inst, Wako, Saitama, Japan; [Koistinaho, Jari] Univ Eastern Finland, Al Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA USA; [Halle, Annett] Ctr Adv European Studies & Res CAESAR, Max Planck Res Grp Neuroimmunol, Bonn, Germany; [Town, Terrence] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Morgan, Dave] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Byrd Alzheimers Inst, Tampa, FL USA; [Shinohara, Mari L.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Perry, V. Hugh] Southampton Gen Hosp, Sch Biol Sci, Southampton SO9 4XY, Hants, England; [Holmes, Clive] Univ Southampton, Clin & Expt Sci, Southampton, Hants, England; [Holmes, Clive] Southern Hlth Fdn Trust, Moorgreen Hosp, Memory Assessment & Res Ctr, Southampton, Hants, England; [Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, New Orleans, LA USA; [Brooks, David J.] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Hammersmith Hosp, London, England; [Hunot, Stephane] CNRS, UMR 7225, Expt Therapeut Neurodegenerat, Paris, France; [Joseph, Bertrand] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Deigendesch, Nikolaus] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Garaschuk, Olga] Univ Tubingen, Inst Physiol 2, Tubingen, Germany; [Boddeke, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Breitner, John C.] Douglas Mental Hlth Univ Inst, Ctr Studies Prevent Alzheimers Dis, Montreal, PQ, Canada; [Breitner, John C.] McGill Univ, Fac Med, Montreal, PQ, Canada	Heneka, MT (reprint author), Univ Bonn, Dept Neurol, Univ Hosp Bonn, D-53127 Bonn, Germany.	michael.heneka@ukb.uni-bonn.de	Garaschuk, Olga/G-5633-2015; Verkhratsky, Alexei/J-4527-2013	Verkhratsky, Alexei/0000-0003-2592-9898	Boehringer Ingelheim Pharma; Veterans Affairs; US National Institutes of Health (NIH) [WO 2007103435 A3]; UK National MS Society; MEXT, Japan; Baxter; NIH	MTH and MPK have a patent pending on nitration of amyloid 13 peptides (WO 2011006871 A1). GEL has a patent pending on an RXR agonist in Alzheimer's disease (WO 2011006157 A2). AH reports grants from Boehringer Ingelheim Pharma during the preparation of the Review. SAF reports grants from Veterans Affairs and the US National Institutes of Health (NIH) during the preparation of the Review, and a patent for curcumin formulation (application no. 60,779,817 [WO 2007103435 A3]) with royalties paid. RMR reports grants from the UK National MS Society during the preparation of the Review. CV reports grants from Pfizer, outside the submitted work. KY reports grants from MEXT, Japan, during the preparation of the Review. JK reports grants from Baxter, and personal fees from Medeia Therapeutics, outside the submitted work. CH reports grants from Pfizer, outside the submitted work. GMC reports grants from Veterans Affairs and NIH during the preparation of the Review. All other authors declare no competing interests.	Aisen PS, 2002, NEUROLOGY, V58, P1050; Breitner J, 2013, ALZHEIMERS DEMENT, V9, P714, DOI 10.1016/j.jalz.2012.11.012; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Laske C, 2010, CURR ALZHEIMER RES, V7, P409; Tan MS, 2014, J ALZHEIMERS DIS, V38, P633, DOI 10.3233/JAD-131148; Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084; Chakrabarty P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-36; Brown BM, 2013, MOL PSYCHIATR, V18, P864, DOI 10.1038/mp.2012.162; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; Rapic S, 2013, NEUROBIOL AGING, V34, P351, DOI 10.1016/j.neurobiolaging.2012.04.016; Almond MH, 2013, THORAX, V68, P684, DOI 10.1136/thoraxjnl-2012-203009; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Smits HA, 2002, J NEUROIMMUNOL, V127, P160, DOI 10.1016/S0165-5728(02)00112-1; Kim JV, 2006, J IMMUNOL, V177, P5269; Brenneis C, 2011, J BIOL CHEM, V286, P2331, DOI 10.1074/jbc.M110.157362; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Thiabaud G, 2013, ANGEW CHEM INT EDIT, V52, P8041, DOI 10.1002/anie.201302989; ROGERS J, 1993, NEUROLOGY, V43, P1609; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; Xiang ZM, 2002, GENE EXPRESSION, V10, P271; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Morgan D, 2005, J NEUROPATH EXP NEUR, V64, P743, DOI 10.1097/01.jnen.0000178444.33972.e0; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; Godbout JP, 2009, IMMUNOL ALLERGY CLIN, V29, P321, DOI 10.1016/j.iac.2009.02.007; Yasuno F, 2012, PSYCHIAT RES-NEUROIM, V203, P67, DOI 10.1016/j.pscychresns.2011.08.013; Rohn TT, 2009, INT J CLIN EXP MED, V2, P300; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Venneti S, 2009, NEUROBIOL AGING, V30, P1217, DOI 10.1016/j.neurobiolaging.2007.11.005; Chauveau F, 2009, J NUCL MED, V50, P468, DOI 10.2967/jnumed.108.058669; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; Harrington C, 2011, CURR ALZHEIMER RES, V8, P592; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Yokokura M, 2011, EUR J NUCL MED MOL I, V38, P343, DOI 10.1007/s00259-010-1612-0; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Strohmeyer R, 2002, J NEUROIMMUNOL, V131, P135, DOI 10.1016/S0165-5728(02)00272-2; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Sastre M, 2003, J NEUROSCI, V23, P9796; Montine TJ, 1999, NEUROLOGY, V53, P1495; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Orre M, 2013, BRAIN, V136, P1415, DOI 10.1093/brain/awt083; Pihlaja R, 2011, GLIA, V59, P1643, DOI 10.1002/glia.21212; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Heneka MT, 2006, J NEUROSCI, V26, P1343, DOI 10.1523/JNEUROSCI.4236-05.2006; Lee YK, 2009, NEUROBIOL LEARN MEM, V92, P356, DOI 10.1016/j.nlm.2009.04.003; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007; Schuitemaker A, 2013, NEUROBIOL AGING, V34, P128, DOI 10.1016/j.neurobiolaging.2012.04.021; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Kalinin S, 2007, NEUROBIOL AGING, V28, P1206, DOI 10.1016/j.neurobiolaging.2006.06.003; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Slawik H, 2004, NEUROCHEM INT, V45, P653, DOI 10.1016/j.neuint.2004.04.007; Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Kummer MP, 2014, J NEUROSCI, V34, P8845, DOI 10.1523/JNEUROSCI.4027-13.2014; Woodling NS, 2014, J NEUROSCI, V34, P5882, DOI 10.1523/JNEUROSCI.0410-14.2014; Reines SA, 2004, NEUROLOGY, V62, P66; Beauquis J, 2013, EXP NEUROL, V239, P28, DOI 10.1016/j.expneurol.2012.09.009; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fricker M, 2013, J BIOL CHEM, V288, P9145, DOI 10.1074/jbc.M112.427880; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Brosseron F, 2014, MOL NEUROBIOL, V50, P534, DOI 10.1007/s12035-014-8657-1; Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Aisen PS, 2000, NEUROLOGY, V54, P588; O'Sullivan JB, 2010, J NEUROIMMUNOL, V220, P34, DOI 10.1016/j.jneuroim.2009.12.007; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Savarin-Vuaillat C, 2007, NEUROTHERAPEUTICS, V4, P590, DOI 10.1016/j.nurt.2007.07.004; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Olabarria M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-55; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Martinotti G, 2012, J BIOL REG HOMEOS AG, V26, P347; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Lista S, 2013, PROG NEUROBIOL, V101, P18, DOI 10.1016/j.pneurobio.2012.06.006; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Shi J, 2012, ANN NEUROL, V72, P788, DOI 10.1002/ana.23677; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Heneka MT, 2011, CURR NEUROPHARMACOL, V9, P643, DOI 10.2174/157015911798376325; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Ishizuka K, 1997, PSYCHIAT CLIN NEUROS, V51, P135, DOI 10.1111/j.1440-1819.1997.tb02375.x; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; PACE JL, 1983, J IMMUNOL, V130, P2011; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Kalinin S, 2012, NEUROBIOL AGING, V33, P1651, DOI 10.1016/j.neurobiolaging.2011.04.012; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Bentham P., 2008, LANCET NEUROL, V7, P41; Britschgi M, 2011, MOL CELL PROTEOMICS, V10; Chakrabarty P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-16; Chauveau F, 2011, EUR J NUCL MED MOL I, V38, P509, DOI 10.1007/s00259-010-1628-5; Chidiac C, 2012, MED MALADIES INFECT, V42, P501, DOI 10.1016/j.medmal.2012.04.003; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; de Jong D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001475; Edison P, 2007, J NEUROL NEUROSUR PS, V78, P219; Fitz NF, 2013, SCIENCE, V340, P924; Galimberti Daniela, 2008, Curr Aging Sci, V1, P30; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jarre A, 2014, CELL SIGNAL, V26, P2040, DOI 10.1016/j.cellsig.2014.05.019; Jekabsone A, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-24; Ji K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056293; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Krabbe G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060921; Kulijewicz-Nawrot M, 2012, J ANAT, V221, P252, DOI 10.1111/j.1469-7580.2012.01536.x; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Kurita M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039212; Kyrkanides S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-112; Lue LF, 2001, NEUROBIOL AGING, V22, P945, DOI 10.1016/S0197-4580(01)00311-6; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Price AR, 2013, SCIENCE, V340, P924; Rentzos M, 2006, J NEUROL SCI, V249, P110, DOI 10.1016/j.jns.2006.05.063; Roberts JC, 2009, EXP NEUROL, V216, P459, DOI 10.1016/j.expneurol.2009.01.002; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Shi H, 2012, NEUROBIOL AGING, V33, pe5; Shi H, 2012, NEUROBIOL AGING, V33, P1849; Shie FS, 2005, BRAIN PATHOL, V15, P134; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tesseur I, 2013, SCIENCE, V340, P924; Unden AL, 2007, CLIN SCI, V112, P363, DOI 10.1042/CS20060128; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; Van Gool WA, 2001, LANCET, V358, P455, DOI 10.1016/S0140-6736(01)05623-9; Veeraraghavalu K, 2013, SCIENCE, V340, P924; Villeda S, 2008, NEURON, V59, P527, DOI 10.1016/j.neuron.2008.08.005; Vodovotz Y, 1996, J EXP MED, V184, P1425, DOI 10.1084/jem.184.4.1425; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yeh CY, 2011, ASN NEURO, V3, DOI 10.1042/AN20110025; Zhao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015816; Zotova E, 2013, BRAIN, V136, P2677, DOI 10.1093/brain/awt210	232	43	46	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2015	14	4					388	405				18	Clinical Neurology	Neurosciences & Neurology	CE5RD	WOS:000351892400014		
J	Esaki, S; Yamano, K; Katsumi, S; Minakata, T; Murakami, S				Esaki, Shinichi; Yamano, Koji; Katsumi, Sachiyo; Minakata, Toshiya; Murakami, Shingo			Facial Nerve Palsy After Reactivation of Herpes Simplex Virus Type 1 in Diabetic Mice	LARYNGOSCOPE			English	Article						Bell's palsy; herpes simplex virus; diabetes mellitus; HSV-1 reactivation	BELLS-PALSY; LYMPHOCYTE-T; MELLITUS; OPHTHALMOPLEGIA; SUBPOPULATIONS; PARALYSIS; SALIVA; MOUSE; MODEL	Objectives/HypothesisBell's palsy is highly associated with diabetes mellitus (DM). Either the reactivation of herpes simplex virus type 1 (HSV-1) or diabetic mononeuropathy has been proposed to cause the facial paralysis observed in DM patients. However, distinguishing whether the facial palsy is caused by herpetic neuritis or diabetic mononeuropathy is difficult. We previously reported that facial paralysis was aggravated in DM mice after HSV-1 inoculation of the murine auricle. In the current study, we induced HSV-1 reactivation by an auricular scratch following DM induction with streptozotocin (STZ). Study DesignControlled animal study. MethodsDiabetes mellitus was induced with streptozotocin injection in only mice that developed transient facial nerve paralysis with HSV-1. Recurrent facial palsy was induced after HSV-1 reactivation by auricular scratch. ResultsAfter DM induction, the number of cluster of differentiation 3 (CD3)(+) T cells decreased by 70% in the DM mice, and facial nerve palsy recurred in 13% of the DM mice. Herpes simplex virus type 1 deoxyribonucleic acid (DNA) was detected in the facial nerve of all of the DM mice with palsy, and HSV-1 capsids were found in the geniculate ganglion using electron microscopy. Herpes simplex virus type 1 DNA was also found in some of the DM mice without palsy, which suggested the subclinical reactivation of HSV-1. ConclusionsThese results suggested that HSV-1 reactivation in the geniculate ganglion may be the main causative factor of the increased incidence of facial paralysis in DM patients. Level of EvidenceN/A. Laryngoscope, 125:E143-E148, 2015	[Esaki, Shinichi; Yamano, Koji; Katsumi, Sachiyo; Minakata, Toshiya; Murakami, Shingo] Nagoya City Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Sci, Nagoya, Aichi 4678602, Japan; [Esaki, Shinichi; Yamano, Koji; Katsumi, Sachiyo; Minakata, Toshiya; Murakami, Shingo] Nagoya City Univ, Sch Med, Nagoya, Aichi 4678602, Japan; [Esaki, Shinichi] Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Esaki, S (reprint author), Nagoya City Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678602, Japan.	sesaki@med.nagoyacu.ac.jp			Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [23791919, 25861579]	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (23791919, 25861579). The authors have no other funding, financial relationships, or conflicts of interest to disclose.	Abiko Y, 2002, OTOL NEUROTOL, V23, P779, DOI 10.1097/00129492-200209000-00028; Acaroglu G, 2008, OPHTHALMOLOGICA, V222, P225, DOI 10.1159/000130070; ADOUR KK, 1974, ARCH OTOLARYNGOL, V99, P114; SUGITA T, 1995, ANN OTO RHINOL LARYN, V104, P574; Murakami S, 1996, ANN INTERN MED, V124, P27; Bosco D, 2011, ACTA NEUROL SCAND, V123, P68, DOI 10.1111/j.1600-0404.2010.01365.x; Mojadadi S, 2009, CELL MOL IMMUNOL, V6, P111, DOI 10.1038/cmi.2009.15; AVIEL A, 1983, ANN OTO RHINOL LARYN, V92, P187; Dworacka M, 2007, CIRC J, V71, P962, DOI 10.1253/circj.71.962; Esaki S, 2012, OTOL NEUROTOL, V33, P1452, DOI 10.1097/MAO.0b013e318268d54d; Esaki S, 2013, INT J CANCER, V132, P1592, DOI 10.1002/ijc.27823; Furuta Y, 1998, J MED VIROL, V54, P162, DOI 10.1002/(SICI)1096-9071(199803)54:3<162::AID-JMV3>3.0.CO;2-3; Gilden DH, 2004, NEW ENGL J MED, V351, P1323, DOI 10.1056/NEJMcp041120; Greco D, 2009, ACTA DIABETOL, V46, P23, DOI 10.1007/s00592-008-0053-8; HILL TJ, 1978, J GEN VIROL, V39, P21, DOI 10.1099/0022-1317-39-1-21; HOPF HC, 1990, NEUROLOGY, V40, P1041; Kanazawa A, 2007, ACTA OTO-LARYNGOL, V127, P888, DOI 10.1080/00016480601075399; RAFF MC, 1968, NEW ENGL J MED, V279, P17, DOI 10.1056/NEJM196807042790104; SCHMID DS, 1983, J IMMUNOL, V131, P479; Takahashi H, 2001, J NEUROPATH EXP NEUR, V60, P621; Tekgul H, 2004, PEDIATR NEUROL, V31, P258, DOI 10.1016/j.pediatrneurol.2004.05.003; Turriziani O, 2014, J MED VIROL, V86, P1752, DOI 10.1002/jmv.23917; WATANABE K, 1990, DIABETES RES CLIN PR, V10, P19, DOI 10.1016/0168-8227(90)90077-7; Yanagihara N, 1988, Ann Otol Rhinol Laryngol Suppl, V137, P5	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	APR	2015	125	4					E143	E148		10.1002/lary.24994		6	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CE2YB	WOS:000351686900004		
J	Kita, T; Ishii, K; Yoshikawa, K; Yasuo, K; Yamamoto, K; Awazu, K				Kita, Tetsuya; Ishii, Katsunori; Yoshikawa, Kazushi; Yasuo, Kenzo; Yamamoto, Kazuyo; Awazu, Kunio			In vitro study on selective removal of bovine demineralized dentin using nanosecond pulsed laser at wavelengths around 5.8 mu m for realizing less invasive treatment of dental caries	LASERS IN MEDICAL SCIENCE			English	Article						Nanosecond pulsed laser; 5.8 mu mwavelength; In vitro; Bovine dentin; Selective demineralized dentin removal; Tensile bonding strength	INDENTATION SYSTEM UMIS; BOND STRENGTH; EXCAVATION TECHNIQUES; MINERAL-CONTENT; CARIOUS DENTIN; ENAMEL; MICROHARDNESS; HARDNESS; MODULUS; TEETH	In the treatment of dental caries, less invasive methods are strongly required. However, conventional dental lasers cannot always achieve selective removal of caries or good bonding with a composite resin. Based on the optical absorption characteristics of dentin, wavelengths around 6 mu m are promising in this regard. Our previous study indicated the possibility of selective removal of demineralized dentin using a nanosecond pulsed laser at wavelengths around 6 mu m. In the present study, the optimal laser irradiation conditions were investigated for achieving selective removal of demineralized dentin. Bovine dentin was used, and its laser ablation characteristics were evaluated. The results indicated that demineralized dentin could be selectively removed, without causing cracking or damage to sound dentin, at laser wavelengths of 5.75 and 5.80 mu m and average power densities of 30-40 W/cm(2). These optimal laser irradiation conditions also realized higher bonding strength with a composite resin than was possible using an Er:YAG laser. The use of nanosecond pulses allowed the thermal confinement condition to be satisfied, leading to a reduction in tissue damage, including degradation of dental pulp vitality. Thus, a nanosecond pulsed laser at 5.8 mu m was found to be effective for less invasive caries treatment.	[Kita, Tetsuya; Ishii, Katsunori; Awazu, Kunio] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yoshikawa, Kazushi; Yasuo, Kenzo; Yamamoto, Kazuyo] Osaka Dent Univ, Dept Operat Dent, Hirakata, Osaka 5731121, Japan; [Awazu, Kunio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Awazu, Kunio] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Awazu, K (reprint author), Osaka Univ, Ctr Adv Med Engn & Informat, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	awazu@see.eng.osaka-u.ac.jp			JSPS KAKENHI [24241029]; Tateishi Science and Technology Foundation	This work was supported by JSPS KAKENHI Grant No. 24241029 and Tateishi Science and Technology Foundation.	Angker L, 2004, EUR J ORAL SCI, V112, P231, DOI 10.1111/j.1600-0722.2004.00123.x; Neves AD, 2011, J DENT, V39, P154, DOI 10.1016/j.jdent.2010.11.006; Kinney JH, 1996, ARCH ORAL BIOL, V41, P9, DOI 10.1016/0003-9969(95)00109-3; BROWN WS, 1970, J DENT RES, V49, P752, DOI 10.1177/00220345700490040701; Pugach MK, 2009, J DENT RES, V88, P71, DOI 10.1177/0022034508327552; Angker L, 2004, ARCH ORAL BIOL, V49, P369, DOI 10.1016/j.archorlbio.2003.12.005; Tyas MJ, 2000, INT DENT J, V50, P1; Dunn WJ, 2005, DENT MATER, V21, P616, DOI 10.1016/j.dental.2004.11.003; ARENDS J, 1992, J DENT RES, V71, P924; FEATHERSTONE JDB, 1983, CARIES RES, V17, P385; KODAKA T, 1992, CARIES RES, V26, P139; Celiberti P, 2006, CARIES RES, V40, P117, DOI 10.1159/000091057; Chimello-Sousa DT, 2006, J DENT, V34, P245, DOI 10.1016/j.jdent.2005.06.009; Choi K, 2006, OPER DENT, V31, P590, DOI 10.2341/05-108; Hazama H, 2007, P SOC PHOTO-OPT INS, V6455, P45507, DOI 10.1117/12.700112; Heya M, 2005, J JPN SOC LASER SURG, V36, P323; KINNEY JH, 1993, ARCH ORAL BIOL, V38, P1003, DOI 10.1016/0003-9969(93)90114-2; Marshall G W Jr, 1993, Quintessence Int, V24, P606; Neves AD, 2011, DENT MATER, V27, P552, DOI 10.1016/j.dental.2011.02.008; Osuka K, 2009, PHOTOMED LASER SURG, V27, P395, DOI 10.1089/pho.2008.2163; Saiki M, 2011, P 33 IEEE EMBS, P318; Saiki M, 2011, P SOC PHOTO-OPT INS, V7887; Uchizono T, 2005, J JPN SOC LASER SURG, V25, P265; Yasuda G, 2007, EUR J ORAL SCI, V115, P87, DOI 10.1111/j.1600-0722.2007.00425.x; Youn JI, 2012, LASER MED SCI, V28, P519	25	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	APR	2015	30	3					961	967		10.1007/s10103-013-1517-9		7	Engineering, Biomedical; Surgery	Engineering; Surgery	CE5IB	WOS:000351863700003		
J	Kobayashi, HH				Kobayashi, Hill Hiroki			RESEARCH IN HUMAN-COMPUTER-BIOSPHERE INTERACTION	LEONARDO			English	Article								Currently human-computer interaction (HCI) is primarily focused on human-centric interactions. However, people experience many non-human-centric interactions every day. Interactions with nature can reinforce the importance of our relationship with nature. This paper presents the author's vision of human-computer-biosphere interaction (HCBI) to facilitate non-human-centric interaction with the goal of moving society towards environmental sustainability.	Univ Tokyo, Ctr Spatial Informat Sci, Chiba 2778568, Japan	Kobayashi, HH (reprint author), Univ Tokyo, Ctr Spatial Informat Sci, Chiba 2778568, Japan.	kobayashi@csis.u-tokyo.ac.jp					[Anonymous], 2010, P 28 INT C HUM FACT, DOI DOI 10.1145/1753326.1753625; Giannachi G., 2012, ARCHAEOLOGICS PRESEN, pxvii; Hewett Baecker, 1992, DEFINITION OF HUMAN; Itoh Y., 2002, CHI 2002, P810; Kobayashi H., 2009, CHI 09 HUM FACT COMP, P2509; Lee P., 2006, PERS UBIQUIT COMPUT, V10, P301; Mancini Clara, 2011, Interactions, V18, DOI 10.1145/1978822.1978836; Pereira R, 2010, FIRST INTERDISCIPLIN, P1; Ueoka R., 2008, ACM SIGGRAPH 008 ART, P103, DOI 10.1145/1400385.1400458	9	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0024-094X	1530-9282		LEONARDO	Leonardo	APR	2015	48	2					186	187		10.1162/LEON_a_00982		2	Art	Art	CE4AW	WOS:000351773800018		
J	Tanaka, I				Tanaka, Ikuko			Estimating body weight and habitat type from extinct avian and avian-like theropod footprints	LETHAIA			English	Article						Avian; bodyweight; footprint; habitat; morphology; theropod	MESOZOIC BIRDS; EVOLUTION; RECORD; MASS; MAMMALS; FLIGHT; WORK; SIZE	The relationship between body weight and footprint area of modern avians was derived and used to estimate the body weights of non-avian theropods taxa from the Triassic to Cretaceous and extinct avian taxa from the Cretaceous periods. Geometric information, such as the area and shape of fossil tracks of extinct avians and non-avian theropods, was used to estimate body weight and habitat type. The percentage prediction and standard error of estimates indicated that the body weight estimated from track area is comparable with body weight estimated from body fossils bones. Therefore, this approach is useful when the fossilized track record is richer than the fossilized skeletal record. The data sets for avians and reptiles were combined and used to derive a body weight-area relationship that may be applicable to a broader range of organisms, such as plantigrade quadrupeds and digitigrade bipeds. Additionally, scatter plots of the relationship between habitat type and footprint shape of modern avians were used to infer the habitat type of extinct avians. This finding suggests that the pes of animals, living in areas characterized by fluctuating water levels, and under conditions facilitating the preservation of footprints, were similar in form to those of extant semi-aquatic avians.	Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Tanaka, I (reprint author), Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Nada Ku, 1-1 Rokkoudai, Kobe, Hyogo 6578501, Japan.	itanaka@stu.kobe-u.ac.jp					Alonso RN, 1986, ACT 4 C ARG PAL BIOE, V2, P33, DOI [10.1016/j.acuro.2014.11.005, DOI 10.1016/J.ACURO.2014.11.005]; ANDERSON JF, 1985, J ZOOL, V207, P53; Kubo T, 2011, PALAEOGEOGR PALAEOCL, V299, P197, DOI 10.1016/j.palaeo.2010.11.001; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Milan J, 2006, PALAEOGEOGR PALAEOCL, V231, P253, DOI 10.1016/j.palaeo.2004.12.022; LOCKLEY MG, 1992, PHILOS T ROY SOC B, V336, P113, DOI 10.1098/rstb.1992.0051; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Henderson DM, 2010, J VERTEBR PALEONTOL, V30, P768, DOI 10.1080/02724631003758334; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Hone DWE, 2008, J EVOLUTION BIOL, V21, P618, DOI 10.1111/j.1420-9101.2007.01483.x; Avnimelech M. A., 1966, P ISR AC SCI HUM SEC, V1, P1; Azuma Yoichi, 2002, Memoir of the Fukui Prefectural Dinosaur Museum, V1, P1; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; CURRIE P J, 1981, Journal of Vertebrate Paleontology, V1, P257; Damuth J. D., 1990, BODY SIZE MAMMALIAN; Ellenberger P., 1970, IUGS 2 S GONDW STRAT, P343; Ericson M., 2009, PLOS ONE, V4, P1; Feduccia A., 1996, ORIGIN EVOLUTION BIR; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Fuentes Vidarte C. F., 1996, ESTUD GEOL-MADRID, V52, P63; Gierlinski Gerard, 1994, Ichnos, V3, P99; Gill F. B., 2007, ORNITHOLOGY; Heckert Andrew B., 2000, Gaia (Lisboa), V15, P63; Ishigaki S., 1986, NATURE STUDY, V32, P6; Klein H., 2007, NEW MEXICO MUSEUM NA, V41, P120; Leonardi G., 1994, ANNOTATED ATLAS S AM; Lockley MG, 2009, GEOL Q, V53, P433; Lu JC, 2010, ACTA GEOSCI SIN, V31, P46; Mehl MG, 1931, AM J SCI, V21, P441; Michilsens F, 2009, J ZOOL, V279, P236, DOI 10.1111/j.1469-7998.2009.00611.x; Milan J, 2004, B GEOL SOC DENMARK, V51, P71; Paul GS, 1988, PREDATORY DINOSAURS, VSimon and Schuster; Lockley Martin G., 2002, P405; Schmidt-Nielsen K, 1984, SCALING WHY IS ANIMA; Smith R. J., 1984, AM J PHYSIOL, V246, P152; Ubukata T., 2004, GEOSCIENCE REPORTS S, V31, P65; Xing Li-Da, 2013, Vertebrata Palasiatica, V51, P184; YALDEN DW, 1971, IBIS, V113, P349, DOI 10.1111/j.1474-919X.1971.tb05165.x; Yang S. Y., 1995, ICHNOS, V4, P221; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zhen S., 1994, MEMOIRS BEIJING NATU, V54, P108	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0024-1164	1502-3931		LETHAIA	Lethaia	APR	2015	48	2					188	195		10.1111/let.12098		8	Paleontology	Paleontology	CE3OP	WOS:000351736600005		
J	Tsubaki, M; Takeda, T; Ogawa, N; Sakamoto, K; Shimaoka, H; Fujita, A; Itoh, T; Imano, M; Ishizaka, T; Satou, T; Nishida, S				Tsubaki, Masanobu; Takeda, Tomoya; Ogawa, Naoki; Sakamoto, Kotaro; Shimaoka, Hirotaka; Fujita, Arisa; Itoh, Tatsuki; Imano, Motohiro; Ishizaka, Toshihiko; Satou, Takao; Nishida, Shozo			Overexpression of survivin via activation of ERK1/2, Akt, and NF-kappa B plays a central role in vincristine resistance in multiple myeloma cells	LEUKEMIA RESEARCH			English	Article						Multiple myeloma; Survivin; Vincristine; Drug resistance	MULTIDRUG-RESISTANCE; HEMATOLOGICAL MALIGNANCIES; DRUG-RESISTANCE; ANTICANCER DRUGS; IN-VITRO; APOPTOSIS; EXPRESSION; SENSITIVITY; INHIBITION; PATHWAY	The acquisition of anti-cancer drug resistance is a major limitation of chemotherapy for multiple myeloma(MM) and it is thus important to identify the mechanisms by which MM cells develop such drug resistance. In a previous study, we showed that multidrug resistance (MDR) involves the overexpression of MDR1 and survivin in vincristine-resistant RPMI8226/VCR cells. However, the underlying mechanism of MDR remains unclear. In this study, we investigated the mechanism of MDR in RPMI8226/VCR cells, and found that RPMI8226/VCR cells exhibit increased levels of activated ERK1/2, Akt, and NF-kappa B, while the levels of activated mTOR, p38MAPK, and JNK do not differ between RPMI8226/VCR cells and their vincristine-susceptible counterparts. In addition, the inhibition of ERK1/2, Akt, or NF-kappa B by inhibitors reversed thedrug resistance of RPMI8226/VCR cells via the suppression of survivin expression, but did not affect MDR1 expression; RNA silencing of survivin expression completely reversed vincristine resistance, while MDR1 silencing only weakly suppressed vincristine resistance in RPMI8226/VCR cells. These results indicate that enhanced survivin expression via the activation of ERK1/2, Akt, and NF-kappa B plays a critical role in vincristine resistance in RPMI8226/VCR cells. Our findings suggest that ERK1/2, Akt, and NF-kappa B inhibitors are potentially useful as anti-MDR agents for the treatment of vincristine-resistant MM. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsubaki, Masanobu; Takeda, Tomoya; Ogawa, Naoki; Sakamoto, Kotaro; Shimaoka, Hirotaka; Fujita, Arisa; Nishida, Shozo] Kinki Univ, Sch Pharm, Div Pharmacotherapy, Higashiosaka, Osaka 5778502, Japan; [Ogawa, Naoki; Ishizaka, Toshihiko] Sakai City Hosp, Dept Pharm, Sakai, Osaka, Japan; [Itoh, Tatsuki] Kinki Univ, Sch Agr, Dept Food Sci & Nutr, Nara, Nara, Japan; [Imano, Motohiro] Kinki Univ, Sch Med, Dept Surg, Osakasayama, Osaka, Japan; [Satou, Takao] Kinki Univ, Sch Med, Dept Pathol, Osakasayama, Osaka, Japan	Nishida, S (reprint author), Kinki Univ, Sch Pharm, Div Pharmacotherapy, Higashiosaka, Osaka 5778502, Japan.	nishida@phar.kindai.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) - Supported Program for the Strategic Research Foundation at Private Universities	This work was supported in part by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) and by Ministry of Education, Culture, Sports, Science, and Technology (MEXT) - Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018.	Ahn KC, 2013, BIOCHEM BIOPH RES CO, V441, P507, DOI 10.1016/j.bbrc.2013.10.096; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; Que WZ, 2012, APMIS, V120, P195, DOI 10.1111/j.1600-0463.2011.02836.x; Simonian PL, 1997, BLOOD, V90, P1208; Kojima H, 2006, ARCH OTOLARYNGOL, V132, P682, DOI 10.1001/archotol.132.6.682; Zhang HR, 2013, J INT MED RES, V41, P584, DOI 10.1177/0300060513480920; Tamm I, 1998, CANCER RES, V58, P5315; Covelli A, 1999, ANN ONCOL, V10, P53, DOI 10.1023/A:1008332318884; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Meinel FG, 2010, MOL CANCER THER, V9, P300, DOI 10.1158/1535-7163.MCT-09-0645; Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763; Kisucka J, 2001, GEN PHYSIOL BIOPHYS, V20, P439; Tsubaki M, 2013, EUR J CANCER, V49, P3708, DOI 10.1016/j.ejca.2013.07.010; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; Tsubaki M, 2012, LEUKEMIA RES, V36, P1315, DOI 10.1016/j.leukres.2012.07.003; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Galski H, 2006, LEUKEMIA RES, V30, P1151, DOI 10.1016/j.leukres.2006.02.016; Reece DE, 2008, LEUKEMIA LYMPHOMA, V49, P1470, DOI 10.1080/10428190802064941; Richardson P, 2007, HEMATOL-AM SOC HEMAT, V2007, P317, DOI 10.1182/asheducation-2007.1.317; Sonneveld P, 2000, J INTERN MED, V247, P521, DOI 10.1046/j.1365-2796.2000.00689.x; Tohnya TM, 2004, CANCER BIOL THER, V3, P1060; Tsubaki M, 2014, LEUKEMIA RES, V38, P121, DOI 10.1016/j.leukres.2013.10.017; Tulpule A, 2002, LEUKEMIA RES, V26, P121, DOI 10.1016/S0145-2126(01)00113-8; Zhang M, 2005, PROSTATE, V64, P293, DOI 10.1002/pros.20263	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	APR	2015	39	4					445	452		10.1016/j.leukres.2015.01.016		8	Oncology; Hematology	Oncology; Hematology	CE3GK	WOS:000351714500010		
J	Fotios, S; Uttley, J; Cheal, C; Hara, N				Fotios, S.; Uttley, J.; Cheal, C.; Hara, N.			Using eye-tracking to identify pedestrians' critical visual tasks, Part 1. Dual task approach	LIGHTING RESEARCH & TECHNOLOGY			English	Article							GAZE; ATTENTION; FIXATION; ENVIRONMENT; LOCOMOTION; MOVEMENTS; DIRECTION; BEHAVIOR; WALKING; VISION	This paper investigates the critical visual tasks of pedestrians, the first step in a review of design guidance for lighting in residential roads. Eye tracking was used to record pedestrians' visual fixations when walking outdoors in daytime and after dark with a concurrent dual task to better understand which fixations were critical. Fixations at critical instances, these being shown by slow reactions to the secondary task, were categorised into one of eight groups. Of these, the path and other people were the most frequent items, with people more likely to be fixated at a far distance and the path at a near distance. After dark the path was more likely to be fixated and other people less likely to be fixated compared with daylight.	[Fotios, S.; Uttley, J.; Cheal, C.] Univ Sheffield, Sch Architecture, Sheffield S10 2TN, S Yorkshire, England; [Hara, N.] Kansai Univ, Fac Environm & Urban Engn, Dept Architecture, Suita, Osaka, Japan	Fotios, S (reprint author), Univ Sheffield, Sch Architecture, Arts Tower,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	steve.fotios@sheffield.ac.uk			EPSRC as part of the MERLIN project [EP/H050817]; University College London (UCL); City University London; EPSRC; Kansai University	This work was carried out through support from EPSRC (EP/H050817) as part of the MERLIN project, a collaboration with University College London (UCL) and City University London, the EPSRC-funded E-Futures Doctoral Training Centre for Interdisciplinary Energy Research, University of Sheffield and Kansai University's Overseas Research Program for the year of 2012.	Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Fotios S, 2012, LIGHTING RES TECHNOL, V44, P69, DOI 10.1177/1477153511432678; Underwood G, 2005, OPHTHAL PHYSL OPT, V25, P346, DOI 10.1111/j.1475-1313.2005.00290.x; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Vansteenkiste P, 2013, ACCIDENT ANAL PREV, V51, P222, DOI 10.1016/j.aap.2012.11.025; Triesch J, 2003, J VISION, V3, P86, DOI 10.1167/3.1.9; Davoudian N, 2012, LIGHTING RES TECHNOL, V44, P438, DOI 10.1177/1477153512437157; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Marigold DS, 2007, NEUROSCIENCE, V144, P302, DOI 10.1016/j.neuroscience.2006.09.006; Jovancevic-Misic J, 2009, J NEUROSCI, V29, P6234, DOI 10.1523/JNEUROSCI.5570-08.2009; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; Forster S, 2009, COGNITION, V111, P345, DOI 10.1016/j.cognition.2009.02.006; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Taylor T, 2013, ACCIDENT ANAL PREV, V58, P175, DOI 10.1016/j.aap.2013.02.008; Boot WR, 2005, PSYCHON B REV, V12, P662, DOI 10.3758/BF03196755; British Standards Institution, 1992, BS5489 3; British Standards Institution, 2012, 548912013 BS; British Standards Institution (BSI), 2003, 1320122003 BS EN; BSI, 2003, BS548912003; Caminada JF, 1980, 43 PHIL LIGHT DES EN; Field A, 2005, DISCOVERING STAT USI; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Fotios S, 2015, LIGHTING RES TECHNOL, V47, P149, DOI 10.1177/1477153514522473; Fotios S, 2013, PROCEEDINGS OF THE CIE CENTENARY CONFERENCE TOWARDS A NEW CENTURY OF LIGHT, P234; Fotios SA, 2013, LEUKOS, V9, P245, DOI 10.1582/LEUKOS.2013.09.04.002; Foulsham T, 2013, CAN J EXP PSYCHOL, V67, P51, DOI 10.1037/a0030217; Hall Edward T, 1966, HIDDEN DIMENSION; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Logadottir A, 2011, LIGHTING RES TECHNOL, V43, P403, DOI 10.1177/1477153511400971; Pashler HE, 1998, PSYCHOL ATTENTION; POULTON EC, 1977, BRIT J PSYCHOL, V68, P409; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; SIMONS R.H., 1987, P CIE VEN JUN 17 25, P274; Turano KA, 2001, OPTOMETRY VISION SCI, V78, P667, DOI 10.1097/00006324-200109000-00012; Underwood G., 2003, TRANSPORT RES F-TRAF, V6, P289, DOI DOI 10.1016/J.TRF.2003.09.002; Unwin J, 2011, INGINERIA ILUMINATUL, V13, P29; Uttley J, 2013, ARCHIT SCI REV, V56, P306, DOI 10.1080/00038628.2012.724380	42	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1477-1535	1477-0938		LIGHTING RES TECHNOL	Lighting Res. Technol.	APR	2015	47	2					133	148		10.1177/1477153514522472		16	Construction & Building Technology; Optics	Construction & Building Technology; Optics	CE3AN	WOS:000351696300003		
J	Li, H; Wang, S; Takayama, K; Harada, T; Okamoto, I; Iwama, E; Fujii, A; Ota, K; Hidaka, N; Kawano, Y; Nakanishi, Y				Li, Heyan; Wang, Shuo; Takayama, Koichi; Harada, Taishi; Okamoto, Isamu; Iwama, Eiji; Fujii, Akiko; Ota, Keiichi; Hidaka, Noriko; Kawano, Yuko; Nakanishi, Yoichi			Nicotine induces resistance to erlotinib via cross-talk between alpha 1 nAChR and EGFR in the non-small cell lung cancer xenograft model	LUNG CANCER			English	Article						Epidermal growth factor receptor tyrosine kinase inhibitor; Erlotinib; Nicotine; Nicotine acetylcholine receptor; Non-small cell lung cancer; Resistance	ACETYLCHOLINE-RECEPTORS; MEDIATED ACTIVATION; EPITHELIAL-CELLS; IN-VIVO; GROWTH; PROLIFERATION; SMOKING; EXPRESSION; SMOKERS; PATHWAYS	Objectives: Given our previously published study, a 1 nicotinic acetylcholine receptor (nAChR) plays an essential role in nicotine-induced cell signaling and nicotine-induced resistance to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer (NSCLC) PC9 cells. The aim of this study was to investigate the potential mechanism between nAChR and EGFR for nicotine-induced resistance to EGFR-TKI erlotinib in the NSCLC xenograft model. Materials and methods: We identified the role of nicotine to EGFR/AKT/ERK pathways and to erlotinib-resistance in NSCLC PC9 and HCC827 cells by MTS assay and western blot. Then, we established the PC9 xenograft model with nicotine exposure and treated mice with erlotinib combined with vehicle or nicotine. Results: We confirmed the effects of nicotine on EGFR/AKT/ERK pathways and determined nicotine's potential in preventing from the effect of erlotinib on NSCLC cells. Then, we showed that nicotine exposures can promote tumor growth and induce resistance to erlotinib in the PC9 xenograft model. Our results also indicated that chronic oral administration of nicotine can cause more significant erlotinib-resistance compared with acute i.v. injection of nicotine through activating a 1 nAChR and EGFR pathways. Conclusions: These results suggest that nicotine contributes to the progression and erlotinib-resistance of the NSCLC xenograft model via the cooperation between nAChR and EGFR. (c) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Li, Heyan; Wang, Shuo; Takayama, Koichi; Harada, Taishi; Okamoto, Isamu; Iwama, Eiji; Fujii, Akiko; Ota, Keiichi; Hidaka, Noriko; Kawano, Yuko; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 8128582, Japan; [Wang, Shuo] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Takayama, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	koichi-t@kokyu.med.kyushu-u.ac.jp			Research Institute for Diseases of the Chest, Kyushu University (Fukuoka, Japan)	This study was supported by Research Institute for Diseases of the Chest, Kyushu University (Fukuoka, Japan); and was performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Ministry of Education, Culture, Sports, Science and Technology of Japan.	Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-00510C; Tsai JR, 2006, DNA CELL BIOL, V25, P312, DOI 10.1089/dna.2006.25.312; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Zeng F, 2012, MED ONCOL, V29, P364, DOI 10.1007/s12032-010-9792-9; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Cataldo JK, 2010, ONCOLOGY-BASEL, V78, P289, DOI 10.1159/000319937; Clark GM, 2006, CLIN LUNG CANCER, V7, P389, DOI 10.3816/CLC.2006.n.022; Egleton RD, 2009, PHARMACOL THERAPEUT, V121, P205, DOI 10.1016/j.pharmthera.2008.10.007; Pollack VA, 1999, J PHARMACOL EXP THER, V291, P739; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Khalil AA, 2013, BRAIN TUMOR PATHOL, V30, P73, DOI 10.1007/s10014-012-0101-5; [Anonymous], 2014, CANC FACTS FIG; Chen RJ, 2008, TOXICOL SCI, V104, P283, DOI 10.1093/toxsci/kfn086; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Wang S, 2013, J THORAC ONCOL, V8, P719, DOI 10.1097/JTO.0b013e31828b51d4; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; WAGENKNECHT LE, 1990, AM J PUBLIC HEALTH, V80, P1053, DOI 10.2105/AJPH.80.9.1053; Siu ECK, 2007, MOL PHARMACOL, V71, P826, DOI 10.1124/mol.106.032086; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; Benowitz N. L., 2009, HDB EXP PHARM, V192, P29, DOI DOI 10.1007/978-3-540-69248-5_2; Catassi A, 2008, MUTAT RES-REV MUTAT, V659, P221, DOI 10.1016/j.mrrev.2008.04.002; Clark G, 2005, LUNG CANCER-J IASLC, V49, pS368, DOI 10.1016/S0169-5002(05)81439-4; Connors SK, 2009, ONCOGENE, V28, P921, DOI 10.1038/onc.2008.429; Davis R, 2009, PLOS ONE, V4, P9; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; HILL P, 1983, J CHRON DIS, V36, P439, DOI 10.1016/0021-9681(83)90136-4; Improgo MR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00251; Jensen K., 2012, TRANSL GASTROINTEST, V1, P81, DOI DOI 10.3978/J.ISSN.2224-4778.2011.12.01; Maier CR, 2011, CANCER PREV RES, V4, P1743, DOI 10.1158/1940-6207.CAPR-11-0365; Nishioka T, 2011, BREAST CANCER RES, V13, P11; Nordquist LT, 2004, CHEST, V126, P347, DOI 10.1378/chest.126.2.347; Ouchi KF, 2006, CANCER CHEMOTH PHARM, V57, P693, DOI 10.1007/s00280-005-0079-3; Parsons A, 2010, BMJ-BRIT MED J, P340; Rogers SW, 2005, MONOGRAPH NATL CANC, P133	41	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	APR	2015	88	1					1	8		10.1016/j.lungcan.2015.01.017		8	Oncology; Respiratory System	Oncology; Respiratory System	CE4IS	WOS:000351794900001		
J	Togashi, Y; Hayashi, H; Okamoto, K; Fumita, S; Terashima, M; de Velasco, MA; Sakai, K; Fujita, Y; Tomida, S; Nakagawa, K; Nishio, K				Togashi, Yosuke; Hayashi, Hidetoshi; Okamoto, Kunio; Fumita, Soichi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nakagawa, Kazuhiko; Nishio, Kazuto			Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal	LUNG CANCER			English	Article						Non-small cell lung cancer; Epidermal growth factor receptor mutation; Epidermal growth factor receptor tyrosine kinase inhibitor; Nicotine; Cigarette smoking	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; OPEN-LABEL; ACETYLCHOLINE-RECEPTORS; ACQUIRED-RESISTANCE; CELL-PROLIFERATION; 1ST-LINE TREATMENT; JAPANESE PATIENTS; TUMOR-GROWTH; PHASE-III	Background: Some of patients with non-small cell lung cancer (NSCLC) harboring somatic activating mutations of the epidermal growth factor receptor gene (EGFR mutations) show poor responses to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) treatment. Cigarette smoking is the strongest documented risk factor for the development of lung cancer. Nicotine, while not carcinogenic by itself, has been shown to induce proliferation, angiogenesis, and the epithelial-mesenchymal transition; these effects might be associated with EGFR-TKI resistance. Materials and methods: PC-9 and 11-18 cell lines (EGFR-mutated NSCLC cell lines) were cultured with 1 mu M nicotine for 3 months and were designated as PC-9/N and 11-18/N cell lines, respectively. The sensitivities of these cell lines to EGFR-TKI were then tested in vitro. Moreover, the association between the smoking status and the progression-free survival (PFS) period was investigated in patients with EGFR-mutated NSCLC who were treated with gefitinib. Results: The PC-9/N and 11-18/N cell lines were resistant to EGFR-TKI, compared with controls. The phosphorylation of EGFR in these cell lines was reduced by EGFR-TKI to a smaller extent than that observed in controls, and a higher concentration of EGFR-TKI was capable of further decreasing the phosphorylation. Clinically, smoking history was an independent predictor of a poor PFS period on gefitinib treatment. Conclusions: Chronic nicotine exposure because of cigarette smoking mediates resistance to EGFR-TKI via an EGFR signal. Smoking cessation is of great importance, while resistance may be overcome through the administration of high-dose EGFR-TKI. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Togashi, Yosuke; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka, Japan; [Hayashi, Hidetoshi; Okamoto, Kunio; Fumita, Soichi; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Sayama, Osaka, Japan; [Hayashi, Hidetoshi; Okamoto, Kunio; Fumita, Soichi] Kishiwada Municipal Hosp, Dept Med Oncol, Osaka, Japan	Nishio, K (reprint author), Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka, Japan.	knishio@med.kindai.ac.jp			Third-Term Comprehensive 10-Year Strategy for Cancer Control [13801892];  [26-12493]	This study was supported by the Third-Term Comprehensive 10-Year Strategy for Cancer Control (Kazuto Nishio; 13801892) and Grant-in Aid for Japan Society for Promotion of Science Fellows (Yosuke Togashi; 26-12493).	Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Wu CH, 2011, CLIN CANCER RES, V17, P3533, DOI 10.1158/1078-0432.CCR-10-2434; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Remon J, 2014, CANCER TREAT REV, V40, P93, DOI 10.1016/j.ctrv.2013.06.002; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Ferketich AK, 2013, CANCER-AM CANCER SOC, V119, P847, DOI 10.1002/cncr.27824; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Filosto S, 2012, MOL CANCER THER, V11, P795, DOI 10.1158/1535-7163.MCT-11-0698; Filosto S, 2013, MOL CANCER THER, V12, P1579, DOI 10.1158/1535-7163.MCT-12-1029; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Wang S, 2013, J THORAC ONCOL, V8, P719, DOI 10.1097/JTO.0b013e31828b51d4; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Yamamoto N, 2008, CANCER CHEMOTH PHARM, V61, P489, DOI 10.1007/s00280-007-0494-8; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Nakagawa K, 2003, ANN ONCOL, V14, P922, DOI 10.1093/annonc/mdg250; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI [10.1016/j.tips.2007.12.006, 10.1016/j.tips,2007.12.006]; Ou SHI, 2013, J CLIN PATHOL, V66, P839, DOI 10.1136/jclinpath-2012-201296; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Benowitz NL, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.01.015; HECHT SS, 1988, CANCER LETT, V42, P141, DOI 10.1016/0304-3835(88)90251-0; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Zhang Y, 2014, CLIN LUNG CANC	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	APR	2015	88	1					16	23		10.1016/j.lungcan.2015.01.027		8	Oncology; Respiratory System	Oncology; Respiratory System	CE4IS	WOS:000351794900003		
J	Henschke, CI; Yip, R; Boffetta, P; Markowitz, S; Miller, A; Hanaoka, T; Wu, N; Zulueta, JJ; Yankelevitz, DF				Henschke, Claudia I.; Yip, Rowena; Boffetta, Paolo; Markowitz, Steven; Miller, Albert; Hanaoka, Takaomi; Wu, Ning; Zulueta, Javier J.; Yankelevitz, David F.		I-ELCAP Investigators	CT screening for lung cancer: Importance of emphysema for never smokers and smokers	LUNG CANCER			English	Article						Emphysema; Lung cancer; Smokers; Never smokers; CT screening; Secondhand tobacco smoke exposure	ENVIRONMENTAL TOBACCO-SMOKE; OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; 2ND-HAND SMOKE; UNITED-STATES; MORTALITY; EXPOSURE; SOCIETY; RISK; TOMOGRAPHY	Purpose: To address the prevalence of lung cancer in high and low-risk people according to their smoking history, age, and CT findings of emphysema. Methods: We reviewed the baseline low-dose CF scans of 62,124 current, former and never smokers, aged 40-90 to determine the prevalence of lung cancer. We performed logistic regression analysis of the prevalence of lung cancer to determine the odds ratio (OR) for emphysema, conditionally on age, female gender, and ethnicity. Results: The prevalence of lung cancer was 1.4% (95% CI: 1.3-1.6) for current smokers, 1.1% (95% CI: 1.0-1.2) for former smokers, and 0.4% (95% CI: 0.3-0.6) for never smokers. Emphysema was identified in 28.5% (6,684), 20.6% (5,422), and 1.6% (194) of current, former, and never smokers, respectively. The prevalence of lung cancer among current smokers was 1.1% for those without emphysema vs. 2.3% for those with emphysema (odds ratio [OR] 1.8; 95% confidence interval [CI]: 1.4-2.2) and the corresponding difference for former smokers was 0.9% vs. 1.8% (OR: 1.7; 95% CI: 13-2.2), and for never smokers, it was 0.4% vs. 2.6% (OR: 6.3; 95% CI: 2.4-16.9). Conclusions: Identification of emphysema in low-dose CT scans increases the risk of lung cancer and is important in determining follow-up of current, former, and never smokers. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Henschke, Claudia I.; Yip, Rowena; Yankelevitz, David F.] Mt Sinai Sch Med, Dept Radiol, New York, NY 10029 USA; [Yip, Rowena; Boffetta, Paolo] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY 10029 USA; [Markowitz, Steven; Miller, Albert] CUNY Queens Coll, Flushing, NY 11367 USA; [Hanaoka, Takaomi] Azumi Gen Hosp, Nagano, Japan; [Wu, Ning] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Zulueta, Javier J.] Univ Navarra Clin, Pamplona, Spain	Henschke, CI (reprint author), Mt Sinai Sch Med, Dept Radiol, 1 Gustave Levy Pl, New York, NY 10029 USA.	Claudia.Henschke@mountsinai.org			Flight Attendant Medical Research Institute	This report has been funded in part by the Flight Attendant Medical Research Institute. The sponsor had no involvement in any study design, data collection, data analysis and interpretation and manuscript writing.	Henschke CI, 2006, NEW ENGL J MED, V355, P1763; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Coultas DB, 2001, AM J RESP CRIT CARE, V164, P372; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Vineis P, 2005, BRIT MED J, V330, P277, DOI 10.1136/bmj.38327.648472.82; WHITTEMORE AS, 1995, AM J PUBLIC HEALTH, V85, P702, DOI 10.2105/AJPH.85.5.702; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; de Torres JP, 2011, CHEST, V139, P36, DOI 10.1378/chest.10-0984; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Zulueta JJ, 2012, CHEST, V141, P1216, DOI 10.1378/chest.11-0101; Thun MJ, 1997, J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Beatty AL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-81; Cardenas VM, 1997, CANCER CAUSE CONTROL, V8, P57, DOI 10.1023/A:1018483121625; Jordan RE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000153; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; New York Early Lung Cancer Action Project I, 2007, RADIOLOGY, V243, P239; Office on Smoking and Health (US), 2006, HLTH CONS INV EXP TO; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; Thun MJ, 1997, PREV MED, V26, P422, DOI 10.1006/pmed.1997.0182; TREDANIEL J, 1994, EUR RESPIR J, V7, P173, DOI 10.1183/09031936.94.07010173; US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health, 2010, TOB SMOK CAUS DIS BI; U.S. Public Health Service, 1964, SMOK HLTH REP ADV CO, P33; Yankelevitz DF, 2013, JACC-CARDIOVASC IMAG, V6, P651, DOI 10.1016/j.jcmg.2013.02.004	27	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	APR	2015	88	1					42	47		10.1016/j.lungcan.2015.01.014		6	Oncology; Respiratory System	Oncology; Respiratory System	CE4IS	WOS:000351794900006		
J	Fukushima, T; Tateishi, K; Hanaoka, M; Koizumi, T				Fukushima, Toshirou; Tateishi, Kazunari; Hanaoka, Masayuki; Koizumi, Tomonobu			Clinical outcomes in patients with small cell lung cancer in a single institute: Comparative analysis of radiographic screening with symptom-prompted patients	LUNG CANCER			English	Article						SCLC; CT screening; Radiographic survey; Prognosis; Lung cancer; Health screening	SPIRAL CT; STAGE; EDITION; SURGERY; PROJECT; TUMOR; JAPAN	Objectives: The present study was performed to evaluate the differences in clinical characteristics and survival outcomes of patients with small cell lung cancer (SCLC) according to methods used for detecting the disease: radiographic screening or symptomatically prompted. Materials and methods: The clinical findings and actual treatment outcomes were estimated according to three means of detection of SCLC: computed tomography (CT), radiographic test, and symptom-prompted cases. Results: We identified 147 patients (male/female ratio: 127/20; mean age: 68.1 years old) between 2000 and 2011. The patients were divided into three categories according to method of detection: chest CT (CT; n =24), radiographic screening (CXR; n =37), and symptom-prompted cases (symptom; n = 86). There was no significant shift to early TNM stage distribution in the CT or CXR group compared with the symptom group. However, the rates of limited disease (LD)-SCLC were significantly higher in the CT and CXR groups than the symptom group. Median survival times were 17.0 months (95% confidence interval (CI): 11.6-22.4) in the CT group, 19.0 months (95%CI: 11.7-126.3) in the CXR group, and 12.0 months (95%0: 9.6-14.4) in the symptom group. There were statistically significant differences in overall survival between CT and symptom groups (P< 0.05) and between CXR and symptom groups (P< 0.001). However, there was no significant difference in survival between CT and CXR groups. Conclusions: Radiographic (CT plus OCR) testing contributes to better clinical outcome in patients with SCLC. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Fukushima, Toshirou; Koizumi, Tomonobu] Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, Nagano 3908621, Japan; [Fukushima, Toshirou; Tateishi, Kazunari; Hanaoka, Masayuki] Shinshu Univ, Sch Med, Dept Internal Med 1, Nagano 3908621, Japan	Koizumi, T (reprint author), Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, 3-1-1 Asahi Matsumoto, Nagano 3908621, Japan.	tomonobu@shinshu-u.ac					Rodriguez E, 2010, CURR ONCOL REP, V12, P327, DOI 10.1007/s11912-010-0120-5; Lim E, 2008, J THORAC ONCOL, V3, P1267, DOI 10.1097/JTO.0b013e318189a860; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Schreiber D, 2010, CANCER-AM CANCER SOC, V116, P1350, DOI 10.1002/cncr.24853; Austin JHM, 2012, LUNG CANCER, V76, P339, DOI 10.1016/j.lungcan.2011.11.017; Henschke CI, 2006, ARCH INTERN MED, V166, P321; Stinchcombe TE, 2010, ONCOLOGIST, V15, P187, DOI 10.1634/theoncologist.2009-0298; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P139, DOI 10.1093/jjco/hyq169; Sone S, 2007, LUNG CANCER, V56, P207, DOI 10.1016/j.lungcan.2006.12.014; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Shepherd FA, 2007, J THORAC ONCOL, V2, P1067, DOI 10.1097/JTO.0b013e31815bdc0d; Turrisi AT, 1999, NEW ENGL J MED, V340, P265, DOI 10.1056/NEJM199901283400403; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Kaneko M, 1996, RADIOLOGY, V201, P798; Church TR, 2003, ACAD RADIOL, V10, P713, DOI 10.1016/S1076-6332(03)80095-8; Cuffe S, 2011, J THORAC ONCOL, V6, P818, DOI 10.1097/JTO.0b013e31820c2f2e; Dubey S, 2009, AM J RESP CRIT CARE, V179, P860, DOI 10.1164/rccm.200902-0289UP; Fukushima T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0623-7; Koike T, 2009, J THORAC ONCOL, V4, P1364, DOI 10.1097/JTO.0b013e3181ba2054; Kondo R, 2011, LUNG CANCER, V74, P433, DOI 10.1016/j.lungcan.2011.05.007; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Samson DJ, 2007, CHEST, V132, p314S, DOI 10.1378/chest.07-1384; Sobin LH, 2002, UICC TNM CLASSIFICAT; Stahel RA, 1989, LUNG CANCER, V5, P119, DOI 10.1016/0169-5002(89)90156-6	24	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	APR	2015	88	1					48	51		10.1016/j.lungcan.2015.01.025		4	Oncology; Respiratory System	Oncology; Respiratory System	CE4IS	WOS:000351794900007		
J	Takenaka, T; Takenoyama, M; Inamasu, E; Yoshida, T; Toyokawa, G; Nosaki, K; Hirai, F; Yamaguchi, M; Shimokawa, M; Seto, T; Ichinose, Y				Takenaka, Tomoyoshi; Takenoyama, Mitsuhiro; Inamasu, Eiko; Yoshida, Tsukihisa; Toyokawa, Gouji; Nosaki, Kaname; Hirai, Fumihiko; Yamaguchi, Masafumi; Shimokawa, Mototsugu; Seto, Takashi; Ichinose, Yukito			Role of surgical resection for patients with limited disease-small cell lung cancer	LUNG CANCER			English	Article						Limited disease-small cell lung cancer; Surgery; Overall survival; Chemotherapy; Radiotherapy; Lung cancer	FORTHCOMING 7TH EDITION; PHASE-II TRIAL; STAGING PROJECT; INTERNATIONAL-ASSOCIATION; EMISSION-TOMOGRAPHY; TNM-CLASSIFICATION; FDG-PET; SURGERY; CHEMOTHERAPY; PROPOSALS	Objectives: Although chemotherapy and radiotherapy are recommended for patients with limited disease small cell lung cancer (LD-SCLC), several series have reported favorable survival outcomes even in patients with stages II and III disease who underwent surgical resection. The purpose of this study is to compare the outcomes of the use of surgical resection to the other conventional non-surgical treatments in patients with LD-SCLC with respect to each clinical stage. Materials and methods: We retrospectively reviewed 277 patients who received treatment for LD-SCLC and compared the outcomes of the use of surgical resection to the other conventional non-surgical treatments. Results: The clinical stage was stage I in 50 cases (18%), stage II in 53 cases (19%) and stage III in 174 cases (63%). Eighty-eight patients received surgical resection and 189 patients were treated with nonsurgical treatment. Surgery was performed in 44 patients (88%) with stage 1,27 patients (52%) with stage II and 17 patients (10%) with stage III disease. The five-year survival rates of the patients according to clinical stage were 58% in stage I, 29% in stage II and 18% in stage III. The five-year survival rates of the patients with and without surgical resection according to clinical stage were as follows: 62% and 25% in stage I (p <0.01), 33% and 24% in stage II (p = 0.95), 18% and 18% in stage III (p =0.35), respectively. In 44 propensity score-matched pairs with stages II and III disease, including matching for variables such as age, gender and the PS, the five-year survival rates was better in patients with surgical resection than in those without surgery (p = 0.04). Conclusion: Surgical resection is effective for the patients with stage I LD-SCLC and some cases of stage II or III disease. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Takenaka, Tomoyoshi; Takenoyama, Mitsuhiro; Inamasu, Eiko; Yoshida, Tsukihisa; Toyokawa, Gouji; Nosaki, Kaname; Hirai, Fumihiko; Yamaguchi, Masafumi; Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; [Shimokawa, Mototsugu; Ichinose, Yukito] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan	Takenaka, T (reprint author), Natl Hosp Org, Kyushu Canc Ctr, Dept Thorac Oncol, Minami Ku, Notame 3-1-1, Fukuoka 8111395, Japan.	ttake@surg2.med.kyushu-u.ac.jp					[Anonymous], 2013, CHEST, V143; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Tsuchiya R, 2005, J THORAC CARDIOV SUR, V129, P977, DOI 10.1016/j.jtcvs.2004.05.030; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Schreiber D, 2010, CANCER-AM CANCER SOC, V116, P1350, DOI 10.1002/cncr.24853; Fischer BM, 2007, ANN ONCOL, V18, P338, DOI 10.1093/annonc/mdl374; Bradley JD, 2004, J CLIN ONCOL, V22, P3248, DOI 10.1200/JCO.2004.11.089; Yu JB, 2010, J THORAC ONCOL, V5, P215, DOI 10.1097/JTO.0b013e3181cd3208; Brock MV, 2005, J THORAC CARDIOV SUR, V129, P64, DOI 10.1016/j.jtcvs.2004.08.022; Badzio A, 2004, EUR J CARDIO-THORAC, V26, P183, DOI 10.1016/j.ejcts.2004.04.012; Shepherd FA, 2007, J THORAC ONCOL, V2, P1067, DOI 10.1097/JTO.0b013e31815bdc0d; Micke P, 2002, LUNG CANCER-J IASLC, V37, P271, DOI 10.1016/S0169-5002(02)00072-7; Brink I, 2004, EUR J NUCL MED MOL I, V31, P1614, DOI 10.1007/s00259-004-1606-x; Chin R, 2002, LUNG CANCER-J IASLC, V37, P1, DOI 10.1016/S0169-5002(01)00492-5; Eberhardt W, 1999, BRIT J CANCER, V81, P1206, DOI 10.1038/sj.bjc.6690830; FOX W, 1973, LANCET, V2, P616; Hanagiri T, 2009, J THORAC ONCOL, V4, P964, DOI 10.1097/JTO.0b013e3181a8cd84; Inoue M, 2000, ANN THORAC SURG, V70, P1615, DOI 10.1016/S0003-4975(00)01401-6; Kut V, 2007, AM J CLIN ONCOL-CANC, V30, P45, DOI 10.1097/01.coc.0000239095.09662.19; LAD T, 1994, CHEST, V106, pS320, DOI 10.1378/chest.106.6.320S; MILLER AB, 1969, LANCET, V2, P501; National Comprehensive Cancer Network (NCCN), 2013, NCCN CLIN PRACT GUID; Toyoda Y, 2009, JPN J CLIN ONCOL, V38, P534	25	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	APR	2015	88	1					52	56		10.1016/j.lungcan.2015.01.010		5	Oncology; Respiratory System	Oncology; Respiratory System	CE4IS	WOS:000351794900008		
J	Takeda, M; Okamoto, I; Nakagawa, K				Takeda, Masayuki; Okamoto, Isamu; Nakagawa, Kazuhiko			Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer	LUNG CANCER			English	Article						Epidermal growth factor receptor; Non-small cell lung cancer; Tyrosine kinase inhibitor; Adverse event; pooled analysis; ethnic difference	FACTOR-RECEPTOR MUTATIONS; PHASE-II TRIAL; JAPANESE PATIENTS; OPEN-LABEL; 1ST-LINE GEFITINIB; GENE-MUTATIONS; ONCOLOGY-GROUP; CHEMOTHERAPY; ERLOTINIB; AFATINIB	Objectives: Three epidermal growth factor receptor (EGER) tyrosine kinase inhibitors (TKIs) - afatinib, erlotinib, and gefitinib - are available for the treatment of patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). Given the long-term exposure of such patients to EGFR-TKIs, the toxicological properties of these agents in these individuals may differ from those observed in unselected patients. We compared the frequencies of severe adverse events (AEs) among EGFR mutation-positive NSCLC patients treated with these three EGFR-TKIs. Materials and methods: We performed a pooled analysis of severe AEs according to the type of EGFR-TKI administered with the use of data extracted from prospective clinical trials that evaluated the clinical efficacy of gefitinib, erlotinib, or afatinib in NSCLC patients with EGFR mutations. Results: Twenty-one trials published between 2006 and 2014 and including 1468 patients were eligible for analysis. Patients in 13 trials (n = 457) received gefitinib, those in 5 trials (n = 513) received erlotinib, and those in 3 trials (n = 498) received afatinib. Rash and diarrhea of grade >= 3 were significantly more frequent with afatinib therapy than with erlotinib or gefitinib therapy. The frequency of interstitial lung disease (ILD) of grade >= 3 was low (0.6-2.2%) with all three EGFR-TKIs and did not differ significantly among them. Gefitinib was associated with a significantly higher frequency of hepatotoxicity of grade >= 3 compared with erlotinib or afatinib. The overall frequency of AEs leading to treatment withdrawal was 6.1% (83 of 1354 evaluable patients), with such AEs occurring significantly more often with afatinib or gefitinib than with erlotinib. The most common withdrawal AEs were skin toxicity, ILD, and hepatotoxicity. Conclusion: Such information on AEs should facilitate selection of the most appropriate EGFR-TKI for EGFR mutation-positive NSCLC patients with regard to mitigation of the risk for certain types of toxicity. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Takeda, Masayuki; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Sayama, Osaka 5898511, Japan; [Okamoto, Isamu] Kyushu Univ Hosp, Ctr Clin & Translat Res, Higashi Ku, Fukuoka 8128582, Japan	Okamoto, I (reprint author), Kyushu Univ Hosp, Ctr Clin & Translat Res, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okamotoi@kokyu.med.kyushu-u.ac.jp			National Cancer Center Research and Development Fund [26-A-4]; Uehara Memorial Foundation; Takeda Science Foundation	This study was supported in part by The National Cancer Center Research and Development Fund 26-A-4, Uehara Memorial Foundation, and Takeda Science Foundation.	Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Maemondo M, 2012, J THORAC ONCOL, V7, P1417, DOI 10.1097/JTO.0b013e318260de8b; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Yang JCH, 2012, LANCET ONCOL, V13, P539, DOI 10.1016/S1470-2045(12)70086-4; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Goto K, 2013, LUNG CANCER, V82, P109, DOI 10.1016/j.lungcan.2013.07.003; Sutani A, 2006, BRIT J CANCER, V95, P1483, DOI 10.1038/sj.bjc.6603466; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Petrelli F, 2012, CLIN LUNG CANCER, V13, P107, DOI 10.1016/j.cllc.2011.08.005; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Nelson V, 2013, ONCOTARGETS THER, V6, P135, DOI 10.2147/OTT.S23165; Sugio K, 2009, LUNG CANCER, V64, P314, DOI 10.1016/j.lungcan.2008.09.010; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Liaw YF, 2010, ANTIVIR THER, V15, P25, DOI 10.3851/IMP1621; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Natale RB, 2011, J CLIN ONCOL, V29, P1059, DOI 10.1200/JCO.2010.28.5981; Kijima T, 2011, J CLIN ONCOL, V29, pE588, DOI 10.1200/JCO.2010.34.3368; Yamada K, 2013, JPN J CLIN ONCOL, V43, P629, DOI 10.1093/jjco/hyt056; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Yoshida K, 2007, J THORAC ONCOL, V2, P22, DOI 10.1097/01243894-200701000-00006; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Asahina H, 2006, BRIT J CANCER, V95, P998, DOI 10.1038/sj.bjc.6603393; Asami K, 2011, CLIN LUNG CANCER, V12, P387; Rosell R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005133; Sunaga N, 2007, LUNG CANCER, V56, P383, DOI 10.1016/j.lungcan.2007.01.025; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1	36	6	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	APR	2015	88	1					74	79		10.1016/j.lungcan.2015.01.026		6	Oncology; Respiratory System	Oncology; Respiratory System	CE4IS	WOS:000351794900012		
J	Koizumi, T; Fukushima, T; Tatai, T; Kobayashi, T; Sekiguchi, N; Sakamoto, A; Sasaki, S				Koizumi, Tomonobu; Fukushima, Toshirou; Tatai, Toshiharu; Kobayashi, Takashi; Sekiguchi, Nodoka; Sakamoto, Akiyuki; Sasaki, Shigeru			Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer	LUNG CANCER			English	Article						Taste change; Appetite loss; Toxicity; Chemotherapy; Molecular tagetd agent; ALK inhibitor	SAFETY; CHEMOTHERAPY; DYSFUNCTION; CH5424802; TASTE	We describe a case of dysgeusia that developed gradually over one week after initiation of crizotinib administration for treatment of ALK-positive non-small cell lung cancer, necessitating discontinuation of the agent. The symptom was accompanied by progressive loss in appetite and body weight. Alectinib, a novel alternative ALK inhibitor, was administered and has been successfully continued without any toxicity, including dysgeusia. The present case indicates that dysgeusia is an important toxicity associated with crizotinib, which could adversely affect nutritional condition and quality of life. We describe the clinical course and present a review of crizotinib-induced dysgeusia. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Koizumi, Tomonobu; Fukushima, Toshirou; Tatai, Toshiharu; Kobayashi, Takashi; Sekiguchi, Nodoka; Sakamoto, Akiyuki; Sasaki, Shigeru] Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, Matsumoto, Nagano 3908621, Japan	Koizumi, T (reprint author), Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tomonobu@shinshu-u.ac.jp					Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Cowart BJ, 2011, ORAL DIS, V17, P2, DOI 10.1111/j.1601-0825.2010.01719.x; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Awad Mark M, 2014, Clin Adv Hematol Oncol, V12, P429; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Qian HL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-683	11	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	APR	2015	88	1					112	113		10.1016/j.lungcan.2015.01.018		2	Oncology; Respiratory System	Oncology; Respiratory System	CE4IS	WOS:000351794900019		
J	Chen, BL; Hsu, YS; Mino, K				Chen, Been-Lon; Hsu, Yu-Shan; Mino, Kazuo			WELFARE IMPLICATIONS AND EQUILIBRIUM INDETERMINACY IN A TWO-SECTOR GROWTH MODEL WITH CONSUMPTION EXTERNALITIES	MACROECONOMIC DYNAMICS			English	Article						Two-Sector Model; Consumption Externalities; Efficiency; Indeterminacy	STRUCTURAL TRANSFORMATION; INCOME; HABIT; HAPPINESS; JONESES; EXPLANATION; TAXATION; UTILITY; CHOICE; SECTOR	In one-sector neoclassical growth models, consumption externalities lead to an inefficient allocation in a steady state and indeterminate equilibrium toward a steady state only if there is a labor-leisure trade-off. This paper shows that in a two-sector neoclassical growth model, even without a labor-leisure trade-off, consumption spillovers easily lead to an inefficient allocation in a steady state and indeterminate equilibrium toward a steady state. Negative consumption spillovers that yield ove-accumulation of capital in a one-sector model may lead to underaccumulation or overaccumulation of capital in two-sector models, depending on the relative capital intensity between sectors. Moreover, a two-sector model economy with consumption externalities is less stabilized than an otherwise identical one-sector model economy.	[Chen, Been-Lon] Acad Sinica, Taipei 11529, Taiwan; [Hsu, Yu-Shan] Natl Chung Cheng Univ, Taipei, Taiwan; [Mino, Kazuo] Kyoto Univ, Inst Econ Res, Kyoto 6068501, Japan	Chen, BL (reprint author), Acad Sinica, Inst Econ, 128 Acad Rd Sect 2, Taipei 11529, Taiwan.	bchen@econ.sinica.edu.tw			Taiwan National Science Council [NSC 101-2410-H-001 -003 -MY3]	We thank Roger Farmer, Xavier Raurich, Jang-Ting Guo, two anonymous referees of this journal, and participants at the 2011 Asian Meeting of the Econometrics Society held in Seoul (Korea) for valuable suggestions on earlier drafts. Chen acknowledges the financial support of the Taiwan National Science Council through Grant NSC 101-2410-H-001 -003 -MY3.	Abel Andrew B., 1990, AM ECON REV, V80, P38; Alonso-Carrera Jaime, 2008, J PUBLIC ECON, V92, P1751; Alonso-Carrera Jaime, 2008, J ECON DYN CONTROL, V32, P2883; Alpizar Francisco, 2005, J ECON BEHAV ORGAN, V56, P405; Alvarez-Cuadrado Francisco, 2004, J ECON GROWTH, V9, P47; Abel AB, 1999, J MONETARY ECON, V43, P3, DOI 10.1016/S0304-3932(98)00039-7; Abel AB, 2005, REV ECON STUD, V72, P21, DOI 10.1111/0034-6527.00322; Valentinyi A, 2008, REV ECON DYNAM, V11, P820, DOI 10.1016/j.red.2008.02.003; Fisher WH, 2000, J ECON, V72, P241, DOI 10.1007/BF01231266; Frank RH, 2005, AM ECON REV, V95, P137, DOI 10.1257/000282805774670392; Oswald AJ, 1997, ECON J, V107, P1815, DOI 10.1111/1468-0297.00260; Solnick SJ, 1998, J ECON BEHAV ORGAN, V37, P373; Ljungqvist L, 2000, AM ECON REV, V90, P356, DOI 10.1257/aer.90.3.356; Dupor B, 2003, AM ECON REV, V93, P423, DOI 10.1257/000282803321455395; Campbell JY, 1999, J POLIT ECON, V107, P205, DOI 10.1086/250059; Whelan K, 2003, J MONEY CREDIT BANK, V35, P627, DOI 10.1353/mcb.2003.0032; Easterlin RA, 2001, ECON J, V111, P465, DOI 10.1111/1468-0297.00646; Ogaki M, 1998, J POLIT ECON, V106, P1078, DOI 10.1086/250040; Lee D, 2006, ECONOMETRICA, V74, P1, DOI 10.1111/j.1468-0262.2006.00648.x; Benhabib J, 1996, J MONETARY ECON, V37, P421, DOI 10.1016/0304-3932(96)01257-3; Maurer J, 2008, ECON J, V118, P454, DOI 10.1111/j.1468-0297.2007.02129.x; BENHABIB J, 1991, J POLIT ECON, V99, P1166, DOI 10.1086/261796; Turnovsky SJ, 2007, EUR ECON REV, V51, P479, DOI 10.1016/j.euroecorev.2005.12.001; Chen BL, 2013, J ECON, V109, P245, DOI 10.1007/s00712-012-0301-9; Arrow Kenneth J., 2009, ECON J, V119, P497; Benhabib Jess, 2000, REV ECON DYNAM, V3, P523, DOI 10.1006/redy.2000.0100; Carlsson Fredrik, 2007, ECONOMICA, V74, P586; Carroll Christopher D., 1997, J ECON GROWTH, V2, P339; Chen BL, 2007, J MONEY CREDIT BANK, V39, P25, DOI 10.1111/j.0022-2879.2007.00002.x; Chen BL, 2007, ECON LETT, V95, P96, DOI 10.1016/j.econlet.2006.09.020; Clark AE, 2008, J ECON LIT, V46, P95, DOI 10.1257/jel.46.1.95; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; Doi J, 2008, J ECON DYN CONTROL, V32, P3055, DOI 10.1016/j.jedc.2007.10.008; Duarte M, 2010, Q J ECON, V125, P129; Dusenbery James S., 1949, INCOME SAVING THEORY; Easterlin R. A., 1974, NATIONS HOUSEHOLDS E, P89; FARMER REA, 1994, J ECON THEORY, V63, P42, DOI 10.1006/jeth.1994.1032; GALI J, 1994, J MONEY CREDIT BANK, V26, P1, DOI 10.2307/2078030; GREENWOOD J, 1991, J POLIT ECON, V99, P1188, DOI 10.1086/261797; Grishchenko Olesya V., 2010, J ECON BUS, V62, P176; Hori T, 2011, J ECON, V102, P29, DOI 10.1007/s00712-010-0160-1; Hume D., 1748, ENQUIRY HUMAN UNDERS; BENHABIB J, 1994, J ECON THEORY, V63, P19, DOI 10.1006/jeth.1994.1031; Kim J, 2005, J ECON BEHAV ORGAN, V57, P421, DOI 10.1016/j.jebo.2005.04.001; Liu WF, 2005, J PUBLIC ECON, V89, P1097, DOI 10.1016/j.jpubeco.2003.12.004; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1162/003355305774268255; Marshall Alfred, 1898, PRINCIPLES EC; Ravina Enrichetta, 2007, WORKING PAPER; Ravn Morten, 2006, REV ECON STUD, V73, P195; Rogerson R, 2008, J POLIT ECON, V116, P235, DOI 10.1086/588029; Veblen T., 2012, THEORY LEISURE CLASS; WEDER M, 2004, PORT ECON J, V3, P1, DOI 10.1007/s10258-004-0026-y; Zabalza Antoni, 1980, J PUBLIC ECON, V14, P245	53	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1365-1005	1469-8056		MACROECON DYN	Macroecon. Dyn.	APR	2015	19	3					535	577		10.1017/S1365100514000613		43	Economics	Business & Economics	CE6JY	WOS:000351943900003		
J	Ohtaki, E				Ohtaki, Eisei			A NOTE ON THE EXISTENCE AND UNIQUENESS OF STATIONARY MONETARY EQUILIBRIUM IN A STOCHASTIC OLG MODEL	MACROECONOMIC DYNAMICS			English	Article						Stationary Monetary Equilibrium; Conditional Pareto Otimality; Stochastic Overlapping Generations Model	OVERLAPPING GENERATIONS MODELS; OPTIMALITY	This paper directly shows the equivalence between the existence of stationary monetary equilibrium and the conditional Pareto suboptimality of the initial endowment in a stochastic overlapping generations model. Especially, it gives short and constructive proofs for existence and uniqueness.	[Ohtaki, Eisei] Kanagawa Univ, Yokohama, Kanagawa 2218686, Japan	Ohtaki, E (reprint author), Kanagawa Univ, Fac Econ, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa 2218686, Japan.	ohtaki@kanagawa-u.ac.jp					AIYAGARI SR, 1991, J ECON THEORY, V54, P69; Chattopadhyay S, 1999, J ECON THEORY, V89, P21, DOI 10.1006/jeth.1999.2543; Gottardi P, 1996, J ECON THEORY, V71, P75, DOI 10.1006/jeth.1996.0109; LUCAS RE, 1972, J ECON THEORY, V4, P103, DOI 10.1016/0022-0531(72)90142-1; Magill M, 2003, ECON THEOR, V21, P435, DOI 10.1007/s00199-002-0287-6; MANUELLI R, 1990, J ECON THEORY, V51, P268, DOI 10.1016/0022-0531(90)90019-G; Ohtaki E, 2013, MATH SOC SCI, V65, P60, DOI 10.1016/j.mathsocsci.2012.06.002; Ohtaki E., 2011, EC B, V31, P485; Takayama A., 1974, MATH EC	9	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1365-1005	1469-8056		MACROECON DYN	Macroecon. Dyn.	APR	2015	19	3					701	707		10.1017/S1365100513000515		7	Economics	Business & Economics	CE6JY	WOS:000351943900008		
J	Hashimoto, H; Fujii, T; Kohara, S; Nakanishi, K; Yogi, C; Peterlik, H; Nakanishi, M; Takada, J				Hashimoto, Hideki; Fujii, Tatsuo; Kohara, Shinji; Nakanishi, Koji; Yogi, Chihiro; Peterlik, Herwig; Nakanishi, Makoto; Takada, Jun			Structural transformations of heat-treated bacterial iron oxide	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Amorphous materials; Composite materials; Nanostructures; Oxides	PORE-SIZE DISTRIBUTION; LEPTOTHRIX-OCHRACEA; SYNTHETIC FERRIHYDRITE; THERMAL-DECOMPOSITION; SOL-GEL; NANOPARTICLES; ORIGIN; ADSORPTION; HEMATITE; SPECTRA	A bacterial siliceous iron oxide microtubule (diameter: ca. 1 mu m, 15Fe(2)O(3)center dot 8SiO(2)center dot P2O6 center dot 30H(2)O) produced by Leptothrbc ochracea was heat treated in air and its structural transformation was investigated in detail by microscopy, diffractometry, and spectroscopy. Although the heat-treated bacterial iron oxide retained its original microtubular structure, its nanoscopic, middle-range, and local structures changed drastically. Upon heat treatment, nanosized pores were formed and their size changed depending on temperature. The Fe O Si linkages were gradually cleaved with increasing temperature, causing the progressive separation of Fe and Si ions into iron oxide and amorphous silicate phases, respectively. Concomitantly, global connectivity and local structure of FeO6 octahedra in the iron oxide nanoparticles systematically changed depending on temperature. These comprehensive investigations clearly revealed various structural changes of the bacterial iron oxide which is an important guideline for the future exploration of novel bio-inspired materials. (C) 2015 Elsevier B.V. All rights reserved.	[Hashimoto, Hideki; Fujii, Tatsuo; Nakanishi, Makoto; Takada, Jun] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Hashimoto, Hideki; Takada, Jun] JST, CREST, Okayama 7008530, Japan; [Kohara, Shinji] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Nakanishi, Koji] Kyoto Univ, Off Soc Acad Collaborat Innovat, Uji 6110011, Japan; [Yogi, Chihiro] Ritsumeikan Univ, SR Ctr, Kusatsu, Shiga 5258577, Japan; [Peterlik, Herwig] Univ Vienna, Fac Phys, A-1090 Vienna, Austria	Hashimoto, H (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	hideki-h@cc.okayama-u.ac.jp	Peterlik, Herwig/F-9831-2014	Peterlik, Herwig/0000-0002-2113-9920	Special Funds for Education and Research from the Ministry of Education, Culture, Sports, Science and Technology; JSPS KAKENHI [24654089, 24510151, 24760550, 23360309]	This study was financially supported by the Special Funds for Education and Research from the Ministry of Education, Culture, Sports, Science and Technology and JSPS KAKENHI Grant Number 24654089, 24510151, 24760550, and 23360309. Soft X-ray XAFS measurements were performed at BL-10 in SR center. HEXRD experiments were performed at BL04B2 in SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2007A1883, 2009B1116, and 2013A1098). Fe K-edge XAFS measurements were performed with approval from the Photon Factory Program Advisory Committee (Proposal No. 2007G112).	Jambor JL, 1998, CHEM REV, V98, P2549, DOI 10.1021/cr970105t; Seehra MS, 2004, SOLID STATE COMMUN, V130, P597, DOI 10.1016/j.ssc.2004.03.022; Hashimoto H, 2013, ACS APPL MATER INTER, V5, P5194, DOI 10.1021/am401029r; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Suzuki T, 2011, APPL ENVIRON MICROB, V77, P7873, DOI 10.1128/AEM.06003-11; Michel FM, 2007, SCIENCE, V316, P1726, DOI 10.1126/science.1142525; Hashimoto H, 2013, MATER RES BULL, V48, P1174, DOI 10.1016/j.materresbull.2012.12.022; Wang XM, 2013, ENVIRON SCI TECHNOL, V47, P10322, DOI 10.1021/es401301z; Bruce PG, 2008, ANGEW CHEM INT EDIT, V47, P2930, DOI 10.1002/anie.200702505; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; EGGLETON RA, 1988, CLAY CLAY MINER, V36, P111, DOI 10.1346/CCMN.1988.0360203; LI D, 1995, PHYS CHEM MINER, V22, P115; Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6; Hashimoto H, 2012, MATER CHEM PHYS, V137, P571, DOI 10.1016/j.matchemphys.2012.10.002; GHIORSE WC, 1984, ANNU REV MICROBIOL, V38, P515; Sitarz M, 2000, SPECTROCHIM ACTA A, V56, P1819, DOI 10.1016/S1386-1425(00)00241-9; Wu SH, 2013, CHEM SOC REV, V42, P3862, DOI 10.1039/c3cs35405a; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Pabisch S, 2012, CHEM PHYS LETT, V521, P91, DOI 10.1016/j.cplett.2011.11.049; Jiang CH, 2006, NANO TODAY, V1, P28, DOI 10.1016/S1748-0132(06)70114-1; Lee KT, 2011, NANO TODAY, V6, P28, DOI 10.1016/j.nantod.2010.11.002; Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018; Hashimoto H, 2012, MATER CHEM PHYS, V136, P1156, DOI 10.1016/j.matchemphys.2012.08.070; Spring S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P758, DOI 10.1007/0-387-30745-1_35; NAONO H, 1989, J COLLOID INTERF SCI, V128, P146, DOI 10.1016/0021-9797(89)90393-7; Hashimoto H, 2012, DYES PIGMENTS, V95, P639, DOI 10.1016/j.dyepig.2012.06.024; Daou TJ, 2006, CHEM MATER, V18, P4399, DOI 10.1021/cm060805r; SCARANO D, 1993, J CHEM SOC FARADAY T, V89, P4123, DOI 10.1039/ft9938904123; MURAD E, 1980, AM MINERAL, V65, P1044; DOLLIMORE D, 1964, J APPL CHEM, V14, P109; Ema T, 2011, GREEN CHEM, V13, P3187, DOI 10.1039/c1gc15877e; Sakai T, 2010, ORG BIOMOL CHEM, V8, P336, DOI 10.1039/b919497e; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Schauermann S, 2013, ACCOUNTS CHEM RES, V46, P1673, DOI 10.1021/ar300225s; Hashimoto H, 2014, ACS APPL MATER INTER, V6, P5374, DOI 10.1021/am500905y; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Lu L, 2005, J PHYS CHEM B, V109, P17151, DOI 10.1021/jp052780+; Campbell AS, 2002, LANGMUIR, V18, P7804, DOI 10.1021/la011741w; Cannas C, 2001, J NON-CRYST SOLIDS, V286, P64, DOI 10.1016/S0022-3093(01)00504-X; Cornell RM, 2003, IRON OXIDES STRUCTUR; DOLLIMOR.D, 1970, J COLLOID INTERF SCI, V33, P508, DOI 10.1016/0021-9797(70)90002-0; Glasauer SM, 2000, CLAY CLAY MINER, V48, P51, DOI 10.1346/CCMN.2000.0480106; Glatter O., 1982, SMALL ANGLE XRAY SCA; Greenwood N. N., 1971, MOSSBAUER SPECTROSCO; Jitianu A, 2002, J MATER CHEM, V12, P1401, DOI 10.1039/b110652j; Kohara S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/50/506101; Manceau A, 2011, AM MINERAL, V96, P521, DOI 10.2138/am.2011.3583; MANCEAU A, 1993, CLAY MINER, V28, P165, DOI 10.1180/claymin.1993.028.2.01; Nakanishi K., 2012, ADV TOPICS MEASUREME, P400; NAONO H, 1987, J COLLOID INTERF SCI, V120, P439, DOI 10.1016/0021-9797(87)90370-5	50	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	APR 1	2015	155						67	75		10.1016/j.matchemphys.2015.01.067		9	Materials Science, Multidisciplinary	Materials Science	CE2MJ	WOS:000351649400010		
J	Kozawa, T; Kataoka, N; Kondo, A; Nakamura, E; Abe, H; Naito, M				Kozawa, Takahiro; Kataoka, Noriaki; Kondo, Akira; Nakamura, Eri; Abe, Hiroya; Naito, Makio			Facile preparation of porous LiFePO4/C composite granules by mechanical process	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Composite materials; Microporous materials; Electrical characterization; Rietveld analysis	LITHIUM-ION BATTERIES; CATHODE MATERIALS; ELECTROCHEMICAL PERFORMANCE; CARBON; ELECTRODES; DIFFRACTION; TRIPHYLITE; STABILITY; CAPACITY; DENSITY	Lithium iron phosphate (LiFePO4) which is a promising cathode material for lithium-ion batteries requires particle size reduction, carbon coating and granulation to improve its electrochemical performances and increase the energy densities. In addition, their composite granules desire a porous structure in order to assist the penetration of liquid electrolyte. Here, we report a facile preparation of porous LiFePO4/C composite granules by a mechanical method using an attrition-type mill. By the mechanical treatment of starting materials, LiFePO4/C composite granules with an average pore size of 20-30 nm were synthesized in one-step process without atmosphere control and external heating. This simple mechanical technique does not require additional pore forming agents. According to the cell tests, a favorable cycle performance was exhibited. (C) 2015 Elsevier B.V. All rights reserved.	[Kozawa, Takahiro; Kataoka, Noriaki; Kondo, Akira; Nakamura, Eri; Abe, Hiroya; Naito, Makio] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Kozawa, T (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	t-kozawa@jwri.osaka-u.ac.jp			JSPS KAKENHI [24360315]	This work was supported by JSPS KAKENHI Grant Number 24360315. We would like to thank Dr. M. Okumiya of Osaka University for his fruitful discussion.	Andersson AS, 2000, ELECTROCHEM SOLID ST, V3, P66, DOI 10.1149/1.1390960; Kozawa T, 2014, CERAM INT, V40, P16127, DOI 10.1016/j.ceramint.2014.07.043; Wang GX, 2010, ADV MATER, V22, P4944, DOI 10.1002/adma.201002045; Ravet N, 2001, J POWER SOURCES, V97-8, P503, DOI 10.1016/S0378-7753(01)00727-3; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; STRELTSOV VA, 1993, ACTA CRYSTALLOGR B, V49, P147, DOI 10.1107/S0108768192004701; Prosini PP, 2002, SOLID STATE IONICS, V148, P45, DOI 10.1016/S0167-2738(02)00134-0; Sun CW, 2011, J AM CHEM SOC, V133, P2132, DOI 10.1021/ja1110464; Huang H, 2001, ELECTROCHEM SOLID ST, V4, pA170, DOI 10.1149/1.1396695; Takeuchi T, 2005, J POWER SOURCES, V146, P575, DOI 10.1016/j.jpowsour.2005.03.099; Belharouak I, 2005, ELECTROCHEM COMMUN, V7, P983, DOI 10.1016/j.elecom.2005.06.019; Dominko R, 2005, J ELECTROCHEM SOC, V152, pA607, DOI 10.1149/1.1860492; Yang JL, 2013, ENERG ENVIRON SCI, V6, P1521, DOI 10.1039/c3ee24163g; Izumi F, 2007, SOL ST PHEN, V130, P15; Yang JL, 2012, J MATER CHEM, V22, P7537, DOI 10.1039/c2jm30380a; Doeff MM, 2003, ELECTROCHEM SOLID ST, V6, pA207, DOI 10.1149/1.1601372; Wang JJ, 2012, ENERG ENVIRON SCI, V5, P5163, DOI 10.1039/c1ee01263k; Croce F, 2002, ELECTROCHEM SOLID ST, V5, pA47, DOI 10.1149/1.1449302; Delacourt C, 2006, ELECTROCHEM SOLID ST, V9, pA352, DOI 10.1149/1.2201987; Chen ZH, 2002, J ELECTROCHEM SOC, V149, pA1184, DOI 10.1149/1.1498255; Hsu KF, 2004, J MATER CHEM, V14, P2690, DOI 10.1039/b406774f; Smith AJ, 2010, J ELECTROCHEM SOC, V157, pA196, DOI 10.1149/1.3268129; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Oh SW, 2009, ELECTROCHEM SOLID ST, V12, pA181, DOI 10.1149/1.3143901; Dominko R., 2006, J POWER SOURCES, V153, P274; Koltypin M, 2007, ELECTROCHEM SOLID ST, V10, pA40, DOI 10.1149/1.2403974; Kondo A, 2014, ADV POWDER TECHNOL, V25, P1280, DOI 10.1016/j.apt.2014.03.005; Ohara S, 2008, J EUR CERAM SOC, V28, P1815, DOI 10.1016/j.jeurceramsoc.2007.11.014; Wang J., ENERGY ENV SCI; Zhong ME, 2010, MATER CHEM PHYS, V119, P428, DOI 10.1016/j.matchemphys.2009.09.017	30	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	APR 1	2015	155						246	251		10.1016/j.matchemphys.2015.02.038		6	Materials Science, Multidisciplinary	Materials Science	CE2MJ	WOS:000351649400032		
J	Zarate-Trivino, DG; Prokhorov, E; Luna-Barcenas, G; Mendez-Nonell, J; Gonzalez-Campos, JB; Elizalde-Pena, E; Mota-Morales, JD; Santiago-Jacinto, P; Terrones, M; Gomez-Salazar, S; Nuno-Donlucas, SM; Sanchez, IC				Zarate-Trivino, D. G.; Prokhorov, E.; Luna-Barcenas, G.; Mendez-Nonell, J.; Gonzalez-Campos, J. B.; Elizalde-Pena, E.; Mota-Morales, Josue D.; Santiago-Jacinto, P.; Terrones, M.; Gomez-Salazar, S.; Nuno-Donlucas, S. M.; Sanchez, I. C.			The effect of CNT functionalization on electrical and relaxation phenomena in MWCNT/chitosan composites	MATERIALS CHEMISTRY AND PHYSICS			English	Article						Biomaterials; Electrical properties; Dielectric properties; Microstructure	WALLED CARBON NANOTUBES; INDUCED PHASE-SEPARATION; DIELECTRIC-RELAXATION; POLYMER ELECTROLYTES; CHITOSAN; POLYSACCHARIDES; NANOCOMPOSITES; CONDUCTIVITY; DISPERSION; SCAFFOLDS	The effect of the type of CNT (functionalized and non-functionalized) on the dielectric relaxation phenomena and conductivity of MWCNT/chitosan (MWCNT/CS) was investigated. Composites were prepared by the solvent cast method by homogeneously dispersing CNT into a CS matrix. FTIR analysis suggests the formation of hydrogen bonding in functionalized-MWCNT/CS whereas the CS remains unaffected in non-functionalized films. In the low conductivity region, the alpha-relaxation process associated with a glass transition in CS is affected by the MWCNT; the Vogel temperature increases due to a decrease of the water content. The sigma-relaxation exhibits a typical Arrhenius-type temperature dependence that is independent on the moisture content. Strong interfacial interactions of functionalized-MWCNT with the CS matrix are responsible for high values of the contact resistance R-c between individual CNT. Conversely, non-functionalized MWCNTs exhibit a typical 3D percolation threshold at ca. 4 wt %. (C) 2015 Elsevier B.V. All rights reserved.	[Zarate-Trivino, D. G.; Prokhorov, E.; Luna-Barcenas, G.; Mota-Morales, Josue D.] Cinvestav Unidad Queretaro, Queretaro 76230, Qro, Mexico; [Mendez-Nonell, J.] Cinvestav Unidad Saltillo, Ramos Arizpe 25900, Mexico; [Gonzalez-Campos, J. B.] Univ Michoacana, Morelia 58060, Michoacan, Mexico; [Elizalde-Pena, E.] Univ Autonoma Queretaro, Nanotechnol Program, Queretaro 76010, Qro, Mexico; [Santiago-Jacinto, P.] Univ Nacl Autonoma Mexico, Inst Phys, Mexico City 04510, DF, Mexico; [Terrones, M.] Shinshu Univ, Res Ctr Exot Nanocarbons JST, Nagano 3808553, Japan; [Terrones, M.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Terrones, M.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Gomez-Salazar, S.; Nuno-Donlucas, S. M.] Univ Guadalajara, Dept Chem Engn, Guadalajara 44100, Mexico; [Sanchez, I. C.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78703 USA	Prokhorov, E (reprint author), Cinvestav Unidad Queretaro, Libramiento Norponiente 2000, Queretaro 76230, Qro, Mexico.	prokhorov@gro.cinvestav.mx	Mota-Morales, Josue/B-4052-2011; 	Mota-Morales, Josue/0000-0001-8257-0709; Prokhorov, Evgen/0000-0003-2611-2521	CONACYT of Mexico	This work was partially supported by CONACYT of Mexico. The authors are grateful to J.A. Munoz-Salas for technical assistance in electrical measurements, A. Mauricio for assistance in FTIR measurements. The authors also thank to Dr. Vicente Garibay for TEM facilities and Dr. Guadalupe Zavala for her technical assistance in the sample preparation process.	Aharony A., 1994, INTRO PERCOLATION TH; Wubbenhorst M, 2002, J NON-CRYST SOLIDS, V305, P40, DOI 10.1016/S0022-3093(02)01086-4; Iamsamai C, 2010, CARBON, V48, P25, DOI 10.1016/j.carbon.2009.06.060; Yang K, 2009, CARBON, V47, P1723, DOI 10.1016/j.carbon.2009.02.029; Liu YL, 2009, CARBOHYD POLYM, V76, P232, DOI 10.1016/j.carbpol.2008.10.021; Wang YY, 2014, POLYMER, V55, P4067, DOI 10.1016/j.polymer.2014.06.085; NAMIKAWA H, 1975, J NON-CRYST SOLIDS, V18, P173, DOI 10.1016/0022-3093(75)90019-8; Kohler M, 2008, EUR PHYS J E, V27, P115, DOI 10.1140/epje/i2008-10357-8; Lau C, 2008, LANGMUIR, V24, P7004, DOI 10.1021/la8005597; Sharma M, 2013, J PHYS CHEM B, V117, P8589, DOI 10.1021/jp4033723; Liu YY, 2005, CARBON, V43, P3178, DOI 10.1016/j.carbon.2005.06.020; Macutkevic J, 2013, J NANOPHOTONICS, V7, DOI 10.1117/1.JNP.7.073593; Spinks GM, 2006, SENSOR ACTUAT B-CHEM, V115, P678, DOI 10.1016/j.snb.2005.10.047; Casagrande T, 2008, MATER CHEM PHYS, V111, P42, DOI 10.1016/j.matchemphys.2008.03.010; Kumar B, 2012, J MATER CHEM, V22, P10656, DOI 10.1039/c2jm30527e; Tkac J, 2006, ELECTROCHEM COMMUN, V8, P899, DOI 10.1016/j.elecom.2006.03.028; Tang CY, 2009, POLYM DEGRAD STABIL, V94, P124, DOI 10.1016/j.polymdegradstab.2008.09.008; Guadagno L, 2011, CARBON, V49, P1919, DOI 10.1016/j.carbon.2011.01.017; Zawadzki J, 2010, CARBOHYD POLYM, V80, P394, DOI 10.1016/j.carbpol.2009.11.037; Shen JF, 2007, COMPOS SCI TECHNOL, V67, P3041, DOI 10.1016/j.compscitech.2007.04.025; Luz RAD, 2011, MATER CHEM PHYS, V130, P1072, DOI 10.1016/j.matchemphys.2011.08.038; Tsangaris GM, 1998, J MATER SCI, V33, P2027, DOI 10.1023/A:1004398514901; Venkatesan J, 2012, INT J BIOL MACROMOL, V50, P393, DOI 10.1016/j.ijbiomac.2011.12.032; Carson L, 2009, MATER LETT, V63, P617, DOI 10.1016/j.matlet.2008.11.060; Einfeldt J, 2001, PROG POLYM SCI, V26, P1419, DOI 10.1016/S0079-6700(01)00020-X; Barton J. L., 1966, VERRES REFR, V20, P328; Blythe T., 2005, ELECT PROPERTIES POL; Despond S, 2005, J POLYM SCI POL PHYS, V43, P48, DOI 10.1002/polb.20277; Einfeldt J, 2003, J NON-CRYST SOLIDS, V320, P40, DOI 10.1016/S0022-3093(03)00086-3; Gonzalez-Campos JB, 2009, J POLYM SCI POL PHYS, V47, P2259, DOI 10.1002/polb.21823; Gonzalez-Campos J. B., 2011, FOCUS CHITOSAN RES, P141; Heilmann A., 2003, POLYM FILMS EMBEDDED; Hu Y, 2010, ACS NANO, V4, P3498, DOI 10.1021/nn1006013; Ito N, 2005, J CHEM PHYS, V123, DOI [10.1063/1.2036972, 10.1063/1.12036972]; Ke G, 2007, BIOMACROMOLECULES, V8, P322, DOI 10.1021/bm0604146; Kovacs Z.J., 2007, COMPOS SCI TECHNOL, V67, P922; Logakis E, 2009, POLYMER, V50, P5103, DOI 10.1016/j.polymer.2009.08.038; Macutkevic J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4815870; Nakajima T., 1972, C EL INS DIEL PHEN N, P166; Ozdilek C, 2011, POLYMER, V52, P4480, DOI 10.1016/j.polymer.2011.07.048; Perez C., 2010, J NANOSTR POLYM NANO, V6, P61; Pradhan DK, 2014, MATER CHEM PHYS, V147, P1016, DOI 10.1016/j.matchemphys.2014.06.053; Schroder TB, 2000, PHYS REV LETT, V84, P310, DOI 10.1103/PhysRevLett.84.310; Shieh YT, 2006, EUR POLYM J, V42, P3162, DOI 10.1016/j.eurpolymj.2006.09.006; Sweetman LJ, 2008, J MATER CHEM, V18, P5417, DOI 10.1039/b809406n; Wu TF, 2011, MATER CHEM PHYS, V129, P932, DOI 10.1016/j.matchemphys.2011.05.030	46	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0254-0584	1879-3312		MATER CHEM PHYS	Mater. Chem. Phys.	APR 1	2015	155						252	261		10.1016/j.matchemphys.2015.02.041		10	Materials Science, Multidisciplinary	Materials Science	CE2MJ	WOS:000351649400033		
J	Fujie, K; Winkler, M; Yokota, T				Fujie, Kentarou; Winkler, Michael; Yokota, Tomomi			Boundedness of solutions to parabolic-elliptic Keller-Segel systems with signal-dependent sensitivity	MATHEMATICAL METHODS IN THE APPLIED SCIENCES			English	Article						chemotaxis; global existence; boundedness	CHEMOTAXIS SYSTEM; GLOBAL EXISTENCE; AGGREGATION; EQUATIONS; COLLAPSE	This paper deals with the parabolic-elliptic Keller-Segel system with signal-dependent chemotactic sensitivity function, {u(t) = Delta u - del. u chi(v)del v), x is an element of Omega, t > 0, 0 = Delta v - v + u, x is an element of Omega, t > 0, under homogeneous Neumann boundary conditions in a smooth bounded domain Omega subset of R-n, n >= 2, with initial data u(0) is an element of C-0 ((Omega) over bar) satisfying u(0) >= 0 and integral(Omega) u(0) > 0. The chemotactic sensitivity function chi(v) is assumed to satisfy 0 < chi(v) <= chi(0/)v(k), k >= 1, chi(0) > 0. The global existence of weak solutions in the special case chi(v) = chi(0)/v is shown by Biler (Adv. Math. Sci. Appl. 1999; 9:347-359). Uniform boundedness and blow-up of radial solutions are studied by Nagai and Senba (Adv. Math. Sci. Appl. 1998; 8: 145-156). However, the global existence and uniform boundedness of classical nonradial solutions are left as an open problem. This paper gives an answer to the problem. Namely, it is shown that the system possesses a unique global classical solution that is uniformly bounded if chi(0) < 2/n (k = 1); chi(0) < 2/n . k(k)/(k-1)(k-1) gamma(k-1) (k > 1), where gamma > 0 is a constant depending on Omega and u(0). Copyright (c) 2014 JohnWiley & Sons, Ltd.	[Fujie, Kentarou; Yokota, Tomomi] Tokyo Univ Sci, Dept Math, Tokyo 162, Japan; [Winkler, Michael] Univ Paderborn, Inst Math, D-33098 Paderborn, Germany	Yokota, T (reprint author), Tokyo Univ Sci, Dept Math, Tokyo 162, Japan.	yokota@rs.kagu.tus.ac.jp			JSPS [25400119]	The authors would like to thank Dr. Sachiko Ishida for numerous useful remarks. T. Yokota is supported by Grant-in-Aid for Scientific Research (C), no. 25400119, JSPS.	Stinner C, 2011, NONLINEAR ANAL-REAL, V12, P3727, DOI 10.1016/j.nonrwa.2011.07.006; Winkler M, 2011, MATH METHOD APPL SCI, V34, P176, DOI 10.1002/mma.1346; Othmer HG, 1997, SIAM J APPL MATH, V57, P1044; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; Horstmann D, 2005, J DIFFER EQUATIONS, V215, P52, DOI 10.1016/j.jde.2004.10.022; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Osaki K, 2002, NONLINEAR ANAL-THEOR, V51, P119, DOI 10.1016/S0362-546X(01)00815-X; KELLER EF, 1971, J THEOR BIOL, V30, P235, DOI 10.1016/0022-5193(71)90051-8; Winkler M, 2010, MATH NACHR, V283, P1664, DOI 10.1002/mana.200810838; Bilers P, 1999, J ADV MATH APL, V9, P347; Bilers P, 1998, J ADV MATH APPL, V8, P715; Breziss H, 1983, ANAL FONCTIONNELLE T; Herrero M.A., 1997, ANN SC NORM SUPER, V24, P663; Hillen T, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S0218202512500480; Ladyenskajas OA, 1968, LINEAR QUASILINEAR E; Manasevich R, 2013, EUR J APPL MATH, V24, P273, DOI 10.1017/S095679251200040X; Nagai T, 2011, COMMUN CONTEMP MATH, V13, P795, DOI 10.1142/S0219199711004440; Nagais T, 1998, J ADV MATH APPL, V8, P145; Nagais T., 1995, J ADV MATH APPL, V5, P581; Osaki K., 2001, FUNKC EKVACIOJ-SER I, V44, P441; Senbas T., 1997, J ADV MATH APPL, V7, P79; Sleeman BD, 2001, MATH METHOD APPL SCI, V24, P405, DOI 10.1002/mma.212	22	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0170-4214	1099-1476		MATH METHOD APPL SCI	Math. Meth. Appl. Sci.	APR	2015	38	6					1212	1224		10.1002/mma.3149		13	Mathematics, Applied	Mathematics	CE3PZ	WOS:000351741800017		
J	Nakahara, H; Ueda, SY; Miyamoto, T				Nakahara, Hidehiro; Ueda, Shin-Ya; Miyamoto, Tadayoshi			Low-Frequency Severe-Intensity Interval Training Improves Cardiorespiratory Functions	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CARDIOVASCULAR ADAPTATIONS; INTERVAL TRAINING; EXERCISE INTENSITY; EXERCISE DURATION	CARDIAC STRUCTURE; ENDOTHELIAL FUNCTION; AEROBIC FITNESS; EXERCISE; ENDURANCE; HUMANS; ADAPTATIONS; MORPHOLOGY; CYCLISTS; CAPACITY	Purpose The present study investigated the effects of severe-intensity interval training at a frequency of once a week on cardiorespiratory function at rest and during exercise. Methods Fourteen young healthy males were randomly assigned to either an interval training group or control group. Cardiorespiratory function was investigated by incremental maximal exercise test and constant work rate submaximal exercise test before and after the intervention period in all subjects. Submaximal exercise test was conducted at two work rates (80% ventilatory threshold (VT) level and 100% VT level plus 50% of the difference between VT and peak oxygen consumption (VO2)) for 8 min; the same work rates and duration were used before and after training. Left ventricular adaptations were assessed by echocardiography under supine resting conditions before and after training. In the interval training group, seven subjects performed cycle ergometer training once per week for 3 months. The training consisted of three bouts of exercises to volitional fatigue at 80% maximum work rate. Results Increased VO2max (+13%, P = 0.015), VT (+21%, P = 0.001), and left ventricular posterior wall thickness (+18%, P = 0.002) and reduced minute ventilation (-12%, P = 0.032) and blood lactate concentration (-16%, P = 0.025) during high-intensity exercise were observed after the training program compared with baseline. Although not significant, VO2 and cycling economy (VO2 per work rate) during high-intensity exercise decreased slightly after training. Conclusion The present results indicate that severe-intensity interval training, even when performed at a low frequency, markedly improves cardiorespiratory function as well as induces cardiac morphological adaptations involving left ventricular hypertrophy and cardiorespiratory metabolic response during submaximal exercise. The present findings may provide new insights for low-frequency, severe-intensity interval training in the field of sports science.	[Nakahara, Hidehiro; Ueda, Shin-Ya; Miyamoto, Tadayoshi] Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka, Osaka 5590034, Japan	Nakahara, H (reprint author), Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka, Osaka 5590034, Japan.	nakahara@morinomiya-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [19500574]	This study was supported in part by a Grant-in-Aid for Scientific Research (No. 19500574) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	American College Of Sports Medicine, 1998, MED SCI SPORTS EXERC, V30, P975, DOI DOI 10.1097/00005768-199806000-00032; Anderson T, 1993, J STRENGTH COND RES, V7, P185; Baggish AL, 2008, J APPL PHYSIOL, V104, P1121, DOI 10.1152/japplphysiol.01170.2007; Kemi OJ, 2004, CIRCULATION, V109, P2897, DOI 10.1161/01.CIR.0000129308.04757.72; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020; CLARKSON PM, 1988, J APPL PHYSIOL, V65, P1; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; White MD, 1996, J APPL PHYSIOL, V81, P1249; COX ML, 1986, J APPL PHYSIOL, V61, P926; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013c3180304570; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Laursen PB, 2002, MED SCI SPORT EXER, V34, P1801, DOI 10.1097/00005768-200211000-00017; SAHN DJ, 1978, CIRCULATION, V58, P1072; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Pluim BM, 2000, CIRCULATION, V101, P336; Carrick-Ranson G, 2014, J APPL PHYSIOL, V116, P736, DOI 10.1152/japplphysiol.00342.2013; Matsuo T, 2014, MED SCI SPORT EXER, V46, P42, DOI 10.1249/MSS.0b013e3182a38da8; HICKSON RC, 1985, J APPL PHYSIOL, V58, P492; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Seiler S, 2005, MED SCI SPORT EXER, V37, P1601, DOI 10.1249/01.mss.0000177560.18014.d8; POOLE DC, 1985, J APPL PHYSIOL, V58, P1115; Windecker S, 2002, AM J PHYSIOL-HEART C, V282, pH2216, DOI 10.1152/ajpheart.00977.2001; MEYER K, 1990, CLIN CARDIOL, V13, P851; CASABURI R, 1987, J APPL PHYSIOL, V63, P1533; FAGARD R, 1983, CIRCULATION, V67, P896; Foley A, 2011, BRIT J SPORT MED, V45, P978, DOI 10.1136/bjsm.2009.063966; Haykowsky MJ, 1998, CAN J CARDIOL, V14, P678; HUTTUNEN NP, 1989, DIABETES CARE, V12, P737, DOI 10.2337/diacare.12.10.737; Miyamoto T, 2012, EUR J APPL PHYSIOL, V112, P237, DOI 10.1007/s00421-011-1968-2; Miyamura M, 1998, JPN J PHYSIOL, V48, P17, DOI 10.2170/jjphysiol.48.17; Pollock M L, 1977, Ann N Y Acad Sci, V301, P310, DOI 10.1111/j.1749-6632.1977.tb38209.x	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	APR	2015	47	4					789	798		10.1249/MSS.0000000000000477		10	Sport Sciences	Sport Sciences	CE1QU	WOS:000351587800015		
J	Khajavi, LT; Morita, K; Yoshikawa, T; Barati, M				Khajavi, Leili Tafaghodi; Morita, Kazuki; Yoshikawa, Takeshi; Barati, Mansoor			Removal of Boron from Silicon by Solvent Refining Using Ferrosilicon Alloys	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							SOLAR-GRADE-SILICON; IMPURITY GETTER; DOPED SILICON; IRON; SI; SOLIDIFICATION; PURIFICATION; CELLS	The distribution of boron between purified solid silicon and iron-silicon melt was evaluated to investigate the possibility of boron removal from silicon by solvent refining with iron-silicon alloys. The distribution coefficient, defined as the ratio of the mole fraction of boron in solid to that of liquid, was found to be strongly dependent on boron concentration. Solvent refining at lower temperatures resulted in smaller distribution coefficient values. The boron removal percentages for the lowest boron concentration examined in this study were 70 pct [1583 K (1310 degrees C)], 65 pct [1533 K (1260 degrees C)], and 65 pct [1483 K (1210 degrees C)]. The values obtained for interaction parameter of boron on iron in solid silicon are as follows: -813 +/- 53 [1583 K (1310 degrees C)], -830 +/- 92 [1533 K (1260 degrees C)], -863 +/- 91 [1483 K (1210 degrees C)]. Lower temperature resulted in smaller distribution coefficient and higher silicon yield. (C) The Minerals, Metals & Materials Society and ASM International 2014	[Khajavi, Leili Tafaghodi; Barati, Mansoor] Univ Toronto, Dept Mat Sci & Engn, Toronto, ON M5S 3E4, Canada; [Morita, Kazuki; Yoshikawa, Takeshi] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Khajavi, LT (reprint author), Univ Toronto, Dept Mat Sci & Engn, 184 Coll St,Suite 140, Toronto, ON M5S 3E4, Canada.	leili.tafaghodikhajavi@utoronto.ca	Morita, Kazuki/N-6397-2015		Natural Sciences and Engineering Research Council of Canada (NSERC)	This research is partly supported by Natural Sciences and Engineering Research Council of Canada (NSERC).	Yin Z, 2011, CAN METALL QUART, V50, P166, DOI 10.1179/000844311X12949307643551; BATHEY BR, 1982, J MATER SCI, V17, P3077, DOI 10.1007/BF01203469; Johnston MD, 2012, JOM-US, V64, P935, DOI 10.1007/s11837-012-0384-3; Esfahani S, 2011, MET MATER INT, V17, P1009, DOI 10.1007/s12540-011-6020-x; Istratov AA, 2006, MAT SCI ENG B-SOLID, V134, P282, DOI 10.1016/j.mseb.2006.06.023; JUNEJA JM, 1986, HYDROMETALLURGY, V16, P69, DOI 10.1016/0304-386X(86)90052-6; Yoshikawa T, 2009, J CRYST GROWTH, V311, P776, DOI 10.1016/j.jcrysgro.2008.09.095; Yoshikawa T, 2005, METALL MATER TRANS B, V36, P731, DOI 10.1007/s11663-005-0076-2; Morita K, 2003, INTERMETALLICS, V11, P1111, DOI 10.1016/S0966-9795(03)00148-1; Yoshikawa T, 2012, JOM-US, V64, P946, DOI 10.1007/s11837-012-0371-8; Woditsch P, 2002, SOL ENERG MAT SOL C, V72, P11, DOI 10.1016/S0927-0248(01)00146-5; Mitrasinovic AM, 2009, SILICON-NETH, V1, P239, DOI 10.1007/s12633-009-9025-z; Birkholz J.E., 2005, J APPL PHYS, V97, P97; Bonnier E., 1965, METALLURGIE, V7, P299; BROTHERTON SD, 1985, J APPL PHYS, V57, P1941, DOI 10.1063/1.335468; CHEN JS, 1991, FRESEN J ANAL CHEM, V340, P357, DOI 10.1007/BF00321582; DRIOLE J, 1971, METALL, V25, P2; Esfahani S., 2010, MAT CHALL ALT REN EN; FELDMAN C, 1961, ANAL CHEM, V33, P1916, DOI 10.1021/ac50154a040; Flynn H., 2006, PROMETHEUS I SUSTAIN, P1; Fredriksson H, 2012, SOLIDIFICATION CRYST; GAO X, 1991, APPL PHYS LETT, V59, P2133, DOI 10.1063/1.106103; Haarahiltunen A., 2008, APPL PHYS LETT, V92; HALL RN, 1953, J PHYS CHEM-US, V57, P836, DOI 10.1021/j150509a021; Khajavi LT, 2012, HIGH TEMP MAT PR-ISR, V31, P627, DOI 10.1515/htmp-2012-0100; Li-qiang X., 1986, FRESEN Z ANAL CHEM, V325, P534, DOI 10.1007/BF00635682; Lupis C. H. P., 1983, CHEM THERMODYNAMICS; Lynch D, 2009, JOM-US, V61, P41, DOI 10.1007/s11837-009-0166-8; Massalski T. B., 1990, BINARY ALLOY PHASE D; McHugo SA, 1998, APPL PHYS LETT, V73, P1424, DOI 10.1063/1.121964; Mitrasinovic AM, 2012, METALL MATER TRANS B, V43, P379, DOI 10.1007/s11663-011-9614-2; NAKASHIMA H, 1994, MATER SCI FORUM, V143-, P1191; Obinata I., 1957, SCI REP RITU A, VA9, P118; PIZZINI S, 1982, SOL ENERG MATER, V6, P253, DOI 10.1016/0165-1633(82)90035-1; SHEPHERD WH, 1962, J PHYS CHEM SOLIDS, V23, P1697, DOI 10.1016/0022-3697(62)90207-X; Talvitie H., 2011, J APPL PHYS, V109; WEBER ER, 1983, APPL PHYS A-MATER, V30, P1, DOI 10.1007/BF00617708; WIJARANAKULA W, 1993, J ELECTROCHEM SOC, V140, P275, DOI 10.1149/1.2056102; Yoshikawa T., 2005, EPD C; Yoshikawa T., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/j.stam.2003.12.007	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	APR	2015	46	2					615	620		10.1007/s11663-014-0236-3		6	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CE5GW	WOS:000351860300012		
J	Voisin, L; Damm, G; Okura, T				Voisin, Leandro; Damm, Gonzalo; Okura, Takahiko			Phase Relations, Precious Elements Distribution, and Activities in the Cu-Fe-Pb-As System Saturated with Carbon at 1473 K (1200 degrees C)	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							MINOR ELEMENTS; QUADRATIC FORMALISM; NUMERICAL-ANALYSIS; SI DEOXIDATION; ALLOYS; NI	In order to develop a new pyrometallurgical process for the elimination of detrimental arsenic and the recovery of precious elements, such as, silver, gold, and platinum from arsenic-rich copper-lead scraps, the phase relations in the Cu-Fe-Pb-As system saturated with carbon and the distribution of precious elements between the condensed phases generated during the equilibrium at high temperature were investigated. The investigation was carried out by performing a series of laboratory scale experiments using an electrical furnace at 1473 K (1200 degrees C), followed by the quenching of molten samples taken on the final stage. The samples obtained from the experiments were analyzed using electron probe X-ray micro analysis, inductively couple plasma, and carbon infrared spectrometry techniques. The results were discussed on the basis of the activity coefficient of arsenic, interaction parameters of minor components, and distribution parameters for precious metals in the three equilibrated alloy phases of lead-rich, copper-rich, and iron-rich that coexists in the corresponding miscibility gap. The present results suggest that the recovery of valuable silver and gold into the copper-rich alloy and lead-rich alloy phases and the elimination of arsenic and iron into the iron-rich alloy phase might be feasible. (C) The Minerals, Metals & Materials Society and ASM International 2014	[Voisin, Leandro; Damm, Gonzalo] Univ Chile, Adv Min Technol Ctr, Santiago, Chile; [Voisin, Leandro; Damm, Gonzalo] Univ Chile, Min Engn Dept, Santiago, Chile; [Okura, Takahiko] Waseda Univ, Tokyo, Japan	Voisin, L (reprint author), Univ Chile, Adv Min Technol Ctr, POB 837-0451, Santiago, Chile.	lvoisin@ing.uchile.cl			Chilean national fund for scientific and technological development, project FONDECYT [1120341]	The authors would like to acknowledge the Chilean national fund for scientific and technological development, project FONDECYT 1120341, for the financial support that led to a successful realization of this study.	DARKEN LS, 1967, T METALL SOC AIME, V239, P80; Energy and environmental profile of the US mining industry, 2002, LEAD AND ZINC, P1; Hayes P.C., 2010, LEAD ZINC 2010 TMS M, V1, P345; Hino M., 1986, METALL REV MMIJ, V3, P61; HINO M, 1986, METALL TRANS B, V17, P755, DOI 10.1007/BF02657137; Itagaki K., 1978, B RES I DRESS METALL, V34, P45; Itagaki K, 2005, MONATSH CHEM, V136, P1847, DOI 10.1007/s00706-005-0394-8; KELLOGG HH, 1966, T METALL SOC AIME, V236, P602; Massalski T.B., BINARY ALLOY PHASE D, P280; Miki T, 2003, MATER TRANS, V44, P1817, DOI 10.2320/matertrans.44.1817; Miki T, 2004, ISIJ INT, V44, P1800, DOI 10.2355/isijinternational.44.1800; Morachevskii AG, 2011, RUSS J APPL CHEM+, V84, P602, DOI 10.1134/S1070427211040082; Okamoto H., 1990, J PHASE EQUILIB, V13, P545; Voisin L, 2006, RARE METALS, V25, P488, DOI 10.1016/S1001-0521(06)60089-2; Voisin L, 2004, MATER TRANS, V45, P2851, DOI 10.2320/matertrans.45.2851; Voisin L, 2005, MATER TRANS, V46, P3030, DOI 10.2320/matertrans.46.3030; Voisin L, 2005, MATER TRANS, V46, P74, DOI 10.2320/matertrans.46.74; Wagner C., 1952, THERMODYNAMICS ALLOY, P51	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	APR	2015	46	2					680	687		10.1007/s11663-014-0246-1		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CE5GW	WOS:000351860300018		
J	Yokoyama, Y				Yokoyama, Yoshihiko			Development of an Automatic Fabrication System for Cast Glassy Alloys	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							BULK-METALLIC-GLASS; STRUCTURAL RELAXATION; AMORPHOUS-ALLOYS	The developed automatic fabrication system comprised three component functions: weighing, alloying, and casting. The measurement error of automatic weighing specimen was about less 1 pct for Zr-based master alloys (approximately 30 g). Especially, sufficient stirrer effect of arcmelting ingot for homogeneity can be achieved by the development of sinusoidal arcing and applying magnetic field. In order to achieve superior homogeneity of the glass structure with no secondary phase (i.e., an intermetallic compound with a high melting temperature), a prealloying process should be advisable. In this study, high reliability of the density and mechanical properties of automatic processed cast glassy alloys (CGAs) was successfully obtained. The developed automatic fabrication process has a potential to accelerate the industrial application of CGAs in the near future. (C) The Minerals, Metals & Materials Society and ASM International 2015	[Yokoyama, Yoshihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Yokoyama, Yoshihiko] Tohoku Univ, World Premier Inst, Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Yokoyama, Yoshihiko] Inst Complex Mat, IFW Dresden, D-01171 Dresden, Germany	Yokoyama, Y (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	yy@imr.tohoku.ac.jp			JSPS KAKENHI [23560857]; New Energy and Industrial Technology Development Organization (NEDO)	The author thanks I. Narita, K. Ohmura, and Y. Murakami for their skillful technical support in this study. The author also greatly thanks M. Sato, T. Yamaguchi, and M. Kobayashi at YKK Co. Ltd., T. Yokoyama, Y. Kawai, M. Kameyama, and Y. Chiba at DIAVAC Ltd., M. Nagaoka and M. Hisa at Nisshin Giken Co. Ltd., and K. Suzuki, N. Kubo, and K. Iryouda at GES Co. Ltd. for the construction of the automatic fabrication system. This research was funded in part by a JSPS KAKENHI Grant-in-Aid for Scientific Research (C) Project No. 23560857, New Energy and Industrial Technology Development Organization (NEDO), a research project named "Cast Glassy Alloy Inorganic Materials Joining Technology Development'' in Japan, a Grant-in-aid for a research and development project on advanced cast glassy alloys from the Institute for Materials Research, and WPI at Tohoku University.	Kumar G, 2009, NATURE, V457, P868, DOI 10.1038/nature07718; KUI HW, 1984, APPL PHYS LETT, V45, P615, DOI 10.1063/1.95330; Wang D, 2005, ACTA MATER, V53, P2969, DOI 10.1016/j.actamat.2005.03.012; Johnson WL, 1999, MRS BULL, V24, P42; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Schroers J, 2010, ADV MATER, V22, P1566, DOI 10.1002/adma.200902776; Wang WH, 2012, PROG MATER SCI, V57, P487, DOI 10.1016/j.pmatsci.2011.07.001; Johnson WL, 2011, SCIENCE, V332, P828, DOI 10.1126/science.1201362; Liu CT, 2002, INTERMETALLICS, V10, P1105, DOI 10.1016/S0966-9795(02)00131-0; Lee JG, 2004, METALL MATER TRANS A, V35A, P3753, DOI 10.1007/s11661-004-0281-7; [Anonymous], [No title captured], Patent No. 8701742; Lu ZP, 2003, APPL PHYS LETT, V83, P2581, DOI 10.1063/1.1614833; Yokoyama Y, 2008, ACTA MATER, V56, P6097, DOI 10.1016/j.actamat.2008.08.026; Wang GY, 2008, ADV ENG MATER, V10, P1030, DOI 10.1002/adem.200800133; Gazzano M, 2004, BIOMACROMOLECULES, V5, P553, DOI 10.1021/bm0343951; GREER AL, 1984, J NON-CRYST SOLIDS, V61-2, P737, DOI 10.1016/0022-3093(84)90633-1; Inoue A, 2004, MAT SCI ENG A-STRUCT, V375, P16, DOI 10.1016/j.msea.2003.10.159; Ishida M, 2002, INTERMETALLICS, V10, P1259, DOI 10.1016/S0966-9795(02)00162-0; Johnson W L, 2002, JOM, V54, P40; Kakiuchi H, 2001, MATER TRANS, V42, P678, DOI 10.2320/matertrans.42.678; KAWAMURA Y, 1993, MATER T JIM, V34, P969; Kim S. J., 2012, APPL PHYS LETT, V101; Kundig AA, 2004, MAT SCI ENG A-STRUCT, V375, P327, DOI 10.1016/j.msea.2003.10.269; Markiv V. Y., 1970, POWDER METALL MET C+, V12, P53; Yasuda H, 2005, MATER TRANS, V46, P2762, DOI 10.2320/matertrans.46.2762; Yokoyama Y, 2002, MATER TRANS, V43, P2316, DOI 10.2320/matertrans.43.2316; Yokoyama Y, 2004, MATER TRANS, V45, P1819, DOI 10.2320/matertrans.45.1819; Yokoyama Y, 1995, MATER T JIM, V36, P1398; Yokoyama Y, 2002, MATER TRANS, V43, P575, DOI 10.2320/matertrans.43.575; Yokoyama Y, 2007, MATER TRANS, V48, P1363, DOI 10.2320/matertrans.MF200624	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	APR	2015	46	2					893	905		10.1007/s11663-014-0282-x		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CE5GW	WOS:000351860300039		
J	Kawasaki, M; Nobuchi, T; Nakafushi, Y; Nose, M; Shiojiri, M				Kawasaki, Masahiro; Nobuchi, Tadashi; Nakafushi, Yuta; Nose, Masateru; Shiojiri, Makoto			Structure and Biomechanics of Culms of Phragmites australis Used for Reeds of Japanese Wind Instrument "Hichiriki"	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						common reed; double reed wind instrument; hardness; plant anatomy; Young's modulus	ARUNDO DONAX; AIR COLUMN; CLARINET; VIBRATIONS	Hichiriki is a traditional Japanese double-reed wind instrument used in Japanese ancient imperial court music, gagaku, which has been performed since the 7th century. The best reeds for hichiriki have been made of culms or stems of Phragmites australis (P. australis) that are harvested from only a limited reed bed at Udono near Kyoto. The aim of this study is to elucidate why the stems from Udono are the best materials for hichiriki reeds. Plant anatomy was examined for choice stems of P. australis grown in different reed beds in Japan as well as morphology, and the local indentation hardness and Young's modulus of tissues on the cross-sections of some representatives of hichiriki reeds were measured. It is concluded that the good stems for hichiriki reeds have an outer diameter of about 11 mm, a wall thickness of about 1 mm and comparatively homogeneous structure where harder materials, such as epidermis, hypodermis, sclerenchymatous cells, and vascular bundle sheaths with hard walls, are orderly deployed with softer materials such as parenchyma cells and vascular bundles. This structure has smaller differences of hardness and Young's modulus between the hard and soft materials in the reed, providing the best music performance. Microsc. Res. Tech. 78:260-267, 2015. (c) 2015 Wiley Periodicals, Inc.	[Kawasaki, Masahiro] JEOL USA Inc, Peabody, MA 01960 USA; [Nobuchi, Tadashi] Kyoto Univ, Kyoto 6068501, Japan; [Nakafushi, Yuta] Toyama Univ, Sch Sci & Engn, Toyama 9308555, Japan; [Nose, Masateru] Toyama Univ, Fac Art & Design, Toyama 9338588, Japan; [Shiojiri, Makoto] Kyoto Inst Technol, Kyoto 6068585, Japan; [Shiojiri, Makoto] Toyama Univ, Fac Engn, Toyama 9308555, Japan	Kawasaki, M (reprint author), JEOL USA Inc, 11 Dearborn Rd, Peabody, MA 01960 USA.	kawasaki@jeol.com; shiojiri@pc4.so-net.ne.jp					Tranchida D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364863; Spatz HC, 1997, PHILOS T ROY SOC B, V352, P1, DOI 10.1098/rstb.1997.0001; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.0002; BACKUS J, 1961, J ACOUST SOC AM, V33, P806, DOI 10.1121/1.1908803; BACKUS J, 1963, J ACOUST SOC AM, V35, P305, DOI 10.1121/1.1918458; BENADE AH, 1988, J ACOUST SOC AM, V83, P292, DOI 10.1121/1.396431; GILBERT J, 1989, J ACOUST SOC AM, V86, P35, DOI 10.1121/1.398352; HIRSCHBERG A, 1994, J PHYS IV, V4, P559, DOI 10.1051/jp4:19945120; IDOGAWA T, 1993, J ACOUST SOC AM, V93, P540, DOI 10.1121/1.405633; Kolesik P, 1998, ANN BOT-LONDON, V81, P151, DOI 10.1006/anbo.1997.0548; Kolesil P, 1999, CLARINET, V26, P70; Lawton C. E., 1996, Recent advances in wood anatomy. Proceedings of the Third Pacific Regional Wood Anatomy Conference, Rotorua, 20-24 November, 1994., P308; Montague MJ, 2012, CLARINET, P62; Morris I, 1971, PILLOW BOOK SEI SHON; Obataya E., 1996, THESIS KYOTO U KYOTO; Obataya E., 1996, PIPERS, V181, P32; Schuring M, 2013, PIPERS, V381, P10; STEWART SE, 1980, J ACOUST SOC AM, V68, P109, DOI 10.1121/1.384635; Tyler Royall, 2001, TALE GENJI; Veselack MSW, 1979, THESIS BALL STATE U	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	APR	2015	78	4					260	267		10.1002/jemt.22469		8	Anatomy & Morphology; Biology; Microscopy	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	CE2WY	WOS:000351683400003		
J	Takeuchi, M; Arai, S				Takeuchi, Miyuki; Arai, Shoji			Upper mantle can in-situ fracture: an implication from a cataclastic peridotite xenolith from Megata, Northeast Japan arc	MINERALOGY AND PETROLOGY			English	Article							SHEAR ZONES; ULTRAMAFIC PSEUDOTACHYLYTES; DEFORMATION; EARTHQUAKES; BENEATH; CONSTRAINTS; PETROLOGY; TEXTURES; PYROXENE; COMPLEX	A peculiar peridotite xenolith with cataclastic texture was found from Ichinomegata crater, Megata volcano, the Northeast Japan arc. This peridotite xenolith is the same in mineral assemblage and mineral chemistry (olivine, Fo(90); spinel, Cr/(Cr + Al) atomic ratio, 0.2) to some fertile mantle lherzolites, but quite different in texture from all the documented mantle peridotite xenoliths from Ichinomegata and other localities on Earth. The peridotite is a mixture of coarse and fine grains of olivine, orthopyroxene, clinopyroxene, chromian spinel. The coarse mineral grains are angular but never elongated like those in mylonite. All minerals have been fragmented, and the fragmented pyroxenes and chromian spinel form thin streaks in fine-grained olivine-rich matrix. These features indicate that brittle fracturing does occur even in the upper mantle possibly along pre-existing deep-seated faults that have been frequent in the Northeast Japan arc. Some of the fine grains (< 100 mu m across) of olivine and pyroxenes display strong intra-grain and inter-grain chemical variations; some are more refractory and the others are more evolved in chemistry than the coarse grains. This suggests a possibility of very small degree frictional melting of peridotite upon cataclastic fracturing.	[Takeuchi, Miyuki; Arai, Shoji] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan	Takeuchi, M (reprint author), Kanazawa Univ, Dept Earth Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	takeuchi-miyuki@stu.kanazawa-u.ac.jp					Abe N, 1993, SCI REP KANAZAWA U, V38, P1; Abe N., 1992, J MINERAL PETROL EC, V87, P305; Abe N, 1999, P INT KIMBERLITE C, V7, P233; WITTEICKSCHEN G, 1991, CONTRIB MINERAL PETR, V106, P431, DOI 10.1007/BF00321986; KARATO S, 1989, TECTONOPHYSICS, V168, P255, DOI 10.1016/0040-1951(89)90221-7; Dijkstra AH, 2004, GEOL SOC SPEC PUBL, V224, P11, DOI 10.1144/GSL.SP.2004.224.01.02; ARAI S, 1994, CHEM GEOL, V113, P191, DOI 10.1016/0009-2541(94)90066-3; Kaeser B, 2006, J PETROL, V47, P2149, DOI 10.1093/petrology/egl040; Arai S, 2007, GONDWANA RES, V11, P180, DOI 10.1016/j.gr.2006.04.004; JOLIVET L, 1994, J GEOPHYS RES-SOL EA, V99, P22237, DOI 10.1029/93JB03463; XU YG, 1993, TECTONOPHYSICS, V225, P337, DOI 10.1016/0040-1951(93)90304-3; Austrheim H, 2004, TERRA NOVA, V16, P193, DOI 10.1111/j.1365-3121.2004.00551.x; MERCIER JCC, 1975, J PETROL, V16, P454; Wolfe CJ, 2003, SCIENCE, V300, P478, DOI 10.1126/science.1082205; IRVING AJ, 1980, AM J SCI, V280, P389; BASU AR, 1977, TECTONOPHYSICS, V43, P213; OBATA M, 1995, TECTONOPHYSICS, V242, P313, DOI 10.1016/0040-1951(94)00228-2; Aoki K, 1974, JAPAN SCI REP TOHO 3, V12, P395; Aoki K, 1973, J JAPAN ASSOC MIN PE, V68, P303; Cabanes N, 1986, EARTH PLANET SC LETT, V81, P23; Dalton JA, 1996, AM MINERAL, V81, P194; Del Gaudio P, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005990; EISSLER HK, 1986, J GEOPHYS RES-SOLID, V91, P2063, DOI 10.1029/JB091iB02p02063; Falus G, 2004, CONTRIB MINERAL PETR, V146, P493, DOI 10.1007/s00410-003-0513-7; Horie S, 1964, KAGAKU, V34, P98; Ishida Y, 2004, SCI REPORTS KANAZAWA, V48, P31; JOLIVET L, 1991, J GEOPHYS RES-SOLID, V96, P4367, DOI 10.1029/90JB02455; Katsui Y., 1979, J FS HOKKAIDO U 4, V19, P157; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Kuno H, 1967, ULTRAMAFIC RELATED R, P337; Morishita T, 2005, GEOSTAND GEOANAL RES, V29, P107, DOI 10.1111/j.1751-908X.2005.tb00659.x; Nixon PH, 1973, LESOTHO KIMBERLITES, P48; Piccardo GB, 2010, J PETROL, V51, P81, DOI 10.1093/petrology/egp067; Rassios A, 1994, B GEOL SOC GREECE, V30, P109; Roedder E., 1984, REV MINERAL, V12, P12; SHIBATA K, 1979, CONTRIB MINERAL PETR, V70, P381, DOI 10.1007/BF00371045; Sibson RH, 1977, J GEOL SOC LONDON, V133, P775; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; TAKAHASHI E, 1986, J VOLCANOL GEOTH RES, V29, P355, DOI 10.1016/0377-0273(86)90051-X; TAKAHASHI E, 1978, B VOLCANOL, V41, P529, DOI DOI 10.1007/BF02597385; TURCOTTE DL, 1986, J GEOPHYS RES-SOLID, V91, P1921, DOI 10.1029/JB091iB02p01921; Ueda T, 2008, GEOLOGY, V36, P607, DOI 10.1130/G24739A.1; WELLS PRA, 1977, CONTRIB MINERAL PETR, V62, P129, DOI 10.1007/BF00372872; WILSHIRE HG, 1989, TECTONOPHYSICS, V161, P23, DOI 10.1016/0040-1951(89)90298-9; Yang K, 2010, J GEODYN, V50, P424, DOI 10.1016/j.jog.2010.05.005	45	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0930-0708	1438-1168		MINER PETROL	Mineral. Petrol.	APR	2015	109	2					283	294		10.1007/s00710-015-0365-7		12	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CE3DS	WOS:000351706000009		
J	HoungAloune, S; Hiroyoshi, N; Ito, M				HoungAloune, Sengpasith; Hiroyoshi, Naoki; Ito, Mayumi			Stability of As(V)-sorbed schwertmannite under porphyry copper mine conditions	MINERALS ENGINEERING			English	Article						Schwertmannite; As(V); Stability; Porphyry copper mine; Tailing; Spent ore	ACID SULFATE WATERS; ALKALINE CONDITIONS; TRANSFORMATION; IRON; DRAINAGE; ARSENATE; GOETHITE; PH; FERRIHYDRITE; BEHAVIOR	Arsenic (As), a very poisonous inorganic pollutant is a major toxicant in tailings of porphyry copper deposits. Retention of As by Schwertmannite (a ferric-oxyhydroxysulfate mineral) has attracted much attention in recent years due to its strong binding affinity to toxic As species. The stability of As(V)-sorbed schwertmannite under copper mine waste conditions is not fully understood. The present study investigates the effect of Cu2+, Fe2+, pH, and ageing time on the stability of As(V)-sorbed schwertmannite (Sch-As). The results indicate that Cu2+ has no significant effect on the stability of Sch-As and that the As(V) incorporated in schwertmannite can retard or significantly inhibit Fe2+-catalyzed transformation of schwertmannite to goethite under acidic conditions (pH 3-4). The Sch-As aged at different pHs from 3 to 11 at 25 degrees C exhibits no mineralogical phase changes even after ageing for 120-days; however the concentration of As released from the solid phase appears to be strongly pH-dependent even after ageing for only 24 h. The release of As was negligible at pHs from 2 to 7, and there was considerableTelease of As at extremely acidic and alkaline conditions. This indicates that the release of As from Sch-As was controlled by environmental factors such as pH, Cu2+, and Fe2+ rather than time. (C)) 2015 Elsevier Ltd. All rights reserved.	[HoungAloune, Sengpasith; Hiroyoshi, Naoki; Ito, Mayumi] Hokkaido Univ, Grad Sch Engn, Div Sustainable Resources Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	HoungAloune, S (reprint author), Hokkaido Univ, Grad Sch Engn, Div Sustainable Resources Engn, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	h.sengpasith@gmail.com			Hokkaido University; Sumitomo Metal Mining Co., LTD.	This work is supported by a collaborative research program between Hokkaido University and Sumitomo Metal Mining Co., LTD.	Regenspurg S, 2004, GEOCHIM COSMOCHIM AC, V68, P1185, DOI 10.1016/j.gca.2003.07.015; Vithana CL, 2014, CHEM GEOL, V372, P1, DOI 10.1016/j.chemgeo.2014.02.012; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Knorr KH, 2007, APPL GEOCHEM, V22, P2006, DOI 10.1016/j.apgeochem.2007.04.017; Burton ED, 2009, ENVIRON SCI TECHNOL, V43, P9202, DOI 10.1021/es902461x; Antelo J, 2012, J COLLOID INTERF SCI, V386, P338, DOI 10.1016/j.jcis.2012.07.008; Burton ED, 2012, GEOCHIM COSMOCHIM AC, V96, P134, DOI 10.1016/j.gca.2012.08.007; Bigham JM, 1996, GEOCHIM COSMOCHIM AC, V60, P2111, DOI 10.1016/0016-7037(96)00091-9; Sun TC, 1996, WATER AIR SOIL POLL, V91, P307, DOI 10.1007/BF00666266; Burton ED, 2013, ENVIRON SCI TECHNOL, V47, P2221, DOI 10.1021/es303867t; Carlson L, 2002, ENVIRON SCI TECHNOL, V36, P1712, DOI 10.1021/es0110271; WAYCHUNAS GA, 1995, PHYSICA B, V208, P481, DOI 10.1016/0921-4526(94)00730-J; Dou XM, 2013, WATER RES, V47, P2938, DOI 10.1016/j.watres.2013.01.035; Jonsson J, 2005, APPL GEOCHEM, V20, P179, DOI 10.1016/j.apgeochem.2004.04.008; Coussy S, 2012, J ENVIRON MANAGE, V93, P10, DOI 10.1016/j.jenvman.2011.08.015; Paige CR, 1996, WATER ENVIRON RES, V68, P981, DOI 10.2175/106143096X128009; Acero P, 2006, GEOCHIM COSMOCHIM AC, V70, P4130, DOI 10.1016/j.gca.2006.06.1367; Davidson LE, 2008, AM MINERAL, V93, P1326, DOI 10.2138/am.2008.2761; Maillot F, 2013, GEOCHIM COSMOCHIM AC, V104, P310, DOI 10.1016/j.gca.2012.11.016; HoungAloune S, 2014, HYDROMETALLURGY, V147, P30, DOI 10.1016/j.hydromet.2014.04.001; Liao YH, 2011, CHEMOSPHERE, V83, P295, DOI 10.1016/j.chemosphere.2010.12.060; Ochromowicz K, 2013, PHYSICOCHEM PROBL MI, V49, P357, DOI 10.5277/ppmp130132; Fukushi K, 2003, APPL GEOCHEM, V18, P1267, DOI 10.1016/S0883-2927(03)00011-8; Nordstrom DK, 2011, ELEMENTS, V7, P393, DOI 10.2113/gselements.7.6.393; Burton ED, 2008, GEOCHIM COSMOCHIM AC, V72, P4551, DOI 10.1016/j.gca.2008.06.019; Bigham JM, 2000, REV MINERAL GEOCHEM, V40, P351, DOI 10.2138/rmg.2000.40.7; BIGHAM JM, 1994, MINERAL MAG, V58, P641, DOI 10.1180/minmag.1994.058.393.14; Regenspurg S, 2005, APPL GEOCHEM, V20, P1226, DOI 10.1016/j.apgeochem.2004.12.002; Schwertmann U, 2005, CLAY MINER, V40, P63, DOI 10.1180/0009855054010155; Khorasanipour M, 2011, APPL GEOCHEM, V26, P714, DOI 10.1016/j.apgeochem.2011.01.030; Burton ED, 2010, ENVIRON SCI TECHNOL, V44, P2016, DOI 10.1021/es903424h; Lin XM, 2003, WATER AIR SOIL POLL, V143, P155, DOI 10.1023/A:1022850308363; Dold B, 2001, J GEOCHEM EXPLOR, V74, P3, DOI 10.1016/S0375-6742(01)00174-1; Long G, 2012, MINER ENG, V36-38, P179, DOI 10.1016/j.mineng.2012.03.032; Antelo J, 2013, GEOCHIM COSMOCHIM AC, V119, P149, DOI 10.1016/j.gca.2013.05.029; Berger BR, 2008, 20081321 US GEOL SUR; BLGHAM JM, 1990, GEOCHIMICA COSMOCHIM, V54, P2743, DOI 10.1016/0016-7037(90)90009-A; Branson J.L, 2004, P NAT M AM SOC MIN R; EPA, COPP MIN PROD WAST R; Fernandez-Martinez A, 2010, AM MINERAL, V95, P1312, DOI 10.2138/am.2010.3446; Houngaloune S., 2015, INT J CHEM ENG APPL, V6, P32; JOHN D. A., 2010, 20105070B US GEOL SU; Lottermoser B.G., 2003, MINE WASTES CHARACTE; Paikaray S, 2012, APPL GEOCHEM, V27, P590, DOI 10.1016/j.apgeochem.2011.12.013; Paikaray S, 2010, MINE WATER ENVIRON, V29, P263, DOI 10.1007/s10230-010-0118-0; Peacey J, 2004, T NONFERR METAL SOC, V14, P560; Raghav M, 2013, J HAZARD MATER, V263, P525, DOI 10.1016/j.jhazmat.2013.10.009; Rose S, 2000, APPL GEOCHEM, V15, P27, DOI 10.1016/S0883-2927(99)00015-3; Stumm W., 1996, AQUATIC CHEM CHEM EQ, P1022	49	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-6875			MINER ENG	Miner. Eng.	APR	2015	74						51	59		10.1016/j.mineng.2015.01.003		9	Engineering, Chemical; Mineralogy; Mining & Mineral Processing	Engineering; Mineralogy; Mining & Mineral Processing	CE6RI	WOS:000351965200006		
J	Nagaoka, K; Hino, S; Sakamoto, A; Anan, K; Takase, R; Umehara, T; Yokoyama, S; Sasaki, Y; Nakao, M				Nagaoka, Katsuya; Hino, Shinjiro; Sakamoto, Akihisa; Anan, Kotaro; Takase, Ryuta; Umehara, Takashi; Yokoyama, Shigeyuki; Sasaki, Yutaka; Nakao, Mitsuyoshi			Lysine-Specific Demethylase 2 Suppresses Lipid Influx and Metabolism in Hepatic Cells	MOLECULAR AND CELLULAR BIOLOGY			English	Article							FATTY LIVER-DISEASE; HISTONE DEMETHYLATION; HUMAN GENOME; METHYLATION; EPIGENETICS; CHROMATIN; DISTINCT; STEATOHEPATITIS; TRANSCRIPTION; MECHANISMS	Cells link environmental fluctuations, such as nutrition, to metabolic remodeling. Epigenetic factors are thought to be involved in such cellular processes, but the molecular basis remains unclear. Here we report that the lysine-specific demethylase 2 (LSD2) suppresses the flux and metabolism of lipids to maintain the energy balance in hepatic cells. Using transcriptome and chromatin immunoprecipitation-sequencing analyses, we revealed that LSD2 represses the genes involved in lipid influx and metabolism through demethylation of histone H3K4. Selective recruitment of LSD2 at lipid metabolism gene loci was mediated in part by a stress-responsive transcription factor, c-Jun. Intriguingly, LSD2 depletion increased the intracellular levels of many lipid metabolites, which was accompanied by an increased susceptibility to toxic cell damage in response to fatty acid exposure. Our data demonstrate that LSD2 maintains metabolic plasticity under fluctuating environment in hepatocytes by mediating the cross talk between the epigenome and metabolism.	[Nagaoka, Katsuya; Hino, Shinjiro; Sakamoto, Akihisa; Anan, Kotaro; Takase, Ryuta; Nakao, Mitsuyoshi] Kumamoto Univ, Dept Med Cell Biol, Inst Mol Embryol, Kumamoto, Japan; [Nagaoka, Katsuya] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Kumamoto, Japan; [Umehara, Takashi; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Nakao, Mitsuyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Hino, S (reprint author), Kumamoto Univ, Dept Med Cell Biol, Inst Mol Embryol, Kumamoto, Japan.	s-hino@kumamoto-u.ac.jp; mnakao@gpo.kumamoto-u.ac.jp	Umehara, Takashi/N-5683-2015	Umehara, Takashi/0000-0003-3464-2960	Ministry of Education, Culture, Sports, Science and Technology of Japan [3307]; Takeda Science Foundation; Japan Society for the Promotion of Science; Nakatomi Foundation; Japan Science and Technology Agency (CREST)	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas and on Innovative Areas (3307) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Japan Science and Technology Agency (CREST) to M.N., and by a grant from the Takeda Science Foundation to M.N. and S.H. This work was also supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by the Nakatomi Foundation to S.H.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Kakisaka K, 2012, AM J PHYSIOL-GASTR L, V302, pG77, DOI 10.1152/ajpgi.00301.2011; Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Veazey KJ, 2013, ALCOHOL CLIN EXP RES, V37, P1111, DOI 10.1111/acer.12080; Hasenfuss SC, 2014, CELL METAB, V19, P84, DOI 10.1016/j.cmet.2013.11.018; van Essen D, 2010, MOL CELL, V39, P750, DOI 10.1016/j.molcel.2010.08.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Czaja MJ, 2010, TRENDS ENDOCRIN MET, V21, P707, DOI 10.1016/j.tem.2010.08.010; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Yang Z, 2010, CELL RES, V20, P276, DOI 10.1038/cr.2010.12; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Fuest M, 2012, HEPATOLOGY, V55, P408, DOI 10.1002/hep.24699; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Lienhart WD, 2013, ARCH BIOCHEM BIOPHYS, V535, P150, DOI 10.1016/j.abb.2013.02.015; Duteil D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5093; Gupta J, 2012, BIOCHIMIE, V94, P2656, DOI 10.1016/j.biochi.2012.08.011; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Hino S, 2013, J HUM GENET, V58, P410, DOI 10.1038/jhg.2013.57; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Murray RK, 1999, HARPERS BIOCH; Pan DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066294; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	APR	2015	35	7					1068	1080		10.1128/MCB.01404-14		13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CE3PG	WOS:000351739200001		
J	Bauer, O; Sharir, A; Kimura, A; Hantisteanu, S; Takeda, S; Groner, Y				Bauer, Omri; Sharir, Amnon; Kimura, Ayako; Hantisteanu, Shay; Takeda, Shu; Groner, Yoram			Loss of Osteoblast Runx3 Produces Severe Congenital Osteopenia	MOLECULAR AND CELLULAR BIOLOGY			English	Article							BONE-MINERAL DENSITY; COMPONENT LINKAGE ANALYSIS; CHONDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; REGULATED EXPRESSION; SKELETAL DEVELOPMENT; KNOCKOUT MICE; CLEIDOCRANIAL DYSPLASIA; CRE RECOMBINASE; TRANSGENIC MICE	Congenital osteopenia is a bone demineralization condition that is associated with elevated fracture risk in human infants. Here we show that Runx3, like Runx2, is expressed in precommitted embryonic osteoblasts and that Runx3-deficient mice develop severe congenital osteopenia. Runx3-deficient osteoblast-specific (Runx3(fl/fl)/Col1 alpha 1-cre), but not chondrocyte-specific (Runx3(fl/fl)/Col1 alpha 2-cre), mice are osteopenic. This demonstrates that an osteoblastic cell-autonomous function of Runx3 is required for proper osteogenesis. Bone histomorphometry revealed that decreased osteoblast numbers and reduced mineral deposition capacity in Runx3-deficient mice cause this bone formation deficiency. Neonatal bone and cultured primary osteoblast analyses revealed a Runx3-deficiency-associated decrease in the number of active osteoblasts resulting from diminished proliferation and not from enhanced osteoblast apoptosis. These findings are supported by Runx3-null culture transcriptome analyses showing significant decreases in the levels of osteoblastic markers and increases in the levels of Notch signaling components. Thus, while Runx2 is mandatory for the osteoblastic lineage commitment, Runx3 is nonredundantly required for the proliferation of these precommitted cells, to generate adequate numbers of active osteoblasts. Human RUNX3 resides on chromosome 1p36, a region that is associated with osteoporosis. Therefore, RUNX3 might also be involved in human bone mineralization.	[Bauer, Omri; Sharir, Amnon; Hantisteanu, Shay; Groner, Yoram] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Kimura, Ayako; Takeda, Shu] Tokyo Med & Dent Univ, Dept Orthoped, Tokyo, Japan	Groner, Y (reprint author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	Yoram.Groner@weizmann.ac.il			Israel Science Foundation (ISF)	This study was supported by a grant from the Israel Science Foundation (ISF) to Y.G.	Adhami MD, 2015, J BONE MINER RES, V30, P71, DOI 10.1002/jbmr.2321; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Devoto M, 2005, EUR J HUM GENET, V13, P781, DOI 10.1038/sj.ejhg.5201411; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Baker-LePain JC, 2011, CURR OPIN RHEUMATOL, V23, P389, DOI 10.1097/BOR.0b013e3283474dbe; Huang QY, 2009, BONE, V44, P984, DOI 10.1016/j.bone.2009.01.368; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Huang W, 2007, FRONT BIOSCI, V12, P3068, DOI 10.2741/2296; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Devoto M, 1998, EUR J HUM GENET, V6, P151, DOI 10.1038/sj.ejhg.5200169; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; LEFEBVRE O, 1995, DEVELOPMENT, V121, P947; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; Yoshida CA, 2005, CRIT REV EUKAR GENE, V15, P243; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Devoto M, 2001, HUM MOL GENET, V10, P2447, DOI 10.1093/hmg/10.21.2447; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Callis GM, 2007, THEORY PRACTICE HIST; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; Dumas A, 2008, CYTOTECHNOLOGY, V58, P163, DOI 10.1007/s10616-009-9184-1; Kajita M, 2003, J HUM GENET, V48, P77, DOI 10.1007/s100380300010; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Klein O F, 2001, J Bone Miner Res, V16, P1953; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee YH, 2006, J HUM GENET, V51, P480, DOI 10.1007/s10038-006-0390-9; Levanon D, 2009, BLOOD CELL MOL DIS, V43, P1, DOI 10.1016/j.bcmd.2009.01.009; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Levanon D, 2003, BLOOD CELL MOL DIS, V30, P161, DOI 10.1016/S1079-9796(03)00023-8; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Lim KE, 2014, J BONE MINER RES; Margolis DS, 2006, BONE, V39, P477, DOI 10.1016/j.bone.2006.02.064; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; McLean RR, 2004, J BONE MINER RES, V19, P410, DOI 10.1359/JBMR.0301261; Qin X., 2014, J BONE MINER RES; Rauch F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P194; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Sato S, 2008, ARTHRITIS RHEUM, V58, P2764, DOI 10.1002/art.23805; Schinke T, 2008, BONE, V42, P524, DOI 10.1016/j.bone.2007.11.009; Sharma P, 2006, BIOTECHNIQUES, V41, P539, DOI 10.2144/000112280; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Spotila LD, 2000, J BONE MINER RES, V15, P1376, DOI 10.1359/jbmr.2000.15.7.1376; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Sullivan JC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-228; SUNDIN OH, 1990, DEVELOPMENT, V108, P47; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Warshawsky H, 1982, MUSCULOSKELETAL SYST, P33; WILLIAMS SN, 1991, J ANIM SCI, V69, P1232; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Yamashiro T, 2002, MECH DEVELOP, V119, pS107, DOI 10.1016/S0925-4773(03)00101-1; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038	82	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	APR	2015	35	7					1097	1109		10.1128/MCB.01106-14		13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CE3PG	WOS:000351739200003		
J	Iwano, S; Satou, A; Matsumura, S; Sugiyama, N; Ishihama, Y; Toyoshima, F				Iwano, Sayaka; Satou, Ayaka; Matsumura, Shigeru; Sugiyama, Naoyuki; Ishihama, Yasushi; Toyoshima, Fumiko			PCTK1 Regulates Integrin-Dependent Spindle Orientation via Protein Kinase A Regulatory Subunit KAP0 and Myosin X	MOLECULAR AND CELLULAR BIOLOGY			English	Article							CELL-DIVISION; ADHERENT CELLS; FAMILY; MITOSIS; SPERMATOGENESIS; PHOSPHORYLATION; SUPERFAMILY; INHIBITION; PROTEOMICS; PCTAIRE-1	Integrin-dependent cell-extracellular matrix (ECM) adhesion is a determinant of spindle orientation. However, the signaling pathways that couple integrins to spindle orientation remain elusive. Here, we show that PCTAIRE-1 kinase (PCTK1), a member of the cyclin-dependent kinases (CDKs) whose function is poorly characterized, plays an essential role in this process. PCTK1 regulates spindle orientation in a kinase-dependent manner. Phosphoproteomic analysis together with an RNA interference screen revealed that PCTK1 regulates spindle orientation through phosphorylation of Ser83 on KAP0, a regulatory subunit of protein kinase A (PKA). This phosphorylation is dispensable for KAP0 dimerization and for PKA binding but is necessary for its interaction with myosin X, a regulator of spindle orientation. KAP0 binds to the FERM domain of myosin X and enhances the association of myosin X-FERM with beta 1 integrin. This interaction between myosin X-FERM and beta 1 integrin appeared to be crucial for spindle orientation control. We propose that PCTK1-KAP0-myosin X-beta 1 integrin is a functional module providing a link between ECM and the actin cytoskeleton in the ECM-dependent control of spindle orientation.	[Iwano, Sayaka; Matsumura, Shigeru; Toyoshima, Fumiko] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Sakyo Ku, Kyoto, Japan; [Iwano, Sayaka; Matsumura, Shigeru; Toyoshima, Fumiko] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto, Japan; [Satou, Ayaka; Sugiyama, Naoyuki; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular BioAnal, Sakyo Ku, Kyoto, Japan	Ishihama, Y (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular BioAnal, Sakyo Ku, Kyoto, Japan.	yishiham@pharm.kyoto-u.ac.jp; ftoyoshi@virus.kyoto-u.ac.jp			Funding Program for Next Generation World-Leading Researchers [LS069]; Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by grants from the Funding Program for Next Generation World-Leading Researchers (LS069; F.T.), Naito Foundation (F.T.), and Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan (S.I.).	LAMB NJC, 1991, EMBO J, V10, P1523; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Besset V, 1999, CELL GROWTH DIFFER, V10, P173; Fu WY, 2011, NEUROSCIENCE, V180, P353, DOI 10.1016/j.neuroscience.2011.02.024; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Imamura H, 2014, J PROTEOME RES, V13, P3410, DOI 10.1021/pr500319y; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; HONDA H, 1983, INT REV CYTOL, V81, P191; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Berg JS, 2000, J CELL SCI, V113, P3439; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Matsumura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1634; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Charrasse S, 1999, CELL GROWTH DIFFER, V10, P611; MEYERSON M, 1992, EMBO J, V11, P2909; Cole AR, 2009, NEUROSIGNALS, V17, P288, DOI 10.1159/000231895; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Hertwig O., 1884, JENAISCHE Z NATURWIS, V18, P276; Hodge T, 2000, J CELL SCI, V113, P3353; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; Lagos-Cabre R, 2008, REPRODUCTION, V135, P471, DOI 10.1530/REP-07-0389; MENDENHALL MD, 1988, P NATL ACAD SCI USA, V85, P4426, DOI 10.1073/pnas.85.12.4426; OKUDA T, 1992, ONCOGENE, V7, P2249; Oliver TN, 1999, CELL MOL LIFE SCI, V56, P243, DOI 10.1007/s000180050426; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Shimizu K, 2014, FEBS LETT, V588, P3030, DOI 10.1016/j.febslet.2014.05.060; Skalhegg BS, 1997, FRONT BIOSCI, V2, P331; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Tacon D, 2004, BIOCHEM SOC T, V32, P689; TASKEN KA, 1995, BBA-GENE STRUCT EXPR, V1260, P269, DOI 10.1016/0167-4781(94)00203-F; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241	52	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	APR	2015	35	7					1197	1208		10.1128/MCB.01017-14		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CE3PG	WOS:000351739200010		
J	Nomura, W; Inoue, Y				Nomura, Wataru; Inoue, Yoshiharu			Methylglyoxal Activates the Target of Rapamycin Complex 2-Protein Kinase C Signaling Pathway in Saccharomyces cerevisiae	MOLECULAR AND CELLULAR BIOLOGY			English	Article							PKC1 GENE-PRODUCT; GROWTH-CONTROL; CELL-GROWTH; 1,3-BETA-GLUCAN SYNTHASE; ACTIN CYTOSKELETON; OXIDATIVE STRESS; EXCHANGE FACTOR; BUDDING YEAST; AGC KINASES; PROTEIN	Methylglyoxal is a typical 2-oxoaldehyde derived from glycolysis. We show here that methylglyoxal activates the Pkc1-Mpk1 mitogen-activated protein (MAP) kinase cascade in a target of rapamycin complex 2 (TORC2)-dependent manner in the budding yeast Saccharomyces cerevisiae. We demonstrate that TORC2 phosphorylates Pkc1 at Thr1(125) and Ser1(143). Methylglyoxal enhanced the phosphorylation of Pkc1 at Ser1(143), which transmitted the signal to the downstream Mpk1 MAP kinase cascade. We found that the phosphorylation status of Pkc1T1(125) affected the phosphorylation of Pkc1 at Ser1(143), in addition to its protein levels. Methylglyoxal activated mammalian TORC2 signaling, which, in turn, phosphorylated Akt at Ser(473). Our results suggest that methylglyoxal is a conserved initiator of TORC2 signaling among eukaryotes.	[Nomura, Wataru; Inoue, Yoshiharu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Mol Microbiol Lab, Uji, Kyoto, Japan	Inoue, Y (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Mol Microbiol Lab, Uji, Kyoto, Japan.	y_inoue@kais.kyoto-u.ac.jp					Angeloni C, 2014, BIOMED RES INT, DOI 10.1155/2014/238485; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Denis V, 2005, EUKARYOT CELL, V4, P36, DOI 10.1128/EC.4.1.36-45.2005; IRIE K, 1993, MOL CELL BIOL, V13, P3076; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; NONAKA H, 1995, EMBO J, V14, P5931; Jacoby JJ, 1997, FEBS LETT, V417, P219, DOI 10.1016/S0014-5793(97)01287-8; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Matafome P, 2013, ENDOCRINE, V43, P472, DOI 10.1007/s12020-012-9795-8; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Pruyne D, 2000, J CELL SCI, V113, P571; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P7, DOI 10.1093/ndt/15.suppl_1.7; Mizunuma M, 1998, NATURE, V392, P303; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Saka A, 2001, J BIOL CHEM, V276, P46165, DOI 10.1074/jbc.M103805200; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Maeta K, 2005, J BIOL CHEM, V280, P253, DOI 10.1074/jbc.M408061200; Nakamura T, 1996, MOL GEN GENET, V251, P211; Inoue Y, 2011, SEMIN CELL DEV BIOL, V22, P278, DOI 10.1016/j.semcdb.2011.02.002; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Helliwell SB, 1998, GENETICS, V148, P99; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; Takatsume Y, 2006, J BIOL CHEM, V281, P9086, DOI 10.1074/jbc.M511037200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; ANTONSSON B, 1994, J BIOL CHEM, V269, P16821; Ho HL, 2005, CURR GENET, V47, P273, DOI 10.1007/s00294-005-0570-8; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Inoue SB, 1999, J BIOL CHEM, V274, P38119, DOI 10.1074/jbc.274.53.38119; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jin CY, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/320823; Maeta K, 2004, MOL CELL BIOL, V24, P8753, DOI 10.1128/MCB.24.19.8753; PARAVICINI G, 1992, MOL CELL BIOL, V12, P4896; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848; Schmitz HP, 2002, MOL MICROBIOL, V44, P829, DOI 10.1046/j.1365-2958.2002.02925.x; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Wilk S, 2010, MOL GENET GENOMICS, V284, P217, DOI 10.1007/s00438-010-0563-2	60	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	APR	2015	35	7					1269	1280		10.1128/MCB.01118-14		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CE3PG	WOS:000351739200015		
J	Ohta, S; Wood, L; Toramoto, I; Yagyu, KI; Fukagawa, T; Earnshaw, WC				Ohta, Shinya; Wood, Laura; Toramoto, Iyo; Yagyu, Ken-Ichi; Fukagawa, Tatsuo; Earnshaw, William C.			CENP-32 is required to maintain centrosomal dominance in bipolar spindle assembly	MOLECULAR BIOLOGY OF THE CELL			English	Article							XENOPUS EGG EXTRACTS; PHRAGMOPLAST MICROTUBULE ARRAYS; TUBULIN RING COMPLEX; DROSOPHILA S2 CELLS; PLUS-END DYNAMICS; MITOTIC SPINDLE; CG-NAP; CORTICAL DYNEIN; PROTEIN COMPLEX; AURORA-A	Centrosomes nucleate spindle formation, direct spindle pole positioning, and are important for proper chromosome segregation during mitosis in most animal cells. We previously reported that centromere protein 32 (CENP-32) is required for centrosome association with spindle poles during metaphase. In this study, we show that CENP-32 depletion seems to release centrosomes from bipolar spindles whose assembly they had previously initiated. Remarkably, the resulting anastral spindles function normally, aligning the chromosomes to a metaphase plate and entering anaphase without detectable interference from the free centrosomes, which appear to behave as free asters in these cells. The free asters, which contain reduced but significant levels of CDK5RAP2, show weak interactions with spindle microtubules but do not seem to make productive attachments to kinetochores. Thus CENP-32 appears to be required for centrosomes to integrate into a fully functional spindle that not only nucleates astral microtubules, but also is able to nucleate and bind to kinetochore and central spindle microtubules. Additional data suggest that NuMA tethers microtubules at the anastral spindle poles and that augmin is required for centrosome detachment after CENP-32 depletion, possibly due to an imbalance of forces within the spindle.	[Ohta, Shinya; Wood, Laura; Earnshaw, William C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Ohta, Shinya; Toramoto, Iyo; Yagyu, Ken-Ichi] Kochi Univ, Sch Med, Nankoku, Oko Cho, Kochi 7838505, Japan; [Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Fukagawa, Tatsuo] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan	Ohta, S (reprint author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	shinya.ohta@kochi-u.ac.jp; bill.earnshaw@ed.ac.uk			Japan Society for the Promotion of Science KAKENHI Grant [25870487]; Wellcome Trust Principal Research Fellowship Grant [073915];  [077707];  [092076]	We thank Mikiko Takahashi (Teikyo Heisei University, Tokyo, Japan) for CG-NAP antibody. We thank Shuji Sakamoto, Mikiro Takaishi, and Takuma Higuchi (Kochi University, Kochi, Japan) for critical reading of the manuscript. This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 25870487 to S.O. and Wellcome Trust Principal Research Fellowship Grant 073915 to W.C.E. The Wellcome Trust Centre for Cell Biology is supported by Core Grants 077707 and 092076.	Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Nazarova E, 2013, MOL BIOL CELL, V24, P3238, DOI 10.1091/mbc.E13-05-0232; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Ozaki Y, 2012, MOL CELL, V47, P694, DOI 10.1016/j.molcel.2012.06.033; Patel K, 2012, CYTOSKELETON, V69, P155, DOI 10.1002/cm.21005; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Sharp DJ, 2000, MOL BIOL CELL, V11, P241; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Saunders W, 1997, MOL BIOL CELL, V8, P1025; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015; Bird SL, 2013, MOL BIOL CELL, V24, P2506, DOI 10.1091/mbc.E13-03-0150; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Zhang CM, 1999, J CELL SCI, V112, P2453; Hotta T, 2012, PLANT CELL, V24, P1494, DOI 10.1105/tpc.112.096610; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Ho CMK, 2011, PLANT CELL, V23, P2606, DOI 10.1105/tpc.111.086892; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Reis R, 2009, J CELL SCI, V122, P2543, DOI 10.1242/jcs.044818; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Moutinho-Pereira S, 2013, P NATL ACAD SCI USA, V110, P19808, DOI 10.1073/pnas.1320013110; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Masoud K, 2013, PLANT J, V75, P245, DOI 10.1111/tpj.12179; Hashimoto T, 2013, CURR OPIN PLANT BIOL, V16, P698, DOI 10.1016/j.pbi.2013.09.002; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Byers B, 1974, Cold Spring Harb Symp Quant Biol, V38, P123; Espiritu EB, 2012, DEV BIOL, V368, P242, DOI 10.1016/j.ydbio.2012.05.016; Haren Laurence, 2009, BMC Res Notes, V2, P64, DOI 10.1186/1756-0500-2-64; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068523; Kamasaki T, 2013, J CELL BIOL, V202, P25, DOI 10.1083/jcb.201304031; KARSENTI E, 1984, J CELL BIOL, V99, pS47, DOI 10.1083/jcb.99.1.47s; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Miller L, 2009, NEUROGASTROENT MOTIL, V21, P813, DOI 10.1111/j.1365-2982.2009.01294.x; Morales-Mulia S, 2005, MOL BIOL CELL, V16, P3176, DOI 10.1091/mbc.E04-12-1110; Oshimori N, 2009, EMBO J, V28, P2066, DOI 10.1038/emboj.2009.161; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; UZBEKOV RE, 1995, J PHOTOCH PHOTOBIO B, V29, P163, DOI 10.1016/1011-1344(95)07129-P; Wakefield JG, 2000, CURR BIOL, V10, P1367, DOI 10.1016/S0960-9822(00)00776-4	70	1	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	APR 1	2015	26	7					1225	1237		10.1091/mbc.E14-09-1366		13	Cell Biology	Cell Biology	CE6KU	WOS:000351946100003		
J	Yoshinaga, T; Shigemitsu, T; Nishimata, H; Takei, T; Yoshida, M				Yoshinaga, Takuma; Shigemitsu, Takamasa; Nishimata, Hiroto; Takei, Takayuki; Yoshida, Masahiro			Angiopoietin-like protein 2 is a potential biomarker for gastric cancer	MOLECULAR MEDICINE REPORTS			English	Article						angiopoietin-like protein 2; gastric cancer; biomarker; serum; HGC-27 cell line; MKN7 cell line	INFLAMMATION; CA-19-9; CEA	Globally, gastric cancer is one of the most common types of cancer and is the second leading cause of cancer-induced mortality. Early detection of gastric cancer is able to contribute to a reduction of its mortality. For early detection, more specific and sensitive biomarkers than the classic biomarkers, including carcinoembryonic antigen, carbohydrate antigen 19-9 and C-reactive protein, are required. The present study focused on the evaluation of the potential of angiopoietin-like protein 2 (ANGPTL2) as a novel biomarker for gastric cancer. The expression levels of ANGPTL2 in undifferentiated and differentiated gastric cancer cell lines (HGC-27 and MKN7, respectively) were therefore investigated. Additionally, ANGPTL2 levels in the serum of gastric cancer patients were compared with those of healthy individuals to evaluate the possibility of the protein as a predictive biomarker for gastric cancer. It was established that the expression levels of ANGPTL2 mRNA and protein were higher in undifferentiated HGC-27 cells than those in differentiated MKN7 cells. In a patient study, it was indicated that the levels of ANGPTL2 in the serum of gastric cancer patients were higher than those in healthy controls. The diagnostic performance of ANGPTL2 was assessed by constructing a receiver operating characteristic (ROC) curve and was evaluated by calculating the area under each ROC curve (AUC). For the discrimination of patients with gastric cancer from healthy individuals, the AUC for ANGPTL2 was 0.774 (P=0.005) (95% confidence interval, 0.615-0.933). These results suggested that ANGPTL2 was a potential biomarker for gastric cancer.	[Yoshinaga, Takuma; Shigemitsu, Takamasa; Takei, Takayuki; Yoshida, Masahiro] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Engn, Kagoshima 8900065, Japan; [Yoshinaga, Takuma] Nanpuh Hosp, Div Clin Applicat, Kagoshima 8920854, Japan; [Nishimata, Hiroto] Nanpuh Hosp, Dept Gastroenterol, Kagoshima 8920854, Japan	Yoshida, M (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	myoshida@cen.kagoshima-u.ac.jp			Division of Gene Research, Kagoshima University; Divisions of Gastrointestinal Surgery and Clinical Laboratory, Nanpuh Hospital (Kagoshima, Japan)	The present study was supported in part by the Division of Gene Research, Kagoshima University and the Divisions of Gastrointestinal Surgery and Clinical Laboratory, Nanpuh Hospital (Kagoshima, Japan).	Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Presta LG, 1997, CANCER RES, V57, P4593; Loei H, 2012, J PROTEOME RES, V11, P1759, DOI 10.1021/pr201014h; Li C, 2013, J SURG ONCOL, V108, P89, DOI 10.1002/jso.23358; Oike Y, 2004, INT J HEMATOL, V80, P21, DOI 10.1532/ijh97.04034; Wang QW, 2013, UROL ONCOL-SEMIN ORI, V31, P312, DOI 10.1016/j.urolonc.2011.01.006; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Sfiligoi C, 2003, INT J CANCER, V103, P466, DOI 10.1002/ijc.10851; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Kikuchi R, 2008, CANCER RES, V68, P5067, DOI 10.1158/0008-5472.CAN-08-0062; Carpelan-Holmstrom M, 2002, ANTICANCER RES, V22, P2311; Jass JR, 1989, HISTOLOGICAL TYPING, DOI [10.1007/978-3-642-83693-0, DOI 10.1007/978-3-642-83693-0]; Lukaszewicz-Zajac M, 2011, CLIN EXP MED, V11, P89, DOI 10.1007/s10238-010-0114-5; Tan YK, 2006, EUR J GASTROEN HEPAT, V18, P821, DOI 10.1097/00042737-200608000-00004; Yu X, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0365-y	16	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2015	11	4					2653	2658		10.3892/mmr.2014.3040		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CE3FG	WOS:000351711100038		
J	Nishioka, A; Ogawa, Y; Kariya, S; Hamada, N; Nogami, M; Inomata, T; Ueno, H				Nishioka, Akihito; Ogawa, Yasuhiro; Kariya, Shinji; Hamada, Norihiko; Nogami, Munenobu; Inomata, Taisuke; Ueno, Hikaru			Reduction of fibroproliferative changes in irradiated rat lung with soluble transforming growth factor-beta receptor	MOLECULAR MEDICINE REPORTS			English	Article						transforming growth factor-; adenoviral vector; radiation-induced pulmonary injury; gene therapy	TGF-BETA; II RECEPTOR; RADIATION; FIBROSIS; INJURY; EXPRESSION; DAMAGE; ALPHA	The present study investigated whether established fibroproliferative changes in the irradiated rat lung are histopathologically reduced by an adenovirus-mediated soluble transforming growth factor (TGF)- type II receptor. Replication-defective adenoviral vectors expressing a type II human TGF- receptor (AdT-ExR) were prepared. Male Fisher-344 rats were divided into the C, R and R + T groups. The rats in the C group did not receive irradiation or treatment. The rats in the R and R + T group each received 30 Gy irradiation to the right lung. Eight weeks following irradiation, the rats in the R and R + T group were treated with saline or AdT-ExR, respectively. To analyze the TGF- expression, myofibroblast proliferation and macrophage/monocyte infiltration, sections of the lung were immunohistochemically stained at 16 weeks following irradiation. Silver staining was performed for semi-quantitative evaluation of the fibroproliferative changes. Definitive TGF- expression, myofibroblast proliferation and macrophage/monocyte infiltration were observed in the lungs of the R group, but were significantly lower in the lungs of the R + T group. With respect to the fibroproliferative changes, the proportion of red-stained areas in the R + T group was markedly lower than that in the R group. These data indicate that fibroproliferative changes induced by radiation are reversible and that TGF- has a critical role in fibroproliferative changes in the irradiated lung. The present results suggest that gene therapy with an adenoviral vector expressing a soluble TGF- receptor may be effective in reducing the established pulmonary fibrosis caused by radiation.	[Nishioka, Akihito; Ogawa, Yasuhiro; Kariya, Shinji; Hamada, Norihiko; Nogami, Munenobu] Kochi Univ, Sch Med, Dept Diagnost Radiol & Radiat Oncol, Nankoku, Kochi 7838505, Japan; [Inomata, Taisuke] Shimane Univ, Dept Radiat Oncol, Izumo, Shimane 6938501, Japan; [Ueno, Hikaru] Univ Occupat & Environm Hlth, Sch Med, Dept Biochem & Mol Pathophysiol, Fukuoka 8078556, Japan	Nishioka, A (reprint author), Kochi Univ, Sch Med, Dept Diagnost Radiol & Radiat Oncol, Okoh Cho, Nankoku, Kochi 7838505, Japan.	nishiokaa@kochi-u.ac.jp					GABBIANI G, 1994, PATHOL RES PRACT, V190, P851; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Yi ES, 1996, INFLAMMATION, V20, P339, DOI 10.1007/BF01486737; FINKELSTEIN JN, 1994, INT J RADIAT ONCOL, V28, P621; DELANIAN S, 1994, RADIOTHER ONCOL, V32, P12, DOI 10.1016/0167-8140(94)90444-8; Lefaix JL, 1996, INT J RADIAT ONCOL, V35, P305, DOI 10.1016/0360-3016(96)00061-2; Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; Anscher MS, 2006, INT J RADIAT ONCOL, V65, P876, DOI 10.1016/j.ijrobp.2006.02.051; Franko AJ, 1997, RADIAT RES, V147, P245, DOI 10.2307/3579426; Gauter-Fleckenstein B, 2010, FREE RADICAL BIO MED, V48, P1034, DOI 10.1016/j.freeradbiomed.2010.01.020; Lefaix JL, 1999, INT J RADIAT ONCOL, V43, P839, DOI 10.1016/S0360-3016(98)00419-2; Nishioka A, 2004, INT J RADIAT ONCOL, V58, P1235, DOI 10.1016/j.ijrobp.2003.11.006; Nishioka A, 2005, INT J RADIAT ONCOL, V61, P308, DOI 10.1016/j.ijrobp.2004.08.041; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1; Rabbani ZN, 2003, INT J RADIAT ONCOL, V57, P563, DOI 10.1016/S0360-3016(03)00639-4; Sakamoto T, 2000, GENE THER, V7, P1915, DOI 10.1038/sj.gt.3301320; Ueno H, 2000, HUM GENE THER, V11, P33, DOI 10.1089/10430340050016139	17	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2015	11	4					2659	2663		10.3892/mmr.2014.3064		5	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CE3FG	WOS:000351711100039		
J	Takahashi, T; Tanaka, T; Tsushima, Y; Muragaki, K; Uehara, K; Takeuchi, S; Maeda, H; Yamagata, Y; Nakayama, M; Yoshimi, A; Abe, K				Takahashi, Toru; Tanaka, Takumi; Tsushima, Yusei; Muragaki, Kimihide; Uehara, Kenji; Takeuchi, Shunsuke; Maeda, Hiroshi; Yamagata, Youhei; Nakayama, Mayumi; Yoshimi, Akira; Abe, Keietsu			Ionic interaction of positive amino acid residues of fungal hydrophobin RolA with acidic amino acid residues of cutinase CutL1	MOLECULAR MICROBIOLOGY			English	Article							ASPERGILLUS-ORYZAE; MAGNAPORTHE-GRISEA; TRICHODERMA-REESEI; CYTOCHROME-C; GENE; SURFACE; PROTEIN; SCHIZOPHYLLUM; AMPHIPHILE; NIDULANS	Hydrophobins are amphipathic proteins secreted by filamentous fungi. When the industrial fungus Aspergillus oryzae is grown in a liquid medium containing the polyester polybutylene succinate co-adipate (PBSA), it produces RolA, a hydrophobin, and CutL1, a PBSA-degrading cutinase. Secreted RolA attaches to the surface of the PBSA particles and recruits CutL1, which then condenses on the particles and stimulates the hydrolysis of PBSA. Here, we identified amino acid residues that are required for the RolA-CutL1 interaction by using site-directed mutagenesis. We quantitatively analyzed kinetic profiles of the interactions between RolA variants and CutL1 variants by using a quartz crystal microbalance (QCM). The QCM analyses revealed that Asp142, Asp171 and Glu31, located on the hydrophilic molecular surface of CutL1, and His32 and Lys34, located in the N-terminus of RolA, play crucial roles in the RolA-CutL1 interaction via ionic interactions. RolA immobilized on a QCM electrode strongly interacted with CutL1 (K-D=6.5nM); however, RolA with CutL1 variants, or RolA variants with CutL1, showed markedly larger K-D values, particularly in the interaction between the double variant RolA-H32S/K34S and the triple variant CutL1-E31S/D142S/D171S (K-D=78.0nM). We discuss a molecular prototype model of hydrophobin-based enzyme recruitment at the solid-water interface.	[Takahashi, Toru; Maeda, Hiroshi; Yamagata, Youhei; Nakayama, Mayumi; Yoshimi, Akira; Abe, Keietsu] Tohoku Univ, Microbial Genom Lab, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9818555, Japan; [Tanaka, Takumi; Tsushima, Yusei; Muragaki, Kimihide; Nakayama, Mayumi; Yoshimi, Akira; Abe, Keietsu] Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Appl Microbiol Lab, Sendai, Miyagi 9818555, Japan; [Uehara, Kenji; Takeuchi, Shunsuke] Tohoku Univ, Grad Sch Agr Sci, Dept Mol & Cell Biol, Enzymol Lab, Sendai, Miyagi 9818555, Japan; [Maeda, Hiroshi; Yamagata, Youhei] Tokyo Univ Agr & Technol, Dept Appl Mol Biol & Biochem, Fuchu, Tokyo 1838509, Japan	Abe, K (reprint author), Tohoku Univ, Microbial Genom Lab, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9818555, Japan.	kabe@biochem.tohoku.ac.jp			KAKENHI (Japan Society for the Promotion of Science) [20380175, 24658281]; RITE (Research Institute of Innovative Technology for the Earth)	This work was partly supported by KAKENHI (Japan Society for the Promotion of Science), a Grant-in-Aid for Scientific Research (B) (grant no. 20380175 to K.A.), and Challenging Exploratory Research (grant no. 24658281 to K.A.). K.A. also would like to thank RITE (Research Institute of Innovative Technology for the Earth) for their financial support through the Joint Program to Promote Technological Development. We thank Du Pont-Mitsui Fluorochemicals for the gift of the Teflon PFA350 suspension. We also thank Katsuhiko Kitamoto for providing the Aspergillus oryzae NSlD-tApEnBdIVdV2. We thank Hideaki Koike, Tomonori Fujioka, Osamu Mizutani, Kentaro Furukawa, Kei Nanatani, Keiko Orui, Yoonkyung Kim, Daiki Sato, Megumi Nagayama, Yuki Terauchi, Naoki Abe and Natsumi Okada for their helpful discussions and technical assistance.	Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005; Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Wosten HAB, 1999, CURR BIOL, V9, P85, DOI 10.1016/S0960-9822(99)80019-0; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2832, DOI 10.1021/bi00684a007; Corvis Y, 2005, ANAL CHEM, V77, P1622, DOI 10.1021/ac048897w; Liu ZQ, 2009, J AM CHEM SOC, V131, P15711, DOI 10.1021/ja9046697; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Chandra M, 2009, J IND MICROBIOL BIOT, V36, P605, DOI 10.1007/s10295-009-0544-9; Takahashi T, 2011, J BIOSCI BIOENG, V112, P529, DOI 10.1016/j.jbiosc.2011.08.007; Hakanpaa J, 2006, PROTEIN SCI, V15, P2129, DOI 10.1110/ps.062326706; Maeda H, 2005, APPL MICROBIOL BIOT, V67, P778, DOI 10.1007/s00253-004-1853-6; Askolin S, 2006, BIOMACROMOLECULES, V7, P1295, DOI 10.1021/bm050676s; Ohtaki S, 2006, APPL ENVIRON MICROB, V72, P2407, DOI 10.1128/AEM.72.4.2407-2413.2006; WESSELS JGH, 1991, PLANT CELL, V3, P793; Janssen MI, 2002, BIOMATERIALS, V23, P4847, DOI 10.1016/S0142-9612(02)00240-5; Takahashi T, 2005, MOL MICROBIOL, V57, P1780, DOI 10.1111/j.1365-2958.2005.04803.x; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; SWEIGARD JA, 1992, MOL GEN GENET, V232, P174; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; WESSELS JGH, 1994, ANNU REV PHYTOPATHOL, V32, P413; Wang ZF, 2010, LANGMUIR, V26, P8491, DOI 10.1021/la101240e; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Degani O, 2013, PHYSIOL MOL PLANT P, V83, P25, DOI 10.1016/j.pmpp.2013.03.003; desVocht M. L., 1998, BIOPHYS J, V74, P2059; desVries O. M. H., 1993, ARCH MICROBIOL, V159, P330; Fang XH, 2001, PHYTOCHEMISTRY, V57, P1035, DOI 10.1016/S0031-9422(01)00106-6; Hama H, 2004, ENDOCRINOLOGY, V145, P3935, DOI 10.1210/en.2004-0074; HATA Y, 1992, CURR GENET, V22, P85, DOI 10.1007/BF00351466; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Ichishima E, 2000, BIOSCI BIOTECH BIOCH, V64, P675, DOI 10.1271/bbb.64.675; Janssen MI, 2004, BIOMATERIALS, V25, P2731, DOI 10.1016/j.biomaterials.2003.09.060; Kontermann R. E., 2010, ANTIBODY ENG; Miles E W, 1977, Methods Enzymol, V47, P431; Morris VK, 2012, BIOMOL NMR ASSIGN, V6, P83, DOI 10.1007/s12104-011-9330-5; Nishimura M, 2009, BIOSCI BIOTECH BIOCH, V73, P1779, DOI 10.1271/bbb.90146; Sambrook J., 2012, MOL CLONING LAB MANU; Scholtmeijer K, 2002, APPL ENVIRON MICROB, V68, P1367, DOI 10.1128/AEM.68.3.1367-1373.2002; Scholtmeijer K, 2009, J BIOL CHEM, V284, P26309, DOI 10.1074/jbc.M109.005553; Tanaka T, 2014, BIOSCI BIOTECH BIOCH, V78, P1693, DOI 10.1080/09168451.2014.932684; Wang X, 2002, PROTEIN SCI, V11, P1172, DOI 10.1110/ps.4530102; Wang YD, 1998, ARCH BIOCHEM BIOPHYS, V352, P193, DOI 10.1006/abbi.1998.0590; Yoon J, 2009, APPL MICROBIOL BIOT, V82, P691, DOI 10.1007/s00253-008-1815-5	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	APR	2015	96	1					14	27		10.1111/mmi.12915		14	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CE5BT	WOS:000351845600003		
J	Winkelstroter, LK; Bom, VLP; de Castro, PA; Ramalho, LNZ; Goldman, MHS; Brown, NA; Rajendran, R; Ramage, G; Bovier, E; dos Reis, TF; Savoldi, M; Hagiwara, D; Goldman, GH				Winkelstroeter, Lizziane K.; Pedro Bom, Vinicius Leite; de Castro, Patricia Alves; Zambelli Ramalho, Leandra Naira; Goldman, Maria Helena S.; Brown, Neil Andrew; Rajendran, Ranjith; Ramage, Gordon; Bovier, Elodie; dos Reis, Thaila Fernanda; Savoldi, Marcela; Hagiwara, Daisuke; Goldman, Gustavo H.			High osmolarity glycerol response PtcB phosphatase is important for Aspergillus fumigatus virulence	MOLECULAR MICROBIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-WALL INTEGRITY; HIGH-EFFICIENCY TRANSFORMATION; TYROSINE PHOSPHATASES; CANDIDA-ALBICANS; STRESS-RESPONSE; ASEXUAL DEVELOPMENT; PHOSPHORYL TRANSFER; CATALYTIC SUBUNIT; SIGNALING PATHWAY	Aspergillus fumigatus is a fungal pathogen that is capable of adapting to different host niches and to avoid host defenses. An enhanced understanding of how, and which, A.fumigatus signal transduction pathways are engaged in the regulation of these processes is essential for the development of improved disease control strategies. Protein phosphatases are central to numerous signal transduction pathways. To comprehend the functions of protein phosphatases in A.fumigatus, 32 phosphatase catalytic subunit encoding genes were identified. We have recognized PtcB as one of the phosphatases involved in the high osmolarity glycerol response (HOG) pathway. The ptcB mutant has both increased phosphorylation of the p38 MAPK (SakA) and expression of osmo-dependent genes. The ptcB strain was more sensitive to cell wall damaging agents, had increased chitin and -1,3-glucan, and impaired biofilm formation. The ptcB strain was avirulent in a murine model of invasive pulmonary aspergillosis. These results stress the importance of the HOG pathway in the regulation of pathogenicity determinants and virulence in A.fumigatus.	[Winkelstroeter, Lizziane K.; Pedro Bom, Vinicius Leite; de Castro, Patricia Alves; Brown, Neil Andrew; Bovier, Elodie; dos Reis, Thaila Fernanda; Savoldi, Marcela; Goldman, Gustavo H.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Zambelli Ramalho, Leandra Naira] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, Brazil; [Rajendran, Ranjith; Ramage, Gordon] Univ Glasgow, Infect & Immun Res Grp, Glasgow Dent Sch, Sch Med,Coll Med Vet & Life Sci, Glasgow G2 3JZ, Lanark, Scotland; [Hagiwara, Daisuke] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Goldman, Gustavo H.] Natl Lab Sci & Technol Bioethanol CTBE, Campinas, SP, Brazil	Goldman, GH (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	ggoldman@usp.br		Rajendran, Ranjith/0000-0002-1069-7986	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	We would like to thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for providing financial support. We also would like to thank the editor and the three reviewers for their comments and suggestions, and Drs Axel Brakhage and Vito Valiante for providing us the A. fumigatus Delta mpkA mutant.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; Erental A, 2007, MOL PLANT MICROBE IN, V20, P944, DOI 10.1094/MPMI-20-8-0944; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Cuellar-Cruz M, 2012, FUTURE MICROBIOL, V7, P755, DOI [10.2217/fmb.12.48, 10.2217/FMB.12.48]; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Shepardson KM, 2013, MICROBES INFECT, V15, P259, DOI 10.1016/j.micinf.2012.11.010; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Son S, 2009, EUKARYOT CELL, V8, P573, DOI 10.1128/EC.00346-08; Zhang MM, 2010, PROTEIN SCI, V19, P974, DOI 10.1002/pro.375; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Käfer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Reyes G, 2006, EUKARYOT CELL, V5, P1934, DOI 10.1128/EC.00178-06; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Xue T, 2004, EUKARYOT CELL, V3, P557, DOI 10.1128/EC.3.2.557-560.2004; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; Brewster JL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005458; Shopova I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00141; Chung D, 2014, MOL MICROBIOL, V92, P1279, DOI 10.1111/mmi.12626; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Di Stasio M, 2009, MOL MICROBIOL, V73, P73, DOI 10.1111/j.1365-2958.2009.06747.x; Du YX, 2013, CURR GENET, V59, P33, DOI 10.1007/s00294-012-0385-3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Feng JR, 2010, YEAST, V27, P753, DOI 10.1002/yea.1778; Ghosh A, 2014, G3-GENES GENOM GENET, V4, P349, DOI 10.1534/g3.113.008813; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; HERRERAESTRELLA A, 1990, MOL MICROBIOL, V4, P839, DOI 10.1111/j.1365-2958.1990.tb00654.x; Hoi JWS, 2011, MOL BIOL CELL, V22, P1896, DOI 10.1091/mbc.E10-11-0914; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025311; Lee KT, 2014, EUKARYOT CELL, V13, P796, DOI 10.1128/EC.00069-14; Ma DM, 2013, MYCOPATHOLOGIA, V175, P13, DOI 10.1007/s11046-012-9600-5; MAY GS, 2008, MYCOLOGY S, V26, P121; Muszkieta L, 2014, FUNGAL GENET BIOL, V66, P79, DOI 10.1016/j.fgb.2014.02.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook J., 1989, MOL CLONING LAB MANU; Sanvoisin J, 2001, BIOORG MED CHEM LETT, V11, P471, DOI 10.1016/S0960-894X(00)00694-6; Shin JH, 2013, MOL PLANT PATHOL, V14, P518, DOI 10.1111/mpp.12023; tensCate J. M., 2009, J DENT RES, V88, P105; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Williams NH, 2004, BBA-PROTEINS PROTEOM, V1697, P279, DOI 10.1016/j.bbapap.2003.11.031; Yang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061307; Yang QQ, 2013, ENVIRON MICROBIOL, V15, P2696, DOI 10.1111/1462-2920.12126; ZUCKERKANDL EMILE, 1965, P97	69	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	APR	2015	96	1					42	54		10.1111/mmi.12919		13	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CE5BT	WOS:000351845600005		
J	Okumura, K				Okumura, Ko			Strength and toughness of biocomposites consisting of soft and hard elements: A few fundamental models	MRS BULLETIN			English	Article							LOBSTER HOMARUS-AMERICANUS; SPIDER SILK; MECHANICAL-PROPERTIES; FRACTURE-MECHANICS; BIOLOGICAL COMPOSITES; BIOINSPIRED DESIGN; HYBRID MATERIALS; ORGANIC MATRIX; NACRE STRONG; ORB-WEB	Certain biocomposites exploit the combination of soft and hard elements to achieve high strength and toughness. In nacre, found inside certain seashells or on the surface of pearls, hard layers of micron-scale thickness are glued together by thin layers of soft proteins to realize remarkable strength and toughness. In spider webs, stiffer radial threads are connected by softer spiral threads to produce a light and resistant structure. In the exoskeleton of lobsters, organic fibers form a chiral structure in an inorganic matrix. This article reviews progress in the understanding of the mechanical superiority of such soft-hard biocomposites. In particular, simple physical views are presented that allow an intuitive understanding of how their remarkable structures contribute to enhancing their fracture resistance in the presence of cracks, and how such structures are physically optimized in terms of mechanical properties. Such fundamental insights could be useful as guiding principles for developing artificial, reinforced materials.	Ochanomizu Univ, Dept Phys, Tokyo, Japan	Okumura, K (reprint author), Ochanomizu Univ, Dept Phys, Tokyo, Japan.	okumura@phys.ocha.ac.jp			MEXT, Japan [2206]; JSPS, Japan [24244066]; ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	This research was supported by Grant-in-Aid for Scientific Research on Innovative Areas, "Fusion Materials (Area no. 2206)," of MEXT, Japan, by a Grant-in-Aid for Scientific Research (A) (No. 24244066) of JSPS, Japan, and by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).	Ackbarow T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006015; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Fabritius HO, 2009, ADV MATER, V21, P391, DOI 10.1002/adma.200801219; Sachs C, 2006, J MATER RES, V21, P1987, DOI 10.1557/JMR.2006.0241; Yamamoto Y, 2008, CRYST GROWTH DES, V8, P4062, DOI 10.1021/cg800447w; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Rao MP, 1999, SCIENCE, V286, P102, DOI 10.1126/science.286.5437.102; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; Sone N, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.074604; Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Ji BH, 2010, ANNU REV MATER RES, V40, P77, DOI 10.1146/annurev-matsci-070909-104424; Corte L, 2007, MACROMOLECULES, V40, P5606, DOI 10.1021/ma0706935; Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a; Kamat S, 2000, NATURE, V405, P1036; Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Fratzl P, 2007, ADV MATER, V19, P2657, DOI 10.1002/adma.200602394; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Takehara Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.148001; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Kotha SP, 2001, J MATER SCI, V36, P2001, DOI 10.1023/A:1017526830874; Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Yokota M, 2011, P NATL ACAD SCI USA, V108, P6395, DOI 10.1073/pnas.1017112108; Osaki S, 1996, NATURE, V384, P419, DOI 10.1038/384419a0; Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; Hellmich C, 2004, EUR J MECH A-SOLID, V23, P783, DOI 10.1016/j.euromechsol.2004.05.004; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150; Okumura K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.124802; Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019; Aoyanagi Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.034402; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Meyers MA, 2006, JOM-US, V58, P35, DOI 10.1007/s11837-006-0138-1; EMLET RB, 1982, BIOL BULL, V163, P264, DOI 10.2307/1541265; Sumitomo T, 2008, J MATER RES, V23, P1466, DOI 10.1557/JMR.2008.0184; Aoyanagi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066108; Beyerlein IJ, 1996, INT J SOLIDS STRUCT, V33, P2543, DOI 10.1016/0020-7683(95)00172-7; Brochard-Wyart F., 2005, GOUTTES BULLES PERLE; Currey J. D., 2002, BONES STRUCTURE MECH; de Gennes PG, 1999, REV MOD PHYS, V71, pS374, DOI 10.1103/RevModPhys.71.S374; de Gennes P. G., 1979, SCALING CONCEPTS POL; de Gennes PG, 2000, CR ACAD SCI IV-PHYS, V1, P257; Emile O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167402; Evans A., 2001, J MATER RES, V16, P2476; Fischer FD, 2012, INT J FRACTURE, V173, P57, DOI 10.1007/s10704-011-9657-z; GAO HJ, 1991, INT J SOLIDS STRUCT, V27, P1663; Hamamoto Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026118; Hamamoto Y, 2013, ADV ENG MATER, V15, P522, DOI 10.1002/adem.201300061; Kashima Y, 2014, ACS MACRO LETT, V3, P419, DOI 10.1021/mz500122v; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kolednik O, 2011, ADV FUNCT MATER, V21, P3634, DOI 10.1002/adfm.201100443; LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0; MASTERS WM, 1984, BEHAV ECOL SOCIOBIOL, V15, P207, DOI 10.1007/BF00292977; Muju S, 2000, COMPOS SCI TECHNOL, V60, P2213, DOI 10.1016/S0266-3538(00)00016-6; Nakagawa S, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.114801; Nukala PKVV, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066106; Okumura K, 2005, J PHYS-CONDENS MAT, V17, pS2879, DOI 10.1088/0953-8984/17/31/015; Okumura K, 2003, EUROPHYS LETT, V63, P701, DOI 10.1209/epl/i2003-00578-y; Okumura K, 2002, EUR PHYS J E, V7, P303, DOI 10.1140/epje/i2001-10096-4; Sarikaya M., 1995, BIOMIMETICS DESIGN P, P35; Shiina Y, 2006, EUROPHYS LETT, V76, P588, DOI 10.1209/epl/i2006-10328-9; Vincent J, 2012, STRUCTURAL BIOMATERI; WIRTH E, 1992, J COMP PHYSIOL A, V171, P359; WITT PN, 1965, SCIENCE, V149, P1190, DOI 10.1126/science.149.3689.1190; Zhou HJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028104	82	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0883-7694	1938-1425		MRS BULL	MRS Bull.	APR	2015	40	4					333	339		10.1557/mrs.2015.66		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CE9GG	WOS:000352151500012		
J	Li, Z; Chen, XW; Ma, JH				Li, Zhi; Chen, Xiao-Wei; Ma, Jianhua			Adaptively imperceptible video watermarking based on the local motion entropy	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Human visual system; Block-matching techniques; Local motion entropy; Embedding strength		This paper proposes an adaptively imperceptible video watermarking algorithm using the entropy model for local motion characterization. The algorithm firstly combines Human Visual System (HVS) with the block- matching techniques to get the motion-related information. Then it utilizes the entropy model to statistically analyze above motion-related information to obtain the motion entropy of frame. Successively, this algorithm divides every frame into local regions, and then local motion entropy can be obtained according to the motion-related information in local region. By combining the local motion entropy with the motion entropy of frame, the motion characteristics visual masking is adaptively calculated. Based on the motion characteristics visual masking and the contents of video frames, the maximum strength of watermarking is calculated in every block. Experiments indicate that using entropy to local motion characteristics can significantly improve the watermarking imperceptibility, effectively resist common attacks for video watermarking and consequently achieve higher robustness.	[Li, Zhi; Chen, Xiao-Wei] Guizhou Univ, Coll Comp Sci & Technol, Guiyang 550003, Peoples R China; [Ma, Jianhua] Hosei Univ, Fac Comp & Informat Sci, Tokyo, Japan	Li, Z (reprint author), Guizhou Univ, Coll Comp Sci & Technol, Guiyang 550003, Peoples R China.	lizhigzu@163.com; gzu@vip.sina.com; jianhua@hosei.ac.jp			Science and Technology Foundation of Guizhou Province of China [20102257]; National Natural Science Foundation [61262076]; Scientific Research Fund for talents recruiting of Guizhou University [2009009]	This work is supported by the project of the Science and Technology Foundation of Guizhou Province of China under Grant No.20102257; The National Natural Science Foundation under Grant No.61262076; Scientific Research Fund for talents recruiting of Guizhou University under Grant No.2009009.	AGUI T, 1991, IEICE TRANS COMMUN, V74, P1337; Agung IW, 2004, IEE P-VIS IMAGE SIGN, V151, P146, DOI 10.1049/ip-vis:20030972; El'Arbi M, 2011, MULTIMED TOOLS APPL, V55, P579, DOI 10.1007/s11042-010-0580-5; Pitas I, 1996, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, PROCEEDINGS - VOL III, P215; Gostman C., 1996, IEEE T IMAGE PROCESS, V5, P794; Isao E, 2003, LNC, V2939, P184; Jiang XM, 2013, MULTIMED TOOLS APPL, V62, P545, DOI 10.1007/s11042-011-0857-3; Kim S.-M., 2004, P 37 HAW INT C SYST, P1; Li Z, 2007, P 10 CAD GARPHICS BE, P512; LI Zhi, 2005, J COMPUTER APPL, V25, P2148; Li Zhi, 2010, Journal of Software, V21, DOI 10.3724/SP.J.1001.2010.03569; Liu H-m, 2001, IEEE INT C MULT EXP, P257; Liu S-h, 2012, J COMMUN, V31, P14; Podilchuk Zeng W, 1997, P SPIE IS T LE IM 97, P310; Qi S, 2004, COMP ENG APPL, V40, P54; Wang LY, 2012, IEEE MULTIMEDIA, V19, P70; WU Yi-Quan, 2009, J BASIC SCI ENG, V17, P986; Zhang Wei-wei, 2012, Journal on Communications, V33	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	APR	2015	74	8					2781	2802		10.1007/s11042-013-1678-3		22	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CE2ZL	WOS:000351692300012		
J	Nakayama, M; Fujimoto, M				Nakayama, Minoru; Fujimoto, Masashi			Features of Oculo-motors and their chronological changes in response to varying sizes of visual stimuli	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Visual object size viewed; Accommodation; Eye movement; Pupil; Visual Evoked Potential (VEP)	EYE-MOVEMENTS	The chronological process of eye accommodation used when viewing objects was analysed to predict the size of viewed objects. Viewer's visual evoked potentials (VEP), eye movements and pupil oscillations were measured while six sizes of Landolt circles were presented for 1s each. The significant features of the metrics were extracted to illustrate the perception process and the resulting sizes of visual stimuli. The stimulus sizes affect P1 and N1 delay times of VEP, means of eye movement lengths and pupil diameters and oscillations during the second 500 milliseconds of observation. The feasibility of prediction of stimulus sizes viewed was confirmed using the features of eye behaviour and support vector machines. Both indices of eye movements and pupil diameters were determined to be significant features for making predictions. The influences of the combination of features and viewer's individual factors were also confirmed. This result suggests that features of oculo-motor indices reflect the size of objects being viewed and that these viewing sizes can be predicted using the features.	[Nakayama, Minoru] Tokyo Inst Technol, Human Syst Sci, Meguro Ku, Tokyo 1528552, Japan; [Fujimoto, Masashi] Tokyo Inst Technol, Tokyo 152, Japan	Nakayama, M (reprint author), Tokyo Inst Technol, Human Syst Sci, Meguro Ku, Tokyo 1528552, Japan.	nakayama@cradle.titech.ac.jp					Abe H., 2006, Journal of the Institute of Image Information and Television Engineers, V60, DOI 10.3169/itej.60.397; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Tatler BW, 2010, I-PERCEPTION, V1, P7, DOI 10.1068/i0382; Privitera CM, 2000, IEEE T PATTERN ANAL, V22, P970, DOI 10.1109/34.877520; Bacon-Mace N, 2007, J EXP PSYCHOL HUMAN, V33, P1013, DOI 10.1037/0096-1523.33.5.1013; Blankertz B, 2001, P NEUR INF PROC S NI, P157; Chang C.C., 2001, LIBSVM LIB SUPPORT V; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Devlaminck D, 2009, P 17 EUR S ART NEUR, P415; Duchowski AT, 2006, CHI2006 WORKSH GETT; Fujimoto Masashi, 2011, IEICE Transactions on Information and Systems (Japanese Edition), VJ94-D; Grainger J, 2009, BRAIN RES, V1270, P45, DOI 10.1016/j.brainres.2009.02.080; Japan Society of Vision Science, 2001, HDB VIS INF PROC; Maeda Y., 2007, IEICE T D, VJ90-D, P715; Nakayama M, 2012, P IEEE 11 INT C TRUS, P1513; Nakayama M., 2011, Proceedings 2011 IEEE Symposium on Computational Intelligence for Multimedia, Signal and Vision Processing (CIMSIVP 2011), DOI 10.1109/CIMSIVP.2011.5949240; Niwa S, 1997, JISHO KANREN DENI; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rugg MD, 1997, COGNITIVE NEUROSCIEN; Shawe-Taylor J., 2000, INTRO SUPPORT VECTOR; Shiba Y, 1976, TOUKEITEKI HOUHOU 2	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	APR	2015	74	8					2841	2859		10.1007/s11042-013-1824-y		19	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CE2ZL	WOS:000351692300015		
J	Kondo, Y				Kondo, Yohei			Ibadi Discussions on Conversion and Commitment	MUSLIM WORLD			English	Article									Univ Tokyo, Tokyo 1138654, Japan	Kondo, Y (reprint author), Univ Tokyo, Tokyo 1138654, Japan.						Abu l-Hasan M., 1985, AL MUTABAR, Vii, P189; Abu l-Hasan M., 1985, KITAB AL ISTIQAMA, Vi, p[15, 20, 24]; al-'Awtabi, 1990, AL DIYA, Viii, P33; al-'Awtabi, 1999, KITAB AL IBANA FIL L, Viv, P546; al-'Awtabi Abu l-Mundhir Salama, 1990, KITAB AL DIYA, Viii, P82; al-Bisyawi Abu l-Hasan 'Ali, 1984, JAMI ABI L HASAN AL, Vi, P268; al-Hadrami Abu Ishaq Ibrahim, 2011, MUKHTAS AR AL KHISAI, P123; al-Izkawi Abu Jabir Muhammad, 1995, AL JAMI LI IBN JAFAR, Vi, P67; al-Jaytali Abu Tahir 'Abd al-Rahman, 2008, QANATIR AL KHAYRAT, Vi, P127; al-Khurasani Abu Ghanim Bishr, 2007, AL MUDAWWANAT AL KUB, Vii, P183; al-Kindi Abu 'Abdullah Muhammad, 1984, BAYAN AL SHAR, Viii, P70; al-Kudami, 1985, AL KUDAM I AL JAMI A, Vi, P13; al-Rahili Mahbub, 2009, ABWA B MIN AL SUNNA, P243; al-Shaqasi Khamis b. Sa'id, 2006, MANHAJ AL TALIB IN W, Vi, P535; Cuperly P., 1984, INTRODUCTION A L ETU, V54-57, P130; Ferrante J., 2006, SOCIOLOGY A GLOBAL P, P529; Francesca E., 2005, JERUSALEM STUDIES IN, V30, P261; Furak Ibn, 2008, ALLAH TA ALA WALI L, P254; Kanter R. M., 1973, COMMITMENT AND COMMU, P65; Kashif S., 1986, AL SIYAR WAL JAWA BA, Vii, P25; Kohlberg E., 1986, JERUSALEM STUDIES AR, V7, P139; McGuire M., 2002, RELIGION THE SOCIAL, P84; Roberts K. A., 2004, RELIGION IN SOCIOLOG, P100; Wilkinson J. C., 2010, IBADISM ORIGINS AND, P219; Wilson B., 1982, WILSON RELIGION IN S, P91	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-4909	1478-1913		MUSLIM WORLD	Muslim World	APR	2015	105	2			SI		224	235		10.1111/muwo.12093		12	Asian Studies; Religion	Asian Studies; Religion	CE5CE	WOS:000351846900007		
J	Miyazaki, M; Chiba, M; Eguchi, H; Ohki, T; Ishiwata, S				Miyazaki, Makito; Chiba, Masataka; Eguchi, Hiroki; Ohki, Takashi; Ishiwata, Shin'ichi			Cell-sized spherical confinement induces the spontaneous formation of contractile actomyosin rings in vitro	NATURE CELL BIOLOGY			English	Article							ACTIN-FILAMENTS; MYOSIN-II; F-ACTIN; ALPHA-ACTININ; FISSION YEAST; THERMAL FLUCTUATIONS; HEAVY-MEROMYOSIN; ATP-ACTIN; ADP-ACTIN; CYTOKINESIS	During cell division, many animal cells transform into a spherical shape and assemble a contractile ring composed of actin filaments and myosin motors at the equator to separate the cell body into two. Although actomyosin regulatory proteins are spatio-temporally controlled during cytokinesis, the direct contribution of cell shape and actomyosin activity to the contractile ring assembly remains unclear. Here, we demonstrated in vitro that actin polymerization inside cell-sized spherical droplets induced the spontaneous formation of single ring-shaped actin bundles in the presence of bundling factors. Despite a lack of spatial regulatory signals, the rings always assembled at the equator to minimize the elastic energy of the bundles. Myosin promoted ring formation by the dynamic remodelling of actin networks, and an increase in the effective concentration of myosin triggered ring contraction. These results will help us understand how animal cells coordinate cell shape and actomyosin activities to direct cytokinesis.	[Miyazaki, Makito; Chiba, Masataka; Eguchi, Hiroki; Ohki, Takashi; Ishiwata, Shin'ichi] Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; [Ishiwata, Shin'ichi] Waseda Biosci Res Inst Singapore WABIOS, Singapore 138667, Singapore	Ishiwata, S (reprint author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	ishiwata@waseda.jp			Japan Science Society; Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank K. Kinosita Jr, K. Takiguchi and K. Yoshikawa for helpful discussions, and H. Kubota, K. Sato and S. Ishii for actin preparation. This work was supported in part by a Sasakawa Scientific Research Grant from The Japan Science Society (M.M.), Grants-in-Aid for Young Scientists (B) and Scientific Research on Innovative Areas (M.M.), and Grants-in-Aid for Specially Promoted Research and Scientific Research (S) (S.I.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; ASAKURA S, 1954, J CHEM PHYS, V22, P1255; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Tanaka-Takiguchi Y, 2004, J MOL BIOL, V341, P467, DOI 10.1016/j.jmb.2004.06.019; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Carvalho A, 2009, CELL, V137, P926, DOI 10.1016/j.cell.2009.03.021; Alvarado J, 2013, NAT PHYS, V9, P591, DOI [10.1038/nphys2715, 10.1038/NPHYS2715]; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Kondo T, 2013, NATURE, V494, P125, DOI 10.1038/nature11792; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Claessens MMAE, 2006, NAT PHYS, V2, P186, DOI 10.1038/nphys241; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Thoresen T, 2013, BIOPHYS J, V104, P655, DOI 10.1016/j.bpj.2012.12.042; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Pinto IM, 2013, BIOPHYS J, V105, P547, DOI 10.1016/j.bpj.2013.06.033; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Mishra M, 2013, NAT CELL BIOL, V15, P853, DOI 10.1038/ncb2781; Hase M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2174004; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Chiba M, 2014, BIOPHYS J, V107, P346, DOI 10.1016/j.bpj.2014.05.039; Cramer LP, 1997, MOL BIOL CELL, V8, P109; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Falzone TT, 2013, BIOPHYS J, V104, P1709, DOI 10.1016/j.bpj.2013.01.017; FUJIME S, 1971, J MOL BIOL, V62, P251, DOI 10.1016/0022-2836(71)90144-6; FUJIME S, 1970, J PHYS SOC JPN, V29, P751, DOI 10.1143/JPSJ.29.751; FUJIWARA K, 1978, J CELL BIOL, V79, P268, DOI 10.1083/jcb.79.1.268; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; HARRIS A, 1973, DEV BIOL, V35, P97, DOI 10.1016/0012-1606(73)90009-2; Laporte D, 2012, MOL BIOL CELL, V23, P3094, DOI 10.1091/mbc.E12-02-0123; MABUCHI I, 1985, J CELL BIOL, V100, P375, DOI 10.1083/jcb.100.2.375; MAUPIN P, 1986, J ULTRA MOL STRUCT R, V94, P92, DOI 10.1016/0889-1605(86)90055-8; Mishra M, 2012, J CELL SCI, V125, P3850, DOI 10.1242/jcs.103788; Negishi M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051921; Ohki T, 2012, J MUSCLE RES CELL M, V33, P351, DOI 10.1007/s10974-012-9323-8; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; SANGER JM, 1980, J CELL BIOL, V86, P568, DOI 10.1083/jcb.86.2.568; SANGER JM, 1984, CELL TISSUE RES, V237, P409; SCHROEDE.TE, 1972, J CELL BIOL, V53, P419, DOI 10.1083/jcb.53.2.419; Soares e Silva M., 2011, SOFT MATTER, V7, P10631; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783; Zumdieck A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000696	62	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2015	17	4					480	+		10.1038/ncb3142		22	Cell Biology	Cell Biology	CE6BJ	WOS:000351920500018		
J	Tayi, AS; Kaeser, A; Matsumoto, M; Aida, T; Stupp, SI				Tayi, Alok S.; Kaeser, Adrien; Matsumoto, Michio; Aida, Takuzo; Stupp, Samuel I.			Supramolecular ferroelectrics	NATURE CHEMISTRY			English	Review							COLUMNAR LIQUID-CRYSTAL; ROOM-TEMPERATURE FERROELECTRICITY; IONIC PHASE-TRANSITION; SCANNING PROBE MICROSCOPY; CHARGE-TRANSFER COMPLEXES; METAL-ORGANIC FRAMEWORK; CHLORANIL TTF-CA; TETRATHIAFULVALENE-CHLORANIL; SPONTANEOUS POLARIZATION; ACHIRAL MOLECULES	Supramolecular chemistry uses non-covalent interactions to coax molecules into forming ordered assemblies. The construction of ordered materials with these reversible bonds has led to dramatic innovations in organic electronics, polymer science and biomaterials. Here, we review how supramolecular strategies can advance the burgeoning field of organic ferroelectricity. Ferroelectrics -materials with a spontaneous and electrically reversible polarization -are touted for use in non-volatile computer memories, sensors and optics. Historically, this physical phenomenon has been studied in inorganic materials, although some organic examples are known and strong interest exists to extend the search for ferroelectric molecular systems. Other undiscovered applications outside this regime could also emerge. We describe the key features necessary for molecular and supramolecular dipoles in organic ferroelectrics and their incorporation into ordered systems, such as porous frameworks and liquid crystals. The goal of this Review is to motivate the development of innovative supramolecular ferroelectrics that exceed the performance and usefulness of known systems.	[Tayi, Alok S.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02143 USA; [Tayi, Alok S.; Kaeser, Adrien; Matsumoto, Michio; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Aida, Takuzo] RIKEN Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA	Stupp, SI (reprint author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Stupp, Samuel/B-6737-2009; Matsumoto, Michio/H-3363-2015				AKUTAGAWA T, 1994, LIQ CRYST, V17, P659, DOI 10.1080/02678299408037337; Jain P, 2008, J AM CHEM SOC, V130, P10450, DOI 10.1021/ja801952e; Kobayashi K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237601; Liu YM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.078103; Miyajima D, 2012, SCIENCE, V336, P209, DOI 10.1126/science.1217954; Fu DW, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.257601; ATHENSTAEDT H, 1961, NATURWISSENSCHAFTEN, V48, P465; Szafranski M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215507; Horiuchi S, 2005, NAT MATER, V4, P163, DOI 10.1038/nmat1298; Kishikawa K, 2005, J AM CHEM SOC, V127, P2565, DOI 10.1021/ja046100c; Gorecka E, 2004, J AM CHEM SOC, V126, P15946, DOI 10.1021/ja044597k; TORRANCE JB, 1981, PHYS REV LETT, V46, P253, DOI 10.1103/PhysRevLett.46.253; Kumar M, 2014, PHYS CHEM CHEM PHYS, V16, P1300, DOI 10.1039/c3cp54190h; Heredia A, 2012, ADV FUNCT MATER, V22, P2996, DOI 10.1002/adfm.201103011; Reddy RA, 2011, SCIENCE, V332, P72, DOI 10.1126/science.1197248; Gorbitz CH, 2001, CHEM-EUR J, V7, P5153, DOI 10.1002/1521-3765(20011203)7:23<5153::AID-CHEM5153>3.0.CO;2-N; Valasek J, 1921, PHYS REV, V17, P475, DOI 10.1103/PhysRev.17.475; TORRANCE JB, 1981, PHYS REV LETT, V47, P1747, DOI 10.1103/PhysRevLett.47.1747; SHAMOS MH, 1967, NATURE, V213, P267, DOI 10.1038/213267a0; Dantlgraber G, 2002, ANGEW CHEM INT EDIT, V41, P2408, DOI 10.1002/1521-3773(20020703)41:13<2408::AID-ANIE2408>3.0.CO;2-M; Winston EB, 2008, PHYS CHEM CHEM PHYS, V10, P5188, DOI 10.1039/b808104b; Li DB, 2008, NAT MATER, V7, P473, DOI 10.1038/nmat2198; OKAMOTO H, 1991, PHYS REV B, V43, P8224, DOI 10.1103/PhysRevB.43.8224; Gan ZX, 2013, ANGEW CHEM INT EDIT, V52, P2055, DOI 10.1002/anie.201207992; Li H, 1999, NATURE, V402, P276; Akutagawa T, 2009, NAT MATER, V8, P342, DOI [10.1038/nmat2377, 10.1038/NMAT2377]; Horiuchi S, 2011, ADV MATER, V23, P2098, DOI 10.1002/adma.201100359; Zhang W, 2013, J AM CHEM SOC, V135, P5230, DOI 10.1021/ja3110335; Gould SL, 2008, J AM CHEM SOC, V130, P3246, DOI 10.1021/ja077122c; Miyajima D, 2010, J AM CHEM SOC, V132, P8530, DOI 10.1021/ja101866e; Katrusiak A, 1999, PHYS REV LETT, V82, P576, DOI 10.1103/PhysRevLett.82.576; CLARK NA, 1980, APPL PHYS LETT, V36, P899, DOI 10.1063/1.91359; Wen Z, 2013, NAT MATER, V12, P617, DOI [10.1038/nmat3649, 10.1038/NMAT3649]; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; KAWAI H, 1969, JPN J APPL PHYS, V8, P975, DOI 10.1143/JJAP.8.975; XU B, 1995, J AM CHEM SOC, V117, P5011, DOI 10.1021/ja00122a039; Horiuchi S, 2007, ANGEW CHEM INT EDIT, V46, P3497, DOI 10.1002/anie.200700407; Kagawa F, 2010, NAT PHYS, V6, P169, DOI 10.1038/NPHYS1503; Zhang QC, 2013, ANGEW CHEM INT EDIT, V52, P12602, DOI 10.1002/anie.201306193; Ortony JH, 2014, NAT MATER, V13, P812, DOI [10.1038/nmat3979, 10.1038/NMAT3979]; SCHEROWSKY G, 1995, J MATER CHEM, V5, P417, DOI 10.1039/jm9950500417; Xu GC, 2010, J AM CHEM SOC, V132, P9588, DOI 10.1021/ja104263m; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Comotti A, 2014, ANGEW CHEM INT EDIT, V53, P1043, DOI 10.1002/anie.201309362; Kofinger J, 2008, P NATL ACAD SCI USA, V105, P13218, DOI 10.1073/pnas.0801448105; Fu DW, 2011, ADV MATER, V23, P5658, DOI 10.1002/adma.201102938; Kalinin SV, 2007, ANNU REV MATER RES, V37, P189, DOI 10.1146/annurev.matsci.37.052506.084323; Zhang W, 2009, COORDIN CHEM REV, V253, P2980, DOI 10.1016/j.ccr.2009.02.028; Lagerwall ST, 2004, FERROELECTRICS, V301, P15, DOI 10.1080/00150190490464827; Fu DW, 2013, SCIENCE, V339, P425, DOI 10.1126/science.1229675; Kobr L, 2012, J AM CHEM SOC, V134, P10122, DOI 10.1021/ja302173y; Horiuchi S, 2008, J AM CHEM SOC, V130, P13382, DOI 10.1021/ja8032235; Su XC, 1998, PHYS REV LETT, V80, P1533, DOI 10.1103/PhysRevLett.80.1533; Kumai R, 2007, J AM CHEM SOC, V129, P12920, DOI 10.1021/ja075406r; Sawamura M, 2002, NATURE, V419, P702, DOI 10.1038/nature01110; Barbera J, 1998, J AM CHEM SOC, V120, P2908, DOI 10.1021/ja9735012; Scott JF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/02/021001; Haase W, 2002, LIQ CRYST, V29, P133, DOI 10.1080/02678290110093741; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; Devautour-Vinot S, 2012, CHEM MATER, V24, P2168, DOI 10.1021/cm300863c; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Fitie CFC, 2010, J AM CHEM SOC, V132, P6892, DOI 10.1021/ja101734g; Deng HX, 2010, NAT CHEM, V2, P439, DOI [10.1038/nchem.654, 10.1038/NCHEM.654]; Ye HY, 2014, J AM CHEM SOC, V136, P10033, DOI 10.1021/ja503344b; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Reddy RA, 2006, J MATER CHEM, V16, P907, DOI 10.1039/b504400f; Horiuchi S, 2005, J AM CHEM SOC, V127, P5010, DOI 10.1021/ja042212s; Cui HB, 2005, ANGEW CHEM INT EDIT, V44, P6508, DOI 10.1002/anie.200501867; GIRLANDO A, 1983, J CHEM PHYS, V79, P1075, DOI 10.1063/1.445833; Piperno S, 2013, ANGEW CHEM INT EDIT, V52, P6513, DOI 10.1002/anie.201301836; Elemans JAAW, 2009, ANGEW CHEM INT EDIT, V48, P7298, DOI 10.1002/anie.200806339; XU B, 1993, J AM CHEM SOC, V115, P1159, DOI 10.1021/ja00056a056; Naber RCG, 2005, NAT MATER, V4, P243, DOI 10.1038/nmat1329; Kholkin A, 2010, ACS NANO, V4, P610, DOI 10.1021/nn901327v; LeBard DN, 2010, J PHYS CHEM B, V114, P9246, DOI 10.1021/jp1006999; Vukotic VN, 2012, NAT CHEM, V4, P456, DOI [10.1038/nchem.1354, 10.1038/NCHEM.1354]; Fu DW, 2011, J AM CHEM SOC, V133, P12780, DOI 10.1021/ja204540g; Li T, 2011, ACTA MATER, V59, P3667, DOI 10.1016/j.actamat.2011.03.001; Jain P, 2009, J AM CHEM SOC, V131, P13625, DOI 10.1021/ja904156s; Alves H, 2008, NAT MATER, V7, P574, DOI 10.1038/nmat2205; Horiuchi S, 2003, SCIENCE, V299, P229, DOI 10.1126/science.1076129; Hird M, 2011, LIQ CRYST, V38, P1467, DOI 10.1080/02678292.2011.625126; JACKSON SM, 1995, J CHEM PHYS, V103, P7647, DOI 10.1063/1.470285; Araoka F, 2013, ADV MATER, V25, P4014, DOI 10.1002/adma.201301380; BOCK H, 1992, LIQ CRYST, V12, P697, DOI 10.1080/02678299208029104; COX SD, 1988, J AM CHEM SOC, V110, P2986, DOI 10.1021/ja00217a057; Cui H., J AM CHEM SOC; Dalcanale E, 2000, LIQ CRYST, V27, P1161; Das A, 2014, ANGEW CHEM INT EDIT, V53, P2038, DOI 10.1002/anie.201307756; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Desiraju GR, 2002, ACCOUNTS CHEM RES, V35, P565, DOI 10.1021/ar010054t; Eremin A., 2012, SOFT MATTER, V9, P615; GIRLANDO A, 1986, SOLID STATE COMMUN, V57, P891, DOI 10.1016/0038-1098(86)90918-X; Guillon D., 2007, ADV CHEM PHYS, P1; Horansky RD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014302; Horiuchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2322; Jakli A, 1997, LIQ CRYST, V22, P309; Kalinin SV, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194008; Khuong TAV, 2006, ACCOUNTS CHEM RES, V39, P413, DOI 10.1021/ar0680217; Kilian D, 2000, LIQ CRYST, V27, P509; Kumai R., J CHEM PHYS; Lang SB, 2000, IEEE T DIELECT EL IN, V7, P466, DOI 10.1109/94.868063; Leuchtag HR, 1999, FERROELECTRICS, V220, P157, DOI 10.1080/00150199908216214; Lines M. E., 1977, PRINCIPLES APPL FERR; Liu YM, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168101; Liu YM, 2014, P NATL ACAD SCI USA, V111, pE2780, DOI 10.1073/pnas.1402909111; MALTHETE J, 1987, J AM CHEM SOC, V109, P7544, DOI 10.1021/ja00258a057; Marlow F, 1996, MOL CRYST LIQ CRYS A, V276, P295, DOI 10.1080/10587259608039390; Matsuzaki H, 2005, J PHYS SOC JPN, V74, P2925, DOI 10.1143/JPSJ.74.2925; Meyer RB, 1975, J PHYS LETT-PARIS, V36, P69, DOI 10.1051/jphyslet:0197500360306900; Naber R. C. G., 2009, ADV MATER, V22, P933; Ng TN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00585; Okada Y, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041701; Pleiner H, 2003, MOL CRYST LIQ CRYST, V396, P169, DOI 10.1080/15421400390213285; SOLOMON AL, 1956, PHYS REV, V104, P1191, DOI 10.1103/PhysRev.104.1191; Takezoe H, 2006, JPN J APPL PHYS 1, V45, P597, DOI 10.1143/JJAP.45.597; Tayi AS, 2012, NATURE, V488, P485, DOI 10.1038/nature11395; TODOROV AT, 1994, LANGMUIR, V10, P2344, DOI 10.1021/la00019a053; Zhang W., 2011, CHEM REV, V112, P1163; Zhao HX, 2011, P NATL ACAD SCI USA, V108, P3481, DOI 10.1073/pnas.1010310108; ZIMMERMANN H, 1985, Z NATURFORSCH A, V40, P149	124	17	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	APR	2015	7	4					281	294		10.1038/NCHEM.2206		14	Chemistry, Multidisciplinary	Chemistry	CE3UY	WOS:000351756200007		
J	Bony, S; Stevens, B; Frierson, DMW; Jakob, C; Kageyama, M; Pincus, R; Shepherd, TG; Sherwood, SC; Siebesma, AP; Sobel, AH; Watanabe, M; Webb, MJ				Bony, Sandrine; Stevens, Bjorn; Frierson, Dargan M. W.; Jakob, Christian; Kageyama, Masa; Pincus, Robert; Shepherd, Theodore G.; Sherwood, Steven C.; Siebesma, A. Pier; Sobel, Adam H.; Watanabe, Masahiro; Webb, Mark J.			Clouds, circulation and climate sensitivity	NATURE GEOSCIENCE			English	Article							LAST GLACIAL MAXIMUM; SELF-AGGREGATION; ATMOSPHERIC CIRCULATION; PHYSICAL-MECHANISMS; CONVECTION; MODEL; SIMULATIONS; FEEDBACKS; RADIATION; CMIP5	Fundamental puzzles of climate science remain unsolved because of our limited understanding of how clouds, circulation and climate interact. One example is our inability to provide robust assessments of future global and regional climate changes. However, ongoing advances in our capacity to observe, simulate and conceptualize the climate system now make it possible to fill gaps in our knowledge. We argue that progress can be accelerated by focusing research on a handful of important scientific questions that have become tractable as a result of recent advances. We propose four such questions below; they involve understanding the role of cloud feedbacks and convective organization in climate, and the factors that control the position, the strength and the variability of the tropical rain belts and the extratropical storm tracks.	[Bony, Sandrine] Univ Paris 06, LMD IPSL, CNRS, UMR 8539, F-75252 Paris, France; [Stevens, Bjorn] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Frierson, Dargan M. W.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Jakob, Christian] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Kageyama, Masa] CEA CNRS UVSQ, LSCE IPSL, UMR 8212, F-91191 Gif Sur Yvette, France; [Pincus, Robert] Univ Colorado, CIRES, Boulder, CO 80309 USA; [Pincus, Robert] NOAA, Earth Syst Res Lab, Div Phys Sci, Boulder, CO 80305 USA; [Shepherd, Theodore G.] Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England; [Sherwood, Steven C.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Sherwood, Steven C.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Siebesma, A. Pier] KNMI, NL-3730 AE De Bilt, Netherlands; [Sobel, Adam H.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA; [Watanabe, Masahiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778568, Japan; [Webb, Mark J.] Hadley Ctr, Exeter EX1 3PB, Devon, England	Bony, S (reprint author), Univ Paris 06, LMD IPSL, CNRS, UMR 8539, 4 Pl Jussieu,Mail Box 99, F-75252 Paris, France.	bony@lmd.jussieu.fr	Jakob, Christian/A-1082-2010; Stevens, Bjorn/A-1757-2013; Pincus, Robert/B-1723-2013; KAGEYAMA, Masa/F-2389-2010; Sobel, Adam/K-4014-2015; Sherwood, Steven/B-5673-2008	Jakob, Christian/0000-0002-5012-3207; Stevens, Bjorn/0000-0003-3795-0475; Pincus, Robert/0000-0002-0016-3470; KAGEYAMA, Masa/0000-0003-0822-5880; Sobel, Adam/0000-0003-3602-0567; Sherwood, Steven/0000-0001-7420-8216	LABEX L-IPSL; Max Planck Society for the Advancement of Science; Joint UK DECC/Defra Met Office Hadley Centre Climate Programme [GA01101]	This paper was developed as part of the Grand Challenge on Clouds, Circulation and Climate Sensitivity of the World Climate Research Programme. The process of identifying a handful of key scientific questions culminated in a workshop whose participants are gratefully acknowledged: D. Abbot, P. Bauer, M. Biasutti, H. Douville, J-L. Dufresne, A. Del Genio, K. Emanuel, Q. Fu, J. Hargreaves, S. Harrison, I. Held, C. Hohenegger, B. Hoskins, S. Kang, H. Kawai, S. A. Klein, N. Loeb, T. Mauritsen, B. Mapes, M. Miller, C. Muller, C. Prentice, C. Risi, M. Satoh, C. Schumacher, B. Wielicki, M. Yoshimori and P. Zuidema. We thank the German Weather Service, PMIP, EUMETSAT and NASA for data. M. Doutriaux-Boucher (EUMETSAT) provided the satellite products used in Fig. 2a and b. S.B. and B.S. acknowledge support from the LABEX L-IPSL and the Max Planck Society for the Advancement of Science. M.J.W. was supported by the Joint UK DECC/Defra Met Office Hadley Centre Climate Programme (GA01101).	Jakob C, 2010, B AM METEOROL SOC, V91, P869, DOI 10.1175/2009BAMS2898.1; Riviere G, 2010, J CLIMATE, V23, P2987, DOI 10.1175/2010JCLI3372.1; Butler AH, 2010, J CLIMATE, V23, P3474, DOI 10.1175/2010JCLI3228.1; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; Kang SM, 2008, J CLIMATE, V21, P3521, DOI 10.1175/2007JCLI2146.1; Hartmann DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015835; Miyamoto Y, 2013, GEOPHYS RES LETT, V40, P4922, DOI 10.1002/grl.50944; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; HOUZE RA, 1982, J METEOROL SOC JPN, V60, P396; Bretherton CS, 2005, J ATMOS SCI, V62, P4273, DOI 10.1175/JAS3614.1; Seifert A, 2013, ATMOS CHEM PHYS, V13, P5631, DOI 10.5194/acp-13-5631-2013; Donohoe A, 2013, J CLIMATE, V26, P3597, DOI 10.1175/JCLI-D-12-00467.1; Martin GM, 2010, J CLIMATE, V23, P5933, DOI 10.1175/2010JCLI3541.1; Neggers RAJ, 2007, J CLIMATE, V20, P2623, DOI 10.1175/JCLI4079.1; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Hwang YT, 2013, P NATL ACAD SCI USA, V110, P4935, DOI 10.1073/pnas.1213302110; HELD IM, 1980, J ATMOS SCI, V37, P515, DOI 10.1175/1520-0469(1980)037<0515:NASCIA>2.0.CO;2; Bony S, 2005, J ATMOS SCI, V62, P2770, DOI 10.1175/JAS3506.1; Held I, 2014, SCIENCE, V343, P1206, DOI 10.1126/science.1248447; Rieck M, 2012, J ATMOS SCI, V69, P2538, DOI 10.1175/JAS-D-11-0203.1; Joos H, 2012, Q J ROY METEOR SOC, V138, P407, DOI 10.1002/qj.934; Muller CJ, 2012, J ATMOS SCI, V69, P2551, DOI 10.1175/JAS-D-11-0257.1; Shepherd TG, 2014, NAT GEOSCI, V7, P703, DOI 10.1038/NGEO2253; Stevens B, 2013, SCIENCE, V340, P1053, DOI 10.1126/science.1237554; Ceppi P, 2014, GEOPHYS RES LETT, V41, P3244, DOI 10.1002/2014GL060043; Marsham JH, 2013, GEOPHYS RES LETT, V40, P1843, DOI 10.1002/grl.50347; Kohfeld KE, 2000, QUATERNARY SCI REV, V19, P321, DOI 10.1016/S0277-3791(99)00068-2; Zelinka MD, 2012, J CLIMATE, V25, P3715, DOI 10.1175/JCLI-D-11-00248.1; Wing AA, 2014, J ADV MODEL EARTH SY, V6, P59, DOI 10.1002/2013MS000269; Zhang MH, 2013, J ADV MODEL EARTH SY, V5, P826, DOI 10.1002/2013MS000246; Zhao M, 2014, J CLIMATE, V27, P1845, DOI 10.1175/JCLI-D-13-00145.1; Grise KM, 2014, J CLIMATE, V27, P6074, DOI 10.1175/JCLI-D-14-00113.1; Simpson IR, 2014, J ATMOS SCI, V71, P2489, DOI 10.1175/JAS-D-13-0325.1; Tobin I, 2012, J CLIMATE, V25, P6885, DOI 10.1175/JCLI-D-11-00258.1; Perez-Sanz A, 2014, CLIM PAST, V10, P551, DOI 10.5194/cp-10-551-2014; Bony S., 2013, MONOGRAPH CLIMATE SC, P391; Boucher O, 2013, CLIMATE CHANGE 2013, P571, DOI DOI 10.1017/CBO9781107415324.016; Brayshaw DJ, 2009, J ATMOS SCI, V66, P2539, DOI 10.1175/2009JAS3078.1; Chagnon S., 2013, Q J R METEOROL SOC, V139, P1270; Cooke R., 2013, ENV SYST DECIS, V34, P98; Emanuel K, 2002, METEOROLOGY MILLENNI, P1; Biasutti M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026067; Lorenz E. N, 1969, GLOBAL CIRCULATION A, P3; Sherwood S. C., 2013, CLIMATE SCI SERVING, P73; SLINGO A, 1988, Q J ROY METEOR SOC, V114, P1027, DOI 10.1002/qj.49711448209; Stevens B, 2013, PHYS TODAY, V66, P29, DOI 10.1063/PT.3.2009; Stocker T. F., 2013, CLIMATE CHANGE 2013, P1, DOI DOI 10.7930/J0Z31WJ2; Woollings T, 2010, PHILOS T R SOC A, V368, P3733, DOI 10.1098/rsta.2010.0040	50	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	APR	2015	8	4					261	268		10.1038/NGEO2398		8	Geosciences, Multidisciplinary	Geology	CE8HK	WOS:000352082300014		
J	Hiranuma, N; Mohler, O; Yamashita, K; Tajiri, T; Saito, A; Kiselev, A; Hoffmann, N; Hoose, C; Jantsch, E; Koop, T; Murakami, M				Hiranuma, N.; Moehler, O.; Yamashita, K.; Tajiri, T.; Saito, A.; Kiselev, A.; Hoffmann, N.; Hoose, C.; Jantsch, E.; Koop, T.; Murakami, M.			Ice nucleation by cellulose and its potential contribution to ice formation in clouds	NATURE GEOSCIENCE			English	Article							ATMOSPHERIC PROCESSES; MINERAL DUST; PARTICLES; CLIMATE; NUCLEI; MICROBIOLOGY; EFFICIENCY; SYSTEM	Ice particles in the atmosphere influence clouds, precipitation and climate, and often form with help from aerosols that serve as ice-nucleating particles. Biological particles(1), including non-proteinaceous ones(2,3), contribute to the diverse spectrum of ice-nucleating particles(4,5). However, little is known about their atmospheric abundance and ice nucleation efficiency, and their role in clouds and the climate system is poorly constrained(6). One biological particle type, cellulose, has been shown to exist in an airborne form that is prevalent throughout the year even at remote and elevated locations(7,8). Here we report experiments in a cloud simulation chamber(9) to demonstrate that microcrystalline cellulose particles can act as efficient ice-nucleating particles in simulated supercooled clouds. In six immersion mode freezing experiments, we measured the ice nucleation active surface-site densities of aerosolized cellulose across a range of temperatures. Using these active surface-site densities, we developed parameters describing the ice nucleation ability of these particles(10) and applied them to observed atmospheric cellulose and plant debris concentrations in a global aerosol model. We find that ice nucleation by cellulose becomessignificant (>0.1l(-1)) below about -21 degrees C, temperatures relevant to mixed-phase clouds. We conclude that the ability of cellulose to act as ice-nucleating particles requires a revised quantification of their role in cloud formation and precipitation.	[Hiranuma, N.; Moehler, O.; Kiselev, A.; Hoffmann, N.; Hoose, C.] Karlsruhe Inst Technol, Inst Meteorol & Climate Res Atmospher Aerosol Res, D-76021 Karlsruhe, Germany; [Moehler, O.; Yamashita, K.; Tajiri, T.; Murakami, M.] Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Yamashita, K.] Natl Res Inst Earth Sci & Disaster Prevent, Snow & Ice Res Ctr, Nagaoka, Niigata 9400821, Japan; [Hoose, C.] Karlsruhe Inst Technol, Inst Meteorol & Climate Res Troposphere Res, D-76049 Karlsruhe, Germany; [Jantsch, E.; Koop, T.] Univ Bielefeld, Fac Chem, D-33615 Bielefeld, Germany	Hiranuma, N (reprint author), Karlsruhe Inst Technol, Inst Meteorol & Climate Res Atmospher Aerosol Res, D-76021 Karlsruhe, Germany.	seong.moon@kit.edu	Koop, Thomas/B-7861-2008; Hiranuma, Naruki/D-3780-2014	Koop, Thomas/0000-0002-7571-3684; Hiranuma, Naruki/0000-0001-7790-4807	Helmholtz Association through its research programme 'Atmosphere and Climate (ATMO)'; Deutsche Forschungsgemeinschaft (DFG) [FOR 1525, MO668/4-1, KO2944/2-1, HO4612/1-1]; JSPS KAKENHI [23244095]; Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory	The authors acknowledge partial financial support by the Helmholtz Association through its research programme 'Atmosphere and Climate (ATMO)' and the Deutsche Forschungsgemeinschaft (DFG) through the Research Unit FOR 1525 (INUIT, grant No MO668/4-1, KO2944/2-1 and HO4612/1-1). This work was partly supported by JSPS KAKENHI Grant Number 23244095. O. Seland, D. Olivie and A. Kirkevag are acknowledged for providing the CAM4-Oslo simulations. Technical support from T. Kisely for the BET measurements is acknowledged. N. Hiranuma acknowledges A. Abdelmonem, C. Anquetil-Deck and T. C. J. Hill for useful discussion on BINPs. N. Hiranuma and O.M. thank P. Weidler for the XRD measurements and data interpretation. E. Jantsch and T. Koop thank C. Budke for helpful suggestions on the BINARY experiments. The authors also express their thanks for technical support from S. Shutthanandan and G. Kulkarni with the HIM measurements. HIM research was performed in the Environmental Molecular Science Laboratory, a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory.	Burrows SM, 2013, ATMOS CHEM PHYS, V13, P245, DOI 10.5194/acp-13-245-2013; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Despres VR, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.15598; Niemand M, 2012, J ATMOS SCI, V69, P3077, DOI 10.1175/JAS-D-11-0249.1; Attard E, 2012, ATMOS CHEM PHYS, V12, P10667, DOI 10.5194/acp-12-10667-2012; DeMott PJ, 2010, P NATL ACAD SCI USA, V107, P11217, DOI 10.1073/pnas.0910818107; Wex H, 2014, ATMOS CHEM PHYS, V14, P5529, DOI 10.5194/acp-14-5529-2014; Morris CE, 2011, BIOGEOSCIENCES, V8, P17, DOI 10.5194/bg-8-17-2011; Kirkevag A, 2013, GEOSCI MODEL DEV, V6, P207, DOI 10.5194/gmd-6-207-2013; Marcolli C, 2014, ATMOS CHEM PHYS, V14, P2071, DOI 10.5194/acp-14-2071-2014; Pohlker C, 2012, ATMOS MEAS TECH, V5, P37, DOI 10.5194/amt-5-37-2012; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Hiranuma N, 2014, ATMOS CHEM PHYS, V14, P2315, DOI 10.5194/acp-14-2315-2014; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; Legrand M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008080; Pummer BG, 2012, ATMOS CHEM PHYS, V12, P2541, DOI 10.5194/acp-12-2541-2012; Morris CE, 2013, ATMOS CHEM PHYS, V13, P4223, DOI 10.5194/acp-13-4223-2013; Mohler O, 2006, ATMOS CHEM PHYS, V6, P3007; Boucher O, 2013, CLIMATE CHANGE 2013; Hoose C, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024009; KROG JO, 1979, NATURE, V282, P300, DOI 10.1038/282300a0; Puxbaum H, 2003, ATMOS ENVIRON, V37, P3693, DOI 10.1016/S1352-2310(03)00451-5; Quiroz-Castaneda R. E., 2013, SUSTAINABLE DEGRADAT; Sanchez-Ochoa A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008180; Sesartic A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014029; Tajiri T, 2013, J METEOROL SOC JPN, V91, P687, DOI 10.2151/jmsj.2013-509; Vali G., 1985, J AEROSOL SCI, V16, P575, DOI [10.1016/0021-8502(85)90009-6, DOI 10.1016/0021-8502(85)90009-6]; Zhao HB, 2006, ENERG FUEL, V20, P807, DOI 10.1021/ef050319a	30	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	APR	2015	8	4					273	277		10.1038/NGEO2374		5	Geosciences, Multidisciplinary	Geology	CE8HK	WOS:000352082300016		
J	D'Hondt, S; Inagaki, F; Zarikian, CA; Abrams, LJ; Dubois, N; Engelhardt, T; Evans, H; Ferdelman, T; Gribsholt, B; Harris, RN; Hoppie, BW; Hyun, JH; Kallmeyer, J; Kim, J; Lynch, JE; McKinley, CC; Mitsunobu, S; Morono, Y; Murray, RW; Pockalny, R; Sauvage, J; Shimono, T; Shiraishi, F; Smith, DC; Smith-Duque, CE; Spivack, AJ; Steinsbu, BO; Suzuki, Y; Szpak, M; Toffin, L; Uramoto, G; Yamaguchi, YT; Zhang, GL; Zhang, XH; Ziebis, W				D'Hondt, Steven; Inagaki, Fumio; Zarikian, Carlos Alvarez; Abrams, Lewis J.; Dubois, Nathalie; Engelhardt, Tim; Evans, Helen; Ferdelman, Timothy; Gribsholt, Britta; Harris, Robert N.; Hoppie, Bryce W.; Hyun, Jung-Ho; Kallmeyer, Jens; Kim, Jinwook; Lynch, Jill E.; McKinley, Claire C.; Mitsunobu, Satoshi; Morono, Yuki; Murray, Richard W.; Pockalny, Robert; Sauvage, Justine; Shimono, Takaya; Shiraishi, Fumito; Smith, David C.; Smith-Duque, Christopher E.; Spivack, Arthur J.; Steinsbu, Bjorn Olav; Suzuki, Yohey; Szpak, Michal; Toffin, Laurent; Uramoto, Goichiro; Yamaguchi, Yasuhiko T.; Zhang, Guo-liang; Zhang, Xiao-Hua; Ziebis, Wiebke			Presence of oxygen and aerobic communities from sea floor to basement in deep-sea sediments	NATURE GEOSCIENCE			English	Article							MARINE-SEDIMENTS; PACIFIC-OCEAN; MICROBIAL RESPIRATION; SUBSEAFLOOR SEDIMENTS; PRESERVATION; CONSUMPTION; ABUNDANCE; RATES; WATER; MODEL	The depth of oxygen penetration into marine sediments differs considerably from one region to another1,2. In areas with high rates of microbial respiration, O-2 penetrates only millimetres to centimetres into the sediments(3), but active anaerobic microbial communities are present in sediments hundreds of metres or more below the sea floor(4-7). In areas with low sedimentary respiration, O-2 penetratesmuchdeeper(8-12) but the depth to which microbial communities persist was previously unknown(9,10,13). The sediments underlying the South Pacific Gyre exhibit extremely low areal rates of respiration(9). Here we show that, in this region, microbial cells and aerobic respiration persist through the entire sediment sequence to depths of at least 75 metres below sea floor. Based on the Redfield stoichiometry of dissolved O-2 and nitrate, we suggest that net aerobic respiration in these sediments is coupled to oxidation of marine organic matter. We identify a relationship of O-2 penetration depth to sedimentation rate and sediment thickness. Extrapolating this relationship, we suggest that oxygen and aerobic communities may occur throughout the entire sediment sequence in 15-44% of the Pacific and 9-37% of the global sea floor. Subduction of the sediment and basalt from these regions is a source of oxidized material to the mantle.	[D'Hondt, Steven; Inagaki, Fumio; Zarikian, Carlos Alvarez; Dubois, Nathalie; Engelhardt, Tim; Evans, Helen; Ferdelman, Timothy; Gribsholt, Britta; Harris, Robert N.; Hoppie, Bryce W.; Hyun, Jung-Ho; Kallmeyer, Jens; Kim, Jinwook; Lynch, Jill E.; Mitsunobu, Satoshi; Morono, Yuki; Murray, Richard W.; Shimono, Takaya; Shiraishi, Fumito; Smith, David C.; Smith-Duque, Christopher E.; Spivack, Arthur J.; Steinsbu, Bjorn Olav; Suzuki, Yohey; Szpak, Michal; Toffin, Laurent; Uramoto, Goichiro; Yamaguchi, Yasuhiko T.; Zhang, Guo-liang; Zhang, Xiao-Hua; Ziebis, Wiebke] Integrated Ocean Drilling Program Expedit 329 Shi, Tokyo, Japan; [D'Hondt, Steven; Pockalny, Robert; Sauvage, Justine; Smith, David C.; Spivack, Arthur J.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Inagaki, Fumio; Morono, Yuki; Uramoto, Goichiro] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan; [Zarikian, Carlos Alvarez; Evans, Helen] Texas A&M Univ, Int Ocean Discovery Program, College Stn, TX 77845 USA; [Abrams, Lewis J.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28409 USA; [Dubois, Nathalie] Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Engelhardt, Tim] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Meeres, D-26129 Oldenburg, Germany; [Ferdelman, Timothy] Max Planck Inst Marine Mikrobiol, Dept Biogeochem, D-28359 Bremen, Germany; [Gribsholt, Britta] Aarhus Univ, Ctr Geomicrobiol, DK-8000 Aarhus, Denmark; [Harris, Robert N.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Hoppie, Bryce W.] Minnesota State Univ, Dept Chem & Geol, Mankato, MN 56001 USA; [Hyun, Jung-Ho] Hanyang Univ, Dept Marine Sci & Convergent Technol, Ansan 426791, Gyeonggi Do, South Korea; [Kallmeyer, Jens] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany; [Kim, Jinwook] Yonsei Univ, Earth Syst Sci, Seoul 120749, South Korea; [Lynch, Jill E.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [McKinley, Claire C.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77813 USA; [Mitsunobu, Satoshi] Univ Shizuoka, Inst Environm Sci, Suruuga Ku, Shizuoka 4228526, Japan; [Murray, Richard W.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Shimono, Takaya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Shiraishi, Fumito] Hiroshima Univ, Grad Sch Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Smith-Duque, Christopher E.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Steinsbu, Bjorn Olav] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Suzuki, Yohey; Yamaguchi, Yasuhiko T.] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Szpak, Michal] Dublin City Univ, Sch Chem Sci, Dublin 9, Ireland; [Toffin, Laurent] IFREMER, Ctr Bretagne, F-29280 Plouzane, France; [Zhang, Guo-liang] Chinese Acad Sci, South China Sea Inst Oceanol, Qingdao 266071, Peoples R China; [Zhang, Xiao-Hua] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China; [Ziebis, Wiebke] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	D'Hondt, S (reprint author), Integrated Ocean Drilling Program Expedit 329 Shi, Tokyo, Japan.	dhondt@uri.edu	Kallmeyer, Jens/I-3554-2012		US National Science Foundation (NSF); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); European Consortium for Ocean Research Drilling; the Ministry of Science and Technology (People's Republic of China); Korea Institute of Geoscience and Mineral Resources; Australian Research Council; New Zealand Institute for Geological and Nuclear Sciences; Ministry of Earth Sciences (India); NSF Division of Ocean Sciences [0939564, 1130735, 1433150]; Japan Society for the Promotion of Science (JSPS) [26251041, 24651018, 24687004, GR102]; Deutsche Forschungsgemeinschaft	This research would not have been possible without the dedicated effort of the drilling crew, ship's crew and scientific staff of the Drillship JOIDES Resolution. We thank the shipboard scientific party, coring crew and ship's crew of piston-coring expedition KN223 for dedicated effort that allowed us to test our global O<INF>2</INF> model in the North Atlantic. We thank V.M. Fulfer and M. J. Hayden for assistance with data compilation. The project was undertaken as part of Integrated Ocean Drilling Program (IODP) Expedition 329. The expedition was funded by the US National Science Foundation (NSF); the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); the European Consortium for Ocean Research Drilling; the Ministry of Science and Technology (People's Republic of China); the Korea Institute of Geoscience and Mineral Resources; the Australian Research Council and the New Zealand Institute for Geological and Nuclear Sciences; and the Ministry of Earth Sciences (India). Post-expedition analyses were funded by the NSF Division of Ocean Sciences (grant 0939564 to S. D'H. and grant 1130735 to S. D'H. and A. J. S.), the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Science Research (no. 26251041, 24651018, 24687004, and GR102 in the NEXT Program: to F.I. and Y.M.) through the MEXT, and the Deutsche Forschungsgemeinschaft (grant to J. Kallmeyer). Expedition KN223 was funded by the NSF Division of Ocean Sciences (grant 1433150 to A. J. S., S. D'H. and R.P.). This is a contribution to the Deep Carbon Observatory (DCO). It is Center for Dark Energy Biosphere Investigations (C-DEBI) publication 254.	ANDERSON LA, 1995, GLOBAL BIOGEOCHEM CY, V9, P621, DOI 10.1029/95GB01902; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Evans KA, 2012, EARTH-SCI REV, V113, P11, DOI 10.1016/j.earscirev.2012.03.003; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; MIDDELBURG JJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1577, DOI 10.1016/0016-7037(89)90239-1; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Hedges JI, 1999, AM J SCI, V299, P529, DOI 10.2475/ajs.299.7-9.529; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Roy H, 2012, SCIENCE, V336, P922, DOI 10.1126/science.1219424; Blair CC, 2007, ASTROBIOLOGY, V7, P951, DOI 10.1089/ast.2007.0150; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Sleep NH, 2012, ANNU REV EARTH PL SC, V40, P277, DOI 10.1146/annurev-earth-092611-090602; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Cowper A.D, 1926, INVESTIGATIONS THEOR, V1926; D'Hondt S., 2011, P IODP, V329; Divins D. L., 2008, NGDC TOTAL SEDIMENT; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549; EMERSON S, 1985, DEEP-SEA RES, V32, P1, DOI 10.1016/0198-0149(85)90014-7; GIESKES JM, 1986, INITIAL REP DEEP SEA, V92, P423; Heath G. R., 1977, FATE FOSSIL FUEL CO2, P605; Hensen C., 2000, MARINE GEOCHEMISTRY, P209; JAHNKE R, 1982, EARTH PLANET SC LETT, V61, P233, DOI 10.1016/0012-821X(82)90056-5; Laske G., 1997, EOS T AGU, V78, pF483; MORITA RY, 1955, DEEP-SEA RES, V3, P66, DOI 10.1016/0146-6313(55)90036-8; MURRAY JW, 1980, SCIENCE, V209, P1527, DOI 10.1126/science.209.4464.1527; Orcutt BN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3539; REVSBECH NP, 1980, SCIENCE, V207, P1355; Wang GZ, 2008, GEOCHIM COSMOCHIM AC, V72, P3479, DOI 10.1016/j.gca.2008.04.024	31	11	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	APR	2015	8	4					299	304		10.1038/NGEO2387		6	Geosciences, Multidisciplinary	Geology	CE8HK	WOS:000352082300021		
J	Winkler, EA; Nishida, Y; Sagare, AP; Rege, SV; Bell, RD; Perlmutter, D; Sengillo, JD; Hillman, S; Kong, P; Nelson, AR; Sullivan, JS; Zhao, Z; Meiselman, HJ; Wenby, RB; Soto, J; Abel, ED; Makshanoff, J; Zuniga, E; De Vivo, DC; Zlokovic, BV				Winkler, Ethan A.; Nishida, Yoichiro; Sagare, Abhay P.; Rege, Sanket V.; Bell, Robert D.; Perlmutter, David; Sengillo, Jesse D.; Hillman, Sara; Kong, Pan; Nelson, Amy R.; Sullivan, John S.; Zhao, Zhen; Meiselman, Herbert J.; Wenby, Rosalinda B.; Soto, Jamie; Abel, E. Dale; Makshanoff, Jacob; Zuniga, Edward; De Vivo, Darryl C.; Zlokovic, Berislav V.			GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration	NATURE NEUROSCIENCE			English	Article							BLOOD-BRAIN-BARRIER; DIMINISHED GLUCOSE-TRANSPORT; AMYLOID PRECURSOR PROTEIN; RECEPTOR-RELATED PROTEIN; BETA-PEPTIDE; TRANSGENIC MICE; MOUSE MODEL; FDG-PET; METABOLISM; HAPLOINSUFFICIENCY	The glucose transporter GLUT1 at the blood-brain barrier (BBB) mediates glucose transport into the brain. Alzheimer's disease is characterized by early reductions in glucose transport associated with diminished GLUT1 expression at the BBB. Whether GLUT1 reduction influences disease pathogenesis remains, however, elusive. Here we show that GLUT1 deficiency in mice overexpressing amyloid beta-peptide (A beta) precursor protein leads to early cerebral microvascular degeneration, blood flow reductions and dysregulation and BBB breakdown, and to accelerated amyloid beta-peptide (A beta) pathology, reduced A beta clearance, diminished neuronal activity, behavioral deficits, and progressive neuronal loss and neurodegeneration that develop after initial cerebrovascular degenerative changes. We also show that GLUT1 deficiency in endothelium, but not in astrocytes, initiates the vascular phenotype as shown by BBB breakdown. Thus, reduced BBB GLUT1 expression worsens Alzheimer's disease cerebrovascular degeneration, neuropathology and cognitive function, suggesting that GLUT1 may represent a therapeutic target for Alzheimer's disease vasculo-neuronal dysfunction and degeneration.	[Winkler, Ethan A.; Sagare, Abhay P.; Rege, Sanket V.; Sengillo, Jesse D.; Kong, Pan; Nelson, Amy R.; Sullivan, John S.; Zhao, Zhen; Makshanoff, Jacob; Zuniga, Edward; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Winkler, Ethan A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Nishida, Yoichiro; Bell, Robert D.; Perlmutter, David; Sengillo, Jesse D.; Hillman, Sara] Univ Rochester, Sch Med & Dent, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY USA; [Nishida, Yoichiro] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Tokyo, Japan; [Meiselman, Herbert J.; Wenby, Rosalinda B.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Soto, Jamie; Abel, E. Dale] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA; [Soto, Jamie; Abel, E. Dale] Univ Iowa, Carver Coll Med, Div Endocrinol & Metab, Iowa City, IA USA; [De Vivo, Darryl C.] Columbia Univ, Colleen Giblin Labs Pediat Neurol Res, New York, NY USA	Zlokovic, BV (reprint author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	zhao, zhen/A-2080-2012	zhao, zhen/0000-0001-8967-5570	US National Institutes of Health [AG039452, AG023084, NS034467, U01 HL087947, R01DK092065]	We thank E. Schauwecker for most helpful discussion. This research was supported by US National Institutes of Health grants AG039452, AG023084 and NS034467 to B.V.Z. and U01 HL087947 and R01DK092065 to E.D.A.	Muneer PMA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-23; Agarwal Neeraj, 2007, Int J Med Sci, V4, P232; Allen A, 2013, BEHAV BRAIN RES, V240, P95, DOI 10.1016/j.bbr.2012.11.025; Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152; Baskurt OK, 2009, BIORHEOLOGY, V46, P251, DOI 10.3233/BIR-2009-0536; Mooradian AD, 1997, NEUROBIOL AGING, V18, P469, DOI 10.1016/S0197-4580(97)00111-5; Ullner PM, 2009, NEUROBIOL DIS, V36, P60, DOI 10.1016/j.nbd.2009.06.014; SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507; Benarroch EE, 2014, NEUROLOGY, V82, P1374, DOI 10.1212/WNL.0000000000000328; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Piert M, 1996, J NUCL MED, V37, P201; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI 10.1007/s00259-008-1039-z; KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Mosconi L, 2006, J NUCL MED, V47, P1778; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Zheng PP, 2010, ANN NEUROL, V68, P835, DOI 10.1002/ana.22318; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; Protas HD, 2013, JAMA NEUROL, V70, P320, DOI 10.1001/2013.jamaneurol.286; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Zhao Z, 2014, NEURON, V82, P728, DOI 10.1016/j.neuron.2014.05.012; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Mosconi L, 2013, NEUROBIOL AGING, V34, P22, DOI 10.1016/j.neurobiolaging.2012.03.002; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Llorente-Cortes V, 2006, J MOL BIOL, V359, P950, DOI 10.1016/j.jmb.2006.04.008; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Wang D, 2006, HUM MOL GENET, V15, P1169, DOI 10.1093/hmg/ddl032; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460; Bolanos JP, 2008, BBA-BIOENERGETICS, V1777, P789, DOI 10.1016/j.bbabio.2008.04.011; Choeiri C, 2005, NEUROSCIENCE, V130, P591, DOI 10.1016/j.neuroscience.2004.09.011; HORWOOD N, 1994, VIRCHOWS ARCH, V425, P69; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323; LaRue B, 2004, J NEUROSCI METH, V138, P233, DOI 10.1016/j.jneumeth.2004.04.026; Maeda K, 2000, J CEREBR BLOOD F MET, V20, P10, DOI 10.1097/00004647-200001000-00003; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Uchida Yasuo, 2013, Fluids Barriers CNS, V10, P21, DOI 10.1186/2045-8118-10-21; VANNUCCI SJ, 1994, J NEUROCHEM, V62, P240; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205; Zeller K, 1997, J CEREBR BLOOD F MET, V17, P204; ZLOKOVIC BV, 1993, J BIOL CHEM, V268, P8019	63	8	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					521	+		10.1038/nn.3966		13	Neurosciences	Neurosciences & Neurology	CE4DL	WOS:000351780900013		
J	Yoshimatsu, K; Koide, H; Hoshino, Y; Shea, KJ				Yoshimatsu, Keiichi; Koide, Hiroyuki; Hoshino, Yu; Shea, Kenneth J.			Preparation of abiotic polymer nanoparticles for sequestration and neutralization of a target peptide toxin	NATURE PROTOCOLS			English	Article							PROTEIN FIBRILLATION; PHASE-TRANSITION; AFFINITY; PARTICLES; TEMPERATURE; MICROGELS; MELITTIN; DESIGN; MICROEMULSIONS; PERSPECTIVE	Synthetic polymer nanoparticles (NPs) with intrinsic affinity for target biomacromolecules hold great promise in the development of novel tools for biological and biomedical research. We recently reported the design and synthesis of abiotic, synthetic polymer NPs with high intrinsic affinity for a peptide toxin melittin. The NP was selected by screening a small library of NPs (similar to 100 nm) composed of various ratios of monomers that contain functional groups complementary to the peptide melittin. The selected polymer NP, a co-polymer of acrylic acid (AAc), N-tert-butylacrylamide (TBAm), N-isopropylacrylamide (NIPAm) and N, N'-methylenebisacrylamide (BIS), effectively captures and neutralizes the toxicity of the peptide through a combination of electrostatic and hydrophobic interactions. This protocol describes a step-by-step procedure for the preparation and evaluation of synthetic polymer NPs for sequestration and neutralization of the target peptide toxin. The polymer NPs can be synthesized in a one-step polymerization reaction using commercially available reagents. The polymerization reaction for the synthesis of polymer NPs takes several hours, and the total protocol including subsequent purification and characterization by dynamic light scattering, NMR and toxicity neutralization assays takes 1-2 weeks in total.	[Yoshimatsu, Keiichi; Koide, Hiroyuki; Hoshino, Yu; Shea, Kenneth J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Koide, Hiroyuki] Univ Shizuoka, Dept Med Biochem, Grad Div Pharmaceut Sci, Shizuoka 4228526, Japan; [Hoshino, Yu] Kyushu Univ, Dept Chem Engn, Fukuoka 812, Japan	Shea, KJ (reprint author), Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA.	kjshea@uci.edu	Yoshimatsu, Keiichi/H-4984-2013	Yoshimatsu, Keiichi/0000-0002-1428-0029	US National Science Foundation [DMR-1308363]; Japan Society for the Promotion of Science (JSPS)	This research was supported by the US National Science Foundation (DMR-1308363). H.K. is a recipient of the Japan Society for the Promotion of Science (JSPS) Fellowship.	Smith MH, 2011, MACROMOLECULES, V44, P8154, DOI 10.1021/ma201365p; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Gajski G, 2013, ENVIRON TOXICOL PHAR, V36, P697, DOI 10.1016/j.etap.2013.06.009; Hoshino Y, 2009, SMALL, V5, P1562, DOI 10.1002/smll.200900186; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]; WU X, 1994, COLLOID POLYM SCI, V272, P467, DOI 10.1007/BF00659460; Nayak S, 2005, ANGEW CHEM INT EDIT, V44, P7686, DOI 10.1002/anie.200501321; Yonamine Y, 2012, BIOMACROMOLECULES, V13, P2952, DOI 10.1021/bm300986j; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Son DJ, 2006, J PHARMACOL EXP THER, V317, P627, DOI 10.1124/jpet.105.095901; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; Zeng ZY, 2012, J AM CHEM SOC, V134, P2681, DOI 10.1021/ja209959t; Mahon CS, 2014, NAT CHEM, V6, P665, DOI [10.1038/nchem.1994, 10.1038/NCHEM.1994]; Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f; Hoshino Y, 2012, J AM CHEM SOC, V134, P18177, DOI 10.1021/ja3080192; Beierle JM, 2014, ANGEW CHEM INT EDIT, V53, P9275, DOI 10.1002/anie.201404881; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Cabaleiro-Lago C, 2008, J AM CHEM SOC, V130, P15437, DOI 10.1021/ja8041806; Lindman S, 2007, NANO LETT, V7, P914, DOI 10.1021/nI062743+; Kawaguchi H, 2014, POLYM INT, V63, P925, DOI 10.1002/pi.4675; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Hu XB, 2011, LANGMUIR, V27, P4142, DOI 10.1021/la200114s; Lee SH, 2012, J AM CHEM SOC, V134, P15765, DOI 10.1021/ja303612d; Debord JD, 2003, LANGMUIR, V19, P7662, DOI 10.1021/la0342924; Hoshino Y, 2008, J AM CHEM SOC, V130, P15242, DOI 10.1021/ja8062875; Yoshimatsu K, 2012, ANGEW CHEM INT EDIT, V51, P2405, DOI 10.1002/anie.201107797; ANTONIETTI M, 1995, MACROMOL CHEM PHYSIC, V196, P441, DOI 10.1002/macp.1995.021960201; Hoshino Y, 2012, P NATL ACAD SCI USA, V109, P33, DOI 10.1073/pnas.1112828109; CANDAU F, 1984, J COLLOID INTERF SCI, V101, P167, DOI 10.1016/0021-9797(84)90017-1; MCPHEE W, 1993, J COLLOID INTERF SCI, V156, P24, DOI 10.1006/jcis.1993.1075; PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8; Armarego WLF, 2009, PURIFICATION OF LABORATORY CHEMICALS, 6TH EDITION, P1; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; HABERMAN.E, 1971, N-S ARCH PHARMAKOL, V270, P1, DOI 10.1007/BF00997294; Hoshino Y, 2014, POLYM J, V46, P537, DOI 10.1038/pj.2014.33; Hu XB, 2011, COLLOID POLYM SCI, V289, P333, DOI 10.1007/s00396-010-2347-y; Islam MR, 2014, J MATER CHEM B, V2, P2444, DOI 10.1039/c3tb21657h; Ito S, 1999, LANGMUIR, V15, P4289, DOI 10.1021/la9811867; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Li B, 2006, ONKOLOGIE, V29, P367, DOI 10.1159/000094711; MEUNIER F, 1995, POLYM ADVAN TECHNOL, V6, P489, DOI 10.1002/pat.1995.220060710; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Simpson ID, 2008, WILD ENVIRON MED, V19, P186, DOI 10.1580/08-WEME-CON-194.1; Spiller HA, 2010, AM J EMERG MED, V28, P780, DOI 10.1016/j.ajem.2009.03.021; Weisman A, 2014, BIOMACROMOLECULES, V15, P3290, DOI 10.1021/bm500666j; Yonamine Y, 2013, ACS APPL MATER INTER, V5, P374, DOI 10.1021/am302404q; Yoshimatsu K, 2014, J AM CHEM SOC, V136, P1194, DOI 10.1021/ja410817p	48	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	APR	2015	10	4					595	604		10.1038/nprot.2015.032		10	Biochemical Research Methods	Biochemistry & Molecular Biology	CE6FP	WOS:000351932400006		
J	Masuda, S; Miyagawa, S; Sougawa, N; Sawa, Y				Masuda, Shigeo; Miyagawa, Shigeru; Sougawa, Nagako; Sawa, Yoshiki			CD30-targeting immunoconjugates and bystander effects	NATURE REVIEWS CLINICAL ONCOLOGY			English	Letter							ANTIBODY-DRUG CONJUGATE; CANCER		[Masuda, Shigeo; Miyagawa, Shigeru; Sougawa, Nagako; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.						Horwitz SM, 2014, BLOOD, V123, P3095, DOI 10.1182/blood-2013-12-542142; Okeley NM, 2010, CLIN CANCER RES, V16, P888, DOI 10.1158/1078-0432.CCR-09-2069; Golfier S, 2014, MOL CANCER THER, V13, P1537, DOI 10.1158/1535-7163.MCT-13-0926; Beckwith KA, 2014, LEUKEMIA, V28, P1501, DOI 10.1038/leu.2014.32; Tai YT, 2014, BLOOD, V123, P3128, DOI 10.1182/blood-2013-10-535088; Kularatne SA, 2014, ANGEW CHEM INT EDIT, V53, P11863, DOI 10.1002/anie.201408103; DiPippo VA, 2015, PROSTATE, V75, P303, DOI 10.1002/pros.22916; Smaglo BG, 2014, NAT REV CLIN ONCOL, V11, P637, DOI 10.1038/nrclinonc.2014.159; Sussman D, 2014, MOL CANCER THER, V13, P2991, DOI 10.1158/1535-7163.MCT-13-0896; Tannir NM, 2014, INVEST NEW DRUG, V32, P1246, DOI 10.1007/s10637-014-0151-0; 2014, NAT REV CLIN ONCOL, V11, P637	11	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4774	1759-4782		NAT REV CLIN ONCOL	Nat. Rev. Clin. Oncol.	APR	2015	12	4					245	245		10.1038/nrclinonc.2014.159-c1		1	Oncology	Oncology	CE6CQ	WOS:000351924100008		
J	Roche, PA; Furuta, K				Roche, Paul A.; Furuta, Kazuyuki			The ins and outs of MHC class II-mediated antigen processing and presentation	NATURE REVIEWS IMMUNOLOGY			English	Review							PLASMACYTOID DENDRITIC CELLS; CD4(+) T-CELLS; HISTOCOMPATIBILITY COMPLEX-II; INVARIANT CHAIN COMPLEXES; PEPTIDE COMPLEXES; CROSS-PRESENTATION; HLA-DR; INFLAMMATORY STIMULI; DOWN-REGULATION; LIPID RAFTS	Antigenic peptide-loaded MHC class II molecules (peptide-MHC class II) are constitutively expressed on the surface of professional antigen-presenting cells (APCs), including dendritic cells, B cells, macrophages and thymic epithelial cells, and are presented to antigen-specific CD4(+) T cells. The mechanisms of antigen uptake, the nature of the antigen processing compartments and the lifetime of cell surface peptide-MHC class II complexes can vary depending on the type of APC. It is likely that these differences are important for the function of each distinct APC subset in the generation of effective adaptive immune responses. In this Review, we describe our current knowledge of the mechanisms of uptake and processing of antigens, the intracellular formation of peptide-MHC class II complexes, the intracellular trafficking of peptide-MHC class II complexes to the APC plasma membrane and their ultimate degradation.	[Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Furuta, Kazuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Immunobiol, Okayama 7008530, Japan	Roche, PA (reprint author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	paul.roche@nih.gov			Japan Society for the Promotion of Science; Intramural Research Program of the US National Institutes of Health	The authors acknowledge the many investigators in the field whose primary data could not be cited in this Review owing to space limitations. The authors also thank the anonymous referees who provided excellent advice in the preparation of this manuscript. This work was supported by the Japan Society for the Promotion of Science (to K.F.) and by the Intramural Research Program of the US National Institutes of Health (to P.A.R.).	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Anderson H. A., 2014, BIOCH BIOPHYS ACTA; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Manoury B, 2003, IMMUNITY, V18, P489, DOI 10.1016/S1074-7613(03)00085-2; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Klein E, 2005, INT IMMUNOL, V17, P477, DOI 10.1093/intimm/dxh228; PINET V, 1994, J IMMUNOL, V152, P4852; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594; Neefjes J, 1999, EUR J IMMUNOL, V29, P1421, DOI 10.1002/(SICI)1521-4141(199905)29:05<1421::AID-IMMU1421>3.0.CO;2-C; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Young LJ, 2007, P NATL ACAD SCI USA, V104, P17753, DOI 10.1073/pnas.0708622104; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Crotzer VL, 2010, IMMUNOLOGY, V131, P9, DOI 10.1111/j.1365-2567.2010.03321.x; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Clement CC, 2011, TRENDS IMMUNOL, V32, P6, DOI 10.1016/j.it.2010.10.004; Odeberg J, 2003, BLOOD, V101, P4870, DOI 10.1182/blood-2002-05-1504; KLEIJMEER MJ, 1995, J IMMUNOL, V154, P5715; Mantegazza AR, 2012, IMMUNITY, V36, P782, DOI 10.1016/j.immuni.2012.02.018; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Mohan JF, 2013, J EXP MED, V210, P2403, DOI 10.1084/jem.20130582; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Denzer K, 2000, J IMMUNOL, V165, P1259; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Tomazin R, 1999, NAT MED, V5, P1039; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Russell DG, 2007, CELL MICROBIOL, V9, P849, DOI 10.1111/j.1462-5822.2007.00920.x; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Yuseff MI, 2011, IMMUNITY, V35, P361, DOI 10.1016/j.immuni.2011.07.008; Romao S, 2013, J CELL BIOL, V203, P757, DOI 10.1083/jcb.201308173; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Griffin JP, 1997, J IMMUNOL, V158, P1523; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Bonaccorsi I, 2014, J IMMUNOL, V192, P824, DOI 10.4049/jimmunol.1301039; Bozzacco L, 2011, J PROTEOME RES, V10, P5016, DOI 10.1021/pr200503g; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Gauvreau ME, 2009, TRAFFIC, V10, P1518, DOI 10.1111/j.1600-0854.2009.00948.x; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Nashar TO, 2005, J IMMUNOL, V174, P1306; Chatterjee B, 2012, BLOOD, V120, P2011, DOI 10.1182/blood-2012-01-402370; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Lautwein A, 2002, EUR J IMMUNOL, V32, P3348, DOI 10.1002/1521-4141(200212)32:12<3348::AID-IMMU3348>3.0.CO;2-S; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Leung CS, 2013, BLOOD, V121, P1584, DOI 10.1182/blood-2012-08-450775; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341; Ressing ME, 2005, J VIROL, V79, P841, DOI 10.1128/JVI.79.2.841-852.2005; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Pierre P, 1997, NATURE, V388, P787; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Temme S, 2010, J IMMUNOL, V184, P236, DOI 10.4049/jimmunol.0902192; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601289; Siemasko K, 1998, J IMMUNOL, V160, P5203; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Bastos-Amador P, 2012, J LEUKOCYTE BIOL, V91, P751, DOI 10.1189/jlb.0111054; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Hoffmann E, 2012, P NATL ACAD SCI USA, V109, P14556, DOI 10.1073/pnas.1203912109; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Antoniou AN, 2002, EUR J IMMUNOL, V32, P530, DOI 10.1002/1521-4141(200202)32:2<530::AID-IMMU530>3.0.CO;2-X; Bosch B, 2013, J BIOL CHEM, V288, P13236, DOI 10.1074/jbc.M112.442640; Bourgeois-Daigneault MC, 2013, J CELL SCI, V126, P989, DOI 10.1242/jcs.117804; Bourgeois-Daigneault MC, 2012, J IMMUNOL, V188, P4959, DOI 10.4049/jimmunol.1102708; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Eren E, 2006, SCAND J IMMUNOL, V63, P7, DOI 10.1111/j.1365-3083.2005.01700.x; Furuta K, 2012, P NATL ACAD SCI USA, V109, P19380, DOI 10.1073/pnas.1213868109; Furuta K, 2013, P NATL ACAD SCI USA, V110, P20188, DOI 10.1073/pnas.1312994110; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Hegde NR, 2002, J VIROL, V76, P10929, DOI 10.1128/JVI.76.21.10929-10941.2002; Hunt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037330; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Karacsonyi C, 2004, J BIOL CHEM, V279, P34818, DOI 10.1074/jbc.M404608200; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; KLEIJMEER MJ, 1994, J INVEST DERMATOL, V103, P516, DOI 10.1111/1523-1747.ep12395666; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; Lapaque N, 2009, P NATL ACAD SCI USA, V106, P14052, DOI 10.1073/pnas.0906735106; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Le Roux D, 2007, MOL BIOL CELL, V18, P3451, DOI 10.1091/mbc.E06-12-1114; Ma JK, 2012, P NATL ACAD SCI USA, V109, P8820, DOI 10.1073/pnas.1202977109; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Mahaweni N. M., 2013, J EXTRACELL VESICLES, V2, P22492; Mantegazza AR, 2014, P NATL ACAD SCI USA, V111, P15508, DOI 10.1073/pnas.1412998111; MOMBURG F, 1993, J EXP MED, V178, P1453, DOI 10.1084/jem.178.4.1453; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Poloso NJ, 2004, J IMMUNOL, V173, P4539; Rocha N, 2008, EMBO J, V27, P1, DOI 10.1038/sj.emboj.7601945; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; SOUSA CRE, 1993, J EXP MED, V178, P509; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; ten Broeke T, 2011, TRAFFIC, V12, P1025, DOI 10.1111/j.1600-0854.2011.01212.x; Toussaint H, 2008, J VIROL, V82, P8373, DOI 10.1128/JVI.00670-08; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Zuo JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002455	152	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	APR	2015	15	4					203	216		10.1038/nri3818		14	Immunology	Immunology	CE5CH	WOS:000351847200006		
J	Ishida, Y				Ishida, Yu			Response to "Brain Magnetic Resonance Imaging in Influenza A (H1N1) 2009-Associated Encephalopathy"	NEUROPEDIATRICS			English	Letter							CHILDREN		Tokyo Med Univ Hosp, Dept Pediat, Shinjuku Ku, Tokyo 1600023, Japan	Ishida, Y (reprint author), Tokyo Med Univ Hosp, Dept Pediat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	ishiyu@tokyo-med.ac.jp					Ishida Y, 2015, NEUROPEDIATRICS, V46, P20, DOI 10.1055/s-0034-1393708; Kawashima H, 2012, J MED VIROL, V84, P1151, DOI 10.1002/jmv.23317	2	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0174-304X	1439-1899		NEUROPEDIATRICS	Neuropediatrics	APR	2015	46	2					148	148		10.1055/s-0035-1546275		1	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CE6NK	WOS:000351954400016		
J	Kashiwazaki, D; Akioka, N; Kuwayama, N; Noguchi, K; Tanaka, K; Kuroda, S				Kashiwazaki, Daina; Akioka, Naoki; Kuwayama, Naoya; Noguchi, Kyo; Tanaka, Kortaro; Kuroda, Satoshi			Pathophysiology of Acute Cerebrovascular Syndrome in Patients With Carotid Artery Stenosis: A Magnetic Resonance Imaging/Single-Photon Emission Computed Tomography Study	NEUROSURGERY			English	Article						Carotid artery stenosis; Magnetic Resonance Imaging; Mechanisms; Single-Photon Emission Tomography	TRANSIENT ISCHEMIC ATTACK; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; CEREBRAL HYPERPERFUSION; HEMODYNAMIC IMPAIRMENT; ATHEROSCLEROTIC PLAQUE; INTRAPLAQUE HEMORRHAGE; SYMPTOMATIC PATIENTS; TERM PROGNOSIS; STROKE COUNCIL	BACKGROUND:The mechanisms underlying acute cerebrovascular syndrome in patients with carotid artery stenosis remain unclear.OBJECTIVE:To assess the relationships among infarct localization, hemodynamics, and plaque components.METHODS:This prospective study included 38 patients with acute cerebrovascular syndrome resulting from ipsilateral carotid artery stenosis. Cerebral infarct localization was categorized into 3 patterns (cortical, border zone, and mixed pattern). Carotid plaque components were evaluated with T1-weighted magnetic resonance imaging and time-of-flight imaging. Cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) were also quantified.RESULTS:Infarcts were identified in 38 patients with the use of diffusion-weighted magnetic resonance imaging. On the basis of the assessment of hemodynamics, the cortical pattern was seen in 18 of 21 patients with type 1 ischemia (normal CBF, normal CVR), whereas the mixed pattern was seen in 2 patients with type 2 ischemia (normal CBF, impaired CVR) and 12 of 15 patients with type 3 ischemia (impaired CBF, impaired CVR). The plaque components were categorized into fibrous (4 patients), lipid-rich (14 patients), and intraplaque hemorrhage (IPH; 20 patients). Of the patients with fibrous plaque, 2 had border-zone and 2 had mixed-pattern infarcts. Of the patients with lipid-rich plaque, 7 had cortical and 6 had mixed-pattern infarcts. Of patients with intraplaque hemorrhage, 11 had cortical and 9 had mixed-pattern infarcts.CONCLUSION:Cortical infarction occurs as a result of vulnerable plaque. Reduced cerebral perfusion induces border-zone infarction. Both factors are implicated in mixed-pattern infarction. Developments in noninvasive diagnostic modalities allow us to explore the mechanisms behind acute cerebrovascular syndrome in carotid artery stenosis and to determine the ideal therapies.ABBREVIATIONS:ACVS, acute cerebrovascular syndromeCBF, cerebral blood flowCVR, cerebrovascular reactivityDWI, diffusion-weighted imagingIPH, intraplaque hemorrhageNASCET, North American Symptomatic Carotid Surgery TrialSPECT, single-photon emission computed tomographyTIA, transient ischemic attackTOF, time-of-flight	[Kashiwazaki, Daina; Akioka, Naoki; Kuwayama, Naoya; Kuroda, Satoshi] Toyama Univ, Grad Sch Med & Pharmacol Sci, Dept Neurosurg, Toyama 930, Japan; [Noguchi, Kyo] Toyama Univ, Grad Sch Med & Pharmacol Sci, Dept Radiol, Toyama 930, Japan; [Tanaka, Kortaro] Toyama Univ Hosp, Dept Neurol, Toyama, Japan	Kashiwazaki, D (reprint author), Univ Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neurosurg, 2630 Sugitani, Toyama 9300194, Japan.	gktqx702@yahoo.co.jp					Achterberg S, 2013, CEREBROVASC DIS, V36, P190, DOI 10.1159/000353675; Komoribayashi N, 2006, J CEREBR BLOOD F MET, V26, P878, DOI 10.1038/sj.jcbf.9600244; Kuroda S, 2001, STROKE, V32, P2110, DOI 10.1161/hs0901.095692; Biller J, 1998, CIRCULATION, V97, P501; MOORE WS, 1995, STROKE, V26, P188; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Yamauchi H, 2005, J NUCL MED, V46, P1973; Takaya N, 2005, CIRCULATION, V111, P2768, DOI 10.1161/CIRCULATIONAHA.104.504167; Mono ML, 2012, CEREBROVASC DIS, V34, P343, DOI 10.1159/000343227; Hirooka R, 2009, AM J NEURORADIOL, V30, P559, DOI 10.3174/ajnr.A1389; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Altaf N, 2008, J VASC SURG, V47, P337, DOI 10.1016/j.jvs.2007.09.064; Hill MD, 2004, NEUROLOGY, V62, P2015; Parmar JP, 2010, CIRCULATION, V122, P2031, DOI 10.1161/CIRCULATIONAHA.109.866053; Saito A, 2012, NEURORADIOLOGY, V54, P1187, DOI 10.1007/s00234-012-1025-9; Ogasawara K, 2003, J NEUROSURG, V99, P504, DOI 10.3171/jns.2003.99.3.0504; Kuroda S, 2004, J NUCL MED, V45, P943; POLLANEN MS, 1990, CAN J NEUROL SCI, V17, P395; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Man BL, 2009, STROKE, V40, P3211, DOI 10.1161/STROKEAHA.109.557041; Derdeyn CP, 2001, RADIOLOGY, V220, P195; BOGOUSSLAVSKY J, 1986, ANN NEUROL, V20, P346, DOI 10.1002/ana.410200312; Iida H, 2010, J NUCL MED, V51, P1624, DOI 10.2967/jnumed.110.078352; Aso K, 2009, EUR J NUCL MED MOL I, V36, P294, DOI 10.1007/s00259-008-0886-y; Kang DW, 2002, ARCH NEUROL-CHICAGO, V59, P1577, DOI 10.1001/archneur.59.10.1577; Derdeyn CP, 2007, CEREBROVASC DIS, V24, P11, DOI 10.1159/000103111; Kumral E, 2004, CEREBROVASC DIS, V17, P287, DOI 10.1159/000077339; Kuroda S, 2014, ACTA NEUROCHIR, V156, P77, DOI 10.1007/s00701-013-1961-0; Liu XS, 2012, AM J NEURORADIOL, V33, P1257, DOI 10.3174/ajnr.A2965; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; PESSIN MS, 1979, ANN NEUROL, V6, P245, DOI 10.1002/ana.410060311; Uchiyama S, 2014, FRONT NEUROL NEUROSC, V33, P11, DOI 10.1159/000351888; VANDERZWAN A, 1992, J NEUROSURG, V77, P927, DOI 10.3171/jns.1992.77.6.0927; WATERSTON JA, 1990, ARCH NEUROL-CHICAGO, V47, P953; Yoshida K, 2008, AM J NEURORADIOL, V29, P868, DOI 10.3174/ajnr.A1015	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	APR	2015	76	4					427	433		10.1227/NEU.0000000000000655		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE1ZX	WOS:000351613000029		
J	Ohue, S; Kohno, S; Inoue, A; Yamashita, D; Matsumoto, S; Suehiro, S; Kumon, Y; Kikuchi, K; Ohnishi, T				Ohue, Shiro; Kohno, Shohei; Inoue, Akihiro; Yamashita, Daisuke; Matsumoto, Shirabe; Suehiro, Satoshi; Kumon, Yoshiaki; Kikuchi, Keiichi; Ohnishi, Takanori			Surgical results of tumor resection using tractography-integrated navigation-guided fence-post catheter techniques and motor-evoked potentials for preservation of motor function in patients with glioblastomas near the pyramidal tracts	NEUROSURGICAL REVIEW			English	Article						Glioblastoma; Motor-evoked potential; Navigation; Tractography; Pyramidal tract	LOW-GRADE GLIOMAS; BRAIN-TUMORS; MAGNETIC-RESONANCE; SUBCORTICAL STIMULATION; NEURONAVIGATION SYSTEM; CLINICAL ARTICLE; FIBER TRACKING; SUPRATENTORIAL SURGERY; ELECTRICAL-STIMULATION; IMAGING TRACTOGRAPHY	The current optimal surgery for glioblastomas (GBMs) near the pyramidal tract (PT) is to remove as much tumor as possible and to preserve motor function. The purpose of this study is to investigate the usefulness of tractography-integrated navigation-guided fence-post catheter techniques and motor-evoked potentials (MEPs) for preserving postoperative motor function after GBM surgery. We retrospectively examined 49 patients who underwent resection for GBM near the PT. Diffusion tensor (DT) imaging-based tractography of the PT was performed preoperatively and integrated into the navigation system. When possible, silicon catheters were used as "fence-posts" and were inserted along the tumor boundaries, avoiding the PT, before tumor removal using the navigation system (fence-post catheter techniques). Cortical and subcortical MEPs were also monitored during resection of the tumor. Fence-post catheter techniques using a tractography-integrated navigation system were used in 45 of 49 patients. This technique enabled placement of the catheters, avoided the motor pathways, and allowed easier resection of the tumors. Tumors near the PT were resected using subcortical and cortical MEPs. The amplitudes of cortical MEPs after tumor removal were maintained at over 33 % of those obtained before resection. Thirty-six patients showed obvious responses of subcortical MEPs at a parts per thousand currency sign20 mA. The degree of resection was gross total in 21 patients, subtotal in 21, and partial in seven. One month after surgery, only one patient showed worsened motor function. Therefore, fence-post catheter techniques using a tractography-integrated navigation system and MEPs may contribute to preserving motor function after surgery for GBMs that are near the PT.	[Ohue, Shiro; Kohno, Shohei; Inoue, Akihiro; Yamashita, Daisuke; Matsumoto, Shirabe; Suehiro, Satoshi; Kumon, Yoshiaki; Kikuchi, Keiichi; Ohnishi, Takanori] Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon, Ehime, Japan; [Kikuchi, Keiichi] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime, Japan	Ohue, S (reprint author), Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon, Ehime, Japan.	sohue@m.ehime-u.ac.jp		inoue, akihiro/0000-0002-7438-2369			Keles GE, 2004, J NEUROSURG, V100, P369, DOI 10.3171/jns.2004.100.3.0369; Neuloh G, 2007, NEUROSURGERY, V61, P337, DOI [10.1227/01.neu.0000279227.50826.6c, 10.1227/01.NEU.0000119326.15032.00]; Mikuni N, 2007, J NEUROSURG, V106, P593, DOI 10.3171/jns.2007.106.4.593; Brell M, 2000, ACTA NEUROCHIR, V142, P739, DOI 10.1007/s007010070088; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Chang EF, 2011, J NEUROSURG, V114, P566, DOI 10.3171/2010.6.JNS091246; Neuloh G, 2004, NEUROSURGERY, V54, P1061, DOI 10.1227/01.NEU.0000119326.15032.00; Duffau H, 2007, NEUROPHYSIOL CLIN, V37, P373, DOI 10.1016/j.neucli.2007.09.003; Nossek E, 2011, J NEUROSURG, V114, P738, DOI 10.3171/2010.8.JNS10639; Berman JI, 2007, J NEUROSURG, V107, P488, DOI 10.3171/JNS-07/09/0488; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Gumprecht HK, 1999, NEUROSURGERY, V44, P97, DOI 10.1097/00006123-199901000-00056; McDonald JD, 1999, J NEUROSURG, V90, P591, DOI 10.3171/jns.1999.90.3.0591; Stadlbauer A, 2007, NEUROIMAGE, V34, P949, DOI 10.1016/j.neuroimage.2006.08.051; Kamada K, 2009, J NEUROSURG, V111, P785, DOI 10.3171/2008.9.JNS08414; Deletis V, 1993, Adv Neurol, V63, P201; Kombos T, 2009, J CLIN NEUROPHYSIOL, V26, P422, DOI 10.1097/WNP.0b013e3181c2c0dc; MacDonald DB, 2013, CLIN NEUROPHYSIOL, V124, P2291, DOI 10.1016/j.clinph.2013.07.025; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Seidel K, 2013, J NEUROSURG, V118, P287, DOI 10.3171/2012.10.JNS12895; Nimsky C, 2005, NEUROSURGERY, V56, P130, DOI 10.1227/01.NEU.0000144842.18771.30; Szelenyi A, 2010, NEUROSURGERY, V67, P302, DOI 10.1227/01.NEU.0000371973.46234.46; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Duffau H, 2005, J NEUROL NEUROSUR PS, V76, P845, DOI 10.1136/jnnp.2004.048520; Roux FE, 1999, ACTA NEUROCHIR, V141, P71, DOI 10.1007/s007010050268; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Berman JI, 2004, J NEUROSURG, V101, P66, DOI 10.3171/jns.2004.101.1.0066; Coenen VA, 2003, SURG NEUROL, V60, P381, DOI 10.1016/S0090-3019(03)00392-6; Dorward NL, 1998, J NEUROSURG, V88, P656, DOI 10.3171/jns.1998.88.4.0656; Eisner W, 2002, J NEUROL NEUROSUR PS, V72, P378, DOI 10.1136/jnnp.72.3.378; Feigl GC, 2010, J NEUROSURG, V113, P352, DOI 10.3171/2009.10.JNS09447; Gonzalez-Darder JM, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.11.FOCUS09234; Gumprecht HK, 1999, NEUROSURGERY, V44, P104, DOI DOI 10.1097/00006123-199901000-00056; Hendler T, 2003, J NEUROSURG, V99, P1018, DOI 10.3171/jns.2003.99.6.1018; Kajiwara K, 2010, MINIM INVAS NEUROSUR, V53, P86, DOI 10.1055/s-0030-1249053; Kamada K, 2005, J NEUROSURG, V102, P664, DOI 10.3171/jns.2005.102.4.0664; Maciunas R, 1999, ADV NEUROSURGICAL NA, P289; Maesawa S, 2010, WORLD NEUROSURG, V74, P153, DOI 10.1016/j.wneu.2010.03.022; McGirt MJ, 2009, NEUROSURGERY, V65, P469; MedicalResearchCouncil, 1943, AIDS INV PER NERV IN; Neuloh G, 2004, ADV TECH STAND NEUR, V29, P171; Nimsky C, 2005, NEUROSURGERY, V56, P138; Ohnishi T, 2012, NEUROSURGERY, V70; Ohue S, 2012, NEUROSURGERY, V70, P283, DOI 10.1227/NEU.0b013e31823020e6; Ohue S, 2010, NEUROL MED-CHIR, V50, P291; Ohue S, 2014, TUMORS CENT NERV SYS, V11, P51; Sala F, 2003, J Neurosurg Sci, V47, P79; Samset E, 2005, MINIM INVAS NEUROSUR, V48, P73, DOI 10.1055/s-2004-830224; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.neu.0000317304.31579.17, 10.1227/01.NEU.0000297118.47076.5F]; Wang YXJ, 2010, J NEUROSURG, V113, P1144, DOI 10.3171/2010.7.JNS10393; Yoshikawa K, 2006, J NEURO-ONCOL, V78, P91, DOI 10.1007/s11060-005-9064-2; Zhu FP, 2012, NEUROSURGERY, V71, P1170, DOI 10.1227/NEU.0b013e318271bc61; Zhu FP, 2012, NEUROSURGERY, V71, P1183, DOI [10. 1227/ NEU. 0b013e318271bc61, DOI 10.1227/NEU.0B013E318271BC61]	55	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2015	38	2					293	306		10.1007/s10143-014-0593-z		14	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE1AT	WOS:000351544400017		
J	Lipski, SM; Hayashi, M; Chernov, M; Levivier, M; Okada, Y				Lipski, Samuel M.; Hayashi, Motohiro; Chernov, Mikhail; Levivier, Marc; Okada, Yoshikazu			Modern Gamma Knife radiosurgery of vestibular schwannomas: treatment concept, volumetric tumor response, and functional results	NEUROSURGICAL REVIEW			English	Article						Gamma Knife surgery; Microradiosurgery; Vestibular schwannoma; Treatment; Outcome	SURGERY CLINICAL ARTICLE; LONG-TERM OUTCOMES; AUTOMATIC POSITIONING SYSTEM; UNILATERAL ACOUSTIC NEUROMA; CURRENT TREATMENT STRATEGY; QUALITY-OF-LIFE; STEREOTACTIC RADIOSURGERY; HEARING PRESERVATION; FOLLOW-UP; MANAGEMENT	The objective of the present study was longitudinal evaluation of the volumetric tumor response and functional results after Gamma Knife radiosurgery of vestibular schwannomas, performed according to the modern standards of treatment. From October 2003 to September 2007, 133 consecutive patients with vestibular schwannomas were treated according to the concept of robotic Gamma Knife microradiosurgery, which is based on precise irradiation of the lesion, sparing adjacent structures, and delivery of the high radiation energy to the target. Multiple small-sized isocenters located within the border of the neoplasm were applied. The mean marginal dose was 11.5 Gy (range, 11-12 Gy). In total, 126 cases with a minimum posttreatment follow-up of 2 years (range, 2-7 years; median, 4 years) were analyzed. Temporary enlargement was noted in 25 % of tumors at 6 months after radiosurgery. At 3 years of follow-up, tumor shrinkage, stabilization, and increase in volume were marked in 73 %, 23 %, and 4 % of cases, respectively. All progressing lesions spontaneously stabilized later on and did not require additional management. In 3 % of patients, transitory impairment of the facial nerve function was marked; however, neither its permanent dysfunction nor trigeminal neuropathy attributed to radiosurgery was noted. Impairment of hearing compared to its pretreatment level was revealed in 4 %, 12 %, 13 %, and 16 % of patients at 6 months, 1 year, 2 years, and 3 years after radiosurgery, respectively, and this trend was statistically significant (P = 0.0042). Overall, 77 % of patients with serviceable hearing before treatment preserved it 3 years thereafter. In conclusion, modern Gamma Knife radiosurgery provides effective and safe management of vestibular schwannomas. Nevertheless, possible temporary tumor enlargement, delay of its growth arrest, transient dysfunction of the cranial nerves, and gradual deterioration of hearing after irradiation should be always taken into consideration.	[Lipski, Samuel M.; Hayashi, Motohiro; Chernov, Mikhail; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan; [Hayashi, Motohiro; Chernov, Mikhail] Tokyo Womens Med Univ, Fac Adv Technosurg, Tokyo 1628666, Japan; [Lipski, Samuel M.] Tivoli Univ Hosp, Dept Ear Nose & Throat, La Louviere, Belgium; [Levivier, Marc] Univ Lausanne, Dept Neurosurg, CHU Vaudois, Lausanne, Switzerland; [Levivier, Marc] Univ Lausanne, Gamma Knife Ctr, CHU Vaudois, Lausanne, Switzerland	Hayashi, M (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	GKRmoto@gmail.com			Gamma Knife Unit of the Tokyo Women's Medical University	Dr. Samuel M. Lipski had training fellowship in the Gamma Knife Unit of the Tokyo Women's Medical University from October to November 2009. This study represents a part of the Innovative Project of ELEKTA Research Collaboration with Tokyo Women's Medical University/TWIns.	Chung WY, 2005, J NEUROSURG, V102, P87; Nagano O, 2010, J NEUROSURG, V113, P122, DOI 10.3171/2010.8.GKS10960; Koos WT, 1998, J NEUROSURG, V88, P506, DOI 10.3171/jns.1998.88.3.0506; Meijer OWM, 2008, AM J NEURORADIOL, V29, P906, DOI 10.3174/ajnr.A0969; Yang I, 2010, J NEUROSURG, V112, P851, DOI 10.3171/2009.8.JNS0985; Tamura M, 2009, NEUROSURGERY, V64, P289, DOI 10.1227/01.NEU.0000338256.87936.7C; Hasegawa T, 2011, J NEUROSURG, V115, P1078, DOI 10.3171/2011.7.JNS11749; Carlson ML, 2013, J NEUROSURG, V118, P579, DOI 10.3171/2012.9.JNS12919; Yomo S, 2010, ACTA NEUROCHIR, V152, P47, DOI 10.1007/s00701-009-0510-3; Pollock BE, 2006, NEUROSURGERY, V59, P77, DOI 10.1227/01.NEU.0000219217.14930.14; Hayhurst C, 2012, NEURO-ONCOLOGY, V14, P87, DOI 10.1093/neuonc/nor171; Breivik CN, 2013, NEUROSURGERY, V73, P48, DOI 10.1227/01.neu.0000429862.50018.b9; Yomo S, 2012, J NEUROSURG, V117, P877, DOI 10.3171/2012.7.JNS10672; Nakai T, 2013, NEURORADIOLOGY, V55, P615, DOI 10.1007/s00234-013-1156-7; Massager N, 2007, J NEUROSURG, V107, P733, DOI 10.3171/JNS-07/10/0733; Rowe J, 2007, NEUROSURGERY, V60, P60, DOI 10.1227/NEU.0000255492.34063.32; Chopra R, 2007, INT J RADIAT ONCOL, V68, P845, DOI 10.1016/j.ijrobp.2007.01.001; Hasegawa T, 2013, J NEUROSURG, V118, P557, DOI 10.3171/2012.10.JNS12523; Fukuoka S, 2009, PROG NEUROL, V22, P45, DOI 10.1159/000163382; Hayhurst C, 2012, INT J RADIAT ONCOL, V82, P2041, DOI 10.1016/j.ijrobp.2011.02.017; Myrseth E, 2009, NEUROSURGERY, V64, P654, DOI 10.1227/01.NEU.0000340684.60443.55; Pollock BE, 2006, NEUROSURGERY, V58, P241, DOI 10.1227/01.NEU.0000194833.66593.8B; Lunsford LD, 2005, J NEUROSURG, V102, P195; Babu R, 2013, J NEUROSURG, V119, P121, DOI 10.3171/2013.1.JNS121370; Roos DE, 2012, INT J RADIAT ONCOL, V82, P1352, DOI 10.1016/j.ijrobp.2011.04.068; GARDNER G, 1988, ANN OTO RHINOL LARYN, V97, P55; Myrseth E, 2007, ACTA NEUROCHIR, V149, P647, DOI 10.1007/s00701-007-1179-0; Roundy N, 2012, J NEUROSURG, V116, P697, DOI 10.3171/2011.12.JNS111404; Arthurs BJ, 2011, AM J CLIN ONCOL-CANC, V34, P265, DOI 10.1097/COC.0b013e3181dbc2ab; Arthurs BJ, 2011, NEUROSURG REV, V34, P265, DOI 10.1007/s10143-011-0307-8; Baschnagel AM, 2013, J NEUROSURG, V118, P571, DOI 10.3171/2012.10.JNS12880; Beegle RD, 2007, J NEUROSURG, V107, P913, DOI 10.3171/JNS-07/11/0913; Chuang CC, 2012, J NEUROSURG, V117, P63, DOI 10.3171/2012.7.GKS121003; Chung WY, 2010, J NEUROSURG, V113, P112, DOI 10.3171/2010.8.GKS10954; Delsanti Christine, 2008, Prog Neurol Surg, V21, P93, DOI 10.1159/000156712; Djalilian HR, 2007, AM J OTOLARYNG, V28, P338, DOI 10.1016/j.amjoto.2006.09.008; Franco-Vidal V, 2007, OTOL NEUROTOL, V28, P240, DOI 10.1097/01.mao.0000244360.57379.d4; Ganz J, 2009, ACTA NEUROCHIR, V151, P9, DOI 10.1007/s00701-008-0174-4; Han JH, 2012, CANCER-AM CANCER SOC, V118, P5441, DOI 10.1002/cncr.27501; Hasegawa T, 2006, NEUROSURGERY, V58, P1119, DOI 10.1227/01.NEU.0000215947.35646.DD; Hasegawa T, 2005, J NEUROSURG, V102, P10, DOI 10.3171/jns.2005.102.1.0010; Hayashi Motohiro, 2013, Acta Neurochir Suppl, V116, P5, DOI 10.1007/978-3-7091-1376-9_2; Hayashi M, 2010, RADIOSURG, V7, P175, DOI 10.1159/000288729; Hayashi M, 2006, J NEUROSURG, V105, P12; Hayashi Motohiro, 2013, Acta Neurochir Suppl, V116, P167, DOI 10.1007/978-3-7091-1376-9_26; Hayashi M, 2006, J NEUROSURG, V105, P5; Hayashi Motohiro, 2013, Acta Neurochir Suppl, V116, P25, DOI 10.1007/978-3-7091-1376-9_5; Hempel JM, 2006, EUR ARCH OTO-RHINO-L, V263, P714, DOI 10.1007/s00405-006-0054-6; Horstmann GA, 2002, J NEUROSURG, V97, P450; House WF, 1985, OTOLARYNGOL HEAD NEC, V93, P184; Huang Chuan-Fu, 2005, J Chin Med Assoc, V68, P315; Inoue HK, 2005, J NEUROSURG, V102, P111; Iwai Y, 2003, NEUROSURGERY, V53, P282, DOI 10.1227/01.NEU.0000073416.22608.B3; Kim CH, 2010, J CLIN NEUROSCI, V17, P214, DOI 10.1016/j.jocn.2009.07.087; Kondziolka D, 2003, NEUROSURGERY, V53, P815, DOI 10.1227/01.NEU.0000083027.44876.B2; Landy HJ, 2004, STEREOT FUNCT NEUROS, V82, P147, DOI 10.1159/000081347; Linskey ME, 2008, J NEUROSURG, V109, P129, DOI 10.3171/JNS/2008/109/12/S20; Milligan BD, 2012, J NEUROSURG, V116, P598, DOI 10.3171/2011.11.JNS11811; Murphy ES, 2011, J NEUROSURG, V114, P432, DOI 10.3171/2009.12.JNS091339; Nagano O, 2008, J NEUROSURG, V109, P811, DOI 10.3171/JNS/2008/109/11/0811; Nakaya K, 2010, INT J RADIAT ONCOL, V77, P988, DOI 10.1016/j.ijrobp.2009.06.089; Neuhaus O, 2007, NEUROLOGY, V68, P590, DOI 10.1212/01.wnl.0000256344.92133.dc; Park KY, 2009, J NEUROSURG, V110, P540, DOI 10.3171/2008.9.JNS08860; Park SH, 2013, J NEUROSURG, V118, P566, DOI 10.3171/2012.10.JNS12747; Patel J, 2014, BRIT J NEUROSURG, V28, P20, DOI 10.3109/02688697.2013.815323; Pollock BE, 2009, J NEUROSURG, V111, P840, DOI 10.3171/2009.3.JNS08949; Regis J, 2010, J NEUROSURG, V113, P105, DOI 10.3171/2010.8.GKS101058; Régis Jean, 2007, Prog Neurol Surg, V20, P129; Regis J, 2002, J NEUROSURG, V97, P588; Rowe JG, 2003, J NEUROL NEUROSUR PS, V74, P1536, DOI 10.1136/jnnp.74.11.1536; Sun SB, 2012, J NEUROSURG, V117, P57, DOI 10.3171/2012.7.GKS12783; Tamura M, 2004, NEUROCHIRURGIE, V50, P338; Timmer FCA, 2011, LARYNGOSCOPE, V121, P1834, DOI 10.1002/lary.21908; van de Langenberg R, 2011, J NEUROSURG, V115, P885, DOI 10.3171/2011.6.JNS101963; Varughese JK, 2012, INT J RADIAT ONCOL, V84, P162; Wackym PA, 2008, J NEUROSURG, V109, P137, DOI 10.3171/JNS/2008/109/12/S21; Wangerid T, 2014, ACTA NEUROCHIR, V156, P389, DOI 10.1007/s00701-013-1924-5; Williams BJ, 2013, J NEUROSURG, V119, P463, DOI 10.3171/2013.4.JNS122195; Yang HC, 2011, J NEUROSURG, V114, P801, DOI 10.3171/2010.8.JNS10674	79	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2015	38	2					309	318		10.1007/s10143-014-0601-3		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE1AT	WOS:000351544400019		
J	Kohno, M; Sora, S; Sato, H; Shinogami, M; Yoneyama, H				Kohno, Michihiro; Sora, Shigeo; Sato, Hiroaki; Shinogami, Masanobu; Yoneyama, Hidehiko			Clinical features of vestibular schwannomas in patients who experience hearing improvement after surgery	NEUROSURGICAL REVIEW			English	Article						Acoustic neuroma surgery; Postoperative hearing improvement; Neurinoma; Distortion product otoacoustic emissions; Vestibular schwannoma	ACOUSTIC NEUROMA SURGERY; CEREBELLOPONTINE ANGLE TUMORS; NERVE-CONDUCTION BLOCK; COCHLEAR NERVE; FOSSA APPROACH; OTOACOUSTIC EMISSIONS; PRESERVATION; REMOVAL; EXCISION; RECOVERY	Postoperative improvements in hearing in patients with vestibular schwannoma are extremely rare. We reviewed nine cases retrospectively to investigate the clinical features of these cases. Hearing improvement was defined as an improvement in hearing class according to American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) criteria. The nine patients comprised five men and four women with a mean age of 40.4 years. Of the nine tumors, three were solid and six cystic; mean tumor size was 29.7 mm. Mean pure tone average (PTA) and mean speech discrimination scores (SDS) were 47.5 dB and 22.8 %, respectively, preoperatively and 29.6 dB and 83.9 %, respectively, postoperatively. AAO-HNS class distribution was class B:1 and D:8, preoperatively, and class A: 5 and B:4, postoperatively. A lateral suboccipital retrosigmoid approach with a lateral (park bench) position was used in all nine patients. Clinical features of these vestibular schwannomas included (1) large cystic tumors, (2) sudden onset hearing loss, (3) the presence of a valley shape in the middle-pitch area on preoperative audiograms, (4) almost intact preoperative inner ear function, (5) a low SDS relative to PTA preoperatively, (6) surgical treatment via a lateral suboccipital approach within 6 months of the most recent exacerbation of hearing loss, (7) observation of I waves in preoperative, intraoperative, and postoperative auditory brainstem response (ABR) recordings, and (8) postoperative improvement in mainly the middle-pitch range and SDS. For surgical treatment of vestibular schwannomas with the above clinical features, a translabyrinthine approach and cochlear nerve section (unless the I wave on the intraoperative ABR trace disappears) should be avoided, regardless of the patient's preoperative hearing level, if a surgeon hopes to maximize the chances of preserving or improving hearing.	[Kohno, Michihiro; Sora, Shigeo; Sato, Hiroaki] Tokyo Metropolitan Police Hosp, Dept Neurosurg, Tokyo, Japan; [Shinogami, Masanobu] Tokyo Metropolitan Police Hosp, Dept Otolaryngol, Tokyo, Japan; [Kohno, Michihiro] Tokyo Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1600023, Japan; [Yoneyama, Hidehiko] Yoneyama Clin, Dept Otolaryngol, Fujinomiya, Shizuoka, Japan	Kohno, M (reprint author), Tokyo Med Univ, Dept Neurosurg, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	mkouno-nsu@umin.ac.jp					ABRAMSON M, 1985, LARYNGOSCOPE, V95, P1318; Amano M, 2011, ACTA NEUROCHIR, V153, P1059, DOI 10.1007/s00701-010-0937-6; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146; Roosli C, 2012, OTOL NEUROTOL, V33, P473, DOI 10.1097/MAO.0b013e318248ee02; Sameshima T, 2010, NEUROSURGERY, V67, P640, DOI 10.1227/01.NEU.0000374853.97891.FB; MATTOX DE, 1977, ANN OTO RHINOL LARYN, V86, P463; KVETON JF, 1990, LARYNGOSCOPE, V100, P473; Roberson JB, 1999, LARYNGOSCOPE, V109, P904, DOI 10.1097/00005537-199906000-00012; BERG HM, 1986, OTOLARYNG HEAD NECK, V94, P15; Brackmann DE, 1979, ACOUSTIC TUMORS, V2, P15; CHAI W, 1981, J NEUROSURG, V54, P268, DOI 10.3171/jns.1981.54.2.0268; COHEN NL, 1985, OTOLARYNG HEAD NECK, V93, P126; Committee on Hearing and Equilibrium, 1995, OTOLARYNGOL HEAD NEC, V113, P179; Fahlbusch R, 1998, ACTA NEUROCHIR, V140, P771, DOI 10.1007/s007010050178; FISCHER G, 1980, NEUROSURGERY, V7, P154; Friedman RA, 2001, OTOLARYNG HEAD NECK, V125, P544, DOI 10.1067/mhn.2001.119675; Fukaya T, 1993, Nihon Jibiinkoka Gakkai Kaiho, V96, P24; GANTZ BJ, 1986, ANN OTO RHINOL LARYN, V95, P454; GOEBEL JA, 1993, OTOLARYNG HEAD NECK, V109, P1025; HARNER SG, 1981, ARCH OTOLARYNGOL, V107, P590; HIGGS WA, 1973, ARCH OTOLARYNGOL, V98, P73; Inoue Y, 2003, EUR ARCH OTO-RHINO-L, V260, P487, DOI 10.1007/s00405-003-0583-1; Ishikawa K, 1994, OTOLARYNGOL HEAD NEC, V64, P15; JANNETTA PJ, 1984, ANN SURG, V200, P513, DOI 10.1097/00000658-198410000-00012; KAWAGUCHI T, 1994, SURG NEUROL, V42, P326, DOI 10.1016/0090-3019(94)90403-0; Kohno M, 2014, WORLD NEUROSURG, V81, P357, DOI 10.1016/j.wneu.2012.09.008; Kohno M, 2011, ACTA NEUROCHIR, V153, P2273, DOI 10.1007/s00701-011-1105-3; Kohno M, 2011, NEUROSURGERY, V68, P1006, DOI 10.1227/NEU.0b013e318208f37f; KVETON JF, 1989, OTOLARYNG HEAD NECK, V100, P594; Lanzino G, 1997, NEUROSURGERY, V41, P469, DOI 10.1097/00006123-199708000-00029; LEVINE RA, 1984, ANN OTO RHINOL LARYN, V93, P116; MAURER PK, 1988, NEUROSURGERY, V22, P573; Meiteles LZ, 2002, J NEUROSURG, V96, P796, DOI 10.3171/jns.2002.96.4.0796; NADOL JB, 1987, LARYNGOSCOPE, V97, P1287, DOI 10.1288/00005537-198711000-00007; Niranjan A, 1999, NEUROSURG CLIN N AM, V10, P305; OGAWA K, 1991, ACTA OTO-LARYNGOL, P138; PENSAK ML, 1985, LARYNGOSCOPE, V95, P1188; PERLMAN H B, 1959, Laryngoscope, V69, P591; Popovtzer A., 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P101; PRASHER DK, 1995, ACTA OTO-LARYNGOL, V115, P375, DOI 10.3109/00016489509139332; SAUNDERS JE, 1995, OTOLARYNG HEAD NECK, V113, P23, DOI 10.1016/S0194-5998(95)70140-0; SEKIYA T, 1986, ACTA NEUROCHIR, V81, P142, DOI 10.1007/BF01401237; SEKIYA T, 1987, NEUROSURGERY, V21, P631; SEKIYA T, 1987, J NEUROSURG, V67, P244, DOI 10.3171/jns.1987.67.2.0244; SHELTON C, 1990, OTOLARYNG HEAD NECK, V103, P963; Sterkers J M, 1984, Adv Otorhinolaryngol, V34, P187; Stidham KR, 2001, OTOL NEUROTOL, V22, P917, DOI 10.1097/00129492-200111000-00035; TATOR CH, 1985, J NEUROSURG, V63, P168, DOI 10.3171/jns.1985.63.2.0168; TELIAN SA, 1988, ARCH OTOLARYNGOL, V114, P85; VELLUTINI EAS, 1991, NEUROSURGERY, V28, P310; Weber PC, 1996, AM J OTOL, V17, P669; WIDICK MP, 1994, OTOLARYNG HEAD NECK, V111, P407; Yanagihara N, 1994, EAR NOSE THROAT J, V73, P890; YLIKOSKI J, 1978, ARCH OTOLARYNGOL, V104, P679	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2015	38	2					331	341		10.1007/s10143-014-0599-6		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE1AT	WOS:000351544400023		
J	Masuoka, J; Matsushima, T; Inoue, K; Nakahara, Y; Takase, Y; Kawashima, M				Masuoka, Jun; Matsushima, Toshio; Inoue, Kouhei; Nakahara, Yukiko; Takase, Yukinori; Kawashima, Masatou			Outcome of microvascular decompression for trigeminal neuralgia treated with the stitched sling retraction technique	NEUROSURGICAL REVIEW			English	Article						Microvascular decompression; Trigeminal neuralgia; Transposition; Sling retraction technique	VASCULAR TRANSPOSITION; TEFLON; SERIES; NERVE	The purpose of this retrospective study was to describe and evaluate the long-term outcome of microvascular decompression (MVD) with the stitched sling retraction technique for treating trigeminal neuralgia (TN). Between January 2007 and December 2012, 50 patients with idiopathic TN underwent MVD using the stitched sling retraction technique at our institution. The median follow-up period was 5.2 years (range, 1.8-6.8 years). Using Kaplan-Meier analysis, the rates of complete pain relief without medications were 88 % at 1 year and 83 % at 5 years. Recurrence was noted in two patients, and one patient was re-treated using a complementary procedure for pain relief. Although transient complications were observed in seven patients, no permanent neurological deficit was observed. We conclude that the stitched sling retraction technique is a safe and effective treatment for TN and maintains substantial pain relief and low recurrence rates over a long period of time.	[Masuoka, Jun; Matsushima, Toshio; Inoue, Kouhei; Nakahara, Yukiko; Takase, Yukinori; Kawashima, Masatou] Saga Univ, Fac Med, Dept Neurosurg, Saga 8498501, Japan	Masuoka, J (reprint author), Saga Univ, Fac Med, Dept Neurosurg, 5-1-1 Nabeshima, Saga 8498501, Japan.	masuoka@cc.saga-u.ac.jp					AMMAR A, 1990, NEUROSURG REV, V13, P299, DOI 10.1007/BF00346368; Matsushima T, 2000, ACTA NEUROCHIR, V142, P557, DOI 10.1007/s007010050469; Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701; Shigeno T, 2002, NEUROL MED-CHIR, V42, P184, DOI 10.2176/nmc.42.184; Rogers CL, 2000, INT J RADIAT ONCOL, V47, P1013, DOI 10.1016/S0360-3016(00)00513-7; Hitotsumatsu T, 2003, NEUROSURGERY, V53, P1436, DOI 10.1227/01.NEU.0000093431.43456.3B; MATSUSHIMA T, 1989, NEUROSURGERY, V24, P890; JANNETTA PJ, 1967, J NEUROSURG, V26, P159, DOI 10.3171/jns.1967.26.1part2.0159; Attabib N, 2007, J NEUROSURG, V106, P929, DOI 10.3171/jns.2007.106.5.929; Masuoka J, 2011, NEUROSURG REV, V34, P373, DOI 10.1007/s10143-011-0310-0; Fujimaki T, 1996, ACTA NEUROCHIR, V138, P1307, DOI 10.1007/BF01411060; FUKUSHIMA T, 1982, Neurological Surgery, V10, P1257; Melvill RL, 1996, J NEUROSURG, V84, P127, DOI 10.3171/jns.1996.84.1.0127; Mitsos AP, 2008, NEUROSURG REV, V31, P327, DOI 10.1007/s10143-008-0144-6; Premsagar IC, 1997, J NEUROSURG, V87, P454, DOI 10.3171/jns.1997.87.3.0454; Sindou M, 2008, NEUROSURGERY, V63, P341, DOI 10.1227/01.NEU.0000327022.79171.D6; Tronnier VM, 2001, NEUROSURGERY, V48, P1261, DOI 10.1097/00006123-200106000-00014; Yasargil MG, 1984, MICRONEUROSURGERY, P133	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2015	38	2					361	365		10.1007/s10143-015-0607-5		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE1AT	WOS:000351544400029		
J	Miyashita, T; Ataka, H; Tanno, T				Miyashita, Tomohiro; Ataka, Hiromi; Tanno, Takaaki			Animated respiratory movement of a spinal intradural arachnoid cyst visualized by intraoperative ultrasonography	NEUROSURGICAL REVIEW			English	Article						Spinal intradural arachnoid cyst; Respiratory movement; Pulsation; Ultrasonography; Thoracic spine	MR	This study aims to describe the animated respiratory movement of a spinal intradural arachnoid cyst visualized by intraoperative ultrasonography. A 69-year-old man with a spinal arachnoid cyst of the thoracic spine presented with gait disturbance. Magnetic resonance images showed a mild anterior displacement and flattening of the spinal cord at T4-T5. We performed ultrasonography before incision of the dura during the operation and observed the movement of the cyst consisting of not only pulsation in accordance with the cardiac cycle but also rhythmic expansion and contraction in accordance with the respiratory cycle. In the inspiratory phase, the cyst gradually expanded and pulsated in accordance with the cardiac cycle. In the expiratory phase, the cyst gradually contracted with the same pulsation. After resection of the cyst, the patient's neurological improvements were excellent. To our knowledge, this is the first report of animated respiratory movement of a spinal arachnoid cyst visualized by intraoperative ultrasonography. Although cine magnetic resonance imaging can detect spinal intradural arachnoid cysts preoperatively, intraoperative ultrasonography is useful for close analysis of their movement and pathology. Considering the dynamic compression mechanism revealed in this study, we think that an early operation should be performed for such cysts.	[Miyashita, Tomohiro] Matsudo City Hosp, Spine Ctr, Matsudo, Chiba 2718511, Japan; [Ataka, Hiromi; Tanno, Takaaki] Matsudo Orthopaed Hosp, Spine Ctr, Matsudo, Chiba 2710043, Japan	Miyashita, T (reprint author), Matsudo City Hosp, Spine Ctr, 4005 Kamihongo, Matsudo, Chiba 2718511, Japan.	tommiya3@yahoo.co.jp					ANDREWS BT, 1988, J NEUROSURG, V68, P544, DOI 10.3171/jns.1988.68.4.0544; Shimizu H, 1997, NEUROSURGERY, V41, P95, DOI 10.1097/00006123-199707000-00020; Baba T, 2010, ACTA NEUROCHIR, V152, P1245, DOI 10.1007/s00701-009-0571-3; GALZIO RJ, 1982, SURG NEUROL, V17, P388, DOI 10.1016/0090-3019(82)90321-4; QUENCER RM, 1990, NEURORADIOLOGY, V32, P371; SKLAR E, 1989, AM J ROENTGENOL, V153, P1057; Sugiyama S, 2002, RINSHO SEIKEI GEKA, V37, P217; Wang MY, 2003, SURG NEUROL, V60, P49, DOI 10.1016/S0090-3019(03)00149-6	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2015	38	2					391	393		10.1007/s10143-014-0598-7		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE1AT	WOS:000351544400039		
J	Van Bockhaven, J; Spichal, L; Novak, O; Strnad, M; Asano, T; Kikuchi, S; Hofte, M; De Vleesschauwer, D				Van Bockhaven, Jonas; Spichal, Lukas; Novak, Ondrej; Strnad, Miroslav; Asano, Takayuki; Kikuchi, Shoshi; Hofte, Monica; De Vleesschauwer, David			Silicon induces resistance to the brown spot fungus Cochliobolus miyabeanus by preventing the pathogen from hijacking the rice ethylene pathway	NEW PHYTOLOGIST			English	Article						Bipolaris oryzae; Cochliobolus miyabeanus; disease resistance; plant-microbe interactions; rice (Oryza sativa L.); silicon (Si)	PLANT-DISEASE RESISTANCE; SYSTEMIC RESISTANCE; PSEUDOMONAS-SYRINGAE; ABSCISIC-ACID; GLUTAMATE-DEHYDROGENASE; NITROGEN MOBILIZATION; ARABIDOPSIS-THALIANA; MAGNAPORTHE-GRISEA; BIPOLARIS-ORYZAE; LEAF SENESCENCE	Although numerous studies have shown the ability of silicon (Si) to mitigate a wide variety of abiotic and biotic stresses, relatively little is known about the underlying mechanism(s). Here, we have investigated the role of hormone defense pathways in Si-induced resistance to the rice brown spot fungus Cochliobolus miyabeanus. To delineate the involvement of multiple hormone pathways, a multidisciplinary approach was pursued, combining exogenous hormone applications, pharmacological inhibitor experiments, time-resolved hormone measurements, and bioassays with hormone-deficient and/or -insensitive mutant lines. Contrary to other types of induced resistance, we found Si-induced brown spot resistance to function independently of the classic immune hormones salicylic acid and jasmonic acid. Our data also rule out a major role of the abscisic acid (ABA) and cytokinin pathways, but suggest that Si mounts resistance to C.miyabeanus by preventing the fungus from hijacking the rice ethylene (ET) machinery. Interestingly, rather than suppressing rice ET signaling per se, Si probably interferes with the production and/or action of fungal ET. Together our findings favor a scenario whereby Si induces brown spot resistance by disarming fungal ET and argue that impairment of pathogen virulence factors is a core resistance mechanism underpinning Si-induced plant immunity.	[Van Bockhaven, Jonas; Hofte, Monica; De Vleesschauwer, David] Univ Ghent, Fac Biosci Engn, Lab Phytopathol, B-9000 Ghent, Belgium; [Spichal, Lukas; Strnad, Miroslav] Palacky Univ, Dept Chem Biol & Genet, Ctr Reg Hana Biotechnol & Agr Res, Fac Sci, CZ-78371 Olomouc, Czech Republic; [Novak, Ondrej; Strnad, Miroslav] Palacky Univ & Inst Expt Bot ASCR, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Fac Sci, CZ-78371 Olomouc, Czech Republic; [Novak, Ondrej; Strnad, Miroslav] Inst Expt Bot ASCR, CZ-78371 Olomouc, Czech Republic; [Asano, Takayuki; Kikuchi, Shoshi] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan	De Vleesschauwer, D (reprint author), Univ Ghent, Fac Biosci Engn, Lab Phytopathol, B-9000 Ghent, Belgium.	david.devleesschauwer@ugent.be	Novak, Ondrej/F-7031-2014	Novak, Ondrej/0000-0003-3452-0154	Flemish Institute for the Stimulation of Scientific-Technological Research in Industry (IWT, Belgium); Ghent University [GOA 01GB3013]; Research Foundation Flanders [FWO G.0833.12N]; FWO; Ministry of Education, Youth and Sports of the Czech Republic [LO1204]	We thank Dr Marie-Christine Van Labeke for her help with the ET measurements, Shoshi Kikuchi's laboratory for assistance during the microarray experiment and Dr Tim De Meyer for supervising the analysis of the microarray data. In addition, we are grateful to Drs He, Yang, Nick, An, and Matsuoka for sharing rice mutant and transgenic lines. Hana Martinkova and Michaela Glosova are acknowledged for their help with the CK measurements. This work was supported by a specialization fellowship of the Flemish Institute for the Stimulation of Scientific-Technological Research in Industry (IWT, Belgium) given to J.V.B., grants from the Special Research Fund of Ghent University (GOA 01GB3013), the Research Foundation Flanders (FWO G.0833.12N), and an FWO postdoctoral fellowship to D.D.V. The project of the Ministry of Education, Youth and Sports of the Czech Republic (the National Program for Sustainability I, grant LO1204) is also gratefully acknowledged.	Ahn Il-Pyung, 2005, Phytopathology, V95, P1248, DOI 10.1094/PHYTO-95-1248; Dallagnol LJ, 2013, PLANT PATHOL, V62, P120, DOI 10.1111/j.1365-3059.2012.02606.x; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Thuan NTN, 2006, EUR J PLANT PATHOL, V114, P381, DOI 10.1007/s10658-006-0002-8; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Grant MR, 2013, MICROB BIOTECHNOL, V6, P212, DOI 10.1111/1751-7915.12017; Zwack PJ, 2013, PLANT CELL PHYSIOL, V54, P971, DOI 10.1093/pcp/pct049; Jun SH, 2004, PLANT CELL PHYSIOL, V45, P281, DOI 10.1093/pcp/pch033; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Qiu XH, 2009, PLANT CELL REP, V28, P1115, DOI 10.1007/s00299-009-0709-z; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; De Meyer G, 1999, EUR J PLANT PATHOL, V105, P513, DOI 10.1023/A:1008741015912; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Chain F, 2009, MOL PLANT MICROBE IN, V22, P1323, DOI 10.1094/MPMI-22-11-1323; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; De Vleesschauwer D, 2009, ADV BOT RES, V51, P223, DOI 10.1016/S0065-2296(09)51006-3; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Savary S, 2000, PLANT DIS, V84, P341, DOI 10.1094/PDIS.2000.84.3.341; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Riemann M, 2013, PLANT J, V74, P226, DOI 10.1111/tpj.12115; Chowdappa P, 2013, BIOL CONTROL, V65, P109, DOI 10.1016/j.biocontrol.2012.11.009; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Brunings AM, 2009, ANN APPL BIOL, V155, P161, DOI 10.1111/j.1744-7348.2009.00347.x; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; Koga H, 2004, PHYSIOL MOL PLANT P, V65, P3, DOI 10.1016/j.pmpp.2004.11.002; Shoresh M, 2005, PHYTOPATHOLOGY, V95, P76, DOI 10.1094/PHYTO-95-0076; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Pageau K, 2006, J EXP BOT, V57, P547, DOI 10.1093/jxb/erj035; Ghareeb H, 2011, PHYSIOL MOL PLANT P, V75, P83, DOI 10.1016/j.pmpp.2010.11.004; Fauteux F, 2006, P NATL ACAD SCI USA, V103, P17554, DOI 10.1073/pnas.0606330103; Dubois F, 2003, PLANT PHYSIOL BIOCH, V41, P565, DOI 10.1016/S0981-9428(03)00075-5; Van Bockhaven J, 2013, J EXP BOT, V64, P1281, DOI 10.1093/jxb/ers329; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; FUKUDA H, 1992, BIOCHEM BIOPH RES CO, V188, P483, DOI 10.1016/0006-291X(92)91081-Z; Vos IA, 2013, PLANT PATHOL, V62, P43, DOI 10.1111/ppa.12105; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; Lee SK, 2010, AGROFOREST SYST, V80, P333, DOI 10.1007/s10457-010-9299-6; Rodrigues FA, 2005, PHYSIOL MOL PLANT P, V66, P144, DOI 10.1016/j.pmpp.2005.06.002; Domenech J, 2007, PLANT SOIL, V290, P43, DOI 10.1007/s11104-006-9089-0; Ye M, 2013, P NATL ACAD SCI USA, V110, pE3631, DOI 10.1073/pnas.1305848110; Bailey TA, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P185, DOI 10.1007/978-1-4020-9500-9_19; Chague V, 2006, MOL PLANT MICROBE IN, V19, P33, DOI 10.1094/MPMI-19-0033; De Vleesschauwer D, 2013, TRENDS PLANT SCI, V18, P555, DOI 10.1016/j.tplants.2013.07.002; Hewitt E. J., 1975, PLANT MINERAL NUTR; Hwang SunJoo, 2007, Journal of Crop Science and Biotechnology, V10, P281; Kim HS, 2011, MOL PLANT MICROBE IN, V24, P719, DOI 10.1094/MPMI-11-10-0267; Kim YH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-13; Masclaux-Daubresse C, 2005, PLANTA, V221, P580, DOI 10.1007/s00425-004-1468-2; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Muller C, 2001, PLANT CELL ENVIRON, V24, P191, DOI 10.1046/j.1365-3040.2001.00664.x; Petti C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-224; Riemann M, 2003, PLANT PHYSIOL, V133, P1820, DOI 10.1104/pp.103.027490; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Shabana YM, 2008, BRAZ J MICROBIOL, V39, P438, DOI 10.1590/S1517-83822008000300006; Spichal L, 2009, FEBS J, V276, P244, DOI 10.1111/j.1742-4658.2008.06777.x; VIDHYASEKARAN P, 1992, PHYSIOL MOL PLANT P, V41, P307, DOI 10.1016/0885-5765(92)90018-Q; Yuan YZ, 2007, PHYSIOL PLANTARUM, V129, P296, DOI 10.1111/j.1399-3054.2006.00806.x; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	62	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	APR	2015	206	2					761	773		10.1111/nph.13270		13	Plant Sciences	Plant Sciences	CE3QD	WOS:000351742300028		
J	Taniguchi, T				Taniguchi, Takeshi			Explosion of solutions to nonlinear stochastic wave equations with multiplicative noise	NONLINEAR ANALYSIS-THEORY METHODS & APPLICATIONS			English	Article						Stochastic wave equations; Solution; Explosion	EVOLUTION-EQUATIONS; NONEXISTENCE; EXISTENCE	Let D. Rd be an open bounded domain in the d- dimensional Euclidian space Rd with smooth boundary. D. In this paper we investigate the local existence, global existence and explosion of solutions to the following stochastic wave equation:..... dX( t) = Y( t) dt, dY( t) = (.X( t) - | Y( t)| p Y( t) + | X( t)| q X( t)) dt + B( t, X( t), Y( t)) dW( t), p, q > 0, X( 0) = X0, Y( 0) = Y0, X( t) |. D = 0, ( 0.1) where. =.. 2/. x2i is a Laplace operator. The processW( t) denotes a cylindrical Brownian process on a complete probability space ( O, F, P) with filtration of the usual condition. c 2015 Elsevier Ltd. All rights reserved.	Kurume Univ, Grad Sch Comparat Culture, Div Math Sci, Kurume, Fukuoka 8398502, Japan	Taniguchi, T (reprint author), Kurume Univ, Grad Sch Comparat Culture, Div Math Sci, Kurume, Fukuoka 8398502, Japan.	takeshi_taniguchi@kurume-u.ac.jp					Chow PL, 2009, ANN APPL PROBAB, V19, P2039, DOI 10.1214/09-AAP602; Vitillaro E, 1999, ARCH RATION MECH AN, V149, P155, DOI 10.1007/s002050050171; Ondrejat M, 2004, J EVOL EQU, V4, P169, DOI 10.1007/s00028-003-0130-y; Barbu V, 2007, STOCH PROC APPL, V117, P1001, DOI 10.1016/j.spa.2006.11.006; Bo LJ, 2008, J DIFFER EQUATIONS, V244, P170, DOI 10.1016/j.jde.2007.10.016; Chow P. L., 2007, STOCHASTIC PARTIAL D; Chow PL, 2012, STOCH ANAL APPL, V30, P543, DOI 10.1080/07362994.2012.668448; Da Prato Zabzuky, 1992, STOCHASTIC EQUATIONS; Gao H., 2013, INFIN DIMENS ANAL QU, V16; GEORGIEV V, 1994, J DIFFER EQUATIONS, V109, P295, DOI 10.1006/jdeq.1994.1051; Hu Q., 2007, ELECT J DIFFERENTIAL, P1; Kim JU, 2008, APPL MATH OPT, V58, P29, DOI 10.1007/s00245-007-9029-2; Lions J. L., 1969, QUELQUES METHODES RE; Malek J., 1996, WEAK MESURE VALUED S; Massaoudi S., 2001, MATH NACHR, V231, P1; Massaoudi S., 2004, MATH METHOD APPL SCI, V27, P1687; Pardoux E., 1979, Stochastics, V3, DOI 10.1080/17442507908833142; Temam R., 1989, INFINITE DINENSIONAL	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0362-546X	1873-5215		NONLINEAR ANAL-THEOR	Nonlinear Anal.-Theory Methods Appl.	APR	2015	117						47	64		10.1016/j.na.2015.01.004		18	Mathematics, Applied; Mathematics	Mathematics	CE5GU	WOS:000351860100004		
J	Nakamori, S; Takimoto, K				Nakamori, Saori; Takimoto, Kazuhiro			A Bernstein type theorem for parabolic k-Hessian equations	NONLINEAR ANALYSIS-THEORY METHODS & APPLICATIONS			English	Article						Bernstein type theorem; Fully nonlinear equation; Parabolic Hessian equation; Pogorelov type lemma	NONLINEAR ELLIPTIC-EQUATIONS; MONGE-AMPERE EQUATIONS; DIRICHLET PROBLEM; CALABI; REGULARITY; POGORELOV; JORGENS	We are concerned with the characterization of entire solutions to the parabolic k-Hessian equation of the form -u(t) F-k(D(2)u) = 1 in R-n x (-infinity, 0]. We prove that for 1 <= k <= n, any strictly convex-monotone solution u = u(x, t) is an element of C-4,C-2(R-n x (-infinity, 0]) to -u(t) F-k(D(2)u) = 1 in R-n x(-infinity, 0] must be a linear function of t plus a quadratic polynomial of x, under some growth assumptions on u. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakamori, Saori; Takimoto, Kazuhiro] Hiroshima Univ, Grad Sch Sci, Dept Math, Higashihiroshima, Hiroshima 7398526, Japan	Nakamori, S (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.	d113989@hiroshima-u.ac.jp; takimoto@math.sci.hiroshima-u.ac.jp			Japan Society for the Promotion of Science [25400169]	The authors would like to thank the anonymous reviewers for careful reading and useful suggestions. This research was supported by the Grant-in-Aid for Scientific Research No. 25400169 from Japan Society for the Promotion of Science.	Caffarelli L, 2003, COMMUN PUR APPL MATH, V56, P549, DOI 10.1002/cpa.10067; Trudinger NS, 1999, ANN MATH, V150, P579, DOI 10.2307/121089; Trudinger NS, 2002, J FUNCT ANAL, V193, P1, DOI 10.1006/jfan.2001.3925; Gutierrez CE, 1998, INDIANA U MATH J, V47, P1459; WANG XJ, 1994, INDIANA U MATH J, V43, P25, DOI 10.1512/iumj.1994.43.43002; Chou KS, 2001, COMMUN PUR APPL MATH, V54, P1029, DOI 10.1002/cpa.1016; Bao JG, 2003, AM J MATH, V125, P301, DOI 10.1353/ajm.2003.0007; Bernstein S., 1915, COMM SOC MATH KHARKO, V15, P38; CAFFARELLI L, 1985, ACTA MATH-DJURSHOLM, V155, P261, DOI 10.1007/BF02392544; Caffarelli L., 1995, TOPICS PDES MONGE AM; Calabi E., 1958, MICH MATH J, V5, P105, DOI DOI 10.1307/MMJ/1028998055; CHENG SY, 1986, COMMUN PUR APPL MATH, V39, P839, DOI 10.1002/cpa.3160390606; Colesanti A, 1997, B AUST MATH SOC, V56, P459; Gutierrez C.E., 2001, MONGE AMPERE EQUATIO; Ivochkina N.M., 1987, MATH USSR SB, V128, p[403, 403], DOI 10.1070/SM1987v056n02ABEH003043; Ivochkina N.M., 1994, TOPOL METHOD NONL AN, V4, P19; Jian HY, 2013, J DIFFER GEOM, V93, P431; Jorgens K., 1954, MATH ANN, V127, P130, DOI 10.1007/BF01361114; KRYLOV NV, 1976, SIBERIAN MATH J+, V17, P226, DOI 10.1007/BF00967569; Lieberman G. M., 1996, 2 ORDER PARABOLIC DI; Pogorelov A.V., 1971, SOV MATH DOKL, V12, P1436; Pogorelov A.V., 1972, GEOM DEDICATA, V1, P33, DOI 10.1007/BF00147379; Trudinger NS, 1995, ACTA MATH-DJURSHOLM, V175, P151, DOI 10.1007/BF02393303; Trudinger NS, 1997, COMMUN PART DIFF EQ, V22, P1251; Trudinger N.S., 1997, TOPOL METHOD NONL AN, V10, P225; URBAS JIE, 1990, INDIANA U MATH J, V39, P355, DOI 10.1512/iumj.1990.39.39020; Wang G., 1993, J PARTIAL DIFFERENTI, V3, P75; Xiong JG, 2011, J DIFFER EQUATIONS, V250, P367, DOI 10.1016/j.jde.2010.08.024	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0362-546X	1873-5215		NONLINEAR ANAL-THEOR	Nonlinear Anal.-Theory Methods Appl.	APR	2015	117						211	220		10.1016/j.na.2015.01.010		10	Mathematics, Applied; Mathematics	Mathematics	CE5GU	WOS:000351860100015		
J	Guo, R; Oka, Y				Guo, Rui; Oka, Yoshiaki			CFD analysis of coolant channel geometries for a tightly packed fuel rods assembly at subcritical pressure	NUCLEAR ENGINEERING AND DESIGN			English	Article							CRITICAL HEAT-FLUX; SINGLE BUBBLES; FLOW; VALIDATION; SUBCHANNEL	This paper analyzes the thermal hydraulic performance of channels with different cross sectional geometries, which were adopted by tightly packed fuel rods assembly for high breeding at operating pressure of PWR and BWR. The calculations were carried out to assess the geometrical effect of coolant channels on thermal-hydraulic parameters by using a CFD code STAR-CCM+. It is found that one type of channel geometry (geometry B) is superior to others because of broad design area of power, cladding temperature and pressure drop. (C) 2014 Elsevier B.V. All rights reserved.	[Guo, Rui; Oka, Yoshiaki] Waseda Univ, Grad Sch Adv Sci & Engn, Nucl Energy, Tokyo 1698555, Japan	Guo, R (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Nucl Energy, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	guorui@asagi.waseda.jp					RANZ WE, 1952, CHEM ENG PROG, V48, P141; AUTON TR, 1988, J FLUID MECH, V197, P241, DOI 10.1017/S0022112088003246; WEISMAN J, 1983, INT J HEAT MASS TRAN, V26, P1463; Krepper E, 2011, NUCL ENG DES, V241, P3851, DOI 10.1016/j.nucengdes.2011.07.003; Roy RP, 2002, J HEAT TRANS-T ASME, V124, P73, DOI 10.1115/1.1418698; LOCKETT MJ, 1975, T I CHEM ENG-LOND, V53, P267; Krepper E, 2007, NUCL ENG DES, V237, P716, DOI 10.1016/j.nucengdes.2006.10.023; Conner ME, 2010, NUCL ENG DES, V240, P2088, DOI 10.1016/j.nucengdes.2009.11.031; Groeneveld DC, 2007, NUCL ENG DES, V237, P1909, DOI 10.1016/j.nucengdes.2007.02.014; Tomiyama A, 1998, JSME INT J B-FLUID T, V41, P472; Tomiyama A, 2002, CHEM ENG SCI, V57, P1849, DOI 10.1016/S0009-2509(02)00085-4; CD-Adapco, 2013, STAR CCM VERS 8 02 U; Cui XZ, 2003, J NUCL SCI TECHNOL, V40, P719, DOI 10.3327/jnst.40.719; Guo R., NUCL ENG DES; Habib MA, 2014, ANN NUCL ENERGY, V70, P188, DOI 10.1016/j.anucene.2014.03.016; Horvath A., 2012, NUCL ENG DES, V247, P1168; In WK, 2013, NUCL ENG DES, V258, P211, DOI 10.1016/j.nucengdes.2013.02.006; Ismail C., 1997, ASME, V119, P584; Kurul N., 1990, P 9 HEAT TRANSF C JE; Liu B., 2004, P 2004 INT M LWR FUE, P127; OECD, 2012, NUCL FUEL SAF CRIT T, P21; OECD, 2010, TEST FACILITIES, P24; Pierre C.C., 1966, INT J HEAT MASS TRAN, V10, P237; Reinders R., 2003, P ENS TOP FUEL 2003; ROACHE PJ, 1994, J FLUID ENG-T ASME, V116, P405, DOI 10.1115/1.2910291; SHAH MM, 1987, INT J HEAT FLUID FL, V8, P326, DOI 10.1016/0142-727X(87)90069-5; Wagner W., 1998, IAPWSIF97; Yang S.-G., 2005, P ICAPP 05; Oka Y, 2013, J NUCL SCI TECHNOL, V50, P15, DOI 10.1080/00223131.2013.750053; Yoshida Taishi, 2013, P 2013 21 INT C NUCL	30	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	APR 1	2015	284						115	129		10.1016/j.nucengdes.2014.11.039		15	Nuclear Science & Technology	Nuclear Science & Technology	CE6RW	WOS:000351966800014		
J	Liu, ML; Erkan, N; Ishiwatari, Y; Okamoto, K				Liu, Maolong; Erkan, Nejdet; Ishiwatari, Yuki; Okamoto, Koji			Passive depressurization accident management strategy for boiling water reactors	NUCLEAR ENGINEERING AND DESIGN			English	Article							ANALYSIS CODE SAMPSON; IMPACT PROJECT; BWR; IMPACT/SAMPSON; CAPABILITY	According to the current severe accident management guidance, operators are required to depressurize the reactor coolant system to prevent or mitigate the effects of direct containment heating using the safety/relief valves. During the course of a severe accident, the pressure boundary might fail prematurely, resulting in a rapid depressurization of the reactor cooling system before the startup of SRV operation. In this study, we demonstrated that a passive depressurization system could be used as a severe accident management tool under the severe accident conditions to depressurize the reactor coolant system and to prevent an additional devastating sequence of events and direct containment heating. The sensitivity analysis performed with SAMPSON code also demonstrated that the passive depressurization system with an optimized leakage area and failure condition is more efficient in managing a severe accident. (C) 2014 Elsevier B.V. All rights reserved.	[Liu, Maolong; Ishiwatari, Yuki] Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Tokyo 1138654, Japan; [Erkan, Nejdet; Okamoto, Koji] Univ Tokyo, Sch Engn, Nucl Profess Sch, Tokyo 1138654, Japan; [Ishiwatari, Yuki] Hitachi GE Nucl Energy Ltd, Tokyo, Japan	Liu, ML (reprint author), Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Tokyo 1138654, Japan.	liuml@vis.t.u-tokyo.ac.jp					KIM MH, 1990, NUCL ENG DES, V118, P193, DOI 10.1016/0029-5493(90)90057-5; Morita K, 1999, NUCL ENG DES, V189, P337, DOI 10.1016/S0029-5493(98)00267-2; LEISTIKOW S, 1985, WERKST KORROS, V36, P105; Cadiou T., 2002, JOINT IAEA NEA TECHN; Hanson D., 1990, DEPRESSURIZATION ACC; Hering W., 2002, WISSENSCHAFTLICHE BE; Hidaka M, 2002, J NUCL SCI TECHNOL, V39, P520, DOI 10.3327/jnst.39.520; Hodge S., 1992, IDENTIFICATION ASSES; HODGE SA, 1994, NUCL ENG DES, V148, P185, DOI 10.1016/0029-5493(94)90109-0; Huh C, 2009, NUCL ENG DES, V239, P2521, DOI 10.1016/j.nucengdes.2009.07.028; Ikeda T, 2003, J NUCL SCI TECHNOL, V40, P591, DOI 10.3327/jnst.40.591; Ikeda T, 2003, J NUCL SCI TECHNOL, V40, P246, DOI 10.3327/jnst.40.246; Kasahara N., 2014, P ASME 2014 PRESS VE; Kawahara K, 2013, J NUCL SCI TECHNOL, V50, P201, DOI 10.1080/00223131.2013.757474; Klein D., 2012, FUKUSHIMA DAIICHI AN; Koshizuka S., 2012, J ATOM ENERG SOC JPN, V54, P642; Liang TKS, 2002, NUCL ENG DES, V211, P69, DOI 10.1016/S0029-5493(01)00442-3; Liu M., 2013, JPN J MULTIPH FLOW, V27, P298; Liu ML, 2014, NUCL TECHNOL, V186, P216; Maschek W., 2005, M C, V2005, P12; Murata K., 1997, CODE MANUAL CONTAIN; Naitoh M., 2005, ICONE 13 BEIJ CHIN; Nuclear Emergency Response Headquarters, 2011, JAP GOV IAEA MIN C N, P1; OTT LJ, 1989, NUCL ENG DES, V115, P289, DOI 10.1016/0029-5493(89)90054-X; Shirakawa N., 2000, P NTHAS2 2 JAP KOR S; Terada M., 2003, P 10 INT TOP M NUCL; Ujita H, 1999, J NUCL SCI TECHNOL, V36, P1076, DOI 10.3327/jnst.36.1076; Ujita H, 2002, JSME INT J B-FLUID T, V45, P607, DOI 10.1299/jsmeb.45.607	28	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	APR 1	2015	284						176	184		10.1016/j.nucengdes.2014.12.020		9	Nuclear Science & Technology	Nuclear Science & Technology	CE6RW	WOS:000351966800019		
J	Sychov, M; Bakhmetyev, V; Kotomin, A; Dushenok, S; Kozlov, A; Tamamura, H; Nakanishi, Y; Hara, K; Kominami, H; Mimura, H				Sychov, Maxim; Bakhmetyev, Vadim; Kotomin, Alexandr; Dushenok, Sergey; Kozlov, Alexey; Tamamura, Hideo; Nakanishi, Yoichiro; Hara, Kazuhiko; Kominami, Hiroko; Mimura, Hidenori			Effect of shock wave treatment on luminescence of ZnS:Cu,Cl phosphors	OPTICAL MATERIALS			English	Article						Zinc sulfide; Photoluminescence; Electroluminescence; Activator solubility; Shock wave treatment; Phosphor		It is shown that shock wave treatment of ZnS:Cu phosphor between synthesis and annealing steps by placing phosphor powder into preservation ampoule and subjecting to the effect of explosion has positive effect on photo- and electroluminescence brightness due to increase of activator (copper) solubility in phosphor matrix and formation of additional Cls-Cu-zn and Cls-V-zn luminescent centers. (C) 2015 Elsevier B.V. All rights reserved.	[Sychov, Maxim; Bakhmetyev, Vadim; Kotomin, Alexandr; Dushenok, Sergey; Kozlov, Alexey] St Petersburg Inst Technol, St Petersburg 190013, Russia; [Tamamura, Hideo] Showa Denko Co Ltd, Tokyo, Japan; [Nakanishi, Yoichiro; Hara, Kazuhiko; Kominami, Hiroko; Mimura, Hidenori] Shizuoka Univ, Res Inst Elect, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan	Sychov, M (reprint author), St Petersburg Inst Technol, Moskovsky Prospect 26, St Petersburg 190013, Russia.	msychov@yahoo.com			Russian fund for basic research [14-07-00277]; Russian Ministry of Education and Science [14.574.21.0002, RFMEFI57414X0002]	This work was partly supported by Russian fund for basic research, Grant 14-07-00277 and Russian Ministry of Education and Science (Contract 14.574.21.0002, ID RFMEFI57414X0002).	[Anonymous], 2007, Patent application, Patent No. [WO/2007/043676, 2007043676]; [Anonymous], 2010, Patent application, Patent No. [JP 2010-104681, 201010681]; [Anonymous], 2007, Patent application, Patent No. [JP 2007-224174A, 2007224174]; [Anonymous], 2007, Patent application, Patent No. [US 2007/080631A1, 2007080631]; [Anonymous], 2007, Patent application, Patent No. [US 2007/080327A1, 2007080327]; Bakhmet'ev V.V., 2012, INORG MATER, V9, P884; Bakhmet'ev V.V., 2012, RUSS J APPL CHEM, V6, P843; Bhatti HS, 2000, INDIAN J ENG MATER S, V7, P461; Kennedy G. B., 2008, 9 INT S EXPL PROD NE; Kominami H, 2013, OPT MATER, V35, P1109, DOI 10.1016/j.optmat.2012.12.025; Mjakin SV, 2009, CONDENS MATTER RES T, P1; Shionoya S., 2006, PHOSPHOR HDB; Sychov M.M., 2012, SEMICONDUCTORS, V5, P696	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	APR	2015	42						174	177		10.1016/j.optmat.2015.01.005		4	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CE4KU	WOS:000351800300028		
J	Masai, H; Hino, Y; Yanagida, T; Fujimoto, Y				Masai, Hirokazu; Hino, Yusuke; Yanagida, Takayuki; Fujimoto, Yutaka			Photoluminescence and radioluminescence properties of MnO-doped SnO-ZnO-P2O5 glasses	OPTICAL MATERIALS			English	Article						Photoluminescence; Radioluminescence; Glass; Sn2+; Mn2+	WHITE-LIGHT EMISSION; ENERGY-TRANSFER; PHOSPHATE-GLASS; SN2+	In this study, the photoluminescence and radioluminescence properties of MnO-doped SnO-ZnO-P2O5 glasses are examined. We have confirmed that linear dose-dependence and radioluminescence emission decay depend on Mn2+ concentration. Energy transfer from donor Sn2+ center to acceptor Mn2+ center is observed in both photoluminescence and radioluminescence processes, and the energy transfer efficiency is more than 90% when the Mn2+/Sn2+ ratio is 5. Since emission intensity of Mn2+ is higher than that of Sn2+ in radioluminescence compared to photoluminescence, it is suggested that energy transfer from the host matrix to Mn2+ center by X-ray occurred preferentially over energy transfer to Sn2+ center. The present results suggest that the conventional parity rule for photoluminescence is not always adaptable for radioluminescence, although emission-related energy levels are the same for both the processes. (C) 2015 Elsevier B.V. All rights reserved.	[Masai, Hirokazu; Hino, Yusuke] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Yanagida, Takayuki; Fujimoto, Yutaka] Kyushu Inst Technol, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan	Masai, H (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	masai_h@scl.kyoto-u.ac.jp	Yanagida, Takayuki/F-1814-2014	Yanagida, Takayuki/0000-0002-4298-5886	JSPS KAKENHI [26709048]; Collaborative Research Program of I.C.R., Kyoto University [2014-31]; SPRITS Program of Kyoto University	This work was partially supported by the JSPS KAKENHI Grant-in-Aid for Young Scientists (A) Number 26709048, Collaborative Research Program of I.C.R., Kyoto University (Grant #2014-31), and the SPRITS Program of Kyoto University.	ACEVES R, 1995, J LUMIN, V65, P113, DOI 10.1016/0022-2313(95)00069-3; Seitz F, 1938, J CHEM PHYS, V6, P150, DOI 10.1063/1.1750216; Masai H, 2012, J NON-CRYST SOLIDS, V358, P265, DOI 10.1016/j.jnoncrysol.2011.09.025; REISFELD R, 1979, J SOLID STATE CHEM, V28, P391, DOI 10.1016/0022-4596(79)90090-2; MINISCALCO WJ, 1991, J LIGHTWAVE TECHNOL, V9, P234, DOI 10.1109/50.65882; Yanagida T, 2013, OPT MATER, V35, P1987, DOI 10.1016/j.optmat.2012.11.002; Yanagida T, 2013, OPT MATER, V35, P2480, DOI 10.1016/j.optmat.2013.07.002; Kawano M, 2009, OPT MATER, V32, P277, DOI 10.1016/j.optmat.2009.08.001; Masai H, 2011, OPT LETT, V36, P2868, DOI 10.1364/OL.36.002868; Masai H, 2011, J CERAM SOC JPN, V119, P726, DOI 10.2109/jcersj2.119.726; Yanagida T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.062401; TANABE Y, 1954, J PHYS SOC JPN, V9, P753, DOI 10.1143/JPSJ.9.753; LAYNE CB, 1977, PHYS REV B, V16, P10, DOI 10.1103/PhysRevB.16.10; Masai H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766340; Masai H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.082102; Masai H, 2014, J MATER CHEM C, V2, P2137, DOI 10.1039/c3tc32259a; Machado IEC, 2004, J NON-CRYST SOLIDS, V348, P113, DOI 10.1016/j.jnoncrysol.2004.08.135; Masai H, 2012, OPT EXPRESS, V20, P27319, DOI 10.1364/OE.20.027319; WACHTEL A, 1966, J ELECTROCHEM SOC, V113, P128, DOI 10.1149/1.2423884; CLAPP RH, 1947, J OPT SOC AM, V37, P355, DOI 10.1364/JOSA.37.000355; Yanagida T, 2013, RADIAT MEAS, V55, P99, DOI 10.1016/j.radmeas.2012.05.014; Kano T., 2007, PHOSPHOR HDB, P191; Masai H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03541; Masai H., OPT MAT EXP IN PRESS; Masai H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819102; Masai H, 2014, B CHEM SOC JPN, V87, P556, DOI 10.1246/bcsj.20130281; Mendez A, 1998, J LUMIN, V79, P269, DOI 10.1016/S0022-2313(98)00040-4; MufiozF A., 1988, PHYS REV B, V38, P9980; SKUJA L, 1992, J NON-CRYST SOLIDS, V149, P77, DOI 10.1016/0022-3093(92)90056-P; Tamatani M., 2007, PHOSPHOR HDB, P183; Tanimizu S, 2007, PHOSPHOR HDB, P155; van Eijk CWE, 2012, IEEE T NUCL SCI, V59, P2242, DOI 10.1109/TNS.2012.2186154; Yanagida T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FK02	33	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	APR	2015	42						381	384		10.1016/j.optmat.2015.01.031		4	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CE4KU	WOS:000351800300064		
J	Segawa, H; Hirosaki, N; Ohki, S; Deguchi, K; Shimizu, T				Segawa, Hiroyo; Hirosaki, Naoto; Ohki, Shinobu; Deguchi, Kenzo; Shimizu, Tadashi			Exploration of metaphosphate glasses dispersed with Eu-doped SiAlON for white LED applications	OPTICAL MATERIALS			English	Article						Metaphosphate glass; SiAlON; White LED; Photoluminescence	PHOSPHATE-GLASSES	Ca-alpha-SiAlON:Eu2+ oxynitride phosphors are typical luminescent materials with a high thermal tolerance. A series of metaphosphate glass samples (50MO-50P(2)O(5); mol%, M = Zn, Ca, and Ba) were prepared in order to investigate their ability to disperse Ca-alpha-SiAlON:Eu2+ phosphor powders. The glass structures of all of the samples were formed using Q(2) species and composed in long chain networks by investigation of the NMR and Raman spectra. In the glass samples, SiAlON was dispersed until reaching 5 or 6 mass%. The color due to irradiation by a blue LED (wavelength of 450 nm) depended on the glass composition, concentration of SiAlON, and thickness of the composite. Regarding the glass formation and quantum efficiency, the BaP glass with between 3 and 4 mass% SiAlON composite was determined to be the most suitable for use as a host material for white LEDs. (C) 2015 Elsevier B.V. All rights reserved.	[Segawa, Hiroyo; Hirosaki, Naoto; Ohki, Shinobu; Deguchi, Kenzo; Shimizu, Tadashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Segawa, H (reprint author), Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	SEGAWA.Hiroyo@nims.go.jp					Hirosaki N, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1935027; Uheda K, 2000, J LUMIN, V87-9, P967, DOI 10.1016/S0022-2313(99)00494-9; Segawa H, 2013, OPT MATER, V35, P2677, DOI 10.1016/j.optmat.2013.08.006; Morena R, 2000, J NON-CRYST SOLIDS, V263, P382, DOI 10.1016/S0022-3093(99)00678-X; Xie RJ, 2004, APPL PHYS LETT, V84, P5404, DOI 10.1063/1.1767596; Segawa H, 2010, OPT MATER, V33, P170, DOI 10.1016/j.optmat.2010.10.004; Sakuma K, 2004, OPT LETT, V29, P2001, DOI 10.1364/OL.29.002001; Mahmoud KH, 2013, J NON-CRYST SOLIDS, V363, P116, DOI 10.1016/j.jnoncrysol.2012.12.004; BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8; Boyarina I. L., 1982, OGNEUPORY, V4, P44; Chen P., 2001, GLASS PHYS CHEM+, V37, P29; Mao ZY, 2012, J MATER CHEM, V22, P19839, DOI 10.1039/c2jm33581f; Mao ZY, 2012, J MATER CHEM, V22, P824, DOI 10.1039/c1jm15084g; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Veasey DL, 1999, APPL PHYS LETT, V74, P789, DOI 10.1063/1.123368	15	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	APR	2015	42						399	405		10.1016/j.optmat.2015.01.036		7	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CE4KU	WOS:000351800300068		
J	Kataoka, H; Omagari, S; Nakanishi, T; Hasegawa, Y				Kataoka, Hisataka; Omagari, Shun; Nakanishi, Takayuki; Hasegawa, Yasuchika			EVA thin film with thermo- and moisture-stable luminescent copolymer beads composed of Eu(III) complexes for improvement of energy conversion efficiency on silicon solar cell	OPTICAL MATERIALS			English	Article						Lanthanide; Europium; Complex; Copolymer	LANTHANIDE COORDINATION POLYMERS; EMISSION QUANTUM EFFICIENCY; FAST RADIATION RATE; HIGHLY LUMINESCENT; ORGANIC FRAMEWORKS; PHOTOPHYSICAL PROPERTIES; TERNARY COMPLEXES; SOLID-STATE; LIGANDS; EUROPIUM	Luminescent beads composed of Eu(hfa)(3)(TPPO)(2) (hfa: hexafluoroacetylacetonate, TPPO: triphenylphosphine oxide) in PMMA copolymer (polymethylmethacrylate- styrene and polymethylmethacrylate-tri-fluoromethylmethacrylate copolymers), PMMA-St-Eu and PMMA-TF-Eu have been reported for improvement of energy conversion efficiency on silicon solar cell. The PMMA-St-Eu and PMMA-TF-Eu beads are prepared using radical initiator AIBN (2,2-azobisisobutyronitrile) without BPO (Benzoyl peroxide) which promotes decomposition of Eu(hfa)(3)(TPPO)(2). The emission properties of EVA (ethylene vinyl acetate) film with PMMA-St-Eu or PMMA-TF-Eu beads are characterized by the emission spectra and lifetimes. Thermo- and moisture-stabilities of the EVA films are performed under high temperature and high moisture condition (85 degrees C85%RH). Increase percentage the solar cell short circuit current efficiency in the solar cell modulation using with EVA film containing PMMA-St-Eu beads with size in 70 mu m was estimated to 1.2%. Thermo- and moisture-stable PMMA-St-Eu and PMMA-TF-Eu beads for solar sealing film are demonstrated for the first time. (C) 2015 Elsevier B.V. All rights reserved.	[Kataoka, Hisataka; Omagari, Shun; Nakanishi, Takayuki; Hasegawa, Yasuchika] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Hasegawa, Y (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	hasegaway@eng.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24102012, 2401]	This work was party supported by Grants-in-Aid for Scientific Research on Innovative Areas of New Polymeric Materials Based on Element-Blocks (No. 2401) (24102012) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Andres J, 2011, INORG CHEM, V50, P10082, DOI 10.1021/ic200983y; Hasegawa Y, 2003, J PHYS CHEM A, V107, P1697, DOI 10.1021/jp022397u; Nakamura K, 2007, J PHYS CHEM A, V111, P3029, DOI 10.1021/jp067672h; Wartenberg N, 2013, CHEM-EUR J, V19, P3477, DOI 10.1002/chem.201203657; Eliseeva SV, 2011, INORG CHEM, V50, P5137, DOI 10.1021/ic200450x; Carlos LD, 2011, CHEM SOC REV, V40, P536, DOI 10.1039/c0cs00069h; Rodrigues MO, 2012, J PHYS CHEM C, V116, P19951, DOI 10.1021/jp3054789; Bo QB, 2011, INORG CHEM, V50, P10163, DOI 10.1021/ic201124c; Nonat A, 2012, CHEM-EUR J, V18, P8163, DOI 10.1002/chem.201200087; Andolina CM, 2011, EUR J INORG CHEM, P154, DOI 10.1002/ejic.201000779; Li YA, 2012, INORG CHEM, V51, P9629, DOI 10.1021/ic300665a; Andreiadis ES, 2012, DALTON T, V41, P1268, DOI 10.1039/c1dt11627d; Smith DG, 2012, CHEM COMMUN, V48, P8520, DOI 10.1039/c2cc34267g; Miyata K, 2011, CHEM-EUR J, V17, P521, DOI 10.1002/chem.201001993; Lewis DJ, 2011, J AM CHEM SOC, V133, P1033, DOI 10.1021/ja109157g; Kataoka H, 2014, J ALLOY COMPD, V601, P293, DOI 10.1016/j.jallcom.2014.01.165; Eliseeva SV, 2010, CHEM SOC REV, V39, P189, DOI 10.1039/b905604c; Tropiano M, 2011, J AM CHEM SOC, V133, P11847, DOI 10.1021/ja203069s; Smith DG, 2012, CHEM-EUR J, V18, P11604, DOI 10.1002/chem.201201738; Shi M, 2005, INORG CHEM, V44, P8929, DOI 10.1021/ic050844p; Miyata K, 2013, ANGEW CHEM INT EDIT, V52, P6413, DOI 10.1002/anie.201301448; Ablet A, 2013, CHEM-ASIAN J, V8, P95, DOI 10.1002/asia.201200813; Katkova MA, 2010, DALTON T, V39, P6599, DOI 10.1039/c001152e; Lewis DJ, 2012, DALTON T, V41, P13138, DOI 10.1039/c2dt31106b; An JY, 2011, J AM CHEM SOC, V133, P1220, DOI 10.1021/ja109103t; Sykes D, 2011, CHEM COMMUN, V47, P2279, DOI 10.1039/c0cc04562d; Kido J, 2002, CHEM REV, V102, P2357, DOI 10.1021/cr010448y; Hasegawa Y, 1996, J PHYS CHEM-US, V100, P10201, DOI 10.1021/jp960290z; Xu J, 2013, CHEM-EUR J, V19, P4556, DOI 10.1002/chem.201204061; Ramya AR, 2012, INORG CHEM, V51, P8818, DOI 10.1021/ic300654e; Liu HG, 2004, J LUMIN, V110, P11, DOI 10.1016/j.jlumin.2004.04.001; Hua KT, 2012, INORG CHEM, V51, P647, DOI 10.1021/ic202094p; Parker D, 2002, CHEM REV, V102, P1977, DOI 10.1021/cr010452+; de Bettencourt-Dias A, 2012, J AM CHEM SOC, V134, P6987, DOI 10.1021/ja209572m; Bunzli Jean.-Claude G., 2010, CHEM REV, V110, P2729; Burin ME, 2012, ORG ELECTRON, V13, P3203, DOI 10.1016/j.orgel.2012.09.021; Dziczkowski J, 2012, PROG ORG COAT, V73, P308, DOI 10.1016/j.porgcoat.2010.12.006; Edkins RM, 2012, CHEM COMMUN, V48, P9977, DOI 10.1039/c2cc33005a; Hasegwa Y, 2008, J PHYS CHEM A, V112, P803, DOI 10.1021/jp075855d; Hasegawa Y, 1999, CHEM LETT, P35; Katkova M. A., 2010, INORG CHEM, V49, P5049; Kido J., 1994, APPL PHYS LETT, V65, P17; Kishimoto S., 2011, B CHEM SOC JPN, V82, P148; Mohapatra S, 2012, INORG CHEM, V51, P4891, DOI 10.1021/ic300237e; Moudam O, 2009, CHEM COMMUN, P6649, DOI 10.1039/b914978c; Nadella S, 2012, CHEM-EUR J, V18, P16784, DOI 10.1002/chem.201201705; Pushkarev AP, 2014, J MATER CHEM C, V2, P1532, DOI 10.1039/c3tc32054e; Sturzbecher-Hoehne M, 2011, DALTON T, V40, P8340, DOI 10.1039/c1dt10840a; Varlan M, 2012, CHEM COMMUN, V48, P12059, DOI 10.1039/c2cc36172h; Zhang JL, 2012, CHINESE CHEM LETT, V23, P945, DOI 10.1016/j.cclet.2012.06.012	50	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	APR	2015	42						411	416		10.1016/j.optmat.2015.01.038		6	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CE4KU	WOS:000351800300070		
J	Sekiguchi, D; Adachi, S				Sekiguchi, Daisuke; Adachi, Sadao			Synthesis and photoluminescence spectroscopy of BaGeF6:Mn4+ red phosphor	OPTICAL MATERIALS			English	Article						Red phosphor; BaGeF6; K2SiF6; Hexafluorometallate; White-LED	OPTICAL-PROPERTIES; HIGH-PRESSURE; LUMINESCENCE; CRYSTALS; SPECTRA; IONS; TRANSITIONS; FREQUENCIES; FLUORIDES	We synthesized Mn4+-activated BaGeF6 red phosphor by the chemical reaction method from HF, H2SiF6, BaF2, KMnO4, and GeO2 powder. The structural and optical properties of BaGeF6:Mn4+ were investigated using X-ray diffraction analysis, secondary electron microscopy observation, electron spin resonance measurement, photoluminescence (PL), PL excitation (PLE) and Raman scattering spectroscopies, and luminescence decay time measurement. Temperature dependence of the PL intensity was measured from T = 20 to 500 K and analyzed by taking into consideration the Bose-Einstein phonon occupation number. The PLE spectra measured at T = 20 and 300 K and luminescence decay time at T = 20-460 K were also analyzed based on the Franck-Condon and conventional thermal quenching models, respectively. Comprehensive discussion was given on the Me-related PL properties and Raman scattering behaviors in a family of the barium hexafluorometallate phosphors. (C) 2015 Elsevier B.V. All rights reserved.	[Sekiguchi, Daisuke; Adachi, Sadao] Gunma Univ, Fac Sci & Technol, Div Elect & Informat, Kiryu, Gumma 3768515, Japan	Adachi, S (reprint author), Gunma Univ, Fac Sci & Technol, Div Elect & Informat, Kiryu, Gumma 3768515, Japan.	adachi@el.gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26289085, 25630120]	This work was supported by a Grant-in-Aid for Scientific Research (B) (26289085) and a Grant-in-Aid for Exploratory Research (25630120) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors would like to thank T. Miyazaki, T. Nakamura, and H. Oike for their experimental supports and useful discussion.	Aleksandrovsky AS, 2007, PHYS SOLID STATE+, V49, P1695, DOI 10.1134/S1063783407090156; Sekiguchi D, 2013, J APPL PHYS, V113, DOI 10.1063/1.4803880; Arai Y, 2011, J LUMIN, V131, P2652, DOI 10.1016/j.jlumin.2011.06.042; Kasa R, 2012, J ELECTROCHEM SOC, V159, pJ89, DOI 10.1149/2.005204jes; Setlur AA, 2010, CHEM MATER, V22, P4076, DOI 10.1021/cm100960g; Okamoto S, 2010, J ELECTROCHEM SOC, V157, pJ59, DOI 10.1149/1.3276089; Adachi S, 2012, J ELECTROCHEM SOC, V159, pJ34, DOI 10.1149/2.064202jes; Galanciak D, 2005, J PHYS-CONDENS MAT, V17, P7185, DOI 10.1088/0953-8984/17/46/003; Xu YK, 2012, J ELECTROCHEM SOC, V159, pE11, DOI 10.1149/2.026201jes; Arai Y, 2011, J ELECTROCHEM SOC, V158, pJ179, DOI 10.1149/1.3576124; Arai T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.092401; Singh V, 2007, OPT MATER, V30, P468, DOI 10.1016/j.optmat.2007.01.003; Hoshino R, 2013, J APPL PHYS, V114, DOI 10.1063/1.4836896; Arai T, 2011, J APPL PHYS, V110, DOI 10.1063/1.3639298; Takahashi T, 2008, J ELECTROCHEM SOC, V155, pE183, DOI 10.1149/1.2993159; Brik MG, 2013, J LUMIN, V133, P69, DOI 10.1016/j.jlumin.2011.08.047; Jiang XY, 2014, J MATER CHEM C, V2, P2301, DOI 10.1039/c3tc31878h; Zhydachevskii Y, 2006, J PHYS-CONDENS MAT, V18, P11385, DOI 10.1088/0953-8984/18/49/028; Arai T, 2011, J APPL PHYS, V109, DOI 10.1063/1.3592156; BEGUN GM, 1967, INORG CHEM, V6, P2212, DOI 10.1021/ic50058a018; Benkic P., 2001, ALLG CHEM, V627, P1952; BREITINGER D, 1977, J SOLID STATE CHEM, V22, P233, DOI 10.1016/0022-4596(77)90042-1; Brylmar Z., 2004, FERROELECTRICS, V298, P43; CHODOS SL, 1976, J CHEM PHYS, V65, P4816, DOI 10.1063/1.432952; GRIFFITHS JE, 1964, INORG CHEM, V3, P1134, DOI 10.1021/ic50018a014; GRINBERG M, 1993, J LUMIN, V54, P369, DOI 10.1016/0022-2313(93)90005-8; Hoard JL, 1940, J AM CHEM SOC, V62, P3126, DOI 10.1021/ja01868a060; Hoshino R, 2014, ECS J SOLID STATE SC, V3, pR144, DOI 10.1149/2.0031408jss; Jiang XY, 2014, DALTON T, V43, P9414, DOI 10.1039/c4dt00781f; Kaminska A, 2000, PHYS REV B, V62, P10802, DOI 10.1103/PhysRevB.62.10802; Nakamoto K., 2009, INFRARED RAMAN SPECT; Nara J, 2011, J APPL PHYS, V109, DOI 10.1063/1.3576118; Nara J, 2011, J APPL PHYS, V110, DOI 10.1063/1.3664916; Sekiguchi D, 2014, ECS J SOLID STATE SC, V3, pR60, DOI 10.1149/2.025404jss; Tamatani M., 2007, PHOSPHOR HDB, P167; Yen W. M., 2007, INORGANIC PHOSPHORS	36	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	APR	2015	42						417	422		10.1016/j.optmat.2015.01.039		6	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CE4KU	WOS:000351800300071		
J	Lockley, MG; Li, RH; Matsukawa, M; Xing, LD; Li, JJ; Liu, MW; Xu, X				Lockley, Martin G.; Li, Rihui; Matsukawa, Masald; Xing, Lida; Li, Jianjun; Liu, Mingwei; Xu, Xing			Tracking the yellow dragons: Implications of China's largest dinosaur tracksite (Cretaceous of the Zhucheng area, Shandong Province, China)	PALAEOGEOGRAPHY PALAEOCLIMATOLOGY PALAEOECOLOGY			English	Article						Lower Cretaceous; Shandong Province; China; Footprints; Theropods; Sauropods; Turtles	TIANJIALOU-FORMATION; PTEROSAUR TRACKS; BIRD TRACK; ASSEMBLAGE; KOREA	Surfaces with more than 2200 dinosaur footprints from the Huanglonggou (Yellow Dragon Valley) site near Zhucheng, in Shandong Province, were excavated for scientific study and with a view to future development as an educational site suitable for further research and tourism. Although geographically close to spectacular and historically famous Upper Cretaceous sites yielding vast bone assemblages, representing giant hadrosaurs and other dinosaurs from the Wangshi Group, the tracksite is in the Lower Cretaceous Yangjiazhuang Formation (equivalent in part to the Longwangzhuang Formation), represents an entirely different dinosaurian fauna, dominated by small theropods. In contrast to a recent pre-excavation study of a localized outcrop which identified only three theropod track morphotypes, in a sample of 135 tracks, the present study has identified at least 2000 additional tracks including those of sauropods and turtles. It is therefore possible to present a more complete interpretation of the site based on the larger and more diverse track assemblage presently exposed. Three theropod track morphotypes are identified as grallatorid morphotypes A and B, with the latter assigned to Grallator yangi comb. nov., and Corpulentapus lilasia. Tracks have been identified from at least 5 levels, of which level 4 exhibits the vast majority in an excellent state of preservation. Other recent studies, which we re-evaluate, suggest the tracks help define an ENE-WSW shoreline with the lake center to the SSE. In terms of number of tracks documented the Huanglonggou site is one of the largest dinosaur tracksites in China, or indeed in the world. (C) 2015 Elsevier B.V. All rights reserved.	[Lockley, Martin G.] Univ Colorado, Dinosaur Trackers Res Grp, Denver, CO 80217 USA; [Li, Rihui] China Geol Survey, Qingdao Inst Marine Geol, Qingdao 266071, Peoples R China; [Matsukawa, Masald] Tokyo Gakugei Univ, Dept Environm Sci, Koganei, Tokyo 1848501, Japan; [Xing, Lida] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Li, Jianjun] Beijing Museum Nat Hist, Beijing, Peoples R China; [Liu, Mingwei] Shandong Prov 4 Inst Geol & Mineral Resources, Weifang 261021, Peoples R China; [Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	Lockley, MG (reprint author), Univ Colorado, Dinosaur Trackers Res Grp, Denver, CO 80217 USA.	Martin.Lockley@UCDenver.edu		Xing, Lida/0000-0003-3923-9206	National Natural Science Foundation of China [40972005, 40572011]; China Geological Survey [GZH200800501, 1212011220113]; office of the University of Colorado Denver; office of the Dinosaur Tracks Museum; office of the Dinosaur Trackers Research Group	This study was supported financially by National Natural Science Foundation of China (grant nos.: 40972005 and 40572011 to R. Li), and partly supported by China Geological Survey (Nos. GZH200800501, 1212011220113). The study was also supported, in part, by the offices of the University of Colorado Denver, Dinosaur Tracks Museum and Dinosaur Trackers Research Group. All specimens with the prefix CU have were transferred, in 2012, to the University of Colorado Museum of Natural History (UCM) and will in future have the replacement prefix UCM, without change to the numbers. We thank Yanxia Zhang and Kebai Wang of the Zhucheng Municipal Bureau of Tourism, Zhucheng, Shandong for their help with field work. We thank Neffra Matthews, National Operations Center, USDOI-Bureau of Land Management, Federal Center, Denver, Colorado, for help producing the image used in Figure 14C. We thank Richard McCrea of the Peace Region Palaeontological Research Center, British Columbia, and Spencer Lucas, New Mexico Museum of Natural History and Science for their helpful reviews of the first draft of this manuscript.	Alcala L., 1972, DINOSAUR TRACKS NEXT; Xing Li-Da, 2012, Palaeoworld, V21, P50, DOI 10.1016/j.palwor.2012.02.004; Xing LD, 2014, PALAIOS, V29, P137, DOI 10.2110/palo.2014.012; Lockley MG, 2009, GEOL Q, V53, P415; Xing LD, 2013, CRETACEOUS RES, V45, P114, DOI 10.1016/j.cretres.2013.07.009; Lockley MG, 2007, NATURWISSENSCHAFTEN, V94, P657, DOI 10.1007/s00114-007-0239-x; Hunt Adrian P., 2007, Ichnos, V14, P59, DOI 10.1080/10420940601006826; Li RH, 2015, CRETACEOUS RES, V52, P83, DOI 10.1016/j.cretres.2014.08.004; Li RH, 2005, CHINESE SCI BULL, V50, P1149, DOI 10.1360/982004-823; Kim JY, 2012, ICHNOS, V19, P28, DOI 10.1080/10420940.2012.660414; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Hwang KG, 2002, GEOL MAG, V139, P421, DOI 10.1017/S0016756802006647; Lockley MG, 2013, ACTA GEOL SIN-ENGL, V87, P1, DOI 10.1111/1755-6724.12026; [陈军 Chen Jun], 2013, [古地理学报, Journal of Palaeogeography], V15, P505; Ellenberger P., 1972, PALAEOVERTEBRATA MEM; Foster John R., 1997, Ichnos, V5, P121; Hitchcock E., 1858, ICHNOLOGY NEW ENGLAN; [旷红伟 Kuang Hongwei], 2013, [古地理学报, Journal of Palaeogeography], V15, P435; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Li Rihui, 2000, Geological Review (Beijing), V46, P605; Li RH, 2011, CRETACEOUS RES, V32, P422, DOI 10.1016/j.cretres.2010.10.006; Lockley K.G., 2008, CRETACEOUS RES, V29, P115; Lockley K.G., 2010, N M MUS NAT HIST SCI, V51, P99; Lockley M.G., 1989, P3; Lockley M. G., 1995, DINOSAUR TRACKS OTHE; Lockley Martin G., 1994, P241; LOCKLEY MG, 1986, GEOL SOC AM BULL, V97, P1163, DOI 10.1130/0016-7606(1986)97<1163:NALDTS>2.0.CO;2; Lockley M.G, 1991, TRACKING DINOSAURS N; LOCKLEY M.G., 2014, NEW MEXICO MUSEUM NA, V62, P393; Lockley M.G., 2012, 11 MES TERR EC ABSTR, P311; Lockley Martin G., 2012, Journal of Stratigraphy, V36, P503; LOCKLEY M G, 1986, Palaios, V1, P37, DOI 10.2307/3514457; Lockley MG, 1997, J PALEONTOLOGICAL SO, V2, P17; Lockley M.G., 2007, ICHNOS, V14, P39; Locldey M. G., 2012, 11 MES TERR EC AUG 1, P315; Olsen P. E., 1980, FIELD STUDIES NEW JE, P352; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586; [彭楠 Peng Nan], 2013, [古地理学报, Journal of Palaeogeography], V15, P517; Song M., 2003, REGIONAL GEOLOGY SHA; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; Thulborn R.A., 1990, DINOSAUR TRACKS; [王宝红 Wang Baohong], 2013, [古地理学报, Journal of Palaeogeography], V15, P454; [汪明伟 Wang Mingwei], 2013, [古地理学报, Journal of Palaeogeography], V15, P489; Weems R.E., 1992, P 26 FOR GEOL IND MI, V119, P113; Whyte M.A., 2001, UK ICHNOS, V8, P233; [Xing Lida 邢立达], 2010, [地质通报, Geological Bulletin of China], V29, P1105; [许欢 Xu Huan], 2013, [古地理学报, Journal of Palaeogeography], V15, P467; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53	48	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-0182	1872-616X		PALAEOGEOGR PALAEOCL	Paleogeogr. Paleoclimatol. Paleoecol.	APR 1	2015	423						62	79		10.1016/j.palaeo.2015.01.028		18	Geography, Physical; Geosciences, Multidisciplinary; Paleontology	Physical Geography; Geology; Paleontology	CE4KD	WOS:000351798600006		
J	Misumi, Y; Hoashi, T; Kagisaki, K; Yazaki, S; Kitano, M; Kurosaki, K; Shiraishi, I; Ichikawa, H				Misumi, Yusuke; Hoashi, Takaya; Kagisaki, Koji; Yazaki, Satoshi; Kitano, Masataka; Kurosaki, Kenichi; Shiraishi, Isao; Ichikawa, Hajime			The Importance of Hybrid Stage I Palliation for Neonates with Critical Aortic Stenosis and Reduced Left Ventricular Function	PEDIATRIC CARDIOLOGY			English	Article						Critical aortic stenosis; Balloon aortic valvuloplasty; Endocardial fibroelastosis; Hybrid stage I palliation	ROSS PROCEDURE; RISK-FACTORS; VALVOTOMY; OUTCOMES; REINTERVENTION; INTERVENTION; INFANTS; GROWTH	The optimal management strategy for neonates with congenital aortic stenosis, two balanced ventricles, and duct-dependent systemic circulation (critical aortic stenosis) is still controversial. Thirteen patients with critical aortic stenosis underwent balloon aortic valvotomy (BAV) between 1996 and 2013, at the median age of 1 day old (range 0-28). Since 2010, bilateral pulmonary artery banding with ductal stenting following BAV was conducted for patients with reduced left ventricular (LV) function as a hybrid stage I palliation for the bridge to decision for further treatment. A follow-up was completed on all patients and the median follow-up period was 3.3 years (max 16.0). The overall survival rate at 15 years was 67.1 %. Six of the seven patients with maintained LV function could go on to the definitive Ross or Konno-aortic valve replacement at the median duration of 311 days after initial BAV, without any mortality. Three of four patients with reduced LV function died before 2010 with conventional treatment. With use of a hybrid stage I palliation, one of two patients ultimately underwent Fontan completion at 38 months of age and the other successfully underwent the definitive Ross-Konno operation at 9 months of age after recovery of the LV function. Although a statistically significant improvement has not been observed yet, the application of hybrid stage I palliation following BAV would be a favorable alternative for patients with reduced LV function to avoid a high-risk neonatal Ross or Norwood-type operation, and also to determine further treatment carefully.	[Misumi, Yusuke; Hoashi, Takaya; Kagisaki, Koji; Ichikawa, Hajime] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka 5650873, Japan; [Yazaki, Satoshi; Kitano, Masataka; Kurosaki, Kenichi; Shiraishi, Isao] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5650873, Japan	Hoashi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, 5-7-1 Fujishiro dai, Suita, Osaka 5650873, Japan.	thoashi@surg1.med.osaka-u.ac.jp					McElhinney DB, 2005, CIRCULATION, V111, P451, DOI 10.1161/01.CIR.0000153809.88286.2E; Han RK, 2007, J AM COLL CARDIOL, V50, P2406, DOI 10.1016/j.jacc.2007.07.082; Lofland GK, 2001, J THORAC CARDIOV SUR, V121, P10, DOI 10.1067/mtc.2001.111207; Hammel JM, 2013, EUR J CARDIO-THORAC, V43, P143, DOI 10.1093/ejcts/ezs197; Shinkawa T, 2010, ANN THORAC SURG, V89, P1827, DOI 10.1016/j.athoracsur.2010.02.107; Corno AF, 2005, EUR J CARDIO-THORAC, V27, P67, DOI 10.1016/j.ejcts.2004.10.034; Hraska V, 2012, ANN THORAC SURG, V94, P1519, DOI 10.1016/j.athoracsur.2012.03.056; Kadner A, 2008, ANN THORAC SURG, V85, P803, DOI 10.1016/j.athoracsur.2007.07.047; Reich O, 2004, HEART, V90, P70, DOI 10.1136/heart.90.1.70; ZEEVI B, 1989, CIRCULATION, V80, P831; Hickey EJ, 2012, J THORAC CARDIOV SUR, V144, P409, DOI 10.1016/j.jtcvs.2011.09.076; Borghi A, 1999, Heart, V82, pe10; Brown JW, 2006, ANN THORAC SURG, V81, P236, DOI 10.1016/j.athoracsur.2005.06.075; Brown SC, 2009, EUR J CARDIO-THORAC, V35, P1080, DOI 10.1016/j.ejcts.2009.02.012; McCrindle BW, 2001, CIRCULATION, V104, pI152; Miyamoto T, 2006, EUR J CARDIO-THORAC, V30, P35, DOI 10.1016/j.ejcts.2006.03.050; Pass RH, 2002, CATHETER CARDIO INTE, V55, P88, DOI 10.1002/ccd.10085	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	APR	2015	36	4					726	731		10.1007/s00246-014-1074-4		6	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CE1EA	WOS:000351553700004		
J	Kitagawa, A; Oka, N; Kimura, S; Ando, H; Honda, T; Takanashi, M; Mineo, E; Miyaji, K; Ishii, M				Kitagawa, Atsushi; Oka, Norihiko; Kimura, Sumito; Ando, Hisashi; Honda, Takashi; Takanashi, Manabu; Mineo, Eri; Miyaji, Kagami; Ishii, Masahiro			Clinical Utility of the Plasma Brain Natriuretic Peptide Level in Monitoring Tetralogy of Fallot Patients over the Long Term After Initial Intracardiac Repair: Considerations for Pulmonary Valve Replacement	PEDIATRIC CARDIOLOGY			English	Article						Tetralogy of Fallot; Pulmonary valve regurgitation; Pulmonary valve replacement; Brain natriuretic peptide	CARDIOVASCULAR MAGNETIC-RESONANCE; SUDDEN-DEATH; SURGICAL REPAIR; QRS DURATION; MULTICENTER; REGURGITATION; DYSFUNCTION; DISEASE; SURGERY; ADULTS	Clinicians are currently encountering an increasing number of patients in the long-term period after tetralogy of Fallot (TOF) repair presenting with pulmonary valve regurgitation (PR) or right ventricular (RV) dysfunction. The purpose of this study was to evaluate the clinical utility of the plasma brain natriuretic peptide (BNP) level and consider surgical indications and timing of pulmonary valve replacement (PVR). We examined 33 patients (21 males, 12 females, mean age 14.5 +/- A 2.8 years) who underwent TOF repair at Kitasato University Hospital. All patients were evaluated using echocardiography and blood sampling. The mean age at the time of initial repair was 1.3 +/- A 0.7 years. The patients with moderate-severe PR exhibited significantly higher plasma BNP levels than the patients with trivial-mild PR (mean 37.5 +/- A 33.1 vs. 17.3 +/- A 6.6 pg/ml, p = 0.013). The mean plasma BNP level with cardiac symptoms was higher than that observed in the patients without any symptoms (71.4 +/- A 46.1 vs. 25.0 +/- A 14.0 pg/ml, p = 0.005). The mean BNP level was significantly decreased after PVR (71.3 +/- A 46.1-26.1 +/- A 13.2 pg/ml, p = 0.009), and the plasma BNP level was found to be positively correlated with the RV end-diastolic pressure (r = 0.851; p = 0.008). The optimal BNP cut-off value for considering PVR was 32.15 pg/ml (sensitivity, 85.7 %; specificity, 83.3 %). The plasma BNP level may become a useful diagnostic tool for considering the indications and optimal timing of PVR over the long term after TOF repair.	[Kitagawa, Atsushi; Kimura, Sumito; Ando, Hisashi; Honda, Takashi; Takanashi, Manabu; Mineo, Eri; Ishii, Masahiro] Kitasato Univ, Sch Med, Dept Pediat, Sagamihara, Kanagawa 2520374, Japan; [Oka, Norihiko; Miyaji, Kagami] Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Oka, N (reprint author), Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	norihiko@rr.iij4u.or.jp					Abd El Rahman MY, 2000, HEART, V84, P416; GATZOULIS MA, 1995, CIRCULATION, V92, P231; Khairy P, 2004, CIRCULATION, V109, P1994, DOI 10.1161/01.CIR.0000126495.11040.BD; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; Yeo KTJ, 2003, CLIN CHIM ACTA, V338, P107, DOI 10.1016/j.cccn.2003.08.016; Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664; MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901; LILLEHEI CW, 1955, ANN SURG, V142, P418, DOI 10.1097/00000658-195509000-00010; Kucher N, 2003, CIRCULATION, V108, P2191, DOI 10.1161/01.CIR.0000100687.99687.CE; Doughan AR, 2005, AM J CARDIOL, V95, P1511, DOI 10.1016/j.amjcard.2005.01.100; Eindhoven JA, 2012, J AM COLL CARDIOL, V60, P2140, DOI 10.1016/j.jacc.2012.02.092; Henkens IR, 2007, ANN THORAC SURG, V83, P907, DOI 10.1016/j.athoracsur.2006.09.090; Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825; Tang WHW, 2007, CIRCULATION, V116, pE99, DOI 10.1161/CIRCULATIONAHA.107.185267; Gengsakul A, 2007, EUR J CARDIO-THORAC, V32, P462, DOI 10.1016/j.ejcts.2007.06.009; Li W, 2004, AM HEART J, V147, P165, DOI 10.1016/S0002-8703(03)00527-1; Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8; Geva T, 2010, CIRCULATION, V122, pS201, DOI 10.1161/CIRCULATIONAHA.110.951178; Norozi K, 2005, CHEST, V128, P2563, DOI 10.1378/chest.128.4.2563; BRICKER JT, 1995, CIRCULATION, V92, P158; Mir TS, 2005, CARDIOL YOUNG, V15, P396, DOI 10.1017/S1047951105000831; Ooi A, 2006, EUR J CARDIO-THORAC, V30, P917, DOI 10.1016/j.ejcts.2006.08.022; QUATTLEBAUM TG, 1976, CIRCULATION, V54, P289; Saul JP, 1999, J CARDIOVASC ELECTR, V10, P1271, DOI 10.1111/j.1540-8167.1999.tb00305.x	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	APR	2015	36	4					752	758		10.1007/s00246-014-1075-3		7	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CE1EA	WOS:000351553700008		
J	Zheng, Q; Wu, H; Yu, Q; Kim, DH; Lipton, JH; Angelini, S; Soverini, S; Vivona, D; Takahashi, N; Cao, J				Zheng, Q.; Wu, H.; Yu, Q.; Kim, D. H. (Dennis); Lipton, J. H.; Angelini, S.; Soverini, S.; Vivona, D.; Takahashi, N.; Cao, J.			ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis	PHARMACOGENOMICS JOURNAL			English	Article							MAJOR MOLECULAR RESPONSE; GENE MDR1 POLYMORPHISMS; CHRONIC-PHASE; TRANSPORTER POLYMORPHISMS; KINASE INHIBITORS; CLINICAL-RESPONSE; DOSE IMATINIB; RESISTANCE; THERAPY; ASSOCIATION	Imatinib mesylate, a competitive tyrosine kinase inhibitor, is considered the first-line therapy drug for Ph+ chronic myeloid leukemia (CML). Three single-nucleotide polymorphisms (SNPs) in the ATP-binding cassette, subfamily B (MDR/TAP), member 1 gene (ABCB1/MDR1), c.1236C>T, c.2677G>T/A and c.3435C>T, have been shown to affect cellular transport/metabolism of imatinib. The associations between these SNPs and imatinib response in CML patients have been widely evaluated, but the results were inconsistent. To derive a conclusive assessment of the associations, we performed a meta-analysis by combining data from a total of 12 reports including 1826 patients. The results showed that the 2677G allele or 3435T allele predicted a worse response to imatinib in CML patients, whereas 1236CC genotype was associated with better response in CML patients from Asian region. In conclusion, this meta-analysis suggests that c.1236C>T, c.2677G>T/A and c.3435C>T can be served as predictive markers for the therapeutical use of imatinib in CML patients.	[Zheng, Q.; Cao, J.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou 310009, Zhejiang, Peoples R China; [Wu, H.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Q.] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Kim, D. H. (Dennis); Lipton, J. H.] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Chron Myelogenous Leukemia Grp, Toronto, ON, Canada; [Angelini, S.] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Soverini, S.] Univ Bologna, Inst Hematol, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Vivona, D.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Takahashi, N.] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan	Cao, J (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Res Ctr, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	caoj@zju.edu.cn		Angelini, Sabrina/0000-0002-1609-0421; SOVERINI, SIMONA/0000-0002-4508-0353	FAPESP, Brazil [09/54184-0]	We would like to thank Dr Francisco Cervantes from Hematology Department, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain for providing us their raw genotype data. Part of the work was supported by grant FAPESP, Brazil (#09/54184-0) to Dr Douglas Vivona.	Hegedus T, 2002, BBA-MOL BASIS DIS, V1587, P318, DOI 10.1016/S0925-4439(02)00095-9; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Deenik W, 2010, BLOOD, V116, P6144, DOI 10.1182/blood-2010-07-296954; Etienne G, 2014, HAEMATOLOGICA, V99, P458, DOI 10.3324/haematol.2013.095158; Petain A, 2008, CLIN CANCER RES, V14, P7102, DOI 10.1158/1078-0432.CCR-08-0950; Gardner ER, 2006, CLIN PHARMACOL THER, V80, P192, DOI 10.1016/j.clpt.2006.05.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cortes JE, 2009, LEUKEMIA, V23, P1537, DOI 10.1038/leu.2009.88; Seong SJ, 2013, ANN ONCOL, V24, P756, DOI 10.1093/annonc/mds532; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kim DH, 2010, CLIN CANCER RES, V16, P5339, DOI 10.1158/1078-0432.CCR-10-1638; Vivona D, 2012, BLOOD CELL MOL DIS, V48, P132, DOI 10.1016/j.bcmd.2011.11.001; Rosti G, 2012, CRIT REV ONCOL HEMAT, V82, P159, DOI 10.1016/j.critrevonc.2011.04.002; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Kim DH, 2009, CLIN CANCER RES, V15, P4750, DOI 10.1158/1078-0432.CCR-09-0145; Ni LN, 2011, MED ONCOL, V28, P265, DOI 10.1007/s12032-010-9456-9; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Zu BL, 2014, PHARMACOGENOMICS, V15, P667, DOI 10.2217/pgs.13.222; Egger M, 1997, BRIT MED J, V315, P629; Takahashi N, 2010, J HUM GENET, V55, P731, DOI 10.1038/jhg.2010.98; Gurney H, 2007, CLIN PHARMACOL THER, V82, P33, DOI 10.1038/sj.clpt.6100201; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Assef Y, 2009, LEUKEMIA RES, V33, P710, DOI 10.1016/j.leukres.2008.09.024; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Vivona D, 2014, ONCOL LETT, V7, P1313, DOI 10.3892/ol.2014.1857; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Angelini S, 2013, HAEMATOLOGICA, V98, P193, DOI 10.3324/haematol.2012.066480; Milojkovic D, 2009, CLIN CANCER RES, V15, P7519, DOI 10.1158/1078-0432.CCR-09-1068; Yamakawa Y, 2011, THER DRUG MONIT, V33, P244, DOI 10.1097/FTD.0b013e31820beb02; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Maffioli M, 2011, LEUKEMIA RES, V35, P1014, DOI 10.1016/j.leukres.2010.12.004; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Bhamidipati Pavan Kumar, 2013, Ther Adv Hematol, V4, P103, DOI 10.1177/2040620712468289; Chen Wei-wei, 2012, Zhonghua Yi Xue Za Zhi, V92, P1405; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diamond JM, 2011, LEUKEMIA LYMPHOMA, V52, P12, DOI 10.3109/10428194.2010.546920; Dulucq S, 2010, BLOOD, V116, P6145, DOI 10.1182/blood-2010-08-298794; Eadie LN, 2014, CLIN PHARMACOL THER, V95, P294, DOI 10.1038/clpt.2013.208; Elghannam DM, 2013, HEMATOL AMSTERDAM NE, V19, P123; Lu PH, 2011, BREAST CANCER RES TR, V126, P663, DOI 10.1007/s10549-010-1151-1; Widmer N, 2003, BLOOD, V102, P1142, DOI 10.1182/blood-2003-03-0993	47	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1470-269X	1473-1150		PHARMACOGENOMICS J	Pharmacogenomics J.	APR	2015	15	2					127	134		10.1038/tpj.2014.54		8	Genetics & Heredity; Pharmacology & Pharmacy	Genetics & Heredity; Pharmacology & Pharmacy	CE4DE	WOS:000351780200003		
J	Dominoni, DM; Van't Hof, TJ; Partecke, J				Dominoni, Davide M.; Van't Hof, Thomas J.; Partecke, Jesko			Social cues are unlikely to be the single cause for early reproduction in urban European blackbirds (Turdus merula)	PHYSIOLOGY & BEHAVIOR			English	Article						Light at night; Light pollution; Social cues; Social stimuli; Urbanization; Timing of reproduction	WHITE-CROWNED SPARROWS; BREEDING BIRDS; URBANIZATION; ENDOCRINOLOGY; PRODUCTIVITY; TEMPERATURE; SONGBIRDS; IMPACT; FIELD; LIFE	Despite urban ecology being an established field of research, there is still surprisingly little information about the relative contribution of specific environmental factors driving the observed changes in the behavior and physiology of city dwellers. One of the most reported effects of urbanization is the advanced phenology observed in birds. Many factors have been suggested to underline such effect, including warmer microclimate, anthropogenic food supply and light pollution. Since social stimuli are known to affect reproductive timing and breeding density is usually higher in urban populations compared to rural ones, we experimentally tested whether social interactions could advance the onset of reproduction in European blackbirds (Turdus merula). We housed male blackbirds of rural and urban origins with or without a conspecific female, and recorded their seasonal variation in gonadal size and production of luteinizing hormone (LH). Paired and unpaired males of both urban and rural origins did not significantly differ in their timing of gonadal growth. Moreover, rural and urban birds did not differ in their response to the social stimuli, rather they became reproductively active at the same time, a result that confirms previous studies that attributed the difference in reproductive timing observed in the field to phenotypic plasticity. We conclude that social stimuli do not contribute substantially to the observed early onset of reproductive physiology in urban bird species, rather other factors such as light pollution are likely to be stronger drivers of these physiological changes. (C) 2015 Elsevier Inc. All rights reserved.	[Dominoni, Davide M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Van't Hof, Thomas J.] Takizaki Corp, Bunkyo Ku, Tokyo 1130021, Japan; [Dominoni, Davide M.; Partecke, Jesko] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Dominoni, Davide M.; Partecke, Jesko] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Dominoni, DM (reprint author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.	davide.dominoni@glasgow.ac.uk			Max Planck Society; Volkswagen Foundation [I/84 389 (alt I/82 745)]; International Max Planck Research School for Organismal Biology	J.P. was funded by the Max Planck Society and by a grant ('Initiative Evolutionary Biology', grant number I/84 389 (alt I/82 745)) of the Volkswagen Foundation. T.V.H. was funded by the Max Planck Society. D.D was funded by the International Max Planck Research School for Organismal Biology.	Schaper SV, 2012, GEN COMP ENDOCR, V179, P53, DOI 10.1016/j.ygcen.2012.07.021; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; Waas JR, 2005, P ROY SOC B-BIOL SCI, V272, P383, DOI 10.1098/rspb.2004.2949; Wingfield JC, 1996, GEN COMP ENDOCR, V101, P242, DOI 10.1006/gcen.1996.0027; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Helm B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0016; Caro SP, 2007, BEHAV PROCESS, V75, P1, DOI 10.1016/j.beproc.2007.02.011; Schoech SJ, 2009, INTEGR COMP BIOL, V49, P480, DOI 10.1093/icb/icp005; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Schoech SJ, 2003, AUK, V120, P1114, DOI 10.1642/0004-8038(2003)120[1114:DDATPI]2.0.CO;2; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Dominoni D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3017; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Daan S, 1996, J ANIM ECOL, V65, P539, DOI 10.2307/5734; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Partecke J, 2005, J AVIAN BIOL, V36, P295, DOI 10.1111/j.0908-8857.2005.03344.x; Mueller JC, 2013, MOL ECOL, V22, P3629, DOI 10.1111/mec.12288; Partecke J, 2004, P ROY SOC B-BIOL SCI, V271, P1995, DOI 10.1098/rspb.2004.2821; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Tramontin AD, 1999, J NEUROSCI, V19, P476; BALL GF, 1993, AM ZOOL, V33, P185; Bates Douglas, 2007, LME4 LINEAR MIXED EF; Caro SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001517; Daan S., 1989, P INT ORNITHOL C, V19, P392; Deviche P., 2013, AVIAN URBAN ECOLOGY, P98; Dominoni DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085069; Dominoni DM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-60; DUFTY AM, 1986, HORM BEHAV, V20, P222, DOI 10.1016/0018-506X(86)90020-6; Ellison P, 2001, FERTILE GROUND NATUR; Farner D. S., 1975, AVIAN BIOL, V5; Fitter A. H., 1987, ENV PHYSL PLANTS; Foster RG, 2009, SEASONS OF LIFE: THE BIOLOGICAL RHYTHMS THAT ENABLE LIVING THINGS TO THRIVE AND SURVIVE, P1; GWINNER E, 1975, Zeitschrift fuer Tierpsychologie, V38, P34; Gwinner E, 1986, CIRCANNUAL RHYTHMS; MOORE MC, 1982, HORM BEHAV, V16, P323, DOI 10.1016/0018-506X(82)90030-7; Partecke J, 2006, J ORNITHOL, V147, P549, DOI 10.1007/s10336-006-0078-0; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Stephan B., 1985, AMSEL TURDUS MERULA, P95; WILSON FE, 1978, GEN COMP ENDOCR, V34, P251, DOI 10.1016/0016-6480(78)90218-6; WINGFIELD JC, 1976, CONDOR, V78, P570, DOI 10.2307/1367117	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	APR 1	2015	142						14	19		10.1016/j.physbeh.2015.01.026		6	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CE7TF	WOS:000352044000003		
J	Matsuo, K; Palmer, JB				Matsuo, Koichiro; Palmer, Jeffrey B.			Coordination of oro-pharyngeal food transport during chewing and respiratory phase	PHYSIOLOGY & BEHAVIOR			English	Article						Deglutition; Fluoroscopy; Breathing; Eating; Oral food propulsion; Mastication	SOFT PALATE; MASTICATION; TONGUE; MOVEMENT; PATTERN	When eating solid food, the tongue intermittently propels triturated food to the oropharynx or valleculae, where a bolus accumulates before swallowing. The tongue motion during this food transport (stage II transport, Sill) is distinctly different from that during chewing, and is more similar to the oral propulsive stage of swallowing. Therefore, we tested the hypothesis that the onset of STII cycles was more likely to occur during expiration than inspiration. Videofluorography was recorded in a lateral projection while 10 healthy subjects ate solid foods. Respiration was concurrently monitored with plethysmography. Jaw motion cycles were classified as masticatory or swallowing. Masticatory cycles were further divided into chewing cycles and STII cycles. Sill cycles were defined as those with bolus propulsion through the fauces by the tongue squeezing against the palate (without swallowing). Overall, 28% (62/223) of chewing cycles were initiated during inspiration, compared with only 12% (9/76) of STII cycles in this phase. The fraction of masticatory cycles occurring during inspiration was significantly smaller for STII cycles than for chewing cycles (Odds Ratio: 0.37 [95% CI: 0.17-.0.78], p = 0.01). All 36 swallowing cycles had onset during expiration. Our findings reveal that stage II oro-pharyngeal food transport is linked to expiration, as is the oral propulsive stage of swallowing. This suggests a similarity in the neural control of these two feeding behaviors. (C) 2015 Elsevier Inc. All rights reserved.	[Matsuo, Koichiro; Palmer, Jeffrey B.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD 21287 USA; [Matsuo, Koichiro] Fujita Hlth Univ, Dept Dent, Toyoake, Aichi 4701192, Japan; [Palmer, Jeffrey B.] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Palmer, Jeffrey B.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD 21287 USA	Matsuo, K (reprint author), 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	kmatsuo@fujita-hu.ac.jp			USPHS from the National Institute on Deafness and other Communication Disorders [R01 DC 02123]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [21792163, 26463200]	The late Dr. Karen Hiiemae contributed immeasurably to the planning and design of this study. Chune Yang provided superb technical assistance. This research was supported by USPHS Award R01 DC 02123 from the National Institute on Deafness and other Communication Disorders and a Grant-in-Aid for Scientific Research (21792163, 26463200) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ertekin C, 2003, CLIN NEUROPHYSIOL, V114, P2226, DOI 10.1016/S1388-2457(03)00237-2; NISHINO T, 1991, J APPL PHYSIOL, V70, P988; SMITH J, 1989, CHEST, V96, P578, DOI 10.1378/chest.96.3.578; Charbonneau I, 2005, J SPEECH LANG HEAR R, V48, P34, DOI 10.1044/1092-4388(2005/004); Dua KS, 1997, GASTROENTEROLOGY, V112, P73, DOI 10.1016/S0016-5085(97)70221-X; SELLEY WG, 1989, AGE AGEING, V18, P168, DOI 10.1093/ageing/18.3.168; Martin-Harris B, 2003, J APPL PHYSIOL, V94, P1735, DOI 10.1152/japplphysiol.00806.2002; Yamada Y, 2005, RESP PHYSIOL NEUROBI, V147, P177, DOI 10.1016/j.resp.2005.02.017; Klahn MS, 1999, DYSPHAGIA, V14, P131, DOI 10.1007/PL00009594; Matsuo K, 2005, J DENT RES, V84, P39; Bailey EF, 2004, J APPL PHYSIOL, V96, P440, DOI 10.1152/japplphysiol.00733.2003; Bellingham MC, 1998, CLIN EXP PHARMACOL P, V25, P847, DOI 10.1111/j.1440-1681.1998.tb02166.x; Martin-Harris B., 2006, COORDINATION RESP SW; Matsuo K, 2010, J DENT RES, V89, P1401, DOI 10.1177/0022034510377336; Matsuo K, 2008, J APPL PHYSIOL, V104, P674, DOI 10.1152/japplphysiol.00527.2007; MCFARLAND DH, 1995, J NEUROPHYSIOL, V74, P1509; Mioche L, 2002, ARCH ORAL BIOL, V47, P267, DOI 10.1016/S0003-9969(02)00007-9; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469; Sawczuk A, 2001, CRIT REV ORAL BIOL M, V12, P18; Taniguchi H, 2013, DYSPHAGIA, V28, P419, DOI 10.1007/s00455-013-9453-1; Tsuiki S, 2000, EUR RESPIR J, V15, P906, DOI 10.1034/j.1399-3003.2000.15e16.x	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	APR 1	2015	142						52	56		10.1016/j.physbeh.2015.01.035		5	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CE7TF	WOS:000352044000009		
J	Fukuoka, H				Fukuoka, Hidenori			New potential targets for treatment of Cushing's disease: epithelial growth factor receptor and cyclin-dependent kinases	PITUITARY			English	Article						Cushing's disease; EGFR; TKI; Cyclin E; Targeted therapy	PITUITARY TUMORIGENESIS; ERBB RECEPTORS; CANCER; INHIBITORS; P27(KIP1); TUMORS; CABERGOLINE; PASIREOTIDE; EXPRESSION; MANAGEMENT	Background Cushing's disease (CD) is caused by adrenocorticotropic hormone (ACTH)-producing pituitary adenomas (ACTHomas). Drug treatment for CD consists of three strategies: pituitary tumor-targeted therapy, steroidogenesis inhibitors, and glucocorticoid receptor antagonists. All of these strategies are under development, and several new drugs have recently been approved for clinical use or are being tested in clinical trials. Pituitary-targeted drugs are a particularly important method in the treatment of CD. Available pituitary tumor-targeted drugs include a dopamine receptor agonist and a somatostatin analog. Since disrupted cell cycle signaling is clearly associated with pathogenesis of ACTHomas which express active forms of epithelial growth factor receptor (EGFR), cyclins, and the catalytic subunit of cyclin-dependent kinases (CDKs), we focused on these molecules as therapeutic targets for ACTHomas. Methods In this review, a literature search were performed using PubMed with following terms; Cushing's disease, EGFR, CDKs, cell cycle, and targeted therapy. Conclusion Accumulating evidence demonstrates that EGFR and cyclin E-CDK2 may be promising targets for treating ACTHomas.	Kobe Univ Hosp, Div Diabet & Endocrinol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Fukuoka, H (reprint author), Kobe Univ Hosp, Div Diabet & Endocrinol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fukuokah@med.kobe-u.ac.jp			Japanese Ministry of Education Science, Culture, Sports, Science, and Technology [24790945]	The Author would like to thank Dr. Shlomo Melmed for special support. This work was supported in part by a Grant-in-Aid for Scientific Research from Japanese Ministry of Education Science, Culture, Sports, Science, and Technology 24790945. We would like to thank Editage (www.editage.jp) for English language editing.	Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137; Biller BMK, 2008, J CLIN ENDOCR METAB, V93, P2454, DOI 10.1210/jc.2007-2734; Vilar L, 2010, PITUITARY, V13, P123, DOI 10.1007/s11102-009-0209-8; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Feelders RA, 2010, NEW ENGL J MED, V362, P1846, DOI 10.1056/NEJMc1000094; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Pivonello R, 2009, J CLIN ENDOCR METAB, V94, P223, DOI 10.1210/jc.2008-1533; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; Godbout A, 2010, EUR J ENDOCRINOL, V163, P709, DOI 10.1530/EJE-10-0382; Dickson MA, 2014, CLIN CANCER RES, V20, P3379, DOI 10.1158/1078-0432.CCR-13-1551; Tritos NA, 2011, NAT REV ENDOCRINOL, V7, P279, DOI 10.1038/nrendo.2011.12; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Pitts TM, 2014, PHARMACOL THERAPEUT, V142, P258, DOI 10.1016/j.pharmthera.2013.12.010; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Theodoropoulou M, 2004, J ENDOCRINOL, V183, P385, DOI 10.1677/joe.1.05616; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Galimberti F, 2010, CLIN CANCER RES, V16, P109, DOI 10.1158/1078-0432.CCR-09-2151; Chien WM, 2006, P NATL ACAD SCI USA, V103, P4122, DOI 10.1073/pnas.0509514103; Cooper O, 2011, ENDOCR-RELAT CANCER, V18, pR197, DOI 10.1530/ERC-11-0066; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; Fleseriu M, 2012, PITUITARY, V15, P330, DOI 10.1007/s11102-012-0397-5; Hallaert DYH, 2007, CELL DEATH DIFFER, V14, P1958, DOI 10.1038/sj.cdd.4402211; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Musat Madalina, 2002, Pituitary, V5, P235, DOI 10.1023/A:1025325832698; Musat M, 2010, MOL CELL ENDOCRINOL, V326, P25, DOI 10.1016/j.mce.2010.03.017; Nair BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2929; Occhi G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003350; Pivonello R, 2014, CLIN ENDOCRINOL, V81, P408, DOI 10.1111/cen.12431; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Roussel-Gervais A, 2010, MOL ENDOCRINOL, V24, P1835, DOI 10.1210/me.2010-0091; Tichomirowa MA, 2012, ENDOCR-RELAT CANCER, V19, P233, DOI 10.1530/ERC-11-0362	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	APR	2015	18	2					274	278		10.1007/s11102-015-0637-6		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CE1IO	WOS:000351565500016		
J	Ventureira, MR; Sobarzo, CMA; Naito, M; Zanuzzi, C; Barbeito, C; Cebra, E				Ventureira, M. R.; Sobarzo, C. M. A.; Naito, M.; Zanuzzi, C.; Barbeito, C.; Cebra, E.			EARLY PLACENTAL ANGIOGENFSIS-VASCULARIZATION AND VEGF/KDR RECEPTOR EXPRESSION DURING MOUSE ORGANOGENESIS AFTER PERIGESTATIONAL ALCOHOL CONSUMPTION	PLACENTA			English	Meeting Abstract	6th Latin American Symposium on Maternal-Fetal Interaction and Placenta / 5th Latin American Symposium on Reproductive Immunology	APR 13-16, 2015	Mar del Plata, ARGENTINA						[Ventureira, M. R.; Cebra, E.] Univ Buenos Aires, FCEN, IFIBYNE UBA CONICET Biodivers & Expt Biol Dept, Lab Reprod & Maternal Embryon Physiopathol, Buenos Aires, DF, Argentina; [Sobarzo, C. M. A.] Univ Buenos Aires, INBIOMED UBA CONICET Sch Med, Buenos Aires, DF, Argentina; [Naito, M.] Aichi Med Univ, Dept Anat, Nagakute, Aichi 48011, Japan; [Zanuzzi, C.; Barbeito, C.] Natl Univ La Plata UNLP, Fac Vet Sci, Histol & Embriol Basic Sci Dept, Buenos Aires, DF, Argentina								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	APR	2015	36	4				PA.10	491	491				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CE4JI	WOS:000351796500094		
J	Umemoto, N; Kanda, Y; Ohnuma, T; Osawa, T; Numata, T; Sakuda, S; Taira, T; Fukamizo, T				Umemoto, Naoyuki; Kanda, Yuka; Ohnuma, Takayuki; Osawa, Takuo; Numata, Tomoyuki; Sakuda, Shohei; Taira, Toki; Fukamizo, Tamo			Crystal structures and inhibitor binding properties of plant class V chitinases: the cycad enzyme exhibits unique structural and functional features	PLANT JOURNAL			English	Article						crystal structure; chitinase; cycad; chitin oligosaccharide; transglycosylation; allosamidin	HUMAN MACROPHAGE CHITINASE; SERRATIA-MARCESCENS; GH19 CHITINASE; COCCIDIOIDES-IMMITIS; TOBACCO CHITINASES; AROMATIC RESIDUES; SUBSTRATE; ALLOSAMIDIN; LYSOZYME; HYDROLYSIS	A classV (glycoside hydrolase family18) chitinase from the cycad Cycas revoluta (CrChiA) is a plant chitinase that has been reported to possess efficient transglycosylation (TG) activity. We solved the crystal structure of CrChiA, and compared it with those of classV chitinases from Nicotiana tabacum (NtChiV) and Arabidopsis thaliana (AtChiC), which do not efficiently catalyze the TG reaction. All three chitinases had a similar (/)(8) barrel fold with an (+) insertion domain. In the acceptor binding site (+1, +2 and +3) of CrChiA, the Trp168 side chain was found to stack face-to-face with the +3 sugar. However, this interaction was not found in the identical regions of NtChiV and AtChiC. In the DxDxE motif, which is essential for catalysis, the carboxyl group of the middle Asp (Asp117) was always oriented toward the catalytic acid Glu119 in CrChiA, whereas the corresponding Asp in NtChiV and AtChiC was oriented toward the first Asp. These structural features of CrChiA appear to be responsible for the efficient TG activity. When binding of the inhibitor allosamidin was evaluated using isothermal titration calorimetry, the changes in binding free energy of the three chitinases were found to be similar to each other, i.e. between -9.5 and -9.8kcal mol(-1). However, solvation and conformational entropy changes in CrChiA were markedly different from those in NtChiV and AtChiC, but similar to those of chitinaseA from Serratia marcescens (SmChiA), which also exhibits significant TG activity. These results provide insight into the molecular mechanism underlying the TG reaction and the molecular evolution from bacterial chitinases to plant classV chitinases.	[Umemoto, Naoyuki; Kanda, Yuka; Ohnuma, Takayuki; Fukamizo, Tamo] Kinki Univ, Dept Adv Biosci, Nara 6318505, Japan; [Osawa, Takuo; Numata, Tomoyuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Sakuda, Shohei] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Taira, Toki] Univ Ryukyus, Dept Biosci & Biotechnol, Nishihara, Okinawa 9030213, Japan	Fukamizo, T (reprint author), Kinki Univ, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	fukamizo@nara.kindai.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1101035]; Japan Society for the Promotion of Science [26-7951]	This work was supported by the 'Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy' (2011-2015) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (S1101035). N.U. was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (26-7951).	Aguilera B, 2003, J BIOL CHEM, V278, P40911, DOI 10.1074/jbc.M301804200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Sasaki C, 2006, GLYCOBIOLOGY, V16, P1242, DOI 10.1093/glycob/cwl043; Aronson NN, 2006, BIOSCI BIOTECH BIOCH, V70, P243, DOI 10.1271/bbb.70.243; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; PACE CN, 1995, PROTEIN SCI, V4, P2411; MELCHERS LS, 1994, PLANT J, V5, P469; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Baban J, 2010, J PHYS CHEM B, V114, P6144, DOI 10.1021/jp909801x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Horn SJ, 2006, BIOCATAL BIOTRANSFOR, V24, P39, DOI 10.1080/10242420500518482; Arakane Y, 2012, CURR DRUG TARGETS, V13, P442; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Bortone K, 2002, J MOL BIOL, V320, P293, DOI 10.1016/S0022-2836(02)00444-B; SAKUDA S, 1987, J ANTIBIOT, V40, P296; Aronson NN, 2003, BIOCHEM J, V376, P87; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BROGLIE K, 1991, SCIENCE, V254, P1194, DOI 10.1126/science.254.5035.1194; Brunner F, 1998, PLANT J, V14, P225; Cederkvist FH, 2007, BIOCHEMISTRY-US, V46, P12347, DOI 10.1021/bi701029u; Fukamizo T, 2001, BIOCHEMISTRY-US, V40, P2448, DOI 10.1021/bi001537s; HENRISSAT B, 1991, BIOCHEM J, V280, P309; Honda Y, 1998, BBA-PROTEIN STRUCT M, V1388, P53, DOI 10.1016/S0167-4838(98)00153-8; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MURPHY KP, 1994, BIOPHYS CHEM, V51, P311, DOI 10.1016/0301-4622(94)00052-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuhaus JM, 1996, PLANT MOL BIOL REP, V14, P102, DOI 10.1007/BF02684897; Ohnuma T, 2011, PLANTA, V234, P123, DOI 10.1007/s00425-011-1390-3; Ohnuma T, 2011, PLANT MOL BIOL, V75, P291, DOI 10.1007/s11103-010-9727-z; Ohnuma T, 2012, FEBS J, V279, P3639, DOI 10.1111/j.1742-4658.2012.08723.x; Ohnuma T, 2013, FEBS LETT, V587, P2691, DOI 10.1016/j.febslet.2013.07.008; Ohnuma T, 2014, BBA-PROTEINS PROTEOM, V1844, P793, DOI 10.1016/j.bbapap.2014.02.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sasaki C, 2002, J BIOCHEM, V131, P557; Sasaki C, 2003, PLANT MOL BIOL, V52, P43, DOI 10.1023/A:1023972007681; Taira T, 2009, GLYCOBIOLOGY, V19, P1452, DOI 10.1093/glycob/cwp119; Taira T, 2010, BBA-PROTEINS PROTEOM, V1804, P668, DOI 10.1016/j.bbapap.2009.10.015; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619; vansAalten D. M., 2001, P NATL ACAD SCI USA, V98, P8979; YAMADA H, 1981, CARBOHYD RES, V92, P160, DOI 10.1016/S0008-6215(00)85993-5	52	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	APR	2015	82	1					54	66		10.1111/tpj.12785		13	Plant Sciences	Plant Sciences	CE2WR	WOS:000351682300005		
J	Hirano, T; Kazama, Y; Ishii, K; Ohbu, S; Shirakawa, Y; Abe, T				Hirano, Tomonari; Kazama, Yusuke; Ishii, Kotaro; Ohbu, Sumie; Shirakawa, Yuki; Abe, Tomoko			Comprehensive identification of mutations induced by heavy-ion beam irradiation in Arabidopsis thaliana	PLANT JOURNAL			English	Article						heavy-ion beam; mutation; genomic rearrangement; resequencing; Arabidopsis thaliana	LINEAR-ENERGY-TRANSFER; CHROMOSOMAL TRANSLOCATION FORMATION; HIGH-LET IRRADIATION; CARBON-IONS; GAMMA-IRRADIATION; MOLECULAR NATURE; DNA-DAMAGE; END; RICE; RADIATION	Heavy-ion beams are widely used for mutation breeding and molecular biology. Although the mutagenic effects of heavy-ion beam irradiation have been characterized by sequence analysis of some restricted chromosomal regions or loci, there have been no evaluations at the whole-genome level or of the detailed genomic rearrangements in the mutant genomes. In this study, using array comparative genomic hybridization (array-CGH) and resequencing, we comprehensively characterized the mutations in Arabidopsis thaliana genomes irradiated with Ar or Fe ions. We subsequently used this information to investigate the mutagenic effects of the heavy-ion beams. Array-CGH demonstrated that the average number of deleted areas per genome were 1.9 and 3.7 following Ar-ion and Fe-ion irradiation, respectively, with deletion sizes ranging from 149 to 602180bp; 81% of the deletions were accompanied by genomic rearrangements. To provide a further detailed analysis, the genomes of the mutants induced by Ar-ion beam irradiation were resequenced, and total mutations, including base substitutions, duplications, in/dels, inversions, and translocations, were detected using three algorithms. All three resequenced mutants had genomic rearrangements. Of the 22 DNA fragments that contributed to the rearrangements, 19 fragments were responsible for the intrachromosomal rearrangements, and multiple rearrangements were formed in the localized regions of the chromosomes. The interchromosomal rearrangements were detected in the multiply rearranged regions. These results indicate that the heavy-ion beams led to clustered DNA damage in the chromosome, and that they have great potential to induce complicated intrachromosomal rearrangements. Heavy-ion beams will prove useful as unique mutagens for plant breeding and the establishment of mutant lines.	[Hirano, Tomonari; Kazama, Yusuke; Abe, Tomoko] RIKEN, Innovat Ctr, Wako, Saitama 3510198, Japan; [Hirano, Tomonari; Kazama, Yusuke; Ishii, Kotaro; Ohbu, Sumie; Shirakawa, Yuki; Abe, Tomoko] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan	Abe, T (reprint author), RIKEN, Innovat Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tomoabe@riken.jp	Kazama, Yusuke/L-7253-2015		Social Infrastructure Technology Development Program from RIKEN; Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program) [GR096]; Council for Science and Technology Policy (CSTP), MEXT KAKENHI [221S0002]; Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP) [25292009]	We thank the RIKEN Research Resources Center of the Brain Science Institute for performing DNA sequencing. This experiment was performed at the RIBF operated by the RIKEN Nishina Center and Center for Nuclear Study, University of Tokyo. This research was supported by Social Infrastructure Technology Development Program from RIKEN; a grant from the Japan Society for the Promotion of Science (JSPS) to TA (GR096) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)', which was initiated by the Council for Science and Technology Policy (CSTP), MEXT KAKENHI (TA, no. 221S0002); Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), 'Technologies for creating next-generation agriculture, forestry and fisheries' (funding agency Bio-oriented Technology Research Advancement Institution, NARO); and Grant-in-Aid for Scientific Research (B) (YK, no. 25292009).	Abe T, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P99, DOI 10.1079/9781780640853.0099; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Kim TW, 2005, PLANT CELL, V17, P2397, DOI 10.1105/tpc.105.033738; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Pastwa E, 2003, RADIAT RES, V159, P251, DOI 10.1667/0033-7587(2003)159[0251:RORIDD]2.0.CO;2; Sato Y, 2006, BREEDING SCI, V56, P179, DOI 10.1270/jsbbs.56.179; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lavelle C, 2014, INT J BIOCHEM CELL B, V49, P84, DOI 10.1016/j.biocel.2014.01.012; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Friedland W, 2013, MUTAT RES-GEN TOX EN, V756, P213, DOI 10.1016/j.mrgentox.2013.06.013; Fernandez-Banet J, 2014, GENOMICS, V103, P189, DOI 10.1016/j.ygeno.2014.01.003; Tanaka A, 2010, J RADIAT RES, V51, P223, DOI 10.1269/jrr.09143; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Asaithamby A, 2011, MUTAT RES-FUND MOL M, V711, P87, DOI 10.1016/j.mrfmmm.2010.11.002; Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Pecinka A, 2013, TRENDS PLANT SCI, V18, P625, DOI 10.1016/j.tplants.2013.07.005; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Wang HY, 2010, NUCLEIC ACIDS RES, V38, P3245, DOI 10.1093/nar/gkq069; Soni A, 2014, NUCLEIC ACIDS RES, V42, P6380, DOI 10.1093/nar/gku298; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Bruggemann E, 1996, PLANT J, V10, P755, DOI 10.1046/j.1365-313X.1996.10040755.x; Bolle C, 2013, PLANT J, V75, P157, DOI 10.1111/tpj.12197; Morita R, 2009, GENES GENET SYST, V84, P361; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Charbonnel C, 2011, DNA REPAIR, V10, P611, DOI 10.1016/j.dnarep.2011.04.002; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5; Naito K, 2005, GENETICS, V169, P881, DOI 10.1534/genetics.104.033654; Krishnan A, 2009, PLANT PHYSIOL, V149, P165, DOI 10.1104/pp.108.128918; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Belfield EJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-224; Belfield EJ, 2012, GENOME RES, V22, P1306, DOI 10.1101/gr.131474.111; Bolle C, 2011, CURR GENOMICS, V12, P1, DOI 10.2174/138920211794520187; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Hase Y, 2012, MUTAT RES-FUND MOL M, V731, P41, DOI 10.1016/j.mrfmmm.2011.10.004; Hirano T, 2012, MUTAT RES-FUND MOL M, V735, P19, DOI 10.1016/j.mrfmmm.2012.04.010; Kanaya T, 2008, PLANT BIOTECHNOL, V25, P91, DOI 10.5511/plantbiotechnology.25.91; Kaul S, 2000, NATURE, V408, P796; Kazama Y, 2008, PLANT BIOTECHNOL, V25, P113, DOI 10.5511/plantbiotechnology.25.113; Kazama Y, 2013, GENES GENET SYST, V88, P189; Kazama Y, 2012, PLANT BIOTECHNOL-NAR, V29, P441, DOI 10.5511/plantbiotechnology.12.0921a; Kazama Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-161; Miyazaki K., 2006, PLANT BIOTECHNOL, V23, P163, DOI 10.5511/plantbiotechnology.23.163; Morita R, 2007, GENES GENET SYST, V82, P321, DOI 10.1266/ggs.82.321; Nagano AJ, 2008, PLANT J, V56, P1058, DOI 10.1111/j.1365-313X.2008.03656.x; O'Rourke JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00210; Ogawa T, 2009, PLANT PHYSIOL, V151, P114, DOI 10.1104/pp.109.139683; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Ryuto H, 2008, PLANT BIOTECHNOL, V25, P119, DOI 10.5511/plantbiotechnology.25.119; Shikazono N, 2005, J EXP BOT, V56, P587, DOI 10.1093/jxb/eri047; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Suzuki M, 2006, ONCOL REP, V16, P1293; Tsuruoka C, 2008, RADIAT RES, V170, P163, DOI 10.1667/RR1279.1; Uchida N, 2011, PLANT CELL PHYSIOL, V52, P716, DOI 10.1093/pcp/pcr029; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	APR	2015	82	1					93	104		10.1111/tpj.12793		12	Plant Sciences	Plant Sciences	CE2WR	WOS:000351682300008		
J	Matsuoka, D; Yasufuku, T; Furuya, T; Nanmori, T				Matsuoka, Daisuke; Yasufuku, Takuto; Furuya, Tomoyuki; Nanmori, Takashi			An abscisic acid inducible Arabidopsis MAPKKK, MAPKKK18 regulates leaf senescence via its kinase activity	PLANT MOLECULAR BIOLOGY			English	Article						ABA; Leaf senescence; MAPK cascade; MAPKKK; Protein kinase assay	RAF-LIKE MAP3K; GUARD-CELLS; MEDIATES ABA; PROTEIN; EXPRESSION; CASCADES; PLANTS; MAP3K-DELTA-4; AGROBACTERIUM; TOLERANCE	Abscisic acid (ABA) is a phytohormone that regulates many physiological functions, such as plant growth, development and stress responses. The MAPK cascade plays an important role in ABA signal transduction. Several MAPK and MAPKK molecules are reported to function in ABA signaling; however, there have been few studies related to the identification of MAPKKK upstream of MAPKK in ABA signaling. In this study, we show that an Arabidopsis MAPKKK, MAPKKK18 functions in ABA signaling. The expression of MAPKKK18 was induced by ABA treatment. Yeast two-hybrid analysis revealed that MAPKKKK18 interacted with MKK3, which interacted with C-group MAPK, MPK1/2/7. Immunoprecipitated kinase assay showed that the 3xFlag-tagged MAPKKK18, expressed in Arabidopsis plants, was activated when treated with ABA. These results indicate the possibility that the MAPK cascade is composed of MAPKKK18, MKK3 and MPK1/2/7 in ABA signaling. The transgenic plants overexpressing MAPKKK18 (35S:MAPKKK18) and its kinase negative mutant (35S:MAPKKK18 KN) were generated, and their growth was monitored. Compared with the WT plant, 35S:MAPKKK18 and 35S:MAPKKK18 KN showed smaller and bigger phenotypes, respectively. Senescence of the rosette leaves was promoted in 35S:MAPKKK18, but suppressed in 35S:MAPKKK18 KN. Furthermore, ABA-induced leaf senescence was accelerated in 35S:MAPKKK18. These results suggest that MAPKKK18 controls the plant growth by adjusting the timing of senescence via its protein kinase activity in ABA dependent manners.	[Matsuoka, Daisuke; Yasufuku, Takuto; Furuya, Tomoyuki; Nanmori, Takashi] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Nanmori, Takashi] Kobe Univ, Res Ctr Environm Genom, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan	Matsuoka, D (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	matsuoka@people.kobe-u.ac.jp					Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Menges M, 2008, NEW PHYTOL, V179, P643, DOI 10.1111/j.1469-8137.2008.02552.x; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Liu YK, 2012, PLANT CELL REP, V31, P1, DOI 10.1007/s00299-011-1130-y; Khan M, 2014, GERONTOLOGY, V60, P49, DOI 10.1159/000354334; Hwa CM, 2008, ACTA PHYSIOL PLANT, V30, P277, DOI 10.1007/s11738-007-0117-3; Sasayama D, 2011, PLANT BIOTECHNOL-NAR, V28, P463, DOI 10.5511/plantbiotechnology.11.1027a; Matsuoka D, 2002, PLANT J, V29, P637, DOI 10.1046/j.0960-7412.2001.01246.x; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zhang KW, 2012, PLANT J, V69, P667, DOI 10.1111/j.1365-313X.2011.04821.x; Bechtold N, 1998, METH MOL B, V82, P259; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Lee IC, 2011, PLANT CELL PHYSIOL, V52, P651, DOI 10.1093/pcp/pcr026; Shitamichi N, 2013, PLANT BIOTECHNOL-NAR, V30, P111, DOI 10.5511/plantbiotechnology.13.0108a; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Munemasa S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00472; Takahashi Y, 2004, J BIOCHEM, V136, P127, DOI 10.1093/jb/mvh118; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wise AA, 2006, METH MOL B, V343, P43	28	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	APR	2015	87	6					565	575		10.1007/s11103-015-0295-0		11	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CE8IW	WOS:000352086700003		
J	Toyama, H; Kamiyama, T; Yahara, T				Toyama, Hironori; Kamiyama, Takayuki; Yahara, Tetsukazu			A genome-wide AFLP replacement in a hybrid population derived from two closely related Viola species from contrasting habitats	PLANT SYSTEMATICS AND EVOLUTION			English	Article						Hybrid; Adaptation; Sister species; Different light requirement; AFLP; Japan	MULTILOCUS GENOTYPE DATA; FRAGMENT LENGTH POLYMORPHISM; SELF-FERTILIZATION; GENETIC-STRUCTURE; MOLECULAR EVIDENCE; FERTILE F(1)S; PLANT; HYBRIDIZATION; EVOLUTION; MARKERS	Hybrid zones formed from genetically and ecologically differentiated species provide an opportunity to examine how genetics and ecology interact to determine species boundaries. In this study, we examined a hybrid zone generated by invasion of shade-loving Viola eizanensis into habitat occupied by its close relative, V. chaerophylloides var. sieboldiana, which prefers more open areas. We used 339 AFLP loci to estimate genomic composition and generation of hybrids, and confirmed maternal inheritance through sequencing of the cpDNA atpI-atpH intergenic spacer region. Phenotypic variation was assessed using leaf thickness (leaf mass/area) and leaf dissection (leaf perimeter/area), which were diversified between species. Genetic analyses showed that the AFLP of hybrid individuals in having maternal origin from V. chaerophylloides var. sieboldiana were replaced by V. eizanensis in response to habitat. Significant correlations were observed between hybrid indices and the two leaf traits. These results suggest that genes of V. eizanensis that are adaptive to shaded habitats are fixed in the hybrids, and that the degree of leaf thickness and dissection is important in adaptation of the hybrids to their light environments.	[Toyama, Hironori; Yahara, Tetsukazu] Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, Fukuoka 8128581, Japan; [Kamiyama, Takayuki] Japanese Soc Plant Systemat, Nikko, Tochigi 3211262, Japan	Toyama, H (reprint author), Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	htohyscb@kyushu-u.org			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9]	We thank all colleagues of the ecological laboratory of Kyushu University who provided helpful discussion. This work was partially supported by a Grant-in-Aid for JSPS (Japan Society for the Promotion of Science) and a grant from the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan.	Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1999, GENETICS, V152, P713; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; NASON JD, 1992, AM J BOT, V79, P101, DOI 10.2307/2445203; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Milne RI, 2003, MOL ECOL, V12, P2719, DOI 10.1046/j.1365-294X.2003.01942.x; Anderson EC, 2002, GENETICS, V160, P1217; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; Minder AM, 2007, MOL ECOL, V16, P2504, DOI 10.1111/j.1365-294X.2007.03292.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; LESICA P, 1988, CONSERV BIOL, V2, P275, DOI 10.1111/j.1523-1739.1988.tb00184.x; Pannell JR, 2006, LANDSCAPE ECOL, V21, P837, DOI 10.1007/s10980-005-5389-7; Busch JW, 2005, AM J BOT, V92, P1503, DOI 10.3732/ajb.92.9.1503; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Pritchard JK, 2000, GENETICS, V155, P945; GUREVITCH J, 1988, AM J BOT, V75, P1298, DOI 10.2307/2444452; Barrett SCH, 2003, PHILOS T ROY SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; Vogel S, 2009, NEW PHYTOL, V183, P13, DOI 10.1111/j.1469-8137.2009.02854.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gaskin JF, 2009, BIOL INVASIONS, V11, P1121, DOI 10.1007/s10530-008-9384-1; Moeller DA, 2005, EVOLUTION, V59, P786, DOI 10.1554/04-656; Culley TM, 2001, HEREDITY, V86, P545, DOI 10.1046/j.1365-2540.2001.00875.x; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; SCHOEN DJ, 1984, AM J BOT, V71, P711, DOI 10.2307/2443368; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Sack L, 2006, AM J BOT, V93, P829, DOI 10.3732/ajb.93.6.829; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; LORD EM, 1980, AM J BOT, V67, P1430, DOI 10.2307/2442871; SCHEMSKE DW, 1978, ECOLOGY, V59, P351, DOI 10.2307/1936379; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coart E, 2003, MOL ECOL, V12, P845, DOI 10.1046/j.1365-294X.2003.01778.x; Nicotra AB, 2008, OECOLOGIA, V154, P625, DOI 10.1007/s00442-007-0865-1; Wyka TP, 2012, OECOLOGIA, V170, P11, DOI 10.1007/s00442-012-2279-y; Falush D, 2003, GENETICS, V164, P1567; Levin DA, 2010, J ECOL, V98, P1276, DOI 10.1111/j.1365-2745.2010.01715.x; Arnold M.L., 1997, NATURAL HYBRIDIZATIO; COLE CT, 1992, AM J BOT, V79, P567, DOI 10.2307/2444869; EXCOFFIER L, 1992, GENETICS, V131, P479; Gillespie J H, 2004, POPULATION GENETICS; Hama E, 2002, WILD VIOLETS JAPAN C; HARTL D. L., 2000, PRIMER POPULATION GE; Igari M, 1996, VIOLETS OF JAPAN; Kameyama Y, 2008, J EVOLUTION BIOL, V21, P588, DOI 10.1111/j.1420-9101.2007.01476.x; Moccia MD, 2007, MOL ECOL, V16, P2855, DOI 10.1111/j.1365-294X.2007.03240.x; Neuffer B, 1999, MOL ECOL, V8, P365, DOI 10.1046/j.1365-294X.1998.00566.x; R Core Team, 2012, R LANG ENV STAT COMP; Schoen DJ, 2008, INT J PLANT SCI, V169, P119, DOI 10.1086/523356; Toyama H, 2012, J PLANT STUDIES, V1, P26; Toyama H, 2009, J PLANT RES, V122, P389, DOI 10.1007/s10265-009-0235-7; Vekemans X, 2002, AFLP SURV VERSION 1; WALLER DM, 1979, AM J BOT, V66, P313, DOI 10.2307/2442608; Zha HG, 2008, BOT J LINN SOC, V156, P119	60	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0378-2697	1615-6110		PLANT SYST EVOL	Plant Syst. Evol.	APR	2015	301	4					1073	1084		10.1007/s00606-014-1137-2		12	Plant Sciences; Evolutionary Biology	Plant Sciences; Evolutionary Biology	CE5IH	WOS:000351864500001		
J	Ida, K				Ida, K.			New concepts of transport physics in toroidal plasmas	PLASMA PHYSICS AND CONTROLLED FUSION			English	Article						transport; toroidal plasma; non-local; non-diffusive	REVERSED SHEAR PLASMAS; EDGE ELECTRIC-FIELD; H-MODE; MOMENTUM-TRANSPORT; JFT-2M TOKAMAK; HEAT-TRANSPORT; ASDEX UPGRADE; BARRIER; DISCHARGES; JT-60U	New concepts of transport physics in toroidal plasmas is reviewed. The transport characteristics of non-diffusion and non-locality of transport has been recognized to be important in determining radial structures of density, rotation, and temperature, as well as non-linearity in the flux-gradient relation. The non-diffusive term of momentum transport appears as a 'spontaneous rotation and intrinsic torque', while the non-diffusive term of particle transport appears as a 'particle pinch and particle exhaust'. The sign and magnitude of these non-diffusive terms have been found to be sensitive to the turbulence state, which causes reversal phenomena. In the momentum transport, the spontaneous flow reversal from the co-(parallel to plasma current) direction to the counter- (anti-parallel to plasma current) direction and vice versa have been commonly observed even when the plasma parameter changes slightly. In the particle transport, especially in the impurity transport, reversals of convective radial flux from inward to outward are also observed in toroidal plasmas as phenomena of density peaking/flattening and impurity accumulation/exhaust. Non-locality of transport has been observed in the response to perturbations, such as a core temperature rise associated with the cooling at edge by pellet injection, strong coupling of transport at different radii as seen in the curvature transition of ITB, and spatial propagation of ITB regions. The turbulence with meso-scale and long correlation, which are strong candidates for causing the non-locality of the transport, have been confirmed experimentally and the coupling between the different turbulence scales has also been identified in various devices.	Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Ida, K (reprint author), Natl Inst Fus Sci, Toki, Gifu 5095292, Japan.	ida@nifs.ac.jp			JSPS Japan [21224014, 23246164]; National Institute for Fusion Science grant administrative budget [NIFS10ULHH021]	The author would like to thank the LHD experiment group and the JT-60 team for their support of these experiments. This work is partly supported by a Grant-in-Aid for Specially-Promoted Research (No. 21224014) and a Grant-in-Aid for Scientific Research (No. 23246164) of JSPS Japan. This work is also partly supported by the National Institute for Fusion Science grant administrative budget, NIFS10ULHH021.	Mantica P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.185002; Fujita T, 1997, PHYS REV LETT, V78, P2377, DOI 10.1103/PhysRevLett.78.2377; Stroth U, 2001, PHYS REV LETT, V86, P5910, DOI 10.1103/PhysRevLett.86.5910; Mantica P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.175002; Ida K, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/6/064007; Ida K, 2010, CONTRIB PLASM PHYS, V50, P558, DOI 10.1002/ctpp.200900041; Greenwald M, 1997, NUCL FUSION, V37, P793, DOI 10.1088/0029-5515/37/6/I07; Mantica P, 1999, PHYS REV LETT, V82, P5048, DOI 10.1103/PhysRevLett.82.5048; Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; NAGASHIMA K, 1994, NUCL FUSION, V34, P449, DOI 10.1088/0029-5515/34/3/I12; Rhodes TL, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063022; Connor JW, 2004, NUCL FUSION, V44, pR1, DOI 10.1088/0029-5515/44/4/R01; Ryter F, 2001, PLASMA PHYS CONTR F, V43, pA323, DOI 10.1088/0741-3335/43/12A/325; Ida K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095024; Ida K, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/1/013022; Kissick MW, 1996, NUCL FUSION, V36, P1691, DOI 10.1088/0029-5515/36/12/I09; Bortolon A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.235003; Hidalgo C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.065001; WARE AA, 1970, PHYS REV LETT, V25, P916, DOI 10.1103/PhysRevLett.25.916; Imbeaux F, 2001, PLASMA PHYS CONTR F, V43, P1503, DOI 10.1088/0741-3335/43/11/306; Rice JE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.265001; Ida K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085003; Ida K, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.055001; Tanaka K, 2006, NUCL FUSION, V46, P110, DOI 10.1088/0029-5515/46/1/013; KOIDE Y, 1994, PHYS REV LETT, V72, P3662, DOI 10.1103/PhysRevLett.72.3662; Yoshida M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.105002; IDA K, 1995, PHYS REV LETT, V74, P1990, DOI 10.1103/PhysRevLett.74.1990; Ida K, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/4/045001; Inagaki S, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/11/114014; Diamond PH, 1997, PHYS REV LETT, V78, P1472, DOI 10.1103/PhysRevLett.78.1472; DIAMOND PH, 1995, PHYS PLASMAS, V2, P3685, DOI 10.1063/1.871068; Fujisawa A, 2003, PLASMA PHYS CONTR F, V45, pR1, DOI 10.1088/0741-3335/45/8/201; GENTLE KW, 1995, PHYS REV LETT, V74, P3620, DOI 10.1103/PhysRevLett.74.3620; GROEBNER RJ, 1990, PHYS REV LETT, V64, P3015, DOI 10.1103/PhysRevLett.64.3015; Gruber O, 1999, PHYS REV LETT, V83, P1787, DOI 10.1103/PhysRevLett.83.1787; Hidalgo C, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/7/074003; Ida K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/1/015005; Ida K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.125006; Ida K, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.124501; Ida K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.055003; Ida K, 1998, J PHYS SOC JPN, V67, P4089, DOI 10.1143/JPSJ.67.4089; Inagaki S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113006; Itoh SI, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215001; KALLENBACH A, 1991, PLASMA PHYS CONTR F, V33, P595, DOI 10.1088/0741-3335/33/6/004; Kamiya K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.045004; Mantica P, 2000, PHYS REV LETT, V85, P4535; Nunami M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4704568; Sakamoto Y, 2001, NUCL FUSION, V41, P865, DOI 10.1088/0029-5515/41/7/307; SCOTT SD, 1990, PHYS REV LETT, V64, P531, DOI 10.1103/PhysRevLett.64.531; Takenaga H, 2006, PLASMA PHYS CONTR F, V48, pA401, DOI 10.1088/0741-3335/48/5A/S41; TERRY PW, 1989, PHYS FLUIDS B-PLASMA, V1, P1932, DOI 10.1063/1.859111; WAGNER F, 1994, PLASMA PHYS CONTR F, V36, pA61, DOI 10.1088/0741-3335/36/7A/006; WAGNER F, 1982, PHYS REV LETT, V49, P1408, DOI 10.1103/PhysRevLett.49.1408; IDA K, 1990, PHYS REV LETT, V65, P1364, DOI 10.1103/PhysRevLett.65.1364	54	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0741-3335	1361-6587		PLASMA PHYS CONTR F	Plasma Phys. Control. Fusion	APR	2015	57	4							044007	10.1088/0741-3335/57/4/044007		10	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE2HW	WOS:000351637700008		
J	Kajita, S; De Bock, M; von Hellermann, M; Kukushkin, A; Barnsley, R				Kajita, Shin; De Bock, Maarten; von Hellermann, Manfred; Kukushkin, Andrei; Barnsley, Robin			Ray tracing analysis of stray light for charge exchange recombination spectroscopy on ITER	PLASMA PHYSICS AND CONTROLLED FUSION			English	Article						stray light; ray tracing; charge exchange recombination spectroscopy; ITER	TOKAMAK; REFLECTIONS	Charge exchange recombination spectroscopy (CXRS) provides basic measurements in ITER such as the ion temperature, plasma rotation, and the impurity and helium content. One of the issues concerning all spectroscopic measurements in ITER is the influence of the reflection of light in a vacuum vessel, since ITER will have a full metallic wall, which has higher optical reflectance than a carbon wall. The noise level can be enhanced and the signal can be disturbed by the reflection. In this study, the influences of the light reflection on the CXRS measurement have been investigated using a ray tracing simulation. Influences of the reflection of the active CXRS signal, the light emission from the divertor and scrape off layer, and bremsstrahlung are quantitatively shown in typical discharge scenario cases.	[Kajita, Shin] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan; [De Bock, Maarten; von Hellermann, Manfred; Kukushkin, Andrei; Barnsley, Robin] ITER Org, F-13115 St Paul Les Durance, France; [Kukushkin, Andrei] RSC Kurchatov Inst, Moscow 123182, Russia; [Kukushkin, Andrei] NRNU MEPhI, Moscow 115409, Russia	Kajita, S (reprint author), Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan.	kajita.shin@nagoya-u.jp	Kajita, Shin/Q-1020-2015				Hassaballa S, 2004, IEEE T PLASMA SCI, V32, P127, DOI 10.1109/TPS.2004.823980; Reichle R, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491199; De Bock M, 2012, SYSTEM DESIGN DESCRI; Hollmann EM, 2003, REV SCI INSTRUM, V74, P3984, DOI 10.1063/1.1602941; KADOTA K, 1980, NUCL FUSION, V20, P209, DOI 10.1088/0029-5515/20/2/010; Kajita S, J NUCL MAT; Kajita S, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/8/085020; Schunke B, 2005, REV SCI INSTRUM, V76, DOI [10.1063/1.1988315, 10.1063/1.988315]; von Hellermann MG, 2008, AIP CONF PROC, V988, P165	9	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0741-3335	1361-6587		PLASMA PHYS CONTR F	Plasma Phys. Control. Fusion	APR	2015	57	4							045009	10.1088/0741-3335/57/4/045009		9	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE2HW	WOS:000351637700021		
J	Kasuya, N; Sugita, S; Inagaki, S; Itoh, K; Yagi, M; Itoh, SI				Kasuya, N.; Sugita, S.; Inagaki, S.; Itoh, K.; Yagi, M.; Itoh, S-I			Simulation study of hysteresis in the gradient-flux relation in toroidal plasma turbulence	PLASMA PHYSICS AND CONTROLLED FUSION			English	Article						turbulence; hysteresis; global mode; heat modulation; nonlinear dynamics; seesaw effect; turbulence spreading	TRANSPORT	Global nonlinear simulations with heat modulation are carried out to understand the turbulent transport mechanism in toroidal plasmas. Rapid propagation of the heat modulation and a hysteresis in the gradient-flux relation are found in the turbulent simulation of drift-interchange modes. A global mode is excited nonlinearly, and the nonlinear couplings with Reynolds stress take a finite temporal duration for self-consistent redistribution of the energy. The mode also has a seesaw effect: increase of the amplitude of the global mode at one position affects the turbulence at the other radial position not by inducing the radial flux by itself, but by absorbing the energy from microscopic modes. Successive excitations of microscopic modes cause the accelerated propagation of the flux change like turbulence spreading after the onset of modulation. Owing to these non-diffusive processes, the hysteresis appears in the gradient-flux relation, which is compared with experiments.	[Kasuya, N.; Inagaki, S.; Itoh, S-I] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Kasuya, N.; Inagaki, S.; Itoh, K.; Yagi, M.; Itoh, S-I] Kyushu Univ, Res Ctr Plasma Turbulence, Kasuga, Fukuoka 8168580, Japan; [Sugita, S.] Chubu Univ, Int Digital Earth Appl Sci Res Ctr, Kasugai, Aichi 4878501, Japan; [Itoh, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Yagi, M.] Japan Atom Energy Agcy, Aomori 0393212, Japan	Kasuya, N (reprint author), Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan.	kasuya@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		JSPS [24760703, 23244113, 21224014]; NIFS [NIFS13KNST050, NIFS13KOCT001]; RIAM of Kyushu University; Asada Science foundation	Authors acknowledge discussions with Prof A Fujisawa, Prof K Ida, Dr M Sasaki, and Dr Y Nagashima. This work is supported by the Grant-in-Aid for Young Scientists (24760703), for Scientific Research (23244113, 21224014) of JSPS and for JSPS Fellows (10J04534), by the collaboration program of NIFS (NIFS13KNST050, NIFS13KOCT001) and of RIAM of Kyushu University, and Asada Science foundation.	Naulin V, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1905603; Hahm TS, 2004, PLASMA PHYS CONTR F, V46, pA323, DOI 10.1088/0741-3335/46/5A/036; Budaev VP, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024014; Naulin V, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2141396; Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; YUSHMANOV PN, 1990, NUCL FUSION, V30, P1999, DOI 10.1088/0029-5515/30/10/001; Fujisawa A, 2007, NUCL FUSION, V47, pS718, DOI 10.1088/0029-5515/47/10/S19; Gurcan OD, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1853385; Del-Castillo-Negrete D, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/7/075009; Dif-Pradalier G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.025401; Garbet X, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2824375; Gentle KW, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2163251; GENTLE KW, 1995, PHYS REV LETT, V74, P3620, DOI 10.1103/PhysRevLett.74.3620; Ida K, 2012, P 24 FUS EN C SAN DI; Inagaki S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115001; Inagaki S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113006; Itoh K, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/9/095016; Itoh K., 2009, J PLASMA FUSION RES, V8, P119; Itoh SI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00860; Itoh SI, 2001, PLASMA PHYS CONTR F, V43, P1055, DOI 10.1088/0741-3335/43/8/304; Itoh SI, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073035; Kasuya N, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4902102; Kasuya N, 2011, PLASMA SCI TECHNOL, V13, P326, DOI 10.1088/1009-0630/13/3/11; Kasuya N, 2013, PLASMA FUSION RES, V8; Kim S S, 2010, P 23 FUS EN C DAEJ K; Stroth U, 1996, PLASMA PHYS CONTR F, V38, P611, DOI 10.1088/0741-3335/38/4/010; Tamura N, 2007, NUCL FUSION, V47, P449, DOI 10.1088/0029-5515/47/5/009; Wakatani M., 1998, STELLARATOR HELIOTRO	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0741-3335	1361-6587		PLASMA PHYS CONTR F	Plasma Phys. Control. Fusion	APR	2015	57	4							044010	10.1088/0741-3335/57/4/044010		8	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CE2HW	WOS:000351637700011		
J	Raymo, JM; Musick, K; Iwasawa, M				Raymo, James M.; Musick, Kelly; Iwasawa, Miho			Gender Equity, Opportunity Costs of Parenthood, and Educational Differences in Unintended First Births: Insights from Japan	POPULATION RESEARCH AND POLICY REVIEW			English	Article						Low fertility; Unintended fertility; Gender and family roles; Japan	UNITED-STATES; CONTRACEPTIVE FAILURE; FERTILITY INTENTIONS; PREGNANCY INTENTIONS; NATIONAL-SURVEY; FAMILY GROWTH; CHILDBEARING; CHILDREN; ABORTION; MARRIAGE	We examine educational differences in the intendedness of first births in Japan using data from a nationally representative survey of married women (N = 2,373). We begin by describing plausible scenarios for a negative, null, and positive educational gradient in unintended first births. In contrast to well-established results from the U.S., we find evidence of a positive educational gradient in Japan. Net of basic demographic controls, university graduates are more likely than less-educated women to report first births as unintended. This pattern is consistent with a scenario emphasizing the high opportunity costs of motherhood in countries such as Japan where growing opportunities for women in employment and other domains of public life have not been accompanied by changes in the highly asymmetric roles of men and women within the family. We discuss potential implications of this suggestive finding for other low-fertility settings.	[Raymo, James M.] Univ Wisconsin, Dept Sociol, Madison, WI 53706 USA; [Raymo, James M.] Univ Wisconsin, Ctr Demog & Ecol, Madison, WI 53706 USA; [Musick, Kelly] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY USA; [Musick, Kelly] Cornell Univ, Cornell Populat Ctr, Ithaca, NY USA; [Iwasawa, Miho] Natl Inst Social Secur & Populat Res, Tokyo, Japan	Raymo, JM (reprint author), Univ Wisconsin, Dept Sociol, 1180 Observ Dr, Madison, WI 53706 USA.	jraymo@ssc.wisc.edu			Center for Demography and Ecology - Eunice Kennedy Shriver National Institute for Child Health and Human Development [R24HD047873]; Cornell Population Center - Eunice Kennedy Shriver National Institute for Child Health and Human Development [5R24HD058488]	The authors gratefully acknowledge support from the Center for Demography and Ecology (R24HD047873) and the Cornell Population Center (5R24HD058488), both funded through grants from the Eunice Kennedy Shriver National Institute for Child Health and Human Development. Permission to use data from the National Fertility Surveys was obtained through the National Institute of Population and Social Security Research on the basis of the Statistics Act (Act No. 53 of 2007), Article 32.	Carlson M, 2004, DEMOGRAPHY, V41, P237, DOI 10.1353/dem.2004.0012; Joyce T, 2011, NEW ENGL J MED, V365, P1466, DOI 10.1056/NEJMp1109889; Barber JS, 1999, J HEALTH SOC BEHAV, V40, P231, DOI 10.2307/2676350; Su JH, 2012, J MARRIAGE FAM, V74, P1182, DOI 10.1111/j.1741-3737.2012.01006.x; Joyce TJ, 2000, DEMOGRAPHY, V37, P83, DOI 10.2307/2648098; Gibson-Davis CM, 2005, J MARRIAGE FAM, V67, P1301, DOI 10.1111/j.1741-3737.2005.00218.x; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; Williams L, 2000, SOC BIOL, V47, P147; Perelli-Harris B, 2010, POPUL DEV REV, V36, P775, DOI 10.1111/j.1728-4457.2010.00357.x; Raymo JM, 2008, J MARRIAGE FAM, V70, P847; SILVERMAN J, 1987, FAM PLANN PERSPECT, V19, P94, DOI 10.2307/2135174; Trussell J, 1999, FAM PLANN PERSPECT, V31, P246, DOI 10.2307/2991573; Kaufmann RB, 1997, AM J EPIDEMIOL, V145, P810; McLanahan S, 2004, DEMOGRAPHY, V41, P607, DOI 10.1353/dem.2004.0033; Augustine JM, 2009, ANN AM ACAD POLIT SS, V624, P99, DOI 10.1177/0002716209334694; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Barber JS, 2009, CHILD DEV, V80, P921, DOI 10.1111/j.1467-8624.2009.01306.x; Baydar N, 1995, FAM PLANN PERSPECT, V27, P228, DOI 10.2307/2136174; Becker G. S., 1991, TREATISE FAMILY; Boling P., 2007, POLITICAL EC JAPANS, P131; BUMPASS LL, 1987, POP STUD-J DEMOG, V41, P347, DOI 10.1080/0032472031000142946; Bumpass L. L., 2009, Asian Population Studies, V5, P215, DOI 10.1080/17441730903351479; Casterline JB, 2007, DEMOGRAPHY, V44, P729, DOI 10.1353/dem.2007.0043; Crissey SR, 2005, POPUL RES POLICY REV, V24, P593, DOI 10.1007/s11113-005-5734-1; Edin K., 2007, UNMARRIED COUPLES CH, P25; Eisenberg L, 1995, BEST INTENTIONS UNIN; Finer L. B., 2006, ABORTION WOMENS LIVE; Hertog E, 2011, J FAM ISSUES, V32, P1674, DOI 10.1177/0192513X11409333; HEWITT B, 2010, POPULATION REV, V0049; Hirao K., 2007, POLITICAL EC JAPANS, P170; Japan Statistics Bureau, 2003, SUMM RES 2001 SURV T; Kathryn Edin, 2005, PROMISES I CAN KEEP; Kye B., 2011, DELAY 1 MARRIA UNPUB; McDonald P., 2000, J POPULATION RES, V17, P1, DOI DOI 10.1007/BF03029445; Miller W B, 1994, Adv Popul, V2, P1; Moos MK, 1997, WOMEN HEALTH ISS, V7, P385, DOI 10.1016/S1049-3867(97)00081-9; Morgan SP, 2002, POPUL RES POLICY REV, V21, P319, DOI 10.1023/A:1020078406216; Mosher W. D., 2012, 55 NAT HLTH STAT, V55; Musick K, 2009, SOC FORCES, V88, P543; Nagase N., 2014, ANN M POP ASS AM BOS; National Institute of Population and Social Security Research, 2012, LAT POP STAT; National Institute of Population and Social Security Research, 2012, MARR PROC FERT JAP M; Philipov D., 2011, VIENNA YB POPULATION, V9, P37, DOI DOI 10.1553/POPULATIONYEARBOOK2011S37; Raymo JM, 2013, DEMOGR RES, V28, P177, DOI 10.4054/DemRes.2013.28.6; Raymo JM, 2011, SOC SCI RES, V40, P460, DOI 10.1016/j.ssresearch.2010.10.005; RYDER NB, 1973, FAM PLANN PERSPECT, V5, P133, DOI 10.2307/2133810; Sato R., 2006, JAPANESE J POPULATIO, V4, P33; Schoen R, 1999, J MARRIAGE FAM, V61, P790, DOI 10.2307/353578; Shishido K., 2009, INT J JAP SOCIOL, V18, P97; Stanford J B, 2000, Matern Child Health J, V4, P183, DOI 10.1023/A:1009575514205; Tsuya N. O., 2013, ANN M POP ASS AM NEW; Tsuya NO, 1995, GENDER FAMILY CHANGE, P139; TSUYA NO, 2005, ASIAN POPULATION STU, V0001; U.S. Census Bureau, 2012, CURR POP SURV ANN SO; Westoff CF, 1996, INT FAM PLAN PERSPEC, V22, P16, DOI 10.2307/2950797; Williams L, 1999, FAM PLANN PERSPECT, V31, P220, DOI 10.2307/2991569; Yamaguchi K., 2005, RES HOUSEHOLD EC, V66, P57; Zabin L S, 1993, J Res Adolesc, V3, P67, DOI 10.1207/s15327795jra0301_4	59	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-5923	1573-7829		POPUL RES POLICY REV	Popul. Res. Policy Rev.	APR	2015	34	2					179	199		10.1007/s11113-014-9348-3		21	Demography	Demography	CE1BA	WOS:000351545200002		
J	Nakazato, T				Nakazato, Tsutomu			Multilayer adhering model for holdup and separation behavior of fine particles in a powder-particle fluidized bed	POWDER TECHNOLOGY			English	Article						Fluidized bed; Coarse particle; Fine particle holdup; Multilayer adhesion; Aerosol penetration; Aerosol filtration	COHESIVE POWDERS; ELUTRIATION; GENERATOR; REMOVAL; COLLECTION; AEROSOL; GASES	Time variation of the holdup of fine particles in a powder-particle fluidized bed was formulated on the basis of a multilayer adhering model. Unsteady-state experiments using a fluidized bed of 550 mu m-silica sand, limestone, and glass beads were conducted under different operating conditions, changing the inlet concentration of aerosol fines (aluminum hydroxide), superficial gas velocity, and particle size of the fines (0.5 to 3 mu m). The multilayer adhering model provided nearly the same value as that experimentally obtained. The model was modified so as to interpret numerous separable layers, which were subjected to being removed as fine-particle agglomerates. A change in the mechanism of the elutriation of fine particles with the size of fine particles was explained. (C) 2015 Elsevier B.V. All rights reserved.	Kagoshima Univ, Dept Chem Engn, Kagoshima 8900065, Japan	Nakazato, T (reprint author), Kagoshima Univ, Dept Chem Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	nakazato@cen.kagoshima-u.ac.jp					GELDART D, 1973, POWDER TECHNOL, V7, P285, DOI 10.1016/0032-5910(73)80037-3; [Anonymous], 1994, INT CHEM ENG; Li JL, 2004, CHEM ENG SCI, V59, P2777, DOI 10.1016/j.ces.2004.02.021; Prenni AJ, 2000, AEROSOL SCI TECH, V32, P465, DOI 10.1080/027868200303588; Li JL, 2001, POWDER TECHNOL, V118, P209, DOI 10.1016/S0032-5910(00)00404-6; WEN CY, 1966, AICHE J, V12, P610, DOI 10.1002/aic.690120343; Li JL, 2001, ADV POWDER TECHNOL, V12, P187, DOI 10.1163/15685520052385014; Calvert G, 2009, ADV POWDER TECHNOL, V20, P4, DOI 10.1016/j.apt.2008.09.001; Yu AB, 1997, POWDER TECHNOL, V92, P185, DOI 10.1016/S0032-5910(97)03219-1; Clift R., 1981, PROGR FILTRATION SEP, V2, P75; DOGANOGLU Y, 1978, T I CHEM ENG-LOND, V56, P239; GHADIRI M, 1993, CHEM ENG RES DES, V71, P371; Iinoya K., 1980, GENERATION AEROSOLS, P189; Ishikura T., 2011, SPOUTED SPOUT FLUID, P175; LUA AC, 1992, J AEROSOL SCI, V23, P737; Mahmoud EA, 2006, CHEM ENG SCI, V61, P766, DOI 10.1016/j.ces.2005.08.005; MARPLE VA, 1978, AM IND HYG ASSOC J, V39, P26, DOI 10.1080/0002889778507709; MCCARTHY D, 1976, IND ENG CHEM PROC DD, V15, P266, DOI 10.1021/i260058a010; Nakazato T, 2006, ADV POWDER TECHNOL, V17, P433, DOI 10.1163/156855206777866128; Nakazato T, 2008, J CHEM ENG JPN, V41, P678, DOI 10.1252/jcej.07WE092; Patterson R.G., 1977, FLUIDIZATION THEORIE, P64; PETERS MH, 1982, AICHE J, V28, P39, DOI 10.1002/aic.690280107; Roller PS, 1930, IND ENG CHEM, V22, P1206, DOI 10.1021/ie50251a031; Taneda D, 1998, KAGAKU KOGAKU RONBUN, V24, P418; Xu J., 1998, THESIS GUNMA U JAPAN; Yamamoto T, 2013, KAGAKU KOGAKU RONBUN, V39, P60, DOI 10.1252/kakoronbunshu.39.60	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0032-5910	1873-328X		POWDER TECHNOL	Powder Technol.	APR	2015	274						289	295		10.1016/j.powtec.2015.01.017		7	Engineering, Chemical	Engineering	CE6UH	WOS:000351973200036		
J	Inoue, M; Hasegawa, A; Hosoi, Y; Sugiura, K				Inoue, Mai; Hasegawa, A.; Hosoi, Y.; Sugiura, K.			Breed, gender and age pattern of diagnosis for veterinary care in insured dogs in Japan during fiscal year 2010	PREVENTIVE VETERINARY MEDICINE			English	Article						Annual prevalence; Diagnosis; Dogs; Insurance; Japan	INSURANCE DATA; SWEDISH DOGS; MORTALITY; SWEDEN; POPULATION; SURVIVAL; TUMORS; DEATH	We calculated the annual prevalence of diseases of 18 diagnostic categories in the insured dog population in Japan, using data from 299,555 dogs insured between April 2010 and March 2011. The prevalence was highest for dermatological disorders (22.6% for females and 23.3% for males), followed by otic diseases (16.4% for females and 17.2% for males) and digestive system disorders (15.7% for females and 16.4% for males). The prevalence of cardiovascular, urinary, neoplasia and endocrine disorders, increased with age; infectious diseases and injuries showed a high prevalence at young ages, and the prevalence of musculoskeletal and respiratory disorders showed a bimodal peak at young and old ages. A large variation in prevalence was observed between breeds for dermatological, otic, digestive, ophthalmological and cardiovascular disorders. (C) 2015 Elsevier B.V. All rights reserved.	[Inoue, Mai; Hosoi, Y.; Sugiura, K.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Inoue, Mai] Anicom Insurance Inc, Shinjuku Ku, Tokyo 1610033, Japan; [Hasegawa, A.] Anicom Pafe Inc, Shinjuku Ku, Tokyo 1610033, Japan	Sugiura, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aksugiur@mail.ecc.u-tokyo.ac.jp					Egenvall A, 2000, VET REC, V146, P551; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Egenvall A, 1998, PREV VET MED, V36, P51, DOI 10.1016/S0167-5877(98)00073-7; Summers JF, 2010, VET J, V183, P39, DOI 10.1016/j.tvjl.2009.11.002; Egenvall A, 2000, VET REC, V146, P519; Egenvall A, 2000, PREV VET MED, V46, P1, DOI 10.1016/S0167-5877(00)00135-5; Bonnett BN, 1997, VET REC, V141, P40; Edney A.T.B., 1997, THESIS U LONDON LOND, P290; Edwards D S, 2003, Vet Comp Oncol, V1, P200, DOI 10.1111/j.1476-5810.2003.00025.x; Egenvall A, 2007, CAN J VET RES, V71, P292; Egenvall A, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-42; Gough A, 2010, BREED PREDISPOSITION, V2nd; JFPA, 2013, STUD DOG CAT POP JAP; MAFF, 2002, AN HYG WEEKL; Martin S., 1987, VET EPIDEMIOLOGY PRI; Nodtvedt A, 2006, ACTA VET SCAND, V48, P1, DOI 10.1186/1751-0147-48-8; Nodtvedt A, 2006, VET REC, V159, P241; Nødtvedt Ane, 2007, Vet Dermatol, V18, P309, DOI 10.1111/j.1365-3164.2007.00617.x; O'Neill Dan G, 2014, Canine Genet Epidemiol, V1, P2, DOI 10.1186/2052-6687-1-2; O'Neill DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090501; The Kennel Club, 2004, PUR DOG HLTH SURV RE; TJRK, 2008, STAT DOG CAT DIS TRE; WHO, 2011, ICD 10 INT CLASS DIS	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-5877	1873-1716		PREV VET MED	Prev. Vet. Med.	APR 1	2015	119	1-2					54	60		10.1016/j.prevetmed.2015.02.010		7	Veterinary Sciences	Veterinary Sciences	CE4IB	WOS:000351793200007		
J	Matsuzawa, T				Matsuzawa, Tetsuro			Seventy years after the end of World War II	PRIMATES			English	Editorial Material									[Matsuzawa, Tetsuro] Japan Monkey Ctr, Inuyama, Aichi, Japan; [Matsuzawa, Tetsuro] Kyoto Univ, Inuyama, Aichi, Japan	Matsuzawa, T (reprint author), Japan Monkey Ctr, Inuyama, Aichi, Japan.	matsuzawa.tetsuro.8w@kyoto-u.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	APR	2015	56	2					105	106		10.1007/s10329-015-0464-4		2	Zoology	Zoology	CE6KX	WOS:000351946400001		
J	Ohashi, G				Ohashi, Gaku			Pestle-pounding and nut-cracking by wild chimpanzees at Kpala, Liberia	PRIMATES			English	Article						Chimpanzee; Culture; Tool use; Oil palm; Nonprotected areas; Liberia; Bossou	TOOL USE; BOSSOU; BEHAVIOR; GUINEA; NIMBA	Bossou in Guinea is one of the longitudinal study sites of wild chimpanzees, and is located only a few kilometers away from the national border between Guinea and Liberia. The forests in the area spread over the national border of Guinea, and the Bossou chimpanzees have been found to use the neighboring Liberian forest. Local assistants and I started surveying these forests in Liberia, and found that additional groups of chimpanzees lived in Nimba County, Liberia. The present study reports tool use behaviors by chimpanzees living in forests of the Kpala area in Nimba County. We directly observed pestle-pounding behavior, which had been confirmed only in the Bossou group of wild chimpanzees. Moreover, we heard sounds of nut-cracking, and successfully filmed chimpanzees cracking open oil palm nuts with stones. The uniqueness of stone-tool use behaviors has been emphasized with the group of chimpanzees that have been longitudinally studied at Bossou, but the behaviors probably have a wide distribution in this area. Emigrant chimpanzees are thought to contribute to the propagation of the cultural tool-use behaviors. It is also thought that, if the distantly located groups share similar cultural behaviors, there might be genetic exchange between them. Conservation efforts should be needed not only at Bossou, but also in a wider area including nonprotected forests beyond the national border.	[Ohashi, Gaku] Chubu Univ, Kasugai, Aichi 4878501, Japan; [Ohashi, Gaku] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto 6068203, Japan; [Ohashi, Gaku] Japan Monkey Ctr, Inuyama, Aichi 4840081, Japan	Ohashi, G (reprint author), Chubu Univ, Matsumoto Cho, Kasugai, Aichi 4878501, Japan.	gaku.ohashi@gmail.com			KAKENHI, JSPS Core-to-Core Program, A. Advanced Research Networks [20002001, 24000001]; JSPS AA Science Platform Program	I wish to thank the Forestry Development Authority of Liberia, the Direction Nationale de la Recherche Scientifique et de l'Innovation Technologique and the Institut de Recherche Environnementale de Bossou in Guinea for the permissions to conduct research. Special thanks are due to all field assistants: Peter Laywee, Jonathan Yeanamie, Pascal Goumy, Jiles Dore, Henry Gberegbe, Paquile Cherif, Boniface Zogbila, Gouano Zogbila, and Vincent Toraore, for their hard work in the field. I Thank Prof. Tetsuro Matsuzawa, Prof. Gen Yamakoshi, and Prof. Yukimaru Sugiyama for their supervision, and all of the colleagues of the Bossou chimpanzee research project team for their support and advice. Prof. Gen Yamakoshi, Dr. Chris Martin, Yuka Imai, and an anonymous reviewer kindly checked an earlier version of this manuscript. This study was financially supported by KAKENHI (nos. 20002001 and 24000001), JSPS Core-to-Core Program, A. Advanced Research Networks to Prof. Tetsuro Matsuzawa, and the Grants of JSPS AA Science Platform Program to Prof. Takeshi Furuichi.	ANDERSON J R, 1983, Primates, V24, P594, DOI 10.1007/BF02381692; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; KORTLANDT A, 1986, J HUM EVOL, V15, P77, DOI 10.1016/S0047-2484(86)80068-9; BEATTY H, 1951, J MAMMAL, V32, P118; Butynski Thomas M., 2003, P5; Yamakoshi G, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P537; Goodall J., 1965, P425; Humle T, 2004, INT J PRIMATOL, V25, P551, DOI 10.1023/B:IJOP.0000023575.93644.f4; Humle T, 2011, CHIMPANZEES BOSSOU N, P361; Matsuzawa T, 2011, PRIMATOL MONOGR, P361, DOI 10.1007/978-4-431-53921-6_38; Matsuzawa T, 2011, PRIMATOL MONOGR, P1, DOI 10.1007/978-4-431-53921-6; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; McGrew WC, 1992, CHIMPANZEE MAT CULTU; Ohashi G, 2006, PAN AFRICA NEWS, V13, P10; Ohashi G, 2011, PRIMATOL MONOGR, P313, DOI 10.1007/978-4-431-53921-6_32; Ohashi G, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P439, DOI 10.1007/4-431-30248-4_26; Savage TS, 1843, BOSTON J NAT HIST, V4, P362; SUGIYAMA Y, 1994, NATURE, V367, P327, DOI 10.1038/367327a0; Yamakoshi G, 2011, PRIMATOL MONOGR, P107, DOI 10.1007/978-4-431-53921-6_11; YAMAKOSHI G, 1995, PRIMATES, V36, P489, DOI 10.1007/BF02382871; Yamakoshi G, 2011, PRIMATOL MONOGR, P35, DOI 10.1007/978-4-431-53921-6_5	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	APR	2015	56	2					113	117		10.1007/s10329-015-0459-1		5	Zoology	Zoology	CE6KX	WOS:000351946400003		
J	Kim, Y; Martinez, L; Choe, JC; Lee, DJ; Tomonaga, M				Kim, Yena; Martinez, Laura; Choe, Jae Chun; Lee, Dal-Ju; Tomonaga, Masaki			Orangutans (Pongo spp.) do not spontaneously share benefits with familiar conspecifics in a choice paradigm	PRIMATES			English	Article						Choice paradigm; Orangutans; Prosociality; Social environments	CAPUCHIN MONKEYS; BORNEAN ORANGUTANS; CHIMPANZEES HELP; CEBUS-APELLA; FOOD; PYGMAEUS; EVOLUTION; BEHAVIOR; OTHERS; COOPERATION	Humans are thought to be unique in their ability to help others voluntarily even though it may sometimes incur substantial costs. However, there are a growing number of studies showing that prosocial behaviors can be observed, not only in humans, but also among nonhuman primates that live in complex social groups. Prosociality has often been described as a major factor that facilitates group living. Nonetheless, it has seldom been explored whether solitary living primates, such as orangutans, share this propensity. In the present study, we tested four captive orangutans (Pongo abelii x pigmaeus, Pongo pigmaeus) in a simple food-delivering task. They had a choice, incurring the same cost, between getting a food reward for themselves and providing an additional food reward to a conspecific recipient passively sitting in an adjacent booth. Two orangutans played the actor's role, and two orangutans participated as recipients. The results showed that the actors did not choose to deliver food to the recipients more often than expected by chance (51.3 % on average). The control condition demonstrated that this tendency was independent of the actor's understanding of the task. These findings suggest that orangutans do not spontaneously share benefits with other conspecifics, even when the prosocial choice does not disadvantage them. This study gives the first experimental evidence that socially housed captive orangutans do not behave prosocially in a choice paradigm experiment. Further studies using a different experimental paradigm should be conducted to examine whether this tendency is consistent with previous findings hypothesizing that the enhanced prosocial propensity shown in humans and other group living primates is an evolutionary outcome of living in complex social environments.	[Kim, Yena; Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, Inuyama, Aichi 4848506, Japan; [Martinez, Laura] Natl Commiss Nat Protected Areas, Mexico City 14210, DF, Mexico; [Martinez, Laura; Choe, Jae Chun] Ewha Womans Univ, Div EcoSci, Seoul 120750, South Korea; [Choe, Jae Chun] Natl Inst Ecol, Seocheon Gun 325813, Chungcheongnam, South Korea; [Lee, Dal-Ju] Seoul Zoo, Gwacheon Si 427702, Gyeonggi Do, South Korea	Kim, Y (reprint author), Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, 41-2 Kanrin, Inuyama, Aichi 4848506, Japan.	wildlife1984@gmail.com			JSPS [23220006, 25666]; MEXT, Japan; Ewha Womans University	This research was financially supported by a JSPS Grant-in-Aid for Scientific Research (#23220006 to MT and #25666 to YK) and by the Global COE program to Kyoto University from MEXT, Japan. The work was also supported by the Ewha Global Top5 Grant 2013 of Ewha Womans University. We are thankful to the Director Jeong Rae Rho and the zookeepers at the Seoul Zoo for helping us to accomplish the experiment. We also thank the primate team of Ewha Womans University for their assistance, especially Wonhee Lee, Haneul Jang, Yoonsoo Choi, and other volunteer students. This study could not have been conducted without the support of Prof. Tetsuro Matsuzawa, Prof. Misato Hayashi, Prof. Ikuma Adachi, and the CICASP (Center for International Collaboration and Advanced Studies on Primatology) members of Primate Research Institute. We are also very grateful to Prof. Michael A Huffman, Dr. Noko Kuze, Tomoyuki Tajima, and Yuki Hanazuka for their invaluable comments. The current study adhered to the 2010 Version of the Guide for the Care and Use of Laboratory Primates by the Primate Research Institute, Kyoto University, and was approved by the Animal Welfare and Animal Care Committee of the Primate Research Institute, Kyoto University, and by the Animal Research Committee of Kyoto University. Seoul Zoo is a member of World Association of Zoos and Aquariums (WAZA), and our study was conducted according to these guidelines and the Ethical Guidelines for the Conduct of Research on Animals by Zoos and Aquariums of WAZA.	Amici F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1699; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Jaeggi AV, 2008, AM J PRIMATOL, V70, P533, DOI 10.1002/ajp.20525; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Takimoto A, 2011, ANIM COGN, V14, P715, DOI 10.1007/s10071-011-0406-5; Chalmeau R, 1997, INT J PRIMATOL, V18, P23, DOI 10.1023/A:1026337006136; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barnes JL, 2008, BIOL LETTERS, V4, P638, DOI 10.1098/rsbl.2008.0410; Burkart JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5747; Call J., 1994, Human Evolution, V9, P297, DOI 10.1007/BF02435516; Custance D.M., 2001, Animal Cognition, V4, P305, DOI 10.1007/s100710100100; Drayton LA, 2014, ANIM COGN, V17, P689, DOI 10.1007/s10071-013-0700-5; House BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103422; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Liebal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084299; POOLE TB, 1987, ZOO BIOL, V6, P315, DOI 10.1002/zoo.1430060406; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Skerry AE, 2011, ANIM COGN, V14, P647, DOI 10.1007/s10071-011-0399-0; Stoinski TS, 2003, J COMP PSYCHOL, V117, P272, DOI 10.1037/0735-7036.117.3.272; Suchak M, 2012, P NATL ACAD SCI USA, V109, P15191, DOI 10.1073/pnas.1213173109; Tajima T, 2010, PRIMATES, V51, P179, DOI 10.1007/s10329-009-0180-z; Takimoto A, 2010, ANIM COGN, V13, P249, DOI 10.1007/s10071-009-0262-8; Tan J, 2014, PREFERENCE PARADIGM; van Noordwijk MA, 2009, BEHAV ECOL SOCIOBIOL, V63, P883, DOI 10.1007/s00265-009-0728-3; Yamamoto S, 2012, SOC JUSTICE RES, V25, P233, DOI 10.1007/s11211-012-0160-0; Yamamoto S, 2009, ANIM COGN, V12, pS27, DOI 10.1007/s10071-009-0276-2; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; ZUCKER EL, 1986, DEV PSYCHOBIOL, V19, P315, DOI 10.1002/dev.420190404	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0032-8332	1610-7365		PRIMATES	Primates	APR	2015	56	2					193	200		10.1007/s10329-015-0460-8		8	Zoology	Zoology	CE6KX	WOS:000351946400011		
J	Miyazaki, C				Miyazaki, Chikashi			A COHOMOLOGICAL CRITERION FOR SPLITTING OF VECTOR BUNDLES ON MULTIPROJECTIVE SPACE	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Cohomological criterion; Castelnuovo-Mumford regularity	REGULARITY	This paper is devoted to the study of a cohomological criterion for the splitting of a vector bundle on multiprojective space. The criterion extends a result of Ballico-Malaspina towards a generalization of the Horrocks criterion on multiprojective space.	Saga Univ, Dept Math, Saga 8408502, Japan	Miyazaki, C (reprint author), Saga Univ, Dept Math, Honjo Machi 1, Saga 8408502, Japan.	miyazaki@ms.saga-u.ac.jp			Japan Society for the Promotion of Science [21540044]	This work was partially supported by Grant-in-Aid for Scientific Research (C) (21540044) Japan Society for the Promotion of Science.	Ballico E, 2011, J ALGEBRA, V345, P137, DOI 10.1016/j.jalgebra.2011.08.015; Costa L, 2005, J ALGEBRA, V294, P73, DOI 10.1016/j.jalgebra.2005.08.035; Horrocks G., 1964, P LOND MATH SOC, V14, P689; Maclagan D, 2004, J REINE ANGEW MATH, V571, P179; Mumford David, 1966, ANN MATH STUD, V59	5	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	APR	2015	143	4					1435	1440	PII S0002-9939(2014)12347-1			6	Mathematics, Applied; Mathematics	Mathematics	CE3RG	WOS:000351745400007		
J	Zhang, ZC; Furushima, T; Manabe, K; Tada, K; Sasaki, O				Zhang, Zicheng; Furushima, Tsuyoshi; Manabe, Ken-ichi; Tada, Kazuo; Sasaki, Osamu			Development of dieless metal bellows forming process with local heating technique	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART B-JOURNAL OF ENGINEERING MANUFACTURE			English	Article						Metal bellows; dieless metal bellows forming process; compression; local heating technique; bellows shape		In the traditional manufacture methods of metal bellows, such as tube bulging and hydroforming, the dies and tools are generally used. In these methods, it is very inconvenient to change the shapes of bellows because the dies and tools should be changed, which often result in extremely high cost. In this study, a novel manufacture method without any dies and tools for producing the metal bellows with various shapes was proposed. This novel method is called as dieless bellows forming process with local heating technique. The factors which affect the shape of metal bellows and the deformation behavior of metal tubes during the dieless metal bellows forming process were investigated by experiment and finite element method simulation in this study. The metal tubes (SUS304, JIS) with the dimensions of 13.8 (D)x2 (t) mm and 25 (D)x2 (t) mm were used to study the availability of the newly proposed method for manufacturing the metal bellows with different tubular materials. As a result, the metal bellows with good shapes were successfully obtained using the newly proposed method. The results also showed that the shape of the metal bellows can be easily changed by adjusting the compression ratio. It was clarified that the deformation parameters, such as compression ratio and heating length, have the significant effects on the convolution height, pitch and deformation behavior of metal tube during dieless metal bellows forming process. The suitable parameters should be chosen to manufacture the metal bellows with the expected shape.	[Zhang, Zicheng] Northeastern Univ, Sch Mech Engn & Automat, Shenyang 110819, Liaoning Provin, Peoples R China; [Zhang, Zicheng; Furushima, Tsuyoshi; Manabe, Ken-ichi; Tada, Kazuo] Tokyo Metropolitan Univ, Dept Mech Engn, Tokyo 158, Japan; [Sasaki, Osamu] Showarasenkan Seisakusyo Co Ltd, Tokyo, Japan	Zhang, ZC (reprint author), Northeastern Univ, Sch Mech Engn & Automat, 11 Lane 3,Wenhua Rd, Shenyang 110819, Liaoning Provin, Peoples R China.	zhangzicheng2004@126.com			Showarasenkan Seisakusyo Co., Ltd of Japan; Scientific Research Starting Foundation for Introduced Talents of Northeastern University, P.R. China [02080021233061]	This work was supported by the Showarasenkan Seisakusyo Co., Ltd of Japan and the Scientific Research Starting Foundation for Introduced Talents of Northeastern University, P.R. China (Grant No. 02080021233061).	Lee SK, 2000, J MANUF SYST, V19, P249, DOI 10.1016/S0278-6125(01)80004-2; Faraji G, 2009, J MATER PROCESS TECH, V209, P3431, DOI 10.1016/j.jmatprotec.2008.07.057; Shapiro Y, 2011, SENSOR ACTUAT A-PHYS, V167, P484, DOI 10.1016/j.sna.2011.03.008; Kang BH, 2007, J MATER PROCESS TECH, V194, P1, DOI 10.1016/j.jmatprotec.2007.02.029; Becht C, 2000, INT J PRES VES PIP, V77, P843, DOI 10.1016/S0308-0161(00)00078-8; Furushima T, 2012, J JSTP, V53, P251; Furushima T, 2012, P 63 JAP JOINT C TEC, P179; Koyama H, 2008, P 59 JAP JOINT C TEC, P275; Teramae T, 2000, J JAPAN SOC TECHNOLO, V41, P1118	9	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4054	2041-2975		P I MECH ENG B-J ENG	Proc. Inst. Mech. Eng. Part B-J. Eng. Manuf.	APR	2015	229	4			SI		664	669		10.1177/0954405413519610		6	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CE6OL	WOS:000351957500011		
J	Yashiro, I; Tagiri, M; Ogawa, H; Tashima, K; Takashima, S; Hara, H; Hirabayashi, M; Hochi, S				Yashiro, Ikuko; Tagiri, Miho; Ogawa, Hayato; Tashima, Kazuya; Takashima, Seiji; Hara, Hiromasa; Hirabayashi, Masumi; Hochi, Shinichi			High revivability of vitrified-warmed bovine mature oocytes after recovery culture with alpha-tocopherol	REPRODUCTION			English	Article							IN-VITRO FERTILIZATION; HIGH DEVELOPMENTAL RATES; CELL NUCLEAR TRANSFER; L-ASCORBIC-ACID; MOUSE OOCYTES; MAMMALIAN FERTILIZATION; PORCINE EMBRYOS; CRYO-TOLERANCE; L-CARNITINE; VITRIFICATION	The objective of this study was to investigate whether developmental competence of vitrified-warmed bovine oocytes can be improved by antioxidant treatment during recovery culture. In experiment 1, one of the two antioxidants (either L-ascorbic acid or alpha-tocopherol) was added as a supplement to the recovery culture medium to which postwarming oocytes were exposed for 2 h before IVF. The exposure to a-tocopherol had a positive effect on rescuing the oocytes as assessed by the blastocyst yield 8 days after the IVF (35.1-36.3% vs 19.2-25.8% in untreated postwarming oocytes). Quality of expanding blastocysts harvested on Day 8 was comparable between alpha-tocopherol-treated vitrification group and fresh control group in terms of total cell number and chromosomal ploidy. In experiment 2, level of reactive oxygen species, mitochondrial activity, and distribution of cortical granules in a-tocopherol-treated postwarming oocytes were assessed. No obvious differences from the control data were found in these parameters. However, the treatment with alpha-tocopherol increased the percentage of zygotes exhibiting normal single aster formation (90.3% vs 48.0% in untreated postwarming oocytes; 10 h post-IVF). It was concluded that alpha-tocopherol treatment of vitrified-warmed bovine mature oocytes during recovery culture can improve their revivability, as shown by the high blastocyst yield and the higher mean total cell number in the blastocysts.	[Yashiro, Ikuko; Tagiri, Miho; Takashima, Seiji; Hochi, Shinichi] Shinshu Univ, Grad Sch Sci & Technol, Nagano 3868567, Japan; [Ogawa, Hayato; Tashima, Kazuya; Takashima, Seiji; Hochi, Shinichi] Shinshu Univ, Fac Text Sci & Technol, Nagano 3868567, Japan; [Hara, Hiromasa; Hirabayashi, Masumi] Natl Inst Physiol Sci, Aichi 4448787, Japan	Hochi, S (reprint author), Shinshu Univ, Grad Sch Sci & Technol, Nagano 3868567, Japan.	shochi@shinshu-u.ac.jp			Japan Society for the Promotion of Science [24580407]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 24580407 to S Hochi).	Hara H, 2012, THERIOGENOLOGY, V77, P908, DOI 10.1016/j.theriogenology.2011.09.018; Schatten H, 2009, MOL HUM REPROD, V15, P531, DOI 10.1093/molehr/gap049; Fabbri R, 2000, MOL CELL ENDOCRINOL, V169, P39, DOI 10.1016/S0303-7207(00)00349-X; Hwang IS, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109769; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1<53::AID-MRD6>3.0.CO;2-V; Chen SU, 2003, MOL CELL ENDOCRINOL, V202, P101, DOI 10.1016/S0303-7207(03)00070-4; FUKU E, 1995, CRYOBIOLOGY, V32, P139, DOI 10.1006/cryo.1995.1013; Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; Zhao XM, 2011, FERTIL STERIL, V95, P2786, DOI 10.1016/j.fertnstert.2011.04.089; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Tai WY, 2010, J PHYS CHEM B, V114, P15642, DOI 10.1021/jp1014719; Goud AP, 2005, REPROD BIOMED ONLINE, V11, P43; Larman MG, 2006, REPRODUCTION, V131, P53, DOI 10.1530/rep.1.00878; QUINN P, 1982, J REPROD FERTIL, V66, P161; Coticchio G, 2009, REPROD BIOMED ONLINE, V19, P29; Chankitisakul V, 2013, THERIOGENOLOGY, V79, P590, DOI 10.1016/j.theriogenology.2012.11.011; Hara H, 2011, J REPROD DEVELOP, V57, P428, DOI 10.1262/jrd.10-167N; Papis K, 2000, THERIOGENOLOGY, V54, P651, DOI 10.1016/S0093-691X(00)00380-0; Olson SE, 2000, BIOL REPROD, V62, P248, DOI 10.1095/biolreprod62.2.248; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; CARROLL J, 1990, J REPROD FERTIL, V90, P547; Gutnisky C, 2013, REPROD FERT DEVELOP, V25, P1026, DOI 10.1071/RD12193; Hara H, 2014, ZYGOTE, V22, P476, DOI 10.1017/S0967199413000105; Hossein MS, 2007, ANIM REPROD SCI, V100, P107, DOI 10.1016/j.anireprosci.2006.06.013; Hwang IS, 2014, BIOMED RES INT, DOI 10.1155/2014/570647; Hyttel P, 2000, MOL REPROD DEV, V56, P80, DOI 10.1002/(SICI)1098-2795(200005)56:1<80::AID-MRD10>3.3.CO;2-L; Jeong YW, 2006, THERIOGENOLOGY, V66, P2104, DOI 10.1016/j.theriogenology.2006.06.007; Kohaya N, 2011, J REPROD DEVELOP, V57, P675, DOI 10.1262/jrd.11-066H; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300; Ledda S, 2001, THERIOGENOLOGY, V55, P1359, DOI 10.1016/S0093-691X(01)00487-3; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Martino NA, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-27; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; Navara CS, 1996, P NATL ACAD SCI USA, V93, P5384, DOI 10.1073/pnas.93.11.5384; Phongnimitr T, 2013, ANIM SCI J, V84, P719, DOI 10.1111/asj.12067; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; Yoshizawa Midori, 1998, Journal of Reproduction and Development, V44, P59, DOI 10.1262/jrd.44.59	38	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	APR	2015	149	4					347	355		10.1530/REP-14-0594		9	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	CE6AX	WOS:000351919100009		
J	Maruko, I; Iida, T; Oyamada, H; Sugano, Y; Saito, M; Sekiryu, T				Maruko, Ichiro; Iida, Tomohiro; Oyamada, Hiroshi; Sugano, Yukinori; Saito, Masaaki; Sekiryu, Tetsuju			SUBFOVEAL CHOROIDAL THICKNESS CHANGES AFTER INTRAVITREAL RANIBIZUMAB AND PHOTODYNAMIC THERAPY FOR RETINAL ANGIOMATOUS PROLIFERATION	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						choroidal thickness; retinal angiomatous proliferation; intravitreal ranibizumab; photodynamic therapy; recurrence; EDI-OCT	BEVACIZUMAB AVASTIN TREATMENT; OPTICAL COHERENCE TOMOGRAPHY; MACULAR DEGENERATION; SURGICAL ABLATION; TYPE-3 NEOVASCULARIZATION; VASCULOPATHY; TRIAMCINOLONE; VERTEPORFIN	Purpose: To evaluate the subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in patients with retinal angiomatous proliferation. Methods: Subfoveal choroidal thickness was retrospectively measured using enhanced depth imaging optical coherence tomography. Results: Thirty-two eyes of 26 patients (average age, 82 years) with newly diagnosed retinal angiomatous proliferation were examined. All eyes were treated with intravitreal ranibizumab and photodynamic therapy. In 14 eyes without recurrence over 6-month follow-up (average, 8.4 months), mean subfoveal choroidal thickness decreased from 198 mu m at baseline to 169 mu m (85.4%) at 3 months and to 173 mu m (87.3%) at 6 months after treatment (P <0.01 compared with baseline, respectively). In 18 eyes with recurrence over 3-month follow-up, mean subfoveal choroidal thickness decreased from 199 mu m at baseline to 171 mu m (85.9%) at 3 months after treatment and 176 mu m (88.4%) even at recurrence (P <0.01 compared with baseline, respectively). Conclusion: Subfoveal choroidal thickness after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation decreased to approximately 85% compared with baseline by 3 months after treatment, and the trend persisted in eyes with or without recurrence during follow-up. This may indicate that choroidal changes are not associated with recurrence in retinal angiomatous proliferation.	[Maruko, Ichiro; Oyamada, Hiroshi; Sugano, Yukinori; Saito, Masaaki; Sekiryu, Tetsuju] Fukushima Med Univ, Dept Ophthalmol, Sch Med, Fukushima, Japan; [Maruko, Ichiro; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Sch Med, Tokyo 1628666, Japan	Maruko, I (reprint author), Tokyo Womens Med Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	imaruko@twmu.ac.jp					Meyerle CB, 2007, RETINA-J RET VIT DIS, V27, P451, DOI 10.1097/IAE.0b013e318030ea80; Gross NE, 2005, RETINA-J RET VIT DIS, V25, P713, DOI 10.1097/00006982-200509000-00005; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Saito M, 2012, AM J OPHTHALMOL, V153, P504, DOI 10.1016/j.ajo.2011.08.038; Kuroiwa S, 2003, RETINA-J RET VIT DIS, V23, P417, DOI 10.1097/00006982-200306000-00027; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Maruko I, 2013, AM J OPHTHALMOL, V156, P548, DOI 10.1016/j.ajo.2013.03.041; Silva RM, 2007, GRAEF ARCH CLIN EXP, V245, P1131, DOI 10.1007/s00417-006-0532-y; Bottoni F, 2005, ARCH OPHTHALMOL-CHIC, V123, P1644, DOI 10.1001/archopht.123.12.1644; Sakimoto S, 2005, AM J OPHTHALMOL, V139, P917, DOI 10.1016/j.ajo.2004.10.046; Boscia F, 2004, AM J OPHTHALMOL, V138, P1077, DOI 10.1016/j.ajo.2004.06.072; Hemeida TS, 2010, BRIT J OPHTHALMOL, V94, P701, DOI 10.1136/bjo.2009.167627; Maruko I, 2011, AM J OPHTHALMOL, V151, P594, DOI 10.1016/j.ajo.2010.10.030; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Konstantinidis L, 2009, GRAEF ARCH CLIN EXP, V247, P1165, DOI 10.1007/s00417-009-1089-3; Rouvas AA, 2009, RETINA-J RET VIT DIS, V29, P536, DOI 10.1097/IAE.0b013e318196b1de; Ogasawara Masashi, 2012, Nippon Ganka Gakkai Zasshi, V116, P643; Lee MY, 2011, RETINA-J RET VIT DIS, V31, P65, DOI 10.1097/IAE.0b013e3181e586e3; Ghazi NG, 2008, RETINA-J RET VIT DIS, V28, P689, DOI 10.1097/IAE.0b013e318162d982; Freund KB, 2008, RETINA-J RET VIT DIS, V28, P201, DOI 10.1097/IAE.0b013e3181669504; Yamazaki T, 2012, OPHTHALMOLOGY, V119, P1621, DOI 10.1016/j.ophtha.2012.02.022; Bashshur ZF, 2008, AM J OPHTHALMOL, V145, P249, DOI 10.1016/j.ajo.2007.09.031; Yannuzzi LA, 2008, RETINA-J RET VIT DIS, V28, P375, DOI 10.1097/IAE.0b013e3181619c55; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Kim JH, 2013, AM J OPHTHALMOL, V155, P743, DOI 10.1016/j.ajo.2012.11.001; Yamazaki T, 2014, RETINA-J RET VIT DIS, V34, P1316, DOI 10.1097/IAE.0000000000000086; Borrillo JL, 2003, ARCH OPHTHALMOL-CHIC, V121, P558, DOI 10.1001/archopht.121.4.558; Boscia F, 2006, GRAEF ARCH CLIN EXP, V244, P1224, DOI 10.1007/s00417-005-0205-2; Costagliola C, 2007, AM J OPHTHALMOL, V144, P449, DOI 10.1016/j.ajo.2007.05.025; Joeres S, 2007, GRAEF ARCH CLIN EXP, V245, P1597, DOI 10.1007/s00417-007-0580-y; Johnson TM, 2006, RETINA-J RET VIT DIS, V26, P765, DOI 10.1097/01.iae.0000244264.98642.af; Krieglstein TR, 2006, BRIT J OPHTHALMOL, V90, P1357, DOI 10.1136/bjo.2006.092536; Lai TYY, 2007, GRAEF ARCH CLIN EXP, V245, P1877, DOI 10.1007/s00417-007-0679-1; Lo Giudice G, 2009, RETINA-J RET VIT DIS, V29, P949, DOI 10.1097/IAE.0b013e3181af106d; Saito M, 2010, AM J OPHTHALMOL, V149, P472, DOI 10.1016/j.ajo.2009.09.016; Saito M, 2008, AM J OPHTHALMOL, V146, P935, DOI 10.1016/j.ajo.2008.06.033; Shiragami C, 2007, RETINA-J RET VIT DIS, V27, P198, DOI 10.1097/01.iae.0000224938.61915.f0; Slakter JS, 2000, OPHTHALMOLOGY, V107, P742, DOI 10.1016/S0161-6420(00)00009-9; Yannuzzi LA, 2000, RETINA, V21, P416	39	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	APR	2015	35	4					648	654				7	Ophthalmology	Ophthalmology	CE5OL	WOS:000351884900011		
J	Shiragami, C; Fukuda, K; Yamaji, H; Morita, M; Shiraga, F				Shiragami, Chieko; Fukuda, Kouki; Yamaji, Hidetaka; Morita, Misako; Shiraga, Fumio			A METHOD TO DECREASE THE FREQUENCY OF UNINTENTIONAL SLIPPAGE AFTER VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						retinal slippage; rhegmatogenous retinal detachment; vitrectomy; fundus autofluorescence; face-down position; binocular diplopia; vertical deviation; extorsion; hyperautofluorescent line; lipofuscin	MACULAR TRANSLOCATION; AUTOFLUORESCENCE; MANAGEMENT	Purpose: To investigate a method for preventing retinal slippage after standard vitrectomy for rhegmatogenous retinal detachment. Methods: Eighty six eyes with bullous rhegmatogenous retinal detachment underwent successful standard vitrectomy. Patients were divided into 2 groups. In Group 1, 44 patients started face-down positioning at approximately 10 minutes after the end of the surgery. In Group 2, 42 patients started face-down positioning immediately at the end of the surgery. Postoperative retinal slippage was determined by fundus autofluorescence at 1 month postoperatively. Statistical analysis examined several factors to determine the association between the start time of the face-down positioning and retinal slippage. Results: Retinal slippage occurred in 63.6% of Group 1 and in 24.0% of Group 2 patients. This difference was statistically significant (P = 0.004, Fisher's exact probability test). Both the extent of retinal slippage (P = 0.029) and the face-down position (P < 0.001) were significantly associated with the retinal slippage. Conclusion: Earlier implementation of face-down positioning may prevent retinal slippage after surgery in eyes with rhegmatogenous retinal detachment treated by standard vitrectomy.	[Shiragami, Chieko; Fukuda, Kouki; Yamaji, Hidetaka; Morita, Misako] Kagawa Univ, Fac Med, Dept Ophthalmol, Miki, Kagawa 7610793, Japan; [Shiraga, Fumio] Okayama Univ, Sch Med, Dept Ophthalmol, Okayama 7008530, Japan	Shiragami, C (reprint author), Kagawa Univ, Sch Med, Dept Ophthalmol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	chappi@kms.ac.jp					Stangos AN, 2004, AM J OPHTHALMOL, V138, P952, DOI 10.1016/j.ajo.2004.06.086; Spaide R, 2008, RETINA-J RET VIT DIS, V28, P5, DOI 10.1097/IAE.0b013e318158eca4; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Codenotti M, 2013, RETINA-J RET VIT DIS, V33, P349, DOI 10.1097/IAE.0b013e318263d180; COMARATTA MR, 1991, CURR OPIN OPHTHALMOL, V2, P291; GUYTON DL, 1988, GRAEF ARCH CLIN EXP, V226, P241, DOI 10.1007/BF02181189; Guyton DL, 1983, AM ORTHOPT J, V33, P7; Holgado S, 2006, OPHTHALMOLOGY, V113, P63, DOI 10.1016/j.ophtha.2005.09.022; Ohtsuki H, 2004, AM J OPHTHALMOL, V137, P125, DOI 10.1016/S0002-9394(03)00846-8; Pandya VB, 2012, CLIN EXP OPHTHALMOL, V40, P88, DOI 10.1111/j.1442-9071.2011.02666.x; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; SEN DK, 1980, BRIT J OPHTHALMOL, V64, P354, DOI 10.1136/bjo.64.5.354; Shiragami C, 2010, OPHTHALMOLOGY, V117, P86, DOI 10.1016/j.ophtha.2009.06.025; von Noorden G K, 1984, J Pediatr Ophthalmol Strabismus, V21, P126	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	APR	2015	35	4					758	763				6	Ophthalmology	Ophthalmology	CE5OL	WOS:000351884900026		
J	Nagai, N; Izumi-Nagai, K; Suzuki, M; Shinoda, H; Koto, T; Uchida, A; Mochimaru, H; Tomita, Y; Miyake, S; Kobayashi, S; Sasaki, M; Tsubota, K; Ozawa, Y				Nagai, Norihiro; Izumi-Nagai, Kanako; Suzuki, Misa; Shinoda, Hajime; Koto, Takashi; Uchida, Atsuro; Mochimaru, Hiroshi; Tomita, Yohei; Miyake, Seiji; Kobayashi, Saori; Sasaki, Mariko; Tsubota, Kazuo; Ozawa, Yoko			ASSOCIATION OF MACULAR PIGMENT OPTICAL DENSITY WITH SERUM CONCENTRATION OF OXIDIZED LOW-DENSITY LIPOPROTEIN IN HEALTHY ADULTS	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						lutein; macular pigment; oxidized LDL	EYE DISEASE; HUMAN RETINA; COHORT-I; LUTEIN; ZEAXANTHIN; DEGENERATION; CAROTENOIDS; PLASMA; ATHEROSCLEROSIS; METABOLISM	Purpose: To analyze the association between macular pigment optical density (MPOD), which reflects lutein (L), zeaxanthin (Z), and meso-zeaxanthin (MZ) in the macula, and background characteristics. Methods: Fifty-five healthy adult volunteers were analyzed. Macular pigment optical density was measured using a heterochromatic flicker photometry technique, and serum concentrations of carotenoids and lipoproteins were by high-performance liquid chromatography and enzyme-linked immunosorbent assay, respectively. Dietary intake of nutrient was determined by a validated self-administered questionnaire on ingestion frequency. Results: Macular pigment optical density was positively correlated with serum concentrations of L and Z and dietary L intake and inversely correlated with serum oxidized low-density lipoprotein (LDL). Although MPOD decreased with age (95% confidence interval, -0.011 to -0.002; correlation coefficient, -0.269; P = 0.007), serum L/Z and dietary L intake did not. In contrast, serum oxidized LDL was positively correlated with age (95% confidence interval, 0.69-2.34; correlation coefficient, 0.333; P = 0.0004). After adjusting for age, sex, and oxidized LDL, serum L was positively correlated with MPOD (95% confidence interval, 0.88-1.69; P = 0.000001). After adjusting for age, sex, and serum L, serum oxidized LDL was inversely correlated with MPOD (95% confidence interval, -0.002 to -0.0004; P = 0.006). Conclusion: Macular pigment optical density was inversely correlated with serum oxidized LDL. Further study to know the impact of oxidized LDL on MPOD may be warranted.	[Nagai, Norihiro; Izumi-Nagai, Kanako; Suzuki, Misa; Miyake, Seiji; Sasaki, Mariko; Ozawa, Yoko] Keio Univ, Sch Med, Lab Retinal Cell Biol, Tokyo 1608582, Japan; [Nagai, Norihiro; Izumi-Nagai, Kanako; Suzuki, Misa; Shinoda, Hajime; Koto, Takashi; Uchida, Atsuro; Mochimaru, Hiroshi; Tomita, Yohei; Sasaki, Mariko; Tsubota, Kazuo; Ozawa, Yoko] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Miyake, Seiji; Kobayashi, Saori] Wakasa Seikatsu Corp, Kyoto, Japan	Ozawa, Y (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp			Wakasa Seikatsu Co, Ltd; Ministry of Education, Science, and Culture of Japan (MEXT); Wakasa Seikatsu Co, Ltd.	Partially supported by a grant from Wakasa Seikatsu Co, Ltd, and by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan (MEXT) to Y. Ozawa.; S. Miyake and S. Kobayashi are employees of the Wakasa Seikatsu Co, Ltd, and K. Tsubota and Y. Ozawa received research funding from Wakasa Seikatsu Co, Ltd. The remaining authors have no financial/conflicting interests to disclose.	Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Howells O, 2013, INVEST OPHTH VIS SCI, V54, P2711, DOI 10.1167/iovs.12-10957; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Sasaki M, 2012, J NUTR BIOCHEM, V23, P423, DOI 10.1016/j.jnutbio.2011.01.006; Yonekura L, 2007, MOL NUTR FOOD RES, V51, P107, DOI 10.1002/mnfr.200600145; Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431; Bhosale P, 2009, BIOCHEMISTRY-US, V48, P4798, DOI 10.1021/bi9004478; Liew SHM, 2005, INVEST OPHTH VIS SCI, V46, P4430, DOI 10.1167/iovs.05-0519; Wang W, 2007, AM J CLIN NUTR, V85, P762; Meyers KJ, 2013, INVEST OPHTH VIS SCI, V54, P2333, DOI 10.1167/iovs.12-10867; Obana A, 2008, OPHTHALMOLOGY, V115, P147, DOI 10.1016/j.ophtha.2007.02.028; Khachik F, 2002, INVEST OPHTH VIS SCI, V43, P3383; Connor WE, 2007, INVEST OPHTH VIS SCI, V48, P4226, DOI 10.1167/iovs.06-1275; Bernstein PS, 2012, INVEST OPHTH VIS SCI, V53, P6178, DOI 10.1167/iovs.12-10275; Sharpe LT, 1998, VISION RES, V38, P3233, DOI 10.1016/S0042-6989(97)00457-4; BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033; Bovier ER, 2013, NUTRIENTS, V5, P750, DOI 10.3390/nu5030750; Li BX, 2010, ARCH BIOCHEM BIOPHYS, V504, P56, DOI 10.1016/j.abb.2010.07.024; Hammond BR, 2000, INVEST OPHTH VIS SCI, V41, P1492; Ciulla TA, 2001, OPHTHALMOLOGY, V108, P730, DOI 10.1016/S0161-6420(00)00655-2; Blasiak J, 2014, BIOMED RES INT, DOI 10.1155/2014/768026; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017; McKay GJ, 2013, OPHTHALMOLOGY, V120, P1632, DOI 10.1016/j.ophtha.2013.01.030; Naruko T, 2006, ARTERIOSCL THROM VAS, V26, P877, DOI 10.1161/01.ATV.0000209886.31510.7f; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Barker FM, 2011, INVEST OPHTH VIS SCI, V52, P3934, DOI 10.1167/iovs.10-5898; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; Calvo MM, 2005, CRIT REV FOOD SCI, V45, P671, DOI 10.1080/10408690590957034; Trieschmann M, 2007, EXP EYE RES, V84, P718, DOI 10.1016/j.exer.2006.12.010; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Curran-Celentano J, 2001, AM J CLIN NUTR, V74, P796; Bone RA, 1997, EXP EYE RES, V64, P211, DOI 10.1006/exer.1996.0210; Bernstein PS, 2002, OPHTHALMOLOGY, V109, P1780, DOI 10.1016/S0161-6420(02)01173-9; Loane E, 2010, INVEST OPHTH VIS SCI, V51, P5897, DOI 10.1167/iovs.09-4878; Itabe H, 2012, J CLIN BIOCHEM NUTR, V51, P1, DOI 10.3164/jcbn.11-00020R1; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Ehara S, 2001, CIRCULATION, V103, P1955; Beatty S, 2004, ARCH BIOCHEM BIOPHYS, V430, P70, DOI 10.1016/j.abb.2004.03.015; Bone RA, 2004, ARCH BIOCHEM BIOPHYS, V430, P137, DOI 10.1016/j.abb.2004.04.003; Brodeur MR, 2005, J LIPID RES, V46, P687, DOI 10.1194/jlr.M400165-JLR200; Chew EY, 2012, OPHTHALMOLOGY, V119, P2282, DOI 10.1016/j.ophtha.2012.05.027; Dietzel M, 2011, INVEST OPHTH VIS SCI, V52, P3452, DOI 10.1167/iovs.10-6713; Hamilton CA, 1997, PHARMACOL THERAPEUT, V74, P55, DOI 10.1016/S0163-7258(96)00202-1; Kirby ML, 2011, BRIT J NUTR, V105, P1036, DOI 10.1017/S0007114510004721; Nolan JM, 2012, INVEST OPHTH VIS SCI, V53, P7855, DOI 10.1167/iovs.11-9367; Olea JL, 2012, EUR J OPHTHALMOL, V22, P404, DOI 10.5301/ejo.5000023; Qin L, 2011, INVEST OPHTH VIS SCI, V52, P5029, DOI 10.1167/iovs.11-7240; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Renzi LM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-33; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225; Sasaki S, 2003, J EPIDEMIOL, V13, pS57; Tsubono Y, 2003, J EPIDEMIOL, V13, pS125; Uno M, 2003, J NEUROL NEUROSUR PS, V74, P312, DOI 10.1136/jnnp.74.3.312; Zerbib J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007341	56	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	APR	2015	35	4					820	826				7	Ophthalmology	Ophthalmology	CE5OL	WOS:000351884900034		
J	Kanno, H; Pearse, DD; Ozawa, H; Itoi, E; Bunge, MB				Kanno, Haruo; Pearse, Damien D.; Ozawa, Hiroshi; Itoi, Eiji; Bunge, Mary Bartlett			Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus	REVIEWS IN THE NEUROSCIENCES			English	Article						axonal regeneration; clinical trial; neuroprotection; transplantation	OLFACTORY-ENSHEATHING GLIA; MESENCHYMAL STROMAL CELLS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; FUNCTIONAL RECOVERY; AXONAL REGENERATION; CHONDROITINASE ABC; PERIPHERAL-NERVE; CONTUSION INJURY; PRECURSOR CELLS	Transplantation of Schwann cells (SCs) is a promising therapeutic strategy for spinal cord repair. The introduction of SCs into the injured spinal cord has been shown to reduce tissue loss, promote axonal regeneration, and facilitate myelination of axons for improved sensorimotor function. The pathology of spinal cord injury (SCI) comprises multiple processes characterized by extensive cell death, development of a milieu inhibitory to growth, and glial scar formation, which together limits axonal regeneration. Many studies have suggested that significant functional recovery following SCI will not be possible with a single therapeutic strategy. The use of additional approaches with SC transplantation may be needed for successful axonal regeneration and sufficient functional recovery after SCI. An example of such a combination strategy with SC transplantation has been the complementary administration of neuroprotective agents/growth factors, which improves the effect of SCs after SCI. Suspension of SCs in bioactive matrices can also enhance transplanted SC survival and increase their capacity for supporting axonal regeneration in the injured spinal cord. Inhibition of glial scar formation produces a more permissive interface between the SC transplant and host spinal cord for axonal growth. Co-transplantation of SCs and other types of cells such as olfactory ensheathing cells, bone marrow mesenchymal stromal cells, and neural stem cells can be a more effective therapy than transplantation of SCs alone following SCI. This article reviews some of the evidence supporting the combination of SC transplantation with additional strategies for SCI repair and presents a prospectus for achieving better outcomes for persons with SCI.	[Kanno, Haruo; Ozawa, Hiroshi; Itoi, Eiji] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kanno, Haruo; Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	Kanno, H (reprint author), Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kanno-h@isis.ocn.ne.jp	Pearse, Damien/D-3176-2011	Pearse, Damien/0000-0003-1783-221X	NIH [09923, 056281]; Miami Project; Buoniconti Fund; Reeve Foundation International Consortium; Uehara Memorial Foundation	We appreciate the hard work by students and fellows over the years and help from the Animal, Viral Vector, Electron Microscopy and Imaging Cores in the Miami Project. Funding was received from NIH grants (09923 and 056281) to M.B.B. and D.D.P., respectively, the Miami Project and the Buoniconti Fund, the Reeve Foundation International Consortium, and the Uehara Memorial Foundation (HK). M.B.B. is the Christine E. Lynn Distinguished Professor of Neuroscience.	Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Fraher JP, 2000, J ANAT, V196, P137; Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309; Imaizumi T, 1998, J NEUROSCI, V18, P6176; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Takami T, 2002, J NEUROSCI, V22, P6670; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Yazdani SO, 2013, CYTOTHERAPY, V15, P782, DOI 10.1016/j.jcyt.2013.03.012; Luo JA, 2011, GLIA, V59, P424, DOI 10.1002/glia.21111; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; Kumar AA, 2009, EXP CLIN TRANSPLANT, V7, P241; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Kamada T, 2011, NEUROPATHOLOGY, V31, P48, DOI 10.1111/j.1440-1789.2010.01130.x; Siriphorn A, 2010, J NEUROCHEM, V115, P864, DOI 10.1111/j.1471-4159.2010.06770.x; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277; Shand J, 2012, PEDIATRICS, V130, P972, DOI 10.1542/peds.2012-2482; Zhang XB, 2007, J NEUROTRAUM, V24, P1863, DOI 10.1089/neu.2007.0334; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036; Zhang JF, 2011, NEUROSCI LETT, V497, P128, DOI 10.1016/j.neulet.2011.04.045; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Plant GW, 2001, MOL CELL NEUROSCI, V17, P471, DOI 10.1006/mcne.2000.0948; Schaal SM, 2007, CELL TRANSPLANT, V16, P207; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Lipson AC, 2003, EXP NEUROL, V180, P167, DOI 10.1016/S0014-4486(02)00058-4; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Nagoshi N, 2011, GLIA, V59, P771, DOI 10.1002/glia.21150; Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Enzmann GU, 2006, J NEUROTRAUM, V23, P479, DOI 10.1089/neu.2006.23.479; Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2; Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041; Bunge MB, 2008, J SPINAL CORD MED, V31, P262; BLAKEMORE WF, 1985, J NEUROL SCI, V70, P207, DOI 10.1016/0022-510X(85)90088-7; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; Bunge Mary Bartlett, 2012, Handb Clin Neurol, V109, P523, DOI 10.1016/B978-0-444-52137-8.00032-2; Bunge MB, 2003, J REHABIL RES DEV, V40, P55; Casella G T, 1996, Glia, V17, P327, DOI 10.1002/(SICI)1098-1136(199608)17:4<327::AID-GLIA7>3.0.CO;2-W; Enomoto M, 2013, EXP NEUROL, V248, P170, DOI 10.1016/j.expneurol.2013.06.013; Flora G, 2013, CELL TRANSPLANT, V22, P2203, DOI 10.3727/096368912X658872; Fouad K, 2009, SPINAL CORD, V47, P727, DOI 10.1038/sc.2009.10; Golden KL, 2007, EXP NEUROL, V207, P203, DOI 10.1016/j.expneurol.2007.06.023; Guest J, 2013, CURR OPIN ORGAN TRAN, V18, P682, DOI 10.1097/MOT.0000000000000026; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hill CE, 2010, J NEUROTRAUM, V27, P1685, DOI 10.1089/neu.2010.1272; Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; LEVI ADO, 1995, J NEUROSCI, V15, P1329; Li Y, 2003, J NEUROSCI, V23, P727; Liu QY, 2012, STEM CELL TRANSL MED, V1, P266, DOI 10.5966/sctm.2011-0042; Matsuse D, 2010, J NEUROPATH EXP NEUR, V69, P973, DOI 10.1097/NEN.0b013e3181eff6dc; Niapour A, 2012, CELL TRANSPLANT, V21, P827, DOI 10.3727/096368911X593163; Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809; Pearse DD, 2004, J NEUROTRAUM, V21, P1223, DOI 10.1089/0897715041953876; Pourheydar B, 2012, CELL J, V13, P213; Ramon-Cueto A, 2001, RESTOR NEUROL NEUROS, V19, P149; Rossi SL, 2009, CURR OPIN BIOTECH, V20, P552, DOI 10.1016/j.copbio.2009.09.008; RUTKOWSKI JL, 1995, NAT MED, V1, P80, DOI 10.1038/nm0195-80; Saberi H, 2011, J NEUROSURG-SPINE, V15, P515, DOI 10.3171/2011.6.SPINE10917; Suzuki Y, 2014, RESTOR NEUROL NEUROS, V32, P473, DOI 10.3233/RNN-130363; Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8; URFER R, 1994, EMBO J, V13, P5896; Wang HB, 2012, ARCH MED SCI, V8, P563, DOI 10.5114/aoms.2012.29412; Wang ZH, 1996, ACTA NEUROPATHOL, V91, P180; Williams R.R., 2014, CELL TRANSPLANT; Zhou XH, 2012, CELL TRANSPLANT, V21, pS39, DOI 10.3727/096368912X633752	86	4	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	APR	2015	26	2					121	128		10.1515/revneuro-2014-0068		8	Neurosciences	Neurosciences & Neurology	CE6CW	WOS:000351924800001		
